Mitch Report

date generated: 2024-10-30

Background

Mitch performs unidimensional and multidimensional gene set enrichment analysis. The concept behind this dates to work by Cox and Mann (https://doi.org/10.1186/1471-2105-13-S16-S12). This implementation is suited to R based workflows of multi-omics datasets. This software was developed by Antony Kaspi and Mark Ziemann. Learn more about Mitch at the website: https://github.com/markziemann/Mitch

Input profiles

Here is the first few lines of the input profile.

The profiling data being passed to mitch

	d1	d2	d3	d4	d5	d6
5_8S_rRNA	-0.6891322	-2.4785772	0.1666742	-1.6447949	-2.3372298	1.6789113
A1BG	0.2163555	-1.7542511	-1.0533748	0.7426509	0.1044466	-0.4773423
A1BG-AS1	-0.4425330	-1.0734377	-0.2260162	0.1261025	-0.3112331	0.3881952
A1CF	-0.5935004	0.5521424	1.1773907	-0.0456164	-0.9717789	-0.3059749
A2M	1.2986453	1.6603819	1.7931937	-1.6576434	-2.6139611	0.6340902
A2M-AS1	0.4479278	1.3818491	0.7455551	-2.2029246	-2.4240570	-1.0223656

Here are some metrics about the input data profile:

Profiling data metrics

	Profile metrics
num_genes_in_profile	21032
duplicated_genes_present	0
num_profile_genes_in_sets	13675
num_profile_genes_not_in_sets	7357

Here is a plot of the input profiles. Note the dynamic ranges.

Here is the contour plot of the profile including all detected genes.

Input genesets

Here are some metrics about the gene sets used:

GMT file of genesets:

Gene set metrics

	Gene sets metrics
num_genesets	10454
num_genesets_excluded	4003
num_genesets_included	6451

Interactive enrichment scatterplot

All sets with FDR<0.05. Try hovering over the points.

Top N sets irrespective of FDR. Try hovering over the points.

A heatmap of S values for top results

A plot of effect size versus significance

Significance is the -log2(p.adjustMANOVA) and effect size is the s.dist which is the hypotenuse of the s scores.

Results table

Top N= 50 gene sets

set	setSize	pMANOVA	p.adjustMANOVA	s.dist	s.crp_t0_adj	s.crp_eos_adj	s.crp_pod1_adj	s.avb_t0_adj	s.avb_eos_adj	s.avb_pod1_adj	p.crp_t0_adj	p.crp_eos_adj	p.crp_pod1_adj	p.avb_t0_adj	p.avb_eos_adj	p.avb_pod1_adj
GOBP ANTIGEN PROCESSING AND PRESENTATION ENDOGENOUS LIPID ANTIGEN VIA MHC CLASS IB	5	1.60e-06	1.62e-05	2.05	-0.8200	-0.94500	-0.96200	-0.5590	-0.83500	-0.8460	0.001500	2.52e-04	1.95e-04	3.04e-02	1.23e-03	0.001060
GOMF LIPID ANTIGEN BINDING	5	1.60e-06	1.62e-05	2.05	-0.8200	-0.94500	-0.96200	-0.5590	-0.83500	-0.8460	0.001500	2.52e-04	1.95e-04	3.04e-02	1.23e-03	0.001060
GOMF INTERLEUKIN 1 RECEPTOR ACTIVITY	5	1.50e-04	9.70e-04	1.60	-0.6120	-0.21600	0.85600	-0.6380	-0.95000	0.3280	0.017700	4.03e-01	9.18e-04	1.35e-02	2.35e-04	0.204000
GOMF OLIGOSACCHARYL TRANSFERASE ACTIVITY	5	8.51e-05	5.86e-04	1.56	-0.8500	-0.77300	0.31400	0.0279	-0.66400	0.7490	0.001000	2.75e-03	2.24e-01	9.14e-01	1.01e-02	0.003730
GOMF UNMETHYLATED CPG BINDING	10	3.38e-06	3.20e-05	1.45	0.6480	0.69900	0.36600	0.8640	0.56400	0.0763	0.000390	1.28e-04	4.53e-02	2.20e-06	2.02e-03	0.676000
GOBP ANTIGEN PROCESSING AND PRESENTATION OF LIPID ANTIGEN VIA MHC CLASS IB	7	1.41e-04	9.18e-04	1.42	-0.6810	-0.68100	-0.57400	-0.2840	-0.68800	-0.4530	0.001800	1.79e-03	8.53e-03	1.93e-01	1.61e-03	0.038000
GOCC SARCOPLASMIC RETICULUM LUMEN	5	2.44e-04	1.50e-03	1.40	-0.2950	-0.26100	0.78000	0.4470	-0.42600	0.9090	0.253000	3.13e-01	2.51e-03	8.37e-02	9.90e-02	0.000428
GOMF GUANYLATE CYCLASE ACTIVITY	5	5.15e-03	2.01e-02	1.37	-0.5090	-0.66100	0.31200	-0.4640	-0.59100	0.7270	0.048700	1.05e-02	2.28e-01	7.23e-02	2.21e-02	0.004860
GOCC SIGNAL PEPTIDASE COMPLEX	5	2.96e-03	1.28e-02	1.34	-0.7340	-0.75600	-0.33300	-0.3380	-0.43000	0.5270	0.004500	3.41e-03	1.97e-01	1.91e-01	9.59e-02	0.041100
GOMF SERINE TYPE CARBOXYPEPTIDASE ACTIVITY	5	6.20e-04	3.37e-03	1.34	-0.8300	-0.67100	0.17100	-0.7430	-0.16000	0.2060	0.001300	9.31e-03	5.07e-01	4.02e-03	5.36e-01	0.425000
GOBP SIALYLATION	6	3.67e-03	1.52e-02	1.33	0.3440	0.49400	0.57000	0.6640	0.46000	0.6470	0.145000	3.62e-02	1.57e-02	4.86e-03	5.10e-02	0.006030
GOMF LARGE RIBOSOMAL SUBUNIT RRNA BINDING	5	1.09e-02	3.70e-02	1.31	-0.3890	-0.93800	-0.74800	-0.0977	-0.12600	-0.3360	0.132000	2.82e-04	3.77e-03	7.05e-01	6.24e-01	0.193000
GOMF NEUROTROPHIN BINDING	7	6.72e-04	3.62e-03	1.31	-0.1030	-0.25300	0.76500	-0.4810	-0.79200	0.4340	0.638000	2.47e-01	4.53e-04	2.76e-02	2.86e-04	0.046900
GOBP GANGLIOSIDE CATABOLIC PROCESS	5	2.11e-03	9.62e-03	1.30	-0.8370	-0.66400	-0.35300	-0.5250	0.05580	-0.3900	0.001190	1.01e-02	1.72e-01	4.20e-02	8.29e-01	0.131000
GOMF C PALMITOYLTRANSFERASE ACTIVITY	5	1.99e-02	5.91e-02	1.30	-0.4560	-0.47300	0.28100	-0.4810	-0.84000	0.4970	0.077500	6.69e-02	2.77e-01	6.26e-02	1.14e-03	0.054500
GOBP VIRAL TRANSLATIONAL TERMINATION REINITIATION	5	1.11e-02	3.75e-02	1.30	-0.2740	-0.81400	-0.75800	0.0841	-0.24100	-0.5570	0.289000	1.63e-03	3.34e-03	7.45e-01	3.50e-01	0.030900
GOMF NERVE GROWTH FACTOR BINDING	6	3.46e-03	1.45e-02	1.29	-0.1580	-0.18400	0.78500	-0.4800	-0.76600	0.4260	0.503000	4.34e-01	8.70e-04	4.17e-02	1.15e-03	0.070900
GOCC EUKARYOTIC TRANSLATION INITIATION FACTOR 3 COMPLEX EIF3M	7	2.24e-03	1.01e-02	1.29	-0.4700	-0.83100	-0.72700	-0.1270	-0.25700	-0.3600	0.031100	1.41e-04	8.59e-04	5.62e-01	2.39e-01	0.098700
GOMF PHOSPHATIDYLETHANOLAMINE FLIPPASE ACTIVITY	5	6.44e-03	2.41e-02	1.28	0.3080	0.61600	0.69000	0.4820	-0.14800	0.6620	0.233000	1.70e-02	7.51e-03	6.19e-02	5.66e-01	0.010300
GOBP CANNABINOID SIGNALING PATHWAY	6	3.79e-03	1.56e-02	1.28	-0.2150	-0.56500	-0.00637	-0.6120	-0.92600	-0.1830	0.362000	1.66e-02	9.78e-01	9.39e-03	8.60e-05	0.437000
GOBP SHORT CHAIN FATTY ACID CATABOLIC PROCESS	6	8.54e-04	4.46e-03	1.27	-0.3430	-0.71300	-0.70800	0.0958	0.43900	-0.5290	0.145000	2.50e-03	2.68e-03	6.84e-01	6.28e-02	0.024700
GOCC IGA IMMUNOGLOBULIN COMPLEX	7	3.99e-05	2.98e-04	1.26	-0.2410	-0.87500	-0.04020	0.1710	-0.75500	0.4180	0.270000	6.07e-05	8.54e-01	4.33e-01	5.45e-04	0.055800
GOMF PROTEIN PHOSPHATASE 2B BINDING	5	4.20e-03	1.70e-02	1.26	0.0595	0.29900	0.48600	0.4950	0.63300	0.7860	0.818000	2.47e-01	5.98e-02	5.55e-02	1.42e-02	0.002340
GOCC PROTEASOME CORE COMPLEX ALPHA SUBUNIT COMPLEX	7	7.39e-05	5.19e-04	1.25	-0.6100	-0.75000	-0.22900	-0.3980	-0.13300	0.6280	0.005170	5.88e-04	2.95e-01	6.85e-02	5.42e-01	0.004020
GOMF PRIMARY AMINE OXIDASE ACTIVITY	6	1.76e-05	1.41e-04	1.24	0.5150	0.20900	-0.33600	-0.6810	-0.06960	-0.8100	0.028900	3.75e-01	1.54e-01	3.86e-03	7.68e-01	0.000586
GOBP GLUCURONATE CATABOLIC PROCESS TO XYLULOSE 5 PHOSPHATE	5	4.31e-03	1.73e-02	1.24	-0.5650	-0.59900	-0.71900	0.0257	0.55100	-0.2090	0.028800	2.03e-02	5.37e-03	9.21e-01	3.28e-02	0.418000
GOCC BOX C D RNP COMPLEX	5	9.57e-03	3.31e-02	1.23	0.0616	-0.77700	-0.72100	0.0224	-0.18100	-0.6000	0.811000	2.61e-03	5.24e-03	9.31e-01	4.84e-01	0.020300
GOBP NEGATIVE REGULATION OF FIBROBLAST APOPTOTIC PROCESS	6	1.89e-03	8.75e-03	1.23	-0.1200	0.37300	0.68200	0.3880	0.24600	0.8210	0.610000	1.14e-01	3.83e-03	9.99e-02	2.97e-01	0.000493
GOBP REGULATION OF COMPLEMENT DEPENDENT CYTOTOXICITY	8	8.25e-04	4.32e-03	1.22	0.2250	0.67500	0.77400	-0.0418	-0.15600	0.6020	0.270000	9.43e-04	1.51e-04	8.38e-01	4.45e-01	0.003190
GOBP REGULATION OF CONNECTIVE TISSUE REPLACEMENT	5	1.17e-02	3.90e-02	1.21	-0.1170	0.30400	0.66400	-0.2050	-0.65900	0.6570	0.651000	2.39e-01	1.01e-02	4.28e-01	1.07e-02	0.011000
GOCC ENDOPLASMIC RETICULUM CHAPERONE COMPLEX	11	9.15e-08	1.13e-06	1.20	-0.3610	-0.52700	0.54500	0.2690	-0.58300	0.5760	0.038300	2.46e-03	1.75e-03	1.22e-01	8.12e-04	0.000938
GOBP REGULATION OF NITRIC OXIDE MEDIATED SIGNAL TRANSDUCTION	5	2.72e-03	1.19e-02	1.20	-0.3690	-0.53300	0.50100	-0.4890	-0.70600	-0.1570	0.154000	3.89e-02	5.24e-02	5.80e-02	6.26e-03	0.543000
GOMF HEMOGLOBIN BINDING	7	6.18e-03	2.33e-02	1.19	0.3350	0.33800	0.72800	0.4290	0.11400	0.6860	0.124000	1.22e-01	8.48e-04	4.93e-02	6.03e-01	0.001680
GOMF NITRITE REDUCTASE ACTIVITY	5	3.73e-02	9.45e-02	1.19	-0.3480	-0.43100	0.45400	-0.3710	-0.83700	0.2640	0.177000	9.49e-02	7.87e-02	1.51e-01	1.19e-03	0.306000
GOCC BASEMENT MEMBRANE COLLAGEN TRIMER	5	3.06e-03	1.31e-02	1.19	-0.1040	0.39300	0.39500	-0.7770	-0.64000	-0.2720	0.688000	1.28e-01	1.27e-01	2.63e-03	1.31e-02	0.293000
GOBP ESTABLISHMENT OF MITOTIC SISTER CHROMATID COHESION	7	9.66e-06	8.16e-05	1.18	-0.4760	0.49700	0.47600	0.4300	0.21800	0.6850	0.029300	2.28e-02	2.93e-02	4.90e-02	3.17e-01	0.001700
GOCC OLIGOSACCHARYLTRANSFERASE COMPLEX	13	3.61e-08	4.70e-07	1.18	-0.6170	-0.80300	-0.08950	0.1710	-0.40800	0.4090	0.000118	5.26e-07	5.76e-01	2.86e-01	1.09e-02	0.010600
GOBP SA NODE CELL TO ATRIAL CARDIAC MUSCLE CELL SIGNALING	5	2.75e-02	7.53e-02	1.18	-0.1220	0.21700	0.74100	-0.6200	-0.49800	0.3910	0.635000	4.00e-01	4.10e-03	1.64e-02	5.39e-02	0.130000
GOMF MHC CLASS I PROTEIN COMPLEX BINDING	7	5.05e-04	2.83e-03	1.18	0.5260	0.52300	0.27100	0.7000	0.06890	0.5190	0.016000	1.65e-02	2.14e-01	1.35e-03	7.52e-01	0.017300
GOBP REGULATION OF CALCIUM ION EXPORT ACROSS PLASMA MEMBRANE	5	3.87e-02	9.71e-02	1.18	-0.3570	-0.74700	0.11800	-0.3230	-0.67900	0.3500	0.167000	3.81e-03	6.48e-01	2.12e-01	8.57e-03	0.176000
GOBP NEGATIVE REGULATION OF INTERFERON ALPHA PRODUCTION	6	1.84e-02	5.52e-02	1.18	0.2790	0.53000	0.53000	0.5800	0.37200	0.5200	0.236000	2.45e-02	2.45e-02	1.39e-02	1.14e-01	0.027400
GOBP COMPLEMENT DEPENDENT CYTOTOXICITY	11	7.39e-05	5.19e-04	1.18	0.1480	0.57500	0.73000	-0.0239	-0.01370	0.7040	0.395000	9.51e-04	2.74e-05	8.91e-01	9.37e-01	0.000052
GOCC MHC CLASS II PROTEIN COMPLEX	15	1.60e-08	2.20e-07	1.17	0.0425	-0.45100	-0.67100	0.2890	0.59200	-0.5400	0.775000	2.52e-03	6.88e-06	5.28e-02	7.25e-05	0.000289
GOCC CYTOSOLIC LARGE RIBOSOMAL SUBUNIT	52	2.48e-31	2.58e-29	1.17	-0.2550	-0.87600	-0.69000	-0.0976	-0.00894	-0.2350	0.001460	7.43e-28	7.08e-18	2.24e-01	9.11e-01	0.003310
GOBP N ACYLPHOSPHATIDYLETHANOLAMINE METABOLIC PROCESS	6	2.71e-02	7.45e-02	1.17	-0.3780	-0.47400	-0.79100	-0.1280	0.10200	-0.5930	0.109000	4.43e-02	7.90e-04	5.86e-01	6.64e-01	0.011800
GOBP GANGLIOSIDE BIOSYNTHETIC PROCESS VIA LACTOSYLCERAMIDE	5	2.20e-02	6.39e-02	1.17	0.2070	0.29800	0.69900	0.4820	-0.21700	0.6840	0.424000	2.48e-01	6.78e-03	6.20e-02	4.01e-01	0.008090
GOMF MITOCHONDRION TARGETING SEQUENCE BINDING	5	4.82e-02	1.14e-01	1.17	-0.7460	-0.61400	-0.55000	-0.3240	-0.14800	0.0291	0.003850	1.73e-02	3.31e-02	2.10e-01	5.67e-01	0.910000
GOCC TOM COMPLEX	7	3.90e-03	1.60e-02	1.16	-0.4090	-0.78900	-0.63200	-0.3020	-0.26500	-0.0614	0.060800	2.99e-04	3.76e-03	1.66e-01	2.25e-01	0.778000
GOBP BRUSH BORDER ASSEMBLY	5	2.31e-02	6.62e-02	1.16	0.6320	0.20900	0.51200	0.5300	0.49700	0.3460	0.014500	4.17e-01	4.74e-02	4.02e-02	5.44e-02	0.181000
GOBP REGULATION OF ENDOPLASMIC RETICULUM TUBULAR NETWORK ORGANIZATION	6	4.38e-03	1.75e-02	1.16	-0.5550	0.00412	0.48200	-0.0906	-0.31000	0.8320	0.018600	9.86e-01	4.08e-02	7.01e-01	1.89e-01	0.000418

---

Results (complete table)

Click HERE to show results for all gene sets

Complete results

set	setSize	pMANOVA	p.adjustMANOVA	s.dist	s.crp_t0_adj	s.crp_eos_adj	s.crp_pod1_adj	s.avb_t0_adj	s.avb_eos_adj	s.avb_pod1_adj	p.crp_t0_adj	p.crp_eos_adj	p.crp_pod1_adj	p.avb_t0_adj	p.avb_eos_adj	p.avb_pod1_adj
GOBP ANTIGEN PROCESSING AND PRESENTATION ENDOGENOUS LIPID ANTIGEN VIA MHC CLASS IB	5	1.60e-06	1.62e-05	2.0500	-8.20e-01	-9.45e-01	-9.62e-01	-5.59e-01	-8.35e-01	-8.46e-01	1.50e-03	2.52e-04	1.95e-04	3.04e-02	1.23e-03	1.06e-03
GOMF LIPID ANTIGEN BINDING	5	1.60e-06	1.62e-05	2.0500	-8.20e-01	-9.45e-01	-9.62e-01	-5.59e-01	-8.35e-01	-8.46e-01	1.50e-03	2.52e-04	1.95e-04	3.04e-02	1.23e-03	1.06e-03
GOMF INTERLEUKIN 1 RECEPTOR ACTIVITY	5	1.50e-04	9.70e-04	1.6000	-6.12e-01	-2.16e-01	8.56e-01	-6.38e-01	-9.50e-01	3.28e-01	1.77e-02	4.03e-01	9.18e-04	1.35e-02	2.35e-04	2.04e-01
GOMF OLIGOSACCHARYL TRANSFERASE ACTIVITY	5	8.51e-05	5.86e-04	1.5600	-8.50e-01	-7.73e-01	3.14e-01	2.79e-02	-6.64e-01	7.49e-01	1.00e-03	2.75e-03	2.24e-01	9.14e-01	1.01e-02	3.73e-03
GOMF UNMETHYLATED CPG BINDING	10	3.38e-06	3.20e-05	1.4500	6.48e-01	6.99e-01	3.66e-01	8.64e-01	5.64e-01	7.63e-02	3.90e-04	1.28e-04	4.53e-02	2.20e-06	2.02e-03	6.76e-01
GOBP ANTIGEN PROCESSING AND PRESENTATION OF LIPID ANTIGEN VIA MHC CLASS IB	7	1.41e-04	9.18e-04	1.4200	-6.81e-01	-6.81e-01	-5.74e-01	-2.84e-01	-6.88e-01	-4.53e-01	1.80e-03	1.79e-03	8.53e-03	1.93e-01	1.61e-03	3.80e-02
GOCC SARCOPLASMIC RETICULUM LUMEN	5	2.44e-04	1.50e-03	1.4000	-2.95e-01	-2.61e-01	7.80e-01	4.47e-01	-4.26e-01	9.09e-01	2.53e-01	3.13e-01	2.51e-03	8.37e-02	9.90e-02	4.28e-04
GOMF GUANYLATE CYCLASE ACTIVITY	5	5.15e-03	2.01e-02	1.3700	-5.09e-01	-6.61e-01	3.12e-01	-4.64e-01	-5.91e-01	7.27e-01	4.87e-02	1.05e-02	2.28e-01	7.23e-02	2.21e-02	4.86e-03
GOCC SIGNAL PEPTIDASE COMPLEX	5	2.96e-03	1.28e-02	1.3400	-7.34e-01	-7.56e-01	-3.33e-01	-3.38e-01	-4.30e-01	5.27e-01	4.50e-03	3.41e-03	1.97e-01	1.91e-01	9.59e-02	4.11e-02
GOMF SERINE TYPE CARBOXYPEPTIDASE ACTIVITY	5	6.20e-04	3.37e-03	1.3400	-8.30e-01	-6.71e-01	1.71e-01	-7.43e-01	-1.60e-01	2.06e-01	1.30e-03	9.31e-03	5.07e-01	4.02e-03	5.36e-01	4.25e-01
GOBP SIALYLATION	6	3.67e-03	1.52e-02	1.3300	3.44e-01	4.94e-01	5.70e-01	6.64e-01	4.60e-01	6.47e-01	1.45e-01	3.62e-02	1.57e-02	4.86e-03	5.10e-02	6.03e-03
GOMF LARGE RIBOSOMAL SUBUNIT RRNA BINDING	5	1.09e-02	3.70e-02	1.3100	-3.89e-01	-9.38e-01	-7.48e-01	-9.77e-02	-1.26e-01	-3.36e-01	1.32e-01	2.82e-04	3.77e-03	7.05e-01	6.24e-01	1.93e-01
GOMF NEUROTROPHIN BINDING	7	6.72e-04	3.62e-03	1.3100	-1.03e-01	-2.53e-01	7.65e-01	-4.81e-01	-7.92e-01	4.34e-01	6.38e-01	2.47e-01	4.53e-04	2.76e-02	2.86e-04	4.69e-02
GOBP GANGLIOSIDE CATABOLIC PROCESS	5	2.11e-03	9.62e-03	1.3000	-8.37e-01	-6.64e-01	-3.53e-01	-5.25e-01	5.58e-02	-3.90e-01	1.19e-03	1.01e-02	1.72e-01	4.20e-02	8.29e-01	1.31e-01
GOMF C PALMITOYLTRANSFERASE ACTIVITY	5	1.99e-02	5.91e-02	1.3000	-4.56e-01	-4.73e-01	2.81e-01	-4.81e-01	-8.40e-01	4.97e-01	7.75e-02	6.69e-02	2.77e-01	6.26e-02	1.14e-03	5.45e-02
GOBP VIRAL TRANSLATIONAL TERMINATION REINITIATION	5	1.11e-02	3.75e-02	1.3000	-2.74e-01	-8.14e-01	-7.58e-01	8.41e-02	-2.41e-01	-5.57e-01	2.89e-01	1.63e-03	3.34e-03	7.45e-01	3.50e-01	3.09e-02
GOMF NERVE GROWTH FACTOR BINDING	6	3.46e-03	1.45e-02	1.2900	-1.58e-01	-1.84e-01	7.85e-01	-4.80e-01	-7.66e-01	4.26e-01	5.03e-01	4.34e-01	8.70e-04	4.17e-02	1.15e-03	7.09e-02
GOCC EUKARYOTIC TRANSLATION INITIATION FACTOR 3 COMPLEX EIF3M	7	2.24e-03	1.01e-02	1.2900	-4.70e-01	-8.31e-01	-7.27e-01	-1.27e-01	-2.57e-01	-3.60e-01	3.11e-02	1.41e-04	8.59e-04	5.62e-01	2.39e-01	9.87e-02
GOMF PHOSPHATIDYLETHANOLAMINE FLIPPASE ACTIVITY	5	6.44e-03	2.41e-02	1.2800	3.08e-01	6.16e-01	6.90e-01	4.82e-01	-1.48e-01	6.62e-01	2.33e-01	1.70e-02	7.51e-03	6.19e-02	5.66e-01	1.03e-02
GOBP CANNABINOID SIGNALING PATHWAY	6	3.79e-03	1.56e-02	1.2800	-2.15e-01	-5.65e-01	-6.37e-03	-6.12e-01	-9.26e-01	-1.83e-01	3.62e-01	1.66e-02	9.78e-01	9.39e-03	8.60e-05	4.37e-01
GOBP SHORT CHAIN FATTY ACID CATABOLIC PROCESS	6	8.54e-04	4.46e-03	1.2700	-3.43e-01	-7.13e-01	-7.08e-01	9.58e-02	4.39e-01	-5.29e-01	1.45e-01	2.50e-03	2.68e-03	6.84e-01	6.28e-02	2.47e-02
GOCC IGA IMMUNOGLOBULIN COMPLEX	7	3.99e-05	2.98e-04	1.2600	-2.41e-01	-8.75e-01	-4.02e-02	1.71e-01	-7.55e-01	4.18e-01	2.70e-01	6.07e-05	8.54e-01	4.33e-01	5.45e-04	5.58e-02
GOMF PROTEIN PHOSPHATASE 2B BINDING	5	4.20e-03	1.70e-02	1.2600	5.95e-02	2.99e-01	4.86e-01	4.95e-01	6.33e-01	7.86e-01	8.18e-01	2.47e-01	5.98e-02	5.55e-02	1.42e-02	2.34e-03
GOCC PROTEASOME CORE COMPLEX ALPHA SUBUNIT COMPLEX	7	7.39e-05	5.19e-04	1.2500	-6.10e-01	-7.50e-01	-2.29e-01	-3.98e-01	-1.33e-01	6.28e-01	5.17e-03	5.88e-04	2.95e-01	6.85e-02	5.42e-01	4.02e-03
GOMF PRIMARY AMINE OXIDASE ACTIVITY	6	1.76e-05	1.41e-04	1.2400	5.15e-01	2.09e-01	-3.36e-01	-6.81e-01	-6.96e-02	-8.10e-01	2.89e-02	3.75e-01	1.54e-01	3.86e-03	7.68e-01	5.86e-04
GOBP GLUCURONATE CATABOLIC PROCESS TO XYLULOSE 5 PHOSPHATE	5	4.31e-03	1.73e-02	1.2400	-5.65e-01	-5.99e-01	-7.19e-01	2.57e-02	5.51e-01	-2.09e-01	2.88e-02	2.03e-02	5.37e-03	9.21e-01	3.28e-02	4.18e-01
GOCC BOX C D RNP COMPLEX	5	9.57e-03	3.31e-02	1.2300	6.16e-02	-7.77e-01	-7.21e-01	2.24e-02	-1.81e-01	-6.00e-01	8.11e-01	2.61e-03	5.24e-03	9.31e-01	4.84e-01	2.03e-02
GOBP NEGATIVE REGULATION OF FIBROBLAST APOPTOTIC PROCESS	6	1.89e-03	8.75e-03	1.2300	-1.20e-01	3.73e-01	6.82e-01	3.88e-01	2.46e-01	8.21e-01	6.10e-01	1.14e-01	3.83e-03	9.99e-02	2.97e-01	4.93e-04
GOBP REGULATION OF COMPLEMENT DEPENDENT CYTOTOXICITY	8	8.25e-04	4.32e-03	1.2200	2.25e-01	6.75e-01	7.74e-01	-4.18e-02	-1.56e-01	6.02e-01	2.70e-01	9.43e-04	1.51e-04	8.38e-01	4.45e-01	3.19e-03
GOBP REGULATION OF CONNECTIVE TISSUE REPLACEMENT	5	1.17e-02	3.90e-02	1.2100	-1.17e-01	3.04e-01	6.64e-01	-2.05e-01	-6.59e-01	6.57e-01	6.51e-01	2.39e-01	1.01e-02	4.28e-01	1.07e-02	1.10e-02
GOCC ENDOPLASMIC RETICULUM CHAPERONE COMPLEX	11	9.15e-08	1.13e-06	1.2000	-3.61e-01	-5.27e-01	5.45e-01	2.69e-01	-5.83e-01	5.76e-01	3.83e-02	2.46e-03	1.75e-03	1.22e-01	8.12e-04	9.38e-04
GOBP REGULATION OF NITRIC OXIDE MEDIATED SIGNAL TRANSDUCTION	5	2.72e-03	1.19e-02	1.2000	-3.69e-01	-5.33e-01	5.01e-01	-4.89e-01	-7.06e-01	-1.57e-01	1.54e-01	3.89e-02	5.24e-02	5.80e-02	6.26e-03	5.43e-01
GOMF HEMOGLOBIN BINDING	7	6.18e-03	2.33e-02	1.1900	3.35e-01	3.38e-01	7.28e-01	4.29e-01	1.14e-01	6.86e-01	1.24e-01	1.22e-01	8.48e-04	4.93e-02	6.03e-01	1.68e-03
GOMF NITRITE REDUCTASE ACTIVITY	5	3.73e-02	9.45e-02	1.1900	-3.48e-01	-4.31e-01	4.54e-01	-3.71e-01	-8.37e-01	2.64e-01	1.77e-01	9.49e-02	7.87e-02	1.51e-01	1.19e-03	3.06e-01
GOCC BASEMENT MEMBRANE COLLAGEN TRIMER	5	3.06e-03	1.31e-02	1.1900	-1.04e-01	3.93e-01	3.95e-01	-7.77e-01	-6.40e-01	-2.72e-01	6.88e-01	1.28e-01	1.27e-01	2.63e-03	1.31e-02	2.93e-01
GOBP ESTABLISHMENT OF MITOTIC SISTER CHROMATID COHESION	7	9.66e-06	8.16e-05	1.1800	-4.76e-01	4.97e-01	4.76e-01	4.30e-01	2.18e-01	6.85e-01	2.93e-02	2.28e-02	2.93e-02	4.90e-02	3.17e-01	1.70e-03
GOCC OLIGOSACCHARYLTRANSFERASE COMPLEX	13	3.61e-08	4.70e-07	1.1800	-6.17e-01	-8.03e-01	-8.95e-02	1.71e-01	-4.08e-01	4.09e-01	1.18e-04	5.26e-07	5.76e-01	2.86e-01	1.09e-02	1.06e-02
GOBP SA NODE CELL TO ATRIAL CARDIAC MUSCLE CELL SIGNALING	5	2.75e-02	7.53e-02	1.1800	-1.22e-01	2.17e-01	7.41e-01	-6.20e-01	-4.98e-01	3.91e-01	6.35e-01	4.00e-01	4.10e-03	1.64e-02	5.39e-02	1.30e-01
GOMF MHC CLASS I PROTEIN COMPLEX BINDING	7	5.05e-04	2.83e-03	1.1800	5.26e-01	5.23e-01	2.71e-01	7.00e-01	6.89e-02	5.19e-01	1.60e-02	1.65e-02	2.14e-01	1.35e-03	7.52e-01	1.73e-02
GOBP REGULATION OF CALCIUM ION EXPORT ACROSS PLASMA MEMBRANE	5	3.87e-02	9.71e-02	1.1800	-3.57e-01	-7.47e-01	1.18e-01	-3.23e-01	-6.79e-01	3.50e-01	1.67e-01	3.81e-03	6.48e-01	2.12e-01	8.57e-03	1.76e-01
GOBP NEGATIVE REGULATION OF INTERFERON ALPHA PRODUCTION	6	1.84e-02	5.52e-02	1.1800	2.79e-01	5.30e-01	5.30e-01	5.80e-01	3.72e-01	5.20e-01	2.36e-01	2.45e-02	2.45e-02	1.39e-02	1.14e-01	2.74e-02
GOBP COMPLEMENT DEPENDENT CYTOTOXICITY	11	7.39e-05	5.19e-04	1.1800	1.48e-01	5.75e-01	7.30e-01	-2.39e-02	-1.37e-02	7.04e-01	3.95e-01	9.51e-04	2.74e-05	8.91e-01	9.37e-01	5.20e-05
GOCC MHC CLASS II PROTEIN COMPLEX	15	1.60e-08	2.20e-07	1.1700	4.25e-02	-4.51e-01	-6.71e-01	2.89e-01	5.92e-01	-5.40e-01	7.75e-01	2.52e-03	6.88e-06	5.28e-02	7.25e-05	2.89e-04
GOCC CYTOSOLIC LARGE RIBOSOMAL SUBUNIT	52	2.48e-31	2.58e-29	1.1700	-2.55e-01	-8.76e-01	-6.90e-01	-9.76e-02	-8.94e-03	-2.35e-01	1.46e-03	7.43e-28	7.08e-18	2.24e-01	9.11e-01	3.31e-03
GOBP N ACYLPHOSPHATIDYLETHANOLAMINE METABOLIC PROCESS	6	2.71e-02	7.45e-02	1.1700	-3.78e-01	-4.74e-01	-7.91e-01	-1.28e-01	1.02e-01	-5.93e-01	1.09e-01	4.43e-02	7.90e-04	5.86e-01	6.64e-01	1.18e-02
GOBP GANGLIOSIDE BIOSYNTHETIC PROCESS VIA LACTOSYLCERAMIDE	5	2.20e-02	6.39e-02	1.1700	2.07e-01	2.98e-01	6.99e-01	4.82e-01	-2.17e-01	6.84e-01	4.24e-01	2.48e-01	6.78e-03	6.20e-02	4.01e-01	8.09e-03
GOMF MITOCHONDRION TARGETING SEQUENCE BINDING	5	4.82e-02	1.14e-01	1.1700	-7.46e-01	-6.14e-01	-5.50e-01	-3.24e-01	-1.48e-01	2.91e-02	3.85e-03	1.73e-02	3.31e-02	2.10e-01	5.67e-01	9.10e-01
GOCC TOM COMPLEX	7	3.90e-03	1.60e-02	1.1600	-4.09e-01	-7.89e-01	-6.32e-01	-3.02e-01	-2.65e-01	-6.14e-02	6.08e-02	2.99e-04	3.76e-03	1.66e-01	2.25e-01	7.78e-01
GOBP BRUSH BORDER ASSEMBLY	5	2.31e-02	6.62e-02	1.1600	6.32e-01	2.09e-01	5.12e-01	5.30e-01	4.97e-01	3.46e-01	1.45e-02	4.17e-01	4.74e-02	4.02e-02	5.44e-02	1.81e-01
GOBP REGULATION OF ENDOPLASMIC RETICULUM TUBULAR NETWORK ORGANIZATION	6	4.38e-03	1.75e-02	1.1600	-5.55e-01	4.12e-03	4.82e-01	-9.06e-02	-3.10e-01	8.32e-01	1.86e-02	9.86e-01	4.08e-02	7.01e-01	1.89e-01	4.18e-04
GOBP REGULATION OF MONOATOMIC ANION TRANSMEMBRANE TRANSPORT	5	1.43e-02	4.57e-02	1.1500	1.60e-01	6.62e-01	1.34e-01	6.29e-01	4.80e-01	4.72e-01	5.34e-01	1.04e-02	6.05e-01	1.49e-02	6.31e-02	6.76e-02
GOMF RETROMER COMPLEX BINDING	9	3.01e-04	1.80e-03	1.1500	-6.82e-01	-4.22e-01	2.94e-01	-2.05e-01	-6.60e-01	3.40e-01	3.92e-04	2.83e-02	1.27e-01	2.87e-01	6.07e-04	7.70e-02
GOCC ARP2 3 PROTEIN COMPLEX	9	1.58e-04	1.02e-03	1.1500	-5.18e-01	-3.23e-01	4.73e-01	-1.11e-04	-4.79e-01	7.03e-01	7.13e-03	9.38e-02	1.40e-02	1.00e+00	1.29e-02	2.62e-04
GOBP PROTEIN FOLDING IN ENDOPLASMIC RETICULUM	11	8.33e-07	8.82e-06	1.1400	-6.88e-01	-2.46e-01	4.85e-01	2.79e-02	-4.55e-01	5.73e-01	7.82e-05	1.58e-01	5.31e-03	8.73e-01	8.91e-03	9.99e-04
GOCC F ACTIN CAPPING PROTEIN COMPLEX	7	3.01e-03	1.30e-02	1.1400	-3.61e-01	-2.26e-01	6.85e-01	-1.69e-01	-3.23e-01	7.20e-01	9.84e-02	3.00e-01	1.68e-03	4.38e-01	1.39e-01	9.77e-04
GOMF HISTONE H3K4ME H3K4ME2 H3K4ME3 DEMETHYLASE ACTIVITY	5	1.82e-02	5.49e-02	1.1400	4.20e-01	6.47e-01	3.77e-01	7.27e-01	1.14e-01	1.08e-01	1.04e-01	1.22e-02	1.44e-01	4.89e-03	6.58e-01	6.76e-01
GOBP NEGATIVE REGULATION OF BLOOD VESSEL ENDOTHELIAL CELL PROLIFERATION INVOLVED IN SPROUTING ANGIOGENESIS	5	1.46e-03	7.03e-03	1.1300	-1.78e-01	-3.33e-01	6.31e-01	-5.68e-01	-6.12e-01	-2.19e-01	4.90e-01	1.98e-01	1.46e-02	2.79e-02	1.78e-02	3.96e-01
GOBP SEQUESTERING OF IRON ION	5	5.67e-02	1.29e-01	1.1300	-5.26e-01	-7.78e-01	-4.18e-01	-2.24e-01	-1.99e-01	-3.69e-01	4.17e-02	2.60e-03	1.05e-01	3.85e-01	4.40e-01	1.53e-01
GOBP PEPTIDE ANTIGEN ASSEMBLY WITH MHC CLASS II PROTEIN COMPLEX	14	2.51e-07	2.89e-06	1.1300	4.07e-02	-4.43e-01	-6.49e-01	2.66e-01	5.70e-01	-5.15e-01	7.92e-01	4.12e-03	2.63e-05	8.51e-02	2.20e-04	8.55e-04
GOCC PROTON TRANSPORTING ATP SYNTHASE COMPLEX CATALYTIC CORE F 1	5	3.68e-02	9.36e-02	1.1300	-4.23e-01	-8.81e-01	-4.86e-01	3.15e-02	-2.81e-01	-1.84e-02	1.01e-01	6.42e-04	5.99e-02	9.03e-01	2.77e-01	9.43e-01
GOBP NEGATIVE REGULATION OF DENDRITIC CELL APOPTOTIC PROCESS	6	1.27e-02	4.16e-02	1.1300	3.72e-01	9.30e-02	7.15e-01	1.75e-01	2.58e-02	7.60e-01	1.15e-01	6.93e-01	2.41e-03	4.58e-01	9.13e-01	1.27e-03
GOBP L LEUCINE CATABOLIC PROCESS	5	1.30e-02	4.23e-02	1.1300	-4.25e-01	-5.23e-01	-8.57e-01	1.89e-02	2.80e-01	3.19e-03	9.98e-02	4.29e-02	9.08e-04	9.42e-01	2.78e-01	9.90e-01
GOBP VENTRICULAR CARDIAC MUSCLE CELL DEVELOPMENT	5	2.75e-02	7.53e-02	1.1200	-4.87e-01	-7.13e-01	7.17e-02	-2.55e-02	-7.04e-01	1.22e-01	5.96e-02	5.78e-03	7.81e-01	9.21e-01	6.42e-03	6.38e-01
GOBP POSITIVE REGULATION OF CD8 POSITIVE ALPHA BETA T CELL DIFFERENTIATION	5	1.33e-02	4.31e-02	1.1200	1.10e-01	5.53e-01	6.10e-01	3.04e-01	-2.77e-01	6.34e-01	6.69e-01	3.23e-02	1.82e-02	2.40e-01	2.83e-01	1.41e-02
GOBP FORMATION OF CYTOPLASMIC TRANSLATION INITIATION COMPLEX	15	6.59e-06	5.84e-05	1.1200	-3.90e-01	-7.40e-01	-6.59e-01	-1.33e-01	-1.51e-01	-2.90e-01	8.91e-03	6.83e-07	9.91e-06	3.71e-01	3.12e-01	5.21e-02
GOCC PLATELET DENSE GRANULE MEMBRANE	6	2.48e-02	6.97e-02	1.1200	-4.46e-01	-4.39e-01	4.56e-01	-2.45e-01	-5.83e-01	5.08e-01	5.88e-02	6.26e-02	5.33e-02	2.98e-01	1.34e-02	3.11e-02
GOBP RESPONSE TO GRAM POSITIVE BACTERIUM	5	9.39e-03	3.27e-02	1.1200	-2.38e-01	6.51e-01	7.30e-01	1.42e-02	1.48e-01	4.72e-01	3.57e-01	1.18e-02	4.70e-03	9.56e-01	5.67e-01	6.78e-02
GOCC ATP BINDING CASSETTE ABC TRANSPORTER COMPLEX	5	1.46e-02	4.64e-02	1.1200	7.13e-01	-5.17e-02	3.37e-01	7.83e-01	6.87e-02	1.06e-02	5.74e-03	8.41e-01	1.92e-01	2.41e-03	7.90e-01	9.67e-01
GOBP OBSERVATIONAL LEARNING	5	6.20e-02	1.38e-01	1.1100	1.77e-01	5.58e-01	6.90e-01	8.52e-02	-1.53e-01	6.25e-01	4.94e-01	3.08e-02	7.52e-03	7.42e-01	5.53e-01	1.55e-02
GOCC UBIQUINONE BIOSYNTHESIS COMPLEX	6	1.06e-02	3.59e-02	1.1100	-8.12e-02	-6.62e-01	-8.16e-01	1.38e-01	1.23e-01	-3.06e-01	7.31e-01	4.96e-03	5.37e-04	5.57e-01	6.02e-01	1.95e-01
GOBP SA NODE CELL TO ATRIAL CARDIAC MUSCLE CELL COMMUNICATION	6	2.04e-02	6.00e-02	1.1100	3.64e-02	2.19e-01	7.30e-01	-5.04e-01	-5.18e-01	3.58e-01	8.77e-01	3.54e-01	1.94e-03	3.26e-02	2.80e-02	1.29e-01
GOBP REGULATION OF FEVER GENERATION	7	4.69e-05	3.43e-04	1.1100	-9.74e-02	3.40e-01	7.15e-01	-7.58e-01	1.60e-03	1.43e-01	6.56e-01	1.19e-01	1.05e-03	5.17e-04	9.94e-01	5.13e-01
GOCC MPP7 DLG1 LIN7 COMPLEX	5	4.96e-02	1.17e-01	1.1100	-6.41e-01	6.46e-03	1.37e-01	-6.97e-01	-5.02e-01	2.50e-01	1.31e-02	9.80e-01	5.95e-01	6.93e-03	5.17e-02	3.32e-01
GOCC HEMIDESMOSOME	7	1.70e-02	5.22e-02	1.1100	4.22e-01	5.75e-01	4.18e-01	5.49e-01	2.29e-01	4.38e-01	5.32e-02	8.41e-03	5.56e-02	1.19e-02	2.95e-01	4.47e-02
GOMF UBIQUITIN LIGASE INHIBITOR ACTIVITY	9	6.00e-04	3.28e-03	1.1100	-2.41e-01	-8.13e-01	-6.76e-01	-3.79e-03	-2.59e-02	-2.27e-01	2.11e-01	2.38e-05	4.45e-04	9.84e-01	8.93e-01	2.39e-01
GOMF PORIN ACTIVITY	6	4.81e-02	1.14e-01	1.1100	-5.60e-01	-6.90e-01	-5.10e-01	-2.81e-01	-3.06e-01	-7.03e-02	1.75e-02	3.44e-03	3.05e-02	2.33e-01	1.95e-01	7.66e-01
GOCC MCRD MEDIATED MRNA STABILITY COMPLEX	5	5.94e-02	1.34e-01	1.1100	-6.62e-01	-5.40e-01	-3.39e-01	-4.11e-01	-3.73e-01	2.70e-01	1.04e-02	3.65e-02	1.89e-01	1.12e-01	1.49e-01	2.97e-01
GOCC EXTRINSIC COMPONENT OF MITOCHONDRIAL INNER MEMBRANE	6	8.34e-03	2.98e-02	1.1100	-1.92e-01	-6.10e-01	-7.90e-01	9.64e-02	3.74e-01	-2.01e-01	4.15e-01	9.61e-03	8.03e-04	6.83e-01	1.13e-01	3.93e-01
GOBP REGULATION OF MITOCHONDRIAL RNA CATABOLIC PROCESS	5	4.56e-02	1.09e-01	1.1000	-4.36e-01	-7.10e-01	-4.03e-01	-1.90e-01	-5.59e-01	1.00e-01	9.15e-02	5.97e-03	1.18e-01	4.63e-01	3.05e-02	6.98e-01
GOBP POST TRANSLATIONAL PROTEIN TARGETING TO MEMBRANE TRANSLOCATION	7	1.64e-03	7.76e-03	1.1000	-6.84e-01	-3.96e-01	1.00e-01	-2.95e-02	-5.67e-01	5.05e-01	1.72e-03	6.93e-02	6.47e-01	8.93e-01	9.38e-03	2.06e-02
GOBP INTERLEUKIN 4 MEDIATED SIGNALING PATHWAY	10	4.30e-04	2.47e-03	1.1000	2.04e-01	5.09e-01	3.89e-01	6.01e-01	3.31e-01	5.33e-01	2.65e-01	5.31e-03	3.33e-02	9.95e-04	7.00e-02	3.52e-03
GOCC INTRACILIARY TRANSPORT PARTICLE A	8	2.81e-03	1.23e-02	1.1000	1.48e-01	2.40e-01	-4.37e-01	2.13e-01	7.86e-01	-5.20e-01	4.68e-01	2.40e-01	3.22e-02	2.97e-01	1.19e-04	1.08e-02
GOCC EXTERNAL SIDE OF APICAL PLASMA MEMBRANE	5	3.74e-02	9.47e-02	1.1000	2.22e-01	2.24e-01	7.00e-01	1.80e-01	-5.35e-01	5.43e-01	3.90e-01	3.87e-01	6.68e-03	4.86e-01	3.83e-02	3.55e-02
GOBP NEGATIVE REGULATION OF MONOCYTE DIFFERENTIATION	5	1.74e-02	5.29e-02	1.1000	6.27e-01	6.25e-01	8.65e-02	6.36e-01	5.56e-02	-7.00e-02	1.53e-02	1.56e-02	7.38e-01	1.38e-02	8.30e-01	7.86e-01
GOCC EKC KEOPS COMPLEX	5	8.45e-03	3.01e-02	1.1000	1.97e-01	-5.41e-01	-5.73e-01	4.95e-01	5.45e-01	-2.02e-02	4.46e-01	3.63e-02	2.66e-02	5.54e-02	3.46e-02	9.38e-01
GOBP PROTEIN LOCALIZATION TO CENP A CONTAINING CHROMATIN	7	2.92e-03	1.27e-02	1.1000	-2.36e-01	-6.28e-01	3.68e-01	5.74e-02	-5.22e-01	5.83e-01	2.81e-01	4.02e-03	9.20e-02	7.93e-01	1.68e-02	7.60e-03
GOMF HISTONE H3K9ME2 METHYLTRANSFERASE ACTIVITY	6	5.70e-02	1.30e-01	1.1000	5.18e-01	6.00e-01	2.78e-01	6.10e-01	3.44e-01	6.27e-02	2.80e-02	1.09e-02	2.39e-01	9.71e-03	1.45e-01	7.90e-01
GOBP ACROSOMAL VESICLE EXOCYTOSIS	5	5.37e-03	2.08e-02	1.0900	1.59e-01	5.49e-02	-1.16e-01	6.12e-01	6.47e-01	-5.98e-01	5.37e-01	8.32e-01	6.52e-01	1.78e-02	1.22e-02	2.06e-02
GOBP ATRIAL CARDIAC MUSCLE TISSUE DEVELOPMENT	5	3.47e-02	8.94e-02	1.0900	1.00e-01	1.04e-01	-1.53e-01	7.17e-01	7.78e-01	1.66e-01	6.98e-01	6.88e-01	5.54e-01	5.51e-03	2.59e-03	5.21e-01
GOBP RESPONSE TO CORTISOL	5	1.47e-02	4.68e-02	1.0900	-1.15e-01	-1.21e-01	8.04e-01	-2.88e-01	-6.40e-01	1.48e-01	6.56e-01	6.40e-01	1.84e-03	2.65e-01	1.32e-02	5.68e-01
GOBP FORMATION OF TRANSLATION PREINITIATION COMPLEX	7	1.05e-03	5.33e-03	1.0900	-5.76e-01	-5.94e-01	-4.76e-01	-4.25e-01	1.10e-01	2.82e-01	8.27e-03	6.53e-03	2.92e-02	5.17e-02	6.13e-01	1.96e-01
GOMF OXIDOREDUCTASE ACTIVITY ACTING ON A SULFUR GROUP OF DONORS NAD P AS ACCEPTOR	11	3.30e-06	3.14e-05	1.0900	-6.42e-01	-4.43e-01	4.47e-01	4.54e-04	-3.06e-01	5.27e-01	2.25e-04	1.10e-02	1.02e-02	9.98e-01	7.90e-02	2.45e-03
GOBP POSITIVE REGULATION OF SYNAPTIC VESICLE RECYCLING	7	6.89e-03	2.55e-02	1.0900	-4.08e-01	-5.72e-01	2.62e-03	-1.47e-01	-7.90e-01	2.00e-01	6.16e-02	8.82e-03	9.90e-01	5.02e-01	2.95e-04	3.60e-01
GOMF GLYCOGEN BINDING	6	5.29e-02	1.22e-01	1.0800	5.89e-01	3.79e-01	6.76e-02	5.69e-01	5.45e-01	2.47e-01	1.25e-02	1.08e-01	7.74e-01	1.58e-02	2.07e-02	2.95e-01
GOCC ENDOPLASMIC RETICULUM PALMITOYLTRANSFERASE COMPLEX	8	1.20e-02	3.96e-02	1.0800	-4.45e-01	-5.28e-01	1.31e-03	-4.18e-01	-6.81e-01	2.45e-01	2.94e-02	9.66e-03	9.95e-01	4.05e-02	8.47e-04	2.29e-01
GOBP POSITIVE REGULATION OF FEVER GENERATION	6	1.06e-04	7.13e-04	1.0800	-1.70e-01	2.51e-01	6.83e-01	-7.85e-01	-2.63e-03	3.39e-03	4.71e-01	2.88e-01	3.74e-03	8.62e-04	9.91e-01	9.89e-01
GOCC EUKARYOTIC 48S PREINITIATION COMPLEX	17	3.55e-06	3.35e-05	1.0800	-4.11e-01	-6.96e-01	-6.19e-01	-2.14e-01	-1.90e-01	-2.16e-01	3.33e-03	6.64e-07	9.91e-06	1.27e-01	1.74e-01	1.24e-01
GOBP ENERGY COUPLED PROTON TRANSMEMBRANE TRANSPORT AGAINST ELECTROCHEMICAL GRADIENT	5	7.45e-03	2.73e-02	1.0800	1.26e-01	-6.75e-01	3.08e-02	-2.14e-01	-6.33e-01	-4.89e-01	6.25e-01	8.92e-03	9.05e-01	4.08e-01	1.43e-02	5.82e-02
GOBP HYPOXIA INDUCIBLE FACTOR 1ALPHA SIGNALING PATHWAY	5	6.72e-03	2.50e-02	1.0800	-2.99e-01	5.08e-01	1.41e-01	6.07e-02	6.94e-01	5.52e-01	2.46e-01	4.92e-02	5.85e-01	8.14e-01	7.23e-03	3.25e-02
GOCC ENDOPLASMIC RETICULUM TUBULAR NETWORK MEMBRANE	5	7.95e-02	1.66e-01	1.0700	-3.94e-01	-2.67e-01	4.49e-01	-2.08e-01	-4.31e-01	7.06e-01	1.28e-01	3.01e-01	8.20e-02	4.20e-01	9.50e-02	6.28e-03
GOMF 1 PHOSPHATIDYLINOSITOL 4 5 BISPHOSPHATE 3 KINASE ACTIVITY	7	9.69e-04	4.94e-03	1.0700	-2.76e-01	5.19e-01	4.17e-01	1.83e-01	4.93e-01	5.99e-01	2.07e-01	1.75e-02	5.58e-02	4.03e-01	2.39e-02	6.05e-03
GOBP METAPHASE ANAPHASE TRANSITION OF MEIOTIC CELL CYCLE	5	2.17e-02	6.30e-02	1.0700	8.17e-02	-2.52e-01	5.29e-01	4.37e-01	-4.05e-01	6.66e-01	7.52e-01	3.29e-01	4.05e-02	9.08e-02	1.16e-01	9.86e-03
GOBP NEGATIVE REGULATION OF HEPATOCYTE APOPTOTIC PROCESS	6	4.25e-03	1.71e-02	1.0700	-2.66e-01	4.73e-01	6.11e-01	8.54e-02	-2.87e-01	6.25e-01	2.58e-01	4.50e-02	9.49e-03	7.17e-01	2.24e-01	8.05e-03
GOBP POSITIVE REGULATION OF SYNAPTIC VESICLE ENDOCYTOSIS	5	3.31e-02	8.63e-02	1.0700	-3.85e-01	-5.13e-01	-1.38e-01	-1.63e-01	-8.30e-01	3.60e-02	1.36e-01	4.70e-02	5.93e-01	5.29e-01	1.31e-03	8.89e-01
GOCC MMXD COMPLEX	5	4.55e-02	1.09e-01	1.0700	-4.26e-02	-4.54e-01	-5.66e-01	3.18e-01	1.34e-01	-7.06e-01	8.69e-01	7.87e-02	2.84e-02	2.19e-01	6.03e-01	6.28e-03
GOMF GABA A RECEPTOR ACTIVITY	5	9.72e-03	3.35e-02	1.0700	1.75e-01	4.01e-01	4.72e-01	-7.58e-01	-3.66e-01	-1.48e-01	4.98e-01	1.20e-01	6.77e-02	3.33e-03	1.56e-01	5.66e-01
GOBP REGULATION OF CILIUM BEAT FREQUENCY INVOLVED IN CILIARY MOTILITY	7	1.40e-02	4.49e-02	1.0700	-2.38e-01	-3.20e-01	-7.66e-01	-1.19e-01	4.01e-01	-4.67e-01	2.76e-01	1.42e-01	4.45e-04	5.86e-01	6.59e-02	3.22e-02
GOMF MHC CLASS IB RECEPTOR ACTIVITY	8	5.26e-05	3.80e-04	1.0700	2.63e-01	4.78e-01	3.70e-01	4.48e-01	-2.49e-01	6.64e-01	1.98e-01	1.93e-02	6.99e-02	2.83e-02	2.23e-01	1.13e-03
GOBP UTERINE SMOOTH MUSCLE CONTRACTION	6	8.71e-03	3.08e-02	1.0700	-5.45e-01	-3.17e-01	4.50e-01	-5.49e-01	-4.82e-01	2.39e-02	2.08e-02	1.78e-01	5.60e-02	1.99e-02	4.09e-02	9.19e-01
GOBP 4FE 4S CLUSTER ASSEMBLY	5	5.98e-02	1.35e-01	1.0600	-1.58e-01	-7.37e-01	-5.97e-01	1.35e-01	1.65e-02	-4.37e-01	5.41e-01	4.31e-03	2.08e-02	6.02e-01	9.49e-01	9.06e-02
GOMF SMALL PROTEIN ACTIVATING ENZYME BINDING	5	3.40e-02	8.80e-02	1.0600	-5.39e-01	-7.55e-01	-3.57e-01	1.69e-01	-3.14e-01	1.35e-01	3.70e-02	3.44e-03	1.67e-01	5.12e-01	2.24e-01	6.01e-01
GOBP PARENTAL BEHAVIOR	7	7.75e-03	2.81e-02	1.0600	-5.44e-01	-2.59e-01	5.22e-01	-1.77e-01	-4.01e-01	5.52e-01	1.26e-02	2.35e-01	1.69e-02	4.17e-01	6.59e-02	1.15e-02
GOBP PROTEIN DEMETHYLATION	9	6.23e-04	3.39e-03	1.0600	2.21e-01	5.20e-01	1.17e-01	7.25e-01	5.05e-01	-1.35e-01	2.50e-01	6.93e-03	5.43e-01	1.66e-04	8.68e-03	4.84e-01
GOBP POSITIVE REGULATION OF ANOIKIS	5	9.59e-03	3.31e-02	1.0600	3.42e-01	-5.52e-01	-3.11e-01	5.20e-01	-1.24e-01	-5.70e-01	1.85e-01	3.25e-02	2.28e-01	4.41e-02	6.32e-01	2.72e-02
GOMF NUCLEASE INHIBITOR ACTIVITY	6	2.63e-02	7.29e-02	1.0600	-4.01e-01	-8.16e-01	-3.26e-01	3.57e-02	-4.17e-01	-1.45e-01	8.86e-02	5.40e-04	1.66e-01	8.80e-01	7.68e-02	5.38e-01
GOCC PLATELET ALPHA GRANULE MEMBRANE	16	2.52e-06	2.45e-05	1.0600	-3.11e-01	-4.22e-01	4.34e-01	-4.43e-01	-4.54e-01	5.12e-01	3.12e-02	3.44e-03	2.65e-03	2.13e-03	1.68e-03	3.87e-04
GOBP ISG15 PROTEIN CONJUGATION	6	1.64e-03	7.76e-03	1.0600	-3.60e-01	-5.56e-01	-8.15e-01	-3.25e-02	-9.63e-02	1.16e-01	1.26e-01	1.83e-02	5.47e-04	8.90e-01	6.83e-01	6.24e-01
GOBP POSITIVE REGULATION OF PROTEIN LOCALIZATION TO SYNAPSE	5	6.62e-02	1.45e-01	1.0600	5.35e-01	5.61e-01	3.52e-01	3.48e-01	4.75e-01	-2.33e-01	3.82e-02	2.99e-02	1.73e-01	1.78e-01	6.57e-02	3.68e-01
GOMF MICROFIBRIL BINDING	5	1.58e-01	2.69e-01	1.0600	6.26e-01	4.20e-01	4.42e-01	4.51e-01	3.37e-01	2.11e-01	1.54e-02	1.04e-01	8.69e-02	8.11e-02	1.92e-01	4.14e-01
GOBP PLASMA CELL DIFFERENTIATION	8	7.66e-03	2.79e-02	1.0600	2.49e-01	4.53e-01	7.57e-01	-1.75e-01	-3.26e-01	3.83e-01	2.23e-01	2.66e-02	2.10e-04	3.92e-01	1.11e-01	6.05e-02
GOBP CGMP BIOSYNTHETIC PROCESS	6	4.65e-02	1.11e-01	1.0600	-3.33e-01	-5.78e-01	1.78e-01	-3.27e-01	-5.86e-01	4.42e-01	1.58e-01	1.43e-02	4.50e-01	1.65e-01	1.29e-02	6.06e-02
GOBP TRIGEMINAL NERVE DEVELOPMENT	6	1.61e-02	4.99e-02	1.0600	3.50e-02	3.47e-01	-7.62e-02	5.25e-01	7.80e-01	3.26e-01	8.82e-01	1.41e-01	7.46e-01	2.58e-02	9.38e-04	1.67e-01
GOMF DOUBLE STRANDED DNA 3 5 DNA EXONUCLEASE ACTIVITY	6	3.94e-02	9.83e-02	1.0600	1.29e-01	-2.07e-01	-5.74e-01	4.02e-01	4.15e-01	-6.28e-01	5.86e-01	3.79e-01	1.50e-02	8.81e-02	7.82e-02	7.76e-03
GOCC MITOCHONDRIAL INTERMEMBRANE SPACE PROTEIN TRANSPORTER COMPLEX	6	2.09e-02	6.12e-02	1.0600	-1.91e-01	-7.34e-01	-6.32e-01	2.58e-01	8.03e-02	-2.59e-01	4.17e-01	1.86e-03	7.36e-03	2.75e-01	7.33e-01	2.72e-01
GOMF STRUCTURAL CONSTITUENT OF RIBOSOME	157	8.22e-85	8.46e-82	1.0500	-1.59e-01	-8.14e-01	-6.22e-01	1.00e-02	-3.48e-02	-1.82e-01	5.79e-04	6.85e-70	1.90e-41	8.28e-01	4.52e-01	8.44e-05
GOCC NUCLEOLAR RIBONUCLEASE P COMPLEX	7	6.65e-03	2.48e-02	1.0500	-4.46e-03	-7.23e-01	-6.70e-01	5.35e-02	-6.04e-03	-3.67e-01	9.84e-01	9.20e-04	2.13e-03	8.07e-01	9.78e-01	9.26e-02
GOBP INTRACELLULAR AMINO ACID HOMEOSTASIS	7	2.17e-03	9.87e-03	1.0500	-4.01e-01	8.95e-02	-6.89e-01	3.48e-01	5.05e-01	-2.97e-01	6.62e-02	6.82e-01	1.60e-03	1.11e-01	2.08e-02	1.73e-01
GOBP SUCKLING BEHAVIOR	8	2.59e-03	1.15e-02	1.0500	-6.09e-01	-2.30e-01	1.09e-01	-2.81e-01	-4.84e-01	5.98e-01	2.88e-03	2.60e-01	5.93e-01	1.68e-01	1.78e-02	3.38e-03
GOBP LEUKOCYTE ADHESION TO ARTERIAL ENDOTHELIAL CELL	5	7.91e-03	2.85e-02	1.0500	-5.82e-02	4.35e-01	5.60e-01	-7.69e-01	-9.30e-02	-4.99e-03	8.22e-01	9.22e-02	3.02e-02	2.91e-03	7.19e-01	9.85e-01
GOBP G2 MI TRANSITION OF MEIOTIC CELL CYCLE	6	1.23e-03	6.10e-03	1.0500	5.33e-01	-4.04e-01	2.27e-01	6.02e-01	-4.09e-01	2.77e-01	2.38e-02	8.67e-02	3.35e-01	1.06e-02	8.31e-02	2.40e-01
GOCC SORTING ENDOSOME	5	4.10e-02	1.01e-01	1.0500	-9.90e-02	3.49e-01	6.13e-01	3.83e-01	1.57e-01	6.50e-01	7.01e-01	1.76e-01	1.76e-02	1.38e-01	5.43e-01	1.18e-02
GOMF RNA DNA HYBRID RIBONUCLEASE ACTIVITY	6	3.21e-02	8.41e-02	1.0500	-1.57e-01	-6.39e-01	-6.15e-01	1.74e-01	1.22e-01	-4.94e-01	5.06e-01	6.73e-03	9.03e-03	4.60e-01	6.05e-01	3.62e-02
GOBP INTESTINAL CHOLESTEROL ABSORPTION	10	2.22e-03	1.00e-02	1.0500	2.74e-01	4.03e-01	6.89e-01	3.10e-01	2.17e-01	4.94e-01	1.34e-01	2.73e-02	1.60e-04	8.91e-02	2.35e-01	6.82e-03
GOBP RRNA 3 END PROCESSING	10	7.72e-04	4.08e-03	1.0500	-3.33e-01	-5.41e-01	-6.94e-01	1.19e-02	3.44e-01	-3.11e-01	6.84e-02	3.05e-03	1.44e-04	9.48e-01	5.98e-02	8.90e-02
GOMF UBIQUINOL CYTOCHROME C REDUCTASE ACTIVITY	7	8.19e-03	2.94e-02	1.0500	-2.61e-01	-7.67e-01	-3.12e-01	5.37e-02	-5.21e-01	-2.57e-01	2.33e-01	4.39e-04	1.53e-01	8.06e-01	1.69e-02	2.39e-01
GOCC FC RECEPTOR COMPLEX	5	7.19e-02	1.54e-01	1.0500	2.18e-01	1.58e-01	5.43e-01	4.66e-01	2.86e-01	6.54e-01	3.99e-01	5.40e-01	3.54e-02	7.10e-02	2.69e-01	1.13e-02
GOCC LARGE RIBOSOMAL SUBUNIT	109	4.51e-57	2.09e-54	1.0500	-1.38e-01	-8.12e-01	-6.10e-01	3.52e-02	-6.89e-02	-1.93e-01	1.31e-02	8.65e-49	3.11e-28	5.26e-01	2.14e-01	5.08e-04
GOBP CHROMOSOME MOVEMENT TOWARDS SPINDLE POLE	6	1.14e-02	3.81e-02	1.0500	-2.48e-01	1.92e-02	5.58e-01	3.15e-01	-1.15e-01	7.79e-01	2.93e-01	9.35e-01	1.79e-02	1.81e-01	6.24e-01	9.55e-04
GOBP XENOBIOTIC TRANSPORT ACROSS BLOOD BRAIN BARRIER	5	2.90e-02	7.81e-02	1.0400	5.77e-01	2.97e-01	6.97e-01	3.31e-01	-2.74e-01	-1.19e-02	2.55e-02	2.50e-01	6.93e-03	2.00e-01	2.89e-01	9.63e-01
GOCC IGM IMMUNOGLOBULIN COMPLEX	8	1.69e-04	1.08e-03	1.0400	2.12e-01	-6.39e-01	2.25e-01	2.31e-01	-6.07e-01	4.05e-01	3.00e-01	1.75e-03	2.71e-01	2.57e-01	2.95e-03	4.74e-02
GOBP REGULATION OF MITOCHONDRIAL ATP SYNTHESIS COUPLED ELECTRON TRANSPORT	6	1.22e-02	4.01e-02	1.0400	-2.20e-01	-6.62e-01	2.13e-01	1.07e-01	-4.69e-01	5.67e-01	3.50e-01	5.01e-03	3.65e-01	6.49e-01	4.64e-02	1.62e-02
GOBP PROTEIN INSERTION INTO MEMBRANE FROM INNER SIDE	5	7.23e-02	1.55e-01	1.0400	-4.55e-01	-7.48e-01	-4.64e-01	-2.83e-01	1.11e-02	-1.46e-01	7.83e-02	3.77e-03	7.26e-02	2.73e-01	9.66e-01	5.72e-01
GOMF PHOSPHATIDYLSERINE FLOPPASE ACTIVITY	9	6.17e-03	2.32e-02	1.0400	2.41e-01	4.92e-01	5.61e-01	4.55e-01	1.84e-01	4.74e-01	2.10e-01	1.05e-02	3.58e-03	1.81e-02	3.38e-01	1.39e-02
GOBP REGULATION OF POSTSYNAPSE ASSEMBLY	5	2.39e-02	6.78e-02	1.0400	-1.90e-01	4.29e-01	4.73e-01	3.89e-01	4.03e-01	5.68e-01	4.62e-01	9.67e-02	6.73e-02	1.32e-01	1.18e-01	2.79e-02
GOMF PHOSPHOLIPASE INHIBITOR ACTIVITY	7	3.52e-03	1.47e-02	1.0400	-2.15e-01	-4.75e-01	5.92e-01	-3.45e-01	-5.01e-01	2.88e-01	3.24e-01	2.94e-02	6.64e-03	1.14e-01	2.16e-02	1.87e-01
GOBP MITOCHONDRIAL RESPIRASOME ASSEMBLY	7	2.50e-02	7.00e-02	1.0400	-5.73e-01	-5.96e-01	-8.84e-02	-2.33e-01	-4.43e-01	3.67e-01	8.65e-03	6.31e-03	6.85e-01	2.87e-01	4.26e-02	9.29e-02
GOBP IRIS MORPHOGENESIS	5	6.62e-03	2.47e-02	1.0400	-6.51e-01	3.63e-01	5.25e-01	-2.74e-01	-3.16e-01	2.65e-01	1.17e-02	1.60e-01	4.22e-02	2.89e-01	2.22e-01	3.04e-01
GOCC IGG IMMUNOGLOBULIN COMPLEX	10	2.35e-06	2.30e-05	1.0400	1.06e-02	-6.37e-01	-1.64e-03	4.68e-01	-5.01e-01	4.45e-01	9.54e-01	4.82e-04	9.93e-01	1.05e-02	6.11e-03	1.48e-02
GOMF RS DOMAIN BINDING	5	1.43e-01	2.52e-01	1.0400	-5.13e-01	-3.48e-01	-4.12e-01	-4.00e-01	-3.61e-01	-4.78e-01	4.70e-02	1.78e-01	1.11e-01	1.21e-01	1.62e-01	6.39e-02
GOBP SERINE PHOSPHORYLATION OF STAT PROTEIN	5	1.20e-01	2.24e-01	1.0400	-1.43e-01	-1.96e-01	4.70e-01	-4.29e-01	-5.57e-01	5.44e-01	5.79e-01	4.47e-01	6.88e-02	9.63e-02	3.09e-02	3.50e-02
GOBP LYMPHOCYTE AGGREGATION	5	5.51e-02	1.27e-01	1.0300	2.03e-01	3.33e-01	5.35e-01	6.69e-01	1.26e-01	4.12e-01	4.31e-01	1.97e-01	3.85e-02	9.59e-03	6.24e-01	1.11e-01
GOCC NETWORK FORMING COLLAGEN TRIMER	6	1.02e-02	3.50e-02	1.0300	-4.78e-02	2.44e-01	3.63e-01	-7.39e-01	-5.52e-01	-1.59e-01	8.39e-01	3.01e-01	1.23e-01	1.71e-03	1.91e-02	5.00e-01
GOBP XYLULOSE 5 PHOSPHATE METABOLIC PROCESS	6	1.28e-02	4.18e-02	1.0300	-5.51e-01	-5.69e-01	-5.24e-01	-1.05e-01	3.67e-01	-1.52e-01	1.93e-02	1.59e-02	2.63e-02	6.55e-01	1.20e-01	5.19e-01
GOBP REGULATION OF MATRIX METALLOPEPTIDASE SECRETION	5	6.33e-02	1.40e-01	1.0300	-4.07e-01	-1.17e-01	1.88e-01	-4.08e-01	-7.83e-01	2.73e-01	1.15e-01	6.49e-01	4.67e-01	1.14e-01	2.44e-03	2.90e-01
GOBP PROTEIN DEUBIQUITINATION INVOLVED IN UBIQUITIN DEPENDENT PROTEIN CATABOLIC PROCESS	6	8.08e-05	5.61e-04	1.0300	1.99e-01	7.98e-01	3.41e-01	2.76e-01	-4.13e-01	1.69e-01	3.98e-01	7.09e-04	1.48e-01	2.42e-01	7.97e-02	4.74e-01
GOCC MHC PROTEIN COMPLEX	23	6.88e-09	9.94e-08	1.0300	-8.96e-02	-4.01e-01	-6.72e-01	2.25e-01	4.15e-01	-4.73e-01	4.57e-01	8.76e-04	2.44e-08	6.18e-02	5.73e-04	8.49e-05
GOBP PROTEIN REPAIR	7	2.02e-02	5.97e-02	1.0300	-3.42e-01	-5.73e-01	7.00e-02	-3.13e-01	-5.51e-01	4.63e-01	1.17e-01	8.67e-03	7.49e-01	1.52e-01	1.15e-02	3.41e-02
GOMF C3HC4 TYPE RING FINGER DOMAIN BINDING	6	1.19e-01	2.21e-01	1.0300	5.54e-01	4.42e-01	7.22e-02	5.36e-01	4.97e-01	-1.39e-01	1.87e-02	6.06e-02	7.60e-01	2.31e-02	3.50e-02	5.55e-01
GOBP VESTIBULOCOCHLEAR NERVE MORPHOGENESIS	5	2.13e-02	6.22e-02	1.0300	-4.96e-02	1.85e-01	-2.47e-01	3.20e-01	8.81e-01	2.90e-01	8.48e-01	4.74e-01	3.40e-01	2.15e-01	6.42e-04	2.62e-01
GOMF FATTY ACYL COA SYNTHASE ACTIVITY	5	5.26e-03	2.05e-02	1.0300	-9.29e-02	6.33e-01	6.36e-02	-7.93e-01	8.75e-02	-9.80e-02	7.19e-01	1.43e-02	8.06e-01	2.12e-03	7.35e-01	7.04e-01
GOMF PEROXIREDOXIN ACTIVITY	8	2.88e-03	1.25e-02	1.0300	-4.49e-01	-8.36e-01	-1.89e-01	-1.59e-01	-1.87e-01	2.43e-01	2.80e-02	4.23e-05	3.55e-01	4.36e-01	3.59e-01	2.35e-01
GOMF HISTONE H3K4 MONOMETHYLTRANSFERASE ACTIVITY	8	7.77e-03	2.81e-02	1.0200	4.26e-01	5.80e-01	4.34e-01	5.41e-01	2.25e-01	-3.25e-02	3.69e-02	4.49e-03	3.36e-02	8.06e-03	2.70e-01	8.74e-01
GOBP INTERLEUKIN 2 MEDIATED SIGNALING PATHWAY	8	8.31e-03	2.97e-02	1.0200	3.50e-01	4.56e-01	4.17e-01	5.91e-01	8.00e-02	4.34e-01	8.65e-02	2.55e-02	4.10e-02	3.80e-03	6.95e-01	3.36e-02
GOBP MITOCHONDRIAL RIBOSOME ASSEMBLY	12	4.69e-05	3.43e-04	1.0200	8.55e-02	-5.26e-01	-6.56e-01	4.46e-01	8.34e-02	-3.56e-01	6.08e-01	1.62e-03	8.29e-05	7.45e-03	6.17e-01	3.27e-02
GOCC GATOR1 COMPLEX	5	1.71e-02	5.24e-02	1.0200	5.93e-01	2.51e-01	3.98e-02	6.46e-01	-9.95e-02	-4.50e-01	2.16e-02	3.30e-01	8.77e-01	1.24e-02	7.00e-01	8.16e-02
GOMF MHC CLASS II RECEPTOR ACTIVITY	9	2.92e-04	1.76e-03	1.0200	-7.43e-02	-4.46e-01	-5.20e-01	1.79e-01	5.56e-01	-4.79e-01	6.99e-01	2.06e-02	6.90e-03	3.51e-01	3.87e-03	1.29e-02
GOCC RIBOSOMAL SUBUNIT	181	3.81e-91	7.06e-88	1.0200	-1.62e-01	-7.91e-01	-5.97e-01	-4.28e-03	-5.32e-02	-1.73e-01	1.77e-04	7.91e-76	7.41e-44	9.21e-01	2.17e-01	5.87e-05
GOCC TORC1 COMPLEX	6	1.84e-03	8.56e-03	1.0200	5.52e-01	-9.49e-02	1.88e-01	7.08e-01	-4.01e-02	-4.30e-01	1.91e-02	6.87e-01	4.24e-01	2.68e-03	8.65e-01	6.79e-02
GOBP THYROID HORMONE TRANSPORT	6	1.80e-02	5.43e-02	1.0100	-1.99e-01	-6.30e-01	2.22e-01	1.17e-01	-6.00e-01	4.12e-01	3.99e-01	7.54e-03	3.46e-01	6.21e-01	1.09e-02	8.04e-02
GOBP QUINOLINATE METABOLIC PROCESS	5	6.20e-02	1.38e-01	1.0100	-1.09e-01	2.63e-01	-4.98e-01	4.12e-01	7.19e-01	-1.07e-01	6.72e-01	3.09e-01	5.40e-02	1.11e-01	5.37e-03	6.79e-01
GOBP RNA GUANINE N7 METHYLATION	6	1.83e-02	5.51e-02	1.0100	-2.08e-01	-6.85e-01	-5.16e-01	4.11e-01	-3.71e-02	-2.75e-01	3.77e-01	3.66e-03	2.85e-02	8.11e-02	8.75e-01	2.43e-01
GOBP SCARNA LOCALIZATION TO CAJAL BODY	5	8.43e-02	1.73e-01	1.0100	-3.12e-01	-7.22e-01	-5.82e-01	1.91e-01	-3.50e-02	-1.69e-01	2.27e-01	5.17e-03	2.42e-02	4.60e-01	8.92e-01	5.13e-01
GOBP REGULATION OF PLASMA CELL DIFFERENTIATION	5	6.39e-02	1.41e-01	1.0100	2.28e-01	4.17e-01	6.48e-01	5.18e-02	-4.82e-01	3.75e-01	3.78e-01	1.06e-01	1.21e-02	8.41e-01	6.19e-02	1.46e-01
GOCC BBSOME	8	1.50e-03	7.20e-03	1.0100	-3.29e-01	1.29e-01	-5.84e-01	-2.49e-01	6.20e-01	-3.28e-01	1.07e-01	5.27e-01	4.21e-03	2.22e-01	2.38e-03	1.08e-01
GOBP ANTERIOR COMMISSURE MORPHOGENESIS	5	2.39e-02	6.77e-02	1.0100	-2.36e-01	2.70e-01	5.90e-01	4.09e-01	6.93e-03	6.10e-01	3.61e-01	2.96e-01	2.24e-02	1.14e-01	9.79e-01	1.82e-02
GOBP RRNA 5 END PROCESSING	5	6.28e-02	1.40e-01	1.0100	2.82e-01	-2.07e-01	-5.15e-01	5.00e-01	6.83e-02	-6.09e-01	2.75e-01	4.24e-01	4.62e-02	5.27e-02	7.91e-01	1.83e-02
GOBP REGULATION OF TRANSLATION INITIATION IN RESPONSE TO ENDOPLASMIC RETICULUM STRESS	8	1.68e-02	5.16e-02	1.0100	-6.55e-01	-2.55e-01	1.60e-01	-3.74e-01	-5.40e-01	2.47e-01	1.33e-03	2.13e-01	4.32e-01	6.67e-02	8.19e-03	2.26e-01
GOBP POSITIVE REGULATION OF NEURON PROJECTION ARBORIZATION	7	2.84e-02	7.69e-02	1.0100	4.02e-01	5.49e-01	1.59e-01	3.84e-01	5.43e-01	-2.82e-01	6.56e-02	1.18e-02	4.65e-01	7.85e-02	1.28e-02	1.96e-01
GOMF INHIBITORY MHC CLASS I RECEPTOR ACTIVITY	8	1.41e-03	6.85e-03	1.0100	-2.44e-01	-1.52e-01	6.13e-01	1.08e-01	9.11e-03	7.35e-01	2.33e-01	4.58e-01	2.68e-03	5.95e-01	9.64e-01	3.15e-04
GOBP NEGATIVE REGULATION OF MEIOTIC CELL CYCLE PHASE TRANSITION	5	3.14e-02	8.28e-02	1.0000	8.78e-02	-2.69e-01	5.03e-01	4.65e-01	-4.02e-01	5.45e-01	7.34e-01	2.97e-01	5.14e-02	7.17e-02	1.19e-01	3.49e-02
GOBP REGULATION OF HEPATOCYTE APOPTOTIC PROCESS	7	1.38e-03	6.71e-03	1.0000	-3.29e-01	5.35e-01	5.13e-01	1.55e-02	-2.26e-01	5.46e-01	1.32e-01	1.42e-02	1.88e-02	9.43e-01	3.00e-01	1.23e-02
GOBP B CELL CHEMOTAXIS	6	2.35e-02	6.70e-02	1.0000	3.43e-01	-3.80e-02	7.03e-01	3.45e-01	-3.60e-01	3.81e-01	1.46e-01	8.72e-01	2.87e-03	1.43e-01	1.27e-01	1.06e-01
GOMF AMINOACYL TRNA HYDROLASE ACTIVITY	5	6.62e-02	1.45e-01	1.0000	-3.09e-01	-7.54e-01	-4.28e-01	7.06e-02	-3.88e-01	4.04e-02	2.31e-01	3.50e-03	9.71e-02	7.84e-01	1.33e-01	8.76e-01
GOBP TRNA THIO MODIFICATION	5	3.89e-02	9.74e-02	1.0000	3.49e-01	-4.68e-01	-3.82e-01	5.61e-01	1.14e-01	-4.35e-01	1.76e-01	6.97e-02	1.39e-01	2.98e-02	6.59e-01	9.19e-02
GOBP RESPONSE TO INTERLEUKIN 2	9	4.94e-03	1.94e-02	1.0000	2.62e-01	4.80e-01	4.09e-01	5.81e-01	1.66e-01	4.16e-01	1.74e-01	1.27e-02	3.38e-02	2.54e-03	3.89e-01	3.05e-02
GOBP DETOXIFICATION OF COPPER ION	6	9.98e-03	3.42e-02	1.0000	2.49e-01	-4.66e-01	4.57e-01	2.21e-01	-4.16e-01	5.41e-01	2.90e-01	4.83e-02	5.23e-02	3.49e-01	7.77e-02	2.16e-02
GOBP MEIOTIC CELL CYCLE PHASE TRANSITION	11	1.09e-05	9.10e-05	1.0000	3.28e-01	-3.35e-01	3.65e-01	5.27e-01	-4.07e-01	4.54e-01	5.96e-02	5.44e-02	3.63e-02	2.46e-03	1.94e-02	9.08e-03
GOBP NEGATIVE REGULATION OF CHROMATIN ORGANIZATION	5	6.76e-02	1.47e-01	1.0000	1.08e-01	6.36e-01	3.80e-01	5.07e-01	2.69e-01	3.35e-01	6.77e-01	1.37e-02	1.41e-01	4.97e-02	2.98e-01	1.95e-01
GOMF MYOSIN LIGHT CHAIN BINDING	5	3.52e-02	9.05e-02	1.0000	-6.54e-02	-4.89e-01	2.82e-01	-1.68e-01	-7.85e-01	-1.84e-01	8.00e-01	5.83e-02	2.75e-01	5.16e-01	2.36e-03	4.76e-01
GOBP U4 SNRNA 3 END PROCESSING	8	8.72e-03	3.08e-02	1.0000	-1.15e-01	-6.24e-01	-7.08e-01	6.91e-03	5.46e-02	-3.07e-01	5.72e-01	2.24e-03	5.26e-04	9.73e-01	7.89e-01	1.33e-01
GOMF HEXOKINASE ACTIVITY	5	1.05e-01	2.02e-01	1.0000	-2.27e-01	7.48e-02	6.45e-01	-4.83e-02	-4.57e-01	5.61e-01	3.79e-01	7.72e-01	1.24e-02	8.52e-01	7.68e-02	2.99e-02
GOMF HISTONE H3K27ME2 H3K27ME3 DEMETHYLASE ACTIVITY	5	2.30e-02	6.60e-02	0.9990	-3.48e-02	7.36e-01	4.43e-01	3.57e-01	3.46e-01	1.10e-01	8.93e-01	4.39e-03	8.64e-02	1.67e-01	1.80e-01	6.69e-01
GOCC GAMMA DELTA T CELL RECEPTOR COMPLEX	6	4.91e-04	2.76e-03	0.9980	4.68e-01	5.50e-01	-1.89e-01	4.25e-01	2.51e-01	4.42e-01	4.70e-02	1.97e-02	4.23e-01	7.12e-02	2.86e-01	6.06e-02
GOBP NEGATIVE REGULATION OF DELAYED RECTIFIER POTASSIUM CHANNEL ACTIVITY	6	1.69e-02	5.19e-02	0.9980	-4.04e-01	-5.22e-02	5.94e-01	-2.67e-01	-3.73e-02	6.36e-01	8.64e-02	8.25e-01	1.17e-02	2.57e-01	8.74e-01	6.94e-03
GOCC MYOSIN FILAMENT	11	5.74e-03	2.20e-02	0.9980	6.05e-01	5.03e-01	1.78e-01	4.92e-01	3.07e-01	-9.55e-02	5.16e-04	3.87e-03	3.06e-01	4.68e-03	7.82e-02	5.83e-01
GOBP MEIOTIC CYTOKINESIS	6	1.69e-02	5.19e-02	0.9980	-3.21e-01	2.33e-01	4.15e-01	4.52e-02	1.50e-01	8.01e-01	1.73e-01	3.23e-01	7.87e-02	8.48e-01	5.24e-01	6.78e-04
GOBP REGULATION OF BARBED END ACTIN FILAMENT CAPPING	5	9.42e-02	1.88e-01	0.9980	-3.24e-01	-5.22e-01	3.70e-01	-4.18e-01	-5.26e-01	1.72e-01	2.10e-01	4.32e-02	1.52e-01	1.05e-01	4.18e-02	5.05e-01
GOCC TRANSLOCON COMPLEX	6	9.51e-03	3.29e-02	0.9950	-5.45e-01	-5.30e-01	-3.01e-01	9.34e-02	-5.24e-01	1.96e-01	2.08e-02	2.45e-02	2.02e-01	6.92e-01	2.62e-02	4.07e-01
GOBP INTRACELLULAR GLUTAMATE HOMEOSTASIS	5	1.59e-02	4.95e-02	0.9940	-3.33e-01	2.12e-01	-6.36e-01	4.06e-01	5.04e-01	-8.38e-02	1.97e-01	4.12e-01	1.37e-02	1.16e-01	5.08e-02	7.45e-01
GOBP NOTOCHORD MORPHOGENESIS	7	2.50e-02	7.01e-02	0.9940	6.00e-01	1.35e-01	3.44e-01	6.49e-01	4.86e-02	2.58e-01	5.94e-03	5.35e-01	1.15e-01	2.95e-03	8.24e-01	2.37e-01
GOBP REGULATION OF CELLULAR PH REDUCTION	6	4.73e-02	1.12e-01	0.9930	-9.17e-02	-1.20e-01	4.65e-01	-2.14e-01	-7.77e-01	3.11e-01	6.97e-01	6.11e-01	4.85e-02	3.64e-01	9.81e-04	1.87e-01
GOBP N ACYLETHANOLAMINE METABOLIC PROCESS	5	7.64e-02	1.61e-01	0.9920	-3.11e-01	-1.64e-02	-6.51e-01	-2.43e-01	4.94e-01	-4.00e-01	2.28e-01	9.49e-01	1.16e-02	3.47e-01	5.56e-02	1.21e-01
GOMF HAPTOGLOBIN BINDING	8	1.82e-02	5.49e-02	0.9900	6.06e-01	1.95e-01	5.05e-01	4.49e-01	-1.40e-02	3.44e-01	2.98e-03	3.41e-01	1.34e-02	2.78e-02	9.45e-01	9.22e-02
GOMF PHOSPHATIDYLSERINE FLIPPASE ACTIVITY	5	1.88e-01	3.03e-01	0.9900	2.84e-01	4.80e-01	4.62e-01	3.17e-01	2.08e-01	5.58e-01	2.71e-01	6.33e-02	7.33e-02	2.19e-01	4.21e-01	3.06e-02
GOCC TRANSLATION PREINITIATION COMPLEX	19	1.20e-05	9.93e-05	0.9900	-4.39e-01	-6.42e-01	-5.16e-01	-2.45e-01	-1.72e-01	-1.39e-01	9.25e-04	1.26e-06	9.87e-05	6.48e-02	1.94e-01	2.93e-01
GOBP RESPONSE TO DISACCHARIDE	5	1.33e-01	2.40e-01	0.9890	-4.93e-01	-3.27e-01	-3.80e-01	-3.00e-01	-2.63e-01	-5.70e-01	5.62e-02	2.06e-01	1.41e-01	2.45e-01	3.09e-01	2.73e-02
GOCC POSTSYNAPTIC ACTIN CYTOSKELETON	5	1.27e-02	4.15e-02	0.9880	2.54e-01	3.60e-01	4.73e-01	7.40e-01	7.36e-02	-6.54e-02	3.25e-01	1.63e-01	6.73e-02	4.16e-03	7.76e-01	8.00e-01
GOMF ADENYLATE CYCLASE REGULATOR ACTIVITY	7	4.12e-02	1.02e-01	0.9870	-2.19e-01	-5.26e-01	1.51e-01	-4.56e-01	-5.90e-01	2.66e-01	3.16e-01	1.59e-02	4.88e-01	3.66e-02	6.82e-03	2.24e-01
GOCC MITOCHONDRIAL SMALL RIBOSOMAL SUBUNIT	32	2.47e-15	6.74e-14	0.9870	-1.30e-01	-7.87e-01	-5.74e-01	1.12e-02	-7.42e-02	-4.18e-02	2.05e-01	1.22e-14	1.92e-08	9.12e-01	4.67e-01	6.83e-01
GOBP NEGATIVE REGULATION OF SEQUESTERING OF TRIGLYCERIDE	5	1.62e-01	2.74e-01	0.9860	-3.33e-01	-7.32e-02	5.47e-01	-2.57e-01	-5.08e-01	4.84e-01	1.97e-01	7.77e-01	3.43e-02	3.20e-01	4.93e-02	6.10e-02
GOBP HEMATOPOIETIC STEM CELL MIGRATION TO BONE MARROW	5	8.60e-02	1.75e-01	0.9860	-2.24e-01	-4.91e-02	6.38e-01	1.38e-02	-5.32e-01	4.78e-01	3.86e-01	8.49e-01	1.34e-02	9.57e-01	3.95e-02	6.41e-02
GOBP TOLL LIKE RECEPTOR 8 SIGNALING PATHWAY	5	5.23e-03	2.04e-02	0.9860	-5.30e-01	5.11e-01	4.38e-01	1.44e-01	2.28e-01	4.06e-01	4.03e-02	4.76e-02	8.96e-02	5.77e-01	3.78e-01	1.16e-01
GOBP NEGATIVE REGULATION OF PROTEIN EXIT FROM ENDOPLASMIC RETICULUM	10	2.70e-03	1.18e-02	0.9860	-6.02e-01	-5.56e-01	-1.68e-03	-1.66e-01	-3.08e-01	4.21e-01	9.76e-04	2.32e-03	9.93e-01	3.64e-01	9.17e-02	2.12e-02
GOCC HEMOGLOBIN COMPLEX	10	3.56e-03	1.49e-02	0.9850	5.52e-01	1.59e-01	5.57e-01	4.10e-01	-9.83e-02	3.90e-01	2.52e-03	3.83e-01	2.27e-03	2.46e-02	5.90e-01	3.29e-02
GOCC CYTOSOLIC SMALL RIBOSOMAL SUBUNIT	43	5.77e-17	1.87e-15	0.9840	-2.47e-01	-7.19e-01	-5.73e-01	-1.32e-01	-8.57e-03	-2.12e-01	5.08e-03	3.16e-16	7.90e-11	1.33e-01	9.23e-01	1.60e-02
GOCC WEIBEL PALADE BODY	5	5.80e-02	1.32e-01	0.9840	-2.53e-01	9.26e-02	7.07e-01	1.31e-01	-1.56e-01	5.95e-01	3.28e-01	7.20e-01	6.16e-03	6.11e-01	5.46e-01	2.11e-02
GOMF LIPOPEPTIDE BINDING	9	1.79e-02	5.40e-02	0.9840	-5.21e-01	-3.73e-01	-5.20e-01	-2.88e-01	-2.70e-01	-3.61e-01	6.75e-03	5.27e-02	6.86e-03	1.34e-01	1.61e-01	6.07e-02
GOBP DETOXIFICATION OF INORGANIC COMPOUND	12	1.85e-04	1.17e-03	0.9830	-6.16e-02	-3.44e-01	5.67e-01	4.68e-02	-3.91e-01	6.07e-01	7.12e-01	3.88e-02	6.76e-04	7.79e-01	1.91e-02	2.69e-04
GOBP POSITIVE REGULATION OF PYROPTOSIS	5	4.04e-02	1.00e-01	0.9820	4.78e-02	1.51e-01	-1.71e-01	4.42e-01	7.20e-01	4.43e-01	8.53e-01	5.58e-01	5.07e-01	8.68e-02	5.33e-03	8.62e-02
GOBP NEUTROPHIL CLEARANCE	6	1.44e-02	4.59e-02	0.9810	-7.57e-01	-3.15e-01	2.52e-01	-7.86e-02	-2.32e-01	4.09e-01	1.32e-03	1.82e-01	2.86e-01	7.39e-01	3.25e-01	8.28e-02
GOBP CAMP CATABOLIC PROCESS	8	6.05e-03	2.29e-02	0.9810	9.54e-03	5.33e-01	5.80e-01	2.39e-01	3.56e-01	3.97e-01	9.63e-01	9.07e-03	4.49e-03	2.43e-01	8.08e-02	5.17e-02
GOCC NLRP1 INFLAMMASOME COMPLEX	5	1.07e-01	2.06e-01	0.9800	-1.55e-02	3.08e-01	-3.16e-01	4.44e-01	7.49e-01	-9.15e-02	9.52e-01	2.33e-01	2.22e-01	8.54e-02	3.74e-03	7.23e-01
GOBP SPHINGOMYELIN BIOSYNTHETIC PROCESS	10	3.15e-03	1.35e-02	0.9790	-6.77e-01	-3.44e-01	9.84e-02	-2.76e-01	-5.27e-01	1.35e-01	2.11e-04	5.94e-02	5.90e-01	1.31e-01	3.87e-03	4.60e-01
GOMF 1 PHOSPHATIDYLINOSITOL 4 PHOSPHATE 3 KINASE ACTIVITY	7	7.34e-03	2.69e-02	0.9790	-9.87e-02	5.94e-01	3.60e-01	3.35e-01	4.97e-01	3.28e-01	6.51e-01	6.52e-03	9.91e-02	1.25e-01	2.29e-02	1.33e-01
GOBP NEGATIVE REGULATION OF IRE1 MEDIATED UNFOLDED PROTEIN RESPONSE	5	5.33e-02	1.23e-01	0.9780	-5.98e-01	-4.18e-01	-4.53e-02	-2.50e-03	-4.65e-01	4.54e-01	2.05e-02	1.05e-01	8.61e-01	9.92e-01	7.19e-02	7.88e-02
GOBP POSITIVE REGULATION OF LYMPHOCYTE ANERGY	5	6.53e-03	2.44e-02	0.9780	3.72e-01	2.57e-01	3.07e-01	3.90e-01	-4.80e-01	5.26e-01	1.50e-01	3.19e-01	2.35e-01	1.31e-01	6.31e-02	4.18e-02
GOCC SMALL RIBOSOMAL SUBUNIT	75	6.37e-33	7.38e-31	0.9780	-1.97e-01	-7.50e-01	-5.74e-01	-7.12e-02	-3.67e-02	-1.40e-01	3.16e-03	2.57e-29	7.62e-18	2.86e-01	5.83e-01	3.64e-02
GOBP POSITIVE REGULATION OF HEMATOPOIETIC STEM CELL PROLIFERATION	6	4.94e-03	1.94e-02	0.9770	-5.42e-01	2.46e-01	-5.73e-01	-1.93e-01	3.73e-02	-4.84e-01	2.14e-02	2.96e-01	1.52e-02	4.13e-01	8.74e-01	4.02e-02
GOBP POSITIVE REGULATION OF ARTERY MORPHOGENESIS	5	2.10e-01	3.27e-01	0.9770	3.56e-01	5.98e-01	3.16e-01	2.56e-01	5.21e-01	1.83e-01	1.68e-01	2.06e-02	2.21e-01	3.21e-01	4.36e-02	4.78e-01
GOBP REGULATION OF ARTERY MORPHOGENESIS	5	2.10e-01	3.27e-01	0.9770	3.56e-01	5.98e-01	3.16e-01	2.56e-01	5.21e-01	1.83e-01	1.68e-01	2.06e-02	2.21e-01	3.21e-01	4.36e-02	4.78e-01
GOBP TRNA SURVEILLANCE	8	7.38e-03	2.70e-02	0.9770	-2.21e-01	-4.61e-01	-7.13e-01	-8.01e-02	3.51e-01	-2.35e-01	2.78e-01	2.40e-02	4.76e-04	6.95e-01	8.60e-02	2.49e-01
GOBP PENILE ERECTION	5	1.57e-01	2.68e-01	0.9770	-3.90e-01	-2.90e-01	3.88e-01	-5.55e-01	-4.39e-01	2.57e-01	1.31e-01	2.61e-01	1.33e-01	3.15e-02	8.89e-02	3.19e-01
GOBP PROTEIN INSERTION INTO MITOCHONDRIAL MEMBRANE	7	4.67e-02	1.12e-01	0.9760	-3.87e-01	-6.73e-01	-4.73e-01	-2.27e-01	-4.59e-02	-2.70e-01	7.60e-02	2.04e-03	3.02e-02	2.99e-01	8.34e-01	2.16e-01
GOMF ANKYRIN REPEAT BINDING	6	2.23e-02	6.45e-02	0.9750	-2.81e-02	4.08e-01	-1.09e-01	6.63e-01	5.77e-01	2.27e-03	9.05e-01	8.39e-02	6.44e-01	4.93e-03	1.43e-02	9.92e-01
GOBP POSITIVE REGULATION OF SODIUM PROTON ANTIPORTER ACTIVITY	5	8.26e-02	1.70e-01	0.9750	9.44e-02	2.43e-01	6.77e-01	2.68e-01	2.53e-01	5.37e-01	7.15e-01	3.47e-01	8.78e-03	3.00e-01	3.27e-01	3.75e-02
GOMF PYRUVATE DEHYDROGENASE ACTIVITY	5	1.27e-01	2.32e-01	0.9740	-5.71e-01	-6.20e-01	-1.64e-01	-2.44e-01	-1.95e-01	3.38e-01	2.70e-02	1.64e-02	5.26e-01	3.45e-01	4.50e-01	1.91e-01
GOBP RELAXATION OF VASCULAR ASSOCIATED SMOOTH MUSCLE	5	1.01e-01	1.97e-01	0.9740	-2.29e-01	-6.11e-01	3.06e-01	-9.96e-02	-5.07e-01	4.03e-01	3.75e-01	1.80e-02	2.37e-01	7.00e-01	4.96e-02	1.19e-01
GOCC HAPTOGLOBIN HEMOGLOBIN COMPLEX	9	1.43e-02	4.57e-02	0.9720	4.71e-01	2.03e-01	5.59e-01	4.43e-01	1.84e-02	4.16e-01	1.45e-02	2.93e-01	3.70e-03	2.14e-02	9.24e-01	3.05e-02
GOBP NEGATIVE REGULATION OF VASCULAR ASSOCIATED SMOOTH MUSCLE CELL DIFFERENTIATION	7	4.20e-02	1.03e-01	0.9720	9.00e-02	3.18e-01	-4.51e-01	4.04e-01	6.30e-01	-2.67e-01	6.80e-01	1.45e-01	3.88e-02	6.39e-02	3.88e-03	2.21e-01
GOBP MITOCHONDRIAL PROTON TRANSPORTING ATP SYNTHASE COMPLEX ASSEMBLY	8	6.83e-03	2.53e-02	0.9710	-5.83e-02	-6.66e-01	-5.35e-01	-1.88e-02	9.37e-02	-4.48e-01	7.75e-01	1.11e-03	8.80e-03	9.27e-01	6.46e-01	2.80e-02
GOBP POSITIVE REGULATION OF APOPTOTIC PROCESS INVOLVED IN DEVELOPMENT	5	5.48e-03	2.12e-02	0.9710	1.46e-01	2.79e-01	4.29e-01	6.50e-01	4.54e-01	-1.74e-01	5.72e-01	2.80e-01	9.67e-02	1.18e-02	7.84e-02	4.99e-01
GOBP POSITIVE REGULATION OF APOPTOTIC PROCESS INVOLVED IN MORPHOGENESIS	5	5.48e-03	2.12e-02	0.9710	1.46e-01	2.79e-01	4.29e-01	6.50e-01	4.54e-01	-1.74e-01	5.72e-01	2.80e-01	9.67e-02	1.18e-02	7.84e-02	4.99e-01
GOMF UBIQUITIN LIKE PROTEIN SPECIFIC ENDOPEPTIDASE ACTIVITY	5	4.93e-03	1.94e-02	0.9710	-6.82e-01	2.78e-01	-3.62e-01	-1.95e-02	4.13e-01	3.13e-01	8.26e-03	2.82e-01	1.61e-01	9.40e-01	1.10e-01	2.26e-01
GOCC EUKARYOTIC TRANSLATION INITIATION FACTOR 3 COMPLEX	16	1.02e-04	6.94e-04	0.9710	-3.57e-01	-6.32e-01	-5.89e-01	-9.78e-02	-1.29e-01	-2.05e-01	1.35e-02	1.21e-05	4.45e-05	4.98e-01	3.71e-01	1.55e-01
GOBP BASE EXCISION REPAIR GAP FILLING	14	5.70e-05	4.10e-04	0.9700	2.33e-01	-1.89e-01	-3.43e-01	6.59e-01	4.56e-01	-3.04e-01	1.31e-01	2.21e-01	2.62e-02	1.96e-05	3.16e-03	4.90e-02
GOCC NUCLEOLAR EXOSOME RNASE COMPLEX	10	2.14e-03	9.74e-03	0.9690	-9.59e-02	-5.70e-01	-7.02e-01	5.82e-02	1.68e-01	-2.84e-01	5.99e-01	1.79e-03	1.21e-04	7.50e-01	3.57e-01	1.19e-01
GOBP MITOTIC SPINDLE ELONGATION	11	4.31e-06	3.98e-05	0.9690	2.19e-01	-2.85e-01	3.79e-01	7.44e-01	1.74e-01	2.85e-01	2.09e-01	1.02e-01	2.95e-02	1.90e-05	3.18e-01	1.02e-01
GOBP PROSTATE GLANDULAR ACINUS DEVELOPMENT	5	1.99e-01	3.15e-01	0.9680	3.85e-01	4.70e-01	3.06e-01	3.92e-01	5.60e-01	8.43e-02	1.36e-01	6.86e-02	2.35e-01	1.29e-01	3.02e-02	7.44e-01
GOMF ACTIVIN RECEPTOR ACTIVITY TYPE I	5	6.16e-02	1.38e-01	0.9680	-2.65e-01	3.48e-01	5.41e-01	1.57e-01	1.46e-01	6.38e-01	3.05e-01	1.78e-01	3.62e-02	5.43e-01	5.71e-01	1.35e-02
GOBP PHENOTYPIC SWITCHING	6	7.30e-02	1.56e-01	0.9670	2.22e-01	8.94e-02	-3.54e-01	3.10e-01	6.09e-01	-5.35e-01	3.47e-01	7.05e-01	1.33e-01	1.89e-01	9.80e-03	2.32e-02
GOCC RIBONUCLEASE MRP COMPLEX	9	2.62e-03	1.15e-02	0.9640	-5.54e-02	-7.21e-01	-5.67e-01	1.93e-01	3.57e-03	-2.16e-01	7.73e-01	1.78e-04	3.21e-03	3.17e-01	9.85e-01	2.61e-01
GOBP PROTEIN N LINKED GLYCOSYLATION VIA ASPARAGINE	23	3.13e-08	4.10e-07	0.9630	-5.03e-01	-4.97e-01	9.50e-02	-6.84e-02	-4.33e-01	4.76e-01	2.94e-05	3.69e-05	4.31e-01	5.70e-01	3.29e-04	7.86e-05
GOCC CIA COMPLEX	5	1.31e-01	2.37e-01	0.9620	3.53e-02	-5.31e-01	-5.90e-01	2.36e-01	5.24e-02	-4.85e-01	8.91e-01	3.99e-02	2.23e-02	3.61e-01	8.39e-01	6.01e-02
GOBP MITOCHONDRIAL RNA CATABOLIC PROCESS	6	7.14e-02	1.53e-01	0.9620	-4.75e-01	-5.87e-01	-2.65e-01	-9.31e-02	-5.19e-01	8.36e-02	4.37e-02	1.28e-02	2.60e-01	6.93e-01	2.77e-02	7.23e-01
GOBP NEGATIVE REGULATION OF PROTEIN EXPORT FROM NUCLEUS	6	5.63e-02	1.29e-01	0.9620	-3.90e-01	-6.62e-01	1.98e-01	-1.42e-01	-4.72e-01	2.28e-01	9.77e-02	4.99e-03	4.01e-01	5.46e-01	4.51e-02	3.34e-01
GOBP SUGAR MEDIATED SIGNALING PATHWAY	6	7.01e-02	1.51e-01	0.9610	5.53e-01	1.49e-01	1.83e-01	6.35e-01	3.76e-01	-1.32e-01	1.91e-02	5.27e-01	4.38e-01	7.04e-03	1.11e-01	5.76e-01
GOCC CYTOSOLIC RIBOSOME	112	6.00e-45	1.32e-42	0.9600	-2.40e-01	-7.31e-01	-5.41e-01	-8.21e-02	-5.17e-02	-1.70e-01	1.19e-05	7.35e-41	4.47e-23	1.33e-01	3.44e-01	1.86e-03
GOCC TIM22 MITOCHONDRIAL IMPORT INNER MEMBRANE INSERTION COMPLEX	7	1.67e-02	5.14e-02	0.9600	-1.91e-01	-4.51e-01	-7.74e-01	-5.33e-02	2.18e-01	-1.78e-01	3.83e-01	3.90e-02	3.87e-04	8.07e-01	3.19e-01	4.14e-01
GOBP POSITIVE REGULATION OF MONOCYTE DIFFERENTIATION	8	7.58e-03	2.77e-02	0.9590	1.32e-01	3.17e-03	-2.37e-01	6.28e-01	5.59e-01	-3.73e-01	5.18e-01	9.88e-01	2.46e-01	2.10e-03	6.17e-03	6.78e-02
GOCC GABA RECEPTOR COMPLEX	6	6.22e-03	2.34e-02	0.9580	3.03e-01	4.75e-01	3.43e-01	-6.14e-01	-1.67e-01	-2.79e-01	1.99e-01	4.38e-02	1.46e-01	9.14e-03	4.79e-01	2.37e-01
GOMF GABA RECEPTOR ACTIVITY	6	6.22e-03	2.34e-02	0.9580	3.03e-01	4.75e-01	3.43e-01	-6.14e-01	-1.67e-01	-2.79e-01	1.99e-01	4.38e-02	1.46e-01	9.14e-03	4.79e-01	2.37e-01
GOBP MITOCHONDRIAL ELECTRON TRANSPORT SUCCINATE TO UBIQUINONE	5	6.60e-02	1.45e-01	0.9570	-3.73e-01	-7.06e-01	-2.85e-01	1.23e-01	-3.06e-01	2.97e-01	1.48e-01	6.29e-03	2.70e-01	6.34e-01	2.36e-01	2.50e-01
GOMF NAADP SENSITIVE CALCIUM RELEASE CHANNEL ACTIVITY	5	6.45e-02	1.42e-01	0.9560	4.45e-01	6.87e-01	1.39e-01	-1.26e-01	1.95e-01	-4.12e-01	8.46e-02	7.76e-03	5.91e-01	6.25e-01	4.50e-01	1.10e-01
GOBP RESPONSE TO INTERLEUKIN 9	7	2.82e-02	7.65e-02	0.9550	3.05e-01	3.98e-01	2.34e-01	5.65e-01	2.02e-01	4.96e-01	1.63e-01	6.79e-02	2.83e-01	9.63e-03	3.54e-01	2.30e-02
GOBP REGULATION OF ACTIVATION OF JANUS KINASE ACTIVITY	5	1.55e-01	2.66e-01	0.9550	3.88e-01	2.22e-01	-5.49e-02	5.32e-01	5.84e-01	2.91e-01	1.33e-01	3.91e-01	8.32e-01	3.94e-02	2.36e-02	2.59e-01
GOMF TOLL LIKE RECEPTOR 4 BINDING	5	1.07e-01	2.05e-01	0.9550	-2.99e-01	2.23e-01	4.13e-01	-3.32e-01	-4.33e-01	5.53e-01	2.47e-01	3.89e-01	1.10e-01	1.98e-01	9.37e-02	3.24e-02
GOBP OXYGEN TRANSPORT	10	8.64e-03	3.06e-02	0.9550	5.15e-01	2.36e-01	4.89e-01	3.93e-01	-2.77e-02	4.43e-01	4.82e-03	1.96e-01	7.39e-03	3.15e-02	8.79e-01	1.52e-02
GOBP NEGATIVE REGULATION OF B CELL RECEPTOR SIGNALING PATHWAY	7	1.03e-01	2.00e-01	0.9540	5.07e-01	3.88e-01	3.10e-01	4.75e-01	2.68e-01	3.28e-01	2.01e-02	7.52e-02	1.55e-01	2.95e-02	2.19e-01	1.32e-01
GOMF 5S RRNA BINDING	9	4.41e-03	1.76e-02	0.9530	-2.61e-01	-8.27e-01	-1.97e-01	-1.32e-01	-3.11e-01	4.87e-02	1.75e-01	1.71e-05	3.05e-01	4.94e-01	1.06e-01	8.00e-01
GOMF NADPLUS NUCLEOSIDASE ACTIVITY	8	2.95e-03	1.28e-02	0.9530	-3.79e-01	3.63e-01	4.64e-01	-9.27e-02	-2.56e-01	5.86e-01	6.35e-02	7.56e-02	2.32e-02	6.50e-01	2.10e-01	4.09e-03
GOBP REGULATION OF HISTAMINE SECRETION BY MAST CELL	6	1.08e-01	2.06e-01	0.9520	-4.85e-01	-5.71e-01	-8.68e-02	-4.02e-01	-3.01e-01	2.92e-01	3.97e-02	1.54e-02	7.13e-01	8.80e-02	2.01e-01	2.15e-01
GOBP MESENDODERM DEVELOPMENT	6	2.10e-02	6.14e-02	0.9520	1.22e-01	6.27e-01	-3.95e-01	1.52e-01	3.83e-01	-4.15e-01	6.05e-01	7.81e-03	9.41e-02	5.19e-01	1.05e-01	7.83e-02
GOCC MESSENGER RIBONUCLEOPROTEIN COMPLEX	6	2.07e-02	6.09e-02	0.9520	-4.98e-01	5.86e-02	5.30e-01	-4.28e-01	-4.26e-01	8.91e-02	3.47e-02	8.04e-01	2.45e-02	6.92e-02	7.07e-02	7.05e-01
GOBP POSITIVE REGULATION OF MICROTUBULE NUCLEATION	8	3.08e-02	8.15e-02	0.9520	2.96e-01	3.92e-01	-8.73e-02	5.26e-01	5.18e-01	-3.34e-01	1.47e-01	5.48e-02	6.69e-01	9.99e-03	1.12e-02	1.01e-01
GOCC MITOCHONDRIAL LARGE RIBOSOMAL SUBUNIT	56	7.95e-26	5.54e-24	0.9520	-1.32e-02	-7.47e-01	-5.29e-01	1.74e-01	-1.12e-01	-1.55e-01	8.64e-01	3.61e-22	7.10e-12	2.42e-02	1.48e-01	4.49e-02
GOBP NEGATIVE REGULATION OF T CELL MEDIATED CYTOTOXICITY	9	8.74e-03	3.08e-02	0.9510	4.82e-02	4.45e-01	5.30e-01	2.82e-01	3.22e-02	5.85e-01	8.02e-01	2.07e-02	5.89e-03	1.43e-01	8.67e-01	2.36e-03
GOCC ORGANELLAR RIBOSOME	89	4.31e-42	7.69e-40	0.9510	-4.76e-02	-7.56e-01	-5.38e-01	1.29e-01	-1.01e-01	-1.17e-01	4.37e-01	4.88e-35	1.53e-18	3.53e-02	1.01e-01	5.55e-02
GOBP REGULATION OF CYCLIC NUCLEOTIDE PHOSPHODIESTERASE ACTIVITY	6	5.36e-02	1.24e-01	0.9500	-1.64e-01	-2.15e-01	2.68e-01	-2.28e-01	-6.24e-01	5.63e-01	4.87e-01	3.61e-01	2.56e-01	3.32e-01	8.13e-03	1.70e-02
GOBP REGULATION OF MICROVILLUS ASSEMBLY	6	3.92e-02	9.80e-02	0.9500	1.98e-02	5.75e-01	6.46e-01	-2.13e-01	1.46e-01	2.97e-01	9.33e-01	1.48e-02	6.16e-03	3.67e-01	5.36e-01	2.07e-01
GOBP CAP DEPENDENT TRANSLATIONAL INITIATION	7	3.16e-02	8.30e-02	0.9490	-2.93e-01	-5.35e-01	-4.96e-01	8.97e-02	-3.25e-01	-4.12e-01	1.79e-01	1.43e-02	2.30e-02	6.81e-01	1.36e-01	5.90e-02
GOMF RIBOSOMAL LARGE SUBUNIT BINDING	14	1.55e-03	7.37e-03	0.9490	-5.32e-01	-5.76e-01	-3.77e-01	-2.56e-01	-2.78e-01	-1.47e-02	5.67e-04	1.88e-04	1.46e-02	9.68e-02	7.20e-02	9.24e-01
GOCC T CELL RECEPTOR COMPLEX	118	2.00e-43	4.03e-41	0.9490	4.17e-01	4.11e-01	-1.02e-01	4.13e-01	5.80e-01	2.01e-01	5.29e-15	1.19e-14	5.52e-02	9.05e-15	1.20e-27	1.61e-04
GOBP POSITIVE REGULATION OF T HELPER 1 CELL DIFFERENTIATION	5	7.58e-02	1.60e-01	0.9490	-6.11e-01	-1.96e-01	4.27e-01	-3.90e-01	-2.41e-01	3.10e-01	1.79e-02	4.49e-01	9.85e-02	1.31e-01	3.50e-01	2.30e-01
GOBP NEURON NEURON SYNAPTIC TRANSMISSION	6	1.34e-01	2.41e-01	0.9480	-4.87e-01	-3.16e-01	-1.75e-02	-5.65e-01	-4.04e-01	2.84e-01	3.88e-02	1.81e-01	9.41e-01	1.66e-02	8.69e-02	2.29e-01
GOBP POSITIVE REGULATION OF PLASMINOGEN ACTIVATION	7	5.27e-03	2.05e-02	0.9480	-3.58e-01	-4.56e-01	5.46e-01	-5.94e-02	-3.64e-01	3.58e-01	1.01e-01	3.67e-02	1.23e-02	7.85e-01	9.52e-02	1.01e-01
GOMF THIOREDOXIN DEPENDENT PEROXIREDOXIN ACTIVITY	6	4.27e-02	1.04e-01	0.9470	-4.07e-01	-7.88e-01	-2.57e-01	-1.57e-01	-8.81e-02	1.07e-01	8.40e-02	8.34e-04	2.76e-01	5.07e-01	7.09e-01	6.50e-01
GOMF NEDD8 TRANSFERASE ACTIVITY	7	3.38e-02	8.77e-02	0.9460	-3.72e-01	-5.48e-01	1.24e-01	-2.71e-01	-3.22e-01	5.14e-01	8.86e-02	1.20e-02	5.69e-01	2.14e-01	1.40e-01	1.86e-02
GOBP POSITIVE REGULATION OF AGGREPHAGY	5	1.34e-01	2.41e-01	0.9460	3.30e-01	9.82e-02	7.02e-01	1.87e-01	-3.66e-01	3.38e-01	2.01e-01	7.04e-01	6.53e-03	4.69e-01	1.57e-01	1.91e-01
GOCC SPECTRIN	9	3.80e-02	9.58e-02	0.9460	5.81e-01	4.57e-01	3.65e-01	2.94e-01	2.71e-01	2.32e-01	2.52e-03	1.76e-02	5.78e-02	1.26e-01	1.59e-01	2.27e-01
GOBP SPINDLE ELONGATION	13	2.67e-07	3.05e-06	0.9450	1.63e-01	-3.58e-01	3.57e-01	7.03e-01	1.40e-01	3.13e-01	3.08e-01	2.56e-02	2.60e-02	1.15e-05	3.81e-01	5.04e-02
GOBP L LEUCINE METABOLIC PROCESS	7	3.56e-02	9.13e-02	0.9450	-3.56e-01	-6.22e-01	-5.99e-01	-3.99e-02	1.09e-01	-8.49e-02	1.03e-01	4.35e-03	6.05e-03	8.55e-01	6.19e-01	6.97e-01
GOMF BETA N ACETYLHEXOSAMINIDASE ACTIVITY	5	2.15e-01	3.32e-01	0.9450	-5.15e-01	-3.37e-01	-4.32e-01	-4.79e-01	1.47e-03	-3.12e-01	4.59e-02	1.92e-01	9.47e-02	6.34e-02	9.95e-01	2.27e-01
GOMF BETA 2 MICROGLOBULIN BINDING	9	1.70e-02	5.20e-02	0.9450	-3.78e-01	-2.19e-01	-6.70e-01	-1.05e-02	1.34e-01	-4.85e-01	4.96e-02	2.56e-01	5.03e-04	9.56e-01	4.87e-01	1.17e-02
GOCC IMMUNOGLOBULIN COMPLEX	105	1.85e-61	9.55e-59	0.9430	6.19e-02	-5.54e-01	1.34e-01	4.17e-01	-4.33e-01	4.47e-01	2.73e-01	1.02e-22	1.75e-02	1.52e-13	1.62e-14	2.50e-15
GOBP REGULATION OF NATURAL KILLER CELL CHEMOTAXIS	6	1.41e-03	6.85e-03	0.9430	5.95e-01	3.27e-01	1.99e-01	-9.99e-02	-6.15e-01	-2.62e-02	1.17e-02	1.65e-01	3.99e-01	6.72e-01	9.10e-03	9.12e-01
GOMF HISTONE H3K9 MONOMETHYLTRANSFERASE ACTIVITY	5	2.61e-01	3.81e-01	0.9420	3.62e-01	6.13e-01	2.41e-01	3.85e-01	3.52e-01	2.26e-01	1.61e-01	1.76e-02	3.51e-01	1.36e-01	1.73e-01	3.82e-01
GOCC GLYCOPROTEIN IB IX V COMPLEX	5	7.53e-03	2.75e-02	0.9420	5.96e-01	-4.34e-01	4.15e-01	-2.19e-02	-4.12e-01	2.71e-02	2.10e-02	9.28e-02	1.08e-01	9.32e-01	1.11e-01	9.16e-01
GOBP MEMBRANOUS SEPTUM MORPHOGENESIS	7	6.56e-02	1.44e-01	0.9410	2.15e-01	3.75e-01	2.23e-01	5.79e-01	4.53e-01	3.28e-01	3.24e-01	8.58e-02	3.07e-01	8.01e-03	3.78e-02	1.33e-01
GOCC LSM1 7 PAT1 COMPLEX	5	7.37e-02	1.57e-01	0.9400	-2.77e-01	-7.94e-01	-2.76e-01	8.05e-02	-1.97e-01	2.36e-01	2.83e-01	2.11e-03	2.86e-01	7.55e-01	4.44e-01	3.61e-01
GOBP REGULATION OF TETRAPYRROLE METABOLIC PROCESS	8	4.34e-02	1.06e-01	0.9400	-4.42e-01	-3.28e-01	-5.15e-01	-4.36e-01	2.94e-02	-3.53e-01	3.05e-02	1.08e-01	1.16e-02	3.28e-02	8.85e-01	8.35e-02
GOCC MITOCHONDRIAL RESPIRATORY CHAIN COMPLEX III	15	4.40e-05	3.25e-04	0.9400	-2.29e-01	-7.55e-01	-3.51e-01	7.88e-02	-2.62e-01	-2.49e-01	1.24e-01	4.04e-07	1.87e-02	5.97e-01	7.94e-02	9.45e-02
GOCC SNO S RNA CONTAINING RIBONUCLEOPROTEIN COMPLEX	22	1.11e-07	1.35e-06	0.9390	-1.16e-01	-6.74e-01	-5.88e-01	1.08e-01	-2.67e-02	-2.35e-01	3.47e-01	4.32e-08	1.76e-06	3.81e-01	8.29e-01	5.59e-02
GOBP PROTEIN TO MEMBRANE DOCKING	5	1.95e-01	3.12e-01	0.9390	-5.77e-01	-5.13e-01	9.90e-02	-1.92e-01	-4.36e-01	2.22e-01	2.55e-02	4.71e-02	7.01e-01	4.56e-01	9.16e-02	3.91e-01
GOBP TRNA TRANSPORT	5	1.81e-01	2.96e-01	0.9380	-4.62e-01	-7.23e-01	-1.78e-01	-2.37e-01	-2.38e-01	2.11e-02	7.38e-02	5.14e-03	4.91e-01	3.58e-01	3.57e-01	9.35e-01
GOCC PICLN SM PROTEIN COMPLEX	6	1.45e-02	4.61e-02	0.9380	-9.62e-02	-7.67e-01	-5.08e-01	-1.54e-01	-3.01e-02	1.97e-02	6.83e-01	1.14e-03	3.12e-02	5.14e-01	8.98e-01	9.33e-01
GOCC CHROMOSOME PASSENGER COMPLEX	6	1.68e-03	7.91e-03	0.9370	2.38e-02	-4.04e-01	4.21e-01	6.49e-01	1.03e-01	3.25e-01	9.20e-01	8.63e-02	7.39e-02	5.93e-03	6.61e-01	1.67e-01
GOBP REGULATION OF NK T CELL DIFFERENTIATION	6	7.73e-02	1.62e-01	0.9370	-2.65e-01	-8.04e-03	5.80e-01	-1.50e-01	-5.55e-01	3.76e-01	2.62e-01	9.73e-01	1.39e-02	5.25e-01	1.86e-02	1.10e-01
GOBP IRES DEPENDENT VIRAL TRANSLATIONAL INITIATION	11	7.51e-03	2.74e-02	0.9370	-4.43e-01	-6.28e-01	-4.91e-01	-9.17e-02	-1.35e-01	-1.35e-01	1.09e-02	3.08e-04	4.77e-03	5.99e-01	4.38e-01	4.37e-01
GOMF 7S RNA BINDING	7	2.47e-02	6.95e-02	0.9360	-3.74e-01	-6.91e-01	-1.68e-01	-5.95e-02	-3.02e-01	3.68e-01	8.63e-02	1.55e-03	4.41e-01	7.85e-01	1.67e-01	9.19e-02
GOBP POSITIVE REGULATION OF INTERLEUKIN 23 PRODUCTION	5	1.60e-01	2.72e-01	0.9350	2.17e-01	7.21e-01	3.86e-01	1.45e-01	3.68e-01	5.49e-02	4.00e-01	5.26e-03	1.35e-01	5.74e-01	1.54e-01	8.32e-01
GOBP MITOCHONDRIAL RNA MODIFICATION	9	2.41e-02	6.81e-02	0.9350	-2.83e-01	-6.01e-01	-4.37e-01	-2.45e-01	-1.40e-01	-4.02e-01	1.41e-01	1.78e-03	2.31e-02	2.04e-01	4.68e-01	3.69e-02
GOMF NADPLUS PROTEIN ASPARTATE ADP RIBOSYLTRANSFERASE ACTIVITY	5	1.30e-01	2.37e-01	0.9330	2.97e-01	-5.79e-03	-6.53e-01	1.24e-01	2.40e-01	-5.32e-01	2.50e-01	9.82e-01	1.14e-02	6.32e-01	3.52e-01	3.94e-02
GOBP MITOCHONDRIAL ELECTRON TRANSPORT UBIQUINOL TO CYTOCHROME C	14	1.44e-04	9.38e-04	0.9330	-3.13e-01	-7.66e-01	-2.92e-01	5.28e-02	-2.84e-01	-1.30e-01	4.25e-02	6.81e-07	5.85e-02	7.32e-01	6.57e-02	4.01e-01
GOBP HEMIDESMOSOME ASSEMBLY	5	2.29e-01	3.48e-01	0.9330	4.37e-01	3.95e-01	4.81e-01	4.03e-01	-4.41e-02	3.57e-01	9.09e-02	1.26e-01	6.24e-02	1.19e-01	8.64e-01	1.66e-01
GOBP ESTABLISHMENT OF SISTER CHROMATID COHESION	10	2.72e-04	1.65e-03	0.9320	-1.32e-01	4.29e-01	4.51e-01	4.74e-01	1.27e-01	4.72e-01	4.71e-01	1.88e-02	1.35e-02	9.43e-03	4.88e-01	9.72e-03
GOBP PARALLEL ACTIN FILAMENT BUNDLE ASSEMBLY	5	1.22e-01	2.26e-01	0.9320	6.49e-02	2.93e-01	-2.11e-01	4.17e-01	7.20e-01	2.05e-01	8.02e-01	2.56e-01	4.13e-01	1.07e-01	5.31e-03	4.28e-01
GOBP REGULATION OF VASCULAR WOUND HEALING	8	3.57e-03	1.49e-02	0.9320	-1.67e-01	-7.65e-02	5.80e-01	-4.32e-01	-5.54e-01	-6.25e-02	4.14e-01	7.08e-01	4.50e-03	3.42e-02	6.62e-03	7.59e-01
GOBP PEXOPHAGY	7	9.72e-03	3.35e-02	0.9320	-2.39e-01	-1.22e-01	-5.14e-01	1.40e-01	7.15e-01	-1.48e-02	2.73e-01	5.75e-01	1.85e-02	5.20e-01	1.05e-03	9.46e-01
GOCC MHC CLASS I PROTEIN COMPLEX	9	1.12e-02	3.77e-02	0.9310	-4.04e-01	-3.82e-01	-6.99e-01	5.38e-02	8.17e-03	-2.59e-01	3.56e-02	4.73e-02	2.83e-04	7.80e-01	9.66e-01	1.78e-01
GOBP PROLINE TRANSMEMBRANE TRANSPORT	7	2.20e-02	6.39e-02	0.9310	-2.77e-01	-3.37e-02	3.30e-01	-9.72e-02	-4.84e-01	6.61e-01	2.05e-01	8.77e-01	1.30e-01	6.56e-01	2.66e-02	2.46e-03
GOCC LSM2 8 COMPLEX	7	2.00e-02	5.92e-02	0.9310	-2.99e-01	-6.98e-01	-5.26e-01	-7.84e-02	8.80e-02	1.02e-02	1.71e-01	1.39e-03	1.59e-02	7.19e-01	6.87e-01	9.63e-01
GOBP SPINDLE MIDZONE ASSEMBLY	13	2.11e-07	2.45e-06	0.9310	6.47e-02	-4.51e-01	2.82e-01	6.96e-01	6.02e-02	3.02e-01	6.86e-01	4.83e-03	7.86e-02	1.38e-05	7.07e-01	5.96e-02
GOMF IGG RECEPTOR ACTIVITY	6	5.08e-02	1.19e-01	0.9300	3.80e-01	5.30e-01	4.84e-01	4.52e-02	4.47e-01	6.21e-02	1.07e-01	2.46e-02	3.99e-02	8.48e-01	5.82e-02	7.92e-01
GOBP ECTODERMAL CELL DIFFERENTIATION	6	4.39e-03	1.76e-02	0.9300	-3.77e-02	2.57e-01	7.21e-01	-2.43e-01	-4.41e-01	-1.55e-01	8.73e-01	2.76e-01	2.22e-03	3.03e-01	6.16e-02	5.11e-01
GOMF CYSTEINE TYPE EXOPEPTIDASE ACTIVITY	6	1.47e-02	4.66e-02	0.9300	-4.19e-01	-3.88e-01	-6.23e-01	1.23e-01	2.87e-01	2.30e-01	7.56e-02	9.95e-02	8.24e-03	6.03e-01	2.24e-01	3.30e-01
GOCC MITOCHONDRIAL PROTON TRANSPORTING ATP SYNTHASE COMPLEX COUPLING FACTOR F O	10	1.26e-03	6.20e-03	0.9300	-1.91e-01	-8.33e-01	-2.75e-01	4.24e-02	-2.35e-01	3.83e-02	2.95e-01	5.05e-06	1.33e-01	8.16e-01	1.99e-01	8.34e-01
GOBP REGULATION OF FOCAL ADHESION DISASSEMBLY	6	4.59e-03	1.83e-02	0.9290	4.25e-02	7.45e-01	2.67e-01	4.62e-01	6.37e-02	1.34e-01	8.57e-01	1.57e-03	2.57e-01	5.02e-02	7.87e-01	5.71e-01
GOBP REGULATION OF CELL COMMUNICATION BY ELECTRICAL COUPLING INVOLVED IN CARDIAC CONDUCTION	7	5.93e-02	1.34e-01	0.9290	-4.52e-01	-5.02e-01	1.05e-01	-1.41e-01	-4.26e-01	4.41e-01	3.82e-02	2.14e-02	6.31e-01	5.18e-01	5.07e-02	4.35e-02
GOCC BETA CATENIN TCF COMPLEX	13	3.44e-03	1.45e-02	0.9290	3.44e-01	4.18e-01	3.83e-01	4.79e-01	3.81e-01	2.18e-01	3.15e-02	8.99e-03	1.69e-02	2.76e-03	1.74e-02	1.74e-01
GOBP NITRIC OXIDE TRANSPORT	5	1.95e-01	3.11e-01	0.9290	4.60e-01	3.73e-01	6.33e-01	2.76e-01	8.45e-02	1.64e-01	7.48e-02	1.48e-01	1.42e-02	2.85e-01	7.44e-01	5.25e-01
GOMF DNA DEMETHYLASE ACTIVITY	5	6.13e-02	1.37e-01	0.9280	1.91e-01	-3.10e-01	-6.44e-01	5.01e-01	2.20e-01	-1.19e-01	4.59e-01	2.30e-01	1.26e-02	5.25e-02	3.94e-01	6.46e-01
GOMF PROSTANOID RECEPTOR ACTIVITY	10	5.70e-03	2.19e-02	0.9270	-3.11e-01	-3.47e-01	4.80e-01	-3.23e-01	-4.47e-01	3.29e-01	8.82e-02	5.74e-02	8.60e-03	7.71e-02	1.44e-02	7.19e-02
GOBP POSITIVE REGULATION OF PROTEIN LOCALIZATION TO EARLY ENDOSOME	9	2.76e-03	1.20e-02	0.9250	-1.48e-02	1.97e-02	5.43e-01	2.87e-01	-4.60e-01	5.16e-01	9.39e-01	9.19e-01	4.75e-03	1.36e-01	1.69e-02	7.32e-03
GOBP G PROTEIN COUPLED RECEPTOR SIGNALING PATHWAY INVOLVED IN HEART PROCESS	5	1.11e-01	2.10e-01	0.9250	-4.03e-01	-3.40e-01	4.87e-01	-6.21e-02	-3.85e-01	4.35e-01	1.19e-01	1.88e-01	5.96e-02	8.10e-01	1.36e-01	9.18e-02
GOBP SPERMINE METABOLIC PROCESS	5	1.81e-01	2.96e-01	0.9250	-4.01e-01	-7.39e-01	-2.96e-01	-1.40e-01	-1.66e-01	-1.16e-01	1.21e-01	4.20e-03	2.52e-01	5.87e-01	5.20e-01	6.54e-01
GOMF CYCLIC NUCLEOTIDE ACTIVATED MONOATOMIC ION CHANNEL ACTIVITY	5	2.64e-02	7.30e-02	0.9250	-2.22e-01	1.18e-01	2.21e-01	-3.50e-01	-6.97e-01	-3.67e-01	3.91e-01	6.47e-01	3.93e-01	1.76e-01	6.93e-03	1.55e-01
GOBP POSITIVE REGULATION OF HUMORAL IMMUNE RESPONSE MEDIATED BY CIRCULATING IMMUNOGLOBULIN	6	1.68e-02	5.17e-02	0.9250	3.28e-01	4.54e-01	1.52e-01	4.87e-03	6.44e-01	-3.21e-01	1.64e-01	5.41e-02	5.19e-01	9.84e-01	6.27e-03	1.74e-01
GOCC PROTON TRANSPORTING ATP SYNTHASE COMPLEX	21	7.11e-07	7.64e-06	0.9240	-3.20e-01	-7.75e-01	-3.09e-01	-1.01e-02	-2.34e-01	-1.41e-02	1.11e-02	7.78e-10	1.41e-02	9.36e-01	6.30e-02	9.11e-01
GOBP REGULATION OF ESTABLISHMENT OF T CELL POLARITY	6	9.92e-03	3.41e-02	0.9240	2.42e-02	6.96e-02	5.41e-01	6.02e-01	-2.36e-01	3.70e-01	9.18e-01	7.68e-01	2.18e-02	1.06e-02	3.17e-01	1.16e-01
GOCC PROTON TRANSPORTING ATP SYNTHASE COMPLEX COUPLING FACTOR F O	13	1.05e-04	7.12e-04	0.9240	-1.92e-01	-8.30e-01	-2.26e-01	1.92e-02	-2.74e-01	-9.64e-03	2.30e-01	2.17e-07	1.59e-01	9.04e-01	8.68e-02	9.52e-01
GOBP POSITIVE REGULATION OF HEPATOCYTE PROLIFERATION	6	4.14e-02	1.02e-01	0.9230	-1.40e-01	3.56e-01	7.33e-01	-1.65e-01	-2.66e-01	2.67e-01	5.53e-01	1.32e-01	1.87e-03	4.84e-01	2.58e-01	2.58e-01
GOCC UNIPLEX COMPLEX	6	9.21e-03	3.21e-02	0.9230	-3.49e-01	-6.71e-01	-2.96e-01	-3.67e-01	1.40e-01	1.96e-01	1.38e-01	4.41e-03	2.10e-01	1.20e-01	5.52e-01	4.06e-01
GOBP CELLULAR DETOXIFICATION OF ALDEHYDE	7	4.17e-02	1.03e-01	0.9230	-4.07e-01	-5.62e-01	-5.84e-01	-1.24e-01	1.17e-01	-3.41e-02	6.24e-02	1.00e-02	7.47e-03	5.71e-01	5.93e-01	8.76e-01
GOMF BILE ACID TRANSMEMBRANE TRANSPORTER ACTIVITY	8	1.35e-02	4.37e-02	0.9230	9.07e-02	-2.72e-01	5.23e-01	-2.57e-01	-6.34e-01	1.65e-01	6.57e-01	1.82e-01	1.04e-02	2.08e-01	1.91e-03	4.18e-01
GOMF IMMUNOGLOBULIN RECEPTOR ACTIVITY	11	6.42e-03	2.41e-02	0.9230	3.96e-01	4.85e-01	4.36e-01	1.35e-01	4.09e-01	2.89e-01	2.30e-02	5.34e-03	1.22e-02	4.37e-01	1.89e-02	9.70e-02
GOCC ENDOCYTIC VESICLE LUMEN	19	2.13e-07	2.47e-06	0.9220	2.99e-01	-3.29e-02	6.25e-01	4.76e-01	-5.62e-02	3.73e-01	2.42e-02	8.04e-01	2.41e-06	3.28e-04	6.72e-01	4.89e-03
GOCC PROTEASOME CORE COMPLEX	18	1.82e-07	2.13e-06	0.9200	-3.12e-01	-7.66e-01	-2.40e-01	-1.40e-01	-8.76e-02	2.79e-01	2.18e-02	1.81e-08	7.84e-02	3.03e-01	5.20e-01	4.08e-02
GOMF PROTEASOME ACTIVATING ACTIVITY	6	2.64e-02	7.30e-02	0.9200	-3.08e-01	-7.29e-01	5.90e-02	1.41e-02	-1.76e-01	4.31e-01	1.91e-01	1.99e-03	8.02e-01	9.52e-01	4.56e-01	6.72e-02
GOCC GLYCOSYLPHOSPHATIDYLINOSITOL N ACETYLGLUCOSAMINYLTRANSFERASE GPI GNT COMPLEX	7	4.86e-02	1.15e-01	0.9200	-2.05e-01	-6.64e-01	-4.19e-01	-1.07e-01	-8.60e-02	-4.12e-01	3.47e-01	2.35e-03	5.52e-02	6.25e-01	6.94e-01	5.92e-02
GOBP PROTEIN MATURATION BY 4FE 4S CLUSTER TRANSFER	8	7.70e-05	5.38e-04	0.9200	2.95e-01	-7.10e-01	-3.90e-01	2.22e-01	1.84e-01	1.44e-01	1.49e-01	5.08e-04	5.61e-02	2.77e-01	3.68e-01	4.80e-01
GOBP ADHERENS JUNCTION MAINTENANCE	6	6.49e-02	1.43e-01	0.9200	2.23e-01	-1.72e-01	6.16e-01	-1.23e-01	-5.24e-01	3.14e-01	3.44e-01	4.65e-01	9.02e-03	6.01e-01	2.63e-02	1.83e-01
GOBP POSITIVE REGULATION OF MITOCHONDRIAL TRANSLATION	16	3.12e-05	2.37e-04	0.9180	-4.69e-02	-6.43e-01	-5.59e-01	6.81e-02	5.67e-02	-3.28e-01	7.45e-01	8.56e-06	1.07e-04	6.37e-01	6.94e-01	2.33e-02
GOMF GLUCOSE BINDING	11	4.08e-03	1.66e-02	0.9180	-2.05e-01	5.22e-02	6.30e-01	-9.32e-02	-3.95e-01	4.86e-01	2.38e-01	7.64e-01	2.97e-04	5.92e-01	2.31e-02	5.29e-03
GOMF RETINYL PALMITATE ESTERASE ACTIVITY	5	1.45e-01	2.54e-01	0.9180	3.26e-01	6.49e-02	5.80e-01	4.89e-01	3.76e-02	3.93e-01	2.07e-01	8.02e-01	2.46e-02	5.81e-02	8.84e-01	1.28e-01
GOBP REGULATION OF ALDOSTERONE METABOLIC PROCESS	6	5.68e-02	1.29e-01	0.9170	2.56e-01	-5.77e-02	5.79e-01	1.41e-01	-5.61e-01	3.20e-01	2.77e-01	8.07e-01	1.41e-02	5.51e-01	1.72e-02	1.74e-01
GOBP NOTOCHORD DEVELOPMENT	13	1.63e-03	7.73e-03	0.9160	4.62e-01	1.43e-01	3.30e-01	5.39e-01	3.36e-01	3.05e-01	3.91e-03	3.72e-01	3.96e-02	7.70e-04	3.57e-02	5.72e-02
GOMF POTASSIUM CHLORIDE SYMPORTER ACTIVITY	8	4.34e-02	1.06e-01	0.9160	3.93e-01	5.61e-01	4.91e-01	2.25e-01	2.77e-01	4.33e-02	5.43e-02	6.03e-03	1.63e-02	2.70e-01	1.74e-01	8.32e-01
GOBP 2FE 2S CLUSTER ASSEMBLY	11	6.41e-04	3.47e-03	0.9160	-3.85e-02	-7.27e-01	-4.97e-01	1.47e-01	2.92e-02	-1.98e-01	8.25e-01	2.99e-05	4.32e-03	3.97e-01	8.67e-01	2.57e-01
GOCC CDC73 PAF1 COMPLEX	6	1.98e-02	5.87e-02	0.9150	-2.53e-01	6.38e-02	1.73e-01	3.65e-01	3.69e-01	6.86e-01	2.83e-01	7.87e-01	4.64e-01	1.21e-01	1.17e-01	3.63e-03
GOBP CYTOSOL TO ENDOPLASMIC RETICULUM TRANSPORT	5	1.28e-01	2.34e-01	0.9150	3.88e-01	3.87e-01	1.54e-01	6.93e-01	1.24e-01	1.33e-01	1.33e-01	1.34e-01	5.50e-01	7.30e-03	6.30e-01	6.07e-01
GOMF OXO ACID LYASE ACTIVITY	5	2.42e-01	3.60e-01	0.9150	-4.02e-01	-1.76e-01	-5.86e-01	-3.55e-01	3.14e-02	-4.17e-01	1.19e-01	4.95e-01	2.31e-02	1.70e-01	9.03e-01	1.07e-01
GOCC DYNACTIN COMPLEX	8	8.36e-03	2.98e-02	0.9150	-5.06e-01	-5.81e-01	9.08e-02	9.25e-02	-2.49e-01	4.05e-01	1.31e-02	4.42e-03	6.57e-01	6.51e-01	2.23e-01	4.74e-02
GOMF HISTONE H4 DEMETHYLASE ACTIVITY	5	6.44e-03	2.41e-02	0.9150	-1.98e-01	6.37e-01	4.69e-01	3.65e-01	-7.63e-02	1.79e-01	4.44e-01	1.36e-02	6.95e-02	1.57e-01	7.68e-01	4.88e-01
GOBP REGULATION OF APOPTOTIC PROCESS INVOLVED IN DEVELOPMENT	7	1.09e-03	5.48e-03	0.9140	8.07e-02	2.02e-01	4.51e-01	5.75e-01	5.04e-01	3.50e-02	7.12e-01	3.56e-01	3.90e-02	8.38e-03	2.10e-02	8.73e-01
GOBP GLUTATHIONE CATABOLIC PROCESS	5	1.52e-02	4.78e-02	0.9140	1.31e-01	-1.90e-02	5.21e-01	2.23e-01	5.08e-01	4.88e-01	6.11e-01	9.41e-01	4.36e-02	3.87e-01	4.89e-02	5.85e-02
GOBP NERVE GROWTH FACTOR SIGNALING PATHWAY	10	3.77e-03	1.56e-02	0.9130	-4.56e-01	2.56e-02	4.70e-01	-1.16e-01	-3.07e-01	5.44e-01	1.26e-02	8.89e-01	1.00e-02	5.24e-01	9.24e-02	2.89e-03
GOBP REGULATION OF RESPIRATORY GASEOUS EXCHANGE BY NERVOUS SYSTEM PROCESS	7	1.37e-01	2.45e-01	0.9130	3.74e-01	4.54e-01	2.38e-01	3.87e-01	5.12e-01	1.37e-01	8.69e-02	3.73e-02	2.75e-01	7.61e-02	1.90e-02	5.31e-01
GOBP MAST CELL CYTOKINE PRODUCTION	6	1.11e-02	3.74e-02	0.9130	-3.03e-01	4.79e-01	3.85e-01	-3.85e-01	-4.64e-01	1.10e-02	1.98e-01	4.22e-02	1.03e-01	1.03e-01	4.91e-02	9.63e-01
GOCC SEC61 TRANSLOCON COMPLEX	5	4.94e-02	1.16e-01	0.9120	-4.93e-01	-4.74e-01	-3.02e-01	1.25e-01	-4.89e-01	1.39e-01	5.63e-02	6.65e-02	2.42e-01	6.29e-01	5.83e-02	5.91e-01
GOBP COLLAGEN ACTIVATED TYROSINE KINASE RECEPTOR SIGNALING PATHWAY	8	6.04e-03	2.28e-02	0.9120	-1.02e-01	1.29e-01	2.32e-01	-4.86e-01	-7.00e-01	-1.57e-01	6.16e-01	5.28e-01	2.56e-01	1.74e-02	6.03e-04	4.43e-01
GOBP CAMP PKA SIGNAL TRANSDUCTION	5	7.44e-02	1.58e-01	0.9120	-3.08e-01	-3.41e-01	2.46e-01	2.84e-02	-2.09e-02	7.47e-01	2.33e-01	1.86e-01	3.41e-01	9.12e-01	9.36e-01	3.82e-03
GOCC RIBOSOME	223	1.40e-87	1.63e-84	0.9110	-1.83e-01	-7.17e-01	-5.10e-01	1.58e-02	-9.15e-02	-1.16e-01	2.51e-06	1.22e-76	1.70e-39	6.84e-01	1.86e-02	2.92e-03
GOBP CADMIUM ION TRANSMEMBRANE TRANSPORT	5	1.53e-01	2.63e-01	0.9110	-4.53e-01	-5.39e-02	3.93e-01	-2.27e-01	-5.69e-01	3.01e-01	7.91e-02	8.35e-01	1.28e-01	3.79e-01	2.75e-02	2.44e-01
GOBP PROTEIN POLYUFMYLATION	5	8.06e-02	1.68e-01	0.9110	-5.22e-01	-4.93e-01	-4.34e-01	-9.06e-02	-6.21e-02	3.37e-01	4.32e-02	5.61e-02	9.32e-02	7.26e-01	8.10e-01	1.93e-01
GOBP DENDRITIC CELL APOPTOTIC PROCESS	9	1.92e-02	5.73e-02	0.9110	5.23e-02	1.66e-01	6.41e-01	1.97e-01	-1.24e-02	5.91e-01	7.86e-01	3.90e-01	8.73e-04	3.05e-01	9.49e-01	2.13e-03
GOBP POST EMBRYONIC HEMOPOIESIS	5	3.02e-01	4.22e-01	0.9100	-4.01e-01	-3.05e-01	-4.88e-01	-3.47e-01	-5.14e-02	-4.63e-01	1.21e-01	2.38e-01	5.90e-02	1.79e-01	8.42e-01	7.29e-02
GOMF PYRUVATE DEHYDROGENASE ACETYL TRANSFERRING PHOSPHATASE ACTIVITY	5	1.16e-01	2.17e-01	0.9100	2.18e-02	2.34e-01	2.83e-01	3.68e-01	2.21e-01	7.13e-01	9.33e-01	3.65e-01	2.74e-01	1.54e-01	3.93e-01	5.74e-03
GOBP POSITIVE REGULATION OF ENDOCYTIC RECYCLING	6	1.55e-01	2.66e-01	0.9090	2.38e-01	1.55e-01	5.68e-01	2.39e-01	-3.06e-02	6.05e-01	3.12e-01	5.10e-01	1.61e-02	3.10e-01	8.97e-01	1.03e-02
GOCC SUPER ELONGATION COMPLEX	6	9.37e-02	1.87e-01	0.9090	-3.15e-01	9.80e-02	5.89e-01	-2.25e-01	-4.25e-01	3.74e-01	1.81e-01	6.78e-01	1.25e-02	3.40e-01	7.12e-02	1.13e-01
GOMF ADENOSINE 3 5 BISPHOSPHATE TRANSMEMBRANE TRANSPORTER ACTIVITY	5	1.95e-01	3.12e-01	0.9090	-3.05e-01	-4.68e-01	-4.17e-01	-5.93e-02	-4.08e-01	-4.12e-01	2.38e-01	7.00e-02	1.07e-01	8.18e-01	1.14e-01	1.10e-01
GOBP CYTOPLASMIC TRANSLATIONAL INITIATION	42	1.83e-11	3.58e-10	0.9090	-3.42e-01	-6.20e-01	-4.90e-01	-1.44e-01	-1.54e-01	-1.96e-01	1.23e-04	3.40e-12	3.77e-08	1.07e-01	8.43e-02	2.77e-02
GOBP LIPID DIGESTION	12	3.15e-03	1.35e-02	0.9090	1.03e-01	4.25e-01	6.45e-01	1.38e-01	1.10e-01	4.33e-01	5.36e-01	1.09e-02	1.09e-04	4.06e-01	5.10e-01	9.48e-03
GOBP REGULATION OF PLASMA MEMBRANE REPAIR	7	1.70e-02	5.21e-02	0.9080	-4.07e-01	-5.34e-01	3.52e-01	-2.45e-01	-4.19e-01	1.19e-01	6.25e-02	1.44e-02	1.07e-01	2.62e-01	5.51e-02	5.86e-01
GOBP REGULATION OF CALCIDIOL 1 MONOOXYGENASE ACTIVITY	7	3.53e-04	2.08e-03	0.9070	1.33e-01	4.76e-01	5.32e-01	-2.52e-01	4.66e-01	-1.21e-01	5.42e-01	2.91e-02	1.49e-02	2.49e-01	3.27e-02	5.81e-01
GOMF MANGANESE ION TRANSMEMBRANE TRANSPORTER ACTIVITY	8	3.63e-03	1.51e-02	0.9070	-4.25e-01	6.13e-02	5.06e-01	-1.58e-01	-5.71e-01	1.73e-01	3.72e-02	7.64e-01	1.32e-02	4.39e-01	5.13e-03	3.97e-01
GOBP POSITIVE REGULATION OF PHOSPHOLIPID TRANSLOCATION	5	9.86e-02	1.94e-01	0.9070	1.52e-01	4.81e-01	1.31e-01	2.84e-01	3.70e-01	5.77e-01	5.56e-01	6.26e-02	6.13e-01	2.72e-01	1.52e-01	2.54e-02
GOBP PROLINE TRANSPORT	9	2.48e-02	6.95e-02	0.9070	-1.46e-01	-1.22e-02	4.72e-01	-1.59e-01	-4.77e-01	5.70e-01	4.48e-01	9.50e-01	1.43e-02	4.10e-01	1.32e-02	3.04e-03
GOBP VOCALIZATION BEHAVIOR	9	7.35e-03	2.69e-02	0.9070	-1.39e-02	4.67e-01	2.31e-01	4.27e-01	4.21e-01	4.37e-01	9.43e-01	1.54e-02	2.29e-01	2.65e-02	2.88e-02	2.32e-02
GOBP REGULATION OF CD8 POSITIVE ALPHA BETA T CELL DIFFERENTIATION	8	2.07e-02	6.08e-02	0.9060	8.86e-02	3.07e-01	6.30e-01	2.54e-01	-2.65e-01	4.31e-01	6.64e-01	1.32e-01	2.02e-03	2.14e-01	1.95e-01	3.46e-02
GOBP REGULATION OF LIPOPHAGY	5	2.09e-02	6.12e-02	0.9040	-2.05e-01	1.33e-01	4.33e-01	2.92e-01	-5.31e-01	4.51e-01	4.27e-01	6.06e-01	9.38e-02	2.58e-01	3.96e-02	8.07e-02
GOMF PROTEIN DISULFIDE REDUCTASE NAD P H ACTIVITY	8	1.28e-03	6.29e-03	0.9040	-5.78e-01	-3.67e-01	3.65e-01	1.26e-01	-1.64e-01	4.16e-01	4.66e-03	7.23e-02	7.36e-02	5.37e-01	4.22e-01	4.14e-02
GOBP NEURAL PLATE REGIONALIZATION	6	7.88e-02	1.65e-01	0.9040	2.95e-01	3.14e-01	-5.33e-01	1.81e-01	3.53e-01	-4.35e-01	2.10e-01	1.83e-01	2.37e-02	4.44e-01	1.35e-01	6.47e-02
GOBP POSITIVE REGULATION OF NUCLEOTIDE BINDING DOMAIN LEUCINE RICH REPEAT CONTAINING RECEPTOR SIGNALING PATHWAY	7	8.69e-04	4.52e-03	0.9040	-2.37e-01	4.32e-01	-6.41e-02	4.70e-01	4.64e-01	-3.66e-01	2.77e-01	4.78e-02	7.69e-01	3.14e-02	3.36e-02	9.37e-02
GOCC CRD MEDIATED MRNA STABILITY COMPLEX	5	2.16e-01	3.33e-01	0.9040	-6.52e-01	-3.57e-01	-4.98e-02	-2.50e-01	-2.84e-01	3.43e-01	1.15e-02	1.66e-01	8.47e-01	3.33e-01	2.72e-01	1.84e-01
GOMF COMPLEMENT COMPONENT C3B BINDING	5	1.34e-01	2.41e-01	0.9030	-1.87e-01	1.70e-01	5.00e-01	-4.16e-01	-5.70e-01	5.17e-02	4.68e-01	5.10e-01	5.26e-02	1.07e-01	2.72e-02	8.41e-01
GOCC GLYCOGEN GRANULE	6	1.73e-01	2.87e-01	0.9020	2.87e-01	3.58e-01	2.18e-01	5.65e-01	3.46e-01	3.41e-01	2.23e-01	1.29e-01	3.55e-01	1.66e-02	1.42e-01	1.48e-01
GOCC PALMITOYLTRANSFERASE COMPLEX	11	1.50e-02	4.74e-02	0.9020	-3.61e-01	-4.34e-01	3.82e-02	-3.70e-01	-5.24e-01	2.86e-01	3.82e-02	1.27e-02	8.26e-01	3.34e-02	2.64e-03	1.01e-01
GOBP MITOCHONDRIAL TRNA PROCESSING	14	4.44e-03	1.77e-02	0.9020	-3.95e-01	-5.73e-01	-4.04e-01	-2.51e-01	-2.00e-01	-2.48e-01	1.04e-02	2.04e-04	8.85e-03	1.04e-01	1.94e-01	1.08e-01
GOBP INNATE IMMUNE RESPONSE IN MUCOSA	17	3.12e-06	2.98e-05	0.9010	-1.06e-01	-6.04e-01	3.05e-01	-6.66e-02	-5.65e-01	1.39e-01	4.50e-01	1.62e-05	2.94e-02	6.34e-01	5.48e-05	3.23e-01
GOBP AUTOPHAGIC CELL DEATH	8	8.38e-03	2.99e-02	0.9010	-6.32e-01	-3.35e-01	2.40e-01	-7.97e-02	-4.40e-01	2.05e-01	1.95e-03	1.01e-01	2.40e-01	6.96e-01	3.10e-02	3.15e-01
GOBP REGULATION OF DNA DAMAGE RESPONSE SIGNAL TRANSDUCTION BY P53 CLASS MEDIATOR RESULTING IN TRANSCRIPTION OF P21 CLASS MEDIATOR	6	1.08e-01	2.07e-01	0.9010	-1.36e-01	-5.00e-01	-6.71e-01	1.13e-01	1.49e-01	-2.38e-01	5.63e-01	3.38e-02	4.42e-03	6.32e-01	5.27e-01	3.12e-01
GOBP POSITIVE REGULATION OF ESTABLISHMENT OF PROTEIN LOCALIZATION TO TELOMERE	10	1.26e-03	6.20e-03	0.9000	-2.15e-01	-7.81e-01	-2.57e-01	2.12e-01	-1.78e-01	1.09e-01	2.40e-01	1.89e-05	1.60e-01	2.45e-01	3.31e-01	5.52e-01
GOMF GROWTH HORMONE RECEPTOR BINDING	5	2.51e-01	3.70e-01	0.9000	1.95e-01	5.62e-01	3.14e-01	3.91e-01	3.06e-01	3.33e-01	4.49e-01	2.95e-02	2.24e-01	1.30e-01	2.36e-01	1.97e-01
GOBP WYBUTOSINE METABOLIC PROCESS	6	1.25e-01	2.30e-01	0.9000	-4.33e-01	-4.65e-01	-5.88e-01	-2.15e-01	-1.01e-01	-6.12e-02	6.60e-02	4.85e-02	1.27e-02	3.62e-01	6.69e-01	7.95e-01
GOBP REGULATION OF SKELETAL MUSCLE TISSUE REGENERATION	5	2.37e-01	3.55e-01	0.8990	6.32e-01	5.17e-01	2.58e-01	2.32e-01	9.26e-02	-1.18e-01	1.44e-02	4.55e-02	3.18e-01	3.68e-01	7.20e-01	6.48e-01
GOBP REGULATION OF ENDODERMAL CELL DIFFERENTIATION	5	8.79e-02	1.78e-01	0.8990	-7.06e-01	-4.42e-01	9.68e-02	-8.72e-02	-2.93e-01	1.09e-01	6.27e-03	8.72e-02	7.08e-01	7.36e-01	2.56e-01	6.74e-01
GOBP LEUKOCYTE AGGREGATION	11	1.01e-03	5.13e-03	0.8980	3.13e-02	4.86e-01	6.99e-01	7.31e-02	7.27e-02	2.63e-01	8.57e-01	5.23e-03	5.96e-05	6.75e-01	6.76e-01	1.30e-01
GOBP RESPONSE TO INTERFERON ALPHA	18	2.83e-06	2.74e-05	0.8970	2.06e-02	2.70e-01	2.57e-01	4.69e-01	2.35e-01	6.24e-01	8.80e-01	4.76e-02	5.89e-02	5.78e-04	8.38e-02	4.52e-06
GOBP REGULATION OF CALCIUM IMPORT INTO THE MITOCHONDRION	6	9.40e-02	1.88e-01	0.8960	-7.76e-02	-6.57e-01	-4.74e-01	1.42e-01	-8.78e-02	-3.36e-01	7.42e-01	5.30e-03	4.44e-02	5.46e-01	7.10e-01	1.54e-01
GOBP FEMALE MEIOSIS CHROMOSOME SEGREGATION	5	4.28e-02	1.05e-01	0.8960	2.05e-01	-4.74e-01	1.35e-01	5.79e-01	-7.36e-02	4.19e-01	4.28e-01	6.62e-02	6.00e-01	2.49e-02	7.76e-01	1.04e-01
GOBP NEGATIVE REGULATION OF ADENYLATE CYCLASE ACTIVATING ADRENERGIC RECEPTOR SIGNALING PATHWAY	5	9.10e-02	1.83e-01	0.8950	1.48e-01	3.47e-01	4.36e-01	5.87e-01	3.32e-01	1.18e-01	5.66e-01	1.79e-01	9.10e-02	2.31e-02	1.99e-01	6.47e-01
GOMF DNA TOPOISOMERASE ACTIVITY	6	2.23e-02	6.45e-02	0.8940	8.51e-02	6.79e-02	4.30e-01	7.05e-01	4.33e-02	3.24e-01	7.18e-01	7.73e-01	6.80e-02	2.80e-03	8.54e-01	1.70e-01
GOBP MANCHETTE ASSEMBLY	6	5.26e-02	1.22e-01	0.8940	2.70e-01	4.79e-01	-2.40e-01	-1.20e-01	5.90e-01	-2.76e-01	2.53e-01	4.20e-02	3.08e-01	6.11e-01	1.24e-02	2.42e-01
GOCC U6 SNRNP	8	2.32e-02	6.64e-02	0.8930	-3.30e-01	-6.29e-01	-5.29e-01	-2.42e-02	1.06e-01	-2.77e-02	1.06e-01	2.05e-03	9.63e-03	9.06e-01	6.04e-01	8.92e-01
GOBP GRANZYME MEDIATED PROGRAMMED CELL DEATH SIGNALING PATHWAY	8	8.75e-04	4.55e-03	0.8930	1.22e-01	2.11e-01	2.29e-01	5.16e-01	-2.00e-01	6.16e-01	5.50e-01	3.01e-01	2.62e-01	1.15e-02	3.26e-01	2.57e-03
GOMF PROTEIN DISULFIDE ISOMERASE ACTIVITY	18	1.05e-05	8.81e-05	0.8930	-4.16e-01	-4.60e-01	2.61e-01	5.16e-03	-3.73e-01	4.52e-01	2.22e-03	7.19e-04	5.53e-02	9.70e-01	6.17e-03	8.95e-04
GOBP INTERLEUKIN 27 MEDIATED SIGNALING PATHWAY	7	6.13e-04	3.34e-03	0.8930	-1.71e-01	-3.66e-01	-2.44e-01	1.42e-01	1.11e-01	7.36e-01	4.34e-01	9.38e-02	2.65e-01	5.16e-01	6.12e-01	7.43e-04
GOBP NATURAL KILLER CELL CHEMOTAXIS	8	1.61e-02	5.00e-02	0.8920	5.63e-01	4.90e-01	3.79e-01	1.71e-01	-2.15e-01	1.38e-01	5.82e-03	1.63e-02	6.33e-02	4.03e-01	2.91e-01	4.99e-01
GOBP CRD MEDIATED MRNA STABILIZATION	10	1.99e-02	5.91e-02	0.8920	-5.84e-01	-4.43e-01	-1.08e-02	-2.64e-01	-2.91e-01	3.21e-01	1.38e-03	1.53e-02	9.53e-01	1.48e-01	1.12e-01	7.86e-02
GOCC TRANSCRIPTION FACTOR AP 1 COMPLEX	5	3.22e-02	8.43e-02	0.8910	1.88e-01	5.39e-01	1.13e-01	-5.04e-01	2.70e-01	-3.58e-01	4.66e-01	3.67e-02	6.63e-01	5.08e-02	2.96e-01	1.66e-01
GOBP POSITIVE REGULATION OF DNA DAMAGE RESPONSE SIGNAL TRANSDUCTION BY P53 CLASS MEDIATOR RESULTING IN TRANSCRIPTION OF P21 CLASS MEDIATOR	5	1.83e-01	2.97e-01	0.8910	2.74e-02	-4.05e-01	-6.26e-01	2.05e-01	3.40e-01	-2.79e-01	9.16e-01	1.16e-01	1.53e-02	4.27e-01	1.87e-01	2.80e-01
GOBP COPI COATED VESICLE BUDDING	6	1.73e-02	5.29e-02	0.8910	-4.97e-01	-4.02e-01	1.06e-01	2.85e-01	-3.81e-01	3.83e-01	3.49e-02	8.79e-02	6.53e-01	2.27e-01	1.06e-01	1.05e-01
GOBP CYTOPLASMIC TRANSLATION	157	5.85e-51	1.94e-48	0.8910	-2.72e-01	-6.47e-01	-4.98e-01	-1.44e-01	-6.37e-02	-1.68e-01	3.87e-09	1.24e-44	4.60e-27	1.83e-03	1.68e-01	2.89e-04
GOBP REGULATION OF MRNA CIS SPLICING VIA SPLICEOSOME	5	2.61e-01	3.81e-01	0.8900	-1.73e-02	-2.43e-01	-6.02e-01	-1.48e-02	3.01e-01	-5.28e-01	9.47e-01	3.47e-01	1.97e-02	9.54e-01	2.43e-01	4.10e-02
GOBP SYNAPTIC VESICLE RECYCLING VIA ENDOSOME	5	8.98e-02	1.81e-01	0.8890	-2.20e-01	2.99e-01	5.76e-01	2.50e-01	1.28e-02	5.10e-01	3.95e-01	2.47e-01	2.58e-02	3.34e-01	9.60e-01	4.85e-02
GOMF HYDROLASE ACTIVITY ACTING ON CARBON NITROGEN BUT NOT PEPTIDE BONDS IN LINEAR AMIDINES	7	4.39e-02	1.07e-01	0.8890	3.34e-01	3.05e-01	7.09e-01	-1.48e-01	-1.79e-01	1.71e-01	1.26e-01	1.63e-01	1.16e-03	4.96e-01	4.11e-01	4.34e-01
GOMF ICOSANOID BINDING	7	1.18e-02	3.92e-02	0.8880	1.07e-01	4.43e-01	3.38e-01	-4.82e-01	-3.35e-01	3.49e-01	6.24e-01	4.23e-02	1.21e-01	2.72e-02	1.25e-01	1.10e-01
GOBP VESTIBULOCOCHLEAR NERVE DEVELOPMENT	7	5.08e-02	1.19e-01	0.8860	1.57e-01	2.00e-01	-6.08e-02	4.18e-01	6.90e-01	2.57e-01	4.71e-01	3.58e-01	7.81e-01	5.55e-02	1.58e-03	2.39e-01
GOMF CYTOCHROME B5 REDUCTASE ACTIVITY ACTING ON NAD P H	6	1.83e-01	2.98e-01	0.8860	-5.45e-01	-2.07e-01	2.00e-01	-3.26e-01	-4.35e-01	3.32e-01	2.08e-02	3.81e-01	3.97e-01	1.67e-01	6.50e-02	1.59e-01
GOBP REGULATION OF EOSINOPHIL MIGRATION	5	7.40e-02	1.57e-01	0.8850	9.10e-02	1.66e-01	5.75e-01	5.02e-01	2.50e-01	3.20e-01	7.24e-01	5.20e-01	2.60e-02	5.21e-02	3.32e-01	2.15e-01
GOBP REGULATION OF PHOSPHOLIPID TRANSLOCATION	6	7.83e-02	1.64e-01	0.8850	1.20e-01	5.35e-01	2.09e-01	2.15e-01	3.32e-01	5.32e-01	6.11e-01	2.33e-02	3.76e-01	3.61e-01	1.60e-01	2.40e-02
GOMF DOUBLE STRANDED DNA EXODEOXYRIBONUCLEASE ACTIVITY	8	4.84e-02	1.14e-01	0.8850	1.54e-01	-2.35e-01	-4.83e-01	4.23e-01	3.21e-01	-4.34e-01	4.50e-01	2.50e-01	1.79e-02	3.84e-02	1.16e-01	3.36e-02
GOBP ANATOMICAL STRUCTURE REGRESSION	8	2.29e-02	6.58e-02	0.8840	5.56e-01	4.58e-01	4.13e-01	1.18e-01	-2.19e-01	1.73e-01	6.43e-03	2.48e-02	4.29e-02	5.65e-01	2.84e-01	3.96e-01
GOCC NUCLEAR PORE CENTRAL TRANSPORT CHANNEL	6	1.84e-01	2.98e-01	0.8840	-3.71e-01	-5.79e-01	-4.38e-01	-1.77e-01	-2.05e-02	-2.93e-01	1.16e-01	1.40e-02	6.32e-02	4.54e-01	9.31e-01	2.15e-01
GOMF CLATHRIN LIGHT CHAIN BINDING	6	9.44e-02	1.88e-01	0.8840	1.85e-02	4.59e-01	9.12e-02	4.70e-01	5.61e-01	1.65e-01	9.38e-01	5.18e-02	6.99e-01	4.62e-02	1.73e-02	4.84e-01
GOBP LEARNED VOCALIZATION BEHAVIOR OR VOCAL LEARNING	7	3.81e-02	9.60e-02	0.8840	-3.33e-02	3.89e-01	3.71e-01	2.01e-01	7.17e-02	6.68e-01	8.79e-01	7.49e-02	8.92e-02	3.57e-01	7.43e-01	2.22e-03
GOBP TRACHEA FORMATION	6	6.72e-02	1.47e-01	0.8840	-4.38e-01	-3.98e-01	2.60e-01	-1.06e-01	-5.90e-01	5.66e-02	6.33e-02	9.10e-02	2.69e-01	6.54e-01	1.23e-02	8.10e-01
GOBP TRACHEA MORPHOGENESIS	6	6.72e-02	1.47e-01	0.8840	-4.38e-01	-3.98e-01	2.60e-01	-1.06e-01	-5.90e-01	5.66e-02	6.33e-02	9.10e-02	2.69e-01	6.54e-01	1.23e-02	8.10e-01
GOBP COCHLEA MORPHOGENESIS	9	1.09e-02	3.69e-02	0.8840	5.43e-02	2.83e-01	-1.75e-01	5.35e-01	5.75e-01	2.24e-01	7.78e-01	1.41e-01	3.64e-01	5.44e-03	2.82e-03	2.44e-01
GOBP CAMKK AMPK SIGNALING CASCADE	6	9.01e-03	3.15e-02	0.8840	-9.00e-02	3.22e-01	3.13e-01	4.17e-02	-4.52e-01	6.04e-01	7.03e-01	1.72e-01	1.84e-01	8.60e-01	5.54e-02	1.04e-02
GOMF L ALANINE TRANSMEMBRANE TRANSPORTER ACTIVITY	7	1.42e-02	4.54e-02	0.8830	-1.88e-01	-2.04e-01	2.28e-01	8.64e-02	-6.05e-01	5.27e-01	3.89e-01	3.51e-01	2.96e-01	6.92e-01	5.56e-03	1.57e-02
GOBP METALLO SULFUR CLUSTER ASSEMBLY	28	1.15e-09	1.81e-08	0.8830	-1.07e-01	-6.76e-01	-5.05e-01	1.28e-01	8.21e-02	-1.79e-01	3.26e-01	5.78e-10	3.74e-06	2.41e-01	4.52e-01	1.01e-01
GOBP RETINA VASCULATURE MORPHOGENESIS IN CAMERA TYPE EYE	6	9.09e-02	1.83e-01	0.8830	-1.78e-01	3.16e-01	6.54e-01	-2.43e-01	-1.16e-01	3.84e-01	4.50e-01	1.80e-01	5.54e-03	3.02e-01	6.21e-01	1.04e-01
GOBP MITOCHONDRIAL TRANSLATION	130	2.30e-50	7.11e-48	0.8820	-9.74e-02	-7.01e-01	-4.97e-01	1.01e-01	-6.18e-02	-1.28e-01	5.51e-02	1.69e-43	1.07e-22	4.67e-02	2.24e-01	1.20e-02
GOBP NEGATIVE REGULATION OF TOLL LIKE RECEPTOR 9 SIGNALING PATHWAY	5	8.78e-02	1.78e-01	0.8820	-1.35e-01	1.20e-01	-6.56e-02	5.90e-01	5.31e-01	3.31e-01	6.01e-01	6.43e-01	7.99e-01	2.23e-02	3.96e-02	2.00e-01
GOCC MITOTIC COHESIN COMPLEX	7	8.58e-03	3.05e-02	0.8810	-2.99e-01	2.85e-01	3.17e-01	3.85e-01	1.95e-01	5.65e-01	1.71e-01	1.92e-01	1.46e-01	7.77e-02	3.71e-01	9.64e-03
GOBP GLYCOLIPID TRANSPORT	8	6.83e-03	2.53e-02	0.8810	-5.75e-01	-3.43e-01	-4.00e-01	1.60e-01	3.77e-01	2.29e-03	4.89e-03	9.30e-02	4.98e-02	4.32e-01	6.49e-02	9.91e-01
GOCC RNA POLYMERASE I COMPLEX	13	2.04e-04	1.28e-03	0.8810	-9.42e-02	-7.10e-01	-2.87e-01	1.30e-01	-2.17e-01	-3.39e-01	5.57e-01	9.17e-06	7.27e-02	4.18e-01	1.75e-01	3.42e-02
GOCC CYTOLYTIC GRANULE	14	4.81e-04	2.72e-03	0.8800	-6.10e-03	1.48e-01	4.82e-01	8.79e-02	-3.35e-01	6.33e-01	9.68e-01	3.38e-01	1.79e-03	5.69e-01	3.01e-02	4.11e-05
GOBP EOSINOPHIL DIFFERENTIATION	5	4.30e-02	1.05e-01	0.8800	-4.47e-04	1.13e-01	7.52e-01	-6.66e-02	1.42e-01	4.14e-01	9.99e-01	6.62e-01	3.57e-03	7.97e-01	5.84e-01	1.09e-01
GOMF P TYPE CALCIUM TRANSPORTER ACTIVITY	7	4.21e-03	1.70e-02	0.8800	-5.42e-02	5.35e-01	4.47e-01	4.93e-01	1.51e-01	1.35e-01	8.04e-01	1.42e-02	4.05e-02	2.38e-02	4.90e-01	5.36e-01
GOBP DETERMINATION OF LIVER LEFT RIGHT ASYMMETRY	5	2.76e-01	3.96e-01	0.8790	-5.03e-01	-1.05e-01	-7.40e-02	-6.01e-01	-3.33e-01	-1.76e-01	5.12e-02	6.83e-01	7.74e-01	2.00e-02	1.98e-01	4.96e-01
GOBP REGULATION OF ESTABLISHMENT OF PROTEIN LOCALIZATION TO CHROMOSOME	12	1.13e-03	5.63e-03	0.8790	-2.84e-01	-7.34e-01	-3.11e-01	1.17e-01	-1.96e-01	5.73e-02	8.85e-02	1.06e-05	6.20e-02	4.82e-01	2.39e-01	7.31e-01
GOCC METHYLOSOME	12	2.23e-04	1.38e-03	0.8780	-3.58e-03	-7.35e-01	-4.45e-01	1.59e-01	-6.25e-02	-5.97e-02	9.83e-01	1.02e-05	7.57e-03	3.42e-01	7.08e-01	7.20e-01
GOBP REGULATION OF RNA POLYMERASE II TRANSCRIPTION PREINITIATION COMPLEX ASSEMBLY	6	6.36e-02	1.41e-01	0.8780	-4.81e-01	2.01e-02	-5.93e-01	3.94e-02	3.42e-01	-2.64e-01	4.14e-02	9.32e-01	1.19e-02	8.67e-01	1.47e-01	2.63e-01
GOBP NEGATIVE REGULATION OF CYTOKINESIS	5	3.36e-02	8.72e-02	0.8780	2.58e-01	-6.50e-01	2.28e-01	1.86e-01	-4.38e-01	6.29e-02	3.18e-01	1.19e-02	3.77e-01	4.71e-01	8.98e-02	8.08e-01
GOBP INTESTINE SMOOTH MUSCLE CONTRACTION	5	1.53e-01	2.64e-01	0.8780	-4.76e-01	9.69e-02	-1.00e-01	-6.65e-01	-1.78e-01	-2.27e-01	6.53e-02	7.07e-01	6.97e-01	1.01e-02	4.91e-01	3.80e-01
GOBP URONIC ACID METABOLIC PROCESS	9	1.92e-02	5.73e-02	0.8780	-4.76e-01	-5.90e-01	-3.94e-01	-1.30e-01	9.09e-02	-1.25e-01	1.34e-02	2.17e-03	4.08e-02	5.01e-01	6.37e-01	5.17e-01
GOBP TRANSFERRIN TRANSPORT	9	1.79e-03	8.34e-03	0.8770	2.05e-01	4.82e-01	5.03e-01	4.69e-01	1.35e-01	-5.85e-02	2.88e-01	1.22e-02	9.02e-03	1.48e-02	4.84e-01	7.61e-01
GOBP DENTINOGENESIS	5	8.18e-02	1.69e-01	0.8760	-2.01e-01	-6.13e-01	3.60e-01	-9.90e-02	-4.27e-01	1.71e-01	4.37e-01	1.76e-02	1.63e-01	7.01e-01	9.80e-02	5.07e-01
GOCC TUBULAR ENDOSOME	5	1.15e-01	2.16e-01	0.8760	-4.47e-01	-2.82e-01	1.63e-01	9.80e-02	-2.16e-01	6.36e-01	8.32e-02	2.75e-01	5.29e-01	7.04e-01	4.03e-01	1.37e-02
GOMF C X C CHEMOKINE BINDING	5	5.24e-02	1.21e-01	0.8760	3.02e-01	1.01e-01	2.45e-01	-3.64e-01	-6.88e-01	1.51e-02	2.42e-01	6.95e-01	3.43e-01	1.59e-01	7.75e-03	9.53e-01
GOBP REGULATION OF NEUROTROPHIN TRK RECEPTOR SIGNALING PATHWAY	8	2.60e-02	7.23e-02	0.8760	3.44e-01	3.67e-01	5.87e-01	-3.05e-01	-1.35e-01	2.39e-01	9.24e-02	7.19e-02	4.02e-03	1.35e-01	5.09e-01	2.41e-01
GOCC GROWTH CONE MEMBRANE	6	6.15e-02	1.37e-01	0.8750	1.11e-01	-5.87e-02	2.61e-01	5.72e-01	3.25e-01	4.99e-01	6.38e-01	8.03e-01	2.69e-01	1.53e-02	1.68e-01	3.42e-02
GOMF GLUTATHIONE DISULFIDE OXIDOREDUCTASE ACTIVITY	5	2.87e-01	4.06e-01	0.8750	-3.61e-01	-3.79e-01	2.80e-01	-3.56e-01	-3.51e-01	4.03e-01	1.62e-01	1.42e-01	2.78e-01	1.68e-01	1.74e-01	1.19e-01
GOBP REGULATION OF GAP JUNCTION ASSEMBLY	6	2.45e-02	6.91e-02	0.8740	2.39e-01	5.59e-01	3.68e-01	-4.75e-01	1.77e-01	-1.97e-02	3.11e-01	1.76e-02	1.19e-01	4.38e-02	4.52e-01	9.33e-01
GOCC IRON SULFUR CLUSTER ASSEMBLY COMPLEX	12	2.95e-04	1.77e-03	0.8730	4.50e-02	-7.11e-01	-4.10e-01	2.17e-01	-1.79e-03	-2.00e-01	7.87e-01	1.99e-05	1.39e-02	1.93e-01	9.91e-01	2.31e-01
GOMF GLYCINE TRANSMEMBRANE TRANSPORTER ACTIVITY	6	3.26e-03	1.39e-02	0.8730	1.65e-01	-1.34e-01	1.35e-01	2.79e-01	-6.83e-01	3.93e-01	4.83e-01	5.69e-01	5.67e-01	2.36e-01	3.78e-03	9.53e-02
GOBP CELLULAR HYPOTONIC RESPONSE	9	2.20e-02	6.37e-02	0.8730	-6.07e-02	7.03e-02	5.74e-01	1.19e-01	-1.42e-02	6.40e-01	7.53e-01	7.15e-01	2.85e-03	5.36e-01	9.41e-01	8.92e-04
GOBP GROWTH HORMONE RECEPTOR SIGNALING PATHWAY VIA JAK STAT	10	1.40e-03	6.82e-03	0.8730	-4.09e-02	4.17e-01	4.41e-01	4.96e-01	1.67e-01	3.43e-01	8.23e-01	2.23e-02	1.57e-02	6.64e-03	3.61e-01	6.04e-02
GOBP CYTOLYSIS	5	1.51e-01	2.62e-01	0.8730	2.94e-01	1.81e-01	-6.77e-02	3.87e-01	5.92e-01	3.71e-01	2.55e-01	4.83e-01	7.93e-01	1.34e-01	2.18e-02	1.51e-01
GOMF ACETYL COA C ACYLTRANSFERASE ACTIVITY	7	4.92e-03	1.94e-02	0.8720	-2.52e-01	-6.07e-01	-1.32e-01	1.52e-01	1.65e-01	5.11e-01	2.49e-01	5.39e-03	5.44e-01	4.87e-01	4.50e-01	1.92e-02
GOBP NEGATIVE REGULATION OF NEURON MIGRATION	6	1.33e-01	2.40e-01	0.8720	3.98e-01	4.39e-01	4.66e-01	3.78e-01	-1.18e-01	1.91e-01	9.17e-02	6.27e-02	4.83e-02	1.09e-01	6.17e-01	4.18e-01
GOCC TETRASPANIN ENRICHED MICRODOMAIN	9	1.12e-02	3.77e-02	0.8720	-1.19e-01	-5.68e-01	3.06e-01	-2.07e-01	-4.68e-01	2.62e-01	5.35e-01	3.19e-03	1.12e-01	2.83e-01	1.50e-02	1.73e-01
GOMF LIGASE ACTIVITY FORMING CARBON CARBON BONDS	7	3.33e-02	8.67e-02	0.8720	-3.17e-01	-3.24e-01	-4.72e-01	3.99e-01	3.96e-01	-1.24e-01	1.46e-01	1.38e-01	3.04e-02	6.78e-02	6.94e-02	5.70e-01
GOBP ASPARAGINE METABOLIC PROCESS	5	1.32e-01	2.39e-01	0.8710	-2.49e-01	-1.99e-01	-5.94e-01	-4.54e-01	1.94e-01	-2.44e-01	3.34e-01	4.40e-01	2.14e-02	7.86e-02	4.52e-01	3.45e-01
GOBP LIPOPHAGY	7	1.12e-02	3.77e-02	0.8710	-2.44e-01	-1.09e-01	4.54e-01	1.36e-01	-6.24e-01	2.71e-01	2.64e-01	6.19e-01	3.76e-02	5.34e-01	4.26e-03	2.15e-01
GOMF CLASS I DNA APURINIC OR APYRIMIDINIC SITE ENDONUCLEASE ACTIVITY	7	2.74e-02	7.51e-02	0.8700	1.71e-01	-3.86e-01	-5.84e-01	4.32e-01	1.75e-01	-1.43e-01	4.34e-01	7.69e-02	7.48e-03	4.80e-02	4.23e-01	5.14e-01
GOMF C METHYLTRANSFERASE ACTIVITY	7	5.93e-02	1.34e-01	0.8700	1.03e-02	-5.24e-01	-6.07e-01	-3.66e-02	3.07e-02	-3.32e-01	9.62e-01	1.64e-02	5.38e-03	8.67e-01	8.88e-01	1.28e-01
GOMF MITOCHONDRIAL RIBOSOME BINDING	8	1.62e-02	5.02e-02	0.8690	-4.27e-02	-6.86e-01	-4.50e-01	2.23e-01	3.73e-02	-1.68e-01	8.34e-01	7.78e-04	2.74e-02	2.76e-01	8.55e-01	4.11e-01
GOBP RESPIRATORY CHAIN COMPLEX III ASSEMBLY	9	8.03e-03	2.89e-02	0.8680	-9.61e-02	-7.00e-01	-4.46e-01	-1.33e-01	-2.60e-02	-1.93e-01	6.17e-01	2.75e-04	2.05e-02	4.88e-01	8.92e-01	3.15e-01
GOBP PENTOSE PHOSPHATE SHUNT NON OXIDATIVE BRANCH	5	1.62e-01	2.74e-01	0.8680	-5.04e-01	-6.27e-01	6.61e-02	-1.01e-01	-2.48e-01	1.77e-01	5.10e-02	1.52e-02	7.98e-01	6.94e-01	3.36e-01	4.94e-01
GOBP POSITIVE REGULATION OF MAINTENANCE OF SISTER CHROMATID COHESION	6	6.67e-02	1.46e-01	0.8680	-4.40e-01	-4.84e-01	-9.89e-02	3.87e-02	-3.17e-01	4.62e-01	6.17e-02	3.99e-02	6.75e-01	8.70e-01	1.79e-01	4.99e-02
GOCC CHROMOSOME CENTROMERIC CORE DOMAIN	8	1.17e-02	3.90e-02	0.8680	-2.37e-01	-5.96e-01	2.06e-01	1.72e-01	-3.47e-01	3.85e-01	2.46e-01	3.48e-03	3.13e-01	3.98e-01	8.90e-02	5.94e-02
GOMF OPSONIN RECEPTOR ACTIVITY	5	1.18e-02	3.92e-02	0.8670	-2.91e-01	4.13e-01	2.85e-01	-4.04e-01	-1.40e-01	-4.82e-01	2.61e-01	1.10e-01	2.69e-01	1.18e-01	5.88e-01	6.18e-02
GOBP NEGATIVE REGULATION OF PROTEIN CATABOLIC PROCESS IN THE VACUOLE	5	9.65e-02	1.91e-01	0.8670	-2.40e-02	-3.51e-01	4.57e-01	3.40e-01	-2.16e-01	5.07e-01	9.26e-01	1.74e-01	7.70e-02	1.88e-01	4.03e-01	4.96e-02
GOMF CARBONYL REDUCTASE NADPH ACTIVITY	9	9.96e-03	3.42e-02	0.8670	-1.13e-01	-4.66e-01	-5.72e-01	1.53e-01	3.87e-01	-1.46e-01	5.58e-01	1.55e-02	2.97e-03	4.27e-01	4.43e-02	4.49e-01
GOCC SPECTRIN ASSOCIATED CYTOSKELETON	8	5.15e-02	1.20e-01	0.8670	5.98e-01	3.53e-01	3.99e-01	1.50e-01	-2.54e-02	2.94e-01	3.39e-03	8.41e-02	5.05e-02	4.63e-01	9.01e-01	1.50e-01
GOBP PROTEIN LOCALIZATION TO MOTILE CILIUM	5	3.10e-01	4.30e-01	0.8670	-1.67e-01	1.03e-01	4.84e-01	-4.29e-01	-3.74e-01	3.93e-01	5.19e-01	6.90e-01	6.07e-02	9.69e-02	1.47e-01	1.28e-01
GOBP ALANINE TRANSPORT	12	2.26e-04	1.40e-03	0.8660	-6.49e-02	-8.82e-03	3.76e-01	8.05e-02	-6.32e-01	4.46e-01	6.97e-01	9.58e-01	2.42e-02	6.29e-01	1.49e-04	7.50e-03
GOBP BRANCHED CHAIN AMINO ACID BIOSYNTHETIC PROCESS	5	1.62e-02	5.02e-02	0.8660	1.26e-01	-5.16e-01	-2.27e-01	2.29e-01	4.30e-01	-4.24e-01	6.26e-01	4.58e-02	3.80e-01	3.76e-01	9.62e-02	1.01e-01
GOCC GAMMA SECRETASE COMPLEX	7	4.09e-02	1.01e-01	0.8660	-5.50e-01	-4.02e-01	-9.89e-03	-5.40e-03	-4.97e-01	1.97e-01	1.18e-02	6.56e-02	9.64e-01	9.80e-01	2.29e-02	3.67e-01
GOBP POSITIVE REGULATION OF RESPONSE TO TYPE II INTERFERON	6	2.10e-01	3.27e-01	0.8660	4.45e-01	3.51e-01	4.76e-01	2.45e-01	-1.02e-01	3.62e-01	5.90e-02	1.37e-01	4.35e-02	2.98e-01	6.64e-01	1.25e-01
GOCC RESPIRATORY CHAIN COMPLEX IV	20	1.22e-05	1.00e-04	0.8650	-2.53e-01	-7.16e-01	-2.38e-01	-4.59e-02	-3.33e-01	5.25e-02	4.98e-02	2.96e-08	6.59e-02	7.22e-01	9.91e-03	6.84e-01
GOMF RNA POLYMERASE I ACTIVITY	10	1.70e-03	7.99e-03	0.8650	-1.13e-01	-6.94e-01	-2.53e-01	1.90e-01	-1.69e-01	-3.53e-01	5.35e-01	1.45e-04	1.65e-01	2.99e-01	3.56e-01	5.30e-02
GOBP ORNITHINE METABOLIC PROCESS	8	6.45e-02	1.42e-01	0.8650	-1.84e-01	-2.21e-01	5.08e-01	-1.29e-01	-4.41e-01	4.42e-01	3.67e-01	2.80e-01	1.29e-02	5.29e-01	3.07e-02	3.02e-02
GOBP NEGATIVE T CELL SELECTION	11	1.50e-02	4.74e-02	0.8640	2.08e-01	3.16e-01	8.71e-02	5.34e-01	4.83e-01	2.79e-01	2.32e-01	6.99e-02	6.17e-01	2.17e-03	5.49e-03	1.09e-01
GOBP POSITIVE REGULATION OF PROTEIN K63 LINKED UBIQUITINATION	8	1.31e-02	4.26e-02	0.8640	-5.37e-01	6.75e-02	3.08e-01	-4.59e-01	3.53e-03	3.85e-01	8.52e-03	7.41e-01	1.32e-01	2.44e-02	9.86e-01	5.95e-02
GOBP L ASPARTATE IMPORT ACROSS PLASMA MEMBRANE	5	8.86e-02	1.79e-01	0.8640	3.55e-01	-2.57e-01	5.01e-01	9.85e-02	-1.60e-01	5.18e-01	1.69e-01	3.19e-01	5.26e-02	7.03e-01	5.37e-01	4.47e-02
GOBP UDP N ACETYLGLUCOSAMINE TRANSMEMBRANE TRANSPORT	5	2.31e-01	3.49e-01	0.8630	-5.49e-01	-2.03e-01	-1.26e-01	-3.40e-01	-5.19e-01	3.78e-02	3.35e-02	4.32e-01	6.26e-01	1.88e-01	4.43e-02	8.84e-01
GOMF UDP N ACETYLGLUCOSAMINE TRANSMEMBRANE TRANSPORTER ACTIVITY	5	2.31e-01	3.49e-01	0.8630	-5.49e-01	-2.03e-01	-1.26e-01	-3.40e-01	-5.19e-01	3.78e-02	3.35e-02	4.32e-01	6.26e-01	1.88e-01	4.43e-02	8.84e-01
GOBP NEGATIVE REGULATION OF CELL ADHESION MEDIATED BY INTEGRIN	10	1.46e-02	4.64e-02	0.8630	3.94e-02	3.45e-01	5.86e-01	5.20e-02	-2.95e-01	4.38e-01	8.29e-01	5.91e-02	1.34e-03	7.76e-01	1.07e-01	1.64e-02
GOMF HISTONE H3K27 METHYLTRANSFERASE ACTIVITY	6	3.47e-02	8.94e-02	0.8630	2.17e-01	1.97e-01	-8.12e-03	5.48e-01	3.14e-01	-5.09e-01	3.57e-01	4.04e-01	9.73e-01	2.01e-02	1.83e-01	3.07e-02
GOBP NEUTROPHIL EXTRAVASATION	13	7.25e-04	3.87e-03	0.8620	-7.67e-02	2.76e-01	5.01e-01	3.20e-01	1.76e-01	5.27e-01	6.32e-01	8.46e-02	1.77e-03	4.60e-02	2.71e-01	1.01e-03
GOBP EPITHELIAL CELL FATE COMMITMENT	6	7.53e-02	1.59e-01	0.8620	2.81e-02	1.43e-01	5.67e-01	2.84e-01	2.51e-01	5.07e-01	9.05e-01	5.44e-01	1.62e-02	2.29e-01	2.87e-01	3.15e-02
GOBP CELL MIGRATION INVOLVED IN HEART DEVELOPMENT	9	4.28e-03	1.73e-02	0.8620	-4.64e-03	2.72e-01	5.03e-01	4.26e-01	3.45e-01	3.40e-01	9.81e-01	1.58e-01	9.00e-03	2.69e-02	7.29e-02	7.73e-02
GOBP RIBOSOMAL SMALL SUBUNIT ASSEMBLY	18	2.33e-05	1.82e-04	0.8620	-2.63e-02	-6.08e-01	-5.55e-01	6.43e-02	-1.35e-02	-2.46e-01	8.47e-01	8.02e-06	4.60e-05	6.37e-01	9.21e-01	7.03e-02
GOCC EUKARYOTIC TRANSLATION INITIATION FACTOR 2B COMPLEX	5	7.94e-02	1.66e-01	0.8610	1.37e-01	-6.28e-01	-4.10e-01	1.31e-01	1.75e-01	-3.34e-01	5.95e-01	1.49e-02	1.12e-01	6.12e-01	4.98e-01	1.96e-01
GOMF GAMMA CATENIN BINDING	8	3.12e-02	8.24e-02	0.8610	5.69e-02	8.47e-02	6.11e-01	2.68e-01	-3.02e-01	4.41e-01	7.80e-01	6.78e-01	2.77e-03	1.90e-01	1.38e-01	3.08e-02
GOBP POSITIVE REGULATION OF TOLL LIKE RECEPTOR 7 SIGNALING PATHWAY	5	3.79e-02	9.58e-02	0.8600	-6.97e-01	-3.95e-03	-1.78e-01	1.09e-02	1.51e-01	4.47e-01	6.99e-03	9.88e-01	4.90e-01	9.66e-01	5.58e-01	8.36e-02
GOCC PLATELET DENSE TUBULAR NETWORK	10	8.58e-03	3.05e-02	0.8600	2.97e-01	4.68e-01	4.73e-01	4.26e-01	-4.96e-02	1.57e-01	1.04e-01	1.04e-02	9.61e-03	1.96e-02	7.86e-01	3.91e-01
GOBP DENDRITE SELF AVOIDANCE	5	2.55e-01	3.75e-01	0.8590	-5.65e-01	-1.70e-01	9.78e-02	-3.14e-01	-2.96e-01	4.41e-01	2.86e-02	5.11e-01	7.05e-01	2.24e-01	2.51e-01	8.79e-02
GOCC MULTIMERIC RIBONUCLEASE P COMPLEX	10	6.41e-03	2.40e-02	0.8590	-7.45e-02	-6.41e-01	-5.28e-01	1.40e-01	2.98e-02	-1.51e-01	6.83e-01	4.48e-04	3.86e-03	4.42e-01	8.70e-01	4.07e-01
GOMF RIBONUCLEASE P RNA BINDING	10	6.41e-03	2.40e-02	0.8590	-7.45e-02	-6.41e-01	-5.28e-01	1.40e-01	2.98e-02	-1.51e-01	6.83e-01	4.48e-04	3.86e-03	4.42e-01	8.70e-01	4.07e-01
GOMF OSMOSENSOR ACTIVITY	5	2.81e-01	4.01e-01	0.8580	2.46e-01	5.93e-01	3.88e-01	1.39e-02	3.55e-01	2.19e-01	3.41e-01	2.17e-02	1.33e-01	9.57e-01	1.70e-01	3.96e-01
GOBP REGULATION OF MESENCHYMAL STEM CELL DIFFERENTIATION	9	6.20e-02	1.38e-01	0.8580	3.55e-01	3.04e-01	4.74e-01	1.72e-01	6.83e-02	5.08e-01	6.50e-02	1.14e-01	1.38e-02	3.70e-01	7.23e-01	8.25e-03
GOMF OXYGEN CARRIER ACTIVITY	9	3.83e-02	9.64e-02	0.8570	4.66e-01	1.58e-01	4.59e-01	3.39e-01	-1.15e-01	3.92e-01	1.55e-02	4.11e-01	1.71e-02	7.81e-02	5.51e-01	4.15e-02
GOMF OXIDOREDUCTASE ACTIVITY ACTING ON DIPHENOLS AND RELATED SUBSTANCES AS DONORS	9	6.90e-02	1.49e-01	0.8570	-3.56e-01	-5.32e-01	-3.85e-01	-1.14e-01	-2.34e-01	-3.29e-01	6.42e-02	5.69e-03	4.52e-02	5.54e-01	2.24e-01	8.72e-02
GOBP VIRAL TRANSLATION	19	2.54e-04	1.55e-03	0.8570	-4.07e-01	-5.79e-01	-4.23e-01	-5.05e-02	-1.91e-01	-1.26e-01	2.15e-03	1.26e-05	1.39e-03	7.03e-01	1.50e-01	3.43e-01
GOCC PROTEASOME REGULATORY PARTICLE BASE SUBCOMPLEX	12	7.33e-04	3.91e-03	0.8570	-3.54e-01	-5.86e-01	9.91e-02	5.35e-02	-1.85e-01	4.67e-01	3.38e-02	4.35e-04	5.52e-01	7.48e-01	2.68e-01	5.07e-03
GOBP DEHYDROASCORBIC ACID TRANSPORT	7	1.89e-01	3.05e-01	0.8560	4.14e-01	5.24e-01	2.82e-01	2.08e-01	3.98e-01	7.82e-02	5.79e-02	1.63e-02	1.97e-01	3.40e-01	6.84e-02	7.20e-01
GOMF DEHYDROASCORBIC ACID TRANSMEMBRANE TRANSPORTER ACTIVITY	7	1.89e-01	3.05e-01	0.8560	4.14e-01	5.24e-01	2.82e-01	2.08e-01	3.98e-01	7.82e-02	5.79e-02	1.63e-02	1.97e-01	3.40e-01	6.84e-02	7.20e-01
GOMF U4 SNRNA BINDING	6	1.41e-01	2.50e-01	0.8560	2.74e-01	-2.32e-01	-4.02e-01	5.24e-01	3.28e-01	-2.45e-01	2.46e-01	3.26e-01	8.84e-02	2.61e-02	1.64e-01	2.99e-01
GOBP PROTEIN HISTIDYL MODIFICATION TO DIPHTHAMIDE	7	8.44e-02	1.73e-01	0.8560	-5.40e-02	-4.96e-01	-5.98e-01	-9.32e-02	-1.03e-01	-3.25e-01	8.05e-01	2.29e-02	6.11e-03	6.69e-01	6.37e-01	1.36e-01
GOBP POSITIVE REGULATION OF MHC CLASS I BIOSYNTHETIC PROCESS	5	1.66e-01	2.79e-01	0.8560	2.96e-02	6.58e-01	2.62e-01	1.97e-01	4.33e-01	6.00e-02	9.09e-01	1.09e-02	3.11e-01	4.45e-01	9.32e-02	8.16e-01
GOBP LIPID DROPLET DISASSEMBLY	5	1.29e-01	2.35e-01	0.8550	-3.79e-01	-2.39e-01	4.88e-01	2.23e-02	-4.09e-01	3.53e-01	1.42e-01	3.55e-01	5.86e-02	9.31e-01	1.13e-01	1.72e-01
GOBP PHOSPHATIDYLINOSITOL ACYL CHAIN REMODELING	5	3.17e-01	4.37e-01	0.8550	1.71e-01	2.60e-01	5.45e-01	-1.25e-01	-1.65e-01	5.43e-01	5.08e-01	3.15e-01	3.47e-02	6.28e-01	5.22e-01	3.56e-02
GOBP POSITIVE REGULATION OF TRANSLATION IN RESPONSE TO ENDOPLASMIC RETICULUM STRESS	5	6.08e-02	1.36e-01	0.8550	-4.99e-01	-1.02e-02	4.85e-01	-5.74e-02	-4.47e-01	2.09e-01	5.32e-02	9.69e-01	6.05e-02	8.24e-01	8.35e-02	4.17e-01
GOBP POSITIVE REGULATION OF FC RECEPTOR MEDIATED STIMULATORY SIGNALING PATHWAY	5	9.74e-02	1.92e-01	0.8550	-2.75e-01	5.09e-01	3.49e-01	-4.42e-03	7.67e-02	5.18e-01	2.86e-01	4.89e-02	1.77e-01	9.86e-01	7.67e-01	4.47e-02
GOBP NEURAL PLATE PATTERN SPECIFICATION	8	5.29e-02	1.22e-01	0.8550	3.51e-01	4.79e-01	-2.84e-01	2.89e-01	3.91e-01	-2.46e-01	8.54e-02	1.90e-02	1.64e-01	1.57e-01	5.52e-02	2.28e-01
GOBP REGULATION OF RNA BINDING	7	1.28e-01	2.33e-01	0.8550	-4.13e-01	-5.05e-01	-5.12e-01	4.99e-02	-1.50e-02	-2.00e-01	5.84e-02	2.06e-02	1.91e-02	8.19e-01	9.45e-01	3.60e-01
GOBP PROTEIN RETENTION IN GOLGI APPARATUS	5	7.66e-02	1.61e-01	0.8550	8.18e-02	5.68e-01	2.72e-01	2.77e-01	-9.50e-03	5.00e-01	7.51e-01	2.78e-02	2.92e-01	2.83e-01	9.71e-01	5.30e-02
GOBP CELL PROLIFERATION INVOLVED IN METANEPHROS DEVELOPMENT	5	2.51e-01	3.70e-01	0.8540	4.55e-01	3.84e-01	1.30e-01	3.26e-01	3.21e-01	3.86e-01	7.78e-02	1.37e-01	6.15e-01	2.06e-01	2.14e-01	1.35e-01
GOBP NOTCH RECEPTOR PROCESSING	8	4.63e-02	1.11e-01	0.8530	-5.87e-01	-3.96e-01	5.97e-02	-1.52e-01	-4.41e-01	7.58e-02	4.05e-03	5.22e-02	7.70e-01	4.56e-01	3.10e-02	7.10e-01
GOBP DNA REPLICATION DEPENDENT CHROMATIN ASSEMBLY	6	1.67e-01	2.79e-01	0.8530	9.27e-02	-1.89e-01	-5.12e-01	4.11e-01	4.61e-01	-2.01e-01	6.94e-01	4.22e-01	2.98e-02	8.15e-02	5.06e-02	3.95e-01
GOBP TRNA 5 END PROCESSING	16	8.49e-05	5.86e-04	0.8530	-1.92e-01	-6.90e-01	-4.58e-01	3.94e-02	1.42e-03	-5.50e-02	1.84e-01	1.74e-06	1.53e-03	7.85e-01	9.92e-01	7.03e-01
GOBP PONS DEVELOPMENT	7	6.69e-02	1.46e-01	0.8520	-3.68e-01	-2.56e-01	1.06e-01	-1.79e-01	-6.70e-01	1.85e-01	9.19e-02	2.41e-01	6.27e-01	4.13e-01	2.15e-03	3.96e-01
GOMF ACETYLESTERASE ACTIVITY	5	5.82e-02	1.32e-01	0.8520	-2.70e-01	-9.35e-02	4.12e-01	3.32e-01	2.29e-01	5.59e-01	2.97e-01	7.17e-01	1.10e-01	1.99e-01	3.75e-01	3.03e-02
GOBP GLYCOSIDE CATABOLIC PROCESS	7	5.68e-02	1.29e-01	0.8520	-5.05e-01	-4.70e-01	-2.62e-01	-2.03e-01	-2.99e-02	-3.73e-01	2.06e-02	3.11e-02	2.30e-01	3.53e-01	8.91e-01	8.74e-02
GOBP NEGATIVE REGULATION OF RELAXATION OF MUSCLE	6	1.09e-01	2.09e-01	0.8520	1.88e-01	5.42e-01	4.18e-02	5.22e-01	3.38e-01	-9.33e-02	4.25e-01	2.14e-02	8.59e-01	2.68e-02	1.52e-01	6.92e-01
GOMF PROTON TRANSPORTING ATP SYNTHASE ACTIVITY ROTATIONAL MECHANISM	16	3.54e-05	2.67e-04	0.8520	-2.80e-01	-7.29e-01	-8.96e-02	1.02e-01	-2.46e-01	1.93e-01	5.24e-02	4.39e-07	5.35e-01	4.79e-01	8.86e-02	1.82e-01
GOCC ACETYLCHOLINE GATED CHANNEL COMPLEX	8	1.91e-02	5.72e-02	0.8520	1.65e-01	1.82e-01	4.14e-01	4.90e-01	-1.78e-01	4.72e-01	4.19e-01	3.73e-01	4.26e-02	1.65e-02	3.85e-01	2.07e-02
GOMF RRNA ADENINE METHYLTRANSFERASE ACTIVITY	7	1.44e-02	4.58e-02	0.8510	-2.30e-01	-5.17e-01	-5.77e-01	-2.37e-01	4.61e-02	1.14e-01	2.91e-01	1.79e-02	8.16e-03	2.77e-01	8.33e-01	6.03e-01
GOBP NEGATIVE REGULATION OF DIGESTIVE SYSTEM PROCESS	10	8.13e-03	2.92e-02	0.8510	1.40e-01	1.20e-01	2.79e-01	6.28e-01	1.95e-01	4.24e-01	4.44e-01	5.10e-01	1.26e-01	5.83e-04	2.87e-01	2.02e-02
GOCC DNA RECOMBINASE MEDIATOR COMPLEX	7	7.98e-02	1.66e-01	0.8510	-3.63e-01	-5.48e-01	-4.52e-01	-2.59e-01	9.69e-02	-1.02e-01	9.59e-02	1.21e-02	3.82e-02	2.35e-01	6.57e-01	6.39e-01
GOBP NEGATIVE REGULATION OF VOLTAGE GATED POTASSIUM CHANNEL ACTIVITY	7	5.83e-02	1.32e-01	0.8510	-4.40e-01	-1.01e-01	4.26e-01	-3.33e-01	-1.26e-01	4.60e-01	4.39e-02	6.45e-01	5.09e-02	1.27e-01	5.62e-01	3.52e-02
GOBP ISOLEUCINE METABOLIC PROCESS	7	3.04e-03	1.31e-02	0.8500	1.85e-01	-3.96e-01	-2.82e-01	1.89e-01	5.90e-01	-2.61e-01	3.96e-01	6.99e-02	1.97e-01	3.86e-01	6.82e-03	2.32e-01
GOBP AMINOPHOSPHOLIPID TRANSLOCATION	7	6.54e-02	1.44e-01	0.8500	3.93e-02	5.38e-01	2.99e-01	1.91e-01	2.34e-01	5.01e-01	8.57e-01	1.37e-02	1.70e-01	3.81e-01	2.83e-01	2.18e-02
GOMF AMINOPHOSPHOLIPID FLIPPASE ACTIVITY	7	6.54e-02	1.44e-01	0.8500	3.93e-02	5.38e-01	2.99e-01	1.91e-01	2.34e-01	5.01e-01	8.57e-01	1.37e-02	1.70e-01	3.81e-01	2.83e-01	2.18e-02
GOCC MATRIX SIDE OF MITOCHONDRIAL INNER MEMBRANE	6	4.54e-02	1.09e-01	0.8500	-1.57e-01	-6.25e-01	-5.25e-01	8.81e-02	-8.53e-02	1.25e-01	5.05e-01	8.05e-03	2.59e-02	7.09e-01	7.18e-01	5.95e-01
GOBP 7 METHYLGUANOSINE CAP HYPERMETHYLATION	8	3.54e-03	1.48e-02	0.8490	2.33e-03	-7.05e-01	-3.91e-01	1.30e-01	-1.37e-01	1.87e-01	9.91e-01	5.50e-04	5.55e-02	5.23e-01	5.02e-01	3.61e-01
GOBP POSITIVE REGULATION OF TELOMERASE RNA LOCALIZATION TO CAJAL BODY	15	8.21e-05	5.69e-04	0.8490	-1.85e-01	-7.46e-01	-2.09e-01	1.60e-01	-2.45e-01	2.84e-02	2.16e-01	5.63e-07	1.62e-01	2.85e-01	1.01e-01	8.49e-01
GOBP CELLULAR RESPONSE TO INTERFERON ALPHA	8	2.69e-02	7.40e-02	0.8490	-5.85e-02	4.30e-01	2.66e-01	3.25e-01	3.17e-01	5.05e-01	7.74e-01	3.50e-02	1.93e-01	1.11e-01	1.21e-01	1.34e-02
GOMF CYCLASE ACTIVATOR ACTIVITY	6	2.62e-01	3.82e-01	0.8490	-3.85e-01	-5.81e-01	-1.98e-01	-2.30e-01	-3.63e-01	9.60e-02	1.02e-01	1.36e-02	4.01e-01	3.29e-01	1.23e-01	6.84e-01
GOCC CHAPERONIN CONTAINING T COMPLEX	9	1.22e-02	4.01e-02	0.8480	-3.15e-01	-7.25e-01	-1.77e-01	4.21e-02	-1.65e-01	1.87e-01	1.02e-01	1.66e-04	3.58e-01	8.27e-01	3.91e-01	3.32e-01
GOBP GLYCOLIPID CATABOLIC PROCESS	16	6.55e-06	5.81e-05	0.8480	-6.36e-01	-4.37e-01	-4.00e-02	-3.30e-01	-8.58e-03	-1.18e-01	1.07e-05	2.47e-03	7.82e-01	2.23e-02	9.53e-01	4.14e-01
GOMF SIGNAL RECOGNITION PARTICLE BINDING	8	1.50e-02	4.73e-02	0.8480	-3.80e-01	-5.31e-01	-6.24e-02	1.70e-01	-2.62e-01	4.38e-01	6.25e-02	9.35e-03	7.60e-01	4.06e-01	2.00e-01	3.19e-02
GOMF LIPOPOLYSACCHARIDE IMMUNE RECEPTOR ACTIVITY	6	6.48e-03	2.42e-02	0.8480	-7.23e-01	2.56e-01	-6.27e-02	-2.31e-01	1.80e-01	-2.04e-01	2.18e-03	2.77e-01	7.90e-01	3.27e-01	4.46e-01	3.86e-01
GOBP INHIBITORY POSTSYNAPTIC POTENTIAL	9	2.65e-02	7.32e-02	0.8480	3.35e-01	2.92e-01	3.84e-01	4.70e-01	3.85e-01	6.76e-02	8.14e-02	1.30e-01	4.58e-02	1.46e-02	4.55e-02	7.25e-01
GOMF HISTONE H3K4 TRIMETHYLTRANSFERASE ACTIVITY	8	6.92e-02	1.50e-01	0.8480	3.64e-01	3.87e-01	3.92e-01	5.06e-01	6.37e-02	1.50e-01	7.44e-02	5.78e-02	5.51e-02	1.31e-02	7.55e-01	4.63e-01
GOBP RESPONSE TO ERYTHROPOIETIN	6	1.06e-01	2.03e-01	0.8480	-1.04e-02	-4.86e-01	2.53e-01	-1.09e-01	-4.79e-01	4.22e-01	9.65e-01	3.94e-02	2.84e-01	6.44e-01	4.24e-02	7.33e-02
GOBP ATRIOVENTRICULAR VALVE FORMATION	5	2.78e-01	3.98e-01	0.8470	1.61e-01	3.49e-01	9.55e-02	5.99e-01	4.22e-01	1.56e-01	5.34e-01	1.76e-01	7.11e-01	2.04e-02	1.02e-01	5.45e-01
GOBP VENOUS BLOOD VESSEL MORPHOGENESIS	6	1.77e-01	2.92e-01	0.8460	2.27e-01	3.81e-01	1.13e-01	4.64e-01	5.26e-01	-1.22e-01	3.36e-01	1.06e-01	6.32e-01	4.91e-02	2.55e-02	6.06e-01
GOBP PEPTIDE ANTIGEN ASSEMBLY WITH MHC PROTEIN COMPLEX	19	5.34e-06	4.82e-05	0.8460	-3.88e-03	-4.08e-01	-4.23e-01	3.31e-01	4.09e-01	-3.07e-01	9.77e-01	2.06e-03	1.43e-03	1.26e-02	2.03e-03	2.05e-02
GOBP REGULATION OF MEMBRANE TUBULATION	5	1.78e-01	2.92e-01	0.8460	1.03e-01	2.11e-01	4.64e-01	4.72e-01	-1.12e-01	4.58e-01	6.90e-01	4.14e-01	7.22e-02	6.77e-02	6.65e-01	7.58e-02
GOMF PRERIBOSOME BINDING	6	1.03e-01	2.00e-01	0.8460	-1.41e-01	-7.08e-01	-3.26e-01	3.99e-02	-2.94e-01	1.40e-02	5.49e-01	2.67e-03	1.66e-01	8.66e-01	2.12e-01	9.52e-01
GOMF GLYCERALDEHYDE 3 PHOSPHATE DEHYDROGENASE NADPLUS NON PHOSPHORYLATING ACTIVITY	6	1.76e-01	2.90e-01	0.8460	-4.81e-01	-2.37e-01	-4.71e-01	-1.48e-01	1.88e-01	-3.86e-01	4.12e-02	3.15e-01	4.58e-02	5.30e-01	4.26e-01	1.02e-01
GOMF INTERMEDIATE FILAMENT BINDING	7	1.53e-01	2.64e-01	0.8460	-2.74e-01	-6.45e-02	3.18e-01	-4.24e-01	-5.73e-01	1.61e-01	2.09e-01	7.68e-01	1.45e-01	5.19e-02	8.62e-03	4.59e-01
GOBP REGULATION OF MEMBRANE REPOLARIZATION DURING CARDIAC MUSCLE CELL ACTION POTENTIAL	5	2.76e-01	3.95e-01	0.8460	2.03e-01	4.06e-01	4.91e-01	-1.26e-01	1.14e-01	4.89e-01	4.31e-01	1.16e-01	5.75e-02	6.26e-01	6.58e-01	5.81e-02
GOBP MAMMARY GLAND BRANCHING INVOLVED IN PREGNANCY	6	2.20e-01	3.39e-01	0.8460	1.35e-01	4.75e-01	4.84e-01	8.01e-03	1.65e-01	4.58e-01	5.66e-01	4.41e-02	3.99e-02	9.73e-01	4.83e-01	5.21e-02
GOCC MANNOSYLTRANSFERASE COMPLEX	5	1.26e-01	2.31e-01	0.8460	1.26e-02	-5.62e-01	-4.97e-01	8.82e-02	-3.31e-01	-1.87e-01	9.61e-01	2.95e-02	5.44e-02	7.33e-01	2.00e-01	4.70e-01
GOMF N ACYLSPHINGOSINE AMIDOHYDROLASE ACTIVITY	7	1.41e-01	2.50e-01	0.8460	-3.98e-01	-1.75e-01	2.24e-01	-4.25e-01	-2.98e-01	4.55e-01	6.83e-02	4.22e-01	3.05e-01	5.17e-02	1.72e-01	3.71e-02
GOBP ALDEHYDE CATABOLIC PROCESS	10	1.11e-02	3.75e-02	0.8450	-2.22e-01	-6.47e-01	-4.64e-01	1.50e-01	2.03e-02	-9.63e-02	2.25e-01	3.98e-04	1.11e-02	4.11e-01	9.12e-01	5.98e-01
GOMF ACETYLCHOLINE GATED MONOATOMIC CATION SELECTIVE CHANNEL ACTIVITY	8	4.47e-02	1.08e-01	0.8450	2.75e-01	1.89e-01	3.85e-01	5.58e-01	-1.86e-02	3.78e-01	1.78e-01	3.54e-01	5.94e-02	6.23e-03	9.28e-01	6.39e-02
GOBP NEGATIVE REGULATION OF INTERLEUKIN 5 PRODUCTION	5	1.26e-01	2.31e-01	0.8450	3.86e-01	4.03e-02	2.87e-01	5.74e-01	-2.05e-01	3.31e-01	1.35e-01	8.76e-01	2.66e-01	2.63e-02	4.27e-01	2.00e-01
GOMF PHOSPHATIDYLINOSITOL 3 KINASE ACTIVATOR ACTIVITY	5	4.71e-02	1.12e-01	0.8440	-4.00e-01	2.12e-01	6.09e-01	-1.57e-01	-3.11e-01	1.27e-01	1.21e-01	4.13e-01	1.85e-02	5.44e-01	2.29e-01	6.22e-01
GOMF UBIQUITIN PROTEIN TRANSFERASE INHIBITOR ACTIVITY	12	3.81e-03	1.57e-02	0.8440	-9.04e-02	-6.30e-01	-5.04e-01	-7.32e-03	-4.88e-02	-2.27e-01	5.88e-01	1.58e-04	2.52e-03	9.65e-01	7.70e-01	1.74e-01
GOBP RESPONSE TO VITAMIN A	7	3.45e-02	8.89e-02	0.8440	-1.26e-01	2.45e-02	5.20e-01	8.39e-02	1.82e-01	6.20e-01	5.65e-01	9.11e-01	1.71e-02	7.01e-01	4.03e-01	4.50e-03
GOCC CYTOCHROME COMPLEX	35	3.35e-10	5.72e-09	0.8430	-2.25e-01	-7.13e-01	-2.41e-01	9.24e-03	-2.97e-01	-7.42e-02	2.13e-02	2.72e-13	1.36e-02	9.25e-01	2.33e-03	4.48e-01
GOBP PLASMA MEMBRANE RAFT ASSEMBLY	5	1.89e-01	3.04e-01	0.8430	1.37e-01	-2.88e-01	4.50e-01	1.31e-01	-3.08e-01	5.43e-01	5.96e-01	2.66e-01	8.14e-02	6.12e-01	2.32e-01	3.55e-02
GOBP POSITIVE REGULATION OF VESICLE TRANSPORT ALONG MICROTUBULE	5	8.69e-02	1.77e-01	0.8430	5.41e-01	2.98e-01	-3.91e-01	5.89e-02	1.27e-01	-3.96e-01	3.60e-02	2.49e-01	1.30e-01	8.20e-01	6.23e-01	1.26e-01
GOMF MHC CLASS II PROTEIN BINDING	6	1.81e-01	2.96e-01	0.8430	2.54e-01	1.41e-01	-2.96e-01	6.14e-01	3.50e-01	-1.98e-01	2.82e-01	5.51e-01	2.10e-01	9.17e-03	1.37e-01	4.02e-01
GOMF XMP 5 NUCLEOSIDASE ACTIVITY	6	2.01e-01	3.18e-01	0.8430	-5.16e-02	2.17e-01	5.01e-01	-2.81e-01	-1.85e-01	5.44e-01	8.27e-01	3.57e-01	3.36e-02	2.33e-01	4.32e-01	2.11e-02
GOBP INTERLEUKIN 5 MEDIATED SIGNALING PATHWAY	5	1.18e-01	2.21e-01	0.8430	-1.55e-01	2.10e-01	3.92e-01	-3.12e-02	3.57e-01	6.00e-01	5.48e-01	4.17e-01	1.29e-01	9.04e-01	1.67e-01	2.02e-02
GOBP PEPTIDOGLYCAN METABOLIC PROCESS	5	5.51e-02	1.27e-01	0.8420	4.43e-01	8.76e-02	6.15e-01	-1.21e-01	1.33e-01	3.08e-01	8.65e-02	7.35e-01	1.72e-02	6.39e-01	6.08e-01	2.32e-01
GOBP REGULATION OF PHOSPHATIDYLINOSITOL DEPHOSPHORYLATION	6	1.48e-03	7.11e-03	0.8420	-3.48e-01	4.58e-01	1.10e-01	1.45e-01	-1.81e-01	5.59e-01	1.40e-01	5.20e-02	6.40e-01	5.39e-01	4.43e-01	1.77e-02
GOBP SPERMIDINE METABOLIC PROCESS	8	3.10e-02	8.18e-02	0.8410	1.67e-02	-5.12e-01	-4.02e-01	1.34e-01	5.37e-02	-5.14e-01	9.35e-01	1.22e-02	4.92e-02	5.12e-01	7.92e-01	1.19e-02
GOBP REGULATION OF CELL COMMUNICATION BY ELECTRICAL COUPLING	9	4.12e-02	1.02e-01	0.8410	-4.21e-01	-3.96e-01	2.33e-01	-1.29e-01	-3.34e-01	4.37e-01	2.87e-02	3.97e-02	2.26e-01	5.02e-01	8.23e-02	2.33e-02
GOMF CYCLOHYDROLASE ACTIVITY	5	7.39e-02	1.57e-01	0.8410	-1.89e-01	-7.12e-01	-3.54e-01	-5.21e-02	1.21e-01	1.46e-01	4.63e-01	5.81e-03	1.71e-01	8.40e-01	6.39e-01	5.71e-01
GOCC FLOTILLIN COMPLEX	8	3.71e-03	1.54e-02	0.8410	-4.41e-01	3.54e-02	5.74e-01	7.15e-02	-1.84e-01	3.78e-01	3.08e-02	8.62e-01	4.93e-03	7.26e-01	3.67e-01	6.43e-02
GOBP MAGNESIUM ION HOMEOSTASIS	8	2.34e-02	6.69e-02	0.8400	3.19e-01	3.47e-01	2.67e-01	4.28e-01	4.24e-01	-2.22e-01	1.18e-01	8.88e-02	1.92e-01	3.58e-02	3.79e-02	2.77e-01
GOCC NUCLEAR EXOSOME RNASE COMPLEX	16	3.66e-04	2.14e-03	0.8400	-2.52e-01	-5.56e-01	-5.68e-01	-1.45e-02	4.86e-02	-9.09e-02	8.11e-02	1.18e-04	8.38e-05	9.20e-01	7.36e-01	5.29e-01
GOCC PREFOLDIN COMPLEX	7	6.73e-03	2.50e-02	0.8400	-1.42e-01	-6.74e-01	-3.07e-01	8.27e-02	1.56e-01	3.24e-01	5.15e-01	2.00e-03	1.60e-01	7.05e-01	4.74e-01	1.38e-01
GOBP REGULATION OF DNA DIRECTED DNA POLYMERASE ACTIVITY	9	2.35e-02	6.70e-02	0.8400	1.51e-01	-2.42e-01	-6.17e-01	7.57e-02	3.31e-01	-3.56e-01	4.33e-01	2.09e-01	1.34e-03	6.94e-01	8.51e-02	6.44e-02
GOBP PROTEIN O LINKED GLYCOSYLATION VIA SERINE	8	1.45e-02	4.62e-02	0.8390	-2.88e-01	-5.33e-02	5.11e-01	1.83e-01	-2.26e-02	5.69e-01	1.58e-01	7.94e-01	1.24e-02	3.71e-01	9.12e-01	5.30e-03
GOBP DETERMINATION OF LEFT RIGHT ASYMMETRY IN LATERAL MESODERM	6	7.97e-03	2.87e-02	0.8390	-6.31e-01	-4.29e-01	-3.24e-02	1.54e-01	-2.02e-01	-2.38e-01	7.44e-03	6.89e-02	8.91e-01	5.13e-01	3.92e-01	3.12e-01
GOBP REGULATION OF CDC42 PROTEIN SIGNAL TRANSDUCTION	5	7.47e-03	2.73e-02	0.8390	-2.89e-01	-1.48e-01	2.73e-01	6.55e-01	2.66e-01	1.55e-01	2.62e-01	5.66e-01	2.90e-01	1.12e-02	3.02e-01	5.47e-01
GOCC CELL TIP	6	2.54e-02	7.11e-02	0.8390	-6.43e-01	-7.21e-02	2.73e-01	-3.81e-01	-2.36e-01	-9.93e-02	6.41e-03	7.60e-01	2.46e-01	1.06e-01	3.17e-01	6.74e-01
GOMF LIGAND GATED SODIUM CHANNEL ACTIVITY	9	1.17e-01	2.19e-01	0.8390	4.30e-01	3.32e-01	-1.21e-02	4.79e-01	4.02e-01	-1.34e-01	2.56e-02	8.49e-02	9.50e-01	1.28e-02	3.69e-02	4.86e-01
GOBP POSITIVE REGULATION OF GASTRO INTESTINAL SYSTEM SMOOTH MUSCLE CONTRACTION	5	2.01e-01	3.18e-01	0.8380	-5.76e-01	-5.49e-03	-1.85e-01	-5.50e-01	-2.92e-03	-1.87e-01	2.58e-02	9.83e-01	4.74e-01	3.33e-02	9.91e-01	4.70e-01
GOCC EPSILON DNA POLYMERASE COMPLEX	5	2.87e-01	4.07e-01	0.8380	-4.18e-01	-5.01e-01	-3.74e-01	3.42e-02	-1.79e-01	-3.23e-01	1.06e-01	5.25e-02	1.48e-01	8.95e-01	4.89e-01	2.11e-01
GOBP LOW DENSITY LIPOPROTEIN RECEPTOR PARTICLE METABOLIC PROCESS	5	2.22e-03	1.00e-02	0.8380	-1.19e-01	-2.63e-01	3.92e-01	1.99e-01	-4.67e-01	-4.55e-01	6.46e-01	3.08e-01	1.29e-01	4.41e-01	7.03e-02	7.83e-02
GOBP POSITIVE REGULATION OF PLATELET AGGREGATION	9	1.52e-02	4.78e-02	0.8380	-2.92e-01	-4.65e-01	3.23e-01	-3.73e-01	-3.72e-01	1.35e-01	1.29e-01	1.57e-02	9.37e-02	5.27e-02	5.31e-02	4.85e-01
GOBP DEOXYRIBONUCLEOSIDE DIPHOSPHATE METABOLIC PROCESS	5	3.39e-02	8.79e-02	0.8370	3.57e-01	-4.05e-01	-2.20e-01	4.08e-01	2.86e-01	3.36e-01	1.67e-01	1.17e-01	3.94e-01	1.14e-01	2.69e-01	1.94e-01
GOBP NEGATIVE REGULATION OF SMOOTH MUSCLE CELL DIFFERENTIATION	13	2.36e-03	1.06e-02	0.8360	1.83e-02	3.10e-01	-2.51e-01	4.62e-01	5.15e-01	-2.47e-01	9.09e-01	5.29e-02	1.17e-01	3.96e-03	1.31e-03	1.23e-01
GOBP AMINO ACID SALVAGE	5	2.25e-01	3.44e-01	0.8360	-3.25e-01	-4.56e-01	-5.42e-01	-2.39e-01	1.64e-01	-8.51e-02	2.09e-01	7.75e-02	3.58e-02	3.55e-01	5.24e-01	7.42e-01
GOBP L METHIONINE SALVAGE FROM METHYLTHIOADENOSINE	5	2.25e-01	3.44e-01	0.8360	-3.25e-01	-4.56e-01	-5.42e-01	-2.39e-01	1.64e-01	-8.51e-02	2.09e-01	7.75e-02	3.58e-02	3.55e-01	5.24e-01	7.42e-01
GOBP RESPONSE TO CORTICOSTERONE	11	3.16e-04	1.89e-03	0.8350	-8.77e-02	-1.84e-01	1.95e-01	-4.92e-01	-3.99e-01	-4.67e-01	6.15e-01	2.91e-01	2.64e-01	4.74e-03	2.21e-02	7.37e-03
GOBP POSITIVE REGULATION OF RNA BINDING	5	2.76e-01	3.96e-01	0.8350	-3.21e-01	-5.35e-01	-4.13e-01	1.22e-01	-1.96e-01	-2.90e-01	2.14e-01	3.83e-02	1.10e-01	6.37e-01	4.48e-01	2.62e-01
GOBP REGULATION OF MICROVILLUS LENGTH	6	1.48e-01	2.58e-01	0.8350	4.99e-01	2.62e-02	4.40e-01	3.64e-01	8.70e-02	3.38e-01	3.43e-02	9.11e-01	6.22e-02	1.23e-01	7.12e-01	1.52e-01
GOBP NEGATIVE REGULATION OF TOLL LIKE RECEPTOR 2 SIGNALING PATHWAY	5	3.55e-02	9.10e-02	0.8340	-2.29e-01	6.80e-01	2.67e-01	-1.27e-01	2.59e-01	-1.61e-01	3.75e-01	8.50e-03	3.01e-01	6.23e-01	3.16e-01	5.33e-01
GOBP MINERALOCORTICOID BIOSYNTHETIC PROCESS	7	8.44e-02	1.73e-01	0.8330	3.38e-01	3.19e-02	5.11e-01	2.63e-01	-3.46e-01	3.60e-01	1.21e-01	8.84e-01	1.92e-02	2.29e-01	1.13e-01	9.94e-02
GOBP MINERALOCORTICOID METABOLIC PROCESS	7	8.44e-02	1.73e-01	0.8330	3.38e-01	3.19e-02	5.11e-01	2.63e-01	-3.46e-01	3.60e-01	1.21e-01	8.84e-01	1.92e-02	2.29e-01	1.13e-01	9.94e-02
GOBP ABSCISSION	5	2.76e-01	3.95e-01	0.8330	-4.04e-01	-5.88e-01	-3.03e-01	-1.21e-02	-1.33e-01	-2.73e-01	1.17e-01	2.27e-02	2.40e-01	9.63e-01	6.06e-01	2.90e-01
GOBP REGULATION OF OPSONIZATION	5	2.92e-01	4.12e-01	0.8330	5.32e-02	5.97e-02	-3.31e-01	3.22e-01	5.92e-01	-3.50e-01	8.37e-01	8.17e-01	2.00e-01	2.13e-01	2.18e-02	1.75e-01
GOCC U7 SNRNP	7	3.62e-02	9.25e-02	0.8320	-1.01e-01	-6.70e-01	-4.82e-01	1.04e-02	2.92e-02	-1.06e-02	6.43e-01	2.14e-03	2.71e-02	9.62e-01	8.93e-01	9.61e-01
GOBP REGULATION OF ELECTRON TRANSFER ACTIVITY	5	1.66e-01	2.78e-01	0.8320	-1.41e-01	-7.51e-01	-1.74e-01	6.18e-02	-2.65e-01	7.20e-02	5.85e-01	3.64e-03	5.01e-01	8.11e-01	3.05e-01	7.81e-01
GOCC POSTSYNAPTIC ENDOSOME MEMBRANE	5	4.21e-01	5.30e-01	0.8320	3.35e-01	3.05e-01	2.56e-01	5.24e-01	2.81e-01	2.63e-01	1.95e-01	2.38e-01	3.22e-01	4.25e-02	2.76e-01	3.08e-01
GOBP MULTI PASS TRANSMEMBRANE PROTEIN INSERTION INTO ER MEMBRANE	9	9.51e-04	4.87e-03	0.8320	-5.14e-01	-5.17e-01	2.28e-02	3.14e-01	-2.24e-01	1.08e-01	7.53e-03	7.24e-03	9.06e-01	1.02e-01	2.45e-01	5.77e-01
GOCC MULTI PASS TRANSLOCON COMPLEX	9	9.51e-04	4.87e-03	0.8320	-5.14e-01	-5.17e-01	2.28e-02	3.14e-01	-2.24e-01	1.08e-01	7.53e-03	7.24e-03	9.06e-01	1.02e-01	2.45e-01	5.77e-01
GOBP REGULATION OF MEIOTIC CELL CYCLE PHASE TRANSITION	8	1.16e-02	3.86e-02	0.8320	3.39e-01	-2.29e-01	3.42e-01	4.83e-01	-3.06e-01	2.86e-01	9.69e-02	2.63e-01	9.35e-02	1.81e-02	1.34e-01	1.61e-01
GOBP PYRIMIDINE DEOXYRIBONUCLEOTIDE BIOSYNTHETIC PROCESS	6	8.66e-02	1.76e-01	0.8320	-1.69e-01	-6.98e-01	-3.18e-01	-1.27e-01	-2.01e-01	1.41e-01	4.73e-01	3.09e-03	1.78e-01	5.90e-01	3.94e-01	5.50e-01
GOCC AMINOACYL TRNA SYNTHETASE MULTIENZYME COMPLEX	11	2.68e-02	7.37e-02	0.8320	-3.48e-01	-5.78e-01	-4.56e-01	-8.31e-02	-9.48e-02	-1.15e-01	4.58e-02	9.02e-04	8.80e-03	6.33e-01	5.86e-01	5.09e-01
GOBP LYMPHOCYTE MIGRATION INTO LYMPHOID ORGANS	8	4.00e-02	9.96e-02	0.8320	-3.11e-01	-4.80e-02	4.39e-01	4.21e-02	-3.73e-01	5.09e-01	1.28e-01	8.14e-01	3.15e-02	8.37e-01	6.76e-02	1.26e-02
GOBP INTERLEUKIN 11 MEDIATED SIGNALING PATHWAY	5	4.77e-02	1.13e-01	0.8320	-6.90e-02	5.35e-01	2.21e-01	3.90e-01	3.09e-02	4.46e-01	7.89e-01	3.83e-02	3.93e-01	1.31e-01	9.05e-01	8.40e-02
GOBP REGULATION OF HEPATOCYTE PROLIFERATION	11	4.01e-03	1.64e-02	0.8320	8.93e-02	5.24e-01	5.98e-01	9.82e-02	-1.09e-01	1.74e-01	6.08e-01	2.61e-03	5.96e-04	5.73e-01	5.29e-01	3.19e-01
GOBP REVERSIBLE DIFFERENTIATION	5	2.51e-01	3.70e-01	0.8320	1.31e-01	7.85e-02	-2.97e-01	2.05e-01	5.72e-01	-4.59e-01	6.12e-01	7.61e-01	2.50e-01	4.28e-01	2.69e-02	7.53e-02
GOBP POSITIVE REGULATION OF STEROID HORMONE SECRETION	6	7.05e-02	1.52e-01	0.8310	3.79e-01	-1.26e-01	4.48e-01	-2.28e-01	-4.90e-01	1.97e-01	1.08e-01	5.92e-01	5.73e-02	3.33e-01	3.76e-02	4.03e-01
GOMF GLYCEROPHOSPHOLIPID FLIPPASE ACTIVITY	11	8.87e-03	3.11e-02	0.8310	3.46e-01	5.56e-01	2.56e-01	3.75e-01	6.97e-02	2.28e-01	4.68e-02	1.42e-03	1.42e-01	3.14e-02	6.89e-01	1.90e-01
GOMF DNA RNA HYBRID BINDING	5	1.23e-02	4.03e-02	0.8310	1.11e-01	1.24e-01	2.59e-01	7.41e-01	-1.84e-01	-1.13e-01	6.67e-01	6.32e-01	3.16e-01	4.11e-03	4.75e-01	6.61e-01
GOBP PROTEIN LOCALIZATION TO NUCLEAR BODY	12	8.58e-04	4.48e-03	0.8310	-2.02e-01	-7.07e-01	-3.00e-01	2.23e-01	-4.64e-02	8.85e-02	2.26e-01	2.22e-05	7.17e-02	1.82e-01	7.81e-01	5.96e-01
GOMF N ACETYLLACTOSAMINE SYNTHASE ACTIVITY	5	1.85e-01	3.00e-01	0.8310	2.42e-01	-5.64e-02	4.88e-01	3.90e-01	-3.21e-01	3.67e-01	3.49e-01	8.27e-01	5.87e-02	1.31e-01	2.14e-01	1.55e-01
GOBP NEGATIVE REGULATION OF FILOPODIUM ASSEMBLY	5	3.07e-01	4.28e-01	0.8300	-5.72e-02	4.68e-02	4.23e-01	-4.99e-01	-4.83e-01	1.49e-01	8.25e-01	8.56e-01	1.01e-01	5.33e-02	6.14e-02	5.63e-01
GOMF TRANSCRIPTION ELONGATION FACTOR ACTIVITY	7	2.24e-01	3.43e-01	0.8300	-3.77e-01	-4.35e-01	-1.06e-01	-3.86e-01	-3.94e-01	-2.05e-01	8.39e-02	4.64e-02	6.27e-01	7.66e-02	7.10e-02	3.47e-01
GOBP REGULATION OF DNA TOPOISOMERASE ATP HYDROLYZING ACTIVITY	5	1.88e-01	3.04e-01	0.8300	1.77e-02	1.38e-01	2.73e-01	4.85e-01	1.39e-01	5.84e-01	9.45e-01	5.93e-01	2.91e-01	6.05e-02	5.91e-01	2.37e-02
GOBP VESICLE TETHERING TO GOLGI	5	6.88e-02	1.49e-01	0.8300	-5.61e-01	5.94e-02	-2.00e-01	-3.69e-01	3.48e-01	2.71e-01	2.99e-02	8.18e-01	4.38e-01	1.53e-01	1.78e-01	2.93e-01
GOMF ICOSANOID TRANSMEMBRANE TRANSPORTER ACTIVITY	6	7.10e-02	1.53e-01	0.8300	-6.67e-02	-2.64e-01	5.52e-01	-2.59e-01	-4.86e-01	8.43e-02	7.77e-01	2.62e-01	1.93e-02	2.73e-01	3.94e-02	7.21e-01
GOBP RIBOSOMAL LARGE SUBUNIT BIOGENESIS	64	2.90e-19	1.16e-17	0.8290	-1.61e-01	-6.63e-01	-4.31e-01	3.61e-02	-1.57e-01	-1.00e-01	2.59e-02	4.00e-20	2.43e-09	6.18e-01	3.00e-02	1.66e-01
GOBP POSITIVE REGULATION OF TOLERANCE INDUCTION	10	3.34e-03	1.41e-02	0.8290	1.43e-03	1.43e-02	3.50e-01	1.05e-01	-5.17e-01	5.36e-01	9.94e-01	9.38e-01	5.56e-02	5.64e-01	4.67e-03	3.33e-03
GOBP REGULATION OF TRANSLATION IN RESPONSE TO ENDOPLASMIC RETICULUM STRESS	12	1.66e-03	7.83e-03	0.8290	-5.31e-01	-8.50e-02	2.76e-01	-1.68e-01	-4.91e-01	2.30e-01	1.46e-03	6.10e-01	9.73e-02	3.13e-01	3.24e-03	1.67e-01
GOBP POSITIVE REGULATION OF RAC PROTEIN SIGNAL TRANSDUCTION	8	3.15e-02	8.29e-02	0.8290	-1.11e-01	4.04e-01	3.65e-01	1.90e-01	1.01e-01	5.75e-01	5.86e-01	4.76e-02	7.36e-02	3.51e-01	6.20e-01	4.84e-03
GOMF HISTONE H3K36 DEMETHYLASE ACTIVITY	10	3.05e-02	8.10e-02	0.8290	2.02e-01	4.01e-01	2.04e-01	5.53e-01	3.30e-01	1.67e-01	2.69e-01	2.79e-02	2.64e-01	2.44e-03	7.08e-02	3.61e-01
GOBP NITRIC OXIDE CGMP MEDIATED SIGNALING	7	1.11e-03	5.58e-03	0.8280	-1.34e-01	-1.36e-01	7.15e-01	-2.97e-01	-4.19e-02	2.21e-01	5.39e-01	5.34e-01	1.06e-03	1.74e-01	8.48e-01	3.10e-01
GOBP POSITIVE REGULATION OF RESPIRATORY BURST	7	1.77e-01	2.92e-01	0.8280	-4.36e-01	-5.32e-01	-3.78e-01	-6.73e-02	-2.44e-01	-7.76e-02	4.59e-02	1.47e-02	8.36e-02	7.58e-01	2.63e-01	7.22e-01
GOMF TRAIL BINDING	5	2.23e-01	3.41e-01	0.8280	1.88e-01	6.90e-01	-3.90e-04	9.58e-02	4.06e-01	-9.29e-03	4.66e-01	7.52e-03	9.99e-01	7.11e-01	1.16e-01	9.71e-01
GOCC U4 SNRNP	10	9.82e-04	5.00e-03	0.8280	1.26e-01	-6.66e-01	-4.29e-01	2.04e-01	2.45e-03	4.59e-03	4.90e-01	2.68e-04	1.87e-02	2.64e-01	9.89e-01	9.80e-01
GOBP BILE ACID SECRETION	6	1.66e-01	2.79e-01	0.8280	2.28e-01	2.34e-01	6.40e-01	-1.83e-01	-6.93e-02	3.60e-01	3.33e-01	3.20e-01	6.60e-03	4.37e-01	7.69e-01	1.27e-01
GOBP REGULATION OF CYTOPLASMIC TRANSLATIONAL INITIATION	8	1.89e-01	3.04e-01	0.8270	-3.71e-01	-4.88e-01	-3.31e-01	-2.61e-01	-2.91e-01	-2.15e-01	6.90e-02	1.69e-02	1.05e-01	2.01e-01	1.54e-01	2.93e-01
GOBP REGULATION OF FC RECEPTOR MEDIATED STIMULATORY SIGNALING PATHWAY	10	2.27e-03	1.02e-02	0.8270	-3.19e-01	3.75e-01	3.47e-01	1.27e-01	9.77e-02	5.44e-01	8.06e-02	4.01e-02	5.74e-02	4.86e-01	5.93e-01	2.90e-03
GOCC FILTRATION DIAPHRAGM	7	1.53e-01	2.64e-01	0.8270	-6.51e-02	2.48e-01	5.13e-01	-3.16e-01	-3.17e-01	3.94e-01	7.65e-01	2.56e-01	1.87e-02	1.48e-01	1.46e-01	7.13e-02
GOBP XMP METABOLIC PROCESS	7	7.10e-02	1.53e-01	0.8270	-7.21e-02	-5.71e-01	-5.10e-01	2.54e-01	9.64e-02	-1.39e-01	7.41e-01	8.91e-03	1.96e-02	2.45e-01	6.59e-01	5.24e-01
GOBP POSITIVE REGULATION OF T HELPER 17 CELL LINEAGE COMMITMENT	6	8.51e-02	1.74e-01	0.8270	3.09e-01	3.08e-01	1.69e-01	6.77e-01	7.86e-02	-1.16e-02	1.90e-01	1.91e-01	4.74e-01	4.08e-03	7.39e-01	9.61e-01
GOMF NADH DEHYDROGENASE UBIQUINONE ACTIVITY	41	5.62e-13	1.27e-11	0.8270	-1.46e-01	-7.39e-01	-2.43e-01	-4.55e-02	-2.30e-01	-4.18e-02	1.06e-01	2.51e-16	7.17e-03	6.14e-01	1.08e-02	6.44e-01
GOMF MEMBRANE INSERTASE ACTIVITY	17	1.39e-04	9.07e-04	0.8260	-3.35e-01	-6.76e-01	-3.22e-01	6.52e-02	-6.79e-02	2.55e-02	1.68e-02	1.37e-06	2.15e-02	6.42e-01	6.28e-01	8.56e-01
GOMF DNA APURINIC OR APYRIMIDINIC SITE ENDONUCLEASE ACTIVITY	11	4.01e-03	1.64e-02	0.8260	1.72e-01	-3.68e-01	-5.11e-01	4.04e-01	2.78e-01	-1.25e-01	3.22e-01	3.44e-02	3.35e-03	2.02e-02	1.10e-01	4.72e-01
GOMF RNA POLYMERASE III TRANSCRIPTION REGULATORY REGION SEQUENCE SPECIFIC DNA BINDING	8	1.65e-02	5.09e-02	0.8260	2.31e-01	-3.76e-01	-2.73e-01	4.13e-01	-2.61e-02	-4.92e-01	2.58e-01	6.55e-02	1.81e-01	4.32e-02	8.98e-01	1.60e-02
GOCC BBAF COMPLEX	9	4.38e-03	1.75e-02	0.8260	2.37e-01	1.92e-01	4.67e-01	5.67e-01	-1.72e-01	1.42e-01	2.19e-01	3.18e-01	1.54e-02	3.24e-03	3.72e-01	4.60e-01
GOBP REGULATION OF MYOFIBROBLAST DIFFERENTIATION	6	2.37e-02	6.73e-02	0.8260	-5.19e-01	2.71e-01	3.90e-01	2.89e-02	-1.52e-01	4.04e-01	2.76e-02	2.51e-01	9.85e-02	9.03e-01	5.18e-01	8.68e-02
GOCC MITOCHONDRIAL PROTEIN CONTAINING COMPLEX	276	5.69e-91	8.79e-88	0.8260	-1.56e-01	-6.81e-01	-4.09e-01	3.64e-02	-1.31e-01	-8.89e-02	8.11e-06	4.13e-85	1.16e-31	2.98e-01	1.79e-04	1.11e-02
GOBP TRNA THREONYLCARBAMOYLADENOSINE MODIFICATION	5	2.56e-01	3.76e-01	0.8250	-1.58e-01	-3.41e-01	-6.14e-01	1.21e-01	3.54e-01	-1.52e-01	5.40e-01	1.87e-01	1.74e-02	6.38e-01	1.70e-01	5.56e-01
GOMF THREONINE TYPE ENDOPEPTIDASE ACTIVITY	7	2.27e-02	6.53e-02	0.8250	-9.19e-02	-6.73e-01	-3.86e-01	1.66e-01	2.08e-01	-2.11e-02	6.74e-01	2.05e-03	7.70e-02	4.47e-01	3.41e-01	9.23e-01
GOBP PROTEIN IMPORT INTO PEROXISOME MATRIX SUBSTRATE RELEASE	5	1.76e-01	2.90e-01	0.8250	-2.00e-01	-4.48e-01	-4.37e-01	4.53e-01	1.90e-01	-9.04e-02	4.39e-01	8.26e-02	9.09e-02	7.95e-02	4.61e-01	7.26e-01
GOMF 1 PHOSPHATIDYLINOSITOL 3 KINASE ACTIVITY	10	2.67e-03	1.17e-02	0.8250	-1.62e-01	5.79e-01	1.58e-01	2.26e-01	4.06e-01	2.80e-01	3.74e-01	1.53e-03	3.87e-01	2.15e-01	2.61e-02	1.26e-01
GOBP REGULATION OF ISOMERASE ACTIVITY	7	4.71e-02	1.12e-01	0.8250	-1.29e-01	1.60e-01	4.34e-01	3.80e-01	-3.91e-03	5.52e-01	5.53e-01	4.64e-01	4.66e-02	8.18e-02	9.86e-01	1.14e-02
GOBP NEGATIVE REGULATION OF CAMP DEPENDENT PROTEIN KINASE ACTIVITY	7	4.53e-02	1.09e-01	0.8250	-1.72e-01	-3.21e-01	2.45e-01	2.23e-02	-1.01e-01	6.91e-01	4.32e-01	1.42e-01	2.62e-01	9.19e-01	6.43e-01	1.55e-03
GOBP HRI MEDIATED SIGNALING	6	3.10e-01	4.30e-01	0.8250	-3.76e-01	-5.72e-01	-2.54e-01	-2.87e-01	-2.54e-01	-1.23e-02	1.10e-01	1.53e-02	2.82e-01	2.24e-01	2.81e-01	9.58e-01
GOMF SERINE TYPE EXOPEPTIDASE ACTIVITY	10	3.55e-03	1.48e-02	0.8250	-5.70e-01	-2.60e-01	-1.20e-01	-4.87e-01	1.01e-01	-1.59e-01	1.80e-03	1.54e-01	5.10e-01	7.63e-03	5.82e-01	3.83e-01
GOBP MANGANESE ION TRANSPORT	10	8.86e-03	3.11e-02	0.8250	-2.50e-01	1.34e-01	5.19e-01	-7.23e-02	-4.64e-01	3.31e-01	1.72e-01	4.64e-01	4.47e-03	6.92e-01	1.11e-02	6.97e-02
GOMF RRNA BINDING	64	2.40e-17	7.91e-16	0.8240	-1.60e-01	-6.08e-01	-4.75e-01	2.77e-02	-1.13e-01	-2.13e-01	2.72e-02	3.70e-17	4.99e-11	7.02e-01	1.17e-01	3.25e-03
GOBP REGULATION OF TOLL LIKE RECEPTOR 7 SIGNALING PATHWAY	6	2.45e-02	6.90e-02	0.8240	-5.23e-01	5.73e-02	-8.21e-03	1.71e-01	2.88e-01	5.39e-01	2.64e-02	8.08e-01	9.72e-01	4.68e-01	2.22e-01	2.23e-02
GOBP DTTP METABOLIC PROCESS	5	4.84e-02	1.14e-01	0.8240	-4.80e-02	-6.05e-01	-1.49e-01	2.11e-01	7.79e-02	4.87e-01	8.53e-01	1.91e-02	5.63e-01	4.13e-01	7.63e-01	5.95e-02
GOBP INOSITOL TRISPHOSPHATE BIOSYNTHETIC PROCESS	5	5.17e-02	1.20e-01	0.8240	-4.42e-01	1.03e-01	6.06e-01	-9.63e-02	-5.25e-02	3.06e-01	8.69e-02	6.91e-01	1.90e-02	7.09e-01	8.39e-01	2.36e-01
GOMF PROTEINASE ACTIVATED RECEPTOR ACTIVITY	5	7.31e-02	1.56e-01	0.8230	4.19e-01	-9.92e-02	3.97e-01	-1.13e-01	-5.19e-01	-2.32e-01	1.05e-01	7.01e-01	1.25e-01	6.61e-01	4.46e-02	3.69e-01
GOBP POSITIVE REGULATION OF ARP2 3 COMPLEX MEDIATED ACTIN NUCLEATION	8	1.45e-01	2.54e-01	0.8230	-3.76e-01	-2.27e-01	2.60e-01	-4.36e-01	-3.67e-01	3.04e-01	6.55e-02	2.66e-01	2.03e-01	3.26e-02	7.24e-02	1.37e-01
GOBP THIAMINE DIPHOSPHATE METABOLIC PROCESS	5	3.89e-01	5.02e-01	0.8230	-4.07e-01	-4.04e-01	-5.13e-01	-7.69e-02	-1.54e-01	-2.37e-01	1.15e-01	1.18e-01	4.69e-02	7.66e-01	5.50e-01	3.60e-01
GOBP REGULATION OF SYNAPTIC VESICLE MEMBRANE ORGANIZATION	7	4.80e-02	1.14e-01	0.8230	3.59e-01	1.70e-01	2.64e-01	3.43e-01	5.69e-01	8.90e-02	9.96e-02	4.36e-01	2.27e-01	1.16e-01	9.11e-03	6.83e-01
GOBP MITOCHONDRIAL ELECTRON TRANSPORT CYTOCHROME C TO OXYGEN	18	1.79e-04	1.14e-03	0.8230	-2.19e-01	-6.77e-01	-2.01e-01	-6.51e-02	-3.53e-01	4.41e-02	1.07e-01	6.65e-07	1.41e-01	6.33e-01	9.42e-03	7.46e-01
GOCC PROTEASOME CORE COMPLEX BETA SUBUNIT COMPLEX	10	1.26e-03	6.22e-03	0.8230	-1.21e-01	-7.75e-01	-2.28e-01	7.18e-03	-2.42e-02	9.43e-02	5.06e-01	2.18e-05	2.12e-01	9.69e-01	8.95e-01	6.05e-01
GOBP NEGATIVE REGULATION OF TRANSLATIONAL ELONGATION	5	3.21e-01	4.41e-01	0.8230	-5.22e-01	-4.06e-01	-1.36e-01	-1.55e-01	-4.23e-01	-1.36e-01	4.33e-02	1.16e-01	5.99e-01	5.49e-01	1.02e-01	5.97e-01
GOBP RESPIRATORY CHAIN COMPLEX IV ASSEMBLY	27	1.41e-07	1.69e-06	0.8220	-1.92e-01	-6.13e-01	-4.96e-01	-1.06e-01	-1.81e-02	-8.10e-02	8.49e-02	3.47e-08	8.25e-06	3.39e-01	8.71e-01	4.66e-01
GOMF G PROTEIN COUPLED NEUROTRANSMITTER RECEPTOR ACTIVITY	5	1.44e-01	2.54e-01	0.8220	3.05e-01	5.04e-01	9.17e-02	-1.09e-01	5.29e-01	1.70e-01	2.38e-01	5.12e-02	7.23e-01	6.73e-01	4.07e-02	5.09e-01
GOBP INTESTINAL LIPID ABSORPTION	14	1.12e-02	3.77e-02	0.8210	2.63e-01	4.15e-01	4.98e-01	2.38e-01	1.96e-01	2.98e-01	8.87e-02	7.16e-03	1.25e-03	1.23e-01	2.05e-01	5.33e-02
GOBP TRNA 5 LEADER REMOVAL	13	1.67e-03	7.85e-03	0.8210	-1.58e-01	-6.63e-01	-4.49e-01	5.48e-02	-4.32e-02	-5.25e-02	3.23e-01	3.50e-05	5.08e-03	7.32e-01	7.88e-01	7.43e-01
GOBP VESICLE FUSION WITH GOLGI APPARATUS	8	7.38e-03	2.70e-02	0.8200	-3.30e-01	-2.12e-01	2.42e-02	-9.18e-02	7.34e-02	7.10e-01	1.06e-01	2.99e-01	9.05e-01	6.53e-01	7.19e-01	5.08e-04
GOMF BIOTIN BINDING	5	1.55e-01	2.67e-01	0.8200	-3.94e-01	-8.89e-02	-5.80e-01	2.52e-01	3.13e-01	-1.04e-01	1.27e-01	7.31e-01	2.48e-02	3.28e-01	2.26e-01	6.88e-01
GOBP RIBOSOMAL LARGE SUBUNIT ASSEMBLY	21	1.07e-05	8.93e-05	0.8180	-1.09e-01	-6.34e-01	-3.74e-01	1.52e-01	-1.32e-01	-2.74e-01	3.87e-01	4.82e-07	3.03e-03	2.27e-01	2.94e-01	2.97e-02
GOBP CARDIAC VASCULAR SMOOTH MUSCLE CELL DIFFERENTIATION	5	2.44e-03	1.09e-02	0.8180	-2.08e-01	7.69e-03	6.55e-01	3.82e-01	1.91e-01	1.18e-01	4.20e-01	9.76e-01	1.12e-02	1.39e-01	4.60e-01	6.48e-01
GOBP SIGNAL PEPTIDE PROCESSING	13	8.14e-03	2.92e-02	0.8180	-5.16e-01	-4.56e-01	-1.20e-01	-1.55e-01	-2.88e-01	2.71e-01	1.27e-03	4.41e-03	4.53e-01	3.34e-01	7.17e-02	9.05e-02
GOBP NEGATIVE REGULATION OF FIBROBLAST MIGRATION	8	1.37e-01	2.45e-01	0.8180	-3.71e-01	-3.09e-01	2.38e-01	-3.65e-01	-4.86e-01	9.92e-02	6.93e-02	1.30e-01	2.43e-01	7.34e-02	1.73e-02	6.27e-01
GOMF CYSTEINE TYPE ENDOPEPTIDASE ACTIVITY INVOLVED IN EXECUTION PHASE OF APOPTOSIS	5	1.97e-01	3.13e-01	0.8180	-4.94e-01	-2.47e-01	-1.14e-01	-2.56e-01	-3.01e-01	4.41e-01	5.55e-02	3.38e-01	6.59e-01	3.22e-01	2.44e-01	8.77e-02
GOBP RESPONSE TO FUNGICIDE	6	1.35e-01	2.43e-01	0.8180	3.12e-01	1.87e-01	1.18e-01	5.98e-01	3.46e-01	-2.14e-01	1.86e-01	4.27e-01	6.18e-01	1.12e-02	1.43e-01	3.64e-01
GOCC TIM23 MITOCHONDRIAL IMPORT INNER MEMBRANE TRANSLOCASE COMPLEX	16	1.50e-03	7.17e-03	0.8170	-1.51e-01	-5.86e-01	-4.54e-01	9.52e-03	-1.41e-01	-2.73e-01	2.95e-01	4.88e-05	1.66e-03	9.47e-01	3.29e-01	5.90e-02
GOCC HISTONE PRE MRNA 3 END PROCESSING COMPLEX	6	2.64e-01	3.84e-01	0.8160	-3.70e-01	-5.80e-01	-4.15e-01	-2.95e-02	-9.01e-02	-1.07e-01	1.17e-01	1.38e-02	7.81e-02	9.00e-01	7.02e-01	6.49e-01
GOBP REGULATION OF VITAMIN D BIOSYNTHETIC PROCESS	6	1.92e-02	5.74e-02	0.8160	2.96e-01	3.84e-01	4.82e-01	-1.77e-01	4.09e-01	-1.07e-02	2.09e-01	1.03e-01	4.10e-02	4.53e-01	8.24e-02	9.64e-01
GOCC ALPHA BETA T CELL RECEPTOR COMPLEX	10	6.11e-04	3.33e-03	0.8160	3.86e-01	1.12e-01	-2.98e-01	4.30e-01	3.58e-01	3.21e-01	3.45e-02	5.38e-01	1.03e-01	1.86e-02	5.00e-02	7.87e-02
GOMF POTASSIUM ION LEAK CHANNEL ACTIVITY	8	5.76e-02	1.31e-01	0.8160	3.50e-02	3.52e-01	3.55e-01	4.24e-01	3.34e-01	3.52e-01	8.64e-01	8.51e-02	8.16e-02	3.76e-02	1.02e-01	8.51e-02
GOBP ETHANOL METABOLIC PROCESS	8	4.03e-02	1.00e-01	0.8160	-3.49e-01	-3.10e-01	-2.95e-01	-1.02e-01	-4.87e-01	-3.35e-01	8.71e-02	1.29e-01	1.49e-01	6.16e-01	1.70e-02	1.01e-01
GOMF CXCR CHEMOKINE RECEPTOR BINDING	11	1.12e-03	5.61e-03	0.8160	-4.57e-02	-2.33e-01	4.70e-01	-4.89e-01	-3.85e-01	1.78e-02	7.93e-01	1.82e-01	6.97e-03	4.94e-03	2.69e-02	9.19e-01
GOMF RAGE RECEPTOR BINDING	9	7.46e-02	1.58e-01	0.8160	-2.75e-01	6.76e-02	3.88e-01	-4.05e-01	-3.19e-01	4.10e-01	1.53e-01	7.26e-01	4.38e-02	3.53e-02	9.74e-02	3.31e-02
GOBP REELIN MEDIATED SIGNALING PATHWAY	8	3.98e-02	9.92e-02	0.8150	1.12e-01	2.63e-01	4.87e-01	4.67e-01	-4.00e-02	3.56e-01	5.83e-01	1.98e-01	1.71e-02	2.21e-02	8.45e-01	8.15e-02
GOBP NK T CELL DIFFERENTIATION	11	2.89e-03	1.25e-02	0.8150	-1.66e-01	2.49e-01	5.16e-01	9.48e-02	-3.54e-01	4.18e-01	3.40e-01	1.53e-01	3.03e-03	5.86e-01	4.21e-02	1.64e-02
GOBP MECHANOSENSORY BEHAVIOR	8	7.59e-02	1.60e-01	0.8150	1.72e-02	2.54e-01	3.99e-01	1.64e-01	6.32e-02	6.40e-01	9.33e-01	2.14e-01	5.09e-02	4.22e-01	7.57e-01	1.71e-03
GOBP REGULATION OF NEURON PROJECTION ARBORIZATION	13	2.00e-02	5.93e-02	0.8150	3.38e-01	4.90e-01	1.11e-01	4.10e-01	3.50e-01	-7.88e-02	3.46e-02	2.22e-03	4.86e-01	1.04e-02	2.91e-02	6.23e-01
GOBP ATP SYNTHESIS COUPLED ELECTRON TRANSPORT	93	5.73e-29	5.06e-27	0.8140	-2.04e-01	-7.10e-01	-2.31e-01	1.48e-02	-2.52e-01	2.83e-02	6.93e-04	2.13e-32	1.17e-04	8.05e-01	2.68e-05	6.38e-01
GOBP SENSORY PERCEPTION OF SOUR TASTE	5	2.82e-01	4.02e-01	0.8140	4.09e-01	7.80e-02	1.27e-01	5.30e-01	4.35e-01	-6.19e-02	1.13e-01	7.63e-01	6.24e-01	4.03e-02	9.19e-02	8.11e-01
GOBP TETRAHYDROFOLATE BIOSYNTHETIC PROCESS	7	1.09e-02	3.68e-02	0.8140	-3.74e-02	-4.69e-01	-1.79e-02	3.37e-01	1.97e-01	5.37e-01	8.64e-01	3.15e-02	9.35e-01	1.23e-01	3.66e-01	1.39e-02
GOMF RDNA BINDING	9	2.31e-03	1.04e-02	0.8140	-6.11e-02	-2.72e-01	-3.16e-01	3.26e-01	-3.00e-01	-5.37e-01	7.51e-01	1.57e-01	1.01e-01	9.01e-02	1.20e-01	5.30e-03
GOBP NEGATIVE REGULATION OF DENDRITIC CELL DIFFERENTIATION	5	8.48e-02	1.73e-01	0.8140	4.35e-01	2.51e-01	-1.55e-02	-3.93e-02	6.35e-01	-6.62e-02	9.19e-02	3.30e-01	9.52e-01	8.79e-01	1.39e-02	7.98e-01
GOBP NEURAL PLATE DEVELOPMENT	7	2.34e-01	3.53e-01	0.8130	3.48e-01	4.68e-01	-4.33e-02	3.73e-01	3.86e-01	-1.77e-01	1.11e-01	3.20e-02	8.43e-01	8.70e-02	7.68e-02	4.18e-01
GOBP POSITIVE REGULATION OF WNT SIGNALING PATHWAY PLANAR CELL POLARITY PATHWAY	6	3.52e-01	4.68e-01	0.8130	4.17e-01	3.14e-01	3.54e-01	4.32e-01	1.39e-01	2.37e-01	7.71e-02	1.83e-01	1.33e-01	6.66e-02	5.56e-01	3.15e-01
GOCC RESPIRASOME	95	9.65e-29	8.44e-27	0.8130	-2.07e-01	-7.07e-01	-2.39e-01	-1.24e-02	-2.46e-01	-9.91e-03	4.93e-04	8.79e-33	5.75e-05	8.35e-01	3.39e-05	8.67e-01
GOBP POSITIVE REGULATION OF TRANSLATION IN RESPONSE TO STRESS	6	5.86e-02	1.33e-01	0.8120	-5.75e-01	-1.58e-01	2.90e-01	-1.30e-01	-4.43e-01	8.25e-02	1.47e-02	5.03e-01	2.19e-01	5.81e-01	6.04e-02	7.26e-01
GOBP REGULATION OF MITOCHONDRIAL TRANSLATION	25	7.26e-07	7.78e-06	0.8120	-5.52e-02	-6.15e-01	-4.65e-01	1.45e-01	-3.32e-02	-2.00e-01	6.33e-01	1.02e-07	5.77e-05	2.10e-01	7.74e-01	8.42e-02
GOBP REGULATION OF ANTIGEN PROCESSING AND PRESENTATION OF PEPTIDE ANTIGEN	5	3.54e-01	4.69e-01	0.8120	2.74e-01	-8.68e-02	-3.46e-01	3.74e-01	4.73e-01	-3.05e-01	2.88e-01	7.37e-01	1.80e-01	1.48e-01	6.71e-02	2.38e-01
GOBP GLYCEROL 3 PHOSPHATE METABOLIC PROCESS	8	3.24e-03	1.38e-02	0.8120	-4.18e-01	5.26e-01	1.09e-01	5.57e-03	3.01e-01	3.24e-01	4.07e-02	1.00e-02	5.93e-01	9.78e-01	1.40e-01	1.12e-01
GOBP AMYLOID BETA CLEARANCE BY CELLULAR CATABOLIC PROCESS	6	7.26e-02	1.55e-01	0.8110	5.19e-02	3.82e-01	6.23e-01	-3.64e-02	2.45e-01	2.47e-01	8.26e-01	1.05e-01	8.27e-03	8.77e-01	2.99e-01	2.95e-01
GOBP SMOOTH MUSCLE CELL CHEMOTAXIS	7	2.30e-01	3.48e-01	0.8110	4.48e-01	2.24e-01	1.70e-01	4.46e-01	3.46e-01	2.44e-01	4.01e-02	3.04e-01	4.35e-01	4.11e-02	1.13e-01	2.64e-01
GOMF STRUCTURAL CONSTITUENT OF CHROMATIN	44	3.19e-14	8.09e-13	0.8110	-1.12e-01	-5.99e-01	2.32e-01	-1.28e-01	-3.94e-01	2.47e-01	2.00e-01	6.14e-12	7.85e-03	1.41e-01	5.95e-06	4.57e-03
GOBP CELLULAR RESPONSE TO NITROGEN LEVELS	9	9.26e-02	1.85e-01	0.8100	-4.10e-01	-4.70e-01	-2.72e-01	-2.13e-01	-3.82e-01	4.83e-02	3.33e-02	1.46e-02	1.57e-01	2.69e-01	4.73e-02	8.02e-01
GOMF SHORT CHAIN CARBOXYLESTERASE ACTIVITY	6	4.97e-02	1.17e-01	0.8100	-1.22e-01	-1.49e-02	4.31e-01	3.39e-01	2.98e-01	5.02e-01	6.06e-01	9.50e-01	6.77e-02	1.50e-01	2.06e-01	3.32e-02
GOBP POSITIVE REGULATION OF STORE OPERATED CALCIUM CHANNEL ACTIVITY	5	7.48e-02	1.59e-01	0.8100	1.07e-01	4.23e-01	3.13e-01	5.28e-01	-1.19e-01	2.74e-01	6.79e-01	1.01e-01	2.26e-01	4.10e-02	6.46e-01	2.89e-01
GOCC ELONGATOR HOLOENZYME COMPLEX	6	2.11e-01	3.28e-01	0.8100	-9.65e-02	-3.46e-01	-6.21e-01	5.52e-02	2.72e-01	-2.52e-01	6.82e-01	1.42e-01	8.38e-03	8.15e-01	2.49e-01	2.84e-01
GOBP MRNA 3 SPLICE SITE RECOGNITION	6	5.90e-02	1.33e-01	0.8100	2.87e-02	-1.52e-01	-3.46e-01	6.87e-01	1.95e-01	3.52e-02	9.03e-01	5.18e-01	1.42e-01	3.56e-03	4.07e-01	8.81e-01
GOBP NAIL DEVELOPMENT	5	1.82e-01	2.97e-01	0.8090	4.34e-01	1.96e-01	3.56e-01	2.44e-02	-1.05e-01	5.39e-01	9.32e-02	4.47e-01	1.68e-01	9.25e-01	6.84e-01	3.70e-02
GOMF GLYCEROL 3 PHOSPHATE O ACYLTRANSFERASE ACTIVITY	5	1.86e-01	3.01e-01	0.8090	-6.33e-01	-1.82e-02	1.15e-01	-3.32e-01	2.27e-03	3.61e-01	1.43e-02	9.44e-01	6.56e-01	1.99e-01	9.93e-01	1.62e-01
GOMF RNA POLYMERASE III TYPE 3 PROMOTER SEQUENCE SPECIFIC DNA BINDING	6	6.95e-02	1.50e-01	0.8090	3.00e-01	-2.56e-01	-1.98e-01	4.35e-01	-3.50e-02	-5.19e-01	2.03e-01	2.77e-01	4.02e-01	6.49e-02	8.82e-01	2.78e-02
GOMF D LOOP DNA BINDING	5	1.33e-01	2.40e-01	0.8090	2.52e-01	-2.60e-01	-1.76e-01	6.76e-01	1.13e-01	1.49e-01	3.29e-01	3.14e-01	4.96e-01	8.83e-03	6.62e-01	5.63e-01
GOBP POSITIVE REGULATION OF SYNAPTIC TRANSMISSION GABAERGIC	9	6.20e-02	1.38e-01	0.8090	-1.58e-01	-7.48e-02	5.25e-01	-2.42e-02	-2.86e-01	5.15e-01	4.12e-01	6.98e-01	6.40e-03	9.00e-01	1.37e-01	7.44e-03
GOBP REGULATION OF INTESTINAL ABSORPTION	6	2.59e-01	3.79e-01	0.8080	3.42e-01	2.99e-01	2.89e-01	5.31e-01	2.83e-01	3.68e-02	1.46e-01	2.05e-01	2.21e-01	2.43e-02	2.30e-01	8.76e-01
GOMF THIOREDOXIN DISULFIDE REDUCTASE NADPH ACTIVITY	6	5.61e-02	1.28e-01	0.8080	-5.34e-01	-3.02e-01	3.54e-01	3.68e-03	-2.03e-01	3.31e-01	2.35e-02	2.01e-01	1.33e-01	9.88e-01	3.89e-01	1.60e-01
GOCC CKM COMPLEX	5	8.14e-02	1.69e-01	0.8080	-3.66e-01	2.86e-01	2.31e-01	9.48e-02	-7.06e-02	6.08e-01	1.57e-01	2.68e-01	3.71e-01	7.14e-01	7.85e-01	1.85e-02
GOBP POSITIVE REGULATION OF CELL CELL ADHESION MEDIATED BY CADHERIN	7	7.38e-02	1.57e-01	0.8080	2.30e-01	2.93e-01	5.03e-01	-2.25e-01	-4.57e-01	3.38e-02	2.92e-01	1.79e-01	2.12e-02	3.03e-01	3.62e-02	8.77e-01
GOBP CELLULAR RESPONSE TO ALDOSTERONE	6	2.08e-01	3.25e-01	0.8080	3.48e-01	3.25e-01	1.56e-01	3.29e-01	5.20e-01	-1.52e-01	1.40e-01	1.68e-01	5.09e-01	1.63e-01	2.74e-02	5.19e-01
GOBP REGULATION OF LOCOMOTION INVOLVED IN LOCOMOTORY BEHAVIOR	5	7.25e-02	1.55e-01	0.8080	-4.53e-01	1.32e-01	-2.15e-01	3.29e-01	5.20e-01	6.83e-02	7.97e-02	6.08e-01	4.06e-01	2.02e-01	4.40e-02	7.92e-01
GOBP MITOCHONDRIAL GENE EXPRESSION	167	3.60e-52	1.32e-49	0.8070	-1.18e-01	-6.31e-01	-4.62e-01	7.54e-02	-7.18e-02	-1.20e-01	8.76e-03	3.32e-45	5.71e-25	9.26e-02	1.09e-01	7.24e-03
GOMF CATALYTIC ACTIVITY ACTING ON A RRNA	21	8.84e-06	7.53e-05	0.8070	-2.20e-02	-5.55e-01	-5.49e-01	2.23e-02	3.44e-02	-2.01e-01	8.61e-01	1.08e-05	1.33e-05	8.60e-01	7.85e-01	1.11e-01
GOBP ARGININE CATABOLIC PROCESS	7	5.57e-02	1.28e-01	0.8070	6.86e-02	-1.37e-01	6.44e-01	1.18e-01	-2.09e-01	3.94e-01	7.53e-01	5.30e-01	3.16e-03	5.89e-01	3.38e-01	7.12e-02
GOMF CHLORIDE ION BINDING	6	5.68e-02	1.29e-01	0.8070	-4.85e-01	-3.11e-01	-3.66e-03	-5.59e-01	4.25e-02	-7.63e-02	3.98e-02	1.87e-01	9.88e-01	1.78e-02	8.57e-01	7.46e-01
GOCC RNA POLYMERASE TRANSCRIPTION FACTOR SL1 COMPLEX	5	3.99e-01	5.10e-01	0.8070	-2.40e-01	-2.36e-01	-4.80e-01	-3.96e-01	-1.21e-01	-3.68e-01	3.52e-01	3.62e-01	6.32e-02	1.25e-01	6.38e-01	1.54e-01
GOMF OXIDOREDUCTION DRIVEN ACTIVE TRANSMEMBRANE TRANSPORTER ACTIVITY	66	4.55e-19	1.79e-17	0.8060	-1.50e-01	-6.89e-01	-2.94e-01	2.24e-03	-2.38e-01	-1.02e-01	3.57e-02	3.50e-22	3.62e-05	9.75e-01	8.28e-04	1.54e-01
GOMF DEOXYRIBONUCLEASE I ACTIVITY	5	3.98e-01	5.10e-01	0.8060	2.82e-01	1.79e-01	5.51e-01	1.99e-01	6.85e-02	4.37e-01	2.74e-01	4.88e-01	3.30e-02	4.42e-01	7.91e-01	9.07e-02
GOBP NEUTROPHIL APOPTOTIC PROCESS	6	6.75e-02	1.47e-01	0.8060	-1.56e-01	3.16e-01	3.43e-01	1.71e-01	4.84e-01	3.80e-01	5.09e-01	1.81e-01	1.46e-01	4.69e-01	4.00e-02	1.07e-01
GOBP REGULATION OF LONG CHAIN FATTY ACID IMPORT ACROSS PLASMA MEMBRANE	6	1.70e-03	8.01e-03	0.8060	-3.56e-01	4.06e-02	2.99e-01	-2.59e-01	-2.38e-01	-5.55e-01	1.31e-01	8.63e-01	2.05e-01	2.72e-01	3.12e-01	1.86e-02
GOBP NUCLEOTIDE BINDING OLIGOMERIZATION DOMAIN CONTAINING 1 SIGNALING PATHWAY	8	9.17e-05	6.28e-04	0.8060	-5.53e-01	1.26e-01	4.27e-01	-1.96e-01	-2.28e-01	-2.33e-01	6.71e-03	5.38e-01	3.65e-02	3.37e-01	2.64e-01	2.54e-01
GOBP NEGATIVE REGULATION OF SODIUM ION TRANSPORT	8	1.18e-01	2.20e-01	0.8060	-1.52e-01	-4.84e-01	1.01e-02	-3.53e-01	-5.12e-01	6.90e-02	4.57e-01	1.78e-02	9.61e-01	8.37e-02	1.21e-02	7.35e-01
GOMF 2 ACYLGLYCEROL 3 PHOSPHATE O ACYLTRANSFERASE ACTIVITY	9	8.80e-03	3.10e-02	0.8060	-3.74e-01	3.29e-01	4.46e-01	-2.87e-02	4.70e-02	4.46e-01	5.18e-02	8.77e-02	2.06e-02	8.82e-01	8.07e-01	2.05e-02
GOBP NEGATIVE REGULATION OF INTRACELLULAR PROTEIN TRANSPORT	29	1.28e-06	1.32e-05	0.8050	-4.54e-01	-4.46e-01	7.20e-02	-1.68e-01	-2.82e-01	3.61e-01	2.27e-05	3.19e-05	5.02e-01	1.18e-01	8.69e-03	7.57e-04
GOMF SODIUM CHANNEL INHIBITOR ACTIVITY	7	7.04e-02	1.52e-01	0.8050	-1.56e-01	-4.62e-01	1.46e-01	-5.12e-01	-3.24e-01	1.43e-01	4.75e-01	3.41e-02	5.05e-01	1.89e-02	1.37e-01	5.14e-01
GOBP CARTILAGE CONDENSATION	7	6.74e-02	1.47e-01	0.8050	5.50e-02	6.21e-01	6.94e-02	2.21e-01	4.19e-01	-1.71e-01	8.01e-01	4.42e-03	7.50e-01	3.12e-01	5.49e-02	4.34e-01
GOMF CHONDROITIN SULFATE BINDING	6	1.61e-01	2.73e-01	0.8050	6.59e-02	1.86e-01	7.45e-02	4.12e-01	5.75e-01	3.20e-01	7.80e-01	4.30e-01	7.52e-01	8.02e-02	1.48e-02	1.75e-01
GOBP REGULATION OF TERMINATION OF DNA TEMPLATED TRANSCRIPTION	5	5.38e-02	1.24e-01	0.8050	-9.96e-02	5.05e-01	4.96e-01	2.34e-01	-2.26e-01	1.74e-01	7.00e-01	5.03e-02	5.48e-02	3.65e-01	3.82e-01	5.00e-01
GOMF CCR5 CHEMOKINE RECEPTOR BINDING	6	1.91e-01	3.06e-01	0.8040	2.43e-01	2.68e-01	4.60e-01	-1.09e-01	-3.47e-01	4.15e-01	3.03e-01	2.56e-01	5.10e-02	6.44e-01	1.41e-01	7.82e-02
GOBP REGULATION OF MAST CELL ACTIVATION INVOLVED IN IMMUNE RESPONSE	5	3.02e-01	4.22e-01	0.8040	3.97e-01	1.14e-01	3.44e-01	3.67e-01	3.54e-01	3.13e-01	1.24e-01	6.58e-01	1.83e-01	1.55e-01	1.71e-01	2.25e-01
GOMF SMALL RIBOSOMAL SUBUNIT RRNA BINDING	8	2.37e-02	6.72e-02	0.8040	-2.27e-01	-4.66e-01	-5.88e-01	1.77e-02	1.66e-01	6.78e-02	2.65e-01	2.25e-02	3.98e-03	9.31e-01	4.16e-01	7.40e-01
GOBP PROTEIN INSERTION INTO MITOCHONDRIAL INNER MEMBRANE	13	2.09e-03	9.52e-03	0.8040	-1.34e-01	-5.62e-01	-5.24e-01	1.23e-01	1.33e-01	-7.84e-02	4.02e-01	4.54e-04	1.08e-03	4.42e-01	4.07e-01	6.24e-01
GOBP ANTEROGRADE DENDRITIC TRANSPORT	8	1.23e-01	2.27e-01	0.8040	1.41e-01	1.29e-01	6.32e-01	-5.41e-02	-2.14e-01	4.03e-01	4.89e-01	5.28e-01	1.97e-03	7.91e-01	2.94e-01	4.86e-02
GOBP PLATELET DERIVED GROWTH FACTOR RECEPTOR ALPHA SIGNALING PATHWAY	6	1.99e-01	3.15e-01	0.8040	-1.69e-01	-1.38e-01	2.95e-01	-1.57e-01	-3.16e-01	6.22e-01	4.73e-01	5.58e-01	2.11e-01	5.05e-01	1.81e-01	8.28e-03
GOBP PLANAR CELL POLARITY PATHWAY INVOLVED IN NEURAL TUBE CLOSURE	6	1.03e-01	2.00e-01	0.8040	1.48e-01	1.70e-01	2.06e-02	5.66e-01	4.57e-01	-2.55e-01	5.29e-01	4.70e-01	9.30e-01	1.63e-02	5.25e-02	2.79e-01
GOBP ESTABLISHMENT OF LYMPHOCYTE POLARITY	13	6.41e-05	4.56e-04	0.8040	-7.86e-02	2.24e-03	4.51e-01	4.79e-01	-2.68e-01	3.66e-01	6.24e-01	9.89e-01	4.82e-03	2.76e-03	9.43e-02	2.22e-02
GOMF HISTONE H3K9 DEMETHYLASE ACTIVITY	10	8.77e-05	6.02e-04	0.8040	-1.64e-01	4.64e-01	1.04e-01	5.57e-01	2.69e-01	-1.03e-01	3.70e-01	1.11e-02	5.70e-01	2.30e-03	1.40e-01	5.74e-01
GOBP REGULATION OF SEQUESTERING OF TRIGLYCERIDE	12	6.00e-03	2.27e-02	0.8030	-3.66e-01	-8.59e-02	4.84e-01	-2.34e-01	-3.89e-01	2.51e-01	2.82e-02	6.07e-01	3.69e-03	1.61e-01	1.95e-02	1.32e-01
GOCC NF KAPPAB COMPLEX	5	3.86e-01	5.00e-01	0.8030	3.11e-01	3.71e-01	-3.51e-02	4.61e-01	3.38e-01	-2.87e-01	2.29e-01	1.51e-01	8.92e-01	7.41e-02	1.90e-01	2.66e-01
GOCC PLATELET DENSE TUBULAR NETWORK MEMBRANE	9	2.88e-02	7.77e-02	0.8030	2.61e-01	4.14e-01	4.44e-01	4.46e-01	2.95e-02	8.68e-02	1.76e-01	3.14e-02	2.10e-02	2.04e-02	8.78e-01	6.52e-01
GOMF CD4 RECEPTOR BINDING	7	1.39e-01	2.48e-01	0.8030	1.20e-01	5.18e-02	-2.04e-01	4.97e-01	5.79e-01	5.25e-02	5.81e-01	8.12e-01	3.49e-01	2.27e-02	8.00e-03	8.10e-01
GOBP REGULATION OF NEUTROPHIL DEGRANULATION	8	1.16e-03	5.75e-03	0.8030	-2.73e-01	5.49e-01	4.96e-01	1.23e-01	3.94e-02	7.73e-02	1.81e-01	7.20e-03	1.52e-02	5.46e-01	8.47e-01	7.05e-01
GOCC IMMUNOGLOBULIN COMPLEX CIRCULATING	11	2.79e-04	1.69e-03	0.8020	6.26e-02	-4.05e-01	9.87e-03	4.72e-01	-3.04e-01	4.01e-01	7.19e-01	2.01e-02	9.55e-01	6.70e-03	8.07e-02	2.13e-02
GOBP POSITIVE REGULATION OF GOLGI TO PLASMA MEMBRANE PROTEIN TRANSPORT	5	3.02e-01	4.22e-01	0.8010	-5.65e-01	-4.40e-01	-6.04e-02	-4.50e-02	-3.24e-01	1.39e-01	2.88e-02	8.86e-02	8.15e-01	8.62e-01	2.09e-01	5.91e-01
GOBP POSITIVE REGULATION OF TOLL LIKE RECEPTOR 2 SIGNALING PATHWAY	6	8.05e-02	1.67e-01	0.8010	-9.00e-02	2.70e-01	1.49e-01	5.65e-01	3.32e-01	3.30e-01	7.03e-01	2.52e-01	5.28e-01	1.65e-02	1.59e-01	1.62e-01
GOMF LIPASE INHIBITOR ACTIVITY	9	7.74e-03	2.80e-02	0.8010	-2.00e-01	-1.80e-01	6.15e-01	-2.16e-01	-2.98e-01	2.36e-01	3.00e-01	3.49e-01	1.41e-03	2.62e-01	1.22e-01	2.20e-01
GOBP POSITIVE REGULATION OF SODIUM ION TRANSMEMBRANE TRANSPORTER ACTIVITY	14	3.94e-03	1.61e-02	0.8010	1.08e-01	2.56e-01	5.95e-01	1.19e-01	1.25e-01	4.25e-01	4.85e-01	9.76e-02	1.17e-04	4.41e-01	4.18e-01	5.91e-03
GOBP PURINE RIBONUCLEOSIDE CATABOLIC PROCESS	5	2.98e-01	4.18e-01	0.8000	3.92e-01	3.61e-01	-3.17e-02	3.01e-01	4.39e-01	2.69e-01	1.29e-01	1.63e-01	9.02e-01	2.44e-01	8.88e-02	2.97e-01
GOMF SINGLE STRANDED DNA 3 5 DNA EXONUCLEASE ACTIVITY	5	3.61e-02	9.22e-02	0.8000	1.14e-01	-1.16e-01	-1.65e-01	6.27e-01	-2.06e-01	-3.88e-01	6.59e-01	6.53e-01	5.22e-01	1.51e-02	4.25e-01	1.33e-01
GOBP PROTEIN LOCALIZATION TO NUCLEOPLASM	14	6.72e-04	3.62e-03	0.8000	-1.88e-01	-6.69e-01	-3.61e-01	1.63e-01	3.26e-03	1.28e-02	2.23e-01	1.47e-05	1.95e-02	2.92e-01	9.83e-01	9.34e-01
GOCC PHAGOCYTIC VESICLE LUMEN	5	2.04e-01	3.20e-01	0.8000	3.74e-01	8.42e-02	5.53e-01	2.81e-01	-3.10e-01	1.06e-01	1.47e-01	7.44e-01	3.23e-02	2.77e-01	2.29e-01	6.81e-01
GOBP SRP DEPENDENT COTRANSLATIONAL PROTEIN TARGETING TO MEMBRANE SIGNAL SEQUENCE RECOGNITION	8	4.43e-02	1.07e-01	0.8000	1.87e-01	-2.52e-01	5.13e-01	-7.26e-02	-3.69e-01	3.69e-01	3.59e-01	2.18e-01	1.21e-02	7.22e-01	7.03e-02	7.05e-02
GOBP SKELETAL MYOFIBRIL ASSEMBLY	6	4.74e-02	1.13e-01	0.7990	3.77e-01	5.82e-01	2.26e-01	-2.63e-01	-1.82e-01	6.86e-02	1.10e-01	1.36e-02	3.39e-01	2.64e-01	4.40e-01	7.71e-01
GOBP NEGATIVE REGULATION OF PROTEIN TARGETING TO MEMBRANE	5	3.43e-01	4.60e-01	0.7980	-1.51e-01	-5.10e-01	1.93e-03	-1.50e-01	-5.69e-01	9.41e-02	5.60e-01	4.84e-02	9.94e-01	5.61e-01	2.76e-02	7.16e-01
GOBP NECROPTOTIC SIGNALING PATHWAY	8	1.14e-01	2.15e-01	0.7980	9.07e-02	3.81e-01	3.52e-01	2.34e-01	3.43e-01	4.32e-01	6.57e-01	6.19e-02	8.44e-02	2.51e-01	9.33e-02	3.42e-02
GOMF ANKYRIN BINDING	13	2.22e-02	6.42e-02	0.7980	2.25e-01	3.04e-01	5.23e-01	2.54e-01	-9.50e-03	3.94e-01	1.60e-01	5.79e-02	1.09e-03	1.12e-01	9.53e-01	1.38e-02
GOBP FATTY ACID ALPHA OXIDATION	6	1.58e-01	2.70e-01	0.7980	-1.82e-01	-4.83e-01	-5.59e-01	-2.94e-02	2.12e-01	-1.08e-01	4.40e-01	4.04e-02	1.77e-02	9.01e-01	3.68e-01	6.47e-01
GOBP CHOLESTEROL CATABOLIC PROCESS	6	2.13e-01	3.31e-01	0.7980	6.26e-02	8.10e-02	-4.04e-01	-4.60e-02	4.07e-01	-5.43e-01	7.90e-01	7.31e-01	8.68e-02	8.45e-01	8.39e-02	2.12e-02
GOBP LIMB BUD FORMATION	5	2.60e-01	3.80e-01	0.7980	1.92e-01	6.15e-01	3.93e-01	9.89e-02	2.34e-01	-5.54e-02	4.58e-01	1.73e-02	1.28e-01	7.02e-01	3.66e-01	8.30e-01
GOBP POSITIVE REGULATION OF MEMORY T CELL DIFFERENTIATION	6	1.78e-01	2.93e-01	0.7980	-2.29e-01	-3.20e-01	-4.79e-01	2.68e-01	3.93e-01	-1.59e-01	3.31e-01	1.75e-01	4.20e-02	2.55e-01	9.58e-02	5.00e-01
GOBP FEVER GENERATION	8	2.18e-03	9.88e-03	0.7980	-9.41e-02	2.16e-01	5.06e-01	-5.68e-01	4.10e-02	2.76e-03	6.45e-01	2.90e-01	1.31e-02	5.41e-03	8.41e-01	9.89e-01
GOBP POSITIVE REGULATION OF PROTEIN MONOUBIQUITINATION	5	1.65e-01	2.78e-01	0.7970	1.73e-01	-7.20e-02	-8.48e-02	5.46e-01	3.24e-01	4.37e-01	5.02e-01	7.80e-01	7.43e-01	3.45e-02	2.10e-01	9.08e-02
GOCC SIGNAL RECOGNITION PARTICLE	10	5.34e-03	2.07e-02	0.7970	8.54e-02	-4.53e-01	3.31e-01	-1.97e-01	-3.55e-01	3.85e-01	6.40e-01	1.31e-02	7.00e-02	2.81e-01	5.17e-02	3.48e-02
GOBP GLYCINE TRANSPORT	7	7.45e-03	2.73e-02	0.7960	7.26e-02	-1.11e-01	1.57e-01	1.42e-01	-6.77e-01	3.36e-01	7.40e-01	6.12e-01	4.71e-01	5.15e-01	1.91e-03	1.23e-01
GOBP CORONARY ARTERY MORPHOGENESIS	7	1.22e-02	4.01e-02	0.7960	-3.11e-01	4.24e-01	2.40e-01	2.41e-01	4.49e-01	2.01e-01	1.54e-01	5.20e-02	2.72e-01	2.70e-01	3.95e-02	3.58e-01
GOBP PROTEIN O LINKED GLYCOSYLATION VIA THREONINE	9	4.74e-03	1.88e-02	0.7960	-5.47e-01	-3.53e-01	3.03e-01	8.83e-03	-1.49e-01	3.09e-01	4.46e-03	6.69e-02	1.16e-01	9.63e-01	4.40e-01	1.09e-01
GOBP NEGATIVE REGULATION OF RYANODINE SENSITIVE CALCIUM RELEASE CHANNEL ACTIVITY	8	6.47e-02	1.43e-01	0.7960	-4.76e-01	-4.80e-01	-9.52e-02	-1.49e-01	-9.77e-02	3.68e-01	1.97e-02	1.88e-02	6.41e-01	4.67e-01	6.32e-01	7.15e-02
GOBP NEGATIVE REGULATION OF HORMONE BIOSYNTHETIC PROCESS	8	1.68e-01	2.81e-01	0.7960	1.02e-01	2.45e-01	5.66e-01	1.63e-02	-1.10e-01	4.79e-01	6.19e-01	2.30e-01	5.53e-03	9.36e-01	5.90e-01	1.89e-02
GOBP REGULATION OF ENDOSOME TO PLASMA MEMBRANE PROTEIN TRANSPORT	5	2.61e-01	3.81e-01	0.7950	3.09e-01	2.63e-01	6.60e-01	-1.67e-02	-1.18e-01	1.34e-01	2.31e-01	3.08e-01	1.06e-02	9.48e-01	6.47e-01	6.03e-01
GOBP CARDIAC NEURAL CREST CELL DIFFERENTIATION INVOLVED IN HEART DEVELOPMENT	9	8.15e-04	4.28e-03	0.7950	-6.14e-01	-2.82e-01	2.94e-01	-2.42e-01	-1.70e-01	-5.09e-02	1.43e-03	1.43e-01	1.27e-01	2.09e-01	3.76e-01	7.91e-01
GOBP AMYLOID BETA CLEARANCE BY TRANSCYTOSIS	7	3.82e-02	9.62e-02	0.7950	-4.91e-01	1.17e-01	4.20e-01	-3.23e-02	-1.14e-01	4.33e-01	2.44e-02	5.91e-01	5.45e-02	8.82e-01	6.03e-01	4.73e-02
GOBP RESPONSE TO LUTEINIZING HORMONE	5	2.84e-01	4.04e-01	0.7950	-1.24e-01	2.81e-01	4.00e-01	1.75e-01	1.13e-01	5.78e-01	6.32e-01	2.77e-01	1.21e-01	4.97e-01	6.60e-01	2.53e-02
GOBP HINDBRAIN RADIAL GLIA GUIDED CELL MIGRATION	8	2.14e-01	3.31e-01	0.7950	5.10e-01	4.13e-01	3.03e-01	2.59e-01	1.77e-01	1.05e-01	1.25e-02	4.31e-02	1.38e-01	2.05e-01	3.86e-01	6.07e-01
GOBP RESPONSE TO ACTINOMYCIN D	5	3.26e-01	4.44e-01	0.7950	-3.21e-01	-2.36e-01	-4.77e-01	1.03e-01	5.92e-02	-4.81e-01	2.14e-01	3.62e-01	6.49e-02	6.90e-01	8.19e-01	6.24e-02
GOBP RESPONSE TO HYDROSTATIC PRESSURE	7	1.88e-01	3.03e-01	0.7940	2.16e-02	2.32e-01	4.76e-01	1.42e-01	6.11e-02	5.71e-01	9.21e-01	2.87e-01	2.92e-02	5.15e-01	7.79e-01	8.87e-03
GOBP REGULATION OF BONE DEVELOPMENT	6	2.62e-01	3.82e-01	0.7940	-2.36e-01	-1.55e-01	-4.88e-01	-2.17e-01	2.38e-01	-4.57e-01	3.17e-01	5.12e-01	3.85e-02	3.58e-01	3.12e-01	5.23e-02
GOBP CHRONIC INFLAMMATORY RESPONSE	14	3.66e-03	1.52e-02	0.7940	5.28e-02	1.81e-01	5.82e-01	-3.26e-01	-3.34e-01	1.94e-01	7.32e-01	2.42e-01	1.61e-04	3.47e-02	3.03e-02	2.09e-01
GOBP EMBRYONIC DIGESTIVE TRACT MORPHOGENESIS	6	2.69e-01	3.88e-01	0.7940	2.13e-02	7.15e-02	5.04e-01	-1.62e-01	-1.52e-01	5.67e-01	9.28e-01	7.62e-01	3.27e-02	4.91e-01	5.19e-01	1.62e-02
GOCC PROTEIN PHOSPHATASE 4 COMPLEX	5	1.26e-01	2.31e-01	0.7940	-5.45e-01	1.30e-01	3.09e-01	-9.47e-02	-3.02e-01	3.46e-01	3.47e-02	6.16e-01	2.32e-01	7.14e-01	2.42e-01	1.80e-01
GOBP REGULATION OF NEUTROPHIL EXTRAVASATION	7	1.12e-01	2.12e-01	0.7930	-1.60e-01	-2.32e-02	4.73e-01	1.62e-01	-8.79e-02	5.88e-01	4.62e-01	9.15e-01	3.03e-02	4.58e-01	6.87e-01	7.09e-03
GOBP POSITIVE REGULATION OF AMYLOID BETA CLEARANCE	6	3.44e-02	8.88e-02	0.7930	1.35e-01	6.59e-02	7.06e-01	2.33e-01	5.36e-02	2.26e-01	5.68e-01	7.80e-01	2.74e-03	3.23e-01	8.20e-01	3.38e-01
GOBP COPPER ION TRANSMEMBRANE TRANSPORT	7	3.59e-02	9.19e-02	0.7930	-6.53e-01	-9.86e-02	1.96e-02	-2.90e-01	1.64e-01	2.84e-01	2.75e-03	6.51e-01	9.28e-01	1.84e-01	4.53e-01	1.94e-01
GOMF COPPER ION TRANSMEMBRANE TRANSPORTER ACTIVITY	7	3.59e-02	9.19e-02	0.7930	-6.53e-01	-9.86e-02	1.96e-02	-2.90e-01	1.64e-01	2.84e-01	2.75e-03	6.51e-01	9.28e-01	1.84e-01	4.53e-01	1.94e-01
GOCC DERLIN 1 RETROTRANSLOCATION COMPLEX	8	4.23e-02	1.04e-01	0.7930	-4.84e-01	-3.12e-01	9.68e-02	1.23e-02	-4.62e-01	2.72e-01	1.78e-02	1.27e-01	6.35e-01	9.52e-01	2.37e-02	1.83e-01
GOCC PTW PP1 PHOSPHATASE COMPLEX	7	3.23e-02	8.45e-02	0.7920	-1.23e-01	1.63e-01	2.18e-01	3.68e-01	3.19e-04	6.34e-01	5.74e-01	4.56e-01	3.17e-01	9.17e-02	9.99e-01	3.65e-03
GOMF CGMP BINDING	9	5.75e-03	2.20e-02	0.7920	-2.52e-01	-1.03e-01	2.57e-01	-1.34e-01	-6.67e-01	-1.51e-01	1.90e-01	5.92e-01	1.81e-01	4.86e-01	5.25e-04	4.32e-01
GOCC RNA POLYMERASE I TRANSCRIPTION REGULATOR COMPLEX	6	2.19e-01	3.37e-01	0.7910	-5.28e-02	-3.42e-01	-5.11e-01	-1.86e-01	-2.45e-01	-3.89e-01	8.23e-01	1.46e-01	3.03e-02	4.30e-01	2.99e-01	9.91e-02
GOMF FERROUS IRON TRANSMEMBRANE TRANSPORTER ACTIVITY	6	2.62e-01	3.82e-01	0.7910	-6.47e-02	-1.55e-01	2.43e-01	-3.87e-01	-6.12e-01	1.20e-01	7.84e-01	5.12e-01	3.02e-01	1.01e-01	9.45e-03	6.09e-01
GOMF PHOSPHATIDYLCHOLINE FLOPPASE ACTIVITY	8	1.36e-01	2.44e-01	0.7910	4.50e-01	3.03e-01	3.52e-01	4.45e-01	8.99e-02	2.84e-02	2.75e-02	1.38e-01	8.44e-02	2.91e-02	6.60e-01	8.90e-01
GOBP INTERLEUKIN 33 MEDIATED SIGNALING PATHWAY	8	4.82e-02	1.14e-01	0.7910	-6.00e-01	-1.63e-02	2.27e-01	-2.94e-01	-3.00e-01	1.91e-01	3.28e-03	9.36e-01	2.66e-01	1.49e-01	1.42e-01	3.50e-01
GOBP POSITIVE REGULATION OF PROTEIN NEDDYLATION	5	2.58e-01	3.78e-01	0.7910	-6.78e-01	-9.34e-02	-1.59e-01	-2.97e-01	-2.04e-01	4.60e-02	8.68e-03	7.18e-01	5.37e-01	2.50e-01	4.30e-01	8.58e-01
GOBP POSITIVE REGULATION OF HUMORAL IMMUNE RESPONSE	12	7.80e-04	4.12e-03	0.7910	2.17e-01	4.22e-01	3.03e-01	5.95e-02	5.46e-01	-8.09e-02	1.94e-01	1.14e-02	6.91e-02	7.21e-01	1.05e-03	6.28e-01
GOBP PLATELET DEGRANULATION	7	1.61e-02	5.01e-02	0.7910	-3.03e-01	5.27e-01	3.54e-01	-1.23e-01	3.04e-01	1.51e-01	1.65e-01	1.58e-02	1.05e-01	5.73e-01	1.64e-01	4.88e-01
GOBP CELLULAR RESPONSE TO HYDROPEROXIDE	7	4.87e-02	1.15e-01	0.7900	-5.15e-01	1.96e-02	3.36e-01	-4.00e-01	-1.33e-02	2.93e-01	1.84e-02	9.29e-01	1.23e-01	6.68e-02	9.51e-01	1.79e-01
GOBP REGULATION OF CD4 POSITIVE CD25 POSITIVE ALPHA BETA REGULATORY T CELL DIFFERENTIATION	7	1.88e-01	3.03e-01	0.7900	2.90e-01	-8.56e-02	-3.15e-01	4.57e-01	4.31e-01	-1.99e-01	1.84e-01	6.95e-01	1.49e-01	3.62e-02	4.85e-02	3.61e-01
GOBP POSITIVE REGULATION OF VITAMIN D RECEPTOR SIGNALING PATHWAY	6	2.96e-04	1.78e-03	0.7900	-4.22e-01	8.99e-02	1.71e-01	-1.64e-02	5.43e-01	-3.38e-01	7.31e-02	7.03e-01	4.69e-01	9.45e-01	2.13e-02	1.52e-01
GOCC SMALL SUBUNIT PROCESSOME	72	1.24e-18	4.58e-17	0.7900	-1.54e-01	-6.10e-01	-4.30e-01	2.13e-02	-1.36e-01	-1.58e-01	2.34e-02	3.42e-19	2.71e-10	7.55e-01	4.58e-02	2.07e-02
GOBP DEOXYRIBONUCLEOSIDE MONOPHOSPHATE BIOSYNTHETIC PROCESS	8	9.60e-02	1.90e-01	0.7900	-2.63e-01	-6.09e-01	-1.70e-01	-4.17e-02	-3.74e-01	1.21e-01	1.98e-01	2.88e-03	4.06e-01	8.38e-01	6.67e-02	5.54e-01
GOBP ANGIOGENESIS INVOLVED IN CORONARY VASCULAR MORPHOGENESIS	5	1.91e-01	3.06e-01	0.7900	-1.52e-01	3.77e-01	1.51e-01	1.76e-01	4.22e-01	4.77e-01	5.55e-01	1.45e-01	5.58e-01	4.96e-01	1.02e-01	6.48e-02
GOBP HYPOTONIC RESPONSE	10	4.37e-02	1.06e-01	0.7890	-6.22e-02	2.81e-02	5.32e-01	6.99e-02	-1.06e-01	5.65e-01	7.34e-01	8.78e-01	3.59e-03	7.02e-01	5.60e-01	1.97e-03
GOMF HISTONE UBIQUITIN LIGASE ACTIVITY	11	4.81e-02	1.14e-01	0.7890	1.90e-01	3.68e-01	4.36e-01	2.89e-01	4.76e-02	4.18e-01	2.75e-01	3.45e-02	1.22e-02	9.66e-02	7.85e-01	1.62e-02
GOBP REGULATION OF REMOVAL OF SUPEROXIDE RADICALS	5	4.70e-02	1.12e-01	0.7890	-3.32e-02	-4.91e-02	2.67e-01	1.05e-04	4.97e-01	5.49e-01	8.98e-01	8.49e-01	3.01e-01	1.00e+00	5.43e-02	3.36e-02
GOBP PROSTAGLANDIN SECRETION	11	8.27e-05	5.72e-04	0.7890	-2.17e-01	1.27e-01	5.24e-01	-5.18e-01	6.69e-02	1.11e-01	2.12e-01	4.65e-01	2.64e-03	2.94e-03	7.01e-01	5.22e-01
GOCC DENDRITIC SPINE HEAD	5	1.06e-01	2.03e-01	0.7890	-3.06e-01	-2.57e-01	4.73e-01	-1.97e-01	-4.47e-01	-2.16e-02	2.37e-01	3.20e-01	6.69e-02	4.46e-01	8.32e-02	9.33e-01
GOMF BETA GALACTOSIDE CMP ALPHA 2 3 SIALYLTRANSFERASE ACTIVITY	6	3.45e-01	4.62e-01	0.7890	2.58e-01	2.74e-01	1.30e-01	4.36e-01	4.61e-01	2.45e-01	2.73e-01	2.45e-01	5.81e-01	6.43e-02	5.03e-02	2.98e-01
GOBP AMINO ACID NEUROTRANSMITTER REUPTAKE	5	5.18e-01	6.12e-01	0.7890	-2.93e-01	-3.31e-01	-1.64e-01	-4.31e-01	-4.30e-01	-1.72e-01	2.57e-01	2.01e-01	5.25e-01	9.53e-02	9.60e-02	5.05e-01
GOBP POSITIVE REGULATION OF NEUROEPITHELIAL CELL DIFFERENTIATION	6	1.53e-01	2.63e-01	0.7880	-1.08e-01	-2.58e-01	4.00e-01	-3.56e-02	-6.02e-01	1.39e-01	6.46e-01	2.74e-01	8.96e-02	8.80e-01	1.07e-02	5.56e-01
GOBP MATURATION OF LSU RRNA	24	2.33e-06	2.28e-05	0.7880	-1.41e-01	-6.20e-01	-3.97e-01	-1.90e-04	-2.43e-01	-8.59e-03	2.30e-01	1.45e-07	7.70e-04	9.99e-01	3.97e-02	9.42e-01
GOBP COPII COATED VESICLE CARGO LOADING	18	1.17e-07	1.42e-06	0.7880	-3.62e-01	4.58e-02	4.72e-01	3.14e-01	-1.44e-01	3.80e-01	7.76e-03	7.37e-01	5.26e-04	2.11e-02	2.89e-01	5.20e-03
GOMF SYNDECAN BINDING	5	2.84e-01	4.04e-01	0.7880	-4.40e-01	5.98e-03	-2.69e-01	-5.79e-01	-5.88e-02	-1.28e-01	8.86e-02	9.82e-01	2.98e-01	2.50e-02	8.20e-01	6.21e-01
GOBP NEGATIVE REGULATION OF ASTROCYTE DIFFERENTIATION	9	1.32e-01	2.39e-01	0.7870	2.89e-01	5.54e-01	1.91e-01	2.93e-01	3.22e-01	6.75e-02	1.33e-01	4.03e-03	3.20e-01	1.28e-01	9.48e-02	7.26e-01
GOBP AXONOGENESIS INVOLVED IN INNERVATION	7	8.37e-02	1.72e-01	0.7870	1.86e-02	1.05e-01	3.16e-01	2.23e-01	3.44e-01	5.83e-01	9.32e-01	6.30e-01	1.47e-01	3.08e-01	1.15e-01	7.51e-03
GOBP SYNAPTIC VESICLE ENDOSOMAL PROCESSING	9	1.50e-02	4.73e-02	0.7870	-4.23e-01	1.17e-01	3.82e-01	4.05e-02	-1.03e-01	5.18e-01	2.80e-02	5.44e-01	4.73e-02	8.33e-01	5.91e-01	7.08e-03
GOMF RIBONUCLEASE P ACTIVITY	12	3.11e-03	1.33e-02	0.7870	-8.47e-02	-6.67e-01	-3.92e-01	7.94e-03	-1.11e-01	-1.67e-02	6.11e-01	6.24e-05	1.86e-02	9.62e-01	5.04e-01	9.20e-01
GOBP REGULATION OF MYOSIN LIGHT CHAIN PHOSPHATASE ACTIVITY	7	2.35e-02	6.70e-02	0.7860	-3.68e-01	4.07e-01	4.13e-01	-1.67e-01	2.02e-01	2.80e-01	9.14e-02	6.25e-02	5.86e-02	4.45e-01	3.55e-01	1.99e-01
GOBP ENDOPLASMIC RETICULUM MEMBRANE ORGANIZATION	12	1.22e-03	6.02e-03	0.7860	-4.37e-01	-3.30e-01	2.64e-02	1.74e-01	-2.24e-01	4.87e-01	8.74e-03	4.80e-02	8.74e-01	2.97e-01	1.79e-01	3.48e-03
GOBP RIBOSOMAL SMALL SUBUNIT BIOGENESIS	103	5.53e-27	4.20e-25	0.7860	-1.58e-01	-6.06e-01	-4.36e-01	-1.30e-02	-1.08e-01	-1.52e-01	5.70e-03	1.91e-26	1.94e-14	8.19e-01	5.71e-02	7.61e-03
GOCC AXOLEMMA	10	5.92e-02	1.34e-01	0.7860	5.00e-01	3.94e-01	3.02e-01	1.16e-01	3.11e-01	1.04e-01	6.20e-03	3.10e-02	9.77e-02	5.25e-01	8.86e-02	5.70e-01
GOBP MODULATION OF INHIBITORY POSTSYNAPTIC POTENTIAL	5	7.39e-02	1.57e-01	0.7860	1.42e-01	9.75e-02	3.85e-01	6.04e-01	2.73e-01	-2.86e-03	5.83e-01	7.06e-01	1.36e-01	1.94e-02	2.90e-01	9.91e-01
GOBP PHOSPHOLIPID EFFLUX	7	1.26e-03	6.21e-03	0.7850	1.28e-01	1.32e-01	2.37e-01	4.28e-01	3.23e-01	-4.90e-01	5.58e-01	5.46e-01	2.77e-01	5.00e-02	1.39e-01	2.48e-02
GOBP RESPONSE TO GONADOTROPIN RELEASING HORMONE	6	1.74e-01	2.88e-01	0.7850	4.44e-01	2.07e-01	5.54e-01	-7.65e-02	-2.62e-02	2.53e-01	5.98e-02	3.80e-01	1.88e-02	7.46e-01	9.11e-01	2.83e-01
GOBP PROTON MOTIVE FORCE DRIVEN ATP SYNTHESIS	74	3.50e-23	1.87e-21	0.7850	-1.31e-01	-7.09e-01	-2.34e-01	5.95e-02	-1.96e-01	4.19e-04	5.05e-02	4.73e-26	4.87e-04	3.76e-01	3.52e-03	9.95e-01
GOBP POSITIVE REGULATION OF RECEPTOR CATABOLIC PROCESS	6	6.97e-02	1.50e-01	0.7850	2.96e-02	1.15e-01	5.18e-01	3.55e-01	-3.61e-01	2.79e-01	9.00e-01	6.26e-01	2.80e-02	1.33e-01	1.26e-01	2.36e-01
GOMF MHC CLASS II PROTEIN COMPLEX BINDING	25	2.88e-07	3.28e-06	0.7850	-1.22e-02	-4.33e-01	-3.98e-01	2.11e-01	3.42e-01	-3.29e-01	9.16e-01	1.75e-04	5.79e-04	6.81e-02	3.09e-03	4.37e-03
GOMF POTASSIUM PROTON ANTIPORTER ACTIVITY	9	7.20e-02	1.54e-01	0.7850	-4.03e-02	3.54e-01	5.65e-01	-7.00e-02	-9.56e-03	4.06e-01	8.34e-01	6.56e-02	3.36e-03	7.16e-01	9.60e-01	3.51e-02
GOBP FACIAL NERVE MORPHOGENESIS	7	8.60e-02	1.75e-01	0.7850	1.09e-01	2.37e-01	-2.56e-02	2.26e-01	6.95e-01	1.14e-01	6.18e-01	2.78e-01	9.06e-01	3.01e-01	1.45e-03	6.00e-01
GOMF C ACETYLTRANSFERASE ACTIVITY	7	8.82e-03	3.10e-02	0.7840	-4.35e-02	-6.06e-01	5.94e-02	1.46e-01	9.57e-02	4.60e-01	8.42e-01	5.52e-03	7.86e-01	5.03e-01	6.61e-01	3.49e-02
GOBP METHYLGLYOXAL METABOLIC PROCESS	6	1.32e-01	2.39e-01	0.7840	-1.17e-01	-6.28e-01	-3.45e-01	2.86e-01	-1.28e-02	-7.26e-02	6.21e-01	7.75e-03	1.43e-01	2.25e-01	9.57e-01	7.58e-01
GOBP POSITIVE REGULATION OF T CELL TOLERANCE INDUCTION	8	9.00e-03	3.15e-02	0.7830	5.26e-02	-4.19e-03	2.39e-01	1.21e-01	-5.21e-01	5.18e-01	7.97e-01	9.84e-01	2.43e-01	5.55e-01	1.07e-02	1.12e-02
GOBP ALKANESULFONATE TRANSMEMBRANE TRANSPORT	6	3.21e-02	8.41e-02	0.7830	-3.07e-01	3.41e-02	1.17e-01	-1.52e-01	-6.81e-01	-1.33e-01	1.93e-01	8.85e-01	6.21e-01	5.19e-01	3.86e-03	5.72e-01
GOBP LYMPHOCYTE ANERGY	8	2.04e-02	6.00e-02	0.7830	2.21e-01	1.06e-01	3.00e-01	3.11e-01	-3.19e-01	5.15e-01	2.80e-01	6.02e-01	1.41e-01	1.28e-01	1.18e-01	1.17e-02
GOBP GASTRO INTESTINAL SYSTEM SMOOTH MUSCLE CONTRACTION	8	1.83e-02	5.52e-02	0.7830	-5.92e-01	1.19e-01	1.93e-02	-4.84e-01	2.37e-02	-1.18e-01	3.74e-03	5.59e-01	9.25e-01	1.78e-02	9.07e-01	5.62e-01
GOBP DOLICHYL DIPHOSPHATE METABOLIC PROCESS	5	5.81e-02	1.32e-01	0.7830	-3.13e-01	-6.48e-01	1.47e-01	2.00e-01	-5.99e-02	1.76e-01	2.26e-01	1.22e-02	5.70e-01	4.38e-01	8.17e-01	4.96e-01
GOBP PYRIMIDINE DEOXYRIBONUCLEOSIDE TRIPHOSPHATE METABOLIC PROCESS	6	2.99e-02	7.99e-02	0.7830	-2.63e-02	-6.63e-01	-2.32e-01	9.90e-02	4.54e-02	3.28e-01	9.11e-01	4.94e-03	3.25e-01	6.75e-01	8.47e-01	1.65e-01
GOMF ADP RIBOSE DIPHOSPHATASE ACTIVITY	6	2.36e-01	3.53e-01	0.7830	-6.21e-01	-3.82e-01	-2.50e-01	-1.07e-01	-7.92e-02	-3.74e-02	8.46e-03	1.05e-01	2.89e-01	6.50e-01	7.37e-01	8.74e-01
GOCC INTRACILIARY TRANSPORT PARTICLE	22	2.91e-05	2.23e-04	0.7820	-1.10e-01	1.20e-01	-4.50e-01	5.04e-02	5.62e-01	-2.55e-01	3.72e-01	3.30e-01	2.56e-04	6.82e-01	5.08e-06	3.84e-02
GOBP REGULATION OF PROTEIN LOCALIZATION TO CHROMOSOME TELOMERIC REGION	14	4.39e-04	2.52e-03	0.7820	-1.60e-01	-6.63e-01	-1.32e-01	2.38e-01	-2.28e-01	1.44e-01	3.00e-01	1.76e-05	3.92e-01	1.24e-01	1.40e-01	3.51e-01
GOBP FACIAL NERVE STRUCTURAL ORGANIZATION	6	1.13e-01	2.14e-01	0.7820	-3.87e-02	2.14e-01	-1.92e-01	1.09e-01	7.18e-01	-1.93e-02	8.70e-01	3.65e-01	4.15e-01	6.45e-01	2.33e-03	9.35e-01
GOMF SINGLE STRANDED DNA 5 3 DNA EXONUCLEASE ACTIVITY	5	1.96e-01	3.12e-01	0.7820	-2.59e-01	-2.19e-01	-4.67e-01	3.93e-01	3.44e-01	7.02e-02	3.15e-01	3.96e-01	7.04e-02	1.28e-01	1.83e-01	7.86e-01
GOCC RIBONUCLEASE P COMPLEX	14	6.42e-04	3.48e-03	0.7810	-7.61e-02	-6.75e-01	-3.72e-01	4.57e-02	-9.34e-02	9.61e-03	6.22e-01	1.22e-05	1.60e-02	7.67e-01	5.45e-01	9.50e-01
GOBP PRIMITIVE ERYTHROCYTE DIFFERENTIATION	5	2.71e-02	7.44e-02	0.7810	2.07e-01	-5.51e-01	3.96e-01	2.61e-02	-8.27e-02	3.16e-01	4.22e-01	3.30e-02	1.25e-01	9.19e-01	7.49e-01	2.21e-01
GOBP FLAVONOID METABOLIC PROCESS	5	4.13e-01	5.24e-01	0.7810	-2.62e-01	-3.56e-01	-6.17e-02	-2.93e-01	-4.95e-01	-2.83e-01	3.10e-01	1.68e-01	8.11e-01	2.57e-01	5.52e-02	2.73e-01
GOBP POSITIVE REGULATION OF TOLL LIKE RECEPTOR 9 SIGNALING PATHWAY	6	2.93e-02	7.88e-02	0.7800	-4.24e-01	-7.68e-02	1.27e-01	4.11e-01	-1.61e-02	4.87e-01	7.18e-02	7.45e-01	5.91e-01	8.11e-02	9.45e-01	3.87e-02
GOBP RESPONSE TO REDOX STATE	13	1.62e-03	7.67e-03	0.7800	-2.28e-01	-5.14e-01	-1.56e-02	4.91e-02	-2.72e-01	4.63e-01	1.54e-01	1.32e-03	9.22e-01	7.59e-01	8.96e-02	3.82e-03
GOMF 1 ALKYL 2 ACETYLGLYCEROPHOSPHOCHOLINE ESTERASE ACTIVITY	6	1.24e-01	2.29e-01	0.7800	1.61e-01	3.54e-01	-1.24e-01	5.80e-01	2.98e-01	1.27e-01	4.95e-01	1.33e-01	5.99e-01	1.38e-02	2.06e-01	5.92e-01
GOBP OLFACTORY NERVE DEVELOPMENT	6	3.25e-01	4.43e-01	0.7790	1.63e-01	4.35e-01	5.07e-01	-9.97e-02	-6.98e-02	3.46e-01	4.89e-01	6.50e-02	3.16e-02	6.72e-01	7.67e-01	1.43e-01
GOCC FASCIA ADHERENS	5	2.22e-01	3.41e-01	0.7790	-3.86e-01	-2.22e-01	2.15e-01	-2.28e-01	-5.38e-01	-1.43e-01	1.35e-01	3.90e-01	4.05e-01	3.78e-01	3.72e-02	5.79e-01
GOBP L LEUCINE IMPORT ACROSS PLASMA MEMBRANE	5	6.08e-02	1.36e-01	0.7780	-2.19e-01	-4.16e-01	-1.87e-01	5.10e-01	-2.59e-01	-1.52e-01	3.97e-01	1.07e-01	4.69e-01	4.84e-02	3.17e-01	5.57e-01
GOBP L LYSINE TRANSMEMBRANE TRANSPORT	5	1.10e-01	2.09e-01	0.7780	-2.87e-01	-3.12e-01	-3.62e-01	4.53e-01	-5.48e-02	-2.93e-01	2.66e-01	2.27e-01	1.61e-01	7.93e-02	8.32e-01	2.56e-01
GOMF L LYSINE TRANSMEMBRANE TRANSPORTER ACTIVITY	5	1.10e-01	2.09e-01	0.7780	-2.87e-01	-3.12e-01	-3.62e-01	4.53e-01	-5.48e-02	-2.93e-01	2.66e-01	2.27e-01	1.61e-01	7.93e-02	8.32e-01	2.56e-01
GOBP POSITIVE REGULATION OF HAIR FOLLICLE DEVELOPMENT	6	4.65e-02	1.11e-01	0.7780	2.33e-02	2.48e-01	-6.35e-02	-4.81e-02	7.21e-01	-1.35e-01	9.21e-01	2.93e-01	7.88e-01	8.38e-01	2.24e-03	5.68e-01
GOCC EQUATORIAL MICROTUBULE ORGANIZING CENTER	5	1.56e-01	2.68e-01	0.7780	-2.27e-01	1.70e-01	-3.27e-01	1.21e-01	2.18e-01	-5.96e-01	3.79e-01	5.11e-01	2.06e-01	6.41e-01	3.99e-01	2.10e-02
GOCC PROTEASOME REGULATORY PARTICLE LID SUBCOMPLEX	7	2.02e-02	5.96e-02	0.7770	-5.73e-02	-4.47e-01	3.56e-01	3.72e-01	-1.95e-01	3.12e-01	7.93e-01	4.07e-02	1.02e-01	8.79e-02	3.73e-01	1.52e-01
GOBP REGULATION OF ADIPONECTIN SECRETION	7	2.98e-02	7.97e-02	0.7770	4.69e-04	5.80e-01	1.46e-01	-3.72e-01	2.35e-01	-2.30e-01	9.98e-01	7.89e-03	5.03e-01	8.85e-02	2.81e-01	2.92e-01
GOBP TELOMERE MAINTENANCE VIA SEMI CONSERVATIVE REPLICATION	9	7.18e-03	2.64e-02	0.7770	2.30e-01	-2.28e-01	-5.72e-02	6.96e-01	-2.69e-02	1.06e-01	2.33e-01	2.37e-01	7.66e-01	3.01e-04	8.89e-01	5.82e-01
GOBP CELLULAR RESPONSE TO ELECTRICAL STIMULUS	9	4.73e-02	1.12e-01	0.7760	-1.67e-01	-7.96e-02	4.77e-01	-9.49e-02	-6.31e-02	5.73e-01	3.84e-01	6.79e-01	1.32e-02	6.22e-01	7.43e-01	2.93e-03
GOMF PHOSPHORYLATION DEPENDENT PROTEIN BINDING	9	4.52e-02	1.09e-01	0.7760	-2.21e-02	2.88e-01	5.67e-01	2.19e-01	1.89e-02	3.87e-01	9.09e-01	1.35e-01	3.24e-03	2.55e-01	9.22e-01	4.44e-02
GOMF ATP DEPENDENT PEPTIDASE ACTIVITY	7	1.42e-01	2.52e-01	0.7760	-2.22e-01	-3.49e-01	-4.78e-01	1.30e-01	-1.71e-01	-3.96e-01	3.10e-01	1.10e-01	2.86e-02	5.51e-01	4.33e-01	6.99e-02
GOCC LATE ENDOSOME LUMEN	6	1.01e-01	1.97e-01	0.7760	-2.76e-02	-1.84e-01	2.00e-03	-4.87e-01	-2.99e-01	-4.91e-01	9.07e-01	4.36e-01	9.93e-01	3.87e-02	2.05e-01	3.74e-02
GOBP PROGESTERONE RECEPTOR SIGNALING PATHWAY	9	7.69e-02	1.62e-01	0.7760	-5.88e-01	-2.45e-01	2.67e-02	-2.15e-01	-3.38e-01	1.87e-01	2.25e-03	2.03e-01	8.90e-01	2.65e-01	7.95e-02	3.31e-01
GOBP NEGATIVE REGULATION OF MEMBRANE PROTEIN ECTODOMAIN PROTEOLYSIS	6	1.35e-01	2.42e-01	0.7760	-1.35e-01	1.19e-01	4.81e-01	1.34e-01	-4.02e-01	3.98e-01	5.68e-01	6.15e-01	4.13e-02	5.69e-01	8.83e-02	9.12e-02
GOBP SUCCINATE METABOLIC PROCESS	5	7.79e-02	1.63e-01	0.7760	-3.28e-01	-3.72e-01	7.37e-02	-2.02e-01	2.05e-01	5.17e-01	2.04e-01	1.50e-01	7.75e-01	4.35e-01	4.27e-01	4.51e-02
GOBP FORMATE METABOLIC PROCESS	5	4.05e-01	5.17e-01	0.7750	1.49e-01	2.41e-01	4.80e-01	3.57e-02	-2.95e-01	4.49e-01	5.64e-01	3.50e-01	6.28e-02	8.90e-01	2.54e-01	8.19e-02
GOCC RPAP3 R2TP PREFOLDIN LIKE COMPLEX	11	7.38e-03	2.70e-02	0.7750	8.25e-02	-5.09e-01	-4.40e-01	3.20e-01	1.47e-01	-1.31e-01	6.36e-01	3.44e-03	1.16e-02	6.62e-02	3.98e-01	4.51e-01
GOBP PHOSPHATIDYLCHOLINE CATABOLIC PROCESS	12	3.74e-02	9.47e-02	0.7740	2.07e-01	3.31e-01	3.13e-01	4.05e-01	3.49e-01	2.51e-01	2.14e-01	4.71e-02	6.02e-02	1.52e-02	3.62e-02	1.32e-01
GOMF PROTEIN DEMETHYLASE ACTIVITY	28	2.55e-10	4.42e-09	0.7740	3.87e-02	4.62e-01	2.45e-01	5.43e-01	1.68e-01	3.42e-02	7.23e-01	2.29e-05	2.49e-02	6.56e-07	1.23e-01	7.54e-01
GOBP REGULATION OF MITOCHONDRIAL DNA METABOLIC PROCESS	5	3.99e-01	5.11e-01	0.7740	-3.89e-01	-3.64e-01	-4.74e-01	8.54e-02	-2.81e-02	-2.88e-01	1.32e-01	1.59e-01	6.62e-02	7.41e-01	9.13e-01	2.65e-01
GOBP LIVER MORPHOGENESIS	17	2.14e-04	1.33e-03	0.7740	2.27e-04	4.58e-01	5.50e-01	1.64e-01	1.62e-02	2.44e-01	9.99e-01	1.08e-03	8.55e-05	2.43e-01	9.08e-01	8.12e-02
GOBP SPINAL CORD ASSOCIATION NEURON DIFFERENTIATION	5	2.79e-01	3.99e-01	0.7740	-4.09e-01	-1.18e-01	-1.34e-01	-4.06e-01	-1.71e-01	-4.53e-01	1.13e-01	6.49e-01	6.03e-01	1.16e-01	5.09e-01	7.94e-02
GOBP GLYCOSYLCERAMIDE CATABOLIC PROCESS	5	4.02e-02	9.99e-02	0.7740	-4.63e-01	8.43e-02	5.03e-01	-3.48e-01	-2.15e-02	5.25e-02	7.31e-02	7.44e-01	5.12e-02	1.78e-01	9.34e-01	8.39e-01
GOBP MITOCHONDRIAL ELECTRON TRANSPORT NADH TO UBIQUINONE	50	1.66e-14	4.30e-13	0.7740	-1.17e-01	-6.98e-01	-2.15e-01	-1.09e-02	-2.27e-01	2.98e-03	1.53e-01	1.31e-17	8.50e-03	8.94e-01	5.46e-03	9.71e-01
GOCC NADH DEHYDROGENASE COMPLEX	50	3.24e-15	8.79e-14	0.7730	-7.66e-02	-7.04e-01	-2.42e-01	2.34e-02	-1.88e-01	-4.25e-02	3.48e-01	6.93e-18	3.03e-03	7.75e-01	2.14e-02	6.03e-01
GOMF OXIDOREDUCTASE ACTIVITY ACTING ON A HEME GROUP OF DONORS	14	5.89e-03	2.24e-02	0.7730	-1.92e-01	-6.32e-01	-2.91e-01	8.96e-03	-2.64e-01	-8.24e-02	2.13e-01	4.26e-05	5.96e-02	9.54e-01	8.69e-02	5.93e-01
GOCC ALPHA DNA POLYMERASE PRIMASE COMPLEX	5	2.96e-01	4.15e-01	0.7730	1.04e-01	-3.34e-01	-5.45e-01	3.08e-01	2.37e-01	-1.65e-01	6.87e-01	1.96e-01	3.49e-02	2.33e-01	3.60e-01	5.22e-01
GOBP TRNA THREONYLCARBAMOYLADENOSINE METABOLIC PROCESS	16	2.60e-03	1.15e-02	0.7720	-1.45e-01	-4.97e-01	-5.00e-01	-4.27e-02	1.06e-01	-2.57e-01	3.15e-01	5.76e-04	5.39e-04	7.67e-01	4.64e-01	7.56e-02
GOBP FAS SIGNALING PATHWAY	6	3.98e-01	5.10e-01	0.7720	-4.20e-01	-2.00e-01	1.44e-01	-4.26e-01	-3.25e-01	2.68e-01	7.48e-02	3.97e-01	5.42e-01	7.05e-02	1.68e-01	2.56e-01
GOBP MAST CELL PROLIFERATION	6	3.07e-01	4.28e-01	0.7720	2.20e-02	4.04e-01	5.25e-01	3.17e-02	1.85e-02	3.94e-01	9.26e-01	8.67e-02	2.60e-02	8.93e-01	9.37e-01	9.42e-02
GOBP LUNG SACCULE DEVELOPMENT	5	3.06e-01	4.27e-01	0.7720	4.82e-03	3.60e-01	1.28e-01	4.00e-01	5.18e-01	1.43e-01	9.85e-01	1.63e-01	6.19e-01	1.21e-01	4.48e-02	5.80e-01
GOCC INNER MITOCHONDRIAL MEMBRANE PROTEIN COMPLEX	153	3.32e-42	6.03e-40	0.7720	-1.83e-01	-6.59e-01	-3.17e-01	-8.78e-03	-1.52e-01	-6.44e-02	9.36e-05	4.01e-45	1.28e-11	8.51e-01	1.19e-03	1.69e-01
GOCC PHOSPHATIDYLINOSITOL 3 KINASE COMPLEX CLASS I	9	1.57e-02	4.90e-02	0.7720	-5.94e-02	5.41e-01	2.88e-01	3.33e-01	2.81e-01	1.61e-01	7.58e-01	4.91e-03	1.35e-01	8.35e-02	1.44e-01	4.04e-01
GOBP TAIL ANCHORED MEMBRANE PROTEIN INSERTION INTO ER MEMBRANE	17	1.16e-04	7.71e-04	0.7710	-2.14e-01	-6.54e-01	-2.26e-01	2.24e-01	-1.24e-01	6.65e-02	1.26e-01	2.98e-06	1.07e-01	1.10e-01	3.77e-01	6.35e-01
GOCC MICROTUBULE MINUS END	7	2.41e-01	3.59e-01	0.7710	3.67e-01	1.86e-01	4.89e-01	3.18e-01	7.30e-02	2.84e-01	9.31e-02	3.95e-01	2.51e-02	1.45e-01	7.38e-01	1.93e-01
GOBP RECEPTOR LOCALIZATION TO NON MOTILE CILIUM	5	6.78e-02	1.47e-01	0.7710	-4.04e-01	2.40e-01	-4.01e-01	-3.51e-01	2.72e-01	1.25e-01	1.18e-01	3.53e-01	1.21e-01	1.74e-01	2.92e-01	6.29e-01
GOBP PEPTIDYL SERINE AUTOPHOSPHORYLATION	8	8.12e-02	1.68e-01	0.7710	9.02e-02	5.46e-01	3.22e-01	2.61e-01	1.18e-01	3.19e-01	6.59e-01	7.44e-03	1.15e-01	2.01e-01	5.64e-01	1.18e-01
GOBP NEGATIVE REGULATION OF HUMORAL IMMUNE RESPONSE MEDIATED BY CIRCULATING IMMUNOGLOBULIN	10	5.74e-02	1.31e-01	0.7710	1.39e-01	2.79e-01	4.66e-01	1.71e-01	2.60e-01	4.28e-01	4.47e-01	1.27e-01	1.06e-02	3.48e-01	1.55e-01	1.92e-02
GOMF MUTLALPHA COMPLEX BINDING	7	1.15e-01	2.16e-01	0.7700	7.05e-02	-1.50e-01	-2.74e-01	4.86e-01	5.00e-01	6.00e-02	7.47e-01	4.92e-01	2.09e-01	2.58e-02	2.19e-02	7.83e-01
GOCC PYRUVATE DEHYDROGENASE COMPLEX	6	2.31e-01	3.49e-01	0.7700	-4.21e-01	-5.54e-01	-2.96e-01	-6.05e-02	-1.13e-02	1.30e-01	7.40e-02	1.87e-02	2.09e-01	7.98e-01	9.62e-01	5.81e-01
GOMF ADENOSINE DEAMINASE ACTIVITY	11	5.14e-02	1.20e-01	0.7700	2.82e-01	2.11e-01	-2.25e-01	4.31e-01	4.81e-01	2.24e-02	1.05e-01	2.26e-01	1.97e-01	1.32e-02	5.69e-03	8.97e-01
GOBP PHOSPHATIDYLSERINE EXPOSURE ON APOPTOTIC CELL SURFACE	6	2.32e-01	3.50e-01	0.7700	6.85e-02	3.33e-01	5.13e-01	2.48e-01	2.12e-01	3.29e-01	7.71e-01	1.58e-01	2.95e-02	2.93e-01	3.69e-01	1.63e-01
GOBP HISTAMINE SECRETION	12	1.54e-02	4.83e-02	0.7700	-3.97e-01	-3.33e-01	1.04e-01	-3.24e-01	-1.64e-01	4.26e-01	1.73e-02	4.56e-02	5.32e-01	5.21e-02	3.25e-01	1.06e-02
GOMF RNA 2 O METHYLTRANSFERASE ACTIVITY	9	8.00e-03	2.88e-02	0.7700	2.31e-01	-4.87e-01	-4.16e-01	3.16e-01	1.67e-01	-1.27e-02	2.30e-01	1.13e-02	3.05e-02	1.00e-01	3.86e-01	9.47e-01
GOMF HISTONE H3K9 METHYLTRANSFERASE ACTIVITY	11	6.67e-02	1.46e-01	0.7700	3.34e-01	4.51e-01	1.21e-01	4.37e-01	2.59e-01	6.43e-02	5.54e-02	9.56e-03	4.87e-01	1.20e-02	1.36e-01	7.12e-01
GOBP REGULATION OF PRESYNAPTIC MEMBRANE POTENTIAL	9	6.35e-02	1.41e-01	0.7690	4.88e-01	2.93e-01	3.54e-02	1.41e-01	4.02e-01	-2.91e-01	1.12e-02	1.28e-01	8.54e-01	4.65e-01	3.70e-02	1.31e-01
GOBP REGULATION OF PHOSPHOLIPASE A2 ACTIVITY	6	4.06e-01	5.17e-01	0.7690	-4.77e-01	-3.21e-01	-8.45e-02	-3.39e-01	-3.45e-01	-1.36e-01	4.31e-02	1.73e-01	7.20e-01	1.50e-01	1.43e-01	5.63e-01
GOBP GANGLIOSIDE BIOSYNTHETIC PROCESS	12	3.02e-02	8.05e-02	0.7690	1.15e-01	2.90e-01	4.13e-01	3.12e-01	7.12e-02	4.69e-01	4.89e-01	8.16e-02	1.32e-02	6.14e-02	6.69e-01	4.92e-03
GOMF GAMMA AMINOBUTYRIC ACID TRANSMEMBRANE TRANSPORTER ACTIVITY	5	1.58e-01	2.69e-01	0.7680	2.38e-01	3.84e-01	2.94e-01	-3.81e-01	-2.78e-01	-2.78e-01	3.56e-01	1.37e-01	2.56e-01	1.40e-01	2.82e-01	2.81e-01
GOBP PLASMA MEMBRANE TO ENDOSOME TRANSPORT	8	1.13e-01	2.13e-01	0.7680	-3.41e-01	-4.04e-01	1.56e-01	-3.97e-02	-4.86e-01	2.19e-01	9.49e-02	4.76e-02	4.44e-01	8.46e-01	1.74e-02	2.83e-01
GOBP NEGATIVE REGULATION OF CELL DIVISION	12	9.39e-04	4.83e-03	0.7680	3.01e-01	-3.04e-01	2.99e-01	2.46e-01	-4.94e-01	1.11e-01	7.12e-02	6.79e-02	7.31e-02	1.40e-01	3.03e-03	5.07e-01
GOMF GLUCURONOSYL N ACETYLGALACTOSAMINYL PROTEOGLYCAN 4 BETA N ACETYLGALACTOSAMINYLTRANSFERASE ACTIVITY	5	1.10e-01	2.09e-01	0.7680	-2.28e-01	7.88e-02	4.61e-01	1.85e-01	-4.55e-01	2.78e-01	3.77e-01	7.60e-01	7.44e-02	4.73e-01	7.78e-02	2.82e-01
GOCC CAMP DEPENDENT PROTEIN KINASE COMPLEX	6	1.59e-01	2.71e-01	0.7680	-2.41e-01	7.59e-03	3.39e-01	2.04e-01	-4.24e-02	6.11e-01	3.07e-01	9.74e-01	1.51e-01	3.86e-01	8.57e-01	9.59e-03
GOMF UDP GLUCOSYLTRANSFERASE ACTIVITY	9	2.48e-02	6.95e-02	0.7680	-2.73e-01	1.78e-01	3.08e-01	-7.05e-03	-2.05e-01	5.88e-01	1.56e-01	3.56e-01	1.09e-01	9.71e-01	2.86e-01	2.25e-03
GOBP RESPONSE TO CYCLOHEXIMIDE	5	4.05e-01	5.17e-01	0.7680	-9.91e-02	3.22e-01	5.33e-01	-1.53e-01	-1.73e-01	3.71e-01	7.01e-01	2.12e-01	3.88e-02	5.53e-01	5.04e-01	1.51e-01
GOBP INNER CELL MASS CELL DIFFERENTIATION	5	1.83e-01	2.98e-01	0.7680	-3.58e-02	4.56e-01	2.56e-01	3.24e-01	7.75e-02	4.51e-01	8.90e-01	7.71e-02	3.22e-01	2.10e-01	7.64e-01	8.08e-02
GOBP PROTEIN UFMYLATION	6	1.75e-01	2.89e-01	0.7670	-4.04e-01	-4.30e-01	-4.63e-01	-6.01e-02	2.40e-02	1.49e-01	8.64e-02	6.81e-02	4.95e-02	7.99e-01	9.19e-01	5.29e-01
GOBP SODIUM INDEPENDENT ORGANIC ANION TRANSPORT	5	2.93e-01	4.13e-01	0.7670	7.83e-02	-4.55e-02	5.88e-01	-2.08e-01	-4.09e-01	1.56e-01	7.62e-01	8.60e-01	2.27e-02	4.21e-01	1.13e-01	5.46e-01
GOMF SULFATIDE BINDING	5	5.29e-02	1.22e-01	0.7670	-5.26e-01	-2.72e-01	-1.69e-01	4.06e-01	1.97e-01	-8.03e-02	4.17e-02	2.93e-01	5.12e-01	1.16e-01	4.45e-01	7.56e-01
GOBP BERGMANN GLIAL CELL DIFFERENTIATION	10	8.17e-03	2.93e-02	0.7670	-4.15e-01	-1.66e-02	4.31e-01	-2.90e-01	-3.80e-01	4.39e-02	2.29e-02	9.28e-01	1.84e-02	1.12e-01	3.75e-02	8.10e-01
GOBP HEPARAN SULFATE PROTEOGLYCAN BIOSYNTHETIC PROCESS ENZYMATIC MODIFICATION	8	5.52e-02	1.27e-01	0.7670	1.48e-01	3.83e-02	3.40e-01	3.54e-01	-2.29e-01	5.22e-01	4.68e-01	8.51e-01	9.56e-02	8.33e-02	2.63e-01	1.06e-02
GOMF HEPARAN SULFATE SULFOTRANSFERASE ACTIVITY	8	5.52e-02	1.27e-01	0.7670	1.48e-01	3.83e-02	3.40e-01	3.54e-01	-2.29e-01	5.22e-01	4.68e-01	8.51e-01	9.56e-02	8.33e-02	2.63e-01	1.06e-02
GOBP CYTOCHROME COMPLEX ASSEMBLY	37	8.80e-10	1.42e-08	0.7670	-1.64e-01	-5.98e-01	-4.38e-01	-6.31e-02	3.68e-02	-7.68e-02	8.39e-02	2.98e-10	3.93e-06	5.06e-01	6.99e-01	4.19e-01
GOMF U3 SNORNA BINDING	10	3.88e-03	1.59e-02	0.7670	2.12e-02	-4.40e-01	-3.10e-01	3.72e-01	-3.18e-01	-2.41e-01	9.07e-01	1.61e-02	8.92e-02	4.14e-02	8.14e-02	1.88e-01
GOBP REGULATION OF PROSTAGLANDIN SECRETION	9	8.67e-04	4.52e-03	0.7660	-1.82e-01	1.76e-01	5.45e-01	-4.29e-01	1.45e-01	1.43e-01	3.45e-01	3.62e-01	4.63e-03	2.57e-02	4.52e-01	4.58e-01
GOMF TRANSLATION INITIATION FACTOR ACTIVITY	49	8.03e-10	1.30e-08	0.7660	-3.77e-01	-5.44e-01	-3.15e-01	-1.46e-01	-1.63e-01	2.40e-02	4.83e-06	4.34e-11	1.38e-04	7.67e-02	4.83e-02	7.72e-01
GOMF ADENINE TRANSMEMBRANE TRANSPORTER ACTIVITY	5	4.92e-01	5.91e-01	0.7660	9.90e-02	6.99e-02	-4.46e-01	2.74e-01	4.61e-01	-2.91e-01	7.01e-01	7.87e-01	8.39e-02	2.88e-01	7.45e-02	2.60e-01
GOBP SEROTONIN SECRETION	7	1.23e-01	2.27e-01	0.7650	1.97e-01	2.60e-02	5.02e-01	-3.55e-01	-3.65e-01	1.88e-01	3.67e-01	9.05e-01	2.15e-02	1.04e-01	9.42e-02	3.89e-01
GOBP TELOMERASE RNA LOCALIZATION	19	1.77e-04	1.13e-03	0.7650	-2.57e-01	-6.36e-01	-2.94e-01	1.25e-01	-1.09e-01	-2.74e-02	5.26e-02	1.57e-06	2.63e-02	3.45e-01	4.09e-01	8.36e-01
GOBP PYRIMIDINE DIMER REPAIR	9	6.45e-02	1.42e-01	0.7650	-7.37e-02	-1.12e-01	-6.47e-01	1.09e-01	1.91e-01	-3.17e-01	7.02e-01	5.60e-01	7.74e-04	5.73e-01	3.21e-01	9.96e-02
GOMF CYCLASE REGULATOR ACTIVITY	9	1.63e-01	2.75e-01	0.7640	-2.56e-01	-4.22e-01	1.47e-02	-4.12e-01	-4.11e-01	4.92e-02	1.83e-01	2.85e-02	9.39e-01	3.25e-02	3.28e-02	7.98e-01
GOBP RESOLUTION OF DNA RECOMBINATION INTERMEDIATES	6	1.38e-01	2.46e-01	0.7640	4.00e-01	-1.01e-01	3.94e-01	4.65e-01	-1.15e-01	1.72e-01	9.00e-02	6.67e-01	9.43e-02	4.88e-02	6.25e-01	4.65e-01
GOBP CD8 POSITIVE ALPHA BETA T CELL DIFFERENTIATION	14	2.57e-03	1.14e-02	0.7640	2.15e-01	3.59e-01	3.66e-01	1.86e-01	-1.74e-01	4.57e-01	1.63e-01	1.99e-02	1.76e-02	2.28e-01	2.59e-01	3.04e-03
GOBP TRANSCRIPTION ELONGATION BY RNA POLYMERASE I	7	2.51e-01	3.70e-01	0.7630	-3.11e-01	-4.54e-01	-3.57e-01	-2.50e-01	-1.49e-02	-2.97e-01	1.54e-01	3.74e-02	1.02e-01	2.52e-01	9.45e-01	1.73e-01
GOBP POSITIVE REGULATION OF BLOOD PRESSURE	14	1.43e-02	4.55e-02	0.7630	-3.56e-01	-3.53e-01	2.34e-01	-1.78e-01	-4.50e-01	2.02e-01	2.11e-02	2.20e-02	1.30e-01	2.49e-01	3.55e-03	1.90e-01
GOCC CMG COMPLEX	11	1.78e-03	8.30e-03	0.7620	3.37e-01	-3.20e-01	-8.63e-02	5.22e-01	8.61e-02	2.80e-01	5.31e-02	6.65e-02	6.20e-01	2.73e-03	6.21e-01	1.08e-01
GOBP RESPONSE TO INTERLEUKIN 3	7	1.96e-01	3.12e-01	0.7620	2.43e-01	1.69e-01	4.74e-01	3.98e-01	1.35e-01	3.03e-01	2.66e-01	4.38e-01	2.98e-02	6.84e-02	5.36e-01	1.65e-01
GOBP PARTURITION	10	1.32e-03	6.45e-03	0.7620	-5.07e-01	-1.93e-01	1.83e-01	-4.89e-01	-1.90e-02	-1.16e-01	5.53e-03	2.91e-01	3.15e-01	7.45e-03	9.17e-01	5.24e-01
GOBP TRNA 3 END PROCESSING	7	1.38e-01	2.47e-01	0.7620	-2.74e-01	-4.75e-01	-4.67e-01	1.59e-01	1.86e-01	-2.68e-02	2.09e-01	2.95e-02	3.22e-02	4.66e-01	3.95e-01	9.02e-01
GOBP NEGATIVE REGULATION OF TROPHOBLAST CELL MIGRATION	5	1.03e-01	2.00e-01	0.7620	-2.94e-01	-3.05e-01	4.58e-01	1.33e-01	-4.23e-02	4.14e-01	2.56e-01	2.38e-01	7.64e-02	6.05e-01	8.70e-01	1.09e-01
GOBP NEGATIVE REGULATION OF T HELPER 2 CELL DIFFERENTIATION	5	4.63e-01	5.67e-01	0.7610	-2.63e-01	7.39e-02	3.77e-01	-4.14e-01	-3.64e-01	2.43e-01	3.08e-01	7.75e-01	1.44e-01	1.09e-01	1.59e-01	3.47e-01
GOMF CAMP DEPENDENT PROTEIN KINASE REGULATOR ACTIVITY	9	1.21e-02	3.99e-02	0.7610	-2.65e-01	-4.90e-01	-9.73e-02	-6.82e-02	-4.25e-02	5.03e-01	1.69e-01	1.09e-02	6.13e-01	7.23e-01	8.25e-01	8.96e-03
GOMF AXON GUIDANCE RECEPTOR ACTIVITY	7	8.31e-02	1.71e-01	0.7610	-9.41e-02	2.13e-01	3.37e-01	2.36e-01	4.01e-01	4.42e-01	6.67e-01	3.30e-01	1.22e-01	2.80e-01	6.65e-02	4.29e-02
GOBP COBALT ION TRANSPORT	7	1.73e-01	2.86e-01	0.7610	-1.92e-01	-2.25e-01	1.37e-01	-2.26e-01	-5.33e-01	3.70e-01	3.79e-01	3.02e-01	5.29e-01	3.00e-01	1.46e-02	9.00e-02
GOBP PROTEIN MATURATION BY IRON SULFUR CLUSTER TRANSFER	17	1.12e-05	9.35e-05	0.7610	9.83e-02	-6.14e-01	-3.55e-01	2.16e-01	1.37e-01	-4.69e-03	4.83e-01	1.17e-05	1.12e-02	1.22e-01	3.27e-01	9.73e-01
GOBP NEGATIVE REGULATION OF INFLAMMATORY RESPONSE TO WOUNDING	7	3.05e-02	8.10e-02	0.7610	-1.40e-01	9.95e-02	5.24e-01	3.33e-01	-2.52e-01	3.16e-01	5.20e-01	6.48e-01	1.63e-02	1.27e-01	2.49e-01	1.47e-01
GOMF RNA POLYMERASE II CTD HEPTAPEPTIDE REPEAT KINASE ACTIVITY	10	7.18e-03	2.64e-02	0.7610	-9.07e-02	1.65e-01	5.11e-01	3.49e-01	-1.64e-01	3.66e-01	6.19e-01	3.68e-01	5.17e-03	5.61e-02	3.68e-01	4.52e-02
GOBP BRANCHING INVOLVED IN LABYRINTHINE LAYER MORPHOGENESIS	10	9.00e-02	1.81e-01	0.7600	8.44e-02	2.67e-01	5.58e-01	-1.29e-01	-9.82e-02	4.03e-01	6.44e-01	1.44e-01	2.25e-03	4.80e-01	5.91e-01	2.73e-02
GOCC MICROVESICLE	5	2.65e-01	3.84e-01	0.7600	-4.84e-01	-2.84e-01	-1.70e-01	-2.31e-01	-9.26e-02	4.15e-01	6.11e-02	2.72e-01	5.11e-01	3.70e-01	7.20e-01	1.08e-01
GOMF OLFACTORY RECEPTOR ACTIVITY	47	2.09e-12	4.56e-11	0.7600	1.03e-01	2.68e-01	4.69e-01	-4.38e-01	-2.69e-01	1.05e-01	2.21e-01	1.47e-03	2.66e-08	1.99e-07	1.45e-03	2.15e-01
GOBP RESPONSE TO IRON II ION	5	1.80e-01	2.95e-01	0.7600	-3.26e-02	-4.71e-01	-8.82e-03	1.37e-01	-5.12e-01	2.71e-01	8.99e-01	6.80e-02	9.73e-01	5.96e-01	4.74e-02	2.94e-01
GOBP REGULATION OF PROTEIN LOCALIZATION TO ENDOSOME	13	9.99e-03	3.43e-02	0.7600	3.85e-02	1.32e-01	4.66e-01	2.38e-01	-2.21e-01	4.86e-01	8.10e-01	4.09e-01	3.63e-03	1.38e-01	1.67e-01	2.42e-03
GOMF PROTEIN CYSTEINE S STEAROYLTRANSFERASE ACTIVITY	7	1.77e-01	2.92e-01	0.7600	-5.05e-01	-2.22e-02	1.78e-01	-3.15e-01	-2.12e-01	3.81e-01	2.06e-02	9.19e-01	4.14e-01	1.49e-01	3.31e-01	8.06e-02
GOMF MOLECULAR TAG ACTIVITY	13	2.66e-03	1.17e-02	0.7600	-2.76e-01	-5.51e-01	-2.51e-01	-4.53e-02	-1.97e-01	3.05e-01	8.51e-02	5.76e-04	1.18e-01	7.77e-01	2.19e-01	5.66e-02
GOMF NADPLUS NUCLEOTIDASE CYCLIC ADP RIBOSE GENERATING	13	5.87e-04	3.22e-03	0.7590	-3.50e-01	3.80e-01	3.09e-01	-5.34e-02	-8.46e-02	4.51e-01	2.91e-02	1.76e-02	5.35e-02	7.39e-01	5.97e-01	4.83e-03
GOBP NADH DEHYDROGENASE COMPLEX ASSEMBLY	59	8.71e-17	2.78e-15	0.7580	-1.32e-01	-6.63e-01	-3.33e-01	-3.32e-02	-7.53e-02	-3.21e-02	8.06e-02	1.20e-18	9.86e-06	6.59e-01	3.17e-01	6.70e-01
GOBP REGULATION OF MONOCYTE DIFFERENTIATION	15	8.87e-03	3.11e-02	0.7580	3.14e-01	2.39e-01	-1.02e-02	5.68e-01	2.83e-01	-1.32e-01	3.53e-02	1.10e-01	9.45e-01	1.41e-04	5.78e-02	3.77e-01
GOBP RRNA PSEUDOURIDINE SYNTHESIS	8	1.01e-01	1.97e-01	0.7580	-3.05e-02	-4.69e-01	-4.48e-01	2.60e-01	-3.82e-02	-2.90e-01	8.81e-01	2.16e-02	2.82e-02	2.03e-01	8.52e-01	1.56e-01
GOBP PERICYTE CELL DIFFERENTIATION	7	3.32e-01	4.50e-01	0.7580	4.00e-01	2.98e-01	2.93e-01	3.37e-01	3.29e-01	1.33e-01	6.66e-02	1.72e-01	1.80e-01	1.23e-01	1.31e-01	5.41e-01
GOMF HYDROLASE ACTIVITY ACTING ON ETHER BONDS	10	3.05e-02	8.11e-02	0.7580	-1.74e-01	-1.60e-02	-3.62e-01	2.51e-01	5.34e-01	-2.55e-01	3.41e-01	9.30e-01	4.77e-02	1.70e-01	3.48e-03	1.63e-01
GOMF TRNA SPECIFIC RIBONUCLEASE ACTIVITY	16	7.91e-04	4.17e-03	0.7570	-9.13e-02	-5.96e-01	-4.31e-01	1.33e-01	-4.68e-02	-6.78e-02	5.27e-01	3.63e-05	2.85e-03	3.58e-01	7.46e-01	6.39e-01
GOCC CELL TRAILING EDGE	15	2.55e-03	1.13e-02	0.7570	1.38e-01	1.82e-01	4.65e-01	4.17e-01	-7.20e-02	3.56e-01	3.55e-01	2.23e-01	1.82e-03	5.21e-03	6.29e-01	1.71e-02
GOBP INSULIN METABOLIC PROCESS	11	8.39e-03	2.99e-02	0.7570	-3.34e-01	1.51e-01	4.83e-01	1.07e-02	-7.15e-02	4.47e-01	5.49e-02	3.85e-01	5.50e-03	9.51e-01	6.82e-01	1.02e-02
GOCC BRCA1 A COMPLEX	8	1.11e-01	2.11e-01	0.7570	-5.03e-01	-4.91e-01	-2.67e-01	3.45e-02	-7.52e-02	2.60e-02	1.38e-02	1.61e-02	1.90e-01	8.66e-01	7.12e-01	8.99e-01
GOBP ASYMMETRIC NEUROBLAST DIVISION	5	3.69e-01	4.84e-01	0.7570	1.77e-01	6.17e-01	3.19e-01	-9.62e-02	1.60e-01	1.57e-01	4.94e-01	1.70e-02	2.16e-01	7.09e-01	5.34e-01	5.44e-01
GOBP DOUBLE STRAND BREAK REPAIR VIA CLASSICAL NONHOMOLOGOUS END JOINING	9	7.92e-02	1.65e-01	0.7570	7.80e-02	3.78e-01	4.65e-03	3.82e-01	4.69e-01	2.41e-01	6.85e-01	4.94e-02	9.81e-01	4.75e-02	1.48e-02	2.11e-01
GOBP REGULATION OF MICROVILLUS ORGANIZATION	12	3.68e-02	9.37e-02	0.7570	2.59e-01	3.01e-01	5.43e-01	7.56e-02	1.16e-01	3.18e-01	1.20e-01	7.15e-02	1.13e-03	6.50e-01	4.85e-01	5.67e-02
GOBP PML BODY ORGANIZATION	7	1.58e-01	2.69e-01	0.7560	-4.13e-01	-1.23e-01	1.70e-01	-1.34e-01	-2.85e-01	5.08e-01	5.86e-02	5.73e-01	4.37e-01	5.40e-01	1.92e-01	1.99e-02
GOBP CALMODULIN DEPENDENT KINASE SIGNALING PATHWAY	8	4.48e-03	1.79e-02	0.7560	-3.49e-02	2.85e-01	1.81e-01	2.15e-01	-2.22e-01	6.00e-01	8.64e-01	1.63e-01	3.76e-01	2.93e-01	2.77e-01	3.27e-03
GOBP EYELID DEVELOPMENT IN CAMERA TYPE EYE	6	1.51e-01	2.61e-01	0.7550	-8.41e-02	6.32e-02	3.23e-01	1.99e-02	2.28e-01	6.35e-01	7.21e-01	7.89e-01	1.71e-01	9.33e-01	3.33e-01	7.09e-03
GOBP REGULATION OF TOOTH MINERALIZATION	5	3.23e-01	4.42e-01	0.7550	4.02e-01	6.54e-02	-1.24e-01	3.16e-01	1.35e-01	-5.21e-01	1.19e-01	8.00e-01	6.31e-01	2.21e-01	6.01e-01	4.38e-02
GOBP BLOOD COAGULATION INTRINSIC PATHWAY	7	7.28e-02	1.55e-01	0.7550	3.15e-01	-2.27e-01	4.83e-01	-4.24e-02	-3.42e-01	2.59e-01	1.49e-01	2.99e-01	2.68e-02	8.46e-01	1.17e-01	2.35e-01
GOMF INTERLEUKIN 6 RECEPTOR BINDING	6	7.36e-02	1.57e-01	0.7550	-5.52e-01	-2.04e-01	3.56e-01	-7.82e-02	-1.56e-01	2.58e-01	1.91e-02	3.88e-01	1.32e-01	7.40e-01	5.08e-01	2.74e-01
GOBP BRANCHING MORPHOGENESIS OF A NERVE	9	1.50e-01	2.61e-01	0.7550	2.24e-01	5.20e-01	2.89e-01	1.59e-01	2.47e-01	2.82e-01	2.44e-01	6.90e-03	1.33e-01	4.10e-01	1.99e-01	1.43e-01
GOBP CAMP METABOLIC PROCESS	17	1.07e-03	5.39e-03	0.7540	7.62e-02	5.21e-01	3.59e-01	2.50e-01	2.81e-01	1.46e-01	5.87e-01	1.97e-04	1.04e-02	7.46e-02	4.50e-02	2.98e-01
GOBP ESTABLISHMENT OF PROTEIN LOCALIZATION TO MITOCHONDRIAL MEMBRANE	35	1.48e-07	1.76e-06	0.7540	-2.81e-01	-5.72e-01	-3.88e-01	-9.68e-02	-2.01e-02	-5.09e-02	4.01e-03	4.81e-09	6.97e-05	3.22e-01	8.37e-01	6.02e-01
GOBP L ALANINE TRANSPORT	8	2.03e-02	5.99e-02	0.7540	-5.35e-02	-1.95e-01	1.68e-01	1.54e-01	-5.37e-01	4.33e-01	7.93e-01	3.39e-01	4.11e-01	4.52e-01	8.50e-03	3.41e-02
GOBP REGULATION OF L GLUTAMATE IMPORT ACROSS PLASMA MEMBRANE	6	4.32e-01	5.40e-01	0.7540	-4.50e-01	-3.19e-01	-6.15e-03	-3.10e-01	-3.27e-01	2.45e-01	5.61e-02	1.76e-01	9.79e-01	1.88e-01	1.65e-01	2.98e-01
GOBP FRUCTOSE 2 6 BISPHOSPHATE METABOLIC PROCESS	5	1.04e-01	2.02e-01	0.7540	-2.81e-01	4.65e-01	4.83e-01	1.24e-02	-9.10e-02	1.78e-01	2.77e-01	7.20e-02	6.15e-02	9.62e-01	7.24e-01	4.90e-01
GOMF FRUCTOSE 2 6 BISPHOSPHATE 2 PHOSPHATASE ACTIVITY	5	1.04e-01	2.02e-01	0.7540	-2.81e-01	4.65e-01	4.83e-01	1.24e-02	-9.10e-02	1.78e-01	2.77e-01	7.20e-02	6.15e-02	9.62e-01	7.24e-01	4.90e-01
GOBP CD4 POSITIVE OR CD8 POSITIVE ALPHA BETA T CELL LINEAGE COMMITMENT	26	5.33e-06	4.81e-05	0.7530	3.96e-01	3.86e-01	2.24e-01	4.12e-01	-1.63e-02	2.03e-01	4.75e-04	6.47e-04	4.85e-02	2.74e-04	8.86e-01	7.26e-02
GOBP NEGATIVE REGULATION OF NEUROTRANSMITTER SECRETION	6	2.10e-01	3.27e-01	0.7530	3.01e-02	1.78e-01	4.25e-01	2.99e-01	2.98e-01	4.19e-01	8.98e-01	4.51e-01	7.17e-02	2.05e-01	2.07e-01	7.52e-02
GOBP NOREPINEPHRINE SECRETION	10	2.37e-02	6.73e-02	0.7530	-1.84e-01	-1.90e-01	3.52e-01	-4.92e-01	-3.61e-01	-1.02e-02	3.14e-01	2.98e-01	5.42e-02	7.02e-03	4.80e-02	9.56e-01
GOBP CELLULAR RESPONSE TO L GLUTAMATE	5	3.65e-01	4.80e-01	0.7530	2.34e-01	-4.66e-02	-4.59e-01	4.04e-01	3.49e-01	-1.20e-01	3.65e-01	8.57e-01	7.58e-02	1.18e-01	1.76e-01	6.42e-01
GOMF PROTEIN ANTIGEN BINDING	8	8.91e-02	1.80e-01	0.7520	2.18e-01	4.81e-01	3.29e-01	3.53e-01	-1.27e-02	2.34e-01	2.85e-01	1.86e-02	1.07e-01	8.42e-02	9.50e-01	2.53e-01
GOBP GERMINAL CENTER FORMATION	13	3.06e-03	1.31e-02	0.7520	1.01e-01	4.04e-01	5.35e-01	2.22e-01	1.94e-01	1.40e-01	5.27e-01	1.17e-02	8.38e-04	1.66e-01	2.26e-01	3.81e-01
GOBP NEGATIVE REGULATION OF POTASSIUM ION TRANSMEMBRANE TRANSPORTER ACTIVITY	11	4.00e-02	9.97e-02	0.7520	-2.64e-01	-5.59e-02	4.71e-01	-1.57e-01	-2.12e-01	4.49e-01	1.29e-01	7.48e-01	6.83e-03	3.67e-01	2.23e-01	9.90e-03
GOBP NEGATIVE REGULATION OF CERAMIDE BIOSYNTHETIC PROCESS	5	5.60e-01	6.49e-01	0.7520	-3.13e-01	-4.91e-01	-3.68e-01	-1.57e-01	-2.22e-01	-1.31e-01	2.25e-01	5.71e-02	1.54e-01	5.44e-01	3.91e-01	6.12e-01
GOCC CYTOSOLIC PROTEASOME COMPLEX	5	2.72e-01	3.92e-01	0.7520	-4.21e-01	-4.96e-01	3.75e-02	6.02e-02	-1.14e-01	3.52e-01	1.03e-01	5.47e-02	8.84e-01	8.16e-01	6.59e-01	1.73e-01
GOMF FLOPPASE ACTIVITY	16	9.55e-03	3.30e-02	0.7520	2.82e-01	3.42e-01	3.21e-01	4.28e-01	1.07e-01	2.66e-01	5.06e-02	1.79e-02	2.63e-02	3.00e-03	4.59e-01	6.53e-02
GOMF OXIDOREDUCTASE ACTIVITY ACTING ON THE CH NH2 GROUP OF DONORS OXYGEN AS ACCEPTOR	13	1.59e-03	7.55e-03	0.7520	2.01e-01	6.50e-02	-2.58e-01	-3.32e-01	4.22e-02	-5.85e-01	2.10e-01	6.85e-01	1.07e-01	3.82e-02	7.92e-01	2.60e-04
GOBP AMINOPHOSPHOLIPID TRANSPORT	9	5.96e-02	1.34e-01	0.7520	-1.08e-01	4.06e-01	3.67e-01	7.69e-02	1.55e-01	4.74e-01	5.76e-01	3.51e-02	5.66e-02	6.90e-01	4.22e-01	1.38e-02
GOBP GLUTAMATE SECRETION NEUROTRANSMISSION	7	1.44e-01	2.54e-01	0.7520	-6.46e-02	4.09e-01	4.53e-01	-1.06e-01	1.96e-01	3.72e-01	7.67e-01	6.07e-02	3.79e-02	6.26e-01	3.69e-01	8.83e-02
GOMF MYOSIN V BINDING	13	1.22e-02	4.02e-02	0.7520	-2.72e-01	-1.48e-01	3.59e-01	1.31e-02	-2.31e-01	5.35e-01	8.92e-02	3.56e-01	2.49e-02	9.35e-01	1.49e-01	8.31e-04
GOBP ATRIOVENTRICULAR CANAL DEVELOPMENT	5	8.01e-02	1.67e-01	0.7520	-4.61e-01	2.82e-01	2.76e-01	6.71e-02	-2.06e-01	3.87e-01	7.42e-02	2.74e-01	2.86e-01	7.95e-01	4.26e-01	1.34e-01
GOBP DETOXIFICATION OF NITROGEN COMPOUND	5	5.22e-01	6.16e-01	0.7520	-5.08e-01	-2.33e-01	9.17e-02	-3.66e-01	-3.18e-01	9.01e-02	4.90e-02	3.66e-01	7.23e-01	1.56e-01	2.18e-01	7.27e-01
GOCC OUTER KINETOCHORE	18	2.23e-05	1.75e-04	0.7510	-2.32e-02	-4.44e-01	1.06e-01	3.03e-01	-2.15e-01	4.66e-01	8.65e-01	1.10e-03	4.37e-01	2.60e-02	1.14e-01	6.17e-04
GOCC COPII VESICLE COAT	16	2.91e-06	2.79e-05	0.7510	-4.30e-01	2.39e-02	3.34e-01	2.80e-01	-2.05e-01	3.83e-01	2.88e-03	8.68e-01	2.07e-02	5.28e-02	1.55e-01	8.03e-03
GOCC 90S PRERIBOSOME	26	2.68e-06	2.59e-05	0.7510	2.16e-02	-5.20e-01	-3.99e-01	2.53e-01	-5.57e-02	-2.60e-01	8.49e-01	4.49e-06	4.25e-04	2.58e-02	6.23e-01	2.18e-02
GOBP LIPOXYGENASE PATHWAY	9	1.06e-01	2.03e-01	0.7510	-8.74e-02	-2.95e-01	9.85e-02	-4.50e-01	-5.02e-01	-7.51e-02	6.50e-01	1.26e-01	6.09e-01	1.95e-02	9.08e-03	6.96e-01
GOBP NEGATIVE REGULATION OF PHOSPHOLIPASE ACTIVITY	6	3.18e-01	4.38e-01	0.7500	-2.95e-01	-8.13e-02	-1.58e-02	-5.14e-01	-3.76e-01	-2.51e-01	2.11e-01	7.30e-01	9.46e-01	2.91e-02	1.11e-01	2.87e-01
GOBP DETECTION OF CELL DENSITY	6	1.71e-01	2.84e-01	0.7500	-4.65e-02	3.86e-01	3.39e-01	1.63e-01	-5.29e-02	5.16e-01	8.44e-01	1.01e-01	1.50e-01	4.88e-01	8.22e-01	2.86e-02
GOBP POSITIVE REGULATION OF MICROGLIAL CELL ACTIVATION	5	5.17e-01	6.11e-01	0.7500	-2.13e-01	1.68e-02	3.44e-01	-3.29e-01	-4.09e-01	3.51e-01	4.10e-01	9.48e-01	1.83e-01	2.03e-01	1.14e-01	1.74e-01
GOBP PROTEIN INSERTION INTO MITOCHONDRIAL OUTER MEMBRANE	15	7.87e-03	2.84e-02	0.7500	-3.45e-01	-5.53e-01	-2.56e-01	-2.29e-01	-1.19e-01	6.73e-02	2.07e-02	2.06e-04	8.55e-02	1.24e-01	4.25e-01	6.52e-01
GOBP NEGATIVE REGULATION OF INTERLEUKIN 4 PRODUCTION	6	1.11e-01	2.11e-01	0.7490	1.78e-01	-4.21e-01	2.94e-01	-1.15e-01	-5.02e-01	8.88e-04	4.49e-01	7.40e-02	2.12e-01	6.26e-01	3.31e-02	9.97e-01
GOBP POSITIVE REGULATION OF PROTEIN POLYUBIQUITINATION	16	5.17e-04	2.88e-03	0.7490	-5.31e-01	-1.39e-02	1.29e-01	-3.38e-01	2.81e-02	3.84e-01	2.36e-04	9.23e-01	3.72e-01	1.93e-02	8.46e-01	7.86e-03
GOBP NEGATIVE REGULATION OF TRANSCRIPTION BY COMPETITIVE PROMOTER BINDING	10	2.71e-02	7.44e-02	0.7490	4.60e-02	1.31e-01	5.08e-01	3.75e-01	-6.20e-02	3.72e-01	8.01e-01	4.74e-01	5.37e-03	4.00e-02	7.34e-01	4.16e-02
GOCC KATANIN COMPLEX	5	4.70e-01	5.73e-01	0.7490	-4.71e-01	-3.34e-01	-2.32e-01	-3.10e-01	-7.18e-02	-2.68e-01	6.80e-02	1.96e-01	3.70e-01	2.29e-01	7.81e-01	3.00e-01
GOMF UNIPORTER ACTIVITY	5	3.78e-01	4.93e-01	0.7480	-2.02e-01	-4.59e-01	2.21e-01	-2.85e-01	-4.20e-01	4.61e-02	4.33e-01	7.58e-02	3.93e-01	2.69e-01	1.04e-01	8.58e-01
GOBP REGULATION OF TRANSLATIONAL INITIATION IN RESPONSE TO STRESS	15	8.22e-03	2.94e-02	0.7480	-5.26e-01	-2.68e-01	2.49e-02	-1.78e-01	-3.37e-01	2.56e-01	4.15e-04	7.20e-02	8.67e-01	2.34e-01	2.39e-02	8.63e-02
GOCC PRERIBOSOME LARGE SUBUNIT PRECURSOR	19	3.05e-05	2.32e-04	0.7480	8.39e-02	-6.02e-01	-2.69e-01	1.72e-01	-2.63e-01	-1.38e-01	5.27e-01	5.46e-06	4.23e-02	1.94e-01	4.76e-02	2.97e-01
GOBP TRNA AMINOACYLATION FOR MITOCHONDRIAL PROTEIN TRANSLATION	8	6.03e-02	1.36e-01	0.7480	5.18e-02	-5.42e-01	-4.31e-01	1.68e-01	1.33e-01	-1.76e-01	8.00e-01	7.93e-03	3.46e-02	4.09e-01	5.14e-01	3.89e-01
GOBP RIBOSOME ASSEMBLY	58	1.24e-13	2.94e-12	0.7480	-1.22e-01	-5.86e-01	-3.90e-01	8.84e-02	-1.05e-01	-1.75e-01	1.07e-01	1.17e-14	2.71e-07	2.45e-01	1.67e-01	2.14e-02
GOBP DETECTION OF CALCIUM ION	10	3.91e-02	9.79e-02	0.7470	-8.91e-02	-5.56e-01	1.15e-01	-1.28e-01	-4.32e-01	1.57e-01	6.26e-01	2.33e-03	5.29e-01	4.85e-01	1.80e-02	3.89e-01
GOBP REGULATION OF NUCLEOTIDE BINDING OLIGOMERIZATION DOMAIN CONTAINING 2 SIGNALING PATHWAY	9	2.10e-04	1.31e-03	0.7470	-3.48e-01	5.10e-01	2.14e-01	1.93e-01	2.64e-01	-1.54e-01	7.04e-02	8.07e-03	2.67e-01	3.16e-01	1.70e-01	4.23e-01
GOBP ALDITOL CATABOLIC PROCESS	6	3.71e-02	9.43e-02	0.7470	-4.82e-01	2.90e-01	-8.52e-02	1.78e-01	4.43e-01	8.26e-02	4.11e-02	2.18e-01	7.18e-01	4.51e-01	6.04e-02	7.26e-01
GOBP ROSTROCAUDAL NEURAL TUBE PATTERNING	7	9.62e-02	1.90e-01	0.7470	-2.42e-01	2.91e-01	-3.34e-01	-1.53e-02	4.06e-01	-3.72e-01	2.68e-01	1.82e-01	1.26e-01	9.44e-01	6.31e-02	8.80e-02
GOMF SIALYLTRANSFERASE ACTIVITY	16	1.86e-02	5.57e-02	0.7470	2.45e-01	4.33e-01	2.90e-01	2.24e-01	3.20e-01	2.71e-01	8.93e-02	2.69e-03	4.46e-02	1.22e-01	2.69e-02	6.05e-02
GOBP HEAT ACCLIMATION	6	1.83e-01	2.98e-01	0.7460	-5.46e-02	5.62e-02	-1.72e-01	4.46e-01	5.46e-01	-1.58e-01	8.17e-01	8.12e-01	4.65e-01	5.86e-02	2.06e-02	5.03e-01
GOBP DIAPEDESIS	6	1.17e-01	2.19e-01	0.7460	-2.51e-01	1.99e-01	1.64e-01	2.62e-01	3.68e-01	4.72e-01	2.87e-01	3.98e-01	4.86e-01	2.67e-01	1.18e-01	4.51e-02
GOBP T HELPER CELL LINEAGE COMMITMENT	20	2.19e-04	1.36e-03	0.7460	3.64e-01	3.52e-01	2.12e-01	4.94e-01	1.37e-02	1.07e-01	4.82e-03	6.50e-03	1.01e-01	1.30e-04	9.15e-01	4.08e-01
GOBP MESENCHYMAL EPITHELIAL CELL SIGNALING	5	1.67e-01	2.80e-01	0.7460	5.54e-02	9.01e-02	-3.17e-01	-4.40e-01	-2.90e-01	-4.09e-01	8.30e-01	7.27e-01	2.20e-01	8.85e-02	2.62e-01	1.13e-01
GOCC MITOCHONDRIAL PERMEABILITY TRANSITION PORE COMPLEX	6	3.85e-01	4.99e-01	0.7460	-7.82e-02	-2.90e-01	-4.38e-01	-1.51e-01	-2.03e-02	-5.01e-01	7.40e-01	2.19e-01	6.31e-02	5.21e-01	9.31e-01	3.36e-02
GOBP INTERLEUKIN 6 MEDIATED SIGNALING PATHWAY	15	3.82e-04	2.23e-03	0.7460	-8.95e-02	3.51e-01	1.50e-01	4.21e-01	2.46e-01	4.07e-01	5.48e-01	1.87e-02	3.15e-01	4.79e-03	9.89e-02	6.41e-03
GOBP ONCOGENE INDUCED CELL SENESCENCE	5	7.50e-02	1.59e-01	0.7460	4.17e-01	-2.73e-01	8.62e-02	3.81e-01	1.56e-01	-3.60e-01	1.06e-01	2.90e-01	7.38e-01	1.40e-01	5.45e-01	1.63e-01
GOBP POSITIVE REGULATION OF GRANULOCYTE DIFFERENTIATION	7	2.36e-01	3.54e-01	0.7460	-1.30e-01	-1.08e-02	3.80e-01	-6.14e-02	-3.70e-01	5.04e-01	5.52e-01	9.60e-01	8.13e-02	7.78e-01	9.04e-02	2.10e-02
GOBP CGMP METABOLIC PROCESS	10	1.10e-01	2.09e-01	0.7450	-2.06e-01	-4.24e-01	7.81e-02	-2.62e-01	-4.61e-01	2.16e-01	2.59e-01	2.03e-02	6.69e-01	1.52e-01	1.16e-02	2.38e-01
GOBP PEPTIDYL ARGININE METHYLATION TO ASYMMETRICAL DIMETHYL ARGININE	7	4.76e-02	1.13e-01	0.7450	1.30e-01	-1.58e-01	-3.22e-01	6.31e-01	3.19e-02	-1.01e-01	5.51e-01	4.69e-01	1.40e-01	3.83e-03	8.84e-01	6.43e-01
GOBP MATURATION OF LSU RRNA FROM TRICISTRONIC RRNA TRANSCRIPT SSU RRNA 5 8S RRNA LSU RRNA	16	2.85e-04	1.72e-03	0.7450	-9.22e-02	-5.98e-01	-3.92e-01	6.78e-02	-1.57e-01	8.08e-02	5.23e-01	3.47e-05	6.61e-03	6.39e-01	2.76e-01	5.76e-01
GOBP DE NOVO AMP BIOSYNTHETIC PROCESS	8	1.04e-01	2.00e-01	0.7450	-2.51e-01	-5.48e-01	-4.17e-01	9.86e-02	8.75e-02	-2.12e-02	2.20e-01	7.24e-03	4.12e-02	6.29e-01	6.68e-01	9.17e-01
GOBP POSITIVE REGULATION OF INTERLEUKIN 5 PRODUCTION	8	5.02e-02	1.18e-01	0.7450	-3.21e-01	2.74e-01	4.34e-01	-2.24e-02	-1.76e-01	3.96e-01	1.16e-01	1.80e-01	3.35e-02	9.13e-01	3.89e-01	5.22e-02
GOCC PROTEASOME ACCESSORY COMPLEX	24	9.87e-07	1.04e-05	0.7450	-2.22e-01	-4.97e-01	1.52e-01	1.48e-01	-1.43e-01	4.39e-01	5.99e-02	2.51e-05	1.97e-01	2.10e-01	2.26e-01	1.94e-04
GOBP CARDIAC NEURAL CREST CELL DEVELOPMENT INVOLVED IN OUTFLOW TRACT MORPHOGENESIS	6	1.71e-02	5.22e-02	0.7440	-6.25e-01	-1.10e-01	2.53e-01	-2.85e-01	1.49e-02	-7.44e-02	7.99e-03	6.41e-01	2.83e-01	2.27e-01	9.50e-01	7.52e-01
GOBP NEGATIVE REGULATION OF THYMOCYTE APOPTOTIC PROCESS	8	1.04e-01	2.01e-01	0.7440	7.42e-03	3.79e-01	1.89e-01	3.98e-01	3.28e-01	3.28e-01	9.71e-01	6.33e-02	3.54e-01	5.11e-02	1.08e-01	1.08e-01
GOBP THYMIC T CELL SELECTION	21	1.54e-04	9.93e-04	0.7440	2.68e-01	3.88e-01	-2.27e-02	4.68e-01	2.78e-01	1.87e-01	3.38e-02	2.08e-03	8.57e-01	2.07e-04	2.72e-02	1.39e-01
GOBP NEGATIVE REGULATION OF PROTEIN LOCALIZATION TO CHROMATIN	6	9.87e-02	1.94e-01	0.7440	2.09e-01	-8.36e-02	5.46e-02	6.75e-01	1.48e-01	-1.48e-01	3.76e-01	7.23e-01	8.17e-01	4.17e-03	5.29e-01	5.30e-01
GOMF PROTEIN TRANSMEMBRANE TRANSPORTER ACTIVITY	25	7.81e-05	5.45e-04	0.7440	-4.24e-01	-4.66e-01	-3.26e-01	-4.16e-02	-2.14e-01	4.84e-02	2.44e-04	5.39e-05	4.78e-03	7.19e-01	6.38e-02	6.75e-01
GOMF ISOCITRATE DEHYDROGENASE NAD P PLUS ACTIVITY	5	8.40e-02	1.72e-01	0.7440	-2.85e-01	-5.90e-01	-1.15e-01	2.72e-01	1.81e-01	-6.62e-02	2.69e-01	2.24e-02	6.57e-01	2.92e-01	4.84e-01	7.98e-01
GOBP COTRANSLATIONAL PROTEIN TARGETING TO MEMBRANE	25	2.07e-05	1.63e-04	0.7440	-3.17e-01	-4.62e-01	1.97e-02	-3.21e-02	-3.01e-01	3.84e-01	6.08e-03	6.45e-05	8.65e-01	7.81e-01	9.17e-03	8.83e-04
GOMF PHOSPHATIDIC ACID TRANSFER ACTIVITY	7	4.42e-02	1.07e-01	0.7440	-2.91e-01	-5.10e-01	-1.22e-01	2.10e-01	1.75e-01	3.45e-01	1.83e-01	1.95e-02	5.76e-01	3.36e-01	4.22e-01	1.14e-01
GOBP POSITIVE REGULATION OF MITOCHONDRIAL OUTER MEMBRANE PERMEABILIZATION INVOLVED IN APOPTOTIC SIGNALING PATHWAY	8	1.07e-01	2.06e-01	0.7430	3.83e-01	-7.77e-02	-1.89e-01	5.15e-01	1.26e-01	-2.88e-01	6.05e-02	7.03e-01	3.54e-01	1.17e-02	5.38e-01	1.58e-01
GOBP CELLULAR RESPONSE TO POTASSIUM ION	10	1.22e-01	2.27e-01	0.7430	3.89e-01	2.85e-01	1.31e-01	3.81e-01	2.87e-01	2.74e-01	3.31e-02	1.19e-01	4.74e-01	3.69e-02	1.16e-01	1.33e-01
GOMF TRNA SPECIFIC ADENOSINE DEAMINASE ACTIVITY	6	4.04e-01	5.15e-01	0.7430	3.72e-01	1.96e-01	8.53e-02	5.53e-01	2.33e-01	8.69e-02	1.15e-01	4.05e-01	7.17e-01	1.90e-02	3.23e-01	7.13e-01
GOBP ERBB2 EGFR SIGNALING PATHWAY	6	3.52e-03	1.47e-02	0.7430	-9.43e-02	3.68e-01	5.62e-01	5.65e-02	-4.14e-02	-2.95e-01	6.89e-01	1.19e-01	1.71e-02	8.11e-01	8.61e-01	2.11e-01
GOBP POSITIVE REGULATION OF MAMMARY GLAND EPITHELIAL CELL PROLIFERATION	6	1.32e-01	2.39e-01	0.7430	3.94e-02	9.35e-02	4.96e-01	4.47e-01	-4.16e-02	3.05e-01	8.67e-01	6.92e-01	3.52e-02	5.78e-02	8.60e-01	1.96e-01
GOBP ADP TRANSPORT	10	4.56e-02	1.09e-01	0.7430	-1.34e-01	-5.09e-01	-2.55e-01	3.15e-02	-2.72e-01	-3.66e-01	4.62e-01	5.27e-03	1.62e-01	8.63e-01	1.36e-01	4.52e-02
GOCC MITOCHONDRIAL CRISTA	8	2.16e-01	3.33e-01	0.7420	1.16e-01	1.52e-01	4.72e-01	1.44e-01	-1.20e-01	5.07e-01	5.68e-01	4.58e-01	2.09e-02	4.80e-01	5.58e-01	1.30e-02
GOBP GAS TRANSPORT	12	3.70e-02	9.41e-02	0.7420	3.58e-01	1.37e-01	4.30e-01	2.43e-01	-1.67e-01	3.63e-01	3.15e-02	4.11e-01	9.87e-03	1.45e-01	3.16e-01	2.95e-02
GOBP CRANIAL NERVE STRUCTURAL ORGANIZATION	7	6.87e-02	1.49e-01	0.7420	-4.25e-02	2.76e-01	-6.94e-02	5.16e-02	6.80e-01	5.73e-02	8.46e-01	2.07e-01	7.51e-01	8.13e-01	1.84e-03	7.93e-01
GOBP MUCOSA ASSOCIATED LYMPHOID TISSUE DEVELOPMENT	5	2.36e-01	3.54e-01	0.7420	-3.85e-02	3.37e-01	1.51e-01	2.62e-01	1.98e-01	5.52e-01	8.81e-01	1.91e-01	5.58e-01	3.10e-01	4.43e-01	3.26e-02
GOCC CORVET COMPLEX	7	9.01e-03	3.15e-02	0.7420	-3.73e-01	-1.74e-01	-1.27e-01	5.43e-01	2.43e-01	-1.01e-01	8.71e-02	4.25e-01	5.60e-01	1.28e-02	2.66e-01	6.43e-01
GOBP MITOCHONDRIAL RESPIRATORY CHAIN COMPLEX ASSEMBLY	97	6.74e-28	5.43e-26	0.7410	-1.42e-01	-6.25e-01	-3.70e-01	-3.70e-02	-1.04e-02	-1.03e-02	1.59e-02	1.60e-26	2.98e-10	5.29e-01	8.59e-01	8.61e-01
GOMF SPHINGOSINE 1 PHOSPHATE RECEPTOR ACTIVITY	7	2.40e-01	3.58e-01	0.7410	3.57e-01	5.56e-02	-2.67e-01	4.76e-01	3.44e-01	-5.28e-02	1.02e-01	7.99e-01	2.21e-01	2.93e-02	1.15e-01	8.09e-01
GOBP RELAXATION OF SMOOTH MUSCLE	8	9.84e-02	1.94e-01	0.7410	-2.75e-01	-4.06e-01	3.34e-01	-1.39e-01	-3.40e-01	2.48e-01	1.78e-01	4.69e-02	1.02e-01	4.96e-01	9.58e-02	2.25e-01
GOBP DORSAL AORTA MORPHOGENESIS	5	6.89e-02	1.49e-01	0.7400	-3.46e-01	4.50e-01	3.42e-01	1.96e-01	2.00e-01	1.73e-01	1.80e-01	8.12e-02	1.85e-01	4.48e-01	4.40e-01	5.03e-01
GOMF WATER TRANSMEMBRANE TRANSPORTER ACTIVITY	8	1.23e-01	2.28e-01	0.7400	-6.66e-02	-1.76e-01	-2.04e-02	-4.72e-01	-5.27e-01	-1.10e-01	7.44e-01	3.89e-01	9.20e-01	2.09e-02	9.87e-03	5.90e-01
GOMF ACETYLCHOLINE RECEPTOR ACTIVITY	10	1.66e-01	2.79e-01	0.7390	2.91e-01	3.27e-01	3.37e-01	3.06e-01	1.66e-01	3.47e-01	1.12e-01	7.38e-02	6.46e-02	9.34e-02	3.65e-01	5.75e-02
GOBP DNA REPLICATION CHECKPOINT SIGNALING	19	1.89e-04	1.20e-03	0.7390	2.14e-01	-8.76e-02	2.55e-01	5.30e-01	8.88e-02	3.73e-01	1.07e-01	5.09e-01	5.42e-02	6.35e-05	5.03e-01	4.90e-03
GOCC RNA POLYMERASE III COMPLEX	18	1.47e-03	7.07e-03	0.7390	-1.54e-01	-5.62e-01	-3.85e-01	4.05e-02	-2.04e-01	-1.21e-01	2.57e-01	3.62e-05	4.72e-03	7.66e-01	1.33e-01	3.73e-01
GOBP NEGATIVE REGULATION OF AUTOPHAGY OF MITOCHONDRION	7	1.82e-01	2.96e-01	0.7390	2.72e-02	2.33e-01	-1.57e-01	4.33e-01	4.75e-01	-2.29e-01	9.01e-01	2.85e-01	4.72e-01	4.73e-02	2.94e-02	2.95e-01
GOMF SNORNA BINDING	32	1.51e-07	1.79e-06	0.7380	-7.53e-02	-5.00e-01	-3.63e-01	1.85e-01	-2.24e-01	-2.72e-01	4.61e-01	9.62e-07	3.85e-04	7.07e-02	2.85e-02	7.85e-03
GOCC COPI COATED VESICLE MEMBRANE	18	1.30e-04	8.55e-04	0.7380	-3.30e-01	-3.76e-01	1.53e-01	1.86e-01	-2.78e-01	4.00e-01	1.52e-02	5.78e-03	2.62e-01	1.73e-01	4.10e-02	3.33e-03
GOBP TRIF DEPENDENT TOLL LIKE RECEPTOR SIGNALING PATHWAY	11	1.11e-02	3.73e-02	0.7380	-1.92e-02	4.92e-01	-2.59e-01	1.67e-01	4.47e-01	-9.22e-02	9.12e-01	4.75e-03	1.37e-01	3.38e-01	1.03e-02	5.97e-01
GOBP REGULATION OF KERATINOCYTE MIGRATION	11	1.38e-02	4.46e-02	0.7380	6.77e-02	4.80e-01	5.20e-01	4.87e-02	-1.51e-01	1.21e-01	6.97e-01	5.89e-03	2.80e-03	7.80e-01	3.86e-01	4.88e-01
GOBP REGULATION OF SKELETAL MUSCLE CONTRACTION BY CALCIUM ION SIGNALING	6	3.90e-01	5.03e-01	0.7380	1.67e-01	2.39e-01	3.15e-01	3.18e-01	2.81e-01	4.25e-01	4.78e-01	3.10e-01	1.81e-01	1.78e-01	2.33e-01	7.16e-02
GOBP INTRACILIARY RETROGRADE TRANSPORT	14	9.49e-03	3.28e-02	0.7380	2.59e-02	3.95e-02	-4.32e-01	7.51e-02	5.36e-01	-2.52e-01	8.67e-01	7.98e-01	5.13e-03	6.27e-01	5.17e-04	1.03e-01
GOBP REGULATION OF CEREBELLAR GRANULE CELL PRECURSOR PROLIFERATION	5	2.44e-01	3.62e-01	0.7380	3.44e-02	-2.32e-02	5.60e-01	-1.81e-01	-4.43e-01	1.32e-02	8.94e-01	9.28e-01	3.01e-02	4.83e-01	8.61e-02	9.59e-01
GOBP REGULATION OF ODONTOGENESIS OF DENTIN CONTAINING TOOTH	6	3.65e-01	4.80e-01	0.7380	-9.75e-02	-8.87e-02	4.44e-01	-6.12e-02	-2.18e-01	5.28e-01	6.79e-01	7.07e-01	5.96e-02	7.95e-01	3.56e-01	2.51e-02
GOBP SPHINGOID BIOSYNTHETIC PROCESS	13	4.42e-02	1.07e-01	0.7380	-2.23e-01	-2.53e-01	2.37e-01	-2.07e-01	-4.74e-01	3.28e-01	1.65e-01	1.15e-01	1.40e-01	1.96e-01	3.06e-03	4.09e-02
GOMF TRANSLATION ACTIVATOR ACTIVITY	7	3.03e-01	4.23e-01	0.7380	-3.69e-01	-5.23e-01	-1.25e-01	-9.25e-02	-3.29e-01	4.42e-02	9.12e-02	1.66e-02	5.66e-01	6.72e-01	1.31e-01	8.40e-01
GOBP NEGATIVE REGULATION OF MACROPHAGE CHEMOTAXIS	6	1.54e-01	2.65e-01	0.7370	-9.73e-03	-6.39e-01	-1.41e-01	1.55e-01	-3.01e-01	1.28e-02	9.67e-01	6.68e-03	5.49e-01	5.12e-01	2.01e-01	9.57e-01
GOMF NUCLEAR RETINOID X RECEPTOR BINDING	14	5.61e-07	6.13e-06	0.7370	-7.95e-02	3.33e-01	4.92e-01	4.06e-01	1.05e-01	-9.06e-02	6.06e-01	3.08e-02	1.43e-03	8.57e-03	4.97e-01	5.57e-01
GOBP REGULATION OF DNA TEMPLATED DNA REPLICATION INITIATION	14	7.26e-04	3.87e-03	0.7370	2.51e-01	-2.31e-01	4.24e-02	6.37e-01	1.09e-02	1.41e-01	1.03e-01	1.35e-01	7.84e-01	3.71e-05	9.44e-01	3.62e-01
GOBP AMINO ACID BETAINE BIOSYNTHETIC PROCESS	5	3.64e-01	4.79e-01	0.7370	-2.98e-01	4.86e-02	2.43e-01	-3.32e-01	-9.18e-02	5.24e-01	2.49e-01	8.51e-01	3.46e-01	1.99e-01	7.22e-01	4.25e-02
GOBP UREA TRANSMEMBRANE TRANSPORT	6	2.64e-01	3.84e-01	0.7370	-4.59e-02	-1.72e-01	2.18e-02	-4.61e-01	-5.45e-01	-3.09e-02	8.45e-01	4.66e-01	9.26e-01	5.06e-02	2.07e-02	8.96e-01
GOMF UREA TRANSMEMBRANE TRANSPORTER ACTIVITY	6	2.64e-01	3.84e-01	0.7370	-4.59e-02	-1.72e-01	2.18e-02	-4.61e-01	-5.45e-01	-3.09e-02	8.45e-01	4.66e-01	9.26e-01	5.06e-02	2.07e-02	8.96e-01
GOMF L ARGININE TRANSMEMBRANE TRANSPORTER ACTIVITY	8	8.93e-02	1.80e-01	0.7370	-3.92e-01	-3.31e-01	-4.45e-01	1.48e-01	-1.21e-01	-2.13e-01	5.50e-02	1.05e-01	2.92e-02	4.69e-01	5.53e-01	2.97e-01
GOBP PROTEIN LOCALIZATION TO EARLY ENDOSOME	13	3.36e-03	1.42e-02	0.7370	-1.88e-01	-5.65e-02	4.01e-01	2.22e-01	-3.10e-01	4.45e-01	2.41e-01	7.24e-01	1.22e-02	1.67e-01	5.29e-02	5.46e-03
GOBP ADAPTIVE IMMUNE MEMORY RESPONSE	6	1.61e-01	2.73e-01	0.7360	4.38e-01	-1.78e-01	-2.69e-01	4.30e-01	2.49e-01	1.06e-03	6.31e-02	4.51e-01	2.53e-01	6.84e-02	2.91e-01	9.96e-01
GOBP FOLIC ACID CONTAINING COMPOUND BIOSYNTHETIC PROCESS	9	1.13e-02	3.78e-02	0.7360	2.72e-02	-4.06e-01	5.13e-02	3.89e-01	1.15e-01	4.58e-01	8.88e-01	3.49e-02	7.90e-01	4.34e-02	5.50e-01	1.74e-02
GOMF RETINAL DEHYDROGENASE ACTIVITY	6	3.84e-01	4.97e-01	0.7360	1.03e-02	-1.12e-01	-5.50e-01	1.10e-01	3.29e-01	-3.25e-01	9.65e-01	6.34e-01	1.96e-02	6.42e-01	1.63e-01	1.67e-01
GOBP POSITIVE REGULATION OF MITOTIC SISTER CHROMATID SEGREGATION	6	7.80e-02	1.63e-01	0.7360	9.34e-02	-2.84e-01	-2.35e-02	6.55e-01	1.27e-01	-8.03e-02	6.92e-01	2.29e-01	9.21e-01	5.48e-03	5.90e-01	7.33e-01
GOCC EMC COMPLEX	10	1.41e-02	4.53e-02	0.7350	-2.32e-01	-6.00e-01	-8.35e-02	2.17e-01	-1.06e-01	2.47e-01	2.03e-01	1.01e-03	6.48e-01	2.34e-01	5.60e-01	1.76e-01
GOBP PROTEIN INSERTION INTO ER MEMBRANE	30	1.73e-08	2.37e-07	0.7350	-3.39e-01	-5.52e-01	-1.22e-01	2.55e-01	-1.72e-01	1.12e-01	1.31e-03	1.70e-07	2.49e-01	1.57e-02	1.03e-01	2.88e-01
GOMF OXYGEN BINDING	13	3.34e-02	8.70e-02	0.7350	5.21e-01	2.10e-01	3.72e-01	2.50e-01	5.06e-02	1.44e-01	1.13e-03	1.90e-01	2.01e-02	1.19e-01	7.52e-01	3.68e-01
GOMF U6 SNRNA BINDING	14	6.26e-03	2.35e-02	0.7350	-5.44e-02	-2.93e-01	-4.43e-01	3.83e-01	3.19e-01	-8.30e-02	7.24e-01	5.76e-02	4.14e-03	1.32e-02	3.86e-02	5.91e-01
GOMF S METHYLTRANSFERASE ACTIVITY	6	2.40e-01	3.58e-01	0.7340	2.51e-02	3.42e-01	3.95e-02	2.04e-01	6.06e-01	1.09e-01	9.15e-01	1.47e-01	8.67e-01	3.87e-01	1.02e-02	6.45e-01
GOBP SMALL NUCLEOLAR RIBONUCLEOPROTEIN COMPLEX ASSEMBLY	10	7.24e-02	1.55e-01	0.7340	-2.30e-01	-5.40e-01	-3.73e-01	3.32e-03	2.45e-02	-2.34e-01	2.08e-01	3.08e-03	4.13e-02	9.85e-01	8.93e-01	2.00e-01
GOBP POSITIVE REGULATION OF HEAT GENERATION	8	2.66e-03	1.17e-02	0.7340	-1.46e-01	3.19e-01	3.86e-01	-4.48e-01	2.35e-01	-1.04e-01	4.75e-01	1.18e-01	5.86e-02	2.83e-02	2.49e-01	6.11e-01
GOMF STEROL ESTERASE ACTIVITY	7	2.49e-02	6.98e-02	0.7340	1.71e-01	1.52e-01	4.17e-01	2.46e-01	4.89e-01	1.14e-01	4.32e-01	4.86e-01	5.63e-02	2.59e-01	2.52e-02	6.01e-01
GOBP PROTEIN LOCALIZATION TO CYTOPLASMIC STRESS GRANULE	8	2.83e-02	7.67e-02	0.7340	-5.41e-01	-1.12e-01	-1.56e-01	-5.40e-02	2.52e-01	3.77e-01	8.07e-03	5.85e-01	4.44e-01	7.91e-01	2.17e-01	6.48e-02
GOCC PHOSPHOLIPID TRANSLOCATING ATPASE COMPLEX	13	2.05e-02	6.02e-02	0.7330	1.28e-01	3.86e-01	2.73e-01	2.94e-01	1.51e-01	4.34e-01	4.26e-01	1.59e-02	8.81e-02	6.66e-02	3.45e-01	6.68e-03
GOBP RRNA BASE METHYLATION	10	5.10e-02	1.19e-01	0.7330	-1.74e-02	-4.65e-01	-4.18e-01	8.12e-02	1.37e-01	-3.47e-01	9.24e-01	1.09e-02	2.20e-02	6.57e-01	4.52e-01	5.73e-02
GOBP BASOLATERAL PROTEIN SECRETION	5	6.73e-02	1.47e-01	0.7330	-2.55e-01	-1.36e-01	2.20e-01	5.62e-01	-9.85e-02	2.82e-01	3.23e-01	5.99e-01	3.93e-01	2.95e-02	7.03e-01	2.75e-01
GOMF RETINOIC ACID BINDING	7	8.07e-03	2.90e-02	0.7330	-1.78e-02	1.77e-01	4.22e-01	5.67e-01	7.81e-02	8.07e-03	9.35e-01	4.19e-01	5.30e-02	9.39e-03	7.21e-01	9.71e-01
GOMF PROTEIN ARGININE OMEGA N ASYMMETRIC METHYLTRANSFERASE ACTIVITY	6	4.62e-02	1.11e-01	0.7330	8.82e-02	-3.56e-01	-3.44e-01	4.93e-01	-2.00e-01	3.46e-02	7.08e-01	1.31e-01	1.44e-01	3.65e-02	3.95e-01	8.83e-01
GOBP NEGATIVE REGULATION OF HEART RATE	8	7.80e-03	2.82e-02	0.7330	-1.84e-01	-5.35e-01	3.23e-01	-7.08e-02	-6.08e-02	3.22e-01	3.66e-01	8.80e-03	1.14e-01	7.29e-01	7.66e-01	1.14e-01
GOCC PROTON TRANSPORTING TWO SECTOR ATPASE COMPLEX CATALYTIC DOMAIN	16	9.23e-03	3.22e-02	0.7330	-3.65e-01	-4.82e-01	-3.82e-03	-1.18e-01	-3.04e-01	2.55e-01	1.14e-02	8.40e-04	9.79e-01	4.16e-01	3.55e-02	7.77e-02
GOMF CENTROMERIC DNA BINDING	6	6.83e-02	1.48e-01	0.7320	2.83e-02	-5.19e-01	-1.64e-01	2.99e-01	-4.07e-02	3.85e-01	9.04e-01	2.78e-02	4.87e-01	2.04e-01	8.63e-01	1.02e-01
GOBP HEPARAN SULFATE PROTEOGLYCAN CATABOLIC PROCESS	9	8.90e-02	1.80e-01	0.7320	-3.07e-01	-8.21e-02	-4.23e-01	-3.52e-02	4.57e-02	-5.03e-01	1.11e-01	6.70e-01	2.81e-02	8.55e-01	8.12e-01	8.93e-03
GOBP ATP BIOSYNTHETIC PROCESS	92	4.18e-24	2.44e-22	0.7320	-1.54e-01	-6.51e-01	-2.43e-01	5.73e-02	-1.57e-01	-3.36e-02	1.06e-02	3.20e-27	5.48e-05	3.42e-01	9.09e-03	5.78e-01
GOCC PRE SNORNP COMPLEX	7	1.35e-01	2.43e-01	0.7320	-1.33e-01	-4.77e-01	-4.16e-01	-2.36e-01	1.13e-01	-2.22e-01	5.43e-01	2.89e-02	5.67e-02	2.80e-01	6.04e-01	3.10e-01
GOBP REGULATION OF PANCREATIC JUICE SECRETION	6	1.50e-01	2.61e-01	0.7320	6.60e-02	5.25e-02	1.87e-01	6.34e-01	2.45e-01	1.77e-01	7.79e-01	8.24e-01	4.29e-01	7.13e-03	2.99e-01	4.53e-01
GOBP CONNECTIVE TISSUE REPLACEMENT	10	2.11e-02	6.16e-02	0.7320	-1.20e-01	2.48e-01	4.88e-01	1.77e-01	-2.27e-01	3.72e-01	5.13e-01	1.74e-01	7.51e-03	3.32e-01	2.13e-01	4.18e-02
GOMF CAMP DEPENDENT PROTEIN KINASE INHIBITOR ACTIVITY	7	1.48e-01	2.59e-01	0.7320	-2.95e-01	-4.05e-01	7.98e-02	-2.79e-02	-1.64e-01	5.00e-01	1.76e-01	6.35e-02	7.15e-01	8.98e-01	4.53e-01	2.19e-02
GOBP REGULATION OF TORC2 SIGNALING	6	2.61e-01	3.81e-01	0.7320	1.41e-01	2.02e-01	4.12e-02	5.73e-01	3.73e-01	-7.28e-02	5.51e-01	3.92e-01	8.61e-01	1.50e-02	1.14e-01	7.58e-01
GOBP REGULATION OF PEPTIDYL SERINE DEPHOSPHORYLATION	7	1.98e-01	3.14e-01	0.7310	-2.31e-01	6.41e-02	5.27e-01	-2.12e-01	-2.68e-01	2.89e-01	2.90e-01	7.69e-01	1.58e-02	3.32e-01	2.19e-01	1.86e-01
GOBP RESPONSE TO PHORBOL 13 ACETATE 12 MYRISTATE	6	1.71e-01	2.85e-01	0.7310	-4.61e-02	-3.05e-01	-3.54e-01	1.08e-01	4.06e-01	-3.71e-01	8.45e-01	1.96e-01	1.33e-01	6.46e-01	8.52e-02	1.15e-01
GOBP RETROGRADE TRANS SYNAPTIC SIGNALING	8	2.25e-01	3.44e-01	0.7310	-3.49e-01	-4.76e-01	6.88e-03	-1.59e-01	-4.01e-01	-1.06e-03	8.77e-02	1.97e-02	9.73e-01	4.37e-01	4.94e-02	9.96e-01
GOBP REGULATION OF RESPONSE TO FOOD	9	1.36e-01	2.44e-01	0.7310	-2.40e-01	-3.00e-01	-4.88e-01	-2.46e-01	1.36e-01	-2.65e-01	2.12e-01	1.19e-01	1.13e-02	2.01e-01	4.81e-01	1.69e-01
GOCC DYSTROGLYCAN COMPLEX	5	3.23e-01	4.42e-01	0.7310	-2.96e-01	-3.30e-03	-1.18e-01	-3.73e-01	-2.96e-01	-4.54e-01	2.52e-01	9.90e-01	6.47e-01	1.48e-01	2.52e-01	7.88e-02
GOBP POSITIVE REGULATION OF SODIUM ION TRANSMEMBRANE TRANSPORT	18	4.94e-03	1.94e-02	0.7310	1.94e-01	2.22e-01	5.36e-01	1.77e-01	5.36e-02	3.54e-01	1.54e-01	1.03e-01	8.18e-05	1.94e-01	6.94e-01	9.41e-03
GOBP CONNECTIVE TISSUE REPLACEMENT INVOLVED IN INFLAMMATORY RESPONSE WOUND HEALING	5	3.26e-01	4.44e-01	0.7300	-2.69e-02	8.41e-02	5.55e-01	2.47e-01	-1.46e-01	3.68e-01	9.17e-01	7.45e-01	3.15e-02	3.40e-01	5.72e-01	1.54e-01
GOCC MICROTUBULE BUNDLE	6	4.09e-01	5.20e-01	0.7300	4.30e-01	3.55e-01	1.74e-01	4.25e-01	1.03e-01	1.78e-03	6.80e-02	1.32e-01	4.60e-01	7.11e-02	6.62e-01	9.94e-01
GOBP LNCRNA MEDIATED POST TRANSCRIPTIONAL GENE SILENCING	6	2.79e-01	3.98e-01	0.7300	-1.04e-01	-3.65e-01	2.18e-01	-3.53e-01	-3.34e-01	3.25e-01	6.59e-01	1.22e-01	3.54e-01	1.34e-01	1.56e-01	1.68e-01
GOBP NEGATIVE REGULATION OF MYELINATION	8	6.60e-02	1.45e-01	0.7300	-5.05e-01	-2.80e-01	1.31e-01	-2.70e-01	1.32e-02	3.31e-01	1.33e-02	1.70e-01	5.23e-01	1.87e-01	9.49e-01	1.05e-01
GOBP CORPUS CALLOSUM MORPHOGENESIS	6	2.09e-01	3.26e-01	0.7300	-3.14e-03	4.36e-01	3.15e-01	3.34e-01	1.07e-01	3.48e-01	9.89e-01	6.46e-02	1.82e-01	1.56e-01	6.50e-01	1.40e-01
GOBP INTRACILIARY TRANSPORT INVOLVED IN CILIUM ASSEMBLY	6	9.09e-02	1.83e-01	0.7300	-2.14e-01	3.71e-02	-3.75e-01	-8.94e-02	5.73e-01	9.62e-02	3.64e-01	8.75e-01	1.11e-01	7.05e-01	1.52e-02	6.83e-01
GOMF PROCOLLAGEN PROLINE DIOXYGENASE ACTIVITY	7	2.03e-02	5.99e-02	0.7300	-1.93e-01	-2.64e-01	-1.66e-01	2.69e-01	5.58e-01	-1.19e-01	3.76e-01	2.27e-01	4.48e-01	2.17e-01	1.05e-02	5.84e-01
GOBP RESPONSE TO WATER	11	1.66e-02	5.13e-02	0.7300	-1.29e-01	1.60e-02	5.03e-01	2.29e-01	-8.57e-02	4.51e-01	4.60e-01	9.27e-01	3.88e-03	1.89e-01	6.23e-01	9.55e-03
GOBP REGULATION OF ANAPHASE PROMOTING COMPLEX DEPENDENT CATABOLIC PROCESS	5	3.09e-01	4.29e-01	0.7300	3.56e-01	8.30e-02	3.03e-01	5.53e-01	3.42e-02	-2.10e-03	1.68e-01	7.48e-01	2.40e-01	3.23e-02	8.95e-01	9.94e-01
GOBP CHOLINE TRANSPORT	5	2.27e-01	3.46e-01	0.7290	-2.73e-01	-8.22e-02	3.97e-01	1.92e-01	-3.45e-01	3.70e-01	2.90e-01	7.50e-01	1.24e-01	4.56e-01	1.81e-01	1.52e-01
GOBP PURINE NUCLEOSIDE TRIPHOSPHATE CATABOLIC PROCESS	5	4.24e-01	5.32e-01	0.7290	-3.24e-01	-6.07e-01	-1.35e-01	-1.11e-01	-1.60e-01	4.68e-02	2.09e-01	1.88e-02	6.00e-01	6.67e-01	5.35e-01	8.56e-01
GOBP ACTIVATION OF TRANSMEMBRANE RECEPTOR PROTEIN TYROSINE KINASE ACTIVITY	5	1.91e-01	3.07e-01	0.7290	-1.40e-01	-5.00e-02	-6.67e-01	-8.18e-02	2.03e-01	-1.28e-01	5.87e-01	8.46e-01	9.78e-03	7.51e-01	4.31e-01	6.20e-01
GOBP MIDBRAIN DOPAMINERGIC NEURON DIFFERENTIATION	8	2.60e-02	7.24e-02	0.7290	-6.50e-02	4.82e-01	2.79e-01	2.80e-01	3.72e-01	-2.64e-02	7.50e-01	1.82e-02	1.72e-01	1.71e-01	6.86e-02	8.97e-01
GOBP OSTEOCLAST PROLIFERATION	7	2.83e-02	7.67e-02	0.7290	2.74e-02	3.51e-01	5.43e-01	-3.10e-01	-4.29e-02	-1.22e-01	9.00e-01	1.08e-01	1.29e-02	1.55e-01	8.44e-01	5.75e-01
GOBP ECTODERM DEVELOPMENT	14	1.77e-04	1.13e-03	0.7290	1.65e-01	4.61e-01	4.73e-01	1.83e-03	-1.18e-01	-2.32e-01	2.85e-01	2.80e-03	2.18e-03	9.91e-01	4.43e-01	1.34e-01
GOBP NEGATIVE REGULATION OF VASOCONSTRICTION	8	1.04e-01	2.01e-01	0.7290	-6.07e-02	3.27e-01	3.31e-01	-4.12e-01	-3.15e-01	2.05e-01	7.66e-01	1.10e-01	1.04e-01	4.35e-02	1.23e-01	3.14e-01
GOMF DNA N GLYCOSYLASE ACTIVITY	13	3.85e-03	1.58e-02	0.7290	1.92e-01	-4.67e-01	-4.01e-01	2.51e-01	1.11e-01	-2.01e-01	2.29e-01	3.58e-03	1.23e-02	1.17e-01	4.90e-01	2.10e-01
GOMF TRANSMEMBRANE EPHRIN RECEPTOR ACTIVITY	9	1.57e-01	2.69e-01	0.7290	1.35e-01	2.51e-01	-2.76e-01	3.90e-01	4.58e-01	-1.10e-01	4.83e-01	1.93e-01	1.52e-01	4.25e-02	1.74e-02	5.68e-01
GOBP CARBON DIOXIDE TRANSPORT	8	2.18e-01	3.36e-01	0.7280	2.63e-01	9.81e-02	5.09e-01	2.01e-01	-1.33e-01	3.66e-01	1.97e-01	6.31e-01	1.26e-02	3.25e-01	5.15e-01	7.28e-02
GOMF EPHRIN RECEPTOR ACTIVITY	12	6.90e-02	1.49e-01	0.7280	2.11e-01	2.73e-01	-5.96e-02	3.84e-01	4.98e-01	1.11e-01	2.06e-01	1.02e-01	7.21e-01	2.12e-02	2.84e-03	5.05e-01
GOBP RESPONSE TO LIPOTEICHOIC ACID	8	4.13e-03	1.68e-02	0.7280	-5.44e-01	2.97e-01	3.43e-01	-1.18e-01	-8.79e-02	7.65e-02	7.66e-03	1.46e-01	9.26e-02	5.64e-01	6.67e-01	7.08e-01
GOMF VASOPRESSIN RECEPTOR ACTIVITY	5	7.90e-02	1.65e-01	0.7280	9.56e-02	-3.93e-01	4.22e-01	1.25e-01	-4.06e-01	-8.69e-02	7.11e-01	1.28e-01	1.02e-01	6.28e-01	1.16e-01	7.37e-01
GOBP OSMOSENSORY SIGNALING PATHWAY	8	1.20e-02	3.98e-02	0.7280	-3.05e-01	3.91e-01	4.63e-01	9.67e-02	1.05e-01	2.20e-01	1.35e-01	5.53e-02	2.33e-02	6.36e-01	6.06e-01	2.81e-01
GOBP POSITIVE REGULATION OF HETEROTYPIC CELL CELL ADHESION	10	2.13e-02	6.23e-02	0.7280	3.30e-01	4.01e-01	3.14e-01	-5.20e-02	3.97e-01	-1.50e-02	7.06e-02	2.80e-02	8.54e-02	7.76e-01	2.96e-02	9.34e-01
GOBP MATURATION OF 5 8S RRNA FROM TRICISTRONIC RRNA TRANSCRIPT SSU RRNA 5 8S RRNA LSU RRNA	24	4.40e-05	3.25e-04	0.7280	6.09e-02	-4.66e-01	-4.28e-01	1.86e-01	5.33e-02	-2.97e-01	6.05e-01	7.84e-05	2.83e-04	1.14e-01	6.51e-01	1.19e-02
GOBP DENDRITIC TRANSPORT	11	9.33e-02	1.87e-01	0.7270	-2.68e-03	2.30e-01	5.02e-01	-7.04e-02	-1.19e-01	4.53e-01	9.88e-01	1.86e-01	3.96e-03	6.86e-01	4.95e-01	9.31e-03
GOBP NEGATIVE REGULATION OF CARDIAC MUSCLE CONTRACTION	5	4.32e-01	5.41e-01	0.7270	2.39e-02	-3.40e-02	5.56e-01	7.68e-02	-1.57e-01	4.33e-01	9.26e-01	8.95e-01	3.14e-02	7.66e-01	5.43e-01	9.34e-02
GOCC MYELIN SHEATH ABAXONAL REGION	6	3.14e-01	4.34e-01	0.7270	-4.44e-01	-4.21e-01	-1.54e-01	-3.79e-02	-2.82e-01	2.23e-01	5.96e-02	7.41e-02	5.13e-01	8.72e-01	2.32e-01	3.45e-01
GOBP POSITIVE REGULATION OF EARLY ENDOSOME TO LATE ENDOSOME TRANSPORT	9	3.10e-02	8.18e-02	0.7270	-3.71e-02	3.57e-02	4.35e-01	2.76e-01	-3.63e-01	3.58e-01	8.47e-01	8.53e-01	2.37e-02	1.52e-01	5.93e-02	6.27e-02
GOCC PERICHROMATIN FIBRILS	6	3.61e-01	4.76e-01	0.7270	-3.19e-01	-6.96e-02	-3.91e-01	-2.48e-01	8.20e-02	-4.48e-01	1.76e-01	7.68e-01	9.71e-02	2.93e-01	7.28e-01	5.75e-02
GOBP NEGATIVE REGULATION OF MONOOXYGENASE ACTIVITY	7	3.22e-01	4.41e-01	0.7270	2.58e-01	2.28e-01	4.42e-01	2.12e-01	1.94e-01	3.62e-01	2.36e-01	2.97e-01	4.27e-02	3.30e-01	3.75e-01	9.68e-02
GOBP ECTODERMAL PLACODE DEVELOPMENT	6	6.39e-02	1.42e-01	0.7270	-4.09e-01	-9.74e-02	2.03e-01	3.45e-02	3.21e-01	4.54e-01	8.28e-02	6.80e-01	3.89e-01	8.84e-01	1.74e-01	5.42e-02
GOBP STRESS GRANULE DISASSEMBLY	7	9.82e-02	1.93e-01	0.7270	-2.89e-01	-1.17e-01	3.54e-01	1.87e-01	4.96e-04	5.20e-01	1.85e-01	5.91e-01	1.05e-01	3.91e-01	9.98e-01	1.72e-02
GOBP MITOCHONDRIAL RNA 3 END PROCESSING	7	3.42e-01	4.59e-01	0.7260	-2.92e-01	-5.18e-01	-3.38e-01	-8.27e-02	-2.12e-01	-9.19e-02	1.81e-01	1.77e-02	1.22e-01	7.05e-01	3.31e-01	6.74e-01
GOBP SNORNA LOCALIZATION	6	1.17e-01	2.19e-01	0.7260	-4.31e-02	-4.29e-01	-4.50e-01	-5.69e-02	3.48e-01	-1.23e-01	8.55e-01	6.89e-02	5.64e-02	8.09e-01	1.40e-01	6.03e-01
GOMF ALDEHYDE DEHYDROGENASE NAD P PLUS ACTIVITY	12	1.02e-01	1.98e-01	0.7260	-4.89e-01	-3.56e-01	-1.40e-01	-2.59e-01	-2.69e-01	4.92e-02	3.37e-03	3.28e-02	4.01e-01	1.20e-01	1.07e-01	7.68e-01
GOBP ARF PROTEIN SIGNAL TRANSDUCTION	20	1.01e-05	8.45e-05	0.7260	1.45e-01	3.63e-01	2.94e-01	4.80e-01	2.13e-01	-1.12e-01	2.61e-01	4.97e-03	2.30e-02	2.05e-04	9.93e-02	3.84e-01
GOCC WASH COMPLEX	14	9.21e-03	3.21e-02	0.7260	-4.47e-01	-2.69e-01	1.56e-01	-5.75e-02	-2.09e-01	4.28e-01	3.78e-03	8.08e-02	3.12e-01	7.09e-01	1.76e-01	5.57e-03
GOBP RESPONSE TO INTERLEUKIN 17	15	1.11e-02	3.74e-02	0.7260	2.10e-01	4.75e-01	3.29e-01	7.89e-02	3.61e-01	1.11e-01	1.59e-01	1.45e-03	2.73e-02	5.97e-01	1.55e-02	4.56e-01
GOBP NEGATIVE REGULATION OF NUCLEAR TRANSCRIBED MRNA CATABOLIC PROCESS DEADENYLATION DEPENDENT DECAY	11	6.50e-02	1.43e-01	0.7260	-5.45e-01	-2.76e-01	-1.33e-01	-2.44e-01	-1.67e-01	2.19e-01	1.74e-03	1.13e-01	4.45e-01	1.61e-01	3.38e-01	2.09e-01
GOBP REGULATION OF TOLERANCE INDUCTION	18	6.01e-04	3.28e-03	0.7250	-3.46e-02	-1.18e-01	2.84e-01	1.25e-02	-4.74e-01	4.53e-01	7.99e-01	3.88e-01	3.67e-02	9.27e-01	5.00e-04	8.68e-04
GOCC RNA POLYMERASE II CORE COMPLEX	15	4.40e-03	1.76e-02	0.7250	-1.62e-01	-5.28e-01	-3.89e-01	2.29e-01	-5.31e-02	-1.23e-01	2.77e-01	4.03e-04	9.11e-03	1.25e-01	7.22e-01	4.11e-01
GOBP POSITIVE REGULATION OF ENDOPLASMIC RETICULUM UNFOLDED PROTEIN RESPONSE	12	4.90e-04	2.76e-03	0.7250	-2.65e-01	-2.50e-02	3.34e-01	1.44e-01	-5.41e-01	1.72e-01	1.12e-01	8.81e-01	4.49e-02	3.88e-01	1.17e-03	3.02e-01
GOBP PROTEIN IMPORT INTO MITOCHONDRIAL MATRIX	19	2.61e-03	1.15e-02	0.7250	-1.56e-01	-5.29e-01	-4.09e-01	-5.60e-02	-1.45e-01	-1.74e-01	2.41e-01	6.58e-05	2.02e-03	6.73e-01	2.75e-01	1.88e-01
GOMF BENZODIAZEPINE RECEPTOR BINDING	5	1.43e-01	2.53e-01	0.7250	-4.99e-02	-1.17e-01	3.78e-01	4.54e-01	2.12e-01	3.41e-01	8.47e-01	6.52e-01	1.44e-01	7.90e-02	4.11e-01	1.87e-01
GOCC PRERIBOSOME	105	4.55e-25	2.91e-23	0.7250	-9.07e-02	-5.80e-01	-3.76e-01	5.40e-02	-1.33e-01	-1.40e-01	1.08e-01	9.24e-25	2.83e-11	3.39e-01	1.83e-02	1.35e-02
GOBP PEPTIDYL LYSINE HYDROXYLATION	8	5.80e-03	2.22e-02	0.7250	-4.24e-01	-4.12e-01	1.25e-01	3.03e-01	-2.61e-01	2.20e-02	3.77e-02	4.37e-02	5.42e-01	1.38e-01	2.01e-01	9.14e-01
GOBP DIAPHRAGM DEVELOPMENT	5	2.29e-01	3.47e-01	0.7250	3.52e-01	3.55e-01	1.23e-01	-5.34e-02	4.44e-02	-5.05e-01	1.72e-01	1.69e-01	6.34e-01	8.36e-01	8.63e-01	5.05e-02
GOBP L HISTIDINE TRANSMEMBRANE TRANSPORT	5	2.64e-02	7.30e-02	0.7250	-1.52e-01	-1.88e-01	1.39e-02	6.10e-01	-8.69e-02	-2.94e-01	5.57e-01	4.68e-01	9.57e-01	1.81e-02	7.37e-01	2.54e-01
GOBP NEGATIVE REGULATION OF AMYLOID FIBRIL FORMATION	9	3.35e-03	1.42e-02	0.7240	-2.88e-02	-6.09e-01	1.21e-01	9.67e-02	2.33e-02	3.58e-01	8.81e-01	1.55e-03	5.28e-01	6.16e-01	9.04e-01	6.30e-02
GOCC THO COMPLEX	6	2.21e-01	3.39e-01	0.7240	-2.24e-01	-6.21e-01	-2.67e-01	7.66e-02	-4.10e-02	9.56e-02	3.43e-01	8.40e-03	2.57e-01	7.45e-01	8.62e-01	6.85e-01
GOBP REGULATION OF BRANCHING INVOLVED IN SALIVARY GLAND MORPHOGENESIS	7	1.47e-01	2.57e-01	0.7240	2.97e-02	1.11e-01	2.51e-01	-5.45e-01	-3.85e-01	-4.14e-02	8.92e-01	6.12e-01	2.51e-01	1.25e-02	7.77e-02	8.50e-01
GOBP REGULATION OF SREBP SIGNALING PATHWAY	7	5.23e-02	1.21e-01	0.7230	-4.09e-01	6.97e-02	4.53e-01	3.37e-02	2.75e-03	3.80e-01	6.12e-02	7.49e-01	3.77e-02	8.77e-01	9.90e-01	8.19e-02
GOBP NEGATIVE REGULATION OF PROTEIN LOCALIZATION TO CELL SURFACE	10	1.73e-01	2.87e-01	0.7230	-4.68e-01	-2.40e-01	-1.83e-01	-4.12e-01	-2.07e-01	6.16e-03	1.04e-02	1.89e-01	3.15e-01	2.41e-02	2.58e-01	9.73e-01
GOMF IGG BINDING	8	1.09e-01	2.08e-01	0.7230	2.57e-01	4.13e-01	3.60e-01	7.54e-02	3.88e-01	2.76e-02	2.09e-01	4.33e-02	7.81e-02	7.12e-01	5.74e-02	8.92e-01
GOCC ENDOLYSOSOME LUMEN	5	7.18e-02	1.54e-01	0.7230	-4.31e-01	-7.18e-02	1.16e-01	1.41e-01	4.71e-01	2.78e-01	9.54e-02	7.81e-01	6.54e-01	5.85e-01	6.83e-02	2.82e-01
GOBP POSITIVE REGULATION OF LONG TERM NEURONAL SYNAPTIC PLASTICITY	8	8.54e-02	1.75e-01	0.7220	-5.68e-01	-1.92e-01	-5.20e-02	-2.40e-01	6.38e-02	3.13e-01	5.37e-03	3.46e-01	7.99e-01	2.40e-01	7.55e-01	1.26e-01
GOBP PYRUVATE TRANSPORT	6	1.45e-01	2.54e-01	0.7220	-3.80e-01	-3.97e-01	-2.06e-01	1.22e-01	2.49e-02	4.02e-01	1.07e-01	9.21e-02	3.82e-01	6.05e-01	9.16e-01	8.79e-02
GOBP CELL ADHESION INVOLVED IN HEART MORPHOGENESIS	7	1.83e-01	2.98e-01	0.7220	-1.16e-01	1.31e-01	5.75e-01	3.97e-02	-1.69e-01	3.62e-01	5.95e-01	5.50e-01	8.47e-03	8.56e-01	4.40e-01	9.74e-02
GOBP RESPONSE TO YEAST	7	9.42e-02	1.88e-01	0.7220	-3.23e-01	2.46e-01	4.44e-01	-2.44e-01	-2.90e-01	1.25e-01	1.39e-01	2.59e-01	4.19e-02	2.64e-01	1.83e-01	5.66e-01
GOBP ISOTYPE SWITCHING TO IGA ISOTYPES	7	2.17e-01	3.35e-01	0.7220	-2.39e-01	-4.48e-01	-4.42e-01	4.35e-02	-2.27e-01	-1.22e-01	2.73e-01	4.03e-02	4.29e-02	8.42e-01	2.99e-01	5.77e-01
GOBP INTERKINETIC NUCLEAR MIGRATION	5	2.16e-01	3.33e-01	0.7220	-2.40e-01	3.91e-01	1.96e-01	-3.46e-01	-1.91e-01	3.41e-01	3.53e-01	1.30e-01	4.49e-01	1.81e-01	4.59e-01	1.87e-01
GOBP REGULATION OF WNT PROTEIN SECRETION	5	1.94e-01	3.11e-01	0.7220	-2.95e-01	4.47e-01	3.82e-01	-2.72e-01	3.35e-02	1.14e-01	2.53e-01	8.33e-02	1.40e-01	2.92e-01	8.97e-01	6.59e-01
GOCC CATALYTIC STEP 1 SPLICEOSOME	12	1.77e-03	8.28e-03	0.7210	-9.00e-02	-2.04e-01	-2.86e-01	6.13e-01	1.07e-01	-4.98e-02	5.89e-01	2.22e-01	8.66e-02	2.37e-04	5.21e-01	7.65e-01
GOBP MITOCHONDRIAL RNA PROCESSING	22	2.36e-03	1.06e-02	0.7210	-2.64e-01	-4.91e-01	-3.16e-01	-1.06e-01	-1.95e-01	-2.46e-01	3.23e-02	6.59e-05	1.03e-02	3.89e-01	1.14e-01	4.58e-02
GOBP REGULATION OF SMOOTH MUSCLE CELL CHEMOTAXIS	5	5.92e-01	6.75e-01	0.7210	2.86e-01	2.03e-01	7.34e-02	4.70e-01	3.68e-01	1.87e-01	2.68e-01	4.32e-01	7.76e-01	6.85e-02	1.54e-01	4.69e-01
GOBP MESENCHYMAL STEM CELL DIFFERENTIATION	10	1.78e-01	2.93e-01	0.7210	2.30e-01	2.79e-01	4.51e-01	1.38e-01	1.03e-02	4.07e-01	2.07e-01	1.26e-01	1.35e-02	4.51e-01	9.55e-01	2.57e-02
GOBP REGULATION OF COMPLEMENT ACTIVATION CLASSICAL PATHWAY	7	1.26e-01	2.31e-01	0.7200	-5.62e-02	2.26e-01	3.56e-01	-1.19e-01	2.59e-01	5.07e-01	7.97e-01	3.00e-01	1.03e-01	5.87e-01	2.36e-01	2.02e-02
GOBP NEGATIVE REGULATION OF SCHWANN CELL PROLIFERATION	7	1.69e-01	2.83e-01	0.7200	2.40e-01	1.64e-01	3.60e-01	4.30e-01	-1.59e-01	3.07e-01	2.71e-01	4.52e-01	9.89e-02	4.91e-02	4.67e-01	1.59e-01
GOBP OXIDATIVE PHOSPHORYLATION	138	1.41e-34	1.81e-32	0.7200	-1.62e-01	-6.34e-01	-2.00e-01	1.09e-02	-2.22e-01	2.19e-02	1.05e-03	5.46e-38	5.04e-05	8.25e-01	6.92e-06	6.57e-01
GOBP MAINTENANCE OF APICAL BASAL CELL POLARITY	9	1.48e-01	2.59e-01	0.7200	-6.28e-02	-3.36e-01	2.14e-01	-2.73e-01	-4.89e-01	2.04e-01	7.44e-01	8.07e-02	2.65e-01	1.56e-01	1.11e-02	2.89e-01
GOBP POSITIVE REGULATION OF AMYLOID FIBRIL FORMATION	5	4.98e-01	5.96e-01	0.7200	-2.02e-01	-3.99e-01	1.98e-01	-8.67e-02	-4.77e-01	2.09e-01	4.34e-01	1.22e-01	4.44e-01	7.37e-01	6.49e-02	4.18e-01
GOBP L CYSTINE TRANSPORT	5	2.76e-01	3.96e-01	0.7190	3.06e-01	-2.60e-01	-1.26e-01	4.86e-01	2.90e-01	1.39e-01	2.36e-01	3.14e-01	6.25e-01	6.01e-02	2.62e-01	5.91e-01
GOBP NEGATIVE REGULATION OF NEUROINFLAMMATORY RESPONSE	10	6.18e-02	1.38e-01	0.7180	2.65e-02	3.53e-01	3.66e-01	2.15e-01	3.47e-01	3.00e-01	8.85e-01	5.32e-02	4.49e-02	2.39e-01	5.73e-02	1.01e-01
GOMF 3 5 DNA EXONUCLEASE ACTIVITY	15	1.06e-02	3.59e-02	0.7180	9.28e-02	-1.99e-01	-3.66e-01	3.26e-01	1.98e-01	-4.33e-01	5.34e-01	1.81e-01	1.40e-02	2.87e-02	1.84e-01	3.66e-03
GOBP NEGATIVE REGULATION OF PLATELET AGGREGATION	9	8.70e-02	1.77e-01	0.7180	-2.88e-02	-2.18e-01	4.50e-01	-3.67e-02	-4.64e-01	2.18e-01	8.81e-01	2.57e-01	1.93e-02	8.49e-01	1.59e-02	2.57e-01
GOBP T HELPER 17 CELL LINEAGE COMMITMENT	16	2.49e-03	1.11e-02	0.7180	3.33e-01	4.00e-01	1.78e-01	4.28e-01	2.19e-02	1.69e-01	2.10e-02	5.59e-03	2.18e-01	3.03e-03	8.79e-01	2.41e-01
GOBP REGULATION OF PROTEIN MONOUBIQUITINATION	6	1.51e-01	2.61e-01	0.7170	2.56e-02	-4.23e-02	-1.36e-01	4.39e-01	3.63e-01	4.11e-01	9.14e-01	8.58e-01	5.63e-01	6.28e-02	1.23e-01	8.13e-02
GOMF OXIDOREDUCTASE ACTIVITY ACTING ON OTHER NITROGENOUS COMPOUNDS AS DONORS	10	1.35e-01	2.43e-01	0.7170	-4.06e-01	-3.75e-01	8.87e-02	-2.24e-01	-3.86e-01	3.87e-02	2.62e-02	4.01e-02	6.27e-01	2.20e-01	3.44e-02	8.32e-01
GOMF FLIPPASE ACTIVITY	14	1.08e-02	3.67e-02	0.7170	1.97e-01	5.19e-01	1.96e-01	3.00e-01	1.50e-01	2.34e-01	2.01e-01	7.71e-04	2.05e-01	5.20e-02	3.31e-01	1.30e-01
GOCC PRESPLICEOSOME	17	5.06e-03	1.98e-02	0.7170	2.89e-02	-2.95e-01	-5.14e-01	2.16e-01	6.88e-02	-3.32e-01	8.36e-01	3.53e-02	2.44e-04	1.23e-01	6.23e-01	1.77e-02
GOBP ACTIN FILAMENT BASED TRANSPORT	10	1.02e-01	1.98e-01	0.7160	2.71e-01	3.32e-01	3.65e-01	3.07e-01	-6.96e-02	3.11e-01	1.37e-01	6.90e-02	4.55e-02	9.29e-02	7.03e-01	8.83e-02
GOMF VASCULAR ENDOTHELIAL GROWTH FACTOR RECEPTOR ACTIVITY	6	2.80e-01	4.00e-01	0.7160	-2.22e-01	-5.07e-01	9.24e-02	-3.39e-01	-2.73e-01	9.41e-02	3.47e-01	3.16e-02	6.95e-01	1.50e-01	2.47e-01	6.90e-01
GOBP RRNA METHYLATION	24	2.51e-05	1.95e-04	0.7160	-3.44e-03	-4.95e-01	-4.76e-01	3.12e-03	7.09e-02	-1.89e-01	9.77e-01	2.68e-05	5.41e-05	9.79e-01	5.47e-01	1.10e-01
GOBP RRNA MODIFICATION	33	6.79e-07	7.36e-06	0.7160	-7.96e-03	-4.85e-01	-4.65e-01	6.21e-02	4.81e-02	-2.33e-01	9.37e-01	1.43e-06	3.68e-06	5.37e-01	6.32e-01	2.06e-02
GOBP COLLAGEN ACTIVATED SIGNALING PATHWAY	12	9.68e-03	3.34e-02	0.7150	-1.33e-01	1.58e-01	1.24e-01	-4.59e-01	-4.92e-01	-1.04e-02	4.24e-01	3.42e-01	4.57e-01	5.86e-03	3.14e-03	9.50e-01
GOCC PROTON TRANSPORTING V TYPE ATPASE V1 DOMAIN	10	1.10e-01	2.09e-01	0.7150	-3.01e-01	-2.66e-01	2.52e-01	-1.16e-01	-2.78e-01	4.43e-01	9.98e-02	1.45e-01	1.68e-01	5.26e-01	1.28e-01	1.52e-02
GOBP ADRENAL GLAND DEVELOPMENT	17	9.76e-03	3.36e-02	0.7150	-7.14e-02	-4.50e-02	4.65e-01	-7.61e-02	-3.85e-01	3.67e-01	6.10e-01	7.48e-01	9.02e-04	5.87e-01	6.05e-03	8.76e-03
GOMF ODORANT BINDING	10	3.41e-02	8.81e-02	0.7150	9.71e-02	1.78e-01	2.84e-01	-4.97e-01	-3.77e-01	2.08e-02	5.95e-01	3.30e-01	1.20e-01	6.51e-03	3.88e-02	9.09e-01
GOMF DEOXYNUCLEOSIDE KINASE ACTIVITY	5	3.93e-01	5.06e-01	0.7150	-3.51e-01	-4.54e-01	-5.29e-02	6.23e-02	-2.86e-01	3.07e-01	1.75e-01	7.90e-02	8.38e-01	8.09e-01	2.67e-01	2.35e-01
GOCC CELL POLE	8	8.69e-02	1.77e-01	0.7150	-4.80e-01	-1.55e-01	2.12e-01	-3.70e-01	-2.67e-01	-6.02e-02	1.86e-02	4.47e-01	3.00e-01	6.98e-02	1.92e-01	7.68e-01
GOBP REGULATION OF MITOCHONDRIAL GENE EXPRESSION	33	5.91e-07	6.46e-06	0.7150	-6.69e-02	-5.08e-01	-4.33e-01	1.76e-01	-4.23e-02	-1.68e-01	5.06e-01	4.28e-07	1.67e-05	7.98e-02	6.74e-01	9.51e-02
GOCC NEUROFILAMENT	5	5.36e-02	1.24e-01	0.7150	8.32e-02	1.65e-02	-2.40e-01	-9.13e-02	5.67e-01	3.41e-01	7.47e-01	9.49e-01	3.53e-01	7.24e-01	2.81e-02	1.86e-01
GOBP INSEMINATION	8	2.14e-01	3.32e-01	0.7150	-2.27e-01	-3.75e-01	1.98e-01	-3.68e-01	-3.61e-01	1.20e-01	2.66e-01	6.65e-02	3.32e-01	7.16e-02	7.71e-02	5.58e-01
GOBP ENDONUCLEOLYTIC CLEAVAGE OF TRICISTRONIC RRNA TRANSCRIPT SSU RRNA 5 8S RRNA LSU RRNA	16	1.53e-03	7.31e-03	0.7150	1.64e-01	-3.97e-01	-3.34e-01	2.16e-01	-1.37e-01	-3.85e-01	2.55e-01	5.91e-03	2.06e-02	1.34e-01	3.43e-01	7.63e-03
GOBP SNO S RNA PROCESSING	12	2.30e-02	6.59e-02	0.7150	-1.59e-01	-4.10e-01	-5.29e-01	1.26e-01	1.27e-01	-6.97e-02	3.42e-01	1.39e-02	1.49e-03	4.50e-01	4.45e-01	6.76e-01
GOBP ELASTIN METABOLIC PROCESS	6	1.23e-01	2.27e-01	0.7140	-9.73e-02	2.91e-01	2.76e-01	2.54e-01	4.93e-01	1.79e-01	6.80e-01	2.17e-01	2.41e-01	2.82e-01	3.65e-02	4.47e-01
GOBP KERATINOCYTE MIGRATION	14	5.14e-03	2.01e-02	0.7140	1.66e-01	5.54e-01	4.08e-01	8.10e-02	-4.38e-02	2.00e-02	2.82e-01	3.28e-04	8.29e-03	6.00e-01	7.77e-01	8.97e-01
GOBP NEUROTRANSMITTER GATED ION CHANNEL CLUSTERING	10	2.34e-02	6.69e-02	0.7140	1.16e-01	1.50e-01	5.08e-01	2.26e-01	2.65e-01	3.07e-01	5.27e-01	4.12e-01	5.41e-03	2.15e-01	1.47e-01	9.24e-02
GOBP VENTRICULAR TRABECULA MYOCARDIUM MORPHOGENESIS	10	9.22e-02	1.85e-01	0.7140	4.53e-02	4.82e-01	3.12e-01	1.76e-01	2.48e-01	2.93e-01	8.04e-01	8.34e-03	8.79e-02	3.35e-01	1.75e-01	1.09e-01
GOBP T HELPER 1 CELL CYTOKINE PRODUCTION	8	2.78e-02	7.58e-02	0.7140	5.44e-02	2.43e-01	2.57e-01	-2.20e-01	-5.51e-01	-1.70e-01	7.90e-01	2.34e-01	2.09e-01	2.82e-01	6.92e-03	4.05e-01
GOBP WOUND HEALING INVOLVED IN INFLAMMATORY RESPONSE	7	3.45e-02	8.89e-02	0.7140	-1.29e-01	2.44e-01	5.48e-01	2.79e-01	-1.27e-01	1.96e-01	5.54e-01	2.63e-01	1.20e-02	2.02e-01	5.60e-01	3.69e-01
GOCC ASTROCYTE END FOOT	6	2.31e-01	3.49e-01	0.7130	1.35e-01	3.90e-01	3.44e-01	-7.99e-02	-2.33e-01	3.99e-01	5.67e-01	9.82e-02	1.44e-01	7.35e-01	3.22e-01	9.08e-02
GOCC MEIOTIC SPINDLE	9	3.11e-02	8.22e-02	0.7130	2.04e-01	-2.85e-01	1.79e-01	4.68e-01	-6.28e-02	3.61e-01	2.89e-01	1.39e-01	3.53e-01	1.50e-02	7.44e-01	6.06e-02
GOBP REGULATION OF NEUROTRANSMITTER RECEPTOR LOCALIZATION TO POSTSYNAPTIC SPECIALIZATION MEMBRANE	9	1.83e-01	2.97e-01	0.7130	-3.47e-01	-2.56e-01	-3.26e-01	-1.92e-01	-2.93e-01	-3.06e-01	7.16e-02	1.83e-01	9.03e-02	3.18e-01	1.29e-01	1.12e-01
GOBP MAINTENANCE OF DNA REPEAT ELEMENTS	7	1.41e-01	2.50e-01	0.7130	8.20e-02	-1.40e-01	4.11e-01	1.62e-02	-6.34e-03	5.59e-01	7.07e-01	5.22e-01	5.95e-02	9.41e-01	9.77e-01	1.04e-02
GOBP DNA INTEGRATION	7	4.02e-02	9.99e-02	0.7130	-3.77e-02	-5.52e-01	-2.81e-01	1.61e-01	3.10e-01	3.03e-02	8.63e-01	1.14e-02	1.98e-01	4.61e-01	1.56e-01	8.90e-01
GOBP ANTIGEN PROCESSING AND PRESENTATION VIA MHC CLASS IB	19	3.45e-03	1.45e-02	0.7120	-2.49e-01	-3.35e-01	-4.33e-01	-2.42e-02	-2.14e-01	-3.15e-01	5.99e-02	1.14e-02	1.08e-03	8.55e-01	1.06e-01	1.75e-02
GOBP REGULATION OF ENDOSOME SIZE	13	2.31e-02	6.62e-02	0.7120	-3.33e-01	-4.73e-01	-3.08e-02	-1.52e-01	-2.00e-01	3.30e-01	3.79e-02	3.16e-03	8.48e-01	3.43e-01	2.11e-01	3.93e-02
GOBP MORPHOGENESIS OF AN EPITHELIAL BUD	6	4.49e-01	5.56e-01	0.7120	2.37e-01	5.32e-01	2.34e-01	9.01e-02	2.82e-01	1.61e-01	3.15e-01	2.41e-02	3.21e-01	7.02e-01	2.32e-01	4.95e-01
GOBP SKELETAL MUSCLE SATELLITE CELL ACTIVATION	6	2.76e-01	3.95e-01	0.7120	1.81e-01	4.65e-01	1.08e-01	-1.30e-02	4.94e-01	-4.28e-02	4.42e-01	4.87e-02	6.46e-01	9.56e-01	3.59e-02	8.56e-01
GOMF ENOYL COA HYDRATASE ACTIVITY	12	5.87e-02	1.33e-01	0.7120	-3.79e-01	-3.97e-01	-2.47e-01	-2.85e-01	-2.00e-01	1.51e-01	2.29e-02	1.71e-02	1.39e-01	8.72e-02	2.30e-01	3.64e-01
GOMF NEUREXIN FAMILY PROTEIN BINDING	9	2.24e-01	3.43e-01	0.7110	3.59e-01	4.58e-01	3.36e-01	1.31e-01	5.31e-02	1.88e-01	6.24e-02	1.74e-02	8.10e-02	4.97e-01	7.83e-01	3.29e-01
GOBP HEPARAN SULFATE PROTEOGLYCAN BIOSYNTHETIC PROCESS POLYSACCHARIDE CHAIN BIOSYNTHETIC PROCESS	6	2.72e-02	7.45e-02	0.7110	-3.52e-01	2.27e-01	2.09e-01	1.79e-01	-3.27e-01	3.85e-01	1.35e-01	3.36e-01	3.75e-01	4.48e-01	1.65e-01	1.03e-01
GOBP FARNESYL DIPHOSPHATE METABOLIC PROCESS	5	2.15e-01	3.33e-01	0.7110	-9.41e-02	-5.25e-01	3.49e-02	2.25e-01	-4.23e-02	4.09e-01	7.16e-01	4.19e-02	8.93e-01	3.83e-01	8.70e-01	1.13e-01
GOBP NEGATIVE REGULATION OF GLIAL CELL APOPTOTIC PROCESS	8	2.38e-01	3.56e-01	0.7110	2.83e-01	2.69e-01	1.97e-01	3.82e-01	1.78e-01	3.71e-01	1.66e-01	1.88e-01	3.35e-01	6.15e-02	3.83e-01	6.92e-02
GOMF HISTONE H4K5 ACETYLTRANSFERASE ACTIVITY	11	2.23e-04	1.38e-03	0.7110	-1.47e-01	7.57e-04	-4.20e-01	3.09e-01	-2.41e-01	-3.92e-01	3.99e-01	9.97e-01	1.59e-02	7.60e-02	1.66e-01	2.42e-02
GOBP MEIOTIC SPINDLE ASSEMBLY	11	7.66e-03	2.78e-02	0.7110	4.01e-02	-3.17e-01	1.23e-01	4.31e-01	-1.03e-01	4.38e-01	8.18e-01	6.90e-02	4.81e-01	1.33e-02	5.53e-01	1.19e-02
GOMF STAT FAMILY PROTEIN BINDING	10	6.01e-02	1.35e-01	0.7110	1.16e-01	7.01e-02	5.54e-01	2.47e-01	-7.33e-02	3.37e-01	5.27e-01	7.01e-01	2.42e-03	1.76e-01	6.88e-01	6.48e-02
GOBP NEGATIVE REGULATION OF T CELL CYTOKINE PRODUCTION	9	6.12e-03	2.31e-02	0.7100	4.30e-01	1.43e-01	5.73e-02	1.16e-01	-4.38e-01	-3.00e-01	2.54e-02	4.57e-01	7.66e-01	5.48e-01	2.28e-02	1.19e-01
GOCC H3 HISTONE ACETYLTRANSFERASE COMPLEX	8	8.13e-04	4.27e-03	0.7100	7.11e-02	2.59e-01	-2.06e-01	4.95e-01	-2.12e-01	-3.17e-01	7.28e-01	2.05e-01	3.13e-01	1.54e-02	3.00e-01	1.20e-01
GOMF PHOSPHATIDYLINOSITOL 3 KINASE INHIBITOR ACTIVITY	6	1.63e-01	2.76e-01	0.7100	-4.45e-01	-2.71e-01	-3.04e-01	1.46e-01	-5.02e-02	-3.41e-01	5.88e-02	2.50e-01	1.97e-01	5.35e-01	8.31e-01	1.48e-01
GOBP INTRINSIC APOPTOTIC SIGNALING PATHWAY IN RESPONSE TO HYDROGEN PEROXIDE	7	1.80e-01	2.95e-01	0.7100	-2.16e-01	-5.84e-01	-2.94e-01	1.46e-01	-8.12e-02	5.47e-02	3.23e-01	7.49e-03	1.79e-01	5.04e-01	7.10e-01	8.02e-01
GOBP REGULATION OF CELLULAR RESPONSE TO MACROPHAGE COLONY STIMULATING FACTOR STIMULUS	5	3.19e-01	4.38e-01	0.7100	-2.88e-01	1.43e-01	3.91e-01	-7.46e-02	-4.02e-01	2.84e-01	2.65e-01	5.80e-01	1.30e-01	7.73e-01	1.19e-01	2.72e-01
GOBP GTP BIOSYNTHETIC PROCESS	9	4.29e-02	1.05e-01	0.7100	-2.03e-01	-5.88e-01	-2.99e-01	7.50e-03	1.27e-01	-1.03e-01	2.91e-01	2.25e-03	1.20e-01	9.69e-01	5.10e-01	5.94e-01
GOBP HOST MEDIATED REGULATION OF INTESTINAL MICROBIOTA COMPOSITION	6	3.07e-01	4.27e-01	0.7100	2.24e-01	2.80e-01	-1.60e-01	-3.44e-03	3.77e-01	-4.55e-01	3.42e-01	2.34e-01	4.98e-01	9.88e-01	1.10e-01	5.37e-02
GOBP MAMMARY GLAND INVOLUTION	5	9.87e-02	1.94e-01	0.7100	2.00e-01	1.42e-01	4.01e-01	5.00e-01	6.05e-02	-1.72e-01	4.39e-01	5.83e-01	1.21e-01	5.31e-02	8.15e-01	5.06e-01
GOBP L ARGININE TRANSMEMBRANE TRANSPORT	10	3.43e-02	8.87e-02	0.7090	-4.49e-01	-3.08e-01	-3.57e-01	1.40e-01	-1.03e-01	-2.20e-01	1.38e-02	9.15e-02	5.03e-02	4.43e-01	5.73e-01	2.29e-01
GOBP SPINDLE ASSEMBLY INVOLVED IN FEMALE MEIOSIS	8	3.20e-02	8.38e-02	0.7090	7.92e-02	-4.39e-01	-4.33e-03	3.67e-01	-2.06e-01	3.56e-01	6.98e-01	3.17e-02	9.83e-01	7.19e-02	3.12e-01	8.14e-02
GOMF G PROTEIN ACTIVITY	41	4.43e-08	5.68e-07	0.7090	-4.59e-01	-2.16e-01	2.01e-01	-1.21e-01	-2.70e-01	3.43e-01	3.59e-07	1.69e-02	2.58e-02	1.80e-01	2.77e-03	1.45e-04
GOBP MATURATION OF SSU RRNA	52	8.59e-11	1.57e-09	0.7090	-8.72e-02	-5.41e-01	-3.93e-01	6.00e-02	-1.27e-01	-1.70e-01	2.77e-01	1.51e-11	9.38e-07	4.55e-01	1.13e-01	3.44e-02
GOCC PWP2P CONTAINING SUBCOMPLEX OF 90S PRERIBOSOME	5	4.63e-01	5.67e-01	0.7090	-3.41e-01	-4.90e-01	-3.61e-01	1.09e-01	-6.63e-02	-2.82e-03	1.87e-01	5.76e-02	1.62e-01	6.73e-01	7.97e-01	9.91e-01
GOBP NEGATIVE REGULATION OF SODIUM ION TRANSMEMBRANE TRANSPORT	7	3.42e-01	4.59e-01	0.7080	-1.40e-01	-4.26e-01	-5.04e-02	-3.09e-01	-4.50e-01	1.09e-03	5.22e-01	5.08e-02	8.17e-01	1.57e-01	3.93e-02	9.96e-01
GOMF LYSINE N ACETYLTRANSFERASE ACTIVITY ACTING ON ACETYL PHOSPHATE AS DONOR	5	2.00e-01	3.16e-01	0.7080	4.30e-01	1.14e-01	2.53e-01	3.80e-02	-4.84e-01	6.25e-02	9.62e-02	6.58e-01	3.27e-01	8.83e-01	6.07e-02	8.09e-01
GOBP POSITIVE REGULATION OF PROTEIN LOCALIZATION TO CELL CORTEX	6	3.29e-01	4.47e-01	0.7080	1.86e-02	4.28e-01	-1.67e-01	2.27e-01	4.75e-01	-1.12e-01	9.37e-01	6.95e-02	4.79e-01	3.36e-01	4.38e-02	6.33e-01
GOBP TETRAHYDROBIOPTERIN METABOLIC PROCESS	8	4.28e-02	1.05e-01	0.7080	-1.68e-01	-6.01e-01	-1.93e-01	-2.53e-01	5.73e-03	-1.02e-01	4.12e-01	3.25e-03	3.45e-01	2.15e-01	9.78e-01	6.19e-01
GOBP POSITIVE REGULATION OF SEQUESTERING OF TRIGLYCERIDE	7	8.14e-02	1.69e-01	0.7070	-3.89e-01	-9.48e-02	4.39e-01	-2.17e-01	-3.05e-01	8.51e-02	7.47e-02	6.64e-01	4.42e-02	3.20e-01	1.63e-01	6.97e-01
GOBP PROTON TRANSPORTING TWO SECTOR ATPASE COMPLEX ASSEMBLY	15	6.64e-03	2.47e-02	0.7070	-1.82e-01	-4.70e-01	-3.66e-01	2.01e-02	1.43e-01	-3.02e-01	2.23e-01	1.63e-03	1.40e-02	8.93e-01	3.38e-01	4.25e-02
GOBP CELL SUBSTRATE JUNCTION DISASSEMBLY	8	1.21e-01	2.25e-01	0.7070	1.02e-01	4.90e-01	3.01e-01	3.05e-01	6.42e-02	2.48e-01	6.16e-01	1.63e-02	1.41e-01	1.35e-01	7.53e-01	2.24e-01
GOBP CELLULAR LIPID BIOSYNTHETIC PROCESS	12	6.02e-03	2.28e-02	0.7070	-5.23e-01	-2.04e-01	1.36e-01	-3.19e-01	5.47e-02	2.50e-01	1.72e-03	2.21e-01	4.16e-01	5.58e-02	7.43e-01	1.34e-01
GOBP PURINE RIBONUCLEOSIDE SALVAGE	7	1.95e-01	3.11e-01	0.7070	-2.38e-01	-4.77e-01	3.93e-02	-3.93e-01	-2.14e-01	1.15e-01	2.75e-01	2.87e-02	8.57e-01	7.17e-02	3.27e-01	5.99e-01
GOBP REGULATION OF RECEPTOR CATABOLIC PROCESS	10	8.24e-03	2.95e-02	0.7070	-2.42e-01	-7.29e-02	3.83e-01	9.60e-02	-5.10e-01	1.41e-01	1.85e-01	6.90e-01	3.60e-02	5.99e-01	5.22e-03	4.39e-01
GOMF CILIARY NEUROTROPHIC FACTOR RECEPTOR BINDING	5	2.29e-01	3.47e-01	0.7070	-1.47e-01	6.34e-02	4.32e-01	-4.63e-01	-2.53e-01	-8.97e-02	5.68e-01	8.06e-01	9.41e-02	7.27e-02	3.28e-01	7.28e-01
GOMF 1 ACYLGLYCEROPHOSPHOCHOLINE O ACYLTRANSFERASE ACTIVITY	7	6.88e-02	1.49e-01	0.7060	-4.08e-01	2.19e-01	3.44e-01	1.12e-02	1.33e-01	3.85e-01	6.14e-02	3.16e-01	1.15e-01	9.59e-01	5.42e-01	7.75e-02
GOCC 3M COMPLEX	5	6.51e-01	7.23e-01	0.7060	-3.94e-01	-3.13e-01	-6.78e-02	-2.86e-01	-3.89e-01	-8.52e-02	1.27e-01	2.26e-01	7.93e-01	2.67e-01	1.32e-01	7.41e-01
GOBP CELLULAR RESPONSE TO X RAY	9	4.39e-02	1.07e-01	0.7060	1.04e-01	2.87e-01	-2.20e-01	2.95e-01	4.59e-01	2.43e-01	5.88e-01	1.36e-01	2.53e-01	1.26e-01	1.70e-02	2.06e-01
GOBP POSITIVE REGULATION OF BROWN FAT CELL DIFFERENTIATION	12	1.74e-03	8.17e-03	0.7060	-6.75e-02	5.35e-01	2.97e-01	2.37e-01	2.51e-01	-3.90e-02	6.86e-01	1.34e-03	7.53e-02	1.55e-01	1.33e-01	8.15e-01
GOBP BASE EXCISION REPAIR	42	7.35e-09	1.05e-07	0.7060	1.63e-01	-1.92e-01	-2.91e-01	5.12e-01	2.83e-01	-8.92e-02	6.70e-02	3.11e-02	1.09e-03	9.19e-09	1.53e-03	3.17e-01
GOCC MULTIVESICULAR BODY INTERNAL VESICLE	5	2.54e-01	3.74e-01	0.7060	2.35e-01	-2.44e-01	4.83e-01	2.01e-01	-2.21e-01	2.48e-01	3.63e-01	3.45e-01	6.15e-02	4.37e-01	3.92e-01	3.37e-01
GOCC NEUROFIBRILLARY TANGLE	5	1.76e-01	2.91e-01	0.7060	-1.77e-01	1.47e-01	1.84e-01	-3.13e-01	2.78e-01	4.86e-01	4.94e-01	5.68e-01	4.75e-01	2.26e-01	2.82e-01	5.98e-02
GOMF ARRESTIN FAMILY PROTEIN BINDING	6	1.22e-01	2.26e-01	0.7060	-3.27e-01	3.72e-01	-2.12e-01	-4.41e-03	4.20e-01	-1.80e-01	1.66e-01	1.15e-01	3.69e-01	9.85e-01	7.48e-02	4.46e-01
GOMF KINETOCHORE BINDING	6	2.40e-01	3.58e-01	0.7060	-1.84e-01	-5.12e-01	1.20e-01	1.26e-01	-3.12e-01	2.74e-01	4.36e-01	2.98e-02	6.10e-01	5.94e-01	1.86e-01	2.46e-01
GOMF INWARD RECTIFIER POTASSIUM CHANNEL ACTIVITY	11	2.85e-02	7.71e-02	0.7060	-5.53e-02	2.99e-01	4.00e-01	-4.58e-01	-1.63e-01	9.98e-02	7.51e-01	8.56e-02	2.17e-02	8.59e-03	3.50e-01	5.66e-01
GOBP COBALAMIN METABOLIC PROCESS	9	9.54e-02	1.89e-01	0.7050	2.18e-01	1.21e-01	-1.76e-01	2.68e-01	5.65e-01	1.12e-01	2.58e-01	5.31e-01	3.59e-01	1.63e-01	3.31e-03	5.61e-01
GOBP MITOCHONDRIAL TRANSLATIONAL ELONGATION	5	5.73e-01	6.60e-01	0.7050	-3.23e-01	-4.67e-01	-3.27e-01	-1.17e-01	-2.33e-02	-2.30e-01	2.11e-01	7.04e-02	2.05e-01	6.50e-01	9.28e-01	3.73e-01
GOCC OUTER MITOCHONDRIAL MEMBRANE PROTEIN COMPLEX	22	6.07e-04	3.31e-03	0.7050	-2.59e-01	-5.20e-01	-3.43e-01	-1.95e-01	-5.00e-02	-2.80e-02	3.53e-02	2.38e-05	5.37e-03	1.14e-01	6.85e-01	8.20e-01
GOMF DNA DNA ANNEALING ACTIVITY	7	1.16e-01	2.18e-01	0.7050	4.95e-01	-1.69e-01	1.94e-01	4.04e-01	-5.22e-02	1.37e-01	2.32e-02	4.39e-01	3.74e-01	6.40e-02	8.11e-01	5.30e-01
GOBP BLEB ASSEMBLY	11	1.16e-02	3.86e-02	0.7050	-2.83e-01	-3.54e-01	3.08e-01	-1.13e-01	-6.26e-02	4.24e-01	1.04e-01	4.21e-02	7.71e-02	5.17e-01	7.19e-01	1.50e-02
GOBP NUCLEOTIDE EXCISION REPAIR DNA GAP FILLING	6	7.03e-02	1.51e-01	0.7040	-1.40e-01	-1.73e-02	1.98e-01	2.76e-01	5.16e-01	3.07e-01	5.52e-01	9.41e-01	4.01e-01	2.42e-01	2.85e-02	1.93e-01
GOMF CAMP DEPENDENT PROTEIN KINASE ACTIVITY	5	7.59e-02	1.60e-01	0.7040	-4.44e-01	6.68e-02	-1.89e-01	2.66e-01	1.08e-01	4.19e-01	8.55e-02	7.96e-01	4.65e-01	3.02e-01	6.77e-01	1.04e-01
GOBP SHORT CHAIN FATTY ACID METABOLIC PROCESS	14	1.11e-02	3.74e-02	0.7040	-1.91e-01	-3.05e-01	-4.11e-01	4.66e-02	3.44e-01	-2.76e-01	2.15e-01	4.78e-02	7.71e-03	7.63e-01	2.61e-02	7.37e-02
GOBP MHC CLASS I BIOSYNTHETIC PROCESS	6	2.62e-01	3.82e-01	0.7040	-5.21e-02	4.94e-01	3.25e-01	1.42e-01	2.79e-01	2.12e-01	8.25e-01	3.61e-02	1.68e-01	5.48e-01	2.36e-01	3.70e-01
GOBP PROTEIN C LINKED GLYCOSYLATION	6	1.31e-01	2.37e-01	0.7040	-5.74e-01	-1.46e-01	-3.07e-01	-4.00e-02	-1.96e-01	1.01e-01	1.49e-02	5.35e-01	1.93e-01	8.65e-01	4.06e-01	6.67e-01
GOCC CYTOPLASMIC EXOSOME RNASE COMPLEX	16	8.86e-03	3.11e-02	0.7030	-9.91e-02	-4.37e-01	-5.07e-01	1.01e-02	8.11e-03	-1.91e-01	4.93e-01	2.46e-03	4.44e-04	9.44e-01	9.55e-01	1.86e-01
GOBP LABYRINTHINE LAYER MORPHOGENESIS	14	3.80e-02	9.58e-02	0.7030	9.59e-02	2.77e-01	5.34e-01	8.47e-02	-7.89e-02	3.32e-01	5.34e-01	7.24e-02	5.44e-04	5.83e-01	6.09e-01	3.13e-02
GOBP METANEPHRIC MESENCHYME DEVELOPMENT	6	3.15e-01	4.35e-01	0.7030	1.14e-01	3.86e-01	3.05e-01	9.43e-02	-4.03e-03	4.80e-01	6.27e-01	1.02e-01	1.96e-01	6.89e-01	9.86e-01	4.16e-02
GOBP ESTABLISHMENT OF PROTEIN LOCALIZATION TO ENDOPLASMIC RETICULUM	42	1.76e-08	2.41e-07	0.7030	-2.56e-01	-3.74e-01	1.80e-01	1.04e-02	-2.98e-01	4.10e-01	4.11e-03	2.74e-05	4.39e-02	9.07e-01	8.18e-04	4.31e-06
GOBP CDP CHOLINE PATHWAY	7	3.93e-01	5.06e-01	0.7030	-4.44e-01	-2.18e-01	1.07e-01	-3.67e-01	-2.43e-01	2.11e-01	4.19e-02	3.18e-01	6.25e-01	9.25e-02	2.65e-01	3.33e-01
GOBP RESPONSE TO GRANULOCYTE MACROPHAGE COLONY STIMULATING FACTOR	8	7.44e-02	1.58e-01	0.7030	-2.54e-01	9.60e-02	-3.07e-01	1.45e-01	3.38e-01	-4.37e-01	2.13e-01	6.38e-01	1.32e-01	4.78e-01	9.79e-02	3.23e-02
GOBP SULFUR AMINO ACID CATABOLIC PROCESS	6	3.83e-01	4.96e-01	0.7030	-1.28e-01	-5.07e-01	-1.31e-01	-9.54e-02	-4.38e-01	-5.67e-02	5.87e-01	3.15e-02	5.80e-01	6.86e-01	6.33e-02	8.10e-01
GOBP LIPOXIN METABOLIC PROCESS	5	4.03e-01	5.15e-01	0.7030	2.50e-02	6.75e-02	2.34e-01	-5.06e-01	-4.21e-01	-3.47e-02	9.23e-01	7.94e-01	3.65e-01	5.00e-02	1.03e-01	8.93e-01
GOBP THREONINE METABOLIC PROCESS	5	2.76e-02	7.54e-02	0.7030	4.22e-01	-2.26e-01	3.19e-01	9.23e-02	3.56e-01	1.67e-01	1.02e-01	3.82e-01	2.16e-01	7.21e-01	1.68e-01	5.17e-01
GOBP PROTEIN HEXAMERIZATION	9	4.13e-02	1.02e-01	0.7030	-2.34e-01	-3.31e-01	1.59e-02	4.91e-02	-5.72e-01	7.20e-03	2.25e-01	8.58e-02	9.34e-01	7.98e-01	2.96e-03	9.70e-01
GOCC PAR POLARITY COMPLEX	6	1.28e-01	2.33e-01	0.7030	-6.57e-02	-4.01e-01	-3.73e-01	2.92e-02	-4.30e-01	-5.48e-02	7.81e-01	8.87e-02	1.13e-01	9.01e-01	6.78e-02	8.16e-01
GOBP RESPONSE TO INDOLE 3 METHANOL	6	1.02e-01	1.98e-01	0.7030	-5.00e-01	2.44e-01	2.88e-01	-1.22e-01	-1.73e-01	2.38e-01	3.39e-02	3.02e-01	2.23e-01	6.03e-01	4.62e-01	3.12e-01
GOBP FOREBRAIN NEUROBLAST DIVISION	5	3.50e-01	4.66e-01	0.7030	4.44e-01	9.83e-02	2.75e-01	2.20e-01	-1.91e-01	3.56e-01	8.58e-02	7.04e-01	2.87e-01	3.94e-01	4.60e-01	1.68e-01
GOBP PROTEIN LOCALIZATION TO CILIARY TRANSITION ZONE	7	1.20e-01	2.23e-01	0.7020	-1.51e-02	3.10e-01	-2.52e-01	-1.75e-01	5.15e-01	-1.95e-01	9.45e-01	1.56e-01	2.48e-01	4.23e-01	1.84e-02	3.71e-01
GOBP PHARYNGEAL ARCH ARTERY MORPHOGENESIS	6	3.12e-01	4.32e-01	0.7020	2.25e-03	4.08e-01	2.91e-01	4.43e-02	3.69e-01	3.24e-01	9.92e-01	8.38e-02	2.17e-01	8.51e-01	1.18e-01	1.70e-01
GOBP RIBOSOMAL LARGE SUBUNIT EXPORT FROM NUCLEUS	7	2.04e-01	3.20e-01	0.7020	-2.01e-01	-4.56e-01	-4.18e-02	-1.78e-01	-2.94e-01	3.53e-01	3.57e-01	3.67e-02	8.48e-01	4.14e-01	1.78e-01	1.05e-01
GOBP REGULATION OF PROTEIN K48 LINKED UBIQUITINATION	6	2.98e-01	4.18e-01	0.7020	-3.76e-01	-3.75e-01	-3.89e-01	1.18e-01	2.12e-01	-1.56e-02	1.11e-01	1.11e-01	9.86e-02	6.15e-01	3.68e-01	9.47e-01
GOBP PEPTIDE ANTIGEN ASSEMBLY WITH MHC CLASS I PROTEIN COMPLEX	6	1.30e-01	2.36e-01	0.7020	-2.64e-01	-4.23e-01	2.49e-02	3.67e-01	-1.34e-01	3.02e-01	2.62e-01	7.28e-02	9.16e-01	1.20e-01	5.70e-01	2.00e-01
GOBP ADULT HEART DEVELOPMENT	5	3.66e-01	4.81e-01	0.7020	6.46e-02	5.88e-01	2.45e-01	-1.60e-01	1.43e-01	1.92e-01	8.02e-01	2.27e-02	3.42e-01	5.35e-01	5.80e-01	4.58e-01
GOBP POSITIVE REGULATION OF DNA DAMAGE CHECKPOINT	5	2.57e-01	3.77e-01	0.7020	4.35e-02	-1.62e-01	-2.00e-01	5.72e-01	1.23e-01	-2.86e-01	8.66e-01	5.30e-01	4.38e-01	2.69e-02	6.34e-01	2.68e-01
GOBP POSITIVE REGULATION OF RRNA PROCESSING	10	1.44e-01	2.54e-01	0.7010	-3.24e-01	-4.55e-01	-3.38e-01	-3.25e-02	-3.65e-02	-2.50e-01	7.60e-02	1.26e-02	6.39e-02	8.59e-01	8.41e-01	1.70e-01
GOBP PROTEIN DESUMOYLATION	9	3.95e-02	9.86e-02	0.7010	-5.20e-01	-6.68e-03	-3.59e-01	-1.61e-01	2.50e-01	5.80e-02	6.85e-03	9.72e-01	6.18e-02	4.03e-01	1.94e-01	7.63e-01
GOBP INTERLEUKIN 10 MEDIATED SIGNALING PATHWAY	11	1.57e-02	4.91e-02	0.7010	-1.35e-01	2.65e-01	4.57e-01	2.56e-01	2.97e-03	3.59e-01	4.40e-01	1.28e-01	8.62e-03	1.41e-01	9.86e-01	3.93e-02
GOBP HISTAMINE TRANSPORT	13	1.66e-02	5.13e-02	0.7010	-3.69e-01	-3.23e-01	9.69e-02	-2.55e-01	-8.92e-02	4.12e-01	2.14e-02	4.37e-02	5.45e-01	1.12e-01	5.78e-01	1.02e-02
GOBP RENAL SYSTEM VASCULATURE MORPHOGENESIS	6	2.13e-01	3.31e-01	0.7010	-2.42e-01	1.02e-01	3.81e-01	1.20e-01	1.53e-01	4.90e-01	3.05e-01	6.64e-01	1.06e-01	6.11e-01	5.17e-01	3.76e-02
GOBP CEREBELLAR PURKINJE CELL LAYER FORMATION	10	4.35e-02	1.06e-01	0.7010	-5.69e-02	4.64e-01	-1.73e-01	1.18e-01	4.69e-01	-9.66e-02	7.55e-01	1.11e-02	3.45e-01	5.17e-01	1.02e-02	5.97e-01
GOBP REGULATION OF DOPAMINE RECEPTOR SIGNALING PATHWAY	6	2.76e-01	3.95e-01	0.7010	-3.41e-01	-2.04e-01	1.29e-01	-5.83e-02	-9.99e-02	5.51e-01	1.48e-01	3.86e-01	5.85e-01	8.05e-01	6.72e-01	1.94e-02
GOCC PRP19 COMPLEX	14	8.91e-04	4.61e-03	0.7000	-1.28e-01	-3.72e-01	-1.07e-01	4.60e-01	1.10e-01	3.17e-01	4.08e-01	1.59e-02	4.89e-01	2.89e-03	4.78e-01	3.98e-02
GOBP GAP JUNCTION ASSEMBLY	10	5.12e-02	1.19e-01	0.7000	1.37e-01	3.42e-01	4.89e-01	-2.68e-01	4.77e-02	2.04e-01	4.52e-01	6.12e-02	7.47e-03	1.43e-01	7.94e-01	2.64e-01
GOBP POSITIVE REGULATION OF CALCIUM ION DEPENDENT EXOCYTOSIS	8	4.04e-02	1.00e-01	0.7000	1.61e-01	3.92e-02	3.11e-01	4.40e-01	4.00e-01	1.12e-01	4.31e-01	8.48e-01	1.28e-01	3.13e-02	5.02e-02	5.83e-01
GOBP PURINE DEOXYRIBONUCLEOSIDE MONOPHOSPHATE CATABOLIC PROCESS	5	3.96e-01	5.09e-01	0.7000	4.76e-01	1.23e-01	2.74e-01	2.55e-01	3.24e-01	5.41e-02	6.55e-02	6.35e-01	2.88e-01	3.24e-01	2.09e-01	8.34e-01
GOMF PLUS END DIRECTED MICROTUBULE MOTOR ACTIVITY	15	2.46e-02	6.92e-02	0.6990	2.68e-01	1.19e-01	4.06e-01	1.49e-01	-2.67e-03	4.65e-01	7.21e-02	4.26e-01	6.48e-03	3.17e-01	9.86e-01	1.82e-03
GOMF LIPASE ACTIVATOR ACTIVITY	16	1.71e-02	5.23e-02	0.6990	-3.28e-01	-3.64e-01	8.59e-02	-1.46e-01	-3.10e-01	3.53e-01	2.32e-02	1.17e-02	5.52e-01	3.12e-01	3.18e-02	1.45e-02
GOBP POSITIVE REGULATION OF SEQUESTERING OF CALCIUM ION	13	1.37e-02	4.42e-02	0.6990	-2.04e-01	-5.80e-01	-4.72e-02	4.75e-02	-2.52e-01	2.08e-01	2.03e-01	2.94e-04	7.68e-01	7.67e-01	1.16e-01	1.95e-01
GOBP REGULATION OF RETROGRADE PROTEIN TRANSPORT ER TO CYTOSOL	13	1.70e-02	5.22e-02	0.6990	-4.18e-01	-3.71e-01	4.48e-02	7.31e-03	-1.71e-01	3.81e-01	9.06e-03	2.07e-02	7.80e-01	9.64e-01	2.85e-01	1.73e-02
GOMF DIPHOSPHOTRANSFERASE ACTIVITY	5	3.18e-01	4.37e-01	0.6990	-1.74e-01	-3.91e-01	-5.10e-01	1.93e-01	7.60e-02	5.07e-02	5.01e-01	1.30e-01	4.84e-02	4.56e-01	7.69e-01	8.44e-01
GOBP NEGATIVE REGULATION OF CELLULAR EXTRAVASATION	5	1.79e-01	2.93e-01	0.6990	-4.10e-01	-1.49e-01	-2.01e-01	2.15e-02	-3.85e-01	-3.30e-01	1.12e-01	5.63e-01	4.37e-01	9.34e-01	1.36e-01	2.02e-01
GOBP CELLULAR RESPONSE TO WATER STIMULUS	5	1.50e-01	2.60e-01	0.6990	-2.79e-01	1.07e-01	4.23e-01	2.36e-01	-2.86e-01	2.88e-01	2.81e-01	6.79e-01	1.02e-01	3.60e-01	2.68e-01	2.65e-01
GOBP PRIMITIVE HEMOPOIESIS	9	1.98e-02	5.89e-02	0.6990	5.09e-02	-4.00e-01	4.04e-01	-6.60e-02	-1.78e-01	3.55e-01	7.91e-01	3.76e-02	3.58e-02	7.32e-01	3.55e-01	6.52e-02
GOBP PROSTAGLANDIN TRANSPORT	15	1.04e-04	7.02e-04	0.6990	-1.26e-01	8.91e-02	5.34e-01	-4.10e-01	-8.07e-02	6.40e-02	3.99e-01	5.50e-01	3.40e-04	5.95e-03	5.88e-01	6.68e-01
GOMF HISTONE H2AX KINASE ACTIVITY	5	3.58e-01	4.73e-01	0.6980	2.50e-02	3.38e-01	2.43e-01	2.03e-01	3.74e-02	5.21e-01	9.23e-01	1.91e-01	3.48e-01	4.32e-01	8.85e-01	4.36e-02
GOBP REGULATION OF HEPATIC STELLATE CELL ACTIVATION	5	1.86e-01	3.01e-01	0.6980	-3.52e-01	2.43e-03	1.58e-01	-2.67e-02	-5.41e-01	2.12e-01	1.73e-01	9.93e-01	5.40e-01	9.18e-01	3.62e-02	4.12e-01
GOMF BITTER TASTE RECEPTOR ACTIVITY	5	4.99e-01	5.96e-01	0.6980	-2.03e-01	-2.00e-01	-4.24e-01	-3.13e-01	-2.44e-01	-2.61e-01	4.31e-01	4.38e-01	1.01e-01	2.25e-01	3.44e-01	3.12e-01
GOBP NEGATIVE REGULATION OF RESPONSE TO NUTRIENT LEVELS	8	2.82e-01	4.01e-01	0.6980	-3.06e-01	-3.17e-01	-4.26e-01	-2.51e-01	7.90e-02	-2.08e-01	1.35e-01	1.21e-01	3.70e-02	2.20e-01	6.99e-01	3.09e-01
GOBP MICROGLIA DIFFERENTIATION	11	2.44e-02	6.89e-02	0.6980	-5.71e-01	-1.58e-01	-2.06e-01	-1.29e-01	-2.59e-01	-9.89e-02	1.04e-03	3.65e-01	2.36e-01	4.59e-01	1.37e-01	5.70e-01
GOBP IMMUNE RESPONSE INHIBITING CELL SURFACE RECEPTOR SIGNALING PATHWAY	7	1.94e-01	3.10e-01	0.6980	-2.96e-01	1.77e-01	2.88e-01	-1.50e-01	1.61e-02	5.12e-01	1.75e-01	4.17e-01	1.87e-01	4.91e-01	9.41e-01	1.90e-02
GOBP REGULATION OF STORE OPERATED CALCIUM CHANNEL ACTIVITY	6	1.13e-01	2.14e-01	0.6980	8.58e-03	3.09e-01	3.38e-01	3.64e-01	-2.06e-01	3.20e-01	9.71e-01	1.90e-01	1.52e-01	1.23e-01	3.83e-01	1.74e-01
GOCC MICOS COMPLEX	9	3.82e-02	9.62e-02	0.6980	1.05e-01	-5.43e-01	-3.86e-01	5.09e-02	5.11e-02	-1.63e-01	5.87e-01	4.77e-03	4.50e-02	7.91e-01	7.91e-01	3.96e-01
GOBP NEGATIVE REGULATION OF DENDRITE DEVELOPMENT	5	2.84e-01	4.04e-01	0.6980	5.53e-01	9.18e-02	1.02e-01	1.73e-01	-1.64e-01	-3.25e-01	3.23e-02	7.22e-01	6.94e-01	5.03e-01	5.26e-01	2.08e-01
GOBP TRNA TRANSCRIPTION	13	6.55e-03	2.45e-02	0.6980	8.33e-02	-2.90e-01	-2.77e-01	4.76e-01	3.30e-02	-3.03e-01	6.03e-01	7.02e-02	8.42e-02	2.98e-03	8.37e-01	5.85e-02
GOBP DIPEPTIDE TRANSMEMBRANE TRANSPORT	7	1.11e-01	2.11e-01	0.6980	-4.18e-01	-3.28e-01	2.31e-01	1.12e-01	-2.11e-01	3.06e-01	5.57e-02	1.32e-01	2.90e-01	6.07e-01	3.33e-01	1.60e-01
GOCC PROTEASOME COMPLEX	60	1.40e-14	3.62e-13	0.6980	-2.68e-01	-5.17e-01	5.16e-02	2.69e-02	-1.58e-01	3.44e-01	3.29e-04	4.03e-12	4.89e-01	7.19e-01	3.41e-02	3.95e-06
GOMF VASCULAR ENDOTHELIAL GROWTH FACTOR RECEPTOR 2 BINDING	8	4.96e-02	1.17e-01	0.6970	-6.07e-01	-1.90e-01	1.11e-01	-2.35e-01	-1.13e-01	-2.99e-02	2.93e-03	3.52e-01	5.86e-01	2.49e-01	5.79e-01	8.84e-01
GOBP REGULATION OF THYMOCYTE APOPTOTIC PROCESS	11	6.02e-02	1.35e-01	0.6970	6.50e-02	3.41e-01	-1.45e-02	3.77e-01	4.19e-01	2.18e-01	7.09e-01	5.03e-02	9.33e-01	3.03e-02	1.61e-02	2.10e-01
GOCC PLATELET ALPHA GRANULE	73	5.00e-14	1.23e-12	0.6970	-2.49e-01	-3.85e-01	2.49e-01	-2.06e-01	-3.22e-01	2.60e-01	2.39e-04	1.32e-08	2.41e-04	2.32e-03	1.90e-06	1.20e-04
GOBP RESPIRATORY BURST INVOLVED IN INFLAMMATORY RESPONSE	8	9.17e-02	1.84e-01	0.6970	-7.01e-02	-3.78e-01	-1.58e-01	-4.43e-01	-1.43e-01	-3.10e-01	7.31e-01	6.40e-02	4.40e-01	3.00e-02	4.83e-01	1.29e-01
GOBP NEGATIVE REGULATION OF FATTY ACID TRANSPORT	7	1.61e-02	5.01e-02	0.6970	-1.21e-01	-1.05e-01	1.46e-01	-1.22e-01	-3.27e-01	-5.62e-01	5.78e-01	6.30e-01	5.03e-01	5.78e-01	1.34e-01	1.00e-02
GOBP LAYER FORMATION IN CEREBRAL CORTEX	10	2.11e-02	6.16e-02	0.6960	-1.74e-01	-9.53e-02	2.72e-01	1.58e-01	-4.62e-01	3.66e-01	3.41e-01	6.02e-01	1.37e-01	3.87e-01	1.14e-02	4.52e-02
GOBP REGULATION OF INTRACELLULAR LIPID TRANSPORT	7	1.81e-01	2.96e-01	0.6960	-1.62e-01	-5.03e-01	8.54e-02	1.01e-01	-2.93e-01	3.21e-01	4.57e-01	2.13e-02	6.96e-01	6.43e-01	1.80e-01	1.42e-01
GOMF INOSITOL POLYPHOSPHATE 5 PHOSPHATASE ACTIVITY	6	1.07e-01	2.06e-01	0.6960	1.67e-01	1.59e-01	5.71e-02	5.02e-01	1.51e-01	-3.91e-01	4.78e-01	4.99e-01	8.09e-01	3.31e-02	5.21e-01	9.72e-02
GOBP RIBOSOME BIOGENESIS	306	3.38e-66	2.09e-63	0.6960	-1.50e-01	-5.40e-01	-3.81e-01	4.45e-02	-8.59e-02	-1.25e-01	6.11e-06	9.50e-60	1.78e-30	1.80e-01	9.80e-03	1.68e-04
GOBP TRICARBOXYLIC ACID CYCLE	28	9.41e-06	7.96e-05	0.6960	-3.65e-01	-5.41e-01	-2.05e-01	2.19e-03	-1.85e-02	1.27e-01	8.30e-04	7.07e-07	6.04e-02	9.84e-01	8.65e-01	2.46e-01
GOBP MARGINAL ZONE B CELL DIFFERENTIATION	8	1.27e-01	2.32e-01	0.6960	2.48e-01	1.18e-01	2.51e-01	5.43e-01	2.24e-01	2.39e-02	2.25e-01	5.62e-01	2.18e-01	7.82e-03	2.72e-01	9.07e-01
GOMF PLATELET DERIVED GROWTH FACTOR RECEPTOR BINDING	13	2.84e-02	7.68e-02	0.6960	-1.44e-01	1.97e-02	5.04e-01	-7.72e-02	-3.52e-01	2.82e-01	3.68e-01	9.02e-01	1.66e-03	6.30e-01	2.81e-02	7.87e-02
GOBP TUBULIN COMPLEX ASSEMBLY	8	1.49e-01	2.59e-01	0.6960	-3.45e-01	-4.97e-01	-1.17e-01	-1.25e-02	-1.27e-01	2.97e-01	9.12e-02	1.50e-02	5.66e-01	9.51e-01	5.36e-01	1.45e-01
GOBP PURINE NUCLEOBASE BIOSYNTHETIC PROCESS	10	3.86e-02	9.69e-02	0.6960	-1.71e-01	-5.44e-01	-3.13e-01	-7.62e-02	-1.67e-01	1.64e-01	3.48e-01	2.89e-03	8.70e-02	6.77e-01	3.61e-01	3.68e-01
GOBP METANEPHRIC NEPHRON TUBULE MORPHOGENESIS	5	1.52e-01	2.63e-01	0.6950	-1.76e-01	1.39e-01	-1.18e-01	-9.25e-02	6.18e-01	-1.69e-01	4.94e-01	5.91e-01	6.48e-01	7.20e-01	1.67e-02	5.14e-01
GOBP CARDIAC MUSCLE CELL MYOBLAST DIFFERENTIATION	8	2.39e-01	3.57e-01	0.6950	-1.05e-01	1.71e-01	4.34e-01	-2.32e-01	-9.01e-02	4.39e-01	6.06e-01	4.04e-01	3.34e-02	2.56e-01	6.59e-01	3.15e-02
GOBP MITOCHONDRIAL CALCIUM ION TRANSMEMBRANE TRANSPORT	22	3.87e-04	2.25e-03	0.6950	-3.50e-01	-5.63e-01	-1.56e-01	-3.98e-03	-1.37e-01	-2.17e-02	4.48e-03	4.78e-06	2.06e-01	9.74e-01	2.67e-01	8.60e-01
GOMF IRON ION TRANSMEMBRANE TRANSPORTER ACTIVITY	10	6.49e-02	1.43e-01	0.6950	8.18e-02	6.75e-02	3.35e-01	-3.03e-01	-5.17e-01	6.97e-03	6.54e-01	7.12e-01	6.68e-02	9.72e-02	4.64e-03	9.70e-01
GOMF ASPARTIC TYPE ENDOPEPTIDASE INHIBITOR ACTIVITY	6	2.80e-01	3.99e-01	0.6940	2.73e-01	-6.36e-03	3.84e-01	2.39e-01	-3.61e-01	2.68e-01	2.46e-01	9.78e-01	1.03e-01	3.10e-01	1.26e-01	2.55e-01
GOBP POSITIVE REGULATION OF NITRIC OXIDE SYNTHASE BIOSYNTHETIC PROCESS	14	6.17e-03	2.32e-02	0.6940	-3.63e-01	2.61e-01	2.39e-01	-3.85e-01	-7.70e-02	2.66e-01	1.88e-02	9.03e-02	1.21e-01	1.26e-02	6.18e-01	8.52e-02
GOBP REGULATION OF HUMORAL IMMUNE RESPONSE MEDIATED BY CIRCULATING IMMUNOGLOBULIN	16	4.61e-03	1.83e-02	0.6940	2.10e-01	3.45e-01	3.49e-01	1.09e-01	4.04e-01	1.47e-01	1.46e-01	1.70e-02	1.58e-02	4.51e-01	5.12e-03	3.09e-01
GOMF LOW DENSITY LIPOPROTEIN PARTICLE RECEPTOR ACTIVITY	14	7.03e-04	3.77e-03	0.6940	-9.91e-02	3.30e-01	5.50e-01	1.55e-01	6.71e-02	1.77e-01	5.21e-01	3.25e-02	3.69e-04	3.14e-01	6.64e-01	2.51e-01
GOBP PENTOSE METABOLIC PROCESS	10	1.01e-02	3.47e-02	0.6930	-2.94e-01	-4.04e-01	6.13e-02	2.55e-01	1.26e-01	3.82e-01	1.07e-01	2.69e-02	7.37e-01	1.63e-01	4.92e-01	3.63e-02
GOBP REGULATION OF TRANSLATIONAL INITIATION BY EIF2 ALPHA PHOSPHORYLATION	12	3.54e-02	9.09e-02	0.6930	-4.67e-01	-2.83e-01	2.19e-03	-5.68e-02	-3.17e-01	2.79e-01	5.05e-03	8.91e-02	9.90e-01	7.33e-01	5.69e-02	9.46e-02
GOBP REGULATION OF T CELL COSTIMULATION	5	4.49e-01	5.56e-01	0.6930	4.10e-02	-1.67e-01	3.25e-01	1.60e-01	-1.96e-01	5.31e-01	8.74e-01	5.17e-01	2.09e-01	5.36e-01	4.49e-01	3.99e-02
GOBP OTIC VESICLE DEVELOPMENT	7	1.37e-01	2.45e-01	0.6930	2.44e-01	4.30e-01	-5.49e-02	-1.15e-01	4.69e-01	-9.38e-03	2.64e-01	4.87e-02	8.01e-01	5.97e-01	3.18e-02	9.66e-01
GOBP NEGATIVE REGULATION OF ACTION POTENTIAL	6	3.09e-01	4.29e-01	0.6930	3.24e-01	9.84e-02	5.05e-01	1.44e-01	-2.79e-01	1.09e-01	1.69e-01	6.76e-01	3.23e-02	5.42e-01	2.37e-01	6.43e-01
GOBP UBIQUITIN DEPENDENT ENDOCYTOSIS	6	3.38e-01	4.56e-01	0.6920	2.88e-01	3.69e-01	5.87e-02	4.60e-01	1.49e-01	-1.53e-01	2.23e-01	1.18e-01	8.03e-01	5.11e-02	5.27e-01	5.16e-01
GOCC DNA REPLICATION FACTOR A COMPLEX	12	5.86e-03	2.24e-02	0.6920	-1.65e-02	-3.86e-01	-2.19e-01	4.51e-01	1.83e-01	2.12e-01	9.21e-01	2.06e-02	1.88e-01	6.80e-03	2.73e-01	2.04e-01
GOBP RENAL PROTEIN ABSORPTION	6	1.12e-01	2.12e-01	0.6920	1.09e-01	-3.50e-01	2.36e-01	4.90e-01	-1.04e-01	1.95e-01	6.43e-01	1.38e-01	3.17e-01	3.78e-02	6.60e-01	4.08e-01
GOBP POSITIVE REGULATION OF SPINDLE ASSEMBLY	7	4.75e-01	5.76e-01	0.6920	2.90e-01	4.31e-01	2.17e-01	1.96e-01	3.23e-01	1.35e-01	1.84e-01	4.81e-02	3.19e-01	3.69e-01	1.39e-01	5.37e-01
GOBP NEGATIVE REGULATION OF MUSCLE TISSUE DEVELOPMENT	7	1.39e-01	2.48e-01	0.6910	4.16e-01	-1.01e-01	-1.73e-01	2.24e-01	-9.99e-02	-4.52e-01	5.66e-02	6.44e-01	4.27e-01	3.05e-01	6.47e-01	3.82e-02
GOBP NEGATIVE REGULATION OF ENDOPLASMIC RETICULUM STRESS INDUCED INTRINSIC APOPTOTIC SIGNALING PATHWAY	17	2.76e-04	1.67e-03	0.6910	-1.75e-01	-2.76e-01	1.51e-01	2.15e-01	-4.43e-01	3.24e-01	2.10e-01	4.89e-02	2.81e-01	1.24e-01	1.55e-03	2.08e-02
GOBP REGULATION OF ODONTOBLAST DIFFERENTIATION	6	2.42e-01	3.60e-01	0.6910	2.14e-02	-1.34e-01	4.10e-01	8.22e-02	-5.11e-01	1.52e-01	9.28e-01	5.69e-01	8.23e-02	7.27e-01	3.01e-02	5.19e-01
GOCC CTF18 RFC LIKE COMPLEX	8	1.62e-01	2.75e-01	0.6910	1.25e-01	-2.10e-01	-5.43e-01	2.44e-02	1.63e-01	-3.10e-01	5.40e-01	3.04e-01	7.85e-03	9.05e-01	4.26e-01	1.29e-01
GOCC CASPASE COMPLEX	9	5.87e-03	2.24e-02	0.6910	-2.76e-01	-5.14e-01	1.55e-01	2.86e-01	-2.20e-02	1.72e-01	1.51e-01	7.57e-03	4.21e-01	1.37e-01	9.09e-01	3.71e-01
GOBP CELLULAR RESPONSE TO COCAINE	7	1.55e-01	2.66e-01	0.6910	1.76e-01	4.05e-02	4.57e-01	1.78e-01	2.27e-01	3.90e-01	4.21e-01	8.53e-01	3.64e-02	4.14e-01	2.98e-01	7.36e-02
GOMF OXIDOREDUCTASE ACTIVITY ACTING ON A SULFUR GROUP OF DONORS	53	2.14e-11	4.17e-10	0.6900	-4.07e-01	-3.24e-01	1.55e-01	1.53e-02	-2.20e-01	3.66e-01	2.95e-07	4.54e-05	5.13e-02	8.47e-01	5.67e-03	4.07e-06
GOMF 5 N 7 METHYLGUANOSINE 5 TRIPHOSPHO MRNA HYDROLASE ACTIVITY	10	1.34e-01	2.41e-01	0.6890	-3.59e-01	-4.21e-01	-4.02e-01	-4.70e-02	-7.44e-02	1.32e-03	4.96e-02	2.12e-02	2.76e-02	7.97e-01	6.84e-01	9.94e-01
GOBP LYSOSOMAL MEMBRANE ORGANIZATION	13	5.53e-03	2.13e-02	0.6890	-9.63e-02	-5.48e-01	5.52e-02	1.12e-01	-1.95e-01	3.35e-01	5.48e-01	6.23e-04	7.31e-01	4.85e-01	2.24e-01	3.67e-02
GOBP DNA PROTECTION	6	4.98e-01	5.95e-01	0.6890	-1.48e-01	-4.26e-01	-4.47e-01	-8.46e-02	-5.81e-02	-2.47e-01	5.29e-01	7.09e-02	5.78e-02	7.20e-01	8.05e-01	2.94e-01
GOBP REGULATION OF PERK MEDIATED UNFOLDED PROTEIN RESPONSE	11	2.43e-02	6.87e-02	0.6890	-2.19e-01	8.23e-03	4.65e-01	-2.05e-02	-4.08e-01	2.08e-01	2.09e-01	9.62e-01	7.58e-03	9.06e-01	1.91e-02	2.31e-01
GOBP REGULATION OF MITOCHONDRIAL ELECTRON TRANSPORT NADH TO UBIQUINONE	5	4.35e-01	5.43e-01	0.6880	-9.52e-02	-5.45e-01	-3.21e-01	1.19e-02	-2.53e-01	-1.87e-02	7.12e-01	3.47e-02	2.14e-01	9.63e-01	3.28e-01	9.42e-01
GOBP REGULATION OF GONAD DEVELOPMENT	8	7.66e-02	1.61e-01	0.6880	1.97e-01	-1.36e-01	5.23e-01	1.56e-01	-3.05e-01	1.61e-01	3.35e-01	5.04e-01	1.05e-02	4.45e-01	1.36e-01	4.32e-01
GOMF MORPHOGEN ACTIVITY	5	2.33e-01	3.50e-01	0.6880	-3.18e-02	4.12e-01	-2.48e-03	-2.29e-01	3.06e-01	-3.95e-01	9.02e-01	1.10e-01	9.92e-01	3.75e-01	2.37e-01	1.26e-01
GOBP MYOBLAST MIGRATION	8	2.18e-01	3.36e-01	0.6880	-4.08e-01	-3.12e-01	4.31e-02	-1.36e-01	-1.82e-01	3.94e-01	4.56e-02	1.26e-01	8.33e-01	5.06e-01	3.73e-01	5.36e-02
GOMF BUBBLE DNA BINDING	7	1.39e-01	2.48e-01	0.6880	1.08e-01	-1.41e-01	-3.39e-01	5.52e-01	1.09e-01	-1.01e-01	6.21e-01	5.17e-01	1.20e-01	1.15e-02	6.18e-01	6.42e-01
GOBP POSITIVE REGULATION OF PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR SIGNALING PATHWAY	5	1.54e-01	2.65e-01	0.6870	-3.09e-01	-4.18e-01	3.37e-01	1.20e-01	-1.35e-01	2.37e-01	2.32e-01	1.05e-01	1.92e-01	6.42e-01	6.01e-01	3.60e-01
GOBP REGULATION OF RIBONUCLEASE ACTIVITY	9	1.69e-02	5.19e-02	0.6870	-2.21e-01	-3.93e-01	-2.60e-01	9.03e-02	6.54e-02	4.34e-01	2.51e-01	4.09e-02	1.77e-01	6.39e-01	7.34e-01	2.41e-02
GOBP NEGATIVE REGULATION OF MONOCYTE CHEMOTAXIS	6	1.62e-01	2.75e-01	0.6870	5.01e-02	6.89e-02	1.49e-01	-5.34e-01	-2.37e-01	-3.18e-01	8.32e-01	7.70e-01	5.27e-01	2.35e-02	3.15e-01	1.77e-01
GOBP ENDOTHELIN RECEPTOR SIGNALING PATHWAY	6	2.24e-01	3.43e-01	0.6870	6.61e-02	9.90e-02	4.95e-01	3.65e-01	6.67e-02	2.74e-01	7.79e-01	6.75e-01	3.58e-02	1.22e-01	7.77e-01	2.45e-01
GOBP REGULATION OF GERMINAL CENTER FORMATION	8	6.05e-02	1.36e-01	0.6870	-1.22e-01	3.75e-01	5.23e-01	4.22e-02	7.79e-02	1.87e-01	5.51e-01	6.61e-02	1.05e-02	8.36e-01	7.03e-01	3.61e-01
GOBP TRYPTOPHAN TRANSPORT	6	2.71e-01	3.91e-01	0.6860	-2.83e-01	-2.25e-01	3.09e-02	-9.40e-02	-3.65e-01	4.44e-01	2.30e-01	3.39e-01	8.96e-01	6.90e-01	1.22e-01	5.96e-02
GOBP RETROGRADE TRANS SYNAPTIC SIGNALING BY LIPID	5	5.62e-01	6.50e-01	0.6860	-2.84e-01	-4.79e-01	4.02e-02	-2.25e-01	-3.28e-01	-2.47e-02	2.71e-01	6.36e-02	8.76e-01	3.83e-01	2.05e-01	9.24e-01
GOCC WNT SIGNALOSOME	12	4.18e-03	1.69e-02	0.6860	-9.99e-02	3.98e-01	2.44e-01	3.57e-01	7.47e-02	3.31e-01	5.49e-01	1.71e-02	1.43e-01	3.20e-02	6.54e-01	4.74e-02
GOCC ENDOPLASMIC RETICULUM PROTEIN CONTAINING COMPLEX	119	4.59e-27	3.52e-25	0.6860	-3.63e-01	-4.63e-01	-6.04e-02	8.15e-02	-2.43e-01	2.33e-01	8.09e-12	2.34e-18	2.55e-01	1.25e-01	4.58e-06	1.10e-05
GOBP POSITIVE REGULATION OF CYTOPLASMIC TRANSLATION	14	4.57e-02	1.10e-01	0.6860	-4.40e-01	-2.65e-01	-1.90e-01	-3.38e-01	-1.85e-01	1.50e-01	4.37e-03	8.66e-02	2.19e-01	2.88e-02	2.32e-01	3.32e-01
GOCC PROTON TRANSPORTING TWO SECTOR ATPASE COMPLEX PROTON TRANSPORTING DOMAIN	23	1.31e-04	8.56e-04	0.6850	-2.49e-01	-5.85e-01	-1.25e-01	4.68e-02	-2.02e-01	-8.42e-02	3.88e-02	1.20e-06	2.98e-01	6.98e-01	9.38e-02	4.85e-01
GOBP TRANSCRIPTION DEPENDENT TETHERING OF RNA POLYMERASE II GENE DNA AT NUCLEAR PERIPHERY	7	2.07e-02	6.09e-02	0.6850	-2.12e-01	6.86e-03	-3.28e-01	4.72e-01	-2.61e-02	-3.06e-01	3.31e-01	9.75e-01	1.33e-01	3.06e-02	9.05e-01	1.61e-01
GOBP NEGATIVE REGULATION OF ERYTHROCYTE DIFFERENTIATION	7	1.53e-02	4.79e-02	0.6850	-2.49e-01	1.71e-01	-1.49e-02	-7.51e-02	7.92e-02	-6.05e-01	2.55e-01	4.34e-01	9.46e-01	7.31e-01	7.17e-01	5.53e-03
GOBP PEPTIDYL LYSINE OXIDATION	5	4.19e-01	5.28e-01	0.6850	1.59e-02	1.28e-01	-2.66e-01	-2.33e-01	6.21e-02	-5.69e-01	9.51e-01	6.20e-01	3.04e-01	3.68e-01	8.10e-01	2.75e-02
GOMF PROTEIN LYSINE 6 OXIDASE ACTIVITY	5	4.19e-01	5.28e-01	0.6850	1.59e-02	1.28e-01	-2.66e-01	-2.33e-01	6.21e-02	-5.69e-01	9.51e-01	6.20e-01	3.04e-01	3.68e-01	8.10e-01	2.75e-02
GOBP RESPONSE TO GRAVITY	6	1.57e-01	2.69e-01	0.6850	-3.21e-01	1.99e-01	-4.39e-02	-5.48e-01	1.51e-01	-3.97e-02	1.73e-01	3.98e-01	8.52e-01	2.02e-02	5.23e-01	8.66e-01
GOBP RESPONSE TO LITHIUM ION	11	3.07e-02	8.14e-02	0.6850	2.54e-02	1.42e-01	3.37e-01	4.66e-01	8.19e-02	3.33e-01	8.84e-01	4.14e-01	5.32e-02	7.39e-03	6.38e-01	5.59e-02
GOBP RNA SECONDARY STRUCTURE UNWINDING	9	4.81e-03	1.90e-02	0.6850	-5.80e-01	2.59e-01	9.71e-02	1.60e-02	8.76e-02	2.21e-01	2.60e-03	1.78e-01	6.14e-01	9.34e-01	6.49e-01	2.52e-01
GOBP SEQUESTERING OF TRIGLYCERIDE	15	1.84e-03	8.54e-03	0.6850	-2.46e-01	6.00e-02	4.95e-01	-3.27e-01	-1.86e-01	1.34e-01	9.89e-02	6.88e-01	8.98e-04	2.82e-02	2.13e-01	3.69e-01
GOBP ISOCITRATE METABOLIC PROCESS	6	6.15e-02	1.37e-01	0.6850	-2.26e-01	-5.25e-01	-6.53e-02	3.38e-01	1.21e-01	-9.72e-02	3.38e-01	2.60e-02	7.82e-01	1.52e-01	6.09e-01	6.80e-01
GOBP GLYCEROL TRANSMEMBRANE TRANSPORT	6	3.39e-01	4.56e-01	0.6850	-1.58e-01	1.51e-02	-2.07e-02	-5.09e-01	-4.15e-01	-1.07e-01	5.04e-01	9.49e-01	9.30e-01	3.08e-02	7.80e-02	6.49e-01
GOMF GLYCEROL TRANSMEMBRANE TRANSPORTER ACTIVITY	6	3.39e-01	4.56e-01	0.6850	-1.58e-01	1.51e-02	-2.07e-02	-5.09e-01	-4.15e-01	-1.07e-01	5.04e-01	9.49e-01	9.30e-01	3.08e-02	7.80e-02	6.49e-01
GOMF AMINO ACID SODIUM SYMPORTER ACTIVITY	12	6.16e-02	1.38e-01	0.6850	1.97e-01	3.12e-01	4.53e-01	-1.79e-01	-2.51e-01	1.78e-01	2.37e-01	6.14e-02	6.53e-03	2.83e-01	1.32e-01	2.86e-01
GOBP POSTSYNAPTIC DENSITY PROTEIN 95 CLUSTERING	7	3.59e-01	4.75e-01	0.6840	1.92e-01	2.23e-01	4.98e-01	3.31e-02	8.39e-02	3.55e-01	3.79e-01	3.07e-01	2.26e-02	8.79e-01	7.01e-01	1.04e-01
GOBP SNRNA TRANSPORT	6	4.52e-01	5.58e-01	0.6840	-3.12e-01	-4.35e-01	-2.62e-01	-1.44e-01	-2.89e-01	9.27e-02	1.85e-01	6.48e-02	2.66e-01	5.43e-01	2.21e-01	6.94e-01
GOBP REGULATION OF T HELPER 17 CELL LINEAGE COMMITMENT	8	6.23e-02	1.39e-01	0.6840	3.05e-01	2.33e-01	3.96e-02	5.52e-01	-3.48e-02	-1.17e-01	1.35e-01	2.55e-01	8.46e-01	6.84e-03	8.65e-01	5.67e-01
GOBP REGULATION OF ATTACHMENT OF MITOTIC SPINDLE MICROTUBULES TO KINETOCHORE	9	2.56e-02	7.15e-02	0.6840	-1.56e-01	-1.96e-01	2.62e-01	4.11e-01	-1.77e-01	3.69e-01	4.17e-01	3.08e-01	1.73e-01	3.27e-02	3.58e-01	5.54e-02
GOMF GLYCINE BINDING	5	3.45e-01	4.61e-01	0.6840	-5.38e-02	3.32e-01	1.38e-01	4.14e-01	3.98e-01	7.93e-02	8.35e-01	1.98e-01	5.94e-01	1.09e-01	1.23e-01	7.59e-01
GOCC CHROMATOID BODY	7	1.00e-01	1.96e-01	0.6840	-3.32e-01	1.83e-01	1.03e-01	-8.92e-02	1.35e-01	5.36e-01	1.28e-01	4.02e-01	6.37e-01	6.83e-01	5.37e-01	1.40e-02
GOCC EUKARYOTIC TRANSLATION INITIATION FACTOR 4F COMPLEX	12	5.75e-02	1.31e-01	0.6830	-4.96e-01	-3.79e-01	-5.30e-02	-8.78e-02	-2.54e-01	3.80e-02	2.90e-03	2.30e-02	7.51e-01	5.99e-01	1.27e-01	8.20e-01
GOMF HISTONE H3K14 ACETYLTRANSFERASE ACTIVITY	9	3.23e-04	1.92e-03	0.6830	-1.07e-01	2.38e-01	-3.42e-01	4.36e-01	-1.23e-01	-2.77e-01	5.79e-01	2.17e-01	7.58e-02	2.34e-02	5.25e-01	1.51e-01
GOMF AMINO ACID MONOATOMIC CATION SYMPORTER ACTIVITY	15	2.83e-02	7.67e-02	0.6830	1.97e-01	2.29e-01	4.82e-01	-9.18e-02	-2.90e-01	2.25e-01	1.86e-01	1.25e-01	1.22e-03	5.38e-01	5.22e-02	1.32e-01
GOCC DNA REPLICATION FACTOR C COMPLEX	5	3.67e-01	4.82e-01	0.6830	-9.98e-02	-1.23e-01	-5.13e-01	-2.31e-01	2.96e-01	-1.95e-01	6.99e-01	6.34e-01	4.72e-02	3.70e-01	2.52e-01	4.51e-01
GOBP POSITIVE REGULATION OF ACUTE INFLAMMATORY RESPONSE	21	4.45e-05	3.28e-04	0.6830	-6.88e-02	1.68e-01	4.89e-01	-3.25e-01	5.59e-02	2.92e-01	5.85e-01	1.81e-01	1.04e-04	9.90e-03	6.58e-01	2.05e-02
GOBP CAMP BIOSYNTHETIC PROCESS	7	1.17e-01	2.19e-01	0.6830	2.06e-01	5.00e-01	2.68e-01	2.03e-01	4.48e-02	-2.44e-01	3.46e-01	2.20e-02	2.19e-01	3.53e-01	8.37e-01	2.64e-01
GOBP PROTEIN DENEDDYLATION	11	4.09e-02	1.01e-01	0.6830	-1.34e-01	-5.81e-01	-2.94e-01	5.62e-02	-1.36e-01	4.99e-02	4.42e-01	8.44e-04	9.17e-02	7.47e-01	4.34e-01	7.74e-01
GOBP VENTRICULAR COMPACT MYOCARDIUM MORPHOGENESIS	7	3.06e-02	8.12e-02	0.6830	-1.26e-02	5.61e-01	-4.76e-02	-6.67e-03	2.05e-01	3.26e-01	9.54e-01	1.01e-02	8.27e-01	9.76e-01	3.48e-01	1.35e-01
GOBP SUCCINYL COA CATABOLIC PROCESS	6	9.07e-02	1.82e-01	0.6820	9.86e-03	-5.32e-01	1.53e-01	1.96e-02	-4.30e-02	3.97e-01	9.67e-01	2.41e-02	5.17e-01	9.34e-01	8.55e-01	9.23e-02
GOCC AXON HILLOCK	7	8.80e-02	1.78e-01	0.6820	3.02e-01	-1.21e-01	9.55e-02	4.41e-01	-1.68e-01	3.58e-01	1.66e-01	5.79e-01	6.62e-01	4.32e-02	4.42e-01	1.01e-01
GOBP BRANCHIOMOTOR NEURON AXON GUIDANCE	5	5.60e-01	6.49e-01	0.6820	7.92e-02	3.23e-01	1.54e-01	2.88e-01	4.39e-01	2.35e-01	7.59e-01	2.11e-01	5.50e-01	2.65e-01	8.91e-02	3.62e-01
GOBP ENDODERMAL CELL FATE COMMITMENT	10	7.69e-02	1.62e-01	0.6820	-7.52e-02	2.55e-01	3.13e-01	1.75e-01	2.84e-01	4.31e-01	6.80e-01	1.63e-01	8.67e-02	3.38e-01	1.19e-01	1.84e-02
GOBP BLOOD COAGULATION FIBRIN CLOT FORMATION	11	3.21e-02	8.41e-02	0.6820	6.15e-02	-2.19e-01	4.61e-01	-2.17e-01	-3.41e-01	1.93e-01	7.24e-01	2.08e-01	8.13e-03	2.13e-01	5.01e-02	2.68e-01
GOBP RRNA PROCESSING	218	4.08e-45	9.45e-43	0.6820	-1.20e-01	-5.18e-01	-3.95e-01	5.28e-02	-5.90e-02	-1.41e-01	2.20e-03	9.06e-40	8.88e-24	1.79e-01	1.33e-01	3.25e-04
GOBP NEGATIVE REGULATION OF MHC CLASS II BIOSYNTHETIC PROCESS	5	5.68e-01	6.55e-01	0.6820	-9.40e-02	-2.94e-01	1.36e-01	-2.04e-01	-5.19e-01	2.00e-01	7.16e-01	2.55e-01	5.97e-01	4.29e-01	4.46e-02	4.38e-01
GOBP PEPTIDYL HISTIDINE MODIFICATION	9	1.46e-01	2.56e-01	0.6810	-1.22e-01	-5.11e-01	-4.05e-01	-5.08e-02	-1.17e-01	-8.84e-02	5.26e-01	7.95e-03	3.52e-02	7.92e-01	5.43e-01	6.46e-01
GOBP SKELETAL MUSCLE FIBER DIFFERENTIATION	6	1.93e-01	3.09e-01	0.6810	-2.73e-01	-3.34e-02	-1.66e-01	-3.32e-01	1.09e-01	-4.88e-01	2.47e-01	8.87e-01	4.80e-01	1.58e-01	6.44e-01	3.83e-02
GOBP UV DAMAGE EXCISION REPAIR	13	3.44e-02	8.88e-02	0.6810	-3.22e-01	-2.48e-01	-4.15e-01	1.52e-01	1.45e-01	-2.88e-01	4.43e-02	1.22e-01	9.56e-03	3.44e-01	3.66e-01	7.24e-02
GOBP UDP N ACETYLGLUCOSAMINE BIOSYNTHETIC PROCESS	9	5.53e-02	1.27e-01	0.6810	-3.37e-01	-2.94e-02	-3.06e-01	-2.29e-01	-3.47e-01	-2.88e-01	7.96e-02	8.79e-01	1.12e-01	2.35e-01	7.18e-02	1.35e-01
GOBP SCHWANN CELL PROLIFERATION	8	1.92e-01	3.08e-01	0.6810	1.31e-01	1.97e-01	3.96e-01	2.66e-01	-1.96e-01	3.76e-01	5.20e-01	3.34e-01	5.25e-02	1.93e-01	3.37e-01	6.55e-02
GOBP RESPONSE TO NEMATODE	5	1.46e-01	2.56e-01	0.6810	-2.60e-01	2.11e-01	4.00e-01	-3.39e-01	2.19e-01	1.71e-01	3.14e-01	4.14e-01	1.22e-01	1.90e-01	3.97e-01	5.08e-01
GOCC RDNA HETEROCHROMATIN	5	4.31e-01	5.40e-01	0.6810	-1.98e-02	-1.83e-01	-3.04e-01	4.61e-01	2.22e-01	-2.74e-01	9.39e-01	4.78e-01	2.39e-01	7.42e-02	3.90e-01	2.90e-01
GOBP RESPONSE TO POTASSIUM ION	14	6.48e-02	1.43e-01	0.6810	3.91e-01	2.95e-01	1.57e-01	2.53e-01	2.75e-01	2.42e-01	1.12e-02	5.56e-02	3.09e-01	1.01e-01	7.49e-02	1.17e-01
GOCC SPERM PLASMA MEMBRANE	6	3.45e-01	4.61e-01	0.6800	-2.05e-01	4.25e-02	4.24e-01	1.03e-01	-1.14e-01	4.65e-01	3.86e-01	8.57e-01	7.23e-02	6.64e-01	6.28e-01	4.85e-02
GOBP NEGATIVE REGULATION OF HYPOXIA INDUCED INTRINSIC APOPTOTIC SIGNALING PATHWAY	6	1.92e-01	3.08e-01	0.6800	-2.84e-01	-2.45e-01	2.51e-01	2.00e-01	-3.64e-01	2.94e-01	2.28e-01	2.98e-01	2.87e-01	3.97e-01	1.23e-01	2.12e-01
GOBP COENZYME A BIOSYNTHETIC PROCESS	10	1.18e-02	3.92e-02	0.6800	-8.01e-02	-3.35e-01	-1.09e-01	3.97e-01	3.94e-01	1.39e-01	6.61e-01	6.70e-02	5.52e-01	2.98e-02	3.08e-02	4.47e-01
GOCC U12 TYPE SPLICEOSOMAL COMPLEX	26	5.52e-06	4.96e-05	0.6800	-7.30e-02	-5.69e-01	-3.36e-01	8.56e-02	-8.61e-02	7.08e-02	5.19e-01	5.04e-07	3.00e-03	4.50e-01	4.47e-01	5.32e-01
GOBP SRP DEPENDENT COTRANSLATIONAL PROTEIN TARGETING TO MEMBRANE	20	1.60e-03	7.57e-03	0.6800	-2.10e-01	-4.57e-01	2.53e-02	-4.89e-02	-3.11e-01	3.31e-01	1.04e-01	4.08e-04	8.45e-01	7.05e-01	1.61e-02	1.04e-02
GOCC POST MRNA RELEASE SPLICEOSOMAL COMPLEX	10	1.74e-02	5.29e-02	0.6800	-2.96e-01	-3.52e-01	-3.76e-01	1.86e-01	5.03e-02	2.67e-01	1.05e-01	5.38e-02	3.94e-02	3.07e-01	7.83e-01	1.44e-01
GOCC COPI VESICLE COAT	13	2.94e-03	1.27e-02	0.6800	-3.32e-01	-2.62e-01	1.91e-01	2.65e-01	-2.33e-01	3.50e-01	3.82e-02	1.02e-01	2.34e-01	9.80e-02	1.46e-01	2.89e-02
GOBP APOPTOTIC PROCESS INVOLVED IN MORPHOGENESIS	15	1.49e-03	7.15e-03	0.6800	1.84e-01	1.47e-01	3.60e-01	4.97e-01	1.71e-01	3.13e-02	2.18e-01	3.24e-01	1.59e-02	8.60e-04	2.51e-01	8.34e-01
GOBP REGULATION OF TRANSLATION IN RESPONSE TO STRESS	21	1.37e-04	8.97e-04	0.6790	-4.66e-01	-1.59e-01	1.28e-01	-1.25e-02	-3.55e-01	2.76e-01	2.16e-04	2.08e-01	3.12e-01	9.21e-01	4.81e-03	2.85e-02
GOBP RNA 5 END PROCESSING	37	2.93e-08	3.86e-07	0.6790	-1.17e-01	-5.12e-01	-3.93e-01	1.63e-01	-6.33e-02	2.84e-02	2.20e-01	7.04e-08	3.56e-05	8.63e-02	5.05e-01	7.65e-01
GOBP AUTOCRINE SIGNALING	5	4.98e-01	5.95e-01	0.6790	1.37e-01	4.48e-01	2.00e-01	3.17e-02	2.69e-01	3.59e-01	5.96e-01	8.30e-02	4.38e-01	9.02e-01	2.98e-01	1.65e-01
GOBP CHONDROCYTE HYPERTROPHY	5	1.57e-01	2.68e-01	0.6790	2.64e-02	4.19e-01	3.40e-01	2.37e-01	-2.93e-01	1.65e-01	9.19e-01	1.05e-01	1.89e-01	3.58e-01	2.57e-01	5.22e-01
GOMF ATP TRANSMEMBRANE TRANSPORTER ACTIVITY	12	4.48e-02	1.08e-01	0.6790	-1.53e-01	-4.38e-01	-2.28e-01	-1.19e-04	-2.30e-01	-3.75e-01	3.57e-01	8.57e-03	1.71e-01	9.99e-01	1.69e-01	2.45e-02
GOCC U1 SNRNP	19	1.79e-04	1.14e-03	0.6790	-1.07e-03	-4.80e-01	-4.72e-01	-6.18e-02	-1.80e-02	-5.92e-02	9.94e-01	2.93e-04	3.67e-04	6.41e-01	8.92e-01	6.55e-01
GOMF PYRUVATE TRANSMEMBRANE TRANSPORTER ACTIVITY	5	2.73e-01	3.93e-01	0.6780	-3.10e-01	-3.46e-01	-1.00e-01	6.58e-02	1.32e-01	4.61e-01	2.29e-01	1.81e-01	6.99e-01	7.99e-01	6.09e-01	7.41e-02
GOMF INTRAMOLECULAR OXIDOREDUCTASE ACTIVITY INTERCONVERTING ALDOSES AND KETOSES	6	2.11e-01	3.29e-01	0.6780	-3.83e-02	-4.46e-01	-2.99e-01	2.31e-01	2.94e-01	-1.75e-01	8.71e-01	5.85e-02	2.05e-01	3.27e-01	2.12e-01	4.59e-01
GOCC SPLICEOSOMAL TRI SNRNP COMPLEX	37	5.23e-09	7.64e-08	0.6780	3.69e-03	-4.97e-01	-3.86e-01	2.47e-01	5.75e-02	1.83e-02	9.69e-01	1.69e-07	4.90e-05	9.39e-03	5.45e-01	8.48e-01
GOBP INTERLEUKIN 3 MEDIATED SIGNALING PATHWAY	6	4.35e-01	5.42e-01	0.6780	4.55e-02	2.67e-01	3.20e-01	2.25e-01	2.90e-01	3.86e-01	8.47e-01	2.58e-01	1.74e-01	3.40e-01	2.18e-01	1.01e-01
GOMF RNA POLYMERASE I GENERAL TRANSCRIPTION INITIATION FACTOR ACTIVITY	6	2.36e-01	3.54e-01	0.6780	-1.42e-01	7.38e-02	-4.60e-01	2.69e-01	1.39e-01	-3.61e-01	5.46e-01	7.54e-01	5.09e-02	2.54e-01	5.56e-01	1.25e-01
GOBP SNO S RNA METABOLIC PROCESS	15	1.29e-02	4.21e-02	0.6780	-1.50e-01	-4.53e-01	-4.73e-01	5.04e-02	2.06e-02	-6.88e-02	3.14e-01	2.40e-03	1.51e-03	7.35e-01	8.90e-01	6.45e-01
GOMF BMP BINDING	10	8.85e-02	1.79e-01	0.6770	2.52e-01	5.63e-01	1.60e-01	-6.63e-02	1.90e-01	-1.11e-01	1.67e-01	2.05e-03	3.81e-01	7.17e-01	2.99e-01	5.42e-01
GOCC SHELTERIN COMPLEX	6	1.35e-01	2.42e-01	0.6770	-2.37e-01	-2.79e-01	-1.95e-01	4.41e-01	8.12e-02	2.93e-01	3.15e-01	2.36e-01	4.09e-01	6.16e-02	7.31e-01	2.13e-01
GOMF SUPEROXIDE GENERATING NADPH OXIDASE ACTIVATOR ACTIVITY	9	1.73e-02	5.29e-02	0.6770	1.26e-01	1.09e-01	-1.01e-02	-5.28e-01	-1.18e-02	-3.89e-01	5.14e-01	5.71e-01	9.58e-01	6.05e-03	9.51e-01	4.31e-02
GOBP POSITIVE REGULATION OF IRE1 MEDIATED UNFOLDED PROTEIN RESPONSE	6	1.43e-01	2.53e-01	0.6770	-2.15e-01	-3.22e-01	2.22e-01	1.84e-01	-4.70e-01	6.83e-02	3.63e-01	1.72e-01	3.46e-01	4.36e-01	4.61e-02	7.72e-01
GOBP ELECTRON TRANSPORT CHAIN	121	1.03e-25	7.06e-24	0.6770	-1.88e-01	-5.86e-01	-1.96e-01	3.12e-02	-2.00e-01	2.82e-02	3.66e-04	7.34e-29	1.93e-04	5.54e-01	1.48e-04	5.92e-01
GOBP RETINAL ROD CELL DEVELOPMENT	5	5.15e-01	6.09e-01	0.6770	-1.63e-01	1.36e-02	-5.10e-01	1.10e-02	1.06e-01	-4.00e-01	5.27e-01	9.58e-01	4.83e-02	9.66e-01	6.82e-01	1.21e-01
GOBP SUBSTRATE DEPENDENT CELL MIGRATION CELL EXTENSION	9	2.28e-01	3.46e-01	0.6770	-5.12e-01	-2.34e-01	2.08e-02	-2.47e-01	-2.02e-01	1.99e-01	7.86e-03	2.24e-01	9.14e-01	1.99e-01	2.94e-01	3.00e-01
GOMF IMPORTIN ALPHA FAMILY PROTEIN BINDING	9	6.19e-02	1.38e-01	0.6770	-2.81e-01	-1.35e-01	1.97e-01	1.76e-01	-2.26e-01	4.91e-01	1.44e-01	4.83e-01	3.07e-01	3.62e-01	2.41e-01	1.08e-02
GOMF G PROTEIN COUPLED SEROTONIN RECEPTOR ACTIVITY	7	2.22e-01	3.41e-01	0.6770	9.38e-02	4.51e-01	2.50e-01	-6.08e-02	3.96e-01	1.54e-01	6.68e-01	3.90e-02	2.53e-01	7.81e-01	6.98e-02	4.80e-01
GOBP PYRIMIDINE RIBONUCLEOSIDE DIPHOSPHATE METABOLIC PROCESS	7	8.80e-02	1.78e-01	0.6770	-3.19e-01	2.59e-02	-7.46e-02	3.12e-01	4.26e-01	2.67e-01	1.44e-01	9.05e-01	7.32e-01	1.52e-01	5.11e-02	2.21e-01
GOMF PROTEIN CARBOXYL O METHYLTRANSFERASE ACTIVITY	6	2.57e-01	3.77e-01	0.6770	-5.96e-01	-1.09e-01	-1.76e-01	-1.44e-01	-1.53e-01	1.25e-01	1.15e-02	6.43e-01	4.55e-01	5.43e-01	5.17e-01	5.95e-01
GOMF NADH DEHYDROGENASE ACTIVITY	11	2.95e-02	7.92e-02	0.6770	-8.55e-02	-6.04e-01	-1.98e-01	1.57e-01	-1.31e-01	-6.50e-02	6.23e-01	5.18e-04	2.57e-01	3.67e-01	4.51e-01	7.09e-01
GOBP AXIAL MESODERM DEVELOPMENT	7	2.24e-01	3.43e-01	0.6760	1.88e-01	2.67e-01	-3.89e-01	2.63e-01	3.31e-01	-1.44e-01	3.88e-01	2.21e-01	7.47e-02	2.29e-01	1.30e-01	5.11e-01
GOMF PROTEIN PRENYLTRANSFERASE ACTIVITY	7	2.99e-01	4.19e-01	0.6760	-4.60e-01	-1.62e-01	-3.43e-01	-3.18e-01	1.01e-02	1.43e-02	3.53e-02	4.57e-01	1.16e-01	1.45e-01	9.63e-01	9.48e-01
GOCC REPLISOME	23	1.55e-05	1.25e-04	0.6760	9.45e-02	-3.58e-01	-2.13e-01	4.09e-01	3.23e-01	5.29e-02	4.33e-01	2.96e-03	7.73e-02	6.87e-04	7.24e-03	6.60e-01
GOBP CALCIUM IMPORT INTO THE MITOCHONDRION	16	7.89e-03	2.85e-02	0.6760	-3.03e-01	-5.51e-01	-2.36e-01	-6.92e-02	-9.33e-03	-3.49e-02	3.59e-02	1.37e-04	1.02e-01	6.32e-01	9.49e-01	8.09e-01
GOBP BRANCHING INVOLVED IN PROSTATE GLAND MORPHOGENESIS	5	6.23e-01	7.00e-01	0.6760	1.17e-01	2.83e-01	4.73e-01	-9.60e-02	-3.24e-03	3.59e-01	6.49e-01	2.74e-01	6.67e-02	7.10e-01	9.90e-01	1.64e-01
GOBP ERBB4 SIGNALING PATHWAY	6	8.34e-02	1.72e-01	0.6750	-1.27e-01	5.02e-01	1.06e-01	-1.36e-02	2.40e-01	-3.45e-01	5.90e-01	3.33e-02	6.53e-01	9.54e-01	3.09e-01	1.44e-01
GOBP PROTEIN LOCALIZATION TO ADHERENS JUNCTION	6	2.31e-01	3.49e-01	0.6750	-2.51e-01	6.53e-02	2.87e-01	-9.71e-02	-5.12e-01	1.86e-01	2.88e-01	7.82e-01	2.24e-01	6.81e-01	2.98e-02	4.31e-01
GOBP ODONTOBLAST DIFFERENTIATION	10	6.66e-02	1.46e-01	0.6750	-1.64e-02	-3.48e-01	2.55e-01	-3.06e-03	-5.11e-01	9.06e-02	9.28e-01	5.68e-02	1.63e-01	9.87e-01	5.14e-03	6.20e-01
GOBP ATTACHMENT OF MITOTIC SPINDLE MICROTUBULES TO KINETOCHORE	24	7.03e-06	6.16e-05	0.6750	-5.00e-02	-3.46e-01	1.26e-01	3.43e-01	-1.86e-01	4.07e-01	6.72e-01	3.35e-03	2.86e-01	3.67e-03	1.15e-01	5.64e-04
GOBP CARBOHYDRATE IMPORT ACROSS PLASMA MEMBRANE	5	4.60e-01	5.65e-01	0.6740	3.44e-01	2.79e-01	3.92e-01	2.96e-01	1.06e-01	-7.63e-02	1.82e-01	2.79e-01	1.29e-01	2.52e-01	6.82e-01	7.68e-01
GOBP ACYLGLYCEROL TRANSPORT	5	1.59e-01	2.71e-01	0.6740	1.54e-01	-1.97e-02	4.27e-01	1.93e-01	3.65e-01	2.80e-01	5.51e-01	9.39e-01	9.83e-02	4.56e-01	1.58e-01	2.78e-01
GOBP DOUBLE STRAND BREAK REPAIR VIA SYNTHESIS DEPENDENT STRAND ANNEALING	7	2.05e-01	3.22e-01	0.6740	2.88e-01	-1.41e-01	1.79e-02	4.72e-01	2.73e-01	2.33e-01	1.87e-01	5.18e-01	9.35e-01	3.06e-02	2.11e-01	2.87e-01
GOBP TRIGLYCERIDE RICH LIPOPROTEIN PARTICLE REMODELING	6	1.67e-02	5.14e-02	0.6740	3.27e-01	-1.06e-01	4.76e-01	1.33e-01	-8.91e-02	-2.90e-01	1.65e-01	6.54e-01	4.36e-02	5.73e-01	7.05e-01	2.18e-01
GOBP NEGATIVE REGULATION OF INTERLEUKIN 17 PRODUCTION	13	3.36e-02	8.73e-02	0.6740	-1.15e-01	-4.05e-01	1.16e-01	-1.84e-01	-4.69e-01	-9.87e-02	4.71e-01	1.15e-02	4.68e-01	2.51e-01	3.42e-03	5.38e-01
GOMF PROTEIN GLUTAMINE GAMMA GLUTAMYLTRANSFERASE ACTIVITY	6	5.01e-01	5.98e-01	0.6740	3.10e-01	2.91e-01	3.93e-01	1.95e-01	2.38e-01	1.54e-01	1.89e-01	2.17e-01	9.51e-02	4.09e-01	3.12e-01	5.13e-01
GOBP PROTEIN TARGETING TO PEROXISOME	9	2.64e-01	3.84e-01	0.6740	-4.16e-01	-3.24e-01	-3.72e-01	-1.22e-01	4.69e-02	-1.42e-01	3.06e-02	9.19e-02	5.34e-02	5.28e-01	8.07e-01	4.61e-01
GOBP CALCIUM INDEPENDENT CELL CELL ADHESION VIA PLASMA MEMBRANE CELL ADHESION MOLECULES	8	2.39e-01	3.57e-01	0.6740	1.05e-01	-9.85e-02	-4.30e-01	-1.22e-01	9.76e-02	-4.73e-01	6.09e-01	6.29e-01	3.53e-02	5.49e-01	6.33e-01	2.04e-02
GOMF 3 PHOSPHOADENOSINE 5 PHOSPHOSULFATE BINDING	5	3.31e-01	4.49e-01	0.6740	2.33e-01	4.61e-01	-2.66e-01	1.89e-01	2.26e-01	-1.72e-01	3.66e-01	7.41e-02	3.04e-01	4.65e-01	3.82e-01	5.06e-01
GOBP CELLULAR RESPONSE TO FOLLICLE STIMULATING HORMONE STIMULUS	7	1.93e-01	3.09e-01	0.6740	2.33e-01	7.86e-03	5.71e-01	-1.50e-02	-2.03e-01	1.77e-01	2.85e-01	9.71e-01	8.88e-03	9.45e-01	3.52e-01	4.16e-01
GOBP REGULATION OF FEMALE GONAD DEVELOPMENT	5	5.00e-01	5.98e-01	0.6730	2.95e-01	-4.94e-02	4.55e-01	9.42e-02	-2.82e-01	2.61e-01	2.53e-01	8.48e-01	7.79e-02	7.15e-01	2.75e-01	3.11e-01
GOBP ETHER BIOSYNTHETIC PROCESS	12	3.20e-02	8.38e-02	0.6730	-3.99e-01	-5.86e-02	2.75e-01	-3.71e-01	-7.83e-02	2.67e-01	1.68e-02	7.25e-01	9.95e-02	2.59e-02	6.39e-01	1.09e-01
GOBP VITAMIN B6 METABOLIC PROCESS	5	2.93e-01	4.13e-01	0.6730	2.86e-01	-2.11e-02	4.81e-02	3.40e-01	4.69e-01	-1.81e-01	2.68e-01	9.35e-01	8.52e-01	1.88e-01	6.91e-02	4.84e-01
GOBP T CELL LINEAGE COMMITMENT	30	5.30e-06	4.79e-05	0.6730	3.42e-01	3.68e-01	1.88e-01	3.60e-01	-3.39e-02	1.84e-01	1.18e-03	4.77e-04	7.46e-02	6.41e-04	7.48e-01	8.03e-02
GOBP NEUROBLAST DIVISION	13	4.36e-02	1.06e-01	0.6730	2.70e-01	4.04e-01	3.56e-01	1.57e-01	-1.25e-01	2.22e-01	9.17e-02	1.16e-02	2.63e-02	3.26e-01	4.34e-01	1.66e-01
GOMF ADP TRANSMEMBRANE TRANSPORTER ACTIVITY	9	1.47e-01	2.57e-01	0.6730	-9.90e-02	-4.61e-01	-2.97e-01	1.22e-01	-1.96e-01	-2.97e-01	6.07e-01	1.65e-02	1.23e-01	5.25e-01	3.08e-01	1.23e-01
GOBP CERAMIDE CATABOLIC PROCESS	17	3.43e-03	1.44e-02	0.6730	-4.39e-01	-1.82e-01	2.36e-01	-3.41e-01	-1.26e-01	1.97e-01	1.74e-03	1.93e-01	9.20e-02	1.48e-02	3.67e-01	1.61e-01
GOBP MITOTIC DNA REPLICATION CHECKPOINT SIGNALING	10	5.13e-02	1.19e-01	0.6730	1.24e-01	-1.76e-01	2.11e-01	3.95e-01	2.70e-02	4.52e-01	4.98e-01	3.36e-01	2.47e-01	3.04e-02	8.82e-01	1.33e-02
GOCC U2 SNRNP	25	8.42e-06	7.22e-05	0.6720	-6.92e-02	-5.08e-01	-3.40e-01	2.52e-01	3.04e-02	9.42e-02	5.49e-01	1.09e-05	3.27e-03	2.91e-02	7.92e-01	4.15e-01
GOMF LIGAND GATED MONOATOMIC ION CHANNEL ACTIVITY INVOLVED IN REGULATION OF PRESYNAPTIC MEMBRANE POTENTIAL	5	5.85e-01	6.69e-01	0.6720	3.50e-01	2.05e-01	1.01e-01	4.56e-01	2.05e-01	-1.64e-01	1.76e-01	4.28e-01	6.94e-01	7.72e-02	4.28e-01	5.25e-01
GOMF AP 1 ADAPTOR COMPLEX BINDING	5	2.91e-01	4.10e-01	0.6720	-3.17e-01	-4.72e-01	-1.37e-01	3.20e-01	6.66e-05	8.69e-02	2.20e-01	6.79e-02	5.95e-01	2.16e-01	1.00e+00	7.37e-01
GOBP NUCLEOSIDE TRIPHOSPHATE BIOSYNTHETIC PROCESS	115	1.60e-26	1.20e-24	0.6720	-1.39e-01	-6.07e-01	-2.11e-01	5.70e-02	-1.24e-01	-2.01e-02	1.01e-02	2.05e-29	9.39e-05	2.91e-01	2.17e-02	7.10e-01
GOMF DNA METHYLTRANSFERASE ACTIVITY	6	4.02e-01	5.14e-01	0.6720	4.37e-02	5.28e-02	-1.41e-01	4.18e-01	4.97e-01	7.18e-02	8.53e-01	8.23e-01	5.50e-01	7.64e-02	3.50e-02	7.61e-01
GOBP REGULATION OF AMYLOID FIBRIL FORMATION	13	1.19e-02	3.94e-02	0.6710	-2.05e-01	-4.95e-01	7.65e-02	2.39e-02	-1.37e-01	3.73e-01	2.01e-01	2.00e-03	6.33e-01	8.81e-01	3.92e-01	2.00e-02
GOBP POSITIVE T CELL SELECTION	40	2.29e-07	2.65e-06	0.6710	2.77e-01	3.74e-01	1.52e-01	3.98e-01	9.00e-02	2.11e-01	2.47e-03	4.21e-05	9.72e-02	1.34e-05	3.25e-01	2.08e-02
GOBP PYRUVATE FAMILY AMINO ACID CATABOLIC PROCESS	7	1.65e-01	2.78e-01	0.6710	-6.85e-02	-2.41e-01	-5.82e-01	2.89e-02	2.06e-01	-7.13e-02	7.54e-01	2.70e-01	7.61e-03	8.95e-01	3.45e-01	7.44e-01
GOBP REGULATION OF RESPIRATORY BURST INVOLVED IN INFLAMMATORY RESPONSE	6	2.89e-01	4.09e-01	0.6710	1.82e-02	-2.29e-01	1.69e-02	-4.75e-01	-3.33e-01	-2.45e-01	9.38e-01	3.30e-01	9.43e-01	4.37e-02	1.58e-01	2.99e-01
GOBP FOLATE TRANSMEMBRANE TRANSPORT	5	2.64e-01	3.83e-01	0.6710	-3.62e-01	-7.09e-03	-2.19e-01	-1.34e-01	3.51e-01	-3.60e-01	1.62e-01	9.78e-01	3.96e-01	6.04e-01	1.74e-01	1.63e-01
GOBP EMBRYONIC DIGESTIVE TRACT DEVELOPMENT	15	5.28e-03	2.05e-02	0.6710	1.23e-01	2.12e-01	5.00e-01	-1.21e-01	1.51e-01	3.20e-01	4.11e-01	1.55e-01	7.96e-04	4.18e-01	3.10e-01	3.20e-02
GOCC UBIQUITIN CONJUGATING ENZYME COMPLEX	8	1.40e-01	2.49e-01	0.6710	-2.99e-01	-3.75e-01	5.96e-02	-8.24e-02	-6.62e-02	4.52e-01	1.43e-01	6.60e-02	7.70e-01	6.86e-01	7.46e-01	2.67e-02
GOCC MULTIVESICULAR BODY LUMEN	5	4.84e-01	5.85e-01	0.6700	-1.38e-01	-1.40e-01	-1.05e-01	-4.23e-01	-2.10e-01	-4.20e-01	5.92e-01	5.88e-01	6.83e-01	1.01e-01	4.17e-01	1.04e-01
GOBP ANTIGEN PROCESSING AND PRESENTATION OF ENDOGENOUS ANTIGEN	26	9.11e-04	4.70e-03	0.6700	-2.44e-01	-3.69e-01	-4.32e-01	8.46e-02	-1.81e-02	-2.43e-01	3.11e-02	1.14e-03	1.35e-04	4.55e-01	8.73e-01	3.17e-02
GOBP EMBRYONIC CLEAVAGE	8	1.26e-01	2.31e-01	0.6700	3.98e-02	-1.94e-02	4.01e-01	3.77e-01	-1.58e-01	3.45e-01	8.45e-01	9.24e-01	4.93e-02	6.51e-02	4.38e-01	9.14e-02
GOCC DNA REPLICATION PREINITIATION COMPLEX	12	3.85e-03	1.58e-02	0.6700	2.45e-01	-3.33e-01	-1.41e-01	4.14e-01	9.69e-02	2.76e-01	1.41e-01	4.57e-02	3.99e-01	1.30e-02	5.61e-01	9.73e-02
GOBP NEGATIVE REGULATION OF TRANSCRIPTION REGULATORY REGION DNA BINDING	6	1.57e-01	2.68e-01	0.6690	1.78e-01	-4.06e-01	3.45e-01	1.31e-01	-2.21e-01	2.58e-01	4.50e-01	8.53e-02	1.43e-01	5.77e-01	3.48e-01	2.75e-01
GOMF DNA BINDING BENDING	11	2.36e-02	6.72e-02	0.6690	-2.26e-01	-2.38e-01	2.36e-01	2.65e-01	-1.53e-01	4.37e-01	1.94e-01	1.72e-01	1.76e-01	1.28e-01	3.79e-01	1.21e-02
GOCC U2AF COMPLEX	6	2.83e-01	4.02e-01	0.6690	4.24e-01	-6.47e-03	-1.10e-01	1.28e-01	9.42e-02	-4.80e-01	7.20e-02	9.78e-01	6.40e-01	5.87e-01	6.89e-01	4.18e-02
GOBP POSITIVE REGULATION OF CREB TRANSCRIPTION FACTOR ACTIVITY	10	1.39e-01	2.47e-01	0.6690	3.32e-01	3.01e-01	-1.16e-01	2.60e-01	1.62e-01	-3.73e-01	6.89e-02	9.98e-02	5.24e-01	1.55e-01	3.74e-01	4.11e-02
GOBP N ACETYLNEURAMINATE CATABOLIC PROCESS	6	4.49e-01	5.56e-01	0.6690	-2.81e-01	-1.21e-01	-4.04e-01	-2.86e-02	8.83e-03	-4.35e-01	2.33e-01	6.07e-01	8.64e-02	9.03e-01	9.70e-01	6.51e-02
GOBP REGULATION OF IRE1 MEDIATED UNFOLDED PROTEIN RESPONSE	13	5.84e-03	2.23e-02	0.6690	-2.86e-01	-3.03e-01	4.58e-02	1.64e-01	-4.07e-01	2.81e-01	7.44e-02	5.90e-02	7.75e-01	3.07e-01	1.10e-02	7.93e-02
GOBP DTMP METABOLIC PROCESS	6	1.91e-01	3.07e-01	0.6690	4.32e-02	-6.15e-01	-6.24e-02	-6.99e-02	-2.38e-01	-2.80e-02	8.55e-01	9.04e-03	7.91e-01	7.67e-01	3.12e-01	9.06e-01
GOBP OUTER EAR MORPHOGENESIS	5	6.38e-01	7.13e-01	0.6680	-4.78e-01	-1.93e-01	-1.40e-01	-2.73e-01	-2.83e-01	-8.01e-02	6.40e-02	4.54e-01	5.87e-01	2.91e-01	2.73e-01	7.56e-01
GOMF APOLIPOPROTEIN BINDING	12	4.20e-02	1.03e-01	0.6680	1.48e-01	1.99e-01	5.24e-01	2.51e-01	-1.61e-03	2.16e-01	3.73e-01	2.32e-01	1.66e-03	1.32e-01	9.92e-01	1.95e-01
GOBP VESICLE CARGO LOADING	32	3.96e-08	5.12e-07	0.6680	-4.04e-01	8.99e-02	3.21e-01	6.97e-02	-6.71e-02	4.03e-01	7.74e-05	3.79e-01	1.66e-03	4.95e-01	5.11e-01	7.81e-05
GOBP APOLIPOPROTEIN A I MEDIATED SIGNALING PATHWAY	5	3.41e-01	4.58e-01	0.6680	-4.19e-01	-2.29e-01	3.26e-01	-1.15e-01	-2.85e-01	1.31e-01	1.04e-01	3.75e-01	2.06e-01	6.55e-01	2.70e-01	6.12e-01
GOBP INHIBITORY SYNAPSE ASSEMBLY	11	2.01e-02	5.95e-02	0.6680	-1.14e-01	1.72e-01	3.93e-01	-3.96e-01	-2.82e-01	-1.13e-01	5.12e-01	3.24e-01	2.40e-02	2.30e-02	1.06e-01	5.17e-01
GOMF AMIDINE LYASE ACTIVITY	6	2.43e-01	3.61e-01	0.6680	-1.33e-01	-5.28e-01	-8.17e-02	3.45e-02	-1.67e-01	3.37e-01	5.74e-01	2.51e-02	7.29e-01	8.84e-01	4.78e-01	1.53e-01
GOBP PROTEIN NEDDYLATION	28	1.33e-04	8.70e-04	0.6680	-3.61e-01	-4.58e-01	-1.75e-01	-9.62e-02	-1.40e-01	2.14e-01	9.39e-04	2.68e-05	1.09e-01	3.78e-01	2.01e-01	5.01e-02
GOBP NERVOUS SYSTEM PROCESS INVOLVED IN REGULATION OF SYSTEMIC ARTERIAL BLOOD PRESSURE	5	5.11e-01	6.06e-01	0.6680	2.35e-02	3.64e-01	4.81e-01	1.34e-01	7.14e-02	2.41e-01	9.28e-01	1.59e-01	6.25e-02	6.04e-01	7.82e-01	3.50e-01
GOBP NEGATIVE REGULATION OF T CELL MIGRATION	5	5.02e-01	5.98e-01	0.6670	2.21e-01	-4.16e-02	4.67e-01	4.72e-02	-3.70e-01	1.95e-01	3.93e-01	8.72e-01	7.05e-02	8.55e-01	1.52e-01	4.50e-01
GOMF EXTRACELLULAR MATRIX CONSTITUENT CONFERRING ELASTICITY	9	1.67e-01	2.79e-01	0.6670	1.47e-02	1.07e-01	5.28e-01	-9.49e-02	-3.54e-02	3.80e-01	9.39e-01	5.79e-01	6.06e-03	6.22e-01	8.54e-01	4.83e-02
GOMF PROTEIN KINASE A CATALYTIC SUBUNIT BINDING	12	3.12e-02	8.24e-02	0.6670	-4.10e-02	-1.21e-01	3.61e-01	2.86e-01	-9.66e-02	4.56e-01	8.06e-01	4.69e-01	3.04e-02	8.67e-02	5.63e-01	6.23e-03
GOCC NMDA SELECTIVE GLUTAMATE RECEPTOR COMPLEX	6	2.86e-01	4.05e-01	0.6670	5.51e-02	2.40e-01	6.56e-03	3.08e-01	4.92e-01	-2.18e-01	8.15e-01	3.10e-01	9.78e-01	1.91e-01	3.68e-02	3.56e-01
GOBP LEUKOTRIENE D4 BIOSYNTHETIC PROCESS	5	3.73e-01	4.88e-01	0.6670	8.24e-02	-9.29e-02	2.69e-01	3.02e-01	2.50e-01	4.51e-01	7.50e-01	7.19e-01	2.97e-01	2.42e-01	3.33e-01	8.07e-02
GOBP CELL CYCLE DNA REPLICATION INITIATION	5	2.16e-01	3.33e-01	0.6670	1.81e-01	-4.15e-01	-3.03e-01	3.33e-01	7.66e-02	1.78e-01	4.84e-01	1.08e-01	2.40e-01	1.98e-01	7.67e-01	4.90e-01
GOBP PEPTIDYL ARGININE MODIFICATION	12	1.53e-02	4.81e-02	0.6670	1.52e-03	-3.58e-01	-3.85e-01	4.05e-01	-2.93e-03	-6.75e-02	9.93e-01	3.16e-02	2.11e-02	1.51e-02	9.86e-01	6.86e-01
GOMF ATP DEPENDENT PROTEIN DISAGGREGASE ACTIVITY	6	1.16e-01	2.19e-01	0.6670	3.27e-02	2.61e-01	1.42e-01	4.95e-01	2.57e-01	-2.12e-01	8.90e-01	2.69e-01	5.47e-01	3.59e-02	2.76e-01	3.69e-01
GOMF DISULFIDE OXIDOREDUCTASE ACTIVITY	38	8.90e-08	1.10e-06	0.6670	-4.31e-01	-3.44e-01	1.08e-01	3.47e-02	-1.92e-01	3.01e-01	4.23e-06	2.44e-04	2.48e-01	7.11e-01	4.01e-02	1.34e-03
GOBP INDOLE CONTAINING COMPOUND CATABOLIC PROCESS	8	1.41e-01	2.50e-01	0.6670	-6.96e-02	1.12e-01	-3.76e-01	5.36e-02	5.31e-01	-3.36e-02	7.33e-01	5.83e-01	6.55e-02	7.93e-01	9.34e-03	8.69e-01
GOBP REGULATION OF GOLGI TO PLASMA MEMBRANE PROTEIN TRANSPORT	8	2.41e-01	3.59e-01	0.6670	-4.08e-01	-4.09e-01	1.88e-02	-2.80e-02	-2.17e-01	2.51e-01	4.58e-02	4.54e-02	9.26e-01	8.91e-01	2.89e-01	2.19e-01
GOBP ENDOTHELIAL CELL MORPHOGENESIS	6	1.71e-01	2.84e-01	0.6670	1.35e-01	-1.10e-02	4.25e-01	1.72e-01	2.86e-01	3.66e-01	5.67e-01	9.63e-01	7.17e-02	4.65e-01	2.24e-01	1.20e-01
GOBP SNRNA MODIFICATION	7	2.80e-01	3.99e-01	0.6670	-1.74e-01	-4.12e-01	-4.66e-01	3.41e-02	1.52e-01	-5.21e-02	4.25e-01	5.89e-02	3.28e-02	8.76e-01	4.86e-01	8.11e-01
GOBP POSITIVE THYMIC T CELL SELECTION	13	1.15e-02	3.83e-02	0.6660	1.69e-01	3.51e-01	-3.45e-02	4.38e-01	2.17e-01	2.29e-01	2.91e-01	2.84e-02	8.29e-01	6.24e-03	1.76e-01	1.53e-01
GOBP BLOOD VESSEL MATURATION	6	3.74e-01	4.89e-01	0.6660	1.25e-01	2.06e-01	2.95e-01	4.01e-01	-1.90e-02	3.71e-01	5.95e-01	3.82e-01	2.11e-01	8.89e-02	9.36e-01	1.15e-01
GOBP MEMBRANE HYPERPOLARIZATION	5	6.35e-01	7.10e-01	0.6660	-7.64e-02	1.44e-03	-4.19e-01	1.16e-01	3.60e-01	-3.46e-01	7.67e-01	9.96e-01	1.05e-01	6.53e-01	1.63e-01	1.80e-01
GOMF LEUCINE ZIPPER DOMAIN BINDING	11	3.88e-02	9.73e-02	0.6660	-1.36e-01	-4.66e-01	7.24e-02	-1.31e-01	-3.87e-01	-1.88e-01	4.34e-01	7.45e-03	6.77e-01	4.53e-01	2.62e-02	2.79e-01
GOBP REGULATION OF ENDOSOME ORGANIZATION	5	7.62e-02	1.61e-01	0.6650	-3.87e-01	-4.08e-02	5.11e-01	2.67e-02	-6.84e-03	1.72e-01	1.34e-01	8.75e-01	4.79e-02	9.18e-01	9.79e-01	5.05e-01
GOBP CALCIUM ION EXPORT ACROSS PLASMA MEMBRANE	8	3.35e-01	4.52e-01	0.6650	-3.63e-01	-3.64e-01	-2.14e-02	-1.98e-01	-2.43e-01	2.82e-01	7.55e-02	7.45e-02	9.17e-01	3.31e-01	2.34e-01	1.68e-01
GOBP NEGATIVE REGULATION OF CIRCADIAN RHYTHM	8	2.24e-02	6.46e-02	0.6650	-6.69e-02	1.74e-01	-3.46e-01	4.08e-01	2.86e-02	-3.47e-01	7.43e-01	3.95e-01	8.97e-02	4.57e-02	8.88e-01	8.94e-02
GOMF PROTON CHANNEL ACTIVITY	21	1.25e-04	8.24e-04	0.6650	-7.10e-02	-6.09e-01	-3.84e-02	8.65e-02	-2.33e-01	5.44e-02	5.73e-01	1.36e-06	7.61e-01	4.92e-01	6.45e-02	6.66e-01
GOBP NEGATIVE REGULATION OF LIPOPROTEIN PARTICLE CLEARANCE	7	4.08e-02	1.01e-01	0.6650	-3.88e-02	-3.09e-01	4.63e-01	1.84e-01	-3.01e-01	7.92e-02	8.59e-01	1.57e-01	3.39e-02	4.00e-01	1.68e-01	7.17e-01
GOBP REGULATION OF VITAMIN D RECEPTOR SIGNALING PATHWAY	9	2.22e-03	1.00e-02	0.6640	-3.14e-01	2.15e-01	5.91e-02	1.58e-02	4.71e-01	-2.67e-01	1.03e-01	2.63e-01	7.59e-01	9.35e-01	1.45e-02	1.65e-01
GOBP REGULATION OF PROTEIN LIPIDATION	9	4.51e-02	1.09e-01	0.6640	-3.30e-01	-1.09e-01	4.21e-02	1.76e-01	1.07e-01	5.26e-01	8.67e-02	5.70e-01	8.27e-01	3.60e-01	5.80e-01	6.29e-03
GOBP REGULATION OF MYELOID DENDRITIC CELL ACTIVATION	5	2.79e-01	3.98e-01	0.6640	2.00e-01	4.71e-01	2.46e-01	3.89e-02	-2.07e-01	2.73e-01	4.38e-01	6.80e-02	3.41e-01	8.80e-01	4.23e-01	2.91e-01
GOBP TANGENTIAL MIGRATION FROM THE SUBVENTRICULAR ZONE TO THE OLFACTORY BULB	6	3.96e-01	5.09e-01	0.6640	-1.60e-01	3.26e-01	4.10e-01	-8.76e-02	-8.25e-02	3.57e-01	4.99e-01	1.67e-01	8.20e-02	7.10e-01	7.26e-01	1.30e-01
GOMF FOUR WAY JUNCTION HELICASE ACTIVITY	6	3.89e-01	5.03e-01	0.6640	3.36e-01	-1.52e-02	4.62e-02	4.83e-01	1.75e-01	2.49e-01	1.54e-01	9.49e-01	8.45e-01	4.04e-02	4.58e-01	2.91e-01
GOMF OXIDOREDUCTASE ACTIVITY ACTING ON NAD P H HEME PROTEIN AS ACCEPTOR	10	7.29e-02	1.56e-01	0.6640	-4.01e-01	-8.74e-02	3.05e-01	-1.80e-02	-2.03e-01	3.71e-01	2.81e-02	6.32e-01	9.44e-02	9.22e-01	2.66e-01	4.21e-02
GOBP REGULATION OF T HELPER 1 CELL DIFFERENTIATION	10	1.65e-01	2.78e-01	0.6640	-5.35e-02	-1.96e-03	4.68e-01	5.76e-02	-2.04e-01	4.17e-01	7.70e-01	9.91e-01	1.03e-02	7.52e-01	2.65e-01	2.24e-02
GOBP PROTEIN MATURATION BY PROTEIN FOLDING	8	1.16e-01	2.18e-01	0.6640	-1.91e-01	-4.91e-01	-9.57e-02	2.19e-01	-2.54e-01	2.04e-01	3.49e-01	1.62e-02	6.39e-01	2.83e-01	2.14e-01	3.18e-01
GOCC GPI ANCHOR TRANSAMIDASE COMPLEX	5	1.77e-01	2.92e-01	0.6640	-8.68e-02	-3.34e-01	1.84e-01	4.01e-01	2.05e-01	2.91e-01	7.37e-01	1.95e-01	4.77e-01	1.20e-01	4.28e-01	2.59e-01
GOBP MATURATION OF SSU RRNA FROM TRICISTRONIC RRNA TRANSCRIPT SSU RRNA 5 8S RRNA LSU RRNA	34	2.94e-06	2.82e-05	0.6640	-1.45e-03	-4.96e-01	-3.54e-01	1.20e-01	-9.68e-02	-2.15e-01	9.88e-01	5.61e-07	3.57e-04	2.27e-01	3.29e-01	3.04e-02
GOBP REGULATION OF CENTROMERE COMPLEX ASSEMBLY	6	2.46e-01	3.64e-01	0.6640	-4.51e-01	-4.66e-03	1.57e-01	-1.49e-02	3.83e-02	4.60e-01	5.59e-02	9.84e-01	5.05e-01	9.49e-01	8.71e-01	5.13e-02
GOMF LIM DOMAIN BINDING	5	1.49e-01	2.59e-01	0.6640	-3.90e-01	-3.01e-01	-1.53e-01	3.37e-01	3.39e-02	-2.44e-01	1.31e-01	2.44e-01	5.54e-01	1.91e-01	8.95e-01	3.46e-01
GOBP RETINA VASCULATURE DEVELOPMENT IN CAMERA TYPE EYE	16	5.43e-03	2.10e-02	0.6630	-1.73e-01	2.63e-01	4.70e-01	3.42e-02	-1.78e-02	3.45e-01	2.30e-01	6.85e-02	1.15e-03	8.13e-01	9.02e-01	1.69e-02
GOMF ANAPHASE PROMOTING COMPLEX BINDING	9	1.15e-01	2.16e-01	0.6630	2.95e-01	-1.11e-01	2.49e-01	4.19e-01	-4.55e-02	3.18e-01	1.25e-01	5.63e-01	1.97e-01	2.95e-02	8.13e-01	9.86e-02
GOBP NEGATIVE REGULATION OF AUTOPHAGOSOME MATURATION	5	1.47e-01	2.57e-01	0.6630	7.68e-02	1.08e-01	2.28e-01	5.96e-01	-1.23e-01	2.54e-02	7.66e-01	6.77e-01	3.77e-01	2.11e-02	6.35e-01	9.22e-01
GOMF K63 LINKED DEUBIQUITINASE ACTIVITY	15	1.27e-02	4.13e-02	0.6630	-1.53e-01	3.65e-01	3.74e-01	-5.41e-02	6.53e-02	3.69e-01	3.04e-01	1.45e-02	1.21e-02	7.17e-01	6.62e-01	1.33e-02
GOBP NEGATIVE REGULATION OF ESTABLISHMENT OF PROTEIN LOCALIZATION TO MITOCHONDRION	6	3.23e-01	4.42e-01	0.6630	-1.38e-01	3.49e-01	2.89e-01	-2.41e-01	1.02e-01	3.83e-01	5.58e-01	1.38e-01	2.20e-01	3.07e-01	6.64e-01	1.04e-01
GOMF PHOSPHATIDYLINOSITOL 3 5 BISPHOSPHATE 3 PHOSPHATASE ACTIVITY	11	4.35e-03	1.75e-02	0.6630	-2.79e-01	2.57e-01	2.37e-01	5.76e-02	-2.86e-01	3.94e-01	1.10e-01	1.41e-01	1.73e-01	7.41e-01	1.01e-01	2.37e-02
GOCC PRESYNAPTIC ENDOCYTIC ZONE	8	2.25e-01	3.44e-01	0.6630	-4.25e-01	-3.47e-01	-3.43e-01	8.96e-02	-4.11e-02	-1.05e-01	3.75e-02	8.88e-02	9.27e-02	6.61e-01	8.41e-01	6.06e-01
GOBP MALE GENITALIA DEVELOPMENT	11	7.02e-02	1.51e-01	0.6630	-4.75e-03	-1.52e-01	2.95e-01	-4.37e-01	-3.59e-01	9.80e-02	9.78e-01	3.84e-01	9.01e-02	1.20e-02	3.93e-02	5.73e-01
GOBP HEPATOCYTE DIFFERENTIATION	7	7.70e-02	1.62e-01	0.6630	1.31e-01	-3.55e-01	1.76e-01	4.94e-01	2.24e-03	1.45e-01	5.50e-01	1.04e-01	4.21e-01	2.37e-02	9.92e-01	5.05e-01
GOBP ANTIBACTERIAL HUMORAL RESPONSE	45	3.50e-09	5.21e-08	0.6620	-7.49e-02	-4.52e-01	7.48e-02	5.54e-02	-4.49e-01	1.35e-01	3.85e-01	1.51e-07	3.85e-01	5.20e-01	1.84e-07	1.17e-01
GOBP POSITIVE REGULATION OF HORMONE BIOSYNTHETIC PROCESS	8	2.86e-01	4.06e-01	0.6620	2.15e-01	2.87e-01	5.23e-01	8.24e-02	-5.88e-02	1.63e-01	2.91e-01	1.60e-01	1.05e-02	6.87e-01	7.73e-01	4.25e-01
GOCC VOLTAGE GATED SODIUM CHANNEL COMPLEX	10	1.76e-01	2.91e-01	0.6620	5.20e-02	2.48e-01	4.59e-01	-2.46e-01	-1.40e-01	2.90e-01	7.76e-01	1.74e-01	1.20e-02	1.78e-01	4.42e-01	1.12e-01
GOMF SUPERCOILED DNA BINDING	6	3.85e-01	4.98e-01	0.6620	-4.78e-01	-2.52e-01	-5.89e-02	-7.52e-02	-2.99e-01	2.20e-01	4.28e-02	2.85e-01	8.03e-01	7.50e-01	2.04e-01	3.51e-01
GOBP RETINA LAYER FORMATION	11	6.75e-02	1.47e-01	0.6620	1.25e-01	3.47e-01	4.51e-01	6.84e-02	-2.49e-01	1.80e-01	4.73e-01	4.64e-02	9.55e-03	6.94e-01	1.53e-01	3.02e-01
GOBP VENOUS BLOOD VESSEL DEVELOPMENT	10	2.63e-02	7.28e-02	0.6620	-1.15e-01	4.19e-01	2.12e-01	2.61e-01	3.64e-01	6.33e-02	5.28e-01	2.19e-02	2.45e-01	1.53e-01	4.61e-02	7.29e-01
GOBP SEBACEOUS GLAND DEVELOPMENT	7	1.24e-01	2.29e-01	0.6620	-2.10e-01	2.90e-01	3.14e-01	9.01e-02	-1.93e-01	4.08e-01	3.36e-01	1.84e-01	1.50e-01	6.80e-01	3.78e-01	6.17e-02
GOBP CHIASMA ASSEMBLY	6	2.86e-01	4.05e-01	0.6620	-3.87e-01	-1.92e-01	-3.30e-01	-2.96e-01	-1.80e-01	1.51e-01	1.01e-01	4.16e-01	1.61e-01	2.10e-01	4.45e-01	5.23e-01
GOMF DNA TRANSLOCASE ACTIVITY	5	2.44e-01	3.62e-01	0.6620	-6.13e-02	-3.79e-01	8.03e-02	2.83e-01	-4.52e-01	1.65e-03	8.12e-01	1.42e-01	7.56e-01	2.74e-01	8.03e-02	9.95e-01
GOCC CLATHRIN COMPLEX	7	9.37e-02	1.87e-01	0.6620	-5.30e-01	-9.23e-02	-1.80e-01	1.32e-01	2.01e-01	2.42e-01	1.52e-02	6.73e-01	4.10e-01	5.45e-01	3.58e-01	2.67e-01
GOMF DENEDDYLASE ACTIVITY	6	2.13e-01	3.30e-01	0.6620	1.33e-01	-3.53e-01	-1.72e-01	3.98e-01	3.21e-01	-6.81e-02	5.74e-01	1.34e-01	4.65e-01	9.15e-02	1.73e-01	7.73e-01
GOCC FAR SIN STRIPAK COMPLEX	16	5.80e-03	2.22e-02	0.6620	-4.16e-01	-2.64e-01	6.87e-02	1.88e-02	-3.51e-01	2.57e-01	3.93e-03	6.72e-02	6.34e-01	8.96e-01	1.50e-02	7.54e-02
GOBP NEGATIVE REGULATION OF CELL CELL ADHESION MEDIATED BY CADHERIN	9	1.48e-03	7.10e-03	0.6610	1.71e-01	-1.21e-01	4.47e-01	3.13e-01	3.01e-01	7.24e-02	3.76e-01	5.30e-01	2.03e-02	1.03e-01	1.18e-01	7.07e-01
GOMF AMINOACYLASE ACTIVITY	5	2.97e-01	4.16e-01	0.6610	-4.66e-01	-3.15e-01	-1.53e-01	7.66e-02	2.56e-01	1.62e-01	7.12e-02	2.22e-01	5.53e-01	7.67e-01	3.22e-01	5.31e-01
GOBP MALONYL COA METABOLIC PROCESS	6	2.32e-01	3.50e-01	0.6610	3.44e-01	-1.23e-01	9.84e-03	5.43e-01	-7.76e-02	4.33e-02	1.44e-01	6.01e-01	9.67e-01	2.12e-02	7.42e-01	8.54e-01
GOBP POSITIVE REGULATION OF KIDNEY DEVELOPMENT	6	4.90e-01	5.89e-01	0.6610	2.44e-01	2.91e-01	2.83e-01	1.95e-01	2.83e-02	4.17e-01	3.00e-01	2.17e-01	2.29e-01	4.09e-01	9.04e-01	7.73e-02
GOBP POSITIVE REGULATION OF LYMPHOCYTE CHEMOTAXIS	14	2.36e-02	6.71e-02	0.6610	1.23e-01	6.41e-02	4.66e-01	5.21e-02	-4.00e-01	1.93e-01	4.24e-01	6.78e-01	2.53e-03	7.36e-01	9.57e-03	2.10e-01
GOBP CENTRAL NERVOUS SYSTEM PROJECTION NEURON AXONOGENESIS	22	1.78e-03	8.30e-03	0.6610	6.72e-02	3.37e-01	3.44e-01	3.20e-01	1.65e-01	2.66e-01	5.85e-01	6.20e-03	5.28e-03	9.40e-03	1.80e-01	3.09e-02
GOBP GENITALIA MORPHOGENESIS	7	1.31e-01	2.38e-01	0.6610	-5.93e-02	4.37e-01	7.25e-02	1.31e-01	2.38e-01	4.03e-01	7.86e-01	4.54e-02	7.40e-01	5.48e-01	2.75e-01	6.45e-02
GOBP REGULATION OF PROTEIN FOLDING	9	1.79e-01	2.93e-01	0.6600	-1.02e-01	-3.86e-01	-3.72e-01	8.81e-02	-2.21e-01	-2.85e-01	5.98e-01	4.47e-02	5.33e-02	6.47e-01	2.51e-01	1.38e-01
GOBP NEGATIVE REGULATION OF MYELOID LEUKOCYTE MEDIATED IMMUNITY	9	1.06e-01	2.03e-01	0.6600	5.49e-02	3.83e-01	2.21e-01	4.24e-01	2.11e-01	1.15e-01	7.76e-01	4.68e-02	2.51e-01	2.76e-02	2.74e-01	5.51e-01
GOCC RNA CAP BINDING COMPLEX	15	4.92e-02	1.16e-01	0.6600	-4.71e-01	-3.21e-01	-1.15e-01	-1.46e-01	-2.75e-01	-4.58e-03	1.58e-03	3.13e-02	4.40e-01	3.27e-01	6.51e-02	9.76e-01
GOBP REGULATION OF TOLL LIKE RECEPTOR 2 SIGNALING PATHWAY	10	1.14e-02	3.81e-02	0.6600	-2.17e-01	4.61e-01	2.05e-01	2.08e-01	2.89e-01	8.30e-02	2.35e-01	1.17e-02	2.61e-01	2.54e-01	1.13e-01	6.50e-01
GOBP CARDIAC LEFT VENTRICLE MORPHOGENESIS	7	1.33e-01	2.40e-01	0.6600	-3.97e-02	-5.91e-02	3.61e-01	2.68e-01	-3.97e-01	2.66e-01	8.56e-01	7.86e-01	9.86e-02	2.20e-01	6.91e-02	2.23e-01
GOMF BH3 DOMAIN BINDING	6	2.75e-01	3.94e-01	0.6600	2.33e-01	-9.06e-02	2.55e-01	-1.18e-01	-5.39e-01	5.70e-02	3.23e-01	7.01e-01	2.80e-01	6.18e-01	2.22e-02	8.09e-01
GOBP POSITIVE REGULATION OF TRANSCRIPTION OF NUCLEOLAR LARGE RRNA BY RNA POLYMERASE I	10	9.67e-03	3.34e-02	0.6590	1.81e-01	-3.13e-01	7.50e-02	5.19e-01	-1.16e-01	-1.21e-01	3.22e-01	8.61e-02	6.81e-01	4.46e-03	5.24e-01	5.06e-01
GOBP MDA 5 SIGNALING PATHWAY	10	1.37e-02	4.42e-02	0.6590	-2.92e-02	-2.22e-01	-3.24e-01	2.98e-01	2.92e-01	3.24e-01	8.73e-01	2.25e-01	7.63e-02	1.03e-01	1.10e-01	7.60e-02
GOCC OUTER DYNEIN ARM	7	1.03e-01	1.99e-01	0.6590	-1.02e-01	3.70e-01	-3.92e-01	-1.62e-01	2.60e-01	-1.98e-01	6.40e-01	9.04e-02	7.23e-02	4.57e-01	2.34e-01	3.65e-01
GOMF UBIQUITIN LIKE PROTEIN CONJUGATING ENZYME BINDING	33	1.13e-04	7.58e-04	0.6590	-4.83e-01	-1.92e-01	-1.12e-01	-2.97e-01	-2.22e-01	-1.16e-01	1.53e-06	5.64e-02	2.65e-01	3.18e-03	2.75e-02	2.50e-01
GOBP INTRACILIARY ANTEROGRADE TRANSPORT	16	8.18e-03	2.93e-02	0.6580	-1.54e-01	1.17e-01	-3.81e-01	3.32e-02	4.81e-01	-1.34e-01	2.88e-01	4.18e-01	8.25e-03	8.18e-01	8.58e-04	3.52e-01
GOBP GLANDULAR EPITHELIAL CELL MATURATION	7	3.30e-01	4.48e-01	0.6580	-6.50e-02	2.35e-01	4.81e-01	7.06e-02	-1.50e-01	3.40e-01	7.66e-01	2.82e-01	2.76e-02	7.46e-01	4.92e-01	1.20e-01
GOBP ENDONUCLEOLYTIC CLEAVAGE IN ITS1 TO SEPARATE SSU RRNA FROM 5 8S RRNA AND LSU RRNA FROM TRICISTRONIC RRNA TRANSCRIPT SSU RRNA 5 8S RRNA LSU RRNA	9	7.94e-02	1.66e-01	0.6580	3.14e-01	-3.42e-01	-2.68e-01	2.30e-01	-1.11e-02	-3.04e-01	1.03e-01	7.56e-02	1.64e-01	2.32e-01	9.54e-01	1.14e-01
GOBP POSITIVE REGULATION OF MITOCHONDRIAL MEMBRANE POTENTIAL	7	1.42e-01	2.51e-01	0.6580	-2.38e-01	-5.77e-01	-3.01e-02	1.44e-01	-1.45e-01	1.05e-03	2.75e-01	8.17e-03	8.90e-01	5.10e-01	5.06e-01	9.96e-01
GOBP NEGATIVE REGULATION OF RESPIRATORY BURST	5	4.94e-01	5.92e-01	0.6580	-1.89e-01	-4.18e-01	-6.76e-02	-1.13e-01	-3.30e-01	-3.11e-01	4.64e-01	1.06e-01	7.94e-01	6.62e-01	2.02e-01	2.29e-01
GOBP POSITIVE REGULATION OF ASPARTIC TYPE ENDOPEPTIDASE ACTIVITY INVOLVED IN AMYLOID PRECURSOR PROTEIN CATABOLIC PROCESS	5	5.01e-01	5.98e-01	0.6570	3.03e-01	3.74e-01	8.70e-02	2.78e-01	1.27e-01	-3.16e-01	2.41e-01	1.48e-01	7.36e-01	2.82e-01	6.22e-01	2.22e-01
GOBP NEGATIVE REGULATION OF DNA TEMPLATED TRANSCRIPTION INITIATION	6	2.05e-01	3.22e-01	0.6570	-3.31e-01	-1.96e-01	-3.56e-01	9.06e-02	-2.82e-01	-2.64e-01	1.60e-01	4.07e-01	1.31e-01	7.01e-01	2.32e-01	2.63e-01
GOBP NEGATIVE REGULATION OF INSULIN SECRETION INVOLVED IN CELLULAR RESPONSE TO GLUCOSE STIMULUS	9	6.38e-02	1.41e-01	0.6570	-2.61e-01	-4.10e-01	2.31e-01	-2.71e-01	-1.36e-01	2.24e-01	1.75e-01	3.32e-02	2.30e-01	1.60e-01	4.81e-01	2.45e-01
GOMF ALANINE TRANSMEMBRANE TRANSPORTER ACTIVITY	12	2.79e-02	7.60e-02	0.6570	-2.84e-02	-1.10e-02	2.92e-01	6.11e-03	-5.07e-01	2.96e-01	8.65e-01	9.47e-01	8.01e-02	9.71e-01	2.34e-03	7.61e-02
GOBP AEROBIC RESPIRATION	183	1.43e-37	2.33e-35	0.6560	-1.95e-01	-5.74e-01	-2.13e-01	1.39e-02	-1.33e-01	6.25e-03	5.52e-06	4.62e-41	6.73e-07	7.46e-01	1.87e-03	8.84e-01
GOBP DNA STRAND ELONGATION INVOLVED IN DNA REPLICATION	15	4.17e-03	1.69e-02	0.6560	-6.40e-02	-3.69e-01	-2.66e-01	3.12e-01	2.97e-01	-1.83e-01	6.68e-01	1.33e-02	7.43e-02	3.64e-02	4.66e-02	2.20e-01
GOMF GAP JUNCTION CHANNEL ACTIVITY	6	5.20e-01	6.14e-01	0.6560	3.14e-01	1.39e-01	4.77e-01	1.22e-01	-3.95e-02	2.60e-01	1.82e-01	5.55e-01	4.30e-02	6.04e-01	8.67e-01	2.70e-01
GOMF RNA POLYMERASE II ACTIVITY	11	7.79e-02	1.63e-01	0.6560	-1.58e-01	-4.84e-01	-3.10e-01	1.93e-01	-2.92e-02	-1.90e-01	3.65e-01	5.43e-03	7.46e-02	2.66e-01	8.67e-01	2.76e-01
GOBP HEMATOPOIETIC STEM CELL MIGRATION	9	3.31e-02	8.63e-02	0.6560	-2.90e-01	2.65e-01	3.95e-01	6.88e-02	-1.99e-01	2.73e-01	1.31e-01	1.68e-01	4.00e-02	7.21e-01	3.02e-01	1.56e-01
GOBP PLATELET ACTIVATING FACTOR METABOLIC PROCESS	7	2.33e-01	3.50e-01	0.6560	-3.70e-01	2.14e-01	2.17e-01	-2.70e-01	-7.70e-02	3.48e-01	9.01e-02	3.27e-01	3.19e-01	2.16e-01	7.24e-01	1.11e-01
GOBP OTOLITH DEVELOPMENT	5	5.00e-01	5.98e-01	0.6560	2.16e-01	1.63e-01	-3.83e-01	2.52e-01	3.75e-01	-7.22e-02	4.04e-01	5.27e-01	1.38e-01	3.29e-01	1.46e-01	7.80e-01
GOBP SYNAPTIC VESICLE UNCOATING	5	2.71e-01	3.90e-01	0.6550	2.48e-01	1.45e-01	2.33e-01	5.21e-01	-1.36e-01	-5.26e-02	3.37e-01	5.74e-01	3.67e-01	4.37e-02	5.98e-01	8.38e-01
GOBP POSITIVE REGULATION OF VASCULAR ENDOTHELIAL GROWTH FACTOR RECEPTOR SIGNALING PATHWAY	11	6.55e-05	4.65e-04	0.6550	-2.45e-01	2.71e-01	4.33e-01	5.83e-03	3.23e-01	-6.28e-02	1.59e-01	1.20e-01	1.29e-02	9.73e-01	6.35e-02	7.18e-01
GOBP ENDOPLASMIC RETICULUM TO CYTOSOL TRANSPORT	28	1.97e-05	1.55e-04	0.6550	-2.79e-01	-3.55e-01	1.86e-01	1.00e-01	-3.33e-01	2.63e-01	1.06e-02	1.13e-03	8.85e-02	3.58e-01	2.26e-03	1.60e-02
GOMF MRNA 5 UTR BINDING	22	1.16e-02	3.88e-02	0.6550	-3.62e-01	-4.37e-01	-2.21e-01	-1.72e-01	-1.67e-01	1.10e-02	3.27e-03	3.83e-04	7.26e-02	1.63e-01	1.76e-01	9.29e-01
GOMF ATPASE COUPLED LIPID TRANSMEMBRANE TRANSPORTER ACTIVITY	6	2.39e-01	3.57e-01	0.6540	-6.81e-02	-3.70e-01	2.82e-01	-1.48e-02	-4.54e-01	-3.04e-02	7.73e-01	1.17e-01	2.31e-01	9.50e-01	5.41e-02	8.97e-01
GOBP REGULATION OF HEAT GENERATION	10	6.37e-03	2.39e-02	0.6540	-1.32e-01	2.85e-01	3.87e-01	-3.73e-01	1.98e-01	3.66e-02	4.71e-01	1.19e-01	3.42e-02	4.09e-02	2.78e-01	8.41e-01
GOCC ATAC COMPLEX	14	9.55e-02	1.89e-01	0.6540	-3.34e-01	-3.71e-01	-3.90e-01	-1.15e-01	-1.58e-02	-1.12e-01	3.02e-02	1.61e-02	1.15e-02	4.55e-01	9.19e-01	4.70e-01
GOCC PORE COMPLEX	20	8.28e-03	2.96e-02	0.6540	-1.04e-01	-3.73e-01	-2.84e-01	-2.51e-01	-3.10e-01	-1.94e-01	4.20e-01	3.84e-03	2.81e-02	5.17e-02	1.62e-02	1.33e-01
GOMF PEPTIDOGLYCAN MURALYTIC ACTIVITY	6	1.09e-01	2.07e-01	0.6540	3.14e-01	8.61e-02	4.06e-01	-1.67e-01	2.20e-01	2.84e-01	1.83e-01	7.15e-01	8.49e-02	4.80e-01	3.50e-01	2.28e-01
GOMF PROMOTER ENHANCER LOOP ANCHORING ACTIVITY	5	2.07e-01	3.23e-01	0.6540	2.44e-01	-1.51e-01	1.38e-01	2.74e-01	-4.91e-01	-1.01e-01	3.45e-01	5.60e-01	5.93e-01	2.89e-01	5.71e-02	6.97e-01
GOBP NEGATIVE REGULATION OF PROTEIN POLYUBIQUITINATION	6	1.46e-01	2.56e-01	0.6540	6.91e-02	-4.48e-01	-7.32e-02	2.87e-01	7.94e-02	3.58e-01	7.70e-01	5.72e-02	7.56e-01	2.24e-01	7.36e-01	1.29e-01
GOBP NEGATIVE REGULATION OF GRANULOCYTE DIFFERENTIATION	7	3.74e-02	9.47e-02	0.6540	5.50e-03	3.63e-01	4.57e-01	2.51e-01	-1.36e-01	-7.71e-02	9.80e-01	9.64e-02	3.64e-02	2.50e-01	5.33e-01	7.24e-01
GOBP CENTRAL NERVOUS SYSTEM NEURON AXONOGENESIS	29	7.10e-05	5.00e-04	0.6540	6.79e-02	3.41e-01	3.89e-01	2.80e-01	1.58e-02	2.77e-01	5.27e-01	1.48e-03	2.87e-04	9.17e-03	8.83e-01	9.81e-03
GOBP REGULATION OF ANIMAL ORGAN FORMATION	10	1.24e-01	2.28e-01	0.6540	-2.47e-01	-9.86e-02	3.59e-01	-2.80e-01	-3.81e-01	6.38e-02	1.76e-01	5.89e-01	4.91e-02	1.25e-01	3.72e-02	7.27e-01
GOBP REGULATION OF PROTEIN NEDDYLATION	19	9.98e-03	3.42e-02	0.6540	-3.97e-01	-4.14e-01	-2.78e-01	-6.06e-02	-9.70e-02	9.23e-02	2.74e-03	1.80e-03	3.62e-02	6.48e-01	4.64e-01	4.86e-01
GOMF STEROID HYDROXYLASE ACTIVITY	9	1.56e-01	2.68e-01	0.6540	-2.42e-01	8.97e-02	1.88e-01	-5.05e-01	-1.42e-01	2.23e-01	2.08e-01	6.41e-01	3.30e-01	8.68e-03	4.60e-01	2.47e-01
GOBP MEMBRANE RAFT LOCALIZATION	7	2.74e-01	3.94e-01	0.6540	3.72e-01	-2.39e-02	1.25e-01	3.85e-01	1.35e-01	3.25e-01	8.82e-02	9.13e-01	5.67e-01	7.74e-02	5.36e-01	1.36e-01
GOBP NEGATIVE REGULATION OF TYROSINE PHOSPHORYLATION OF STAT PROTEIN	8	1.24e-01	2.28e-01	0.6540	-3.52e-02	7.63e-02	4.15e-01	-2.83e-01	6.12e-02	4.05e-01	8.63e-01	7.09e-01	4.21e-02	1.65e-01	7.65e-01	4.74e-02
GOBP NEGATIVE REGULATION OF NEUROTRANSMITTER TRANSPORT	9	3.18e-01	4.38e-01	0.6530	1.74e-01	2.06e-01	3.79e-01	2.34e-01	1.44e-01	3.67e-01	3.67e-01	2.84e-01	4.90e-02	2.23e-01	4.53e-01	5.69e-02
GOBP HEPATIC STELLATE CELL ACTIVATION	7	3.78e-01	4.93e-01	0.6530	-2.17e-01	7.60e-02	3.74e-01	-5.12e-02	-2.06e-01	4.35e-01	3.21e-01	7.28e-01	8.69e-02	8.14e-01	3.45e-01	4.64e-02
GOBP POSITIVE REGULATION OF SYSTEMIC ARTERIAL BLOOD PRESSURE	7	1.26e-01	2.31e-01	0.6530	-3.08e-01	-1.75e-01	3.93e-01	6.06e-02	-3.28e-01	1.89e-01	1.58e-01	4.23e-01	7.21e-02	7.81e-01	1.33e-01	3.87e-01
GOBP N TERMINAL PEPTIDYL METHIONINE ACETYLATION	5	6.41e-01	7.15e-01	0.6530	-3.15e-01	-3.06e-01	-2.41e-01	-2.04e-01	-3.66e-01	-2.71e-02	2.23e-01	2.36e-01	3.52e-01	4.31e-01	1.57e-01	9.17e-01
GOMF NAD P H DEHYDROGENASE QUINONE ACTIVITY	5	1.23e-01	2.28e-01	0.6530	-1.22e-01	3.11e-01	-2.94e-01	-2.10e-01	3.60e-01	2.32e-01	6.37e-01	2.28e-01	2.54e-01	4.15e-01	1.63e-01	3.70e-01
GOBP PEPTIDYL ARGININE METHYLATION	9	5.20e-02	1.21e-01	0.6530	5.84e-02	-2.22e-01	-3.74e-01	4.80e-01	3.58e-02	-4.25e-02	7.62e-01	2.48e-01	5.20e-02	1.27e-02	8.52e-01	8.25e-01
GOCC PROXIMAL DENDRITE	5	4.81e-01	5.82e-01	0.6520	1.98e-01	2.09e-01	3.68e-01	-1.09e-01	-4.24e-01	1.26e-01	4.43e-01	4.19e-01	1.54e-01	6.73e-01	1.01e-01	6.27e-01
GOBP BLOOD VESSEL ENDOTHELIAL CELL DIFFERENTIATION	7	1.19e-01	2.21e-01	0.6520	-1.05e-01	1.08e-01	1.37e-01	3.93e-01	4.58e-01	1.43e-01	6.30e-01	6.20e-01	5.31e-01	7.19e-02	3.59e-02	5.14e-01
GOBP PROTEASOME ASSEMBLY	13	5.59e-02	1.28e-01	0.6520	-3.37e-01	-4.69e-01	-1.15e-01	-7.56e-02	-1.46e-01	2.26e-01	3.55e-02	3.38e-03	4.71e-01	6.37e-01	3.61e-01	1.58e-01
GOBP EMBRYONIC HINDLIMB MORPHOGENESIS	10	2.26e-01	3.44e-01	0.6520	2.36e-01	4.00e-01	4.23e-01	1.22e-01	3.82e-02	1.20e-01	1.97e-01	2.86e-02	2.04e-02	5.05e-01	8.34e-01	5.10e-01
GOCC EXORIBONUCLEASE COMPLEX	25	1.53e-03	7.31e-03	0.6520	-1.39e-01	-4.06e-01	-4.52e-01	-1.50e-02	-4.92e-02	-1.84e-01	2.28e-01	4.35e-04	9.24e-05	8.97e-01	6.70e-01	1.11e-01
GOBP PEPTIDYL LYSINE DIMETHYLATION	5	4.20e-01	5.30e-01	0.6520	5.94e-02	-1.49e-01	-2.21e-01	2.41e-01	2.78e-01	-4.64e-01	8.18e-01	5.65e-01	3.92e-01	3.50e-01	2.82e-01	7.27e-02
GOBP FATTY ACYL COA CATABOLIC PROCESS	6	1.63e-01	2.75e-01	0.6520	2.88e-01	-3.53e-01	1.15e-01	4.37e-01	-1.12e-01	-9.84e-03	2.22e-01	1.34e-01	6.26e-01	6.35e-02	6.36e-01	9.67e-01
GOBP UBIQUITIN DEPENDENT GLYCOPROTEIN ERAD PATHWAY	7	1.68e-01	2.81e-01	0.6520	-2.36e-01	7.84e-02	2.39e-01	2.48e-01	2.05e-01	4.49e-01	2.79e-01	7.20e-01	2.74e-01	2.55e-01	3.47e-01	3.96e-02
GOMF MANNOSYL OLIGOSACCHARIDE 1 2 ALPHA MANNOSIDASE ACTIVITY	7	1.68e-01	2.81e-01	0.6520	-2.36e-01	7.84e-02	2.39e-01	2.48e-01	2.05e-01	4.49e-01	2.79e-01	7.20e-01	2.74e-01	2.55e-01	3.47e-01	3.96e-02
GOMF TOXIC SUBSTANCE BINDING	6	3.42e-01	4.59e-01	0.6520	-3.14e-01	-3.27e-01	-9.40e-02	-6.86e-02	-2.49e-01	3.79e-01	1.83e-01	1.65e-01	6.90e-01	7.71e-01	2.90e-01	1.08e-01
GOBP ACTIN FILAMENT NETWORK FORMATION	8	2.49e-01	3.67e-01	0.6510	1.32e-01	6.88e-02	4.39e-01	2.80e-01	9.09e-02	3.50e-01	5.16e-01	7.36e-01	3.14e-02	1.70e-01	6.56e-01	8.69e-02
GOBP LEFT RIGHT AXIS SPECIFICATION	9	3.88e-01	5.02e-01	0.6510	3.65e-01	2.90e-01	9.59e-02	2.75e-01	3.44e-01	-6.41e-02	5.83e-02	1.31e-01	6.18e-01	1.54e-01	7.41e-02	7.39e-01
GOBP MEIOTIC METAPHASE CHROMOSOME ALIGNMENT	5	2.25e-01	3.44e-01	0.6510	1.79e-01	-1.21e-01	-9.26e-02	3.85e-01	9.57e-02	4.60e-01	4.89e-01	6.40e-01	7.20e-01	1.36e-01	7.11e-01	7.46e-02
GOBP BOX C D SNORNP ASSEMBLY	8	1.65e-01	2.78e-01	0.6510	-8.77e-02	-5.35e-01	-3.25e-01	-2.29e-02	6.11e-02	-1.42e-01	6.67e-01	8.79e-03	1.11e-01	9.11e-01	7.65e-01	4.88e-01
GOBP REGULATION OF MAST CELL DEGRANULATION	24	9.69e-04	4.94e-03	0.6510	-3.67e-02	-2.33e-02	4.51e-01	1.10e-01	-2.58e-01	3.75e-01	7.56e-01	8.43e-01	1.33e-04	3.50e-01	2.89e-02	1.47e-03
GOBP HIGH DENSITY LIPOPROTEIN PARTICLE ASSEMBLY	10	3.43e-03	1.44e-02	0.6510	4.06e-02	1.86e-01	1.65e-01	4.06e-01	2.83e-01	-3.40e-01	8.24e-01	3.07e-01	3.66e-01	2.62e-02	1.21e-01	6.30e-02
GOBP REGULATION OF DENDRITIC CELL CHEMOTAXIS	9	5.98e-02	1.35e-01	0.6510	1.39e-01	-4.04e-01	2.60e-01	1.49e-01	-3.62e-01	1.43e-01	4.71e-01	3.58e-02	1.77e-01	4.39e-01	6.00e-02	4.58e-01
GOBP PRIMARY ALCOHOL CATABOLIC PROCESS	9	6.41e-02	1.42e-01	0.6510	-2.88e-01	-2.15e-01	-3.27e-01	1.49e-02	-3.68e-01	-2.28e-01	1.34e-01	2.64e-01	8.97e-02	9.38e-01	5.59e-02	2.37e-01
GOBP CARDIAC MUSCLE CELL CARDIAC MUSCLE CELL ADHESION	5	4.02e-01	5.13e-01	0.6510	-2.28e-01	3.14e-02	4.25e-01	-3.64e-01	-2.36e-01	4.16e-02	3.77e-01	9.03e-01	9.99e-02	1.59e-01	3.60e-01	8.72e-01
GOMF CELL ADHESIVE PROTEIN BINDING INVOLVED IN BUNDLE OF HIS CELL PURKINJE MYOCYTE COMMUNICATION	5	4.02e-01	5.13e-01	0.6510	-2.28e-01	3.14e-02	4.25e-01	-3.64e-01	-2.36e-01	4.16e-02	3.77e-01	9.03e-01	9.99e-02	1.59e-01	3.60e-01	8.72e-01
GOBP GLYCOSIDE METABOLIC PROCESS	15	3.93e-02	9.83e-02	0.6500	-3.53e-01	-3.78e-01	-3.16e-01	-7.87e-02	7.75e-02	-2.05e-01	1.78e-02	1.12e-02	3.43e-02	5.98e-01	6.03e-01	1.68e-01
GOBP PYRIMIDINE NUCLEOSIDE DIPHOSPHATE BIOSYNTHETIC PROCESS	6	2.78e-01	3.98e-01	0.6500	-8.18e-02	-2.91e-01	-2.74e-01	3.91e-01	2.81e-01	1.54e-01	7.28e-01	2.17e-01	2.45e-01	9.74e-02	2.34e-01	5.12e-01
GOMF OXIDATIVE RNA DEMETHYLASE ACTIVITY	5	1.06e-01	2.04e-01	0.6500	-6.04e-02	-6.29e-02	-2.10e-01	5.99e-01	-1.07e-01	8.49e-03	8.15e-01	8.08e-01	4.17e-01	2.03e-02	6.78e-01	9.74e-01
GOBP POSITIVE REGULATION OF SYNAPSE MATURATION	5	3.16e-01	4.36e-01	0.6500	3.99e-02	-3.20e-01	3.45e-01	2.80e-01	-7.85e-02	3.38e-01	8.77e-01	2.16e-01	1.81e-01	2.78e-01	7.61e-01	1.90e-01
GOBP POSITIVE REGULATION OF EXTRACELLULAR MATRIX DISASSEMBLY	6	3.84e-01	4.98e-01	0.6500	-4.97e-02	3.68e-01	2.05e-01	2.75e-01	3.07e-01	2.69e-01	8.33e-01	1.19e-01	3.85e-01	2.43e-01	1.93e-01	2.54e-01
GOMF MICROTUBULE SEVERING ATPASE ACTIVITY	6	5.99e-01	6.81e-01	0.6490	-4.39e-01	-2.56e-01	-2.99e-01	-2.21e-01	-3.04e-02	-1.55e-01	6.24e-02	2.77e-01	2.05e-01	3.49e-01	8.97e-01	5.11e-01
GOBP REGULATION OF CELLULAR AMINO ACID METABOLIC PROCESS	8	4.15e-02	1.02e-01	0.6490	-3.74e-01	-1.76e-01	-1.53e-01	4.16e-01	2.26e-01	6.15e-02	6.71e-02	3.90e-01	4.54e-01	4.17e-02	2.69e-01	7.63e-01
GOBP MEIOTIC CHROMOSOME SEPARATION	8	1.04e-01	2.01e-01	0.6490	1.36e-01	-3.43e-01	2.02e-01	3.18e-01	-2.63e-01	2.72e-01	5.05e-01	9.30e-02	3.22e-01	1.20e-01	1.97e-01	1.83e-01
GOBP POLY A DEPENDENT SNORNA 3 END PROCESSING	8	3.41e-01	4.58e-01	0.6490	-2.29e-01	-2.64e-01	-4.99e-01	3.11e-02	1.39e-01	-1.73e-01	2.63e-01	1.95e-01	1.46e-02	8.79e-01	4.96e-01	3.96e-01
GOBP METHIONINE BIOSYNTHETIC PROCESS	10	1.98e-01	3.14e-01	0.6490	-2.79e-01	-3.30e-01	-4.02e-01	-1.30e-01	1.53e-01	-1.81e-01	1.27e-01	7.11e-02	2.78e-02	4.76e-01	4.03e-01	3.23e-01
GOBP GLUCOSYLCERAMIDE METABOLIC PROCESS	5	3.39e-01	4.56e-01	0.6490	-2.87e-01	2.29e-01	4.52e-01	-5.98e-02	-1.90e-01	2.05e-01	2.66e-01	3.75e-01	8.01e-02	8.17e-01	4.62e-01	4.28e-01
GOBP GLIAL CELL FATE COMMITMENT	6	4.06e-01	5.18e-01	0.6490	-2.38e-01	-2.88e-02	-1.48e-02	-4.60e-01	-2.33e-01	-3.12e-01	3.13e-01	9.03e-01	9.50e-01	5.12e-02	3.23e-01	1.86e-01
GOBP REGULATION OF STEROID HORMONE BIOSYNTHETIC PROCESS	12	3.52e-02	9.04e-02	0.6480	3.04e-02	1.35e-01	4.56e-01	2.61e-01	-2.13e-01	2.83e-01	8.55e-01	4.18e-01	6.28e-03	1.17e-01	2.01e-01	8.94e-02
GOMF RNA POLYMERASE III ACTIVITY	10	3.67e-02	9.34e-02	0.6480	4.46e-02	-5.61e-01	-1.95e-01	1.97e-01	-2.50e-02	-1.63e-01	8.07e-01	2.14e-03	2.84e-01	2.81e-01	8.91e-01	3.73e-01
GOBP MACROPHAGE COLONY STIMULATING FACTOR SIGNALING PATHWAY	6	3.67e-01	4.82e-01	0.6480	9.59e-02	5.77e-02	3.02e-01	4.68e-01	1.31e-01	2.83e-01	6.84e-01	8.07e-01	2.00e-01	4.70e-02	5.78e-01	2.30e-01
GOBP MATERNAL PROCESS INVOLVED IN PARTURITION	5	4.21e-02	1.03e-01	0.6480	-4.24e-01	-2.54e-02	1.90e-01	-2.84e-01	3.35e-01	-1.04e-01	1.00e-01	9.22e-01	4.62e-01	2.72e-01	1.94e-01	6.87e-01
GOBP RESPONSE TO HISTAMINE	6	1.89e-01	3.04e-01	0.6480	-1.48e-01	4.78e-01	2.18e-01	-3.16e-01	1.24e-01	-8.37e-02	5.30e-01	4.26e-02	3.55e-01	1.80e-01	5.97e-01	7.22e-01
GOMF RNA DIRECTED DNA POLYMERASE ACTIVITY	7	1.91e-01	3.06e-01	0.6480	6.89e-02	-1.12e-01	2.53e-02	4.97e-01	1.37e-01	3.69e-01	7.52e-01	6.09e-01	9.08e-01	2.27e-02	5.30e-01	9.09e-02
GOCC MRNA EDITING COMPLEX	5	4.74e-01	5.76e-01	0.6480	8.79e-02	3.07e-01	4.44e-01	2.63e-01	-1.15e-01	1.96e-01	7.34e-01	2.34e-01	8.53e-02	3.09e-01	6.57e-01	4.48e-01
GOBP BILE ACID AND BILE SALT TRANSPORT	15	2.03e-02	5.98e-02	0.6480	1.08e-01	-6.18e-02	5.04e-01	-1.29e-01	-2.51e-01	2.66e-01	4.68e-01	6.79e-01	7.21e-04	3.87e-01	9.27e-02	7.42e-02
GOBP TRANSLATIONAL READTHROUGH	8	1.52e-01	2.63e-01	0.6480	-4.73e-01	-3.65e-01	-1.11e-01	9.54e-02	-1.98e-01	4.88e-02	2.05e-02	7.41e-02	5.86e-01	6.40e-01	3.33e-01	8.11e-01
GOBP POSITIVE REGULATION OF TISSUE REMODELING	7	4.21e-01	5.31e-01	0.6480	-4.49e-01	-1.87e-01	-1.39e-01	-2.33e-01	-3.28e-01	-3.51e-02	3.95e-02	3.91e-01	5.25e-01	2.85e-01	1.33e-01	8.72e-01
GOCC ER MEMBRANE INSERTION COMPLEX	14	8.60e-04	4.49e-03	0.6480	-2.95e-01	-4.48e-01	3.60e-03	3.23e-01	-1.63e-01	7.41e-04	5.57e-02	3.67e-03	9.81e-01	3.63e-02	2.90e-01	9.96e-01
GOBP METHIONINE METABOLIC PROCESS	13	9.37e-02	1.87e-01	0.6470	-3.36e-01	-2.83e-01	-4.28e-01	-1.43e-01	1.02e-01	-1.09e-01	3.58e-02	7.74e-02	7.47e-03	3.73e-01	5.26e-01	4.97e-01
GOBP POSITIVE REGULATION OF FIBROBLAST MIGRATION	14	3.19e-02	8.36e-02	0.6470	-3.34e-01	-2.12e-01	1.14e-01	-2.86e-01	-3.76e-01	-1.63e-01	3.06e-02	1.70e-01	4.61e-01	6.40e-02	1.48e-02	2.91e-01
GOBP POSITIVE REGULATION OF RAS PROTEIN SIGNAL TRANSDUCTION	12	5.10e-02	1.19e-01	0.6470	5.52e-02	3.74e-01	3.23e-01	3.41e-02	3.54e-01	2.14e-01	7.41e-01	2.50e-02	5.27e-02	8.38e-01	3.39e-02	2.00e-01
GOMF BICARBONATE MONOATOMIC ANION ANTIPORTER ACTIVITY	7	3.28e-01	4.47e-01	0.6470	1.23e-01	3.76e-01	9.59e-02	4.25e-01	2.30e-01	1.36e-01	5.73e-01	8.47e-02	6.60e-01	5.12e-02	2.91e-01	5.34e-01
GOBP RENAL SODIUM ION ABSORPTION	8	1.97e-01	3.13e-01	0.6470	8.06e-02	1.58e-01	1.21e-01	2.83e-01	5.03e-01	1.99e-01	6.93e-01	4.40e-01	5.53e-01	1.66e-01	1.38e-02	3.30e-01
GOBP RENAL SODIUM ION TRANSPORT	8	1.97e-01	3.13e-01	0.6470	8.06e-02	1.58e-01	1.21e-01	2.83e-01	5.03e-01	1.99e-01	6.93e-01	4.40e-01	5.53e-01	1.66e-01	1.38e-02	3.30e-01
GOBP NATURAL KILLER CELL ACTIVATION INVOLVED IN IMMUNE RESPONSE	16	6.77e-02	1.47e-01	0.6470	2.10e-01	2.27e-01	3.66e-01	2.37e-01	3.96e-02	3.62e-01	1.46e-01	1.16e-01	1.13e-02	1.00e-01	7.84e-01	1.21e-02
GOBP REGULATION OF TOLL LIKE RECEPTOR 9 SIGNALING PATHWAY	12	7.20e-03	2.65e-02	0.6470	-1.98e-01	8.60e-02	9.08e-02	4.24e-01	1.42e-01	4.05e-01	2.36e-01	6.06e-01	5.86e-01	1.11e-02	3.94e-01	1.52e-02
GOBP PERICARDIUM DEVELOPMENT	8	4.68e-01	5.71e-01	0.6470	2.70e-01	4.23e-01	2.37e-01	1.79e-01	2.12e-01	1.83e-01	1.86e-01	3.82e-02	2.47e-01	3.82e-01	3.00e-01	3.69e-01
GOBP REGULATION OF AMYLOID BETA CLEARANCE	13	1.56e-03	7.42e-03	0.6460	-1.99e-02	-4.03e-02	5.71e-01	-7.08e-02	4.80e-02	2.88e-01	9.01e-01	8.01e-01	3.68e-04	6.58e-01	7.64e-01	7.22e-02
GOBP VITAMIN D RECEPTOR SIGNALING PATHWAY	10	3.45e-03	1.45e-02	0.6460	-1.87e-01	2.94e-01	1.53e-01	9.23e-02	4.91e-01	-1.53e-01	3.06e-01	1.08e-01	4.02e-01	6.13e-01	7.15e-03	4.02e-01
GOBP INNER MITOCHONDRIAL MEMBRANE ORGANIZATION	44	4.74e-08	6.04e-07	0.6460	-1.82e-01	-5.34e-01	-3.09e-01	-2.99e-02	1.53e-02	-4.83e-02	3.67e-02	8.50e-10	3.87e-04	7.32e-01	8.60e-01	5.80e-01
GOBP PROTEIN LIPOYLATION	5	4.71e-01	5.73e-01	0.6460	1.81e-02	-2.28e-01	-3.94e-01	3.74e-01	2.64e-01	2.39e-02	9.44e-01	3.77e-01	1.27e-01	1.47e-01	3.07e-01	9.26e-01
GOBP MEIOTIC SPINDLE ORGANIZATION	17	9.32e-04	4.80e-03	0.6460	1.53e-02	-3.14e-01	1.54e-01	4.05e-01	-1.27e-01	3.39e-01	9.13e-01	2.48e-02	2.72e-01	3.88e-03	3.66e-01	1.54e-02
GOBP MITOCHONDRIAL DNA REPAIR	6	1.58e-01	2.70e-01	0.6460	-7.91e-02	-9.81e-02	-3.37e-01	4.62e-01	1.84e-01	2.01e-01	7.37e-01	6.77e-01	1.52e-01	4.98e-02	4.36e-01	3.94e-01
GOBP NEGATIVE REGULATION OF DOUBLE STRAND BREAK REPAIR VIA NONHOMOLOGOUS END JOINING	7	3.57e-01	4.73e-01	0.6460	1.01e-01	-2.17e-01	-3.48e-01	2.66e-01	4.19e-02	-4.08e-01	6.44e-01	3.20e-01	1.11e-01	2.24e-01	8.48e-01	6.16e-02
GOBP RNA CAPPING	15	7.89e-04	4.16e-03	0.6460	-1.26e-01	-4.12e-01	-2.77e-01	2.38e-01	-1.45e-01	2.78e-01	3.98e-01	5.67e-03	6.36e-02	1.11e-01	3.31e-01	6.24e-02
GOCC LUMENAL SIDE OF MEMBRANE	40	4.08e-06	3.78e-05	0.6460	-2.24e-01	-4.51e-01	-3.57e-01	9.62e-02	1.83e-02	-1.63e-01	1.41e-02	7.79e-07	9.44e-05	2.93e-01	8.42e-01	7.53e-02
GOBP SPLICEOSOMAL SNRNP ASSEMBLY	40	3.39e-07	3.82e-06	0.6450	-1.89e-02	-4.64e-01	-3.63e-01	1.83e-01	6.86e-02	-1.77e-01	8.36e-01	3.76e-07	7.23e-05	4.55e-02	4.53e-01	5.33e-02
GOMF G RICH STRAND TELOMERIC DNA BINDING	10	2.41e-02	6.81e-02	0.6450	-2.62e-01	-3.00e-01	-4.01e-01	2.85e-01	-1.80e-02	1.26e-01	1.52e-01	1.01e-01	2.81e-02	1.19e-01	9.21e-01	4.91e-01
GOBP ACTIVATION OF PROTEIN KINASE B ACTIVITY	12	1.88e-01	3.03e-01	0.6450	-2.64e-01	-4.46e-01	-6.51e-02	-1.95e-01	-3.23e-01	3.21e-02	1.13e-01	7.42e-03	6.96e-01	2.43e-01	5.27e-02	8.47e-01
GOBP PURINE DEOXYRIBONUCLEOSIDE TRIPHOSPHATE METABOLIC PROCESS	7	1.52e-01	2.62e-01	0.6450	-2.99e-01	-5.51e-01	3.04e-02	-3.91e-02	-5.94e-02	1.31e-01	1.71e-01	1.15e-02	8.89e-01	8.58e-01	7.86e-01	5.48e-01
GOCC TRICARBOXYLIC ACID CYCLE HETEROMERIC ENZYME COMPLEX	17	1.97e-02	5.86e-02	0.6450	-3.89e-01	-4.54e-01	-1.76e-01	-4.76e-03	-1.46e-01	8.02e-02	5.50e-03	1.20e-03	2.08e-01	9.73e-01	2.97e-01	5.67e-01
GOMF MHC CLASS I RECEPTOR ACTIVITY	12	2.84e-02	7.69e-02	0.6450	-2.48e-01	-3.40e-02	2.19e-01	1.59e-01	6.95e-02	5.25e-01	1.36e-01	8.39e-01	1.90e-01	3.39e-01	6.77e-01	1.65e-03
GOBP SYNAPTIC VESICLE LUMEN ACIDIFICATION	14	8.82e-03	3.10e-02	0.6450	-4.36e-01	-2.48e-01	2.27e-01	2.28e-02	-1.46e-01	3.02e-01	4.76e-03	1.08e-01	1.41e-01	8.83e-01	3.45e-01	5.02e-02
GOMF LIGASE ACTIVITY FORMING PHOSPHORIC ESTER BONDS	5	3.88e-01	5.02e-01	0.6450	-1.72e-01	-1.57e-01	-2.05e-01	3.48e-01	4.46e-01	3.33e-04	5.07e-01	5.44e-01	4.28e-01	1.78e-01	8.39e-02	9.99e-01
GOMF CO RECEPTOR BINDING	5	7.89e-03	2.85e-02	0.6450	-3.80e-03	5.36e-01	-3.02e-01	7.24e-03	-1.92e-01	5.16e-03	9.88e-01	3.78e-02	2.43e-01	9.78e-01	4.57e-01	9.84e-01
GOCC PROTON TRANSPORTING TWO SECTOR ATPASE COMPLEX	46	1.20e-07	1.45e-06	0.6450	-3.12e-01	-5.13e-01	-7.34e-02	-1.08e-02	-2.16e-01	5.68e-02	2.51e-04	1.77e-09	3.89e-01	9.00e-01	1.11e-02	5.05e-01
GOBP OXALOACETATE METABOLIC PROCESS	7	2.00e-01	3.15e-01	0.6450	7.19e-02	-4.31e-01	-2.93e-01	3.38e-01	1.57e-01	-3.97e-03	7.42e-01	4.82e-02	1.79e-01	1.22e-01	4.72e-01	9.85e-01
GOBP NEGATIVE REGULATION OF HORMONE METABOLIC PROCESS	10	1.80e-01	2.94e-01	0.6450	2.96e-02	1.73e-01	3.37e-01	1.51e-01	-4.95e-02	4.96e-01	8.71e-01	3.44e-01	6.52e-02	4.09e-01	7.86e-01	6.59e-03
GOBP REGULATION OF ADHERENS JUNCTION ORGANIZATION	5	2.08e-01	3.25e-01	0.6450	6.22e-02	-1.38e-01	5.10e-01	1.12e-01	-3.46e-01	-8.67e-03	8.10e-01	5.93e-01	4.82e-02	6.64e-01	1.80e-01	9.73e-01
GOBP NEGATIVE REGULATION OF MEGAKARYOCYTE DIFFERENTIATION	10	8.88e-02	1.80e-01	0.6450	-1.23e-01	-4.09e-01	1.89e-01	1.23e-01	-2.89e-01	3.14e-01	4.99e-01	2.51e-02	3.00e-01	5.02e-01	1.13e-01	8.58e-02
GOBP REGULATION OF OSTEOCLAST DEVELOPMENT	9	5.52e-02	1.27e-01	0.6440	-1.68e-01	2.72e-01	3.88e-01	-2.66e-02	2.84e-01	2.85e-01	3.83e-01	1.58e-01	4.37e-02	8.90e-01	1.40e-01	1.39e-01
GOBP NEGATIVE REGULATION OF CD4 POSITIVE ALPHA BETA T CELL PROLIFERATION	12	4.16e-02	1.02e-01	0.6440	9.31e-02	-4.71e-02	2.69e-01	2.22e-01	-2.24e-01	4.82e-01	5.76e-01	7.78e-01	1.06e-01	1.84e-01	1.79e-01	3.81e-03
GOBP REGULATION OF EARLY ENDOSOME TO LATE ENDOSOME TRANSPORT	19	3.08e-03	1.32e-02	0.6440	-2.79e-01	-2.10e-01	2.47e-01	6.58e-02	-3.36e-01	3.39e-01	3.54e-02	1.13e-01	6.24e-02	6.20e-01	1.12e-02	1.05e-02
GOBP NITRIC OXIDE MEDIATED SIGNAL TRANSDUCTION	15	1.06e-03	5.36e-03	0.6440	-2.83e-02	-6.69e-02	5.69e-01	-1.76e-01	-1.24e-01	1.99e-01	8.50e-01	6.54e-01	1.34e-04	2.39e-01	4.07e-01	1.83e-01
GOBP REGULATION BY VIRUS OF VIRAL PROTEIN LEVELS IN HOST CELL	7	8.44e-02	1.73e-01	0.6440	-1.74e-01	-2.38e-01	-2.45e-01	2.21e-01	1.88e-01	4.29e-01	4.25e-01	2.76e-01	2.62e-01	3.12e-01	3.88e-01	4.94e-02
GOBP ACTIN MYOSIN FILAMENT SLIDING	6	1.92e-01	3.08e-01	0.6440	2.40e-01	-3.42e-01	1.50e-01	3.33e-01	4.16e-02	3.24e-01	3.09e-01	1.47e-01	5.25e-01	1.57e-01	8.60e-01	1.69e-01
GOMF UBIQUITIN CONJUGATING ENZYME BINDING	27	5.14e-04	2.87e-03	0.6440	-4.71e-01	-1.01e-01	-3.66e-02	-3.30e-01	-2.47e-01	-1.07e-01	2.30e-05	3.63e-01	7.42e-01	3.04e-03	2.60e-02	3.37e-01
GOBP MATURE B CELL DIFFERENTIATION INVOLVED IN IMMUNE RESPONSE	25	1.46e-03	7.03e-03	0.6430	2.66e-01	2.04e-01	4.74e-01	2.16e-01	-1.12e-02	1.74e-01	2.15e-02	7.76e-02	4.12e-05	6.11e-02	9.23e-01	1.31e-01
GOBP CEREBELLAR GRANULAR LAYER MORPHOGENESIS	6	2.34e-01	3.53e-01	0.6430	-2.14e-01	-3.00e-01	2.96e-01	-2.87e-01	-6.88e-02	3.22e-01	3.64e-01	2.03e-01	2.09e-01	2.24e-01	7.70e-01	1.72e-01
GOBP NEGATIVE REGULATION OF PROTEIN IMPORT INTO NUCLEUS	13	7.65e-02	1.61e-01	0.6430	-3.70e-01	-2.61e-01	7.05e-02	-1.81e-01	-1.72e-01	3.76e-01	2.11e-02	1.03e-01	6.60e-01	2.60e-01	2.82e-01	1.88e-02
GOBP NEGATIVE REGULATION OF INTERLEUKIN 10 PRODUCTION	17	3.48e-02	8.97e-02	0.6430	2.56e-01	1.39e-01	2.33e-01	3.57e-01	2.86e-01	2.55e-01	6.71e-02	3.21e-01	9.61e-02	1.08e-02	4.15e-02	6.85e-02
GOBP POST TRANSLATIONAL PROTEIN TARGETING TO ENDOPLASMIC RETICULUM MEMBRANE	14	2.02e-02	5.97e-02	0.6430	-2.89e-01	-4.17e-01	5.48e-02	1.14e-01	-2.70e-01	2.59e-01	6.13e-02	6.90e-03	7.23e-01	4.59e-01	8.03e-02	9.32e-02
GOCC INTRACILIARY TRANSPORT PARTICLE B	15	9.43e-03	3.27e-02	0.6430	-1.92e-01	8.56e-02	-3.95e-01	-1.22e-02	4.57e-01	-6.66e-02	1.97e-01	5.66e-01	8.16e-03	9.35e-01	2.19e-03	6.55e-01
GOBP NEGATIVE REGULATION OF VASCULAR PERMEABILITY	12	6.86e-02	1.49e-01	0.6430	1.28e-01	-2.55e-03	4.71e-01	-1.60e-01	-3.65e-01	1.24e-01	4.42e-01	9.88e-01	4.69e-03	3.37e-01	2.85e-02	4.58e-01
GOCC NLRP3 INFLAMMASOME COMPLEX	8	2.41e-02	6.81e-02	0.6430	-4.78e-01	2.05e-01	-1.31e-02	4.73e-02	3.74e-01	1.55e-03	1.92e-02	3.15e-01	9.49e-01	8.17e-01	6.70e-02	9.94e-01
GOMF HISTONE H3 ACETYLTRANSFERASE ACTIVITY	15	2.86e-05	2.19e-04	0.6420	8.16e-02	3.90e-01	-8.22e-02	4.65e-01	-4.07e-02	-1.72e-01	5.84e-01	8.94e-03	5.82e-01	1.82e-03	7.85e-01	2.48e-01
GOBP POSITIVE REGULATION OF PINOCYTOSIS	7	8.38e-02	1.72e-01	0.6420	-5.76e-01	4.18e-02	-1.70e-01	2.30e-02	2.23e-01	-2.29e-02	8.35e-03	8.48e-01	4.37e-01	9.16e-01	3.07e-01	9.16e-01
GOCC LUMENAL SIDE OF ENDOPLASMIC RETICULUM MEMBRANE	31	1.08e-04	7.25e-04	0.6420	-2.33e-01	-4.05e-01	-3.49e-01	1.13e-01	6.70e-02	-2.35e-01	2.46e-02	9.39e-05	7.72e-04	2.78e-01	5.18e-01	2.37e-02
GOBP GLYOXYLATE METABOLIC PROCESS	5	2.68e-01	3.88e-01	0.6420	-3.36e-01	-4.06e-01	-1.24e-01	1.38e-01	2.77e-01	1.55e-01	1.94e-01	1.16e-01	6.32e-01	5.92e-01	2.84e-01	5.48e-01
GOMF TASTE RECEPTOR ACTIVITY	8	4.87e-01	5.87e-01	0.6420	-3.34e-01	-2.42e-01	-2.64e-01	-2.83e-01	-2.29e-01	-2.01e-01	1.02e-01	2.36e-01	1.96e-01	1.66e-01	2.63e-01	3.24e-01
GOBP ADENINE TRANSPORT	6	4.52e-01	5.58e-01	0.6420	-8.27e-02	-1.06e-01	-5.30e-01	1.04e-01	2.76e-01	-1.63e-01	7.26e-01	6.53e-01	2.45e-02	6.59e-01	2.42e-01	4.90e-01
GOMF COLLAGEN BINDING INVOLVED IN CELL MATRIX ADHESION	5	6.27e-01	7.04e-01	0.6420	1.67e-01	2.56e-01	3.84e-01	-1.39e-01	-2.22e-01	3.21e-01	5.17e-01	3.22e-01	1.37e-01	5.90e-01	3.90e-01	2.14e-01
GOCC U5 SNRNP	19	2.21e-04	1.37e-03	0.6420	8.94e-02	-4.18e-01	-3.45e-01	3.27e-01	-3.33e-02	4.78e-02	5.00e-01	1.59e-03	9.23e-03	1.36e-02	8.02e-01	7.19e-01
GOBP DIOL BIOSYNTHETIC PROCESS	20	1.75e-02	5.32e-02	0.6420	-2.59e-01	-4.10e-01	6.36e-02	-2.12e-01	-3.08e-01	1.83e-01	4.53e-02	1.50e-03	6.22e-01	1.01e-01	1.71e-02	1.58e-01
GOBP PYRIMIDINE NUCLEOSIDE DIPHOSPHATE METABOLIC PROCESS	9	6.10e-02	1.37e-01	0.6420	-2.58e-01	-1.23e-01	-1.95e-01	2.97e-01	3.63e-01	2.68e-01	1.79e-01	5.24e-01	3.10e-01	1.23e-01	5.92e-02	1.64e-01
GOCC TRNA METHYLTRANSFERASE COMPLEX	7	2.65e-01	3.85e-01	0.6420	9.40e-03	-4.92e-01	-2.52e-01	1.19e-01	-2.65e-01	-1.50e-01	9.66e-01	2.42e-02	2.49e-01	5.86e-01	2.25e-01	4.91e-01
GOBP GONADOTROPIN SECRETION	6	2.42e-01	3.60e-01	0.6420	-1.11e-01	3.84e-01	3.40e-01	1.46e-01	-1.20e-01	3.17e-01	6.37e-01	1.03e-01	1.49e-01	5.34e-01	6.11e-01	1.79e-01
GOBP PROTEIN LOCALIZATION TO CILIARY MEMBRANE	12	1.23e-02	4.03e-02	0.6420	-3.43e-01	1.45e-02	-4.13e-01	-7.61e-02	3.30e-01	9.42e-02	3.96e-02	9.30e-01	1.33e-02	6.48e-01	4.79e-02	5.72e-01
GOBP ZINC ION IMPORT INTO ORGANELLE	8	4.85e-02	1.15e-01	0.6420	-5.09e-01	-1.81e-02	2.58e-02	8.78e-02	-1.51e-01	3.47e-01	1.26e-02	9.29e-01	8.99e-01	6.67e-01	4.60e-01	8.88e-02
GOMF INOSITOL 1 3 4 5 TETRAKISPHOSPHATE BINDING	5	1.36e-01	2.43e-01	0.6420	2.18e-01	1.87e-01	2.20e-01	1.52e-02	4.58e-01	-2.65e-01	3.98e-01	4.69e-01	3.94e-01	9.53e-01	7.58e-02	3.05e-01
GOBP VACUOLAR PROTON TRANSPORTING V TYPE ATPASE COMPLEX ASSEMBLY	5	4.60e-01	5.64e-01	0.6420	-5.02e-01	-3.59e-01	-1.23e-01	-6.73e-02	7.22e-02	7.69e-02	5.20e-02	1.64e-01	6.33e-01	7.94e-01	7.80e-01	7.66e-01
GOMF MONOATOMIC ANION MONOATOMIC CATION SYMPORTER ACTIVITY	18	2.01e-02	5.95e-02	0.6410	3.21e-01	3.63e-01	3.91e-01	1.52e-01	1.33e-02	1.79e-02	1.86e-02	7.59e-03	4.06e-03	2.64e-01	9.22e-01	8.96e-01
GOBP CARDIOBLAST PROLIFERATION	6	2.37e-01	3.54e-01	0.6410	8.93e-02	2.91e-01	3.71e-01	2.61e-01	3.35e-01	2.66e-02	7.05e-01	2.17e-01	1.15e-01	2.68e-01	1.56e-01	9.10e-01
GOBP LIPOPROTEIN LOCALIZATION	18	2.04e-04	1.28e-03	0.6410	-3.52e-01	-2.16e-02	2.88e-01	1.58e-01	1.40e-01	3.99e-01	9.72e-03	8.74e-01	3.45e-02	2.45e-01	3.06e-01	3.34e-03
GOMF FUCOSE BINDING	6	1.08e-01	2.07e-01	0.6410	-8.70e-03	-6.87e-02	-6.96e-02	-2.44e-01	1.50e-01	-5.65e-01	9.71e-01	7.71e-01	7.68e-01	3.00e-01	5.25e-01	1.65e-02
GOBP THYMOCYTE MIGRATION	6	3.58e-01	4.73e-01	0.6410	1.21e-01	2.88e-01	-2.61e-01	2.69e-01	1.62e-01	-3.83e-01	6.08e-01	2.22e-01	2.68e-01	2.53e-01	4.93e-01	1.04e-01
GOCC CYTOPLASMIC SIDE OF ENDOSOME MEMBRANE	6	3.80e-01	4.94e-01	0.6410	-2.29e-01	-5.15e-02	2.94e-01	1.41e-01	-1.57e-01	4.74e-01	3.31e-01	8.27e-01	2.12e-01	5.50e-01	5.05e-01	4.44e-02
GOCC APICAL DENDRITE	13	1.74e-03	8.15e-03	0.6410	1.42e-02	-3.28e-01	3.66e-01	2.43e-01	-3.24e-01	6.56e-02	9.29e-01	4.07e-02	2.22e-02	1.29e-01	4.28e-02	6.82e-01
GOBP REGULATION OF GLUTAMATE SECRETION NEUROTRANSMISSION	5	5.04e-01	6.00e-01	0.6410	-4.61e-02	3.61e-01	2.93e-01	4.25e-02	3.38e-01	2.76e-01	8.58e-01	1.63e-01	2.56e-01	8.69e-01	1.91e-01	2.85e-01
GOBP POST CHAPERONIN TUBULIN FOLDING PATHWAY	7	4.10e-01	5.21e-01	0.6410	-3.50e-01	-3.93e-01	-6.67e-02	-5.48e-02	-2.60e-01	2.43e-01	1.09e-01	7.21e-02	7.60e-01	8.02e-01	2.34e-01	2.66e-01
GOBP FOLIC ACID TRANSPORT	8	1.55e-01	2.66e-01	0.6400	-4.47e-01	-1.53e-01	-2.04e-01	-2.05e-01	1.27e-01	-2.95e-01	2.85e-02	4.53e-01	3.19e-01	3.15e-01	5.32e-01	1.48e-01
GOBP REGULATION OF SENSORY PERCEPTION	11	1.68e-01	2.81e-01	0.6400	1.66e-01	2.44e-01	4.33e-01	-1.72e-01	-2.26e-01	2.34e-01	3.42e-01	1.61e-01	1.29e-02	3.24e-01	1.95e-01	1.79e-01
GOMF L ASPARTATE TRANSMEMBRANE TRANSPORTER ACTIVITY	7	1.03e-01	2.00e-01	0.6400	2.09e-01	-5.33e-01	-4.31e-02	2.34e-01	-1.54e-01	3.99e-02	3.38e-01	1.47e-02	8.44e-01	2.83e-01	4.81e-01	8.55e-01
GOBP INOSITOL METABOLIC PROCESS	8	1.82e-01	2.96e-01	0.6400	-7.09e-02	3.65e-01	-3.00e-02	3.09e-01	4.02e-01	1.17e-01	7.28e-01	7.39e-02	8.83e-01	1.30e-01	4.91e-02	5.68e-01
GOBP TYPE II HYPERSENSITIVITY	9	1.59e-01	2.71e-01	0.6400	2.46e-01	2.58e-01	3.34e-01	6.25e-02	3.46e-01	2.18e-01	2.01e-01	1.80e-01	8.31e-02	7.45e-01	7.24e-02	2.58e-01
GOBP POSITIVE REGULATION OF MAST CELL DEGRANULATION	12	1.28e-01	2.33e-01	0.6400	-1.21e-02	-1.24e-01	4.03e-01	-6.23e-02	-3.69e-01	3.02e-01	9.42e-01	4.58e-01	1.56e-02	7.09e-01	2.69e-02	6.99e-02
GOMF TRNA GUANINE METHYLTRANSFERASE ACTIVITY	12	6.45e-02	1.42e-01	0.6400	-2.09e-01	-4.36e-01	-3.73e-01	-3.03e-02	1.62e-01	-9.34e-02	2.11e-01	8.85e-03	2.53e-02	8.56e-01	3.30e-01	5.75e-01
GOBP FOREBRAIN MORPHOGENESIS	8	2.57e-01	3.77e-01	0.6390	-3.51e-01	-6.90e-04	1.69e-01	-4.79e-01	-1.60e-01	3.91e-02	8.52e-02	9.97e-01	4.07e-01	1.90e-02	4.34e-01	8.48e-01
GOBP PLASMINOGEN ACTIVATION	19	5.83e-05	4.19e-04	0.6390	-1.04e-01	-2.91e-01	4.58e-01	-8.18e-02	-3.02e-01	7.68e-02	4.34e-01	2.79e-02	5.53e-04	5.37e-01	2.28e-02	5.62e-01
GOBP MITOCHONDRIAL ATP TRANSMEMBRANE TRANSPORT	5	7.04e-01	7.64e-01	0.6390	-1.55e-01	-4.21e-01	-3.65e-01	-7.03e-02	-5.82e-02	-2.56e-01	5.48e-01	1.03e-01	1.58e-01	7.85e-01	8.22e-01	3.22e-01
GOBP NEGATIVE REGULATION OF CHOLESTEROL METABOLIC PROCESS	5	2.69e-01	3.88e-01	0.6390	9.22e-03	-5.05e-01	2.05e-01	2.14e-01	-2.27e-01	1.17e-01	9.72e-01	5.03e-02	4.28e-01	4.08e-01	3.78e-01	6.51e-01
GOCC STEREOCILIUM BASE	6	6.09e-01	6.89e-01	0.6390	-2.54e-01	-1.88e-01	-3.26e-01	-2.83e-01	-1.92e-02	-3.49e-01	2.81e-01	4.25e-01	1.67e-01	2.30e-01	9.35e-01	1.39e-01
GOBP RESPONSE TO MERCURY ION	7	4.23e-01	5.31e-01	0.6390	-2.37e-01	-2.39e-01	3.18e-01	-1.16e-01	-3.41e-01	2.54e-01	2.78e-01	2.74e-01	1.45e-01	5.95e-01	1.18e-01	2.45e-01
GOBP SRP DEPENDENT COTRANSLATIONAL PROTEIN TARGETING TO MEMBRANE TRANSLOCATION	7	2.41e-01	3.59e-01	0.6390	-3.47e-01	-3.87e-01	-2.27e-01	1.12e-01	-2.06e-01	1.79e-01	1.12e-01	7.65e-02	2.98e-01	6.07e-01	3.46e-01	4.13e-01
GOCC POSTSYNAPTIC CYTOSKELETON	9	3.95e-01	5.08e-01	0.6390	2.76e-01	3.93e-01	9.79e-02	2.12e-01	3.45e-01	-6.51e-02	1.51e-01	4.14e-02	6.11e-01	2.71e-01	7.34e-02	7.35e-01
GOMF SODIUM PROTON ANTIPORTER ACTIVITY	11	1.33e-01	2.40e-01	0.6390	-3.32e-02	3.59e-01	3.43e-01	7.38e-03	1.29e-01	3.78e-01	8.49e-01	3.93e-02	4.86e-02	9.66e-01	4.59e-01	2.97e-02
GOMF SPHINGOMYELIN PHOSPHODIESTERASE ACTIVITY	6	2.75e-01	3.95e-01	0.6380	7.76e-02	-1.66e-01	1.08e-01	4.95e-01	-3.98e-03	3.42e-01	7.42e-01	4.80e-01	6.47e-01	3.56e-02	9.87e-01	1.47e-01
GOBP REGULATION OF RETROGRADE TRANSPORT ENDOSOME TO GOLGI	7	2.45e-01	3.63e-01	0.6380	-2.09e-01	5.11e-02	2.02e-01	-2.42e-02	-2.13e-01	5.24e-01	3.39e-01	8.15e-01	3.54e-01	9.12e-01	3.28e-01	1.64e-02
GOMF ACETYLATION DEPENDENT PROTEIN BINDING	24	4.01e-04	2.32e-03	0.6380	2.30e-01	2.78e-01	1.27e-01	5.01e-01	1.03e-01	4.70e-03	5.15e-02	1.85e-02	2.80e-01	2.17e-05	3.83e-01	9.68e-01
GOBP PRENYLATION	10	2.94e-01	4.13e-01	0.6380	-3.40e-01	-2.84e-01	-3.62e-01	-1.92e-01	-1.64e-01	-1.27e-01	6.23e-02	1.20e-01	4.75e-02	2.92e-01	3.70e-01	4.86e-01
GOBP CELLULAR RESPONSE TO MANGANESE ION	9	4.01e-01	5.12e-01	0.6380	-3.01e-01	-3.42e-01	-9.66e-03	-2.20e-01	-3.89e-01	-1.20e-02	1.18e-01	7.57e-02	9.60e-01	2.52e-01	4.34e-02	9.50e-01
GOBP NEGATIVE REGULATION OF CD4 POSITIVE ALPHA BETA T CELL DIFFERENTIATION	20	2.30e-03	1.04e-02	0.6380	1.08e-01	2.69e-01	4.07e-01	4.82e-02	-3.23e-01	2.25e-01	4.03e-01	3.71e-02	1.61e-03	7.09e-01	1.24e-02	8.17e-02
GOBP ESTABLISHMENT OF PLANAR POLARITY INVOLVED IN NEURAL TUBE CLOSURE	7	1.63e-01	2.76e-01	0.6380	8.33e-02	1.90e-01	7.62e-02	4.86e-01	2.84e-01	-2.03e-01	7.03e-01	3.84e-01	7.27e-01	2.59e-02	1.93e-01	3.51e-01
GOMF SUMO POLYMER BINDING	6	5.88e-01	6.71e-01	0.6380	3.12e-01	3.10e-01	2.40e-01	3.14e-01	4.82e-02	2.35e-01	1.86e-01	1.89e-01	3.08e-01	1.83e-01	8.38e-01	3.19e-01
GOBP ADENOSINE TRANSPORT	5	4.08e-01	5.19e-01	0.6380	-2.10e-03	-5.23e-02	-1.77e-01	2.18e-01	5.69e-01	-2.87e-02	9.94e-01	8.40e-01	4.92e-01	3.98e-01	2.75e-02	9.12e-01
GOBP CARDIOBLAST DIFFERENTIATION	11	1.39e-01	2.48e-01	0.6370	-8.72e-02	2.29e-01	3.81e-01	-1.30e-01	2.01e-02	4.29e-01	6.17e-01	1.89e-01	2.87e-02	4.55e-01	9.08e-01	1.37e-02
GOMF MUSCLE ALPHA ACTININ BINDING	11	2.08e-01	3.25e-01	0.6370	-2.34e-01	-2.00e-01	2.94e-01	-1.53e-01	-3.22e-01	3.13e-01	1.79e-01	2.50e-01	9.11e-02	3.81e-01	6.48e-02	7.18e-02
GOBP RIBOSOME ASSOCIATED UBIQUITIN DEPENDENT PROTEIN CATABOLIC PROCESS	7	3.49e-01	4.65e-01	0.6370	1.84e-02	-1.77e-01	4.05e-01	1.08e-01	-2.68e-01	3.57e-01	9.33e-01	4.16e-01	6.37e-02	6.22e-01	2.20e-01	1.02e-01
GOBP NEGATIVE REGULATION OF PLASMINOGEN ACTIVATION	7	1.03e-02	3.51e-02	0.6370	-1.72e-02	-4.52e-01	2.44e-01	-7.05e-02	-1.89e-01	-3.19e-01	9.37e-01	3.85e-02	2.63e-01	7.47e-01	3.88e-01	1.44e-01
GOMF ARYL HYDROCARBON RECEPTOR BINDING	6	3.48e-01	4.64e-01	0.6370	5.14e-03	1.36e-01	-9.84e-02	4.05e-01	3.92e-01	-2.46e-01	9.83e-01	5.64e-01	6.77e-01	8.61e-02	9.61e-02	2.97e-01
GOBP GLUCOCORTICOID BIOSYNTHETIC PROCESS	8	1.41e-01	2.50e-01	0.6370	9.39e-04	2.24e-01	2.71e-01	3.76e-01	-4.45e-02	3.73e-01	9.96e-01	2.72e-01	1.84e-01	6.58e-02	8.27e-01	6.76e-02
GOBP PROTEIN INSERTION INTO ER MEMBRANE BY STOP TRANSFER MEMBRANE ANCHOR SEQUENCE	11	3.93e-02	9.83e-02	0.6370	-2.21e-01	-4.72e-01	-1.66e-02	2.23e-01	-1.40e-01	2.55e-01	2.04e-01	6.72e-03	9.24e-01	2.01e-01	4.23e-01	1.43e-01
GOBP NEGATIVE REGULATION OF IMMUNOGLOBULIN PRODUCTION	11	4.77e-02	1.13e-01	0.6370	2.77e-01	1.76e-01	3.01e-01	-1.43e-01	-4.07e-01	1.46e-01	1.11e-01	3.11e-01	8.39e-02	4.12e-01	1.95e-02	4.01e-01
GOMF NUCLEAR RETINOIC ACID RECEPTOR BINDING	21	7.56e-07	8.09e-06	0.6370	-6.53e-02	3.02e-01	4.02e-01	3.85e-01	7.58e-03	2.23e-02	6.04e-01	1.67e-02	1.41e-03	2.28e-03	9.52e-01	8.59e-01
GOCC HOST CELLULAR COMPONENT	8	1.17e-01	2.19e-01	0.6370	-3.05e-01	-1.22e-01	-4.39e-01	-1.56e-02	3.02e-01	1.14e-01	1.35e-01	5.50e-01	3.15e-02	9.39e-01	1.39e-01	5.77e-01
GOBP REGULATION OF GROWTH RATE	5	3.80e-01	4.94e-01	0.6370	2.63e-01	3.15e-01	-3.54e-01	1.27e-01	1.42e-01	-2.75e-01	3.08e-01	2.23e-01	1.70e-01	6.24e-01	5.83e-01	2.87e-01
GOMF NUCLEAR GLUCOCORTICOID RECEPTOR BINDING	12	1.54e-06	1.57e-05	0.6360	-1.85e-01	1.08e-01	4.86e-01	-1.29e-01	1.62e-02	-3.27e-01	2.68e-01	5.17e-01	3.58e-03	4.39e-01	9.23e-01	5.01e-02
GOBP HEME B METABOLIC PROCESS	9	1.26e-01	2.31e-01	0.6360	3.65e-01	-1.71e-01	-1.50e-01	3.48e-01	3.07e-01	-6.59e-02	5.81e-02	3.73e-01	4.36e-01	7.03e-02	1.10e-01	7.32e-01
GOBP AMP BIOSYNTHETIC PROCESS	13	1.52e-02	4.79e-02	0.6360	-1.94e-01	-5.35e-01	-2.54e-01	3.39e-02	1.18e-01	3.23e-02	2.25e-01	8.31e-04	1.13e-01	8.32e-01	4.62e-01	8.40e-01
GOBP MYOFIBROBLAST DIFFERENTIATION	9	2.13e-02	6.21e-02	0.6360	-4.86e-01	2.06e-01	2.25e-01	1.79e-02	-8.24e-02	2.62e-01	1.16e-02	2.85e-01	2.43e-01	9.26e-01	6.69e-01	1.73e-01
GOBP PROTEIN DEPALMITOYLATION	8	1.09e-01	2.09e-01	0.6360	-2.86e-01	-3.56e-01	-1.57e-01	1.20e-02	4.17e-02	4.12e-01	1.62e-01	8.09e-02	4.43e-01	9.53e-01	8.38e-01	4.36e-02
GOBP PROTEIN TRANSMEMBRANE IMPORT INTO INTRACELLULAR ORGANELLE	37	4.57e-05	3.36e-04	0.6360	-1.78e-01	-4.48e-01	-3.78e-01	1.41e-02	-8.49e-02	-1.48e-01	6.06e-02	2.35e-06	6.99e-05	8.82e-01	3.72e-01	1.20e-01
GOBP REGULATION OF INFLAMMATORY RESPONSE TO WOUNDING	9	3.65e-02	9.30e-02	0.6360	-1.19e-01	1.61e-01	4.82e-01	1.21e-01	-3.21e-01	1.19e-01	5.35e-01	4.03e-01	1.23e-02	5.30e-01	9.50e-02	5.37e-01
GOBP RESPONSE TO INTERLEUKIN 6	25	6.65e-05	4.70e-04	0.6360	9.29e-03	2.64e-01	1.13e-01	4.50e-01	1.84e-01	2.92e-01	9.36e-01	2.24e-02	3.27e-01	9.65e-05	1.12e-01	1.15e-02
GOMF ACTIVIN RECEPTOR ACTIVITY	9	4.89e-02	1.15e-01	0.6360	-4.07e-01	2.57e-01	2.31e-01	-2.39e-02	-2.31e-02	3.44e-01	3.46e-02	1.82e-01	2.30e-01	9.01e-01	9.04e-01	7.36e-02
GOBP LIPID TRANSPORT ACROSS BLOOD BRAIN BARRIER	6	3.98e-02	9.92e-02	0.6360	2.38e-04	-9.32e-02	1.48e-01	4.04e-01	4.14e-01	-1.97e-01	9.99e-01	6.92e-01	5.31e-01	8.63e-02	7.92e-02	4.02e-01
GOMF SODIUM BICARBONATE SYMPORTER ACTIVITY	5	2.84e-02	7.69e-02	0.6360	-4.94e-02	4.74e-01	-3.76e-01	1.63e-01	6.18e-02	6.52e-02	8.48e-01	6.62e-02	1.45e-01	5.28e-01	8.11e-01	8.01e-01
GOBP KILLING BY HOST OF SYMBIONT CELLS	16	1.19e-03	5.91e-03	0.6350	1.03e-01	-3.12e-01	3.79e-01	1.64e-01	-3.35e-01	1.13e-01	4.74e-01	3.05e-02	8.66e-03	2.57e-01	2.03e-02	4.33e-01
GOMF OXIDOREDUCTASE ACTIVITY ACTING ON NAD P H QUINONE OR SIMILAR COMPOUND AS ACCEPTOR	56	2.35e-10	4.09e-09	0.6350	-1.15e-01	-5.59e-01	-2.56e-01	-3.31e-02	-1.03e-01	-3.58e-02	1.35e-01	4.70e-13	9.10e-04	6.68e-01	1.84e-01	6.43e-01
GOBP MEIOTIC CHROMOSOME CONDENSATION	6	2.84e-01	4.04e-01	0.6350	8.69e-02	-7.82e-02	-3.49e-01	4.72e-01	2.04e-01	5.84e-02	7.12e-01	7.40e-01	1.39e-01	4.51e-02	3.87e-01	8.04e-01
GOMF OXIDOREDUCTASE ACTIVITY ACTING ON A SULFUR GROUP OF DONORS DISULFIDE AS ACCEPTOR	9	2.96e-01	4.15e-01	0.6350	-3.48e-01	-4.10e-01	-1.55e-01	-1.18e-01	-2.11e-01	1.79e-01	7.04e-02	3.34e-02	4.19e-01	5.41e-01	2.72e-01	3.53e-01
GOBP UDP N ACETYLGLUCOSAMINE METABOLIC PROCESS	14	1.62e-02	5.01e-02	0.6350	-2.01e-01	-1.28e-01	-2.65e-01	-1.35e-01	-3.76e-01	-3.42e-01	1.92e-01	4.06e-01	8.55e-02	3.82e-01	1.49e-02	2.69e-02
GOBP MATURATION OF 5 8S RRNA	35	8.80e-06	7.51e-05	0.6350	-4.35e-02	-4.75e-01	-3.71e-01	9.82e-02	-8.39e-02	-1.45e-01	6.56e-01	1.12e-06	1.44e-04	3.14e-01	3.90e-01	1.39e-01
GOBP HEPATOCYTE APOPTOTIC PROCESS	18	3.83e-03	1.58e-02	0.6350	-2.36e-01	1.14e-01	3.18e-01	7.44e-02	-1.57e-01	4.50e-01	8.24e-02	4.04e-01	1.94e-02	5.85e-01	2.48e-01	9.39e-04
GOBP RETINAL CELL PROGRAMMED CELL DEATH	5	5.53e-01	6.43e-01	0.6350	2.34e-01	8.34e-02	4.34e-01	-2.07e-01	-3.16e-01	1.01e-01	3.64e-01	7.47e-01	9.25e-02	4.23e-01	2.22e-01	6.96e-01
GOBP RESOLUTION OF MEIOTIC RECOMBINATION INTERMEDIATES	14	5.53e-02	1.27e-01	0.6350	2.30e-01	4.56e-02	2.16e-01	3.49e-01	2.07e-01	3.69e-01	1.35e-01	7.68e-01	1.62e-01	2.36e-02	1.79e-01	1.67e-02
GOBP CONSTITUTIVE SECRETORY PATHWAY	7	1.85e-01	3.00e-01	0.6350	-4.67e-01	1.01e-01	1.58e-01	-1.24e-01	7.29e-02	3.59e-01	3.24e-02	6.42e-01	4.68e-01	5.70e-01	7.38e-01	1.00e-01
GOBP GOLGI LUMEN ACIDIFICATION	13	7.79e-03	2.82e-02	0.6350	-3.84e-01	-2.64e-01	2.36e-01	5.42e-02	-3.40e-01	1.07e-01	1.65e-02	9.90e-02	1.41e-01	7.35e-01	3.39e-02	5.04e-01
GOBP REGULATION OF RESPIRATORY SYSTEM PROCESS	10	3.65e-01	4.81e-01	0.6350	2.57e-01	2.90e-01	1.11e-02	3.63e-01	3.47e-01	2.14e-02	1.59e-01	1.12e-01	9.52e-01	4.71e-02	5.76e-02	9.07e-01
GOBP SULFUR AMINO ACID TRANSPORT	10	8.81e-02	1.79e-01	0.6340	2.38e-01	-1.57e-01	3.38e-02	5.24e-01	2.05e-01	6.15e-02	1.92e-01	3.90e-01	8.53e-01	4.14e-03	2.62e-01	7.36e-01
GOBP DNA UNWINDING INVOLVED IN DNA REPLICATION	21	7.83e-05	5.46e-04	0.6340	3.10e-01	-2.84e-01	-5.86e-02	4.14e-01	6.04e-02	2.19e-01	1.40e-02	2.45e-02	6.42e-01	1.03e-03	6.32e-01	8.28e-02
GOBP ASYMMETRIC CELL DIVISION	16	2.45e-02	6.91e-02	0.6340	-1.54e-01	9.37e-02	4.64e-01	-1.40e-01	-9.71e-02	3.54e-01	2.85e-01	5.16e-01	1.31e-03	3.34e-01	5.01e-01	1.43e-02
GOBP ALDITOL PHOSPHATE METABOLIC PROCESS	10	2.16e-02	6.29e-02	0.6340	-3.19e-01	3.43e-01	3.91e-02	-1.34e-02	2.20e-01	3.64e-01	8.06e-02	6.06e-02	8.31e-01	9.41e-01	2.29e-01	4.62e-02
GOMF 5 DEOXYRIBOSE 5 PHOSPHATE LYASE ACTIVITY	6	1.66e-01	2.79e-01	0.6340	-1.77e-01	-2.33e-01	-2.44e-01	4.10e-01	6.10e-02	2.90e-01	4.54e-01	3.22e-01	3.00e-01	8.17e-02	7.96e-01	2.18e-01
GOCC AUTOLYSOSOME	14	2.70e-02	7.41e-02	0.6340	-4.24e-01	-3.07e-01	-3.31e-01	1.24e-01	2.70e-02	-4.39e-02	6.05e-03	4.68e-02	3.20e-02	4.20e-01	8.61e-01	7.76e-01
GOBP NEGATIVE REGULATION OF T HELPER CELL DIFFERENTIATION	16	2.41e-02	6.81e-02	0.6340	1.65e-01	2.89e-01	4.53e-01	7.32e-02	-2.32e-01	1.64e-01	2.54e-01	4.55e-02	1.71e-03	6.12e-01	1.09e-01	2.57e-01
GOMF CALCIUM CHANNEL INHIBITOR ACTIVITY	10	7.63e-02	1.61e-01	0.6340	-1.91e-01	-5.28e-01	-1.08e-03	-3.99e-02	-1.21e-01	2.64e-01	2.95e-01	3.84e-03	9.95e-01	8.27e-01	5.08e-01	1.48e-01
GOBP CELLULAR RESPONSE TO INSULIN LIKE GROWTH FACTOR STIMULUS	9	2.55e-01	3.75e-01	0.6330	-1.85e-01	-1.85e-01	3.53e-01	-5.36e-02	-3.57e-01	2.79e-01	3.37e-01	3.38e-01	6.63e-02	7.81e-01	6.36e-02	1.48e-01
GOBP EPITHELIAL TO MESENCHYMAL TRANSITION INVOLVED IN ENDOCARDIAL CUSHION FORMATION	10	2.71e-02	7.44e-02	0.6330	-1.69e-01	3.05e-01	2.16e-01	3.42e-01	2.99e-01	1.63e-01	3.54e-01	9.47e-02	2.36e-01	6.12e-02	1.02e-01	3.72e-01
GOBP TRYPTOPHAN METABOLIC PROCESS	10	8.29e-02	1.71e-01	0.6330	-4.96e-02	1.05e-01	-2.82e-01	1.38e-01	5.31e-01	8.30e-02	7.86e-01	5.65e-01	1.22e-01	4.49e-01	3.66e-03	6.50e-01
GOBP 7 METHYLGUANOSINE RNA CAPPING	7	2.35e-02	6.70e-02	0.6330	-2.73e-01	-7.75e-02	-1.46e-01	3.60e-01	-1.54e-01	3.82e-01	2.12e-01	7.22e-01	5.04e-01	9.90e-02	4.81e-01	8.01e-02
GOMF NUCLEOTIDE SUGAR TRANSMEMBRANE TRANSPORTER ACTIVITY	12	7.83e-02	1.64e-01	0.6330	-4.37e-01	-3.21e-01	-6.15e-02	-9.39e-02	-2.84e-01	-1.16e-01	8.74e-03	5.42e-02	7.12e-01	5.73e-01	8.87e-02	4.85e-01
GOBP GLUTATHIONE TRANSPORT	8	1.48e-01	2.59e-01	0.6330	-5.54e-02	-1.44e-01	4.27e-01	1.72e-01	-1.26e-02	4.06e-01	7.86e-01	4.79e-01	3.65e-02	4.00e-01	9.51e-01	4.67e-02
GOBP DETERMINATION OF DORSAL VENTRAL ASYMMETRY	9	1.77e-02	5.36e-02	0.6330	1.75e-01	-6.94e-03	4.64e-01	-3.72e-01	-1.27e-01	-1.84e-02	3.64e-01	9.71e-01	1.60e-02	5.32e-02	5.09e-01	9.24e-01
GOMF PHOSPHATIDYLINOSITOL PHOSPHATE 4 PHOSPHATASE ACTIVITY	9	2.62e-01	3.82e-01	0.6330	4.50e-02	3.76e-01	2.01e-01	2.42e-01	3.33e-01	2.18e-01	8.15e-01	5.08e-02	2.96e-01	2.09e-01	8.40e-02	2.58e-01
GOBP COMPLEMENT RECEPTOR MEDIATED SIGNALING PATHWAY	12	5.48e-02	1.26e-01	0.6330	-1.73e-01	2.49e-01	4.33e-01	-2.40e-01	-2.06e-01	1.46e-01	3.00e-01	1.35e-01	9.47e-03	1.49e-01	2.17e-01	3.83e-01
GOMF C X C CHEMOKINE RECEPTOR ACTIVITY	8	1.75e-01	2.89e-01	0.6330	4.59e-01	1.09e-01	3.25e-01	1.48e-01	-2.04e-01	-9.15e-02	2.47e-02	5.93e-01	1.11e-01	4.67e-01	3.17e-01	6.54e-01
GOCC BRISC COMPLEX	6	4.24e-01	5.33e-01	0.6330	-1.71e-01	-5.19e-01	-2.26e-01	1.46e-01	-1.72e-01	-4.52e-03	4.69e-01	2.78e-02	3.38e-01	5.35e-01	4.66e-01	9.85e-01
GOBP NUCLEOBASE CATABOLIC PROCESS	6	5.34e-02	1.23e-01	0.6320	-5.33e-01	-2.37e-01	3.86e-02	-6.94e-02	1.33e-01	-1.90e-01	2.38e-02	3.16e-01	8.70e-01	7.68e-01	5.74e-01	4.19e-01
GOBP U2 TYPE PRESPLICEOSOME ASSEMBLY	25	6.88e-05	4.86e-04	0.6320	-9.50e-02	-4.55e-01	-3.35e-01	2.54e-01	3.91e-02	7.43e-02	4.11e-01	8.21e-05	3.74e-03	2.78e-02	7.35e-01	5.20e-01
GOCC SCHMIDT LANTERMAN INCISURE	9	3.59e-01	4.74e-01	0.6320	-2.11e-01	-3.44e-01	6.74e-02	-3.35e-01	-3.46e-01	1.37e-03	2.73e-01	7.37e-02	7.26e-01	8.14e-02	7.24e-02	9.94e-01
GOBP REGULATION OF GROWTH HORMONE RECEPTOR SIGNALING PATHWAY	5	1.41e-01	2.50e-01	0.6320	-2.04e-01	-1.44e-01	-3.01e-01	-3.32e-01	-7.62e-02	3.62e-01	4.30e-01	5.77e-01	2.43e-01	1.99e-01	7.68e-01	1.62e-01
GOBP DE NOVO CENTRIOLE ASSEMBLY	5	1.88e-01	3.03e-01	0.6320	2.50e-01	9.94e-02	3.43e-02	-5.59e-02	5.23e-01	2.22e-01	3.32e-01	7.00e-01	8.94e-01	8.29e-01	4.29e-02	3.90e-01
GOBP REGULATION OF CELL PROJECTION SIZE	10	7.18e-02	1.54e-01	0.6320	4.86e-01	3.63e-02	3.17e-01	1.42e-01	1.26e-01	1.60e-01	7.81e-03	8.42e-01	8.26e-02	4.37e-01	4.90e-01	3.81e-01
GOBP BLOOD VESSEL ENDOTHELIAL CELL PROLIFERATION INVOLVED IN SPROUTING ANGIOGENESIS	14	1.45e-03	7.02e-03	0.6320	-9.86e-02	-1.36e-02	5.80e-01	-1.13e-01	-1.54e-01	1.29e-01	5.23e-01	9.30e-01	1.72e-04	4.64e-01	3.17e-01	4.03e-01
GOCC VARICOSITY	6	9.75e-02	1.92e-01	0.6320	1.72e-01	-1.96e-01	-9.16e-02	1.54e-01	5.39e-01	-9.08e-02	4.65e-01	4.07e-01	6.97e-01	5.15e-01	2.22e-02	7.00e-01
GOMF CALMODULIN DEPENDENT PROTEIN PHOSPHATASE ACTIVITY	5	3.52e-01	4.68e-01	0.6320	-5.47e-01	1.15e-02	1.14e-02	-1.36e-01	-2.65e-01	1.05e-01	3.42e-02	9.64e-01	9.65e-01	6.00e-01	3.05e-01	6.84e-01
GOBP AMINOACYL TRNA METABOLISM INVOLVED IN TRANSLATIONAL FIDELITY	13	3.13e-02	8.24e-02	0.6320	5.40e-02	-3.79e-01	-2.79e-01	3.48e-01	1.61e-01	-1.68e-01	7.36e-01	1.80e-02	8.20e-02	3.00e-02	3.16e-01	2.95e-01
GOMF AMINOACYL TRNA EDITING ACTIVITY	13	3.13e-02	8.24e-02	0.6320	5.40e-02	-3.79e-01	-2.79e-01	3.48e-01	1.61e-01	-1.68e-01	7.36e-01	1.80e-02	8.20e-02	3.00e-02	3.16e-01	2.95e-01
GOCC AZUROPHIL GRANULE MEMBRANE	58	1.28e-13	3.04e-12	0.6320	-4.55e-01	-1.41e-01	1.87e-01	6.11e-02	-2.28e-01	2.84e-01	1.99e-09	6.30e-02	1.38e-02	4.21e-01	2.66e-03	1.78e-04
GOMF RIBOSOMAL SMALL SUBUNIT BINDING	17	6.08e-02	1.36e-01	0.6310	-4.01e-01	-3.24e-01	-1.78e-01	-2.95e-01	-1.12e-01	3.81e-02	4.18e-03	2.07e-02	2.05e-01	3.50e-02	4.26e-01	7.85e-01
GOBP POSITIVE REGULATION OF VOLTAGE GATED POTASSIUM CHANNEL ACTIVITY	6	4.63e-01	5.67e-01	0.6310	4.56e-01	2.23e-01	3.22e-01	2.60e-03	-5.36e-02	1.86e-01	5.32e-02	3.44e-01	1.72e-01	9.91e-01	8.20e-01	4.31e-01
GOBP BIOLOGICAL PHASE	5	2.30e-01	3.48e-01	0.6310	-4.15e-01	3.57e-01	-1.99e-03	-5.70e-02	3.09e-01	1.95e-02	1.08e-01	1.67e-01	9.94e-01	8.25e-01	2.31e-01	9.40e-01
GOCC FILOPODIUM MEMBRANE	13	3.85e-02	9.67e-02	0.6310	2.51e-02	3.84e-01	3.97e-01	4.40e-02	-1.86e-01	2.38e-01	8.76e-01	1.66e-02	1.31e-02	7.84e-01	2.46e-01	1.38e-01
GOBP G1 TO G0 TRANSITION	17	1.35e-02	4.38e-02	0.6310	1.24e-01	-8.41e-02	-2.26e-01	2.71e-01	3.82e-01	-3.25e-01	3.75e-01	5.48e-01	1.06e-01	5.31e-02	6.42e-03	2.04e-02
GOBP POSITIVE REGULATION OF MAST CELL ACTIVATION	5	4.28e-01	5.37e-01	0.6310	4.00e-01	2.04e-01	2.33e-01	2.66e-01	-1.48e-01	-2.24e-01	1.21e-01	4.29e-01	3.67e-01	3.03e-01	5.68e-01	3.86e-01
GOMF TRANSMEMBRANE RECEPTOR PROTEIN TYROSINE KINASE ACTIVATOR ACTIVITY	11	9.58e-04	4.91e-03	0.6310	-1.51e-01	3.22e-01	4.99e-01	-8.09e-02	9.63e-02	-8.41e-02	3.85e-01	6.40e-02	4.20e-03	6.42e-01	5.80e-01	6.29e-01
GOBP SPLICEOSOMAL TRI SNRNP COMPLEX ASSEMBLY	15	2.88e-02	7.77e-02	0.6310	-1.46e-01	-3.27e-01	-3.67e-01	2.39e-01	-1.04e-02	-2.79e-01	3.28e-01	2.84e-02	1.39e-02	1.08e-01	9.44e-01	6.12e-02
GOMF OXIDOREDUCTASE ACTIVITY ACTING ON PAIRED DONORS WITH OXIDATION OF A PAIR OF DONORS RESULTING IN THE REDUCTION OF MOLECULAR OXYGEN TO TWO MOLECULES OF WATER	9	6.92e-02	1.50e-01	0.6310	5.23e-02	-1.88e-03	4.56e-01	1.62e-01	1.91e-01	3.52e-01	7.86e-01	9.92e-01	1.77e-02	4.01e-01	3.22e-01	6.72e-02
GOBP RRNA METABOLIC PROCESS	259	8.93e-46	2.12e-43	0.6310	-9.98e-02	-4.71e-01	-3.65e-01	7.63e-02	-6.36e-02	-1.51e-01	5.71e-03	4.73e-39	4.33e-24	3.45e-02	7.80e-02	3.00e-05
GOBP TRNA DECAY	16	4.02e-02	9.99e-02	0.6310	-2.06e-01	-3.95e-01	-4.14e-01	6.74e-02	8.93e-02	-1.25e-01	1.53e-01	6.26e-03	4.18e-03	6.41e-01	5.36e-01	3.87e-01
GOBP NEGATIVE REGULATION OF DENDRITE MORPHOGENESIS	5	5.63e-02	1.29e-01	0.6300	-4.62e-02	4.12e-01	1.63e-01	3.70e-01	-2.27e-01	-1.04e-01	8.58e-01	1.11e-01	5.27e-01	1.52e-01	3.80e-01	6.88e-01
GOBP RIBONUCLEOPROTEIN COMPLEX BIOGENESIS	445	9.03e-79	6.43e-76	0.6300	-1.53e-01	-4.75e-01	-3.63e-01	5.97e-02	-4.94e-02	-1.02e-01	3.22e-08	1.85e-66	1.54e-39	3.09e-02	7.40e-02	2.11e-04
GOBP GAMMA DELTA T CELL DIFFERENTIATION	13	4.72e-02	1.12e-01	0.6300	1.21e-01	4.26e-01	9.62e-02	3.59e-01	2.04e-01	1.49e-01	4.51e-01	7.88e-03	5.48e-01	2.52e-02	2.04e-01	3.53e-01
GOBP POLYKETIDE METABOLIC PROCESS	7	4.52e-01	5.58e-01	0.6300	-1.15e-01	-2.17e-01	-4.54e-01	1.32e-01	2.82e-01	-1.82e-01	5.99e-01	3.20e-01	3.74e-02	5.46e-01	1.96e-01	4.05e-01
GOMF GALACTOSIDASE ACTIVITY	6	4.08e-01	5.19e-01	0.6300	-1.86e-01	-8.56e-02	-4.11e-02	-3.88e-01	-2.23e-01	-3.91e-01	4.30e-01	7.16e-01	8.62e-01	1.00e-01	3.44e-01	9.70e-02
GOMF BMP RECEPTOR ACTIVITY	5	4.77e-01	5.78e-01	0.6300	-3.49e-01	1.91e-01	1.31e-01	-3.89e-01	-2.63e-01	-2.21e-02	1.76e-01	4.58e-01	6.13e-01	1.32e-01	3.09e-01	9.32e-01
GOCC NUCLEAR PORE OUTER RING	10	3.67e-02	9.34e-02	0.6300	-3.86e-01	-1.82e-01	-2.88e-01	3.03e-01	1.45e-01	-1.37e-01	3.47e-02	3.19e-01	1.15e-01	9.74e-02	4.29e-01	4.53e-01
GOBP L KYNURENINE METABOLIC PROCESS	6	3.17e-01	4.37e-01	0.6300	-1.15e-01	-3.93e-03	-2.39e-01	1.57e-01	5.43e-01	8.03e-02	6.26e-01	9.87e-01	3.10e-01	5.06e-01	2.13e-02	7.33e-01
GOMF CTPASE ACTIVITY	6	1.74e-01	2.88e-01	0.6290	-4.08e-01	3.57e-01	1.70e-01	-9.74e-02	3.77e-02	2.49e-01	8.34e-02	1.30e-01	4.70e-01	6.79e-01	8.73e-01	2.91e-01
GOBP NEGATIVE REGULATION OF LENS FIBER CELL DIFFERENTIATION	5	5.37e-01	6.28e-01	0.6290	-6.46e-03	3.98e-02	5.21e-01	-1.01e-01	-3.00e-01	1.50e-01	9.80e-01	8.78e-01	4.35e-02	6.95e-01	2.46e-01	5.62e-01
GOBP HEART VALVE FORMATION	8	3.71e-01	4.87e-01	0.6290	1.88e-01	2.65e-01	1.77e-01	4.50e-01	2.10e-01	1.12e-01	3.57e-01	1.95e-01	3.87e-01	2.76e-02	3.05e-01	5.85e-01
GOBP SUCCINATE TRANSMEMBRANE TRANSPORT	5	5.62e-01	6.50e-01	0.6290	8.61e-02	-2.38e-01	-2.69e-01	4.07e-01	1.71e-01	-2.52e-01	7.39e-01	3.57e-01	2.97e-01	1.15e-01	5.07e-01	3.28e-01
GOMF SUCCINATE TRANSMEMBRANE TRANSPORTER ACTIVITY	5	5.62e-01	6.50e-01	0.6290	8.61e-02	-2.38e-01	-2.69e-01	4.07e-01	1.71e-01	-2.52e-01	7.39e-01	3.57e-01	2.97e-01	1.15e-01	5.07e-01	3.28e-01
GOBP PROTEIN INSERTION INTO MEMBRANE	41	1.04e-07	1.28e-06	0.6290	-2.51e-01	-5.09e-01	-1.70e-01	1.72e-01	-9.43e-02	7.55e-02	5.39e-03	1.69e-08	5.98e-02	5.67e-02	2.96e-01	4.03e-01
GOCC ANNULATE LAMELLAE	5	4.14e-01	5.25e-01	0.6290	-4.63e-02	1.71e-01	2.78e-01	3.42e-01	-9.60e-02	4.01e-01	8.58e-01	5.07e-01	2.82e-01	1.86e-01	7.10e-01	1.21e-01
GOBP SIGNAL COMPLEX ASSEMBLY	8	1.49e-01	2.60e-01	0.6290	-1.38e-02	-4.85e-01	1.03e-01	1.57e-01	-2.72e-01	2.23e-01	9.46e-01	1.75e-02	6.13e-01	4.41e-01	1.82e-01	2.74e-01
GOBP EMBRYONIC PLACENTA MORPHOGENESIS	17	3.42e-02	8.85e-02	0.6280	1.13e-01	2.97e-01	4.50e-01	1.61e-01	-4.65e-02	2.52e-01	4.21e-01	3.41e-02	1.32e-03	2.50e-01	7.40e-01	7.18e-02
GOBP EARLY ENDOSOME TO RECYCLING ENDOSOME TRANSPORT	7	1.20e-01	2.23e-01	0.6280	-3.74e-01	-2.20e-01	-1.04e-01	8.96e-02	-4.24e-01	8.89e-02	8.66e-02	3.14e-01	6.35e-01	6.81e-01	5.21e-02	6.84e-01
GOMF NEUROTROPHIN TRK RECEPTOR BINDING	6	1.66e-01	2.79e-01	0.6280	-2.71e-02	4.37e-01	3.30e-01	1.61e-01	-2.13e-01	1.52e-01	9.09e-01	6.39e-02	1.62e-01	4.93e-01	3.67e-01	5.20e-01
GOBP NUCLEAR PORE COMPLEX ASSEMBLY	11	3.97e-03	1.62e-02	0.6280	-4.10e-01	2.82e-02	-7.13e-02	3.83e-01	2.13e-01	1.70e-01	1.87e-02	8.71e-01	6.82e-01	2.79e-02	2.21e-01	3.30e-01
GOBP REGULATION OF ENDOCYTIC RECYCLING	17	4.41e-02	1.07e-01	0.6280	3.32e-01	2.54e-01	3.63e-01	2.81e-01	3.73e-03	9.50e-02	1.79e-02	7.03e-02	9.48e-03	4.50e-02	9.79e-01	4.98e-01
GOMF HYALURONONGLUCOSAMINIDASE ACTIVITY	6	3.82e-01	4.96e-01	0.6280	2.97e-01	2.37e-01	2.16e-02	4.24e-01	5.53e-02	-2.58e-01	2.08e-01	3.16e-01	9.27e-01	7.22e-02	8.15e-01	2.74e-01
GOMF GLYCOLIPID MANNOSYLTRANSFERASE ACTIVITY	5	1.28e-01	2.33e-01	0.6270	-1.65e-01	-1.53e-01	-4.93e-01	1.98e-01	5.26e-02	2.41e-01	5.23e-01	5.53e-01	5.62e-02	4.42e-01	8.39e-01	3.51e-01
GOBP FRUCTOSE TRANSMEMBRANE TRANSPORT	7	2.06e-01	3.23e-01	0.6270	-3.04e-03	-9.12e-02	-2.09e-01	1.71e-01	5.11e-01	-2.26e-01	9.89e-01	6.76e-01	3.37e-01	4.34e-01	1.92e-02	3.01e-01
GOMF FRUCTOSE TRANSMEMBRANE TRANSPORTER ACTIVITY	7	2.06e-01	3.23e-01	0.6270	-3.04e-03	-9.12e-02	-2.09e-01	1.71e-01	5.11e-01	-2.26e-01	9.89e-01	6.76e-01	3.37e-01	4.34e-01	1.92e-02	3.01e-01
GOMF EPOXIDE HYDROLASE ACTIVITY	8	1.99e-01	3.15e-01	0.6270	-2.34e-01	-1.21e-02	-2.85e-01	1.93e-01	4.55e-01	-1.14e-01	2.52e-01	9.53e-01	1.63e-01	3.46e-01	2.58e-02	5.75e-01
GOBP NEGATIVE REGULATION OF MAST CELL ACTIVATION	10	2.35e-01	3.53e-01	0.6270	2.03e-02	2.59e-01	3.48e-01	2.87e-03	7.31e-02	4.46e-01	9.12e-01	1.56e-01	5.70e-02	9.87e-01	6.89e-01	1.45e-02
GOBP POSITIVE REGULATION OF NATURAL KILLER CELL MEDIATED IMMUNITY	30	2.73e-08	3.64e-07	0.6270	1.50e-01	4.12e-01	1.76e-01	2.36e-01	-1.54e-01	3.00e-01	1.56e-01	9.40e-05	9.44e-02	2.50e-02	1.44e-01	4.43e-03
GOBP REGULATION OF TOLL SIGNALING PATHWAY	5	2.04e-01	3.20e-01	0.6270	-4.41e-01	3.67e-01	1.53e-01	-1.32e-01	1.50e-01	3.26e-02	8.80e-02	1.56e-01	5.54e-01	6.08e-01	5.61e-01	9.00e-01
GOCC TOR COMPLEX	12	3.45e-02	8.89e-02	0.6270	3.22e-01	1.00e-01	2.56e-02	4.86e-01	-9.12e-03	-2.05e-01	5.35e-02	5.48e-01	8.78e-01	3.53e-03	9.56e-01	2.18e-01
GOMF LYSOPHOSPHATIDIC ACID PHOSPHATASE ACTIVITY	5	4.87e-01	5.86e-01	0.6270	6.53e-02	-2.01e-02	-2.72e-01	3.53e-01	3.97e-01	1.78e-01	8.00e-01	9.38e-01	2.92e-01	1.71e-01	1.24e-01	4.91e-01
GOMF MRNA METHYLTRANSFERASE ACTIVITY	12	1.05e-01	2.02e-01	0.6270	-1.79e-01	-3.02e-01	-4.32e-01	1.98e-01	2.40e-02	-2.08e-01	2.82e-01	6.98e-02	9.64e-03	2.35e-01	8.85e-01	2.12e-01
GOBP POSITIVE REGULATION OF NATURAL KILLER CELL PROLIFERATION	8	3.52e-01	4.68e-01	0.6270	-3.51e-01	-1.85e-01	-3.86e-01	1.32e-02	1.39e-01	-2.58e-01	8.56e-02	3.64e-01	5.84e-02	9.48e-01	4.96e-01	2.07e-01
GOBP NUCLEOTIDE TRANSMEMBRANE TRANSPORT	25	1.57e-02	4.90e-02	0.6270	-3.49e-01	-3.48e-01	-2.05e-01	-2.01e-01	-2.34e-01	-1.15e-01	2.54e-03	2.59e-03	7.60e-02	8.24e-02	4.32e-02	3.21e-01
GOBP REGULATION OF AGGREPHAGY	7	3.82e-01	4.95e-01	0.6270	1.39e-01	-4.37e-02	4.64e-01	5.81e-02	-3.18e-01	2.28e-01	5.24e-01	8.41e-01	3.36e-02	7.90e-01	1.45e-01	2.97e-01
GOMF CASPASE BINDING	10	1.36e-01	2.44e-01	0.6270	-2.70e-01	-2.05e-01	1.60e-01	-2.07e-02	-1.00e-01	4.91e-01	1.39e-01	2.61e-01	3.80e-01	9.10e-01	5.82e-01	7.15e-03
GOMF HISTONE H4K16 ACETYLTRANSFERASE ACTIVITY	8	3.40e-02	8.80e-02	0.6270	-2.60e-01	-3.65e-02	-3.83e-01	2.12e-01	-1.87e-01	-3.12e-01	2.04e-01	8.58e-01	6.09e-02	3.00e-01	3.59e-01	1.26e-01
GOBP REGULATION OF LIPOPROTEIN PARTICLE CLEARANCE	13	3.67e-02	9.34e-02	0.6270	-3.08e-02	-2.76e-01	3.34e-01	7.08e-02	-3.99e-01	1.99e-01	8.48e-01	8.44e-02	3.71e-02	6.58e-01	1.28e-02	2.13e-01
GOBP FLOOR PLATE DEVELOPMENT	7	2.14e-01	3.32e-01	0.6270	-6.47e-02	-1.27e-01	-2.17e-01	2.35e-01	5.18e-01	3.67e-02	7.67e-01	5.60e-01	3.20e-01	2.82e-01	1.75e-02	8.67e-01
GOMF MECHANOSENSITIVE MONOATOMIC ION CHANNEL ACTIVITY	13	6.01e-02	1.35e-01	0.6260	3.75e-01	3.19e-01	2.85e-01	-4.25e-02	2.01e-01	1.64e-01	1.92e-02	4.68e-02	7.52e-02	7.91e-01	2.10e-01	3.06e-01
GOMF AMP ACTIVATED PROTEIN KINASE ACTIVITY	5	1.49e-01	2.60e-01	0.6260	-5.33e-01	1.08e-01	-2.85e-01	-1.73e-02	-1.20e-01	1.43e-02	3.88e-02	6.75e-01	2.70e-01	9.47e-01	6.41e-01	9.56e-01
GOMF DNA CLAMP LOADER ACTIVITY	9	9.97e-02	1.95e-01	0.6260	-4.13e-02	-1.63e-01	-5.59e-01	-3.60e-02	1.98e-01	-1.07e-01	8.30e-01	3.98e-01	3.70e-03	8.52e-01	3.04e-01	5.77e-01
GOBP STEROID CATABOLIC PROCESS	13	1.23e-01	2.28e-01	0.6260	-2.01e-01	-2.71e-01	-3.01e-01	-3.16e-01	-2.33e-02	-2.95e-01	2.09e-01	9.10e-02	6.00e-02	4.89e-02	8.84e-01	6.56e-02
GOBP OLIGODENDROCYTE APOPTOTIC PROCESS	5	3.08e-01	4.29e-01	0.6260	-5.73e-02	-1.19e-01	2.55e-01	3.30e-01	2.95e-01	3.37e-01	8.24e-01	6.46e-01	3.23e-01	2.02e-01	2.54e-01	1.92e-01
GOBP BRAINSTEM DEVELOPMENT	5	1.34e-01	2.41e-01	0.6260	-4.19e-01	-1.01e-01	-1.80e-01	1.64e-01	-3.11e-01	2.22e-01	1.05e-01	6.95e-01	4.85e-01	5.24e-01	2.28e-01	3.90e-01
GOCC PLATELET ALPHA GRANULE LUMEN	52	5.65e-08	7.13e-07	0.6260	-2.28e-01	-3.97e-01	1.87e-01	-1.50e-01	-3.08e-01	1.72e-01	4.43e-03	7.31e-07	1.99e-02	6.14e-02	1.21e-04	3.16e-02
GOBP DIACYLGLYCEROL CATABOLIC PROCESS	5	1.43e-01	2.53e-01	0.6260	-1.94e-01	1.52e-01	1.96e-01	3.58e-01	4.04e-01	-2.56e-02	4.53e-01	5.55e-01	4.48e-01	1.66e-01	1.17e-01	9.21e-01
GOBP NEGATIVE REGULATION OF ALPHA BETA T CELL DIFFERENTIATION	22	1.90e-03	8.78e-03	0.6250	9.41e-02	1.89e-01	4.20e-01	2.83e-02	-3.58e-01	2.02e-01	4.45e-01	1.24e-01	6.42e-04	8.18e-01	3.66e-03	1.01e-01
GOBP ESTABLISHMENT OF PROTEIN LOCALIZATION TO TELOMERE	18	2.02e-03	9.27e-03	0.6250	-1.46e-01	-4.89e-01	-1.78e-01	2.72e-01	-1.21e-01	9.97e-02	2.85e-01	3.28e-04	1.90e-01	4.54e-02	3.74e-01	4.64e-01
GOBP TRANSFORMING GROWTH FACTOR BETA1 PRODUCTION	8	1.43e-01	2.53e-01	0.6250	-2.43e-01	-1.34e-01	3.06e-01	-7.71e-02	-4.63e-01	-4.53e-03	2.33e-01	5.12e-01	1.34e-01	7.06e-01	2.35e-02	9.82e-01
GOMF PHOSPHOLIPASE ACTIVATOR ACTIVITY	15	5.84e-02	1.32e-01	0.6250	-2.84e-01	-3.57e-01	3.65e-02	-1.04e-01	-2.66e-01	3.16e-01	5.69e-02	1.68e-02	8.07e-01	4.85e-01	7.49e-02	3.41e-02
GOMF T CELL RECEPTOR BINDING	11	1.02e-01	1.98e-01	0.6250	-1.23e-01	-2.59e-01	-4.19e-01	3.10e-01	1.67e-01	-8.83e-02	4.78e-01	1.36e-01	1.61e-02	7.51e-02	3.36e-01	6.12e-01
GOBP CELLULAR RESPONSE TO CGMP	6	2.87e-01	4.06e-01	0.6240	2.06e-02	-2.54e-01	2.63e-01	5.71e-02	-5.02e-01	-2.98e-02	9.30e-01	2.81e-01	2.65e-01	8.09e-01	3.33e-02	8.99e-01
GOBP PROTEIN NITROSYLATION	13	9.06e-02	1.82e-01	0.6240	-9.11e-02	2.22e-01	3.37e-01	-2.40e-01	-1.14e-01	3.85e-01	5.69e-01	1.66e-01	3.55e-02	1.34e-01	4.79e-01	1.62e-02
GOBP REGULATION OF LENS FIBER CELL DIFFERENTIATION	7	3.14e-01	4.34e-01	0.6240	-1.49e-01	5.08e-03	4.93e-01	-3.17e-02	-2.42e-01	2.55e-01	4.96e-01	9.81e-01	2.40e-02	8.85e-01	2.67e-01	2.42e-01
GOMF EFFLUX TRANSMEMBRANE TRANSPORTER ACTIVITY	11	1.44e-01	2.54e-01	0.6240	1.18e-01	1.40e-01	4.42e-01	2.56e-01	-1.15e-01	2.87e-01	4.99e-01	4.20e-01	1.11e-02	1.42e-01	5.10e-01	9.97e-02
GOBP AMYLOID BETA CLEARANCE	31	3.71e-07	4.17e-06	0.6240	-1.99e-01	6.04e-02	4.95e-01	-1.79e-01	3.25e-03	2.63e-01	5.57e-02	5.61e-01	1.81e-06	8.47e-02	9.75e-01	1.13e-02
GOBP VESICLE TRANSPORT ALONG ACTIN FILAMENT	8	3.26e-01	4.44e-01	0.6240	2.00e-01	1.91e-01	3.80e-01	2.72e-01	-1.60e-01	2.64e-01	3.28e-01	3.50e-01	6.28e-02	1.83e-01	4.34e-01	1.96e-01
GOBP BASE EXCISION REPAIR AP SITE FORMATION	11	6.58e-02	1.44e-01	0.6240	2.08e-01	-3.06e-01	-3.73e-01	2.86e-01	1.26e-01	-1.24e-01	2.33e-01	7.87e-02	3.20e-02	1.00e-01	4.71e-01	4.77e-01
GOBP PLUS END DIRECTED ORGANELLE TRANSPORT ALONG MICROTUBULE	7	1.62e-01	2.75e-01	0.6240	-2.83e-01	3.31e-01	1.77e-01	-1.23e-02	4.07e-02	4.08e-01	1.96e-01	1.29e-01	4.16e-01	9.55e-01	8.52e-01	6.15e-02
GOMF HISTONE H4K12 ACETYLTRANSFERASE ACTIVITY	12	1.04e-03	5.28e-03	0.6240	-1.46e-01	5.18e-03	-3.24e-01	3.97e-01	-1.22e-01	-3.01e-01	3.82e-01	9.75e-01	5.21e-02	1.73e-02	4.65e-01	7.09e-02
GOMF O ACETYLTRANSFERASE ACTIVITY	6	3.29e-01	4.47e-01	0.6240	-4.53e-01	1.06e-01	1.84e-01	-1.53e-01	6.20e-03	3.39e-01	5.44e-02	6.52e-01	4.36e-01	5.17e-01	9.79e-01	1.51e-01
GOMF TRNA URIDINE METHYLTRANSFERASE ACTIVITY	5	5.65e-01	6.53e-01	0.6230	2.85e-01	-1.79e-01	-3.69e-01	1.35e-01	1.25e-01	-3.24e-01	2.70e-01	4.88e-01	1.53e-01	6.02e-01	6.28e-01	2.10e-01
GOBP NEGATIVE REGULATION OF CD4 POSITIVE ALPHA BETA T CELL ACTIVATION	32	1.05e-04	7.09e-04	0.6230	9.63e-02	1.37e-01	3.83e-01	1.10e-01	-2.80e-01	3.51e-01	3.46e-01	1.80e-01	1.74e-04	2.82e-01	6.13e-03	5.94e-04
GOBP POSITIVE REGULATION OF STRESS GRANULE ASSEMBLY	7	3.67e-02	9.35e-02	0.6230	-2.95e-01	-1.81e-01	8.81e-02	3.59e-01	-3.52e-01	9.26e-02	1.77e-01	4.07e-01	6.86e-01	1.00e-01	1.07e-01	6.71e-01
GOBP GLYCERALDEHYDE 3 PHOSPHATE METABOLIC PROCESS	10	1.61e-01	2.73e-01	0.6230	-2.64e-01	-4.89e-01	-1.66e-01	-8.61e-02	-1.01e-01	-1.85e-01	1.48e-01	7.38e-03	3.65e-01	6.38e-01	5.81e-01	3.11e-01
GOBP GOLGI DISASSEMBLY	6	1.60e-01	2.73e-01	0.6230	-2.18e-02	1.31e-01	4.29e-01	4.04e-01	-7.05e-02	1.38e-01	9.26e-01	5.79e-01	6.89e-02	8.69e-02	7.65e-01	5.58e-01
GOMF PH DOMAIN BINDING	8	1.95e-01	3.11e-01	0.6230	2.94e-01	-1.44e-01	-1.78e-01	3.88e-01	-2.54e-02	-3.13e-01	1.50e-01	4.82e-01	3.83e-01	5.72e-02	9.01e-01	1.25e-01
GOMF CALCIUM ACTIVATED POTASSIUM CHANNEL ACTIVITY	7	8.75e-02	1.78e-01	0.6230	5.63e-02	-3.26e-01	1.14e-01	-1.66e-01	-2.80e-01	-3.99e-01	7.96e-01	1.35e-01	6.02e-01	4.48e-01	1.99e-01	6.77e-02
GOMF RNA ENDONUCLEASE ACTIVITY PRODUCING 3 PHOSPHOMONOESTERS	6	1.31e-02	4.26e-02	0.6230	-3.42e-01	-2.83e-01	1.16e-01	3.35e-01	1.00e-01	-2.36e-01	1.47e-01	2.31e-01	6.24e-01	1.56e-01	6.70e-01	3.17e-01
GOBP DUMP METABOLIC PROCESS	6	3.35e-01	4.52e-01	0.6220	3.20e-02	-5.14e-01	1.80e-02	-1.55e-01	-3.13e-01	2.16e-02	8.92e-01	2.93e-02	9.39e-01	5.10e-01	1.85e-01	9.27e-01
GOMF OXIDOREDUCTASE ACTIVITY ACTING ON CH OR CH2 GROUPS DISULFIDE AS ACCEPTOR	5	3.80e-01	4.94e-01	0.6220	-2.46e-01	-3.47e-01	-2.09e-01	1.68e-01	1.22e-01	3.46e-01	3.40e-01	1.79e-01	4.19e-01	5.15e-01	6.36e-01	1.81e-01
GOBP NEUTROPHIL MEDIATED KILLING OF SYMBIONT CELL	9	2.76e-02	7.54e-02	0.6220	-3.56e-02	-3.05e-01	2.85e-01	5.25e-02	-4.24e-01	-1.70e-01	8.53e-01	1.13e-01	1.38e-01	7.85e-01	2.76e-02	3.78e-01
GOBP REGULATION OF LOW DENSITY LIPOPROTEIN PARTICLE CLEARANCE	10	5.75e-02	1.31e-01	0.6220	-5.13e-02	-4.02e-01	2.84e-01	1.12e-01	-3.28e-01	1.49e-01	7.79e-01	2.77e-02	1.20e-01	5.40e-01	7.25e-02	4.13e-01
GOBP POLYAMINE BIOSYNTHETIC PROCESS	14	7.69e-02	1.62e-01	0.6220	-3.09e-01	-4.93e-01	-1.66e-01	-7.64e-02	-1.18e-01	2.98e-02	4.52e-02	1.39e-03	2.81e-01	6.21e-01	4.44e-01	8.47e-01
GOBP RESPONSE TO SODIUM ARSENITE	6	2.97e-01	4.17e-01	0.6220	4.49e-01	9.78e-02	-3.69e-02	-3.83e-02	-4.63e-02	-4.14e-01	5.70e-02	6.78e-01	8.76e-01	8.71e-01	8.44e-01	7.91e-02
GOMF ELECTRON TRANSFER ACTIVITY	110	7.98e-19	3.02e-17	0.6220	-1.82e-01	-5.43e-01	-1.72e-01	-5.93e-02	-1.63e-01	-1.22e-03	9.71e-04	7.33e-23	1.87e-03	2.83e-01	3.23e-03	9.82e-01
GOBP CUT METABOLIC PROCESS	5	6.55e-01	7.26e-01	0.6220	-2.38e-01	-2.27e-01	-4.69e-01	-4.11e-02	2.03e-01	-1.29e-01	3.57e-01	3.80e-01	6.95e-02	8.73e-01	4.33e-01	6.18e-01
GOCC CUL5 RING UBIQUITIN LIGASE COMPLEX	10	2.94e-01	4.13e-01	0.6220	-3.01e-01	-4.01e-01	-2.16e-01	-1.74e-01	-2.26e-01	8.65e-02	9.97e-02	2.82e-02	2.37e-01	3.41e-01	2.16e-01	6.36e-01
GOBP REGULATION OF TRANSLATIONAL FIDELITY	18	1.39e-02	4.46e-02	0.6220	-5.33e-02	-4.38e-01	-3.53e-01	1.14e-01	6.50e-02	-2.23e-01	6.96e-01	1.28e-03	9.61e-03	4.02e-01	6.33e-01	1.01e-01
GOMF RNA ENDONUCLEASE ACTIVITY PRODUCING 5 PHOSPHOMONOESTERS	31	8.70e-05	5.98e-04	0.6220	-6.69e-02	-4.71e-01	-3.54e-01	1.20e-01	-6.06e-02	-1.27e-01	5.19e-01	5.61e-06	6.38e-04	2.46e-01	5.59e-01	2.21e-01
GOCC MITOCHONDRIAL CRISTA JUNCTION	8	4.17e-02	1.03e-01	0.6210	-2.48e-02	-5.48e-01	-2.09e-01	-1.80e-01	7.76e-02	5.13e-02	9.03e-01	7.22e-03	3.07e-01	3.77e-01	7.04e-01	8.01e-01
GOMF CERAMIDE 1 PHOSPHATE BINDING	7	1.34e-01	2.41e-01	0.6210	-2.71e-01	2.29e-01	8.60e-02	1.84e-01	4.35e-01	1.73e-01	2.15e-01	2.93e-01	6.93e-01	3.98e-01	4.63e-02	4.29e-01
GOBP REGULATION OF ICOSANOID SECRETION	13	9.51e-03	3.29e-02	0.6210	-1.42e-01	1.69e-01	4.57e-01	-3.45e-01	-8.45e-02	5.35e-02	3.76e-01	2.92e-01	4.37e-03	3.12e-02	5.98e-01	7.38e-01
GOBP CELLULAR RESPONSE TO EPINEPHRINE STIMULUS	9	1.84e-01	2.98e-01	0.6210	1.87e-01	7.46e-02	4.41e-01	3.15e-01	5.05e-02	2.22e-01	3.32e-01	6.99e-01	2.19e-02	1.02e-01	7.93e-01	2.50e-01
GOCC CHOLINERGIC SYNAPSE	7	4.29e-01	5.38e-01	0.6210	2.15e-01	3.96e-01	3.86e-01	1.42e-01	1.13e-01	2.11e-02	3.24e-01	6.95e-02	7.68e-02	5.15e-01	6.04e-01	9.23e-01
GOMF NARROW PORE CHANNEL ACTIVITY	10	1.34e-01	2.41e-01	0.6210	-5.97e-02	2.22e-01	4.16e-01	2.06e-01	9.18e-02	3.30e-01	7.44e-01	2.25e-01	2.27e-02	2.58e-01	6.15e-01	7.05e-02
GOBP REGULATION OF T HELPER 17 CELL DIFFERENTIATION	20	7.25e-03	2.66e-02	0.6210	2.88e-01	3.93e-01	2.56e-01	2.70e-01	5.03e-02	-8.55e-02	2.56e-02	2.34e-03	4.77e-02	3.67e-02	6.97e-01	5.08e-01
GOBP REGULATION OF INTERLEUKIN 1 MEDIATED SIGNALING PATHWAY	7	4.18e-01	5.28e-01	0.6210	-1.14e-01	9.23e-02	4.76e-01	-1.69e-01	-1.40e-01	2.99e-01	6.00e-01	6.72e-01	2.91e-02	4.38e-01	5.23e-01	1.71e-01
GOBP MEDIUM CHAIN FATTY ACYL COA METABOLIC PROCESS	6	4.03e-01	5.14e-01	0.6210	2.04e-01	-2.17e-01	2.91e-01	-4.35e-02	-3.82e-01	2.53e-01	3.87e-01	3.58e-01	2.16e-01	8.53e-01	1.05e-01	2.83e-01
GOBP VENTRICULAR CARDIAC MUSCLE CELL DIFFERENTIATION	7	1.96e-01	3.12e-01	0.6210	-4.37e-01	-3.26e-01	4.91e-02	9.06e-02	-2.72e-01	5.77e-02	4.53e-02	1.35e-01	8.22e-01	6.78e-01	2.12e-01	7.92e-01
GOBP CORONARY VASCULATURE MORPHOGENESIS	14	2.70e-03	1.18e-02	0.6210	-2.41e-01	4.45e-01	1.16e-01	1.40e-01	2.90e-01	1.07e-01	1.18e-01	3.92e-03	4.54e-01	3.63e-01	6.01e-02	4.89e-01
GOMF GLUCOSYLTRANSFERASE ACTIVITY	17	2.45e-02	6.90e-02	0.6200	-3.49e-01	-9.51e-02	1.53e-01	-1.38e-01	-3.25e-01	3.25e-01	1.26e-02	4.97e-01	2.75e-01	3.24e-01	2.02e-02	2.04e-02
GOBP OVIDUCT DEVELOPMENT	5	4.30e-01	5.38e-01	0.6200	-4.77e-01	-1.83e-02	-1.51e-01	-2.84e-01	2.28e-01	3.94e-02	6.47e-02	9.43e-01	5.58e-01	2.72e-01	3.77e-01	8.79e-01
GOBP MEMBRANE REPOLARIZATION DURING VENTRICULAR CARDIAC MUSCLE CELL ACTION POTENTIAL	10	1.26e-01	2.31e-01	0.6200	-6.76e-02	1.30e-01	2.42e-01	-3.31e-01	-1.41e-01	4.18e-01	7.11e-01	4.77e-01	1.85e-01	6.96e-02	4.41e-01	2.20e-02
GOBP COPULATION	13	1.15e-01	2.17e-01	0.6200	-1.62e-01	-2.27e-01	2.54e-01	-3.28e-01	-2.77e-01	2.41e-01	3.11e-01	1.56e-01	1.13e-01	4.09e-02	8.37e-02	1.32e-01
GOBP NEGATIVE REGULATION OF MICROGLIAL CELL ACTIVATION	6	3.52e-01	4.68e-01	0.6200	-4.49e-02	3.70e-01	2.83e-01	2.48e-01	2.95e-01	1.29e-01	8.49e-01	1.16e-01	2.29e-01	2.92e-01	2.11e-01	5.83e-01
GOBP THYROID HORMONE MEDIATED SIGNALING PATHWAY	6	3.33e-02	8.66e-02	0.6190	-4.77e-01	2.06e-01	7.91e-02	1.30e-01	2.53e-01	-1.63e-01	4.31e-02	3.83e-01	7.37e-01	5.81e-01	2.82e-01	4.89e-01
GOCC LAMININ COMPLEX	7	1.72e-01	2.86e-01	0.6190	4.78e-02	2.11e-01	4.33e-01	-3.33e-01	-1.68e-01	-1.00e-01	8.27e-01	3.34e-01	4.73e-02	1.27e-01	4.43e-01	6.46e-01
GOBP NEGATIVE REGULATION OF RUFFLE ASSEMBLY	7	4.46e-01	5.53e-01	0.6190	-2.14e-01	-2.72e-01	-2.84e-01	-2.62e-02	-1.39e-01	-4.04e-01	3.27e-01	2.13e-01	1.93e-01	9.04e-01	5.24e-01	6.44e-02
GOBP PLATELET MORPHOGENESIS	26	3.57e-05	2.69e-04	0.6190	-2.83e-02	-1.91e-01	3.64e-01	2.86e-01	-1.97e-01	3.05e-01	8.03e-01	9.20e-02	1.32e-03	1.16e-02	8.25e-02	7.08e-03
GOBP NEGATIVE REGULATION OF INTRACELLULAR TRANSPORT	39	2.54e-06	2.48e-05	0.6190	-4.01e-01	-2.49e-01	6.67e-02	-1.98e-02	-1.72e-01	3.54e-01	1.43e-05	7.11e-03	4.71e-01	8.30e-01	6.31e-02	1.29e-04
GOMF MEDIUM CHAIN FATTY ACID COA LIGASE ACTIVITY	8	1.23e-01	2.27e-01	0.6190	-4.61e-02	3.50e-01	1.10e-01	-4.94e-01	-5.29e-02	3.92e-04	8.21e-01	8.66e-02	5.91e-01	1.56e-02	7.96e-01	9.98e-01
GOBP RESPONSE TO SORBITOL	6	4.04e-01	5.15e-01	0.6190	-4.68e-03	1.77e-01	3.58e-01	2.05e-01	-2.25e-01	3.62e-01	9.84e-01	4.52e-01	1.29e-01	3.85e-01	3.41e-01	1.25e-01
GOBP PHOSPHATIDYLINOSITOL 3 PHOSPHATE BIOSYNTHETIC PROCESS	22	2.74e-04	1.66e-03	0.6190	-1.43e-01	3.84e-01	1.08e-01	2.35e-01	3.30e-01	1.98e-01	2.46e-01	1.80e-03	3.82e-01	5.69e-02	7.37e-03	1.08e-01
GOBP INTRACELLULAR SPHINGOLIPID HOMEOSTASIS	5	6.07e-01	6.87e-01	0.6190	-3.59e-01	-3.79e-01	-1.70e-01	3.74e-02	-2.71e-01	-7.83e-02	1.64e-01	1.42e-01	5.10e-01	8.85e-01	2.94e-01	7.62e-01
GOBP CELL ADHESION MOLECULE PRODUCTION	8	7.41e-02	1.58e-01	0.6190	-5.05e-03	1.77e-01	5.69e-01	3.90e-02	6.19e-02	1.47e-01	9.80e-01	3.85e-01	5.29e-03	8.49e-01	7.62e-01	4.71e-01
GOBP POSITIVE REGULATION OF INSULIN LIKE GROWTH FACTOR RECEPTOR SIGNALING PATHWAY	7	3.23e-01	4.42e-01	0.6190	2.26e-01	5.27e-01	1.10e-01	-1.13e-01	1.64e-01	-4.82e-02	3.01e-01	1.58e-02	6.14e-01	6.04e-01	4.53e-01	8.25e-01
GOBP PREASSEMBLY OF GPI ANCHOR IN ER MEMBRANE	8	2.95e-01	4.15e-01	0.6190	-4.45e-01	-6.16e-02	-2.55e-01	-2.12e-01	-8.54e-02	-2.51e-01	2.92e-02	7.63e-01	2.12e-01	2.98e-01	6.76e-01	2.19e-01
GOBP REGULATION OF WNT SIGNALING PATHWAY PLANAR CELL POLARITY PATHWAY	10	3.93e-01	5.06e-01	0.6190	3.89e-01	2.42e-01	1.44e-01	3.41e-01	1.79e-01	5.98e-02	3.30e-02	1.84e-01	4.31e-01	6.21e-02	3.28e-01	7.43e-01
GOBP AUTOPHAGOSOME LYSOSOME FUSION	11	1.48e-03	7.10e-03	0.6180	-1.35e-01	1.21e-01	2.52e-01	4.25e-01	3.23e-01	-3.39e-02	4.37e-01	4.89e-01	1.47e-01	1.46e-02	6.38e-02	8.46e-01
GOBP NEGATIVE REGULATION OF SMAD PROTEIN SIGNAL TRANSDUCTION	17	6.86e-02	1.49e-01	0.6180	1.94e-01	1.90e-01	3.18e-01	2.51e-01	9.46e-02	3.68e-01	1.67e-01	1.75e-01	2.31e-02	7.33e-02	4.99e-01	8.59e-03
GOBP NEGATIVE REGULATION OF MYOSIN LIGHT CHAIN PHOSPHATASE ACTIVITY	5	2.70e-01	3.90e-01	0.6180	-3.99e-01	2.28e-01	3.13e-01	-1.48e-01	1.42e-01	1.76e-01	1.22e-01	3.76e-01	2.26e-01	5.68e-01	5.81e-01	4.95e-01
GOBP TRNA PROCESSING	135	7.05e-22	3.47e-20	0.6180	-1.49e-01	-4.20e-01	-4.12e-01	2.83e-03	5.27e-02	-1.09e-01	2.77e-03	3.68e-17	1.40e-16	9.55e-01	2.91e-01	2.95e-02
GOBP DOUBLE STRAND BREAK REPAIR VIA ALTERNATIVE NONHOMOLOGOUS END JOINING	8	1.13e-01	2.13e-01	0.6180	-4.71e-02	6.49e-02	2.26e-02	3.74e-01	1.27e-01	4.68e-01	8.18e-01	7.51e-01	9.12e-01	6.68e-02	5.33e-01	2.19e-02
GOBP ORGAN INDUCTION	9	3.24e-01	4.42e-01	0.6180	-1.88e-01	-6.79e-03	3.22e-01	-3.08e-01	-3.71e-01	1.04e-01	3.28e-01	9.72e-01	9.42e-02	1.10e-01	5.42e-02	5.91e-01
GOCC COPI COATED VESICLE	25	1.01e-04	6.85e-04	0.6180	-3.07e-01	-3.58e-01	3.30e-02	1.85e-01	-1.57e-01	3.15e-01	7.85e-03	1.94e-03	7.75e-01	1.09e-01	1.73e-01	6.37e-03
GOBP NEGATIVE REGULATION OF HOMOTYPIC CELL CELL ADHESION	11	1.58e-01	2.70e-01	0.6180	-2.17e-02	-1.84e-01	3.95e-01	-6.19e-02	-3.54e-01	2.50e-01	9.01e-01	2.90e-01	2.34e-02	7.22e-01	4.19e-02	1.52e-01
GOBP ACTOMYOSIN CONTRACTILE RING ORGANIZATION	10	2.18e-02	6.32e-02	0.6180	-7.69e-02	3.94e-02	3.92e-01	3.42e-01	-2.53e-01	1.99e-01	6.74e-01	8.29e-01	3.18e-02	6.12e-02	1.65e-01	2.76e-01
GOBP ATF6 MEDIATED UNFOLDED PROTEIN RESPONSE	9	1.00e-01	1.96e-01	0.6180	-3.85e-01	-3.13e-01	7.48e-02	7.34e-02	-3.50e-01	4.19e-02	4.57e-02	1.04e-01	6.98e-01	7.03e-01	6.87e-02	8.28e-01
GOBP NEGATIVE REGULATION OF AMYLOID BETA CLEARANCE	7	9.40e-02	1.88e-01	0.6180	-2.60e-01	-1.14e-01	4.03e-01	-2.16e-01	7.51e-02	2.93e-01	2.34e-01	6.02e-01	6.45e-02	3.22e-01	7.31e-01	1.80e-01
GOMF MRF BINDING	5	1.26e-01	2.31e-01	0.6170	5.75e-02	2.28e-01	5.48e-01	5.44e-02	8.00e-03	-1.51e-01	8.24e-01	3.77e-01	3.39e-02	8.33e-01	9.75e-01	5.60e-01
GOBP SECRETION OF LYSOSOMAL ENZYMES	7	3.13e-01	4.33e-01	0.6170	-2.73e-01	-3.43e-01	-3.02e-01	2.38e-01	1.63e-01	-1.20e-01	2.10e-01	1.16e-01	1.67e-01	2.76e-01	4.56e-01	5.81e-01
GOBP POSITIVE REGULATION OF HELICASE ACTIVITY	6	3.28e-01	4.46e-01	0.6170	-1.98e-01	-3.02e-01	6.09e-02	1.39e-02	-1.04e-02	4.97e-01	4.01e-01	2.00e-01	7.96e-01	9.53e-01	9.65e-01	3.51e-02
GOMF PHOSPHATIDYLINOSITOL MONOPHOSPHATE PHOSPHATASE ACTIVITY	14	8.05e-03	2.90e-02	0.6170	-2.42e-01	2.56e-01	2.53e-01	1.25e-02	-1.78e-01	4.01e-01	1.16e-01	9.77e-02	1.01e-01	9.36e-01	2.48e-01	9.39e-03
GOBP TRIPEPTIDE TRANSPORT	9	9.06e-02	1.82e-01	0.6170	-4.49e-02	-1.64e-01	4.45e-01	1.40e-01	-2.60e-02	3.66e-01	8.15e-01	3.94e-01	2.09e-02	4.69e-01	8.93e-01	5.71e-02
GOCC STEREOCILIA COUPLING LINK	5	3.57e-01	4.72e-01	0.6170	-1.53e-02	2.52e-01	4.30e-02	-4.55e-01	2.57e-02	-3.29e-01	9.53e-01	3.29e-01	8.68e-01	7.82e-02	9.21e-01	2.03e-01
GOBP POSITIVE REGULATION OF NECROPTOTIC PROCESS	6	2.89e-01	4.09e-01	0.6170	1.13e-01	-1.39e-01	-3.53e-02	4.72e-01	7.89e-02	3.44e-01	6.31e-01	5.55e-01	8.81e-01	4.54e-02	7.38e-01	1.44e-01
GOBP CELL AGGREGATION	9	1.86e-01	3.01e-01	0.6170	4.95e-02	4.63e-01	1.43e-01	2.55e-01	2.78e-01	-1.88e-02	7.97e-01	1.61e-02	4.56e-01	1.86e-01	1.49e-01	9.22e-01
GOBP BEHAVIORAL RESPONSE TO NICOTINE	5	4.09e-01	5.20e-01	0.6170	2.00e-01	2.11e-01	1.92e-01	4.72e-01	-1.03e-01	1.61e-01	4.40e-01	4.13e-01	4.57e-01	6.77e-02	6.90e-01	5.34e-01
GOBP REGULATION OF SKELETAL MUSCLE CONTRACTION BY REGULATION OF RELEASE OF SEQUESTERED CALCIUM ION	5	6.27e-01	7.04e-01	0.6170	2.48e-02	1.66e-01	2.32e-01	2.05e-01	2.37e-01	4.48e-01	9.23e-01	5.21e-01	3.70e-01	4.28e-01	3.59e-01	8.28e-02
GOBP ANTIMICROBIAL HUMORAL IMMUNE RESPONSE MEDIATED BY ANTIMICROBIAL PEPTIDE	50	1.82e-09	2.75e-08	0.6170	8.31e-02	-3.14e-01	2.70e-01	-1.90e-01	-4.03e-01	5.82e-02	3.09e-01	1.25e-04	9.48e-04	2.04e-02	7.98e-07	4.76e-01
GOBP POSITIVE REGULATION BY HOST OF VIRAL PROCESS	21	4.59e-04	2.62e-03	0.6170	-2.58e-01	-3.15e-01	1.86e-01	2.07e-01	-1.58e-01	3.34e-01	4.07e-02	1.24e-02	1.39e-01	1.01e-01	2.09e-01	8.00e-03
GOBP DETECTION OF VIRUS	5	1.38e-01	2.47e-01	0.6170	-1.46e-01	2.22e-01	-2.32e-01	2.63e-01	1.96e-01	3.84e-01	5.71e-01	3.90e-01	3.69e-01	3.08e-01	4.47e-01	1.37e-01
GOBP LOCOMOTION INVOLVED IN LOCOMOTORY BEHAVIOR	10	3.03e-02	8.06e-02	0.6160	-5.90e-01	-6.31e-02	-6.37e-02	-1.00e-02	1.10e-01	1.05e-01	1.22e-03	7.30e-01	7.27e-01	9.56e-01	5.49e-01	5.66e-01
GOBP NEGATIVE REGULATION OF TUBULIN DEACETYLATION	5	3.84e-01	4.97e-01	0.6160	-1.58e-01	4.79e-01	-1.79e-02	2.58e-02	3.38e-01	-9.95e-02	5.40e-01	6.35e-02	9.45e-01	9.21e-01	1.91e-01	7.00e-01
GOMF OXIDIZED DNA BINDING	11	5.88e-02	1.33e-01	0.6160	1.94e-01	-2.91e-01	-2.35e-01	3.80e-01	2.37e-01	3.70e-02	2.66e-01	9.42e-02	1.78e-01	2.91e-02	1.74e-01	8.32e-01
GOBP NATURAL KILLER CELL DEGRANULATION	11	1.34e-01	2.41e-01	0.6160	2.07e-02	1.09e-01	3.55e-01	2.98e-01	-3.34e-02	3.89e-01	9.06e-01	5.31e-01	4.15e-02	8.68e-02	8.48e-01	2.57e-02
GOBP ENDOPLASMIC RETICULUM TUBULAR NETWORK FORMATION	5	4.40e-01	5.47e-01	0.6160	-5.07e-01	-2.77e-01	-1.79e-01	1.15e-01	-6.40e-03	2.58e-02	4.98e-02	2.84e-01	4.89e-01	6.55e-01	9.80e-01	9.20e-01
GOMF SODIUM PHOSPHATE SYMPORTER ACTIVITY	6	1.96e-01	3.13e-01	0.6160	4.96e-02	4.87e-01	-2.49e-01	1.19e-01	2.47e-01	-4.97e-02	8.33e-01	3.89e-02	2.90e-01	6.14e-01	2.95e-01	8.33e-01
GOBP REGULATION OF VASCULAR ASSOCIATED SMOOTH MUSCLE CELL DIFFERENTIATION	13	7.88e-02	1.65e-01	0.6160	-2.30e-02	1.92e-01	-2.41e-01	1.00e-01	3.70e-01	-3.70e-01	8.86e-01	2.31e-01	1.32e-01	5.32e-01	2.10e-02	2.10e-02
GOBP AUTOPHAGOSOME MEMBRANE DOCKING	7	3.52e-01	4.68e-01	0.6150	-4.92e-01	-3.41e-01	-6.85e-02	-6.90e-02	-4.88e-02	9.47e-02	2.43e-02	1.18e-01	7.54e-01	7.52e-01	8.23e-01	6.64e-01
GOBP REGULATION OF EPITHELIAL TO MESENCHYMAL TRANSITION INVOLVED IN ENDOCARDIAL CUSHION FORMATION	6	2.40e-01	3.58e-01	0.6150	-2.17e-01	1.63e-01	-2.33e-02	4.06e-01	3.38e-01	1.58e-01	3.57e-01	4.90e-01	9.21e-01	8.48e-02	1.51e-01	5.03e-01
GOCC ENDOPLASMIC RETICULUM QUALITY CONTROL COMPARTMENT	15	2.95e-02	7.91e-02	0.6150	-9.86e-02	-1.30e-01	3.63e-01	1.44e-01	-2.64e-01	3.59e-01	5.09e-01	3.83e-01	1.49e-02	3.34e-01	7.62e-02	1.60e-02
GOBP PROTEIN GERANYLGERANYLATION	6	4.91e-01	5.90e-01	0.6150	-4.37e-01	-1.34e-01	-3.11e-01	-2.65e-01	1.43e-02	4.58e-02	6.37e-02	5.69e-01	1.87e-01	2.62e-01	9.52e-01	8.46e-01
GOMF NUCLEOSIDE KINASE ACTIVITY	9	1.65e-01	2.78e-01	0.6150	-2.86e-01	-4.78e-01	-9.62e-02	1.47e-01	-1.86e-01	4.42e-02	1.38e-01	1.29e-02	6.17e-01	4.45e-01	3.34e-01	8.18e-01
GOBP DERMATAN SULFATE METABOLIC PROCESS	9	3.75e-01	4.90e-01	0.6150	-2.84e-01	-2.60e-01	-3.29e-01	-6.85e-02	-1.35e-01	-3.14e-01	1.40e-01	1.77e-01	8.71e-02	7.22e-01	4.84e-01	1.03e-01
GOBP SENSORY PERCEPTION OF SMELL	64	2.88e-10	4.97e-09	0.6150	3.21e-02	2.24e-01	3.67e-01	-3.47e-01	-2.45e-01	1.09e-01	6.57e-01	1.94e-03	3.90e-07	1.54e-06	7.16e-04	1.33e-01
GOBP SYNAPTIC TRANSMISSION CHOLINERGIC	19	2.67e-02	7.36e-02	0.6150	2.18e-01	2.87e-01	4.23e-01	9.60e-02	1.45e-01	1.97e-01	1.00e-01	3.05e-02	1.41e-03	4.69e-01	2.72e-01	1.38e-01
GOBP POSITIVE REGULATION OF TRANSFORMING GROWTH FACTOR BETA PRODUCTION	14	3.82e-02	9.62e-02	0.6150	-1.37e-01	-1.41e-01	-2.92e-02	-2.26e-01	-5.07e-01	-1.73e-01	3.75e-01	3.60e-01	8.50e-01	1.42e-01	1.03e-03	2.62e-01
GOBP INTRACILIARY TRANSPORT	43	7.86e-07	8.36e-06	0.6140	-6.54e-02	7.20e-02	-3.63e-01	4.17e-02	4.62e-01	-1.44e-01	4.58e-01	4.14e-01	3.72e-05	6.36e-01	1.57e-07	1.03e-01
GOBP AMPA GLUTAMATE RECEPTOR CLUSTERING	7	1.62e-01	2.74e-01	0.6140	-2.70e-02	6.26e-02	4.38e-01	2.22e-01	2.19e-01	2.90e-01	9.02e-01	7.74e-01	4.48e-02	3.09e-01	3.15e-01	1.85e-01
GOCC ZYMOGEN GRANULE	12	1.97e-01	3.13e-01	0.6140	-3.19e-01	-2.58e-01	-1.09e-01	-2.71e-01	-3.22e-01	1.42e-01	5.60e-02	1.22e-01	5.13e-01	1.04e-01	5.33e-02	3.94e-01
GOBP WATER SOLUBLE VITAMIN BIOSYNTHETIC PROCESS	11	1.57e-01	2.69e-01	0.6140	-2.64e-01	-2.96e-01	-3.63e-01	6.56e-02	2.26e-01	-1.82e-01	1.30e-01	8.94e-02	3.71e-02	7.06e-01	1.94e-01	2.97e-01
GOBP REGULATION OF SYNAPTIC VESICLE ENDOCYTOSIS	17	3.05e-02	8.10e-02	0.6140	-1.87e-01	-1.01e-01	2.55e-01	-6.73e-02	-4.10e-01	3.07e-01	1.83e-01	4.71e-01	6.84e-02	6.31e-01	3.40e-03	2.84e-02
GOBP CARNITINE TRANSMEMBRANE TRANSPORT	5	2.10e-01	3.27e-01	0.6140	6.04e-03	1.68e-01	5.90e-01	-2.05e-02	-2.66e-02	1.71e-02	9.81e-01	5.16e-01	2.24e-02	9.37e-01	9.18e-01	9.47e-01
GOBP POSITIVE REGULATION OF RIG I SIGNALING PATHWAY	8	3.01e-02	8.03e-02	0.6140	-1.57e-01	-2.99e-02	-7.71e-02	4.31e-01	-4.70e-02	3.97e-01	4.43e-01	8.83e-01	7.06e-01	3.47e-02	8.18e-01	5.21e-02
GOBP REGULATION OF MAINTENANCE OF SISTER CHROMATID COHESION	9	8.33e-02	1.71e-01	0.6140	-3.43e-01	-2.70e-01	-1.28e-01	1.43e-01	-1.02e-01	3.73e-01	7.44e-02	1.61e-01	5.08e-01	4.58e-01	5.95e-01	5.29e-02
GOBP CARDIAC ATRIUM MORPHOGENESIS	13	8.17e-02	1.69e-01	0.6140	1.72e-01	1.95e-01	2.65e-01	3.29e-01	3.37e-01	1.31e-01	2.83e-01	2.23e-01	9.84e-02	3.99e-02	3.56e-02	4.13e-01
GOBP BONE TRABECULA FORMATION	7	9.80e-02	1.93e-01	0.6130	-3.26e-01	2.30e-01	-3.61e-02	-2.20e-01	-3.04e-02	-4.09e-01	1.36e-01	2.93e-01	8.69e-01	3.15e-01	8.89e-01	6.12e-02
GOBP L PROLINE BIOSYNTHETIC PROCESS	6	2.99e-01	4.18e-01	0.6130	-2.70e-02	-6.32e-02	1.67e-01	1.57e-01	-2.80e-01	4.90e-01	9.09e-01	7.89e-01	4.78e-01	5.04e-01	2.35e-01	3.75e-02
GOBP CORNEA DEVELOPMENT IN CAMERA TYPE EYE	5	7.19e-01	7.77e-01	0.6130	-1.91e-01	-2.22e-02	1.60e-01	-4.40e-01	-3.44e-01	3.80e-02	4.60e-01	9.32e-01	5.35e-01	8.84e-02	1.83e-01	8.83e-01
GOBP POSITIVE REGULATION OF FATTY ACID TRANSPORT	16	2.90e-03	1.26e-02	0.6130	-1.07e-01	1.86e-01	4.59e-01	-3.30e-01	-3.90e-02	9.52e-02	4.61e-01	1.98e-01	1.49e-03	2.22e-02	7.87e-01	5.10e-01
GOBP ADHESION OF SYMBIONT TO HOST CELL	7	3.83e-01	4.97e-01	0.6130	2.16e-01	2.61e-01	3.08e-01	1.40e-01	3.57e-01	1.39e-01	3.23e-01	2.32e-01	1.59e-01	5.22e-01	1.02e-01	5.24e-01
GOBP SYNAPSE PRUNING	9	1.28e-01	2.33e-01	0.6130	-3.04e-01	-6.34e-02	3.67e-01	-2.30e-01	-2.99e-01	4.49e-02	1.14e-01	7.42e-01	5.67e-02	2.32e-01	1.20e-01	8.16e-01
GOBP NEGATIVE REGULATION OF UBIQUITIN PROTEIN LIGASE ACTIVITY	9	4.79e-02	1.14e-01	0.6130	-1.74e-01	-4.67e-01	-2.18e-01	-8.52e-02	1.71e-01	2.08e-01	3.65e-01	1.54e-02	2.57e-01	6.58e-01	3.74e-01	2.80e-01
GOMF HISTONE DEACETYLASE REGULATOR ACTIVITY	6	5.09e-01	6.04e-01	0.6130	2.10e-01	7.11e-02	-2.16e-01	2.82e-01	1.07e-01	-4.34e-01	3.73e-01	7.63e-01	3.60e-01	2.31e-01	6.51e-01	6.55e-02
GOMF VINCULIN BINDING	11	1.30e-03	6.35e-03	0.6130	7.02e-02	-2.02e-03	2.08e-01	3.46e-01	-3.93e-01	-2.29e-01	6.87e-01	9.91e-01	2.31e-01	4.71e-02	2.38e-02	1.88e-01
GOBP CONVERGENT EXTENSION INVOLVED IN GASTRULATION	7	4.23e-01	5.31e-01	0.6130	-1.77e-01	-4.43e-01	-2.72e-01	1.12e-01	-8.76e-02	-2.32e-01	4.19e-01	4.24e-02	2.13e-01	6.09e-01	6.88e-01	2.88e-01
GOBP PHOTORECEPTOR CELL OUTER SEGMENT ORGANIZATION	9	1.81e-01	2.96e-01	0.6130	8.94e-02	4.21e-01	-1.73e-01	2.45e-01	2.88e-01	-1.32e-01	6.42e-01	2.88e-02	3.69e-01	2.04e-01	1.35e-01	4.92e-01
GOBP EMBRYONIC SKELETAL JOINT DEVELOPMENT	5	2.71e-01	3.90e-01	0.6130	3.92e-02	4.15e-01	1.49e-01	4.06e-01	-1.16e-02	1.19e-01	8.79e-01	1.08e-01	5.63e-01	1.16e-01	9.64e-01	6.45e-01
GOCC INSULIN RESPONSIVE COMPARTMENT	6	6.11e-01	6.91e-01	0.6120	-3.70e-01	-2.76e-01	1.67e-02	-2.00e-01	-1.84e-01	2.95e-01	1.16e-01	2.41e-01	9.44e-01	3.96e-01	4.35e-01	2.10e-01
GOBP POSITIVE REGULATION OF SISTER CHROMATID COHESION	9	9.23e-02	1.85e-01	0.6120	-1.95e-01	-3.57e-01	-8.77e-02	1.69e-01	-2.40e-01	3.40e-01	3.10e-01	6.38e-02	6.49e-01	3.80e-01	2.13e-01	7.75e-02
GOBP DNA METHYLATION DEPENDENT HETEROCHROMATIN FORMATION	29	3.47e-03	1.45e-02	0.6120	1.99e-01	2.15e-01	4.95e-02	4.03e-01	3.27e-01	1.33e-01	6.42e-02	4.48e-02	6.45e-01	1.75e-04	2.31e-03	2.17e-01
GOCC SMALL NUCLEAR RIBONUCLEOPROTEIN COMPLEX	76	3.78e-14	9.53e-13	0.6120	-8.64e-02	-4.12e-01	-3.83e-01	2.12e-01	7.12e-02	-6.30e-03	1.93e-01	5.02e-10	7.70e-09	1.37e-03	2.83e-01	9.24e-01
GOBP REGULATION OF CILIUM BEAT FREQUENCY	12	2.08e-01	3.25e-01	0.6120	-2.46e-01	-2.24e-01	-3.13e-01	-2.64e-01	1.60e-02	-3.10e-01	1.41e-01	1.80e-01	6.07e-02	1.13e-01	9.24e-01	6.28e-02
GOMF ALDEHYDE LYASE ACTIVITY	8	2.31e-01	3.49e-01	0.6120	-3.77e-01	-3.97e-01	-1.33e-01	1.22e-01	-5.83e-02	1.98e-01	6.51e-02	5.21e-02	5.15e-01	5.51e-01	7.75e-01	3.32e-01
GOCC POLAR MICROTUBULE	5	2.30e-01	3.49e-01	0.6120	-1.03e-01	-2.87e-02	-1.45e-01	4.50e-01	5.21e-02	-3.69e-01	6.91e-01	9.11e-01	5.74e-01	8.15e-02	8.40e-01	1.53e-01
GOBP TETRAHYDROFOLATE INTERCONVERSION	9	1.08e-01	2.06e-01	0.6120	8.48e-03	-4.77e-01	5.18e-02	1.87e-01	-3.18e-01	8.34e-02	9.65e-01	1.32e-02	7.88e-01	3.30e-01	9.81e-02	6.65e-01
GOBP DORSAL AORTA DEVELOPMENT	7	1.88e-01	3.03e-01	0.6110	-3.38e-01	1.77e-01	4.07e-01	-9.77e-02	-6.07e-02	2.23e-01	1.22e-01	4.18e-01	6.23e-02	6.54e-01	7.81e-01	3.06e-01
GOMF EUKARYOTIC TRANSLATION INITIATION FACTOR 2ALPHA KINASE ACTIVITY	6	3.28e-01	4.46e-01	0.6110	-4.50e-01	-2.63e-01	-2.28e-02	7.12e-02	-2.96e-01	9.32e-02	5.61e-02	2.65e-01	9.23e-01	7.63e-01	2.09e-01	6.92e-01
GOBP REGULATION OF PENTOSE PHOSPHATE SHUNT	6	3.45e-01	4.62e-01	0.6110	1.71e-01	-4.12e-04	-4.09e-02	4.51e-01	1.94e-01	-3.20e-01	4.68e-01	9.99e-01	8.62e-01	5.60e-02	4.11e-01	1.75e-01
GOBP FEMALE MEIOSIS I	10	2.66e-02	7.34e-02	0.6110	2.83e-01	-2.98e-01	-8.19e-02	3.64e-01	-8.44e-02	2.42e-01	1.21e-01	1.02e-01	6.54e-01	4.63e-02	6.44e-01	1.86e-01
GOBP PYRUVATE FAMILY AMINO ACID METABOLIC PROCESS	9	2.48e-01	3.67e-01	0.6110	-9.37e-02	-3.81e-01	-4.43e-01	-1.91e-02	8.89e-02	-1.23e-01	6.26e-01	4.79e-02	2.14e-02	9.21e-01	6.44e-01	5.22e-01
GOBP PROTEIN PROCESSING INVOLVED IN PROTEIN TARGETING TO MITOCHONDRION	7	3.15e-01	4.35e-01	0.6110	-2.58e-01	-1.82e-02	-4.65e-01	-2.38e-01	1.08e-01	-1.48e-01	2.37e-01	9.34e-01	3.31e-02	2.76e-01	6.21e-01	4.97e-01
GOBP POSITIVE REGULATION OF COA TRANSFERASE ACTIVITY	5	8.15e-02	1.69e-01	0.6110	7.76e-02	-9.02e-02	5.89e-01	-4.36e-02	6.22e-02	8.21e-02	7.64e-01	7.27e-01	2.26e-02	8.66e-01	8.10e-01	7.51e-01
GOBP REGULATION OF COA TRANSFERASE ACTIVITY	5	8.15e-02	1.69e-01	0.6110	7.76e-02	-9.02e-02	5.89e-01	-4.36e-02	6.22e-02	8.21e-02	7.64e-01	7.27e-01	2.26e-02	8.66e-01	8.10e-01	7.51e-01
GOCC CYTOPLASMIC SIDE OF ROUGH ENDOPLASMIC RETICULUM MEMBRANE	5	4.20e-01	5.30e-01	0.6110	1.29e-02	-4.93e-01	-3.43e-01	-1.01e-01	-4.85e-02	-2.09e-02	9.60e-01	5.65e-02	1.85e-01	6.95e-01	8.51e-01	9.35e-01
GOBP POSITIVE REGULATION OF ISOTYPE SWITCHING TO IGG ISOTYPES	10	1.21e-01	2.25e-01	0.6110	6.16e-02	2.09e-01	-7.73e-02	3.07e-01	3.64e-01	3.05e-01	7.36e-01	2.53e-01	6.72e-01	9.33e-02	4.63e-02	9.47e-02
GOBP ASTROCYTE CELL MIGRATION	7	4.11e-02	1.02e-01	0.6100	-2.78e-01	-1.49e-01	2.20e-01	-2.16e-01	-2.10e-01	-3.66e-01	2.02e-01	4.96e-01	3.13e-01	3.22e-01	3.37e-01	9.36e-02
GOBP CDC42 PROTEIN SIGNAL TRANSDUCTION	12	8.19e-03	2.94e-02	0.6100	-2.94e-01	-1.72e-01	3.85e-01	1.55e-01	-1.31e-01	2.58e-01	7.76e-02	3.02e-01	2.08e-02	3.51e-01	4.32e-01	1.22e-01
GOBP DOUBLE STRAND BREAK REPAIR VIA BREAK INDUCED REPLICATION	12	2.11e-02	6.16e-02	0.6100	2.27e-01	-2.32e-01	-1.29e-01	4.77e-01	1.84e-03	1.50e-01	1.74e-01	1.65e-01	4.40e-01	4.18e-03	9.91e-01	3.68e-01
GOMF CARBOHYDRATE PROTON SYMPORTER ACTIVITY	6	4.70e-01	5.72e-01	0.6100	-1.42e-02	3.87e-01	1.19e-01	2.72e-01	3.54e-01	9.37e-02	9.52e-01	1.00e-01	6.13e-01	2.49e-01	1.33e-01	6.91e-01
GOBP DENDRITIC CELL ANTIGEN PROCESSING AND PRESENTATION	13	4.94e-03	1.94e-02	0.6100	-3.16e-01	-3.09e-02	-1.75e-01	1.82e-02	3.11e-01	-3.79e-01	4.88e-02	8.47e-01	2.74e-01	9.09e-01	5.20e-02	1.80e-02
GOBP CGMP MEDIATED SIGNALING	18	5.57e-03	2.14e-02	0.6100	-6.79e-02	-1.12e-01	4.45e-01	-1.36e-01	-3.60e-01	9.07e-02	6.18e-01	4.11e-01	1.07e-03	3.19e-01	8.11e-03	5.05e-01
GOMF PHOSPHATIDYLINOSITOL KINASE ACTIVITY	26	8.29e-06	7.12e-05	0.6100	-2.02e-01	3.87e-01	1.38e-01	2.09e-01	3.15e-01	1.41e-01	7.47e-02	6.40e-04	2.23e-01	6.53e-02	5.46e-03	2.15e-01
GOBP MITOCHONDRIAL RNA METABOLIC PROCESS	56	3.07e-07	3.48e-06	0.6100	-1.95e-01	-4.29e-01	-3.57e-01	9.04e-03	-8.34e-02	-1.24e-01	1.18e-02	2.80e-08	3.79e-06	9.07e-01	2.80e-01	1.07e-01
GOCC CONTRACTILE RING	11	1.74e-02	5.29e-02	0.6100	2.03e-02	-7.49e-02	8.34e-02	5.59e-01	-6.15e-02	2.06e-01	9.07e-01	6.67e-01	6.32e-01	1.32e-03	7.24e-01	2.37e-01
GOBP DIADENOSINE POLYPHOSPHATE CATABOLIC PROCESS	5	4.54e-01	5.59e-01	0.6100	-3.34e-01	-1.49e-02	-3.06e-01	-8.29e-02	3.97e-01	3.82e-02	1.95e-01	9.54e-01	2.36e-01	7.48e-01	1.24e-01	8.82e-01
GOBP DICHOTOMOUS SUBDIVISION OF AN EPITHELIAL TERMINAL UNIT	7	8.81e-02	1.79e-01	0.6090	-6.80e-02	2.33e-01	3.69e-01	-2.34e-01	-2.25e-01	-2.66e-01	7.55e-01	2.86e-01	9.10e-02	2.83e-01	3.02e-01	2.22e-01
GOBP ANTIGEN PROCESSING AND PRESENTATION OF EXOGENOUS PEPTIDE ANTIGEN VIA MHC CLASS II	28	1.19e-05	9.88e-05	0.6090	1.37e-02	-1.86e-01	-2.00e-01	2.40e-01	4.46e-01	-1.99e-01	9.00e-01	8.82e-02	6.67e-02	2.77e-02	4.37e-05	6.85e-02
GOMF FERROUS IRON BINDING	21	2.31e-02	6.62e-02	0.6090	-2.00e-01	-2.91e-01	-4.44e-01	3.75e-02	6.56e-02	-2.08e-01	1.13e-01	2.12e-02	4.26e-04	7.66e-01	6.03e-01	9.82e-02
GOBP CALCIUM ION REGULATED EXOCYTOSIS OF NEUROTRANSMITTER	12	2.19e-02	6.34e-02	0.6090	-3.29e-02	2.05e-01	2.95e-01	3.32e-01	3.33e-01	1.40e-01	8.44e-01	2.20e-01	7.66e-02	4.65e-02	4.57e-02	4.02e-01
GOBP NEGATIVE REGULATION OF PROTEIN AUTOPHOSPHORYLATION	7	2.33e-01	3.51e-01	0.6090	-1.81e-01	2.80e-01	3.68e-01	1.72e-01	8.05e-02	2.97e-01	4.06e-01	2.00e-01	9.20e-02	4.30e-01	7.12e-01	1.74e-01
GOBP POSITIVE REGULATION OF PHOSPHOLIPID BIOSYNTHETIC PROCESS	5	4.88e-01	5.87e-01	0.6090	-5.39e-01	-1.55e-02	4.36e-02	-1.63e-01	-1.73e-01	1.45e-01	3.68e-02	9.52e-01	8.66e-01	5.27e-01	5.03e-01	5.73e-01
GOCC TRNA SPLICING LIGASE COMPLEX	8	1.76e-01	2.91e-01	0.6090	-1.12e-01	-4.74e-01	-3.47e-01	8.60e-03	2.73e-04	1.10e-01	5.83e-01	2.02e-02	8.89e-02	9.66e-01	9.99e-01	5.89e-01
GOBP EXTRACELLULAR EXOSOME ASSEMBLY	6	3.73e-01	4.88e-01	0.6090	-2.11e-01	7.98e-02	1.48e-01	-2.44e-01	-4.88e-01	1.69e-02	3.72e-01	7.35e-01	5.31e-01	3.02e-01	3.84e-02	9.43e-01
GOBP LUTEINIZATION	10	1.61e-01	2.73e-01	0.6080	-9.71e-02	5.28e-02	3.51e-01	-4.66e-02	-4.32e-01	2.14e-01	5.95e-01	7.72e-01	5.49e-02	7.99e-01	1.80e-02	2.40e-01
GOBP NEGATIVE REGULATION OF ADENYLATE CYCLASE ACTIVATING G PROTEIN COUPLED RECEPTOR SIGNALING PATHWAY	10	7.57e-02	1.60e-01	0.6080	3.33e-03	2.16e-01	2.82e-01	4.43e-01	1.16e-01	1.85e-01	9.85e-01	2.36e-01	1.23e-01	1.54e-02	5.24e-01	3.11e-01
GOBP CELL MIGRATION IN HINDBRAIN	13	1.92e-01	3.08e-01	0.6080	2.18e-01	4.10e-01	-7.80e-04	2.09e-01	3.27e-01	-5.62e-02	1.73e-01	1.04e-02	9.96e-01	1.92e-01	4.10e-02	7.26e-01
GOMF AMMONIA LYASE ACTIVITY	5	6.19e-01	6.97e-01	0.6080	2.68e-01	2.46e-01	-6.38e-02	4.63e-02	4.43e-01	-1.88e-01	3.00e-01	3.41e-01	8.05e-01	8.58e-01	8.63e-02	4.67e-01
GOBP RESPONSE TO COBALT ION	10	5.22e-02	1.21e-01	0.6080	-2.84e-01	-3.24e-02	-2.15e-01	2.71e-01	3.31e-01	2.41e-01	1.20e-01	8.59e-01	2.38e-01	1.37e-01	6.98e-02	1.86e-01
GOBP REGULATION OF INOSITOL PHOSPHATE BIOSYNTHETIC PROCESS	10	7.23e-02	1.55e-01	0.6080	-2.73e-01	2.52e-03	4.25e-01	6.30e-02	-1.20e-01	3.10e-01	1.35e-01	9.89e-01	2.00e-02	7.30e-01	5.10e-01	8.95e-02
GOBP PULMONARY VALVE MORPHOGENESIS	10	1.52e-02	4.78e-02	0.6080	-1.57e-01	2.93e-01	2.62e-01	1.16e-01	4.19e-01	3.41e-02	3.90e-01	1.08e-01	1.51e-01	5.26e-01	2.18e-02	8.52e-01
GOBP POSITIVE REGULATION OF T CELL DIFFERENTIATION IN THYMUS	8	1.10e-01	2.10e-01	0.6080	7.60e-02	3.29e-01	-1.19e-01	8.63e-02	3.74e-01	3.06e-01	7.10e-01	1.07e-01	5.59e-01	6.73e-01	6.70e-02	1.34e-01
GOBP PANCREATIC JUICE SECRETION	9	9.15e-02	1.84e-01	0.6070	2.79e-02	1.05e-01	2.98e-01	4.77e-01	9.68e-03	2.02e-01	8.85e-01	5.86e-01	1.22e-01	1.32e-02	9.60e-01	2.93e-01
GOBP BRANCHING INVOLVED IN SALIVARY GLAND MORPHOGENESIS	17	1.50e-02	4.73e-02	0.6070	2.18e-01	2.79e-01	4.50e-01	-1.69e-01	-1.01e-01	4.02e-02	1.19e-01	4.66e-02	1.31e-03	2.27e-01	4.69e-01	7.74e-01
GOBP RESPONSE TO INACTIVITY	10	1.77e-01	2.92e-01	0.6070	1.03e-01	2.34e-01	4.77e-01	7.71e-02	-2.18e-01	1.49e-01	5.73e-01	2.00e-01	9.05e-03	6.73e-01	2.32e-01	4.14e-01
GOCC KINESIN COMPLEX	43	1.79e-05	1.43e-04	0.6070	2.90e-01	7.05e-02	3.34e-01	2.82e-01	-3.51e-02	2.95e-01	9.80e-04	4.24e-01	1.49e-04	1.40e-03	6.91e-01	8.28e-04
GOBP NEGATIVE REGULATION OF NUCLEOCYTOPLASMIC TRANSPORT	21	8.04e-03	2.89e-02	0.6070	-3.67e-01	-2.83e-01	1.11e-01	-7.44e-02	-1.62e-01	3.31e-01	3.63e-03	2.45e-02	3.78e-01	5.55e-01	2.00e-01	8.67e-03
GOBP MEIOTIC CELL CYCLE CHECKPOINT SIGNALING	9	9.64e-02	1.91e-01	0.6070	1.56e-01	-1.12e-01	1.07e-01	2.92e-01	-6.05e-02	4.81e-01	4.18e-01	5.61e-01	5.80e-01	1.30e-01	7.53e-01	1.25e-02
GOCC GAP JUNCTION	11	2.70e-01	3.89e-01	0.6060	3.22e-01	1.77e-01	2.83e-01	2.09e-01	6.31e-02	3.24e-01	6.43e-02	3.10e-01	1.04e-01	2.29e-01	7.17e-01	6.31e-02
GOCC MICROTUBULE ORGANIZING CENTER ATTACHMENT SITE	8	3.22e-01	4.41e-01	0.6060	1.25e-01	5.35e-01	1.72e-01	3.37e-02	1.84e-01	3.71e-02	5.42e-01	8.80e-03	3.99e-01	8.69e-01	3.68e-01	8.56e-01
GOBP REGULATION OF MAST CELL CHEMOTAXIS	6	2.29e-01	3.47e-01	0.6060	1.62e-01	-5.04e-02	4.55e-01	3.31e-01	4.00e-02	1.43e-01	4.92e-01	8.31e-01	5.36e-02	1.61e-01	8.65e-01	5.45e-01
GOBP NUCLEAR PORE ORGANIZATION	15	8.91e-04	4.61e-03	0.6060	-4.38e-01	-1.23e-01	-2.22e-01	3.21e-01	8.63e-02	1.10e-02	3.30e-03	4.11e-01	1.36e-01	3.12e-02	5.63e-01	9.41e-01
GOBP MONOCYTE ACTIVATION	10	3.00e-01	4.20e-01	0.6060	-2.08e-01	4.81e-02	3.15e-01	-2.43e-01	-3.38e-01	2.21e-01	2.54e-01	7.92e-01	8.48e-02	1.83e-01	6.41e-02	2.26e-01
GOBP PYRIMIDINE NUCLEOBASE CATABOLIC PROCESS	5	2.01e-01	3.18e-01	0.6060	-5.56e-01	-1.92e-01	3.24e-02	-2.68e-02	1.30e-01	-5.20e-02	3.14e-02	4.58e-01	9.00e-01	9.17e-01	6.16e-01	8.40e-01
GOBP CYTOSOLIC RIBOSOME ASSEMBLY	9	1.85e-01	2.99e-01	0.6060	-2.74e-01	-4.21e-01	-1.27e-01	8.80e-02	-2.51e-01	-1.67e-01	1.54e-01	2.89e-02	5.09e-01	6.48e-01	1.93e-01	3.85e-01
GOMF 3 HYDROXYACYL COA DEHYDRATASE ACTIVITY	8	2.73e-01	3.93e-01	0.6060	-2.86e-01	-2.83e-01	-1.63e-01	-2.79e-01	-1.73e-01	2.66e-01	1.61e-01	1.65e-01	4.26e-01	1.72e-01	3.97e-01	1.93e-01
GOCC PARANODAL JUNCTION	8	2.07e-01	3.24e-01	0.6050	2.43e-01	2.02e-01	3.11e-01	-3.40e-01	-2.32e-01	2.47e-03	2.34e-01	3.23e-01	1.27e-01	9.56e-02	2.55e-01	9.90e-01
GOBP REGULATION OF MAST CELL ACTIVATION	17	7.41e-02	1.58e-01	0.6050	8.89e-02	3.09e-01	3.84e-01	1.11e-01	7.68e-02	3.12e-01	5.25e-01	2.73e-02	6.14e-03	4.29e-01	5.84e-01	2.59e-02
GOCC CHYLOMICRON	5	5.54e-02	1.27e-01	0.6050	1.68e-01	-1.06e-02	3.22e-01	2.53e-02	1.99e-02	-4.83e-01	5.14e-01	9.67e-01	2.12e-01	9.22e-01	9.38e-01	6.17e-02
GOBP RHODOPSIN MEDIATED SIGNALING PATHWAY	8	5.24e-02	1.21e-01	0.6050	2.63e-01	-1.98e-01	9.11e-02	-2.75e-01	-3.33e-01	2.50e-01	1.97e-01	3.33e-01	6.56e-01	1.78e-01	1.02e-01	2.20e-01
GOBP REGULATION OF PHOSPHATE TRANSPORT	7	2.07e-01	3.23e-01	0.6050	-2.16e-01	-2.01e-01	-9.92e-02	-3.34e-02	-5.17e-01	-3.40e-02	3.23e-01	3.58e-01	6.49e-01	8.78e-01	1.79e-02	8.76e-01
GOBP POSITIVE REGULATION OF T HELPER 17 CELL DIFFERENTIATION	9	2.10e-01	3.27e-01	0.6050	1.79e-01	3.66e-01	2.18e-01	3.60e-01	1.39e-01	-6.27e-02	3.54e-01	5.75e-02	2.57e-01	6.17e-02	4.70e-01	7.45e-01
GOBP NEGATIVE REGULATION OF EPITHELIAL CELL PROLIFERATION INVOLVED IN PROSTATE GLAND DEVELOPMENT	6	2.85e-01	4.05e-01	0.6050	-1.57e-01	-4.14e-01	-2.30e-01	1.75e-01	2.93e-01	-1.71e-02	5.04e-01	7.93e-02	3.29e-01	4.58e-01	2.14e-01	9.42e-01
GOBP DENDRITIC TRANSPORT OF RIBONUCLEOPROTEIN COMPLEX	5	5.98e-01	6.80e-01	0.6050	-8.38e-02	1.59e-01	2.73e-01	-3.95e-01	-1.01e-01	3.05e-01	7.46e-01	5.37e-01	2.91e-01	1.26e-01	6.94e-01	2.38e-01
GOBP PLASMA MEMBRANE TUBULATION	18	3.36e-03	1.42e-02	0.6050	-3.35e-02	-1.47e-01	3.70e-01	2.83e-01	-8.53e-02	3.45e-01	8.06e-01	2.79e-01	6.61e-03	3.77e-02	5.31e-01	1.13e-02
GOBP RESPONSE TO CELL CYCLE CHECKPOINT SIGNALING	9	6.88e-02	1.49e-01	0.6040	-1.46e-01	4.78e-02	2.77e-01	4.00e-01	-2.74e-02	3.24e-01	4.49e-01	8.04e-01	1.50e-01	3.79e-02	8.87e-01	9.26e-02
GOBP TRANS SYNAPTIC SIGNALING MODULATING SYNAPTIC TRANSMISSION	7	2.53e-01	3.72e-01	0.6040	-8.18e-02	-2.13e-01	3.56e-01	-3.46e-01	-2.38e-01	1.02e-01	7.08e-01	3.29e-01	1.03e-01	1.13e-01	2.76e-01	6.41e-01
GOMF POLY ADP D RIBOSE BINDING	6	2.65e-01	3.85e-01	0.6040	-9.01e-02	-3.13e-01	-3.07e-01	8.35e-02	3.91e-01	7.17e-02	7.02e-01	1.84e-01	1.93e-01	7.23e-01	9.76e-02	7.61e-01
GOMF PHOSPHATIDYLINOSITOL 3 4 5 TRISPHOSPHATE 5 PHOSPHATASE ACTIVITY	6	2.18e-01	3.37e-01	0.6040	-4.03e-02	2.08e-01	-8.79e-02	2.40e-01	1.84e-01	-4.70e-01	8.64e-01	3.77e-01	7.09e-01	3.09e-01	4.36e-01	4.61e-02
GOBP NEUROENDOCRINE CELL DIFFERENTIATION	8	9.34e-02	1.87e-01	0.6040	-9.50e-02	-1.17e-01	5.28e-01	-2.46e-02	-1.34e-01	2.11e-01	6.42e-01	5.67e-01	9.64e-03	9.04e-01	5.13e-01	3.01e-01
GOBP PARAXIAL MESODERM MORPHOGENESIS	6	3.56e-01	4.72e-01	0.6040	7.87e-02	-1.05e-01	1.16e-01	-2.31e-01	-4.87e-01	2.09e-01	7.39e-01	6.55e-01	6.23e-01	3.28e-01	3.88e-02	3.74e-01
GOBP REGULATION OF GLUCOCORTICOID BIOSYNTHETIC PROCESS	7	1.67e-01	2.80e-01	0.6040	-1.17e-01	1.75e-01	2.95e-01	2.87e-01	-1.86e-01	3.42e-01	5.91e-01	4.23e-01	1.77e-01	1.88e-01	3.94e-01	1.18e-01
GOBP POSITIVE REGULATION OF CYTOPLASMIC TRANSLATIONAL INITIATION	5	7.87e-01	8.28e-01	0.6040	-2.33e-01	-2.93e-01	-1.20e-01	-2.36e-01	-3.50e-01	-1.78e-01	3.67e-01	2.56e-01	6.41e-01	3.60e-01	1.76e-01	4.91e-01
GOBP NEGATIVE REGULATION OF BONE REMODELING	11	9.43e-02	1.88e-01	0.6040	1.48e-01	2.34e-01	5.11e-01	1.03e-01	3.19e-02	1.24e-01	3.97e-01	1.79e-01	3.32e-03	5.56e-01	8.54e-01	4.78e-01
GOBP T HELPER 17 CELL DIFFERENTIATION	30	5.25e-04	2.92e-03	0.6040	2.28e-01	4.58e-01	2.24e-01	2.17e-01	7.17e-02	3.02e-02	3.06e-02	1.44e-05	3.38e-02	3.96e-02	4.96e-01	7.74e-01
GOMF PEPTIDE ANTIGEN BINDING	45	1.82e-05	1.45e-04	0.6040	1.29e-01	-3.42e-02	-3.25e-01	2.78e-01	3.70e-01	-1.64e-01	1.34e-01	6.92e-01	1.58e-04	1.26e-03	1.75e-05	5.76e-02
GOBP POSITIVE REGULATION OF FIBROBLAST GROWTH FACTOR RECEPTOR SIGNALING PATHWAY	6	3.70e-01	4.85e-01	0.6040	-5.36e-01	-1.93e-01	-1.36e-01	-8.51e-03	-1.44e-01	1.32e-02	2.29e-02	4.12e-01	5.64e-01	9.71e-01	5.42e-01	9.55e-01
GOMF 4 IRON 4 SULFUR CLUSTER BINDING	45	3.48e-06	3.28e-05	0.6040	-8.83e-02	-3.76e-01	-3.69e-01	1.75e-01	7.61e-02	-2.06e-01	3.05e-01	1.26e-05	1.86e-05	4.20e-02	3.77e-01	1.67e-02
GOBP POSITIVE REGULATION OF FILOPODIUM ASSEMBLY	25	3.69e-04	2.16e-03	0.6040	-2.07e-01	7.40e-02	2.55e-01	1.48e-01	-3.10e-02	4.78e-01	7.28e-02	5.22e-01	2.74e-02	2.01e-01	7.89e-01	3.54e-05
GOBP GMP BIOSYNTHETIC PROCESS	13	4.02e-02	9.99e-02	0.6030	-1.50e-01	-4.87e-01	-2.72e-01	1.27e-01	1.16e-01	-3.55e-02	3.48e-01	2.38e-03	8.98e-02	4.26e-01	4.70e-01	8.24e-01
GOBP POSITIVE REGULATION OF ATTACHMENT OF SPINDLE MICROTUBULES TO KINETOCHORE	11	1.53e-02	4.81e-02	0.6030	-1.59e-01	-2.66e-01	1.34e-01	4.30e-01	-1.39e-01	2.15e-01	3.62e-01	1.26e-01	4.41e-01	1.36e-02	4.25e-01	2.17e-01
GOBP NEGATIVE REGULATION OF TELOMERE CAPPING	8	1.57e-01	2.68e-01	0.6030	2.02e-01	1.76e-01	-2.58e-01	2.61e-01	3.55e-01	1.78e-01	3.23e-01	3.89e-01	2.07e-01	2.01e-01	8.19e-02	3.84e-01
GOBP EXCITATORY CHEMICAL SYNAPTIC TRANSMISSION	5	2.23e-01	3.42e-01	0.6030	-4.53e-01	2.47e-01	-1.87e-01	4.16e-02	1.57e-01	-1.90e-01	7.91e-02	3.38e-01	4.70e-01	8.72e-01	5.43e-01	4.63e-01
GOBP HEART TRABECULA MORPHOGENESIS	20	2.31e-03	1.04e-02	0.6030	1.84e-02	3.46e-01	1.50e-01	2.48e-01	1.29e-01	3.78e-01	8.87e-01	7.33e-03	2.46e-01	5.44e-02	3.19e-01	3.42e-03
GOBP CATECHOLAMINE UPTAKE INVOLVED IN SYNAPTIC TRANSMISSION	6	2.21e-01	3.40e-01	0.6030	2.47e-01	-3.74e-01	2.16e-01	3.04e-02	-1.83e-01	2.86e-01	2.95e-01	1.13e-01	3.58e-01	8.97e-01	4.38e-01	2.25e-01
GOBP RESPONSE TO SELENIUM ION	8	2.65e-01	3.84e-01	0.6030	-3.55e-02	-3.19e-01	-2.94e-01	-1.43e-01	1.03e-01	-3.79e-01	8.62e-01	1.19e-01	1.51e-01	4.85e-01	6.14e-01	6.31e-02
GOBP POSITIVE REGULATION OF MYOBLAST FUSION	12	1.97e-01	3.13e-01	0.6030	2.09e-02	1.20e-01	3.96e-01	1.17e-01	-1.53e-02	4.22e-01	9.00e-01	4.71e-01	1.75e-02	4.85e-01	9.27e-01	1.13e-02
GOCC MISMATCH REPAIR COMPLEX	10	8.72e-02	1.77e-01	0.6030	-1.57e-01	-3.98e-01	-2.14e-01	-9.83e-02	-2.58e-01	2.41e-01	3.91e-01	2.92e-02	2.41e-01	5.90e-01	1.57e-01	1.86e-01
GOBP POSITIVE REGULATION OF LYSOSOMAL PROTEIN CATABOLIC PROCESS	5	1.03e-01	2.00e-01	0.6030	-1.28e-01	1.94e-01	5.45e-01	-6.59e-02	7.34e-02	-5.09e-02	6.19e-01	4.53e-01	3.47e-02	7.99e-01	7.76e-01	8.44e-01
GOCC INHIBITORY SYNAPSE	6	5.04e-01	6.00e-01	0.6030	7.50e-02	4.90e-01	2.69e-01	4.18e-02	2.09e-01	2.69e-02	7.50e-01	3.78e-02	2.55e-01	8.59e-01	3.76e-01	9.09e-01
GOMF PHOSPHODIESTERASE I ACTIVITY	5	5.86e-01	6.70e-01	0.6030	2.58e-01	2.80e-01	1.56e-01	3.53e-02	4.16e-01	1.40e-01	3.18e-01	2.78e-01	5.47e-01	8.91e-01	1.07e-01	5.88e-01
GOMF CARGO ADAPTOR ACTIVITY	21	2.07e-04	1.29e-03	0.6030	-2.05e-02	-1.34e-01	2.54e-01	4.51e-01	-7.33e-02	2.68e-01	8.71e-01	2.88e-01	4.41e-02	3.50e-04	5.61e-01	3.33e-02
GOBP NEGATIVE REGULATION OF CYCLASE ACTIVITY	9	1.53e-01	2.63e-01	0.6030	1.97e-02	5.42e-01	2.17e-01	6.45e-02	1.11e-01	7.02e-02	9.18e-01	4.84e-03	2.59e-01	7.38e-01	5.63e-01	7.15e-01
GOBP POSITIVE REGULATION OF PROGRAMMED NECROTIC CELL DEATH	8	2.29e-01	3.47e-01	0.6030	1.47e-01	-3.10e-02	-5.82e-02	5.08e-01	1.62e-01	2.30e-01	4.70e-01	8.79e-01	7.76e-01	1.29e-02	4.27e-01	2.59e-01
GOBP SEQUESTERING OF METAL ION	8	3.73e-01	4.88e-01	0.6020	-3.72e-01	-3.76e-01	4.89e-02	-2.11e-01	-1.47e-01	1.23e-01	6.85e-02	6.58e-02	8.11e-01	3.01e-01	4.72e-01	5.47e-01
GOMF HYDROXYMETHYL FORMYL AND RELATED TRANSFERASE ACTIVITY	8	2.16e-01	3.33e-01	0.6020	1.65e-03	-3.54e-01	-4.05e-01	2.67e-01	2.86e-02	-3.74e-02	9.94e-01	8.30e-02	4.74e-02	1.90e-01	8.89e-01	8.55e-01
GOBP EMBRYONIC PROCESS INVOLVED IN FEMALE PREGNANCY	6	3.17e-01	4.36e-01	0.6020	-3.63e-01	1.02e-01	2.20e-01	-3.92e-01	-1.16e-01	-7.35e-02	1.23e-01	6.65e-01	3.52e-01	9.66e-02	6.22e-01	7.55e-01
GOBP POSITIVE REGULATION OF UBIQUITIN PROTEIN LIGASE ACTIVITY	9	1.31e-01	2.37e-01	0.6020	-3.15e-02	-3.61e-01	1.25e-01	2.50e-01	-2.58e-01	2.95e-01	8.70e-01	6.07e-02	5.18e-01	1.94e-01	1.81e-01	1.26e-01
GOBP STABILIZATION OF MEMBRANE POTENTIAL	9	2.59e-01	3.80e-01	0.6020	6.64e-02	1.76e-01	3.24e-01	3.31e-01	2.11e-01	2.61e-01	7.30e-01	3.61e-01	9.20e-02	8.58e-02	2.74e-01	1.74e-01
GOBP RESPONSE TO EPINEPHRINE	11	2.99e-02	7.99e-02	0.6020	1.03e-01	2.84e-02	4.46e-01	3.46e-01	7.95e-02	1.61e-01	5.55e-01	8.71e-01	1.04e-02	4.69e-02	6.48e-01	3.55e-01
GOBP ACETYL COA BIOSYNTHETIC PROCESS FROM PYRUVATE	10	1.02e-01	1.99e-01	0.6020	-3.25e-01	-3.79e-01	-1.65e-01	-7.75e-03	8.47e-02	2.80e-01	7.48e-02	3.80e-02	3.66e-01	9.66e-01	6.43e-01	1.25e-01
GOBP MACROPHAGE INFLAMMATORY PROTEIN 1 ALPHA PRODUCTION	5	4.88e-01	5.87e-01	0.6020	-2.19e-01	3.86e-01	2.31e-01	-2.81e-01	-6.89e-02	1.69e-01	3.96e-01	1.35e-01	3.72e-01	2.76e-01	7.90e-01	5.13e-01
GOBP CRISTAE FORMATION	19	7.61e-03	2.77e-02	0.6020	-6.33e-02	-5.14e-01	-2.75e-01	-1.83e-02	-5.57e-02	-1.22e-01	6.33e-01	1.04e-04	3.83e-02	8.90e-01	6.74e-01	3.57e-01
GOBP INTERLEUKIN 17 MEDIATED SIGNALING PATHWAY	9	2.95e-01	4.14e-01	0.6020	1.38e-01	3.73e-01	1.67e-01	3.32e-01	2.55e-01	-2.39e-02	4.74e-01	5.24e-02	3.86e-01	8.48e-02	1.85e-01	9.01e-01
GOBP RETINAL CONE CELL DIFFERENTIATION	8	1.88e-01	3.03e-01	0.6020	1.92e-01	2.42e-01	4.72e-01	-1.25e-01	-1.56e-01	-6.21e-02	3.47e-01	2.35e-01	2.07e-02	5.40e-01	4.46e-01	7.61e-01
GOBP VACUOLE FUSION	11	7.06e-02	1.52e-01	0.6020	-1.85e-01	-5.05e-01	-3.84e-02	1.14e-01	-9.42e-02	2.23e-01	2.88e-01	3.75e-03	8.25e-01	5.11e-01	5.88e-01	2.00e-01
GOBP TRANSLATIONAL INITIATION	114	6.01e-15	1.60e-13	0.6020	-3.16e-01	-4.25e-01	-2.38e-01	-5.39e-02	-1.47e-01	1.97e-02	5.63e-09	4.46e-15	1.10e-05	3.20e-01	6.60e-03	7.17e-01
GOMF ATPASE COUPLED INTRAMEMBRANE LIPID TRANSPORTER ACTIVITY	24	4.37e-03	1.75e-02	0.6020	1.72e-01	3.66e-01	2.10e-01	3.43e-01	1.11e-01	1.57e-01	1.45e-01	1.91e-03	7.54e-02	3.66e-03	3.44e-01	1.82e-01
GOMF LYSOPHOSPHOLIPID ACYLTRANSFERASE ACTIVITY	20	2.17e-03	9.87e-03	0.6020	-3.69e-01	4.96e-02	3.46e-01	-1.19e-01	-1.19e-01	2.73e-01	4.23e-03	7.01e-01	7.31e-03	3.58e-01	3.56e-01	3.44e-02
GOBP ACTIVATION OF NF KAPPAB INDUCING KINASE ACTIVITY	9	6.67e-02	1.46e-01	0.6020	-1.45e-01	3.52e-01	-3.47e-01	-1.31e-01	2.38e-01	-1.52e-01	4.52e-01	6.74e-02	7.16e-02	4.97e-01	2.17e-01	4.29e-01
GOBP NEUTROPHIL DIFFERENTIATION	10	2.77e-02	7.55e-02	0.6020	-1.61e-01	2.63e-01	2.88e-01	3.44e-01	-9.67e-03	2.56e-01	3.78e-01	1.50e-01	1.14e-01	5.98e-02	9.58e-01	1.61e-01
GOMF INORGANIC DIPHOSPHATE PHOSPHATASE ACTIVITY	5	2.97e-01	4.17e-01	0.6010	-7.61e-02	-5.43e-01	1.13e-01	-4.35e-02	-6.50e-02	2.04e-01	7.68e-01	3.54e-02	6.61e-01	8.66e-01	8.01e-01	4.29e-01
GOMF 2 IRON 2 SULFUR CLUSTER BINDING	25	3.85e-04	2.24e-03	0.6010	-1.61e-01	-4.82e-01	-2.64e-01	1.55e-01	-7.31e-03	9.61e-02	1.63e-01	2.99e-05	2.21e-02	1.80e-01	9.50e-01	4.06e-01
GOBP ENDONUCLEOLYTIC CLEAVAGE IN 5 ETS OF TRICISTRONIC RRNA TRANSCRIPT SSU RRNA 5 8S RRNA LSU RRNA	7	3.80e-01	4.94e-01	0.6010	2.16e-01	-2.08e-01	-3.24e-01	2.95e-01	1.08e-02	-2.82e-01	3.21e-01	3.40e-01	1.38e-01	1.77e-01	9.60e-01	1.96e-01
GOBP EARLY ENDOSOME TO GOLGI TRANSPORT	16	1.61e-02	5.00e-02	0.6010	-2.99e-01	-4.05e-01	2.92e-02	1.23e-01	-2.34e-01	1.94e-01	3.81e-02	5.07e-03	8.40e-01	3.96e-01	1.05e-01	1.80e-01
GOBP NEGATIVE REGULATION OF MYELOID LEUKOCYTE DIFFERENTIATION	40	7.73e-06	6.73e-05	0.6010	2.69e-02	2.41e-01	4.89e-01	6.00e-02	-1.14e-01	2.17e-01	7.69e-01	8.36e-03	8.86e-08	5.12e-01	2.11e-01	1.76e-02
GOBP ANTIBACTERIAL PEPTIDE PRODUCTION	5	5.35e-01	6.26e-01	0.6010	-1.61e-01	-9.25e-02	1.58e-01	-4.94e-01	-2.03e-01	-1.30e-01	5.32e-01	7.20e-01	5.42e-01	5.60e-02	4.31e-01	6.15e-01
GOBP ANTIMICROBIAL PEPTIDE PRODUCTION	5	5.35e-01	6.26e-01	0.6010	-1.61e-01	-9.25e-02	1.58e-01	-4.94e-01	-2.03e-01	-1.30e-01	5.32e-01	7.20e-01	5.42e-01	5.60e-02	4.31e-01	6.15e-01
GOBP MYD88 INDEPENDENT TOLL LIKE RECEPTOR SIGNALING PATHWAY	16	1.16e-02	3.86e-02	0.6010	-6.20e-02	4.09e-01	-1.38e-01	1.74e-01	3.75e-01	-7.89e-03	6.68e-01	4.58e-03	3.38e-01	2.29e-01	9.49e-03	9.56e-01
GOBP ALLANTOIN METABOLIC PROCESS	6	6.55e-01	7.26e-01	0.6010	3.04e-01	1.87e-01	3.22e-01	2.09e-01	2.07e-01	2.07e-01	1.98e-01	4.27e-01	1.72e-01	3.75e-01	3.79e-01	3.79e-01
GOBP POSITIVE REGULATION OF RECEPTOR CLUSTERING	9	1.25e-01	2.30e-01	0.6010	-2.21e-01	2.63e-02	1.62e-01	1.42e-01	-8.43e-02	5.07e-01	2.50e-01	8.92e-01	3.99e-01	4.60e-01	6.62e-01	8.40e-03
GOBP PROTEIN IMPORT INTO PEROXISOME MATRIX RECEPTOR RECYCLING	7	3.23e-01	4.42e-01	0.6000	-2.45e-01	-1.13e-01	-3.84e-01	2.81e-01	2.42e-01	-5.06e-02	2.62e-01	6.04e-01	7.86e-02	1.97e-01	2.67e-01	8.17e-01
GOBP TRANSCRIPTION ELONGATION COUPLED CHROMATIN REMODELING	9	3.53e-02	9.07e-02	0.6000	-4.02e-02	-4.08e-02	-4.38e-02	5.82e-01	7.45e-02	-1.07e-01	8.35e-01	8.32e-01	8.20e-01	2.51e-03	6.99e-01	5.78e-01
GOBP PRIMARY AMINO COMPOUND BIOSYNTHETIC PROCESS	5	3.15e-01	4.35e-01	0.6000	-3.53e-01	1.59e-01	7.12e-03	1.36e-02	4.40e-01	1.30e-01	1.72e-01	5.38e-01	9.78e-01	9.58e-01	8.84e-02	6.14e-01
GOBP DESMOSOME ORGANIZATION	8	2.66e-01	3.85e-01	0.6000	1.13e-01	-3.87e-02	4.29e-01	8.60e-02	4.49e-02	3.91e-01	5.81e-01	8.50e-01	3.55e-02	6.74e-01	8.26e-01	5.58e-02
GOBP POSITIVE REGULATION OF NEUROINFLAMMATORY RESPONSE	11	6.47e-02	1.43e-01	0.6000	-1.21e-01	1.96e-01	3.53e-01	-4.13e-01	-1.03e-01	2.43e-02	4.86e-01	2.61e-01	4.23e-02	1.76e-02	5.56e-01	8.89e-01
GOBP NEGATIVE REGULATION OF OSSIFICATION	27	2.87e-03	1.25e-02	0.6000	1.09e-01	3.61e-01	3.98e-01	1.31e-01	9.38e-02	1.83e-01	3.25e-01	1.18e-03	3.43e-04	2.37e-01	3.99e-01	9.95e-02
GOBP NEGATIVE REGULATION OF DNA TEMPLATED DNA REPLICATION	10	7.83e-02	1.64e-01	0.6000	3.09e-01	-1.63e-01	1.40e-01	3.98e-01	2.26e-01	9.58e-02	9.04e-02	3.74e-01	4.44e-01	2.94e-02	2.16e-01	6.00e-01
GOBP ANGIOTENSIN ACTIVATED SIGNALING PATHWAY	12	1.50e-01	2.60e-01	0.6000	-2.53e-01	-1.64e-01	1.34e-01	-3.42e-01	-1.59e-01	3.30e-01	1.29e-01	3.26e-01	4.22e-01	4.02e-02	3.39e-01	4.80e-02
GOMF P TYPE TRANSMEMBRANE TRANSPORTER ACTIVITY	18	1.95e-03	8.96e-03	0.6000	6.05e-02	3.16e-01	2.78e-01	3.77e-01	1.93e-01	-1.81e-02	6.57e-01	2.04e-02	4.12e-02	5.64e-03	1.57e-01	8.94e-01
GOMF PHOSPHATIDYLINOSITOL TRANSFER ACTIVITY	9	1.70e-01	2.83e-01	0.6000	2.22e-02	2.47e-01	7.58e-02	4.56e-01	2.91e-01	9.99e-03	9.08e-01	2.00e-01	6.94e-01	1.78e-02	1.31e-01	9.59e-01
GOBP PSEUDOURIDINE SYNTHESIS	18	1.59e-02	4.95e-02	0.6000	-4.92e-02	-4.53e-01	-3.57e-01	1.11e-01	-1.02e-02	-1.12e-01	7.18e-01	8.87e-04	8.71e-03	4.13e-01	9.40e-01	4.11e-01
GOBP PROLINE METABOLIC PROCESS	8	2.70e-01	3.89e-01	0.6000	-9.09e-02	-1.23e-01	2.34e-01	1.71e-01	-2.44e-01	4.39e-01	6.56e-01	5.48e-01	2.51e-01	4.02e-01	2.33e-01	3.15e-02
GOBP CELLULAR RESPONSE TO SALT	5	4.19e-01	5.28e-01	0.6000	3.80e-01	-2.09e-02	1.76e-02	9.36e-02	-1.72e-01	-4.19e-01	1.41e-01	9.35e-01	9.46e-01	7.17e-01	5.05e-01	1.05e-01
GOBP CELLULAR RESPONSE TO SODIUM ARSENITE	5	4.19e-01	5.28e-01	0.6000	3.80e-01	-2.09e-02	1.76e-02	9.36e-02	-1.72e-01	-4.19e-01	1.41e-01	9.35e-01	9.46e-01	7.17e-01	5.05e-01	1.05e-01
GOMF HISTONE H4K20 METHYLTRANSFERASE ACTIVITY	8	3.31e-01	4.49e-01	0.6000	9.35e-02	1.34e-01	3.37e-02	4.63e-01	3.42e-01	-1.43e-02	6.47e-01	5.10e-01	8.69e-01	2.33e-02	9.43e-02	9.44e-01
GOMF GDP BINDING	63	8.83e-09	1.25e-07	0.5990	-3.62e-01	-2.04e-01	1.06e-01	-9.51e-02	-2.25e-01	3.40e-01	6.81e-07	5.05e-03	1.48e-01	1.92e-01	1.99e-03	2.98e-06
GOMF TELOMERASE ACTIVITY	6	3.46e-01	4.62e-01	0.5990	8.00e-02	-2.10e-01	-6.47e-02	4.41e-01	1.46e-01	2.99e-01	7.34e-01	3.74e-01	7.84e-01	6.16e-02	5.36e-01	2.05e-01
GOMF LONG CHAIN FATTY ACID BINDING	12	3.84e-02	9.65e-02	0.5990	8.99e-02	3.88e-01	2.06e-01	-3.53e-01	-9.81e-02	1.52e-01	5.90e-01	1.99e-02	2.17e-01	3.40e-02	5.56e-01	3.60e-01
GOCC NUCLEAR LAMINA	12	1.61e-02	5.00e-02	0.5990	2.23e-01	-1.00e-01	-1.20e-02	4.11e-01	-5.92e-02	-3.56e-01	1.81e-01	5.49e-01	9.43e-01	1.37e-02	7.23e-01	3.27e-02
GOBP CELLULAR RESPONSE TO COLD	10	1.59e-02	4.95e-02	0.5990	-2.20e-01	1.57e-01	4.55e-01	1.29e-01	-2.23e-01	1.12e-01	2.28e-01	3.90e-01	1.28e-02	4.81e-01	2.21e-01	5.41e-01
GOBP LONG CHAIN FATTY ACID CATABOLIC PROCESS	7	1.76e-01	2.90e-01	0.5980	3.87e-01	3.13e-02	3.03e-01	-2.30e-01	-1.54e-01	1.97e-01	7.60e-02	8.86e-01	1.66e-01	2.92e-01	4.81e-01	3.66e-01
GOBP TRANSCRIPTION COUPLED NUCLEOTIDE EXCISION REPAIR	10	1.79e-01	2.93e-01	0.5980	-1.04e-01	6.97e-02	-2.70e-01	3.38e-01	3.49e-01	-1.82e-01	5.68e-01	7.03e-01	1.39e-01	6.43e-02	5.57e-02	3.20e-01
GOBP UTP BIOSYNTHETIC PROCESS	8	1.43e-01	2.53e-01	0.5980	-8.01e-02	-5.39e-01	-2.28e-01	3.12e-02	8.59e-02	2.85e-02	6.95e-01	8.31e-03	2.64e-01	8.78e-01	6.74e-01	8.89e-01
GOBP B 1 B CELL DIFFERENTIATION	5	7.10e-01	7.70e-01	0.5980	-1.31e-01	-4.41e-01	1.94e-02	-1.45e-01	-3.52e-01	2.42e-02	6.11e-01	8.79e-02	9.40e-01	5.76e-01	1.72e-01	9.25e-01
GOBP CELLULAR RESPONSE TO BRAIN DERIVED NEUROTROPHIC FACTOR STIMULUS	5	5.81e-01	6.66e-01	0.5980	5.95e-02	3.94e-01	1.15e-01	2.52e-01	1.86e-01	2.96e-01	8.18e-01	1.27e-01	6.55e-01	3.30e-01	4.72e-01	2.52e-01
GOBP NITRIC OXIDE SYNTHASE BIOSYNTHETIC PROCESS	17	1.42e-02	4.54e-02	0.5980	-3.81e-01	1.16e-01	1.56e-01	-3.55e-01	-3.90e-02	2.16e-01	6.48e-03	4.09e-01	2.65e-01	1.12e-02	7.81e-01	1.23e-01
GOMF METAL ION SENSOR ACTIVITY	6	3.49e-01	4.65e-01	0.5980	-3.36e-01	-3.48e-01	6.97e-02	6.07e-02	3.74e-02	3.38e-01	1.54e-01	1.40e-01	7.68e-01	7.97e-01	8.74e-01	1.52e-01
GOBP MEGAKARYOCYTE DEVELOPMENT	22	9.65e-04	4.93e-03	0.5980	-1.00e-02	-2.26e-01	3.72e-01	1.26e-01	-3.34e-01	2.00e-01	9.35e-01	6.64e-02	2.53e-03	3.05e-01	6.63e-03	1.04e-01
GOMF HIGH DENSITY LIPOPROTEIN PARTICLE BINDING	8	2.90e-02	7.81e-02	0.5980	-3.22e-01	6.13e-02	2.75e-01	1.28e-01	3.41e-01	2.06e-01	1.15e-01	7.64e-01	1.79e-01	5.32e-01	9.52e-02	3.14e-01
GOMF UBIQUITIN LIKE PROTEIN CONJUGATING ENZYME ACTIVITY	37	5.63e-05	4.06e-04	0.5970	-2.93e-01	-3.23e-01	4.93e-02	-2.10e-02	-2.77e-01	2.95e-01	2.01e-03	6.70e-04	6.04e-01	8.25e-01	3.51e-03	1.93e-03
GOBP REGULATION OF RIBOSOME BIOGENESIS	6	6.48e-01	7.21e-01	0.5970	-3.77e-01	-3.87e-01	-1.03e-01	-1.36e-01	-1.33e-01	1.35e-01	1.10e-01	1.01e-01	6.61e-01	5.64e-01	5.73e-01	5.66e-01
GOBP MONOATOMIC ANION HOMEOSTASIS	14	1.21e-01	2.25e-01	0.5970	1.16e-01	3.15e-01	3.35e-01	2.10e-01	2.21e-01	1.96e-01	4.53e-01	4.10e-02	3.00e-02	1.73e-01	1.52e-01	2.04e-01
GOMF INSULIN LIKE GROWTH FACTOR II BINDING	5	5.88e-01	6.71e-01	0.5970	-1.00e-01	4.03e-02	4.97e-01	-8.55e-02	-2.21e-01	2.05e-01	6.99e-01	8.76e-01	5.43e-02	7.41e-01	3.91e-01	4.28e-01
GOBP CD4 POSITIVE ALPHA BETA T CELL PROLIFERATION	21	2.15e-03	9.80e-03	0.5970	1.20e-01	2.32e-02	2.66e-01	1.90e-01	-2.78e-01	3.98e-01	3.42e-01	8.54e-01	3.50e-02	1.32e-01	2.76e-02	1.61e-03
GOBP ACTIVATION OF ADENYLATE CYCLASE ACTIVITY	11	1.01e-01	1.96e-01	0.5970	-2.84e-01	-1.40e-01	1.47e-01	-2.63e-01	-3.61e-01	-1.87e-01	1.03e-01	4.20e-01	3.98e-01	1.31e-01	3.82e-02	2.82e-01
GOBP PERIPHERAL NERVOUS SYSTEM MYELIN MAINTENANCE	7	1.28e-01	2.33e-01	0.5970	1.38e-01	-1.23e-01	2.20e-02	4.81e-01	5.11e-02	-2.97e-01	5.26e-01	5.74e-01	9.20e-01	2.76e-02	8.15e-01	1.74e-01
GOMF MYOSIN HEAVY CHAIN BINDING	10	2.87e-01	4.06e-01	0.5970	2.14e-01	9.13e-02	1.54e-01	3.41e-01	2.80e-01	2.90e-01	2.41e-01	6.17e-01	4.00e-01	6.22e-02	1.25e-01	1.12e-01
GOMF PROTEIN SERINE THREONINE KINASE BINDING	10	1.09e-01	2.08e-01	0.5970	-4.52e-01	-8.32e-02	-2.61e-01	-2.12e-01	-1.27e-01	1.26e-01	1.33e-02	6.49e-01	1.53e-01	2.46e-01	4.86e-01	4.91e-01
GOBP REGULATION OF HETEROTYPIC CELL CELL ADHESION	18	2.92e-03	1.27e-02	0.5970	7.90e-02	3.86e-01	3.32e-01	-3.68e-02	2.99e-01	6.88e-03	5.62e-01	4.61e-03	1.48e-02	7.87e-01	2.78e-02	9.60e-01
GOCC NUCLEOID	45	4.04e-06	3.75e-05	0.5970	-1.98e-01	-4.44e-01	-2.98e-01	1.08e-01	-9.08e-02	-1.02e-01	2.13e-02	2.48e-07	5.35e-04	2.11e-01	2.92e-01	2.35e-01
GOBP HEXOSE PHOSPHATE TRANSPORT	6	4.17e-01	5.27e-01	0.5970	3.19e-01	2.76e-01	1.11e-01	8.29e-02	1.09e-01	-3.83e-01	1.75e-01	2.42e-01	6.37e-01	7.25e-01	6.43e-01	1.04e-01
GOMF AROMATASE ACTIVITY	10	1.29e-01	2.35e-01	0.5970	1.39e-01	3.18e-01	3.48e-01	-3.12e-01	2.52e-02	1.24e-01	4.45e-01	8.12e-02	5.64e-02	8.72e-02	8.90e-01	4.96e-01
GOBP DNA CYTOSINE DEAMINATION	9	1.22e-01	2.26e-01	0.5970	3.02e-01	7.79e-02	1.78e-01	1.50e-01	-7.90e-02	4.45e-01	1.17e-01	6.86e-01	3.56e-01	4.37e-01	6.81e-01	2.07e-02
GOBP OSTEOCLAST FUSION	5	7.10e-01	7.70e-01	0.5970	3.63e-01	3.33e-02	7.76e-02	4.34e-01	1.38e-01	9.85e-02	1.60e-01	8.98e-01	7.64e-01	9.29e-02	5.92e-01	7.03e-01
GOBP GLUTATHIONE TRANSMEMBRANE TRANSPORT	7	3.44e-01	4.60e-01	0.5970	5.66e-02	-9.73e-02	3.64e-01	2.69e-01	2.40e-02	3.71e-01	7.95e-01	6.56e-01	9.53e-02	2.18e-01	9.12e-01	8.89e-02
GOBP PTERIDINE CONTAINING COMPOUND BIOSYNTHETIC PROCESS	14	1.35e-02	4.38e-02	0.5960	-1.26e-01	-5.43e-01	-1.09e-01	1.29e-01	-1.01e-02	1.28e-01	4.14e-01	4.37e-04	4.79e-01	4.04e-01	9.48e-01	4.08e-01
GOBP REGULATION OF PROTEIN AUTOUBIQUITINATION	6	5.87e-01	6.70e-01	0.5960	-4.16e-01	-2.29e-01	-2.75e-01	-1.42e-01	-1.84e-01	1.95e-02	7.74e-02	3.32e-01	2.44e-01	5.47e-01	4.36e-01	9.34e-01
GOBP REGULATION OF HYDROGEN PEROXIDE MEDIATED PROGRAMMED CELL DEATH	9	3.56e-01	4.71e-01	0.5960	-3.15e-01	-1.71e-01	-1.02e-01	-2.46e-01	-3.95e-01	-1.44e-02	1.02e-01	3.73e-01	5.98e-01	2.02e-01	4.03e-02	9.40e-01
GOCC ZONA PELLUCIDA RECEPTOR COMPLEX	7	1.74e-01	2.88e-01	0.5960	4.99e-02	-4.97e-01	-2.06e-02	1.71e-01	-6.97e-02	2.66e-01	8.19e-01	2.27e-02	9.25e-01	4.35e-01	7.50e-01	2.22e-01
GOBP REGULATION OF STRESS GRANULE ASSEMBLY	10	2.53e-02	7.08e-02	0.5960	-1.88e-01	-1.65e-01	8.24e-02	2.74e-01	-3.70e-01	2.71e-01	3.04e-01	3.66e-01	6.52e-01	1.33e-01	4.29e-02	1.38e-01
GOBP POSITIVE REGULATION OF SMALL GTPASE MEDIATED SIGNAL TRANSDUCTION	58	1.77e-06	1.78e-05	0.5960	1.51e-01	3.41e-01	2.79e-01	2.27e-01	1.43e-01	2.56e-01	4.74e-02	6.96e-06	2.33e-04	2.80e-03	5.90e-02	7.40e-04
GOBP INTERNAL PEPTIDYL LYSINE ACETYLATION	7	1.04e-01	2.02e-01	0.5950	1.99e-01	1.89e-01	-7.28e-02	2.65e-01	-2.00e-01	-4.04e-01	3.61e-01	3.86e-01	7.39e-01	2.24e-01	3.59e-01	6.43e-02
GOBP PROTEOGLYCAN CATABOLIC PROCESS	10	2.77e-01	3.97e-01	0.5950	-2.94e-01	-1.25e-01	-3.42e-01	-6.06e-02	1.75e-02	-3.63e-01	1.07e-01	4.93e-01	6.14e-02	7.40e-01	9.24e-01	4.70e-02
GOBP INTRACELLULAR SODIUM ION HOMEOSTASIS	14	8.08e-02	1.68e-01	0.5950	1.71e-01	9.63e-02	3.64e-01	3.33e-01	1.08e-01	2.45e-01	2.68e-01	5.33e-01	1.82e-02	3.08e-02	4.84e-01	1.12e-01
GOMF CELL MATRIX ADHESION MEDIATOR ACTIVITY	8	4.44e-01	5.51e-01	0.5950	7.69e-02	3.19e-02	3.40e-01	-2.04e-01	-3.18e-01	2.99e-01	7.06e-01	8.76e-01	9.58e-02	3.18e-01	1.20e-01	1.43e-01
GOCC ORGANELLE INNER MEMBRANE	508	3.91e-84	3.29e-81	0.5950	-1.48e-01	-4.86e-01	-2.97e-01	3.37e-02	-5.39e-02	-6.09e-02	1.11e-08	5.59e-79	1.70e-30	1.94e-01	3.77e-02	1.89e-02
GOMF ARMADILLO REPEAT DOMAIN BINDING	8	1.34e-01	2.42e-01	0.5950	-5.01e-03	1.98e-01	3.30e-01	4.09e-01	-3.82e-02	1.91e-01	9.80e-01	3.31e-01	1.06e-01	4.50e-02	8.52e-01	3.50e-01
GOBP RESPONSE TO VASOPRESSIN	6	6.93e-01	7.56e-01	0.5950	1.93e-01	2.59e-02	-3.01e-01	2.05e-01	2.64e-01	-3.37e-01	4.13e-01	9.13e-01	2.02e-01	3.85e-01	2.63e-01	1.53e-01
GOBP SPLICEOSOMAL CONFORMATIONAL CHANGES TO GENERATE CATALYTIC CONFORMATION	5	5.40e-01	6.31e-01	0.5950	5.53e-02	-2.73e-01	-3.40e-01	3.90e-01	8.08e-02	-4.25e-02	8.30e-01	2.91e-01	1.88e-01	1.31e-01	7.54e-01	8.69e-01
GOBP PYRIMIDINE NUCLEOSIDE BIOSYNTHETIC PROCESS	5	5.08e-01	6.03e-01	0.5940	2.52e-01	-2.40e-01	-3.87e-03	4.60e-01	8.41e-02	1.15e-01	3.28e-01	3.52e-01	9.88e-01	7.49e-02	7.45e-01	6.56e-01
GOBP RHOMBOMERE DEVELOPMENT	5	5.97e-01	6.79e-01	0.5940	-3.84e-01	-7.69e-02	-1.34e-01	-3.86e-01	6.53e-02	-1.70e-01	1.37e-01	7.66e-01	6.03e-01	1.35e-01	8.00e-01	5.11e-01
GOBP PROSTATE GLAND GROWTH	7	1.12e-01	2.12e-01	0.5940	-3.42e-02	1.21e-01	3.31e-02	-1.53e-01	3.26e-01	4.54e-01	8.75e-01	5.78e-01	8.79e-01	4.84e-01	1.35e-01	3.75e-02
GOBP POSITIVE REGULATION OF MYELOID CELL APOPTOTIC PROCESS	8	2.36e-01	3.54e-01	0.5940	3.07e-02	4.24e-01	2.57e-01	-1.60e-01	2.70e-01	9.13e-02	8.81e-01	3.80e-02	2.09e-01	4.34e-01	1.86e-01	6.55e-01
GOBP AUTOPHAGY OF PEROXISOME	16	1.75e-02	5.31e-02	0.5940	-1.64e-01	8.63e-02	-3.29e-01	2.79e-01	3.62e-01	-3.80e-02	2.56e-01	5.50e-01	2.26e-02	5.31e-02	1.23e-02	7.92e-01
GOCC AP 2 ADAPTOR COMPLEX	9	3.50e-02	9.00e-02	0.5940	-8.10e-02	-2.79e-01	6.23e-02	4.81e-01	-1.73e-01	6.01e-02	6.74e-01	1.47e-01	7.46e-01	1.25e-02	3.68e-01	7.55e-01
GOBP NEGATIVE REGULATION OF RELEASE OF CYTOCHROME C FROM MITOCHONDRIA	18	6.44e-02	1.42e-01	0.5940	-3.75e-01	-3.75e-01	-2.20e-01	-1.42e-01	-5.80e-02	-1.08e-02	5.92e-03	5.87e-03	1.07e-01	2.97e-01	6.70e-01	9.37e-01
GOBP BRANCHED CHAIN AMINO ACID METABOLIC PROCESS	27	1.92e-03	8.87e-03	0.5940	-2.64e-01	-3.39e-01	-3.64e-01	2.83e-02	1.64e-01	-8.96e-02	1.77e-02	2.28e-03	1.07e-03	7.99e-01	1.40e-01	4.21e-01
GOBP TETRAPYRROLE CATABOLIC PROCESS	9	7.03e-03	2.60e-02	0.5940	1.50e-01	-4.59e-01	1.97e-01	1.20e-01	-1.37e-01	-2.19e-01	4.36e-01	1.72e-02	3.07e-01	5.33e-01	4.77e-01	2.56e-01
GOBP GLIAL CELL APOPTOTIC PROCESS	15	2.91e-02	7.82e-02	0.5940	-4.90e-02	2.47e-02	2.03e-01	3.16e-01	1.86e-01	4.17e-01	7.42e-01	8.69e-01	1.73e-01	3.43e-02	2.13e-01	5.15e-03
GOBP POSITIVE REGULATION OF ASTROCYTE DIFFERENTIATION	7	4.58e-01	5.63e-01	0.5940	7.18e-02	-3.33e-02	4.61e-01	-4.22e-02	-1.20e-01	3.43e-01	7.42e-01	8.79e-01	3.48e-02	8.47e-01	5.82e-01	1.16e-01
GOBP MIRNA MEDIATED GENE SILENCING BY MRNA DESTABILIZATION	9	6.47e-02	1.43e-01	0.5930	-2.95e-01	1.57e-01	-8.56e-03	7.26e-03	1.57e-01	4.65e-01	1.26e-01	4.14e-01	9.65e-01	9.70e-01	4.15e-01	1.58e-02
GOBP GAMMA DELTA T CELL ACTIVATION	25	1.94e-03	8.92e-03	0.5930	1.53e-01	4.30e-01	3.90e-02	2.58e-01	2.33e-01	1.47e-01	1.86e-01	1.98e-04	7.36e-01	2.56e-02	4.35e-02	2.03e-01
GOMF PHOSPHOLIPASE D ACTIVITY	5	3.04e-01	4.24e-01	0.5930	-4.81e-01	4.83e-02	-1.80e-01	1.74e-01	2.33e-01	3.44e-02	6.23e-02	8.52e-01	4.86e-01	5.01e-01	3.66e-01	8.94e-01
GOBP POSITIVE REGULATION OF OXIDATIVE STRESS INDUCED INTRINSIC APOPTOTIC SIGNALING PATHWAY	6	5.03e-01	5.99e-01	0.5930	-4.59e-01	-2.24e-01	1.03e-01	-8.10e-02	-2.24e-01	1.53e-01	5.14e-02	3.42e-01	6.61e-01	7.31e-01	3.41e-01	5.17e-01
GOBP HYPERSENSITIVITY	17	3.82e-02	9.62e-02	0.5930	1.78e-01	1.56e-01	2.24e-01	1.91e-01	3.09e-01	3.37e-01	2.04e-01	2.65e-01	1.09e-01	1.73e-01	2.73e-02	1.61e-02
GOBP PREPULSE INHIBITION	7	3.57e-01	4.72e-01	0.5930	-6.65e-02	2.40e-01	3.84e-01	5.02e-02	2.14e-01	3.07e-01	7.61e-01	2.72e-01	7.85e-02	8.18e-01	3.28e-01	1.59e-01
GOBP NEGATIVE REGULATION OF ERAD PATHWAY	7	4.63e-01	5.67e-01	0.5930	-3.39e-01	-3.93e-01	-1.96e-01	-1.27e-01	-2.81e-02	1.66e-01	1.21e-01	7.21e-02	3.69e-01	5.59e-01	8.97e-01	4.47e-01
GOBP MAST CELL MIGRATION	10	8.10e-02	1.68e-01	0.5930	-2.12e-03	1.89e-01	4.12e-01	3.22e-01	9.23e-02	1.85e-01	9.91e-01	3.02e-01	2.42e-02	7.76e-02	6.13e-01	3.12e-01
GOBP TRNA MODIFICATION	92	8.01e-12	1.62e-10	0.5930	-1.84e-01	-3.86e-01	-3.82e-01	-2.81e-02	3.86e-02	-1.42e-01	2.23e-03	1.60e-10	2.32e-10	6.42e-01	5.22e-01	1.82e-02
GOCC HOPS COMPLEX	14	4.13e-03	1.68e-02	0.5930	-2.69e-01	-6.62e-02	-4.46e-03	3.92e-01	3.06e-01	1.68e-01	8.19e-02	6.68e-01	9.77e-01	1.12e-02	4.78e-02	2.77e-01
GOBP PLATELET AGGREGATION	63	2.06e-10	3.60e-09	0.5930	-1.44e-01	-2.91e-01	3.06e-01	3.78e-02	-2.95e-01	2.52e-01	4.75e-02	6.37e-05	2.64e-05	6.04e-01	5.22e-05	5.39e-04
GOBP REGULATION OF PLASMINOGEN ACTIVATION	16	2.06e-04	1.29e-03	0.5920	-1.42e-01	-2.91e-01	4.36e-01	-4.17e-02	-2.29e-01	3.51e-02	3.26e-01	4.36e-02	2.50e-03	7.73e-01	1.13e-01	8.08e-01
GOMF DESUMOYLASE ACTIVITY	7	3.71e-01	4.86e-01	0.5920	-4.40e-01	-8.79e-02	-3.24e-01	-1.00e-01	1.86e-01	-9.85e-03	4.37e-02	6.87e-01	1.38e-01	6.46e-01	3.94e-01	9.64e-01
GOBP NEGATIVE REGULATION OF RHO PROTEIN SIGNAL TRANSDUCTION	18	6.26e-02	1.39e-01	0.5920	2.06e-01	2.61e-01	3.52e-01	1.75e-01	-8.10e-02	2.81e-01	1.30e-01	5.48e-02	9.64e-03	2.00e-01	5.52e-01	3.90e-02
GOCC NURF COMPLEX	6	2.86e-01	4.05e-01	0.5920	-2.41e-01	-9.83e-02	-1.07e-01	3.99e-01	2.29e-01	2.45e-01	3.06e-01	6.77e-01	6.51e-01	9.04e-02	3.32e-01	2.99e-01
GOBP MALATE METABOLIC PROCESS	7	6.40e-01	7.14e-01	0.5920	-2.93e-01	-4.13e-01	-2.22e-01	-1.15e-01	-1.72e-01	-4.21e-02	1.79e-01	5.84e-02	3.09e-01	5.99e-01	4.30e-01	8.47e-01
GOMF RNA POLYMERASE I TRANSCRIPTION REGULATORY REGION SEQUENCE SPECIFIC DNA BINDING	9	1.99e-01	3.15e-01	0.5920	3.85e-02	-9.03e-02	-2.11e-01	3.97e-01	1.73e-01	-3.30e-01	8.42e-01	6.39e-01	2.72e-01	3.93e-02	3.68e-01	8.65e-02
GOBP REGULATION OF RESPIRATORY GASEOUS EXCHANGE	16	3.38e-02	8.77e-02	0.5920	5.02e-02	3.13e-01	-1.54e-02	3.18e-01	3.53e-01	-1.53e-01	7.28e-01	3.00e-02	9.15e-01	2.74e-02	1.44e-02	2.89e-01
GOBP INTERLEUKIN 5 PRODUCTION	15	4.16e-02	1.03e-01	0.5920	-5.67e-02	1.01e-01	3.48e-01	1.70e-01	-1.97e-01	3.85e-01	7.04e-01	4.98e-01	1.95e-02	2.55e-01	1.86e-01	9.87e-03
GOCC PLATELET DENSE GRANULE LUMEN	9	6.30e-02	1.40e-01	0.5920	-2.26e-01	-2.28e-01	-3.94e-01	2.78e-01	-1.15e-01	-3.27e-02	2.41e-01	2.35e-01	4.06e-02	1.48e-01	5.50e-01	8.65e-01
GOCC LEWY BODY	8	3.74e-01	4.89e-01	0.5920	-1.85e-01	-3.66e-01	-1.24e-01	-1.10e-01	-2.45e-01	-3.07e-01	3.64e-01	7.28e-02	5.44e-01	5.91e-01	2.30e-01	1.32e-01
GOBP CORTISOL BIOSYNTHETIC PROCESS	6	4.82e-01	5.83e-01	0.5920	1.51e-01	2.62e-01	2.00e-01	3.45e-01	-3.00e-03	3.15e-01	5.21e-01	2.66e-01	3.97e-01	1.43e-01	9.90e-01	1.81e-01
GOBP CORTISOL METABOLIC PROCESS	6	4.82e-01	5.83e-01	0.5920	1.51e-01	2.62e-01	2.00e-01	3.45e-01	-3.00e-03	3.15e-01	5.21e-01	2.66e-01	3.97e-01	1.43e-01	9.90e-01	1.81e-01
GOBP NONRIBOSOMAL PEPTIDE BIOSYNTHETIC PROCESS	14	8.82e-04	4.58e-03	0.5920	1.96e-02	-2.21e-01	1.63e-01	2.57e-01	3.86e-01	2.43e-01	8.99e-01	1.51e-01	2.91e-01	9.54e-02	1.24e-02	1.16e-01
GOBP POSITIVE REGULATION OF CELL FATE COMMITMENT	8	2.12e-01	3.30e-01	0.5920	1.46e-01	2.32e-01	3.23e-01	3.37e-01	-1.70e-01	1.69e-01	4.74e-01	2.56e-01	1.13e-01	9.92e-02	4.05e-01	4.09e-01
GOBP PULMONARY VALVE DEVELOPMENT	14	1.37e-03	6.66e-03	0.5910	-2.39e-01	2.84e-01	3.17e-01	1.26e-01	2.90e-01	1.08e-01	1.22e-01	6.61e-02	4.01e-02	4.14e-01	6.00e-02	4.83e-01
GOBP NEGATIVE REGULATION OF FERROPTOSIS	8	8.96e-02	1.81e-01	0.5910	-1.71e-01	-1.58e-01	-1.14e-01	3.64e-01	3.47e-01	-1.73e-01	4.03e-01	4.38e-01	5.78e-01	7.45e-02	8.96e-02	3.97e-01
GOBP PROXIMAL DISTAL PATTERN FORMATION	12	1.51e-01	2.62e-01	0.5910	1.92e-01	1.83e-01	4.13e-01	-1.34e-01	-2.83e-01	1.01e-01	2.50e-01	2.72e-01	1.32e-02	4.21e-01	8.95e-02	5.43e-01
GOBP POSITIVE REGULATION BY HOST OF VIRAL GENOME REPLICATION	10	1.09e-01	2.09e-01	0.5910	-3.16e-01	-2.31e-01	3.03e-02	1.18e-01	-2.04e-01	3.75e-01	8.40e-02	2.06e-01	8.68e-01	5.17e-01	2.65e-01	4.03e-02
GOCC MHC CLASS I PEPTIDE LOADING COMPLEX	8	1.18e-01	2.20e-01	0.5910	-5.92e-02	-2.56e-01	-6.88e-02	4.11e-01	-5.36e-02	3.23e-01	7.72e-01	2.10e-01	7.36e-01	4.43e-02	7.93e-01	1.14e-01
GOBP REGULATION OF LONG CHAIN FATTY ACID IMPORT INTO CELL	8	1.78e-02	5.39e-02	0.5910	-3.02e-01	8.00e-02	2.61e-01	-2.32e-01	-1.23e-01	-3.38e-01	1.39e-01	6.95e-01	2.00e-01	2.55e-01	5.48e-01	9.77e-02
GOBP DNA TOPOLOGICAL CHANGE	9	4.97e-02	1.17e-01	0.5910	-2.07e-01	-1.05e-01	2.94e-01	3.49e-01	-1.43e-01	2.58e-01	2.82e-01	5.87e-01	1.26e-01	7.01e-02	4.58e-01	1.79e-01
GOBP REGULATION OF CRISTAE FORMATION	5	5.25e-01	6.19e-01	0.5910	-7.16e-02	-4.49e-01	-3.08e-01	-1.47e-01	8.28e-02	-1.37e-01	7.82e-01	8.18e-02	2.33e-01	5.69e-01	7.48e-01	5.95e-01
GOBP POSITIVE REGULATION OF PLATELET ACTIVATION	12	1.22e-01	2.26e-01	0.5910	4.61e-02	-1.14e-01	4.29e-01	-1.52e-01	-3.04e-01	1.85e-01	7.82e-01	4.94e-01	1.00e-02	3.62e-01	6.83e-02	2.68e-01
GOMF DIPEPTIDYL PEPTIDASE ACTIVITY	9	2.68e-01	3.88e-01	0.5910	-4.13e-01	-2.50e-01	-1.46e-01	-2.94e-01	6.08e-02	6.76e-02	3.19e-02	1.94e-01	4.47e-01	1.27e-01	7.52e-01	7.26e-01
GOCC ALPHA KETOACID DEHYDROGENASE COMPLEX	15	9.45e-02	1.88e-01	0.5910	-3.28e-01	-3.71e-01	-2.93e-01	4.50e-02	-7.28e-02	-1.05e-01	2.79e-02	1.29e-02	4.96e-02	7.63e-01	6.26e-01	4.80e-01
GOMF CUPROUS ION BINDING	6	4.70e-01	5.73e-01	0.5910	-1.02e-01	-3.62e-01	1.35e-01	1.78e-02	-1.76e-01	3.97e-01	6.64e-01	1.25e-01	5.65e-01	9.40e-01	4.54e-01	9.21e-02
GOBP NEGATIVE REGULATION OF NATURAL KILLER CELL ACTIVATION	10	1.52e-01	2.63e-01	0.5900	3.57e-01	5.14e-02	4.31e-01	-4.94e-03	-8.26e-02	1.62e-01	5.08e-02	7.78e-01	1.83e-02	9.78e-01	6.51e-01	3.75e-01
GOCC MITOCHONDRIA ASSOCIATED ENDOPLASMIC RETICULUM MEMBRANE CONTACT SITE	20	1.24e-02	4.07e-02	0.5900	-4.52e-01	-2.69e-01	-1.63e-01	-5.79e-02	-1.34e-01	1.54e-01	4.60e-04	3.70e-02	2.08e-01	6.54e-01	3.01e-01	2.33e-01
GOBP POSITIVE REGULATION OF FEEDING BEHAVIOR	7	2.69e-01	3.89e-01	0.5900	1.33e-01	1.61e-01	-8.24e-02	-3.88e-02	3.14e-01	-4.45e-01	5.44e-01	4.61e-01	7.06e-01	8.59e-01	1.50e-01	4.16e-02
GOMF PURINE RIBONUCLEOTIDE TRANSMEMBRANE TRANSPORTER ACTIVITY	20	2.00e-02	5.92e-02	0.5900	-2.17e-01	-3.09e-01	-2.56e-01	-9.01e-03	-1.40e-01	-3.47e-01	9.32e-02	1.66e-02	4.73e-02	9.44e-01	2.79e-01	7.23e-03
GOBP MEMBRANE PROTEIN INTRACELLULAR DOMAIN PROTEOLYSIS	13	1.66e-01	2.78e-01	0.5900	-4.00e-01	-2.48e-01	7.52e-02	-1.28e-01	-2.71e-01	1.76e-01	1.25e-02	1.22e-01	6.39e-01	4.23e-01	9.05e-02	2.71e-01
GOBP TYROSINE CATABOLIC PROCESS	5	2.46e-01	3.65e-01	0.5900	3.97e-01	-3.58e-01	9.14e-03	1.38e-01	-9.52e-02	1.86e-01	1.24e-01	1.66e-01	9.72e-01	5.94e-01	7.12e-01	4.73e-01
GOBP PROTEIN LOCALIZATION TO ENDOPLASMIC RETICULUM	71	9.69e-11	1.74e-09	0.5900	-2.38e-01	-3.21e-01	1.57e-01	3.18e-02	-2.25e-01	3.34e-01	5.19e-04	2.80e-06	2.18e-02	6.43e-01	1.07e-03	1.13e-06
GOBP ESTABLISHMENT OR MAINTENANCE OF CYTOSKELETON POLARITY	7	2.12e-01	3.30e-01	0.5900	-1.40e-01	-2.84e-01	3.54e-01	5.99e-02	-3.32e-01	9.50e-02	5.22e-01	1.93e-01	1.05e-01	7.84e-01	1.29e-01	6.63e-01
GOBP INNERVATION	16	6.74e-02	1.47e-01	0.5900	3.55e-02	1.50e-01	2.98e-01	1.11e-01	9.19e-02	4.63e-01	8.06e-01	3.00e-01	3.91e-02	4.42e-01	5.24e-01	1.34e-03
GOBP ANDROGEN BIOSYNTHETIC PROCESS	5	4.33e-01	5.42e-01	0.5900	-8.61e-02	-1.82e-01	2.77e-01	-3.64e-01	-6.04e-02	3.07e-01	7.39e-01	4.81e-01	2.83e-01	1.59e-01	8.15e-01	2.35e-01
GOBP REGULATION OF PLATELET ACTIVATION	44	7.66e-07	8.16e-06	0.5890	-6.39e-02	-2.16e-01	3.94e-01	-1.20e-01	-2.94e-01	2.00e-01	4.63e-01	1.30e-02	5.96e-06	1.69e-01	7.34e-04	2.15e-02
GOMF GLUTATHIONE TRANSMEMBRANE TRANSPORTER ACTIVITY	6	5.26e-01	6.19e-01	0.5890	1.83e-01	-3.85e-02	4.49e-01	1.60e-01	-1.09e-01	2.70e-01	4.37e-01	8.70e-01	5.66e-02	4.98e-01	6.44e-01	2.51e-01
GOBP PERK MEDIATED UNFOLDED PROTEIN RESPONSE	19	1.16e-02	3.86e-02	0.5890	-2.44e-01	-1.12e-01	2.98e-01	-1.11e-01	-4.06e-01	1.01e-01	6.60e-02	3.99e-01	2.47e-02	4.03e-01	2.21e-03	4.44e-01
GOBP REGULATION OF SYNAPTIC VESICLE TRANSPORT	5	1.37e-01	2.45e-01	0.5890	9.59e-02	1.98e-01	-2.69e-01	-3.70e-01	-2.79e-01	-1.10e-01	7.10e-01	4.44e-01	2.98e-01	1.52e-01	2.79e-01	6.69e-01
GOMF CYTIDYLYLTRANSFERASE ACTIVITY	10	1.63e-01	2.75e-01	0.5890	-3.41e-01	-1.70e-01	1.79e-01	3.32e-02	-7.99e-02	4.03e-01	6.16e-02	3.52e-01	3.27e-01	8.56e-01	6.62e-01	2.74e-02
GOBP THROMBIN ACTIVATED RECEPTOR SIGNALING PATHWAY	12	1.49e-01	2.60e-01	0.5890	3.56e-02	-9.15e-02	4.37e-01	-2.03e-02	-2.98e-01	2.40e-01	8.31e-01	5.83e-01	8.81e-03	9.03e-01	7.41e-02	1.49e-01
GOMF ORGANIC ACID SODIUM SYMPORTER ACTIVITY	18	3.04e-02	8.08e-02	0.5890	2.90e-01	2.66e-01	3.98e-01	9.61e-02	-1.51e-01	4.74e-02	3.34e-02	5.08e-02	3.48e-03	4.80e-01	2.66e-01	7.27e-01
GOBP CELLULAR RESPONSE TO ANTIBIOTIC	12	1.59e-02	4.95e-02	0.5890	-1.68e-01	7.92e-02	-4.98e-02	2.37e-01	4.90e-01	-1.15e-01	3.13e-01	6.35e-01	7.65e-01	1.55e-01	3.26e-03	4.89e-01
GOCC ENDODEOXYRIBONUCLEASE COMPLEX	5	7.53e-01	8.03e-01	0.5890	1.42e-01	2.85e-01	-7.06e-02	3.61e-01	3.31e-01	3.16e-02	5.82e-01	2.70e-01	7.85e-01	1.62e-01	2.00e-01	9.03e-01
GOMF OXIDOREDUCTASE ACTIVITY ACTING ON THE CH NH2 GROUP OF DONORS	16	2.32e-02	6.62e-02	0.5890	1.30e-01	2.92e-02	-2.41e-01	-2.10e-01	-1.29e-02	-4.76e-01	3.67e-01	8.40e-01	9.48e-02	1.45e-01	9.29e-01	9.79e-04
GOBP POSITIVE REGULATION OF SYNAPTIC PLASTICITY	7	3.40e-01	4.57e-01	0.5890	-6.63e-02	1.59e-01	-1.67e-02	3.85e-01	4.10e-01	2.93e-02	7.61e-01	4.67e-01	9.39e-01	7.76e-02	6.06e-02	8.93e-01
GOBP CENTRAL NERVOUS SYSTEM MYELIN FORMATION	6	4.47e-01	5.54e-01	0.5890	-4.08e-01	-1.14e-01	-1.25e-01	-2.10e-01	-7.94e-02	-3.18e-01	8.38e-02	6.29e-01	5.95e-01	3.73e-01	7.36e-01	1.77e-01
GOBP REGULATION OF SKELETAL MUSCLE ACETYLCHOLINE GATED CHANNEL CLUSTERING	5	1.67e-01	2.80e-01	0.5890	-9.84e-02	-1.17e-01	-1.62e-01	2.53e-01	-1.27e-01	4.66e-01	7.03e-01	6.51e-01	5.31e-01	3.27e-01	6.22e-01	7.12e-02
GOMF DEMETHYLASE ACTIVITY	36	2.21e-07	2.56e-06	0.5890	2.38e-02	3.05e-01	1.40e-01	4.59e-01	1.42e-01	5.10e-02	8.05e-01	1.52e-03	1.46e-01	1.89e-06	1.41e-01	5.96e-01
GOBP MIRNA MEDIATED GENE SILENCING BY INHIBITION OF TRANSLATION	19	5.79e-03	2.22e-02	0.5890	-4.08e-02	3.38e-01	2.73e-01	2.74e-01	2.16e-01	1.84e-01	7.58e-01	1.06e-02	3.96e-02	3.83e-02	1.03e-01	1.65e-01
GOBP GAMMA AMINOBUTYRIC ACID METABOLIC PROCESS	6	3.98e-01	5.10e-01	0.5890	-2.61e-01	1.81e-01	1.82e-01	-1.43e-02	1.96e-01	4.17e-01	2.68e-01	4.43e-01	4.40e-01	9.52e-01	4.06e-01	7.70e-02
GOBP PURINE NUCLEOBASE METABOLIC PROCESS	17	5.47e-02	1.26e-01	0.5880	-2.51e-01	-4.63e-01	-2.40e-01	-7.56e-02	-7.29e-02	9.20e-03	7.34e-02	9.40e-04	8.71e-02	5.89e-01	6.03e-01	9.48e-01
GOCC CORTICAL GRANULE	5	5.14e-01	6.08e-01	0.5880	8.28e-04	-3.12e-02	5.01e-01	1.08e-01	-2.05e-01	2.00e-01	9.97e-01	9.04e-01	5.22e-02	6.77e-01	4.27e-01	4.39e-01
GOMF HISTONE H3K4 DEMETHYLASE ACTIVITY	8	1.50e-01	2.60e-01	0.5880	3.75e-03	2.96e-01	1.65e-01	4.54e-01	1.45e-01	6.10e-02	9.85e-01	1.48e-01	4.18e-01	2.61e-02	4.78e-01	7.65e-01
GOBP REGULATION OF INNER EAR AUDITORY RECEPTOR CELL DIFFERENTIATION	5	4.61e-01	5.66e-01	0.5880	7.92e-02	1.64e-01	1.97e-01	2.30e-01	4.67e-01	5.35e-02	7.59e-01	5.24e-01	4.45e-01	3.74e-01	7.07e-02	8.36e-01
GOBP INOSITOL TRISPHOSPHATE METABOLIC PROCESS	9	3.58e-02	9.17e-02	0.5880	-5.18e-01	1.77e-02	2.43e-01	-6.57e-02	-4.53e-02	1.09e-01	7.16e-03	9.27e-01	2.07e-01	7.33e-01	8.14e-01	5.72e-01
GOBP OLIGOSACCHARIDE CATABOLIC PROCESS	10	1.21e-01	2.25e-01	0.5880	-3.74e-01	-2.31e-01	-1.95e-01	-1.38e-01	1.26e-01	-2.82e-01	4.06e-02	2.07e-01	2.87e-01	4.49e-01	4.90e-01	1.23e-01
GOBP REGULATION OF SKELETAL MUSCLE FIBER DEVELOPMENT	6	5.57e-02	1.28e-01	0.5880	3.21e-01	1.57e-01	-2.18e-01	-3.80e-01	-1.39e-01	-7.77e-02	1.73e-01	5.05e-01	3.55e-01	1.07e-01	5.55e-01	7.42e-01
GOBP POSITIVE REGULATION OF ACTIVIN RECEPTOR SIGNALING PATHWAY	7	2.46e-01	3.65e-01	0.5870	-2.39e-01	1.04e-01	-2.47e-01	-3.16e-03	4.68e-02	-4.63e-01	2.74e-01	6.32e-01	2.58e-01	9.88e-01	8.30e-01	3.40e-02
GOMF SULFUR AMINO ACID TRANSMEMBRANE TRANSPORTER ACTIVITY	10	2.02e-01	3.18e-01	0.5870	1.96e-01	-1.67e-01	-1.62e-01	4.25e-01	2.67e-01	1.84e-03	2.83e-01	3.62e-01	3.74e-01	1.98e-02	1.44e-01	9.92e-01
GOBP DETECTION OF MECHANICAL STIMULUS INVOLVED IN SENSORY PERCEPTION OF SOUND	12	5.59e-02	1.28e-01	0.5870	-1.15e-01	1.08e-01	-1.77e-01	-4.74e-01	1.57e-02	-2.52e-01	4.91e-01	5.15e-01	2.88e-01	4.45e-03	9.25e-01	1.31e-01
GOCC PIGMENT GRANULE	102	5.59e-19	2.14e-17	0.5870	-2.95e-01	-2.33e-01	2.44e-01	9.26e-02	-2.13e-01	3.00e-01	2.58e-07	4.89e-05	2.12e-05	1.06e-01	2.03e-04	1.56e-07
GOBP REGULATION OF RECEPTOR CLUSTERING	13	4.74e-02	1.13e-01	0.5870	-1.08e-01	6.11e-02	1.89e-01	2.55e-01	2.60e-02	4.78e-01	5.01e-01	7.03e-01	2.38e-01	1.12e-01	8.71e-01	2.87e-03
GOBP NUCLEAR TRANSCRIBED MRNA CATABOLIC PROCESS DEADENYLATION INDEPENDENT DECAY	7	6.81e-01	7.47e-01	0.5870	2.81e-01	3.04e-01	1.45e-02	2.58e-01	3.00e-01	-1.28e-01	1.98e-01	1.63e-01	9.47e-01	2.37e-01	1.69e-01	5.58e-01
GOBP CORPUS CALLOSUM DEVELOPMENT	25	4.30e-03	1.73e-02	0.5870	2.27e-02	2.86e-01	1.74e-01	2.60e-01	3.15e-01	2.54e-01	8.44e-01	1.33e-02	1.31e-01	2.43e-02	6.36e-03	2.81e-02
GOBP REGULATION OF PROTEIN K63 LINKED UBIQUITINATION	13	4.22e-02	1.03e-01	0.5860	-2.94e-01	-1.23e-01	1.94e-01	-2.17e-01	5.23e-02	3.93e-01	6.63e-02	4.44e-01	2.26e-01	1.75e-01	7.44e-01	1.41e-02
GOBP REGULATION OF HYPERSENSITIVITY	10	1.70e-01	2.84e-01	0.5860	1.73e-01	3.19e-02	1.20e-01	2.56e-01	3.32e-01	3.51e-01	3.42e-01	8.61e-01	5.12e-01	1.61e-01	6.92e-02	5.49e-02
GOBP INTRACELLULAR TRANSPORT OF VIRUS	9	1.47e-01	2.58e-01	0.5860	-3.30e-01	-7.49e-02	-3.55e-01	2.83e-02	3.02e-01	1.06e-01	8.68e-02	6.97e-01	6.49e-02	8.83e-01	1.17e-01	5.80e-01
GOBP POSITIVE REGULATION OF CHONDROCYTE PROLIFERATION	5	3.26e-01	4.44e-01	0.5860	3.60e-01	3.51e-02	-1.05e-02	4.03e-01	-1.88e-01	1.24e-01	1.63e-01	8.92e-01	9.67e-01	1.19e-01	4.67e-01	6.32e-01
GOCC ARYL HYDROCARBON RECEPTOR COMPLEX	5	5.43e-01	6.33e-01	0.5860	-3.27e-01	-3.58e-01	-2.23e-01	1.17e-01	1.04e-01	-1.85e-01	2.06e-01	1.65e-01	3.88e-01	6.49e-01	6.88e-01	4.74e-01
GOBP TRNA METABOLIC PROCESS	200	5.37e-30	5.13e-28	0.5860	-1.25e-01	-4.13e-01	-3.70e-01	6.62e-02	5.28e-02	-1.14e-01	2.37e-03	6.47e-24	1.78e-19	1.07e-01	1.98e-01	5.41e-03
GOBP REGULATION OF MRNA 3 END PROCESSING	9	2.94e-01	4.13e-01	0.5860	-3.43e-01	-3.35e-03	-2.10e-01	-2.83e-01	-8.49e-02	-3.08e-01	7.51e-02	9.86e-01	2.75e-01	1.42e-01	6.59e-01	1.10e-01
GOCC BASAL CORTEX	5	2.48e-01	3.67e-01	0.5860	-3.90e-01	4.17e-01	1.91e-02	-7.82e-02	1.03e-01	2.78e-02	1.31e-01	1.07e-01	9.41e-01	7.62e-01	6.89e-01	9.14e-01
GOCC BARR BODY	8	3.48e-01	4.65e-01	0.5860	-2.05e-01	-1.53e-01	2.18e-01	-1.85e-01	-7.27e-02	4.37e-01	3.15e-01	4.54e-01	2.87e-01	3.65e-01	7.22e-01	3.25e-02
GOMF CARBOHYDRATE PHOSPHATASE ACTIVITY	8	1.82e-01	2.97e-01	0.5860	-2.32e-01	2.58e-01	4.15e-01	-1.59e-01	-3.50e-02	1.53e-01	2.55e-01	2.06e-01	4.20e-02	4.35e-01	8.64e-01	4.54e-01
GOBP REGULATION OF MEMBRANE REPOLARIZATION DURING ACTION POTENTIAL	6	5.53e-01	6.42e-01	0.5860	1.51e-01	3.51e-01	2.74e-01	-1.11e-01	2.02e-01	2.63e-01	5.23e-01	1.37e-01	2.45e-01	6.39e-01	3.91e-01	2.65e-01
GOBP POSITIVE REGULATION OF APOPTOTIC CELL CLEARANCE	6	4.77e-01	5.78e-01	0.5860	2.12e-01	2.73e-01	1.92e-01	1.63e-01	3.86e-01	-1.06e-01	3.69e-01	2.47e-01	4.16e-01	4.90e-01	1.01e-01	6.54e-01
GOMF METAL CLUSTER BINDING	72	1.88e-10	3.30e-09	0.5860	-1.04e-01	-4.04e-01	-3.44e-01	1.67e-01	7.91e-02	-1.28e-01	1.29e-01	2.94e-09	4.49e-07	1.45e-02	2.46e-01	6.11e-02
GOBP NEGATIVE REGULATION OF MEMBRANE POTENTIAL	11	2.07e-01	3.23e-01	0.5860	-3.52e-02	-2.47e-01	-3.83e-01	-5.04e-02	2.13e-01	-2.93e-01	8.40e-01	1.56e-01	2.77e-02	7.72e-01	2.21e-01	9.25e-02
GOCC CHROMOSOME TELOMERIC REPEAT REGION	13	1.40e-02	4.50e-02	0.5850	-1.80e-01	-2.19e-01	-2.06e-01	3.92e-01	9.13e-02	2.41e-01	2.62e-01	1.71e-01	1.99e-01	1.44e-02	5.69e-01	1.32e-01
GOBP NEGATIVE REGULATION OF MUSCLE ORGAN DEVELOPMENT	5	3.43e-01	4.60e-01	0.5850	4.05e-01	-2.26e-01	-1.08e-01	5.91e-02	-2.86e-01	-1.75e-01	1.17e-01	3.81e-01	6.76e-01	8.19e-01	2.69e-01	4.98e-01
GOBP REGULATION OF VESICLE SIZE	20	2.24e-02	6.46e-02	0.5850	-3.36e-01	-3.68e-01	1.71e-02	-9.38e-02	-1.59e-01	2.44e-01	9.38e-03	4.36e-03	8.95e-01	4.68e-01	2.19e-01	5.84e-02
GOBP TOLL LIKE RECEPTOR 7 SIGNALING PATHWAY	11	3.07e-02	8.13e-02	0.5850	-3.92e-01	4.95e-02	1.39e-02	1.62e-01	2.15e-01	3.37e-01	2.44e-02	7.76e-01	9.36e-01	3.52e-01	2.16e-01	5.32e-02
GOCC SMC5 SMC6 COMPLEX	9	3.25e-02	8.49e-02	0.5850	-8.84e-02	-1.84e-01	-1.97e-01	4.26e-02	2.66e-01	4.34e-01	6.46e-01	3.39e-01	3.06e-01	8.25e-01	1.66e-01	2.41e-02
GOBP GANGLION DEVELOPMENT	7	1.81e-01	2.96e-01	0.5840	-2.90e-01	3.52e-01	1.05e-01	-1.20e-01	3.16e-01	8.84e-02	1.83e-01	1.07e-01	6.29e-01	5.82e-01	1.47e-01	6.86e-01
GOBP CYCLIC NUCLEOTIDE CATABOLIC PROCESS	12	8.84e-02	1.79e-01	0.5840	-1.79e-02	1.80e-01	3.77e-01	2.29e-01	1.86e-01	2.82e-01	9.14e-01	2.81e-01	2.38e-02	1.70e-01	2.63e-01	9.06e-02
GOBP REGULATION OF AXON EXTENSION INVOLVED IN AXON GUIDANCE	11	7.68e-02	1.62e-01	0.5840	6.22e-02	3.20e-01	3.12e-01	2.32e-01	2.90e-01	1.07e-02	7.21e-01	6.58e-02	7.32e-02	1.84e-01	9.63e-02	9.51e-01
GOBP NUCLEAR MIGRATION ALONG MICROTUBULE	5	8.08e-01	8.46e-01	0.5840	2.72e-01	1.97e-01	-2.40e-02	3.55e-01	2.73e-01	-1.66e-01	2.93e-01	4.46e-01	9.26e-01	1.69e-01	2.91e-01	5.20e-01
GOBP NEGATIVE REGULATION OF OSTEOCLAST DIFFERENTIATION	26	2.41e-03	1.08e-02	0.5840	-3.40e-02	2.55e-01	4.58e-01	-2.27e-02	-1.06e-01	2.30e-01	7.64e-01	2.42e-02	5.22e-05	8.41e-01	3.49e-01	4.24e-02
GOBP POSITIVE REGULATION OF TROPHOBLAST CELL MIGRATION	5	7.49e-02	1.59e-01	0.5840	-3.62e-01	3.12e-02	1.25e-03	4.35e-01	-1.32e-01	-4.79e-02	1.61e-01	9.04e-01	9.96e-01	9.22e-02	6.08e-01	8.53e-01
GOBP LYSOSOMAL LUMEN ACIDIFICATION	24	5.06e-04	2.83e-03	0.5840	-4.41e-01	-3.67e-01	-5.10e-02	4.67e-02	-5.47e-02	6.18e-02	1.81e-04	1.87e-03	6.65e-01	6.92e-01	6.43e-01	6.00e-01
GOBP SIRNA MEDIATED RETROTRANSPOSON SILENCING BY HETEROCHROMATIN FORMATION	5	4.16e-01	5.26e-01	0.5840	-2.74e-01	2.69e-01	3.78e-02	-3.06e-01	-2.96e-03	3.13e-01	2.88e-01	2.98e-01	8.84e-01	2.36e-01	9.91e-01	2.25e-01
GOBP HEME A METABOLIC PROCESS	10	1.69e-01	2.81e-01	0.5840	1.09e-01	-2.41e-01	-2.81e-01	2.42e-01	3.45e-01	-1.19e-01	5.49e-01	1.87e-01	1.24e-01	1.85e-01	5.91e-02	5.14e-01
GOBP REGULATION OF HORMONE BIOSYNTHETIC PROCESS	20	1.82e-02	5.49e-02	0.5840	4.64e-02	3.06e-01	4.27e-01	1.01e-01	-7.13e-02	2.17e-01	7.19e-01	1.79e-02	9.43e-04	4.35e-01	5.81e-01	9.25e-02
GOMF SPHINGOSINE N ACYLTRANSFERASE ACTIVITY	5	8.19e-01	8.53e-01	0.5830	-2.35e-01	-3.79e-01	-2.02e-01	-1.27e-01	-2.57e-01	-1.35e-01	3.62e-01	1.42e-01	4.34e-01	6.23e-01	3.19e-01	6.02e-01
GOBP REGULATION OF NK T CELL PROLIFERATION	6	5.26e-01	6.19e-01	0.5830	-9.13e-02	1.88e-01	-2.64e-01	2.64e-01	3.39e-01	-2.04e-01	6.99e-01	4.25e-01	2.62e-01	2.64e-01	1.50e-01	3.86e-01
GOMF UBIQUITIN SPECIFIC PROTEASE BINDING	17	2.61e-02	7.26e-02	0.5830	-3.83e-01	-2.60e-01	1.04e-01	-1.27e-02	-2.88e-01	1.76e-01	6.19e-03	6.30e-02	4.56e-01	9.28e-01	3.99e-02	2.10e-01
GOBP POSITIVE REGULATION OF NUCLEOBASE CONTAINING COMPOUND TRANSPORT	5	6.62e-01	7.31e-01	0.5830	-3.66e-01	-1.69e-01	-3.99e-01	3.75e-02	6.46e-02	-1.08e-01	1.56e-01	5.12e-01	1.22e-01	8.85e-01	8.02e-01	6.76e-01
GOBP POSITIVE REGULATION OF RNA EXPORT FROM NUCLEUS	5	6.62e-01	7.31e-01	0.5830	-3.66e-01	-1.69e-01	-3.99e-01	3.75e-02	6.46e-02	-1.08e-01	1.56e-01	5.12e-01	1.22e-01	8.85e-01	8.02e-01	6.76e-01
GOMF TRANSCRIPTION REGULATOR ACTIVATOR ACTIVITY	8	1.59e-01	2.72e-01	0.5830	3.98e-02	2.32e-01	3.78e-01	3.46e-01	-7.99e-02	1.24e-01	8.46e-01	2.55e-01	6.42e-02	9.04e-02	6.95e-01	5.43e-01
GOBP MESENCHYMAL TO EPITHELIAL TRANSITION	9	3.79e-01	4.93e-01	0.5830	4.17e-02	2.25e-01	4.09e-01	-1.52e-01	-5.20e-03	3.10e-01	8.28e-01	2.41e-01	3.35e-02	4.31e-01	9.78e-01	1.07e-01
GOCC TRANSCRIPTION EXPORT COMPLEX	12	8.37e-02	1.72e-01	0.5820	-1.91e-01	-4.51e-01	-2.07e-01	2.03e-01	-8.46e-02	8.49e-02	2.52e-01	6.77e-03	2.15e-01	2.23e-01	6.12e-01	6.11e-01
GOBP S ADENOSYLMETHIONINE CYCLE	7	4.40e-01	5.47e-01	0.5820	-4.09e-01	-2.29e-01	-3.07e-01	2.53e-02	1.52e-01	-2.40e-02	6.07e-02	2.94e-01	1.59e-01	9.08e-01	4.87e-01	9.12e-01
GOBP MEMBRANE RAFT ASSEMBLY	9	1.84e-01	2.98e-01	0.5820	2.74e-02	-3.50e-01	2.76e-01	8.89e-02	-2.89e-01	2.18e-01	8.87e-01	6.88e-02	1.51e-01	6.44e-01	1.34e-01	2.58e-01
GOBP CRANIAL NERVE FORMATION	7	5.32e-01	6.25e-01	0.5820	1.45e-01	3.28e-01	1.91e-01	1.69e-01	3.76e-01	5.17e-02	5.06e-01	1.33e-01	3.81e-01	4.39e-01	8.45e-02	8.13e-01
GOBP REGULATION OF MEMBRANE INVAGINATION	14	4.20e-02	1.03e-01	0.5820	-4.95e-02	1.40e-01	3.62e-01	2.05e-02	2.13e-01	3.73e-01	7.49e-01	3.66e-01	1.90e-02	8.94e-01	1.68e-01	1.56e-02
GOBP REGULATION OF ASPARTIC TYPE ENDOPEPTIDASE ACTIVITY INVOLVED IN AMYLOID PRECURSOR PROTEIN CATABOLIC PROCESS	6	5.48e-01	6.38e-01	0.5810	3.75e-01	2.50e-01	6.75e-02	2.84e-01	4.00e-03	-2.23e-01	1.11e-01	2.89e-01	7.75e-01	2.29e-01	9.86e-01	3.44e-01
GOBP REGULATION OF HIGH VOLTAGE GATED CALCIUM CHANNEL ACTIVITY	8	4.62e-01	5.66e-01	0.5810	-1.28e-01	-2.34e-01	2.05e-02	-2.30e-01	-4.51e-01	1.02e-01	5.30e-01	2.52e-01	9.20e-01	2.61e-01	2.72e-02	6.18e-01
GOBP NEGATIVE REGULATION OF SISTER CHROMATID COHESION	5	4.15e-01	5.26e-01	0.5810	-1.14e-01	9.69e-02	6.73e-02	3.88e-01	7.06e-02	3.95e-01	6.58e-01	7.08e-01	7.94e-01	1.33e-01	7.84e-01	1.27e-01
GOMF SOLUTE POTASSIUM ANTIPORTER ACTIVITY	13	1.27e-01	2.32e-01	0.5810	-7.32e-02	3.18e-01	3.73e-01	-9.82e-02	2.77e-02	2.86e-01	6.48e-01	4.69e-02	1.99e-02	5.40e-01	8.63e-01	7.47e-02
GOBP BONE GROWTH	20	1.42e-03	6.90e-03	0.5810	-1.76e-01	2.35e-01	2.99e-01	2.37e-01	5.59e-02	3.21e-01	1.74e-01	6.87e-02	2.08e-02	6.64e-02	6.65e-01	1.29e-02
GOBP PYRAMIDAL NEURON DIFFERENTIATION	12	1.82e-01	2.97e-01	0.5810	9.37e-02	3.00e-01	3.76e-01	1.45e-01	1.92e-01	1.99e-01	5.74e-01	7.20e-02	2.39e-02	3.86e-01	2.50e-01	2.34e-01
GOCC B CELL RECEPTOR COMPLEX	5	3.17e-01	4.37e-01	0.5810	3.66e-01	-2.80e-01	-2.95e-02	1.42e-01	-3.15e-01	6.51e-02	1.56e-01	2.78e-01	9.09e-01	5.81e-01	2.22e-01	8.01e-01
GOMF L LEUCINE TRANSMEMBRANE TRANSPORTER ACTIVITY	6	3.03e-01	4.22e-01	0.5810	-1.90e-01	-2.61e-01	-2.78e-01	3.49e-01	-1.13e-01	-1.46e-01	4.20e-01	2.69e-01	2.39e-01	1.38e-01	6.31e-01	5.36e-01
GOBP VIRAL RELEASE FROM HOST CELL	27	1.62e-04	1.04e-03	0.5810	-2.35e-01	-3.45e-01	1.08e-01	1.80e-01	-1.29e-01	3.20e-01	3.47e-02	1.93e-03	3.32e-01	1.05e-01	2.45e-01	3.96e-03
GOMF MYRISTOYLTRANSFERASE ACTIVITY	11	1.66e-01	2.78e-01	0.5810	-3.35e-01	-1.97e-01	5.48e-02	-1.12e-01	-8.29e-02	4.05e-01	5.44e-02	2.57e-01	7.53e-01	5.21e-01	6.34e-01	2.01e-02
GOBP POSITIVE REGULATION OF I KAPPAB PHOSPHORYLATION	5	7.77e-01	8.20e-01	0.5810	2.51e-01	1.67e-01	5.98e-03	2.90e-01	3.81e-01	-1.29e-01	3.32e-01	5.18e-01	9.82e-01	2.61e-01	1.40e-01	6.17e-01
GOBP OLFACTORY BEHAVIOR	8	2.23e-01	3.42e-01	0.5810	1.33e-01	2.89e-01	2.67e-01	1.46e-01	-2.21e-01	3.07e-01	5.16e-01	1.57e-01	1.91e-01	4.74e-01	2.78e-01	1.33e-01
GOMF C ACYLTRANSFERASE ACTIVITY	18	2.90e-02	7.81e-02	0.5810	-2.22e-01	-2.34e-01	8.04e-02	-3.22e-01	-1.63e-01	3.11e-01	1.03e-01	8.52e-02	5.55e-01	1.81e-02	2.33e-01	2.25e-02
GOBP REGULATION OF TRIGLYCERIDE CATABOLIC PROCESS	7	3.22e-01	4.41e-01	0.5800	6.73e-02	2.53e-01	3.72e-01	1.66e-01	-2.63e-01	1.82e-01	7.58e-01	2.46e-01	8.86e-02	4.48e-01	2.28e-01	4.05e-01
GOBP POSITIVE REGULATION OF PEPTIDYL LYSINE ACETYLATION	5	9.41e-02	1.88e-01	0.5800	-1.66e-01	-2.08e-02	-5.87e-02	3.34e-01	-4.04e-01	1.74e-01	5.20e-01	9.36e-01	8.20e-01	1.96e-01	1.18e-01	5.00e-01
GOMF TRIPEPTIDE TRANSMEMBRANE TRANSPORTER ACTIVITY	7	3.47e-01	4.64e-01	0.5800	1.63e-01	-7.88e-02	4.69e-01	1.20e-01	-1.12e-01	2.39e-01	4.57e-01	7.18e-01	3.16e-02	5.83e-01	6.07e-01	2.74e-01
GOCC BRCA1 C COMPLEX	6	4.03e-01	5.14e-01	0.5800	-4.87e-01	-8.51e-02	-1.91e-01	-8.24e-02	7.51e-02	2.07e-01	3.87e-02	7.18e-01	4.18e-01	7.27e-01	7.50e-01	3.80e-01
GOBP REGULATION OF MDA 5 SIGNALING PATHWAY	6	3.81e-01	4.95e-01	0.5800	-1.97e-01	-3.57e-01	-2.41e-01	2.18e-01	8.84e-02	2.37e-01	4.04e-01	1.30e-01	3.06e-01	3.54e-01	7.08e-01	3.15e-01
GOBP LYMPHOCYTE CHEMOTAXIS	32	4.90e-04	2.76e-03	0.5800	1.43e-01	1.68e-01	3.76e-01	2.43e-01	-1.46e-01	2.56e-01	1.61e-01	1.00e-01	2.28e-04	1.72e-02	1.53e-01	1.22e-02
GOMF PROTEIN TYROSINE THREONINE PHOSPHATASE ACTIVITY	9	5.79e-02	1.31e-01	0.5800	2.85e-02	2.34e-01	5.04e-02	-1.33e-01	7.02e-02	-5.06e-01	8.82e-01	2.24e-01	7.93e-01	4.90e-01	7.15e-01	8.61e-03
GOMF GLUTAMATE RECEPTOR ACTIVITY	10	2.35e-01	3.53e-01	0.5800	1.09e-01	3.74e-01	1.25e-02	1.64e-01	3.18e-01	-2.37e-01	5.51e-01	4.05e-02	9.46e-01	3.68e-01	8.18e-02	1.94e-01
GOBP CARBOHYDRATE MEDIATED SIGNALING	8	4.21e-01	5.30e-01	0.5800	3.42e-01	1.43e-01	9.73e-02	2.67e-01	3.08e-01	-1.53e-01	9.40e-02	4.84e-01	6.34e-01	1.91e-01	1.32e-01	4.54e-01
GOBP NEGATIVE REGULATION OF T HELPER 1 TYPE IMMUNE RESPONSE	8	3.96e-01	5.09e-01	0.5800	1.49e-01	-9.62e-03	3.54e-01	1.06e-01	-3.26e-01	2.65e-01	4.65e-01	9.62e-01	8.27e-02	6.02e-01	1.10e-01	1.94e-01
GOBP MACROPINOCYTOSIS	10	2.15e-02	6.28e-02	0.5800	-5.56e-01	-1.12e-01	8.00e-02	-7.26e-02	4.83e-02	-1.47e-02	2.32e-03	5.39e-01	6.61e-01	6.91e-01	7.91e-01	9.36e-01
GOMF FERRIC IRON BINDING	7	6.02e-01	6.82e-01	0.5790	-1.60e-01	-4.12e-01	-1.95e-01	-7.98e-02	-2.40e-01	-1.95e-01	4.63e-01	5.88e-02	3.72e-01	7.15e-01	2.71e-01	3.72e-01
GOBP ENDOPLASMIC RETICULUM TUBULAR NETWORK ORGANIZATION	20	2.20e-02	6.37e-02	0.5790	-3.53e-01	-1.12e-01	1.50e-01	-1.10e-01	-2.22e-01	3.38e-01	6.23e-03	3.87e-01	2.46e-01	3.93e-01	8.50e-02	8.87e-03
GOBP POSITIVE REGULATION OF CARDIOCYTE DIFFERENTIATION	7	2.35e-01	3.53e-01	0.5790	-3.88e-01	-1.99e-01	-1.98e-01	5.55e-02	1.49e-01	-2.85e-01	7.58e-02	3.62e-01	3.63e-01	7.99e-01	4.94e-01	1.92e-01
GOCC PRECATALYTIC SPLICEOSOME	52	1.41e-09	2.18e-08	0.5790	-6.20e-02	-3.97e-01	-3.03e-01	2.54e-01	8.39e-02	1.03e-01	4.39e-01	7.17e-07	1.59e-04	1.51e-03	2.96e-01	2.01e-01
GOMF C X3 C CHEMOKINE BINDING	5	5.59e-01	6.48e-01	0.5790	-2.79e-01	-7.01e-02	-1.61e-02	-4.38e-01	-1.96e-02	2.46e-01	2.79e-01	7.86e-01	9.50e-01	9.02e-02	9.40e-01	3.41e-01
GOBP NEGATIVE REGULATION OF TRANSFORMING GROWTH FACTOR BETA1 PRODUCTION	5	6.18e-01	6.97e-01	0.5790	-1.60e-01	2.00e-02	4.09e-01	5.04e-02	-2.63e-01	2.65e-01	5.35e-01	9.38e-01	1.13e-01	8.45e-01	3.08e-01	3.05e-01
GOMF INTERLEUKIN 1 BINDING	8	3.30e-01	4.48e-01	0.5790	3.72e-02	3.88e-02	5.00e-01	4.15e-02	-1.96e-01	2.06e-01	8.55e-01	8.49e-01	1.44e-02	8.39e-01	3.38e-01	3.13e-01
GOBP POSITIVE REGULATION OF VASCULAR ASSOCIATED SMOOTH MUSCLE CELL DIFFERENTIATION	6	1.90e-01	3.05e-01	0.5790	-1.55e-01	4.42e-02	3.82e-03	-2.55e-01	6.58e-02	-4.90e-01	5.12e-01	8.51e-01	9.87e-01	2.79e-01	7.80e-01	3.78e-02
GOBP GOLGI VESICLE BUDDING	10	4.51e-02	1.09e-01	0.5790	-3.48e-01	-1.14e-01	1.37e-01	2.79e-01	-4.03e-02	3.20e-01	5.64e-02	5.32e-01	4.52e-01	1.27e-01	8.25e-01	7.99e-02
GOCC SM LIKE PROTEIN FAMILY COMPLEX	88	9.32e-15	2.46e-13	0.5790	-8.47e-02	-4.06e-01	-3.58e-01	1.70e-01	8.01e-02	1.46e-03	1.70e-01	4.60e-11	6.68e-09	5.88e-03	1.94e-01	9.81e-01
GOBP PHOSPHATIDYLCHOLINE ACYL CHAIN REMODELING	13	5.90e-03	2.24e-02	0.5790	-1.86e-01	1.25e-01	3.42e-01	2.67e-01	2.25e-01	2.13e-01	2.45e-01	4.37e-01	3.26e-02	9.52e-02	1.61e-01	1.83e-01
GOBP DEOXYRIBONUCLEOSIDE TRIPHOSPHATE METABOLIC PROCESS	9	2.59e-01	3.79e-01	0.5780	-3.15e-01	-4.68e-01	-1.10e-01	-2.16e-02	-4.18e-02	4.37e-02	1.01e-01	1.51e-02	5.68e-01	9.11e-01	8.28e-01	8.20e-01
GOMF MISFOLDED PROTEIN BINDING	15	1.11e-02	3.74e-02	0.5780	-1.54e-01	-1.16e-01	3.24e-01	2.29e-01	-2.70e-01	2.59e-01	3.03e-01	4.36e-01	2.98e-02	1.25e-01	7.03e-02	8.27e-02
GOBP POSITIVE REGULATION OF CHROMATIN BINDING	8	3.77e-01	4.92e-01	0.5780	2.74e-01	5.95e-04	2.55e-01	4.05e-01	9.25e-02	1.48e-01	1.80e-01	9.98e-01	2.12e-01	4.73e-02	6.51e-01	4.69e-01
GOCC ATPASE DEPENDENT TRANSMEMBRANE TRANSPORT COMPLEX	16	6.44e-02	1.42e-01	0.5780	2.50e-01	7.84e-02	3.53e-01	3.26e-01	4.09e-02	1.83e-01	8.39e-02	5.87e-01	1.46e-02	2.41e-02	7.77e-01	2.04e-01
GOBP PROTEIN LOCALIZATION TO NON MOTILE CILIUM	10	5.15e-02	1.20e-01	0.5780	-2.32e-01	2.35e-01	-2.67e-01	-1.23e-01	3.56e-01	1.09e-01	2.04e-01	1.97e-01	1.44e-01	4.99e-01	5.15e-02	5.52e-01
GOBP REGULATION OF OPSIN MEDIATED SIGNALING PATHWAY	7	1.34e-01	2.41e-01	0.5780	2.04e-01	-2.16e-01	4.49e-02	-1.97e-01	-3.55e-01	2.80e-01	3.50e-01	3.22e-01	8.37e-01	3.66e-01	1.03e-01	1.99e-01
GOCC CUL4A RING E3 UBIQUITIN LIGASE COMPLEX	14	3.00e-02	8.01e-02	0.5780	-4.76e-01	-2.02e-01	-1.74e-01	4.93e-02	6.83e-02	1.71e-01	2.05e-03	1.91e-01	2.59e-01	7.50e-01	6.58e-01	2.67e-01
GOBP REGULATION OF PLATELET AGGREGATION	23	7.06e-03	2.61e-02	0.5780	-1.60e-01	-1.95e-01	3.52e-01	-1.15e-01	-3.01e-01	2.05e-01	1.83e-01	1.05e-01	3.49e-03	3.39e-01	1.24e-02	8.82e-02
GOMF POLYSACCHARIDE BINDING	20	4.21e-02	1.03e-01	0.5780	1.33e-01	3.66e-01	9.23e-02	1.69e-01	3.80e-01	2.20e-02	3.03e-01	4.59e-03	4.75e-01	1.91e-01	3.26e-03	8.65e-01
GOMF GLUTAMATE GATED RECEPTOR ACTIVITY	8	5.05e-01	6.00e-01	0.5780	1.52e-01	3.69e-01	4.18e-02	2.08e-01	3.38e-01	-1.22e-01	4.58e-01	7.07e-02	8.38e-01	3.08e-01	9.74e-02	5.50e-01
GOBP POSITIVE REGULATION OF HORMONE METABOLIC PROCESS	12	1.05e-01	2.03e-01	0.5770	2.08e-01	2.26e-01	4.55e-01	1.51e-01	6.43e-02	7.30e-02	2.13e-01	1.75e-01	6.37e-03	3.66e-01	7.00e-01	6.61e-01
GOBP REGULATION OF ISOTYPE SWITCHING TO IGE ISOTYPES	7	6.25e-01	7.01e-01	0.5770	1.65e-01	1.00e-01	4.28e-01	2.65e-02	-1.64e-01	2.92e-01	4.50e-01	6.46e-01	4.98e-02	9.03e-01	4.53e-01	1.81e-01
GOBP DETERMINATION OF DIGESTIVE TRACT LEFT RIGHT ASYMMETRY	5	5.16e-01	6.10e-01	0.5770	-2.79e-01	2.10e-03	-4.18e-03	-2.79e-01	-2.14e-01	-3.63e-01	2.80e-01	9.94e-01	9.87e-01	2.80e-01	4.06e-01	1.60e-01
GOBP RENAL RESPONSE TO BLOOD FLOW INVOLVED IN CIRCULATORY RENIN ANGIOTENSIN REGULATION OF SYSTEMIC ARTERIAL BLOOD PRESSURE	5	5.23e-01	6.16e-01	0.5770	-4.09e-01	-7.09e-02	1.69e-01	5.71e-02	-1.36e-01	3.32e-01	1.13e-01	7.84e-01	5.12e-01	8.25e-01	5.98e-01	1.98e-01
GOMF METALLOCHAPERONE ACTIVITY	13	1.01e-01	1.97e-01	0.5770	-2.36e-01	-4.01e-01	-3.32e-01	-1.09e-02	3.44e-02	6.97e-02	1.40e-01	1.23e-02	3.82e-02	9.46e-01	8.30e-01	6.64e-01
GOBP ESTABLISHMENT OF GOLGI LOCALIZATION	7	3.87e-01	5.00e-01	0.5770	-1.13e-01	-2.44e-01	3.17e-01	1.78e-02	-3.76e-01	1.36e-01	6.05e-01	2.64e-01	1.46e-01	9.35e-01	8.51e-02	5.34e-01
GOBP NEGATIVE REGULATION OF MIRNA PROCESSING	7	4.93e-01	5.92e-01	0.5770	2.73e-01	2.26e-01	6.38e-03	3.93e-01	1.56e-01	1.68e-01	2.10e-01	3.01e-01	9.77e-01	7.19e-02	4.73e-01	4.40e-01
GOBP L ASPARTATE TRANSMEMBRANE TRANSPORT	9	8.24e-02	1.70e-01	0.5770	1.85e-01	-4.07e-01	1.83e-01	1.54e-01	-1.28e-01	2.45e-01	3.38e-01	3.47e-02	3.41e-01	4.25e-01	5.06e-01	2.04e-01
GOBP REGULATION OF LEUKOCYTE DEGRANULATION	41	7.21e-07	7.75e-06	0.5770	-6.02e-02	1.80e-01	4.30e-01	2.02e-01	-7.04e-02	2.57e-01	5.05e-01	4.60e-02	1.87e-06	2.50e-02	4.36e-01	4.48e-03
GOCC CUL4B RING E3 UBIQUITIN LIGASE COMPLEX	6	5.22e-01	6.15e-01	0.5770	-2.07e-01	-3.96e-01	-2.95e-01	2.14e-01	-1.49e-02	7.45e-04	3.80e-01	9.27e-02	2.11e-01	3.65e-01	9.49e-01	9.97e-01
GOBP RECEPTOR DIFFUSION TRAPPING	5	3.61e-01	4.77e-01	0.5770	1.36e-01	1.48e-02	5.15e-01	-1.58e-01	-7.90e-03	1.53e-01	5.99e-01	9.54e-01	4.59e-02	5.41e-01	9.76e-01	5.54e-01
GOBP CELLULAR RESPONSE TO ZINC ION	12	2.63e-02	7.29e-02	0.5770	2.59e-02	-3.26e-01	3.36e-01	1.74e-01	-1.15e-01	2.63e-01	8.76e-01	5.04e-02	4.36e-02	2.97e-01	4.91e-01	1.15e-01
GOCC TORC2 COMPLEX	9	1.49e-01	2.60e-01	0.5770	2.49e-01	1.35e-01	-7.49e-02	4.56e-01	-7.66e-03	-1.97e-01	1.96e-01	4.83e-01	6.97e-01	1.78e-02	9.68e-01	3.07e-01
GOCC SCAR COMPLEX	12	8.86e-02	1.79e-01	0.5770	-3.16e-01	-8.64e-02	2.67e-01	-2.10e-02	-1.21e-02	3.91e-01	5.78e-02	6.04e-01	1.09e-01	9.00e-01	9.42e-01	1.90e-02
GOBP PEPTIDYL TYROSINE AUTOPHOSPHORYLATION	12	8.79e-02	1.78e-01	0.5770	1.38e-01	2.65e-01	4.31e-01	1.71e-01	-1.52e-01	7.02e-02	4.09e-01	1.12e-01	9.72e-03	3.04e-01	3.61e-01	6.74e-01
GOBP RISC COMPLEX ASSEMBLY	10	1.26e-02	4.10e-02	0.5760	-4.79e-01	1.81e-01	9.97e-02	1.42e-01	8.12e-02	1.83e-01	8.73e-03	3.21e-01	5.85e-01	4.37e-01	6.56e-01	3.17e-01
GOBP AXO DENDRITIC PROTEIN TRANSPORT	9	1.75e-01	2.90e-01	0.5760	1.11e-01	-1.20e-01	4.52e-01	-1.49e-01	-2.41e-01	1.45e-01	5.65e-01	5.34e-01	1.88e-02	4.39e-01	2.10e-01	4.52e-01
GOMF ATP DEPENDENT PROTEIN BINDING	6	2.83e-01	4.02e-01	0.5760	-3.27e-01	-3.50e-01	1.10e-02	1.37e-01	-2.61e-01	-1.26e-01	1.66e-01	1.37e-01	9.63e-01	5.60e-01	2.69e-01	5.93e-01
GOBP RIBOSOME DISASSEMBLY	37	4.81e-05	3.50e-04	0.5760	-2.47e-01	-3.86e-01	-3.39e-01	-3.86e-02	-1.52e-02	7.53e-02	9.18e-03	4.86e-05	3.65e-04	6.84e-01	8.72e-01	4.28e-01
GOMF MACROMOLECULE TRANSMEMBRANE TRANSPORTER ACTIVITY	30	3.27e-04	1.94e-03	0.5760	-3.77e-01	-3.38e-01	-2.18e-01	8.50e-02	-1.29e-01	5.78e-02	3.48e-04	1.33e-03	3.85e-02	4.20e-01	2.20e-01	5.84e-01
GOBP CELLULAR RESPONSE TO GONADOTROPIN STIMULUS	12	1.49e-01	2.60e-01	0.5760	1.63e-01	5.99e-02	4.77e-01	1.08e-01	-6.26e-02	2.41e-01	3.29e-01	7.19e-01	4.19e-03	5.19e-01	7.07e-01	1.48e-01
GOBP PROTEIN DELIPIDATION	5	4.92e-01	5.91e-01	0.5760	-1.47e-03	-3.79e-01	-1.44e-01	3.91e-01	5.50e-02	-1.03e-01	9.95e-01	1.42e-01	5.76e-01	1.30e-01	8.31e-01	6.90e-01
GOBP POSITIVE REGULATION OF RUFFLE ASSEMBLY	13	7.25e-02	1.55e-01	0.5760	3.60e-01	-3.97e-02	1.99e-01	3.97e-01	5.29e-02	-4.07e-03	2.45e-02	8.04e-01	2.15e-01	1.32e-02	7.41e-01	9.80e-01
GOBP POSITIVE REGULATION OF LIPOPOLYSACCHARIDE MEDIATED SIGNALING PATHWAY	10	1.39e-02	4.46e-02	0.5750	-2.18e-01	-3.91e-01	-2.99e-02	-2.86e-01	1.19e-01	-1.85e-01	2.32e-01	3.23e-02	8.70e-01	1.18e-01	5.16e-01	3.12e-01
GOCC OXIDOREDUCTASE COMPLEX	114	1.48e-17	4.94e-16	0.5750	-1.35e-01	-5.10e-01	-1.76e-01	1.92e-02	-1.45e-01	-8.04e-03	1.28e-02	4.51e-21	1.15e-03	7.24e-01	7.49e-03	8.82e-01
GOBP CELLULAR RESPONSE TO COPPER ION	14	3.00e-02	8.00e-02	0.5750	1.44e-01	-2.54e-01	2.28e-01	1.79e-01	-3.70e-01	1.56e-01	3.50e-01	1.00e-01	1.39e-01	2.47e-01	1.64e-02	3.12e-01
GOMF CAMP RESPONSE ELEMENT BINDING	10	2.35e-02	6.70e-02	0.5750	-3.38e-02	3.15e-01	4.47e-01	-7.04e-02	-7.57e-02	-1.40e-01	8.53e-01	8.41e-02	1.43e-02	7.00e-01	6.78e-01	4.45e-01
GOBP NEGATIVE REGULATION OF PLATELET ACTIVATION	15	1.40e-02	4.50e-02	0.5750	6.20e-02	-2.66e-01	3.95e-01	-4.09e-02	-2.81e-01	1.39e-01	6.78e-01	7.43e-02	8.08e-03	7.84e-01	5.94e-02	3.51e-01
GOBP PROTEIN K11 LINKED DEUBIQUITINATION	9	3.17e-02	8.32e-02	0.5750	-9.36e-02	4.80e-01	1.59e-01	-8.93e-02	-1.85e-01	-1.53e-01	6.27e-01	1.26e-02	4.08e-01	6.43e-01	3.35e-01	4.27e-01
GOBP POSITIVE REGULATION OF EPITHELIAL TUBE FORMATION	5	6.57e-01	7.27e-01	0.5750	3.42e-01	2.93e-01	3.48e-01	-6.21e-02	5.05e-02	-2.39e-02	1.86e-01	2.56e-01	1.78e-01	8.10e-01	8.45e-01	9.26e-01
GOBP BONE MARROW DEVELOPMENT	8	3.25e-01	4.43e-01	0.5750	2.38e-02	1.93e-01	-1.20e-01	3.86e-01	2.88e-01	-2.15e-01	9.07e-01	3.44e-01	5.55e-01	5.89e-02	1.58e-01	2.92e-01
GOBP TRIPEPTIDE TRANSMEMBRANE TRANSPORT	8	2.45e-01	3.63e-01	0.5750	5.45e-02	-1.25e-01	3.92e-01	2.20e-01	4.41e-03	3.31e-01	7.90e-01	5.40e-01	5.49e-02	2.81e-01	9.83e-01	1.05e-01
GOMF POLYPEPTIDE N ACETYLGALACTOSAMINYLTRANSFERASE ACTIVITY	16	9.31e-03	3.24e-02	0.5750	-3.35e-01	-1.52e-01	3.38e-01	-1.53e-01	-1.02e-01	2.16e-01	2.02e-02	2.92e-01	1.93e-02	2.90e-01	4.81e-01	1.35e-01
GOBP NEGATIVE REGULATION OF VASCULAR ASSOCIATED SMOOTH MUSCLE CELL MIGRATION	7	2.00e-01	3.15e-01	0.5740	-4.38e-01	-1.32e-01	-5.50e-04	-1.82e-02	-3.24e-01	-1.25e-01	4.49e-02	5.44e-01	9.98e-01	9.34e-01	1.37e-01	5.68e-01
GOBP RESPONSE TO INTERLEUKIN 15	12	1.94e-01	3.11e-01	0.5740	5.93e-02	2.65e-01	2.54e-02	3.59e-01	3.26e-01	1.41e-01	7.22e-01	1.12e-01	8.79e-01	3.12e-02	5.02e-02	3.96e-01
GOMF HISTONE H4 METHYLTRANSFERASE ACTIVITY	14	1.45e-01	2.55e-01	0.5740	1.34e-01	-4.07e-02	-2.08e-01	4.12e-01	2.93e-01	-1.10e-01	3.87e-01	7.92e-01	1.78e-01	7.65e-03	5.80e-02	4.75e-01
GOBP POSITIVE REGULATION OF MITOTIC SISTER CHROMATID SEPARATION	18	2.41e-03	1.08e-02	0.5740	1.03e-01	-3.94e-01	4.44e-02	3.43e-01	-9.23e-02	1.90e-01	4.51e-01	3.81e-03	7.44e-01	1.18e-02	4.98e-01	1.62e-01
GOBP CD4 POSITIVE CD25 POSITIVE ALPHA BETA REGULATORY T CELL DIFFERENTIATION	10	3.58e-01	4.74e-01	0.5740	2.74e-01	8.65e-02	-1.28e-01	3.33e-01	3.44e-01	5.15e-02	1.34e-01	6.36e-01	4.85e-01	6.86e-02	5.99e-02	7.78e-01
GOBP INTRACELLULAR PROTEIN TRANSMEMBRANE TRANSPORT	28	1.90e-03	8.78e-03	0.5740	-3.77e-01	-3.17e-01	-1.95e-01	-1.14e-02	-2.13e-01	6.01e-02	5.46e-04	3.71e-03	7.45e-02	9.17e-01	5.13e-02	5.82e-01
GOMF RNA METHYLTRANSFERASE ACTIVITY	63	5.88e-09	8.55e-08	0.5740	-1.00e-01	-3.72e-01	-4.08e-01	1.80e-02	8.82e-02	-8.25e-02	1.70e-01	3.22e-07	2.16e-08	8.05e-01	2.26e-01	2.57e-01
GOBP OLIGOSACCHARIDE LIPID INTERMEDIATE BIOSYNTHETIC PROCESS	22	2.36e-02	6.71e-02	0.5740	-2.85e-01	-4.31e-01	-2.16e-01	-8.26e-02	-8.61e-02	3.60e-02	2.04e-02	4.62e-04	7.94e-02	5.02e-01	4.85e-01	7.70e-01
GOMF SINGLE STRANDED DNA EXODEOXYRIBONUCLEASE ACTIVITY	9	1.42e-01	2.51e-01	0.5740	-6.57e-02	-1.17e-01	-2.45e-01	4.81e-01	1.21e-01	-7.35e-02	7.33e-01	5.44e-01	2.03e-01	1.24e-02	5.31e-01	7.02e-01
GOBP GDP MANNOSE METABOLIC PROCESS	8	2.22e-01	3.40e-01	0.5740	1.07e-01	-4.35e-01	-1.71e-01	2.94e-01	-6.14e-02	-9.48e-02	6.00e-01	3.32e-02	4.02e-01	1.50e-01	7.64e-01	6.42e-01
GOBP RESPONSE TO L LEUCINE	14	7.85e-02	1.64e-01	0.5740	6.49e-02	3.52e-01	2.90e-01	2.83e-01	8.71e-02	1.70e-01	6.74e-01	2.24e-02	6.02e-02	6.71e-02	5.72e-01	2.70e-01
GOMF SHORT CHAIN FATTY ACYL COA DEHYDROGENASE ACTIVITY	5	5.79e-01	6.64e-01	0.5740	-3.69e-01	-1.67e-01	-3.83e-01	-1.18e-02	1.07e-01	8.37e-02	1.54e-01	5.18e-01	1.38e-01	9.64e-01	6.80e-01	7.46e-01
GOCC ER UBIQUITIN LIGASE COMPLEX	5	1.36e-01	2.43e-01	0.5740	-4.27e-01	2.38e-01	4.45e-02	1.92e-01	-1.04e-01	2.02e-01	9.85e-02	3.57e-01	8.63e-01	4.57e-01	6.88e-01	4.35e-01
GOBP REGULATION OF STEROID HORMONE SECRETION	14	1.26e-01	2.30e-01	0.5730	1.93e-01	1.22e-02	3.92e-01	1.15e-01	-2.47e-01	2.53e-01	2.11e-01	9.37e-01	1.12e-02	4.56e-01	1.10e-01	1.02e-01
GOBP MRNA 3 END PROCESSING BY STEM LOOP BINDING AND CLEAVAGE	6	3.29e-01	4.47e-01	0.5730	-2.46e-01	-4.05e-01	-1.89e-01	7.93e-02	2.50e-01	-3.09e-03	2.96e-01	8.62e-02	4.23e-01	7.37e-01	2.90e-01	9.90e-01
GOBP POSITIVE REGULATION OF EXTRINSIC APOPTOTIC SIGNALING PATHWAY IN ABSENCE OF LIGAND	9	2.91e-01	4.10e-01	0.5730	-2.81e-01	-3.47e-01	1.41e-01	2.59e-02	-2.60e-01	2.02e-01	1.45e-01	7.12e-02	4.64e-01	8.93e-01	1.76e-01	2.94e-01
GOMF CATALYTIC ACTIVITY ACTING ON A TRNA	138	2.21e-20	9.76e-19	0.5730	-1.47e-01	-4.42e-01	-3.28e-01	2.42e-02	2.32e-02	-5.12e-02	2.84e-03	3.09e-19	2.65e-11	6.23e-01	6.39e-01	2.99e-01
GOBP REGULATION OF FERTILIZATION	7	2.88e-01	4.08e-01	0.5730	-7.17e-02	-1.21e-01	3.23e-01	-1.77e-01	-3.97e-01	-1.22e-01	7.42e-01	5.80e-01	1.39e-01	4.17e-01	6.86e-02	5.78e-01
GOBP RESPONSE TO SYMBIONT	5	8.79e-02	1.78e-01	0.5730	-3.21e-01	-1.94e-01	1.56e-01	6.47e-02	3.95e-01	5.00e-02	2.14e-01	4.52e-01	5.45e-01	8.02e-01	1.26e-01	8.46e-01
GOBP VESICLE TETHERING INVOLVED IN EXOCYTOSIS	9	1.24e-01	2.29e-01	0.5720	-3.75e-01	1.46e-01	1.09e-01	-3.51e-02	-3.34e-02	3.90e-01	5.16e-02	4.49e-01	5.72e-01	8.55e-01	8.62e-01	4.29e-02
GOBP LATERAL VENTRICLE DEVELOPMENT	11	1.42e-01	2.52e-01	0.5720	9.02e-02	3.11e-01	3.40e-01	-1.22e-01	-2.93e-01	7.53e-02	6.04e-01	7.37e-02	5.06e-02	4.84e-01	9.20e-02	6.66e-01
GOBP NEGATIVE REGULATION OF LEUKOCYTE DEGRANULATION	11	3.00e-02	8.00e-02	0.5720	-1.98e-02	3.25e-01	2.63e-01	3.83e-01	6.25e-02	4.51e-02	9.09e-01	6.19e-02	1.31e-01	2.80e-02	7.20e-01	7.96e-01
GOBP POSITIVE REGULATION OF CHROMOSOME CONDENSATION	8	1.96e-01	3.12e-01	0.5720	1.67e-01	-7.15e-02	-2.63e-01	4.45e-01	1.33e-01	1.00e-01	4.13e-01	7.26e-01	1.98e-01	2.94e-02	5.15e-01	6.24e-01
GOCC CONDENSIN COMPLEX	8	1.96e-01	3.12e-01	0.5720	1.67e-01	-7.15e-02	-2.63e-01	4.45e-01	1.33e-01	1.00e-01	4.13e-01	7.26e-01	1.98e-01	2.94e-02	5.15e-01	6.24e-01
GOBP NEGATIVE REGULATION OF CELL SUBSTRATE JUNCTION ORGANIZATION	14	5.12e-02	1.19e-01	0.5720	-4.23e-01	-2.60e-01	9.23e-02	-2.09e-01	-1.67e-01	-3.44e-02	6.15e-03	9.26e-02	5.50e-01	1.75e-01	2.80e-01	8.24e-01
GOBP POSITIVE REGULATION OF PROTEIN SUMOYLATION	11	2.81e-02	7.63e-02	0.5720	-3.03e-02	-2.93e-01	-1.26e-01	4.29e-01	-1.92e-01	-6.11e-02	8.62e-01	9.27e-02	4.70e-01	1.36e-02	2.70e-01	7.26e-01
GOBP GROWTH PLATE CARTILAGE DEVELOPMENT	12	3.44e-02	8.89e-02	0.5720	-2.19e-01	2.30e-01	3.21e-01	1.85e-01	1.21e-01	2.72e-01	1.90e-01	1.67e-01	5.39e-02	2.67e-01	4.68e-01	1.02e-01
GOBP DEVELOPMENT OF SECONDARY SEXUAL CHARACTERISTICS	8	1.21e-02	3.99e-02	0.5720	-9.60e-02	-1.28e-01	1.76e-01	2.85e-01	-2.80e-01	-3.32e-01	6.38e-01	5.30e-01	3.88e-01	1.62e-01	1.70e-01	1.04e-01
GOBP ACROSOME ASSEMBLY	17	3.92e-02	9.81e-02	0.5720	-1.02e-02	1.38e-01	3.92e-01	4.73e-02	-2.97e-01	2.52e-01	9.42e-01	3.24e-01	5.13e-03	7.35e-01	3.40e-02	7.17e-02
GOBP POSITIVE REGULATION OF NATURAL KILLER CELL MEDIATED CYTOTOXICITY	26	3.65e-07	4.10e-06	0.5710	1.28e-01	3.71e-01	9.19e-02	2.40e-01	-1.47e-01	2.91e-01	2.59e-01	1.07e-03	4.17e-01	3.41e-02	1.94e-01	1.01e-02
GOBP RESPONSE TO LECTIN	23	8.28e-07	8.77e-06	0.5710	-6.41e-03	4.67e-01	1.16e-01	4.70e-02	-1.97e-01	2.31e-01	9.58e-01	1.05e-04	3.34e-01	6.97e-01	1.02e-01	5.48e-02
GOBP MAINTENANCE OF PROTEIN LOCALIZATION IN ENDOPLASMIC RETICULUM	11	7.85e-02	1.64e-01	0.5710	-2.27e-01	-2.97e-01	1.80e-01	2.07e-01	-9.85e-02	3.19e-01	1.93e-01	8.86e-02	3.02e-01	2.34e-01	5.72e-01	6.69e-02
GOCC RISC LOADING COMPLEX	8	1.01e-01	1.97e-01	0.5710	-4.91e-01	1.63e-01	1.32e-01	-3.42e-02	2.87e-02	1.97e-01	1.61e-02	4.25e-01	5.17e-01	8.67e-01	8.88e-01	3.35e-01
GOMF TRANSPORTER INHIBITOR ACTIVITY	32	1.08e-04	7.22e-04	0.5710	-1.11e-01	-3.45e-01	6.85e-02	-2.69e-01	-2.03e-01	2.76e-01	2.77e-01	7.26e-04	5.02e-01	8.56e-03	4.70e-02	6.83e-03
GOBP TOLL LIKE RECEPTOR 9 SIGNALING PATHWAY	19	4.32e-04	2.48e-03	0.5710	-2.09e-01	5.15e-02	1.40e-01	3.99e-01	3.41e-02	3.15e-01	1.14e-01	6.97e-01	2.89e-01	2.61e-03	7.97e-01	1.74e-02
GOBP HYPOTHALAMUS CELL DIFFERENTIATION	5	6.45e-01	7.18e-01	0.5710	2.47e-01	5.88e-02	2.21e-02	2.56e-01	4.39e-01	-4.78e-02	3.39e-01	8.20e-01	9.32e-01	3.21e-01	8.90e-02	8.53e-01
GOBP HYPOTHALAMUS GONADOTROPHIN RELEASING HORMONE NEURON DIFFERENTIATION	5	6.45e-01	7.18e-01	0.5710	2.47e-01	5.88e-02	2.21e-02	2.56e-01	4.39e-01	-4.78e-02	3.39e-01	8.20e-01	9.32e-01	3.21e-01	8.90e-02	8.53e-01
GOBP REGULATION OF MRNA EXPORT FROM NUCLEUS	10	1.20e-01	2.24e-01	0.5710	8.69e-03	2.64e-01	1.47e-01	4.26e-01	1.14e-01	2.01e-01	9.62e-01	1.49e-01	4.20e-01	1.98e-02	5.32e-01	2.71e-01
GOBP ACTIVATION OF JANUS KINASE ACTIVITY	10	6.89e-02	1.49e-01	0.5710	7.72e-02	2.64e-02	-1.04e-02	1.28e-01	3.38e-01	4.34e-01	6.72e-01	8.85e-01	9.55e-01	4.84e-01	6.38e-02	1.76e-02
GOBP DIET INDUCED THERMOGENESIS	9	3.06e-01	4.26e-01	0.5710	2.28e-02	3.66e-01	-9.45e-02	1.97e-01	3.74e-01	5.55e-02	9.06e-01	5.70e-02	6.23e-01	3.07e-01	5.18e-02	7.73e-01
GOBP REGULATION OF ER TO GOLGI VESICLE MEDIATED TRANSPORT	10	4.84e-02	1.14e-01	0.5700	-4.71e-01	-1.51e-02	-1.05e-01	2.53e-03	-1.06e-01	2.84e-01	9.84e-03	9.34e-01	5.65e-01	9.89e-01	5.62e-01	1.20e-01
GOBP FAT CELL PROLIFERATION	10	1.96e-01	3.12e-01	0.5700	-1.92e-01	-1.96e-01	-3.06e-01	3.04e-01	1.87e-01	-1.70e-01	2.93e-01	2.82e-01	9.37e-02	9.60e-02	3.06e-01	3.52e-01
GOBP NEGATIVE REGULATION OF P38MAPK CASCADE	6	6.20e-01	6.98e-01	0.5700	1.23e-01	2.46e-01	3.51e-01	-2.55e-01	-1.27e-01	2.11e-01	6.02e-01	2.96e-01	1.36e-01	2.79e-01	5.89e-01	3.70e-01
GOBP COPPER ION IMPORT	6	3.17e-01	4.37e-01	0.5700	-3.24e-01	4.05e-02	3.05e-01	-2.05e-01	1.21e-01	2.63e-01	1.69e-01	8.64e-01	1.96e-01	3.85e-01	6.09e-01	2.64e-01
GOBP NEGATIVE REGULATION OF HUMORAL IMMUNE RESPONSE	15	1.65e-01	2.78e-01	0.5700	9.08e-02	1.99e-01	3.34e-01	6.86e-02	1.74e-03	4.01e-01	5.42e-01	1.82e-01	2.49e-02	6.45e-01	9.91e-01	7.18e-03
GOBP SIRNA PROCESSING	8	1.04e-01	2.02e-01	0.5700	-2.60e-01	-2.01e-01	-1.27e-01	9.93e-02	-2.91e-01	3.26e-01	2.03e-01	3.24e-01	5.34e-01	6.27e-01	1.54e-01	1.11e-01
GOBP T CELL CHEMOTAXIS	20	2.47e-02	6.95e-02	0.5700	1.89e-01	1.20e-01	3.82e-01	2.95e-01	-3.12e-02	2.01e-01	1.43e-01	3.53e-01	3.07e-03	2.24e-02	8.09e-01	1.20e-01
GOBP HEMOGLOBIN METABOLIC PROCESS	15	1.66e-01	2.79e-01	0.5690	1.21e-01	2.24e-01	3.89e-01	1.45e-01	8.74e-02	2.82e-01	4.16e-01	1.33e-01	9.14e-03	3.31e-01	5.58e-01	5.84e-02
GOMF ICOSANOID RECEPTOR ACTIVITY	14	1.49e-01	2.60e-01	0.5690	-3.21e-01	-2.09e-01	2.14e-01	-1.60e-01	-2.19e-01	2.41e-01	3.73e-02	1.76e-01	1.65e-01	2.99e-01	1.56e-01	1.19e-01
GOBP NEGATIVE REGULATION OF AXON EXTENSION INVOLVED IN AXON GUIDANCE	7	3.36e-01	4.53e-01	0.5690	9.24e-02	2.46e-01	2.23e-01	1.46e-01	4.26e-01	4.93e-02	6.72e-01	2.60e-01	3.08e-01	5.02e-01	5.08e-02	8.21e-01
GOBP REGULATION OF I KAPPAB PHOSPHORYLATION	6	5.92e-01	6.75e-01	0.5690	7.64e-02	2.75e-01	-8.75e-03	2.57e-01	3.73e-01	-1.93e-01	7.46e-01	2.43e-01	9.70e-01	2.77e-01	1.13e-01	4.14e-01
GOBP NEGATIVE ADAPTATION OF SIGNALING PATHWAY	11	1.51e-01	2.62e-01	0.5690	3.75e-01	3.29e-01	-1.05e-01	2.26e-03	1.70e-01	-1.87e-01	3.12e-02	5.87e-02	5.47e-01	9.90e-01	3.30e-01	2.83e-01
GOBP DE NOVO PYRIMIDINE NUCLEOBASE BIOSYNTHETIC PROCESS	5	4.44e-01	5.51e-01	0.5690	-1.34e-03	-6.73e-02	1.85e-02	5.35e-01	1.79e-01	-2.69e-02	9.96e-01	7.94e-01	9.43e-01	3.84e-02	4.89e-01	9.17e-01
GOBP RESPONSE TO HEPATOCYTE GROWTH FACTOR	15	3.56e-02	9.12e-02	0.5690	-2.73e-01	2.19e-01	3.05e-01	-9.81e-02	-1.42e-01	2.80e-01	6.73e-02	1.41e-01	4.11e-02	5.10e-01	3.42e-01	6.07e-02
GOBP REPLICATION BORN DOUBLE STRAND BREAK REPAIR VIA SISTER CHROMATID EXCHANGE	6	6.21e-01	6.99e-01	0.5690	9.62e-02	6.76e-02	6.64e-02	3.88e-01	3.30e-01	2.14e-01	6.83e-01	7.74e-01	7.78e-01	1.00e-01	1.61e-01	3.64e-01
GOMF MIRNA INHIBITOR ACTIVITY VIA BASE PAIRING	5	4.72e-01	5.74e-01	0.5690	-6.43e-02	-3.42e-02	-1.89e-03	-4.88e-01	-1.97e-01	2.03e-01	8.03e-01	8.95e-01	9.94e-01	5.90e-02	4.45e-01	4.31e-01
GOBP MITOTIC CHROMOSOME CONDENSATION	19	1.05e-02	3.58e-02	0.5680	2.73e-01	6.15e-02	3.50e-02	4.61e-01	3.10e-02	1.73e-01	3.95e-02	6.43e-01	7.92e-01	5.00e-04	8.15e-01	1.92e-01
GOMF BIS 5 ADENOSYL PENTAPHOSPHATASE ACTIVITY	5	5.28e-01	6.20e-01	0.5680	-4.10e-01	-2.76e-02	-2.03e-01	-1.84e-01	2.48e-01	1.34e-01	1.13e-01	9.15e-01	4.32e-01	4.75e-01	3.38e-01	6.04e-01
GOBP AMP SALVAGE	5	3.34e-01	4.51e-01	0.5680	-9.86e-03	-5.57e-01	-5.01e-02	-4.55e-02	-5.51e-03	8.97e-02	9.70e-01	3.11e-02	8.46e-01	8.60e-01	9.83e-01	7.28e-01
GOBP POSITIVE REGULATION OF MITOCHONDRIAL DEPOLARIZATION	5	5.94e-01	6.77e-01	0.5680	-1.89e-01	-4.62e-01	-1.57e-01	-9.08e-02	-4.25e-02	1.97e-01	4.64e-01	7.35e-02	5.43e-01	7.25e-01	8.69e-01	4.46e-01
GOBP NEGATIVE REGULATION OF LOW DENSITY LIPOPROTEIN PARTICLE CLEARANCE	6	1.60e-01	2.72e-01	0.5680	5.96e-02	-2.18e-01	4.34e-01	1.64e-01	-2.37e-01	-1.13e-02	8.00e-01	3.54e-01	6.57e-02	4.85e-01	3.15e-01	9.62e-01
GOMF THIAMINE PYROPHOSPHATE BINDING	6	4.18e-01	5.28e-01	0.5680	2.74e-02	3.51e-02	1.01e-01	4.39e-01	3.40e-01	4.41e-02	9.07e-01	8.82e-01	6.69e-01	6.24e-02	1.49e-01	8.52e-01
GOBP ALPHA LINOLENIC ACID METABOLIC PROCESS	9	2.91e-02	7.82e-02	0.5680	-2.15e-01	-6.24e-02	2.27e-01	1.22e-01	3.75e-01	2.56e-01	2.64e-01	7.46e-01	2.38e-01	5.27e-01	5.15e-02	1.84e-01
GOBP LEUKOCYTE MIGRATION INVOLVED IN INFLAMMATORY RESPONSE	14	3.72e-02	9.44e-02	0.5680	2.16e-02	1.52e-01	4.13e-01	-3.33e-01	-8.16e-02	1.04e-01	8.89e-01	3.24e-01	7.46e-03	3.09e-02	5.97e-01	5.02e-01
GOBP ACTIVATION OF CYSTEINE TYPE ENDOPEPTIDASE ACTIVITY	12	1.69e-01	2.81e-01	0.5680	-1.51e-01	-2.89e-01	2.41e-01	9.35e-03	-2.29e-01	3.25e-01	3.65e-01	8.27e-02	1.49e-01	9.55e-01	1.69e-01	5.15e-02
GOBP RNA METHYLATION	78	9.56e-11	1.73e-09	0.5680	-7.28e-02	-4.03e-01	-3.72e-01	3.88e-02	4.12e-02	-1.13e-01	2.66e-01	7.17e-10	1.34e-08	5.53e-01	5.29e-01	8.36e-02
GOMF TRNA METHYLTRANSFERASE ACTIVITY	34	3.86e-04	2.25e-03	0.5680	-1.72e-01	-3.74e-01	-3.55e-01	-1.28e-01	5.58e-02	-8.66e-02	8.21e-02	1.60e-04	3.42e-04	1.98e-01	5.73e-01	3.82e-01
GOBP NEGATIVE REGULATION OF COLLATERAL SPROUTING	9	2.14e-01	3.32e-01	0.5680	-3.96e-02	3.04e-01	4.53e-01	-2.35e-02	-1.03e-01	1.11e-01	8.37e-01	1.14e-01	1.86e-02	9.03e-01	5.94e-01	5.66e-01
GOMF SELENIUM BINDING	8	2.73e-01	3.92e-01	0.5680	-3.57e-01	-2.14e-01	-3.22e-02	-1.28e-02	4.65e-02	3.82e-01	8.07e-02	2.94e-01	8.75e-01	9.50e-01	8.20e-01	6.14e-02
GOMF METALLOENDOPEPTIDASE INHIBITOR ACTIVITY	8	4.69e-02	1.12e-01	0.5680	-4.68e-01	-2.83e-02	1.15e-02	1.96e-01	-1.85e-01	1.72e-01	2.19e-02	8.90e-01	9.55e-01	3.37e-01	3.64e-01	4.00e-01
GOBP NEGATIVE REGULATION OF NUCLEASE ACTIVITY	7	1.12e-01	2.12e-01	0.5680	-1.66e-01	-2.53e-01	-2.91e-01	2.67e-01	-1.80e-01	2.05e-01	4.46e-01	2.46e-01	1.83e-01	2.21e-01	4.09e-01	3.48e-01
GOCC FIBRILLAR COLLAGEN TRIMER	6	3.72e-01	4.87e-01	0.5680	-3.27e-01	1.19e-01	-2.67e-01	1.11e-01	3.39e-01	5.13e-02	1.65e-01	6.15e-01	2.58e-01	6.39e-01	1.50e-01	8.28e-01
GOBP OXIDATIVE DEMETHYLATION	6	7.17e-01	7.75e-01	0.5670	2.14e-01	1.99e-01	3.13e-01	2.25e-01	-5.58e-02	2.92e-01	3.64e-01	3.99e-01	1.85e-01	3.40e-01	8.13e-01	2.15e-01
GOBP PROTEIN LOCALIZATION TO ENDOSOME	28	5.32e-05	3.84e-04	0.5670	-2.34e-01	-5.61e-02	2.66e-01	1.88e-01	-2.40e-01	3.17e-01	3.23e-02	6.07e-01	1.49e-02	8.52e-02	2.78e-02	3.68e-03
GOBP REGULATION OF NEUROTRANSMITTER UPTAKE	13	1.61e-01	2.74e-01	0.5670	1.48e-01	-5.30e-02	3.53e-01	-1.25e-01	-2.97e-01	2.62e-01	3.54e-01	7.41e-01	2.74e-02	4.36e-01	6.38e-02	1.02e-01
GOCC POLYPRENYL DIPHOSPHATE SYNTHASE COMPLEX	11	4.07e-01	5.18e-01	0.5670	-3.87e-01	-2.18e-01	-3.89e-02	-2.35e-01	-2.35e-01	1.14e-01	2.64e-02	2.11e-01	8.23e-01	1.77e-01	1.77e-01	5.14e-01
GOBP REGULATION OF SYNAPTIC VESICLE RECYCLING	24	1.05e-02	3.58e-02	0.5670	-1.27e-01	-1.06e-01	3.21e-01	1.16e-02	-3.09e-01	3.09e-01	2.81e-01	3.67e-01	6.43e-03	9.22e-01	8.76e-03	8.78e-03
GOCC DYSTROPHIN ASSOCIATED GLYCOPROTEIN COMPLEX	14	2.16e-01	3.34e-01	0.5670	-2.56e-01	-8.14e-02	7.70e-02	-3.41e-01	-3.58e-01	-3.51e-03	9.78e-02	5.98e-01	6.18e-01	2.73e-02	2.05e-02	9.82e-01
GOMF ALDOSE REDUCTASE NADPH ACTIVITY	8	3.52e-01	4.68e-01	0.5670	-1.23e-02	-8.96e-02	-3.91e-01	3.04e-01	2.60e-01	-2.56e-02	9.52e-01	6.61e-01	5.54e-02	1.37e-01	2.02e-01	9.00e-01
GOBP POTASSIUM ION HOMEOSTASIS	23	3.28e-02	8.56e-02	0.5670	2.21e-01	3.26e-01	1.58e-01	3.10e-01	2.12e-01	-1.83e-02	6.69e-02	6.78e-03	1.89e-01	1.00e-02	7.81e-02	8.79e-01
GOMF ACTIVIN BINDING	10	2.37e-02	6.73e-02	0.5670	-3.55e-01	2.84e-01	4.53e-02	2.09e-01	1.96e-01	1.76e-01	5.22e-02	1.20e-01	8.04e-01	2.53e-01	2.83e-01	3.34e-01
GOMF UBIQUITIN LIKE MODIFIER ACTIVATING ENZYME ACTIVITY	10	1.76e-01	2.90e-01	0.5670	-3.52e-01	-2.92e-01	-2.51e-01	2.64e-02	9.80e-02	1.98e-01	5.40e-02	1.10e-01	1.69e-01	8.85e-01	5.91e-01	2.79e-01
GOCC SPERM HEAD	7	4.23e-01	5.32e-01	0.5670	-1.86e-02	6.50e-02	1.27e-01	-4.39e-01	-2.92e-01	-1.52e-01	9.32e-01	7.66e-01	5.60e-01	4.43e-02	1.82e-01	4.85e-01
GOBP NEGATIVE REGULATION OF FIBROBLAST GROWTH FACTOR RECEPTOR SIGNALING PATHWAY	13	5.18e-02	1.20e-01	0.5670	8.16e-02	4.85e-03	3.22e-01	-2.72e-01	-3.48e-01	-1.27e-01	6.11e-01	9.76e-01	4.47e-02	8.89e-02	2.98e-02	4.28e-01
GOCC NLS DEPENDENT PROTEIN NUCLEAR IMPORT COMPLEX	9	1.39e-01	2.47e-01	0.5670	-4.54e-01	-1.60e-01	-2.17e-01	8.87e-02	4.58e-03	1.88e-01	1.84e-02	4.06e-01	2.60e-01	6.45e-01	9.81e-01	3.29e-01
GOBP ESTABLISHMENT OF ENDOTHELIAL INTESTINAL BARRIER	14	1.10e-02	3.70e-02	0.5670	-1.78e-01	3.91e-01	2.55e-01	1.45e-01	1.96e-01	1.13e-01	2.50e-01	1.14e-02	9.90e-02	3.48e-01	2.04e-01	4.62e-01
GOBP ESTABLISHMENT OF CENTROSOME LOCALIZATION	8	5.60e-01	6.49e-01	0.5670	-2.12e-01	-1.08e-01	2.24e-01	-1.40e-01	-2.77e-01	3.44e-01	2.98e-01	5.97e-01	2.73e-01	4.94e-01	1.75e-01	9.18e-02
GOBP PYRIMIDINE DEOXYRIBONUCLEOSIDE MONOPHOSPHATE METABOLIC PROCESS	9	2.32e-01	3.50e-01	0.5670	-6.65e-03	-4.88e-01	-2.28e-02	-7.01e-02	-2.71e-01	6.14e-02	9.72e-01	1.12e-02	9.06e-01	7.16e-01	1.59e-01	7.50e-01
GOBP VALINE METABOLIC PROCESS	7	4.48e-01	5.55e-01	0.5670	-2.86e-01	-4.45e-01	-1.86e-01	4.98e-02	6.26e-03	-6.63e-02	1.90e-01	4.14e-02	3.95e-01	8.20e-01	9.77e-01	7.61e-01
GOMF STRUCTURAL MOLECULE ACTIVITY CONFERRING ELASTICITY	11	2.23e-01	3.42e-01	0.5670	1.36e-03	1.35e-01	4.41e-01	-1.66e-01	-4.08e-02	2.81e-01	9.94e-01	4.37e-01	1.13e-02	3.40e-01	8.15e-01	1.07e-01
GOBP POSITIVE REGULATION OF FATTY ACID BETA OXIDATION	9	7.15e-02	1.53e-01	0.5670	2.84e-01	1.33e-01	3.09e-01	1.30e-01	-1.46e-01	-3.00e-01	1.41e-01	4.91e-01	1.09e-01	5.00e-01	4.49e-01	1.20e-01
GOCC A BAND	29	5.77e-03	2.21e-02	0.5670	2.39e-01	2.54e-01	2.84e-01	6.75e-02	3.27e-02	3.37e-01	2.58e-02	1.81e-02	8.05e-03	5.29e-01	7.60e-01	1.71e-03
GOBP PYRIMIDINE RIBONUCLEOSIDE TRIPHOSPHATE BIOSYNTHETIC PROCESS	13	5.00e-02	1.17e-01	0.5670	-9.90e-02	-4.93e-01	-1.76e-01	1.48e-01	5.60e-04	-1.25e-01	5.37e-01	2.10e-03	2.72e-01	3.54e-01	9.97e-01	4.35e-01
GOBP OLIGOPEPTIDE TRANSPORT	15	2.86e-02	7.73e-02	0.5670	-1.39e-01	-2.02e-01	3.64e-01	9.07e-02	-1.36e-01	3.19e-01	3.52e-01	1.75e-01	1.46e-02	5.43e-01	3.61e-01	3.25e-02
GOBP NEGATIVE REGULATION OF PLATELET DERIVED GROWTH FACTOR RECEPTOR SIGNALING PATHWAY	9	2.00e-01	3.16e-01	0.5670	7.81e-02	-6.41e-02	4.42e-01	2.16e-01	-1.39e-01	2.22e-01	6.85e-01	7.39e-01	2.16e-02	2.62e-01	4.71e-01	2.49e-01
GOBP POSITIVE REGULATION OF CATECHOLAMINE SECRETION	6	4.45e-01	5.52e-01	0.5670	2.76e-01	1.19e-01	4.29e-01	2.16e-01	8.01e-03	9.83e-03	2.42e-01	6.15e-01	6.90e-02	3.59e-01	9.73e-01	9.67e-01
GOBP AV NODE CELL TO BUNDLE OF HIS CELL SIGNALING	5	6.02e-01	6.83e-01	0.5660	2.90e-01	3.40e-01	2.54e-01	-9.92e-02	-1.60e-01	-1.46e-01	2.62e-01	1.89e-01	3.25e-01	7.01e-01	5.35e-01	5.71e-01
GOBP L GLUTAMATE IMPORT ACROSS PLASMA MEMBRANE	12	2.33e-01	3.50e-01	0.5660	-2.45e-01	-3.05e-01	1.66e-01	-5.85e-02	-2.75e-01	2.47e-01	1.42e-01	6.73e-02	3.19e-01	7.26e-01	9.90e-02	1.39e-01
GOMF PROTEIN GERANYLGERANYLTRANSFERASE ACTIVITY	5	5.90e-01	6.73e-01	0.5660	-3.98e-01	-1.18e-01	-2.92e-01	-1.50e-01	1.51e-01	1.35e-01	1.23e-01	6.49e-01	2.59e-01	5.61e-01	5.59e-01	6.02e-01
GOBP POSITIVE REGULATION OF INTRINSIC APOPTOTIC SIGNALING PATHWAY BY P53 CLASS MEDIATOR	6	4.11e-01	5.22e-01	0.5660	4.82e-02	-4.71e-01	-2.69e-01	1.47e-01	-3.64e-02	2.55e-02	8.38e-01	4.55e-02	2.54e-01	5.34e-01	8.77e-01	9.14e-01
GOBP INTRACELLULAR MONOATOMIC ANION HOMEOSTASIS	7	2.94e-01	4.13e-01	0.5660	-2.09e-01	1.63e-02	1.11e-01	2.72e-01	9.59e-02	4.25e-01	3.38e-01	9.40e-01	6.11e-01	2.12e-01	6.60e-01	5.14e-02
GOMF LONG CHAIN FATTY ACYL COA HYDROLASE ACTIVITY	13	7.66e-02	1.61e-01	0.5660	-2.74e-01	-3.53e-01	-2.54e-01	-8.75e-02	-3.38e-02	2.17e-01	8.71e-02	2.73e-02	1.13e-01	5.85e-01	8.33e-01	1.75e-01
GOMF NUCLEAR IMPORT SIGNAL RECEPTOR ACTIVITY	19	4.07e-03	1.66e-02	0.5660	-4.62e-01	-1.90e-01	-2.06e-01	8.18e-02	-7.75e-03	1.45e-01	4.85e-04	1.51e-01	1.20e-01	5.37e-01	9.53e-01	2.74e-01
GOMF TRANSLATION FACTOR ACTIVITY RNA BINDING	82	1.01e-08	1.41e-07	0.5660	-2.52e-01	-4.16e-01	-2.30e-01	-7.80e-02	-1.53e-01	-2.74e-02	8.14e-05	7.12e-11	3.08e-04	2.22e-01	1.65e-02	6.68e-01
GOBP INTESTINAL EPITHELIAL STRUCTURE MAINTENANCE	5	3.48e-01	4.65e-01	0.5660	-2.62e-01	1.08e-02	1.78e-02	4.21e-01	1.26e-01	2.40e-01	3.10e-01	9.67e-01	9.45e-01	1.03e-01	6.27e-01	3.52e-01
GOBP CELLULAR RESPONSE TO CAFFEINE	9	1.77e-01	2.92e-01	0.5660	-3.84e-01	-4.07e-01	-2.30e-02	-4.07e-02	-5.51e-02	-3.52e-02	4.59e-02	3.44e-02	9.05e-01	8.33e-01	7.75e-01	8.55e-01
GOBP REGULATION OF LYSOSOME SIZE	8	2.63e-01	3.83e-01	0.5660	-8.67e-02	-4.62e-01	-2.56e-02	6.30e-02	-1.44e-01	2.72e-01	6.71e-01	2.38e-02	9.00e-01	7.58e-01	4.81e-01	1.83e-01
GOCC BORC COMPLEX	8	2.63e-01	3.83e-01	0.5660	-8.67e-02	-4.62e-01	-2.56e-02	6.30e-02	-1.44e-01	2.72e-01	6.71e-01	2.38e-02	9.00e-01	7.58e-01	4.81e-01	1.83e-01
GOBP NEGATIVE REGULATION OF CARTILAGE DEVELOPMENT	12	5.67e-02	1.29e-01	0.5650	-1.74e-01	3.16e-01	2.32e-01	1.85e-01	2.00e-01	2.49e-01	2.95e-01	5.84e-02	1.65e-01	2.68e-01	2.31e-01	1.35e-01
GOMF SEMAPHORIN RECEPTOR ACTIVITY	11	1.04e-01	2.01e-01	0.5650	1.12e-01	3.54e-01	9.61e-02	2.02e-01	2.31e-01	-2.79e-01	5.22e-01	4.18e-02	5.81e-01	2.45e-01	1.84e-01	1.09e-01
GOBP NUCLEOTIDE BINDING OLIGOMERIZATION DOMAIN CONTAINING 2 SIGNALING PATHWAY	18	1.47e-05	1.20e-04	0.5650	-3.39e-01	3.38e-01	2.07e-01	-5.12e-02	1.20e-01	-1.75e-01	1.29e-02	1.30e-02	1.29e-01	7.07e-01	3.76e-01	1.98e-01
GOBP CELL MIGRATION INVOLVED IN GASTRULATION	8	2.26e-01	3.44e-01	0.5650	3.04e-01	1.75e-01	2.11e-01	3.32e-01	-1.14e-01	-1.72e-01	1.37e-01	3.92e-01	3.02e-01	1.04e-01	5.78e-01	3.98e-01
GOBP T CELL ACTIVATION VIA T CELL RECEPTOR CONTACT WITH ANTIGEN BOUND TO MHC MOLECULE ON ANTIGEN PRESENTING CELL	10	4.40e-02	1.07e-01	0.5650	-2.68e-02	-6.39e-02	-2.58e-03	2.93e-01	4.70e-01	-9.07e-02	8.83e-01	7.26e-01	9.89e-01	1.08e-01	1.01e-02	6.20e-01
GOBP FACULTATIVE HETEROCHROMATIN FORMATION	39	7.16e-05	5.04e-04	0.5650	1.19e-01	1.54e-01	6.17e-02	4.63e-01	2.43e-01	6.07e-02	1.97e-01	9.53e-02	5.05e-01	5.47e-07	8.60e-03	5.12e-01
GOBP PROTEIN LOCALIZATION TO BASOLATERAL PLASMA MEMBRANE	6	6.37e-01	7.12e-01	0.5650	-2.82e-01	-2.38e-01	-4.30e-03	-3.80e-01	-1.12e-01	1.62e-01	2.32e-01	3.13e-01	9.85e-01	1.07e-01	6.35e-01	4.92e-01
GOBP POSITIVE REGULATION OF MEMBRANE POTENTIAL	10	1.47e-01	2.57e-01	0.5650	-2.68e-01	-4.56e-01	3.01e-02	8.14e-02	-1.14e-01	1.38e-01	1.42e-01	1.26e-02	8.69e-01	6.56e-01	5.31e-01	4.49e-01
GOBP PROTEIN TRANSMEMBRANE TRANSPORT	67	3.64e-08	4.74e-07	0.5650	-3.19e-01	-3.71e-01	-2.08e-01	-1.16e-02	-1.69e-01	8.45e-02	6.17e-06	1.47e-07	3.26e-03	8.70e-01	1.66e-02	2.32e-01
GOBP RIBOSOMAL SMALL SUBUNIT EXPORT FROM NUCLEUS	8	4.85e-01	5.86e-01	0.5650	-2.25e-01	-4.12e-01	-2.49e-01	-1.53e-01	-1.02e-01	5.17e-02	2.71e-01	4.35e-02	2.22e-01	4.54e-01	6.18e-01	8.00e-01
GOMF NAD DEPENDENT HISTONE DEACETYLASE ACTIVITY	5	5.03e-01	5.99e-01	0.5640	8.98e-02	-3.16e-01	-1.54e-01	3.84e-01	-1.35e-01	-1.45e-01	7.28e-01	2.21e-01	5.51e-01	1.37e-01	6.01e-01	5.74e-01
GOBP NEGATIVE REGULATION OF OLIGODENDROCYTE DIFFERENTIATION	6	8.74e-02	1.78e-01	0.5640	-5.64e-02	8.59e-02	4.75e-01	-1.63e-01	-1.20e-01	-2.03e-01	8.11e-01	7.15e-01	4.37e-02	4.90e-01	6.11e-01	3.90e-01
GOCC ENDOPEPTIDASE COMPLEX	78	1.88e-13	4.39e-12	0.5640	-2.28e-01	-4.29e-01	5.74e-02	6.25e-02	-8.94e-02	2.60e-01	5.07e-04	5.84e-11	3.81e-01	3.40e-01	1.72e-01	7.37e-05
GOMF ALPHA GLUCOSIDASE ACTIVITY	6	2.22e-01	3.40e-01	0.5640	1.20e-01	3.79e-01	1.48e-01	3.78e-02	-2.13e-01	-3.02e-01	6.10e-01	1.08e-01	5.31e-01	8.73e-01	3.66e-01	2.00e-01
GOBP POSITIVE REGULATION OF NUCLEASE ACTIVITY	6	5.85e-01	6.69e-01	0.5640	2.08e-01	-5.09e-02	-1.01e-01	3.87e-01	2.07e-01	-2.63e-01	3.78e-01	8.29e-01	6.70e-01	1.01e-01	3.81e-01	2.64e-01
GOMF G PROTEIN BETA SUBUNIT BINDING	14	1.10e-01	2.09e-01	0.5640	-1.27e-01	-5.13e-02	2.82e-01	9.04e-02	-2.07e-01	4.11e-01	4.12e-01	7.40e-01	6.82e-02	5.58e-01	1.80e-01	7.78e-03
GOBP PROTEIN PEPTIDYL PROLYL ISOMERIZATION	16	4.84e-02	1.14e-01	0.5640	-2.84e-01	-4.31e-01	-1.26e-01	-1.35e-01	-2.46e-02	1.29e-01	4.94e-02	2.83e-03	3.82e-01	3.49e-01	8.65e-01	3.72e-01
GOBP POSITIVE REGULATION OF CHOLESTEROL BIOSYNTHETIC PROCESS	5	2.19e-01	3.37e-01	0.5640	-1.28e-01	-1.37e-01	-1.32e-02	4.35e-01	1.07e-01	-2.86e-01	6.21e-01	5.96e-01	9.59e-01	9.23e-02	6.77e-01	2.67e-01
GOBP CELL DIFFERENTIATION IN HINDBRAIN	15	4.64e-02	1.11e-01	0.5640	-5.47e-02	2.74e-01	-2.76e-03	1.19e-01	4.53e-01	1.42e-01	7.14e-01	6.66e-02	9.85e-01	4.23e-01	2.38e-03	3.40e-01
GOCC GID COMPLEX	5	5.58e-01	6.48e-01	0.5640	-1.75e-01	2.41e-02	3.37e-01	1.60e-01	-2.45e-01	2.94e-01	4.97e-01	9.26e-01	1.92e-01	5.35e-01	3.42e-01	2.54e-01
GOBP VASCULAR WOUND HEALING	15	1.90e-02	5.68e-02	0.5640	-2.25e-01	-1.35e-01	3.33e-01	-2.57e-01	-2.67e-01	-1.85e-02	1.31e-01	3.65e-01	2.54e-02	8.51e-02	7.37e-02	9.01e-01
GOBP SOMATIC DIVERSIFICATION OF IMMUNE RECEPTORS VIA SOMATIC MUTATION	14	1.44e-02	4.59e-02	0.5630	-1.09e-01	-2.00e-01	-9.50e-02	3.09e-01	8.08e-02	3.93e-01	4.82e-01	1.96e-01	5.38e-01	4.52e-02	6.01e-01	1.08e-02
GOBP REGULATION OF CELL CELL ADHESION MEDIATED BY INTEGRIN	10	2.74e-01	3.94e-01	0.5630	3.62e-01	9.21e-02	2.15e-01	1.72e-01	8.80e-02	3.07e-01	4.72e-02	6.14e-01	2.40e-01	3.48e-01	6.30e-01	9.27e-02
GOMF VASCULAR ENDOTHELIAL GROWTH FACTOR RECEPTOR BINDING	10	6.10e-02	1.37e-01	0.5630	-4.83e-01	-2.27e-01	9.38e-02	-1.43e-01	-4.27e-02	-4.14e-02	8.18e-03	2.15e-01	6.08e-01	4.35e-01	8.15e-01	8.21e-01
GOMF SEQUENCE SPECIFIC SINGLE STRANDED DNA BINDING	14	1.21e-02	4.00e-02	0.5630	-9.44e-02	-2.32e-01	-3.71e-01	3.32e-01	1.91e-02	8.03e-02	5.41e-01	1.32e-01	1.63e-02	3.16e-02	9.01e-01	6.03e-01
GOBP TRIGLYCERIDE CATABOLIC PROCESS	16	6.61e-02	1.45e-01	0.5630	-1.61e-02	1.18e-01	3.66e-01	-1.06e-02	-3.35e-01	2.38e-01	9.11e-01	4.12e-01	1.12e-02	9.42e-01	2.05e-02	9.92e-02
GOMF SINGLE STRANDED DNA ENDODEOXYRIBONUCLEASE ACTIVITY	11	1.39e-01	2.48e-01	0.5630	-7.32e-02	-1.77e-01	-3.52e-01	9.16e-02	3.84e-01	-2.79e-02	6.74e-01	3.10e-01	4.31e-02	5.99e-01	2.76e-02	8.73e-01
GOBP ORGANELLE INHERITANCE	15	1.98e-02	5.87e-02	0.5630	-1.47e-01	-2.05e-01	3.19e-01	1.69e-01	-2.73e-01	2.21e-01	3.25e-01	1.70e-01	3.25e-02	2.58e-01	6.67e-02	1.39e-01
GOCC GRANULAR COMPONENT	7	4.63e-01	5.67e-01	0.5630	-2.59e-01	-2.98e-01	-3.53e-01	1.58e-01	1.01e-01	2.39e-02	2.35e-01	1.72e-01	1.05e-01	4.68e-01	6.42e-01	9.13e-01
GOBP PROSTHETIC GROUP METABOLIC PROCESS	6	4.67e-01	5.70e-01	0.5630	-1.74e-01	-1.19e-01	-2.07e-01	2.62e-01	3.97e-01	5.83e-02	4.62e-01	6.13e-01	3.80e-01	2.66e-01	9.25e-02	8.05e-01
GOBP HYALURONAN BIOSYNTHETIC PROCESS	12	5.16e-02	1.20e-01	0.5630	1.72e-01	8.20e-02	9.77e-02	3.78e-01	2.70e-01	-2.35e-01	3.01e-01	6.23e-01	5.58e-01	2.33e-02	1.06e-01	1.60e-01
GOMF 3 HYDROXYACYL COA DEHYDROGENASE ACTIVITY	6	6.83e-01	7.49e-01	0.5630	-1.98e-01	-4.07e-01	-2.31e-01	-9.73e-02	-2.17e-01	3.96e-02	4.00e-01	8.41e-02	3.28e-01	6.80e-01	3.56e-01	8.67e-01
GOBP COMMON MYELOID PROGENITOR CELL PROLIFERATION	8	4.52e-02	1.09e-01	0.5630	-3.11e-01	-1.27e-01	-8.96e-02	1.93e-01	3.72e-02	-3.97e-01	1.28e-01	5.33e-01	6.61e-01	3.45e-01	8.55e-01	5.19e-02
GOBP REGULATION OF ADENYLATE CYCLASE ACTIVATING G PROTEIN COUPLED RECEPTOR SIGNALING PATHWAY	16	1.99e-02	5.91e-02	0.5630	1.56e-01	1.90e-02	2.76e-01	4.46e-01	5.83e-02	1.14e-01	2.81e-01	8.95e-01	5.58e-02	1.99e-03	6.86e-01	4.29e-01
GOBP NEGATIVE REGULATION OF EXECUTION PHASE OF APOPTOSIS	6	2.42e-01	3.59e-01	0.5630	-9.67e-02	1.08e-01	1.25e-01	2.67e-01	-1.81e-01	4.19e-01	6.82e-01	6.48e-01	5.97e-01	2.57e-01	4.44e-01	7.52e-02
GOBP POSITIVE REGULATION OF INTRINSIC APOPTOTIC SIGNALING PATHWAY IN RESPONSE TO DNA DAMAGE	7	1.81e-01	2.96e-01	0.5630	-1.17e-01	-2.14e-01	-1.47e-01	3.81e-01	-9.46e-03	-3.01e-01	5.93e-01	3.26e-01	5.02e-01	8.13e-02	9.65e-01	1.68e-01
GOBP PHENOL CONTAINING COMPOUND CATABOLIC PROCESS	8	1.60e-01	2.72e-01	0.5630	6.96e-02	-3.87e-01	-3.05e-02	2.29e-01	-2.23e-01	-2.43e-01	7.33e-01	5.82e-02	8.81e-01	2.61e-01	2.75e-01	2.34e-01
GOBP MEIOTIC SISTER CHROMATID COHESION	12	7.70e-02	1.62e-01	0.5630	-1.13e-01	-1.28e-01	1.42e-01	2.99e-01	3.43e-02	4.21e-01	4.99e-01	4.43e-01	3.96e-01	7.33e-02	8.37e-01	1.16e-02
GOBP TRANSLATION	615	1.30e-84	1.21e-81	0.5620	-1.69e-01	-4.33e-01	-3.01e-01	2.65e-02	-7.29e-02	-6.16e-02	7.40e-13	1.85e-75	2.42e-37	2.63e-01	2.04e-03	9.14e-03
GOMF SUPEROXIDE GENERATING NAD P H OXIDASE ACTIVITY	6	3.45e-01	4.62e-01	0.5620	1.27e-01	3.07e-01	1.88e-01	-3.98e-01	8.30e-02	7.41e-02	5.89e-01	1.93e-01	4.26e-01	9.17e-02	7.25e-01	7.53e-01
GOBP NEGATIVE REGULATION OF FATTY ACID BETA OXIDATION	6	1.88e-01	3.03e-01	0.5620	-3.59e-02	2.54e-01	-3.27e-01	2.70e-02	-1.16e-01	-3.59e-01	8.79e-01	2.81e-01	1.65e-01	9.09e-01	6.22e-01	1.28e-01
GOBP BONE CELL DEVELOPMENT	17	6.72e-03	2.50e-02	0.5620	-1.70e-01	3.18e-02	4.70e-01	-4.41e-02	-3.94e-02	2.49e-01	2.24e-01	8.21e-01	7.95e-04	7.53e-01	7.79e-01	7.59e-02
GOBP REGULATION OF PROTEIN ADP RIBOSYLATION	8	1.93e-01	3.09e-01	0.5620	1.35e-02	-3.30e-01	-3.64e-01	1.85e-01	1.67e-01	1.13e-01	9.47e-01	1.06e-01	7.45e-02	3.66e-01	4.14e-01	5.80e-01
GOBP MEMBRANE TUBULATION	5	4.17e-01	5.27e-01	0.5620	-3.28e-01	-2.60e-02	3.69e-01	1.35e-02	-2.27e-01	1.40e-01	2.04e-01	9.20e-01	1.53e-01	9.58e-01	3.80e-01	5.88e-01
GOBP REGULATION OF NUCLEOTIDE BINDING DOMAIN LEUCINE RICH REPEAT CONTAINING RECEPTOR SIGNALING PATHWAY	14	2.83e-03	1.24e-02	0.5620	-2.84e-01	3.72e-01	2.23e-01	6.18e-02	2.05e-01	3.59e-02	6.54e-02	1.59e-02	1.49e-01	6.89e-01	1.85e-01	8.16e-01
GOBP RESPONSE TO GLYCOPROTEIN	9	2.26e-01	3.44e-01	0.5620	-1.21e-01	1.08e-01	2.12e-01	2.96e-01	1.60e-01	3.63e-01	5.28e-01	5.76e-01	2.72e-01	1.24e-01	4.07e-01	5.93e-02
GOMF THREONINE TYPE PEPTIDASE ACTIVITY	13	1.11e-02	3.74e-02	0.5620	-2.36e-02	-3.05e-01	-1.88e-01	1.36e-01	4.09e-01	4.24e-02	8.83e-01	5.71e-02	2.41e-01	3.97e-01	1.07e-02	7.91e-01
GOBP NEGATIVE REGULATION OF ALPHA BETA T CELL ACTIVATION	40	4.69e-04	2.67e-03	0.5620	1.21e-01	1.31e-01	3.82e-01	1.20e-01	-1.54e-01	3.17e-01	1.87e-01	1.53e-01	2.95e-05	1.87e-01	9.17e-02	5.27e-04
GOBP CHOLESTEROL IMPORT	7	1.04e-01	2.00e-01	0.5620	-2.15e-01	1.62e-01	3.31e-01	-9.93e-02	3.15e-01	1.58e-01	3.26e-01	4.58e-01	1.30e-01	6.49e-01	1.49e-01	4.68e-01
GOBP REGULATION OF LIPID KINASE ACTIVITY	7	3.87e-01	5.00e-01	0.5620	-2.29e-01	2.87e-01	2.18e-01	-9.84e-02	3.15e-02	3.50e-01	2.95e-01	1.89e-01	3.17e-01	6.52e-01	8.85e-01	1.08e-01
GOBP PURINE NUCLEOSIDE CATABOLIC PROCESS	7	6.10e-01	6.89e-01	0.5620	2.33e-01	6.36e-02	-1.26e-01	2.75e-01	4.07e-01	-1.42e-02	2.87e-01	7.71e-01	5.63e-01	2.07e-01	6.23e-02	9.48e-01
GOBP TRANSEPITHELIAL TRANSPORT	20	2.39e-02	6.78e-02	0.5620	-4.74e-03	2.40e-01	4.07e-01	1.41e-01	2.21e-02	2.67e-01	9.71e-01	6.26e-02	1.61e-03	2.73e-01	8.64e-01	3.89e-02
GOBP REGULATION OF BROWN FAT CELL DIFFERENTIATION	18	1.14e-02	3.83e-02	0.5610	4.84e-03	4.18e-01	3.01e-01	1.04e-01	1.95e-01	2.96e-02	9.72e-01	2.14e-03	2.70e-02	4.45e-01	1.52e-01	8.28e-01
GOBP NEGATIVE REGULATION OF CELL VOLUME	5	6.55e-01	7.26e-01	0.5610	-2.80e-01	-1.29e-01	3.12e-01	-2.61e-01	-1.81e-01	1.48e-01	2.78e-01	6.16e-01	2.27e-01	3.13e-01	4.84e-01	5.66e-01
GOBP SPHINGOMYELIN CATABOLIC PROCESS	7	4.15e-01	5.26e-01	0.5610	6.06e-02	-2.77e-02	1.78e-01	4.06e-01	1.63e-02	3.37e-01	7.81e-01	8.99e-01	4.14e-01	6.27e-02	9.41e-01	1.23e-01
GOBP PROTEIN O LINKED FUCOSYLATION	5	5.03e-01	5.99e-01	0.5610	6.47e-02	-1.06e-01	-1.00e-01	3.42e-01	2.13e-01	-3.57e-01	8.02e-01	6.83e-01	6.98e-01	1.86e-01	4.09e-01	1.67e-01
GOBP PROGRAMMED CELL DEATH IN RESPONSE TO REACTIVE OXYGEN SPECIES	13	3.32e-01	4.49e-01	0.5610	-3.09e-01	-2.75e-01	-1.12e-01	-2.26e-01	-2.76e-01	6.71e-02	5.39e-02	8.65e-02	4.86e-01	1.58e-01	8.50e-02	6.75e-01
GOBP REGULATION OF FLAGELLATED SPERM MOTILITY	5	6.97e-01	7.59e-01	0.5610	1.12e-01	3.06e-01	4.01e-01	-9.27e-02	-1.90e-01	5.05e-02	6.65e-01	2.35e-01	1.20e-01	7.20e-01	4.62e-01	8.45e-01
GOBP FUCOSE METABOLIC PROCESS	13	1.89e-01	3.05e-01	0.5610	-2.31e-01	-1.58e-01	-2.90e-01	-1.02e-01	9.49e-02	-3.64e-01	1.49e-01	3.25e-01	7.02e-02	5.24e-01	5.54e-01	2.30e-02
GOMF UBIQUITIN LIGASE COMPLEX SCAFFOLD ACTIVITY	6	3.45e-01	4.62e-01	0.5610	-1.65e-01	-3.66e-01	1.41e-01	1.77e-01	3.52e-02	3.17e-01	4.83e-01	1.21e-01	5.50e-01	4.52e-01	8.81e-01	1.78e-01
GOBP MRNA PSEUDOURIDINE SYNTHESIS	9	1.83e-01	2.97e-01	0.5610	3.27e-03	-4.57e-01	-2.76e-01	4.60e-02	-1.57e-01	5.14e-02	9.86e-01	1.76e-02	1.52e-01	8.11e-01	4.15e-01	7.89e-01
GOBP EMBRYONIC NEUROCRANIUM MORPHOGENESIS	7	5.35e-01	6.27e-01	0.5610	4.88e-02	3.38e-01	4.02e-02	2.57e-01	3.05e-01	1.92e-01	8.23e-01	1.21e-01	8.54e-01	2.39e-01	1.63e-01	3.79e-01
GOMF MANNOSYL OLIGOSACCHARIDE MANNOSIDASE ACTIVITY	9	1.68e-01	2.81e-01	0.5610	-2.85e-01	1.88e-02	2.70e-01	1.37e-01	6.28e-02	3.70e-01	1.39e-01	9.22e-01	1.61e-01	4.77e-01	7.44e-01	5.43e-02
GOBP VENTRICULAR CARDIAC MUSCLE CELL MEMBRANE REPOLARIZATION	17	1.08e-01	2.07e-01	0.5610	-1.51e-01	2.23e-02	2.46e-01	-2.41e-01	-2.49e-01	3.32e-01	2.80e-01	8.74e-01	7.95e-02	8.51e-02	7.57e-02	1.77e-02
GOCC TRANSCRIPTION EXPORT COMPLEX 2	5	6.72e-01	7.39e-01	0.5610	-2.89e-01	-4.00e-01	-1.52e-01	-1.78e-01	1.18e-02	1.25e-01	2.63e-01	1.21e-01	5.56e-01	4.91e-01	9.63e-01	6.28e-01
GOBP TROPHECTODERMAL CELL DIFFERENTIATION	14	1.02e-01	1.98e-01	0.5600	5.97e-02	3.37e-01	2.58e-01	2.75e-01	2.09e-01	1.06e-01	6.99e-01	2.90e-02	9.51e-02	7.44e-02	1.76e-01	4.93e-01
GOMF CYSTEINE TYPE ENDOPEPTIDASE ACTIVITY INVOLVED IN APOPTOTIC SIGNALING PATHWAY	6	1.71e-01	2.85e-01	0.5600	-4.81e-01	-1.05e-02	-1.54e-01	1.75e-01	-5.51e-02	1.57e-01	4.11e-02	9.64e-01	5.13e-01	4.58e-01	8.15e-01	5.04e-01
GOCC AZUROPHIL GRANULE	151	2.92e-24	1.73e-22	0.5600	-3.48e-01	-2.35e-01	1.74e-01	9.27e-03	-2.46e-01	2.16e-01	1.54e-13	5.97e-07	2.24e-04	8.44e-01	1.88e-07	4.42e-06
GOBP DNA DAMAGE RESPONSE SIGNAL TRANSDUCTION RESULTING IN TRANSCRIPTION	16	4.44e-02	1.08e-01	0.5600	9.41e-02	-3.13e-01	-3.13e-01	2.47e-01	1.84e-01	-1.18e-01	5.15e-01	3.01e-02	3.02e-02	8.72e-02	2.02e-01	4.15e-01
GOMF STEROID HORMONE BINDING	5	1.29e-01	2.35e-01	0.5600	-2.19e-01	7.36e-02	3.04e-01	2.33e-01	-3.22e-01	-9.76e-02	3.97e-01	7.76e-01	2.39e-01	3.67e-01	2.12e-01	7.06e-01
GOMF CYTOSKELETON NUCLEAR MEMBRANE ANCHOR ACTIVITY	5	4.67e-01	5.70e-01	0.5600	7.00e-02	5.22e-01	3.84e-02	1.61e-01	9.33e-02	1.84e-02	7.86e-01	4.34e-02	8.82e-01	5.34e-01	7.18e-01	9.43e-01
GOBP PYRIMIDINE NUCLEOSIDE TRIPHOSPHATE BIOSYNTHETIC PROCESS	17	1.08e-02	3.67e-02	0.5600	-8.28e-02	-5.09e-01	-1.52e-01	1.51e-01	-5.88e-03	4.01e-02	5.55e-01	2.81e-04	2.79e-01	2.81e-01	9.67e-01	7.75e-01
GOBP NEGATIVE REGULATION OF MOTOR NEURON APOPTOTIC PROCESS	10	1.81e-01	2.96e-01	0.5600	-2.41e-01	2.86e-03	-1.34e-01	-4.60e-01	-1.43e-01	6.94e-02	1.87e-01	9.87e-01	4.63e-01	1.17e-02	4.34e-01	7.04e-01
GOBP POSITIVE REGULATION OF UNSATURATED FATTY ACID BIOSYNTHETIC PROCESS	6	9.23e-02	1.85e-01	0.5600	-4.59e-02	1.31e-01	1.07e-01	-3.61e-02	3.31e-01	-4.14e-01	8.45e-01	5.80e-01	6.49e-01	8.78e-01	1.60e-01	7.89e-02
GOBP ASPARTATE FAMILY AMINO ACID CATABOLIC PROCESS	11	3.03e-03	1.30e-02	0.5600	1.57e-01	-3.39e-01	-1.67e-01	-1.20e-01	3.26e-01	-1.57e-01	3.67e-01	5.17e-02	3.38e-01	4.90e-01	6.08e-02	3.66e-01
GOBP NUCLEOSIDE BISPHOSPHATE CATABOLIC PROCESS	12	4.07e-02	1.01e-01	0.5590	-5.91e-02	-4.57e-01	1.14e-01	1.39e-01	-7.89e-02	2.49e-01	7.23e-01	6.09e-03	4.95e-01	4.06e-01	6.36e-01	1.36e-01
GOCC CORTICAL ENDOPLASMIC RETICULUM	7	4.62e-01	5.66e-01	0.5590	-3.66e-01	-3.47e-01	-9.73e-02	5.58e-02	-2.13e-01	-2.21e-02	9.39e-02	1.12e-01	6.56e-01	7.98e-01	3.29e-01	9.19e-01
GOMF C4 DICARBOXYLATE TRANSMEMBRANE TRANSPORTER ACTIVITY	12	5.59e-02	1.28e-01	0.5590	1.58e-01	-4.10e-01	-1.37e-01	3.06e-01	-1.84e-02	-8.19e-02	3.44e-01	1.39e-02	4.10e-01	6.61e-02	9.12e-01	6.23e-01
GOCC RIBBON SYNAPSE	11	1.49e-01	2.60e-01	0.5590	1.64e-01	2.00e-01	2.54e-02	4.65e-01	1.32e-01	-1.08e-01	3.47e-01	2.51e-01	8.84e-01	7.59e-03	4.49e-01	5.34e-01
GOBP PARANODAL JUNCTION ASSEMBLY	6	5.75e-01	6.61e-01	0.5590	5.34e-02	-2.68e-01	1.73e-01	-2.56e-01	-3.76e-01	3.22e-02	8.21e-01	2.55e-01	4.63e-01	2.78e-01	1.11e-01	8.91e-01
GOBP MELANOCYTE DIFFERENTIATION	13	6.06e-02	1.36e-01	0.5590	-3.14e-01	6.17e-02	-8.73e-02	-4.33e-01	1.16e-02	1.23e-01	5.00e-02	7.00e-01	5.86e-01	6.92e-03	9.42e-01	4.43e-01
GOBP CRANIAL NERVE MORPHOGENESIS	19	1.09e-02	3.68e-02	0.5590	4.80e-03	1.88e-01	7.43e-02	2.10e-01	4.70e-01	7.98e-02	9.71e-01	1.57e-01	5.75e-01	1.13e-01	3.85e-04	5.47e-01
GOBP HEART TRABECULA FORMATION	7	7.28e-02	1.55e-01	0.5590	-2.95e-01	-2.92e-02	-8.14e-02	2.77e-01	-1.76e-01	3.32e-01	1.77e-01	8.94e-01	7.09e-01	2.05e-01	4.20e-01	1.28e-01
GOBP TRNA WOBBLE BASE MODIFICATION	20	3.53e-02	9.06e-02	0.5590	-5.91e-02	-3.63e-01	-3.78e-01	8.35e-02	2.79e-03	-1.64e-01	6.47e-01	4.93e-03	3.43e-03	5.18e-01	9.83e-01	2.04e-01
GOBP REGULATION OF ENTRY OF BACTERIUM INTO HOST CELL	5	4.95e-01	5.93e-01	0.5590	-2.77e-01	1.31e-02	2.33e-01	-3.65e-01	-1.64e-01	-1.44e-01	2.83e-01	9.60e-01	3.66e-01	1.58e-01	5.25e-01	5.78e-01
GOCC NUCLEOTIDE ACTIVATED PROTEIN KINASE COMPLEX	8	3.36e-02	8.72e-02	0.5590	-3.60e-01	1.19e-01	2.49e-03	2.47e-01	-1.19e-01	3.05e-01	7.77e-02	5.59e-01	9.90e-01	2.26e-01	5.61e-01	1.36e-01
GOBP INTESTINAL EPITHELIAL CELL DEVELOPMENT	12	1.61e-01	2.73e-01	0.5590	-7.47e-02	1.46e-01	4.27e-01	-1.87e-01	-3.41e-02	2.58e-01	6.54e-01	3.81e-01	1.05e-02	2.61e-01	8.38e-01	1.22e-01
GOBP POSITIVE REGULATION OF TRIGLYCERIDE BIOSYNTHETIC PROCESS	12	5.17e-02	1.20e-01	0.5580	-3.54e-02	5.39e-02	-1.37e-01	2.95e-01	2.16e-01	-3.94e-01	8.32e-01	7.47e-01	4.13e-01	7.71e-02	1.94e-01	1.81e-02
GOBP PROTEIN IMPORT INTO PEROXISOME MEMBRANE	6	4.20e-01	5.30e-01	0.5580	-4.27e-01	-2.70e-01	-1.08e-01	-9.10e-03	1.74e-01	1.21e-01	7.03e-02	2.52e-01	6.45e-01	9.69e-01	4.60e-01	6.08e-01
GOBP TELOMERIC LOOP DISASSEMBLY	11	1.18e-01	2.21e-01	0.5580	1.99e-01	-6.60e-02	-5.71e-03	5.13e-01	4.65e-02	-5.20e-02	2.54e-01	7.05e-01	9.74e-01	3.23e-03	7.90e-01	7.65e-01
GOMF TFIID CLASS TRANSCRIPTION FACTOR COMPLEX BINDING	10	3.65e-01	4.80e-01	0.5580	-2.30e-02	-3.54e-01	-3.32e-01	-5.08e-02	-3.82e-02	-2.68e-01	9.00e-01	5.28e-02	6.92e-02	7.81e-01	8.34e-01	1.42e-01
GOBP MITOTIC DNA REPLICATION	17	1.17e-02	3.88e-02	0.5580	1.11e-01	-2.29e-01	1.26e-01	2.84e-01	-1.45e-01	3.59e-01	4.27e-01	1.02e-01	3.70e-01	4.27e-02	3.00e-01	1.03e-02
GOBP DICARBOXYLIC ACID BIOSYNTHETIC PROCESS	11	1.44e-01	2.53e-01	0.5580	-1.12e-01	-1.03e-01	-2.40e-01	2.59e-01	3.93e-01	9.39e-02	5.19e-01	5.54e-01	1.68e-01	1.37e-01	2.39e-02	5.90e-01
GOMF CHEMOKINE ACTIVITY	20	3.02e-03	1.30e-02	0.5580	1.16e-01	-7.17e-02	3.02e-01	-2.61e-01	-3.40e-01	-1.32e-01	3.70e-01	5.79e-01	1.92e-02	4.30e-02	8.49e-03	3.05e-01
GOMF VOLTAGE GATED MONOATOMIC ANION CHANNEL ACTIVITY	13	3.77e-01	4.92e-01	0.5580	-2.93e-01	-2.34e-01	-1.89e-01	-2.71e-01	-1.90e-01	-1.59e-01	6.71e-02	1.44e-01	2.38e-01	9.10e-02	2.35e-01	3.20e-01
GOMF CYSTEINE TYPE ENDOPEPTIDASE INHIBITOR ACTIVITY INVOLVED IN APOPTOTIC PROCESS	17	4.97e-02	1.17e-01	0.5580	-9.53e-02	-4.00e-02	2.22e-01	8.59e-03	-1.69e-01	4.72e-01	4.96e-01	7.75e-01	1.14e-01	9.51e-01	2.26e-01	7.52e-04
GOBP REGULATION OF CAVEOLIN MEDIATED ENDOCYTOSIS	5	1.22e-01	2.26e-01	0.5580	-4.91e-02	-1.64e-01	-2.25e-02	-1.45e-01	4.01e-01	-3.17e-01	8.49e-01	5.26e-01	9.31e-01	5.75e-01	1.21e-01	2.20e-01
GOCC PROCENTRIOLE REPLICATION COMPLEX	6	3.94e-01	5.06e-01	0.5580	-5.00e-02	1.15e-01	-1.15e-01	6.86e-02	4.65e-01	2.47e-01	8.32e-01	6.26e-01	6.26e-01	7.71e-01	4.83e-02	2.94e-01
GOBP VESICLE UNCOATING	7	1.44e-01	2.54e-01	0.5580	4.32e-02	9.66e-02	2.66e-01	4.68e-01	-9.57e-02	2.07e-02	8.43e-01	6.58e-01	2.23e-01	3.19e-02	6.61e-01	9.24e-01
GOBP GLOMERULUS MORPHOGENESIS	7	3.72e-01	4.87e-01	0.5580	-8.28e-02	1.83e-01	3.63e-01	2.31e-01	1.27e-01	2.64e-01	7.04e-01	4.03e-01	9.62e-02	2.91e-01	5.62e-01	2.27e-01
GOBP EPIDERMIS MORPHOGENESIS	19	2.63e-02	7.28e-02	0.5570	1.35e-01	2.79e-01	4.01e-01	5.79e-02	1.73e-01	1.45e-01	3.10e-01	3.55e-02	2.49e-03	6.62e-01	1.91e-01	2.74e-01
GOBP REGULATION OF T CELL ACTIVATION VIA T CELL RECEPTOR CONTACT WITH ANTIGEN BOUND TO MHC MOLECULE ON ANTIGEN PRESENTING CELL	6	2.73e-01	3.93e-01	0.5570	7.91e-02	-3.13e-01	-1.03e-01	2.67e-01	3.20e-01	-1.48e-01	7.37e-01	1.84e-01	6.61e-01	2.57e-01	1.75e-01	5.31e-01
GOBP POSITIVE REGULATION OF PHOSPHOLIPID METABOLIC PROCESS	6	4.08e-01	5.19e-01	0.5570	-4.56e-01	1.21e-01	1.36e-01	-1.57e-01	-1.21e-01	1.72e-01	5.30e-02	6.08e-01	5.63e-01	5.04e-01	6.08e-01	4.65e-01
GOBP CARDIAC MUSCLE CELL PROLIFERATION	36	1.83e-05	1.45e-04	0.5570	2.40e-02	3.24e-01	3.39e-01	2.61e-01	4.92e-02	1.39e-01	8.03e-01	7.64e-04	4.36e-04	6.74e-03	6.10e-01	1.48e-01
GOBP RESPONSE TO INTERLEUKIN 4	34	2.95e-04	1.77e-03	0.5570	1.29e-01	6.11e-02	1.56e-01	4.52e-01	1.59e-01	1.89e-01	1.93e-01	5.38e-01	1.16e-01	5.07e-06	1.08e-01	5.68e-02
GOBP ENDOSOME TO LYSOSOME TRANSPORT VIA MULTIVESICULAR BODY SORTING PATHWAY	16	1.63e-02	5.04e-02	0.5570	-1.86e-01	-4.18e-01	-5.11e-02	1.91e-01	-1.19e-04	2.47e-01	1.98e-01	3.78e-03	7.23e-01	1.85e-01	9.99e-01	8.69e-02
GOCC RIBONUCLEOPROTEIN COMPLEX	683	2.17e-100	1.01e-96	0.5570	-1.35e-01	-4.26e-01	-3.17e-01	7.83e-02	-4.23e-02	-4.32e-02	2.00e-09	6.63e-81	2.22e-45	4.93e-04	5.95e-02	5.46e-02
GOBP AMINO SUGAR BIOSYNTHETIC PROCESS	11	4.02e-02	9.99e-02	0.5560	-1.98e-01	-3.50e-02	-2.67e-01	-3.39e-02	-3.39e-01	-2.87e-01	2.56e-01	8.41e-01	1.25e-01	8.45e-01	5.18e-02	9.96e-02
GOBP POSITIVE REGULATION OF GRANULOCYTE MACROPHAGE COLONY STIMULATING FACTOR PRODUCTION	9	2.29e-01	3.47e-01	0.5560	-1.30e-01	2.31e-01	-1.78e-01	-2.46e-02	2.93e-01	-3.48e-01	4.98e-01	2.31e-01	3.54e-01	8.98e-01	1.28e-01	7.09e-02
GOBP REGULATORY NCRNA MEDIATED HETEROCHROMATIN FORMATION	11	3.66e-01	4.81e-01	0.5560	1.76e-01	1.50e-01	3.27e-01	1.04e-01	9.21e-02	3.60e-01	3.13e-01	3.88e-01	6.03e-02	5.49e-01	5.97e-01	3.87e-02
GOMF MONOCARBOXYLATE SODIUM SYMPORTER ACTIVITY	6	3.57e-01	4.73e-01	0.5560	1.93e-01	9.38e-02	3.62e-01	-8.93e-03	-3.23e-01	-1.67e-01	4.12e-01	6.91e-01	1.25e-01	9.70e-01	1.71e-01	4.77e-01
GOCC U2 TYPE SPLICEOSOMAL COMPLEX	92	2.92e-15	7.93e-14	0.5560	-1.31e-01	-3.56e-01	-3.03e-01	2.44e-01	9.29e-02	7.58e-02	2.95e-02	3.73e-09	5.01e-07	5.36e-05	1.24e-01	2.09e-01
GOBP SNRNA CATABOLIC PROCESS	5	5.64e-01	6.52e-01	0.5560	-3.76e-01	-1.73e-01	-1.78e-01	-1.15e-01	1.93e-01	2.37e-01	1.46e-01	5.04e-01	4.91e-01	6.57e-01	4.55e-01	3.59e-01
GOBP POSITIVE REGULATION OF EXECUTION PHASE OF APOPTOSIS	11	1.01e-01	1.97e-01	0.5560	2.52e-01	9.27e-02	1.97e-01	4.35e-01	-8.39e-02	-3.54e-02	1.47e-01	5.95e-01	2.57e-01	1.24e-02	6.30e-01	8.39e-01
GOBP HIPPOCAMPAL NEURON APOPTOTIC PROCESS	5	8.28e-01	8.61e-01	0.5560	3.17e-01	1.34e-01	-1.42e-01	3.18e-01	2.51e-01	-8.30e-02	2.20e-01	6.04e-01	5.84e-01	2.18e-01	3.32e-01	7.48e-01
GOBP IMPORT INTO THE MITOCHONDRION	49	1.46e-05	1.19e-04	0.5560	-1.77e-01	-4.63e-01	-2.08e-01	-6.95e-02	-1.18e-01	-3.82e-02	3.17e-02	2.09e-08	1.16e-02	4.00e-01	1.54e-01	6.44e-01
GOMF GLYCEROL CHANNEL ACTIVITY	5	6.00e-01	6.81e-01	0.5560	-6.99e-02	-3.42e-02	-7.49e-02	-4.26e-01	-3.40e-01	9.29e-03	7.87e-01	8.95e-01	7.72e-01	9.93e-02	1.87e-01	9.71e-01
GOBP POSITIVE REGULATION OF GLIAL CELL PROLIFERATION	18	9.38e-03	3.26e-02	0.5560	-2.55e-01	2.01e-01	2.10e-01	-8.56e-02	1.93e-01	3.38e-01	6.10e-02	1.40e-01	1.22e-01	5.30e-01	1.57e-01	1.30e-02
GOBP REGULATION OF METAPHASE PLATE CONGRESSION	14	2.68e-02	7.37e-02	0.5550	1.67e-02	-1.14e-01	2.25e-01	4.31e-01	-2.82e-02	2.40e-01	9.14e-01	4.60e-01	1.46e-01	5.19e-03	8.55e-01	1.19e-01
GOMF ALPHA ACTININ BINDING	17	9.17e-02	1.84e-01	0.5550	-4.91e-02	3.11e-02	4.29e-01	-4.42e-02	-1.85e-01	2.91e-01	7.26e-01	8.24e-01	2.19e-03	7.52e-01	1.86e-01	3.78e-02
GOBP CELLULAR RESPONSE TO GROWTH HORMONE STIMULUS	20	1.78e-02	5.38e-02	0.5550	-3.29e-02	2.49e-01	2.82e-01	2.12e-01	1.89e-02	3.47e-01	7.99e-01	5.40e-02	2.89e-02	1.01e-01	8.84e-01	7.21e-03
GOBP POSITIVE REGULATION OF VESICLE FUSION	7	5.26e-01	6.19e-01	0.5550	-1.40e-01	-2.28e-01	2.54e-01	-1.96e-01	-1.60e-01	3.28e-01	5.21e-01	2.97e-01	2.44e-01	3.68e-01	4.64e-01	1.32e-01
GOBP CELLULAR RESPONSE TO L LEUCINE	12	1.28e-01	2.34e-01	0.5550	8.51e-02	3.51e-01	2.60e-01	3.08e-01	6.72e-02	1.03e-01	6.10e-01	3.55e-02	1.19e-01	6.44e-02	6.87e-01	5.37e-01
GOBP PROTEIN IMPORT INTO PEROXISOME MATRIX	14	2.64e-01	3.84e-01	0.5550	-2.28e-01	-2.63e-01	-3.77e-01	-2.62e-02	-2.71e-03	-2.09e-01	1.39e-01	8.84e-02	1.46e-02	8.65e-01	9.86e-01	1.76e-01
GOBP NEGATIVE REGULATION OF PERK MEDIATED UNFOLDED PROTEIN RESPONSE	7	4.81e-01	5.82e-01	0.5550	-9.38e-02	-8.36e-02	3.71e-01	-1.57e-01	-3.55e-01	6.08e-02	6.67e-01	7.02e-01	8.90e-02	4.71e-01	1.04e-01	7.81e-01
GOBP NUCLEAR MRNA SURVEILLANCE	11	2.89e-01	4.09e-01	0.5550	-5.87e-02	-3.15e-01	-4.14e-01	-2.98e-02	3.77e-02	-1.78e-01	7.36e-01	7.05e-02	1.75e-02	8.64e-01	8.29e-01	3.06e-01
GOBP POSITIVE REGULATION OF HOMOTYPIC CELL CELL ADHESION	13	9.19e-02	1.84e-01	0.5540	-1.84e-01	-2.03e-01	3.42e-01	-1.76e-01	-1.66e-01	2.38e-01	2.52e-01	2.05e-01	3.27e-02	2.71e-01	3.01e-01	1.37e-01
GOBP DEOXYRIBONUCLEOTIDE BIOSYNTHETIC PROCESS	14	2.64e-02	7.30e-02	0.5540	-1.00e-01	-4.33e-01	-1.57e-01	1.18e-01	-6.87e-03	2.66e-01	5.16e-01	4.98e-03	3.09e-01	4.46e-01	9.64e-01	8.50e-02
GOBP CELLULAR RESPIRATION	224	2.04e-33	2.49e-31	0.5540	-1.75e-01	-4.83e-01	-1.81e-01	3.04e-02	-9.17e-02	3.46e-02	6.46e-06	9.87e-36	3.23e-06	4.32e-01	1.81e-02	3.72e-01
GOMF MONOATOMIC ANION SODIUM SYMPORTER ACTIVITY	12	1.96e-01	3.12e-01	0.5540	3.45e-01	2.52e-01	3.06e-01	1.07e-01	-1.37e-01	-2.02e-02	3.85e-02	1.31e-01	6.65e-02	5.20e-01	4.10e-01	9.04e-01
GOBP SHORT TERM MEMORY	8	2.51e-01	3.70e-01	0.5540	-2.46e-01	-1.20e-01	4.16e-02	1.23e-01	-4.20e-02	4.61e-01	2.27e-01	5.58e-01	8.39e-01	5.46e-01	8.37e-01	2.38e-02
GOBP NEGATIVE REGULATION OF MACROPHAGE DIFFERENTIATION	5	2.28e-01	3.47e-01	0.5540	-1.06e-01	-8.75e-02	4.52e-01	2.63e-01	-7.68e-02	9.40e-02	6.81e-01	7.35e-01	8.04e-02	3.09e-01	7.66e-01	7.16e-01
GOBP POSITIVE REGULATION OF PROTEIN EXIT FROM ENDOPLASMIC RETICULUM	12	7.77e-02	1.63e-01	0.5540	-1.77e-01	1.70e-01	2.11e-01	2.43e-01	1.88e-01	3.29e-01	2.89e-01	3.07e-01	2.06e-01	1.46e-01	2.61e-01	4.87e-02
GOBP REGULATION OF GLOMERULAR FILTRATION	7	5.99e-01	6.81e-01	0.5540	4.31e-01	1.23e-01	2.30e-01	2.05e-01	7.48e-03	1.00e-01	4.81e-02	5.75e-01	2.91e-01	3.47e-01	9.73e-01	6.46e-01
GOMF PSEUDOURIDINE SYNTHASE ACTIVITY	13	9.39e-02	1.87e-01	0.5530	3.29e-02	-4.19e-01	-3.23e-01	1.30e-01	1.71e-02	-9.06e-02	8.37e-01	8.91e-03	4.37e-02	4.17e-01	9.15e-01	5.72e-01
GOBP NEGATIVE REGULATION OF POST TRANSCRIPTIONAL GENE SILENCING	12	1.82e-01	2.97e-01	0.5530	2.27e-01	2.41e-01	-1.93e-02	3.38e-01	2.04e-01	2.01e-01	1.73e-01	1.48e-01	9.08e-01	4.28e-02	2.22e-01	2.27e-01
GOMF VOLTAGE GATED POTASSIUM CHANNEL ACTIVITY INVOLVED IN VENTRICULAR CARDIAC MUSCLE CELL ACTION POTENTIAL REPOLARIZATION	7	5.43e-01	6.34e-01	0.5530	-2.97e-01	-1.06e-01	7.11e-02	-2.64e-01	-1.06e-01	3.48e-01	1.74e-01	6.26e-01	7.45e-01	2.27e-01	6.27e-01	1.11e-01
GOBP ASPARTATE METABOLIC PROCESS	6	1.16e-01	2.19e-01	0.5530	-3.59e-02	-2.61e-01	-1.67e-01	-3.00e-01	3.33e-01	-9.27e-02	8.79e-01	2.68e-01	4.78e-01	2.04e-01	1.58e-01	6.94e-01
GOMF TRNA PSEUDOURIDINE SYNTHASE ACTIVITY	8	2.96e-01	4.15e-01	0.5530	-7.68e-02	-4.63e-01	-2.76e-01	-4.31e-02	-4.76e-02	7.15e-02	7.07e-01	2.32e-02	1.76e-01	8.33e-01	8.16e-01	7.26e-01
GOBP POSITIVE REGULATION OF ACTIN FILAMENT DEPOLYMERIZATION	12	6.08e-02	1.36e-01	0.5530	-2.98e-01	-3.77e-01	1.80e-01	-5.99e-02	-1.89e-01	6.10e-02	7.41e-02	2.38e-02	2.81e-01	7.19e-01	2.57e-01	7.14e-01
GOBP G PROTEIN COUPLED RECEPTOR INTERNALIZATION	8	2.17e-01	3.34e-01	0.5530	4.03e-01	3.54e-01	-2.07e-03	-1.02e-01	6.47e-02	-6.28e-02	4.84e-02	8.34e-02	9.92e-01	6.17e-01	7.51e-01	7.58e-01
GOBP REGULATION OF ACUTE INFLAMMATORY RESPONSE	36	1.71e-05	1.37e-04	0.5530	1.69e-02	2.01e-01	3.89e-01	-1.32e-01	1.62e-01	2.66e-01	8.60e-01	3.68e-02	5.46e-05	1.71e-01	9.26e-02	5.80e-03
GOMF DYNACTIN BINDING	12	9.69e-02	1.92e-01	0.5530	4.47e-02	3.62e-01	2.03e-01	1.41e-01	-1.61e-02	3.34e-01	7.89e-01	2.99e-02	2.23e-01	3.98e-01	9.23e-01	4.54e-02
GOBP MUSCLE ATROPHY	8	3.90e-01	5.03e-01	0.5530	1.55e-04	-1.08e-01	8.19e-02	-2.31e-01	-4.59e-01	-1.54e-01	9.99e-01	5.97e-01	6.88e-01	2.58e-01	2.46e-02	4.52e-01
GOMF CYSTEINE TYPE ENDOPEPTIDASE ACTIVATOR ACTIVITY	5	4.69e-01	5.72e-01	0.5530	-2.16e-01	3.05e-01	-1.21e-01	-1.19e-01	1.35e-01	-3.45e-01	4.03e-01	2.37e-01	6.41e-01	6.46e-01	6.00e-01	1.82e-01
GOBP REGULATION OF HETEROCHROMATIN FORMATION	22	7.69e-03	2.79e-02	0.5530	5.91e-02	2.19e-01	9.69e-02	4.32e-01	1.87e-01	1.53e-01	6.32e-01	7.57e-02	4.32e-01	4.57e-04	1.29e-01	2.13e-01
GOBP POSITIVE REGULATION OF STRIATED MUSCLE CELL APOPTOTIC PROCESS	9	1.79e-01	2.94e-01	0.5530	-2.47e-01	1.33e-01	-2.54e-01	2.27e-01	2.93e-01	-1.58e-01	1.99e-01	4.89e-01	1.88e-01	2.38e-01	1.28e-01	4.12e-01
GOBP REGULATION OF GRANULOCYTE DIFFERENTIATION	13	6.67e-02	1.46e-01	0.5530	-3.11e-02	1.20e-01	3.79e-01	1.78e-01	-2.54e-01	2.25e-01	8.46e-01	4.56e-01	1.81e-02	2.67e-01	1.13e-01	1.60e-01
GOBP REGULATION OF SYNAPTIC TRANSMISSION DOPAMINERGIC	7	3.89e-01	5.02e-01	0.5530	2.04e-01	1.51e-01	4.10e-01	2.68e-01	5.27e-03	3.47e-02	3.50e-01	4.90e-01	6.02e-02	2.20e-01	9.81e-01	8.74e-01
GOMF CALCIUM MONOATOMIC CATION ANTIPORTER ACTIVITY	10	1.21e-01	2.25e-01	0.5520	-3.53e-01	-2.89e-01	1.03e-01	-5.57e-02	-2.67e-01	-1.08e-01	5.33e-02	1.13e-01	5.73e-01	7.60e-01	1.43e-01	5.56e-01
GOBP BRANCHED CHAIN AMINO ACID CATABOLIC PROCESS	21	2.23e-02	6.44e-02	0.5520	-2.93e-01	-3.10e-01	-3.40e-01	-1.97e-02	7.72e-02	3.42e-02	2.02e-02	1.39e-02	7.00e-03	8.76e-01	5.41e-01	7.86e-01
GOBP REGULATION OF FEAR RESPONSE	8	4.22e-01	5.31e-01	0.5520	7.06e-02	-1.34e-01	-3.21e-01	7.29e-03	3.06e-01	-2.92e-01	7.30e-01	5.13e-01	1.16e-01	9.72e-01	1.33e-01	1.53e-01
GOBP REGULATION OF PINOCYTOSIS	11	2.04e-02	6.01e-02	0.5520	-4.18e-01	-3.22e-02	-7.07e-02	1.08e-01	3.31e-01	-4.92e-02	1.64e-02	8.53e-01	6.85e-01	5.34e-01	5.70e-02	7.77e-01
GOBP TONGUE MORPHOGENESIS	5	6.61e-01	7.30e-01	0.5520	-4.16e-01	-4.79e-02	-6.13e-02	-3.00e-01	5.80e-02	1.79e-01	1.07e-01	8.53e-01	8.12e-01	2.45e-01	8.22e-01	4.88e-01
GOBP MYD88 DEPENDENT TOLL LIKE RECEPTOR SIGNALING PATHWAY	19	7.35e-03	2.69e-02	0.5520	-9.57e-02	2.53e-01	9.93e-02	2.89e-01	1.96e-01	3.16e-01	4.70e-01	5.66e-02	4.54e-01	2.92e-02	1.40e-01	1.72e-02
GOBP POSITIVE REGULATION OF PHOSPHOPROTEIN PHOSPHATASE ACTIVITY	15	1.28e-01	2.33e-01	0.5520	-9.39e-02	-7.12e-02	3.63e-01	2.31e-02	-2.57e-01	3.03e-01	5.29e-01	6.33e-01	1.50e-02	8.77e-01	8.43e-02	4.20e-02
GOBP REGULATION OF TRANSCRIPTION OF NUCLEOLAR LARGE RRNA BY RNA POLYMERASE I	15	7.66e-03	2.79e-02	0.5520	1.00e-01	-3.73e-01	-7.98e-03	3.42e-01	-1.22e-01	-1.53e-01	5.03e-01	1.24e-02	9.57e-01	2.18e-02	4.15e-01	3.05e-01
GOBP PINOCYTOSIS	20	1.16e-04	7.73e-04	0.5510	-4.82e-01	-1.69e-01	-4.27e-02	3.26e-02	1.85e-01	-7.58e-02	1.90e-04	1.90e-01	7.41e-01	8.01e-01	1.51e-01	5.57e-01
GOBP REGULATION OF RAB PROTEIN SIGNAL TRANSDUCTION	7	6.46e-01	7.19e-01	0.5510	2.18e-01	2.64e-01	1.13e-01	3.69e-01	1.90e-01	-4.07e-02	3.17e-01	2.27e-01	6.05e-01	9.06e-02	3.84e-01	8.52e-01
GOCC SMOOTH ENDOPLASMIC RETICULUM	25	5.17e-04	2.88e-03	0.5510	-2.34e-01	-2.69e-01	1.44e-01	2.05e-01	-2.24e-01	2.52e-01	4.27e-02	1.99e-02	2.12e-01	7.62e-02	5.25e-02	2.91e-02
GOBP REGULATION OF CHRONIC INFLAMMATORY RESPONSE	8	3.24e-01	4.43e-01	0.5510	2.95e-01	2.09e-02	3.40e-01	-1.57e-01	-2.73e-01	3.99e-02	1.49e-01	9.18e-01	9.63e-02	4.42e-01	1.81e-01	8.45e-01
GOCC CILIARY TRANSITION FIBER	7	4.94e-01	5.93e-01	0.5510	-4.93e-03	1.12e-01	2.43e-02	3.18e-01	4.08e-01	1.52e-01	9.82e-01	6.08e-01	9.11e-01	1.45e-01	6.16e-02	4.87e-01
GOBP LEUKOTRIENE SIGNALING PATHWAY	5	4.46e-01	5.53e-01	0.5510	-4.22e-01	1.36e-01	-1.82e-01	2.09e-02	2.41e-01	-1.24e-01	1.02e-01	5.99e-01	4.82e-01	9.35e-01	3.51e-01	6.30e-01
GOBP RECEPTOR MEDIATED ENDOCYTOSIS OF VIRUS BY HOST CELL	9	2.67e-01	3.86e-01	0.5510	-3.01e-02	1.03e-01	2.25e-01	-5.77e-02	1.55e-01	4.63e-01	8.76e-01	5.93e-01	2.43e-01	7.65e-01	4.21e-01	1.63e-02
GOCC GAMMA TUBULIN RING COMPLEX	9	1.47e-01	2.57e-01	0.5510	-2.40e-02	-1.21e-01	-4.31e-01	4.98e-03	3.17e-01	3.26e-02	9.01e-01	5.29e-01	2.51e-02	9.79e-01	9.92e-02	8.66e-01
GOBP POSITIVE REGULATION OF CHOLESTEROL EFFLUX	18	6.86e-04	3.69e-03	0.5500	5.39e-02	1.76e-01	2.24e-01	3.88e-01	2.09e-01	-1.56e-01	6.92e-01	1.96e-01	9.99e-02	4.35e-03	1.25e-01	2.51e-01
GOBP POLYPRENOL METABOLIC PROCESS	25	1.54e-02	4.83e-02	0.5500	-2.19e-01	-4.28e-01	-2.47e-01	-3.14e-02	-9.68e-02	7.06e-03	5.75e-02	2.12e-04	3.27e-02	7.86e-01	4.02e-01	9.51e-01
GOBP MICROTUBULE NUCLEATION BY MICROTUBULE ORGANIZING CENTER	5	6.53e-01	7.25e-01	0.5500	-1.16e-02	3.85e-01	-7.81e-02	1.38e-01	3.46e-01	9.68e-02	9.64e-01	1.36e-01	7.62e-01	5.93e-01	1.81e-01	7.08e-01
GOBP VACUOLAR ACIDIFICATION	33	7.91e-05	5.50e-04	0.5500	-4.61e-01	-2.83e-01	-3.51e-02	-1.31e-02	-7.83e-02	5.03e-02	4.60e-06	4.91e-03	7.27e-01	8.96e-01	4.36e-01	6.17e-01
GOBP ENDOCARDIAL CUSHION FORMATION	15	8.58e-02	1.75e-01	0.5500	-3.60e-02	3.00e-01	1.98e-01	2.22e-01	2.51e-01	2.45e-01	8.09e-01	4.45e-02	1.83e-01	1.37e-01	9.29e-02	1.00e-01
GOCC NBAF COMPLEX	14	4.15e-03	1.68e-02	0.5500	1.52e-01	1.49e-01	2.23e-01	3.71e-01	-2.45e-01	-9.84e-02	3.23e-01	3.33e-01	1.49e-01	1.63e-02	1.12e-01	5.24e-01
GOBP AMINOGLYCOSIDE ANTIBIOTIC METABOLIC PROCESS	8	4.87e-01	5.87e-01	0.5500	-2.20e-01	-2.97e-01	-3.63e-01	2.99e-02	1.71e-01	-5.86e-02	2.81e-01	1.45e-01	7.58e-02	8.84e-01	4.01e-01	7.74e-01
GOBP ESCRT COMPLEX DISASSEMBLY	10	1.87e-01	3.02e-01	0.5500	-3.46e-01	-3.09e-01	-4.29e-02	1.15e-01	-2.38e-02	2.68e-01	5.83e-02	9.09e-02	8.14e-01	5.30e-01	8.97e-01	1.43e-01
GOBP CELLULAR RESPONSE TO PROGESTERONE STIMULUS	5	3.33e-01	4.50e-01	0.5500	-3.06e-01	4.02e-01	1.05e-01	-1.00e-01	-8.11e-02	1.37e-01	2.36e-01	1.19e-01	6.84e-01	6.97e-01	7.53e-01	5.96e-01
GOBP LEUKOCYTE CHEMOTAXIS INVOLVED IN INFLAMMATORY RESPONSE	6	2.71e-01	3.91e-01	0.5500	2.07e-01	1.64e-01	3.38e-01	-3.35e-01	1.48e-02	-7.86e-02	3.80e-01	4.87e-01	1.52e-01	1.56e-01	9.50e-01	7.39e-01
GOBP OVULATION	10	2.83e-01	4.03e-01	0.5490	-3.62e-01	-2.20e-01	1.70e-01	-1.50e-01	-2.58e-01	6.46e-02	4.73e-02	2.27e-01	3.53e-01	4.12e-01	1.58e-01	7.24e-01
GOCC MITOCHONDRIAL MATRIX	474	3.14e-74	2.08e-71	0.5490	-1.02e-01	-4.40e-01	-2.98e-01	8.99e-02	1.18e-02	-1.87e-02	1.50e-04	6.22e-61	8.54e-29	8.01e-04	6.59e-01	4.86e-01
GOMF TRIGLYCERIDE LIPASE ACTIVITY	15	5.03e-02	1.18e-01	0.5490	-1.17e-01	1.04e-01	3.36e-01	1.68e-01	-1.65e-01	3.30e-01	4.32e-01	4.86e-01	2.43e-02	2.59e-01	2.68e-01	2.70e-02
GOBP NEGATIVE REGULATION OF GENE EXPRESSION VIA CHROMOSOMAL CPG ISLAND METHYLATION	14	6.41e-02	1.42e-01	0.5490	1.96e-01	2.39e-01	-5.10e-02	3.87e-01	1.57e-01	1.70e-01	2.05e-01	1.21e-01	7.41e-01	1.21e-02	3.10e-01	2.70e-01
GOBP MAINTENANCE OF PROTEIN LOCATION IN MITOCHONDRION	5	3.41e-01	4.58e-01	0.5490	-3.11e-01	-4.95e-02	2.62e-01	2.13e-01	-2.46e-01	1.69e-01	2.29e-01	8.48e-01	3.10e-01	4.10e-01	3.42e-01	5.13e-01
GOBP ESTABLISHMENT OF BLOOD BRAIN BARRIER	13	4.65e-02	1.11e-01	0.5490	6.73e-02	2.87e-01	-8.19e-02	4.04e-01	1.51e-01	-1.48e-01	6.74e-01	7.34e-02	6.09e-01	1.16e-02	3.46e-01	3.56e-01
GOBP NEGATIVE REGULATION OF MACROPHAGE DERIVED FOAM CELL DIFFERENTIATION	11	3.29e-02	8.59e-02	0.5490	-3.81e-01	-2.07e-01	2.44e-01	-5.61e-02	-2.24e-01	-2.60e-02	2.88e-02	2.35e-01	1.61e-01	7.47e-01	1.97e-01	8.81e-01
GOBP NEGATIVE REGULATION OF POTASSIUM ION TRANSMEMBRANE TRANSPORT	14	1.89e-01	3.04e-01	0.5490	-2.35e-02	-3.09e-02	3.94e-01	-6.85e-02	-1.44e-01	3.45e-01	8.79e-01	8.42e-01	1.06e-02	6.57e-01	3.51e-01	2.55e-02
GOBP POSITIVE REGULATION OF CYTOKINE PRODUCTION INVOLVED IN INFLAMMATORY RESPONSE	20	9.44e-03	3.28e-02	0.5490	-7.09e-02	3.66e-01	-4.37e-02	1.23e-01	3.66e-01	-1.07e-01	5.83e-01	4.62e-03	7.35e-01	3.42e-01	4.57e-03	4.08e-01
GOMF TRANSLATION TERMINATION FACTOR ACTIVITY	6	6.35e-01	7.11e-01	0.5490	-2.18e-01	-2.82e-01	-5.90e-03	-5.72e-02	-2.99e-01	2.85e-01	3.55e-01	2.32e-01	9.80e-01	8.08e-01	2.04e-01	2.26e-01
GOBP UBIQUINONE METABOLIC PROCESS	18	6.83e-02	1.48e-01	0.5490	-1.48e-01	-3.50e-01	-3.64e-01	7.79e-02	9.12e-02	-9.88e-02	2.77e-01	1.02e-02	7.45e-03	5.67e-01	5.03e-01	4.68e-01
GOBP TRANSCYTOSIS	17	1.97e-03	9.07e-03	0.5490	-2.89e-01	2.93e-01	1.24e-01	1.13e-01	3.05e-01	1.04e-01	3.91e-02	3.63e-02	3.77e-01	4.20e-01	2.97e-02	4.59e-01
GOBP RESPONSE TO FOLIC ACID	7	3.07e-01	4.28e-01	0.5490	1.81e-01	-2.13e-01	-1.39e-01	-2.04e-02	3.76e-02	-4.49e-01	4.06e-01	3.30e-01	5.23e-01	9.26e-01	8.63e-01	3.96e-02
GOCC INTERCELLULAR CANALICULUS	5	1.25e-01	2.29e-01	0.5490	2.17e-01	-2.21e-01	3.21e-01	-2.97e-01	5.17e-02	1.07e-01	4.02e-01	3.93e-01	2.14e-01	2.50e-01	8.41e-01	6.80e-01
GOBP ATRIAL CARDIAC MUSCLE CELL MEMBRANE REPOLARIZATION	5	2.28e-01	3.46e-01	0.5490	-1.30e-01	2.97e-01	1.25e-01	-2.47e-02	-2.09e-01	-3.69e-01	6.15e-01	2.51e-01	6.28e-01	9.24e-01	4.18e-01	1.53e-01
GOBP REGULATION OF ATRIAL CARDIAC MUSCLE CELL MEMBRANE REPOLARIZATION	5	2.28e-01	3.46e-01	0.5490	-1.30e-01	2.97e-01	1.25e-01	-2.47e-02	-2.09e-01	-3.69e-01	6.15e-01	2.51e-01	6.28e-01	9.24e-01	4.18e-01	1.53e-01
GOBP NEGATIVE REGULATION OF REGULATORY T CELL DIFFERENTIATION	5	7.24e-01	7.80e-01	0.5490	1.62e-01	7.35e-02	2.72e-01	1.96e-01	-1.84e-01	3.50e-01	5.29e-01	7.76e-01	2.92e-01	4.48e-01	4.75e-01	1.75e-01
GOMF O METHYLTRANSFERASE ACTIVITY	22	5.99e-03	2.27e-02	0.5480	-1.57e-02	-3.46e-01	-3.65e-01	1.89e-01	1.07e-01	-1.72e-02	8.99e-01	4.92e-03	3.05e-03	1.25e-01	3.84e-01	8.89e-01
GOBP HINDLIMB MORPHOGENESIS	14	7.51e-02	1.59e-01	0.5480	1.18e-01	3.39e-01	3.95e-01	-1.73e-02	-1.25e-01	-5.55e-03	4.43e-01	2.81e-02	1.06e-02	9.11e-01	4.17e-01	9.71e-01
GOBP REGULATION OF PRESYNAPTIC CYTOSOLIC CALCIUM ION CONCENTRATION	9	2.11e-01	3.29e-01	0.5480	-1.56e-01	3.76e-01	2.87e-01	-2.16e-01	-3.04e-02	6.61e-02	4.17e-01	5.05e-02	1.36e-01	2.62e-01	8.75e-01	7.31e-01
GOBP PEPTIDYL METHIONINE MODIFICATION	10	5.76e-01	6.62e-01	0.5480	-2.81e-01	-2.81e-01	-2.26e-01	-2.13e-01	-1.37e-01	-1.65e-01	1.24e-01	1.24e-01	2.15e-01	2.44e-01	4.54e-01	3.66e-01
GOBP BRANCH ELONGATION OF AN EPITHELIUM	9	1.79e-01	2.94e-01	0.5480	3.01e-01	1.52e-01	4.18e-01	-3.46e-03	-7.10e-02	-8.58e-02	1.18e-01	4.29e-01	3.01e-02	9.86e-01	7.12e-01	6.56e-01
GOBP RESPONSE TO PROTOZOAN	27	3.55e-02	9.10e-02	0.5480	3.32e-01	2.09e-01	2.51e-01	2.26e-01	9.25e-02	1.54e-01	2.85e-03	5.97e-02	2.40e-02	4.21e-02	4.06e-01	1.66e-01
GOBP GLYCOSPHINGOLIPID BIOSYNTHETIC PROCESS	28	1.56e-03	7.42e-03	0.5480	-7.20e-02	3.13e-01	3.21e-01	4.83e-02	-7.05e-02	2.94e-01	5.10e-01	4.10e-03	3.30e-03	6.58e-01	5.19e-01	7.05e-03
GOBP PEPTIDYL LYSINE DEACETYLATION	6	4.16e-01	5.26e-01	0.5480	2.64e-01	-2.73e-01	-7.47e-02	2.06e-01	-1.64e-01	-2.84e-01	2.62e-01	2.47e-01	7.51e-01	3.82e-01	4.87e-01	2.28e-01
GOMF ADP D RIBOSE MODIFICATION DEPENDENT PROTEIN BINDING	7	4.16e-01	5.26e-01	0.5480	3.98e-02	-2.43e-01	-2.86e-01	1.68e-01	3.52e-01	-7.24e-02	8.55e-01	2.66e-01	1.89e-01	4.40e-01	1.07e-01	7.40e-01
GOCC TRANS GOLGI NETWORK TRANSPORT VESICLE	33	3.61e-05	2.71e-04	0.5480	-3.76e-01	-6.92e-02	1.85e-01	5.67e-02	-1.09e-01	3.24e-01	1.89e-04	4.91e-01	6.60e-02	5.73e-01	2.77e-01	1.30e-03
GOBP REGULATION OF TYPE B PANCREATIC CELL PROLIFERATION	10	3.90e-03	1.60e-02	0.5480	4.87e-02	-1.61e-01	1.14e-01	-1.62e-01	6.28e-02	-4.78e-01	7.90e-01	3.77e-01	5.32e-01	3.75e-01	7.31e-01	8.90e-03
GOCC SEMAPHORIN RECEPTOR COMPLEX	13	4.15e-02	1.02e-01	0.5470	1.50e-01	3.08e-01	6.84e-02	2.83e-01	7.37e-02	-3.03e-01	3.47e-01	5.43e-02	6.69e-01	7.71e-02	6.45e-01	5.89e-02
GOMF PRE MIRNA BINDING	9	5.30e-01	6.22e-01	0.5470	-1.86e-01	-2.95e-01	-2.64e-01	-2.83e-01	-1.28e-01	-1.09e-01	3.34e-01	1.26e-01	1.70e-01	1.42e-01	5.05e-01	5.70e-01
GOBP TOXIN METABOLIC PROCESS	8	5.54e-01	6.44e-01	0.5470	1.94e-02	2.95e-01	3.19e-01	-3.40e-02	8.44e-02	3.20e-01	9.24e-01	1.49e-01	1.18e-01	8.68e-01	6.79e-01	1.18e-01
GOMF TRANSLATION REGULATOR ACTIVITY NUCLEIC ACID BINDING	99	5.49e-10	9.16e-09	0.5470	-2.47e-01	-3.99e-01	-2.23e-01	-7.41e-02	-1.54e-01	-1.83e-02	2.14e-05	7.02e-12	1.26e-04	2.03e-01	7.99e-03	7.53e-01
GOBP G QUADRUPLEX DNA UNWINDING	7	2.53e-01	3.72e-01	0.5470	-1.52e-01	-8.83e-02	1.69e-01	3.11e-01	-2.16e-01	3.11e-01	4.86e-01	6.86e-01	4.39e-01	1.55e-01	3.21e-01	1.55e-01
GOMF NON MEMBRANE SPANNING PROTEIN TYROSINE PHOSPHATASE ACTIVITY	12	1.90e-01	3.06e-01	0.5470	-1.83e-01	3.07e-02	2.65e-01	3.21e-02	-2.03e-01	3.90e-01	2.72e-01	8.54e-01	1.12e-01	8.47e-01	2.23e-01	1.93e-02
GOBP PHARYNGEAL SYSTEM DEVELOPMENT	13	2.04e-01	3.20e-01	0.5470	7.33e-02	4.18e-01	2.29e-01	3.92e-02	1.31e-01	2.18e-01	6.47e-01	9.05e-03	1.52e-01	8.07e-01	4.13e-01	1.73e-01
GOBP REGULATION OF SYNAPTIC VESICLE CYCLE	12	8.49e-02	1.74e-01	0.5470	-1.42e-01	-3.38e-02	1.94e-01	2.53e-01	-1.21e-01	4.02e-01	3.95e-01	8.40e-01	2.44e-01	1.30e-01	4.68e-01	1.59e-02
GOBP INFLAMMATORY RESPONSE TO WOUNDING	22	3.34e-04	1.98e-03	0.5470	-1.17e-01	2.51e-01	4.43e-01	9.20e-02	-8.38e-02	1.01e-01	3.40e-01	4.16e-02	3.19e-04	4.55e-01	4.96e-01	4.12e-01
GOCC MIGRASOME	5	6.80e-01	7.46e-01	0.5470	-3.22e-01	-2.37e-01	-2.26e-01	-2.50e-01	1.55e-01	-3.89e-02	2.13e-01	3.59e-01	3.82e-01	3.33e-01	5.48e-01	8.80e-01
GOMF METAL CATION PROTON ANTIPORTER ACTIVITY	19	3.32e-02	8.64e-02	0.5470	-2.39e-01	1.14e-01	3.27e-01	-7.48e-02	-8.26e-02	3.31e-01	7.19e-02	3.91e-01	1.36e-02	5.73e-01	5.33e-01	1.25e-02
GOBP IMMUNOLOGICAL SYNAPSE FORMATION	15	1.14e-01	2.15e-01	0.5470	4.57e-02	1.32e-01	2.55e-01	3.08e-01	6.19e-02	3.40e-01	7.59e-01	3.75e-01	8.74e-02	3.87e-02	6.78e-01	2.28e-02
GOBP PROTEIN RETENTION IN ER LUMEN	7	3.95e-01	5.07e-01	0.5460	-1.23e-01	-4.22e-01	-2.00e-02	1.81e-01	-1.22e-01	2.38e-01	5.72e-01	5.30e-02	9.27e-01	4.08e-01	5.75e-01	2.75e-01
GOBP ER OVERLOAD RESPONSE	11	1.07e-01	2.06e-01	0.5460	-4.03e-01	-1.14e-01	7.63e-02	1.23e-02	-2.92e-01	1.77e-01	2.07e-02	5.11e-01	6.61e-01	9.44e-01	9.38e-02	3.08e-01
GOBP MITOCHONDRIAL PROTEIN PROCESSING	13	1.88e-01	3.03e-01	0.5460	-2.18e-01	-2.54e-01	-3.82e-01	-4.35e-02	1.82e-01	-7.15e-02	1.74e-01	1.13e-01	1.71e-02	7.86e-01	2.56e-01	6.55e-01
GOBP RIBOSOMAL SUBUNIT EXPORT FROM NUCLEUS	15	2.53e-01	3.72e-01	0.5460	-2.90e-01	-3.68e-01	-2.26e-01	-1.14e-01	-1.10e-01	-4.51e-02	5.19e-02	1.36e-02	1.29e-01	4.44e-01	4.60e-01	7.62e-01
GOBP KERATINOCYTE DEVELOPMENT	10	3.10e-01	4.30e-01	0.5460	1.09e-01	1.72e-01	2.08e-01	3.86e-01	2.29e-01	1.08e-01	5.51e-01	3.45e-01	2.54e-01	3.48e-02	2.09e-01	5.53e-01
GOBP MITOTIC SISTER CHROMATID COHESION CENTROMERIC	5	5.57e-01	6.47e-01	0.5460	2.32e-01	-2.00e-01	1.05e-01	2.73e-01	-1.15e-01	3.24e-01	3.69e-01	4.38e-01	6.85e-01	2.90e-01	6.55e-01	2.10e-01
GOCC NUCLEAR CYCLIN DEPENDENT PROTEIN KINASE HOLOENZYME COMPLEX	14	1.20e-02	3.97e-02	0.5460	-3.13e-01	2.06e-01	1.95e-01	6.32e-02	-1.42e-01	3.09e-01	4.29e-02	1.82e-01	2.07e-01	6.82e-01	3.56e-01	4.50e-02
GOMF COMPLEMENT RECEPTOR ACTIVITY	9	2.36e-01	3.54e-01	0.5460	-1.11e-01	2.33e-01	3.96e-01	-1.83e-01	-1.99e-01	3.37e-02	5.66e-01	2.27e-01	3.96e-02	3.41e-01	3.02e-01	8.61e-01
GOCC MON1 CCZ1 COMPLEX	5	7.46e-01	7.98e-01	0.5460	7.77e-02	1.06e-02	3.58e-01	2.14e-01	4.25e-02	3.40e-01	7.63e-01	9.67e-01	1.65e-01	4.08e-01	8.69e-01	1.88e-01
GOBP LOCALIZATION OF CELL	6	3.49e-01	4.65e-01	0.5450	-6.62e-02	-6.59e-02	-7.80e-02	3.77e-01	2.95e-01	-2.32e-01	7.79e-01	7.80e-01	7.41e-01	1.10e-01	2.11e-01	3.24e-01
GOMF SULFATE BINDING	6	5.66e-01	6.54e-01	0.5450	-2.40e-01	-3.38e-01	-2.09e-02	8.98e-02	-3.32e-01	8.03e-02	3.09e-01	1.51e-01	9.29e-01	7.03e-01	1.59e-01	7.33e-01
GOBP RESPONSE TO SODIUM PHOSPHATE	8	2.14e-01	3.32e-01	0.5450	-4.97e-02	1.47e-02	-3.37e-01	-5.74e-02	-2.30e-01	-3.53e-01	8.08e-01	9.43e-01	9.84e-02	7.79e-01	2.60e-01	8.38e-02
GOBP ESTABLISHMENT OF PROTEIN LOCALIZATION TO CHROMOSOME	27	7.34e-04	3.91e-03	0.5450	-7.39e-02	-4.53e-01	-1.43e-01	2.01e-01	-1.55e-01	3.86e-02	5.07e-01	4.61e-05	2.00e-01	7.00e-02	1.63e-01	7.28e-01
GOBP TELOMERIC D LOOP DISASSEMBLY	9	1.90e-01	3.06e-01	0.5450	1.42e-01	-7.29e-02	-1.03e-01	5.07e-01	3.02e-02	5.48e-02	4.59e-01	7.05e-01	5.92e-01	8.45e-03	8.75e-01	7.76e-01
GOCC SERINE TYPE ENDOPEPTIDASE COMPLEX	6	3.29e-01	4.47e-01	0.5450	1.31e-02	3.55e-01	1.72e-01	-1.94e-01	2.25e-01	-2.30e-01	9.56e-01	1.32e-01	4.67e-01	4.10e-01	3.39e-01	3.29e-01
GOCC SERINE TYPE PEPTIDASE COMPLEX	6	3.29e-01	4.47e-01	0.5450	1.31e-02	3.55e-01	1.72e-01	-1.94e-01	2.25e-01	-2.30e-01	9.56e-01	1.32e-01	4.67e-01	4.10e-01	3.39e-01	3.29e-01
GOMF HEXOSAMINIDASE ACTIVITY	13	1.99e-01	3.15e-01	0.5450	-1.08e-01	-2.15e-01	-2.58e-01	-9.44e-03	-5.21e-02	-4.12e-01	4.99e-01	1.80e-01	1.08e-01	9.53e-01	7.45e-01	1.01e-02
GOBP NEGATIVE REGULATION OF STEROID METABOLIC PROCESS	18	3.03e-02	8.08e-02	0.5450	8.42e-02	-2.69e-02	4.60e-01	5.88e-02	-1.21e-01	2.44e-01	5.37e-01	8.44e-01	7.34e-04	6.66e-01	3.75e-01	7.27e-02
GOCC MITOCHONDRIAL ENVELOPE	747	3.43e-100	1.06e-96	0.5450	-1.67e-01	-4.48e-01	-2.48e-01	4.13e-03	-7.02e-02	-3.57e-02	6.68e-15	2.47e-97	6.01e-31	8.48e-01	1.09e-03	9.71e-02
GOBP HISTIDINE METABOLIC PROCESS	8	2.93e-01	4.13e-01	0.5450	-1.58e-01	3.14e-02	-8.51e-02	-5.09e-01	-2.15e-02	-6.38e-02	4.38e-01	8.78e-01	6.77e-01	1.27e-02	9.16e-01	7.55e-01
GOBP EOSINOPHIL MIGRATION	13	1.44e-01	2.54e-01	0.5440	3.64e-01	2.09e-01	3.31e-01	6.96e-02	-4.29e-02	-6.38e-02	2.29e-02	1.93e-01	3.89e-02	6.64e-01	7.89e-01	6.90e-01
GOMF EXTRACELLULAR MATRIX STRUCTURAL CONSTITUENT CONFERRING COMPRESSION RESISTANCE	8	4.21e-01	5.30e-01	0.5440	1.18e-01	2.34e-01	2.60e-01	-1.50e-01	-6.36e-02	3.66e-01	5.62e-01	2.53e-01	2.03e-01	4.63e-01	7.55e-01	7.33e-02
GOBP RESPONSE TO PROSTAGLANDIN D	5	1.42e-01	2.51e-01	0.5440	-2.03e-01	2.00e-04	-4.49e-01	6.01e-02	-2.23e-01	1.85e-03	4.31e-01	9.99e-01	8.23e-02	8.16e-01	3.88e-01	9.94e-01
GOBP NEGATIVE REGULATION OF BLOOD CIRCULATION	17	4.21e-03	1.70e-02	0.5440	-4.43e-02	-9.50e-02	4.30e-01	2.17e-01	-4.92e-02	2.26e-01	7.52e-01	4.98e-01	2.17e-03	1.21e-01	7.25e-01	1.07e-01
GOBP CELLULAR RESPONSE TO MAGNESIUM ION	6	2.08e-01	3.25e-01	0.5440	3.90e-02	7.63e-02	2.98e-01	5.33e-02	4.14e-01	1.59e-01	8.69e-01	7.46e-01	2.06e-01	8.21e-01	7.89e-02	5.01e-01
GOBP REGULATION OF LIPOPROTEIN METABOLIC PROCESS	12	1.39e-01	2.48e-01	0.5440	-2.88e-01	-1.01e-01	9.93e-02	9.48e-03	-7.92e-02	4.32e-01	8.43e-02	5.45e-01	5.51e-01	9.55e-01	6.35e-01	9.56e-03
GOMF GLUCOSIDASE ACTIVITY	10	6.00e-02	1.35e-01	0.5440	2.33e-02	2.24e-01	-4.45e-02	-6.50e-02	-2.17e-01	-4.38e-01	8.98e-01	2.20e-01	8.08e-01	7.22e-01	2.36e-01	1.65e-02
GOBP REGULATION OF CELL ADHESION MEDIATED BY INTEGRIN	40	4.17e-04	2.40e-03	0.5430	3.06e-02	1.23e-01	3.56e-01	1.64e-01	5.07e-02	3.50e-01	7.38e-01	1.78e-01	9.54e-05	7.30e-02	5.79e-01	1.25e-04
GOCC SPINDLE MIDZONE	34	2.45e-05	1.91e-04	0.5430	-1.02e-01	-1.45e-01	2.92e-01	2.47e-01	-1.66e-02	3.43e-01	3.03e-01	1.42e-01	3.24e-03	1.27e-02	8.67e-01	5.45e-04
GOMF RNA POLYMERASE II C TERMINAL DOMAIN BINDING	10	1.26e-01	2.31e-01	0.5430	8.72e-02	2.71e-01	2.65e-01	3.73e-01	6.39e-02	-1.58e-02	6.33e-01	1.37e-01	1.46e-01	4.11e-02	7.26e-01	9.31e-01
GOMF SINGLE STRANDED DNA HELICASE ACTIVITY	23	2.96e-03	1.28e-02	0.5430	1.88e-01	-8.19e-02	-1.16e-01	4.30e-01	1.45e-01	1.84e-01	1.19e-01	4.96e-01	3.35e-01	3.55e-04	2.30e-01	1.28e-01
GOBP POSITIVE REGULATION OF ACTIN NUCLEATION	13	3.24e-01	4.43e-01	0.5430	-2.68e-01	-1.81e-01	1.70e-01	-2.22e-01	-3.18e-01	1.04e-01	9.43e-02	2.58e-01	2.87e-01	1.67e-01	4.70e-02	5.17e-01
GOMF HISTONE H2A UBIQUITIN LIGASE ACTIVITY	6	6.49e-01	7.22e-01	0.5430	3.54e-02	3.28e-01	3.67e-01	-2.57e-02	1.40e-01	1.76e-01	8.81e-01	1.64e-01	1.20e-01	9.13e-01	5.52e-01	4.54e-01
GOMF TOXIN TRANSMEMBRANE TRANSPORTER ACTIVITY	6	3.38e-01	4.56e-01	0.5430	-5.24e-02	-4.86e-02	7.08e-02	5.11e-01	4.68e-02	1.46e-01	8.24e-01	8.37e-01	7.64e-01	3.02e-02	8.42e-01	5.35e-01
GOBP POSITIVE REGULATION OF GLUTAMATE SECRETION	9	2.10e-01	3.27e-01	0.5430	9.70e-02	9.31e-02	2.39e-01	2.67e-01	3.62e-01	1.29e-01	6.14e-01	6.29e-01	2.14e-01	1.65e-01	5.98e-02	5.03e-01
GOBP FATTY ACID BETA OXIDATION USING ACYL COA DEHYDROGENASE	12	1.00e-02	3.44e-02	0.5430	4.23e-02	-4.56e-01	-1.68e-01	-4.03e-02	9.34e-02	2.16e-01	8.00e-01	6.28e-03	3.15e-01	8.09e-01	5.75e-01	1.95e-01
GOBP PIGMENT CATABOLIC PROCESS	7	3.06e-02	8.13e-02	0.5420	7.22e-02	-3.68e-01	3.12e-01	1.86e-01	-6.74e-02	-1.29e-01	7.41e-01	9.14e-02	1.52e-01	3.95e-01	7.57e-01	5.54e-01
GOBP REGULATION OF PLASMA MEMBRANE ORGANIZATION	17	6.41e-02	1.42e-01	0.5420	-3.18e-02	-7.59e-02	4.01e-01	6.39e-02	-2.15e-01	2.76e-01	8.21e-01	5.88e-01	4.24e-03	6.48e-01	1.24e-01	4.84e-02
GOBP MAST CELL DIFFERENTIATION	5	5.76e-01	6.62e-01	0.5420	4.47e-01	3.98e-02	2.21e-01	-2.01e-02	-2.09e-01	-7.05e-03	8.37e-02	8.77e-01	3.91e-01	9.38e-01	4.19e-01	9.78e-01
GOBP METANEPHRIC TUBULE MORPHOGENESIS	6	2.83e-01	4.02e-01	0.5420	-4.09e-02	1.90e-01	5.76e-02	-7.99e-02	4.96e-01	-3.01e-02	8.62e-01	4.21e-01	8.07e-01	7.35e-01	3.55e-02	8.98e-01
GOBP DERMATAN SULFATE PROTEOGLYCAN METABOLIC PROCESS	12	3.30e-01	4.48e-01	0.5420	-2.12e-01	-2.50e-01	-1.92e-01	-1.23e-01	-2.52e-01	-2.66e-01	2.03e-01	1.34e-01	2.49e-01	4.62e-01	1.31e-01	1.10e-01
GOBP ENUCLEATE ERYTHROCYTE DEVELOPMENT	6	6.91e-01	7.54e-01	0.5420	3.55e-01	1.30e-01	2.49e-01	2.93e-01	-4.81e-02	3.20e-02	1.32e-01	5.80e-01	2.91e-01	2.15e-01	8.38e-01	8.92e-01
GOBP PITUITARY GLAND DEVELOPMENT	15	7.79e-02	1.63e-01	0.5420	-3.16e-02	2.07e-01	2.60e-01	-2.57e-01	6.38e-03	3.41e-01	8.32e-01	1.64e-01	8.16e-02	8.44e-02	9.66e-01	2.23e-02
GOBP POSITIVE REGULATION OF INTRACELLULAR STEROID HORMONE RECEPTOR SIGNALING PATHWAY	8	2.60e-01	3.80e-01	0.5420	1.79e-01	3.24e-01	3.83e-02	3.18e-01	5.92e-02	2.24e-01	3.79e-01	1.13e-01	8.51e-01	1.19e-01	7.72e-01	2.72e-01
GOBP NEGATIVE REGULATION OF TYPE 2 IMMUNE RESPONSE	12	1.92e-01	3.07e-01	0.5420	-1.35e-01	-5.03e-02	2.57e-01	-1.40e-01	-4.31e-01	3.56e-02	4.17e-01	7.63e-01	1.23e-01	4.01e-01	9.72e-03	8.31e-01
GOBP NEGATIVE REGULATION OF COMPLEMENT ACTIVATION	12	1.91e-01	3.06e-01	0.5420	-3.49e-02	1.49e-01	2.37e-01	-1.26e-01	-6.34e-02	4.40e-01	8.34e-01	3.73e-01	1.55e-01	4.49e-01	7.04e-01	8.24e-03
GOBP TRANS SYNAPTIC SIGNALING BY LIPID	6	7.61e-01	8.07e-01	0.5420	-1.33e-01	-2.41e-01	1.55e-01	-1.47e-01	-4.00e-01	1.10e-01	5.73e-01	3.07e-01	5.11e-01	5.34e-01	8.98e-02	6.40e-01
GOMF 1 PHOSPHATIDYLINOSITOL BINDING	13	3.16e-02	8.32e-02	0.5420	-3.45e-01	2.10e-01	6.57e-02	-1.07e-01	-1.80e-02	3.38e-01	3.15e-02	1.90e-01	6.82e-01	5.06e-01	9.11e-01	3.46e-02
GOMF GDP PHOSPHATASE ACTIVITY	7	2.07e-01	3.23e-01	0.5410	-2.94e-01	1.53e-01	-1.13e-01	2.23e-01	2.22e-01	2.68e-01	1.78e-01	4.83e-01	6.03e-01	3.08e-01	3.10e-01	2.20e-01
GOMF OPSONIN BINDING	12	2.70e-02	7.41e-02	0.5410	-3.35e-01	1.08e-01	2.32e-01	-1.63e-01	-2.80e-01	-1.02e-01	4.48e-02	5.17e-01	1.64e-01	3.29e-01	9.26e-02	5.40e-01
GOBP COPPER ION TRANSPORT	15	6.13e-02	1.37e-01	0.5410	-3.19e-01	-2.32e-01	1.63e-01	-1.82e-01	-3.56e-02	2.76e-01	3.22e-02	1.20e-01	2.75e-01	2.22e-01	8.11e-01	6.41e-02
GOBP REGULATION OF T CELL DIFFERENTIATION IN THYMUS	21	2.31e-02	6.62e-02	0.5410	1.82e-01	2.94e-01	1.06e-01	1.94e-01	1.62e-01	3.13e-01	1.48e-01	1.96e-02	4.00e-01	1.23e-01	1.98e-01	1.32e-02
GOCC CD95 DEATH INDUCING SIGNALING COMPLEX	6	6.79e-01	7.45e-01	0.5410	-2.95e-01	-1.39e-01	-5.16e-02	-2.04e-01	-3.63e-01	1.02e-01	2.11e-01	5.56e-01	8.27e-01	3.86e-01	1.24e-01	6.64e-01
GOMF CHEMOATTRACTANT ACTIVITY	17	4.44e-02	1.08e-01	0.5410	-1.03e-01	-3.87e-01	-1.25e-01	-3.01e-01	-1.33e-01	-8.86e-02	4.60e-01	5.71e-03	3.74e-01	3.14e-02	3.42e-01	5.27e-01
GOMF AP 2 ADAPTOR COMPLEX BINDING	10	1.82e-01	2.96e-01	0.5410	-9.10e-02	1.37e-01	-7.23e-03	3.48e-01	2.61e-01	2.76e-01	6.18e-01	4.53e-01	9.68e-01	5.68e-02	1.53e-01	1.31e-01
GOBP CERAMIDE 1 PHOSPHATE TRANSPORT	6	4.54e-01	5.60e-01	0.5410	-1.89e-01	1.11e-01	-1.62e-02	2.96e-01	3.57e-01	1.68e-01	4.22e-01	6.38e-01	9.45e-01	2.09e-01	1.29e-01	4.76e-01
GOMF CERAMIDE 1 PHOSPHATE TRANSFER ACTIVITY	6	4.54e-01	5.60e-01	0.5410	-1.89e-01	1.11e-01	-1.62e-02	2.96e-01	3.57e-01	1.68e-01	4.22e-01	6.38e-01	9.45e-01	2.09e-01	1.29e-01	4.76e-01
GOBP T CELL ANTIGEN PROCESSING AND PRESENTATION	6	4.52e-01	5.58e-01	0.5410	5.45e-02	-4.45e-02	-1.07e-01	4.00e-01	1.37e-01	-3.12e-01	8.17e-01	8.50e-01	6.50e-01	8.99e-02	5.61e-01	1.86e-01
GOBP SYNAPTIC MEMBRANE ADHESION	14	5.99e-02	1.35e-01	0.5400	7.09e-02	1.86e-01	2.40e-01	-2.57e-01	-3.36e-01	-1.28e-01	6.46e-01	2.29e-01	1.21e-01	9.58e-02	2.96e-02	4.07e-01
GOBP 5S CLASS RRNA TRANSCRIPTION BY RNA POLYMERASE III	6	5.70e-01	6.58e-01	0.5400	-4.49e-02	-2.35e-01	-2.91e-01	3.63e-01	7.69e-02	-1.12e-01	8.49e-01	3.19e-01	2.17e-01	1.24e-01	7.44e-01	6.36e-01
GOCC TRANSCRIPTION FACTOR TFIIIC COMPLEX	6	5.70e-01	6.58e-01	0.5400	-4.49e-02	-2.35e-01	-2.91e-01	3.63e-01	7.69e-02	-1.12e-01	8.49e-01	3.19e-01	2.17e-01	1.24e-01	7.44e-01	6.36e-01
GOMF DNA REPLICATION ORIGIN BINDING	16	1.59e-02	4.95e-02	0.5400	-9.30e-02	-3.23e-01	-1.37e-02	3.09e-01	-1.26e-01	2.60e-01	5.19e-01	2.54e-02	9.24e-01	3.22e-02	3.82e-01	7.22e-02
GOCC GROWTH FACTOR COMPLEX	5	9.44e-02	1.88e-01	0.5400	2.01e-01	-5.50e-02	2.70e-01	3.62e-02	2.11e-01	-3.60e-01	4.37e-01	8.31e-01	2.95e-01	8.89e-01	4.13e-01	1.63e-01
GOBP GAMMA AMINOBUTYRIC ACID SECRETION	10	1.89e-01	3.04e-01	0.5400	-9.12e-02	3.86e-01	-1.09e-01	1.29e-02	3.09e-01	-1.64e-01	6.18e-01	3.45e-02	5.51e-01	9.44e-01	9.03e-02	3.70e-01
GOBP MONOCYTE DIFFERENTIATION	26	2.34e-03	1.05e-02	0.5400	1.08e-01	2.05e-01	1.18e-01	4.33e-01	1.90e-01	-2.01e-02	3.42e-01	7.02e-02	2.96e-01	1.32e-04	9.28e-02	8.59e-01
GOBP LACTATE TRANSMEMBRANE TRANSPORT	6	1.63e-01	2.76e-01	0.5400	-2.19e-01	6.39e-02	9.96e-02	1.40e-01	-4.19e-01	1.86e-01	3.52e-01	7.86e-01	6.73e-01	5.51e-01	7.54e-02	4.31e-01
GOCC ENDOLYSOSOME MEMBRANE	19	1.21e-03	6.00e-03	0.5400	-5.18e-02	1.21e-01	2.05e-01	4.45e-01	-2.29e-02	1.85e-01	6.96e-01	3.63e-01	1.21e-01	7.86e-04	8.63e-01	1.64e-01
GOCC CLATHRIN SCULPTED VESICLE	7	5.83e-01	6.68e-01	0.5400	3.32e-01	2.37e-02	1.35e-01	3.13e-01	9.01e-02	2.38e-01	1.28e-01	9.13e-01	5.37e-01	1.51e-01	6.80e-01	2.76e-01
GOBP REGULATION OF ENDOPLASMIC RETICULUM UNFOLDED PROTEIN RESPONSE	28	3.57e-04	2.10e-03	0.5400	-2.73e-01	-1.55e-01	1.30e-01	3.83e-02	-3.94e-01	1.40e-01	1.25e-02	1.55e-01	2.33e-01	7.26e-01	3.07e-04	2.00e-01
GOBP NEGATIVE REGULATION OF BIOMINERAL TISSUE DEVELOPMENT	20	5.02e-02	1.18e-01	0.5400	6.68e-02	1.89e-01	4.20e-01	1.22e-01	1.48e-02	2.45e-01	6.05e-01	1.44e-01	1.13e-03	3.46e-01	9.09e-01	5.80e-02
GOCC GOLGI TRANS CISTERNA	10	1.21e-01	2.25e-01	0.5400	8.48e-03	3.18e-02	1.97e-01	4.04e-01	-1.18e-01	2.74e-01	9.63e-01	8.62e-01	2.80e-01	2.71e-02	5.20e-01	1.34e-01
GOBP ADENYLATE CYCLASE ACTIVATING ADRENERGIC RECEPTOR SIGNALING PATHWAY	11	8.71e-03	3.08e-02	0.5400	-7.99e-02	2.61e-01	3.07e-01	3.37e-01	4.70e-02	-7.99e-02	6.46e-01	1.34e-01	7.80e-02	5.26e-02	7.87e-01	6.46e-01
GOBP REGULATION OF BLOOD BRAIN BARRIER PERMEABILITY	8	5.01e-01	5.98e-01	0.5390	-2.58e-01	-4.41e-03	1.02e-02	-4.36e-01	-1.48e-01	-1.11e-01	2.06e-01	9.83e-01	9.60e-01	3.28e-02	4.68e-01	5.86e-01
GOBP REGULATION OF EXTRACELLULAR MATRIX CONSTITUENT SECRETION	7	2.51e-01	3.70e-01	0.5390	3.50e-02	9.09e-02	2.99e-01	1.86e-01	3.61e-01	1.64e-01	8.73e-01	6.77e-01	1.71e-01	3.94e-01	9.81e-02	4.52e-01
GOMF ANTIGEN BINDING	148	4.36e-30	4.21e-28	0.5390	5.52e-02	-3.34e-01	-4.50e-02	3.26e-01	-1.76e-01	1.92e-01	2.46e-01	2.36e-12	3.45e-01	7.48e-12	2.26e-04	5.36e-05
GOBP LEUKOTRIENE TRANSPORT	7	4.09e-01	5.20e-01	0.5390	-2.18e-02	-1.96e-01	2.75e-01	-1.93e-01	-3.61e-01	-9.05e-02	9.21e-01	3.68e-01	2.08e-01	3.78e-01	9.79e-02	6.78e-01
GOBP PRIMARY ALCOHOL BIOSYNTHETIC PROCESS	10	1.85e-01	3.00e-01	0.5390	1.16e-01	-5.85e-02	2.53e-01	3.19e-01	-2.35e-01	2.29e-01	5.26e-01	7.49e-01	1.66e-01	8.09e-02	1.97e-01	2.09e-01
GOMF CARBONATE DEHYDRATASE ACTIVITY	11	1.48e-01	2.59e-01	0.5390	3.77e-01	1.80e-01	2.34e-01	5.30e-02	-1.01e-01	-2.18e-01	3.03e-02	3.00e-01	1.79e-01	7.61e-01	5.63e-01	2.10e-01
GOBP REGULATION OF MONOCYTE EXTRAVASATION	6	2.63e-01	3.82e-01	0.5390	-3.46e-01	1.26e-01	-1.82e-01	-7.25e-02	-1.92e-01	-2.82e-01	1.42e-01	5.92e-01	4.41e-01	7.58e-01	4.15e-01	2.32e-01
GOMF POTASSIUM ION BINDING	7	3.92e-01	5.05e-01	0.5390	-2.10e-01	-2.95e-01	2.35e-01	8.70e-02	-2.70e-01	1.53e-01	3.36e-01	1.77e-01	2.81e-01	6.90e-01	2.17e-01	4.84e-01
GOMF ADENYL NUCLEOTIDE EXCHANGE FACTOR ACTIVITY	15	2.43e-02	6.87e-02	0.5380	-8.98e-02	-1.42e-01	2.23e-01	3.43e-01	-9.32e-02	2.93e-01	5.47e-01	3.41e-01	1.35e-01	2.15e-02	5.32e-01	4.97e-02
GOCC PROTEIN FOLDING CHAPERONE COMPLEX	38	4.98e-06	4.52e-05	0.5380	-2.64e-02	-4.61e-01	-1.37e-01	2.09e-01	-5.87e-02	1.02e-01	7.78e-01	8.51e-07	1.44e-01	2.57e-02	5.31e-01	2.78e-01
GOBP VOLUNTARY MUSCULOSKELETAL MOVEMENT	7	3.45e-01	4.61e-01	0.5380	-2.93e-01	-9.92e-02	2.37e-01	1.69e-01	-1.01e-01	3.15e-01	1.79e-01	6.49e-01	2.77e-01	4.40e-01	6.43e-01	1.50e-01
GOBP NEGATIVE REGULATION OF ALPHA BETA T CELL PROLIFERATION	16	1.04e-01	2.01e-01	0.5380	1.18e-01	2.57e-02	2.98e-01	2.62e-01	-1.07e-01	3.26e-01	4.12e-01	8.59e-01	3.87e-02	6.99e-02	4.61e-01	2.41e-02
GOCC DOPAMINERGIC SYNAPSE	11	2.28e-01	3.46e-01	0.5380	2.63e-01	-2.46e-02	2.76e-01	5.50e-02	-2.23e-01	3.01e-01	1.31e-01	8.88e-01	1.12e-01	7.52e-01	2.00e-01	8.37e-02
GOMF CARBOHYDRATE MONOATOMIC CATION SYMPORTER ACTIVITY	13	1.14e-01	2.15e-01	0.5380	9.54e-02	2.20e-01	1.49e-01	3.02e-01	3.39e-01	-5.96e-02	5.51e-01	1.69e-01	3.51e-01	5.98e-02	3.42e-02	7.10e-01
GOBP CELLULAR RESPONSE TO PURINE CONTAINING COMPOUND	12	8.24e-02	1.70e-01	0.5380	-3.97e-01	-3.12e-01	1.00e-01	-3.51e-03	-7.71e-02	1.35e-01	1.72e-02	6.11e-02	5.48e-01	9.83e-01	6.44e-01	4.17e-01
GOMF NUCLEOSIDE TRIPHOSPHATE DIPHOSPHATASE ACTIVITY	10	2.29e-01	3.47e-01	0.5380	-4.21e-02	-4.73e-01	-2.43e-01	-2.81e-02	-3.84e-02	-4.85e-02	8.18e-01	9.57e-03	1.83e-01	8.78e-01	8.33e-01	7.91e-01
GOMF CALCIUM INDUCED CALCIUM RELEASE ACTIVITY	6	4.19e-01	5.29e-01	0.5380	-1.63e-01	-4.80e-01	7.13e-02	2.88e-02	-7.98e-02	1.43e-01	4.90e-01	4.19e-02	7.62e-01	9.03e-01	7.35e-01	5.45e-01
GOBP POSITIVE REGULATION OF BLOOD BRAIN BARRIER PERMEABILITY	5	5.58e-01	6.47e-01	0.5380	-1.08e-01	1.95e-02	-3.38e-01	-3.63e-01	-9.12e-02	-1.50e-01	6.77e-01	9.40e-01	1.90e-01	1.60e-01	7.24e-01	5.61e-01
GOBP FAT PAD DEVELOPMENT	9	5.12e-01	6.07e-01	0.5380	-2.85e-02	2.42e-01	3.55e-01	-1.54e-02	-6.51e-03	3.21e-01	8.82e-01	2.08e-01	6.49e-02	9.36e-01	9.73e-01	9.54e-02
GOMF IGE BINDING	5	3.32e-01	4.50e-01	0.5380	-1.58e-02	-8.70e-02	2.16e-01	-2.45e-01	1.98e-01	3.69e-01	9.51e-01	7.36e-01	4.03e-01	3.43e-01	4.44e-01	1.54e-01
GOMF NEUROTROPHIN RECEPTOR BINDING	8	3.60e-01	4.76e-01	0.5380	-1.37e-02	2.11e-01	2.96e-01	7.50e-02	-2.55e-01	2.93e-01	9.46e-01	3.02e-01	1.47e-01	7.13e-01	2.12e-01	1.51e-01
GOBP PROTEIN LOCALIZATION TO PHAGOPHORE ASSEMBLY SITE	16	1.87e-02	5.60e-02	0.5370	8.01e-02	1.34e-02	-2.26e-01	4.48e-01	5.40e-02	-1.65e-01	5.79e-01	9.26e-01	1.18e-01	1.90e-03	7.08e-01	2.52e-01
GOBP CELLULAR RESPONSE TO CHOLESTEROL	14	4.84e-02	1.14e-01	0.5370	6.76e-02	3.18e-01	8.39e-02	3.94e-01	1.08e-01	9.48e-02	6.61e-01	3.91e-02	5.87e-01	1.07e-02	4.85e-01	5.39e-01
GOMF 5 3 DNA EXONUCLEASE ACTIVITY	9	3.28e-01	4.46e-01	0.5370	-3.64e-01	-2.52e-01	-2.51e-01	3.67e-02	1.31e-01	1.05e-01	5.84e-02	1.90e-01	1.93e-01	8.49e-01	4.97e-01	5.84e-01
GOBP MITOTIC METAPHASE CHROMOSOME ALIGNMENT	61	7.30e-10	1.20e-08	0.5370	-9.90e-02	-3.43e-01	5.54e-02	2.05e-01	-8.12e-02	3.31e-01	1.81e-01	3.68e-06	4.54e-01	5.50e-03	2.73e-01	7.79e-06
GOMF ARYL SULFOTRANSFERASE ACTIVITY	5	5.27e-01	6.19e-01	0.5370	-2.02e-01	-5.65e-02	-1.42e-01	-4.90e-02	-3.40e-01	-3.26e-01	4.34e-01	8.27e-01	5.82e-01	8.50e-01	1.88e-01	2.07e-01
GOBP NUCLEOLAR CHROMATIN ORGANIZATION	11	1.85e-02	5.56e-02	0.5370	-7.14e-02	3.75e-02	2.55e-02	5.26e-01	3.49e-02	-5.61e-02	6.82e-01	8.30e-01	8.84e-01	2.51e-03	8.41e-01	7.48e-01
GOMF SPHINGOLIPID TRANSFER ACTIVITY	8	1.90e-01	3.06e-01	0.5370	-3.15e-01	-4.98e-02	-2.15e-02	2.84e-01	1.94e-01	2.61e-01	1.23e-01	8.07e-01	9.16e-01	1.64e-01	3.42e-01	2.01e-01
GOBP NEGATIVE REGULATION OF B CELL ACTIVATION	29	8.40e-03	2.99e-02	0.5370	-7.99e-02	3.58e-02	3.71e-01	-3.30e-02	-2.63e-01	2.70e-01	4.56e-01	7.39e-01	5.45e-04	7.58e-01	1.41e-02	1.20e-02
GOMF ATPASE COUPLED ION TRANSMEMBRANE TRANSPORTER ACTIVITY	20	2.30e-02	6.60e-02	0.5370	-3.21e-01	-2.83e-01	1.53e-01	-3.00e-02	-2.47e-01	1.38e-01	1.29e-02	2.82e-02	2.36e-01	8.16e-01	5.55e-02	2.84e-01
GOCC PROTEASE INHIBITOR COMPLEX	6	1.17e-01	2.20e-01	0.5370	-9.11e-02	-2.83e-01	-3.67e-02	5.89e-02	4.41e-01	-1.75e-02	6.99e-01	2.30e-01	8.76e-01	8.03e-01	6.12e-02	9.41e-01
GOBP NEGATIVE REGULATION OF CELL JUNCTION ASSEMBLY	24	2.14e-04	1.33e-03	0.5370	-4.00e-01	-7.66e-02	1.68e-01	-2.89e-01	-6.30e-02	-8.22e-02	6.98e-04	5.16e-01	1.55e-01	1.43e-02	5.93e-01	4.86e-01
GOBP NEGATIVE REGULATION OF TRANSFORMING GROWTH FACTOR BETA PRODUCTION	8	3.64e-01	4.79e-01	0.5360	-2.40e-01	-1.42e-01	3.46e-01	-6.33e-02	-1.35e-01	2.60e-01	2.40e-01	4.86e-01	8.97e-02	7.57e-01	5.08e-01	2.03e-01
GOBP CELLULAR RESPONSE TO OXYGEN RADICAL	17	7.55e-04	4.01e-03	0.5360	-3.66e-02	-2.05e-01	8.33e-02	1.52e-02	3.13e-01	3.73e-01	7.94e-01	1.43e-01	5.52e-01	9.14e-01	2.53e-02	7.81e-03
GOMF PROTEASOME BINDING	16	1.17e-01	2.19e-01	0.5360	-3.47e-01	-3.65e-01	-2.81e-02	-5.50e-02	-1.48e-01	8.99e-02	1.62e-02	1.15e-02	8.46e-01	7.03e-01	3.04e-01	5.33e-01
GOCC TERTIARY GRANULE MEMBRANE	70	7.86e-09	1.12e-07	0.5360	-1.95e-01	1.12e-01	3.28e-01	-8.62e-03	-1.67e-01	3.18e-01	4.82e-03	1.04e-01	2.01e-06	9.01e-01	1.57e-02	4.23e-06
GOBP ACTIN CROSSLINK FORMATION	11	2.29e-01	3.48e-01	0.5360	-1.34e-01	-4.42e-02	-2.60e-01	-5.66e-02	2.81e-01	-3.43e-01	4.41e-01	8.00e-01	1.36e-01	7.45e-01	1.07e-01	4.86e-02
GOBP NEGATIVE REGULATION OF STRIATED MUSCLE CONTRACTION	6	6.00e-01	6.81e-01	0.5360	8.20e-02	3.45e-02	4.18e-01	2.00e-01	1.10e-02	2.53e-01	7.28e-01	8.84e-01	7.59e-02	3.96e-01	9.63e-01	2.83e-01
GOBP FOLIC ACID METABOLIC PROCESS	13	1.59e-01	2.71e-01	0.5360	-1.57e-01	-4.05e-01	1.09e-01	-1.37e-01	-2.15e-01	1.47e-01	3.26e-01	1.15e-02	4.98e-01	3.91e-01	1.79e-01	3.60e-01
GOBP REGULATION OF MITOTIC RECOMBINATION	6	6.14e-01	6.93e-01	0.5360	5.33e-03	-1.95e-01	-2.96e-01	2.87e-01	2.81e-01	2.21e-02	9.82e-01	4.09e-01	2.10e-01	2.23e-01	2.34e-01	9.25e-01
GOMF LEUKOTRIENE C4 SYNTHASE ACTIVITY	5	6.73e-01	7.40e-01	0.5360	-1.98e-02	-3.22e-01	1.83e-01	-2.29e-01	-3.11e-01	-1.66e-02	9.39e-01	2.13e-01	4.78e-01	3.75e-01	2.28e-01	9.49e-01
GOMF SEQUENCE SPECIFIC MRNA BINDING	10	1.65e-01	2.78e-01	0.5360	2.14e-02	-3.14e-01	1.80e-01	7.86e-02	-7.16e-02	3.80e-01	9.07e-01	8.59e-02	3.25e-01	6.67e-01	6.95e-01	3.74e-02
GOBP MITOCHONDRIAL FUSION	35	1.92e-03	8.87e-03	0.5350	-2.81e-01	-3.97e-01	-2.18e-01	-5.98e-03	-4.69e-02	-2.26e-02	4.06e-03	4.77e-05	2.57e-02	9.51e-01	6.31e-01	8.17e-01
GOCC PLATELET DENSE GRANULE	16	5.11e-02	1.19e-01	0.5350	-3.29e-01	-3.00e-01	-1.09e-01	7.99e-02	-2.34e-01	1.22e-01	2.25e-02	3.77e-02	4.52e-01	5.80e-01	1.05e-01	3.98e-01
GOBP RENAL WATER TRANSPORT	6	4.06e-01	5.18e-01	0.5350	6.66e-03	-2.42e-01	-1.25e-01	2.55e-01	-9.21e-02	-3.73e-01	9.77e-01	3.05e-01	5.97e-01	2.79e-01	6.96e-01	1.14e-01
GOMF ER RETENTION SEQUENCE BINDING	5	5.41e-01	6.32e-01	0.5350	1.01e-01	-4.71e-01	6.82e-03	1.23e-01	-1.98e-01	-4.35e-03	6.96e-01	6.84e-02	9.79e-01	6.35e-01	4.42e-01	9.87e-01
GOBP DNA LIGATION INVOLVED IN DNA REPAIR	5	5.73e-01	6.60e-01	0.5350	-3.87e-01	-4.68e-02	-2.34e-01	1.44e-01	2.41e-01	2.47e-02	1.34e-01	8.56e-01	3.65e-01	5.78e-01	3.50e-01	9.24e-01
GOMF BILE ACID BINDING	6	5.44e-01	6.34e-01	0.5350	-3.27e-02	4.36e-01	6.17e-02	1.67e-01	2.46e-01	5.39e-02	8.90e-01	6.46e-02	7.93e-01	4.79e-01	2.97e-01	8.19e-01
GOBP POSITIVE REGULATION OF DNA LIGATION	5	3.66e-01	4.81e-01	0.5340	1.15e-01	-3.49e-01	-3.56e-01	-1.53e-02	1.34e-01	7.79e-02	6.57e-01	1.77e-01	1.68e-01	9.53e-01	6.04e-01	7.63e-01
GOBP NEGATIVE REGULATION OF B CELL PROLIFERATION	16	9.74e-02	1.92e-01	0.5340	-8.16e-02	1.03e-01	3.75e-01	1.12e-01	-4.11e-02	3.37e-01	5.72e-01	4.74e-01	9.38e-03	4.39e-01	7.76e-01	1.97e-02
GOMF PYRIMIDINE NUCLEOTIDE BINDING	5	4.97e-01	5.95e-01	0.5340	-1.66e-01	-4.97e-01	1.71e-02	-5.52e-02	-2.43e-02	8.21e-02	5.19e-01	5.43e-02	9.47e-01	8.31e-01	9.25e-01	7.50e-01
GOMF N ACETYLLACTOSAMINIDE BETA 1 3 N ACETYLGLUCOSAMINYLTRANSFERASE ACTIVITY	5	3.57e-01	4.72e-01	0.5340	-7.59e-02	1.68e-01	3.18e-01	3.10e-01	2.29e-01	3.54e-02	7.69e-01	5.17e-01	2.18e-01	2.30e-01	3.74e-01	8.91e-01
GOBP NEGATIVE REGULATION OF DNA TEMPLATED TRANSCRIPTION ELONGATION	22	4.25e-03	1.72e-02	0.5340	2.15e-01	-2.41e-01	-1.01e-01	4.04e-01	6.34e-02	5.49e-02	8.04e-02	5.04e-02	4.12e-01	1.03e-03	6.07e-01	6.56e-01
GOCC NONHOMOLOGOUS END JOINING COMPLEX	9	2.48e-01	3.67e-01	0.5340	-2.30e-01	-3.33e-01	-9.90e-02	-5.97e-02	6.32e-03	3.28e-01	2.33e-01	8.34e-02	6.07e-01	7.57e-01	9.74e-01	8.80e-02
GOBP NEGATIVE REGULATION OF MULTICELLULAR ORGANISM GROWTH	9	3.89e-01	5.02e-01	0.5340	3.41e-02	1.80e-01	6.67e-02	2.88e-01	4.01e-01	5.51e-02	8.60e-01	3.50e-01	7.29e-01	1.34e-01	3.72e-02	7.75e-01
GOBP CATECHOL CONTAINING COMPOUND CATABOLIC PROCESS	7	3.14e-01	4.34e-01	0.5340	1.51e-01	-3.15e-01	-5.40e-02	1.73e-01	-1.77e-01	-3.15e-01	4.88e-01	1.49e-01	8.05e-01	4.28e-01	4.18e-01	1.49e-01
GOBP TETRAHYDROFOLATE METABOLIC PROCESS	17	1.59e-02	4.96e-02	0.5340	-4.83e-02	-4.19e-01	-6.91e-03	1.86e-01	-8.52e-02	2.56e-01	7.31e-01	2.80e-03	9.61e-01	1.83e-01	5.43e-01	6.80e-02
GOCC HIGH DENSITY LIPOPROTEIN PARTICLE	12	7.90e-02	1.65e-01	0.5340	1.16e-01	-3.44e-02	4.10e-01	2.50e-01	3.62e-02	1.95e-01	4.86e-01	8.37e-01	1.39e-02	1.33e-01	8.28e-01	2.43e-01
GOBP PROTEIN ACTIVATION CASCADE	15	4.41e-02	1.07e-01	0.5340	1.06e-01	-1.64e-01	3.76e-01	-1.67e-01	-2.41e-01	1.39e-01	4.79e-01	2.72e-01	1.16e-02	2.64e-01	1.07e-01	3.51e-01
GOBP REGULATION OF TRANSLATIONAL TERMINATION	9	7.74e-02	1.63e-01	0.5340	8.01e-02	-1.92e-01	-3.23e-02	3.79e-01	-3.08e-01	4.41e-02	6.77e-01	3.20e-01	8.67e-01	4.90e-02	1.09e-01	8.19e-01
GOBP FACE MORPHOGENESIS	23	3.73e-02	9.45e-02	0.5340	7.23e-02	1.30e-01	3.78e-01	6.23e-02	-2.18e-01	2.62e-01	5.48e-01	2.82e-01	1.70e-03	6.05e-01	7.06e-02	2.99e-02
GOCC EARP COMPLEX	5	6.33e-01	7.09e-01	0.5340	4.09e-01	-4.04e-02	1.12e-01	2.51e-01	1.54e-01	-1.29e-01	1.13e-01	8.76e-01	6.65e-01	3.32e-01	5.50e-01	6.17e-01
GOBP MITOTIC NUCLEAR MEMBRANE ORGANIZATION	10	2.14e-01	3.32e-01	0.5340	-9.94e-02	-4.31e-01	5.85e-02	6.81e-02	-2.84e-01	-8.73e-03	5.86e-01	1.82e-02	7.49e-01	7.09e-01	1.20e-01	9.62e-01
GOCC ORGANELLE ENVELOPE LUMEN	88	7.22e-12	1.47e-10	0.5340	-1.40e-01	-4.44e-01	-2.55e-01	5.11e-02	1.07e-03	2.25e-02	2.30e-02	6.24e-13	3.48e-05	4.08e-01	9.86e-01	7.15e-01
GOCC NUCLEAR REPLICATION FORK	40	3.62e-06	3.40e-05	0.5330	1.29e-01	-2.12e-01	-7.05e-03	3.81e-01	2.33e-01	1.54e-01	1.59e-01	2.06e-02	9.39e-01	3.08e-05	1.06e-02	9.19e-02
GOBP N TERMINAL PROTEIN LIPIDATION	5	6.99e-01	7.60e-01	0.5330	-1.46e-01	-1.11e-01	8.90e-02	-1.00e-01	-3.50e-01	3.33e-01	5.72e-01	6.69e-01	7.30e-01	6.98e-01	1.76e-01	1.97e-01
GOBP POSITIVE REGULATION OF CHEMOKINE C X C MOTIF LIGAND 2 PRODUCTION	10	4.73e-01	5.75e-01	0.5330	-1.78e-01	-9.30e-02	-2.78e-01	-2.09e-01	-9.97e-02	-3.37e-01	3.30e-01	6.11e-01	1.28e-01	2.52e-01	5.85e-01	6.51e-02
GOMF NUCLEOSIDE DIPHOSPHATE KINASE ACTIVITY	14	8.02e-03	2.89e-02	0.5330	-7.82e-03	-4.19e-01	-2.53e-01	-1.16e-01	5.11e-02	1.69e-01	9.60e-01	6.61e-03	1.02e-01	4.53e-01	7.41e-01	2.73e-01
GOBP SEGMENT SPECIFICATION	8	2.57e-01	3.77e-01	0.5330	9.32e-02	-2.64e-02	-5.83e-02	1.72e-01	4.91e-01	3.09e-02	6.48e-01	8.97e-01	7.75e-01	4.00e-01	1.62e-02	8.80e-01
GOBP PHASIC SMOOTH MUSCLE CONTRACTION	10	1.19e-01	2.21e-01	0.5330	-3.81e-01	2.17e-01	-2.89e-02	-2.45e-01	1.74e-01	1.49e-02	3.67e-02	2.34e-01	8.74e-01	1.80e-01	3.39e-01	9.35e-01
GOBP RRNA TRANSCRIPTION	40	4.04e-05	3.01e-04	0.5330	-3.19e-02	-3.59e-01	-2.35e-01	2.17e-01	-8.75e-02	-2.09e-01	7.27e-01	8.55e-05	1.00e-02	1.74e-02	3.38e-01	2.21e-02
GOBP SARCOMERE ORGANIZATION	29	1.95e-02	5.81e-02	0.5330	2.11e-01	1.51e-01	3.76e-01	1.31e-01	-7.57e-02	2.28e-01	4.88e-02	1.59e-01	4.55e-04	2.23e-01	4.80e-01	3.36e-02
GOBP NEGATIVE REGULATION OF TRANSLATIONAL INITIATION	21	5.80e-02	1.32e-01	0.5330	-3.27e-01	-3.27e-01	-2.07e-01	-1.27e-02	-1.64e-01	-9.06e-03	9.58e-03	9.50e-03	1.00e-01	9.20e-01	1.92e-01	9.43e-01
GOBP REGULATION OF METALLOPEPTIDASE ACTIVITY	8	8.45e-02	1.73e-01	0.5330	-3.40e-01	4.03e-02	1.67e-01	2.92e-01	-6.31e-02	2.22e-01	9.61e-02	8.43e-01	4.15e-01	1.52e-01	7.57e-01	2.77e-01
GOCC INTERCHROMATIN GRANULE	5	5.25e-01	6.19e-01	0.5330	-1.58e-01	1.38e-01	-3.87e-01	-1.96e-01	-3.40e-02	-2.23e-01	5.42e-01	5.93e-01	1.34e-01	4.47e-01	8.95e-01	3.87e-01
GOMF OXIDOREDUCTASE ACTIVITY ACTING ON CH OR CH2 GROUPS	7	4.29e-01	5.38e-01	0.5320	-1.53e-01	-1.27e-01	9.47e-02	5.70e-02	2.80e-02	4.81e-01	4.84e-01	5.61e-01	6.64e-01	7.94e-01	8.98e-01	2.77e-02
GOBP POSITIVE REGULATION OF METAPHASE ANAPHASE TRANSITION OF CELL CYCLE	14	3.02e-02	8.06e-02	0.5320	9.29e-02	-4.02e-01	-4.31e-02	2.46e-01	-9.02e-02	2.06e-01	5.47e-01	9.14e-03	7.80e-01	1.12e-01	5.59e-01	1.82e-01
GOCC BLOC 1 COMPLEX	14	1.15e-01	2.16e-01	0.5320	-2.37e-01	-3.88e-01	-1.84e-01	6.34e-02	-9.14e-02	1.73e-01	1.24e-01	1.19e-02	2.34e-01	6.81e-01	5.54e-01	2.61e-01
GOMF COMPLEMENT COMPONENT C1Q COMPLEX BINDING	5	1.29e-01	2.35e-01	0.5320	-4.29e-01	6.96e-02	1.81e-01	1.63e-01	-1.46e-01	-1.15e-01	9.64e-02	7.87e-01	4.82e-01	5.28e-01	5.72e-01	6.57e-01
GOMF TRNA BINDING	78	8.14e-09	1.16e-07	0.5320	-1.55e-01	-4.02e-01	-3.05e-01	3.63e-02	-9.63e-03	-4.95e-02	1.78e-02	7.92e-10	3.10e-06	5.80e-01	8.83e-01	4.50e-01
GOMF RNA POLYMERASE ACTIVITY	32	1.08e-03	5.43e-03	0.5320	-1.29e-01	-4.17e-01	-2.62e-01	1.49e-01	-1.72e-02	-4.36e-02	2.08e-01	4.49e-05	1.04e-02	1.45e-01	8.66e-01	6.70e-01
GOBP FIBROBLAST APOPTOTIC PROCESS	22	5.35e-03	2.07e-02	0.5320	-1.93e-01	-4.74e-02	1.76e-01	2.05e-01	-2.62e-03	4.13e-01	1.17e-01	7.00e-01	1.52e-01	9.64e-02	9.83e-01	8.02e-04
GOCC TRAPPII PROTEIN COMPLEX	12	8.34e-02	1.72e-01	0.5320	2.89e-02	-3.38e-01	-1.49e-01	3.45e-01	3.69e-02	1.58e-01	8.62e-01	4.26e-02	3.70e-01	3.83e-02	8.25e-01	3.43e-01
GOMF PHOSPHOTYROSINE RESIDUE BINDING	45	4.44e-05	3.28e-04	0.5320	1.97e-02	1.48e-01	3.51e-01	2.23e-01	-5.30e-02	2.91e-01	8.19e-01	8.48e-02	4.52e-05	9.71e-03	5.38e-01	7.34e-04
GOCC NUCLEOCYTOPLASMIC TRANSPORT COMPLEX	11	1.82e-01	2.97e-01	0.5320	-3.90e-01	-2.26e-01	-2.61e-01	7.96e-02	-4.55e-02	5.87e-02	2.53e-02	1.94e-01	1.33e-01	6.48e-01	7.94e-01	7.36e-01
GOMF NUCLEOSOMAL DNA BINDING	45	3.75e-07	4.20e-06	0.5320	-1.50e-01	-4.75e-01	-2.38e-02	7.47e-02	-5.00e-02	1.63e-01	8.25e-02	3.56e-08	7.83e-01	3.86e-01	5.62e-01	5.90e-02
GOBP NUCLEAR BODY ORGANIZATION	18	4.31e-02	1.05e-01	0.5320	-4.01e-01	-1.28e-01	1.44e-02	-1.12e-01	-2.99e-01	6.24e-02	3.23e-03	3.48e-01	9.16e-01	4.11e-01	2.83e-02	6.47e-01
GOBP DOPAMINE BIOSYNTHETIC PROCESS	7	2.25e-01	3.44e-01	0.5320	-3.47e-01	-9.65e-02	1.19e-01	5.17e-02	2.54e-01	2.67e-01	1.12e-01	6.58e-01	5.87e-01	8.13e-01	2.44e-01	2.20e-01
GOBP NEGATIVE REGULATION OF BONE MINERALIZATION	14	1.68e-01	2.81e-01	0.5320	5.11e-02	2.58e-01	4.11e-01	1.02e-01	1.24e-02	1.84e-01	7.41e-01	9.40e-02	7.79e-03	5.10e-01	9.36e-01	2.33e-01
GOBP MITOTIC NUCLEAR MEMBRANE DISASSEMBLY	8	2.78e-01	3.98e-01	0.5320	-1.05e-01	-2.22e-01	2.55e-01	2.37e-01	-2.05e-02	3.17e-01	6.07e-01	2.78e-01	2.12e-01	2.45e-01	9.20e-01	1.20e-01
GOBP PROTEIN LOCALIZATION TO NUCLEOLUS	17	2.55e-02	7.13e-02	0.5310	-1.31e-01	-4.15e-01	-1.32e-01	2.45e-01	-1.21e-01	3.95e-02	3.50e-01	3.08e-03	3.46e-01	8.05e-02	3.89e-01	7.78e-01
GOBP BASE CONVERSION OR SUBSTITUTION EDITING	15	2.32e-01	3.50e-01	0.5310	2.22e-01	2.20e-01	2.29e-01	2.22e-01	3.36e-02	2.86e-01	1.36e-01	1.39e-01	1.24e-01	1.37e-01	8.22e-01	5.54e-02
GOBP PROTEIN N LINKED GLYCOSYLATION	63	1.07e-07	1.31e-06	0.5310	-2.79e-01	-3.48e-01	-3.81e-02	5.70e-02	-2.15e-01	1.80e-01	1.27e-04	1.77e-06	6.01e-01	4.34e-01	3.23e-03	1.33e-02
GOBP PHOSPHATIDYLINOSITOL MEDIATED SIGNALING	22	9.40e-03	3.27e-02	0.5310	1.28e-02	3.55e-01	2.65e-02	2.46e-01	2.86e-01	-1.13e-01	9.17e-01	3.94e-03	8.30e-01	4.54e-02	2.01e-02	3.60e-01
GOBP PROTEIN RNA COMPLEX ORGANIZATION	199	3.47e-24	2.03e-22	0.5310	-1.52e-01	-3.73e-01	-3.18e-01	1.08e-01	2.16e-02	-8.38e-02	2.15e-04	1.14e-19	1.07e-14	8.94e-03	6.00e-01	4.15e-02
GOCC MIB COMPLEX	13	1.01e-01	1.97e-01	0.5310	-1.18e-01	-4.26e-01	-2.47e-01	-1.38e-01	5.40e-02	-6.12e-02	4.62e-01	7.86e-03	1.22e-01	3.89e-01	7.36e-01	7.02e-01
GOBP POSITIVE REGULATION OF MONOCYTE CHEMOTACTIC PROTEIN 1 PRODUCTION	12	7.42e-02	1.58e-01	0.5310	-1.56e-01	2.91e-01	-1.03e-01	-3.46e-01	1.59e-01	-1.29e-01	3.48e-01	8.05e-02	5.35e-01	3.80e-02	3.39e-01	4.38e-01
GOBP POSITIVE REGULATION OF TOLL LIKE RECEPTOR 4 SIGNALING PATHWAY	12	6.13e-02	1.37e-01	0.5310	-3.29e-01	7.72e-02	-1.71e-01	1.22e-01	3.38e-01	-9.83e-02	4.87e-02	6.43e-01	3.06e-01	4.63e-01	4.27e-02	5.56e-01
GOBP ANTIMICROBIAL HUMORAL RESPONSE	79	3.44e-10	5.87e-09	0.5310	2.99e-02	-3.05e-01	1.90e-01	-5.17e-02	-3.68e-01	1.19e-01	6.46e-01	2.84e-06	3.55e-03	4.27e-01	1.61e-08	6.65e-02
GOBP RESPONSE TO MUSCLE INACTIVITY	8	4.30e-01	5.38e-01	0.5310	1.55e-01	1.60e-01	3.85e-01	8.95e-02	-2.65e-01	7.65e-02	4.48e-01	4.34e-01	5.96e-02	6.61e-01	1.94e-01	7.08e-01
GOBP POSITIVE REGULATION OF SUBSTRATE ADHESION DEPENDENT CELL SPREADING	35	3.14e-07	3.55e-06	0.5310	-1.63e-01	-1.38e-01	3.43e-01	2.08e-01	-2.40e-01	1.33e-01	9.59e-02	1.56e-01	4.53e-04	3.31e-02	1.40e-02	1.73e-01
GOBP LEYDIG CELL DIFFERENTIATION	7	2.75e-01	3.94e-01	0.5310	1.23e-01	2.29e-01	2.09e-01	-1.24e-02	-3.91e-01	1.30e-01	5.72e-01	2.93e-01	3.38e-01	9.55e-01	7.32e-02	5.51e-01
GOCC SMN SM PROTEIN COMPLEX	18	7.84e-03	2.83e-02	0.5300	5.12e-02	-4.56e-01	-2.51e-01	7.57e-02	4.83e-02	7.83e-03	7.07e-01	8.16e-04	6.52e-02	5.78e-01	7.23e-01	9.54e-01
GOMF LIPID KINASE ACTIVITY	39	7.88e-06	6.85e-05	0.5300	-1.18e-01	3.49e-01	2.14e-02	1.91e-01	3.24e-01	6.22e-02	2.02e-01	1.61e-04	8.17e-01	3.90e-02	4.69e-04	5.01e-01
GOBP REGULATION OF EXIT FROM MITOSIS	15	4.56e-02	1.09e-01	0.5300	-1.07e-01	-4.08e-01	-1.69e-01	2.63e-01	2.13e-02	-6.74e-02	4.73e-01	6.16e-03	2.56e-01	7.74e-02	8.86e-01	6.51e-01
GOBP POSITIVE REGULATION OF CYTOPLASMIC MRNA PROCESSING BODY ASSEMBLY	6	1.26e-01	2.31e-01	0.5300	-2.70e-01	3.99e-01	4.91e-02	1.84e-01	-1.06e-02	1.15e-01	2.53e-01	9.06e-02	8.35e-01	4.35e-01	9.64e-01	6.27e-01
GOMF PYRIMIDINE NUCLEOTIDE SUGAR TRANSMEMBRANE TRANSPORTER ACTIVITY	10	2.26e-01	3.44e-01	0.5300	-4.37e-01	-2.31e-01	-1.92e-02	-3.96e-02	-1.81e-01	-4.53e-02	1.67e-02	2.06e-01	9.16e-01	8.28e-01	3.21e-01	8.04e-01
GOBP REGULATION OF LYSOSOMAL LUMEN PH	30	6.73e-04	3.62e-03	0.5300	-4.13e-01	-3.01e-01	-1.04e-01	4.57e-02	-8.53e-03	8.39e-02	9.05e-05	4.36e-03	3.24e-01	6.65e-01	9.36e-01	4.26e-01
GOCC EXTRINSIC COMPONENT OF SYNAPTIC VESICLE MEMBRANE	11	2.80e-01	3.99e-01	0.5300	-1.67e-01	-1.00e-01	2.36e-01	-9.24e-03	-4.09e-02	4.31e-01	3.38e-01	5.64e-01	1.75e-01	9.58e-01	8.14e-01	1.34e-02
GOBP PEPTIDYL TYROSINE DEPHOSPHORYLATION INVOLVED IN INACTIVATION OF PROTEIN KINASE ACTIVITY	5	6.98e-01	7.60e-01	0.5300	4.00e-01	2.64e-01	1.98e-01	-8.81e-02	1.15e-02	-6.11e-02	1.22e-01	3.06e-01	4.42e-01	7.33e-01	9.65e-01	8.13e-01
GOBP COMPLEMENT ACTIVATION LECTIN PATHWAY	5	2.65e-01	3.84e-01	0.5300	2.12e-01	2.21e-01	-2.29e-01	-3.51e-01	8.89e-02	-5.77e-02	4.12e-01	3.92e-01	3.75e-01	1.74e-01	7.31e-01	8.23e-01
GOCC SEH1 ASSOCIATED COMPLEX	14	3.78e-02	9.56e-02	0.5300	1.93e-01	-5.36e-02	-6.61e-02	3.39e-01	-6.16e-02	-3.43e-01	2.10e-01	7.29e-01	6.69e-01	2.81e-02	6.90e-01	2.64e-02
GOBP POSITIVE REGULATION OF PROTEIN LOCALIZATION TO CENTROSOME	7	3.54e-01	4.69e-01	0.5300	2.46e-01	1.16e-01	1.47e-01	4.04e-01	-1.49e-01	7.14e-03	2.61e-01	5.96e-01	4.99e-01	6.43e-02	4.95e-01	9.74e-01
GOBP NEGATIVE REGULATION OF EPIDERMIS DEVELOPMENT	6	3.32e-01	4.50e-01	0.5300	1.24e-01	-1.15e-02	1.64e-01	3.61e-01	3.15e-01	-9.49e-02	5.98e-01	9.61e-01	4.88e-01	1.26e-01	1.82e-01	6.87e-01
GOBP REGULATION OF ENDOPLASMIC RETICULUM STRESS INDUCED INTRINSIC APOPTOTIC SIGNALING PATHWAY	28	4.64e-04	2.64e-03	0.5300	-1.94e-01	-1.98e-01	1.55e-01	1.33e-01	-3.50e-01	1.99e-01	7.50e-02	6.93e-02	1.57e-01	2.23e-01	1.36e-03	6.87e-02
GOMF PROTEIN KINASE A REGULATORY SUBUNIT BINDING	23	1.40e-02	4.49e-02	0.5300	-6.50e-02	1.22e-01	2.75e-01	1.97e-01	-2.62e-02	3.82e-01	5.89e-01	3.12e-01	2.22e-02	1.02e-01	8.28e-01	1.52e-03
GOBP NEGATIVE REGULATION OF VITAMIN METABOLIC PROCESS	6	7.65e-01	8.11e-01	0.5300	9.51e-02	2.44e-01	1.45e-01	3.11e-01	2.42e-01	1.89e-01	6.87e-01	3.00e-01	5.39e-01	1.88e-01	3.04e-01	4.23e-01
GOBP MITOCHONDRIAL MEMBRANE ORGANIZATION	110	1.74e-11	3.44e-10	0.5290	-1.74e-01	-4.02e-01	-2.68e-01	-3.10e-02	-3.67e-02	-1.20e-01	1.67e-03	3.08e-13	1.21e-06	5.74e-01	5.06e-01	2.93e-02
GOMF PROTEIN TRANSPORTER ACTIVITY	38	8.55e-04	4.46e-03	0.5290	-2.81e-01	-3.35e-01	-2.74e-01	2.58e-02	-1.17e-01	-1.18e-02	2.76e-03	3.57e-04	3.52e-03	7.83e-01	2.11e-01	9.00e-01
GOBP CLEARANCE OF FOREIGN INTRACELLULAR NUCLEIC ACIDS	6	6.00e-01	6.81e-01	0.5290	3.35e-01	2.05e-02	1.21e-01	2.78e-01	-6.45e-03	2.74e-01	1.55e-01	9.31e-01	6.07e-01	2.38e-01	9.78e-01	2.45e-01
GOBP POSITIVE REGULATION OF AMINE METABOLIC PROCESS	6	4.85e-01	5.86e-01	0.5290	-2.57e-01	-3.44e-01	-1.55e-01	1.52e-01	1.91e-01	1.11e-01	2.75e-01	1.45e-01	5.11e-01	5.20e-01	4.18e-01	6.38e-01
GOBP NEGATIVE REGULATION OF VIRAL GENOME REPLICATION	50	1.28e-09	2.01e-08	0.5290	7.56e-02	-9.00e-02	-1.41e-02	2.75e-01	2.52e-02	4.36e-01	3.55e-01	2.71e-01	8.63e-01	7.67e-04	7.58e-01	9.83e-08
GOBP INHIBITION OF NEUROEPITHELIAL CELL DIFFERENTIATION	5	4.40e-01	5.47e-01	0.5290	-2.79e-02	2.08e-01	9.47e-02	1.38e-01	4.04e-01	-2.11e-01	9.14e-01	4.20e-01	7.14e-01	5.93e-01	1.18e-01	4.13e-01
GOMF MAP KINASE PHOSPHATASE ACTIVITY	12	9.01e-02	1.82e-01	0.5290	7.20e-02	2.85e-01	-2.66e-03	2.76e-02	1.70e-01	-4.04e-01	6.66e-01	8.69e-02	9.87e-01	8.69e-01	3.09e-01	1.53e-02
GOCC APICOLATERAL PLASMA MEMBRANE	14	2.64e-01	3.83e-01	0.5290	-1.01e-01	-2.26e-01	2.23e-01	-2.07e-01	-3.08e-01	1.77e-01	5.13e-01	1.44e-01	1.49e-01	1.80e-01	4.60e-02	2.51e-01
GOBP PROTECTION FROM NON HOMOLOGOUS END JOINING AT TELOMERE	9	4.36e-01	5.44e-01	0.5290	-1.27e-01	-2.13e-01	-4.11e-01	1.64e-01	9.19e-02	-1.20e-01	5.10e-01	2.68e-01	3.29e-02	3.96e-01	6.33e-01	5.33e-01
GOBP NEGATIVE REGULATION OF ENDOTHELIAL CELL DIFFERENTIATION	7	4.35e-02	1.06e-01	0.5290	-3.37e-01	2.78e-02	1.52e-01	2.00e-01	3.10e-01	-7.33e-02	1.22e-01	8.99e-01	4.86e-01	3.59e-01	1.55e-01	7.37e-01
GOBP POSITIVE REGULATION OF PODOSOME ASSEMBLY	9	1.84e-01	2.99e-01	0.5290	-4.32e-01	-2.68e-02	6.91e-02	-1.27e-01	1.59e-01	2.14e-01	2.47e-02	8.89e-01	7.20e-01	5.09e-01	4.10e-01	2.66e-01
GOBP REGULATION OF NATURAL KILLER CELL PROLIFERATION	9	3.72e-01	4.87e-01	0.5290	-3.62e-01	-5.73e-02	-3.02e-01	-1.59e-02	1.88e-01	-1.34e-01	5.99e-02	7.66e-01	1.16e-01	9.34e-01	3.29e-01	4.86e-01
GOBP QUINONE METABOLIC PROCESS	22	4.08e-02	1.01e-01	0.5290	-2.00e-01	-2.41e-01	-3.67e-01	4.70e-02	1.84e-01	-1.02e-01	1.04e-01	5.02e-02	2.89e-03	7.03e-01	1.34e-01	4.09e-01
GOBP TRACHEA DEVELOPMENT	12	8.96e-02	1.81e-01	0.5280	-1.51e-01	5.04e-03	3.85e-01	1.69e-01	-1.16e-01	2.57e-01	3.65e-01	9.76e-01	2.11e-02	3.09e-01	4.86e-01	1.23e-01
GOBP POSITIVE REGULATION OF PROTEIN LOCALIZATION TO NUCLEOLUS	5	7.00e-01	7.61e-01	0.5280	-2.26e-01	-3.81e-01	-2.04e-01	1.44e-01	-2.35e-02	1.43e-01	3.82e-01	1.40e-01	4.31e-01	5.76e-01	9.28e-01	5.80e-01
GOBP NEGATIVE REGULATION OF CATECHOLAMINE SECRETION	7	4.67e-01	5.70e-01	0.5280	-1.06e-01	1.31e-01	8.53e-02	-4.15e-01	-1.75e-01	-2.02e-01	6.26e-01	5.48e-01	6.96e-01	5.75e-02	4.23e-01	3.54e-01
GOBP NEGATIVE REGULATION OF SYNAPSE ORGANIZATION	5	5.79e-01	6.64e-01	0.5280	-1.88e-01	1.63e-01	3.90e-01	-5.05e-02	-2.30e-01	9.62e-02	4.65e-01	5.28e-01	1.31e-01	8.45e-01	3.72e-01	7.10e-01
GOMF TRNA CYTIDINE METHYLTRANSFERASE ACTIVITY	10	4.12e-01	5.22e-01	0.5280	-2.26e-01	-3.02e-01	-1.09e-01	-3.37e-01	-1.03e-01	2.07e-02	2.16e-01	9.80e-02	5.52e-01	6.51e-02	5.75e-01	9.10e-01
GOBP REPRODUCTIVE BEHAVIOR	27	1.29e-02	4.19e-02	0.5280	-3.12e-01	-2.05e-01	1.74e-01	-1.78e-01	-1.56e-01	2.30e-01	5.01e-03	6.57e-02	1.17e-01	1.10e-01	1.62e-01	3.82e-02
GOBP POSITIVE REGULATION OF RYANODINE SENSITIVE CALCIUM RELEASE CHANNEL ACTIVITY	7	6.55e-01	7.26e-01	0.5280	-9.53e-02	-2.10e-01	1.36e-01	-2.04e-01	-2.78e-01	2.96e-01	6.62e-01	3.37e-01	5.34e-01	3.49e-01	2.03e-01	1.74e-01
GOBP NEGATIVE REGULATION OF CELL SIZE	8	4.03e-01	5.14e-01	0.5270	-2.03e-01	-3.36e-01	-7.52e-02	-1.74e-02	-2.24e-01	-2.61e-01	3.21e-01	9.97e-02	7.13e-01	9.32e-01	2.73e-01	2.01e-01
GOBP RESPONSE TO TYPE III INTERFERON	8	3.28e-01	4.47e-01	0.5270	-5.10e-02	3.74e-01	2.95e-01	8.64e-02	-7.97e-02	1.88e-01	8.03e-01	6.72e-02	1.49e-01	6.72e-01	6.96e-01	3.58e-01
GOBP NEGATIVE REGULATION OF LIPASE ACTIVITY	11	1.61e-01	2.73e-01	0.5270	-9.44e-02	2.11e-02	1.95e-01	-3.75e-01	-2.34e-01	-1.89e-01	5.88e-01	9.04e-01	2.63e-01	3.15e-02	1.78e-01	2.78e-01
GOMF PRENYLTRANSFERASE ACTIVITY	17	1.79e-01	2.94e-01	0.5270	-3.01e-01	-3.51e-01	-1.39e-01	-1.34e-01	-1.33e-01	9.69e-02	3.18e-02	1.22e-02	3.22e-01	3.38e-01	3.42e-01	4.89e-01
GOBP POSITIVE REGULATION OF HYPERSENSITIVITY	6	4.42e-01	5.49e-01	0.5270	-1.45e-01	-1.68e-01	1.17e-01	6.80e-02	1.86e-01	4.19e-01	5.38e-01	4.76e-01	6.18e-01	7.73e-01	4.30e-01	7.55e-02
GOBP POSITIVE REGULATION OF SULFUR METABOLIC PROCESS	5	3.67e-01	4.82e-01	0.5270	-4.54e-01	2.58e-02	2.37e-01	9.60e-03	-1.30e-02	1.23e-01	7.90e-02	9.21e-01	3.59e-01	9.70e-01	9.60e-01	6.34e-01
GOBP NEGATIVE REGULATION OF BEHAVIOR	7	6.59e-01	7.29e-01	0.5270	7.09e-02	4.69e-02	-3.55e-01	5.58e-02	3.12e-01	-2.10e-01	7.45e-01	8.30e-01	1.04e-01	7.98e-01	1.52e-01	3.36e-01
GOBP REGULATION OF BLOOD VESSEL REMODELING	6	3.42e-01	4.59e-01	0.5270	-7.88e-02	-2.59e-01	-4.34e-02	2.45e-01	-3.62e-01	-1.06e-01	7.38e-01	2.72e-01	8.54e-01	2.98e-01	1.24e-01	6.53e-01
GOBP NEGATIVE REGULATION OF STRESS ACTIVATED PROTEIN KINASE SIGNALING CASCADE	8	3.11e-01	4.31e-01	0.5270	8.12e-02	-4.52e-01	-1.94e-01	1.43e-01	-9.57e-03	-9.19e-02	6.91e-01	2.68e-02	3.42e-01	4.84e-01	9.63e-01	6.53e-01
GOBP MITOCHONDRIAL DNA METABOLIC PROCESS	21	1.44e-02	4.59e-02	0.5270	-2.92e-02	-1.55e-01	-3.08e-01	3.68e-01	1.22e-01	-9.12e-02	8.17e-01	2.20e-01	1.47e-02	3.54e-03	3.35e-01	4.69e-01
GOBP NEGATIVE REGULATION OF FIBRINOLYSIS	9	2.75e-03	1.20e-02	0.5270	2.64e-02	-6.62e-02	2.65e-01	1.11e-01	5.31e-02	-4.33e-01	8.91e-01	7.31e-01	1.68e-01	5.65e-01	7.83e-01	2.46e-02
GOMF PHOSPHATIDYLSERINE 1 ACYLHYDROLASE ACTIVITY	8	4.26e-01	5.34e-01	0.5270	3.11e-02	-3.68e-01	-8.21e-02	-2.11e-01	-2.53e-01	-1.62e-01	8.79e-01	7.17e-02	6.88e-01	3.01e-01	2.16e-01	4.28e-01
GOCC PHOTORECEPTOR RIBBON SYNAPSE	7	5.98e-01	6.80e-01	0.5270	1.33e-01	1.88e-02	-1.28e-01	4.44e-01	1.90e-01	-1.02e-01	5.41e-01	9.31e-01	5.58e-01	4.21e-02	3.85e-01	6.41e-01
GOBP POSITIVE REGULATION OF CATECHOLAMINE METABOLIC PROCESS	5	6.30e-01	7.06e-01	0.5270	-3.20e-01	-2.86e-01	-7.14e-02	6.40e-02	1.16e-01	2.65e-01	2.15e-01	2.67e-01	7.82e-01	8.04e-01	6.53e-01	3.05e-01
GOBP METANEPHRIC RENAL VESICLE MORPHOGENESIS	6	5.97e-01	6.79e-01	0.5270	-2.62e-01	-2.41e-02	2.41e-01	-3.62e-01	-9.52e-02	9.79e-02	2.66e-01	9.18e-01	3.07e-01	1.24e-01	6.86e-01	6.78e-01
GOCC NUCLEOSOME	75	1.23e-09	1.93e-08	0.5270	-1.24e-01	-3.75e-01	1.57e-01	-1.23e-02	-2.40e-01	1.96e-01	6.35e-02	1.89e-08	1.86e-02	8.54e-01	3.18e-04	3.31e-03
GOBP CELL CELL ADHESION INVOLVED IN GASTRULATION	9	4.70e-02	1.12e-01	0.5260	-2.36e-01	3.22e-01	3.37e-01	-6.50e-03	5.43e-02	-4.32e-02	2.21e-01	9.45e-02	8.04e-02	9.73e-01	7.78e-01	8.22e-01
GOMF DIPEPTIDASE ACTIVITY	13	2.22e-01	3.41e-01	0.5260	-2.83e-01	-2.15e-01	-3.18e-01	-1.71e-01	1.35e-01	-4.68e-02	7.77e-02	1.79e-01	4.69e-02	2.85e-01	3.98e-01	7.70e-01
GOMF GLYCOSPHINGOLIPID BINDING	8	4.48e-01	5.55e-01	0.5260	7.94e-02	3.81e-02	3.70e-01	-1.06e-01	2.20e-02	3.47e-01	6.97e-01	8.52e-01	6.97e-02	6.04e-01	9.14e-01	8.93e-02
GOBP REGULATION OF CYTOPLASMIC TRANSLATION	32	1.45e-02	4.60e-02	0.5260	-3.68e-01	-1.61e-01	-1.41e-01	-2.75e-01	-1.42e-01	1.24e-02	3.16e-04	1.15e-01	1.68e-01	7.12e-03	1.64e-01	9.03e-01
GOBP RESPONSE TO PEPTIDOGLYCAN	10	2.72e-02	7.46e-02	0.5260	-2.72e-01	9.04e-04	2.94e-01	-1.36e-01	-2.35e-01	-2.07e-01	1.37e-01	9.96e-01	1.08e-01	4.57e-01	1.98e-01	2.56e-01
GOCC DNA DEPENDENT PROTEIN KINASE DNA LIGASE 4 COMPLEX	7	4.53e-01	5.59e-01	0.5260	-2.44e-01	-2.78e-01	-7.65e-02	-4.76e-05	-6.03e-02	3.61e-01	2.64e-01	2.03e-01	7.26e-01	1.00e+00	7.82e-01	9.77e-02
GOBP RETINAL CONE CELL DEVELOPMENT	6	2.94e-01	4.14e-01	0.5260	-4.87e-02	6.71e-02	3.50e-01	-2.24e-01	-2.22e-01	-2.19e-01	8.36e-01	7.76e-01	1.38e-01	3.42e-01	3.46e-01	3.53e-01
GOMF LIPOPROTEIN PARTICLE RECEPTOR ACTIVITY	17	4.89e-03	1.93e-02	0.5260	-9.45e-02	2.73e-01	3.90e-01	1.50e-01	1.05e-01	8.60e-02	5.00e-01	5.11e-02	5.34e-03	2.85e-01	4.54e-01	5.39e-01
GOBP NEGATIVE REGULATION OF CELL GROWTH INVOLVED IN CARDIAC MUSCLE CELL DEVELOPMENT	9	3.18e-01	4.37e-01	0.5260	-1.30e-01	-1.48e-01	2.37e-01	9.13e-02	-3.69e-01	1.92e-01	5.00e-01	4.40e-01	2.18e-01	6.35e-01	5.53e-02	3.19e-01
GOCC PROTEIN PHOSPHATASE TYPE 1 COMPLEX	17	6.78e-02	1.48e-01	0.5260	6.62e-03	2.66e-01	1.90e-01	2.65e-01	1.15e-01	2.93e-01	9.62e-01	5.80e-02	1.74e-01	5.85e-02	4.10e-01	3.62e-02
GOBP REGULATION OF AXON GUIDANCE	6	5.64e-01	6.52e-01	0.5260	2.95e-01	4.67e-02	3.40e-01	-1.67e-01	-1.59e-01	1.35e-01	2.11e-01	8.43e-01	1.49e-01	4.78e-01	5.00e-01	5.66e-01
GOCC CALCINEURIN COMPLEX	5	5.89e-01	6.73e-01	0.5260	-3.80e-01	-1.33e-02	-3.34e-02	-1.20e-01	-3.11e-01	1.42e-01	1.42e-01	9.59e-01	8.97e-01	6.41e-01	2.29e-01	5.83e-01
GOBP NEGATIVE REGULATION OF MIRNA METABOLIC PROCESS	23	2.96e-02	7.94e-02	0.5260	8.07e-02	3.23e-01	2.64e-01	2.22e-01	1.84e-01	1.15e-01	5.03e-01	7.39e-03	2.85e-02	6.56e-02	1.28e-01	3.40e-01
GOCC NUCLEOTIDE EXCISION REPAIR COMPLEX	12	1.68e-01	2.81e-01	0.5260	-2.02e-01	-1.59e-01	-2.80e-01	3.27e-02	3.43e-01	-1.16e-01	2.25e-01	3.42e-01	9.33e-02	8.44e-01	3.98e-02	4.86e-01
GOBP REGULATION OF DNA METHYLATION DEPENDENT HETEROCHROMATIN FORMATION	16	1.65e-01	2.77e-01	0.5260	1.50e-01	1.72e-01	-1.72e-03	3.55e-01	2.59e-01	1.77e-01	2.99e-01	2.33e-01	9.91e-01	1.41e-02	7.32e-02	2.19e-01
GOMF ADENYLATE CYCLASE BINDING	9	3.27e-01	4.46e-01	0.5250	-1.25e-01	4.63e-02	2.37e-01	1.27e-02	-3.36e-01	2.99e-01	5.18e-01	8.10e-01	2.17e-01	9.47e-01	8.12e-02	1.21e-01
GOBP NON LYTIC VIRAL RELEASE	14	1.20e-01	2.24e-01	0.5250	-2.45e-01	-3.59e-01	4.68e-02	2.51e-02	-1.02e-01	2.72e-01	1.12e-01	2.02e-02	7.62e-01	8.71e-01	5.10e-01	7.76e-02
GOMF CYSTEINE TYPE ENDOPEPTIDASE ACTIVITY INVOLVED IN APOPTOTIC PROCESS	11	1.82e-01	2.96e-01	0.5250	-3.89e-01	-1.51e-01	-7.57e-02	-2.52e-02	-3.49e-02	3.08e-01	2.56e-02	3.85e-01	6.64e-01	8.85e-01	8.41e-01	7.72e-02
GOMF RISC COMPLEX BINDING	5	7.09e-01	7.68e-01	0.5250	-3.06e-01	-3.14e-01	-4.49e-02	6.71e-02	-2.78e-01	1.02e-02	2.36e-01	2.24e-01	8.62e-01	7.95e-01	2.82e-01	9.68e-01
GOBP POSITIVE REGULATION OF AUTOPHAGOSOME MATURATION	7	7.69e-02	1.62e-01	0.5250	-1.82e-01	-4.58e-02	-1.57e-01	3.76e-01	-2.14e-01	-1.71e-01	4.04e-01	8.34e-01	4.72e-01	8.52e-02	3.27e-01	4.33e-01
GOBP L LEUCINE TRANSPORT	9	2.61e-01	3.81e-01	0.5250	-1.93e-01	-2.24e-01	-2.85e-01	2.12e-01	-1.26e-01	-2.15e-01	3.16e-01	2.44e-01	1.38e-01	2.70e-01	5.13e-01	2.64e-01
GOMF PROTON TRANSMEMBRANE TRANSPORTER ACTIVITY	155	3.28e-19	1.30e-17	0.5250	-1.83e-01	-4.50e-01	-8.31e-02	3.59e-03	-1.82e-01	1.26e-02	8.58e-05	4.06e-22	7.43e-02	9.39e-01	8.92e-05	7.87e-01
GOBP POSITIVE REGULATION OF RHO PROTEIN SIGNAL TRANSDUCTION	30	6.22e-03	2.34e-02	0.5250	2.16e-01	2.43e-01	1.68e-01	3.54e-01	5.22e-02	1.19e-01	4.10e-02	2.11e-02	1.12e-01	8.03e-04	6.20e-01	2.58e-01
GOBP REGULATION OF INTEGRIN MEDIATED SIGNALING PATHWAY	19	7.09e-02	1.53e-01	0.5250	-9.85e-02	3.39e-02	4.02e-01	-1.19e-01	-1.38e-01	2.64e-01	4.57e-01	7.98e-01	2.42e-03	3.68e-01	2.99e-01	4.61e-02
GOCC OXOGLUTARATE DEHYDROGENASE COMPLEX	10	3.12e-01	4.33e-01	0.5250	-3.30e-01	-2.68e-01	-1.92e-01	4.52e-02	-1.86e-01	-1.46e-01	7.06e-02	1.43e-01	2.94e-01	8.05e-01	3.09e-01	4.24e-01
GOMF PROTEIN BINDING INVOLVED IN HETEROTYPIC CELL CELL ADHESION	10	3.07e-01	4.28e-01	0.5250	-2.87e-01	1.60e-01	1.73e-01	-3.14e-01	-1.80e-01	7.69e-02	1.16e-01	3.80e-01	3.43e-01	8.52e-02	3.24e-01	6.74e-01
GOBP HOMEOSTASIS OF NUMBER OF CELLS WITHIN A TISSUE	30	1.04e-02	3.56e-02	0.5250	1.08e-01	2.58e-01	3.38e-01	6.30e-02	1.63e-01	2.29e-01	3.08e-01	1.44e-02	1.36e-03	5.50e-01	1.23e-01	2.99e-02
GOBP CARNITINE TRANSPORT	7	6.11e-02	1.37e-01	0.5240	-1.68e-01	2.10e-01	4.06e-01	-8.87e-02	1.43e-01	-1.00e-01	4.42e-01	3.37e-01	6.31e-02	6.85e-01	5.12e-01	6.46e-01
GOBP APOPTOTIC CHROMOSOME CONDENSATION	6	4.00e-01	5.12e-01	0.5240	7.79e-02	-3.04e-02	2.72e-01	4.33e-01	7.85e-03	8.10e-02	7.41e-01	8.97e-01	2.49e-01	6.64e-02	9.73e-01	7.31e-01
GOBP REGULATION OF CELL CELL ADHESION MEDIATED BY CADHERIN	16	1.58e-02	4.92e-02	0.5240	1.97e-01	6.03e-02	4.72e-01	7.80e-02	-3.06e-02	5.55e-02	1.73e-01	6.76e-01	1.09e-03	5.89e-01	8.32e-01	7.01e-01
GOBP NEUROTROPHIN SIGNALING PATHWAY	28	4.86e-03	1.92e-02	0.5240	-1.21e-01	1.28e-01	4.06e-01	-1.39e-01	-1.02e-01	2.21e-01	2.67e-01	2.40e-01	1.98e-04	2.02e-01	3.52e-01	4.30e-02
GOBP PLASMA MEMBRANE REPAIR	26	3.43e-03	1.44e-02	0.5240	-2.12e-01	-3.37e-01	1.83e-01	-9.59e-02	-1.38e-01	2.33e-01	6.10e-02	2.91e-03	1.06e-01	3.97e-01	2.24e-01	3.99e-02
GOBP POSITIVE REGULATION OF G PROTEIN COUPLED RECEPTOR SIGNALING PATHWAY	19	2.32e-02	6.64e-02	0.5240	1.11e-03	-1.01e-01	3.53e-01	8.79e-02	1.53e-02	3.63e-01	9.93e-01	4.46e-01	7.76e-03	5.07e-01	9.08e-01	6.12e-03
GOBP REGULATION OF SYNAPTIC TRANSMISSION GABAERGIC	22	1.90e-02	5.68e-02	0.5240	-1.14e-01	1.96e-01	3.01e-01	-1.12e-01	-2.74e-01	2.11e-01	3.56e-01	1.11e-01	1.46e-02	3.64e-01	2.59e-02	8.60e-02
GOMF OUTWARD RECTIFIER POTASSIUM CHANNEL ACTIVITY	16	9.22e-02	1.85e-01	0.5240	3.54e-02	2.92e-01	3.38e-01	4.16e-02	2.02e-01	1.76e-01	8.06e-01	4.33e-02	1.91e-02	7.73e-01	1.62e-01	2.23e-01
GOBP CO TRANSCRIPTIONAL RNA 3 END PROCESSING CLEAVAGE AND POLYADENYLATION PATHWAY	10	3.76e-01	4.91e-01	0.5240	-3.73e-01	-1.78e-01	-2.79e-01	-1.38e-01	-5.73e-02	5.29e-02	4.09e-02	3.29e-01	1.26e-01	4.49e-01	7.54e-01	7.72e-01
GOCC M BAND	21	5.72e-02	1.30e-01	0.5240	2.46e-01	1.13e-01	3.19e-01	2.24e-02	-9.47e-03	3.15e-01	5.10e-02	3.70e-01	1.15e-02	8.59e-01	9.40e-01	1.26e-02
GOBP REACTIVE GLIOSIS	5	5.30e-01	6.23e-01	0.5240	-1.79e-01	3.32e-02	5.89e-02	-2.58e-01	-1.61e-01	-3.81e-01	4.89e-01	8.98e-01	8.20e-01	3.17e-01	5.33e-01	1.40e-01
GOMF RIBOSOME BINDING	101	1.95e-10	3.41e-09	0.5230	-3.07e-01	-3.62e-01	-1.20e-01	-1.61e-02	-1.85e-01	-3.15e-03	1.01e-07	3.16e-10	3.66e-02	7.80e-01	1.35e-03	9.56e-01
GOBP ATTACHMENT OF GPI ANCHOR TO PROTEIN	6	3.43e-01	4.59e-01	0.5230	-1.73e-01	-2.38e-01	9.52e-02	2.57e-01	2.28e-01	2.46e-01	4.64e-01	3.14e-01	6.86e-01	2.76e-01	3.34e-01	2.96e-01
GOBP LENS MORPHOGENESIS IN CAMERA TYPE EYE	14	4.04e-02	1.00e-01	0.5230	-2.43e-01	6.87e-02	3.58e-01	9.75e-02	-3.37e-02	2.66e-01	1.16e-01	6.56e-01	2.03e-02	5.28e-01	8.27e-01	8.44e-02
GOMF SPHINGOLIPID TRANSPORTER ACTIVITY	18	6.19e-02	1.38e-01	0.5230	8.82e-02	6.00e-02	2.94e-01	3.25e-01	-1.58e-02	2.64e-01	5.17e-01	6.59e-01	3.08e-02	1.69e-02	9.08e-01	5.24e-02
GOMF CARDIOLIPIN BINDING	9	1.21e-01	2.24e-01	0.5230	1.56e-01	-4.76e-01	-4.35e-02	5.28e-02	-1.08e-01	7.71e-02	4.17e-01	1.33e-02	8.21e-01	7.84e-01	5.75e-01	6.89e-01
GOMF RNA POLYMERASE II INTRONIC TRANSCRIPTION REGULATORY REGION SEQUENCE SPECIFIC DNA BINDING	6	6.66e-01	7.34e-01	0.5230	-2.69e-01	-2.76e-01	-2.83e-01	-1.23e-01	-1.40e-01	9.92e-02	2.55e-01	2.41e-01	2.29e-01	6.01e-01	5.53e-01	6.74e-01
GOBP REGULATION OF NUCLEAR CELL CYCLE DNA REPLICATION	14	1.49e-01	2.59e-01	0.5230	8.35e-03	7.14e-04	2.88e-01	-1.61e-02	-3.98e-01	1.78e-01	9.57e-01	9.96e-01	6.17e-02	9.17e-01	9.93e-03	2.50e-01
GOMF 3 5 DNA HELICASE ACTIVITY	15	3.92e-02	9.80e-02	0.5230	3.73e-02	-1.08e-01	1.17e-01	4.51e-01	2.38e-02	2.06e-01	8.03e-01	4.69e-01	4.34e-01	2.47e-03	8.73e-01	1.68e-01
GOMF PHOSPHATIDYLINOSITOL 3 5 BISPHOSPHATE 5 PHOSPHATASE ACTIVITY	6	6.03e-01	6.83e-01	0.5230	-6.95e-02	3.45e-01	3.10e-01	7.02e-02	1.41e-01	1.68e-01	7.68e-01	1.43e-01	1.88e-01	7.66e-01	5.50e-01	4.76e-01
GOBP ANTRAL OVARIAN FOLLICLE GROWTH	9	7.00e-02	1.51e-01	0.5230	-3.96e-01	1.48e-01	1.64e-01	-2.18e-01	1.52e-02	-1.40e-01	3.95e-02	4.43e-01	3.93e-01	2.58e-01	9.37e-01	4.67e-01
GOBP LACTATION	30	1.09e-04	7.30e-04	0.5230	-1.97e-01	3.62e-02	3.13e-01	1.62e-01	1.03e-01	3.13e-01	6.16e-02	7.32e-01	3.00e-03	1.26e-01	3.27e-01	2.97e-03
GOBP EMBRYONIC VISCEROCRANIUM MORPHOGENESIS	6	2.27e-01	3.45e-01	0.5230	-1.77e-01	1.70e-01	2.54e-01	3.22e-01	-1.37e-01	1.62e-01	4.54e-01	4.71e-01	2.81e-01	1.73e-01	5.63e-01	4.92e-01
GOMF MALATE DEHYDROGENASE ACTIVITY	6	5.40e-01	6.32e-01	0.5220	-3.58e-01	-3.53e-01	4.52e-02	-3.02e-02	-3.79e-02	1.25e-01	1.29e-01	1.34e-01	8.48e-01	8.98e-01	8.72e-01	5.97e-01
GOBP AIM2 INFLAMMASOME COMPLEX ASSEMBLY	5	5.00e-01	5.97e-01	0.5220	-7.96e-02	2.89e-01	-2.40e-01	1.03e-01	3.08e-01	1.42e-01	7.58e-01	2.63e-01	3.53e-01	6.90e-01	2.34e-01	5.81e-01
GOMF PRIMARY MIRNA BINDING	9	4.81e-01	5.82e-01	0.5220	-1.24e-02	1.92e-02	3.64e-01	1.40e-01	-1.31e-01	3.22e-01	9.49e-01	9.21e-01	5.89e-02	4.67e-01	4.97e-01	9.48e-02
GOMF PROTEIN CARRIER CHAPERONE	34	3.77e-04	2.20e-03	0.5220	-2.47e-01	-4.20e-01	-1.64e-01	-1.36e-03	3.46e-02	8.55e-02	1.26e-02	2.28e-05	9.78e-02	9.89e-01	7.27e-01	3.88e-01
GOMF DELAYED RECTIFIER POTASSIUM CHANNEL ACTIVITY	17	3.87e-02	9.71e-02	0.5220	1.79e-01	2.19e-01	3.28e-01	-1.83e-01	1.10e-01	1.99e-01	2.01e-01	1.18e-01	1.94e-02	1.91e-01	4.33e-01	1.55e-01
GOMF PROTEIN TYROSINE KINASE INHIBITOR ACTIVITY	6	6.83e-01	7.48e-01	0.5220	-2.36e-01	-1.17e-01	2.15e-01	-2.75e-01	-8.17e-02	2.74e-01	3.16e-01	6.20e-01	3.63e-01	2.44e-01	7.29e-01	2.46e-01
GOBP PROTOPORPHYRINOGEN IX BIOSYNTHETIC PROCESS	9	3.23e-01	4.42e-01	0.5220	2.18e-01	-1.20e-01	-1.19e-01	2.56e-01	3.57e-01	-6.13e-02	2.58e-01	5.33e-01	5.38e-01	1.83e-01	6.39e-02	7.50e-01
GOBP PHYSIOLOGICAL CARDIAC MUSCLE HYPERTROPHY	17	7.65e-02	1.61e-01	0.5220	-1.51e-01	-2.05e-01	2.60e-01	4.21e-02	-2.97e-01	2.23e-01	2.82e-01	1.43e-01	6.36e-02	7.64e-01	3.38e-02	1.11e-01
GOBP REGULATION OF CARDIAC MUSCLE CELL MEMBRANE POTENTIAL	5	2.86e-01	4.05e-01	0.5220	1.66e-02	6.79e-02	3.12e-01	3.53e-01	-1.89e-01	-9.63e-02	9.49e-01	7.92e-01	2.26e-01	1.71e-01	4.65e-01	7.09e-01
GOBP ESTROUS CYCLE	12	2.33e-01	3.50e-01	0.5220	3.92e-02	1.74e-01	3.25e-01	2.30e-01	-9.90e-02	2.68e-01	8.14e-01	2.96e-01	5.11e-02	1.68e-01	5.53e-01	1.08e-01
GOMF COPPER CHAPERONE ACTIVITY	7	3.26e-01	4.44e-01	0.5220	-9.01e-02	-3.10e-01	-1.82e-01	1.59e-01	1.74e-01	2.82e-01	6.80e-01	1.56e-01	4.03e-01	4.68e-01	4.24e-01	1.97e-01
GOBP SPHINGOMYELIN METABOLIC PROCESS	18	2.64e-02	7.30e-02	0.5220	-3.34e-01	-1.77e-01	1.20e-01	3.94e-02	-2.91e-01	1.70e-01	1.42e-02	1.93e-01	3.76e-01	7.72e-01	3.27e-02	2.12e-01
GOBP DIADENOSINE POLYPHOSPHATE METABOLIC PROCESS	7	3.96e-01	5.09e-01	0.5220	-2.98e-01	-2.22e-01	-1.88e-01	-1.86e-01	1.93e-01	1.63e-01	1.72e-01	3.09e-01	3.88e-01	3.93e-01	3.76e-01	4.56e-01
GOBP IMMUNOGLOBULIN V D J RECOMBINATION	8	1.26e-01	2.31e-01	0.5210	-2.37e-01	-1.22e-01	-2.30e-01	2.86e-01	-1.22e-02	2.56e-01	2.45e-01	5.51e-01	2.61e-01	1.61e-01	9.52e-01	2.10e-01
GOBP NEGATIVE REGULATION OF RESPONSE TO ENDOPLASMIC RETICULUM STRESS	41	9.08e-05	6.22e-04	0.5210	-2.38e-01	-2.87e-01	1.11e-01	5.85e-02	-2.83e-01	1.91e-01	8.36e-03	1.46e-03	2.18e-01	5.17e-01	1.71e-03	3.40e-02
GOBP POSITIVE REGULATION OF SPINDLE CHECKPOINT	13	8.37e-02	1.72e-01	0.5210	9.88e-02	-2.10e-01	1.27e-01	3.47e-01	-1.31e-01	2.54e-01	5.37e-01	1.89e-01	4.29e-01	3.05e-02	4.12e-01	1.13e-01
GOBP INTRA GOLGI VESICLE MEDIATED TRANSPORT	32	1.01e-04	6.84e-04	0.5210	-2.54e-01	-1.56e-01	9.98e-02	2.01e-01	-9.43e-02	3.51e-01	1.30e-02	1.26e-01	3.28e-01	4.87e-02	3.56e-01	5.90e-04
GOBP ZYMOGEN ACTIVATION	43	5.57e-06	5.00e-05	0.5210	-1.06e-01	-1.70e-01	3.76e-01	-1.76e-02	-2.52e-01	1.61e-01	2.31e-01	5.32e-02	1.97e-05	8.42e-01	4.22e-03	6.85e-02
GOCC PRESYNAPTIC ACTIVE ZONE MEMBRANE	22	1.50e-02	4.74e-02	0.5210	1.06e-01	4.10e-01	1.87e-01	3.34e-02	2.07e-01	-1.14e-01	3.90e-01	8.76e-04	1.28e-01	7.86e-01	9.23e-02	3.55e-01
GOBP MEDIUM CHAIN FATTY ACID BIOSYNTHETIC PROCESS	6	1.33e-01	2.41e-01	0.5210	-3.14e-01	-3.44e-01	1.49e-01	1.75e-02	1.65e-01	6.53e-02	1.83e-01	1.44e-01	5.28e-01	9.41e-01	4.83e-01	7.82e-01
GOBP POSITIVE REGULATION OF INTEGRIN MEDIATED SIGNALING PATHWAY	12	2.72e-01	3.91e-01	0.5210	-1.97e-02	-2.58e-02	3.58e-01	-2.45e-01	-1.65e-01	2.34e-01	9.06e-01	8.77e-01	3.17e-02	1.42e-01	3.23e-01	1.60e-01
GOCC PLASMA MEMBRANE SIGNALING RECEPTOR COMPLEX	240	5.84e-24	3.32e-22	0.5200	2.53e-01	2.54e-01	3.10e-02	2.26e-01	2.58e-01	1.53e-01	1.35e-11	1.11e-11	4.09e-01	1.63e-09	6.11e-12	4.21e-05
GOCC AZUROPHIL GRANULE LUMEN	86	1.77e-11	3.49e-10	0.5200	-2.83e-01	-2.93e-01	1.74e-01	-6.99e-03	-2.20e-01	1.61e-01	5.62e-06	2.54e-06	5.39e-03	9.11e-01	4.21e-04	9.78e-03
GOCC ASTROCYTE PROJECTION	10	3.50e-01	4.67e-01	0.5200	1.30e-01	3.15e-01	1.50e-01	2.07e-01	7.70e-02	2.89e-01	4.78e-01	8.44e-02	4.10e-01	2.58e-01	6.73e-01	1.14e-01
GOMF AROMATIC AMINO ACID TRANSMEMBRANE TRANSPORTER ACTIVITY	9	8.00e-02	1.67e-01	0.5200	-1.26e-01	-2.37e-01	-1.38e-02	3.82e-01	-2.26e-01	-4.05e-02	5.14e-01	2.18e-01	9.43e-01	4.71e-02	2.40e-01	8.33e-01
GOBP REGULATION OF CARDIAC MUSCLE CELL PROLIFERATION	26	5.74e-03	2.20e-02	0.5200	8.33e-02	3.48e-01	2.84e-01	2.27e-01	4.23e-02	9.03e-02	4.62e-01	2.10e-03	1.21e-02	4.49e-02	7.09e-01	4.25e-01
GOBP EMBRYONIC CAMERA TYPE EYE DEVELOPMENT	21	8.49e-03	3.02e-02	0.5200	5.55e-02	4.16e-01	1.93e-01	1.28e-01	1.65e-01	-1.15e-01	6.60e-01	9.56e-04	1.26e-01	3.09e-01	1.90e-01	3.63e-01
GOBP RESPONSE TO BACTERIAL LIPOPROTEIN	8	2.38e-01	3.56e-01	0.5200	-2.47e-01	2.98e-01	6.29e-02	9.60e-02	3.11e-01	1.06e-01	2.27e-01	1.45e-01	7.58e-01	6.38e-01	1.28e-01	6.05e-01
GOCC BLEB	9	8.53e-02	1.74e-01	0.5200	-3.28e-01	-1.86e-01	2.82e-01	8.10e-02	1.76e-02	2.05e-01	8.86e-02	3.34e-01	1.43e-01	6.74e-01	9.27e-01	2.88e-01
GOBP REGULATION OF MITOTIC CENTROSOME SEPARATION	8	7.04e-01	7.64e-01	0.5200	-2.35e-01	-1.74e-01	9.24e-02	-1.92e-01	-3.30e-01	1.74e-01	2.49e-01	3.93e-01	6.51e-01	3.48e-01	1.06e-01	3.95e-01
GOBP FOREGUT MORPHOGENESIS	6	5.72e-01	6.59e-01	0.5200	4.68e-02	3.17e-01	-1.14e-01	-6.39e-02	1.11e-01	-3.71e-01	8.43e-01	1.78e-01	6.28e-01	7.86e-01	6.38e-01	1.15e-01
GOBP SYNAPTIC VESICLE CLUSTERING	10	1.98e-01	3.13e-01	0.5200	1.04e-01	2.21e-01	3.27e-01	3.16e-01	-3.20e-02	4.88e-02	5.69e-01	2.26e-01	7.30e-02	8.36e-02	8.61e-01	7.89e-01
GOCC PHAGOLYSOSOME	7	4.66e-01	5.70e-01	0.5200	-2.88e-02	4.42e-01	-2.34e-02	6.45e-04	2.71e-01	-2.87e-03	8.95e-01	4.30e-02	9.15e-01	9.98e-01	2.14e-01	9.89e-01
GOBP INTEGRIN ACTIVATION	17	3.63e-02	9.26e-02	0.5200	-2.10e-01	-4.08e-01	1.14e-01	-6.64e-02	-1.32e-01	1.57e-01	1.34e-01	3.59e-03	4.17e-01	6.36e-01	3.45e-01	2.62e-01
GOBP SEROTONIN METABOLIC PROCESS	7	1.95e-01	3.12e-01	0.5200	-2.66e-01	2.06e-01	2.80e-02	-2.47e-02	3.72e-01	-1.31e-01	2.24e-01	3.45e-01	8.98e-01	9.10e-01	8.84e-02	5.47e-01
GOBP ENDOPLASMIC RETICULUM TO GOLGI VESICLE MEDIATED TRANSPORT	132	9.33e-21	4.22e-19	0.5200	-2.54e-01	-1.88e-01	9.81e-02	1.65e-01	-1.08e-01	3.49e-01	4.75e-07	1.88e-04	5.17e-02	1.09e-03	3.23e-02	4.33e-12
GOBP SPINAL CORD MOTOR NEURON DIFFERENTIATION	16	1.98e-01	3.14e-01	0.5200	4.00e-02	1.35e-01	-2.90e-01	1.40e-01	2.47e-01	-2.92e-01	7.82e-01	3.49e-01	4.43e-02	3.31e-01	8.73e-02	4.32e-02
GOBP TROPHOBLAST CELL MIGRATION	13	2.34e-02	6.69e-02	0.5200	-3.12e-01	-1.33e-01	2.45e-01	2.01e-01	-7.32e-02	2.22e-01	5.17e-02	4.06e-01	1.27e-01	2.09e-01	6.48e-01	1.65e-01
GOBP PHOSPHATIDYLETHANOLAMINE ACYL CHAIN REMODELING	9	3.74e-01	4.89e-01	0.5190	-3.93e-01	-7.32e-03	-2.56e-01	-1.25e-01	1.22e-01	-1.39e-01	4.11e-02	9.70e-01	1.83e-01	5.18e-01	5.27e-01	4.71e-01
GOMF LIGASE ACTIVITY FORMING CARBON OXYGEN BONDS	41	6.09e-06	5.45e-05	0.5190	8.86e-03	-4.05e-01	-1.89e-01	2.50e-01	8.42e-02	-1.12e-02	9.22e-01	7.08e-06	3.60e-02	5.63e-03	3.51e-01	9.01e-01
GOBP TYPE I PNEUMOCYTE DIFFERENTIATION	6	2.58e-01	3.78e-01	0.5190	-4.71e-01	8.13e-02	1.55e-01	-9.72e-02	8.39e-02	2.51e-02	4.56e-02	7.30e-01	5.11e-01	6.80e-01	7.22e-01	9.15e-01
GOBP RECEPTOR GUANYLYL CYCLASE SIGNALING PATHWAY	6	5.38e-01	6.29e-01	0.5190	-5.37e-02	-3.81e-01	-9.85e-02	-3.47e-02	-2.32e-01	2.39e-01	8.20e-01	1.06e-01	6.76e-01	8.83e-01	3.25e-01	3.10e-01
GOBP POSITIVE REGULATION OF REGULATED SECRETORY PATHWAY	35	2.02e-05	1.59e-04	0.5190	-1.19e-01	6.89e-02	3.81e-01	2.03e-01	-3.44e-03	2.53e-01	2.21e-01	4.80e-01	9.49e-05	3.74e-02	9.72e-01	9.63e-03
GOCC VESICLE COAT	59	2.19e-12	4.77e-11	0.5190	-2.73e-01	-7.36e-02	1.72e-01	2.79e-01	-1.41e-01	2.49e-01	2.80e-04	3.28e-01	2.24e-02	2.12e-04	6.10e-02	9.17e-04
GOBP T HELPER 1 CELL DIFFERENTIATION	21	3.54e-02	9.09e-02	0.5190	1.22e-02	1.94e-01	3.35e-01	1.31e-01	-1.56e-01	2.79e-01	9.23e-01	1.24e-01	7.80e-03	2.97e-01	2.15e-01	2.70e-02
GOBP REGULATION OF PROTEIN OLIGOMERIZATION	5	5.03e-01	5.99e-01	0.5190	3.25e-02	6.34e-02	-1.55e-01	4.84e-01	6.48e-02	4.42e-02	9.00e-01	8.06e-01	5.48e-01	6.09e-02	8.02e-01	8.64e-01
GOBP MONOCYTE CHEMOTACTIC PROTEIN 1 PRODUCTION	16	2.30e-02	6.60e-02	0.5190	-2.40e-01	2.30e-01	-1.65e-01	-3.19e-01	1.63e-01	-6.06e-02	9.71e-02	1.11e-01	2.53e-01	2.73e-02	2.59e-01	6.75e-01
GOBP AMINO ACID ACTIVATION	45	7.07e-07	7.61e-06	0.5190	-1.78e-02	-4.22e-01	-1.81e-01	2.17e-01	1.06e-01	-7.55e-04	8.37e-01	9.88e-07	3.58e-02	1.16e-02	2.17e-01	9.93e-01
GOBP POST ANAL TAIL MORPHOGENESIS	12	1.95e-01	3.11e-01	0.5190	4.60e-04	4.74e-02	1.80e-01	3.53e-01	8.57e-02	3.20e-01	9.98e-01	7.76e-01	2.79e-01	3.43e-02	6.07e-01	5.47e-02
GOBP REGULATION OF PROTEIN POLYUBIQUITINATION	24	5.88e-03	2.24e-02	0.5190	-3.72e-01	-1.66e-01	-7.41e-03	-1.64e-01	6.75e-02	2.68e-01	1.62e-03	1.59e-01	9.50e-01	1.63e-01	5.67e-01	2.29e-02
GOMF PHOSPHOSERINE RESIDUE BINDING	10	2.31e-01	3.49e-01	0.5190	-1.90e-01	-2.53e-01	3.00e-01	-3.03e-03	-2.06e-01	1.92e-01	2.98e-01	1.66e-01	1.01e-01	9.87e-01	2.59e-01	2.94e-01
GOBP BASIC AMINO ACID TRANSPORT	15	4.05e-02	1.00e-01	0.5190	-2.90e-01	-2.65e-01	-1.84e-01	1.70e-01	-1.45e-01	-1.77e-01	5.18e-02	7.57e-02	2.18e-01	2.55e-01	3.31e-01	2.36e-01
GOBP REGULATION OF T CELL EXTRAVASATION	6	4.61e-01	5.66e-01	0.5190	-1.14e-01	-5.05e-02	1.10e-01	4.08e-01	9.77e-02	2.55e-01	6.29e-01	8.30e-01	6.40e-01	8.33e-02	6.79e-01	2.80e-01
GOBP MITOCHONDRIAL TRANSMEMBRANE TRANSPORT	90	1.32e-09	2.06e-08	0.5190	-2.06e-01	-4.28e-01	-1.92e-01	-2.15e-02	-7.41e-02	-9.48e-03	7.32e-04	2.08e-12	1.65e-03	7.24e-01	2.24e-01	8.76e-01
GOBP CELL COMMUNICATION BY ELECTRICAL COUPLING INVOLVED IN CARDIAC CONDUCTION	17	9.95e-02	1.95e-01	0.5180	-1.05e-01	-1.86e-01	2.99e-01	-1.29e-02	-3.06e-01	2.01e-01	4.54e-01	1.84e-01	3.28e-02	9.27e-01	2.92e-02	1.52e-01
GOBP NEGATIVE REGULATION OF POTASSIUM ION TRANSPORT	18	9.17e-02	1.84e-01	0.5180	-2.63e-03	-1.19e-01	3.62e-01	-4.17e-02	-1.85e-01	2.96e-01	9.85e-01	3.84e-01	7.80e-03	7.60e-01	1.74e-01	2.98e-02
GOBP NEGATIVE REGULATION OF ANDROGEN RECEPTOR SIGNALING PATHWAY	10	2.51e-01	3.70e-01	0.5180	9.15e-02	8.83e-02	3.25e-01	3.07e-01	-1.43e-01	1.78e-01	6.16e-01	6.29e-01	7.47e-02	9.26e-02	4.33e-01	3.29e-01
GOMF PEPTIDE ALPHA N ACETYLTRANSFERASE ACTIVITY	7	6.44e-01	7.18e-01	0.5180	-2.76e-02	1.16e-02	-3.64e-01	1.92e-01	1.46e-01	-2.79e-01	8.99e-01	9.57e-01	9.58e-02	3.79e-01	5.05e-01	2.02e-01
GOCC U2 TYPE CATALYTIC STEP 2 SPLICEOSOME	30	3.32e-04	1.96e-03	0.5180	-1.96e-01	-3.50e-01	-1.31e-01	2.29e-01	4.68e-02	1.90e-01	6.35e-02	9.07e-04	2.15e-01	2.97e-02	6.57e-01	7.22e-02
GOBP GPI ANCHOR METABOLIC PROCESS	31	1.20e-02	3.97e-02	0.5180	-2.48e-01	-2.91e-01	-3.16e-01	1.03e-02	7.59e-02	-1.29e-01	1.67e-02	5.09e-03	2.32e-03	9.21e-01	4.65e-01	2.14e-01
GOBP REGULATION OF DNA DEMETHYLATION	5	5.46e-01	6.36e-01	0.5180	2.01e-01	2.02e-01	1.81e-01	-5.26e-02	-2.10e-01	-3.28e-01	4.35e-01	4.33e-01	4.84e-01	8.39e-01	4.17e-01	2.04e-01
GOBP NEGATIVE REGULATION OF LYMPHOCYTE DIFFERENTIATION	44	4.02e-04	2.33e-03	0.5180	1.59e-01	1.44e-01	3.49e-01	5.72e-02	-2.27e-01	2.14e-01	6.77e-02	9.94e-02	6.14e-05	5.11e-01	9.06e-03	1.41e-02
GOBP NEGATIVE REGULATION OF ENDOPLASMIC RETICULUM UNFOLDED PROTEIN RESPONSE	14	1.65e-01	2.78e-01	0.5180	-2.78e-01	-2.16e-01	1.05e-01	-4.38e-02	-3.56e-01	7.15e-02	7.21e-02	1.62e-01	4.95e-01	7.77e-01	2.11e-02	6.43e-01
GOBP KIDNEY MESENCHYME DEVELOPMENT	7	5.98e-01	6.80e-01	0.5180	1.35e-01	3.34e-01	1.55e-01	1.53e-01	8.33e-02	2.90e-01	5.35e-01	1.26e-01	4.77e-01	4.82e-01	7.03e-01	1.84e-01
GOBP CARBON CATABOLITE REGULATION OF TRANSCRIPTION	7	6.06e-01	6.86e-01	0.5180	5.74e-02	3.85e-01	2.77e-01	1.39e-01	5.27e-02	1.35e-01	7.93e-01	7.78e-02	2.04e-01	5.25e-01	8.09e-01	5.37e-01
GOBP DNA REPLICATION SYNTHESIS OF PRIMER	7	6.23e-01	7.01e-01	0.5180	1.26e-01	-1.64e-01	-3.16e-01	2.42e-01	2.38e-01	-1.01e-01	5.63e-01	4.54e-01	1.47e-01	2.67e-01	2.75e-01	6.42e-01
GOBP NEGATIVE REGULATION OF CD8 POSITIVE ALPHA BETA T CELL ACTIVATION	7	3.11e-01	4.31e-01	0.5180	5.66e-02	8.09e-02	4.52e-01	2.97e-02	1.36e-01	1.88e-01	7.95e-01	7.11e-01	3.85e-02	8.92e-01	5.32e-01	3.90e-01
GOCC CUTICULAR PLATE	7	5.66e-01	6.54e-01	0.5180	3.29e-01	-1.39e-02	2.20e-01	2.08e-01	1.03e-01	2.42e-01	1.32e-01	9.49e-01	3.14e-01	3.42e-01	6.39e-01	2.68e-01
GOBP ZINC ION TRANSPORT	22	1.47e-03	7.09e-03	0.5180	-2.74e-01	-1.68e-02	2.20e-01	2.15e-01	-7.15e-02	3.05e-01	2.61e-02	8.92e-01	7.39e-02	8.04e-02	5.62e-01	1.33e-02
GOBP SYNAPTIC ASSEMBLY AT NEUROMUSCULAR JUNCTION	5	5.08e-01	6.03e-01	0.5180	-2.37e-01	-1.48e-01	-1.59e-01	4.52e-03	-4.06e-01	1.00e-02	3.59e-01	5.66e-01	5.38e-01	9.86e-01	1.16e-01	9.69e-01
GOBP REFLEX	6	7.14e-01	7.72e-01	0.5180	-3.94e-01	-1.75e-01	-1.71e-01	-1.02e-01	-1.26e-01	-1.64e-01	9.48e-02	4.57e-01	4.68e-01	6.66e-01	5.93e-01	4.87e-01
GOMF AMMONIUM TRANSMEMBRANE TRANSPORTER ACTIVITY	6	4.63e-01	5.67e-01	0.5180	1.05e-02	3.82e-01	9.31e-02	2.36e-02	1.96e-01	-2.73e-01	9.65e-01	1.05e-01	6.93e-01	9.20e-01	4.06e-01	2.47e-01
GOBP NEGATIVE REGULATION OF EXOCYTOSIS	29	5.72e-04	3.15e-03	0.5180	-2.20e-01	7.82e-02	2.88e-01	9.56e-02	-1.83e-01	2.97e-01	4.06e-02	4.66e-01	7.31e-03	3.73e-01	8.73e-02	5.67e-03
GOMF BASIC AMINO ACID TRANSMEMBRANE TRANSPORTER ACTIVITY	12	1.78e-01	2.93e-01	0.5180	-1.52e-01	-1.89e-01	-3.35e-01	2.04e-01	-5.67e-02	-2.28e-01	3.62e-01	2.56e-01	4.44e-02	2.21e-01	7.34e-01	1.72e-01
GOBP POSITIVE REGULATION OF CYSTEINE TYPE ENDOPEPTIDASE ACTIVITY INVOLVED IN APOPTOTIC SIGNALING PATHWAY	5	8.35e-01	8.67e-01	0.5180	-2.35e-01	-3.47e-01	8.08e-02	-1.09e-01	-2.59e-01	8.24e-02	3.63e-01	1.79e-01	7.54e-01	6.73e-01	3.15e-01	7.50e-01
GOBP FERROPTOSIS	10	4.72e-02	1.12e-01	0.5180	-2.10e-01	-2.05e-01	-3.80e-02	3.39e-01	2.34e-01	-1.05e-01	2.50e-01	2.62e-01	8.35e-01	6.36e-02	2.01e-01	5.66e-01
GOCC CYCLIN CDK POSITIVE TRANSCRIPTION ELONGATION FACTOR COMPLEX	8	1.77e-01	2.92e-01	0.5180	-2.15e-01	2.99e-01	2.43e-01	7.19e-02	-1.59e-01	2.07e-01	2.92e-01	1.44e-01	2.33e-01	7.25e-01	4.37e-01	3.11e-01
GOBP FATTY ACID ELONGATION SATURATED FATTY ACID	7	7.19e-01	7.77e-01	0.5180	-3.05e-01	-2.71e-02	1.27e-01	-2.71e-01	-2.68e-01	1.13e-01	1.62e-01	9.01e-01	5.62e-01	2.15e-01	2.19e-01	6.03e-01
GOBP REGULATION OF INSULIN LIKE GROWTH FACTOR RECEPTOR SIGNALING PATHWAY	13	1.67e-01	2.79e-01	0.5180	2.05e-01	3.45e-01	2.53e-01	-1.10e-01	1.74e-01	-1.25e-02	2.00e-01	3.13e-02	1.14e-01	4.93e-01	2.78e-01	9.38e-01
GOBP VITAMIN D BIOSYNTHETIC PROCESS	8	1.52e-01	2.62e-01	0.5170	9.65e-02	2.48e-01	1.49e-01	-2.96e-01	2.60e-01	-1.39e-01	6.36e-01	2.25e-01	4.64e-01	1.47e-01	2.02e-01	4.95e-01
GOBP NEGATIVE REGULATION OF CHONDROCYTE DIFFERENTIATION	8	2.79e-01	3.98e-01	0.5170	-2.19e-01	3.24e-01	2.56e-01	4.64e-02	9.22e-02	1.96e-01	2.83e-01	1.13e-01	2.10e-01	8.20e-01	6.51e-01	3.36e-01
GOMF HISTONE READER ACTIVITY	18	1.50e-01	2.60e-01	0.5170	1.93e-01	2.93e-02	-1.24e-01	3.52e-01	2.40e-01	-1.82e-01	1.57e-01	8.30e-01	3.64e-01	9.75e-03	7.84e-02	1.82e-01
GOBP KETONE BODY METABOLIC PROCESS	7	3.93e-01	5.06e-01	0.5170	8.06e-02	-3.57e-01	1.35e-01	1.14e-01	-1.25e-01	2.94e-01	7.12e-01	1.02e-01	5.35e-01	6.02e-01	5.66e-01	1.78e-01
GOMF PROTEIN SERINE THREONINE PHOSPHATASE INHIBITOR ACTIVITY	10	1.90e-01	3.06e-01	0.5170	4.78e-02	-2.40e-01	9.14e-02	2.70e-01	8.68e-02	3.45e-01	7.94e-01	1.90e-01	6.17e-01	1.40e-01	6.35e-01	5.89e-02
GOBP REGULATION OF RNA POLYMERASE II REGULATORY REGION SEQUENCE SPECIFIC DNA BINDING	5	7.45e-01	7.97e-01	0.5170	-1.94e-01	-2.76e-01	1.78e-01	5.25e-02	-3.04e-01	1.63e-01	4.52e-01	2.85e-01	4.91e-01	8.39e-01	2.40e-01	5.28e-01
GOBP UBIQUITIN DEPENDENT PROTEIN CATABOLIC PROCESS VIA THE C END DEGRON RULE PATHWAY	12	1.81e-01	2.96e-01	0.5170	-3.97e-01	-2.67e-01	-1.48e-01	3.62e-02	6.74e-02	1.04e-01	1.73e-02	1.09e-01	3.75e-01	8.28e-01	6.86e-01	5.33e-01
GOMF FATTY ACID TRANSMEMBRANE TRANSPORTER ACTIVITY	14	3.22e-01	4.41e-01	0.5170	1.42e-01	2.35e-01	5.94e-02	3.07e-01	3.06e-01	-9.39e-03	3.58e-01	1.27e-01	7.01e-01	4.69e-02	4.75e-02	9.52e-01
GOCC ZONULA ADHERENS	8	1.73e-01	2.87e-01	0.5160	8.18e-02	8.69e-02	4.84e-01	7.98e-02	6.93e-02	8.66e-02	6.89e-01	6.71e-01	1.79e-02	6.96e-01	7.34e-01	6.71e-01
GOBP L PHENYLALANINE METABOLIC PROCESS	6	3.45e-01	4.61e-01	0.5160	1.85e-01	-4.51e-01	-1.50e-01	7.25e-02	-2.13e-02	2.75e-02	4.31e-01	5.58e-02	5.24e-01	7.59e-01	9.28e-01	9.07e-01
GOBP HOMOTYPIC CELL CELL ADHESION	81	7.53e-10	1.23e-08	0.5160	-1.06e-01	-2.02e-01	3.20e-01	-1.12e-03	-2.34e-01	2.39e-01	9.90e-02	1.64e-03	6.18e-07	9.86e-01	2.64e-04	2.05e-04
GOBP MAINTENANCE OF SISTER CHROMATID COHESION	13	2.75e-02	7.53e-02	0.5160	-2.09e-01	-6.13e-02	1.42e-02	2.10e-01	-1.48e-01	3.91e-01	1.92e-01	7.02e-01	9.29e-01	1.90e-01	3.57e-01	1.47e-02
GOBP RESPONSE TO COPPER ION	23	3.71e-03	1.54e-02	0.5160	1.45e-01	-2.66e-01	1.64e-01	1.06e-01	-3.66e-01	4.48e-02	2.30e-01	2.70e-02	1.72e-01	3.78e-01	2.36e-03	7.10e-01
GOBP POSITIVE REGULATION OF KERATINOCYTE PROLIFERATION	8	4.02e-01	5.14e-01	0.5160	1.66e-01	3.28e-01	3.12e-01	1.27e-01	8.12e-02	-1.02e-01	4.15e-01	1.08e-01	1.26e-01	5.32e-01	6.91e-01	6.16e-01
GOMF LBD DOMAIN BINDING	5	5.33e-01	6.25e-01	0.5160	-2.17e-01	2.34e-01	3.81e-01	-8.98e-02	-7.35e-02	7.23e-02	4.00e-01	3.65e-01	1.40e-01	7.28e-01	7.76e-01	7.79e-01
GOMF TAP BINDING	7	3.34e-01	4.51e-01	0.5160	1.45e-01	-7.95e-02	-3.72e-01	2.99e-01	4.56e-03	-1.05e-01	5.07e-01	7.16e-01	8.85e-02	1.71e-01	9.83e-01	6.30e-01
GOBP ACTIVATION OF CYSTEINE TYPE ENDOPEPTIDASE ACTIVITY INVOLVED IN APOPTOTIC PROCESS BY CYTOCHROME C	5	7.26e-01	7.81e-01	0.5160	7.44e-02	-1.60e-02	-1.22e-01	4.47e-01	1.88e-01	1.03e-01	7.73e-01	9.51e-01	6.37e-01	8.37e-02	4.68e-01	6.89e-01
GOMF ADP PHOSPHATASE ACTIVITY	6	4.96e-01	5.94e-01	0.5160	1.43e-01	-6.65e-02	-2.14e-01	1.41e-01	-2.08e-01	-3.63e-01	5.43e-01	7.78e-01	3.63e-01	5.50e-01	3.77e-01	1.23e-01
GOCC ROUGH ENDOPLASMIC RETICULUM MEMBRANE	25	7.64e-03	2.78e-02	0.5160	-2.52e-01	-3.24e-01	-1.85e-02	9.51e-02	-2.16e-01	2.03e-01	2.94e-02	5.01e-03	8.73e-01	4.11e-01	6.12e-02	7.85e-02
GOBP PYRIMIDINE NUCLEOTIDE BIOSYNTHETIC PROCESS	29	4.34e-03	1.74e-02	0.5160	-1.48e-01	-4.45e-01	-1.77e-01	3.79e-02	-1.04e-01	5.05e-02	1.67e-01	3.40e-05	9.84e-02	7.24e-01	3.34e-01	6.38e-01
GOMF INOSITOL PHOSPHATE KINASE ACTIVITY	9	6.08e-02	1.36e-01	0.5160	-3.16e-01	-3.16e-02	4.72e-02	3.70e-01	1.30e-01	9.37e-02	1.01e-01	8.70e-01	8.06e-01	5.44e-02	4.99e-01	6.26e-01
GOBP DEVELOPMENT OF SECONDARY FEMALE SEXUAL CHARACTERISTICS	6	8.19e-02	1.69e-01	0.5160	-1.95e-01	-8.93e-02	1.33e-01	2.16e-01	-1.58e-01	-3.61e-01	4.08e-01	7.05e-01	5.73e-01	3.60e-01	5.02e-01	1.26e-01
GOBP LABYRINTHINE LAYER BLOOD VESSEL DEVELOPMENT	15	2.40e-02	6.79e-02	0.5160	-2.36e-01	-8.22e-02	3.85e-01	1.51e-03	-1.74e-01	1.58e-01	1.14e-01	5.82e-01	9.82e-03	9.92e-01	2.44e-01	2.89e-01
GOCC SYMMETRIC SYNAPSE	7	5.02e-01	5.98e-01	0.5150	6.55e-02	2.53e-01	2.96e-01	2.97e-01	1.30e-01	6.84e-02	7.64e-01	2.46e-01	1.75e-01	1.74e-01	5.52e-01	7.54e-01
GOMF PHOSPHATIDYLCHOLINE TRANSPORTER ACTIVITY	16	1.13e-01	2.13e-01	0.5150	1.60e-01	1.75e-01	2.14e-01	3.84e-01	4.75e-02	1.16e-01	2.67e-01	2.25e-01	1.38e-01	7.79e-03	7.42e-01	4.21e-01
GOMF MISMATCH REPAIR COMPLEX BINDING	11	1.95e-01	3.11e-01	0.5150	-4.28e-02	-1.25e-01	-2.56e-01	3.37e-01	2.33e-01	1.22e-01	8.06e-01	4.73e-01	1.42e-01	5.33e-02	1.81e-01	4.84e-01
GOBP DELAMINATION	5	7.55e-01	8.04e-01	0.5150	4.69e-02	3.76e-01	3.29e-01	-1.65e-02	9.70e-02	5.72e-02	8.56e-01	1.45e-01	2.02e-01	9.49e-01	7.07e-01	8.25e-01
GOMF FATTY ACID ELONGASE ACTIVITY	6	8.30e-01	8.63e-01	0.5150	-2.74e-01	-8.37e-02	7.92e-02	-3.02e-01	-2.89e-01	4.30e-02	2.45e-01	7.22e-01	7.37e-01	2.00e-01	2.20e-01	8.55e-01
GOMF SECONDARY ACTIVE MONOCARBOXYLATE TRANSMEMBRANE TRANSPORTER ACTIVITY	9	2.79e-01	3.98e-01	0.5150	2.27e-02	1.05e-02	3.40e-01	3.21e-02	-3.83e-01	2.88e-02	9.06e-01	9.56e-01	7.73e-02	8.68e-01	4.64e-02	8.81e-01
GOBP POSITIVE REGULATION OF SODIUM ION TRANSPORT	27	2.38e-02	6.75e-02	0.5150	3.46e-02	1.75e-01	4.04e-01	-1.69e-02	-1.86e-02	2.63e-01	7.56e-01	1.15e-01	2.77e-04	8.79e-01	8.67e-01	1.82e-02
GOBP POSITIVE REGULATION OF CHROMOSOME SEPARATION	28	7.84e-04	4.14e-03	0.5150	1.38e-01	-2.13e-01	-1.32e-03	4.09e-01	3.83e-02	1.79e-01	2.06e-01	5.14e-02	9.90e-01	1.82e-04	7.26e-01	1.01e-01
GOMF LOW DENSITY LIPOPROTEIN PARTICLE RECEPTOR BINDING	18	1.77e-02	5.36e-02	0.5150	-7.19e-02	-2.23e-01	1.92e-01	2.90e-01	-1.19e-01	2.74e-01	5.98e-01	1.02e-01	1.59e-01	3.34e-02	3.80e-01	4.42e-02
GOBP RESPONSE TO MOLECULE OF FUNGAL ORIGIN	5	6.22e-01	7.00e-01	0.5140	-3.61e-01	1.96e-01	-1.06e-01	-2.70e-01	6.06e-02	-8.88e-02	1.62e-01	4.48e-01	6.80e-01	2.95e-01	8.14e-01	7.31e-01
GOBP POSITIVE REGULATION OF LAMELLIPODIUM ASSEMBLY	25	5.23e-03	2.04e-02	0.5140	-2.10e-01	1.20e-01	2.81e-01	8.47e-02	-2.08e-03	3.46e-01	6.90e-02	2.99e-01	1.52e-02	4.64e-01	9.86e-01	2.71e-03
GOBP NEGATIVE REGULATION OF T HELPER 17 TYPE IMMUNE RESPONSE	10	1.87e-01	3.03e-01	0.5140	2.77e-01	2.17e-01	1.69e-01	2.40e-01	-1.43e-01	-1.84e-01	1.29e-01	2.35e-01	3.56e-01	1.89e-01	4.32e-01	3.15e-01
GOMF BIOACTIVE LIPID RECEPTOR ACTIVITY	13	2.50e-01	3.69e-01	0.5140	3.93e-01	1.42e-01	-5.37e-02	2.14e-01	2.01e-01	1.72e-02	1.41e-02	3.74e-01	7.37e-01	1.81e-01	2.10e-01	9.15e-01
GOBP AXIS ELONGATION	16	8.11e-02	1.68e-01	0.5140	2.65e-01	5.00e-02	4.02e-01	1.06e-01	-1.86e-02	1.34e-01	6.60e-02	7.29e-01	5.34e-03	4.63e-01	8.98e-01	3.52e-01
GOBP CARDIAC MUSCLE CELL ACTION POTENTIAL INVOLVED IN CONTRACTION	40	1.52e-03	7.29e-03	0.5140	1.23e-02	1.12e-01	3.44e-01	-2.33e-01	-2.26e-01	1.69e-01	8.93e-01	2.20e-01	1.70e-04	1.09e-02	1.35e-02	6.43e-02
GOBP MATURE B CELL DIFFERENTIATION	31	9.49e-03	3.28e-02	0.5140	2.24e-01	1.17e-01	3.75e-01	1.73e-01	-3.74e-02	1.68e-01	3.07e-02	2.58e-01	2.97e-04	9.62e-02	7.19e-01	1.06e-01
GOBP NEGATIVE REGULATION OF MYELOID CELL APOPTOTIC PROCESS	15	2.30e-01	3.49e-01	0.5140	1.72e-01	1.18e-01	2.71e-01	1.60e-01	-7.12e-02	3.42e-01	2.48e-01	4.31e-01	6.93e-02	2.84e-01	6.33e-01	2.19e-02
GOBP PROSTATE GLAND MORPHOGENESIS	12	4.15e-01	5.26e-01	0.5140	3.33e-01	2.14e-01	1.92e-01	1.22e-01	1.79e-01	1.55e-01	4.60e-02	1.99e-01	2.50e-01	4.66e-01	2.83e-01	3.54e-01
GOBP PROTEIN HYDROXYLATION	22	8.92e-04	4.61e-03	0.5140	-2.82e-01	-3.87e-01	-1.24e-02	1.65e-01	-6.09e-02	-5.88e-02	2.20e-02	1.67e-03	9.20e-01	1.81e-01	6.21e-01	6.33e-01
GOBP POSITIVE REGULATION OF MACROPHAGE ACTIVATION	20	5.03e-02	1.18e-01	0.5140	-8.48e-02	1.72e-01	3.66e-01	-4.37e-02	-2.22e-01	2.05e-01	5.12e-01	1.82e-01	4.64e-03	7.35e-01	8.54e-02	1.12e-01
GOBP PROTEIN RNA COMPLEX DISASSEMBLY	10	1.07e-01	2.06e-01	0.5140	-1.70e-01	-4.66e-02	2.31e-01	3.31e-01	1.03e-01	2.44e-01	3.53e-01	7.98e-01	2.07e-01	7.00e-02	5.72e-01	1.81e-01
GOBP PYRIMIDINE NUCLEOSIDE TRIPHOSPHATE METABOLIC PROCESS	22	5.20e-03	2.02e-02	0.5130	-1.38e-01	-4.49e-01	-1.19e-01	1.04e-01	3.19e-02	1.31e-01	2.64e-01	2.69e-04	3.33e-01	3.99e-01	7.96e-01	2.86e-01
GOBP POSITIVE REGULATION OF PROTEIN DEPOLYMERIZATION	15	1.49e-02	4.71e-02	0.5130	-3.15e-01	-2.54e-01	2.64e-01	-6.72e-02	-7.74e-02	1.39e-01	3.45e-02	8.90e-02	7.63e-02	6.52e-01	6.04e-01	3.51e-01
GOBP ERYTHROSE 4 PHOSPHATE PHOSPHOENOLPYRUVATE FAMILY AMINO ACID METABOLIC PROCESS	11	1.07e-01	2.05e-01	0.5130	1.46e-01	-3.66e-01	-2.15e-01	-1.62e-01	-1.26e-01	-1.40e-01	4.01e-01	3.55e-02	2.17e-01	3.52e-01	4.70e-01	4.21e-01
GOCC GLYCOPROTEIN COMPLEX	19	1.02e-01	1.98e-01	0.5130	-3.14e-02	-1.74e-01	1.66e-01	-2.57e-01	-3.72e-01	4.55e-03	8.13e-01	1.88e-01	2.10e-01	5.25e-02	4.99e-03	9.73e-01
GOBP IMMUNOLOGICAL MEMORY FORMATION PROCESS	10	3.52e-01	4.68e-01	0.5130	-1.57e-01	7.38e-02	-2.51e-01	1.80e-01	3.34e-01	-1.62e-01	3.89e-01	6.86e-01	1.69e-01	3.25e-01	6.77e-02	3.74e-01
GOBP CATECHOLAMINE UPTAKE	9	3.00e-01	4.20e-01	0.5130	2.90e-01	-1.55e-01	2.73e-01	1.98e-01	-9.00e-02	1.82e-01	1.33e-01	4.20e-01	1.56e-01	3.03e-01	6.40e-01	3.43e-01
GOBP WNT PROTEIN SECRETION	6	4.59e-01	5.64e-01	0.5130	-9.16e-02	4.55e-01	1.73e-01	-1.07e-01	5.17e-02	-6.03e-02	6.98e-01	5.35e-02	4.62e-01	6.51e-01	8.26e-01	7.98e-01
GOBP NETRIN ACTIVATED SIGNALING PATHWAY	6	6.58e-01	7.28e-01	0.5130	1.67e-01	2.09e-01	2.33e-01	1.17e-01	3.37e-01	9.82e-02	4.80e-01	3.75e-01	3.24e-01	6.20e-01	1.52e-01	6.77e-01
GOBP NUCLEAR MEMBRANE REASSEMBLY	25	2.37e-02	6.73e-02	0.5120	-2.31e-01	-3.58e-01	6.73e-02	-3.14e-02	-2.44e-01	1.28e-01	4.55e-02	1.97e-03	5.60e-01	7.86e-01	3.50e-02	2.66e-01
GOBP BRANCHING INVOLVED IN MAMMARY GLAND DUCT MORPHOGENESIS	17	1.73e-01	2.87e-01	0.5120	1.15e-01	1.83e-01	2.60e-01	2.88e-01	1.52e-01	2.05e-01	4.10e-01	1.92e-01	6.36e-02	3.96e-02	2.79e-01	1.43e-01
GOMF CARBOXYLESTERASE ACTIVITY	5	4.57e-01	5.62e-01	0.5120	-2.49e-01	3.28e-01	-2.34e-02	1.41e-01	2.51e-01	-9.58e-02	3.35e-01	2.04e-01	9.28e-01	5.84e-01	3.31e-01	7.11e-01
GOMF HISTONE H2A DEUBIQUITINASE ACTIVITY	6	4.34e-01	5.42e-01	0.5120	-4.37e-01	-4.62e-02	-1.79e-01	1.20e-01	1.52e-01	4.77e-03	6.39e-02	8.45e-01	4.49e-01	6.10e-01	5.18e-01	9.84e-01
GOMF HIGH VOLTAGE GATED CALCIUM CHANNEL ACTIVITY	11	2.60e-01	3.81e-01	0.5120	2.26e-01	3.45e-01	-8.55e-02	-4.71e-02	1.18e-01	-2.63e-01	1.95e-01	4.79e-02	6.23e-01	7.87e-01	4.99e-01	1.31e-01
GOBP REGULATION OF VENTRICULAR CARDIAC MUSCLE CELL MEMBRANE REPOLARIZATION	15	2.72e-01	3.91e-01	0.5120	-1.38e-01	7.21e-02	2.74e-01	-2.07e-01	-1.87e-01	2.91e-01	3.53e-01	6.29e-01	6.64e-02	1.65e-01	2.09e-01	5.09e-02
GOBP ANGIOGENESIS INVOLVED IN WOUND HEALING	22	5.32e-03	2.06e-02	0.5120	-2.53e-01	-1.62e-01	2.68e-01	-1.72e-01	-2.65e-01	-2.11e-02	4.00e-02	1.90e-01	2.96e-02	1.63e-01	3.17e-02	8.64e-01
GOBP POSITIVE REGULATION OF MEMBRANE PROTEIN ECTODOMAIN PROTEOLYSIS	15	1.51e-04	9.74e-04	0.5120	-1.68e-01	7.60e-02	4.34e-01	-1.45e-01	1.14e-02	-1.37e-01	2.60e-01	6.10e-01	3.64e-03	3.32e-01	9.39e-01	3.59e-01
GOBP REGULATION OF TRANSLATION AT SYNAPSE MODULATING SYNAPTIC TRANSMISSION	6	5.36e-01	6.28e-01	0.5120	-3.35e-01	-1.27e-01	1.64e-01	5.13e-02	3.96e-02	3.20e-01	1.55e-01	5.90e-01	4.87e-01	8.28e-01	8.66e-01	1.75e-01
GOMF DNA POLYMERASE BINDING	20	1.30e-02	4.23e-02	0.5120	1.41e-01	-3.63e-01	-1.75e-01	2.62e-01	2.14e-02	-1.02e-01	2.74e-01	4.97e-03	1.75e-01	4.26e-02	8.68e-01	4.28e-01
GOBP SUBTELOMERIC HETEROCHROMATIN FORMATION	9	2.28e-01	3.47e-01	0.5120	-2.84e-01	-2.36e-01	1.14e-01	1.98e-01	-2.71e-02	2.68e-01	1.40e-01	2.19e-01	5.53e-01	3.03e-01	8.88e-01	1.63e-01
GOCC DNA POLYMERASE COMPLEX	20	9.55e-03	3.30e-02	0.5110	-6.09e-02	-3.17e-01	-1.54e-01	3.07e-01	1.92e-01	-4.90e-02	6.37e-01	1.41e-02	2.34e-01	1.73e-02	1.37e-01	7.04e-01
GOBP VENTRICULAR CARDIAC MUSCLE CELL ACTION POTENTIAL	26	2.24e-02	6.47e-02	0.5110	-5.89e-02	5.73e-02	2.73e-01	-3.38e-01	-2.03e-01	1.59e-01	6.03e-01	6.13e-01	1.61e-02	2.85e-03	7.37e-02	1.62e-01
GOBP TELOMERE LOCALIZATION	7	1.59e-01	2.71e-01	0.5110	-3.20e-01	1.18e-02	-2.63e-01	1.55e-01	4.31e-02	2.53e-01	1.42e-01	9.57e-01	2.29e-01	4.76e-01	8.44e-01	2.47e-01
GOMF UBIQUITIN LIGASE ACTIVATOR ACTIVITY	9	2.59e-01	3.79e-01	0.5110	-7.56e-02	-7.96e-02	1.15e-01	3.88e-01	1.41e-01	2.56e-01	6.95e-01	6.79e-01	5.50e-01	4.36e-02	4.65e-01	1.84e-01
GOBP CELLULAR RESPONSE TO INDOLE 3 METHANOL	5	4.16e-01	5.26e-01	0.5110	-4.62e-01	9.74e-02	1.48e-01	2.20e-02	-4.24e-02	1.21e-01	7.38e-02	7.06e-01	5.67e-01	9.32e-01	8.70e-01	6.40e-01
GOMF PROTEIN ARGININE N METHYLTRANSFERASE ACTIVITY	11	9.48e-02	1.88e-01	0.5110	-2.76e-02	-1.90e-01	-3.14e-01	3.52e-01	-1.43e-04	4.37e-02	8.74e-01	2.75e-01	7.17e-02	4.30e-02	9.99e-01	8.02e-01
GOBP POSITIVE REGULATION OF ODONTOGENESIS	6	5.03e-01	5.99e-01	0.5110	-1.17e-01	-2.13e-01	3.31e-01	-5.10e-02	-4.22e-02	2.97e-01	6.20e-01	3.67e-01	1.60e-01	8.29e-01	8.58e-01	2.08e-01
GOBP PROTEIN LOCALIZATION TO CHROMOSOME TELOMERIC REGION	31	2.06e-04	1.29e-03	0.5110	-1.99e-01	-3.16e-01	-6.43e-02	2.50e-01	-7.99e-02	2.20e-01	5.50e-02	2.31e-03	5.35e-01	1.60e-02	4.41e-01	3.42e-02
GOBP MUCOCILIARY CLEARANCE	6	7.97e-01	8.36e-01	0.5110	1.76e-02	2.41e-01	3.31e-01	3.76e-02	6.49e-02	2.95e-01	9.41e-01	3.06e-01	1.60e-01	8.73e-01	7.83e-01	2.11e-01
GOMF HISTONE H3 METHYLTRANSFERASE ACTIVITY	39	1.95e-04	1.23e-03	0.5110	1.78e-01	2.01e-01	1.25e-01	4.09e-01	7.56e-02	2.26e-04	5.44e-02	2.97e-02	1.75e-01	9.88e-06	4.14e-01	9.98e-01
GOCC EXCITATORY SYNAPSE	32	1.27e-02	4.14e-02	0.5110	2.07e-01	3.73e-01	2.38e-01	5.98e-02	1.37e-01	1.16e-02	4.31e-02	2.62e-04	1.97e-02	5.58e-01	1.80e-01	9.10e-01
GOBP HEPATOCYTE GROWTH FACTOR RECEPTOR SIGNALING PATHWAY	9	4.22e-01	5.31e-01	0.5110	-1.83e-01	1.63e-01	2.19e-01	-3.87e-02	8.19e-03	3.89e-01	3.41e-01	3.98e-01	2.56e-01	8.41e-01	9.66e-01	4.33e-02
GOBP REGULATION OF TRANSLATIONAL INITIATION	77	1.93e-07	2.25e-06	0.5110	-3.31e-01	-3.23e-01	-1.26e-01	-1.87e-02	-1.65e-01	5.83e-02	5.20e-07	9.51e-07	5.52e-02	7.76e-01	1.22e-02	3.77e-01
GOBP ORGAN OR TISSUE SPECIFIC IMMUNE RESPONSE	25	6.74e-03	2.50e-02	0.5110	5.80e-02	-2.56e-01	2.36e-01	2.05e-02	-3.56e-01	9.77e-02	6.16e-01	2.69e-02	4.12e-02	8.59e-01	2.09e-03	3.98e-01
GOBP PURINE NUCLEOSIDE MONOPHOSPHATE BIOSYNTHETIC PROCESS	20	1.23e-02	4.03e-02	0.5100	-2.26e-01	-3.89e-01	-1.71e-01	9.02e-02	1.44e-01	1.70e-02	7.95e-02	2.63e-03	1.85e-01	4.85e-01	2.66e-01	8.95e-01
GOBP ESTABLISHMENT OF PROTEIN LOCALIZATION TO PEROXISOME	19	1.10e-01	2.09e-01	0.5100	-3.44e-01	-2.47e-01	-2.71e-01	-5.43e-02	6.00e-02	-3.45e-02	9.38e-03	6.20e-02	4.12e-02	6.82e-01	6.51e-01	7.95e-01
GOCC ENDOPLASMIC RETICULUM EXIT SITE	30	1.81e-04	1.15e-03	0.5100	-2.29e-01	1.07e-01	2.49e-01	1.70e-01	-7.06e-02	3.17e-01	3.00e-02	3.13e-01	1.80e-02	1.06e-01	5.03e-01	2.65e-03
GOBP VIRAL PROTEIN PROCESSING	30	7.39e-04	3.93e-03	0.5100	-9.81e-02	-7.98e-02	2.44e-01	2.54e-01	-1.23e-01	3.24e-01	3.52e-01	4.49e-01	2.07e-02	1.61e-02	2.42e-01	2.10e-03
GOBP CELLULAR RESPONSE TO THYROID HORMONE STIMULUS	11	3.38e-01	4.56e-01	0.5100	-3.10e-01	-8.74e-02	2.18e-01	-2.43e-01	-1.13e-01	1.92e-01	7.47e-02	6.16e-01	2.10e-01	1.63e-01	5.15e-01	2.70e-01
GOMF K48 LINKED POLYUBIQUITIN MODIFICATION DEPENDENT PROTEIN BINDING	10	2.72e-01	3.91e-01	0.5100	-1.13e-02	-2.79e-01	-2.12e-01	3.06e-01	-2.73e-02	-2.08e-01	9.51e-01	1.27e-01	2.45e-01	9.39e-02	8.81e-01	2.55e-01
GOBP REGULATION OF PROTEIN KINASE A SIGNALING	13	3.08e-01	4.29e-01	0.5100	1.10e-01	2.60e-01	1.01e-01	2.60e-01	2.04e-01	2.47e-01	4.91e-01	1.04e-01	5.27e-01	1.04e-01	2.04e-01	1.23e-01
GOMF GUANYLATE KINASE ACTIVITY	9	4.53e-01	5.59e-01	0.5100	5.65e-02	1.39e-01	4.08e-01	-1.76e-01	-1.81e-01	8.84e-02	7.69e-01	4.69e-01	3.42e-02	3.62e-01	3.47e-01	6.46e-01
GOBP INTRACELLULAR CORTICOSTEROID RECEPTOR SIGNALING PATHWAY	11	2.40e-01	3.58e-01	0.5100	-3.40e-01	-6.10e-02	2.17e-01	-4.35e-02	-2.28e-01	2.00e-01	5.07e-02	7.26e-01	2.14e-01	8.03e-01	1.90e-01	2.50e-01
GOMF TAT PROTEIN BINDING	10	3.67e-01	4.82e-01	0.5100	2.01e-01	-1.29e-02	2.29e-01	3.70e-01	-7.39e-03	1.75e-01	2.72e-01	9.44e-01	2.11e-01	4.28e-02	9.68e-01	3.37e-01
GOBP NEURAL TUBE PATTERNING	21	5.55e-02	1.27e-01	0.5100	-5.62e-02	1.76e-01	-2.45e-01	6.92e-02	3.31e-01	-2.28e-01	6.56e-01	1.62e-01	5.22e-02	5.83e-01	8.64e-03	7.07e-02
GOBP POSITIVE REGULATION OF CARDIAC MUSCLE CELL PROLIFERATION	17	9.49e-02	1.89e-01	0.5100	9.42e-02	3.90e-01	2.68e-01	1.43e-01	5.11e-02	6.47e-02	5.01e-01	5.31e-03	5.61e-02	3.09e-01	7.15e-01	6.44e-01
GOBP LIPID PHOSPHORYLATION	9	4.20e-01	5.29e-01	0.5100	8.90e-02	3.46e-01	-1.47e-01	2.03e-01	2.54e-01	-6.78e-02	6.44e-01	7.19e-02	4.44e-01	2.92e-01	1.86e-01	7.25e-01
GOMF ATP DEPENDENT DIACYLGLYCEROL KINASE ACTIVITY	9	4.20e-01	5.29e-01	0.5100	8.90e-02	3.46e-01	-1.47e-01	2.03e-01	2.54e-01	-6.78e-02	6.44e-01	7.19e-02	4.44e-01	2.92e-01	1.86e-01	7.25e-01
GOBP MONOCYTE EXTRAVASATION	10	3.85e-02	9.68e-02	0.5100	-4.04e-01	2.26e-01	-1.77e-01	3.79e-02	4.44e-02	-1.05e-01	2.70e-02	2.15e-01	3.32e-01	8.36e-01	8.08e-01	5.65e-01
GOBP AXONAL TRANSPORT OF MITOCHONDRION	14	8.67e-02	1.77e-01	0.5100	-4.00e-01	5.47e-02	1.63e-01	-1.54e-01	-7.84e-03	2.15e-01	9.51e-03	7.23e-01	2.91e-01	3.18e-01	9.60e-01	1.64e-01
GOBP MYELOID PROGENITOR CELL DIFFERENTIATION	9	4.00e-01	5.12e-01	0.5100	-3.33e-01	-1.27e-02	1.12e-01	-2.88e-01	-2.12e-01	-9.17e-02	8.37e-02	9.47e-01	5.60e-01	1.35e-01	2.71e-01	6.34e-01
GOBP POSITIVE REGULATION OF GAMMA DELTA T CELL DIFFERENTIATION	7	2.31e-01	3.49e-01	0.5090	-9.84e-02	4.46e-01	8.77e-02	1.83e-01	5.96e-02	7.48e-02	6.52e-01	4.09e-02	6.88e-01	4.02e-01	7.85e-01	7.32e-01
GOMF DEUBIQUITINASE ACTIVATOR ACTIVITY	7	2.66e-01	3.85e-01	0.5090	-2.03e-01	1.83e-01	3.57e-02	3.39e-01	1.37e-01	2.21e-01	3.51e-01	4.03e-01	8.70e-01	1.20e-01	5.29e-01	3.11e-01
GOBP EPITHELIAL CILIUM MOVEMENT INVOLVED IN DETERMINATION OF LEFT RIGHT ASYMMETRY	11	2.60e-01	3.80e-01	0.5090	-1.17e-01	-1.38e-01	1.63e-01	-3.59e-01	-2.40e-01	-1.15e-01	5.02e-01	4.28e-01	3.51e-01	3.90e-02	1.69e-01	5.10e-01
GOBP KYNURENINE METABOLIC PROCESS	9	1.79e-01	2.93e-01	0.5090	-4.69e-02	-6.84e-02	-2.18e-01	1.27e-02	4.35e-01	1.24e-01	8.07e-01	7.22e-01	2.58e-01	9.48e-01	2.38e-02	5.19e-01
GOBP REGULATION OF INTRINSIC APOPTOTIC SIGNALING PATHWAY IN RESPONSE TO OSMOTIC STRESS	6	7.53e-01	8.03e-01	0.5090	3.60e-02	3.03e-02	-3.34e-01	-9.77e-02	9.13e-02	-3.56e-01	8.79e-01	8.98e-01	1.56e-01	6.79e-01	6.99e-01	1.31e-01
GOBP S ADENOSYLMETHIONINE METABOLIC PROCESS	13	1.82e-01	2.97e-01	0.5090	-2.22e-01	-9.86e-03	-3.13e-01	1.68e-01	2.74e-01	-8.87e-02	1.65e-01	9.51e-01	5.06e-02	2.93e-01	8.75e-02	5.80e-01
GOBP NEGATIVE REGULATION OF CHOLESTEROL STORAGE	9	7.85e-02	1.64e-01	0.5090	-1.29e-01	1.18e-01	1.54e-01	4.18e-01	1.72e-01	-6.21e-03	5.02e-01	5.40e-01	4.24e-01	2.98e-02	3.73e-01	9.74e-01
GOBP T CELL SELECTION	52	4.98e-06	4.52e-05	0.5090	2.00e-01	2.97e-01	5.48e-02	3.23e-01	8.71e-02	1.26e-01	1.26e-02	2.16e-04	4.95e-01	5.66e-05	2.77e-01	1.15e-01
GOMF TRNA CYTIDINE 5 METHYLTRANSFERASE ACTIVITY	5	5.29e-01	6.22e-01	0.5080	-1.71e-01	-2.53e-01	-9.68e-02	-3.73e-01	8.94e-02	9.36e-02	5.08e-01	3.27e-01	7.08e-01	1.48e-01	7.29e-01	7.17e-01
GOBP PEPTIDYL LYSINE METHYLATION	23	6.28e-02	1.40e-01	0.5080	-1.97e-01	-2.88e-01	-3.13e-01	-1.01e-01	9.05e-02	-1.44e-01	1.02e-01	1.69e-02	9.42e-03	4.02e-01	4.53e-01	2.33e-01
GOMF MDM2 MDM4 FAMILY PROTEIN BINDING	10	3.34e-01	4.52e-01	0.5080	-2.96e-02	-1.63e-01	-2.63e-01	2.47e-01	9.13e-04	-3.17e-01	8.71e-01	3.72e-01	1.49e-01	1.76e-01	9.96e-01	8.27e-02
GOMF PEPTIDE TRANSMEMBRANE TRANSPORTER ACTIVITY	8	4.65e-01	5.68e-01	0.5080	2.12e-01	6.54e-02	1.91e-01	3.44e-01	2.32e-01	-1.13e-02	2.99e-01	7.49e-01	3.50e-01	9.20e-02	2.55e-01	9.56e-01
GOBP PROTEIN LOCALIZATION TO ENDOPLASMIC RETICULUM EXIT SITE	8	5.80e-01	6.66e-01	0.5080	5.40e-03	1.69e-01	2.11e-01	1.61e-01	8.18e-02	3.90e-01	9.79e-01	4.08e-01	3.00e-01	4.29e-01	6.89e-01	5.60e-02
GOCC COMMITMENT COMPLEX	5	7.30e-01	7.84e-01	0.5080	5.55e-02	-4.07e-01	-2.56e-01	4.81e-02	-1.00e-01	-1.07e-01	8.30e-01	1.15e-01	3.21e-01	8.52e-01	6.99e-01	6.77e-01
GOBP ASTROCYTE ACTIVATION	18	9.49e-05	6.46e-04	0.5080	-2.33e-01	9.85e-02	2.33e-01	-2.43e-01	3.85e-02	-2.81e-01	8.64e-02	4.69e-01	8.76e-02	7.42e-02	7.77e-01	3.87e-02
GOBP MONOUBIQUITINATED PROTEIN DEUBIQUITINATION	9	1.23e-01	2.27e-01	0.5080	-4.19e-01	1.01e-01	4.35e-02	5.74e-02	-6.55e-02	2.51e-01	2.95e-02	6.02e-01	8.21e-01	7.65e-01	7.34e-01	1.93e-01
GOBP REGULATION OF LIPOPROTEIN LIPASE ACTIVITY	5	2.00e-01	3.16e-01	0.5080	-8.29e-02	-3.66e-01	9.05e-02	2.38e-01	1.91e-01	-1.27e-01	7.48e-01	1.56e-01	7.26e-01	3.57e-01	4.60e-01	6.23e-01
GOMF STRUCTURAL CONSTITUENT OF MYELIN SHEATH	9	4.97e-01	5.95e-01	0.5080	7.09e-02	1.59e-01	-3.19e-01	2.53e-03	2.78e-01	-2.21e-01	7.13e-01	4.10e-01	9.72e-02	9.90e-01	1.49e-01	2.52e-01
GOBP PHOSPHATIDYLETHANOLAMINE METABOLIC PROCESS	23	6.57e-02	1.44e-01	0.5080	-2.83e-01	-1.48e-01	-3.02e-01	-5.62e-02	8.03e-02	-2.35e-01	1.89e-02	2.21e-01	1.21e-02	6.41e-01	5.05e-01	5.12e-02
GOMF EXTRACELLULARLY ATP GATED MONOATOMIC CATION CHANNEL ACTIVITY	5	1.44e-01	2.53e-01	0.5080	4.31e-02	-2.63e-01	2.87e-01	-2.54e-01	1.46e-01	1.37e-01	8.68e-01	3.09e-01	2.66e-01	3.26e-01	5.72e-01	5.96e-01
GOBP GALACTOSE CATABOLIC PROCESS	6	5.62e-01	6.51e-01	0.5080	-2.69e-01	-3.21e-01	-1.58e-01	2.33e-01	-4.91e-02	1.23e-02	2.53e-01	1.73e-01	5.01e-01	3.24e-01	8.35e-01	9.58e-01
GOMF RETINAL BINDING	5	6.57e-01	7.27e-01	0.5070	-4.02e-02	8.18e-02	4.31e-02	-2.33e-01	-3.74e-01	-2.30e-01	8.76e-01	7.51e-01	8.68e-01	3.67e-01	1.47e-01	3.73e-01
GOBP NEGATIVE REGULATION OF MICROTUBULE POLYMERIZATION	11	2.44e-01	3.62e-01	0.5070	3.06e-01	9.12e-02	2.07e-01	2.94e-01	-1.62e-01	2.44e-02	7.92e-02	6.01e-01	2.35e-01	9.16e-02	3.53e-01	8.88e-01
GOBP NEGATIVE REGULATION OF EXCITATORY POSTSYNAPTIC POTENTIAL	7	2.65e-01	3.85e-01	0.5070	-2.69e-01	4.24e-02	1.37e-02	2.56e-02	-1.97e-01	3.78e-01	2.17e-01	8.46e-01	9.50e-01	9.07e-01	3.66e-01	8.29e-02
GOMF NUCLEOSIDE BINDING	7	5.55e-01	6.45e-01	0.5070	-5.96e-02	1.63e-01	2.92e-01	2.13e-01	-5.98e-02	3.05e-01	7.85e-01	4.54e-01	1.81e-01	3.30e-01	7.84e-01	1.62e-01
GOBP TROPHOBLAST GIANT CELL DIFFERENTIATION	6	1.26e-01	2.31e-01	0.5070	9.97e-02	3.82e-02	4.62e-01	-4.16e-02	-1.68e-02	-1.73e-01	6.72e-01	8.71e-01	4.98e-02	8.60e-01	9.43e-01	4.62e-01
GOBP POSITIVE REGULATION OF EXTRINSIC APOPTOTIC SIGNALING PATHWAY VIA DEATH DOMAIN RECEPTORS	9	4.47e-02	1.08e-01	0.5070	-2.52e-01	5.76e-02	1.01e-01	-2.68e-01	3.22e-01	-6.84e-02	1.90e-01	7.65e-01	5.99e-01	1.64e-01	9.43e-02	7.22e-01
GOCC PHOSPHATIDYLINOSITOL 3 KINASE COMPLEX CLASS III	7	4.88e-01	5.87e-01	0.5070	-1.21e-01	-1.32e-03	-2.58e-01	3.52e-01	2.30e-01	-6.42e-03	5.80e-01	9.95e-01	2.38e-01	1.07e-01	2.93e-01	9.77e-01
GOBP REGULATION OF PROTEIN LOCALIZATION TO CELL CORTEX	8	6.26e-01	7.03e-01	0.5070	7.85e-02	2.83e-01	2.29e-02	2.45e-01	3.25e-01	-6.92e-02	7.01e-01	1.65e-01	9.11e-01	2.31e-01	1.11e-01	7.35e-01
GOMF HISTONE DECROTONYLASE ACTIVITY	5	5.94e-01	6.76e-01	0.5070	-1.75e-01	-1.73e-01	-1.92e-01	5.77e-02	3.83e-01	9.62e-02	4.98e-01	5.02e-01	4.57e-01	8.23e-01	1.38e-01	7.10e-01
GOBP AMINO ACID IMPORT ACROSS PLASMA MEMBRANE	32	2.87e-03	1.25e-02	0.5070	-1.92e-01	-1.03e-01	2.21e-01	-1.37e-02	-3.44e-01	2.06e-01	5.99e-02	3.13e-01	3.07e-02	8.93e-01	7.60e-04	4.35e-02
GOBP NEGATIVE REGULATION OF T CELL DIFFERENTIATION IN THYMUS	6	6.40e-01	7.14e-01	0.5070	1.21e-01	8.76e-02	3.04e-01	2.30e-01	-2.30e-01	1.91e-01	6.09e-01	7.10e-01	1.97e-01	3.29e-01	3.29e-01	4.17e-01
GOBP CHAPERONE MEDIATED AUTOPHAGY	15	1.01e-01	1.96e-01	0.5070	-2.39e-03	-3.03e-01	2.45e-01	-9.60e-02	-2.85e-01	1.20e-01	9.87e-01	4.22e-02	9.97e-02	5.20e-01	5.57e-02	4.20e-01
GOBP MITOCHONDRIAL TRANSCRIPTION	22	2.37e-02	6.72e-02	0.5070	-1.53e-01	-2.91e-01	-3.81e-01	6.17e-02	8.35e-03	-1.19e-02	2.15e-01	1.80e-02	2.00e-03	6.17e-01	9.46e-01	9.23e-01
GOMF INSULIN LIKE GROWTH FACTOR RECEPTOR BINDING	11	3.27e-01	4.45e-01	0.5070	-1.20e-01	-8.83e-02	2.80e-01	-9.38e-02	-3.78e-01	6.85e-02	4.92e-01	6.12e-01	1.08e-01	5.90e-01	2.99e-02	6.94e-01
GOMF PHOSPHATIDYLINOSITOL 3 KINASE REGULATORY SUBUNIT BINDING	10	1.22e-01	2.26e-01	0.5070	-2.19e-01	1.60e-01	3.26e-01	1.28e-01	1.23e-01	2.13e-01	2.30e-01	3.80e-01	7.40e-02	4.84e-01	5.02e-01	2.43e-01
GOBP MACROMOLECULE METHYLATION	122	4.37e-13	1.00e-11	0.5070	-8.26e-02	-3.56e-01	-3.33e-01	3.94e-02	2.04e-02	-1.02e-01	1.15e-01	1.10e-11	2.09e-10	4.52e-01	6.97e-01	5.07e-02
GOBP PROTON TRANSPORTING V TYPE ATPASE COMPLEX ASSEMBLY	7	4.19e-01	5.29e-01	0.5070	-3.23e-01	-2.45e-01	-1.73e-01	6.46e-02	1.99e-01	-1.35e-01	1.39e-01	2.61e-01	4.27e-01	7.67e-01	3.63e-01	5.35e-01
GOCC CENTRIOLAR SUBDISTAL APPENDAGE	9	5.81e-01	6.67e-01	0.5060	2.28e-01	1.26e-01	4.95e-02	3.90e-01	1.74e-01	-6.02e-02	2.36e-01	5.14e-01	7.97e-01	4.25e-02	3.67e-01	7.54e-01
GOBP CEREBROSPINAL FLUID CIRCULATION	9	1.93e-01	3.10e-01	0.5060	-2.81e-01	1.37e-02	1.98e-01	-1.99e-01	1.77e-01	2.60e-01	1.45e-01	9.43e-01	3.04e-01	3.02e-01	3.57e-01	1.78e-01
GOMF PLATELET DERIVED GROWTH FACTOR BINDING	6	3.99e-01	5.11e-01	0.5060	6.28e-02	-4.30e-01	1.81e-02	-9.33e-02	-1.16e-01	2.11e-01	7.90e-01	6.80e-02	9.39e-01	6.92e-01	6.22e-01	3.70e-01
GOBP ANTIGEN PROCESSING AND PRESENTATION OF EXOGENOUS PEPTIDE ANTIGEN VIA MHC CLASS I	9	2.88e-01	4.08e-01	0.5060	-1.46e-01	3.36e-01	3.33e-02	1.05e-01	2.78e-01	1.81e-01	4.50e-01	8.08e-02	8.63e-01	5.86e-01	1.48e-01	3.48e-01
GOBP POSITIVE REGULATION OF HEART GROWTH	22	3.69e-02	9.38e-02	0.5060	1.27e-01	3.96e-01	2.39e-01	1.47e-01	5.70e-02	3.23e-02	3.03e-01	1.29e-03	5.23e-02	2.34e-01	6.43e-01	7.93e-01
GOBP ERROR PRONE TRANSLESION SYNTHESIS	12	1.28e-01	2.33e-01	0.5060	-3.27e-01	-2.08e-01	-1.10e-01	-2.06e-02	1.80e-01	2.47e-01	5.02e-02	2.13e-01	5.08e-01	9.02e-01	2.79e-01	1.38e-01
GOBP REGULATION OF UBIQUITIN PROTEIN LIGASE ACTIVITY	18	2.28e-02	6.56e-02	0.5060	-1.03e-01	-4.14e-01	-4.67e-02	8.25e-02	-4.33e-02	2.51e-01	4.49e-01	2.36e-03	7.31e-01	5.45e-01	7.50e-01	6.48e-02
GOBP PYRAMIDAL NEURON DEVELOPMENT	10	4.32e-01	5.41e-01	0.5060	8.13e-02	1.90e-01	2.80e-01	2.61e-01	1.93e-01	1.71e-01	6.56e-01	2.98e-01	1.26e-01	1.52e-01	2.90e-01	3.48e-01
GOBP REGULATION OF FIBROBLAST MIGRATION	35	6.47e-04	3.50e-03	0.5060	-3.38e-01	-1.52e-01	1.37e-02	-1.86e-01	-2.31e-01	-1.75e-01	5.46e-04	1.20e-01	8.89e-01	5.68e-02	1.78e-02	7.36e-02
GOBP DETECTION OF MOLECULE OF BACTERIAL ORIGIN	11	8.63e-02	1.76e-01	0.5060	-1.73e-01	3.64e-01	2.35e-02	-5.84e-02	2.25e-01	-1.97e-01	3.21e-01	3.65e-02	8.93e-01	7.37e-01	1.96e-01	2.57e-01
GOBP COPII COATED VESICLE BUDDING	44	1.07e-06	1.12e-05	0.5060	-1.73e-01	-1.10e-01	2.17e-01	2.58e-01	-1.29e-01	2.89e-01	4.72e-02	2.06e-01	1.28e-02	3.11e-03	1.38e-01	9.05e-04
GOBP GTP METABOLIC PROCESS	22	3.51e-02	9.02e-02	0.5060	-2.24e-01	-3.56e-01	6.06e-03	-4.31e-02	-1.24e-01	2.48e-01	6.95e-02	3.80e-03	9.61e-01	7.26e-01	3.15e-01	4.44e-02
GOBP UV PROTECTION	11	2.77e-01	3.96e-01	0.5060	-1.31e-01	-2.73e-01	-2.25e-01	9.61e-02	9.31e-02	-3.09e-01	4.53e-01	1.17e-01	1.96e-01	5.81e-01	5.93e-01	7.64e-02
GOBP NEGATIVE REGULATION OF CALCIUM ION DEPENDENT EXOCYTOSIS	6	7.58e-01	8.06e-01	0.5050	-9.35e-02	-1.37e-01	3.33e-01	-1.02e-01	-2.14e-01	2.46e-01	6.92e-01	5.62e-01	1.57e-01	6.66e-01	3.64e-01	2.96e-01
GOMF CCR CHEMOKINE RECEPTOR BINDING	13	3.15e-01	4.35e-01	0.5050	2.22e-01	1.71e-01	3.87e-01	2.73e-02	-1.22e-01	1.04e-01	1.66e-01	2.85e-01	1.56e-02	8.65e-01	4.47e-01	5.14e-01
GOBP CELLULAR RESPONSE TO LEUCINE STARVATION	12	1.87e-01	3.03e-01	0.5050	-3.94e-01	-1.38e-01	3.25e-02	-4.50e-02	-2.68e-01	7.77e-02	1.81e-02	4.08e-01	8.45e-01	7.87e-01	1.08e-01	6.41e-01
GOBP AMMONIUM ION METABOLIC PROCESS	13	3.23e-02	8.45e-02	0.5050	-2.81e-01	1.77e-01	1.13e-01	-1.64e-01	3.06e-01	1.07e-01	7.97e-02	2.69e-01	4.79e-01	3.06e-01	5.58e-02	5.05e-01
GOMF ACYLGLYCEROL O ACYLTRANSFERASE ACTIVITY	25	9.46e-03	3.28e-02	0.5050	-2.09e-01	3.98e-02	3.66e-01	-1.19e-01	-1.21e-01	2.16e-01	7.11e-02	7.31e-01	1.51e-03	3.02e-01	2.94e-01	6.11e-02
GOMF MRNA 3 UTR AU RICH REGION BINDING	25	4.90e-02	1.15e-01	0.5050	-1.95e-01	-1.62e-01	-2.77e-01	-1.14e-01	-1.69e-01	-2.69e-01	9.17e-02	1.60e-01	1.65e-02	3.24e-01	1.44e-01	1.98e-02
GOBP GLYCOSYLCERAMIDE METABOLIC PROCESS	13	5.16e-02	1.20e-01	0.5050	-3.07e-01	2.18e-01	2.57e-01	-1.04e-01	-1.69e-01	9.06e-02	5.53e-02	1.74e-01	1.09e-01	5.17e-01	2.92e-01	5.72e-01
GOMF CALCIUM DEPENDENT PROTEIN SERINE THREONINE PHOSPHATASE ACTIVITY	7	2.48e-01	3.67e-01	0.5050	-4.68e-01	2.59e-02	-1.16e-01	-1.83e-03	-1.47e-01	1.15e-02	3.20e-02	9.06e-01	5.96e-01	9.93e-01	5.01e-01	9.58e-01
GOMF GUANYLYLTRANSFERASE ACTIVITY	7	4.99e-01	5.96e-01	0.5050	-3.18e-01	-9.02e-02	-2.34e-01	1.15e-01	2.60e-01	-9.90e-02	1.45e-01	6.79e-01	2.84e-01	5.97e-01	2.33e-01	6.50e-01
GOBP POSITIVE REGULATION OF PROTEIN LOCALIZATION TO CELL SURFACE	16	1.15e-01	2.17e-01	0.5050	-2.06e-01	-9.40e-02	-2.53e-01	-8.80e-03	2.00e-01	-3.15e-01	1.53e-01	5.15e-01	8.01e-02	9.51e-01	1.66e-01	2.92e-02
GOBP PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR SIGNALING PATHWAY	17	7.12e-02	1.53e-01	0.5050	5.84e-02	2.83e-01	3.17e-01	2.33e-01	3.39e-04	1.29e-01	6.77e-01	4.34e-02	2.37e-02	9.69e-02	9.98e-01	3.57e-01
GOBP NK T CELL PROLIFERATION	8	5.36e-01	6.28e-01	0.5050	-1.15e-01	9.20e-02	-2.21e-01	1.86e-01	3.33e-01	-1.97e-01	5.75e-01	6.52e-01	2.79e-01	3.63e-01	1.03e-01	3.34e-01
GOBP NEGATIVE REGULATION OF B CELL MEDIATED IMMUNITY	14	3.62e-01	4.78e-01	0.5050	1.73e-01	1.42e-01	3.18e-01	6.12e-02	1.08e-02	3.16e-01	2.64e-01	3.57e-01	3.95e-02	6.92e-01	9.44e-01	4.08e-02
GOBP POSITIVE REGULATION OF NON CANONICAL WNT SIGNALING PATHWAY	10	3.39e-01	4.56e-01	0.5040	2.83e-01	1.79e-01	1.56e-01	3.28e-01	-3.65e-02	-9.65e-02	1.21e-01	3.27e-01	3.92e-01	7.29e-02	8.41e-01	5.97e-01
GOBP NEGATIVE REGULATION OF DENDRITIC SPINE DEVELOPMENT	11	2.54e-01	3.74e-01	0.5040	-1.09e-01	-5.78e-02	3.06e-01	2.44e-02	5.15e-02	3.77e-01	5.32e-01	7.40e-01	7.88e-02	8.88e-01	7.67e-01	3.02e-02
GOBP REGULATION OF VASCULAR ENDOTHELIAL GROWTH FACTOR RECEPTOR SIGNALING PATHWAY	26	1.58e-04	1.02e-03	0.5040	-1.04e-01	2.43e-01	3.14e-01	1.73e-01	2.22e-01	8.24e-02	3.60e-01	3.18e-02	5.57e-03	1.27e-01	5.04e-02	4.67e-01
GOMF TYPE 5 METABOTROPIC GLUTAMATE RECEPTOR BINDING	6	7.48e-01	7.99e-01	0.5040	-9.93e-02	9.83e-03	2.08e-01	-8.04e-02	-2.03e-01	3.92e-01	6.74e-01	9.67e-01	3.77e-01	7.33e-01	3.90e-01	9.65e-02
GOBP RESPONSE TO LEAD ION	19	4.93e-02	1.16e-01	0.5040	-6.25e-02	9.16e-02	1.62e-01	2.14e-01	2.07e-01	3.56e-01	6.37e-01	4.90e-01	2.23e-01	1.06e-01	1.18e-01	7.20e-03
GOBP POSITIVE REGULATION OF GAMMA DELTA T CELL ACTIVATION	9	2.40e-01	3.58e-01	0.5040	-1.38e-01	4.18e-01	1.78e-01	2.96e-02	1.51e-01	6.96e-02	4.72e-01	3.00e-02	3.55e-01	8.78e-01	4.33e-01	7.18e-01
GOBP RNA SPLICING VIA ENDONUCLEOLYTIC CLEAVAGE AND LIGATION	14	1.17e-01	2.20e-01	0.5040	-1.43e-01	-2.18e-01	-3.88e-01	1.71e-01	7.60e-02	-3.53e-03	3.54e-01	1.58e-01	1.19e-02	2.68e-01	6.22e-01	9.82e-01
GOBP REGULATION OF SMOOTH MUSCLE CELL DIFFERENTIATION	30	3.27e-03	1.39e-02	0.5040	4.25e-03	2.21e-01	-5.41e-02	2.86e-01	3.15e-01	-1.47e-01	9.68e-01	3.63e-02	6.08e-01	6.76e-03	2.85e-03	1.65e-01
GOBP SPHINGOSINE 1 PHOSPHATE RECEPTOR SIGNALING PATHWAY	14	2.26e-01	3.45e-01	0.5040	1.86e-01	2.79e-02	1.26e-01	4.10e-01	1.16e-01	1.44e-01	2.28e-01	8.57e-01	4.13e-01	7.86e-03	4.52e-01	3.52e-01
GOBP REGULATION OF MONOATOMIC ANION TRANSPORT	11	4.55e-01	5.60e-01	0.5040	1.39e-01	2.50e-01	5.88e-02	1.62e-01	3.24e-01	1.93e-01	4.24e-01	1.51e-01	7.36e-01	3.53e-01	6.29e-02	2.68e-01
GOBP REGULATION OF APPETITE	12	2.49e-01	3.68e-01	0.5040	-7.68e-02	-1.99e-01	-3.30e-01	-1.11e-01	2.28e-01	-1.88e-01	6.45e-01	2.34e-01	4.79e-02	5.06e-01	1.72e-01	2.59e-01
GOBP PURINE DEOXYRIBONUCLEOTIDE BIOSYNTHETIC PROCESS	5	6.27e-01	7.03e-01	0.5040	-5.83e-03	-3.46e-01	2.51e-02	2.20e-01	1.36e-02	2.91e-01	9.82e-01	1.80e-01	9.22e-01	3.95e-01	9.58e-01	2.59e-01
GOMF ALCOHOL DEHYDROGENASE NADPPLUS ACTIVITY	17	1.23e-01	2.28e-01	0.5040	2.05e-02	-1.70e-01	-3.13e-01	2.46e-01	2.50e-01	-6.19e-02	8.84e-01	2.25e-01	2.56e-02	7.97e-02	7.47e-02	6.59e-01
GOMF DNA DNA TETHERING ACTIVITY	7	4.43e-01	5.50e-01	0.5030	2.78e-01	-6.87e-03	1.71e-01	3.15e-01	-2.19e-01	9.00e-03	2.04e-01	9.75e-01	4.34e-01	1.49e-01	3.16e-01	9.67e-01
GOBP MAST CELL CHEMOTAXIS	8	3.92e-01	5.05e-01	0.5030	1.52e-01	8.08e-02	3.75e-01	2.72e-01	4.23e-02	8.80e-02	4.56e-01	6.92e-01	6.65e-02	1.83e-01	8.36e-01	6.67e-01
GOCC RNA POLYMERASE III TRANSCRIPTION REGULATOR COMPLEX	9	3.49e-01	4.65e-01	0.5030	2.82e-02	-1.96e-01	-2.26e-01	3.89e-01	4.39e-02	-9.83e-02	8.84e-01	3.09e-01	2.40e-01	4.32e-02	8.20e-01	6.10e-01
GOBP CEREBELLAR PURKINJE CELL LAYER MORPHOGENESIS	14	2.91e-01	4.11e-01	0.5030	9.88e-02	3.24e-01	-5.92e-02	1.57e-01	3.32e-01	9.67e-03	5.22e-01	3.58e-02	7.02e-01	3.10e-01	3.13e-02	9.50e-01
GOBP REGULATION OF THE FORCE OF HEART CONTRACTION	16	2.54e-01	3.74e-01	0.5030	1.00e-01	1.50e-01	3.24e-01	1.84e-01	-2.73e-02	2.85e-01	4.88e-01	2.98e-01	2.48e-02	2.03e-01	8.50e-01	4.85e-02
GOBP NEGATIVE REGULATION OF MEIOTIC NUCLEAR DIVISION	6	3.72e-01	4.87e-01	0.5030	2.14e-01	6.50e-02	-1.93e-02	1.78e-01	7.83e-02	4.06e-01	3.63e-01	7.83e-01	9.35e-01	4.50e-01	7.40e-01	8.51e-02
GOBP CILIUM DISASSEMBLY	6	7.02e-01	7.63e-01	0.5030	2.38e-01	-1.67e-02	6.32e-02	3.95e-01	5.72e-02	1.81e-01	3.13e-01	9.43e-01	7.89e-01	9.39e-02	8.08e-01	4.42e-01
GOBP LEUKOCYTE TETHERING OR ROLLING	26	4.56e-02	1.09e-01	0.5030	3.47e-02	1.00e-01	3.80e-01	5.68e-02	-6.76e-02	2.99e-01	7.59e-01	3.75e-01	7.97e-04	6.16e-01	5.51e-01	8.29e-03
GOBP POSITIVE REGULATION OF LEUKOCYTE DEGRANULATION	22	1.16e-02	3.88e-02	0.5030	-1.25e-01	6.14e-02	3.92e-01	7.87e-02	-1.67e-01	2.15e-01	3.08e-01	6.18e-01	1.47e-03	5.23e-01	1.76e-01	8.14e-02
GOBP ARP2 3 COMPLEX MEDIATED ACTIN NUCLEATION	42	1.67e-04	1.07e-03	0.5030	-2.70e-01	-2.27e-01	1.85e-01	-4.29e-03	-2.46e-01	1.83e-01	2.46e-03	1.08e-02	3.80e-02	9.62e-01	5.76e-03	4.04e-02
GOBP RIBONUCLEOPROTEIN COMPLEX LOCALIZATION	12	2.27e-01	3.45e-01	0.5030	1.08e-02	1.81e-01	1.13e-01	3.77e-01	1.78e-01	1.83e-01	9.49e-01	2.78e-01	4.97e-01	2.39e-02	2.85e-01	2.73e-01
GOCC MKS COMPLEX	13	1.94e-01	3.11e-01	0.5030	8.60e-02	3.21e-01	-1.64e-01	-1.49e-02	3.31e-01	-7.61e-02	5.91e-01	4.52e-02	3.05e-01	9.26e-01	3.90e-02	6.35e-01
GOBP NEGATIVE REGULATION OF CYTOPLASMIC TRANSLATION	9	2.89e-01	4.09e-01	0.5030	-2.50e-01	3.01e-01	1.97e-01	-2.12e-01	-6.08e-02	1.10e-01	1.94e-01	1.17e-01	3.07e-01	2.70e-01	7.52e-01	5.68e-01
GOCC CLATHRIN COAT OF COATED PIT	16	9.45e-03	3.28e-02	0.5020	-1.72e-01	-7.64e-02	1.68e-01	3.59e-01	-9.95e-02	2.23e-01	2.34e-01	5.97e-01	2.46e-01	1.28e-02	4.91e-01	1.22e-01
GOBP TRANSITION BETWEEN FAST AND SLOW FIBER	5	3.94e-01	5.06e-01	0.5020	1.11e-01	1.91e-01	9.97e-02	-2.50e-03	-4.39e-01	-1.95e-02	6.66e-01	4.59e-01	6.99e-01	9.92e-01	8.89e-02	9.40e-01
GOBP ANTIGEN PROCESSING AND PRESENTATION OF EXOGENOUS PEPTIDE ANTIGEN	38	4.39e-04	2.52e-03	0.5020	-5.61e-02	-9.96e-02	-2.26e-01	1.85e-01	3.61e-01	-1.52e-01	5.49e-01	2.88e-01	1.57e-02	4.82e-02	1.15e-04	1.06e-01
GOBP CONVERGENT EXTENSION	11	1.74e-01	2.88e-01	0.5020	-6.54e-03	-3.01e-01	-1.22e-01	3.52e-01	1.44e-01	-4.05e-02	9.70e-01	8.34e-02	4.84e-01	4.31e-02	4.07e-01	8.16e-01
GOBP WHITE FAT CELL DIFFERENTIATION	12	2.98e-01	4.18e-01	0.5020	-1.53e-01	-1.44e-01	2.12e-01	7.79e-02	-1.64e-01	3.60e-01	3.58e-01	3.88e-01	2.03e-01	6.40e-01	3.24e-01	3.08e-02
GOBP GAMMA AMINOBUTYRIC ACID TRANSPORT	14	1.09e-01	2.08e-01	0.5020	3.69e-02	3.95e-01	-2.56e-02	-7.22e-02	1.82e-01	-2.35e-01	8.11e-01	1.04e-02	8.68e-01	6.40e-01	2.40e-01	1.27e-01
GOBP ATTACHMENT OF SPINDLE MICROTUBULES TO KINETOCHORE	51	2.02e-06	2.00e-05	0.5020	-8.13e-02	-2.54e-01	1.19e-01	1.83e-01	-1.57e-01	3.30e-01	3.15e-01	1.72e-03	1.41e-01	2.40e-02	5.25e-02	4.64e-05
GOMF ASPARTIC ENDOPEPTIDASE ACTIVITY INTRAMEMBRANE CLEAVING	7	2.63e-01	3.83e-01	0.5020	-2.61e-01	-2.16e-01	7.58e-02	1.62e-01	-3.18e-01	-6.45e-02	2.31e-01	3.23e-01	7.28e-01	4.58e-01	1.45e-01	7.68e-01
GOBP PROTEIN AUTO ADP RIBOSYLATION	11	1.48e-01	2.58e-01	0.5020	9.56e-02	9.67e-03	-4.12e-01	2.14e-01	8.54e-02	-1.41e-01	5.83e-01	9.56e-01	1.79e-02	2.20e-01	6.24e-01	4.19e-01
GOBP INFLAMMATORY CELL APOPTOTIC PROCESS	21	5.69e-02	1.30e-01	0.5020	2.87e-02	2.22e-01	9.00e-02	1.65e-01	3.26e-01	2.45e-01	8.20e-01	7.85e-02	4.75e-01	1.89e-01	9.65e-03	5.24e-02
GOMF HISTONE DEUBIQUITINASE ACTIVITY	8	3.14e-01	4.34e-01	0.5020	-2.76e-01	1.53e-01	-1.47e-01	1.52e-01	3.27e-01	-1.17e-02	1.76e-01	4.54e-01	4.70e-01	4.57e-01	1.09e-01	9.54e-01
GOMF GTP DEPENDENT PROTEIN BINDING	19	2.98e-03	1.29e-02	0.5020	-3.85e-01	-1.44e-01	7.44e-02	1.82e-01	7.39e-02	1.97e-01	3.70e-03	2.78e-01	5.74e-01	1.71e-01	5.77e-01	1.36e-01
GOBP CLATHRIN COATED VESICLE CARGO LOADING	7	4.42e-01	5.50e-01	0.5020	-2.79e-01	1.87e-01	3.21e-02	-2.62e-01	5.71e-02	2.57e-01	2.02e-01	3.92e-01	8.83e-01	2.29e-01	7.94e-01	2.40e-01
GOBP POSITIVE REGULATION OF SKELETAL MUSCLE TISSUE DEVELOPMENT	12	2.36e-01	3.53e-01	0.5020	2.16e-01	3.42e-01	1.99e-01	-4.86e-02	-4.77e-02	2.11e-01	1.96e-01	4.05e-02	2.34e-01	7.71e-01	7.75e-01	2.06e-01
GOBP REGULATION OF 3 UTR MEDIATED MRNA STABILIZATION	5	5.33e-01	6.25e-01	0.5010	-1.78e-01	3.51e-01	-1.09e-01	1.39e-01	2.11e-01	-1.45e-01	4.92e-01	1.74e-01	6.74e-01	5.91e-01	4.14e-01	5.75e-01
GOBP RETINAL BIPOLAR NEURON DIFFERENTIATION	5	3.88e-01	5.01e-01	0.5010	-1.05e-01	3.71e-01	2.64e-01	7.41e-02	4.12e-02	-1.60e-01	6.85e-01	1.51e-01	3.06e-01	7.74e-01	8.73e-01	5.36e-01
GOBP OPSONIZATION	8	4.16e-01	5.26e-01	0.5010	8.75e-02	2.19e-01	-9.05e-03	1.64e-01	2.28e-01	-3.41e-01	6.68e-01	2.83e-01	9.65e-01	4.22e-01	2.63e-01	9.45e-02
GOBP POSITIVE REGULATION OF ENDOPLASMIC RETICULUM STRESS INDUCED INTRINSIC APOPTOTIC SIGNALING PATHWAY	8	4.34e-01	5.42e-01	0.5010	-3.35e-01	-8.07e-02	1.78e-01	-9.26e-02	-2.99e-01	5.09e-02	1.01e-01	6.93e-01	3.84e-01	6.50e-01	1.43e-01	8.03e-01
GOBP TRANSEPITHELIAL CHLORIDE TRANSPORT	7	4.91e-01	5.90e-01	0.5010	-4.10e-02	3.81e-01	1.17e-01	2.07e-01	1.60e-01	1.48e-01	8.51e-01	8.07e-02	5.91e-01	3.42e-01	4.64e-01	4.97e-01
GOBP PROTEIN DNA COMPLEX DISASSEMBLY	20	1.35e-02	4.36e-02	0.5010	8.31e-02	-8.04e-03	4.05e-02	4.84e-01	8.41e-02	3.25e-02	5.20e-01	9.50e-01	7.54e-01	1.78e-04	5.15e-01	8.02e-01
GOMF IMMUNOGLOBULIN RECEPTOR BINDING	19	1.21e-02	3.99e-02	0.5010	-1.84e-02	-1.47e-01	1.47e-01	2.90e-01	-2.39e-01	2.58e-01	8.89e-01	2.69e-01	2.67e-01	2.84e-02	7.15e-02	5.20e-02
GOBP PROTEIN DEGLYCOSYLATION	15	6.50e-02	1.43e-01	0.5010	-3.94e-01	-2.03e-01	-6.48e-02	9.07e-02	3.12e-02	2.03e-01	8.27e-03	1.73e-01	6.64e-01	5.43e-01	8.34e-01	1.72e-01
GOBP INOSITOL PHOSPHATE BIOSYNTHETIC PROCESS	19	5.55e-03	2.13e-02	0.5010	-2.15e-01	7.38e-02	2.83e-01	2.32e-01	3.62e-02	2.54e-01	1.04e-01	5.78e-01	3.30e-02	8.04e-02	7.85e-01	5.53e-02
GOMF C2H2 ZINC FINGER DOMAIN BINDING	12	1.65e-01	2.78e-01	0.5010	3.30e-01	-6.43e-02	7.25e-02	3.43e-01	-1.05e-01	-6.37e-02	4.78e-02	7.00e-01	6.64e-01	3.96e-02	5.27e-01	7.03e-01
GOBP ESTABLISHMENT OF PIGMENT GRANULE LOCALIZATION	18	8.10e-02	1.68e-01	0.5010	-4.43e-01	-1.37e-01	-1.03e-02	-1.54e-01	-6.84e-02	8.41e-02	1.12e-03	3.13e-01	9.40e-01	2.59e-01	6.15e-01	5.37e-01
GOBP CLEAVAGE FURROW FORMATION	7	4.63e-01	5.67e-01	0.5010	-2.13e-01	-1.53e-01	1.84e-01	1.73e-01	4.15e-02	3.42e-01	3.30e-01	4.84e-01	4.00e-01	4.28e-01	8.49e-01	1.17e-01
GOBP HEPOXILIN METABOLIC PROCESS	7	7.37e-01	7.90e-01	0.5010	-4.36e-02	-2.04e-01	-3.11e-01	-1.20e-01	5.68e-02	-3.04e-01	8.42e-01	3.49e-01	1.54e-01	5.82e-01	7.95e-01	1.63e-01
GOBP REGULATION OF PEPTIDYL LYSINE ACETYLATION	9	1.79e-01	2.93e-01	0.5010	-1.18e-01	-2.31e-01	-7.91e-02	1.84e-01	-2.19e-01	3.09e-01	5.41e-01	2.30e-01	6.81e-01	3.40e-01	2.55e-01	1.08e-01
GOMF CARBOXY LYASE ACTIVITY	28	2.52e-02	7.05e-02	0.5010	-2.07e-01	-3.33e-01	-2.71e-01	5.78e-02	1.04e-02	-1.41e-01	5.83e-02	2.27e-03	1.30e-02	5.96e-01	9.24e-01	1.95e-01
GOBP GLYCOSYLCERAMIDE BIOSYNTHETIC PROCESS	6	8.43e-02	1.73e-01	0.5010	-9.26e-02	3.57e-01	2.80e-02	2.24e-01	-2.35e-01	9.29e-02	6.94e-01	1.30e-01	9.05e-01	3.42e-01	3.19e-01	6.94e-01
GOBP LEUKOCYTE ADHESION TO VASCULAR ENDOTHELIAL CELL	39	3.63e-03	1.51e-02	0.5000	-1.43e-02	1.43e-01	3.85e-01	-5.17e-02	-1.41e-01	2.43e-01	8.77e-01	1.22e-01	3.18e-05	5.77e-01	1.27e-01	8.68e-03
GOMF L LEUCINE BINDING	6	2.38e-01	3.56e-01	0.5000	-3.77e-01	1.82e-01	1.57e-01	1.27e-01	-1.10e-01	1.50e-01	1.10e-01	4.41e-01	5.04e-01	5.89e-01	6.41e-01	5.25e-01
GOMF INOSITOL BISPHOSPHATE PHOSPHATASE ACTIVITY	7	5.24e-01	6.17e-01	0.5000	6.18e-02	-8.67e-02	4.28e-02	2.83e-01	2.37e-01	3.17e-01	7.77e-01	6.91e-01	8.45e-01	1.95e-01	2.77e-01	1.46e-01
GOCC AXONEMAL DYNEIN COMPLEX	15	4.87e-02	1.15e-01	0.5000	2.09e-01	3.40e-01	-1.24e-01	-1.66e-01	1.07e-01	-1.93e-01	1.62e-01	2.28e-02	4.06e-01	2.66e-01	4.74e-01	1.96e-01
GOMF CYSTEINE TYPE ENDOPEPTIDASE INHIBITOR ACTIVITY	15	1.13e-01	2.13e-01	0.5000	-1.45e-01	-1.27e-01	1.31e-01	-2.71e-03	-1.97e-02	4.42e-01	3.30e-01	3.95e-01	3.78e-01	9.86e-01	8.95e-01	3.03e-03
GOBP POSITIVE REGULATION BY SYMBIONT OF ENTRY INTO HOST	13	1.10e-01	2.09e-01	0.5000	-1.91e-01	-3.13e-01	-1.73e-01	2.77e-01	4.63e-02	-8.30e-02	2.33e-01	5.04e-02	2.80e-01	8.42e-02	7.72e-01	6.04e-01
GOBP AV NODE CELL TO BUNDLE OF HIS CELL COMMUNICATION	7	6.21e-01	6.99e-01	0.5000	2.44e-01	1.44e-01	3.18e-01	-1.06e-01	-2.38e-01	2.46e-02	2.64e-01	5.08e-01	1.45e-01	6.27e-01	2.75e-01	9.10e-01
GOBP NUCLEOLAR LARGE RRNA TRANSCRIPTION BY RNA POLYMERASE I	24	6.14e-03	2.32e-02	0.5000	-4.95e-02	-3.97e-01	-1.34e-01	1.33e-01	-9.29e-02	-2.14e-01	6.75e-01	7.62e-04	2.56e-01	2.59e-01	4.31e-01	6.90e-02
GOCC PERINUCLEOLAR COMPARTMENT	5	3.45e-01	4.61e-01	0.5000	1.76e-01	2.53e-01	9.12e-02	2.09e-01	-3.14e-01	6.74e-02	4.96e-01	3.28e-01	7.24e-01	4.18e-01	2.23e-01	7.94e-01
GOBP POSITIVE REGULATION OF CHOLESTEROL STORAGE	6	2.67e-02	7.36e-02	0.5000	-5.98e-02	-1.01e-01	2.48e-01	-1.79e-01	3.41e-01	-1.62e-01	8.00e-01	6.69e-01	2.92e-01	4.47e-01	1.48e-01	4.92e-01
GOBP OXALATE TRANSPORT	5	7.69e-01	8.14e-01	0.5000	2.35e-01	4.19e-01	1.21e-01	-5.41e-02	3.71e-02	-1.07e-02	3.64e-01	1.04e-01	6.38e-01	8.34e-01	8.86e-01	9.67e-01
GOBP BARBED END ACTIN FILAMENT CAPPING	24	2.57e-02	7.17e-02	0.5000	-1.46e-01	-1.46e-01	3.06e-01	-2.17e-02	-1.42e-01	3.05e-01	2.15e-01	2.16e-01	9.37e-03	8.54e-01	2.28e-01	9.76e-03
GOBP DNA STRAND ELONGATION	37	2.82e-04	1.71e-03	0.5000	-1.04e-01	-2.87e-01	-2.25e-01	2.83e-01	1.42e-01	-7.76e-02	2.73e-01	2.48e-03	1.79e-02	2.93e-03	1.36e-01	4.14e-01
GOBP MEMBRANE DEPOLARIZATION DURING CARDIAC MUSCLE CELL ACTION POTENTIAL	15	2.60e-01	3.80e-01	0.5000	3.40e-02	1.59e-01	3.22e-01	-1.89e-01	-2.41e-01	1.62e-01	8.20e-01	2.87e-01	3.09e-02	2.04e-01	1.06e-01	2.78e-01
GOBP TRANSFORMING GROWTH FACTOR BETA2 PRODUCTION	7	2.78e-01	3.98e-01	0.5000	-2.45e-01	2.52e-01	2.01e-01	1.64e-01	-3.93e-02	2.40e-01	2.63e-01	2.49e-01	3.56e-01	4.52e-01	8.57e-01	2.71e-01
GOBP REGULATION OF BRANCHING MORPHOGENESIS OF A NERVE	5	6.95e-01	7.58e-01	0.5000	-3.11e-02	2.76e-01	-5.13e-02	1.42e-01	2.97e-01	2.48e-01	9.04e-01	2.85e-01	8.43e-01	5.84e-01	2.50e-01	3.37e-01
GOBP MITOTIC SISTER CHROMATID COHESION	31	2.58e-04	1.58e-03	0.5000	-1.46e-01	1.06e-02	1.30e-01	2.19e-01	-7.16e-02	3.98e-01	1.61e-01	9.19e-01	2.11e-01	3.47e-02	4.90e-01	1.25e-04
GOBP NEGATIVE REGULATION OF SMOOTH MUSCLE CONTRACTION	11	3.77e-01	4.92e-01	0.4990	-4.11e-02	-9.36e-02	2.55e-01	-2.15e-01	-3.57e-01	-1.12e-02	8.13e-01	5.91e-01	1.43e-01	2.18e-01	4.01e-02	9.49e-01
GOBP FEMALE MEIOTIC NUCLEAR DIVISION	30	6.07e-04	3.31e-03	0.4990	3.08e-02	-1.50e-01	2.81e-02	3.58e-01	3.95e-02	3.09e-01	7.70e-01	1.54e-01	7.90e-01	6.93e-04	7.08e-01	3.39e-03
GOBP NEGATIVE REGULATION OF CHROMOSOME SEGREGATION	49	1.05e-06	1.09e-05	0.4990	1.32e-01	-2.32e-01	1.12e-01	2.97e-01	-3.61e-02	2.75e-01	1.11e-01	4.97e-03	1.73e-01	3.15e-04	6.62e-01	8.50e-04
GOBP ATP TRANSPORT	17	2.24e-01	3.43e-01	0.4990	-1.30e-01	-3.22e-01	-2.17e-01	-4.95e-02	-1.41e-01	-2.43e-01	3.54e-01	2.14e-02	1.21e-01	7.24e-01	3.15e-01	8.30e-02
GOBP REGULATION OF GASTRIC ACID SECRETION	5	5.28e-01	6.21e-01	0.4990	-6.62e-02	8.14e-02	2.13e-01	9.09e-02	3.83e-01	1.94e-01	7.98e-01	7.52e-01	4.10e-01	7.25e-01	1.38e-01	4.53e-01
GOBP DORSAL VENTRAL NEURAL TUBE PATTERNING	9	5.98e-01	6.80e-01	0.4990	7.27e-02	2.16e-01	-1.52e-01	1.00e-01	3.69e-01	-1.67e-01	7.06e-01	2.61e-01	4.31e-01	6.03e-01	5.53e-02	3.85e-01
GOBP CHORIONIC TROPHOBLAST CELL DIFFERENTIATION	5	6.24e-01	7.01e-01	0.4990	9.40e-02	-1.78e-01	4.99e-02	2.95e-02	-3.77e-01	-2.51e-01	7.16e-01	4.91e-01	8.47e-01	9.09e-01	1.44e-01	3.31e-01
GOBP NEUROTROPHIN TRK RECEPTOR SIGNALING PATHWAY	21	1.76e-02	5.32e-02	0.4990	1.05e-02	1.43e-01	4.08e-01	-1.83e-01	5.07e-03	1.68e-01	9.34e-01	2.56e-01	1.20e-03	1.46e-01	9.68e-01	1.83e-01
GOBP POSITIVE REGULATION OF LEUKOCYTE TETHERING OR ROLLING	11	1.12e-01	2.12e-01	0.4990	-6.99e-02	4.31e-02	4.53e-01	-1.19e-02	1.79e-02	1.91e-01	6.88e-01	8.04e-01	9.25e-03	9.45e-01	9.18e-01	2.73e-01
GOBP NEGATIVE REGULATION OF CELL MIGRATION INVOLVED IN SPROUTING ANGIOGENESIS	12	1.01e-01	1.96e-01	0.4990	-2.01e-01	-2.46e-01	2.14e-02	-2.60e-01	-9.29e-02	-2.67e-01	2.28e-01	1.40e-01	8.98e-01	1.18e-01	5.77e-01	1.10e-01
GOBP VERY LOW DENSITY LIPOPROTEIN PARTICLE ASSEMBLY	8	2.95e-01	4.14e-01	0.4990	-1.62e-01	2.73e-01	1.36e-01	2.45e-01	2.34e-01	1.20e-01	4.28e-01	1.81e-01	5.05e-01	2.30e-01	2.51e-01	5.58e-01
GOBP PROTEIN EXIT FROM ENDOPLASMIC RETICULUM	47	2.95e-06	2.83e-05	0.4990	-2.52e-01	-2.08e-01	1.41e-01	1.47e-01	-1.98e-01	2.47e-01	2.75e-03	1.37e-02	9.47e-02	8.02e-02	1.86e-02	3.44e-03
GOBP ETHANOLAMINE CONTAINING COMPOUND METABOLIC PROCESS	7	6.27e-01	7.03e-01	0.4980	-1.25e-02	-2.18e-02	-3.15e-01	5.64e-02	3.72e-01	-8.38e-02	9.54e-01	9.20e-01	1.49e-01	7.96e-01	8.86e-02	7.01e-01
GOMF TRANSLATION REGULATOR ACTIVITY	131	1.21e-11	2.40e-10	0.4980	-2.27e-01	-3.71e-01	-2.22e-01	-4.62e-02	-8.46e-02	-1.89e-02	7.21e-06	2.05e-13	1.18e-05	3.62e-01	9.47e-02	7.09e-01
GOBP GRANULOCYTE MACROPHAGE COLONY STIMULATING FACTOR PRODUCTION	10	2.97e-01	4.17e-01	0.4980	-1.26e-01	1.92e-01	-1.71e-01	-1.12e-01	1.72e-01	-3.52e-01	4.89e-01	2.92e-01	3.49e-01	5.39e-01	3.45e-01	5.41e-02
GOMF PROTEIN KINASE A BINDING	43	4.53e-04	2.58e-03	0.4980	-6.16e-02	5.73e-02	2.72e-01	1.38e-01	-3.22e-02	3.84e-01	4.84e-01	5.15e-01	2.06e-03	1.18e-01	7.14e-01	1.33e-05
GOBP POSITIVE REGULATION OF CELL SIZE	9	3.18e-01	4.38e-01	0.4980	-2.79e-01	-2.33e-02	1.59e-01	-1.72e-02	1.33e-01	3.56e-01	1.47e-01	9.04e-01	4.09e-01	9.29e-01	4.91e-01	6.47e-02
GOCC MICROTUBULE END	31	2.44e-03	1.09e-02	0.4980	1.92e-01	1.35e-02	3.02e-01	2.87e-01	-1.32e-01	1.42e-01	6.39e-02	8.96e-01	3.64e-03	5.69e-03	2.04e-01	1.71e-01
GOMF ADENOSINE RECEPTOR BINDING	7	6.44e-01	7.18e-01	0.4980	-3.48e-01	-1.86e-01	-2.78e-01	-5.16e-02	-1.09e-01	-9.51e-03	1.10e-01	3.94e-01	2.02e-01	8.13e-01	6.18e-01	9.65e-01
GOBP NEGATIVE REGULATION OF NERVOUS SYSTEM PROCESS	11	2.30e-01	3.48e-01	0.4980	-3.93e-01	-1.91e-01	1.22e-01	-1.67e-01	-5.67e-02	1.04e-01	2.39e-02	2.73e-01	4.84e-01	3.37e-01	7.45e-01	5.50e-01
GOBP REGULATION OF POTASSIUM ION TRANSMEMBRANE TRANSPORTER ACTIVITY	34	4.02e-03	1.64e-02	0.4980	-1.16e-01	-8.39e-02	3.24e-01	-1.97e-01	-1.58e-01	2.42e-01	2.42e-01	3.97e-01	1.07e-03	4.73e-02	1.11e-01	1.44e-02
GOMF ACETYLGALACTOSAMINYLTRANSFERASE ACTIVITY	29	5.63e-03	2.16e-02	0.4980	-2.43e-01	-9.11e-02	2.99e-01	-4.56e-02	-1.76e-01	2.41e-01	2.37e-02	3.96e-01	5.35e-03	6.71e-01	1.00e-01	2.47e-02
GOBP CELLULAR RESPONSE TO INCREASED OXYGEN LEVELS	10	8.79e-02	1.78e-01	0.4980	-4.55e-01	-1.72e-01	6.16e-02	6.65e-02	1.86e-02	4.71e-02	1.26e-02	3.46e-01	7.36e-01	7.16e-01	9.19e-01	7.96e-01
GOBP IMMUNOLOGICAL MEMORY PROCESS	16	2.49e-01	3.68e-01	0.4980	6.60e-02	-2.05e-02	-2.58e-01	2.73e-01	3.02e-01	-1.01e-01	6.48e-01	8.87e-01	7.40e-02	5.82e-02	3.65e-02	4.84e-01
GOMF CARBON CARBON LYASE ACTIVITY	44	9.21e-04	4.75e-03	0.4980	-2.71e-01	-2.97e-01	-2.71e-01	4.84e-02	1.24e-02	-9.99e-02	1.87e-03	6.59e-04	1.85e-03	5.79e-01	8.87e-01	2.51e-01
GOBP UREA TRANSPORT	8	4.75e-01	5.76e-01	0.4980	-9.40e-02	-9.36e-02	-1.70e-01	-3.31e-01	-2.96e-01	-6.24e-02	6.45e-01	6.47e-01	4.05e-01	1.05e-01	1.48e-01	7.60e-01
GOMF MAP KINASE ACTIVITY	14	2.32e-01	3.50e-01	0.4970	-2.16e-01	-7.67e-03	2.74e-01	-1.35e-01	-2.99e-01	1.33e-01	1.62e-01	9.60e-01	7.55e-02	3.83e-01	5.27e-02	3.87e-01
GOBP PIGMENT ACCUMULATION	10	1.77e-01	2.92e-01	0.4970	-2.35e-01	-1.32e-01	1.14e-01	2.74e-01	-3.19e-02	2.92e-01	1.98e-01	4.69e-01	5.34e-01	1.33e-01	8.61e-01	1.09e-01
GOBP PIGMENT GRANULE MATURATION	10	1.77e-01	2.92e-01	0.4970	-2.35e-01	-1.32e-01	1.14e-01	2.74e-01	-3.19e-02	2.92e-01	1.98e-01	4.69e-01	5.34e-01	1.33e-01	8.61e-01	1.09e-01
GOBP POSITIVE REGULATION OF CYCLIN DEPENDENT PROTEIN KINASE ACTIVITY	11	4.86e-01	5.86e-01	0.4970	-3.34e-01	-2.78e-01	-2.01e-02	-2.10e-01	-1.08e-01	4.92e-02	5.53e-02	1.10e-01	9.08e-01	2.27e-01	5.36e-01	7.78e-01
GOBP GABAERGIC NEURON DIFFERENTIATION	7	4.73e-01	5.75e-01	0.4970	3.51e-02	2.82e-01	3.96e-01	-2.15e-02	8.65e-02	4.31e-02	8.72e-01	1.97e-01	6.96e-02	9.21e-01	6.92e-01	8.43e-01
GOBP NEGATIVE REGULATION OF STEROL TRANSPORT	5	6.38e-01	7.13e-01	0.4970	2.10e-01	1.95e-01	3.47e-01	1.74e-01	4.08e-02	-1.13e-01	4.16e-01	4.51e-01	1.79e-01	5.00e-01	8.74e-01	6.62e-01
GOBP RESPONSE TO THYROID HORMONE	19	7.06e-02	1.52e-01	0.4970	-3.35e-01	-1.51e-01	1.49e-01	-2.51e-01	-9.27e-02	1.35e-01	1.14e-02	2.56e-01	2.61e-01	5.81e-02	4.84e-01	3.08e-01
GOBP REGULATION OF CHEMOKINE MEDIATED SIGNALING PATHWAY	8	4.35e-01	5.43e-01	0.4970	-3.57e-02	1.02e-01	3.28e-01	9.44e-02	1.96e-01	2.84e-01	8.61e-01	6.17e-01	1.08e-01	6.44e-01	3.37e-01	1.65e-01
GOCC COSTAMERE	15	1.66e-01	2.79e-01	0.4970	-1.94e-02	1.63e-01	3.93e-01	-1.53e-01	-1.82e-01	9.60e-02	8.96e-01	2.74e-01	8.45e-03	3.04e-01	2.22e-01	5.20e-01
GOBP REGULATION OF CHAPERONE MEDIATED AUTOPHAGY	8	3.83e-01	4.96e-01	0.4970	-9.93e-03	-1.88e-01	3.15e-01	-1.77e-01	-2.84e-01	-7.57e-03	9.61e-01	3.57e-01	1.22e-01	3.86e-01	1.64e-01	9.70e-01
GOMF OLIGOPEPTIDE BINDING	10	4.47e-01	5.55e-01	0.4970	-2.42e-01	-2.04e-01	-3.29e-01	-9.74e-02	1.66e-01	-4.27e-02	1.86e-01	2.64e-01	7.16e-02	5.94e-01	3.65e-01	8.15e-01
GOBP PROTEIN LOCALIZATION TO CHROMOSOME CENTROMERIC REGION	29	8.99e-04	4.64e-03	0.4970	-1.02e-01	-3.51e-01	5.77e-02	2.13e-01	-8.76e-02	2.40e-01	3.42e-01	1.09e-03	5.91e-01	4.74e-02	4.14e-01	2.54e-02
GOBP LATE ENDOSOME TO LYSOSOME TRANSPORT	21	1.59e-02	4.95e-02	0.4970	-3.44e-01	-1.77e-01	4.24e-03	8.17e-02	-3.78e-02	2.99e-01	6.43e-03	1.61e-01	9.73e-01	5.17e-01	7.65e-01	1.75e-02
GOMF DYNEIN LIGHT CHAIN BINDING	7	1.57e-01	2.68e-01	0.4970	2.57e-01	-1.08e-01	-7.10e-02	-2.68e-01	-2.92e-01	8.30e-02	2.39e-01	6.19e-01	7.45e-01	2.19e-01	1.81e-01	7.04e-01
GOBP REGULATION OF AMPA RECEPTOR ACTIVITY	12	3.27e-01	4.45e-01	0.4970	1.99e-01	2.36e-01	3.22e-01	7.31e-03	1.73e-01	1.34e-01	2.32e-01	1.57e-01	5.35e-02	9.65e-01	3.00e-01	4.22e-01
GOMF POSTSYNAPTIC NEUROTRANSMITTER RECEPTOR ACTIVITY	28	6.96e-02	1.50e-01	0.4970	2.40e-01	3.38e-01	1.67e-01	1.12e-01	1.70e-01	7.73e-02	2.82e-02	1.97e-03	1.26e-01	3.06e-01	1.20e-01	4.79e-01
GOBP EMBRYONIC CAMERA TYPE EYE MORPHOGENESIS	12	4.65e-02	1.11e-01	0.4970	-1.40e-01	3.55e-01	2.80e-01	-5.20e-03	-1.50e-01	9.91e-04	3.99e-01	3.33e-02	9.28e-02	9.75e-01	3.69e-01	9.95e-01
GOMF COLLAGEN RECEPTOR ACTIVITY	6	5.12e-01	6.06e-01	0.4970	-3.80e-02	1.42e-01	2.80e-02	-3.35e-01	-3.29e-01	5.67e-02	8.72e-01	5.48e-01	9.05e-01	1.55e-01	1.62e-01	8.10e-01
GOBP REGULATION OF HOMOTYPIC CELL CELL ADHESION	29	1.22e-02	4.01e-02	0.4970	-1.18e-01	-1.04e-01	3.42e-01	-6.67e-02	-1.88e-01	2.55e-01	2.71e-01	3.34e-01	1.42e-03	5.34e-01	8.00e-02	1.75e-02
GOBP REGULATION OF PROTEIN LOCALIZATION TO NUCLEOLUS	9	3.78e-01	4.93e-01	0.4970	-1.96e-01	-4.03e-01	-1.27e-02	1.09e-01	-1.83e-01	1.86e-02	3.09e-01	3.65e-02	9.47e-01	5.70e-01	3.41e-01	9.23e-01
GOCC EARLY PHAGOSOME	11	1.35e-01	2.42e-01	0.4970	-3.22e-01	2.62e-01	9.86e-02	-1.97e-01	-8.66e-02	1.35e-01	6.47e-02	1.32e-01	5.71e-01	2.58e-01	6.19e-01	4.38e-01
GOMF ACTININ BINDING	22	3.98e-02	9.92e-02	0.4970	-1.24e-02	3.20e-02	4.10e-01	6.18e-02	-1.17e-01	2.45e-01	9.20e-01	7.95e-01	8.73e-04	6.16e-01	3.42e-01	4.70e-02
GOBP REGULATION OF HELICASE ACTIVITY	9	1.72e-01	2.85e-01	0.4960	-9.23e-02	-1.32e-01	-1.52e-01	1.45e-01	1.71e-01	3.83e-01	6.32e-01	4.92e-01	4.31e-01	4.50e-01	3.73e-01	4.64e-02
GOBP GERM CELL PROLIFERATION	8	1.89e-01	3.05e-01	0.4960	-1.84e-02	-4.50e-01	-3.63e-02	4.35e-02	8.40e-02	1.82e-01	9.28e-01	2.74e-02	8.59e-01	8.31e-01	6.81e-01	3.74e-01
GOCC SPECIFIC GRANULE MEMBRANE	88	7.44e-10	1.22e-08	0.4960	-2.09e-01	8.63e-02	2.87e-01	-3.76e-03	-1.30e-01	3.10e-01	6.96e-04	1.62e-01	3.30e-06	9.51e-01	3.45e-02	5.13e-07
GOBP POTASSIUM ION EXPORT ACROSS PLASMA MEMBRANE	13	3.97e-01	5.09e-01	0.4960	-1.86e-01	-1.24e-01	2.45e-01	-2.32e-01	-2.31e-01	1.70e-01	2.46e-01	4.37e-01	1.26e-01	1.48e-01	1.49e-01	2.87e-01
GOBP RESPONSE TO ALDOSTERONE	16	9.80e-02	1.93e-01	0.4960	1.24e-01	1.02e-01	1.29e-01	2.22e-01	3.80e-01	1.01e-01	3.89e-01	4.80e-01	3.71e-01	1.24e-01	8.55e-03	4.84e-01
GOBP REGULATION OF TESTOSTERONE BIOSYNTHETIC PROCESS	5	6.98e-01	7.60e-01	0.4960	4.75e-02	1.28e-01	-6.24e-02	3.27e-01	1.99e-01	2.78e-01	8.54e-01	6.21e-01	8.09e-01	2.05e-01	4.42e-01	2.82e-01
GOBP MIDBODY ABSCISSION	17	6.03e-02	1.36e-01	0.4960	-1.76e-01	-3.20e-01	6.08e-02	6.85e-02	-5.16e-02	3.19e-01	2.09e-01	2.25e-02	6.64e-01	6.25e-01	7.13e-01	2.26e-02
GOBP POSITIVE REGULATION OF FOCAL ADHESION ASSEMBLY	18	1.21e-02	3.99e-02	0.4960	-2.80e-01	-1.44e-01	2.66e-01	-9.21e-02	-2.59e-01	-1.96e-02	3.95e-02	2.90e-01	5.12e-02	4.99e-01	5.66e-02	8.86e-01
GOCC PODOSOME	32	5.94e-03	2.25e-02	0.4960	-1.48e-01	-7.70e-03	3.12e-01	3.84e-02	-1.65e-01	3.13e-01	1.47e-01	9.40e-01	2.24e-03	7.07e-01	1.07e-01	2.17e-03
GOBP ICOSANOID SECRETION	25	2.95e-04	1.77e-03	0.4960	-2.47e-01	8.46e-02	3.08e-01	-2.72e-01	5.16e-02	7.72e-02	3.24e-02	4.64e-01	7.67e-03	1.85e-02	6.55e-01	5.04e-01
GOBP DNA STRAND INVASION	5	5.99e-01	6.81e-01	0.4960	2.38e-01	-1.02e-01	-1.21e-02	2.85e-01	3.14e-04	3.13e-01	3.57e-01	6.93e-01	9.62e-01	2.70e-01	9.99e-01	2.26e-01
GOMF NON MEMBRANE SPANNING PROTEIN TYROSINE KINASE ACTIVITY	43	2.25e-04	1.39e-03	0.4960	-3.13e-03	1.51e-01	3.12e-01	1.31e-01	-1.72e-01	2.81e-01	9.72e-01	8.70e-02	4.03e-04	1.37e-01	5.13e-02	1.42e-03
GOCC CCAAT BINDING FACTOR COMPLEX	5	5.80e-01	6.66e-01	0.4960	-4.06e-01	-2.67e-01	-1.77e-02	9.54e-02	1.91e-03	9.62e-03	1.16e-01	3.01e-01	9.45e-01	7.12e-01	9.94e-01	9.70e-01
GOBP POSITIVE REGULATION OF ACUTE INFLAMMATORY RESPONSE TO ANTIGENIC STIMULUS	8	4.36e-01	5.44e-01	0.4960	-1.82e-01	-2.32e-01	1.13e-01	-3.60e-02	1.63e-02	3.80e-01	3.72e-01	2.55e-01	5.80e-01	8.60e-01	9.36e-01	6.29e-02
GOBP REGULATION OF MITOTIC SISTER CHROMATID SEGREGATION	54	4.81e-07	5.33e-06	0.4960	1.07e-01	-1.94e-01	1.16e-01	3.04e-01	-2.62e-02	3.00e-01	1.74e-01	1.39e-02	1.39e-01	1.10e-04	7.39e-01	1.37e-04
GOBP REGULATION OF VASCULAR ASSOCIATED SMOOTH MUSCLE CONTRACTION	7	4.81e-01	5.82e-01	0.4960	-7.51e-03	4.25e-01	2.14e-01	-1.26e-01	-5.52e-02	-1.07e-02	9.73e-01	5.15e-02	3.26e-01	5.64e-01	8.00e-01	9.61e-01
GOCC ESCRT I COMPLEX	10	1.33e-01	2.40e-01	0.4960	-1.03e-01	-3.94e-03	9.69e-02	4.17e-01	-7.40e-03	2.27e-01	5.72e-01	9.83e-01	5.96e-01	2.24e-02	9.68e-01	2.13e-01
GOBP POSITIVE REGULATION OF CD4 POSITIVE ALPHA BETA T CELL PROLIFERATION	10	1.37e-01	2.44e-01	0.4960	1.35e-01	4.62e-02	1.64e-01	2.63e-01	-3.08e-01	1.85e-01	4.61e-01	8.00e-01	3.71e-01	1.49e-01	9.13e-02	3.12e-01
GOMF S ADENOSYL L METHIONINE BINDING	20	1.23e-01	2.27e-01	0.4950	-1.03e-01	-1.88e-01	-3.60e-01	-5.52e-04	1.95e-01	-1.78e-01	4.23e-01	1.45e-01	5.30e-03	9.97e-01	1.31e-01	1.69e-01
GOBP POSITIVE REGULATION OF ENDOTHELIAL CELL DEVELOPMENT	5	7.13e-01	7.72e-01	0.4950	2.48e-03	6.05e-02	1.28e-01	3.89e-01	2.48e-01	1.11e-01	9.92e-01	8.15e-01	6.21e-01	1.32e-01	3.37e-01	6.66e-01
GOBP CHAPERONE MEDIATED PROTEIN FOLDING	72	9.95e-10	1.58e-08	0.4950	-1.65e-01	-3.92e-01	4.09e-02	1.20e-01	-9.50e-02	1.98e-01	1.57e-02	8.56e-09	5.49e-01	7.82e-02	1.63e-01	3.61e-03
GOMF DNA EXONUCLEASE ACTIVITY	25	3.70e-02	9.41e-02	0.4950	-2.20e-02	-2.17e-01	-2.83e-01	2.17e-01	1.57e-01	-2.15e-01	8.49e-01	6.05e-02	1.44e-02	6.06e-02	1.73e-01	6.33e-02
GOBP THYMOCYTE APOPTOTIC PROCESS	16	1.04e-01	2.02e-01	0.4950	-1.15e-02	6.66e-02	-4.55e-02	4.00e-01	2.62e-01	1.01e-01	9.36e-01	6.45e-01	7.53e-01	5.65e-03	6.95e-02	4.83e-01
GOMF PHOSPHATIDYLINOSITOL 3 5 BISPHOSPHATE PHOSPHATASE ACTIVITY	15	2.61e-02	7.26e-02	0.4950	-2.87e-01	2.51e-01	1.77e-01	-1.63e-02	-1.13e-01	2.36e-01	5.47e-02	9.25e-02	2.36e-01	9.13e-01	4.49e-01	1.13e-01
GOBP REGULATION OF HYALURONAN BIOSYNTHETIC PROCESS	7	4.16e-01	5.26e-01	0.4950	-3.33e-02	-1.36e-01	-1.66e-03	4.36e-01	1.86e-01	3.53e-02	8.79e-01	5.34e-01	9.94e-01	4.59e-02	3.95e-01	8.72e-01
GOMF PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR BINDING	9	2.20e-01	3.39e-01	0.4950	-2.35e-02	2.15e-01	3.00e-01	3.12e-01	-5.13e-03	1.05e-01	9.03e-01	2.64e-01	1.20e-01	1.05e-01	9.79e-01	5.86e-01
GOMF TOLL LIKE RECEPTOR BINDING	14	1.58e-01	2.69e-01	0.4950	-2.25e-01	2.10e-01	2.43e-01	-8.46e-02	-4.05e-02	2.87e-01	1.45e-01	1.74e-01	1.15e-01	5.84e-01	7.93e-01	6.31e-02
GOMF SNRNA BINDING	46	6.28e-04	3.41e-03	0.4950	-1.18e-01	-3.25e-01	-3.17e-01	8.74e-02	3.63e-02	-1.25e-01	1.65e-01	1.35e-04	2.02e-04	3.05e-01	6.70e-01	1.41e-01
GOBP O GLYCAN PROCESSING	36	4.42e-04	2.53e-03	0.4950	-1.13e-01	6.80e-02	3.24e-01	1.49e-02	1.06e-01	3.34e-01	2.42e-01	4.80e-01	7.80e-04	8.77e-01	2.71e-01	5.30e-04
GOBP REGULATION OF PRO B CELL DIFFERENTIATION	7	4.97e-01	5.95e-01	0.4950	-1.45e-01	3.59e-01	1.67e-01	3.95e-03	2.13e-01	1.46e-01	5.06e-01	1.00e-01	4.43e-01	9.86e-01	3.29e-01	5.04e-01
GOBP TELOMERASE HOLOENZYME COMPLEX ASSEMBLY	6	5.02e-01	5.99e-01	0.4950	-1.51e-01	-4.87e-02	1.42e-01	1.12e-02	2.51e-01	3.69e-01	5.21e-01	8.36e-01	5.47e-01	9.62e-01	2.87e-01	1.17e-01
GOBP REGULATION OF CARDIAC MUSCLE CELL DIFFERENTIATION	11	2.78e-01	3.98e-01	0.4950	-1.75e-01	-3.47e-02	-2.56e-01	2.46e-01	2.16e-01	-1.99e-01	3.15e-01	8.42e-01	1.41e-01	1.57e-01	2.15e-01	2.52e-01
GOBP CELL PROLIFERATION INVOLVED IN HEART MORPHOGENESIS	11	7.46e-02	1.58e-01	0.4950	-2.11e-01	2.61e-01	2.68e-01	1.80e-01	7.93e-02	1.45e-01	2.25e-01	1.34e-01	1.23e-01	3.01e-01	6.49e-01	4.04e-01
GOMF SULFURTRANSFERASE ACTIVITY	11	2.99e-01	4.19e-01	0.4950	2.12e-02	-3.09e-01	-3.04e-01	1.98e-01	1.25e-01	-3.83e-02	9.03e-01	7.64e-02	8.04e-02	2.56e-01	4.71e-01	8.26e-01
GOBP ACTIN MODIFICATION	5	6.41e-01	7.15e-01	0.4950	-1.26e-01	1.24e-01	-2.73e-01	3.01e-01	2.18e-01	-2.50e-02	6.25e-01	6.30e-01	2.90e-01	2.44e-01	3.99e-01	9.23e-01
GOBP MULTI CILIATED EPITHELIAL CELL DIFFERENTIATION	6	3.68e-01	4.83e-01	0.4950	-1.92e-02	-7.67e-02	-5.19e-02	5.15e-02	4.63e-01	1.35e-01	9.35e-01	7.45e-01	8.26e-01	8.27e-01	4.94e-02	5.66e-01
GOBP SOMITE ROSTRAL CAUDAL AXIS SPECIFICATION	5	6.37e-01	7.13e-01	0.4940	-1.62e-01	-6.00e-02	7.16e-03	3.07e-01	8.56e-02	3.36e-01	5.32e-01	8.16e-01	9.78e-01	2.34e-01	7.40e-01	1.93e-01
GOBP ADENYLATE CYCLASE ACTIVATING DOPAMINE RECEPTOR SIGNALING PATHWAY	5	2.41e-01	3.58e-01	0.4940	-3.66e-01	1.64e-01	8.80e-03	2.12e-01	-1.43e-01	1.34e-01	1.56e-01	5.26e-01	9.73e-01	4.12e-01	5.80e-01	6.03e-01
GOBP ACETYL COA BIOSYNTHETIC PROCESS	17	3.46e-02	8.93e-02	0.4940	-2.40e-01	-2.20e-01	-1.37e-01	2.28e-01	1.52e-01	2.10e-01	8.69e-02	1.16e-01	3.28e-01	1.04e-01	2.77e-01	1.33e-01
GOBP REGULATION OF FILOPODIUM ASSEMBLY	41	3.15e-04	1.88e-03	0.4940	-2.43e-01	4.09e-02	2.65e-01	-1.19e-02	-1.21e-01	3.14e-01	7.04e-03	6.51e-01	3.34e-03	8.95e-01	1.81e-01	5.09e-04
GOMF CALCIUM SODIUM ANTIPORTER ACTIVITY	8	3.95e-01	5.07e-01	0.4940	-3.33e-01	-2.04e-01	9.77e-02	-1.58e-01	-2.00e-01	-1.31e-01	1.03e-01	3.17e-01	6.32e-01	4.40e-01	3.28e-01	5.20e-01
GOBP REGULATION OF PROTEIN COMPLEX STABILITY	12	1.97e-01	3.13e-01	0.4940	3.77e-03	-3.00e-01	-1.97e-01	2.66e-01	2.07e-01	-3.74e-02	9.82e-01	7.20e-02	2.37e-01	1.10e-01	2.15e-01	8.23e-01
GOBP REGULATION OF HAIR FOLLICLE DEVELOPMENT	9	2.01e-01	3.17e-01	0.4940	-2.31e-01	1.43e-01	-5.28e-02	-1.25e-01	3.89e-01	-2.48e-03	2.29e-01	4.57e-01	7.84e-01	5.15e-01	4.33e-02	9.90e-01
GOBP CELL CYCLE DNA REPLICATION	44	3.63e-06	3.41e-05	0.4940	1.48e-01	-1.86e-01	6.59e-02	3.58e-01	-1.18e-01	2.03e-01	9.04e-02	3.28e-02	4.49e-01	3.96e-05	1.77e-01	2.01e-02
GOCC GOLGI ASSOCIATED VESICLE	80	1.35e-10	2.40e-09	0.4940	-3.77e-01	-1.45e-01	4.96e-02	4.00e-02	-1.27e-01	2.46e-01	5.59e-09	2.47e-02	4.43e-01	5.36e-01	4.94e-02	1.44e-04
GOBP CELL REDOX HOMEOSTASIS	39	9.87e-04	5.03e-03	0.4940	-1.99e-01	-4.11e-01	-3.71e-02	-4.38e-02	-1.40e-01	1.10e-01	3.16e-02	8.87e-06	6.89e-01	6.36e-01	1.30e-01	2.34e-01
GOBP MAMMARY GLAND DUCT MORPHOGENESIS	24	8.20e-02	1.70e-01	0.4940	1.34e-01	2.09e-01	2.25e-01	2.79e-01	1.72e-01	1.54e-01	2.57e-01	7.60e-02	5.60e-02	1.81e-02	1.44e-01	1.90e-01
GOBP REGULATION OF GLIAL CELL APOPTOTIC PROCESS	10	5.25e-01	6.18e-01	0.4940	1.18e-01	1.08e-01	2.03e-01	1.85e-01	1.09e-01	3.62e-01	5.17e-01	5.56e-01	2.67e-01	3.10e-01	5.51e-01	4.77e-02
GOCC INTEGRIN COMPLEX	27	2.61e-02	7.26e-02	0.4930	7.52e-03	2.09e-02	3.88e-01	-7.41e-02	-9.87e-02	2.78e-01	9.46e-01	8.51e-01	4.86e-04	5.05e-01	3.75e-01	1.25e-02
GOCC NADPH OXIDASE COMPLEX	13	8.74e-02	1.78e-01	0.4930	2.76e-01	2.24e-01	2.16e-01	-2.60e-01	1.92e-02	-4.63e-02	8.45e-02	1.63e-01	1.78e-01	1.05e-01	9.05e-01	7.73e-01
GOBP POSITIVE REGULATION OF MESENCHYMAL CELL PROLIFERATION	13	3.42e-01	4.59e-01	0.4930	2.74e-02	1.53e-01	3.17e-01	-1.08e-01	-2.74e-01	1.77e-01	8.64e-01	3.39e-01	4.75e-02	5.01e-01	8.70e-02	2.70e-01
GOMF HISTONE H4 ACETYLTRANSFERASE ACTIVITY	21	3.46e-05	2.61e-04	0.4930	-1.22e-01	9.14e-02	-1.25e-01	4.17e-01	-7.31e-02	-1.58e-01	3.35e-01	4.68e-01	3.22e-01	9.36e-04	5.62e-01	2.11e-01
GOBP POSITIVE REGULATION OF T CELL MEDIATED CYTOTOXICITY	32	2.08e-02	6.11e-02	0.4930	-1.42e-01	-2.90e-01	-3.07e-01	5.24e-02	-4.16e-02	-2.01e-01	1.66e-01	4.59e-03	2.66e-03	6.08e-01	6.84e-01	4.91e-02
GOBP NEGATIVE REGULATION OF PROTEIN SUMOYLATION	8	3.83e-01	4.97e-01	0.4930	5.28e-02	6.47e-02	-3.66e-02	3.62e-01	1.96e-01	-2.55e-01	7.96e-01	7.52e-01	8.58e-01	7.65e-02	3.38e-01	2.11e-01
GOBP OOCYTE CONSTRUCTION	5	7.56e-01	8.04e-01	0.4930	-1.23e-01	-1.97e-01	-3.42e-01	1.64e-01	2.06e-01	5.32e-02	6.35e-01	4.46e-01	1.85e-01	5.26e-01	4.26e-01	8.37e-01
GOBP SODIUM ION EXPORT ACROSS PLASMA MEMBRANE	11	4.50e-01	5.57e-01	0.4920	2.80e-01	1.70e-01	1.45e-01	3.34e-01	1.24e-02	5.14e-02	1.08e-01	3.30e-01	4.05e-01	5.50e-02	9.43e-01	7.68e-01
GOBP HEPARAN SULFATE PROTEOGLYCAN BIOSYNTHETIC PROCESS	25	1.22e-03	6.01e-03	0.4920	-2.74e-01	-1.09e-01	1.54e-01	1.25e-01	-2.91e-01	1.78e-01	1.78e-02	3.44e-01	1.82e-01	2.81e-01	1.18e-02	1.24e-01
GOBP PROTEIN UNFOLDING	5	7.04e-01	7.64e-01	0.4920	6.82e-03	-2.41e-01	-2.68e-01	-1.20e-02	2.75e-01	-1.92e-01	9.79e-01	3.52e-01	2.99e-01	9.63e-01	2.87e-01	4.57e-01
GOBP NUCLEOSIDE MONOPHOSPHATE PHOSPHORYLATION	9	6.55e-02	1.44e-01	0.4920	4.06e-03	-2.89e-01	-2.17e-01	-1.17e-01	9.27e-02	2.99e-01	9.83e-01	1.33e-01	2.60e-01	5.44e-01	6.30e-01	1.20e-01
GOBP REGULATION OF RELEASE OF CYTOCHROME C FROM MITOCHONDRIA	42	1.81e-03	8.41e-03	0.4920	-2.45e-01	-3.06e-01	-2.02e-01	-1.30e-01	1.71e-03	-1.75e-01	5.97e-03	5.90e-04	2.36e-02	1.45e-01	9.85e-01	4.94e-02
GOBP ASPARTATE FAMILY AMINO ACID METABOLIC PROCESS	37	4.10e-04	2.37e-03	0.4920	-1.53e-01	-3.31e-01	-2.50e-01	-1.74e-01	9.67e-02	-8.23e-02	1.06e-01	4.96e-04	8.40e-03	6.64e-02	3.09e-01	3.87e-01
GOBP CELL PROLIFERATION IN BONE MARROW	6	7.48e-01	7.99e-01	0.4920	-1.77e-02	1.15e-01	-2.19e-01	3.71e-02	3.96e-01	-1.51e-01	9.40e-01	6.24e-01	3.53e-01	8.75e-01	9.33e-02	5.22e-01
GOMF ATP DEPENDENT DNA DAMAGE SENSOR ACTIVITY	18	1.02e-01	1.98e-01	0.4920	-1.43e-01	-3.51e-01	-2.74e-01	-1.12e-01	-9.73e-02	3.20e-02	2.93e-01	9.93e-03	4.39e-02	4.09e-01	4.75e-01	8.14e-01
GOMF INSULIN LIKE GROWTH FACTOR BINDING	14	1.52e-01	2.63e-01	0.4920	6.13e-02	6.60e-02	4.45e-01	-4.45e-02	-1.20e-01	1.39e-01	6.92e-01	6.69e-01	3.91e-03	7.73e-01	4.36e-01	3.69e-01
GOBP POSITIVE REGULATION OF TUMOR NECROSIS FACTOR MEDIATED SIGNALING PATHWAY	13	2.02e-01	3.18e-01	0.4920	-2.79e-02	2.50e-01	3.73e-02	3.14e-01	2.61e-01	1.04e-01	8.62e-01	1.18e-01	8.16e-01	5.01e-02	1.03e-01	5.15e-01
GOMF SEMAPHORIN RECEPTOR BINDING	17	4.40e-03	1.76e-02	0.4920	3.14e-02	3.16e-01	1.44e-01	2.51e-01	2.91e-02	-2.39e-01	8.23e-01	2.43e-02	3.05e-01	7.32e-02	8.36e-01	8.82e-02
GOBP NEGATIVE REGULATION OF FATTY ACID BIOSYNTHETIC PROCESS	15	2.65e-01	3.84e-01	0.4920	2.08e-02	4.43e-02	3.10e-01	1.55e-01	-3.36e-02	3.44e-01	8.89e-01	7.66e-01	3.75e-02	2.99e-01	8.22e-01	2.11e-02
GOCC SPERM ANNULUS	6	1.97e-01	3.13e-01	0.4920	-1.97e-02	3.61e-02	-5.07e-02	1.54e-01	-1.94e-01	4.20e-01	9.33e-01	8.78e-01	8.30e-01	5.14e-01	4.11e-01	7.47e-02
GOMF TAU PROTEIN KINASE ACTIVITY	21	4.07e-03	1.66e-02	0.4920	1.87e-02	2.16e-01	2.98e-01	2.14e-01	-2.18e-01	1.12e-01	8.82e-01	8.66e-02	1.79e-02	8.96e-02	8.38e-02	3.74e-01
GOBP ANTIGEN PROCESSING AND PRESENTATION OF EXOGENOUS ANTIGEN	47	2.36e-04	1.46e-03	0.4920	-1.65e-01	-2.04e-01	-2.92e-01	1.20e-01	2.21e-01	-1.58e-01	5.04e-02	1.55e-02	5.36e-04	1.56e-01	8.90e-03	6.13e-02
GOBP COLLECTING DUCT DEVELOPMENT	7	6.10e-01	6.90e-01	0.4920	6.11e-02	1.29e-01	-7.15e-02	3.04e-01	2.49e-01	-2.50e-01	7.80e-01	5.56e-01	7.43e-01	1.64e-01	2.55e-01	2.53e-01
GOBP NEGATIVE REGULATION OF CATION CHANNEL ACTIVITY	21	5.14e-02	1.20e-01	0.4920	-2.51e-01	-1.47e-01	2.02e-01	-1.95e-01	-6.98e-02	2.71e-01	4.67e-02	2.44e-01	1.10e-01	1.21e-01	5.80e-01	3.14e-02
GOBP POSITIVE REGULATION OF G0 TO G1 TRANSITION	5	8.37e-01	8.68e-01	0.4920	-8.35e-02	8.89e-02	-2.56e-01	9.50e-02	3.67e-01	-1.32e-01	7.46e-01	7.31e-01	3.21e-01	7.13e-01	1.55e-01	6.09e-01
GOBP POSITIVE REGULATION OF AXON EXTENSION INVOLVED IN AXON GUIDANCE	5	3.24e-01	4.43e-01	0.4920	-3.42e-01	1.94e-01	2.87e-01	2.30e-02	6.52e-02	1.08e-02	1.85e-01	4.54e-01	2.67e-01	9.29e-01	8.01e-01	9.67e-01
GOBP PROTEIN DE ADP RIBOSYLATION	5	7.18e-01	7.76e-01	0.4920	4.16e-02	-1.26e-01	-4.29e-01	-5.54e-02	1.34e-01	-1.39e-01	8.72e-01	6.25e-01	9.70e-02	8.30e-01	6.04e-01	5.91e-01
GOCC PAM COMPLEX TIM23 ASSOCIATED IMPORT MOTOR	5	6.90e-01	7.54e-01	0.4920	-8.82e-02	-3.56e-01	-2.52e-01	2.70e-02	-1.63e-01	1.27e-01	7.33e-01	1.68e-01	3.30e-01	9.17e-01	5.27e-01	6.22e-01
GOBP NEGATIVE REGULATION OF AMYLOID PRECURSOR PROTEIN BIOSYNTHETIC PROCESS	7	4.81e-01	5.82e-01	0.4920	7.86e-02	-4.01e-02	1.59e-01	1.52e-01	-2.70e-01	3.35e-01	7.19e-01	8.54e-01	4.67e-01	4.86e-01	2.15e-01	1.25e-01
GOMF GUANINE NUCLEOTIDE TRANSMEMBRANE TRANSPORTER ACTIVITY	5	4.63e-01	5.67e-01	0.4910	-2.20e-01	-2.33e-01	-1.08e-02	1.15e-01	-1.62e-01	-3.15e-01	3.93e-01	3.67e-01	9.67e-01	6.57e-01	5.31e-01	2.23e-01
GOBP GLYCINE METABOLIC PROCESS	9	2.41e-01	3.59e-01	0.4910	1.83e-01	-3.58e-01	1.03e-02	1.94e-01	-1.45e-01	1.44e-01	3.43e-01	6.28e-02	9.58e-01	3.13e-01	4.51e-01	4.54e-01
GOBP MAMMARY GLAND MORPHOGENESIS	30	1.06e-02	3.62e-02	0.4910	1.33e-01	1.73e-01	2.50e-01	3.26e-01	1.09e-01	1.14e-01	2.08e-01	1.00e-01	1.78e-02	1.99e-03	3.02e-01	2.80e-01
GOBP GAMMA AMINOBUTYRIC ACID SIGNALING PATHWAY	12	1.11e-01	2.10e-01	0.4910	-2.68e-02	3.09e-01	2.30e-02	-3.22e-01	-1.50e-01	-1.36e-01	8.72e-01	6.38e-02	8.90e-01	5.38e-02	3.68e-01	4.14e-01
GOBP REGULATION OF DNA LIGATION	6	5.34e-01	6.26e-01	0.4910	6.83e-02	-2.57e-01	-3.74e-01	8.30e-02	1.54e-01	1.04e-02	7.72e-01	2.75e-01	1.13e-01	7.25e-01	5.14e-01	9.65e-01
GOBP POSITIVE REGULATION OF PHOSPHATASE ACTIVITY	23	6.93e-02	1.50e-01	0.4910	-9.32e-02	7.17e-02	3.53e-01	-1.54e-02	-9.94e-02	3.04e-01	4.39e-01	5.52e-01	3.36e-03	8.98e-01	4.09e-01	1.16e-02
GOBP CELL ADHESION MEDIATED BY INTEGRIN	74	1.09e-06	1.14e-05	0.4910	1.86e-04	9.82e-02	3.89e-01	3.42e-02	-4.71e-02	2.77e-01	9.98e-01	1.44e-01	7.31e-09	6.11e-01	4.83e-01	3.71e-05
GOBP REGULATION OF LYMPHOCYTE CHEMOTAXIS	19	8.31e-02	1.71e-01	0.4910	1.27e-01	1.24e-01	3.05e-01	3.71e-02	-2.92e-01	1.71e-01	3.37e-01	3.50e-01	2.12e-02	7.79e-01	2.74e-02	1.96e-01
GOCC PEPTIDASE COMPLEX	108	1.10e-13	2.64e-12	0.4910	-2.04e-01	-3.87e-01	-6.53e-03	8.33e-02	-8.65e-02	1.87e-01	2.48e-04	3.57e-12	9.07e-01	1.35e-01	1.21e-01	7.87e-04
GOMF RNA POLYMERASE II CTD HEPTAPEPTIDE REPEAT MODIFYING ACTIVITY	17	1.59e-02	4.95e-02	0.4910	-1.25e-01	3.98e-02	2.15e-01	3.01e-01	-1.30e-01	2.64e-01	3.71e-01	7.76e-01	1.25e-01	3.14e-02	3.52e-01	5.99e-02
GOBP POLYOL CATABOLIC PROCESS	9	9.53e-02	1.89e-01	0.4910	-3.85e-01	1.60e-01	3.03e-02	1.50e-01	2.03e-01	5.03e-02	4.57e-02	4.06e-01	8.75e-01	4.35e-01	2.91e-01	7.94e-01
GOBP CELLULAR RESPONSE TO UV A	5	8.39e-01	8.70e-01	0.4910	2.06e-02	-1.17e-01	1.95e-01	-1.71e-01	-3.98e-01	2.47e-02	9.36e-01	6.50e-01	4.50e-01	5.08e-01	1.23e-01	9.24e-01
GOBP NUCLEOTIDE BINDING DOMAIN LEUCINE RICH REPEAT CONTAINING RECEPTOR SIGNALING PATHWAY	28	3.11e-05	2.36e-04	0.4900	-2.66e-01	3.51e-01	1.90e-01	-1.28e-02	9.91e-02	1.55e-02	1.48e-02	1.31e-03	8.10e-02	9.06e-01	3.64e-01	8.87e-01
GOBP SECONDARY HEART FIELD SPECIFICATION	7	4.13e-01	5.23e-01	0.4900	-4.53e-01	-4.68e-02	-3.88e-02	-1.38e-01	6.24e-02	-9.12e-02	3.79e-02	8.30e-01	8.59e-01	5.26e-01	7.75e-01	6.76e-01
GOCC DYNEIN AXONEMAL PARTICLE	14	1.34e-01	2.41e-01	0.4900	3.60e-01	-9.19e-02	7.03e-02	3.02e-01	-2.10e-02	-7.49e-02	1.97e-02	5.52e-01	6.49e-01	5.02e-02	8.92e-01	6.27e-01
GOMF TRANSLATION ELONGATION FACTOR ACTIVITY	20	6.82e-02	1.48e-01	0.4900	-1.67e-02	-3.93e-01	-2.14e-01	5.68e-02	-1.03e-01	-1.62e-01	8.97e-01	2.37e-03	9.72e-02	6.60e-01	4.23e-01	2.10e-01
GOMF PHOSPHATIDYLINOSITOL 3 KINASE REGULATOR ACTIVITY	11	3.12e-02	8.23e-02	0.4900	-4.25e-01	-5.16e-02	1.11e-01	8.49e-03	-1.69e-01	-1.28e-01	1.47e-02	7.67e-01	5.25e-01	9.61e-01	3.33e-01	4.63e-01
GOMF PHOSPHATIDYLGLYCEROL BINDING	12	1.00e-01	1.96e-01	0.4900	2.37e-03	-3.96e-01	7.31e-03	1.99e-01	2.13e-02	2.08e-01	9.89e-01	1.76e-02	9.65e-01	2.32e-01	8.98e-01	2.11e-01
GOMF CYTIDINE DEAMINASE ACTIVITY	11	3.01e-01	4.20e-01	0.4900	2.32e-01	1.94e-01	1.86e-01	4.41e-02	-4.18e-02	3.32e-01	1.82e-01	2.65e-01	2.84e-01	8.00e-01	8.10e-01	5.67e-02
GOMF NUCLEOCYTOPLASMIC CARRIER ACTIVITY	31	5.78e-04	3.17e-03	0.4900	-3.83e-01	-2.00e-01	-1.64e-01	1.13e-01	-5.22e-02	1.06e-01	2.26e-04	5.34e-02	1.15e-01	2.75e-01	6.15e-01	3.07e-01
GOBP PIGMENT GRANULE LOCALIZATION	20	3.22e-02	8.44e-02	0.4900	-4.45e-01	-1.56e-01	-3.86e-02	-7.07e-02	5.90e-03	1.05e-01	5.64e-04	2.28e-01	7.65e-01	5.84e-01	9.64e-01	4.17e-01
GOBP REGULATION OF MITOCHONDRIAL OUTER MEMBRANE PERMEABILIZATION INVOLVED IN APOPTOTIC SIGNALING PATHWAY	20	4.73e-02	1.12e-01	0.4900	1.13e-01	-2.59e-01	-2.02e-01	1.80e-01	-4.08e-02	-2.92e-01	3.82e-01	4.47e-02	1.17e-01	1.65e-01	7.52e-01	2.38e-02
GOMF 5 3 EXONUCLEASE ACTIVITY	18	1.29e-01	2.35e-01	0.4900	-3.05e-01	-2.47e-01	-2.70e-01	-4.84e-02	9.85e-02	2.41e-02	2.51e-02	6.94e-02	4.71e-02	7.22e-01	4.69e-01	8.59e-01
GOMF INTRAMOLECULAR OXIDOREDUCTASE ACTIVITY TRANSPOSING C C BONDS	12	7.70e-02	1.62e-01	0.4900	1.10e-01	-4.44e-01	-1.61e-01	5.15e-02	2.59e-02	-3.28e-02	5.09e-01	7.69e-03	3.35e-01	7.58e-01	8.76e-01	8.44e-01
GOBP PROTEIN LINEAR POLYUBIQUITINATION	5	7.58e-01	8.06e-01	0.4900	1.08e-01	-9.25e-02	7.19e-02	2.97e-01	1.89e-01	3.01e-01	6.77e-01	7.20e-01	7.81e-01	2.51e-01	4.64e-01	2.44e-01
GOCC CYTOPLASMIC UBIQUITIN LIGASE COMPLEX	8	3.01e-01	4.20e-01	0.4900	-3.39e-01	3.78e-02	3.97e-02	1.25e-01	5.06e-02	3.21e-01	9.65e-02	8.53e-01	8.46e-01	5.40e-01	8.04e-01	1.15e-01
GOBP POSITIVE REGULATION OF MITOTIC CYTOKINESIS	13	1.41e-02	4.52e-02	0.4900	-9.75e-02	-1.15e-01	1.41e-01	4.37e-01	-7.24e-02	2.38e-02	5.43e-01	4.74e-01	3.80e-01	6.31e-03	6.51e-01	8.82e-01
GOBP HEART FIELD SPECIFICATION	9	2.59e-01	3.79e-01	0.4890	-4.42e-01	3.99e-02	1.17e-01	-1.23e-01	-3.75e-03	1.17e-01	2.15e-02	8.36e-01	5.45e-01	5.23e-01	9.84e-01	5.45e-01
GOBP TOLERANCE INDUCTION	27	1.17e-02	3.88e-02	0.4890	-1.12e-01	-8.54e-02	1.87e-01	9.21e-03	-3.52e-01	2.46e-01	3.15e-01	4.43e-01	9.18e-02	9.34e-01	1.53e-03	2.72e-02
GOMF C C CHEMOKINE BINDING	23	6.02e-02	1.35e-01	0.4890	2.70e-01	1.44e-01	3.00e-01	6.45e-02	-1.84e-01	1.32e-01	2.49e-02	2.31e-01	1.27e-02	5.92e-01	1.26e-01	2.74e-01
GOBP NEGATIVE REGULATION OF AUTOPHAGOSOME ASSEMBLY	13	1.59e-01	2.71e-01	0.4890	-3.67e-01	-1.56e-01	-2.06e-01	-4.18e-02	-1.46e-01	1.21e-01	2.20e-02	3.30e-01	1.98e-01	7.94e-01	3.61e-01	4.49e-01
GOMF MAP KINASE KINASE KINASE ACTIVITY	24	1.65e-05	1.33e-04	0.4890	-2.38e-01	3.46e-01	1.21e-01	1.37e-01	1.17e-01	-1.26e-01	4.35e-02	3.36e-03	3.04e-01	2.45e-01	3.20e-01	2.87e-01
GOBP FOREBRAIN REGIONALIZATION	9	1.93e-01	3.09e-01	0.4890	-6.96e-02	4.01e-01	1.36e-02	-2.57e-01	-6.65e-02	-5.20e-02	7.18e-01	3.71e-02	9.44e-01	1.82e-01	7.30e-01	7.87e-01
GOBP REGULATION OF SYNAPTIC VESICLE PRIMING	8	2.71e-01	3.90e-01	0.4890	-4.89e-02	2.12e-01	9.74e-02	3.73e-01	1.97e-01	-6.81e-02	8.11e-01	2.99e-01	6.33e-01	6.78e-02	3.35e-01	7.39e-01
GOBP REGULATION OF CORTISOL BIOSYNTHETIC PROCESS	5	6.36e-01	7.11e-01	0.4890	1.58e-02	2.01e-01	2.19e-01	2.16e-01	-1.93e-01	2.59e-01	9.51e-01	4.36e-01	3.97e-01	4.04e-01	4.56e-01	3.16e-01
GOBP BONE MINERALIZATION INVOLVED IN BONE MATURATION	8	5.97e-01	6.79e-01	0.4890	1.14e-01	8.76e-02	2.67e-01	-9.53e-02	-3.29e-01	1.73e-01	5.76e-01	6.68e-01	1.90e-01	6.41e-01	1.07e-01	3.98e-01
GOBP ACTIN FILAMENT SEVERING	16	1.07e-01	2.06e-01	0.4890	-7.20e-02	-1.15e-01	3.15e-01	1.30e-01	-2.14e-01	2.41e-01	6.18e-01	4.25e-01	2.89e-02	3.67e-01	1.38e-01	9.45e-02
GOMF JUN KINASE KINASE KINASE ACTIVITY	11	7.45e-02	1.58e-01	0.4890	-1.68e-01	3.35e-01	1.42e-01	2.09e-01	1.87e-01	8.17e-04	3.35e-01	5.43e-02	4.14e-01	2.31e-01	2.83e-01	9.96e-01
GOBP FATTY ACID HOMEOSTASIS	11	4.24e-01	5.33e-01	0.4890	1.92e-01	1.54e-01	2.76e-01	2.84e-01	1.30e-01	7.11e-02	2.71e-01	3.76e-01	1.13e-01	1.03e-01	4.55e-01	6.83e-01
GOBP REGULATION OF MODIFICATION OF POSTSYNAPTIC STRUCTURE	8	7.76e-01	8.20e-01	0.4890	-2.75e-01	-1.88e-01	-1.49e-01	-2.70e-01	-1.13e-01	-1.42e-01	1.78e-01	3.57e-01	4.66e-01	1.86e-01	5.80e-01	4.86e-01
GOBP REGULATION OF SNARE COMPLEX ASSEMBLY	13	1.27e-01	2.32e-01	0.4890	-2.82e-02	1.32e-01	4.49e-02	3.88e-01	2.61e-01	-1.34e-02	8.60e-01	4.08e-01	7.79e-01	1.55e-02	1.04e-01	9.33e-01
GOBP PROTEIN TARGETING TO LYSOSOME	31	2.40e-03	1.07e-02	0.4890	-3.64e-01	-1.28e-01	5.53e-02	-2.36e-03	-1.40e-01	2.59e-01	4.46e-04	2.16e-01	5.94e-01	9.82e-01	1.78e-01	1.26e-02
GOBP DEMETHYLATION	36	1.20e-02	3.97e-02	0.4890	1.82e-01	2.93e-01	2.06e-01	2.44e-01	8.27e-02	1.04e-01	5.91e-02	2.32e-03	3.26e-02	1.11e-02	3.91e-01	2.81e-01
GOMF CYCLIN DEPENDENT PROTEIN SERINE THREONINE KINASE ACTIVATOR ACTIVITY	14	1.62e-01	2.74e-01	0.4890	-2.20e-01	-1.63e-01	1.76e-02	-5.36e-02	-1.45e-01	3.73e-01	1.53e-01	2.90e-01	9.09e-01	7.28e-01	3.46e-01	1.56e-02
GOBP NEGATIVE REGULATION OF MYELOID CELL DIFFERENTIATION	70	2.30e-07	2.65e-06	0.4890	-1.05e-02	1.08e-01	4.06e-01	6.95e-02	-1.32e-01	2.00e-01	8.80e-01	1.18e-01	4.37e-09	3.15e-01	5.55e-02	3.74e-03
GOBP POSITIVE REGULATION OF HIPPO SIGNALING	9	2.01e-01	3.17e-01	0.4880	-4.59e-01	-1.32e-02	8.27e-02	-6.64e-02	-1.29e-01	9.22e-03	1.72e-02	9.45e-01	6.68e-01	7.30e-01	5.03e-01	9.62e-01
GOBP NUCLEOBASE BIOSYNTHETIC PROCESS	17	9.31e-02	1.86e-01	0.4880	-1.39e-01	-3.91e-01	-1.79e-01	1.19e-01	-1.10e-01	9.04e-02	3.23e-01	5.24e-03	2.02e-01	3.96e-01	4.32e-01	5.19e-01
GOBP CORTICOSPINAL TRACT MORPHOGENESIS	6	6.78e-01	7.44e-01	0.4880	8.14e-02	2.32e-01	2.19e-01	4.31e-02	-1.45e-01	3.27e-01	7.30e-01	3.26e-01	3.52e-01	8.55e-01	5.39e-01	1.65e-01
GOBP TRANSCRIPTION INITIATION AT RNA POLYMERASE I PROMOTER	14	2.09e-01	3.27e-01	0.4880	3.25e-02	-7.91e-02	-2.91e-01	2.08e-01	2.85e-04	-3.21e-01	8.33e-01	6.08e-01	5.91e-02	1.77e-01	9.99e-01	3.79e-02
GOMF PHOSPHATIDATE PHOSPHATASE ACTIVITY	10	1.43e-01	2.53e-01	0.4880	1.67e-01	4.98e-03	7.04e-02	6.31e-02	-3.00e-01	-3.34e-01	3.60e-01	9.78e-01	7.00e-01	7.30e-01	1.00e-01	6.78e-02
GOBP POSITIVE REGULATION OF PROTEIN CATABOLIC PROCESS IN THE VACUOLE	6	1.82e-01	2.96e-01	0.4880	1.99e-02	1.31e-01	4.47e-01	6.26e-02	6.02e-02	-1.14e-01	9.33e-01	5.78e-01	5.78e-02	7.91e-01	7.99e-01	6.28e-01
GOMF OLEATE TRANSMEMBRANE TRANSPORTER ACTIVITY	5	8.39e-01	8.70e-01	0.4880	-1.19e-02	2.31e-01	-9.33e-02	2.02e-01	3.57e-01	-8.66e-02	9.63e-01	3.72e-01	7.18e-01	4.34e-01	1.66e-01	7.37e-01
GOMF NUCLEOTIDE TRANSMEMBRANE TRANSPORTER ACTIVITY	29	3.56e-02	9.12e-02	0.4880	-2.18e-01	-2.67e-01	-1.65e-01	-8.42e-02	-1.86e-01	-2.25e-01	4.22e-02	1.28e-02	1.25e-01	4.33e-01	8.37e-02	3.60e-02
GOBP KETONE CATABOLIC PROCESS	13	1.63e-01	2.75e-01	0.4880	-8.85e-02	-1.67e-01	-2.89e-01	1.23e-01	3.15e-01	6.70e-02	5.80e-01	2.96e-01	7.14e-02	4.41e-01	4.95e-02	6.76e-01
GOCC TRANSCRIPTION FACTOR TFIIH HOLO COMPLEX	12	3.13e-01	4.33e-01	0.4880	-3.56e-01	-2.45e-01	-1.42e-01	-1.43e-01	7.46e-02	7.07e-02	3.29e-02	1.42e-01	3.93e-01	3.90e-01	6.55e-01	6.72e-01
GOMF VOLTAGE GATED POTASSIUM CHANNEL ACTIVITY INVOLVED IN CARDIAC MUSCLE CELL ACTION POTENTIAL REPOLARIZATION	9	6.00e-01	6.81e-01	0.4880	-1.66e-01	-1.30e-01	6.42e-02	-2.58e-01	-2.40e-01	2.55e-01	3.87e-01	4.98e-01	7.39e-01	1.81e-01	2.13e-01	1.85e-01
GOCC ACTIVIN RECEPTOR COMPLEX	6	5.46e-01	6.36e-01	0.4880	-3.89e-01	1.59e-01	6.69e-03	-1.62e-01	5.62e-02	1.77e-01	9.87e-02	4.99e-01	9.77e-01	4.91e-01	8.12e-01	4.52e-01
GOMF CARBON NITROGEN LIGASE ACTIVITY WITH GLUTAMINE AS AMIDO N DONOR	9	5.32e-01	6.24e-01	0.4880	-2.49e-01	-2.27e-01	-2.70e-01	-3.46e-02	1.91e-01	-1.17e-01	1.96e-01	2.38e-01	1.60e-01	8.57e-01	3.21e-01	5.45e-01
GOBP LYMPHOCYTE COSTIMULATION	44	2.06e-03	9.43e-03	0.4880	1.36e-01	1.78e-01	1.67e-01	3.00e-01	1.20e-01	2.35e-01	1.17e-01	4.08e-02	5.56e-02	5.71e-04	1.70e-01	7.03e-03
GOBP NATURAL KILLER CELL CYTOKINE PRODUCTION	7	3.36e-01	4.54e-01	0.4880	-1.90e-01	-6.09e-02	-1.82e-01	-1.41e-01	-3.80e-01	1.76e-02	3.83e-01	7.80e-01	4.05e-01	5.19e-01	8.14e-02	9.36e-01
GOBP DE NOVO NAD BIOSYNTHETIC PROCESS	8	5.50e-01	6.40e-01	0.4870	-1.26e-01	3.18e-02	-2.87e-01	6.08e-02	3.65e-01	-3.79e-02	5.38e-01	8.76e-01	1.60e-01	7.66e-01	7.38e-02	8.53e-01
GOBP REGULATION OF PROTEIN EXIT FROM ENDOPLASMIC RETICULUM	24	1.08e-02	3.67e-02	0.4870	-3.35e-01	-1.05e-01	7.72e-02	3.65e-02	-3.91e-02	3.25e-01	4.48e-03	3.73e-01	5.13e-01	7.57e-01	7.40e-01	5.92e-03
GOMF HISTONE KINASE ACTIVITY	21	2.76e-02	7.54e-02	0.4870	-8.79e-02	-6.65e-02	2.00e-01	2.49e-01	1.82e-02	3.51e-01	4.86e-01	5.98e-01	1.12e-01	4.86e-02	8.85e-01	5.39e-03
GOCC CIS GOLGI NETWORK MEMBRANE	8	4.79e-01	5.80e-01	0.4870	-6.40e-02	2.04e-02	2.99e-01	1.78e-01	-2.18e-01	2.54e-01	7.54e-01	9.21e-01	1.43e-01	3.82e-01	2.86e-01	2.14e-01
GOBP POSITIVE REGULATION OF CHOLESTEROL METABOLIC PROCESS	9	1.23e-01	2.28e-01	0.4870	8.96e-02	-1.47e-01	1.89e-01	4.09e-01	2.47e-02	-6.33e-02	6.42e-01	4.44e-01	3.25e-01	3.37e-02	8.98e-01	7.42e-01
GOBP POSITIVE REGULATION OF PROTEIN DEUBIQUITINATION	5	6.12e-01	6.91e-01	0.4870	-1.55e-02	1.57e-01	4.14e-01	5.89e-02	1.37e-01	1.37e-01	9.52e-01	5.44e-01	1.09e-01	8.20e-01	5.97e-01	5.95e-01
GOBP PEPTIDYL PROLINE MODIFICATION	27	7.71e-03	2.80e-02	0.4870	-2.19e-01	-4.02e-01	-1.33e-01	-7.01e-02	1.66e-02	6.97e-02	4.85e-02	3.02e-04	2.31e-01	5.28e-01	8.81e-01	5.31e-01
GOMF LYSOPHOSPHATIDIC ACID BINDING	5	5.86e-01	6.70e-01	0.4870	-2.95e-01	-1.65e-01	-4.21e-02	2.39e-01	2.17e-01	1.30e-01	2.53e-01	5.24e-01	8.70e-01	3.54e-01	4.00e-01	6.16e-01
GOMF D1 DOPAMINE RECEPTOR BINDING	5	6.65e-01	7.33e-01	0.4870	-1.93e-01	-2.20e-01	-5.21e-02	2.71e-01	6.88e-03	2.74e-01	4.55e-01	3.94e-01	8.40e-01	2.93e-01	9.79e-01	2.88e-01
GOBP G PROTEIN COUPLED SEROTONIN RECEPTOR SIGNALING PATHWAY	8	4.38e-01	5.45e-01	0.4870	1.05e-01	2.76e-01	2.52e-01	-1.52e-01	2.27e-01	1.09e-01	6.07e-01	1.77e-01	2.17e-01	4.57e-01	2.67e-01	5.93e-01
GOBP NITROGEN CYCLE METABOLIC PROCESS	7	5.49e-01	6.39e-01	0.4870	-3.97e-02	-2.83e-01	2.48e-01	8.29e-02	-1.51e-01	2.53e-01	8.56e-01	1.94e-01	2.57e-01	7.04e-01	4.88e-01	2.46e-01
GOBP UREA CYCLE	7	5.49e-01	6.39e-01	0.4870	-3.97e-02	-2.83e-01	2.48e-01	8.29e-02	-1.51e-01	2.53e-01	8.56e-01	1.94e-01	2.57e-01	7.04e-01	4.88e-01	2.46e-01
GOBP L SERINE BIOSYNTHETIC PROCESS	6	7.45e-01	7.97e-01	0.4870	1.42e-01	-2.60e-02	2.74e-01	7.08e-02	1.30e-02	3.69e-01	5.48e-01	9.12e-01	2.46e-01	7.64e-01	9.56e-01	1.18e-01
GOBP PANTOTHENATE METABOLIC PROCESS	7	6.47e-01	7.19e-01	0.4870	-3.41e-01	-1.61e-01	-1.32e-01	-8.69e-02	-2.62e-01	3.28e-02	1.18e-01	4.62e-01	5.46e-01	6.90e-01	2.30e-01	8.81e-01
GOMF ABC TYPE XENOBIOTIC TRANSPORTER ACTIVITY	11	3.93e-01	5.06e-01	0.4870	2.12e-01	1.06e-01	3.52e-01	3.93e-02	-2.25e-01	6.68e-02	2.23e-01	5.42e-01	4.35e-02	8.21e-01	1.96e-01	7.01e-01
GOCC GEMINI OF COILED BODIES	12	2.22e-01	3.41e-01	0.4860	8.69e-02	-2.44e-01	-2.75e-01	5.14e-02	2.32e-01	-1.93e-01	6.02e-01	1.44e-01	9.85e-02	7.58e-01	1.65e-01	2.46e-01
GOMF ACID AMINO ACID LIGASE ACTIVITY	19	7.83e-02	1.64e-01	0.4860	-1.05e-02	-1.96e-01	-2.56e-01	6.59e-02	2.37e-01	-2.68e-01	9.37e-01	1.40e-01	5.35e-02	6.19e-01	7.35e-02	4.28e-02
GOBP SULFATION	12	7.16e-02	1.54e-01	0.4860	-2.15e-01	-4.29e-02	2.02e-01	1.05e-02	-3.80e-01	-5.38e-02	1.97e-01	7.97e-01	2.25e-01	9.50e-01	2.26e-02	7.47e-01
GOBP PEPTIDYL SERINE DEPHOSPHORYLATION	14	1.84e-01	2.99e-01	0.4860	-3.39e-01	-1.99e-02	2.14e-01	-1.67e-01	-1.82e-01	1.20e-01	2.80e-02	8.97e-01	1.66e-01	2.79e-01	2.38e-01	4.38e-01
GOBP TRNA METHYLATION	40	3.26e-03	1.39e-02	0.4860	-1.39e-01	-3.50e-01	-2.79e-01	-3.86e-02	1.93e-02	-1.22e-01	1.27e-01	1.30e-04	2.24e-03	6.73e-01	8.32e-01	1.83e-01
GOBP REGULATION OF MITOCHONDRIAL TRANSCRIPTION	8	3.19e-01	4.38e-01	0.4860	-1.03e-01	-1.75e-01	-3.33e-01	2.73e-01	-7.04e-02	-6.86e-02	6.13e-01	3.92e-01	1.03e-01	1.81e-01	7.30e-01	7.37e-01
GOCC SPLICEOSOMAL COMPLEX	194	2.42e-23	1.31e-21	0.4860	-1.38e-01	-3.21e-01	-3.03e-01	1.34e-01	5.82e-02	3.26e-02	8.94e-04	1.15e-14	3.52e-13	1.34e-03	1.62e-01	4.33e-01
GOBP REGULATION OF RESPONSE TO TYPE II INTERFERON	13	2.89e-01	4.08e-01	0.4860	2.21e-01	4.07e-02	3.34e-01	2.23e-01	-8.37e-02	1.34e-01	1.68e-01	8.00e-01	3.73e-02	1.65e-01	6.01e-01	4.02e-01
GOCC CHROMATIN SILENCING COMPLEX	13	5.70e-02	1.30e-01	0.4860	-2.15e-01	-1.68e-01	-1.63e-01	3.61e-01	3.54e-02	-5.90e-02	1.79e-01	2.95e-01	3.10e-01	2.42e-02	8.25e-01	7.13e-01
GOBP NEGATIVE REGULATION OF GLIAL CELL PROLIFERATION	14	2.41e-01	3.59e-01	0.4860	4.83e-02	1.85e-01	3.46e-01	2.03e-01	-1.24e-02	1.95e-01	7.54e-01	2.30e-01	2.49e-02	1.88e-01	9.36e-01	2.07e-01
GOMF INSULIN RECEPTOR BINDING	18	1.00e-01	1.96e-01	0.4860	-2.26e-01	9.10e-02	3.01e-01	-8.94e-02	-6.66e-02	2.71e-01	9.76e-02	5.04e-01	2.69e-02	5.11e-01	6.25e-01	4.65e-02
GOMF LONG CHAIN FATTY ACID TRANSMEMBRANE TRANSPORTER ACTIVITY	13	4.10e-01	5.21e-01	0.4860	1.35e-01	1.89e-01	1.36e-01	2.86e-01	2.78e-01	6.31e-02	3.98e-01	2.37e-01	3.94e-01	7.46e-02	8.22e-02	6.94e-01
GOMF NITRIC OXIDE SYNTHASE BINDING	9	4.50e-01	5.57e-01	0.4860	-7.41e-02	1.72e-01	3.65e-01	4.66e-03	-2.06e-01	1.59e-01	7.00e-01	3.73e-01	5.79e-02	9.81e-01	2.85e-01	4.09e-01
GOBP RADIAL GLIA GUIDED PYRAMIDAL NEURON MIGRATION	5	5.76e-01	6.62e-01	0.4850	-4.59e-02	1.83e-01	2.85e-01	2.24e-01	-2.18e-01	1.46e-01	8.59e-01	4.80e-01	2.70e-01	3.85e-01	3.99e-01	5.72e-01
GOBP REGULATION OF VITAMIN METABOLIC PROCESS	11	3.53e-01	4.68e-01	0.4850	1.79e-01	2.80e-01	8.90e-02	-3.06e-03	3.36e-01	-6.32e-02	3.03e-01	1.08e-01	6.09e-01	9.86e-01	5.37e-02	7.17e-01
GOBP DENDRITE ARBORIZATION	7	4.28e-01	5.37e-01	0.4850	-1.21e-02	2.33e-01	3.22e-01	2.39e-01	1.28e-01	6.04e-02	9.56e-01	2.85e-01	1.40e-01	2.73e-01	5.59e-01	7.82e-01
GOBP REGULATION OF PHOSPHATIDYLCHOLINE BIOSYNTHETIC PROCESS	5	4.23e-01	5.32e-01	0.4850	-4.39e-01	7.83e-02	2.79e-03	1.11e-01	-7.05e-02	1.40e-01	8.94e-02	7.62e-01	9.91e-01	6.67e-01	7.85e-01	5.88e-01
GOBP PYRIMIDINE CONTAINING COMPOUND BIOSYNTHETIC PROCESS	38	1.24e-03	6.14e-03	0.4850	-1.50e-01	-4.02e-01	-1.77e-01	8.29e-02	-1.07e-01	4.03e-02	1.09e-01	1.82e-05	5.90e-02	3.76e-01	2.53e-01	6.67e-01
GOBP ASPARTATE FAMILY AMINO ACID BIOSYNTHETIC PROCESS	18	1.09e-01	2.08e-01	0.4850	-1.57e-01	-3.34e-01	-2.72e-01	-1.17e-01	7.97e-02	-6.83e-02	2.50e-01	1.40e-02	4.54e-02	3.92e-01	5.58e-01	6.16e-01
GOBP REGULATION OF ENDOTHELIAL CELL CHEMOTAXIS	11	1.07e-02	3.62e-02	0.4840	-6.74e-02	-2.01e-01	4.26e-01	7.63e-03	-8.98e-02	-3.99e-03	6.99e-01	2.49e-01	1.43e-02	9.65e-01	6.06e-01	9.82e-01
GOMF CARBOXYPEPTIDASE ACTIVITY	30	9.07e-03	3.17e-02	0.4840	-3.01e-01	-2.44e-01	-8.80e-03	-2.76e-01	-3.54e-02	8.39e-02	4.28e-03	2.06e-02	9.34e-01	9.00e-03	7.38e-01	4.27e-01
GOBP RESPONSE TO TESTOSTERONE	32	1.69e-02	5.20e-02	0.4840	-5.11e-02	-4.50e-02	3.50e-01	-9.44e-02	-1.83e-01	2.55e-01	6.17e-01	6.60e-01	6.20e-04	3.55e-01	7.28e-02	1.24e-02
GOBP SPHINGOLIPID MEDIATED SIGNALING PATHWAY	16	1.71e-01	2.84e-01	0.4840	1.84e-01	-4.32e-03	1.21e-01	3.99e-01	8.87e-02	1.39e-01	2.03e-01	9.76e-01	4.02e-01	5.78e-03	5.39e-01	3.36e-01
GOMF ACYL COA OXIDASE ACTIVITY	7	6.70e-01	7.37e-01	0.4840	-1.45e-01	-2.15e-01	1.98e-01	6.93e-02	-1.64e-01	3.10e-01	5.05e-01	3.25e-01	3.64e-01	7.51e-01	4.52e-01	1.56e-01
GOBP LIPOPROTEIN CATABOLIC PROCESS	13	8.24e-02	1.70e-01	0.4840	-1.88e-01	-2.74e-01	5.80e-02	8.12e-02	1.35e-01	3.09e-01	2.41e-01	8.74e-02	7.17e-01	6.12e-01	3.98e-01	5.33e-02
GOBP NEGATIVE REGULATION OF GLIAL CELL DIFFERENTIATION	15	1.42e-01	2.51e-01	0.4840	1.82e-01	3.11e-01	2.55e-01	4.86e-02	1.57e-01	-1.09e-01	2.21e-01	3.68e-02	8.67e-02	7.45e-01	2.93e-01	4.64e-01
GOBP POSITIVE REGULATION OF CAMP MEDIATED SIGNALING	6	8.25e-01	8.59e-01	0.4840	2.73e-01	2.55e-01	-1.74e-03	5.95e-02	2.54e-01	-1.63e-01	2.47e-01	2.80e-01	9.94e-01	8.01e-01	2.81e-01	4.90e-01
GOBP B CELL LINEAGE COMMITMENT	5	8.43e-01	8.72e-01	0.4840	3.71e-01	1.45e-01	-3.78e-03	2.25e-01	2.48e-02	-1.55e-01	1.51e-01	5.75e-01	9.88e-01	3.83e-01	9.24e-01	5.49e-01
GOBP T CELL TOLERANCE INDUCTION	14	1.48e-01	2.58e-01	0.4840	1.13e-01	3.54e-02	2.01e-01	4.51e-02	-2.65e-01	3.27e-01	4.63e-01	8.19e-01	1.93e-01	7.70e-01	8.55e-02	3.42e-02
GOCC TERTIARY GRANULE LUMEN	51	3.29e-04	1.95e-03	0.4840	-1.88e-01	-6.03e-02	2.65e-01	-9.06e-02	-2.78e-01	1.98e-01	1.99e-02	4.56e-01	1.07e-03	2.63e-01	6.03e-04	1.43e-02
GOBP CENTRIOLE ELONGATION	8	2.99e-01	4.18e-01	0.4840	-3.90e-02	2.81e-01	-5.62e-02	1.42e-01	2.02e-01	2.99e-01	8.49e-01	1.69e-01	7.83e-01	4.88e-01	3.22e-01	1.43e-01
GOBP VAGINA DEVELOPMENT	7	2.57e-01	3.77e-01	0.4840	-3.14e-01	-2.16e-01	2.11e-01	-1.12e-01	8.38e-02	1.58e-01	1.51e-01	3.23e-01	3.35e-01	6.07e-01	7.01e-01	4.70e-01
GOBP ASTROCYTE DEVELOPMENT	31	7.99e-05	5.55e-04	0.4830	-2.08e-01	1.38e-01	3.01e-01	-2.59e-01	-9.83e-02	-6.58e-02	4.48e-02	1.82e-01	3.77e-03	1.27e-02	3.43e-01	5.26e-01
GOMF CHROMO SHADOW DOMAIN BINDING	6	5.90e-01	6.73e-01	0.4830	-2.50e-01	8.65e-02	2.21e-01	1.24e-01	7.46e-02	3.06e-01	2.89e-01	7.14e-01	3.49e-01	5.99e-01	7.52e-01	1.94e-01
GOBP AMELOGENESIS	16	1.70e-01	2.83e-01	0.4830	1.55e-01	2.81e-01	3.33e-01	1.37e-01	-1.73e-02	2.72e-02	2.83e-01	5.18e-02	2.12e-02	3.43e-01	9.04e-01	8.51e-01
GOBP NEGATIVE REGULATION OF MEIOTIC CELL CYCLE	11	3.29e-01	4.47e-01	0.4830	1.37e-01	-1.14e-01	1.91e-01	1.78e-01	-1.30e-01	3.42e-01	4.32e-01	5.14e-01	2.73e-01	3.07e-01	4.54e-01	4.98e-02
GOMF TYPE II TRANSFORMING GROWTH FACTOR BETA RECEPTOR BINDING	11	4.32e-01	5.41e-01	0.4830	9.79e-03	3.24e-01	1.18e-01	1.06e-01	2.82e-01	1.54e-01	9.55e-01	6.27e-02	4.98e-01	5.44e-01	1.05e-01	3.78e-01
GOBP REGULATION OF ATTACHMENT OF SPINDLE MICROTUBULES TO KINETOCHORE	22	4.31e-03	1.74e-02	0.4830	-1.28e-01	-1.90e-01	2.04e-01	2.85e-01	-1.03e-01	2.18e-01	2.99e-01	1.22e-01	9.82e-02	2.06e-02	4.05e-01	7.73e-02
GOBP RESPONSE TO L PHENYLALANINE DERIVATIVE	5	7.03e-01	7.64e-01	0.4830	-3.79e-01	-1.27e-01	1.69e-01	-1.86e-01	-6.16e-02	7.94e-02	1.42e-01	6.24e-01	5.13e-01	4.72e-01	8.12e-01	7.59e-01
GOBP C21 STEROID HORMONE BIOSYNTHETIC PROCESS	13	3.44e-01	4.61e-01	0.4830	2.61e-01	2.31e-02	2.98e-01	1.64e-01	-1.26e-01	1.81e-01	1.03e-01	8.85e-01	6.27e-02	3.05e-01	4.31e-01	2.59e-01
GOBP NEGATIVE REGULATION OF RIG I SIGNALING PATHWAY	8	3.75e-01	4.90e-01	0.4830	-1.34e-01	-3.95e-01	-8.04e-02	2.06e-01	-4.72e-02	-9.02e-02	5.10e-01	5.32e-02	6.94e-01	3.14e-01	8.17e-01	6.59e-01
GOBP POSITIVE REGULATION OF MUSCLE TISSUE DEVELOPMENT	15	1.48e-01	2.59e-01	0.4830	1.85e-01	3.68e-01	1.15e-01	-1.41e-02	1.01e-01	1.99e-01	2.14e-01	1.37e-02	4.39e-01	9.25e-01	4.97e-01	1.82e-01
GOBP DIGESTIVE TRACT MORPHOGENESIS	23	9.72e-02	1.92e-01	0.4830	5.28e-02	2.86e-01	3.21e-01	5.39e-02	5.56e-02	1.98e-01	6.61e-01	1.76e-02	7.68e-03	6.55e-01	6.45e-01	1.00e-01
GOBP REGULATION OF GAMMA DELTA T CELL ACTIVATION	11	2.11e-01	3.28e-01	0.4820	-1.32e-01	3.78e-01	1.16e-01	1.44e-02	2.35e-01	6.25e-02	4.50e-01	3.01e-02	5.05e-01	9.34e-01	1.77e-01	7.20e-01
GOCC CATION TRANSPORTING ATPASE COMPLEX	11	4.86e-01	5.86e-01	0.4820	3.86e-02	1.37e-01	3.60e-01	1.18e-01	2.82e-02	2.62e-01	8.25e-01	4.30e-01	3.89e-02	5.00e-01	8.72e-01	1.33e-01
GOBP SINGLE STRAND BREAK REPAIR	10	3.08e-01	4.28e-01	0.4820	-9.02e-02	1.08e-01	-1.95e-01	1.57e-01	3.55e-01	1.54e-01	6.21e-01	5.54e-01	2.86e-01	3.89e-01	5.16e-02	3.98e-01
GOCC NODE OF RANVIER	10	6.01e-01	6.81e-01	0.4820	2.31e-01	1.21e-01	3.52e-01	7.25e-02	-8.06e-02	1.70e-01	2.06e-01	5.07e-01	5.38e-02	6.91e-01	6.59e-01	3.53e-01
GOBP ENDOSOMAL VESICLE FUSION	15	1.90e-02	5.68e-02	0.4820	-2.40e-01	-1.84e-01	-7.61e-02	3.58e-01	8.06e-02	-2.52e-02	1.08e-01	2.17e-01	6.10e-01	1.63e-02	5.89e-01	8.66e-01
GOCC EXON EXON JUNCTION COMPLEX	20	2.60e-02	7.24e-02	0.4820	1.05e-01	-1.70e-01	-2.22e-01	3.53e-01	1.12e-01	7.61e-02	4.15e-01	1.87e-01	8.60e-02	6.23e-03	3.85e-01	5.56e-01
GOBP POSITIVE REGULATION OF INTEGRIN ACTIVATION	6	6.48e-01	7.21e-01	0.4820	-2.75e-01	-3.67e-01	-4.94e-02	-8.20e-02	3.29e-02	1.08e-01	2.44e-01	1.19e-01	8.34e-01	7.28e-01	8.89e-01	6.47e-01
GOBP NEURONAL ACTION POTENTIAL PROPAGATION	6	8.11e-01	8.48e-01	0.4820	-1.59e-01	-2.18e-01	-2.34e-01	-2.41e-01	-2.11e-01	-5.29e-02	5.01e-01	3.55e-01	3.22e-01	3.07e-01	3.71e-01	8.22e-01
GOMF PROTEIN PHOSPHORYLATED AMINO ACID BINDING	57	7.29e-06	6.37e-05	0.4820	-3.53e-02	9.36e-02	3.36e-01	1.86e-01	-5.25e-02	2.68e-01	6.45e-01	2.22e-01	1.13e-05	1.53e-02	4.93e-01	4.54e-04
GOBP ENDOCARDIUM DEVELOPMENT	7	5.66e-01	6.54e-01	0.4820	-3.00e-01	1.55e-01	2.28e-01	-1.71e-01	-1.71e-02	1.93e-01	1.70e-01	4.77e-01	2.97e-01	4.33e-01	9.38e-01	3.78e-01
GOMF MHC CLASS IB PROTEIN BINDING	8	4.24e-01	5.33e-01	0.4820	7.63e-02	1.25e-01	2.06e-01	7.06e-02	-2.80e-01	2.92e-01	7.09e-01	5.40e-01	3.14e-01	7.29e-01	1.70e-01	1.53e-01
GOBP ZYMOGEN INHIBITION	7	4.63e-01	5.67e-01	0.4820	-9.11e-02	5.43e-03	-5.29e-02	1.03e-01	3.75e-01	2.65e-01	6.76e-01	9.80e-01	8.09e-01	6.38e-01	8.58e-02	2.25e-01
GOMF PEPTIDOGLYCAN BINDING	11	1.88e-01	3.04e-01	0.4820	-3.22e-02	8.81e-02	4.25e-01	3.60e-03	-1.98e-01	5.69e-02	8.53e-01	6.13e-01	1.46e-02	9.83e-01	2.55e-01	7.44e-01
GOBP TELOMERE MAINTENANCE IN RESPONSE TO DNA DAMAGE	33	2.18e-03	9.89e-03	0.4820	-1.29e-01	-2.64e-01	-2.45e-01	2.55e-01	3.82e-02	-1.38e-01	1.99e-01	8.69e-03	1.47e-02	1.11e-02	7.04e-01	1.72e-01
GOBP EPITHELIAL TUBE BRANCHING INVOLVED IN LUNG MORPHOGENESIS	17	2.14e-02	6.25e-02	0.4820	7.35e-02	2.14e-01	2.80e-01	-2.23e-01	-1.06e-01	-2.04e-01	6.00e-01	1.26e-01	4.58e-02	1.12e-01	4.49e-01	1.46e-01
GOBP PUTRESCINE BIOSYNTHETIC PROCESS	5	6.98e-01	7.60e-01	0.4820	-7.16e-02	-1.93e-01	1.38e-01	1.27e-01	1.07e-01	3.78e-01	7.82e-01	4.54e-01	5.93e-01	6.22e-01	6.78e-01	1.43e-01
GOBP REGULATION OF DENDRITIC SPINE MAINTENANCE	10	4.67e-01	5.70e-01	0.4820	-2.43e-02	2.03e-01	3.43e-01	9.41e-02	-1.08e-01	2.28e-01	8.94e-01	2.67e-01	6.01e-02	6.06e-01	5.54e-01	2.12e-01
GOCC TRANSCRIPTION FACTOR TFIID COMPLEX	32	5.38e-03	2.08e-02	0.4810	-3.30e-01	-3.07e-01	-6.20e-02	-7.06e-02	-9.48e-03	1.41e-01	1.23e-03	2.67e-03	5.44e-01	4.89e-01	9.26e-01	1.69e-01
GOCC NUCLEAR INCLUSION BODY	12	1.25e-01	2.30e-01	0.4810	-7.28e-02	3.35e-01	1.03e-01	2.58e-01	1.23e-01	1.49e-01	6.62e-01	4.48e-02	5.36e-01	1.21e-01	4.62e-01	3.72e-01
GOBP NEGATIVE REGULATION OF HEMOPOIESIS	87	4.82e-07	5.34e-06	0.4810	1.06e-01	1.77e-01	3.70e-01	4.25e-02	-1.33e-01	1.82e-01	8.64e-02	4.38e-03	2.47e-09	4.93e-01	3.23e-02	3.36e-03
GOBP NEGATIVE REGULATION OF CALCIUM ION TRANSMEMBRANE TRANSPORT	32	2.49e-02	6.98e-02	0.4810	-1.76e-01	-2.93e-01	5.40e-02	-1.05e-01	-2.50e-01	1.95e-01	8.43e-02	4.06e-03	5.97e-01	3.04e-01	1.43e-02	5.63e-02
GOBP LONG CHAIN FATTY ACYL COA BIOSYNTHETIC PROCESS	17	2.83e-01	4.03e-01	0.4810	-1.68e-01	-5.39e-03	2.56e-01	-1.87e-01	-2.64e-01	1.83e-01	2.32e-01	9.69e-01	6.78e-02	1.83e-01	5.94e-02	1.92e-01
GOBP POSITIVE REGULATION OF ALCOHOL BIOSYNTHETIC PROCESS	16	3.39e-02	8.79e-02	0.4810	-9.05e-02	-1.26e-01	3.59e-01	1.48e-01	-1.74e-01	1.62e-01	5.31e-01	3.84e-01	1.28e-02	3.05e-01	2.29e-01	2.61e-01
GOBP NEGATIVE REGULATION OF TRIGLYCERIDE METABOLIC PROCESS	11	1.75e-01	2.89e-01	0.4810	5.19e-02	1.94e-01	4.13e-01	1.37e-01	-1.65e-02	4.00e-02	7.66e-01	2.66e-01	1.76e-02	4.33e-01	9.25e-01	8.18e-01
GOBP DORSAL VENTRAL AXIS SPECIFICATION	10	2.69e-01	3.89e-01	0.4810	-8.94e-02	4.06e-01	1.47e-01	-1.86e-01	3.91e-02	2.83e-02	6.24e-01	2.61e-02	4.21e-01	3.09e-01	8.30e-01	8.77e-01
GOBP REGULATION OF DNA STRAND ELONGATION	17	6.46e-02	1.43e-01	0.4810	-1.38e-01	-2.37e-01	-2.16e-01	3.17e-01	7.42e-02	-6.10e-02	3.25e-01	9.06e-02	1.24e-01	2.35e-02	5.97e-01	6.63e-01
GOBP GRANULOCYTE DIFFERENTIATION	35	7.13e-05	5.02e-04	0.4810	-1.13e-01	1.53e-02	3.43e-01	2.19e-01	-2.55e-02	2.29e-01	2.49e-01	8.75e-01	4.43e-04	2.51e-02	7.94e-01	1.91e-02
GOBP LABYRINTHINE LAYER DEVELOPMENT	32	8.80e-04	4.57e-03	0.4810	-1.23e-01	8.90e-02	3.97e-01	3.94e-02	-1.23e-01	1.84e-01	2.29e-01	3.84e-01	1.00e-04	6.99e-01	2.27e-01	7.17e-02
GOBP PLATELET ACTIVATION	115	2.54e-12	5.46e-11	0.4810	-7.08e-02	-1.74e-01	3.09e-01	1.92e-02	-2.10e-01	2.36e-01	1.90e-01	1.25e-03	9.90e-09	7.22e-01	1.02e-04	1.20e-05
GOBP POSITIVE REGULATION OF CD8 POSITIVE ALPHA BETA T CELL ACTIVATION	8	1.46e-01	2.56e-01	0.4810	4.08e-03	1.44e-01	1.33e-01	1.16e-01	-4.00e-01	1.38e-01	9.84e-01	4.79e-01	5.14e-01	5.70e-01	4.99e-02	5.00e-01
GOBP AUDITORY RECEPTOR CELL MORPHOGENESIS	15	1.79e-01	2.94e-01	0.4810	2.57e-03	1.44e-01	-1.98e-01	5.43e-02	1.25e-01	-3.91e-01	9.86e-01	3.35e-01	1.85e-01	7.16e-01	4.03e-01	8.71e-03
GOMF METALLODIPEPTIDASE ACTIVITY	6	8.46e-01	8.75e-01	0.4810	-2.88e-01	-2.07e-01	-5.83e-02	-3.07e-01	-9.00e-02	4.72e-03	2.22e-01	3.81e-01	8.05e-01	1.93e-01	7.03e-01	9.84e-01
GOBP IRE1 MEDIATED UNFOLDED PROTEIN RESPONSE	19	4.77e-03	1.89e-02	0.4810	-2.60e-01	-9.28e-02	9.06e-03	1.31e-01	-2.99e-01	2.19e-01	4.98e-02	4.84e-01	9.45e-01	3.21e-01	2.40e-02	9.80e-02
GOBP HYPEROSMOTIC SALINITY RESPONSE	9	9.11e-02	1.83e-01	0.4800	-3.17e-01	-1.91e-01	1.17e-01	2.03e-02	2.39e-01	1.50e-01	9.95e-02	3.20e-01	5.42e-01	9.16e-01	2.15e-01	4.36e-01
GOBP POSITIVE REGULATION OF PROTEIN KINASE A SIGNALING	6	8.79e-01	9.01e-01	0.4800	2.09e-01	2.16e-01	1.04e-01	1.91e-01	2.96e-01	7.52e-02	3.76e-01	3.58e-01	6.60e-01	4.18e-01	2.10e-01	7.50e-01
GOBP REGULATION OF T HELPER 2 CELL DIFFERENTIATION	12	2.30e-01	3.49e-01	0.4800	-3.32e-01	3.00e-02	2.06e-01	-1.63e-01	-2.13e-01	7.10e-02	4.63e-02	8.57e-01	2.17e-01	3.28e-01	2.01e-01	6.70e-01
GOBP PYRIMIDINE NUCLEOSIDE MONOPHOSPHATE BIOSYNTHETIC PROCESS	14	1.93e-01	3.09e-01	0.4800	-1.28e-01	-4.09e-01	-6.36e-02	8.09e-02	-1.87e-01	-4.18e-02	4.07e-01	8.07e-03	6.81e-01	6.00e-01	2.27e-01	7.86e-01
GOBP COLUMNAR CUBOIDAL EPITHELIAL CELL MATURATION	10	4.51e-01	5.57e-01	0.4800	4.42e-02	-3.79e-02	3.74e-01	5.00e-02	-2.37e-01	1.69e-01	8.09e-01	8.36e-01	4.03e-02	7.84e-01	1.95e-01	3.55e-01
GOBP PURINE NUCLEOSIDE MONOPHOSPHATE CATABOLIC PROCESS	10	4.37e-01	5.45e-01	0.4800	1.60e-01	1.48e-02	3.27e-01	1.12e-02	3.48e-02	3.11e-01	3.82e-01	9.36e-01	7.36e-02	9.51e-01	8.49e-01	8.83e-02
GOBP RANDOM INACTIVATION OF X CHROMOSOME	8	1.31e-01	2.38e-01	0.4800	-3.70e-01	8.07e-02	1.96e-01	1.44e-01	-1.24e-01	1.14e-01	7.02e-02	6.93e-01	3.38e-01	4.81e-01	5.44e-01	5.75e-01
GOMF INTRAMEMBRANE LIPID TRANSPORTER ACTIVITY	35	3.90e-03	1.60e-02	0.4800	9.75e-02	2.64e-01	1.58e-01	3.06e-01	9.60e-02	1.54e-01	3.18e-01	6.82e-03	1.07e-01	1.74e-03	3.26e-01	1.16e-01
GOBP GROOMING BEHAVIOR	8	2.46e-01	3.65e-01	0.4800	-1.29e-01	-4.27e-01	4.14e-02	1.81e-02	-9.89e-02	-1.40e-01	5.26e-01	3.65e-02	8.39e-01	9.29e-01	6.28e-01	4.94e-01
GOBP IMMATURE B CELL DIFFERENTIATION	11	2.57e-02	7.18e-02	0.4800	-2.30e-01	3.50e-01	8.10e-02	2.10e-01	2.31e-02	6.25e-02	1.87e-01	4.47e-02	6.42e-01	2.27e-01	8.94e-01	7.20e-01
GOBP NEGATIVE REGULATION OF HYDROGEN PEROXIDE METABOLIC PROCESS	5	6.97e-01	7.60e-01	0.4800	6.69e-02	-2.25e-01	2.27e-01	2.51e-01	-1.97e-01	1.46e-01	7.95e-01	3.83e-01	3.79e-01	3.31e-01	4.46e-01	5.71e-01
GOBP MRNA CIS SPLICING VIA SPLICEOSOME	29	1.63e-02	5.06e-02	0.4800	-9.80e-02	-1.99e-01	-3.92e-01	9.35e-02	4.94e-02	-1.25e-01	3.61e-01	6.39e-02	2.55e-04	3.83e-01	6.45e-01	2.43e-01
GOBP URATE METABOLIC PROCESS	7	7.28e-01	7.83e-01	0.4790	1.68e-01	2.46e-01	2.66e-01	-1.08e-01	-1.09e-01	2.16e-01	4.41e-01	2.59e-01	2.23e-01	6.21e-01	6.18e-01	3.23e-01
GOBP REGULATION OF NUCLEASE ACTIVITY	21	5.98e-03	2.27e-02	0.4790	-1.05e-01	-2.76e-01	-2.42e-01	1.79e-01	3.16e-03	2.28e-01	4.07e-01	2.85e-02	5.45e-02	1.56e-01	9.80e-01	7.10e-02
GOBP SKIN MORPHOGENESIS	8	3.08e-01	4.29e-01	0.4790	-7.10e-02	7.87e-02	2.38e-01	3.34e-01	-9.72e-02	2.02e-01	7.28e-01	7.00e-01	2.43e-01	1.02e-01	6.34e-01	3.23e-01
GOMF INOSITOL TRISPHOSPHATE PHOSPHATASE ACTIVITY	12	3.34e-01	4.51e-01	0.4790	1.23e-01	2.19e-01	1.73e-01	3.27e-01	1.72e-01	-1.10e-02	4.59e-01	1.89e-01	2.98e-01	4.99e-02	3.03e-01	9.47e-01
GOBP ENAMEL MINERALIZATION	12	2.69e-01	3.89e-01	0.4790	5.30e-02	1.78e-01	3.85e-01	1.40e-01	-1.12e-01	1.22e-01	7.50e-01	2.85e-01	2.10e-02	4.00e-01	5.03e-01	4.66e-01
GOBP UTP METABOLIC PROCESS	10	2.05e-01	3.22e-01	0.4790	-1.37e-01	-4.01e-01	-2.85e-02	4.02e-02	6.51e-02	2.07e-01	4.54e-01	2.79e-02	8.76e-01	8.26e-01	7.22e-01	2.57e-01
GOCC HFE TRANSFERRIN RECEPTOR COMPLEX	6	2.74e-01	3.94e-01	0.4790	5.70e-02	3.35e-01	-1.78e-01	-2.31e-01	-1.22e-01	-1.18e-01	8.09e-01	1.55e-01	4.49e-01	3.28e-01	6.04e-01	6.18e-01
GOBP ENDOPLASMIC RETICULUM LOCALIZATION	7	4.44e-01	5.51e-01	0.4790	-1.24e-01	-1.94e-01	-1.15e-01	3.55e-01	3.13e-02	1.90e-01	5.70e-01	3.75e-01	5.97e-01	1.04e-01	8.86e-01	3.84e-01
GOBP MITOTIC SISTER CHROMATID SEPARATION	62	1.96e-08	2.66e-07	0.4790	1.32e-01	-2.60e-01	7.17e-02	2.80e-01	-1.86e-02	2.45e-01	7.31e-02	3.91e-04	3.29e-01	1.36e-04	8.00e-01	8.38e-04
GOBP REGULATION OF AUTOPHAGOSOME MATURATION	17	1.54e-03	7.33e-03	0.4790	-1.16e-01	-6.63e-02	-4.68e-02	4.36e-01	-1.28e-01	-5.11e-02	4.09e-01	6.36e-01	7.38e-01	1.86e-03	3.59e-01	7.15e-01
GOBP SYNAPTIC VESICLE DOCKING	6	6.24e-01	7.01e-01	0.4790	-2.47e-01	-1.56e-01	-1.94e-01	2.37e-01	2.15e-01	-6.37e-02	2.95e-01	5.08e-01	4.12e-01	3.15e-01	3.62e-01	7.87e-01
GOBP IMP BIOSYNTHETIC PROCESS	10	3.41e-01	4.58e-01	0.4790	-6.82e-02	-3.16e-01	-1.91e-01	2.39e-01	1.67e-01	-5.53e-02	7.09e-01	8.34e-02	2.96e-01	1.91e-01	3.61e-01	7.62e-01
GOBP CELL DIFFERENTIATION INVOLVED IN EMBRYONIC PLACENTA DEVELOPMENT	15	7.05e-02	1.52e-01	0.4790	-1.27e-01	2.51e-02	3.95e-01	-1.13e-01	-2.01e-01	5.57e-02	3.95e-01	8.66e-01	8.06e-03	4.50e-01	1.78e-01	7.09e-01
GOBP POSITIVE REGULATION OF CELL CYCLE CHECKPOINT	18	2.68e-02	7.37e-02	0.4780	8.35e-02	-1.97e-01	3.57e-02	4.09e-01	-6.07e-02	1.04e-01	5.40e-01	1.48e-01	7.93e-01	2.65e-03	6.56e-01	4.47e-01
GOCC DNA DEPENDENT PROTEIN KINASE COMPLEX	5	6.27e-01	7.04e-01	0.4780	1.37e-02	-1.27e-01	-1.12e-01	4.11e-01	4.85e-04	1.77e-01	9.58e-01	6.23e-01	6.65e-01	1.12e-01	9.99e-01	4.92e-01
GOBP POSITIVE REGULATION OF NATURAL KILLER CELL DIFFERENTIATION	8	5.01e-01	5.98e-01	0.4780	3.78e-02	2.29e-01	-6.27e-02	2.70e-02	3.88e-01	1.42e-01	8.53e-01	2.62e-01	7.59e-01	8.95e-01	5.77e-02	4.87e-01
GOBP CARDIAC MUSCLE CELL CONTRACTION	55	3.88e-04	2.25e-03	0.4780	-3.23e-02	1.42e-01	3.43e-01	-1.34e-01	-1.72e-01	2.07e-01	6.79e-01	6.89e-02	1.09e-05	8.65e-02	2.76e-02	8.02e-03
GOCC INO80 COMPLEX	16	6.05e-02	1.36e-01	0.4780	-1.64e-02	-1.96e-01	-1.59e-01	3.65e-01	1.70e-02	-1.76e-01	9.10e-01	1.75e-01	2.69e-01	1.14e-02	9.06e-01	2.22e-01
GOBP OLFACTORY LOBE DEVELOPMENT	21	4.71e-02	1.12e-01	0.4780	-1.34e-01	2.44e-01	2.26e-01	-2.16e-03	-4.49e-03	3.17e-01	2.89e-01	5.33e-02	7.24e-02	9.86e-01	9.72e-01	1.20e-02
GOBP REGULATION OF ASPARTIC TYPE PEPTIDASE ACTIVITY	7	5.37e-01	6.28e-01	0.4780	2.37e-01	2.02e-01	2.40e-02	1.82e-01	-4.64e-02	-3.09e-01	2.78e-01	3.54e-01	9.12e-01	4.05e-01	8.32e-01	1.56e-01
GOBP NEGATIVE REGULATION OF ENDOPLASMIC RETICULUM CALCIUM ION CONCENTRATION	6	6.69e-01	7.36e-01	0.4780	2.87e-01	-8.53e-03	2.63e-01	2.35e-01	1.26e-01	7.63e-02	2.24e-01	9.71e-01	2.65e-01	3.18e-01	5.92e-01	7.46e-01
GOBP REGULATION OF PLATELET DERIVED GROWTH FACTOR RECEPTOR BETA SIGNALING PATHWAY	7	2.57e-01	3.77e-01	0.4780	-1.58e-01	1.38e-01	3.15e-01	1.95e-01	1.88e-01	1.07e-01	4.69e-01	5.27e-01	1.49e-01	3.71e-01	3.88e-01	6.25e-01
GOBP MISMATCH REPAIR	33	1.07e-02	3.63e-02	0.4780	-2.28e-02	-2.65e-01	-3.25e-01	1.57e-01	9.58e-02	-1.37e-01	8.21e-01	8.52e-03	1.25e-03	1.19e-01	3.41e-01	1.73e-01
GOCC PROTON TRANSPORTING V TYPE ATPASE COMPLEX	24	1.40e-02	4.49e-02	0.4780	-2.87e-01	-2.77e-01	1.36e-01	2.49e-02	-1.81e-01	1.32e-01	1.50e-02	1.90e-02	2.47e-01	8.33e-01	1.25e-01	2.62e-01
GOBP NEGATIVE REGULATION OF G0 TO G1 TRANSITION	5	6.01e-01	6.82e-01	0.4780	-3.22e-01	-5.38e-02	2.37e-01	-1.96e-01	-1.52e-01	-6.20e-02	2.12e-01	8.35e-01	3.58e-01	4.49e-01	5.56e-01	8.10e-01
GOBP INTERFERON ALPHA PRODUCTION	27	2.75e-03	1.20e-02	0.4780	-1.68e-01	2.42e-01	1.37e-01	1.65e-01	1.66e-01	2.60e-01	1.30e-01	2.94e-02	2.17e-01	1.38e-01	1.36e-01	1.94e-02
GOBP INTERMEDIATE FILAMENT BUNDLE ASSEMBLY	5	3.93e-01	5.06e-01	0.4780	5.84e-02	9.96e-02	-1.94e-02	-3.92e-01	1.42e-01	2.00e-01	8.21e-01	7.00e-01	9.40e-01	1.29e-01	5.82e-01	4.38e-01
GOBP ENDOTHELIAL CELL MATRIX ADHESION	5	7.28e-01	7.83e-01	0.4770	9.42e-02	-3.43e-01	-1.16e-01	2.73e-02	-1.11e-01	-2.73e-01	7.15e-01	1.84e-01	6.54e-01	9.16e-01	6.68e-01	2.90e-01
GOBP POSITIVE REGULATION OF ENDOTHELIAL CELL MATRIX ADHESION VIA FIBRONECTIN	5	7.28e-01	7.83e-01	0.4770	9.42e-02	-3.43e-01	-1.16e-01	2.73e-02	-1.11e-01	-2.73e-01	7.15e-01	1.84e-01	6.54e-01	9.16e-01	6.68e-01	2.90e-01
GOMF GALACTOSIDE BINDING	7	5.68e-01	6.56e-01	0.4770	-3.45e-02	4.22e-02	1.48e-01	2.91e-01	2.74e-01	2.08e-01	8.74e-01	8.47e-01	4.98e-01	1.83e-01	2.09e-01	3.40e-01
GOBP PHOSPHATIDYLETHANOLAMINE BIOSYNTHETIC PROCESS	10	6.46e-01	7.19e-01	0.4770	-2.51e-01	-1.21e-01	-2.63e-01	-2.05e-01	2.07e-02	-1.95e-01	1.69e-01	5.08e-01	1.49e-01	2.61e-01	9.10e-01	2.85e-01
GOBP CD8 POSITIVE ALPHA BETA T CELL PROLIFERATION	8	7.03e-01	7.64e-01	0.4770	-5.74e-02	-1.89e-01	-2.35e-01	-4.91e-02	-1.20e-01	-3.42e-01	7.79e-01	3.54e-01	2.49e-01	8.10e-01	5.58e-01	9.44e-02
GOBP ATRIAL SEPTUM DEVELOPMENT	12	2.55e-01	3.74e-01	0.4770	-2.06e-01	-2.09e-01	2.32e-01	-1.78e-01	-2.35e-01	1.99e-02	2.16e-01	2.10e-01	1.63e-01	2.85e-01	1.58e-01	9.05e-01
GOMF OXIDOREDUCTASE ACTIVITY ACTING ON THE ALDEHYDE OR OXO GROUP OF DONORS	36	5.86e-03	2.24e-02	0.4770	-3.53e-01	-2.30e-01	-1.79e-01	-9.29e-02	-7.63e-03	9.79e-02	2.49e-04	1.70e-02	6.26e-02	3.35e-01	9.37e-01	3.09e-01
GOBP RNA MODIFICATION	163	4.82e-16	1.43e-14	0.4770	-9.73e-02	-3.34e-01	-3.14e-01	4.92e-02	3.09e-02	-6.78e-02	3.22e-02	1.87e-13	4.28e-12	2.79e-01	4.96e-01	1.35e-01
GOBP NEUTROPHIL ACTIVATION INVOLVED IN IMMUNE RESPONSE	20	3.80e-02	9.59e-02	0.4770	-8.72e-02	2.05e-01	3.61e-01	9.48e-02	2.96e-03	1.96e-01	5.00e-01	1.13e-01	5.15e-03	4.63e-01	9.82e-01	1.29e-01
GOBP POLY N ACETYLLACTOSAMINE METABOLIC PROCESS	7	7.29e-01	7.84e-01	0.4770	2.69e-01	1.50e-01	2.56e-01	2.55e-01	-3.63e-02	2.03e-02	2.17e-01	4.92e-01	2.41e-01	2.42e-01	8.68e-01	9.26e-01
GOBP RENAL WATER ABSORPTION	5	5.48e-01	6.38e-01	0.4770	-2.83e-02	-1.74e-01	-2.89e-02	1.15e-01	-1.19e-01	-4.10e-01	9.13e-01	4.99e-01	9.11e-01	6.57e-01	6.46e-01	1.12e-01
GOBP ENDOTHELIAL CELL ACTIVATION	8	7.00e-01	7.61e-01	0.4770	-2.63e-01	-3.16e-01	-1.46e-01	-9.78e-02	-9.93e-02	1.33e-01	1.98e-01	1.22e-01	4.74e-01	6.32e-01	6.27e-01	5.14e-01
GOCC ENDOLYSOSOME	28	9.81e-04	5.00e-03	0.4770	-5.50e-02	1.06e-01	1.37e-01	3.99e-01	1.25e-01	1.41e-01	6.15e-01	3.34e-01	2.09e-01	2.60e-04	2.53e-01	1.97e-01
GOBP NEGATIVE REGULATION OF SYSTEMIC ARTERIAL BLOOD PRESSURE	15	1.10e-01	2.09e-01	0.4770	-5.63e-02	2.19e-01	-1.10e-01	-1.43e-01	1.69e-01	-3.39e-01	7.06e-01	1.42e-01	4.62e-01	3.38e-01	2.57e-01	2.29e-02
GOBP NEGATIVE REGULATION OF REACTIVE OXYGEN SPECIES BIOSYNTHETIC PROCESS	14	1.62e-01	2.74e-01	0.4770	-1.10e-01	-2.94e-01	-1.10e-02	9.44e-02	-2.62e-01	2.25e-01	4.78e-01	5.65e-02	9.43e-01	5.41e-01	8.94e-02	1.44e-01
GOCC FEMALE GERM CELL NUCLEUS	10	4.32e-01	5.40e-01	0.4770	-8.56e-02	1.43e-01	-2.55e-01	1.26e-01	3.44e-01	-2.33e-02	6.39e-01	4.35e-01	1.63e-01	4.92e-01	5.96e-02	8.98e-01
GOCC XY BODY	13	1.21e-01	2.26e-01	0.4770	-2.47e-01	-1.29e-01	-1.24e-02	1.54e-01	-2.62e-02	3.53e-01	1.22e-01	4.20e-01	9.38e-01	3.36e-01	8.70e-01	2.76e-02
GOBP POSITIVE REGULATION OF MEGAKARYOCYTE DIFFERENTIATION	10	4.01e-01	5.12e-01	0.4770	-2.25e-01	-2.32e-01	4.93e-02	-4.45e-02	-2.36e-02	3.42e-01	2.17e-01	2.03e-01	7.87e-01	8.08e-01	8.97e-01	6.08e-02
GOBP REGULATION OF NATURAL KILLER CELL DIFFERENTIATION	13	3.16e-01	4.36e-01	0.4760	2.39e-01	2.76e-01	2.25e-01	-6.72e-02	1.64e-01	1.08e-01	1.36e-01	8.51e-02	1.60e-01	6.75e-01	3.07e-01	5.00e-01
GOBP REGULATION OF EXECUTION PHASE OF APOPTOSIS	17	4.05e-02	1.00e-01	0.4760	1.29e-01	9.80e-02	1.72e-01	3.76e-01	-1.18e-01	1.25e-01	3.56e-01	4.84e-01	2.20e-01	7.24e-03	3.99e-01	3.71e-01
GOBP ESTABLISHMENT OF PLANAR POLARITY OF EMBRYONIC EPITHELIUM	9	2.47e-01	3.66e-01	0.4760	7.64e-02	2.41e-01	2.04e-01	3.02e-01	1.03e-01	-1.40e-01	6.91e-01	2.10e-01	2.90e-01	1.17e-01	5.92e-01	4.66e-01
GOCC RETROMER COMPLEX	20	1.48e-02	4.69e-02	0.4760	-2.73e-01	-1.90e-01	8.03e-02	1.88e-01	-1.59e-01	2.22e-01	3.45e-02	1.42e-01	5.34e-01	1.45e-01	2.19e-01	8.52e-02
GOMF PROTEIN KINASE B BINDING	9	1.45e-01	2.54e-01	0.4760	-3.50e-01	2.45e-01	-5.60e-02	-2.68e-02	6.14e-02	1.93e-01	6.93e-02	2.04e-01	7.71e-01	8.89e-01	7.50e-01	3.17e-01
GOBP CYCLOOXYGENASE PATHWAY	8	5.73e-01	6.60e-01	0.4760	-1.86e-01	-3.69e-01	-1.62e-01	-1.72e-01	6.92e-03	-6.74e-03	3.62e-01	7.06e-02	4.29e-01	4.00e-01	9.73e-01	9.74e-01
GOBP REGULATION OF CAMP DEPENDENT PROTEIN KINASE ACTIVITY	11	3.83e-01	4.97e-01	0.4760	-8.60e-02	-6.85e-03	2.19e-01	1.39e-01	-1.29e-01	3.67e-01	6.22e-01	9.69e-01	2.08e-01	4.24e-01	4.58e-01	3.49e-02
GOBP HYDROGEN SULFIDE METABOLIC PROCESS	5	5.78e-01	6.64e-01	0.4760	1.58e-01	-4.86e-02	3.03e-02	1.04e-01	-6.02e-02	-4.29e-01	5.42e-01	8.51e-01	9.07e-01	6.87e-01	8.16e-01	9.68e-02
GOMF ATP DEPENDENT PROTEIN FOLDING CHAPERONE	31	4.86e-04	2.74e-03	0.4760	-1.47e-01	-3.18e-01	6.82e-02	2.30e-01	-2.80e-02	2.12e-01	1.56e-01	2.18e-03	5.11e-01	2.64e-02	7.87e-01	4.09e-02
GOBP FATTY ACID TRANSMEMBRANE TRANSPORT	18	1.16e-02	3.87e-02	0.4760	8.08e-02	1.56e-01	2.18e-01	2.03e-01	3.16e-01	-8.25e-02	5.53e-01	2.51e-01	1.09e-01	1.36e-01	2.03e-02	5.44e-01
GOBP MITOCHONDRIAL OUTER MEMBRANE PERMEABILIZATION	28	3.82e-02	9.62e-02	0.4760	-5.24e-02	-3.11e-01	-2.62e-01	5.09e-02	-1.55e-02	-2.35e-01	6.31e-01	4.38e-03	1.64e-02	6.41e-01	8.87e-01	3.13e-02
GOBP CORNIFIED ENVELOPE ASSEMBLY	6	2.00e-01	3.16e-01	0.4750	-2.14e-01	-1.27e-02	2.03e-01	-4.74e-02	-1.75e-01	-3.25e-01	3.64e-01	9.57e-01	3.89e-01	8.41e-01	4.58e-01	1.67e-01
GOBP POSITIVE REGULATION OF ENDOTHELIAL CELL CHEMOTAXIS	9	1.05e-01	2.03e-01	0.4750	-7.66e-02	-3.15e-01	3.21e-01	4.21e-03	-8.99e-02	9.59e-02	6.91e-01	1.01e-01	9.50e-02	9.83e-01	6.41e-01	6.18e-01
GOBP POSITIVE REGULATION OF CELLULAR EXTRAVASATION	17	1.09e-02	3.69e-02	0.4750	-2.24e-01	1.43e-01	3.06e-01	1.72e-01	2.93e-02	1.76e-01	1.10e-01	3.06e-01	2.90e-02	2.20e-01	8.34e-01	2.08e-01
GOBP PHOSPHATIDYLSERINE ACYL CHAIN REMODELING	7	5.66e-01	6.54e-01	0.4750	-5.77e-02	3.32e-01	3.21e-01	2.29e-02	2.09e-02	9.02e-02	7.91e-01	1.28e-01	1.42e-01	9.17e-01	9.24e-01	6.79e-01
GOMF ASPARTIC TYPE PEPTIDASE ACTIVITY	20	1.13e-01	2.13e-01	0.4750	-2.60e-01	-2.76e-01	6.64e-02	-1.57e-01	-2.26e-01	-4.54e-02	4.45e-02	3.25e-02	6.07e-01	2.25e-01	7.99e-02	7.25e-01
GOBP EPITHELIAL CELL MATURATION	18	5.02e-02	1.18e-01	0.4750	-8.30e-02	-1.58e-01	3.31e-01	6.45e-02	-2.40e-01	1.50e-01	5.42e-01	2.47e-01	1.51e-02	6.36e-01	7.74e-02	2.70e-01
GOBP POSITIVE REGULATION OF T CELL RECEPTOR SIGNALING PATHWAY	19	2.25e-01	3.44e-01	0.4750	2.31e-01	1.16e-01	7.00e-02	2.81e-01	2.03e-01	1.84e-01	8.14e-02	3.83e-01	5.97e-01	3.37e-02	1.26e-01	1.65e-01
GOMF MACROLIDE BINDING	11	1.33e-01	2.40e-01	0.4750	-3.89e-03	-3.40e-01	2.62e-01	8.70e-03	-1.43e-01	1.45e-01	9.82e-01	5.09e-02	1.33e-01	9.60e-01	4.10e-01	4.05e-01
GOBP SPONTANEOUS NEUROTRANSMITTER SECRETION	6	4.67e-01	5.70e-01	0.4750	-2.72e-01	-8.82e-02	1.60e-01	3.91e-02	2.12e-01	2.67e-01	2.49e-01	7.08e-01	4.96e-01	8.68e-01	3.68e-01	2.57e-01
GOBP REGULATION OF RELEASE OF SEQUESTERED CALCIUM ION INTO CYTOSOL BY SARCOPLASMIC RETICULUM	22	1.38e-01	2.47e-01	0.4750	-1.23e-01	-1.05e-01	2.21e-01	-7.05e-02	-2.07e-01	3.20e-01	3.17e-01	3.93e-01	7.29e-02	5.67e-01	9.26e-02	9.29e-03
GOCC NSL COMPLEX	11	1.04e-01	2.00e-01	0.4750	-1.11e-01	-3.69e-02	-2.71e-01	2.09e-01	-1.46e-01	-2.71e-01	5.25e-01	8.32e-01	1.20e-01	2.30e-01	4.00e-01	1.20e-01
GOBP DEVELOPMENTAL INDUCTION	17	1.36e-01	2.43e-01	0.4750	-1.01e-01	1.81e-01	3.38e-01	-1.46e-01	-1.89e-01	1.06e-01	4.72e-01	1.96e-01	1.58e-02	2.97e-01	1.77e-01	4.49e-01
GOBP REGULATION OF NK T CELL ACTIVATION	9	5.95e-01	6.77e-01	0.4750	1.14e-01	1.47e-01	3.10e-02	2.83e-01	3.20e-01	-8.62e-02	5.55e-01	4.46e-01	8.72e-01	1.41e-01	9.63e-02	6.54e-01
GOMF TRANSMEMBRANE RECEPTOR PROTEIN PHOSPHATASE ACTIVITY	12	2.15e-01	3.32e-01	0.4750	1.13e-01	2.66e-01	3.74e-01	-3.62e-02	2.38e-02	-2.11e-02	4.97e-01	1.11e-01	2.50e-02	8.28e-01	8.87e-01	8.99e-01
GOCC ROUGH ENDOPLASMIC RETICULUM	53	1.14e-04	7.61e-04	0.4750	-2.66e-01	-3.04e-01	2.21e-02	-5.52e-03	-2.40e-01	6.47e-02	8.16e-04	1.30e-04	7.81e-01	9.45e-01	2.47e-03	4.15e-01
GOBP MITOTIC CYTOKINETIC PROCESS	31	3.55e-03	1.48e-02	0.4750	-2.45e-01	-2.87e-01	1.06e-01	7.78e-02	-1.51e-01	2.07e-01	1.84e-02	5.68e-03	3.05e-01	4.54e-01	1.45e-01	4.60e-02
GOBP PYRIMIDINE DEOXYRIBONUCLEOTIDE METABOLIC PROCESS	21	1.40e-02	4.49e-02	0.4750	2.10e-02	-4.29e-01	-1.65e-01	5.03e-02	-6.73e-02	7.89e-02	8.68e-01	6.60e-04	1.89e-01	6.90e-01	5.93e-01	5.31e-01
GOCC FICOLIN 1 RICH GRANULE MEMBRANE	57	6.67e-06	5.88e-05	0.4750	-1.69e-01	1.41e-01	3.06e-01	3.44e-02	-2.30e-02	2.85e-01	2.75e-02	6.47e-02	6.25e-05	6.53e-01	7.64e-01	2.00e-04
GOCC PROTON TRANSPORTING V TYPE ATPASE V0 DOMAIN	10	1.23e-01	2.27e-01	0.4750	-3.22e-01	-2.65e-01	5.12e-03	8.26e-02	-1.07e-01	-1.81e-01	7.77e-02	1.47e-01	9.78e-01	6.51e-01	5.56e-01	3.22e-01
GOBP REGULATION OF INTEGRIN ACTIVATION	11	1.63e-01	2.75e-01	0.4740	-1.86e-01	-3.78e-01	1.55e-01	-4.05e-02	-9.01e-02	1.18e-01	2.86e-01	2.99e-02	3.75e-01	8.16e-01	6.05e-01	4.97e-01
GOBP CELLULAR DEFENSE RESPONSE	43	1.33e-04	8.73e-04	0.4740	1.07e-02	3.03e-01	2.17e-01	3.42e-02	-8.18e-02	2.79e-01	9.04e-01	5.79e-04	1.37e-02	6.98e-01	3.54e-01	1.54e-03
GOCC INTERSTITIAL MATRIX	5	8.70e-01	8.94e-01	0.4740	7.79e-02	8.26e-02	3.00e-02	3.14e-01	2.79e-01	1.88e-01	7.63e-01	7.49e-01	9.07e-01	2.25e-01	2.80e-01	4.68e-01
GOMF ABC TYPE GLUTATHIONE S CONJUGATE TRANSPORTER ACTIVITY	8	6.24e-01	7.01e-01	0.4740	-1.31e-01	-2.29e-01	1.85e-01	-1.27e-01	-3.23e-01	-6.65e-03	5.21e-01	2.62e-01	3.64e-01	5.33e-01	1.13e-01	9.74e-01
GOMF GTPASE ACTIVATING PROTEIN BINDING	11	4.84e-01	5.85e-01	0.4740	7.01e-02	1.14e-02	-1.02e-01	3.34e-01	3.04e-01	-7.08e-02	6.87e-01	9.48e-01	5.58e-01	5.48e-02	8.05e-02	6.84e-01
GOBP POSITIVE REGULATION OF EPITHELIAL CELL PROLIFERATION INVOLVED IN WOUND HEALING	5	7.77e-01	8.20e-01	0.4740	6.96e-02	3.48e-01	2.04e-01	-2.35e-01	4.21e-02	-1.41e-02	7.88e-01	1.78e-01	4.30e-01	3.63e-01	8.71e-01	9.56e-01
GOMF SULFURIC ESTER HYDROLASE ACTIVITY	13	3.78e-01	4.93e-01	0.4740	-3.21e-01	-7.72e-02	-1.96e-01	-1.83e-01	-1.50e-01	-1.47e-01	4.51e-02	6.30e-01	2.21e-01	2.54e-01	3.51e-01	3.60e-01
GOCC PARALLEL FIBER TO PURKINJE CELL SYNAPSE	8	6.16e-01	6.95e-01	0.4740	1.18e-01	3.91e-01	4.47e-02	-3.91e-02	2.09e-01	-1.03e-01	5.65e-01	5.55e-02	8.27e-01	8.48e-01	3.07e-01	6.13e-01
GOMF LIPOPROTEIN LIPASE ACTIVITY	6	5.54e-01	6.43e-01	0.4740	1.09e-01	5.61e-02	2.47e-01	1.46e-01	-3.55e-01	2.59e-02	6.43e-01	8.12e-01	2.94e-01	5.35e-01	1.32e-01	9.13e-01
GOBP POSITIVE REGULATION OF BASEMENT MEMBRANE ASSEMBLY INVOLVED IN EMBRYONIC BODY MORPHOGENESIS	5	3.22e-01	4.41e-01	0.4740	-1.69e-01	3.42e-01	7.49e-02	2.16e-01	-6.74e-03	-1.63e-01	5.13e-01	1.86e-01	7.72e-01	4.02e-01	9.79e-01	5.28e-01
GOBP GLUTAMATERGIC NEURON DIFFERENTIATION	10	1.66e-01	2.79e-01	0.4740	-2.24e-01	1.78e-01	3.25e-01	-1.86e-01	1.77e-02	4.45e-02	2.19e-01	3.31e-01	7.52e-02	3.09e-01	9.23e-01	8.07e-01
GOBP RESPONSE TO ODORANT	5	8.37e-01	8.68e-01	0.4740	-2.65e-01	5.49e-02	1.91e-01	-1.17e-01	-2.18e-01	2.31e-01	3.05e-01	8.32e-01	4.60e-01	6.50e-01	3.99e-01	3.70e-01
GOBP STEROL BIOSYNTHETIC PROCESS	49	8.14e-06	7.01e-05	0.4740	-6.61e-02	-3.02e-01	2.03e-01	1.17e-01	-1.67e-01	2.13e-01	4.23e-01	2.52e-04	1.39e-02	1.55e-01	4.31e-02	9.74e-03
GOCC MSL COMPLEX	5	5.19e-01	6.13e-01	0.4740	-1.94e-02	3.53e-01	1.39e-01	3.19e-02	-1.86e-01	2.10e-01	9.40e-01	1.71e-01	5.91e-01	9.02e-01	4.70e-01	4.17e-01
GOBP NEGATIVE REGULATION OF HYDROGEN PEROXIDE MEDIATED PROGRAMMED CELL DEATH	6	5.21e-01	6.15e-01	0.4740	-2.83e-01	-1.45e-01	-3.13e-01	3.31e-03	-1.26e-01	9.54e-02	2.30e-01	5.39e-01	1.84e-01	9.89e-01	5.92e-01	6.86e-01
GOBP REGULATION OF MIRNA TRANSCRIPTION	62	3.38e-06	3.20e-05	0.4730	5.39e-03	2.40e-01	3.74e-01	3.98e-02	4.04e-02	1.54e-01	9.42e-01	1.08e-03	3.54e-07	5.88e-01	5.82e-01	3.65e-02
GOBP VITAMIN TRANSMEMBRANE TRANSPORT	15	1.55e-01	2.66e-01	0.4730	-7.32e-02	6.60e-02	-1.77e-01	1.62e-01	2.33e-01	-3.20e-01	6.24e-01	6.58e-01	2.36e-01	2.78e-01	1.18e-01	3.18e-02
GOMF OXIDOREDUCTASE ACTIVITY ACTING ON THE ALDEHYDE OR OXO GROUP OF DONORS DISULFIDE AS ACCEPTOR	7	6.65e-01	7.33e-01	0.4730	-2.21e-01	-2.82e-01	-2.88e-01	5.33e-02	6.14e-02	8.00e-02	3.12e-01	1.96e-01	1.87e-01	8.07e-01	7.79e-01	7.14e-01
GOCC MCM COMPLEX	11	4.16e-01	5.26e-01	0.4730	1.64e-01	-3.83e-02	-8.34e-02	3.87e-01	1.72e-01	9.92e-02	3.47e-01	8.26e-01	6.32e-01	2.64e-02	3.23e-01	5.69e-01
GOBP CELLULAR EXTRAVASATION	61	1.30e-06	1.34e-05	0.4730	-9.74e-02	1.41e-01	3.15e-01	1.55e-01	1.62e-02	2.66e-01	1.88e-01	5.63e-02	2.05e-05	3.66e-02	8.27e-01	3.19e-04
GOBP REGULATION OF PROTEIN SUMOYLATION	20	1.47e-02	4.66e-02	0.4730	-3.34e-02	-2.11e-01	-1.53e-01	3.55e-01	-4.50e-02	-1.64e-01	7.96e-01	1.03e-01	2.35e-01	5.94e-03	7.27e-01	2.05e-01
GOBP MUSCLE HYPERTROPHY IN RESPONSE TO STRESS	19	6.87e-02	1.49e-01	0.4730	2.73e-01	1.93e-01	1.56e-01	2.82e-01	-9.33e-02	-1.55e-02	3.97e-02	1.46e-01	2.39e-01	3.36e-02	4.81e-01	9.07e-01
GOBP NEGATIVE REGULATION OF TISSUE REMODELING	14	1.56e-01	2.68e-01	0.4730	7.23e-02	1.56e-01	4.22e-01	7.48e-02	-5.29e-02	8.92e-02	6.39e-01	3.14e-01	6.26e-03	6.28e-01	7.32e-01	5.63e-01
GOCC GTPASE ACTIVATOR COMPLEX	11	4.95e-01	5.93e-01	0.4730	-9.49e-02	-3.38e-01	5.64e-03	-1.28e-01	-2.58e-01	1.33e-01	5.86e-01	5.23e-02	9.74e-01	4.61e-01	1.39e-01	4.46e-01
GOBP NUCLEOSIDE SALVAGE	11	2.35e-01	3.53e-01	0.4730	-7.84e-03	-4.07e-01	-1.56e-01	-1.37e-01	-4.02e-02	-1.16e-01	9.64e-01	1.96e-02	3.69e-01	4.32e-01	8.17e-01	5.04e-01
GOMF NADPLUS PROTEIN LYSINE ADP RIBOSYLTRANSFERASE ACTIVITY	5	5.90e-01	6.73e-01	0.4730	3.05e-01	-8.09e-02	-1.92e-01	2.10e-01	1.53e-01	1.42e-01	2.38e-01	7.54e-01	4.58e-01	4.17e-01	5.55e-01	5.82e-01
GOBP CENTRAL NERVOUS SYSTEM NEURON DEVELOPMENT	57	1.24e-04	8.16e-04	0.4730	5.32e-02	2.29e-01	3.21e-01	1.59e-01	4.05e-02	1.96e-01	4.87e-01	2.77e-03	2.76e-05	3.77e-02	5.97e-01	1.06e-02
GOBP REGULATION OF CALCIUM ION IMPORT ACROSS PLASMA MEMBRANE	10	5.55e-01	6.45e-01	0.4730	-1.89e-01	5.91e-02	1.76e-01	-1.95e-01	-2.64e-01	2.13e-01	3.00e-01	7.46e-01	3.34e-01	2.86e-01	1.48e-01	2.43e-01
GOMF MHC PROTEIN COMPLEX BINDING	35	1.18e-03	5.85e-03	0.4730	3.26e-02	-2.33e-01	-1.87e-01	2.53e-01	2.52e-01	-7.54e-02	7.39e-01	1.71e-02	5.49e-02	9.64e-03	9.97e-03	4.40e-01
GOBP NUCLEAR RNA SURVEILLANCE	15	2.22e-01	3.40e-01	0.4730	-1.97e-02	-2.45e-01	-3.69e-01	1.05e-01	7.60e-02	-9.70e-02	8.95e-01	9.98e-02	1.33e-02	4.81e-01	6.10e-01	5.15e-01
GOMF ALPHA N ACETYLGALACTOSAMINIDE ALPHA 2 6 SIALYLTRANSFERASE ACTIVITY	5	8.73e-01	8.96e-01	0.4720	1.28e-01	2.98e-01	1.57e-01	2.04e-01	8.06e-02	2.13e-01	6.21e-01	2.48e-01	5.44e-01	4.30e-01	7.55e-01	4.10e-01
GOBP PROXIMAL TUBULE DEVELOPMENT	8	2.66e-01	3.86e-01	0.4720	2.20e-01	9.77e-02	1.76e-01	1.48e-01	3.08e-02	-3.34e-01	2.80e-01	6.32e-01	3.88e-01	4.70e-01	8.80e-01	1.02e-01
GOBP GLYCOLYTIC PROCESS THROUGH GLUCOSE 6 PHOSPHATE	18	7.97e-03	2.87e-02	0.4720	-2.18e-01	-1.39e-01	3.20e-01	7.95e-02	-2.00e-01	8.49e-02	1.09e-01	3.07e-01	1.88e-02	5.59e-01	1.41e-01	5.33e-01
GOBP MATING BEHAVIOR	22	1.10e-01	2.09e-01	0.4720	-2.80e-01	-2.45e-01	1.01e-01	-1.85e-01	-1.48e-01	1.37e-01	2.31e-02	4.71e-02	4.13e-01	1.34e-01	2.29e-01	2.66e-01
GOCC COHESIN COMPLEX	10	2.97e-01	4.17e-01	0.4720	-1.18e-01	1.31e-01	1.20e-01	2.73e-01	9.19e-02	3.08e-01	5.20e-01	4.72e-01	5.09e-01	1.35e-01	6.15e-01	9.20e-02
GOBP PARASYMPATHETIC NERVOUS SYSTEM DEVELOPMENT	10	1.63e-01	2.76e-01	0.4720	-1.23e-03	1.17e-01	1.73e-01	9.03e-02	4.06e-01	8.10e-02	9.95e-01	5.20e-01	3.45e-01	6.21e-01	2.63e-02	6.58e-01
GOBP LONG CHAIN FATTY ACID IMPORT ACROSS PLASMA MEMBRANE	10	1.69e-02	5.19e-02	0.4720	-9.51e-02	1.77e-01	2.56e-01	-4.18e-02	1.03e-01	-3.24e-01	6.02e-01	3.34e-01	1.61e-01	8.19e-01	5.72e-01	7.64e-02
GOBP NEGATIVE REGULATION OF SINGLE STRANDED VIRAL RNA REPLICATION VIA DOUBLE STRANDED DNA INTERMEDIATE	15	4.92e-02	1.16e-01	0.4720	2.53e-01	-6.14e-02	-2.87e-02	2.90e-01	-9.36e-03	2.64e-01	8.99e-02	6.81e-01	8.47e-01	5.16e-02	9.50e-01	7.63e-02
GOCC TERTIARY GRANULE	154	2.67e-15	7.28e-14	0.4720	-1.93e-01	4.91e-02	2.86e-01	-2.97e-02	-1.67e-01	2.70e-01	3.65e-05	2.93e-01	9.27e-10	5.25e-01	3.42e-04	7.73e-09
GOBP GALACTOSE CATABOLIC PROCESS VIA UDP GALACTOSE	5	7.05e-01	7.65e-01	0.4720	-1.52e-01	-2.33e-01	-2.01e-01	3.08e-01	1.94e-02	9.58e-02	5.56e-01	3.66e-01	4.35e-01	2.33e-01	9.40e-01	7.11e-01
GOMF POLY ADP D RIBOSE MODIFICATION DEPENDENT PROTEIN BINDING	5	7.78e-01	8.21e-01	0.4720	2.72e-02	-2.98e-01	-1.89e-01	2.43e-01	1.68e-01	-1.01e-01	9.16e-01	2.49e-01	4.64e-01	3.47e-01	5.15e-01	6.94e-01
GOBP PYRIMIDINE DEOXYRIBONUCLEOSIDE METABOLIC PROCESS	5	7.04e-01	7.65e-01	0.4720	-8.90e-02	-2.90e-01	-8.45e-02	2.92e-01	-6.94e-02	1.82e-01	7.30e-01	2.61e-01	7.43e-01	2.58e-01	7.88e-01	4.82e-01
GOBP POSITIVE REGULATION OF MITOCHONDRIAL FISSION	19	8.87e-02	1.80e-01	0.4720	-2.66e-01	-2.97e-01	-2.11e-01	1.18e-01	3.94e-02	5.53e-02	4.44e-02	2.48e-02	1.11e-01	3.72e-01	7.66e-01	6.77e-01
GOMF DOUBLE STRANDED TELOMERIC DNA BINDING	9	3.25e-01	4.44e-01	0.4720	-2.68e-02	-1.77e-01	-3.01e-01	1.84e-01	2.11e-01	1.46e-01	8.89e-01	3.59e-01	1.18e-01	3.39e-01	2.72e-01	4.49e-01
GOBP NEGATIVE REGULATION OF RESPONSE TO OXIDATIVE STRESS	9	5.22e-01	6.15e-01	0.4720	-3.13e-01	-2.30e-01	-2.00e-01	-8.60e-02	7.83e-02	1.35e-01	1.04e-01	2.33e-01	3.00e-01	6.55e-01	6.84e-01	4.82e-01
GOBP ACTIN POLYMERIZATION DEPENDENT CELL MOTILITY	7	7.24e-01	7.81e-01	0.4710	-3.17e-01	-1.45e-01	1.11e-02	-1.86e-01	-4.40e-02	2.53e-01	1.47e-01	5.05e-01	9.60e-01	3.95e-01	8.40e-01	2.46e-01
GOBP MRNA SPLICE SITE RECOGNITION	30	2.04e-02	6.01e-02	0.4710	-1.52e-01	-1.51e-01	-3.59e-01	3.44e-02	-4.35e-02	-2.09e-01	1.50e-01	1.51e-01	6.54e-04	7.44e-01	6.80e-01	4.75e-02
GOCC PERINUCLEAR ENDOPLASMIC RETICULUM	18	2.10e-01	3.28e-01	0.4710	-1.63e-01	-7.65e-02	1.76e-01	-8.03e-02	-3.03e-01	2.45e-01	2.32e-01	5.74e-01	1.96e-01	5.55e-01	2.61e-02	7.14e-02
GOBP NEGATIVE REGULATION OF MITOCHONDRIAL OUTER MEMBRANE PERMEABILIZATION INVOLVED IN APOPTOTIC SIGNALING PATHWAY	12	4.70e-01	5.72e-01	0.4710	-2.00e-02	-2.56e-01	-2.33e-01	-4.24e-02	-7.63e-02	-3.06e-01	9.04e-01	1.24e-01	1.61e-01	7.99e-01	6.47e-01	6.65e-02
GOBP REGULATION OF RRNA PROCESSING	16	3.15e-01	4.35e-01	0.4710	-2.19e-01	-3.11e-01	-2.10e-01	-7.47e-03	-6.26e-02	-1.70e-01	1.29e-01	3.13e-02	1.47e-01	9.59e-01	6.65e-01	2.38e-01
GOBP POSITIVE REGULATION OF ADENYLATE CYCLASE ACTIVITY	16	9.45e-02	1.88e-01	0.4710	-1.78e-01	3.66e-03	2.58e-01	-1.83e-01	-2.94e-01	-5.65e-02	2.18e-01	9.80e-01	7.35e-02	2.06e-01	4.15e-02	6.96e-01
GOMF LIPOPROTEIN PARTICLE RECEPTOR BINDING	21	2.49e-02	6.98e-02	0.4710	-3.87e-02	-1.34e-01	2.73e-01	2.36e-01	-7.59e-02	2.57e-01	7.59e-01	2.88e-01	3.03e-02	6.15e-02	5.47e-01	4.11e-02
GOBP POSITIVE REGULATION OF VASCULAR ENDOTHELIAL GROWTH FACTOR PRODUCTION	23	2.36e-03	1.06e-02	0.4710	-3.69e-01	1.60e-01	9.60e-02	-1.98e-01	-6.96e-02	-8.28e-02	2.21e-03	1.84e-01	4.25e-01	1.01e-01	5.63e-01	4.92e-01
GOBP POSITIVE REGULATION OF RELEASE OF CYTOCHROME C FROM MITOCHONDRIA	24	2.80e-02	7.61e-02	0.4710	-1.75e-01	-2.41e-01	-1.99e-01	-1.17e-01	1.03e-01	-2.62e-01	1.38e-01	4.10e-02	9.11e-02	3.21e-01	3.80e-01	2.63e-02
GOMF NUCLEAR THYROID HORMONE RECEPTOR BINDING	27	4.66e-03	1.85e-02	0.4710	-8.47e-02	6.43e-02	1.43e-01	3.04e-01	5.18e-02	3.08e-01	4.46e-01	5.63e-01	1.99e-01	6.30e-03	6.41e-01	5.62e-03
GOCC TRAPPIII PROTEIN COMPLEX	12	2.18e-01	3.37e-01	0.4710	-5.88e-02	-3.91e-01	-1.83e-01	1.44e-01	3.33e-02	9.93e-02	7.24e-01	1.91e-02	2.73e-01	3.86e-01	8.41e-01	5.51e-01
GOCC SPECIFIC GRANULE	156	3.84e-15	1.04e-13	0.4700	-1.36e-01	6.41e-02	3.12e-01	8.46e-03	-1.71e-01	2.69e-01	3.28e-03	1.67e-01	1.81e-11	8.55e-01	2.27e-04	7.05e-09
GOBP REGULATION OF LONG TERM SYNAPTIC DEPRESSION	9	2.99e-01	4.19e-01	0.4700	-2.20e-01	1.67e-01	2.21e-01	-3.56e-02	2.21e-01	2.15e-01	2.54e-01	3.85e-01	2.50e-01	8.53e-01	2.51e-01	2.65e-01
GOBP NEGATIVE REGULATION OF ACUTE INFLAMMATORY RESPONSE	7	6.82e-01	7.48e-01	0.4700	1.09e-03	1.55e-01	-4.81e-02	1.80e-01	3.95e-01	-8.07e-02	9.96e-01	4.77e-01	8.25e-01	4.09e-01	7.06e-02	7.11e-01
GOBP LONG CHAIN FATTY ACYL COA METABOLIC PROCESS	23	1.64e-01	2.77e-01	0.4700	-1.61e-01	-2.96e-02	2.36e-01	-2.17e-01	-2.36e-01	1.90e-01	1.80e-01	8.06e-01	4.97e-02	7.22e-02	5.04e-02	1.15e-01
GOBP CD4 POSITIVE ALPHA BETA T CELL ACTIVATION	112	3.28e-09	4.90e-08	0.4700	1.13e-01	2.42e-01	2.46e-01	2.15e-01	1.65e-02	2.07e-01	3.88e-02	9.94e-06	6.60e-06	8.45e-05	7.63e-01	1.56e-04
GOCC BRAHMA COMPLEX	13	3.04e-02	8.10e-02	0.4700	7.49e-02	6.80e-02	2.03e-01	3.38e-01	-2.29e-01	-5.58e-02	6.40e-01	6.71e-01	2.06e-01	3.48e-02	1.53e-01	7.28e-01
GOCC MITOTIC SPINDLE ASTRAL MICROTUBULE	7	7.78e-01	8.21e-01	0.4700	-1.09e-01	6.86e-02	3.03e-01	-9.51e-02	-5.46e-02	3.17e-01	6.17e-01	7.53e-01	1.65e-01	6.63e-01	8.02e-01	1.46e-01
GOMF ALKALI METAL ION BINDING	12	3.50e-01	4.66e-01	0.4700	-1.54e-01	-1.19e-01	3.09e-01	-2.69e-02	-1.34e-01	2.63e-01	3.56e-01	4.77e-01	6.39e-02	8.72e-01	4.21e-01	1.15e-01
GOBP ESTABLISHMENT OF PROTEIN LOCALIZATION TO CHROMATIN	8	3.63e-01	4.79e-01	0.4700	1.98e-01	-3.53e-01	3.50e-02	1.61e-01	-1.70e-01	2.87e-02	3.31e-01	8.35e-02	8.64e-01	4.31e-01	4.05e-01	8.88e-01
GOBP IODIDE TRANSPORT	5	7.35e-01	7.89e-01	0.4700	-6.78e-02	-7.74e-02	-1.54e-01	8.81e-02	7.66e-02	-4.16e-01	7.93e-01	7.65e-01	5.51e-01	7.33e-01	7.67e-01	1.07e-01
GOBP ENDOPLASMIC RETICULUM ORGANIZATION	93	2.91e-11	5.58e-10	0.4700	-2.80e-01	-2.51e-01	2.58e-02	1.27e-01	-1.33e-01	2.11e-01	3.00e-06	2.77e-05	6.67e-01	3.43e-02	2.61e-02	4.41e-04
GOBP NEGATIVE REGULATION OF ACTIVIN RECEPTOR SIGNALING PATHWAY	12	3.11e-02	8.20e-02	0.4700	-1.75e-01	5.80e-02	3.59e-01	2.19e-01	-1.61e-02	1.01e-01	2.95e-01	7.28e-01	3.15e-02	1.90e-01	9.23e-01	5.45e-01
GOMF WNT PROTEIN BINDING	19	1.16e-01	2.17e-01	0.4700	9.85e-03	3.27e-01	1.73e-01	7.44e-02	1.10e-01	2.57e-01	9.41e-01	1.37e-02	1.91e-01	5.75e-01	4.07e-01	5.23e-02
GOBP NEGATIVE REGULATION OF T CELL DIFFERENTIATION	37	4.47e-03	1.78e-02	0.4700	1.33e-01	1.63e-01	3.03e-01	1.09e-01	-1.98e-01	1.83e-01	1.61e-01	8.68e-02	1.42e-03	2.50e-01	3.73e-02	5.42e-02
GOBP POSITIVE REGULATION OF ORGANIC ACID TRANSPORT	32	9.31e-03	3.24e-02	0.4700	-8.96e-02	1.90e-01	3.45e-01	-9.99e-02	-1.08e-02	2.17e-01	3.80e-01	6.29e-02	7.30e-04	3.28e-01	9.16e-01	3.33e-02
GOBP POSITIVE REGULATION OF CHROMOSOME SEGREGATION	27	2.52e-03	1.12e-02	0.4700	-1.05e-02	-1.47e-01	-1.63e-02	4.17e-01	5.05e-02	1.50e-01	9.25e-01	1.87e-01	8.83e-01	1.79e-04	6.50e-01	1.77e-01
GOCC BLOC COMPLEX	19	9.79e-02	1.93e-01	0.4690	-2.27e-01	-3.24e-01	-2.12e-01	1.01e-01	-3.80e-02	8.54e-02	8.66e-02	1.45e-02	1.10e-01	4.45e-01	7.74e-01	5.20e-01
GOBP REGULATION OF SKELETAL MUSCLE CELL DIFFERENTIATION	12	5.20e-01	6.14e-01	0.4690	-1.95e-01	-8.24e-02	-3.31e-01	-1.38e-01	7.78e-02	-2.02e-01	2.43e-01	6.21e-01	4.72e-02	4.08e-01	6.41e-01	2.26e-01
GOBP POSITIVE REGULATION OF FATTY ACID OXIDATION	12	1.05e-01	2.03e-01	0.4690	2.03e-01	1.17e-01	1.16e-01	1.61e-01	-1.01e-01	-3.40e-01	2.23e-01	4.83e-01	4.88e-01	3.34e-01	5.45e-01	4.14e-02
GOBP CELLULAR RESPONSE TO EXOGENOUS DSRNA	14	5.84e-02	1.32e-01	0.4690	9.19e-02	9.14e-03	-4.65e-02	2.92e-01	4.99e-02	3.48e-01	5.51e-01	9.53e-01	7.63e-01	5.82e-02	7.46e-01	2.41e-02
GOBP REGULATION OF SKELETAL MUSCLE SATELLITE CELL PROLIFERATION	9	2.10e-01	3.27e-01	0.4690	-2.95e-01	9.90e-02	-9.95e-02	-1.67e-01	-4.47e-02	2.89e-01	1.26e-01	6.07e-01	6.05e-01	3.85e-01	8.16e-01	1.33e-01
GOBP REGULATION OF B CELL RECEPTOR SIGNALING PATHWAY	21	1.86e-01	3.01e-01	0.4690	1.40e-01	2.44e-01	2.34e-01	1.38e-01	1.78e-02	2.58e-01	2.68e-01	5.31e-02	6.39e-02	2.74e-01	8.88e-01	4.04e-02
GOBP CHAPERONE MEDIATED PROTEIN COMPLEX ASSEMBLY	21	1.19e-02	3.95e-02	0.4690	-5.47e-03	-4.13e-01	-6.38e-02	1.51e-01	-5.15e-03	1.48e-01	9.65e-01	1.04e-03	6.13e-01	2.32e-01	9.67e-01	2.41e-01
GOBP SKELETAL MUSCLE SATELLITE CELL PROLIFERATION	13	6.84e-02	1.49e-01	0.4690	-3.31e-01	-2.59e-02	-2.55e-01	-1.00e-01	-4.25e-02	1.79e-01	3.87e-02	8.71e-01	1.11e-01	5.32e-01	7.91e-01	2.63e-01
GOBP RESPONSE TO FOLLICLE STIMULATING HORMONE	11	5.44e-01	6.35e-01	0.4680	8.48e-03	1.61e-01	3.41e-01	-1.71e-01	-1.03e-01	1.94e-01	9.61e-01	3.56e-01	5.05e-02	3.26e-01	5.54e-01	2.65e-01
GOMF POLYOL TRANSMEMBRANE TRANSPORTER ACTIVITY	9	4.43e-01	5.50e-01	0.4680	-5.42e-02	1.03e-01	3.91e-02	-4.26e-01	-1.29e-01	-7.71e-02	7.78e-01	5.94e-01	8.39e-01	2.68e-02	5.01e-01	6.89e-01
GOBP NEGATIVE REGULATION OF INTERLEUKIN 12 PRODUCTION	18	1.22e-01	2.26e-01	0.4680	-5.07e-02	2.02e-01	3.26e-01	1.28e-01	1.16e-03	2.31e-01	7.09e-01	1.39e-01	1.65e-02	3.48e-01	9.93e-01	8.97e-02
GOCC MITOTIC SPINDLE MIDZONE	13	2.01e-01	3.18e-01	0.4680	-1.25e-03	-1.12e-01	2.09e-01	2.24e-01	1.03e-01	3.20e-01	9.94e-01	4.86e-01	1.92e-01	1.63e-01	5.20e-01	4.56e-02
GOBP POLYOL TRANSMEMBRANE TRANSPORT	9	5.10e-01	6.05e-01	0.4680	-3.81e-02	1.20e-01	1.04e-01	-3.63e-01	-2.42e-01	-4.88e-02	8.43e-01	5.34e-01	5.91e-01	5.94e-02	2.08e-01	8.00e-01
GOBP EPITHELIAL CELL CELL ADHESION	14	2.84e-01	4.04e-01	0.4680	-8.06e-02	1.14e-01	3.51e-01	-1.77e-01	-1.85e-01	1.07e-01	6.02e-01	4.60e-01	2.31e-02	2.52e-01	2.31e-01	4.89e-01
GOBP NEUTROPHIL DEGRANULATION	14	7.88e-02	1.65e-01	0.4680	-1.80e-01	2.09e-01	3.48e-01	-5.33e-03	-1.03e-01	1.06e-01	2.43e-01	1.76e-01	2.41e-02	9.72e-01	5.07e-01	4.92e-01
GOBP HEPARIN BIOSYNTHETIC PROCESS	9	2.74e-01	3.93e-01	0.4680	-3.76e-01	3.74e-03	4.41e-02	-3.47e-02	-2.59e-01	8.75e-02	5.08e-02	9.85e-01	8.19e-01	8.57e-01	1.79e-01	6.49e-01
GOBP RESPONSE TO BLUE LIGHT	5	8.11e-01	8.48e-01	0.4680	-1.05e-01	8.19e-02	-3.56e-01	5.96e-02	1.10e-01	-2.43e-01	6.85e-01	7.51e-01	1.68e-01	8.17e-01	6.71e-01	3.47e-01
GOBP AMINO SUGAR CATABOLIC PROCESS	13	3.50e-01	4.67e-01	0.4680	-1.04e-01	-8.98e-02	-2.85e-01	6.39e-02	-3.07e-02	-3.37e-01	5.14e-01	5.75e-01	7.57e-02	6.90e-01	8.48e-01	3.52e-02
GOMF STRUCTURAL CONSTITUENT OF POSTSYNAPSE	12	4.10e-01	5.21e-01	0.4680	-5.85e-02	1.75e-01	2.60e-01	6.74e-02	1.28e-01	3.11e-01	7.25e-01	2.94e-01	1.19e-01	6.86e-01	4.44e-01	6.25e-02
GOBP CARDIAC MYOFIBRIL ASSEMBLY	12	1.78e-01	2.93e-01	0.4680	-9.29e-02	1.73e-01	1.69e-01	5.23e-02	-1.62e-01	3.50e-01	5.77e-01	3.01e-01	3.10e-01	7.54e-01	3.30e-01	3.58e-02
GOCC CORE MEDIATOR COMPLEX	26	1.18e-02	3.92e-02	0.4680	1.78e-01	-1.54e-01	-1.15e-01	3.68e-01	9.42e-02	7.39e-02	1.16e-01	1.73e-01	3.12e-01	1.16e-03	4.06e-01	5.14e-01
GOBP CELL CELL JUNCTION MAINTENANCE	16	1.24e-01	2.28e-01	0.4680	1.39e-01	7.01e-02	3.94e-01	-3.48e-02	-1.93e-01	2.95e-02	3.36e-01	6.27e-01	6.42e-03	8.09e-01	1.80e-01	8.38e-01
GOBP ARGININE METABOLIC PROCESS	13	1.72e-01	2.86e-01	0.4670	-8.67e-02	-1.78e-01	3.29e-01	6.63e-02	-1.34e-01	2.21e-01	5.89e-01	2.66e-01	4.01e-02	6.79e-01	4.04e-01	1.68e-01
GOCC DEUTEROSOME	5	7.15e-01	7.73e-01	0.4670	2.79e-02	2.25e-01	-7.76e-02	-9.33e-02	3.84e-01	6.92e-02	9.14e-01	3.83e-01	7.64e-01	7.18e-01	1.37e-01	7.89e-01
GOBP WOUND HEALING SPREADING OF EPIDERMAL CELLS	21	1.51e-02	4.77e-02	0.4670	-2.40e-01	3.46e-02	2.68e-01	-2.37e-01	-1.72e-01	-4.04e-02	5.65e-02	7.84e-01	3.34e-02	6.03e-02	1.71e-01	7.49e-01
GOBP DNA STRAND RESECTION INVOLVED IN REPLICATION FORK PROCESSING	10	4.68e-01	5.70e-01	0.4670	-3.75e-01	-1.55e-01	-8.52e-02	-7.47e-02	-2.90e-02	2.00e-01	4.02e-02	3.95e-01	6.41e-01	6.83e-01	8.74e-01	2.74e-01
GOBP REGULATION OF GAMMA DELTA T CELL DIFFERENTIATION	9	3.12e-01	4.33e-01	0.4670	-9.90e-02	3.91e-01	3.22e-02	1.30e-01	1.83e-01	6.49e-02	6.07e-01	4.23e-02	8.67e-01	4.98e-01	3.43e-01	7.36e-01
GOCC L TYPE VOLTAGE GATED CALCIUM CHANNEL COMPLEX	7	6.16e-01	6.94e-01	0.4670	7.39e-02	3.38e-01	2.07e-01	-1.98e-01	1.27e-01	5.42e-03	7.35e-01	1.22e-01	3.43e-01	3.63e-01	5.60e-01	9.80e-01
GOBP CHONDROCYTE DEVELOPMENT INVOLVED IN ENDOCHONDRAL BONE MORPHOGENESIS	7	4.64e-01	5.68e-01	0.4670	-1.61e-01	1.77e-01	1.64e-03	2.71e-01	2.94e-01	1.70e-04	4.60e-01	4.16e-01	9.94e-01	2.14e-01	1.77e-01	9.99e-01
GOBP REGULATION OF DIGESTIVE SYSTEM PROCESS	24	2.01e-02	5.93e-02	0.4670	-4.24e-02	1.73e-01	8.91e-02	2.76e-01	3.09e-01	7.91e-02	7.19e-01	1.43e-01	4.50e-01	1.91e-02	8.72e-03	5.02e-01
GOMF PURINE NUCLEOTIDE TRANSMEMBRANE TRANSPORTER ACTIVITY	25	8.17e-02	1.69e-01	0.4670	-1.89e-01	-2.56e-01	-1.63e-01	-5.76e-02	-1.75e-01	-2.37e-01	1.03e-01	2.68e-02	1.58e-01	6.18e-01	1.30e-01	4.01e-02
GOMF MAP KINASE KINASE ACTIVITY	14	2.92e-01	4.11e-01	0.4670	-2.15e-01	7.35e-03	2.74e-01	-4.59e-02	-1.98e-01	2.35e-01	1.63e-01	9.62e-01	7.59e-02	7.66e-01	2.00e-01	1.29e-01
GOCC ELASTIC FIBER	5	5.03e-01	5.99e-01	0.4670	3.28e-01	9.08e-03	2.99e-01	-6.85e-02	1.25e-01	2.18e-02	2.04e-01	9.72e-01	2.47e-01	7.91e-01	6.27e-01	9.33e-01
GOMF N6 METHYLADENOSINE CONTAINING RNA READER ACTIVITY	11	1.98e-01	3.13e-01	0.4670	-2.65e-01	1.13e-01	2.50e-01	9.68e-02	-1.94e-02	2.50e-01	1.28e-01	5.16e-01	1.51e-01	5.78e-01	9.11e-01	1.51e-01
GOBP PHOSPHATE ION TRANSMEMBRANE TRANSPORT	13	1.64e-01	2.77e-01	0.4670	-1.68e-01	7.20e-02	-1.66e-01	1.12e-01	2.42e-01	-2.93e-01	2.94e-01	6.53e-01	3.00e-01	4.86e-01	1.31e-01	6.75e-02
GOBP COENZYME A METABOLIC PROCESS	18	4.02e-02	9.99e-02	0.4660	-7.99e-02	-1.99e-01	-3.47e-02	3.08e-01	2.07e-01	1.80e-01	5.57e-01	1.44e-01	7.99e-01	2.35e-02	1.28e-01	1.86e-01
GOMF SNRNP BINDING	9	4.73e-01	5.74e-01	0.4660	-1.12e-01	-3.70e-01	-1.79e-01	1.67e-01	-2.13e-02	8.36e-02	5.60e-01	5.43e-02	3.53e-01	3.84e-01	9.12e-01	6.64e-01
GOMF CHEMOKINE BINDING	31	2.30e-02	6.60e-02	0.4660	1.25e-01	5.61e-02	2.78e-01	-1.17e-01	-2.71e-01	1.85e-01	2.30e-01	5.89e-01	7.37e-03	2.61e-01	8.95e-03	7.49e-02
GOBP VERY LONG CHAIN FATTY ACID BIOSYNTHETIC PROCESS	12	5.85e-01	6.70e-01	0.4660	-2.62e-01	-1.67e-01	-2.22e-02	-2.64e-01	-1.79e-01	1.37e-01	1.16e-01	3.18e-01	8.94e-01	1.13e-01	2.82e-01	4.12e-01
GOCC MICROBODY LUMEN	43	6.61e-05	4.68e-04	0.4660	-1.79e-01	-3.32e-01	-2.13e-01	-1.01e-02	1.62e-01	5.67e-02	4.23e-02	1.65e-04	1.58e-02	9.08e-01	6.56e-02	5.20e-01
GOMF G PROTEIN COUPLED CHEMOATTRACTANT RECEPTOR ACTIVITY	25	8.11e-02	1.68e-01	0.4660	2.62e-01	1.62e-01	2.62e-01	1.91e-01	-8.55e-02	9.96e-02	2.35e-02	1.61e-01	2.32e-02	9.87e-02	4.59e-01	3.89e-01
GOMF OXIDOREDUCTASE ACTIVITY ACTING ON THE CH CH GROUP OF DONORS WITH A FLAVIN AS ACCEPTOR	13	1.39e-01	2.48e-01	0.4660	7.78e-02	-2.93e-01	-2.40e-01	1.19e-01	2.29e-01	-2.81e-02	6.27e-01	6.71e-02	1.34e-01	4.57e-01	1.52e-01	8.61e-01
GOBP POSITIVE REGULATION OF CELL CELL ADHESION MEDIATED BY INTEGRIN	5	4.87e-01	5.87e-01	0.4660	3.15e-01	-2.21e-01	-2.19e-01	1.21e-01	-7.21e-02	4.35e-02	2.23e-01	3.92e-01	3.97e-01	6.40e-01	7.80e-01	8.66e-01
GOMF RIBONUCLEOPROTEIN COMPLEX BINDING	160	1.70e-14	4.38e-13	0.4660	-2.52e-01	-3.39e-01	-1.40e-01	3.99e-02	-1.32e-01	9.54e-03	3.59e-08	1.40e-13	2.24e-03	3.84e-01	3.95e-03	8.35e-01
GOBP INTRACELLULAR ZINC ION HOMEOSTASIS	24	4.21e-02	1.03e-01	0.4660	-8.10e-02	-9.21e-03	2.87e-01	1.51e-01	-5.54e-02	3.20e-01	4.92e-01	9.38e-01	1.51e-02	2.02e-01	6.39e-01	6.61e-03
GOBP COPPER ION HOMEOSTASIS	19	1.97e-01	3.13e-01	0.4660	-1.85e-01	-3.37e-01	-5.43e-02	-1.85e-01	-1.49e-01	9.95e-02	1.62e-01	1.11e-02	6.82e-01	1.63e-01	2.60e-01	4.53e-01
GOBP PROTEIN LIPID COMPLEX ASSEMBLY	21	6.36e-03	2.38e-02	0.4660	1.86e-02	1.72e-01	2.19e-01	3.14e-01	1.97e-01	-4.26e-02	8.82e-01	1.72e-01	8.28e-02	1.26e-02	1.19e-01	7.35e-01
GOBP NEGATIVE REGULATION OF PROTEIN LOCALIZATION TO CELL PERIPHERY	24	8.75e-03	3.08e-02	0.4660	-3.20e-01	-1.69e-01	1.05e-01	9.36e-02	-1.93e-01	1.71e-01	6.73e-03	1.52e-01	3.72e-01	4.27e-01	1.02e-01	1.47e-01
GOBP OUTFLOW TRACT SEPTUM MORPHOGENESIS	16	1.16e-01	2.17e-01	0.4660	-1.11e-01	2.83e-01	1.81e-01	-7.04e-02	2.21e-01	1.94e-01	4.43e-01	4.96e-02	2.10e-01	6.26e-01	1.26e-01	1.79e-01
GOBP LEUKOTRIENE D4 METABOLIC PROCESS	6	6.98e-01	7.60e-01	0.4660	3.16e-02	-8.52e-02	5.88e-02	3.15e-01	2.43e-01	2.16e-01	8.93e-01	7.18e-01	8.03e-01	1.81e-01	3.03e-01	3.59e-01
GOBP CELL CELL ADHESION MEDIATED BY INTEGRIN	15	4.03e-01	5.14e-01	0.4660	1.69e-01	1.56e-01	3.08e-01	4.35e-02	6.35e-02	2.51e-01	2.57e-01	2.95e-01	3.87e-02	7.71e-01	6.70e-01	9.25e-02
GOBP SEMAPHORIN PLEXIN SIGNALING PATHWAY	36	4.54e-05	3.34e-04	0.4660	8.63e-02	2.74e-01	1.79e-01	2.84e-01	4.04e-02	-1.39e-01	3.70e-01	4.37e-03	6.25e-02	3.14e-03	6.75e-01	1.49e-01
GOBP NUCLEOBASE CONTAINING SMALL MOLECULE INTERCONVERSION	8	6.55e-01	7.26e-01	0.4660	-1.17e-01	-3.53e-01	-2.36e-01	-1.27e-01	-7.98e-02	3.88e-03	5.68e-01	8.36e-02	2.47e-01	5.33e-01	6.96e-01	9.85e-01
GOBP SNRNA 3 END PROCESSING	21	8.18e-02	1.69e-01	0.4650	-2.05e-02	-2.53e-01	-2.74e-01	2.38e-01	1.27e-01	-6.56e-02	8.71e-01	4.51e-02	2.95e-02	5.88e-02	3.15e-01	6.03e-01
GOBP FEMALE GENITALIA DEVELOPMENT	10	1.79e-01	2.94e-01	0.4650	-1.18e-01	-1.64e-01	2.34e-01	-1.81e-01	7.50e-02	2.88e-01	5.19e-01	3.70e-01	2.01e-01	3.21e-01	6.81e-01	1.15e-01
GOMF INTRAMOLECULAR OXIDOREDUCTASE ACTIVITY	44	8.59e-05	5.91e-04	0.4650	-1.48e-01	-4.09e-01	-5.03e-03	4.53e-02	-8.38e-02	1.35e-01	9.03e-02	2.64e-06	9.54e-01	6.03e-01	3.36e-01	1.21e-01
GOBP GOLGI TO LYSOSOME TRANSPORT	11	3.82e-02	9.63e-02	0.4650	-2.75e-01	-1.44e-01	2.43e-01	2.09e-01	-1.21e-01	5.42e-02	1.14e-01	4.08e-01	1.63e-01	2.30e-01	4.87e-01	7.56e-01
GOBP CELLULAR MODIFIED AMINO ACID BIOSYNTHETIC PROCESS	37	1.93e-05	1.53e-04	0.4650	-3.27e-02	-2.37e-01	1.27e-01	1.76e-01	1.64e-01	2.92e-01	7.31e-01	1.25e-02	1.82e-01	6.44e-02	8.45e-02	2.12e-03
GOBP PROTEIN POLY ADP RIBOSYLATION	10	3.39e-01	4.56e-01	0.4650	2.51e-01	1.65e-01	3.51e-02	2.88e-01	2.74e-03	2.04e-01	1.69e-01	3.66e-01	8.48e-01	1.14e-01	9.88e-01	2.64e-01
GOBP MAST CELL ACTIVATION	60	3.31e-04	1.96e-03	0.4650	2.41e-02	1.44e-01	3.02e-01	7.66e-02	-6.95e-02	3.05e-01	7.47e-01	5.41e-02	5.06e-05	3.05e-01	3.52e-01	4.46e-05
GOBP POTASSIUM ION IMPORT ACROSS PLASMA MEMBRANE	26	5.52e-02	1.27e-01	0.4650	9.10e-02	2.73e-01	3.48e-01	-1.23e-02	4.67e-03	1.08e-01	4.22e-01	1.58e-02	2.10e-03	9.14e-01	9.67e-01	3.42e-01
GOBP DENSE CORE GRANULE TRANSPORT	8	3.23e-01	4.42e-01	0.4650	1.34e-01	4.26e-01	6.82e-02	-3.99e-02	-9.61e-02	-3.69e-02	5.10e-01	3.71e-02	7.39e-01	8.45e-01	6.38e-01	8.56e-01
GOBP CARDIAC MUSCLE CELL MEMBRANE REPOLARIZATION	25	1.34e-01	2.41e-01	0.4650	-1.33e-01	-1.84e-02	2.40e-01	-1.69e-01	-2.64e-01	2.05e-01	2.51e-01	8.74e-01	3.82e-02	1.43e-01	2.23e-02	7.54e-02
GOBP REGULATION OF APOPTOTIC CELL CLEARANCE	8	6.59e-01	7.29e-01	0.4650	1.60e-01	1.96e-01	1.84e-01	1.37e-01	3.08e-01	6.61e-02	4.34e-01	3.37e-01	3.68e-01	5.03e-01	1.31e-01	7.46e-01
GOBP GALACTOSE METABOLIC PROCESS	9	1.80e-01	2.95e-01	0.4650	-1.72e-01	-2.86e-01	9.40e-03	3.07e-01	-8.24e-02	-6.18e-02	3.72e-01	1.38e-01	9.61e-01	1.11e-01	6.69e-01	7.48e-01
GOBP REGULATION OF FIBRINOLYSIS	12	3.06e-03	1.31e-02	0.4650	2.66e-03	4.12e-02	2.93e-01	-1.26e-02	8.06e-03	-3.58e-01	9.87e-01	8.05e-01	7.88e-02	9.40e-01	9.61e-01	3.18e-02
GOBP REGULATION OF RESPONSE TO REACTIVE OXYGEN SPECIES	8	3.98e-01	5.10e-01	0.4650	-8.96e-02	4.96e-03	1.98e-01	-3.92e-02	2.27e-01	3.39e-01	6.61e-01	9.81e-01	3.31e-01	8.48e-01	2.65e-01	9.64e-02
GOBP FC RECEPTOR MEDIATED STIMULATORY SIGNALING PATHWAY	30	3.88e-04	2.26e-03	0.4640	-1.70e-01	2.05e-01	2.10e-01	2.24e-01	3.37e-02	2.23e-01	1.07e-01	5.23e-02	4.70e-02	3.36e-02	7.50e-01	3.47e-02
GOBP AGGRESOME ASSEMBLY	5	2.54e-01	3.74e-01	0.4640	1.59e-01	-1.30e-01	2.69e-01	-9.58e-02	-1.90e-02	-3.03e-01	5.37e-01	6.14e-01	2.98e-01	7.11e-01	9.41e-01	2.41e-01
GOBP POSITIVE REGULATION OF DENDRITE DEVELOPMENT	10	1.45e-01	2.54e-01	0.4640	4.17e-02	1.01e-01	3.70e-01	2.26e-01	1.19e-01	3.73e-02	8.19e-01	5.80e-01	4.28e-02	2.15e-01	5.14e-01	8.38e-01
GOCC ATG1 ULK1 KINASE COMPLEX	9	1.17e-01	2.19e-01	0.4640	-3.57e-01	9.39e-02	-1.15e-02	2.30e-01	3.81e-02	1.58e-01	6.39e-02	6.26e-01	9.53e-01	2.31e-01	8.43e-01	4.12e-01
GOMF CALCIUM DEPENDENT PROTEIN KINASE ACTIVITY	8	3.64e-01	4.79e-01	0.4640	-1.04e-01	-1.36e-01	2.64e-01	2.34e-01	-1.91e-01	1.60e-01	6.11e-01	5.07e-01	1.96e-01	2.53e-01	3.49e-01	4.33e-01
GOCC GARP COMPLEX	5	8.82e-01	9.03e-01	0.4640	2.91e-01	5.48e-02	1.89e-01	2.89e-01	8.75e-02	3.20e-02	2.60e-01	8.32e-01	4.64e-01	2.63e-01	7.35e-01	9.01e-01
GOBP INDOLALKYLAMINE METABOLIC PROCESS	11	3.92e-01	5.05e-01	0.4640	4.37e-02	9.58e-02	-1.70e-01	1.23e-01	3.94e-01	6.87e-02	8.02e-01	5.82e-01	3.28e-01	4.79e-01	2.35e-02	6.93e-01
GOBP ANTIGEN PROCESSING AND PRESENTATION OF PEPTIDE ANTIGEN VIA MHC CLASS IB	12	4.95e-01	5.94e-01	0.4640	2.76e-03	-1.33e-01	-3.50e-01	1.27e-01	6.29e-02	-2.34e-01	9.87e-01	4.25e-01	3.56e-02	4.45e-01	7.06e-01	1.60e-01
GOBP REGULATION OF ANGIOTENSIN LEVELS IN BLOOD	7	4.88e-01	5.87e-01	0.4640	-2.18e-01	9.72e-02	1.94e-01	-1.62e-01	1.92e-01	2.40e-01	3.17e-01	6.56e-01	3.75e-01	4.57e-01	3.80e-01	2.71e-01
GOBP TELENCEPHALON GLIAL CELL MIGRATION	22	3.29e-02	8.59e-02	0.4640	-2.29e-01	-8.61e-02	2.03e-01	1.01e-02	-3.07e-01	1.42e-01	6.33e-02	4.84e-01	1.00e-01	9.34e-01	1.27e-02	2.48e-01
GOCC SPECIFIC GRANULE LUMEN	61	2.88e-05	2.21e-04	0.4640	-4.27e-02	2.81e-02	3.49e-01	3.97e-02	-2.11e-01	2.11e-01	5.64e-01	7.05e-01	2.40e-06	5.92e-01	4.35e-03	4.32e-03
GOBP POSITIVE REGULATION OF FEAR RESPONSE	5	7.56e-01	8.04e-01	0.4640	1.56e-01	-2.48e-01	-2.87e-01	-5.80e-04	1.19e-01	-1.81e-01	5.45e-01	3.37e-01	2.66e-01	9.98e-01	6.45e-01	4.83e-01
GOBP MESODERMAL CELL FATE COMMITMENT	7	4.76e-01	5.77e-01	0.4640	-3.20e-01	-4.44e-02	2.23e-01	-2.38e-01	-5.51e-02	3.06e-02	1.43e-01	8.39e-01	3.06e-01	2.75e-01	8.01e-01	8.88e-01
GOMF TUMOR NECROSIS FACTOR BINDING	7	6.46e-01	7.19e-01	0.4640	1.47e-01	1.43e-01	3.40e-01	2.24e-01	5.60e-02	6.27e-02	4.99e-01	5.13e-01	1.19e-01	3.04e-01	7.98e-01	7.74e-01
GOBP POSITIVE REGULATION OF DEOXYRIBONUCLEASE ACTIVITY	5	7.87e-01	8.29e-01	0.4640	1.03e-01	-2.46e-01	-1.37e-01	2.90e-01	1.04e-01	-1.74e-01	6.90e-01	3.40e-01	5.96e-01	2.62e-01	6.88e-01	5.01e-01
GOBP NEGATIVE REGULATION OF ANTIGEN PROCESSING AND PRESENTATION	9	3.64e-01	4.79e-01	0.4640	-1.18e-01	-5.50e-02	-1.48e-01	-3.76e-02	1.95e-01	-3.69e-01	5.38e-01	7.75e-01	4.41e-01	8.45e-01	3.11e-01	5.50e-02
GOBP PEPTIDE MODIFICATION	6	7.65e-01	8.11e-01	0.4640	1.31e-01	-5.78e-02	1.84e-01	1.72e-01	2.59e-02	3.61e-01	5.79e-01	8.06e-01	4.34e-01	4.65e-01	9.13e-01	1.26e-01
GOCC ASTER	10	5.00e-01	5.97e-01	0.4640	-2.39e-01	4.13e-02	2.18e-01	-1.51e-01	-9.60e-03	2.93e-01	1.91e-01	8.21e-01	2.32e-01	4.08e-01	9.58e-01	1.09e-01
GOBP CD4 POSITIVE ALPHA BETA T CELL DIFFERENTIATION	87	4.15e-07	4.62e-06	0.4630	8.02e-02	2.87e-01	2.50e-01	1.90e-01	6.23e-02	1.53e-01	1.96e-01	3.78e-06	5.41e-05	2.14e-03	3.15e-01	1.37e-02
GOBP REGULATION OF VASCULOGENESIS	10	3.27e-01	4.46e-01	0.4630	3.01e-02	1.97e-01	2.19e-01	-1.12e-01	-3.38e-01	1.57e-02	8.69e-01	2.81e-01	2.30e-01	5.39e-01	6.42e-02	9.31e-01
GOBP LOW DENSITY LIPOPROTEIN PARTICLE REMODELING	8	4.34e-01	5.42e-01	0.4630	1.68e-01	5.06e-02	3.45e-01	1.96e-01	1.38e-01	8.91e-02	4.10e-01	8.04e-01	9.15e-02	3.38e-01	5.00e-01	6.63e-01
GOBP REGULATION OF NEURON MATURATION	7	6.01e-01	6.81e-01	0.4630	2.13e-01	7.03e-02	2.88e-01	-1.39e-01	4.79e-03	2.49e-01	3.29e-01	7.47e-01	1.87e-01	5.24e-01	9.82e-01	2.54e-01
GOBP REGULATION OF POLYAMINE TRANSMEMBRANE TRANSPORT	5	7.92e-01	8.32e-01	0.4630	-3.22e-01	-2.12e-01	-1.35e-01	-6.86e-03	1.17e-01	1.84e-01	2.12e-01	4.12e-01	6.00e-01	9.79e-01	6.49e-01	4.77e-01
GOMF ORNITHINE DECARBOXYLASE REGULATOR ACTIVITY	5	7.92e-01	8.32e-01	0.4630	-3.22e-01	-2.12e-01	-1.35e-01	-6.86e-03	1.17e-01	1.84e-01	2.12e-01	4.12e-01	6.00e-01	9.79e-01	6.49e-01	4.77e-01
GOBP NEGATIVE REGULATION OF INTERFERON BETA PRODUCTION	14	1.53e-01	2.64e-01	0.4630	-5.26e-02	1.71e-01	1.09e-01	2.32e-01	3.36e-01	6.51e-02	7.34e-01	2.68e-01	4.80e-01	1.33e-01	2.97e-02	6.73e-01
GOCC PSEUDOPODIUM	14	3.68e-02	9.36e-02	0.4630	-3.09e-01	-1.61e-01	2.51e-02	1.32e-01	-2.68e-01	-5.71e-02	4.52e-02	2.96e-01	8.71e-01	3.93e-01	8.30e-02	7.11e-01
GOBP REGULATION OF MACROPHAGE PROLIFERATION	5	7.90e-01	8.31e-01	0.4630	-4.17e-01	-1.69e-01	-2.84e-02	-1.02e-01	6.80e-03	2.66e-02	1.06e-01	5.12e-01	9.12e-01	6.93e-01	9.79e-01	9.18e-01
GOBP SERINE FAMILY AMINO ACID CATABOLIC PROCESS	10	5.11e-01	6.06e-01	0.4630	1.37e-01	-1.56e-01	-1.85e-01	2.08e-01	8.71e-02	-2.94e-01	4.53e-01	3.93e-01	3.11e-01	2.55e-01	6.33e-01	1.08e-01
GOMF INTRAMOLECULAR PHOSPHOTRANSFERASE ACTIVITY	9	5.02e-01	5.99e-01	0.4630	-2.24e-01	7.76e-02	1.56e-01	-9.24e-03	-8.53e-03	3.66e-01	2.45e-01	6.87e-01	4.18e-01	9.62e-01	9.65e-01	5.75e-02
GOBP NUCLEOLUS ORGANIZATION	18	9.11e-03	3.18e-02	0.4630	-1.34e-01	-8.98e-02	-1.28e-01	4.02e-01	1.46e-02	-1.00e-01	3.24e-01	5.10e-01	3.46e-01	3.18e-03	9.15e-01	4.61e-01
GOBP REGULATION OF HEXOKINASE ACTIVITY	5	6.64e-01	7.32e-01	0.4630	5.63e-02	1.12e-02	3.29e-01	5.87e-03	1.89e-01	2.58e-01	8.27e-01	9.65e-01	2.02e-01	9.82e-01	4.64e-01	3.17e-01
GOBP RIBONUCLEOSIDE MONOPHOSPHATE CATABOLIC PROCESS	13	3.45e-01	4.61e-01	0.4630	5.99e-02	-3.11e-02	3.45e-01	-4.43e-02	-5.83e-02	2.92e-01	7.09e-01	8.46e-01	3.14e-02	7.82e-01	7.16e-01	6.81e-02
GOBP NEURON PROJECTION ARBORIZATION	26	3.51e-02	9.03e-02	0.4630	5.47e-02	3.28e-01	1.47e-01	2.16e-01	1.86e-01	2.85e-02	6.29e-01	3.81e-03	1.96e-01	5.61e-02	1.01e-01	8.01e-01
GOBP REGULATION OF CALCIUM ION TRANSPORT INTO CYTOSOL	10	3.60e-01	4.75e-01	0.4620	1.17e-01	-2.64e-01	2.23e-01	3.65e-02	-1.99e-01	1.98e-01	5.20e-01	1.48e-01	2.22e-01	8.41e-01	2.75e-01	2.78e-01
GOBP DETECTION OF TEMPERATURE STIMULUS	14	2.77e-02	7.55e-02	0.4620	-2.59e-01	-2.91e-01	1.03e-01	2.14e-01	-2.53e-03	7.30e-02	9.32e-02	5.91e-02	5.04e-01	1.66e-01	9.87e-01	6.36e-01
GOBP MYOSIN FILAMENT ORGANIZATION	6	6.54e-01	7.25e-01	0.4620	2.93e-01	3.46e-01	-1.11e-02	-4.60e-02	5.10e-02	-5.49e-02	2.14e-01	1.42e-01	9.63e-01	8.45e-01	8.29e-01	8.16e-01
GOBP AROMATIC AMINO ACID TRANSPORT	11	1.52e-01	2.63e-01	0.4620	-2.23e-01	-2.08e-01	2.32e-02	2.26e-01	-2.38e-01	1.08e-01	1.99e-01	2.32e-01	8.94e-01	1.94e-01	1.71e-01	5.33e-01
GOBP CELLULAR RESPONSE TO TESTOSTERONE STIMULUS	11	5.44e-01	6.34e-01	0.4620	-1.73e-01	3.03e-02	1.81e-01	-1.57e-01	-1.64e-01	3.13e-01	3.19e-01	8.62e-01	2.99e-01	3.66e-01	3.47e-01	7.21e-02
GOBP FIBROBLAST ACTIVATION	12	4.57e-01	5.63e-01	0.4620	-1.43e-01	1.71e-02	3.26e-01	-1.48e-01	-1.77e-01	1.83e-01	3.92e-01	9.19e-01	5.06e-02	3.75e-01	2.89e-01	2.72e-01
GOMF ATPASE COUPLED INORGANIC ANION TRANSMEMBRANE TRANSPORTER ACTIVITY	9	5.39e-01	6.30e-01	0.4620	-5.46e-02	-2.04e-02	3.17e-01	-1.83e-01	-2.75e-01	1.90e-02	7.77e-01	9.16e-01	9.93e-02	3.42e-01	1.54e-01	9.21e-01
GOBP CELLULAR RESPONSE TO PROSTAGLANDIN E STIMULUS	14	3.39e-02	8.79e-02	0.4620	-3.82e-01	7.43e-02	2.28e-01	-3.97e-02	-3.64e-02	8.42e-02	1.34e-02	6.30e-01	1.39e-01	7.97e-01	8.14e-01	5.85e-01
GOMF PATTERN RECOGNITION RECEPTOR ACTIVITY	31	1.37e-03	6.68e-03	0.4620	-2.41e-01	2.60e-01	9.60e-02	-2.71e-01	3.68e-02	5.83e-02	2.01e-02	1.22e-02	3.55e-01	9.00e-03	7.23e-01	5.74e-01
GOBP MULTIVESICULAR BODY ORGANIZATION	30	7.01e-03	2.59e-02	0.4620	-2.40e-01	-2.63e-01	1.04e-02	9.76e-02	-9.83e-02	2.59e-01	2.31e-02	1.25e-02	9.22e-01	3.55e-01	3.52e-01	1.42e-02
GOBP PROTEIN K29 LINKED UBIQUITINATION	10	1.51e-01	2.62e-01	0.4620	-1.65e-01	-1.68e-01	7.98e-02	3.64e-01	-5.48e-02	1.26e-01	3.67e-01	3.58e-01	6.62e-01	4.63e-02	7.64e-01	4.90e-01
GOBP POSITIVE REGULATION OF EXCITATORY POSTSYNAPTIC POTENTIAL	23	2.96e-02	7.94e-02	0.4620	8.38e-02	8.46e-02	1.92e-01	3.19e-01	2.32e-01	8.02e-02	4.87e-01	4.82e-01	1.10e-01	8.18e-03	5.39e-02	5.05e-01
GOCC PLASMA MEMBRANE RAFT	88	2.11e-06	2.08e-05	0.4610	3.89e-02	1.46e-01	3.50e-01	5.32e-02	-9.27e-02	2.37e-01	5.28e-01	1.79e-02	1.34e-08	3.89e-01	1.33e-01	1.24e-04
GOBP EYE PHOTORECEPTOR CELL DEVELOPMENT	21	2.49e-02	6.99e-02	0.4610	-1.41e-01	1.19e-01	7.03e-02	-2.67e-01	-2.11e-01	-2.41e-01	2.63e-01	3.45e-01	5.77e-01	3.44e-02	9.35e-02	5.59e-02
GOBP POSITIVE REGULATION OF CALCIUM ION IMPORT ACROSS PLASMA MEMBRANE	8	7.09e-01	7.69e-01	0.4610	-1.04e-01	1.96e-01	2.64e-01	-1.69e-01	-1.26e-01	2.22e-01	6.11e-01	3.37e-01	1.95e-01	4.07e-01	5.39e-01	2.77e-01
GOBP DERMATAN SULFATE PROTEOGLYCAN BIOSYNTHETIC PROCESS	8	5.18e-01	6.12e-01	0.4610	-7.48e-03	-1.65e-01	1.34e-01	-1.29e-02	-4.01e-01	-7.91e-02	9.71e-01	4.18e-01	5.12e-01	9.50e-01	4.94e-02	6.98e-01
GOMF DOPAMINE RECEPTOR BINDING	11	1.35e-01	2.42e-01	0.4610	-3.16e-01	-7.84e-02	1.37e-01	1.78e-01	-1.38e-01	1.94e-01	6.99e-02	6.53e-01	4.31e-01	3.07e-01	4.29e-01	2.66e-01
GOBP RESPONSE TO NITRIC OXIDE	15	2.17e-01	3.35e-01	0.4610	-2.07e-01	-1.29e-01	2.27e-01	2.72e-02	-2.46e-01	2.02e-01	1.65e-01	3.86e-01	1.29e-01	8.55e-01	9.93e-02	1.76e-01
GOBP PROTEIN TRANSPORT WITHIN LIPID BILAYER	6	7.92e-01	8.32e-01	0.4610	-2.07e-01	-1.74e-01	-1.44e-01	-7.42e-02	-2.97e-01	-1.59e-01	3.81e-01	4.60e-01	5.40e-01	7.53e-01	2.08e-01	5.01e-01
GOBP ADP BIOSYNTHETIC PROCESS	5	3.49e-01	4.65e-01	0.4610	1.67e-01	-7.77e-02	3.05e-02	-1.76e-01	2.30e-01	3.06e-01	5.19e-01	7.63e-01	9.06e-01	4.95e-01	3.74e-01	2.36e-01
GOBP INTERNAL PROTEIN AMINO ACID ACETYLATION	10	1.30e-01	2.36e-01	0.4610	1.07e-01	1.28e-01	1.15e-02	3.47e-01	-1.07e-01	-2.29e-01	5.57e-01	4.85e-01	9.50e-01	5.73e-02	5.57e-01	2.10e-01
GOBP POSITIVE REGULATION OF MONOCYTE CHEMOTAXIS	14	8.25e-02	1.70e-01	0.4610	-2.04e-01	-8.84e-02	-6.96e-02	-3.63e-02	2.07e-01	3.37e-01	1.86e-01	5.67e-01	6.52e-01	8.14e-01	1.81e-01	2.89e-02
GOBP NEGATIVE REGULATION OF VASCULAR ENDOTHELIAL GROWTH FACTOR RECEPTOR SIGNALING PATHWAY	11	3.36e-01	4.54e-01	0.4610	-2.86e-02	1.69e-01	2.96e-01	2.35e-01	3.79e-03	1.99e-01	8.69e-01	3.31e-01	8.88e-02	1.76e-01	9.83e-01	2.54e-01
GOMF CALCIUM INDEPENDENT PHOSPHOLIPASE A2 ACTIVITY	8	4.91e-01	5.90e-01	0.4610	-2.65e-01	8.92e-04	2.61e-01	1.54e-02	6.83e-03	2.71e-01	1.94e-01	9.97e-01	2.02e-01	9.40e-01	9.73e-01	1.84e-01
GOMF LIGAND ACTIVATED TRANSCRIPTION FACTOR ACTIVITY	39	1.22e-07	1.48e-06	0.4610	-1.51e-01	2.80e-01	1.21e-01	7.64e-02	2.08e-01	-2.18e-01	1.03e-01	2.48e-03	1.92e-01	4.09e-01	2.47e-02	1.87e-02
GOBP HIGH DENSITY LIPOPROTEIN PARTICLE CLEARANCE	7	3.95e-01	5.08e-01	0.4610	1.24e-01	2.46e-01	2.06e-01	6.41e-02	5.99e-02	-2.93e-01	5.71e-01	2.59e-01	3.45e-01	7.69e-01	7.84e-01	1.79e-01
GOMF NEUROTRANSMITTER RECEPTOR ACTIVITY	34	4.67e-02	1.12e-01	0.4610	2.05e-01	3.32e-01	1.79e-01	8.22e-02	1.39e-01	4.08e-02	3.86e-02	8.03e-04	7.06e-02	4.07e-01	1.62e-01	6.81e-01
GOBP MORPHOGENESIS OF AN EPITHELIAL FOLD	11	1.23e-01	2.27e-01	0.4600	-2.02e-01	3.46e-01	1.34e-01	-7.46e-02	1.44e-01	-8.22e-02	2.46e-01	4.67e-02	4.42e-01	6.68e-01	4.07e-01	6.37e-01
GOBP INTERLEUKIN 18 PRODUCTION	11	1.36e-01	2.43e-01	0.4600	-2.11e-01	3.26e-01	8.61e-02	-1.75e-01	2.77e-02	-1.50e-01	2.26e-01	6.12e-02	6.21e-01	3.15e-01	8.74e-01	3.90e-01
GOMF RNA POLYMERASE II GENERAL TRANSCRIPTION INITIATION FACTOR ACTIVITY	36	5.98e-04	3.27e-03	0.4600	-2.47e-01	-3.00e-01	-3.49e-02	-3.56e-02	6.26e-02	2.33e-01	1.03e-02	1.81e-03	7.17e-01	7.12e-01	5.16e-01	1.56e-02
GOBP NEGATIVE REGULATION OF MRNA PROCESSING	21	5.16e-02	1.20e-01	0.4600	-9.18e-02	-3.16e-01	-1.31e-01	1.24e-01	-2.09e-01	-1.66e-01	4.67e-01	1.22e-02	2.99e-01	3.27e-01	9.67e-02	1.89e-01
GOBP NEGATIVE REGULATION OF ACTIVATED T CELL PROLIFERATION	14	9.53e-02	1.89e-01	0.4600	-8.32e-03	-2.04e-02	2.89e-01	2.92e-01	-1.38e-01	1.53e-01	9.57e-01	8.95e-01	6.10e-02	5.87e-02	3.70e-01	3.23e-01
GOBP PEROXISOME FISSION	10	2.98e-01	4.17e-01	0.4600	-1.51e-01	-3.73e-01	-1.13e-03	2.29e-02	2.39e-02	2.22e-01	4.10e-01	4.14e-02	9.95e-01	9.00e-01	8.96e-01	2.25e-01
GOBP INTERLEUKIN 23 PRODUCTION	8	4.70e-01	5.72e-01	0.4600	-4.02e-02	3.71e-01	2.22e-01	1.20e-01	8.14e-02	4.47e-02	8.44e-01	6.91e-02	2.78e-01	5.57e-01	6.90e-01	8.27e-01
GOBP POSITIVE REGULATION OF TYPE I INTERFERON MEDIATED SIGNALING PATHWAY	17	3.14e-01	4.34e-01	0.4600	1.70e-01	1.34e-01	2.31e-01	2.79e-01	3.60e-02	1.79e-01	2.25e-01	3.38e-01	9.93e-02	4.66e-02	7.97e-01	2.00e-01
GOMF NAD BINDING	51	1.59e-04	1.02e-03	0.4600	-2.38e-01	-3.50e-01	-1.46e-01	7.80e-02	-5.53e-02	-4.51e-02	3.34e-03	1.54e-05	7.09e-02	3.35e-01	4.94e-01	5.78e-01
GOBP FRUCTOSE 6 PHOSPHATE METABOLIC PROCESS	11	4.64e-01	5.68e-01	0.4590	-2.79e-01	-6.06e-02	2.32e-01	-1.55e-01	-1.36e-01	1.82e-01	1.09e-01	7.28e-01	1.82e-01	3.75e-01	4.36e-01	2.95e-01
GOBP FATTY ACID BETA OXIDATION USING ACYL COA OXIDASE	12	1.70e-01	2.84e-01	0.4590	-2.41e-01	-7.98e-02	1.39e-01	2.93e-03	1.73e-01	3.12e-01	1.48e-01	6.32e-01	4.06e-01	9.86e-01	2.99e-01	6.13e-02
GOCC OMEGASOME	5	4.67e-01	5.70e-01	0.4590	-1.30e-01	-1.12e-01	9.98e-02	3.70e-01	-1.85e-01	2.46e-02	6.15e-01	6.63e-01	6.99e-01	1.52e-01	4.74e-01	9.24e-01
GOBP POSITIVE REGULATION OF MITOCHONDRIAL CALCIUM ION CONCENTRATION	9	2.30e-01	3.49e-01	0.4590	-1.08e-01	-2.19e-01	1.17e-01	-5.49e-02	1.52e-01	3.34e-01	5.75e-01	2.56e-01	5.44e-01	7.76e-01	4.28e-01	8.27e-02
GOBP NEUTROPHIL HOMEOSTASIS	19	1.42e-02	4.53e-02	0.4590	-1.94e-01	2.64e-02	2.72e-01	9.86e-02	1.69e-01	2.46e-01	1.43e-01	8.42e-01	4.02e-02	4.57e-01	2.03e-01	6.36e-02
GOBP GLYCOLYTIC PROCESS THROUGH FRUCTOSE 6 PHOSPHATE	22	3.27e-03	1.39e-02	0.4590	-2.13e-01	-3.96e-02	3.29e-01	1.01e-01	-1.74e-01	1.21e-01	8.37e-02	7.48e-01	7.47e-03	4.13e-01	1.58e-01	3.26e-01
GOBP CELLULAR RESPONSE TO GLUCOSE STARVATION	43	8.38e-07	8.85e-06	0.4590	-2.33e-01	-1.07e-01	2.09e-01	1.28e-01	-2.85e-01	6.11e-02	8.08e-03	2.26e-01	1.79e-02	1.48e-01	1.24e-03	4.88e-01
GOBP PLACENTA BLOOD VESSEL DEVELOPMENT	24	8.29e-04	4.34e-03	0.4590	-2.51e-01	3.30e-02	3.56e-01	-9.22e-02	-9.49e-02	4.69e-02	3.35e-02	7.80e-01	2.54e-03	4.34e-01	4.21e-01	6.91e-01
GOBP METANEPHRIC COLLECTING DUCT DEVELOPMENT	6	7.89e-01	8.29e-01	0.4580	-7.33e-02	-7.48e-03	-2.34e-01	1.88e-01	1.55e-01	-3.01e-01	7.56e-01	9.75e-01	3.21e-01	4.24e-01	5.11e-01	2.02e-01
GOBP REGULATION OF SULFUR METABOLIC PROCESS	12	2.02e-01	3.19e-01	0.4580	-2.47e-01	-5.03e-02	1.69e-01	1.46e-01	6.89e-02	3.03e-01	1.39e-01	7.63e-01	3.11e-01	3.80e-01	6.80e-01	6.91e-02
GOCC PERICENTRIOLAR MATERIAL	22	4.32e-02	1.05e-01	0.4580	-7.10e-02	1.64e-01	-1.31e-01	5.54e-02	3.96e-01	3.54e-02	5.64e-01	1.82e-01	2.86e-01	6.53e-01	1.32e-03	7.74e-01
GOBP NEUTROPHIL MEDIATED CYTOTOXICITY	11	1.21e-01	2.25e-01	0.4580	8.30e-02	-1.62e-01	3.21e-01	1.86e-01	-1.98e-01	1.07e-03	6.33e-01	3.53e-01	6.53e-02	2.85e-01	2.56e-01	9.95e-01
GOBP CEREBRAL CORTEX NEURON DIFFERENTIATION	14	4.13e-01	5.24e-01	0.4580	5.73e-02	2.94e-01	1.87e-01	5.24e-02	1.86e-01	2.20e-01	7.11e-01	5.71e-02	2.27e-01	7.34e-01	2.29e-01	1.54e-01
GOBP MITOCHONDRIAL TRANSPORT	167	4.09e-14	1.02e-12	0.4580	-1.77e-01	-3.69e-01	-1.97e-01	-1.13e-02	-4.20e-02	-4.11e-02	7.90e-05	1.81e-16	1.13e-05	8.01e-01	3.49e-01	3.59e-01
GOBP LEUKOCYTE DEGRANULATION	70	3.19e-06	3.04e-05	0.4580	-3.89e-02	1.65e-01	3.21e-01	1.30e-01	-3.73e-02	2.45e-01	5.74e-01	1.73e-02	3.48e-06	5.97e-02	5.90e-01	3.88e-04
GOBP CYTOPLASMIC TRANSLATIONAL ELONGATION	5	8.11e-01	8.48e-01	0.4580	-2.19e-01	-3.41e-01	7.69e-02	-1.37e-01	-9.51e-02	1.08e-01	3.95e-01	1.87e-01	7.66e-01	5.96e-01	7.13e-01	6.76e-01
GOMF ZINC ION TRANSMEMBRANE TRANSPORTER ACTIVITY	19	2.22e-02	6.42e-02	0.4580	-2.70e-01	-1.54e-02	1.61e-01	1.86e-01	1.44e-02	2.76e-01	4.14e-02	9.08e-01	2.26e-01	1.62e-01	9.13e-01	3.73e-02
GOBP REGULATION OF HEMATOPOIETIC STEM CELL PROLIFERATION	11	1.59e-01	2.72e-01	0.4580	-2.55e-01	2.23e-01	-2.59e-01	-5.71e-02	1.38e-01	-7.62e-02	1.44e-01	2.00e-01	1.37e-01	7.43e-01	4.28e-01	6.62e-01
GOMF ALPHA CATENIN BINDING	7	5.71e-01	6.58e-01	0.4580	-1.74e-01	1.39e-01	2.07e-01	-3.02e-01	-1.30e-01	-9.70e-02	4.26e-01	5.25e-01	3.43e-01	1.67e-01	5.51e-01	6.57e-01
GOMF CAMP RESPONSE ELEMENT BINDING PROTEIN BINDING	9	1.17e-01	2.20e-01	0.4580	1.24e-01	-1.39e-01	1.71e-01	2.41e-01	-1.28e-01	-2.67e-01	5.20e-01	4.70e-01	3.75e-01	2.11e-01	5.06e-01	1.65e-01
GOCC SPERM PRINCIPAL PIECE	22	1.63e-02	5.05e-02	0.4580	7.81e-02	2.17e-01	-1.01e-01	-1.16e-01	3.64e-01	-1.32e-02	5.26e-01	7.79e-02	4.11e-01	3.47e-01	3.14e-03	9.15e-01
GOCC CYTOPLASMIC SIDE OF LYSOSOMAL MEMBRANE	13	1.64e-01	2.77e-01	0.4580	-5.14e-02	-3.27e-01	-2.08e-03	5.34e-02	-4.88e-02	3.08e-01	7.48e-01	4.12e-02	9.90e-01	7.39e-01	7.61e-01	5.48e-02
GOBP POSITIVE REGULATION OF MACROPHAGE CHEMOTAXIS	15	2.42e-01	3.60e-01	0.4570	-1.16e-01	-2.38e-02	3.56e-01	-5.41e-02	-1.41e-01	2.14e-01	4.37e-01	8.73e-01	1.70e-02	7.17e-01	3.44e-01	1.51e-01
GOBP REGULATION OF CELLULAR RESPONSE TO HEAT	16	8.12e-02	1.68e-01	0.4570	-2.91e-02	1.23e-01	3.50e-01	1.96e-01	-1.07e-01	1.45e-01	8.40e-01	3.94e-01	1.53e-02	1.75e-01	4.60e-01	3.16e-01
GOBP PROTEIN LOCALIZATION TO NUCLEAR ENVELOPE	13	2.11e-01	3.28e-01	0.4570	-2.06e-01	-1.09e-01	2.04e-01	1.52e-01	-1.08e-01	2.81e-01	1.99e-01	4.98e-01	2.04e-01	3.43e-01	5.01e-01	7.94e-02
GOBP POSITIVE REGULATION OF TRANSCRIPTION REGULATORY REGION DNA BINDING	13	5.46e-01	6.36e-01	0.4570	-1.74e-01	-7.10e-02	2.18e-01	-2.25e-01	-2.17e-01	1.69e-01	2.76e-01	6.58e-01	1.74e-01	1.60e-01	1.76e-01	2.91e-01
GOBP DAMP METABOLIC PROCESS	6	7.93e-01	8.33e-01	0.4570	5.36e-02	4.17e-03	2.08e-01	5.46e-02	3.33e-02	3.98e-01	8.20e-01	9.86e-01	3.77e-01	8.17e-01	8.88e-01	9.10e-02
GOBP POSITIVE REGULATION OF INFLAMMASOME MEDIATED SIGNALING PATHWAY	21	2.71e-03	1.19e-02	0.4570	-2.99e-01	2.63e-01	1.01e-01	2.30e-02	-3.23e-02	1.97e-01	1.76e-02	3.69e-02	4.25e-01	8.55e-01	7.98e-01	1.19e-01
GOBP NEGATIVE REGULATION BY HOST OF VIRAL PROCESS	13	3.33e-01	4.50e-01	0.4570	-3.06e-01	-9.98e-02	1.89e-01	-1.52e-01	-1.96e-01	8.93e-02	5.57e-02	5.33e-01	2.37e-01	3.42e-01	2.22e-01	5.77e-01
GOMF NITRIC OXIDE SYNTHASE REGULATOR ACTIVITY	7	8.46e-01	8.75e-01	0.4570	1.62e-01	1.47e-01	2.45e-01	2.01e-01	1.49e-01	1.97e-01	4.58e-01	5.00e-01	2.62e-01	3.58e-01	4.94e-01	3.68e-01
GOBP LYMPH VESSEL DEVELOPMENT	18	1.98e-01	3.14e-01	0.4570	3.62e-03	2.95e-01	2.09e-01	1.23e-01	1.86e-01	1.68e-01	9.79e-01	3.00e-02	1.25e-01	3.65e-01	1.71e-01	2.17e-01
GOBP CELLULAR MODIFIED AMINO ACID CATABOLIC PROCESS	21	2.48e-02	6.97e-02	0.4570	7.91e-02	-1.52e-01	1.14e-01	1.60e-01	1.02e-01	3.62e-01	5.31e-01	2.27e-01	3.66e-01	2.06e-01	4.20e-01	4.12e-03
GOBP MRNA 5 SPLICE SITE RECOGNITION	7	1.46e-01	2.56e-01	0.4570	4.62e-02	-6.11e-02	-4.31e-01	4.35e-02	-1.23e-01	-4.30e-03	8.33e-01	7.79e-01	4.81e-02	8.42e-01	5.74e-01	9.84e-01
GOBP REGULATION OF SYSTEMIC ARTERIAL BLOOD PRESSURE BY CIRCULATORY RENIN ANGIOTENSIN	12	2.70e-01	3.90e-01	0.4570	-2.98e-01	2.72e-02	1.84e-01	-7.10e-02	5.51e-02	2.79e-01	7.40e-02	8.70e-01	2.71e-01	6.70e-01	7.41e-01	9.46e-02
GOBP RNA POLYMERASE I PREINITIATION COMPLEX ASSEMBLY	9	5.26e-01	6.19e-01	0.4570	-1.43e-02	-1.37e-01	-2.27e-01	2.64e-01	2.44e-02	-2.60e-01	9.41e-01	4.76e-01	2.38e-01	1.70e-01	8.99e-01	1.77e-01
GOBP RIBOSE PHOSPHATE BIOSYNTHETIC PROCESS	210	1.89e-23	1.03e-21	0.4570	-1.37e-01	-4.07e-01	-1.07e-01	7.89e-02	-6.16e-02	5.45e-02	6.43e-04	2.65e-24	7.48e-03	4.87e-02	1.24e-01	1.73e-01
GOBP MELANOSOME ASSEMBLY	19	3.29e-02	8.59e-02	0.4570	-3.94e-01	-1.41e-01	6.05e-03	7.65e-02	-4.10e-02	1.62e-01	2.98e-03	2.87e-01	9.64e-01	5.64e-01	7.57e-01	2.21e-01
GOBP DNA REPAIR DEPENDENT CHROMATIN REMODELING	22	1.75e-02	5.32e-02	0.4570	-1.39e-01	-1.62e-01	-8.07e-02	3.06e-01	2.21e-01	1.19e-01	2.61e-01	1.88e-01	5.12e-01	1.30e-02	7.29e-02	3.33e-01
GOCC AMPHISOME	13	2.97e-01	4.17e-01	0.4560	-2.00e-01	-3.61e-01	-7.89e-02	4.14e-02	-4.54e-02	1.67e-01	2.12e-01	2.42e-02	6.22e-01	7.96e-01	7.77e-01	2.96e-01
GOCC NEURONAL DENSE CORE VESICLE	11	1.56e-01	2.68e-01	0.4560	-1.44e-01	3.67e-01	-5.14e-02	1.09e-01	1.84e-01	-6.74e-02	4.09e-01	3.49e-02	7.68e-01	5.30e-01	2.92e-01	6.99e-01
GOBP NEGATIVE REGULATION OF VIRAL ENTRY INTO HOST CELL	17	5.06e-02	1.18e-01	0.4560	-5.93e-03	-1.92e-02	1.54e-01	3.44e-01	-1.12e-01	2.30e-01	9.66e-01	8.91e-01	2.71e-01	1.40e-02	4.24e-01	1.00e-01
GOBP NUCLEOSIDE MONOPHOSPHATE BIOSYNTHETIC PROCESS	38	4.90e-04	2.76e-03	0.4560	-1.71e-01	-3.78e-01	-1.16e-01	1.44e-01	2.90e-02	3.28e-02	6.82e-02	5.55e-05	2.16e-01	1.24e-01	7.57e-01	7.26e-01
GOBP MITOTIC INTRA S DNA DAMAGE CHECKPOINT SIGNALING	16	3.18e-01	4.37e-01	0.4560	5.37e-02	1.77e-02	-1.68e-01	2.92e-01	3.03e-01	-5.10e-03	7.10e-01	9.03e-01	2.45e-01	4.33e-02	3.61e-02	9.72e-01
GOBP REGULATION OF OVARIAN FOLLICLE DEVELOPMENT	6	5.45e-01	6.35e-01	0.4560	1.46e-01	4.63e-02	6.40e-02	1.96e-01	2.40e-01	-2.91e-01	5.35e-01	8.44e-01	7.86e-01	4.06e-01	3.09e-01	2.17e-01
GOBP ANTIGEN PROCESSING AND PRESENTATION OF PEPTIDE OR POLYSACCHARIDE ANTIGEN VIA MHC CLASS II	33	4.84e-04	2.73e-03	0.4560	-6.32e-02	-1.56e-01	-1.43e-01	1.59e-01	3.14e-01	-1.88e-01	5.30e-01	1.20e-01	1.54e-01	1.14e-01	1.80e-03	6.19e-02
GOBP SYNAPTIC TRANSMISSION GABAERGIC	35	4.32e-03	1.74e-02	0.4560	1.77e-02	2.95e-01	2.76e-01	-1.35e-01	-1.48e-01	6.51e-02	8.56e-01	2.48e-03	4.71e-03	1.68e-01	1.30e-01	5.05e-01
GOBP CELL MOTILITY INVOLVED IN CEREBRAL CORTEX RADIAL GLIA GUIDED MIGRATION	7	8.03e-01	8.42e-01	0.4560	-2.16e-01	-2.03e-01	-9.88e-02	-1.08e-01	-2.66e-01	-1.67e-01	3.22e-01	3.52e-01	6.51e-01	6.20e-01	2.24e-01	4.43e-01
GOBP CELL FATE COMMITMENT INVOLVED IN FORMATION OF PRIMARY GERM LAYER	18	4.89e-02	1.15e-01	0.4560	-2.25e-01	7.84e-02	3.16e-01	-1.52e-01	5.95e-03	1.68e-01	9.89e-02	5.65e-01	2.03e-02	2.64e-01	9.65e-01	2.17e-01
GOBP NEGATIVE REGULATION OF ANTIGEN RECEPTOR MEDIATED SIGNALING PATHWAY	32	2.75e-02	7.53e-02	0.4560	1.74e-01	2.20e-01	8.55e-02	2.86e-01	1.10e-01	1.67e-01	8.91e-02	3.09e-02	4.03e-01	5.16e-03	2.80e-01	1.02e-01
GOCC SYNAPSE ASSOCIATED EXTRACELLULAR MATRIX	5	7.63e-01	8.10e-01	0.4560	1.00e-01	2.49e-01	4.99e-03	-2.05e-01	4.55e-02	-3.02e-01	6.98e-01	3.34e-01	9.85e-01	4.27e-01	8.60e-01	2.42e-01
GOCC TRAMP COMPLEX	5	7.60e-01	8.07e-01	0.4560	-1.25e-01	6.83e-02	-1.42e-01	6.93e-02	3.72e-01	1.54e-01	6.29e-01	7.92e-01	5.82e-01	7.88e-01	1.49e-01	5.51e-01
GOBP ANTIGEN PROCESSING AND PRESENTATION OF ENDOGENOUS PEPTIDE ANTIGEN	19	1.65e-01	2.77e-01	0.4560	-8.97e-02	-1.91e-01	-2.88e-01	2.10e-01	1.75e-01	-7.62e-02	4.98e-01	1.49e-01	2.99e-02	1.14e-01	1.87e-01	5.65e-01
GOBP SECRETORY GRANULE LOCALIZATION	15	2.24e-01	3.42e-01	0.4560	3.88e-02	3.89e-01	7.29e-02	1.06e-01	1.92e-01	-3.98e-02	7.95e-01	9.16e-03	6.25e-01	4.76e-01	1.98e-01	7.90e-01
GOBP T HELPER 17 TYPE IMMUNE RESPONSE	43	7.56e-04	4.01e-03	0.4560	1.20e-01	3.77e-01	1.57e-01	1.48e-01	6.46e-02	-2.12e-02	1.75e-01	1.91e-05	7.40e-02	9.27e-02	4.63e-01	8.10e-01
GOBP NEGATIVE REGULATION OF NITRIC OXIDE METABOLIC PROCESS	10	2.49e-01	3.68e-01	0.4560	5.92e-02	2.45e-01	2.78e-01	2.24e-01	1.09e-01	-6.90e-02	7.46e-01	1.80e-01	1.28e-01	2.20e-01	5.50e-01	7.06e-01
GOBP PLASMA MEMBRANE RAFT ORGANIZATION	8	5.90e-01	6.73e-01	0.4550	1.70e-01	-1.11e-01	3.05e-01	1.46e-01	-7.96e-02	2.14e-01	4.05e-01	5.87e-01	1.35e-01	4.75e-01	6.97e-01	2.95e-01
GOBP POSITIVE REGULATION OF MUSCLE HYPERTROPHY	21	1.59e-01	2.71e-01	0.4550	-1.13e-01	4.00e-02	2.72e-01	1.22e-02	-1.30e-01	3.19e-01	3.69e-01	7.51e-01	3.06e-02	9.23e-01	3.01e-01	1.15e-02
GOMF TAU PROTEIN BINDING	42	8.11e-04	4.27e-03	0.4550	-8.76e-04	-5.71e-02	2.91e-01	1.47e-01	-2.26e-01	2.16e-01	9.92e-01	5.22e-01	1.11e-03	9.90e-02	1.13e-02	1.53e-02
GOBP MITOCHONDRIAL PROTEIN CATABOLIC PROCESS	9	5.29e-01	6.21e-01	0.4550	-1.27e-01	-2.24e-01	-2.84e-01	1.37e-01	-1.29e-01	-1.56e-01	5.09e-01	2.44e-01	1.40e-01	4.76e-01	5.04e-01	4.17e-01
GOMF TRANSPORTER ACTIVATOR ACTIVITY	6	4.50e-01	5.56e-01	0.4550	9.19e-02	-5.80e-02	2.20e-01	3.75e-01	5.51e-02	-5.83e-02	6.97e-01	8.06e-01	3.51e-01	1.12e-01	8.15e-01	8.05e-01
GOBP PROTEIN LOCALIZATION TO CONDENSED CHROMOSOME	15	1.36e-01	2.44e-01	0.4550	-7.04e-02	-2.96e-01	-1.52e-01	2.49e-01	1.44e-01	9.37e-02	6.37e-01	4.75e-02	3.09e-01	9.56e-02	3.33e-01	5.30e-01
GOBP NEGATIVE REGULATION OF ANOIKIS	14	3.37e-01	4.55e-01	0.4550	-6.40e-02	-6.05e-02	2.77e-01	1.10e-01	-1.45e-01	2.98e-01	6.78e-01	6.95e-01	7.29e-02	4.75e-01	3.47e-01	5.34e-02
GOBP EMBRYONIC BRAIN DEVELOPMENT	15	1.44e-01	2.53e-01	0.4540	-1.21e-01	1.76e-01	1.15e-02	1.82e-01	3.49e-01	7.58e-02	4.16e-01	2.38e-01	9.38e-01	2.22e-01	1.93e-02	6.11e-01
GOBP TRANSLATIONAL ELONGATION	67	6.97e-06	6.12e-05	0.4540	-1.24e-01	-3.48e-01	-2.43e-01	7.95e-02	-6.54e-02	1.21e-02	7.93e-02	8.14e-07	5.83e-04	2.60e-01	3.54e-01	8.64e-01
GOBP REGULATION OF PROTEIN LOCALIZATION TO CHROMATIN	9	1.96e-01	3.13e-01	0.4540	-3.21e-02	1.77e-02	6.97e-02	4.47e-01	-1.37e-02	1.55e-02	8.67e-01	9.27e-01	7.17e-01	2.03e-02	9.43e-01	9.36e-01
GOBP POSITIVE REGULATION OF INTERLEUKIN 18 PRODUCTION	7	4.79e-01	5.81e-01	0.4540	-2.68e-01	1.54e-01	-5.98e-02	-1.52e-01	2.64e-01	-1.19e-01	2.20e-01	4.80e-01	7.84e-01	4.86e-01	2.26e-01	5.87e-01
GOCC N TERMINAL PROTEIN ACETYLTRANSFERASE COMPLEX	9	4.32e-01	5.41e-01	0.4540	-3.78e-01	-1.01e-01	-2.13e-01	1.28e-02	-7.52e-03	8.41e-02	4.94e-02	5.99e-01	2.68e-01	9.47e-01	9.69e-01	6.62e-01
GOBP GLAND MORPHOGENESIS	83	1.43e-06	1.46e-05	0.4540	7.95e-02	1.91e-01	3.38e-01	1.48e-01	9.92e-03	1.65e-01	2.10e-01	2.66e-03	1.01e-07	2.01e-02	8.76e-01	9.33e-03
GOBP TYPE B PANCREATIC CELL APOPTOTIC PROCESS	7	6.60e-01	7.29e-01	0.4540	-4.04e-02	-3.50e-01	-1.20e-02	-2.13e-01	-1.78e-01	7.00e-02	8.53e-01	1.09e-01	9.56e-01	3.30e-01	4.15e-01	7.49e-01
GOBP REGULATION OF SECONDARY HEART FIELD CARDIOBLAST PROLIFERATION	5	3.63e-01	4.78e-01	0.4540	-8.36e-02	1.50e-01	2.46e-01	1.57e-01	2.67e-01	-1.43e-01	7.46e-01	5.62e-01	3.41e-01	5.42e-01	3.02e-01	5.81e-01
GOBP REGULATION OF NUCLEAR TRANSCRIBED MRNA CATABOLIC PROCESS DEADENYLATION DEPENDENT DECAY	22	2.93e-02	7.88e-02	0.4540	-3.78e-01	5.04e-02	8.08e-03	-1.58e-01	-1.55e-01	1.07e-01	2.14e-03	6.82e-01	9.48e-01	2.00e-01	2.08e-01	3.87e-01
GOBP EPOXYGENASE P450 PATHWAY	6	8.18e-01	8.53e-01	0.4540	1.36e-01	2.94e-01	2.14e-01	-1.14e-01	3.90e-02	2.02e-01	5.64e-01	2.13e-01	3.63e-01	6.30e-01	8.69e-01	3.91e-01
GOBP POLYAMINE METABOLIC PROCESS	18	1.69e-01	2.81e-01	0.4540	-1.53e-01	-3.80e-01	-1.55e-01	-4.44e-02	-3.12e-02	-1.05e-01	2.61e-01	5.27e-03	2.53e-01	7.45e-01	8.18e-01	4.40e-01
GOBP ADENOSINE METABOLIC PROCESS	10	3.41e-01	4.58e-01	0.4540	8.26e-02	2.13e-01	2.91e-02	9.30e-02	1.71e-01	3.39e-01	6.51e-01	2.44e-01	8.73e-01	6.10e-01	3.48e-01	6.34e-02
GOBP MODIFICATION OF POSTSYNAPTIC STRUCTURE	18	3.17e-01	4.36e-01	0.4540	-1.13e-01	-1.68e-01	1.86e-01	-2.19e-01	-2.63e-01	1.14e-01	4.06e-01	2.17e-01	1.71e-01	1.08e-01	5.35e-02	4.03e-01
GOBP RESCUE OF STALLED RIBOSOME	29	8.52e-03	3.03e-02	0.4540	-1.37e-01	-3.22e-01	-2.53e-01	6.73e-02	-7.13e-02	9.97e-02	2.02e-01	2.73e-03	1.83e-02	5.30e-01	5.06e-01	3.53e-01
GOBP DNA LIGATION	16	2.27e-01	3.46e-01	0.4540	-1.15e-01	-2.51e-01	-2.78e-01	1.53e-01	1.68e-01	-2.53e-02	4.28e-01	8.24e-02	5.42e-02	2.88e-01	2.44e-01	8.61e-01
GOBP REGULATION OF CHOLESTEROL BIOSYNTHETIC PROCESS	14	3.65e-02	9.32e-02	0.4540	-1.41e-01	-2.81e-01	1.03e-01	2.96e-01	-8.82e-02	2.55e-02	3.60e-01	6.86e-02	5.05e-01	5.50e-02	5.68e-01	8.69e-01
GOCC CORNIFIED ENVELOPE	23	7.80e-02	1.63e-01	0.4530	5.56e-02	-1.03e-01	3.21e-01	-1.05e-01	-2.06e-01	1.88e-01	6.44e-01	3.91e-01	7.74e-03	3.85e-01	8.67e-02	1.19e-01
GOBP POSITIVE REGULATION OF T HELPER 1 TYPE IMMUNE RESPONSE	16	7.47e-02	1.58e-01	0.4530	-1.21e-01	1.52e-01	2.44e-01	-1.68e-01	-2.67e-01	-9.44e-02	4.02e-01	2.93e-01	9.12e-02	2.46e-01	6.44e-02	5.13e-01
GOBP REGULATION OF GLIAL CELL PROLIFERATION	31	9.32e-03	3.24e-02	0.4530	-1.26e-01	2.03e-01	2.57e-01	3.26e-02	1.11e-01	2.63e-01	2.25e-01	5.08e-02	1.34e-02	7.53e-01	2.84e-01	1.13e-02
GOBP FOREBRAIN CELL MIGRATION	47	2.29e-03	1.03e-02	0.4530	-2.74e-01	-3.19e-02	1.61e-01	-1.62e-01	-2.33e-01	1.51e-01	1.16e-03	7.05e-01	5.68e-02	5.44e-02	5.68e-03	7.29e-02
GOBP NEGATIVE REGULATION OF INCLUSION BODY ASSEMBLY	10	2.77e-01	3.97e-01	0.4530	1.08e-01	6.55e-02	2.80e-01	3.30e-01	-4.10e-02	2.13e-02	5.54e-01	7.20e-01	1.25e-01	7.10e-02	8.23e-01	9.07e-01
GOBP EXOCRINE SYSTEM DEVELOPMENT	33	2.56e-02	7.16e-02	0.4530	3.02e-02	5.05e-02	3.58e-01	-1.10e-01	-1.15e-01	2.20e-01	7.64e-01	6.16e-01	3.77e-04	2.73e-01	2.52e-01	2.84e-02
GOMF UNFOLDED PROTEIN BINDING	99	3.43e-11	6.48e-10	0.4530	-1.92e-01	-3.35e-01	-5.06e-02	1.63e-01	-5.74e-02	1.54e-01	9.89e-04	8.26e-09	3.84e-01	4.98e-03	3.23e-01	8.09e-03
GOBP SKELETAL MUSCLE CELL PROLIFERATION	19	8.12e-02	1.68e-01	0.4530	-3.11e-01	-9.66e-02	-1.15e-01	-1.45e-01	-1.51e-01	2.06e-01	1.91e-02	4.66e-01	3.87e-01	2.73e-01	2.54e-01	1.20e-01
GOMF LIGAND GATED MONOATOMIC ANION CHANNEL ACTIVITY	20	3.45e-02	8.89e-02	0.4530	1.27e-01	7.00e-02	3.61e-01	-2.00e-01	-1.18e-01	1.43e-02	3.27e-01	5.88e-01	5.25e-03	1.21e-01	3.60e-01	9.12e-01
GOMF PHOSPHATIDYLCHOLINE BINDING	24	3.02e-02	8.05e-02	0.4530	-2.92e-01	-1.87e-01	1.27e-01	5.01e-02	-1.33e-01	2.20e-01	1.32e-02	1.13e-01	2.82e-01	6.71e-01	2.59e-01	6.24e-02
GOBP SEQUESTERING OF EXTRACELLULAR LIGAND FROM RECEPTOR	9	2.96e-01	4.15e-01	0.4530	1.02e-01	1.33e-01	2.64e-01	-3.27e-01	7.62e-03	-3.66e-03	5.95e-01	4.91e-01	1.70e-01	8.90e-02	9.68e-01	9.85e-01
GOMF ESTROGEN RESPONSE ELEMENT BINDING	8	4.91e-01	5.90e-01	0.4530	-1.12e-01	3.64e-01	1.41e-01	-1.90e-01	6.35e-02	1.45e-02	5.82e-01	7.48e-02	4.91e-01	3.53e-01	7.56e-01	9.43e-01
GOBP NEGATIVE REGULATION OF CELLULAR RESPONSE TO HYPOXIA	8	3.52e-01	4.68e-01	0.4520	-1.32e-01	-4.21e-02	1.72e-01	1.47e-01	-3.45e-01	1.23e-01	5.17e-01	8.36e-01	4.00e-01	4.71e-01	9.09e-02	5.47e-01
GOMF SIGNAL SEQUENCE BINDING	44	9.93e-05	6.76e-04	0.4520	-3.45e-01	-1.96e-01	-1.14e-01	8.47e-02	-1.03e-01	1.29e-01	7.62e-05	2.48e-02	1.89e-01	3.31e-01	2.35e-01	1.40e-01
GOBP NUCLEOTIDE SUGAR TRANSMEMBRANE TRANSPORT	12	2.67e-01	3.86e-01	0.4520	-2.91e-01	-2.81e-01	-2.98e-02	5.48e-02	-1.76e-01	-7.89e-02	8.09e-02	9.21e-02	8.58e-01	7.42e-01	2.92e-01	6.36e-01
GOBP SINGLE STRANDED VIRAL RNA REPLICATION VIA DOUBLE STRANDED DNA INTERMEDIATE	19	9.34e-02	1.87e-01	0.4520	1.89e-01	-6.40e-02	1.13e-01	2.96e-01	-4.14e-02	2.50e-01	1.54e-01	6.29e-01	3.94e-01	2.56e-02	7.55e-01	5.91e-02
GOBP RAP PROTEIN SIGNAL TRANSDUCTION	13	1.44e-01	2.54e-01	0.4520	-3.46e-01	4.70e-02	2.00e-01	-8.59e-02	-1.69e-01	7.98e-02	3.06e-02	7.69e-01	2.12e-01	5.92e-01	2.92e-01	6.18e-01
GOMF CHLORIDE CHANNEL INHIBITOR ACTIVITY	6	3.04e-01	4.24e-01	0.4520	1.37e-01	-3.40e-01	-1.25e-01	-8.26e-02	5.99e-02	2.09e-01	5.62e-01	1.49e-01	5.95e-01	7.26e-01	7.99e-01	3.75e-01
GOBP DEDIFFERENTIATION	6	7.46e-01	7.97e-01	0.4520	2.80e-01	1.09e-01	1.97e-01	2.43e-02	-1.69e-01	2.13e-01	2.35e-01	6.44e-01	4.02e-01	9.18e-01	4.72e-01	3.65e-01
GOBP SPERMATID NUCLEUS DIFFERENTIATION	19	2.01e-01	3.18e-01	0.4520	-2.33e-01	-3.38e-02	1.59e-01	-1.17e-01	-9.92e-02	3.16e-01	7.93e-02	7.99e-01	2.29e-01	3.76e-01	4.54e-01	1.71e-02
GOBP NEGATIVE REGULATION OF CALCIUM ION IMPORT	8	5.60e-01	6.49e-01	0.4520	-4.17e-01	-3.26e-02	-1.11e-01	-1.18e-01	-3.78e-03	-5.11e-02	4.10e-02	8.73e-01	5.85e-01	5.64e-01	9.85e-01	8.02e-01
GOMF OLIGOPEPTIDE TRANSMEMBRANE TRANSPORTER ACTIVITY	11	2.24e-01	3.43e-01	0.4520	-3.37e-02	-1.20e-01	3.69e-01	1.02e-01	-8.48e-02	1.87e-01	8.47e-01	4.92e-01	3.42e-02	5.57e-01	6.26e-01	2.84e-01
GOBP NEGATIVE REGULATION OF CAMP MEDIATED SIGNALING	7	6.23e-01	7.01e-01	0.4520	2.53e-01	1.33e-02	1.20e-01	2.92e-01	-1.46e-01	1.38e-01	2.47e-01	9.51e-01	5.81e-01	1.82e-01	5.04e-01	5.27e-01
GOCC STEREOCILIUM TIP	17	1.36e-01	2.43e-01	0.4520	6.63e-02	1.02e-02	-2.47e-01	-2.28e-01	4.37e-02	-2.91e-01	6.36e-01	9.42e-01	7.83e-02	1.03e-01	7.55e-01	3.78e-02
GOBP POSITIVE REGULATION OF CALCIUM ION TRANSPORT INTO CYTOSOL	6	3.91e-01	5.05e-01	0.4520	3.69e-02	-4.20e-01	1.40e-01	5.07e-02	-5.31e-02	3.79e-02	8.75e-01	7.50e-02	5.54e-01	8.30e-01	8.22e-01	8.72e-01
GOBP POSITIVE REGULATION OF RECEPTOR RECYCLING	12	2.03e-01	3.19e-01	0.4510	-2.60e-01	4.24e-02	1.45e-01	1.02e-01	-1.09e-01	3.02e-01	1.18e-01	7.99e-01	3.85e-01	5.42e-01	5.14e-01	7.03e-02
GOBP REGULATION OF GERM CELL PROLIFERATION	7	3.55e-01	4.70e-01	0.4510	5.30e-02	-4.05e-01	-5.96e-02	1.01e-01	1.21e-01	9.34e-02	8.08e-01	6.37e-02	7.85e-01	6.43e-01	5.79e-01	6.69e-01
GOMF SIALIC ACID BINDING	16	1.13e-01	2.14e-01	0.4510	-1.09e-01	6.20e-02	3.76e-01	-1.16e-02	-1.82e-01	1.16e-01	4.50e-01	6.68e-01	9.23e-03	9.36e-01	2.08e-01	4.21e-01
GOBP ESTABLISHMENT OR MAINTENANCE OF TRANSMEMBRANE ELECTROCHEMICAL GRADIENT	8	5.62e-01	6.50e-01	0.4510	2.37e-01	-3.68e-02	6.51e-02	3.46e-01	4.70e-02	-1.41e-01	2.45e-01	8.57e-01	7.50e-01	9.04e-02	8.18e-01	4.89e-01
GOCC KINOCILIUM	8	7.18e-01	7.76e-01	0.4510	-8.15e-02	-1.27e-01	-2.87e-01	-2.27e-01	4.34e-02	-2.12e-01	6.90e-01	5.33e-01	1.60e-01	2.66e-01	8.32e-01	3.00e-01
GOCC ENZYME ACTIVATOR COMPLEX	13	2.70e-01	3.90e-01	0.4510	2.74e-02	-3.26e-01	6.55e-02	-3.67e-02	-2.39e-01	1.84e-01	8.64e-01	4.18e-02	6.83e-01	8.19e-01	1.36e-01	2.51e-01
GOBP REGULATION OF MIRNA CATABOLIC PROCESS	7	8.37e-01	8.68e-01	0.4510	-9.47e-02	3.71e-02	1.97e-01	-2.55e-01	-2.57e-01	1.52e-01	6.64e-01	8.65e-01	3.67e-01	2.43e-01	2.39e-01	4.86e-01
GOBP SECONDARY PALATE DEVELOPMENT	19	9.80e-02	1.93e-01	0.4510	2.02e-02	2.29e-01	2.06e-01	2.55e-01	1.72e-02	2.05e-01	8.79e-01	8.34e-02	1.19e-01	5.39e-02	8.97e-01	1.22e-01
GOBP RESPONSE TO GLUCAGON	11	7.17e-02	1.54e-01	0.4510	-1.56e-01	6.24e-02	1.17e-01	3.76e-01	1.41e-01	3.95e-03	3.69e-01	7.20e-01	5.01e-01	3.09e-02	4.17e-01	9.82e-01
GOBP HEART GROWTH	61	1.41e-06	1.44e-05	0.4510	-1.52e-02	1.77e-01	2.94e-01	2.33e-01	-3.00e-02	1.75e-01	8.38e-01	1.71e-02	7.29e-05	1.65e-03	6.85e-01	1.83e-02
GOBP GLUTAMATE CATABOLIC PROCESS	5	9.12e-01	9.27e-01	0.4510	-2.29e-01	-3.14e-01	-1.26e-01	-1.58e-01	-6.12e-02	-8.41e-02	3.75e-01	2.23e-01	6.25e-01	5.39e-01	8.13e-01	7.45e-01
GOBP POSITIVE REGULATION OF STEROID METABOLIC PROCESS	18	1.75e-02	5.32e-02	0.4510	2.55e-01	-4.00e-03	3.60e-01	9.02e-02	9.55e-03	-2.12e-02	6.09e-02	9.77e-01	8.24e-03	5.08e-01	9.44e-01	8.76e-01
GOMF CALCIUM DEPENDENT PHOSPHOLIPASE A2 ACTIVITY	8	5.04e-01	6.00e-01	0.4510	-2.80e-01	-1.45e-01	5.39e-02	-3.12e-01	3.29e-02	4.57e-02	1.70e-01	4.78e-01	7.92e-01	1.26e-01	8.72e-01	8.23e-01
GOBP AMMONIUM TRANSMEMBRANE TRANSPORT	7	6.81e-01	7.47e-01	0.4510	1.34e-01	3.38e-01	5.57e-02	8.48e-02	9.92e-02	-2.25e-01	5.39e-01	1.21e-01	7.99e-01	6.98e-01	6.49e-01	3.03e-01
GOBP REGULATION OF T HELPER 1 TYPE IMMUNE RESPONSE	28	2.86e-02	7.73e-02	0.4510	-9.60e-02	1.23e-01	3.25e-01	-7.34e-02	-2.19e-01	1.40e-01	3.79e-01	2.62e-01	2.90e-03	5.02e-01	4.45e-02	2.00e-01
GOCC BETA CATENIN DESTRUCTION COMPLEX	12	9.74e-02	1.92e-01	0.4510	8.83e-02	1.74e-01	1.43e-01	3.65e-01	-8.90e-02	-5.92e-02	5.96e-01	2.96e-01	3.90e-01	2.88e-02	5.93e-01	7.23e-01
GOMF INTERLEUKIN 1 RECEPTOR BINDING	10	9.06e-02	1.82e-01	0.4500	-1.95e-01	1.56e-01	2.84e-01	2.00e-01	1.27e-01	6.24e-02	2.85e-01	3.93e-01	1.20e-01	2.73e-01	4.88e-01	7.33e-01
GOCC IKAPPAB KINASE COMPLEX	7	3.41e-01	4.58e-01	0.4500	-2.58e-01	-1.41e-01	5.66e-02	1.82e-01	-2.83e-01	-3.25e-03	2.37e-01	5.19e-01	7.95e-01	4.04e-01	1.95e-01	9.88e-01
GOBP SERTOLI CELL DIFFERENTIATION	15	4.39e-01	5.46e-01	0.4500	1.08e-01	1.42e-01	2.83e-01	5.98e-02	8.27e-02	2.84e-01	4.70e-01	3.42e-01	5.75e-02	6.88e-01	5.79e-01	5.72e-02
GOMF NEUREGULIN BINDING	5	8.32e-01	8.65e-01	0.4500	-6.13e-02	4.24e-02	2.40e-01	-1.58e-01	5.47e-02	3.34e-01	8.12e-01	8.70e-01	3.53e-01	5.42e-01	8.32e-01	1.96e-01
GOMF NEUROTRANSMITTER RECEPTOR ACTIVITY INVOLVED IN REGULATION OF POSTSYNAPTIC MEMBRANE POTENTIAL	23	2.41e-01	3.59e-01	0.4500	2.27e-01	2.99e-01	1.86e-01	1.25e-01	8.59e-02	6.31e-02	5.93e-02	1.31e-02	1.23e-01	2.98e-01	4.76e-01	6.00e-01
GOBP NADPH REGENERATION	21	2.25e-02	6.48e-02	0.4500	-2.67e-01	-2.98e-01	5.14e-02	1.22e-01	-1.50e-01	5.02e-02	3.43e-02	1.81e-02	6.84e-01	3.34e-01	2.35e-01	6.91e-01
GOBP TRNA PSEUDOURIDINE SYNTHESIS	6	7.54e-01	8.04e-01	0.4500	-5.77e-02	-4.14e-01	-1.13e-01	3.26e-02	-1.07e-01	4.73e-02	8.07e-01	7.89e-02	6.30e-01	8.90e-01	6.51e-01	8.41e-01
GOBP REGULATION OF FIBROBLAST APOPTOTIC PROCESS	16	1.21e-01	2.25e-01	0.4500	-2.04e-01	5.97e-02	1.59e-01	1.31e-01	-8.01e-03	3.38e-01	1.57e-01	6.79e-01	2.71e-01	3.65e-01	9.56e-01	1.91e-02
GOBP REGULATION OF POSTSYNAPTIC NEUROTRANSMITTER RECEPTOR INTERNALIZATION	16	4.22e-01	5.31e-01	0.4500	1.31e-01	1.44e-01	2.46e-01	1.67e-01	1.36e-01	2.39e-01	3.65e-01	3.20e-01	8.79e-02	2.47e-01	3.45e-01	9.78e-02
GOBP REGULATION OF TELOMERE MAINTENANCE IN RESPONSE TO DNA DAMAGE	19	1.05e-01	2.03e-01	0.4500	-6.55e-03	-2.34e-01	-1.96e-01	2.75e-01	4.39e-02	-1.77e-01	9.61e-01	7.78e-02	1.40e-01	3.76e-02	7.40e-01	1.82e-01
GOBP REGULATION OF MITOCHONDRIAL MEMBRANE PERMEABILITY INVOLVED IN APOPTOTIC PROCESS	37	1.30e-02	4.24e-02	0.4490	-8.88e-02	-2.95e-01	-2.23e-01	6.59e-02	-6.78e-02	-2.20e-01	3.50e-01	1.92e-03	1.87e-02	4.88e-01	4.75e-01	2.05e-02
GOBP REGULATION OF PLATELET DERIVED GROWTH FACTOR RECEPTOR SIGNALING PATHWAY	17	2.06e-01	3.23e-01	0.4490	1.79e-02	1.76e-01	2.43e-01	2.52e-01	7.34e-02	2.07e-01	8.98e-01	2.10e-01	8.22e-02	7.23e-02	6.00e-01	1.40e-01
GOBP REGULATION OF RESTING MEMBRANE POTENTIAL	6	3.22e-01	4.41e-01	0.4490	4.60e-02	1.42e-01	6.73e-02	1.78e-01	-3.03e-01	2.27e-01	8.45e-01	5.48e-01	7.75e-01	4.50e-01	1.98e-01	3.36e-01
GOBP EMBRYONIC EYE MORPHOGENESIS	16	4.84e-02	1.14e-01	0.4490	-3.35e-02	3.41e-01	2.71e-01	1.33e-02	-9.31e-02	-4.94e-02	8.16e-01	1.82e-02	6.08e-02	9.27e-01	5.19e-01	7.32e-01
GOBP REGULATION OF MIRNA METABOLIC PROCESS	74	2.86e-06	2.76e-05	0.4490	1.16e-02	2.27e-01	3.54e-01	2.66e-02	1.37e-02	1.54e-01	8.63e-01	7.28e-04	1.36e-07	6.92e-01	8.39e-01	2.19e-02
GOBP REGULATION OF CENTROMERIC SISTER CHROMATID COHESION	5	7.94e-01	8.34e-01	0.4490	-6.44e-03	-1.03e-01	-1.25e-01	3.96e-01	1.23e-01	-5.71e-02	9.80e-01	6.89e-01	6.28e-01	1.25e-01	6.35e-01	8.25e-01
GOBP VACUOLAR TRANSMEMBRANE TRANSPORT	7	1.62e-01	2.75e-01	0.4490	-1.87e-01	-1.84e-02	1.01e-01	3.76e-01	5.12e-02	-1.13e-01	3.92e-01	9.33e-01	6.45e-01	8.52e-02	8.15e-01	6.06e-01
GOBP MACROMOLECULE DEPALMITOYLATION	14	1.81e-01	2.96e-01	0.4490	-2.11e-01	-2.82e-01	-1.48e-01	-1.53e-02	8.50e-02	2.19e-01	1.71e-01	6.74e-02	3.37e-01	9.21e-01	5.82e-01	1.57e-01
GOMF PALMITOYL HYDROLASE ACTIVITY	14	1.81e-01	2.96e-01	0.4490	-2.11e-01	-2.82e-01	-1.48e-01	-1.53e-02	8.50e-02	2.19e-01	1.71e-01	6.74e-02	3.37e-01	9.21e-01	5.82e-01	1.57e-01
GOMF TRANSFERASE ACTIVITY TRANSFERRING ALKYL OR ARYL OTHER THAN METHYL GROUPS	52	2.67e-04	1.63e-03	0.4490	-1.24e-01	-3.71e-01	-1.55e-01	-1.39e-01	-6.19e-02	-3.31e-02	1.21e-01	3.59e-06	5.32e-02	8.34e-02	4.40e-01	6.79e-01
GOBP REGULATION OF SUBSTRATE ADHESION DEPENDENT CELL SPREADING	51	7.87e-07	8.37e-06	0.4490	-1.22e-01	-1.80e-01	2.83e-01	1.22e-01	-2.19e-01	1.06e-01	1.32e-01	2.60e-02	4.72e-04	1.31e-01	6.87e-03	1.89e-01
GOBP VESICLE MEDIATED CHOLESTEROL TRANSPORT	8	6.39e-01	7.14e-01	0.4490	-3.87e-02	1.59e-01	3.18e-01	1.61e-01	-8.59e-03	2.18e-01	8.50e-01	4.35e-01	1.19e-01	4.31e-01	9.66e-01	2.85e-01
GOBP REGULATION OF MEMBRANE REPOLARIZATION	23	1.72e-01	2.85e-01	0.4490	-7.64e-02	6.41e-02	2.68e-01	-1.98e-01	-2.43e-01	1.46e-01	5.26e-01	5.95e-01	2.60e-02	9.98e-02	4.41e-02	2.24e-01
GOCC SODIUM CHANNEL COMPLEX	16	4.01e-01	5.13e-01	0.4490	1.78e-01	2.61e-01	2.85e-01	-3.44e-02	3.56e-02	1.35e-01	2.17e-01	7.10e-02	4.85e-02	8.12e-01	8.05e-01	3.51e-01
GOCC SECRETORY GRANULE MEMBRANE	279	3.48e-27	2.74e-25	0.4490	-2.06e-01	1.21e-02	2.58e-01	-4.54e-03	-1.41e-01	2.69e-01	3.10e-09	7.29e-01	1.17e-13	8.96e-01	5.32e-05	1.04e-14
GOMF PEPTIDYL PROLINE DIOXYGENASE ACTIVITY	11	1.99e-01	3.14e-01	0.4490	-1.67e-01	-3.17e-01	-1.05e-01	1.59e-01	1.90e-01	-2.26e-02	3.36e-01	6.90e-02	5.46e-01	3.60e-01	2.75e-01	8.97e-01
GOBP POSITIVE REGULATION OF DNA TEMPLATED DNA REPLICATION	13	7.59e-02	1.60e-01	0.4490	5.98e-03	-2.30e-01	3.98e-02	2.92e-01	-2.20e-01	-1.15e-01	9.70e-01	1.51e-01	8.04e-01	6.83e-02	1.70e-01	4.73e-01
GOMF INSULIN BINDING	5	7.53e-01	8.03e-01	0.4490	5.93e-03	2.79e-01	3.38e-01	9.35e-02	-9.83e-03	2.09e-02	9.82e-01	2.81e-01	1.90e-01	7.17e-01	9.70e-01	9.36e-01
GOBP RESPONSE TO CHEMOKINE	65	1.43e-05	1.17e-04	0.4490	1.37e-01	7.80e-02	3.77e-01	6.78e-03	-1.59e-01	9.29e-02	5.69e-02	2.77e-01	1.41e-07	9.25e-01	2.65e-02	1.95e-01
GOMF ARP2 3 COMPLEX BINDING	13	2.00e-01	3.16e-01	0.4480	-3.99e-02	-1.97e-01	3.19e-01	4.12e-02	-1.81e-01	1.57e-01	8.03e-01	2.18e-01	4.68e-02	7.97e-01	2.58e-01	3.28e-01
GOBP NEGATIVE REGULATION OF PROTEIN LOCALIZATION TO MEMBRANE	29	8.32e-03	2.97e-02	0.4480	-2.66e-01	-1.93e-01	8.68e-02	8.81e-02	-2.11e-01	1.83e-01	1.33e-02	7.20e-02	4.18e-01	4.12e-01	4.89e-02	8.88e-02
GOBP RESPONSE TO TYPE I INTERFERON	68	6.73e-07	7.30e-06	0.4480	6.67e-02	2.80e-02	5.21e-02	3.44e-01	7.26e-02	2.64e-01	3.41e-01	6.89e-01	4.57e-01	9.31e-07	3.01e-01	1.71e-04
GOBP PURINE NUCLEOSIDE DIPHOSPHATE BIOSYNTHETIC PROCESS	6	3.29e-01	4.47e-01	0.4480	2.72e-01	-1.26e-01	8.00e-02	-2.13e-02	2.27e-01	2.30e-01	2.49e-01	5.93e-01	7.34e-01	9.28e-01	3.36e-01	3.30e-01
GOBP CARDIAC MUSCLE CELL ACTION POTENTIAL	57	1.58e-03	7.50e-03	0.4480	-1.37e-02	8.02e-02	3.11e-01	-1.41e-01	-1.81e-01	2.13e-01	8.58e-01	2.95e-01	4.97e-05	6.65e-02	1.84e-02	5.40e-03
GOBP TONIC SMOOTH MUSCLE CONTRACTION	5	6.89e-01	7.53e-01	0.4480	-2.30e-01	-2.81e-01	-1.05e-01	-2.56e-02	2.20e-01	9.53e-02	3.73e-01	2.77e-01	6.84e-01	9.21e-01	3.94e-01	7.12e-01
GOBP CORTICOTROPIN SECRETION	5	6.93e-01	7.56e-01	0.4480	-5.60e-02	1.56e-01	-1.77e-02	-3.41e-01	1.62e-01	-1.76e-01	8.28e-01	5.47e-01	9.45e-01	1.87e-01	5.31e-01	4.96e-01
GOMF VOLTAGE GATED POTASSIUM CHANNEL ACTIVITY	53	7.34e-04	3.91e-03	0.4480	1.66e-01	2.44e-01	3.14e-01	-8.29e-02	-3.07e-03	8.84e-02	3.63e-02	2.10e-03	7.53e-05	2.96e-01	9.69e-01	2.66e-01
GOCC NURD COMPLEX	16	2.85e-01	4.04e-01	0.4480	1.30e-01	-2.56e-03	9.37e-03	3.32e-01	2.67e-01	4.86e-02	3.69e-01	9.86e-01	9.48e-01	2.14e-02	6.46e-02	7.36e-01
GOBP REGULATION OF LIGASE ACTIVITY	9	4.40e-01	5.47e-01	0.4480	-7.44e-02	-2.73e-01	-2.99e-01	-4.64e-02	1.69e-01	1.63e-02	6.99e-01	1.56e-01	1.20e-01	8.09e-01	3.80e-01	9.33e-01
GOBP REGULATION OF FATTY ACID BETA OXIDATION	17	5.49e-02	1.26e-01	0.4480	8.41e-02	1.04e-01	-1.07e-01	1.36e-01	-7.71e-02	-3.83e-01	5.48e-01	4.56e-01	4.45e-01	3.32e-01	5.82e-01	6.22e-03
GOBP MICROVILLUS ORGANIZATION	27	4.27e-02	1.05e-01	0.4480	-2.29e-02	2.75e-01	2.48e-01	1.12e-01	1.25e-01	1.87e-01	8.37e-01	1.35e-02	2.60e-02	3.13e-01	2.60e-01	9.17e-02
GOBP TRICARBOXYLIC ACID METABOLIC PROCESS	14	9.43e-02	1.88e-01	0.4480	-3.37e-01	-2.35e-01	-6.53e-02	1.60e-01	4.06e-02	3.39e-03	2.90e-02	1.28e-01	6.72e-01	2.99e-01	7.93e-01	9.82e-01
GOBP REGULATION OF GLUCOCORTICOID METABOLIC PROCESS	8	3.83e-01	4.96e-01	0.4480	-5.42e-02	5.53e-02	1.80e-01	3.07e-01	-1.44e-01	2.16e-01	7.91e-01	7.87e-01	3.77e-01	1.33e-01	4.80e-01	2.89e-01
GOBP CELL JUNCTION DISASSEMBLY	21	4.90e-02	1.15e-01	0.4480	-1.47e-01	2.42e-01	2.89e-01	1.29e-02	-2.90e-02	1.89e-01	2.45e-01	5.45e-02	2.19e-02	9.19e-01	8.18e-01	1.34e-01
GOBP REGULATION OF PODOSOME ASSEMBLY	12	2.15e-01	3.32e-01	0.4480	-2.91e-01	-3.36e-02	1.42e-01	9.16e-02	8.16e-02	2.82e-01	8.09e-02	8.40e-01	3.96e-01	5.83e-01	6.25e-01	9.09e-02
GOMF GLUCOSE SODIUM SYMPORTER ACTIVITY	5	2.16e-01	3.34e-01	0.4480	1.65e-01	-2.21e-01	2.37e-01	1.04e-01	1.83e-01	-1.54e-01	5.22e-01	3.92e-01	3.60e-01	6.86e-01	4.78e-01	5.52e-01
GOBP DEPYRIMIDINATION	8	5.21e-01	6.14e-01	0.4470	1.61e-01	-2.80e-01	-2.50e-01	1.73e-01	2.17e-02	-5.49e-02	4.31e-01	1.70e-01	2.21e-01	3.97e-01	9.15e-01	7.88e-01
GOCC PHOTORECEPTOR DISC MEMBRANE	11	5.76e-01	6.62e-01	0.4470	-5.20e-02	-7.32e-02	1.28e-01	-1.85e-01	-3.65e-01	9.07e-02	7.65e-01	6.74e-01	4.63e-01	2.89e-01	3.61e-02	6.02e-01
GOBP NEGATIVE REGULATION OF MUSCLE CONTRACTION	18	1.67e-01	2.79e-01	0.4470	-3.59e-02	-6.10e-02	3.33e-01	-1.19e-01	-2.48e-01	9.18e-02	7.92e-01	6.54e-01	1.44e-02	3.81e-01	6.88e-02	5.00e-01
GOBP POSITIVE REGULATION OF PROTEOGLYCAN BIOSYNTHETIC PROCESS	5	8.84e-01	9.05e-01	0.4470	-1.51e-01	1.24e-01	2.30e-01	-2.27e-01	-2.27e-01	7.58e-02	5.58e-01	6.32e-01	3.73e-01	3.80e-01	3.78e-01	7.69e-01
GOMF PHOSPHOLIPID TRANSFER ACTIVITY	22	7.37e-02	1.57e-01	0.4470	-3.89e-02	4.17e-02	-9.31e-02	3.26e-01	2.85e-01	1.96e-02	7.52e-01	7.35e-01	4.50e-01	8.16e-03	2.05e-02	8.74e-01
GOMF NAD P H OXIDASE H2O2 FORMING ACTIVITY	7	4.67e-01	5.70e-01	0.4470	-1.44e-01	2.79e-01	1.47e-01	9.25e-02	2.66e-01	-5.27e-03	5.09e-01	2.01e-01	5.00e-01	6.72e-01	2.22e-01	9.81e-01
GOBP POSITIVE REGULATION OF AMINO ACID TRANSPORT	18	1.84e-01	2.99e-01	0.4470	-8.12e-02	1.15e-01	2.41e-01	1.39e-01	1.74e-02	3.20e-01	5.51e-01	3.98e-01	7.72e-02	3.08e-01	8.98e-01	1.86e-02
GOBP REGULATION OF MYELOID LEUKOCYTE MEDIATED IMMUNITY	51	2.11e-04	1.32e-03	0.4470	-5.30e-02	9.10e-02	3.32e-01	1.28e-01	-2.52e-02	2.48e-01	5.13e-01	2.61e-01	4.15e-05	1.14e-01	7.56e-01	2.15e-03
GOMF POLYAMINE TRANSMEMBRANE TRANSPORTER ACTIVITY	7	3.59e-01	4.74e-01	0.4470	-2.22e-01	-1.72e-01	4.00e-02	2.47e-02	-1.92e-01	-2.86e-01	3.10e-01	4.31e-01	8.55e-01	9.10e-01	3.78e-01	1.90e-01
GOBP POSITIVE REGULATION OF P38MAPK CASCADE	21	1.00e-02	3.43e-02	0.4470	5.53e-02	2.31e-01	1.26e-01	1.37e-01	2.08e-01	-2.56e-01	6.61e-01	6.65e-02	3.18e-01	2.79e-01	9.88e-02	4.26e-02
GOBP RESPONSE TO MISFOLDED PROTEIN	19	1.13e-01	2.13e-01	0.4470	-2.11e-01	-1.80e-01	1.49e-01	1.16e-02	-3.02e-01	9.40e-02	1.11e-01	1.74e-01	2.60e-01	9.30e-01	2.26e-02	4.78e-01
GOBP REGULATION OF HORMONE METABOLIC PROCESS	30	2.21e-02	6.40e-02	0.4470	9.70e-03	1.65e-01	3.20e-01	1.71e-01	2.97e-02	1.99e-01	9.27e-01	1.17e-01	2.44e-03	1.05e-01	7.79e-01	5.87e-02
GOCC COMPACT MYELIN	12	5.00e-01	5.97e-01	0.4470	-2.77e-01	-2.43e-01	-2.64e-03	-2.33e-01	-9.40e-02	-2.36e-02	9.67e-02	1.44e-01	9.87e-01	1.63e-01	5.73e-01	8.87e-01
GOBP VASCULAR TRANSPORT	66	8.53e-06	7.30e-05	0.4460	2.52e-02	1.09e-01	3.54e-01	1.49e-01	-5.04e-03	1.98e-01	7.24e-01	1.25e-01	6.37e-07	3.67e-02	9.44e-01	5.47e-03
GOBP REGULATION OF WOUND HEALING SPREADING OF EPIDERMAL CELLS	8	1.95e-01	3.12e-01	0.4460	-2.43e-01	1.17e-01	1.91e-01	7.79e-02	-2.89e-01	1.16e-02	2.34e-01	5.65e-01	3.49e-01	7.03e-01	1.56e-01	9.55e-01
GOBP MEMBRANE FISSION	42	4.68e-04	2.67e-03	0.4460	-2.83e-01	-1.64e-01	8.82e-02	7.97e-02	-1.38e-01	2.44e-01	1.53e-03	6.67e-02	3.23e-01	3.71e-01	1.22e-01	6.28e-03
GOBP MACROPHAGE PROLIFERATION	7	6.08e-01	6.88e-01	0.4460	-1.48e-01	-1.51e-01	2.54e-01	-3.47e-02	1.51e-02	2.98e-01	4.96e-01	4.90e-01	2.45e-01	8.74e-01	9.45e-01	1.73e-01
GOCC PARASPECKLES	9	2.45e-01	3.63e-01	0.4460	-1.51e-01	-1.36e-01	-1.15e-01	1.08e-01	-3.54e-01	-8.95e-02	4.34e-01	4.80e-01	5.52e-01	5.75e-01	6.63e-02	6.42e-01
GOBP GROWTH HORMONE SECRETION	9	6.53e-01	7.25e-01	0.4460	-1.96e-01	2.92e-02	1.72e-01	-1.89e-01	-3.01e-01	5.98e-02	3.09e-01	8.79e-01	3.71e-01	3.27e-01	1.18e-01	7.56e-01
GOBP CYTIDINE TO URIDINE EDITING	11	6.20e-01	6.98e-01	0.4450	1.92e-01	1.78e-01	2.31e-01	7.79e-02	-4.97e-02	2.61e-01	2.70e-01	3.06e-01	1.85e-01	6.55e-01	7.75e-01	1.35e-01
GOBP RENAL VESICLE FORMATION	5	6.22e-01	6.99e-01	0.4450	-4.07e-02	1.01e-01	2.12e-01	-3.27e-01	-2.45e-02	-1.85e-01	8.75e-01	6.96e-01	4.11e-01	2.06e-01	9.24e-01	4.74e-01
GOBP POSITIVE REGULATION OF REACTIVE OXYGEN SPECIES BIOSYNTHETIC PROCESS	13	1.44e-01	2.53e-01	0.4450	-1.90e-01	2.65e-01	1.22e-01	-9.62e-02	2.50e-01	7.00e-02	2.35e-01	9.76e-02	4.46e-01	5.48e-01	1.18e-01	6.62e-01
GOBP SYNAPTIC VESICLE TRANSPORT	40	8.11e-03	2.91e-02	0.4450	-1.97e-01	4.84e-02	1.73e-01	-1.48e-01	-1.67e-01	2.78e-01	3.10e-02	5.96e-01	5.78e-02	1.05e-01	6.71e-02	2.38e-03
GOBP POSITIVE REGULATION OF NITRIC OXIDE SYNTHASE ACTIVITY	11	1.62e-01	2.75e-01	0.4450	-1.03e-01	-2.10e-01	6.97e-02	3.00e-01	1.76e-01	1.33e-01	5.55e-01	2.27e-01	6.89e-01	8.51e-02	3.12e-01	4.46e-01
GOBP REGULATION OF CARDIAC MUSCLE CELL MEMBRANE REPOLARIZATION	18	3.03e-01	4.22e-01	0.4450	-9.82e-02	1.21e-01	2.80e-01	-1.56e-01	-1.77e-01	1.99e-01	4.71e-01	3.73e-01	3.98e-02	2.51e-01	1.93e-01	1.44e-01
GOCC CATALYTIC STEP 2 SPLICEOSOME	89	9.12e-09	1.28e-07	0.4450	-1.33e-01	-3.09e-01	-2.15e-01	1.79e-01	6.12e-02	5.30e-02	2.99e-02	4.74e-07	4.54e-04	3.49e-03	3.19e-01	3.87e-01
GOBP NEGATIVE REGULATION OF ALCOHOL BIOSYNTHETIC PROCESS	12	3.11e-01	4.31e-01	0.4450	3.66e-03	-8.41e-02	3.13e-01	1.83e-01	-1.43e-01	1.97e-01	9.83e-01	6.14e-01	6.04e-02	2.73e-01	3.90e-01	2.37e-01
GOBP REGULATION OF PHOSPHOLIPID TRANSPORT	14	5.34e-01	6.26e-01	0.4450	2.03e-01	1.07e-01	9.90e-02	2.76e-01	2.33e-01	7.33e-02	1.89e-01	4.90e-01	5.21e-01	7.39e-02	1.32e-01	6.35e-01
GOBP SPECIFICATION OF ANIMAL ORGAN IDENTITY	18	1.67e-01	2.80e-01	0.4450	-2.60e-01	3.63e-02	2.16e-01	-2.30e-01	-1.52e-01	7.78e-02	5.58e-02	7.90e-01	1.13e-01	9.12e-02	2.64e-01	5.68e-01
GOBP POSITIVE REGULATION OF MUCUS SECRETION	5	5.16e-01	6.10e-01	0.4450	-3.29e-01	-1.82e-01	1.64e-02	1.93e-01	-9.41e-02	-9.98e-02	2.02e-01	4.80e-01	9.49e-01	4.56e-01	7.16e-01	6.99e-01
GOBP POSITIVE REGULATION OF EXOCYTOSIS	61	1.59e-06	1.61e-05	0.4450	-1.71e-01	-3.46e-02	3.07e-01	7.89e-02	-1.49e-01	2.12e-01	2.10e-02	6.40e-01	3.45e-05	2.86e-01	4.42e-02	4.17e-03
GOBP RESPONSE TO HYDROPEROXIDE	17	1.47e-01	2.57e-01	0.4450	-3.03e-01	1.67e-02	1.22e-01	-7.88e-02	2.07e-02	2.90e-01	3.07e-02	9.05e-01	3.85e-01	5.74e-01	8.82e-01	3.82e-02
GOBP SYNAPTIC VESICLE MATURATION	22	5.87e-03	2.24e-02	0.4450	-2.74e-01	-9.69e-02	2.68e-01	4.11e-02	8.17e-03	1.99e-01	2.61e-02	4.31e-01	2.95e-02	7.39e-01	9.47e-01	1.06e-01
GOCC POSTSYNAPTIC SPECIALIZATION INTRACELLULAR COMPONENT	16	1.60e-01	2.72e-01	0.4450	1.70e-02	1.81e-01	7.77e-02	2.55e-01	3.00e-01	-5.60e-02	9.06e-01	2.10e-01	5.90e-01	7.70e-02	3.76e-02	6.98e-01
GOBP REGULATION OF BILE ACID BIOSYNTHETIC PROCESS	6	5.69e-01	6.56e-01	0.4450	8.48e-02	1.84e-01	2.02e-01	-4.78e-02	3.35e-01	3.46e-02	7.19e-01	4.34e-01	3.92e-01	8.39e-01	1.55e-01	8.83e-01
GOBP MULTINUCLEAR OSTEOCLAST DIFFERENTIATION	6	8.38e-01	8.69e-01	0.4440	2.47e-01	-5.31e-03	1.84e-01	2.71e-01	-2.77e-02	1.68e-01	2.95e-01	9.82e-01	4.36e-01	2.50e-01	9.07e-01	4.76e-01
GOBP NUCLEOSIDE DIPHOSPHATE BIOSYNTHETIC PROCESS	12	1.62e-01	2.75e-01	0.4440	9.51e-02	-2.09e-01	-9.72e-02	1.85e-01	2.54e-01	1.92e-01	5.68e-01	2.11e-01	5.60e-01	2.68e-01	1.28e-01	2.49e-01
GOBP REGULATION OF NUCLEOBASE CONTAINING COMPOUND TRANSPORT	18	4.58e-02	1.10e-01	0.4440	-9.06e-02	1.72e-01	1.35e-02	3.40e-01	1.65e-01	1.28e-01	5.06e-01	2.07e-01	9.21e-01	1.24e-02	2.25e-01	3.47e-01
GOBP POSITIVE REGULATION OF CENTRIOLE REPLICATION	9	3.51e-01	4.67e-01	0.4440	-1.08e-01	1.19e-01	-2.85e-01	8.40e-02	2.71e-01	1.01e-01	5.76e-01	5.37e-01	1.39e-01	6.62e-01	1.59e-01	5.99e-01
GOCC ENDOPLASMIC RETICULUM TUBULAR NETWORK	27	1.07e-02	3.64e-02	0.4440	-3.57e-01	-1.37e-01	-7.06e-02	2.36e-02	-1.47e-01	1.56e-01	1.34e-03	2.17e-01	5.26e-01	8.32e-01	1.85e-01	1.62e-01
GOMF MAP KINASE TYROSINE SERINE THREONINE PHOSPHATASE ACTIVITY	11	2.18e-01	3.36e-01	0.4440	5.00e-02	2.23e-01	4.40e-02	-3.46e-02	9.63e-02	-3.64e-01	7.74e-01	2.00e-01	8.00e-01	8.42e-01	5.80e-01	3.64e-02
GOBP DOPAMINERGIC NEURON DIFFERENTIATION	16	1.36e-02	4.40e-02	0.4440	-2.39e-01	1.94e-01	1.45e-01	2.12e-01	1.86e-01	4.34e-02	9.75e-02	1.79e-01	3.14e-01	1.42e-01	1.98e-01	7.64e-01
GOMF ACYL COA HYDROLASE ACTIVITY	21	2.17e-02	6.31e-02	0.4440	-1.11e-01	-3.03e-01	-1.65e-01	5.46e-02	6.67e-02	2.42e-01	3.80e-01	1.62e-02	1.89e-01	6.65e-01	5.97e-01	5.53e-02
GOMF MINUS END DIRECTED MICROTUBULE MOTOR ACTIVITY	14	2.86e-01	4.05e-01	0.4440	2.35e-01	3.01e-01	1.80e-01	-1.16e-01	-6.12e-02	4.21e-02	1.28e-01	5.15e-02	2.43e-01	4.51e-01	6.92e-01	7.85e-01
GOBP INTESTINAL EPITHELIAL CELL DIFFERENTIATION	15	3.06e-01	4.26e-01	0.4440	-5.71e-02	1.15e-01	3.40e-01	-1.58e-01	-4.53e-02	1.96e-01	7.02e-01	4.40e-01	2.28e-02	2.88e-01	7.61e-01	1.90e-01
GOBP NEGATIVE REGULATION OF GLYCOGEN METABOLIC PROCESS	6	5.59e-01	6.48e-01	0.4440	2.44e-01	1.44e-01	-3.41e-02	3.26e-01	-9.29e-02	3.07e-02	3.01e-01	5.41e-01	8.85e-01	1.67e-01	6.93e-01	8.96e-01
GOBP REGULATION OF RETINOIC ACID RECEPTOR SIGNALING PATHWAY	11	1.72e-01	2.85e-01	0.4440	-1.04e-01	-1.75e-01	1.78e-02	3.87e-01	-5.50e-03	7.75e-02	5.51e-01	3.16e-01	9.19e-01	2.64e-02	9.75e-01	6.56e-01
GOCC ENDOSOME LUMEN	29	5.09e-02	1.19e-01	0.4440	-3.34e-01	-2.05e-01	-8.18e-03	-1.38e-01	-5.83e-02	1.46e-01	1.88e-03	5.58e-02	9.39e-01	1.98e-01	5.87e-01	1.74e-01
GOBP REGULATION OF DEFENSE RESPONSE TO FUNGUS	5	5.92e-01	6.75e-01	0.4440	1.82e-01	-1.29e-02	1.31e-01	1.46e-01	-7.13e-02	-3.47e-01	4.80e-01	9.60e-01	6.13e-01	5.71e-01	7.82e-01	1.80e-01
GOBP POSITIVE REGULATION OF MYOTUBE DIFFERENTIATION	7	1.18e-01	2.21e-01	0.4440	-1.47e-01	1.70e-01	2.00e-01	2.37e-01	-8.16e-02	-2.09e-01	4.99e-01	4.35e-01	3.61e-01	2.78e-01	7.08e-01	3.39e-01
GOMF FOLIC ACID BINDING	11	2.14e-01	3.31e-01	0.4440	-9.57e-02	-2.20e-01	-8.06e-02	2.23e-01	2.87e-01	3.11e-02	5.83e-01	2.06e-01	6.43e-01	2.00e-01	9.96e-02	8.58e-01
GOBP HEPARAN SULFATE PROTEOGLYCAN METABOLIC PROCESS	10	3.05e-01	4.25e-01	0.4440	9.48e-03	1.29e-02	1.30e-01	2.83e-01	-1.54e-01	2.75e-01	9.59e-01	9.44e-01	4.76e-01	1.21e-01	3.98e-01	1.32e-01
GOBP PYRIMIDINE NUCLEOBASE BIOSYNTHETIC PROCESS	7	3.90e-01	5.03e-01	0.4440	-9.16e-02	-1.72e-01	1.23e-02	3.97e-01	-2.89e-02	-1.53e-02	6.75e-01	4.30e-01	9.55e-01	6.88e-02	8.95e-01	9.44e-01
GOBP RETROGRADE VESICLE MEDIATED TRANSPORT GOLGI TO ENDOPLASMIC RETICULUM	50	1.47e-05	1.20e-04	0.4440	-1.16e-01	-1.79e-01	1.00e-01	2.52e-01	-8.64e-02	2.65e-01	1.55e-01	2.88e-02	2.19e-01	2.06e-03	2.91e-01	1.16e-03
GOBP NEGATIVE REGULATION OF ACTIN FILAMENT DEPOLYMERIZATION	41	1.70e-02	5.21e-02	0.4440	1.06e-01	8.61e-02	2.98e-01	8.78e-02	2.05e-02	2.86e-01	2.41e-01	3.40e-01	9.72e-04	3.30e-01	8.20e-01	1.56e-03
GOBP ER NUCLEUS SIGNALING PATHWAY	46	5.46e-05	3.93e-04	0.4440	-2.95e-01	-9.16e-02	1.90e-01	1.23e-02	-2.19e-01	1.32e-01	5.42e-04	2.82e-01	2.60e-02	8.85e-01	1.00e-02	1.23e-01
GOCC PHAGOPHORE ASSEMBLY SITE	35	8.17e-04	4.29e-03	0.4440	-2.24e-01	-1.02e-01	-2.60e-01	2.41e-01	8.12e-02	-6.31e-02	2.20e-02	2.97e-01	7.74e-03	1.35e-02	4.06e-01	5.18e-01
GOMF RNA POLYMERASE III GENERAL TRANSCRIPTION INITIATION FACTOR ACTIVITY	12	5.30e-01	6.22e-01	0.4430	7.88e-02	-1.71e-01	-2.63e-01	1.84e-01	1.75e-01	-1.66e-01	6.36e-01	3.04e-01	1.15e-01	2.70e-01	2.95e-01	3.18e-01
GOBP CELLULAR RESPONSE TO STEROL DEPLETION	14	9.73e-02	1.92e-01	0.4430	-3.12e-01	-1.09e-01	2.38e-01	1.38e-03	-4.53e-02	1.68e-01	4.32e-02	4.79e-01	1.23e-01	9.93e-01	7.69e-01	2.77e-01
GOBP POSITIVE REGULATION OF ENDOTHELIAL CELL DIFFERENTIATION	8	3.13e-01	4.33e-01	0.4430	-6.82e-02	-1.21e-01	2.66e-01	1.99e-01	-2.56e-01	2.23e-02	7.38e-01	5.52e-01	1.92e-01	3.29e-01	2.10e-01	9.13e-01
GOMF UBIQUINONE BINDING	6	9.10e-01	9.26e-01	0.4430	-2.33e-01	-2.68e-01	-1.20e-01	-1.05e-01	-2.09e-01	3.58e-02	3.24e-01	2.56e-01	6.11e-01	6.57e-01	3.76e-01	8.79e-01
GOBP NEGATIVE REGULATION OF MACROPHAGE MIGRATION	11	3.80e-01	4.94e-01	0.4430	3.80e-02	-2.62e-01	1.18e-01	1.51e-01	-2.26e-01	1.95e-01	8.27e-01	1.32e-01	4.99e-01	3.86e-01	1.94e-01	2.63e-01
GOBP CELLULAR RESPONSE TO NICOTINE	7	4.74e-01	5.76e-01	0.4430	1.72e-01	-1.97e-02	2.67e-01	1.51e-01	2.34e-01	1.32e-01	4.32e-01	9.28e-01	2.22e-01	4.90e-01	2.83e-01	5.45e-01
GOMF DEATH DOMAIN BINDING	10	5.34e-01	6.26e-01	0.4430	1.06e-01	-1.76e-01	1.92e-01	-1.89e-02	-3.05e-01	1.55e-01	5.61e-01	3.36e-01	2.93e-01	9.18e-01	9.54e-02	3.96e-01
GOBP REGULATION OF ACTION POTENTIAL	40	1.50e-02	4.73e-02	0.4430	5.66e-02	2.01e-01	3.25e-01	-6.39e-02	8.18e-03	2.07e-01	5.35e-01	2.78e-02	3.75e-04	4.85e-01	9.29e-01	2.38e-02
GOCC PHOSPHATIDYLINOSITOL 3 KINASE COMPLEX	28	1.18e-02	3.92e-02	0.4430	-9.05e-02	2.96e-01	4.25e-02	1.52e-01	2.59e-01	9.11e-02	4.07e-01	6.70e-03	6.97e-01	1.63e-01	1.79e-02	4.04e-01
GOBP NEGATIVE REGULATION OF RECEPTOR BINDING	8	3.09e-01	4.29e-01	0.4430	1.41e-01	1.11e-01	-1.72e-01	3.41e-01	-6.29e-02	-1.17e-01	4.90e-01	5.86e-01	3.99e-01	9.49e-02	7.58e-01	5.65e-01
GOBP DNA REPLICATION INITIATION	35	1.13e-03	5.64e-03	0.4430	7.82e-02	-2.23e-01	-4.56e-02	3.21e-01	5.75e-02	1.79e-01	4.24e-01	2.27e-02	6.40e-01	1.02e-03	5.56e-01	6.76e-02
GOBP NEGATIVE REGULATION OF VIRAL LIFE CYCLE	20	2.23e-02	6.45e-02	0.4420	1.32e-02	-1.28e-01	6.67e-02	3.68e-01	-1.14e-01	1.63e-01	9.19e-01	3.21e-01	6.05e-01	4.39e-03	3.79e-01	2.08e-01
GOBP DETECTION OF TEMPERATURE STIMULUS INVOLVED IN SENSORY PERCEPTION OF PAIN	12	1.13e-01	2.14e-01	0.4420	-1.69e-01	-2.73e-01	3.67e-03	2.98e-01	6.06e-02	1.97e-02	3.12e-01	1.01e-01	9.82e-01	7.43e-02	7.16e-01	9.06e-01
GOMF TBP CLASS PROTEIN BINDING	24	4.01e-02	9.98e-02	0.4420	-3.33e-01	-1.90e-01	-1.75e-01	4.82e-02	1.09e-01	6.27e-02	4.72e-03	1.08e-01	1.37e-01	6.83e-01	3.57e-01	5.95e-01
GOBP REGULATION OF MITOCHONDRIAL MRNA STABILITY	7	4.85e-01	5.86e-01	0.4420	-3.24e-02	-2.55e-01	-3.80e-02	3.42e-01	-6.16e-02	-8.68e-02	8.82e-01	2.43e-01	8.62e-01	1.17e-01	7.78e-01	6.91e-01
GOMF BETA 1 3 GALACTOSYLTRANSFERASE ACTIVITY	11	5.06e-01	6.02e-01	0.4420	-1.24e-01	1.22e-01	3.32e-01	-3.81e-02	-9.35e-02	2.13e-01	4.77e-01	4.84e-01	5.68e-02	8.27e-01	5.91e-01	2.22e-01
GOMF ACID PHOSPHATASE ACTIVITY	8	4.93e-01	5.92e-01	0.4420	2.13e-02	-2.28e-01	-1.51e-01	1.85e-01	2.92e-01	3.09e-02	9.17e-01	2.65e-01	4.60e-01	3.65e-01	1.53e-01	8.80e-01
GOMF DNA INSERTION OR DELETION BINDING	6	6.10e-01	6.89e-01	0.4420	1.25e-01	-2.05e-01	-3.32e-02	2.00e-01	1.60e-01	2.66e-01	5.97e-01	3.84e-01	8.88e-01	3.96e-01	4.98e-01	2.58e-01
GOBP REGULATION OF PEPTIDYL CYSTEINE S NITROSYLATION	9	5.46e-01	6.36e-01	0.4420	-1.91e-01	1.71e-01	1.19e-01	-2.33e-01	-1.96e-02	2.47e-01	3.22e-01	3.75e-01	5.37e-01	2.27e-01	9.19e-01	1.99e-01
GOMF ATP GATED ION CHANNEL ACTIVITY	6	1.98e-01	3.13e-01	0.4420	-2.76e-03	-3.22e-01	2.14e-01	-9.39e-02	1.39e-01	1.33e-01	9.91e-01	1.72e-01	3.65e-01	6.90e-01	5.56e-01	5.73e-01
GOBP REGULATION OF ASTROCYTE DIFFERENTIATION	18	3.53e-01	4.68e-01	0.4420	1.57e-01	3.21e-01	2.22e-01	8.40e-02	4.87e-02	9.35e-02	2.49e-01	1.85e-02	1.03e-01	5.37e-01	7.20e-01	4.92e-01
GOCC VACUOLAR PROTON TRANSPORTING V TYPE ATPASE V0 DOMAIN	9	1.26e-01	2.31e-01	0.4410	-2.85e-01	-1.93e-01	4.48e-03	1.41e-01	-1.75e-02	-2.37e-01	1.38e-01	3.17e-01	9.81e-01	4.64e-01	9.28e-01	2.18e-01
GOBP THALAMUS DEVELOPMENT	8	8.50e-01	8.78e-01	0.4410	2.75e-01	2.54e-01	4.78e-02	1.64e-01	1.49e-01	-5.91e-02	1.78e-01	2.14e-01	8.15e-01	4.23e-01	4.67e-01	7.72e-01
GOBP NEGATIVE REGULATION OF ACTIN NUCLEATION	7	6.41e-01	7.16e-01	0.4410	-6.76e-02	-2.41e-01	-1.58e-01	2.08e-01	5.87e-02	-2.45e-01	7.57e-01	2.70e-01	4.68e-01	3.40e-01	7.88e-01	2.61e-01
GOMF STRUCTURAL CONSTITUENT OF SYNAPSE	14	3.40e-01	4.57e-01	0.4410	-4.87e-02	2.13e-01	2.56e-01	1.44e-01	8.52e-02	2.31e-01	7.52e-01	1.67e-01	9.73e-02	3.51e-01	5.81e-01	1.34e-01
GOMF G PROTEIN COUPLED AMINE RECEPTOR ACTIVITY	12	4.33e-01	5.41e-01	0.4410	9.20e-02	2.82e-01	8.20e-02	1.65e-02	3.13e-01	-4.31e-02	5.81e-01	9.13e-02	6.23e-01	9.21e-01	6.06e-02	7.96e-01
GOBP RESPONSE TO OXYGEN RADICAL	21	4.99e-03	1.96e-02	0.4410	-1.77e-03	-1.76e-01	2.97e-02	1.07e-01	3.05e-01	2.41e-01	9.89e-01	1.64e-01	8.14e-01	3.96e-01	1.54e-02	5.62e-02
GOCC FANCONI ANAEMIA NUCLEAR COMPLEX	13	3.59e-01	4.75e-01	0.4410	8.01e-04	-1.51e-01	-2.08e-01	2.36e-01	2.69e-01	1.67e-02	9.96e-01	3.47e-01	1.94e-01	1.40e-01	9.31e-02	9.17e-01
GOBP RESPONSE TO MITOCHONDRIAL DEPOLARISATION	20	7.80e-02	1.63e-01	0.4410	-9.51e-02	-2.07e-01	-2.60e-01	2.64e-01	1.34e-02	-6.92e-02	4.61e-01	1.09e-01	4.44e-02	4.06e-02	9.18e-01	5.92e-01
GOCC AP 3 ADAPTOR COMPLEX	11	2.14e-01	3.31e-01	0.4410	-3.24e-01	9.44e-02	-8.56e-02	7.25e-02	1.89e-01	1.80e-01	6.31e-02	5.88e-01	6.23e-01	6.77e-01	2.78e-01	3.02e-01
GOMF LIGASE ACTIVITY FORMING CARBON NITROGEN BONDS	44	7.68e-03	2.79e-02	0.4410	-1.84e-01	-2.80e-01	-2.26e-01	-4.69e-02	4.08e-02	-1.64e-01	3.51e-02	1.29e-03	9.38e-03	5.91e-01	6.40e-01	6.03e-02
GOBP RELAXATION OF CARDIAC MUSCLE	13	1.60e-01	2.73e-01	0.4410	-2.95e-01	-1.17e-01	1.62e-01	-2.45e-02	-2.57e-01	-1.32e-02	6.54e-02	4.64e-01	3.11e-01	8.78e-01	1.08e-01	9.34e-01
GOBP MAMMALIAN OOGENESIS STAGE	9	2.79e-01	3.98e-01	0.4410	-1.54e-01	2.77e-01	1.18e-01	1.08e-01	2.55e-01	-5.49e-02	4.23e-01	1.50e-01	5.40e-01	5.76e-01	1.85e-01	7.75e-01
GOBP PEPTIDYL GLUTAMIC ACID MODIFICATION	19	2.12e-01	3.29e-01	0.4410	-6.46e-02	-1.45e-01	-2.74e-01	-1.59e-01	1.12e-01	-2.37e-01	6.26e-01	2.73e-01	3.88e-02	2.29e-01	4.00e-01	7.41e-02
GOBP NUCLEOSIDE TRIPHOSPHATE CATABOLIC PROCESS	11	3.86e-01	4.99e-01	0.4400	-1.67e-01	-2.28e-01	1.16e-01	-1.29e-01	-1.95e-02	2.90e-01	3.38e-01	1.91e-01	5.06e-01	4.60e-01	9.11e-01	9.60e-02
GOMF CATALYTIC ACTIVITY ACTING ON RNA	380	5.72e-33	6.71e-31	0.4400	-1.48e-01	-2.99e-01	-2.63e-01	1.03e-01	2.96e-02	-4.73e-02	7.61e-07	1.28e-23	1.48e-18	5.35e-04	3.22e-01	1.13e-01
GOBP NEGATIVE REGULATION OF TYPE I INTERFERON MEDIATED SIGNALING PATHWAY	22	1.53e-02	4.80e-02	0.4400	-5.89e-02	-9.83e-02	-1.88e-01	2.90e-01	1.31e-01	2.10e-01	6.33e-01	4.25e-01	1.27e-01	1.85e-02	2.88e-01	8.74e-02
GOBP SYNAPTIC TRANSMISSION DOPAMINERGIC	17	9.86e-02	1.94e-01	0.4400	1.71e-01	-8.71e-02	3.25e-01	1.19e-01	1.64e-03	1.93e-01	2.23e-01	5.34e-01	2.03e-02	3.95e-01	9.91e-01	1.68e-01
GOBP REGULATION OF PHOSPHATIDYLCHOLINE METABOLIC PROCESS	9	2.42e-01	3.60e-01	0.4400	-1.70e-01	2.52e-01	-1.24e-01	2.01e-01	1.41e-01	-1.61e-01	3.78e-01	1.91e-01	5.19e-01	2.97e-01	4.64e-01	4.02e-01
GOMF CAMP BINDING	17	1.47e-02	4.68e-02	0.4400	-1.29e-02	1.21e-01	2.07e-01	4.17e-03	-2.99e-01	-2.15e-01	9.27e-01	3.88e-01	1.39e-01	9.76e-01	3.25e-02	1.24e-01
GOBP ALDITOL METABOLIC PROCESS	17	3.79e-02	9.58e-02	0.4400	-2.70e-01	-5.62e-02	-9.30e-02	7.08e-02	3.20e-01	-4.20e-02	5.44e-02	6.88e-01	5.07e-01	6.13e-01	2.23e-02	7.65e-01
GOBP POSITIVE REGULATION OF SMOOTH MUSCLE CONTRACTION	21	1.96e-02	5.83e-02	0.4400	-1.61e-01	6.32e-04	2.88e-01	-2.83e-01	-6.20e-02	3.63e-02	2.03e-01	9.96e-01	2.24e-02	2.49e-02	6.23e-01	7.73e-01
GOBP POSITIVE REGULATION OF TOLL LIKE RECEPTOR 3 SIGNALING PATHWAY	7	2.08e-01	3.25e-01	0.4400	-3.04e-01	2.76e-01	-1.01e-01	1.12e-01	2.33e-02	4.66e-02	1.64e-01	2.06e-01	6.44e-01	6.09e-01	9.15e-01	8.31e-01
GOBP TAURINE METABOLIC PROCESS	6	7.24e-01	7.81e-01	0.4400	5.49e-02	6.37e-02	3.85e-03	1.38e-01	4.08e-01	3.74e-02	8.16e-01	7.87e-01	9.87e-01	5.60e-01	8.38e-02	8.74e-01
GOMF MUTSALPHA COMPLEX BINDING	7	7.00e-01	7.61e-01	0.4400	-1.54e-01	-1.96e-01	-3.24e-01	1.57e-01	4.59e-02	-8.85e-03	4.81e-01	3.70e-01	1.38e-01	4.73e-01	8.33e-01	9.68e-01
GOBP HEME TRANSPORT	9	6.49e-01	7.22e-01	0.4400	2.26e-02	-2.40e-01	-2.23e-01	1.67e-01	1.09e-01	-2.15e-01	9.07e-01	2.12e-01	2.48e-01	3.87e-01	5.73e-01	2.65e-01
GOMF HEME TRANSMEMBRANE TRANSPORTER ACTIVITY	9	6.49e-01	7.22e-01	0.4400	2.26e-02	-2.40e-01	-2.23e-01	1.67e-01	1.09e-01	-2.15e-01	9.07e-01	2.12e-01	2.48e-01	3.87e-01	5.73e-01	2.65e-01
GOBP POSITIVE REGULATION OF SYNAPTIC TRANSMISSION GLUTAMATERGIC	22	1.17e-01	2.19e-01	0.4400	1.37e-01	2.53e-01	2.84e-01	-2.66e-02	1.47e-01	9.03e-02	2.67e-01	4.00e-02	2.13e-02	8.29e-01	2.33e-01	4.64e-01
GOBP REGULATION OF MEMBRANE PROTEIN ECTODOMAIN PROTEOLYSIS	24	1.33e-03	6.48e-03	0.4400	-7.05e-02	8.43e-02	4.08e-01	-2.96e-02	-1.16e-01	-1.53e-02	5.50e-01	4.75e-01	5.31e-04	8.02e-01	3.26e-01	8.97e-01
GOBP VASCULAR ENDOTHELIAL GROWTH FACTOR RECEPTOR SIGNALING PATHWAY	44	2.50e-06	2.44e-05	0.4400	-1.43e-01	3.89e-02	2.90e-01	1.78e-01	1.41e-01	1.88e-01	1.00e-01	6.55e-01	8.56e-04	4.13e-02	1.06e-01	3.07e-02
GOMF GABA RECEPTOR BINDING	11	4.59e-01	5.64e-01	0.4390	-2.72e-01	-5.06e-02	2.13e-01	-2.58e-02	-1.53e-01	2.17e-01	1.19e-01	7.71e-01	2.20e-01	8.82e-01	3.80e-01	2.12e-01
GOBP ENDOSOME TRANSPORT VIA MULTIVESICULAR BODY SORTING PATHWAY	39	1.88e-03	8.71e-03	0.4390	-2.01e-01	-2.74e-01	3.51e-02	9.68e-02	-8.66e-02	2.44e-01	2.99e-02	3.07e-03	7.05e-01	2.96e-01	3.49e-01	8.34e-03
GOBP NEGATIVE REGULATION OF WOUND HEALING SPREADING OF EPIDERMAL CELLS	5	4.72e-01	5.74e-01	0.4390	-3.40e-01	2.05e-01	-2.61e-02	1.28e-02	-1.23e-01	1.38e-01	1.87e-01	4.27e-01	9.19e-01	9.61e-01	6.33e-01	5.94e-01
GOBP REGULATION OF SODIUM DEPENDENT PHOSPHATE TRANSPORT	5	7.69e-01	8.14e-01	0.4390	-1.97e-01	-7.61e-02	3.91e-02	-1.27e-02	-3.64e-01	1.19e-01	4.45e-01	7.68e-01	8.80e-01	9.61e-01	1.59e-01	6.45e-01
GOBP SUBSTANTIA NIGRA DEVELOPMENT	38	9.47e-03	3.28e-02	0.4390	-2.95e-01	-2.62e-01	-2.04e-03	-1.92e-02	-1.14e-01	1.53e-01	1.64e-03	5.11e-03	9.83e-01	8.38e-01	2.26e-01	1.02e-01
GOMF ORGANIC HYDROXY COMPOUND TRANSMEMBRANE TRANSPORTER ACTIVITY	30	2.75e-02	7.52e-02	0.4390	2.02e-02	-9.72e-02	2.17e-01	-1.11e-01	-3.52e-01	7.42e-03	8.48e-01	3.57e-01	4.01e-02	2.91e-01	8.59e-04	9.44e-01
GOBP REGULATION OF MYOBLAST FUSION	16	3.66e-01	4.81e-01	0.4390	1.29e-03	8.16e-02	2.43e-01	-1.71e-02	-8.90e-03	3.56e-01	9.93e-01	5.72e-01	9.30e-02	9.06e-01	9.51e-01	1.36e-02
GOBP PYRIMIDINE RIBONUCLEOTIDE BIOSYNTHETIC PROCESS	21	6.86e-02	1.49e-01	0.4390	-1.23e-01	-3.93e-01	-1.01e-01	9.97e-02	-3.95e-02	3.84e-02	3.31e-01	1.82e-03	4.22e-01	4.29e-01	7.54e-01	7.61e-01
GOBP ACTIN NUCLEATION	51	4.81e-04	2.72e-03	0.4390	-2.46e-01	-2.10e-01	1.37e-01	1.23e-03	-1.97e-01	1.75e-01	2.34e-03	9.63e-03	9.13e-02	9.88e-01	1.49e-02	3.07e-02
GOBP EPITHELIAL CELL MORPHOGENESIS	23	1.96e-01	3.12e-01	0.4390	-1.00e-02	1.33e-01	2.82e-01	2.48e-02	-1.36e-02	3.08e-01	9.34e-01	2.68e-01	1.94e-02	8.37e-01	9.10e-01	1.07e-02
GOBP ENDOPLASMIC RETICULUM UNFOLDED PROTEIN RESPONSE	70	4.51e-06	4.13e-05	0.4390	-2.77e-01	-1.77e-01	1.80e-02	-4.13e-03	-2.61e-01	1.25e-01	6.08e-05	1.02e-02	7.94e-01	9.52e-01	1.57e-04	6.98e-02
GOBP POSITIVE REGULATION OF BEHAVIOR	14	2.91e-01	4.11e-01	0.4390	1.14e-03	9.38e-02	-1.34e-01	3.91e-02	3.76e-01	-1.50e-01	9.94e-01	5.43e-01	3.85e-01	8.00e-01	1.47e-02	3.30e-01
GOBP VESICLE BUDDING FROM MEMBRANE	83	7.96e-10	1.29e-08	0.4390	-2.10e-01	-1.36e-01	1.93e-01	1.64e-01	-8.24e-02	2.44e-01	9.57e-04	3.27e-02	2.42e-03	9.95e-03	1.95e-01	1.23e-04
GOBP CELLULAR RESPONSE TO ALDEHYDE	13	3.43e-01	4.60e-01	0.4390	-5.84e-02	-1.53e-01	-2.43e-01	8.53e-02	3.03e-01	-8.86e-02	7.16e-01	3.40e-01	1.30e-01	5.94e-01	5.87e-02	5.80e-01
GOBP REGULATION OF GTP BINDING	8	4.13e-01	5.24e-01	0.4390	2.01e-01	1.81e-01	8.88e-02	-4.45e-02	2.38e-02	3.30e-01	3.26e-01	3.75e-01	6.63e-01	8.27e-01	9.07e-01	1.06e-01
GOBP NEGATIVE REGULATION OF CHEMOKINE C C MOTIF LIGAND 5 PRODUCTION	5	6.24e-01	7.01e-01	0.4390	-2.09e-01	-4.28e-02	7.06e-02	1.61e-01	-2.85e-01	1.86e-01	4.18e-01	8.68e-01	7.85e-01	5.34e-01	2.70e-01	4.70e-01
GOBP PHOSPHATIDYLGLYCEROL ACYL CHAIN REMODELING	8	6.97e-01	7.59e-01	0.4390	-1.17e-01	1.85e-02	3.13e-01	-6.79e-02	-2.45e-01	1.26e-01	5.67e-01	9.28e-01	1.25e-01	7.40e-01	2.31e-01	5.36e-01
GOBP AMINO ACID BETAINE TRANSPORT	11	8.95e-02	1.81e-01	0.4390	-2.85e-01	8.74e-02	1.81e-01	-2.30e-01	7.82e-02	-1.07e-01	1.02e-01	6.16e-01	2.98e-01	1.87e-01	6.53e-01	5.37e-01
GOBP SEQUESTERING OF ACTIN MONOMERS	9	5.71e-01	6.58e-01	0.4390	-1.76e-01	-2.60e-01	-2.78e-01	-4.11e-02	-1.01e-01	6.74e-02	3.60e-01	1.77e-01	1.49e-01	8.31e-01	6.00e-01	7.26e-01
GOCC FICOLIN 1 RICH GRANULE LUMEN	122	7.46e-12	1.52e-10	0.4380	-2.87e-01	-2.05e-01	1.28e-01	-2.47e-03	-1.03e-01	2.02e-01	4.29e-08	9.20e-05	1.44e-02	9.62e-01	4.90e-02	1.19e-04
GOMF TUMOR NECROSIS FACTOR RECEPTOR ACTIVITY	9	5.35e-01	6.27e-01	0.4380	2.78e-01	2.25e-01	1.53e-01	-6.39e-02	1.35e-01	-1.35e-01	1.49e-01	2.42e-01	4.25e-01	7.40e-01	4.82e-01	4.82e-01
GOMF BICARBONATE TRANSMEMBRANE TRANSPORTER ACTIVITY	23	6.09e-02	1.37e-01	0.4380	2.32e-01	3.42e-01	1.14e-01	8.05e-02	-2.39e-02	3.89e-02	5.44e-02	4.52e-03	3.44e-01	5.04e-01	8.43e-01	7.47e-01
GOBP POSITIVE REGULATION OF VASCULOGENESIS	9	3.50e-01	4.66e-01	0.4380	-2.45e-02	2.48e-01	1.97e-01	-8.88e-02	-2.85e-01	-4.84e-02	8.99e-01	1.98e-01	3.06e-01	6.45e-01	1.39e-01	8.02e-01
GOBP SPLICEOSOMAL COMPLEX ASSEMBLY	75	1.37e-06	1.40e-05	0.4380	-1.11e-01	-2.56e-01	-3.07e-01	1.38e-01	1.80e-02	-1.81e-02	9.76e-02	1.25e-04	4.22e-06	3.82e-02	7.87e-01	7.86e-01
GOBP ERROR FREE TRANSLESION SYNTHESIS	5	8.85e-01	9.06e-01	0.4380	-2.23e-01	-2.44e-01	-1.75e-01	-7.12e-02	4.56e-02	-2.12e-01	3.87e-01	3.45e-01	4.99e-01	7.83e-01	8.60e-01	4.12e-01
GOBP POSITIVE REGULATION OF LEUKOCYTE ADHESION TO VASCULAR ENDOTHELIAL CELL	21	3.65e-02	9.30e-02	0.4380	-9.85e-02	5.81e-02	3.87e-01	-7.97e-02	-1.02e-01	1.12e-01	4.34e-01	6.45e-01	2.15e-03	5.27e-01	4.20e-01	3.73e-01
GOCC SEX CHROMATIN	6	8.04e-01	8.42e-01	0.4380	-2.54e-01	-2.85e-01	-1.64e-01	1.10e-01	-4.61e-02	-7.04e-02	2.82e-01	2.26e-01	4.87e-01	6.40e-01	8.45e-01	7.65e-01
GOBP T FOLLICULAR HELPER CELL DIFFERENTIATION	5	8.16e-01	8.51e-01	0.4380	-9.10e-02	1.67e-01	2.98e-01	8.10e-02	-1.65e-01	1.83e-01	7.24e-01	5.18e-01	2.49e-01	7.54e-01	5.23e-01	4.79e-01
GOCC AXON INITIAL SEGMENT	12	5.84e-01	6.69e-01	0.4380	2.08e-01	1.49e-01	1.72e-01	1.25e-01	2.15e-01	1.88e-01	2.13e-01	3.71e-01	3.02e-01	4.54e-01	1.98e-01	2.60e-01
GOBP RETROGRADE AXONAL TRANSPORT	17	2.66e-01	3.86e-01	0.4380	8.47e-02	1.95e-01	1.69e-01	1.28e-01	3.25e-02	3.17e-01	5.46e-01	1.63e-01	2.29e-01	3.62e-01	8.17e-01	2.35e-02
GOMF ENDONUCLEASE ACTIVITY ACTIVE WITH EITHER RIBO OR DEOXYRIBONUCLEIC ACIDS AND PRODUCING 3 PHOSPHOMONOESTERS	17	3.96e-02	9.87e-02	0.4370	-8.77e-02	-2.57e-01	-8.96e-02	1.99e-01	4.97e-02	-2.60e-01	5.31e-01	6.69e-02	5.22e-01	1.54e-01	7.23e-01	6.37e-02
GOBP REGULATION OF SYNAPSE MATURATION	15	3.79e-01	4.93e-01	0.4370	-2.28e-02	2.11e-02	2.60e-01	7.09e-02	-1.96e-01	2.82e-01	8.79e-01	8.87e-01	8.16e-02	6.34e-01	1.88e-01	5.90e-02
GOBP DOPAMINE SECRETION	17	3.87e-01	5.00e-01	0.4370	1.93e-01	2.26e-01	2.46e-01	7.73e-02	-6.88e-02	1.78e-01	1.68e-01	1.07e-01	7.94e-02	5.81e-01	6.24e-01	2.04e-01
GOCC FILOPODIUM TIP	17	7.55e-02	1.60e-01	0.4370	-2.75e-01	1.23e-01	5.25e-02	1.45e-02	8.64e-02	3.00e-01	4.96e-02	3.82e-01	7.08e-01	9.18e-01	5.37e-01	3.21e-02
GOBP NEGATIVE REGULATION OF DEPHOSPHORYLATION	27	2.44e-02	6.89e-02	0.4370	-2.36e-01	-5.88e-02	1.51e-01	6.25e-02	-1.40e-01	2.93e-01	3.35e-02	5.97e-01	1.75e-01	5.74e-01	2.08e-01	8.47e-03
GOBP MEDIUM CHAIN FATTY ACID METABOLIC PROCESS	11	2.99e-02	7.99e-02	0.4370	-2.10e-01	-2.23e-01	1.37e-01	3.00e-02	2.62e-01	9.57e-02	2.28e-01	2.01e-01	4.30e-01	8.63e-01	1.32e-01	5.83e-01
GOMF STEROL TRANSFER ACTIVITY	18	7.49e-03	2.74e-02	0.4370	-2.43e-02	-1.05e-01	2.50e-01	3.40e-01	-1.28e-02	3.92e-02	8.59e-01	4.41e-01	6.63e-02	1.26e-02	9.25e-01	7.73e-01
GOCC KINETOCHORE MICROTUBULE	19	1.32e-01	2.39e-01	0.4370	-2.00e-01	-2.83e-01	6.65e-02	-4.11e-02	-5.37e-02	2.48e-01	1.30e-01	3.25e-02	6.16e-01	7.57e-01	6.85e-01	6.10e-02
GOBP POSITIVE REGULATION OF PSEUDOPODIUM ASSEMBLY	11	1.22e-01	2.26e-01	0.4370	-2.10e-01	1.45e-01	1.78e-01	2.18e-01	1.97e-01	8.76e-02	2.27e-01	4.03e-01	3.06e-01	2.10e-01	2.59e-01	6.15e-01
GOMF SECONDARY ACTIVE SULFATE TRANSMEMBRANE TRANSPORTER ACTIVITY	7	8.31e-01	8.64e-01	0.4370	2.78e-01	2.78e-01	1.27e-01	6.48e-02	6.31e-02	-1.10e-01	2.03e-01	2.02e-01	5.62e-01	7.67e-01	7.73e-01	6.16e-01
GOBP POSITIVE REGULATION OF MACROPHAGE DIFFERENTIATION	12	5.23e-01	6.17e-01	0.4370	-1.46e-01	-1.83e-01	2.29e-01	-9.67e-02	-2.33e-01	1.42e-01	3.81e-01	2.73e-01	1.69e-01	5.62e-01	1.62e-01	3.94e-01
GOCC ENDOPLASMIC RETICULUM GOLGI INTERMEDIATE COMPARTMENT MEMBRANE	74	9.05e-09	1.27e-07	0.4370	-1.96e-01	-2.13e-01	1.19e-01	1.99e-01	-6.86e-02	2.20e-01	3.48e-03	1.53e-03	7.78e-02	3.06e-03	3.08e-01	1.09e-03
GOBP NUCLEOSIDE TRANSMEMBRANE TRANSPORT	7	3.42e-01	4.59e-01	0.4370	9.46e-02	-2.86e-01	-1.18e-01	6.15e-02	2.83e-01	4.44e-02	6.65e-01	1.90e-01	5.90e-01	7.78e-01	1.94e-01	8.39e-01
GOBP ENDOCARDIAL CUSHION MORPHOGENESIS	23	1.63e-02	5.06e-02	0.4370	-1.79e-01	2.23e-01	1.41e-01	1.60e-01	1.67e-01	1.89e-01	1.38e-01	6.44e-02	2.40e-01	1.85e-01	1.66e-01	1.17e-01
GOBP REGULATION OF SKELETAL MUSCLE CELL PROLIFERATION	11	4.63e-01	5.67e-01	0.4370	-2.89e-01	-5.62e-02	-2.47e-03	-1.20e-01	-1.67e-01	2.48e-01	9.71e-02	7.47e-01	9.89e-01	4.89e-01	3.36e-01	1.55e-01
GOBP BILE ACID SIGNALING PATHWAY	5	4.06e-01	5.17e-01	0.4360	-1.91e-01	-1.55e-01	2.02e-01	2.78e-01	1.04e-01	3.13e-02	4.59e-01	5.48e-01	4.35e-01	2.82e-01	6.86e-01	9.04e-01
GOBP SODIUM ION HOMEOSTASIS	29	7.14e-02	1.53e-01	0.4360	3.59e-02	1.14e-01	2.94e-01	1.40e-01	5.60e-02	2.59e-01	7.38e-01	2.89e-01	6.13e-03	1.93e-01	6.01e-01	1.58e-02
GOCC ENDOPLASMIC RETICULUM PLASMA MEMBRANE CONTACT SITE	9	2.20e-01	3.38e-01	0.4360	-2.89e-02	6.74e-02	-2.07e-01	3.75e-01	1.24e-02	-4.00e-02	8.81e-01	7.26e-01	2.83e-01	5.16e-02	9.49e-01	8.36e-01
GOMF RACEMASE AND EPIMERASE ACTIVITY ACTING ON CARBOHYDRATES AND DERIVATIVES	10	5.00e-01	5.97e-01	0.4360	-1.51e-01	-3.51e-01	-9.76e-02	1.45e-01	-1.16e-01	-1.11e-02	4.09e-01	5.49e-02	5.93e-01	4.27e-01	5.25e-01	9.51e-01
GOBP POSITIVE REGULATION OF VASCULAR ASSOCIATED SMOOTH MUSCLE CELL APOPTOTIC PROCESS	7	7.82e-01	8.24e-01	0.4360	-2.35e-01	-4.07e-02	1.41e-01	-1.01e-01	-2.95e-01	1.25e-01	2.81e-01	8.52e-01	5.20e-01	6.43e-01	1.77e-01	5.67e-01
GOMF ROUNDABOUT BINDING	5	4.82e-01	5.83e-01	0.4350	-8.90e-02	1.87e-01	3.53e-01	1.32e-01	4.35e-02	-5.52e-02	7.30e-01	4.70e-01	1.72e-01	6.09e-01	8.66e-01	8.31e-01
GOBP CELLULAR RESPONSE TO ATP	17	5.05e-03	1.98e-02	0.4350	-3.08e-01	-5.17e-02	1.17e-01	1.07e-01	2.51e-01	6.42e-02	2.78e-02	7.12e-01	4.05e-01	4.46e-01	7.35e-02	6.47e-01
GOMF L ASCORBIC ACID BINDING	19	3.36e-02	8.72e-02	0.4350	9.84e-03	-3.21e-01	-1.04e-01	2.02e-01	1.86e-01	1.21e-02	9.41e-01	1.55e-02	4.31e-01	1.27e-01	1.61e-01	9.27e-01
GOMF BETA CATENIN BINDING	74	1.70e-05	1.37e-04	0.4350	1.29e-01	2.30e-01	1.62e-01	2.87e-01	9.94e-02	3.86e-02	5.47e-02	6.20e-04	1.61e-02	2.00e-05	1.39e-01	5.65e-01
GOBP REGULATION OF CILIUM DEPENDENT CELL MOTILITY	12	5.84e-01	6.69e-01	0.4350	-9.20e-02	-5.92e-02	-2.80e-01	-1.08e-01	1.55e-01	-2.52e-01	5.81e-01	7.23e-01	9.32e-02	5.17e-01	3.52e-01	1.31e-01
GOBP CELL CELL SIGNALING INVOLVED IN CARDIAC CONDUCTION	16	2.29e-01	3.48e-01	0.4350	6.89e-02	1.19e-01	3.19e-01	-2.15e-01	-1.46e-01	3.26e-02	6.33e-01	4.11e-01	2.71e-02	1.37e-01	3.12e-01	8.21e-01
GOBP RECEPTOR CATABOLIC PROCESS	26	4.74e-04	2.69e-03	0.4350	-1.55e-01	-1.04e-01	2.56e-01	2.24e-01	-1.85e-01	6.89e-02	1.71e-01	3.61e-01	2.41e-02	4.81e-02	1.02e-01	5.43e-01
GOCC ESC E Z COMPLEX	15	3.33e-01	4.50e-01	0.4350	-1.90e-01	-1.74e-01	-2.64e-01	1.59e-01	1.40e-01	-9.07e-02	2.02e-01	2.44e-01	7.65e-02	2.87e-01	3.49e-01	5.43e-01
GOBP PLATELET DERIVED GROWTH FACTOR RECEPTOR BETA SIGNALING PATHWAY	12	2.69e-01	3.88e-01	0.4350	3.92e-02	7.71e-02	3.31e-01	2.32e-01	5.22e-02	1.25e-01	8.14e-01	6.44e-01	4.72e-02	1.64e-01	7.54e-01	4.53e-01
GOBP POSITIVE REGULATION OF DEVELOPMENTAL PIGMENTATION	6	8.86e-01	9.07e-01	0.4350	-1.96e-01	-1.79e-01	-6.08e-02	-2.99e-01	-1.34e-01	8.62e-02	4.07e-01	4.49e-01	7.97e-01	2.04e-01	5.69e-01	7.15e-01
GOBP NEGATIVE REGULATION BY HOST OF VIRAL GENOME REPLICATION	9	6.38e-01	7.13e-01	0.4340	-2.65e-01	-4.16e-02	2.15e-01	-1.43e-01	-1.99e-01	1.02e-01	1.69e-01	8.29e-01	2.63e-01	4.58e-01	3.00e-01	5.97e-01
GOBP PYRIMIDINE RIBONUCLEOSIDE TRIPHOSPHATE METABOLIC PROCESS	16	1.39e-01	2.48e-01	0.4340	-1.79e-01	-3.68e-01	-7.68e-02	1.06e-01	2.68e-02	5.78e-02	2.14e-01	1.08e-02	5.95e-01	4.65e-01	8.53e-01	6.89e-01
GOBP FC EPSILON RECEPTOR SIGNALING PATHWAY	25	4.87e-02	1.15e-01	0.4340	-5.29e-02	3.01e-01	2.06e-01	9.18e-02	1.50e-01	1.48e-01	6.47e-01	9.15e-03	7.52e-02	4.27e-01	1.93e-01	2.00e-01
GOBP BRANCHING INVOLVED IN BLOOD VESSEL MORPHOGENESIS	20	5.35e-03	2.07e-02	0.4340	-1.21e-01	4.07e-03	2.77e-01	2.90e-01	1.47e-03	1.14e-01	3.48e-01	9.75e-01	3.18e-02	2.48e-02	9.91e-01	3.77e-01
GOBP OVULATION FROM OVARIAN FOLLICLE	5	8.71e-01	8.95e-01	0.4340	-3.13e-01	-1.65e-01	1.09e-01	-5.30e-02	-2.03e-01	8.80e-02	2.26e-01	5.23e-01	6.73e-01	8.37e-01	4.32e-01	7.33e-01
GOBP POSITIVE REGULATION OF TRANSCRIPTION BY GLUCOSE	6	9.00e-01	9.17e-01	0.4340	1.58e-01	3.25e-01	2.04e-01	4.58e-02	4.61e-02	1.11e-01	5.04e-01	1.68e-01	3.87e-01	8.46e-01	8.45e-01	6.39e-01
GOMF DYNEIN COMPLEX BINDING	22	7.32e-02	1.56e-01	0.4340	-8.20e-02	1.34e-01	1.57e-01	1.73e-01	5.53e-02	3.26e-01	5.06e-01	2.76e-01	2.03e-01	1.61e-01	6.53e-01	8.12e-03
GOCC TRAPP COMPLEX	17	9.69e-02	1.92e-01	0.4340	-3.75e-02	-2.88e-01	-5.38e-02	2.32e-01	3.34e-02	2.15e-01	7.89e-01	3.99e-02	7.01e-01	9.79e-02	8.12e-01	1.24e-01
GOBP NEGATIVE REGULATION OF CELLULAR RESPONSE TO VASCULAR ENDOTHELIAL GROWTH FACTOR STIMULUS	9	4.71e-01	5.73e-01	0.4340	-1.48e-01	1.10e-02	3.34e-01	5.27e-02	-1.23e-02	2.27e-01	4.43e-01	9.55e-01	8.26e-02	7.84e-01	9.49e-01	2.38e-01
GOBP MICROTUBULE BASED PROTEIN TRANSPORT	14	1.59e-01	2.72e-01	0.4340	3.16e-01	8.47e-02	2.78e-01	-2.68e-02	1.33e-02	-5.62e-02	4.08e-02	5.83e-01	7.20e-02	8.62e-01	9.31e-01	7.16e-01
GOMF ENDONUCLEASE ACTIVITY ACTIVE WITH EITHER RIBO OR DEOXYRIBONUCLEIC ACIDS AND PRODUCING 5 PHOSPHOMONOESTERS	40	3.29e-03	1.40e-02	0.4340	3.38e-03	-3.33e-01	-2.21e-01	1.40e-01	-3.15e-02	-8.83e-02	9.71e-01	2.71e-04	1.55e-02	1.25e-01	7.30e-01	3.34e-01
GOBP DENDRITIC SPINE MAINTENANCE	17	2.43e-01	3.61e-01	0.4340	-9.57e-02	-8.99e-03	2.71e-01	-7.03e-02	-3.04e-01	8.94e-02	4.94e-01	9.49e-01	5.31e-02	6.16e-01	3.00e-02	5.23e-01
GOBP NEGATIVE REGULATION OF PROTEIN ACETYLATION	7	6.41e-01	7.15e-01	0.4340	-1.12e-01	-3.24e-01	-5.96e-02	7.79e-02	1.38e-03	2.47e-01	6.07e-01	1.38e-01	7.85e-01	7.21e-01	9.95e-01	2.58e-01
GOBP NEGATIVE REGULATION OF NUCLEAR DIVISION	56	4.41e-06	4.06e-05	0.4330	8.64e-02	-2.39e-01	3.71e-02	2.56e-01	9.80e-03	2.37e-01	2.63e-01	1.99e-03	6.31e-01	9.03e-04	8.99e-01	2.17e-03
GOBP POSITIVE REGULATION OF MIRNA TRANSCRIPTION	47	1.25e-04	8.25e-04	0.4330	-2.97e-02	1.78e-01	3.74e-01	-3.42e-02	1.71e-02	1.18e-01	7.24e-01	3.51e-02	9.07e-06	6.85e-01	8.39e-01	1.61e-01
GOMF ADENYLATE KINASE ACTIVITY	7	2.59e-01	3.79e-01	0.4330	7.41e-02	-1.64e-01	-4.27e-03	-2.18e-01	6.56e-02	3.22e-01	7.34e-01	4.52e-01	9.84e-01	3.19e-01	7.64e-01	1.40e-01
GOBP TORC2 SIGNALING	13	3.94e-01	5.07e-01	0.4330	6.20e-02	1.83e-01	-4.31e-02	3.39e-01	1.83e-01	-1.69e-02	6.99e-01	2.53e-01	7.88e-01	3.45e-02	2.52e-01	9.16e-01
GOMF SODIUM ION BINDING	6	7.43e-01	7.95e-01	0.4330	-8.04e-02	5.87e-02	3.81e-01	-1.96e-02	-4.88e-02	1.73e-01	7.33e-01	8.03e-01	1.06e-01	9.34e-01	8.36e-01	4.62e-01
GOBP REGULATION OF T CIRCLE FORMATION	7	5.14e-01	6.08e-01	0.4330	-4.79e-02	-1.82e-01	-1.09e-01	2.49e-01	-1.59e-01	-2.31e-01	8.26e-01	4.04e-01	6.18e-01	2.54e-01	4.67e-01	2.91e-01
GOMF UDP GALACTOSE BETA N ACETYLGLUCOSAMINE BETA 1 3 GALACTOSYLTRANSFERASE ACTIVITY	9	5.76e-01	6.62e-01	0.4330	-1.19e-02	1.54e-01	3.66e-01	2.55e-02	-1.34e-01	1.07e-01	9.51e-01	4.24e-01	5.73e-02	8.95e-01	4.86e-01	5.80e-01
GOBP MEMBRANE DEPOLARIZATION DURING ACTION POTENTIAL	18	3.29e-01	4.47e-01	0.4330	9.02e-02	1.17e-01	2.78e-01	-1.11e-01	-2.17e-01	1.70e-01	5.08e-01	3.91e-01	4.09e-02	4.14e-01	1.12e-01	2.11e-01
GOBP POSITIVE REGULATION OF NUCLEAR TRANSCRIBED MRNA CATABOLIC PROCESS DEADENYLATION DEPENDENT DECAY	12	1.47e-01	2.57e-01	0.4330	-3.20e-01	1.72e-01	7.33e-03	-1.50e-01	-1.82e-01	-1.08e-02	5.51e-02	3.03e-01	9.65e-01	3.68e-01	2.75e-01	9.49e-01
GOBP METAPHASE CHROMOSOME ALIGNMENT	98	4.24e-10	7.18e-09	0.4330	-8.69e-02	-2.72e-01	6.72e-02	1.68e-01	-9.13e-02	2.55e-01	1.37e-01	3.36e-06	2.51e-01	4.04e-03	1.18e-01	1.30e-05
GOBP PROTEIN K27 LINKED UBIQUITINATION	12	3.84e-01	4.97e-01	0.4330	-2.02e-02	2.11e-02	1.01e-01	3.05e-01	2.07e-01	2.01e-01	9.04e-01	8.99e-01	5.44e-01	6.70e-02	2.15e-01	2.29e-01
GOBP NEURON RECOGNITION	28	2.48e-02	6.95e-02	0.4330	-3.35e-01	2.73e-02	1.28e-01	-1.21e-01	-9.50e-02	1.86e-01	2.15e-03	8.02e-01	2.42e-01	2.69e-01	3.84e-01	8.92e-02
GOBP REGULATION OF FATTY ACID TRANSPORT	25	6.02e-04	3.28e-03	0.4330	-1.95e-01	7.43e-02	3.00e-01	-1.83e-01	-8.97e-02	-1.10e-01	9.07e-02	5.20e-01	9.51e-03	1.12e-01	4.38e-01	3.43e-01
GOBP CENTRAL NERVOUS SYSTEM MATURATION	6	6.66e-01	7.34e-01	0.4330	6.73e-02	3.11e-01	-4.19e-03	2.45e-01	9.00e-02	1.34e-01	7.75e-01	1.87e-01	9.86e-01	2.99e-01	7.03e-01	5.71e-01
GOCC PEPTIDASE INHIBITOR COMPLEX	9	1.41e-01	2.50e-01	0.4330	-2.33e-01	-2.51e-01	-1.88e-02	3.40e-02	2.43e-01	-9.47e-02	2.25e-01	1.92e-01	9.22e-01	8.60e-01	2.07e-01	6.23e-01
GOBP HEMOGLOBIN BIOSYNTHETIC PROCESS	11	6.49e-01	7.22e-01	0.4320	5.02e-03	1.25e-01	3.32e-01	4.75e-02	-5.97e-02	2.35e-01	9.77e-01	4.74e-01	5.66e-02	7.85e-01	7.32e-01	1.76e-01
GOCC AXONEMAL OUTER DOUBLET	10	7.17e-01	7.75e-01	0.4320	-1.03e-01	-2.38e-01	-1.82e-01	-9.40e-02	-9.73e-02	-2.61e-01	5.71e-01	1.92e-01	3.20e-01	6.07e-01	5.94e-01	1.53e-01
GOBP SCHWANN CELL MIGRATION	5	7.35e-01	7.89e-01	0.4320	3.49e-01	-7.57e-02	-1.61e-01	8.82e-02	-6.19e-02	-1.47e-01	1.76e-01	7.69e-01	5.32e-01	7.33e-01	8.10e-01	5.70e-01
GOBP VESICLE TARGETING TO FROM OR WITHIN GOLGI	33	1.82e-03	8.47e-03	0.4320	-1.23e-01	-2.16e-01	3.04e-02	2.47e-01	-1.09e-01	2.26e-01	2.20e-01	3.21e-02	7.62e-01	1.40e-02	2.79e-01	2.44e-02
GOBP POSITIVE REGULATION OF BMP SIGNALING PATHWAY	19	1.16e-01	2.17e-01	0.4320	4.47e-02	1.77e-01	2.37e-01	2.55e-01	1.62e-01	7.55e-02	7.36e-01	1.82e-01	7.33e-02	5.41e-02	2.21e-01	5.69e-01
GOBP SUCCINYL COA METABOLIC PROCESS	10	4.11e-01	5.22e-01	0.4320	8.18e-04	-2.80e-01	1.08e-01	1.57e-01	-4.13e-02	2.65e-01	9.96e-01	1.26e-01	5.54e-01	3.89e-01	8.21e-01	1.46e-01
GOMF CHEMOREPELLENT ACTIVITY	20	4.55e-02	1.09e-01	0.4320	7.77e-02	3.54e-01	1.96e-01	6.71e-02	-3.26e-02	-1.07e-01	5.48e-01	6.15e-03	1.29e-01	6.04e-01	8.01e-01	4.06e-01
GOBP NEGATIVE REGULATION OF ARP2 3 COMPLEX MEDIATED ACTIN NUCLEATION	5	7.50e-01	8.01e-01	0.4320	-5.67e-02	-3.55e-01	-6.50e-03	8.37e-02	-1.45e-01	-1.70e-01	8.26e-01	1.69e-01	9.80e-01	7.46e-01	5.75e-01	5.09e-01
GOBP INTERLEUKIN 1 ALPHA PRODUCTION	6	3.38e-01	4.56e-01	0.4320	-1.09e-01	-2.67e-01	1.15e-01	-2.86e-01	4.92e-02	-7.89e-02	6.43e-01	2.58e-01	6.25e-01	2.25e-01	8.35e-01	7.38e-01
GOMF STRUCTURAL CONSTITUENT OF NUCLEAR PORE	24	1.67e-02	5.14e-02	0.4320	-1.33e-01	-3.56e-02	-2.55e-01	2.69e-01	5.69e-02	-1.63e-01	2.58e-01	7.63e-01	3.05e-02	2.24e-02	6.29e-01	1.66e-01
GOBP RESPONSE TO STIMULUS INVOLVED IN REGULATION OF MUSCLE ADAPTATION	11	3.31e-01	4.49e-01	0.4320	2.02e-01	5.78e-02	2.72e-01	2.74e-02	-2.37e-01	-1.08e-01	2.47e-01	7.40e-01	1.18e-01	8.75e-01	1.74e-01	5.37e-01
GOCC LAMELLAR BODY	9	6.25e-01	7.02e-01	0.4320	1.43e-01	1.30e-01	3.00e-01	4.25e-02	-2.35e-01	4.91e-02	4.58e-01	5.00e-01	1.19e-01	8.25e-01	2.23e-01	7.99e-01
GOCC PRERIBOSOME SMALL SUBUNIT PRECURSOR	14	2.96e-01	4.15e-01	0.4320	9.85e-02	-2.93e-01	-1.96e-01	1.88e-01	2.34e-02	-1.28e-01	5.23e-01	5.78e-02	2.03e-01	2.22e-01	8.80e-01	4.08e-01
GOCC GOLGI MEDIAL CISTERNA	12	2.66e-01	3.85e-01	0.4320	-1.20e-01	-2.64e-01	-6.21e-02	2.29e-01	-1.34e-01	1.68e-01	4.72e-01	1.13e-01	7.10e-01	1.70e-01	4.23e-01	3.14e-01
GOBP POSITIVE REGULATION OF PROTEIN DEPHOSPHORYLATION	37	5.54e-03	2.13e-02	0.4320	-2.53e-02	-1.59e-01	2.10e-01	1.01e-01	-2.70e-01	1.82e-01	7.90e-01	9.43e-02	2.68e-02	2.88e-01	4.50e-03	5.55e-02
GOBP ALPHA BETA T CELL DIFFERENTIATION	114	1.25e-08	1.74e-07	0.4320	4.95e-02	2.57e-01	2.45e-01	1.68e-01	3.32e-02	1.68e-01	3.61e-01	2.13e-06	6.18e-06	1.88e-03	5.41e-01	1.95e-03
GOBP INTRACELLULAR PH REDUCTION	51	3.29e-04	1.95e-03	0.4320	-3.67e-01	-1.71e-01	-9.23e-03	-4.57e-02	-1.34e-01	4.83e-02	5.81e-06	3.48e-02	9.09e-01	5.72e-01	9.79e-02	5.51e-01
GOBP REGULATION OF NEUTROPHIL ACTIVATION	5	8.18e-01	8.53e-01	0.4320	1.43e-01	8.49e-02	8.41e-02	2.27e-01	2.82e-01	-1.42e-01	5.79e-01	7.42e-01	7.45e-01	3.80e-01	2.74e-01	5.83e-01
GOBP NEGATIVE REGULATION OF FATTY ACID OXIDATION	11	2.83e-01	4.02e-01	0.4310	1.43e-01	3.02e-01	-1.90e-01	8.09e-02	7.93e-02	-1.59e-01	4.12e-01	8.25e-02	2.76e-01	6.42e-01	6.49e-01	3.60e-01
GOBP NEGATIVE REGULATION OF BMP SIGNALING PATHWAY	41	1.04e-03	5.27e-03	0.4310	-7.79e-02	2.84e-01	2.78e-01	4.13e-02	3.46e-02	1.37e-01	3.88e-01	1.63e-03	2.03e-03	6.48e-01	7.02e-01	1.30e-01
GOBP OSTEOBLAST DEVELOPMENT	9	7.72e-01	8.16e-01	0.4310	2.75e-01	2.25e-01	1.89e-01	9.99e-02	1.10e-01	-4.30e-02	1.53e-01	2.42e-01	3.27e-01	6.04e-01	5.69e-01	8.23e-01
GOCC GOLGI ASSOCIATED VESICLE MEMBRANE	49	3.02e-05	2.31e-04	0.4310	-3.08e-01	-1.18e-01	7.63e-02	9.60e-02	-1.37e-01	2.08e-01	1.92e-04	1.54e-01	3.55e-01	2.45e-01	9.60e-02	1.17e-02
GOMF MICROTUBULE MOTOR ACTIVITY	60	7.83e-04	4.13e-03	0.4310	2.09e-01	5.33e-02	2.51e-01	1.03e-01	-8.82e-02	2.41e-01	5.14e-03	4.75e-01	7.87e-04	1.68e-01	2.37e-01	1.24e-03
GOBP MITOCHONDRIAL DNA REPLICATION	14	2.98e-01	4.17e-01	0.4310	-1.31e-01	-1.41e-01	-2.92e-01	1.71e-01	1.80e-01	3.96e-02	3.95e-01	3.60e-01	5.87e-02	2.68e-01	2.43e-01	7.98e-01
GOCC SUMO LIGASE COMPLEX	13	7.81e-02	1.64e-01	0.4310	3.82e-02	-1.07e-01	-2.07e-01	1.62e-01	1.52e-01	2.85e-01	8.11e-01	5.03e-01	1.97e-01	3.13e-01	3.44e-01	7.57e-02
GOBP HARD PALATE DEVELOPMENT	5	7.81e-01	8.23e-01	0.4310	-3.63e-02	2.70e-01	3.15e-01	2.46e-03	-1.09e-01	1.60e-02	8.88e-01	2.96e-01	2.22e-01	9.92e-01	6.72e-01	9.51e-01
GOBP MEMBRANE LIPID CATABOLIC PROCESS	42	2.45e-03	1.09e-02	0.4310	-2.97e-01	-1.81e-01	1.27e-01	-1.57e-01	-8.10e-02	1.32e-01	8.65e-04	4.27e-02	1.55e-01	7.78e-02	3.63e-01	1.40e-01
GOBP NEGATIVE REGULATION OF T CELL APOPTOTIC PROCESS	22	1.89e-01	3.04e-01	0.4310	1.15e-01	1.51e-01	1.68e-01	1.85e-01	4.40e-02	2.91e-01	3.49e-01	2.19e-01	1.72e-01	1.32e-01	7.21e-01	1.80e-02
GOBP CELL COMMUNICATION BY ELECTRICAL COUPLING	21	1.51e-01	2.62e-01	0.4310	3.49e-03	-6.17e-02	2.96e-01	1.22e-01	-1.01e-01	2.63e-01	9.78e-01	6.25e-01	1.89e-02	3.35e-01	4.24e-01	3.67e-02
GOBP POSITIVE REGULATION OF DNA METHYLATION DEPENDENT HETEROCHROMATIN FORMATION	11	3.77e-01	4.92e-01	0.4310	1.13e-01	1.25e-01	-7.05e-02	2.63e-01	1.72e-01	2.31e-01	5.16e-01	4.75e-01	6.86e-01	1.31e-01	3.22e-01	1.85e-01
GOBP RRNA CATABOLIC PROCESS	14	2.54e-01	3.74e-01	0.4310	-1.98e-02	-1.83e-01	-3.24e-01	-7.56e-03	-1.55e-01	-1.50e-01	8.98e-01	2.35e-01	3.60e-02	9.61e-01	3.15e-01	3.30e-01
GOBP NEGATIVE REGULATION OF AMINO ACID TRANSPORT	8	6.95e-01	7.58e-01	0.4310	-1.08e-01	5.55e-02	-1.93e-01	8.20e-02	2.25e-01	-2.76e-01	5.98e-01	7.86e-01	3.45e-01	6.88e-01	2.71e-01	1.76e-01
GOCC MULTIVESICULAR BODY MEMBRANE	26	3.47e-02	8.93e-02	0.4310	7.34e-02	-1.25e-01	2.52e-01	2.07e-01	-7.43e-02	2.28e-01	5.17e-01	2.70e-01	2.59e-02	6.71e-02	5.12e-01	4.39e-02
GOBP WATER TRANSPORT	14	4.27e-01	5.36e-01	0.4300	-8.92e-02	-1.97e-01	-4.09e-02	-1.03e-01	-3.29e-01	-1.34e-01	5.63e-01	2.01e-01	7.91e-01	5.07e-01	3.30e-02	3.87e-01
GOBP MYELOID CELL DEVELOPMENT	82	1.13e-06	1.18e-05	0.4300	-6.74e-02	-1.00e-01	2.88e-01	5.63e-02	-2.05e-01	2.06e-01	2.92e-01	1.17e-01	6.44e-06	3.78e-01	1.35e-03	1.24e-03
GOBP CENP A CONTAINING CHROMATIN ASSEMBLY	9	3.24e-01	4.43e-01	0.4300	2.46e-01	-2.50e-01	-8.89e-02	1.73e-01	1.38e-01	7.47e-02	2.02e-01	1.95e-01	6.44e-01	3.68e-01	4.74e-01	6.98e-01
GOMF U1 SNRNA BINDING	8	5.42e-01	6.33e-01	0.4300	1.20e-01	-3.56e-01	-3.84e-02	5.59e-02	-1.96e-01	-3.51e-02	5.55e-01	8.15e-02	8.51e-01	7.84e-01	3.38e-01	8.63e-01
GOBP SALIVARY GLAND DEVELOPMENT	29	5.47e-02	1.26e-01	0.4300	7.72e-02	9.49e-02	3.55e-01	-8.98e-02	-5.91e-02	1.79e-01	4.72e-01	3.77e-01	9.21e-04	4.03e-01	5.82e-01	9.52e-02
GOBP SYNAPTIC VESICLE BUDDING	10	3.46e-01	4.62e-01	0.4300	-3.06e-01	1.93e-01	1.52e-01	-8.55e-02	-9.96e-03	1.53e-01	9.38e-02	2.90e-01	4.05e-01	6.40e-01	9.57e-01	4.02e-01
GOBP REGULATION OF SOMATIC STEM CELL POPULATION MAINTENANCE	6	5.64e-01	6.52e-01	0.4300	3.01e-01	-2.40e-01	1.17e-01	6.21e-02	-1.25e-01	-5.73e-02	2.01e-01	3.08e-01	6.19e-01	7.92e-01	5.97e-01	8.08e-01
GOBP SMOOTH MUSCLE TISSUE DEVELOPMENT	12	1.71e-01	2.84e-01	0.4300	-2.67e-01	1.24e-01	2.67e-01	4.94e-03	3.91e-02	1.58e-01	1.09e-01	4.58e-01	1.09e-01	9.76e-01	8.15e-01	3.43e-01
GOBP DORSAL SPINAL CORD DEVELOPMENT	8	3.63e-01	4.78e-01	0.4300	-2.14e-01	-1.95e-01	5.56e-02	-1.68e-01	-6.96e-02	-2.55e-01	2.95e-01	3.41e-01	7.86e-01	4.12e-01	7.33e-01	2.11e-01
GOMF DNA ENDONUCLEASE ACTIVITY PRODUCING 3 PHOSPHOMONOESTERS	10	5.76e-01	6.62e-01	0.4300	1.12e-01	-1.93e-01	-1.89e-01	6.16e-02	3.23e-02	-3.07e-01	5.38e-01	2.91e-01	3.00e-01	7.36e-01	8.60e-01	9.26e-02
GOMF HISTONE CHAPERONE ACTIVITY	11	3.02e-01	4.22e-01	0.4300	-2.87e-01	-1.32e-01	-1.09e-01	-6.84e-02	2.39e-01	1.04e-01	9.90e-02	4.49e-01	5.32e-01	6.95e-01	1.69e-01	5.49e-01
GOBP POSITIVE REGULATION OF CELLULAR RESPIRATION	13	2.60e-01	3.80e-01	0.4300	-1.39e-01	-1.90e-02	6.03e-02	2.37e-01	1.61e-01	2.81e-01	3.84e-01	9.06e-01	7.07e-01	1.39e-01	3.15e-01	7.93e-02
GOBP NEGATIVE REGULATION OF TELOMERASE ACTIVITY	8	5.87e-01	6.70e-01	0.4290	2.29e-01	-6.98e-02	-1.62e-01	2.00e-01	2.34e-01	7.60e-02	2.61e-01	7.32e-01	4.27e-01	3.28e-01	2.51e-01	7.10e-01
GOBP REGULATION OF ACUTE INFLAMMATORY RESPONSE TO ANTIGENIC STIMULUS	14	1.77e-01	2.92e-01	0.4290	4.08e-03	-5.93e-02	9.35e-02	5.69e-02	1.69e-01	3.75e-01	9.79e-01	7.01e-01	5.45e-01	7.13e-01	2.74e-01	1.52e-02
GOMF TELOMERASE INHIBITOR ACTIVITY	5	7.97e-01	8.36e-01	0.4290	1.32e-01	-7.70e-02	-8.20e-02	2.44e-01	1.85e-01	2.46e-01	6.09e-01	7.66e-01	7.51e-01	3.45e-01	4.74e-01	3.40e-01
GOBP PROTON TRANSMEMBRANE TRANSPORT	131	3.52e-11	6.63e-10	0.4290	-1.79e-01	-3.54e-01	-1.80e-02	2.50e-02	-1.61e-01	2.55e-02	4.18e-04	2.73e-12	7.22e-01	6.21e-01	1.47e-03	6.14e-01
GOBP LATE ENDOSOME TO VACUOLE TRANSPORT	34	4.50e-03	1.79e-02	0.4290	-2.03e-01	-2.35e-01	8.06e-03	1.44e-01	-1.06e-01	2.37e-01	4.10e-02	1.76e-02	9.35e-01	1.47e-01	2.87e-01	1.69e-02
GOBP CEREBELLAR PURKINJE CELL LAYER DEVELOPMENT	22	2.36e-01	3.53e-01	0.4290	1.08e-01	1.65e-01	6.80e-02	3.06e-01	1.99e-01	8.30e-02	3.80e-01	1.79e-01	5.81e-01	1.28e-02	1.05e-01	5.00e-01
GOBP POSITIVE REGULATION OF ATP BIOSYNTHETIC PROCESS	7	5.07e-01	6.03e-01	0.4290	-2.69e-01	-2.58e-01	7.23e-02	1.17e-01	6.38e-02	1.49e-01	2.17e-01	2.37e-01	7.41e-01	5.93e-01	7.70e-01	4.95e-01
GOCC CCR4 NOT CORE COMPLEX	6	6.07e-01	6.87e-01	0.4290	-7.12e-02	-4.66e-02	-1.20e-01	3.20e-01	6.48e-02	2.37e-01	7.62e-01	8.43e-01	6.11e-01	1.75e-01	7.83e-01	3.15e-01
GOBP MONOACYLGLYCEROL CATABOLIC PROCESS	7	7.00e-01	7.61e-01	0.4290	5.63e-02	-3.41e-01	-7.71e-02	-1.02e-01	-1.87e-01	-1.17e-01	7.96e-01	1.18e-01	7.24e-01	6.42e-01	3.92e-01	5.93e-01
GOCC DENDRITIC SPINE MEMBRANE	9	5.46e-02	1.26e-01	0.4290	-1.95e-01	-1.57e-01	5.20e-02	5.80e-02	2.41e-01	-2.39e-01	3.10e-01	4.14e-01	7.87e-01	7.63e-01	2.10e-01	2.15e-01
GOCC MYOSIN II COMPLEX	13	4.61e-01	5.66e-01	0.4290	2.60e-01	1.04e-01	2.28e-01	2.20e-01	-7.07e-02	1.99e-02	1.05e-01	5.15e-01	1.54e-01	1.71e-01	6.59e-01	9.01e-01
GOBP NEGATIVE REGULATION OF LYASE ACTIVITY	11	3.81e-01	4.95e-01	0.4290	-1.30e-02	3.87e-01	1.78e-01	1.20e-02	2.84e-02	4.31e-02	9.41e-01	2.64e-02	3.08e-01	9.45e-01	8.70e-01	8.04e-01
GOBP NEGATIVE REGULATION OF CENTROSOME DUPLICATION	12	3.89e-01	5.02e-01	0.4290	-5.57e-02	3.87e-02	-3.55e-01	6.03e-03	2.13e-01	-8.80e-02	7.38e-01	8.16e-01	3.31e-02	9.71e-01	2.01e-01	5.97e-01
GOBP REGULATION OF COLLATERAL SPROUTING	16	8.84e-02	1.79e-01	0.4290	4.50e-02	2.17e-01	3.50e-01	1.67e-02	-9.24e-02	-5.70e-02	7.56e-01	1.33e-01	1.53e-02	9.08e-01	5.22e-01	6.93e-01
GOBP REGULATION OF REGULATORY NCRNA PROCESSING	13	4.76e-01	5.77e-01	0.4290	1.23e-01	3.98e-02	-2.15e-01	2.96e-01	1.63e-01	-8.24e-02	4.44e-01	8.04e-01	1.81e-01	6.43e-02	3.09e-01	6.07e-01
GOBP NEGATIVE REGULATION OF ORGANIC ACID TRANSPORT	15	5.63e-02	1.29e-01	0.4290	-1.14e-01	-1.94e-02	-3.47e-02	-1.30e-02	-3.29e-02	-4.10e-01	4.44e-01	8.96e-01	8.16e-01	9.31e-01	8.26e-01	5.99e-03
GOBP TERMINATION OF RNA POLYMERASE II TRANSCRIPTION	10	1.91e-01	3.07e-01	0.4290	-1.22e-01	9.19e-02	5.84e-02	3.83e-01	9.30e-02	3.53e-02	5.03e-01	6.15e-01	7.49e-01	3.58e-02	6.10e-01	8.47e-01
GOBP MICROVILLUS ASSEMBLY	21	7.10e-02	1.53e-01	0.4290	-8.83e-02	3.22e-01	1.95e-01	5.49e-02	1.24e-01	1.26e-01	4.84e-01	1.07e-02	1.22e-01	6.63e-01	3.25e-01	3.17e-01
GOBP REGULATION OF ACYL COA BIOSYNTHETIC PROCESS	5	8.91e-01	9.11e-01	0.4280	1.93e-01	-2.93e-02	1.07e-01	2.46e-01	1.44e-01	2.30e-01	4.55e-01	9.10e-01	6.80e-01	3.41e-01	5.77e-01	3.73e-01
GOBP POSITIVE REGULATION OF VIRAL LIFE CYCLE	23	2.44e-02	6.88e-02	0.4280	-2.78e-01	-2.68e-01	-9.05e-02	1.57e-01	3.43e-02	-9.04e-04	2.08e-02	2.59e-02	4.52e-01	1.93e-01	7.76e-01	9.94e-01
GOBP MESODERM MORPHOGENESIS	48	5.51e-03	2.12e-02	0.4280	1.23e-01	8.87e-02	3.09e-01	1.67e-01	3.37e-03	1.93e-01	1.39e-01	2.88e-01	2.17e-04	4.60e-02	9.68e-01	2.04e-02
GOBP OPTIC NERVE DEVELOPMENT	14	3.94e-01	5.07e-01	0.4280	1.39e-02	1.65e-01	2.28e-01	5.59e-02	2.03e-01	2.45e-01	9.28e-01	2.86e-01	1.40e-01	7.17e-01	1.89e-01	1.13e-01
GOBP NEGATIVE REGULATION OF CGAS STING SIGNALING PATHWAY	12	2.43e-01	3.61e-01	0.4280	7.95e-03	-2.26e-01	-2.32e-01	2.52e-01	-1.18e-01	-3.32e-02	9.62e-01	1.75e-01	1.64e-01	1.31e-01	4.80e-01	8.42e-01
GOBP PLATELET DENSE GRANULE ORGANIZATION	24	1.96e-02	5.83e-02	0.4280	-2.98e-01	-1.30e-01	1.28e-01	1.00e-01	-1.11e-01	1.97e-01	1.15e-02	2.72e-01	2.77e-01	3.96e-01	3.47e-01	9.43e-02
GOBP CARTILAGE DEVELOPMENT INVOLVED IN ENDOCHONDRAL BONE MORPHOGENESIS	20	6.22e-02	1.38e-01	0.4280	-1.45e-01	2.41e-01	1.85e-01	1.25e-01	1.35e-01	1.90e-01	2.61e-01	6.25e-02	1.51e-01	3.32e-01	2.97e-01	1.42e-01
GOBP NEGATIVE REGULATION OF TELOMERE MAINTENANCE VIA TELOMERASE	21	6.50e-02	1.43e-01	0.4280	-1.47e-01	-2.71e-02	-2.12e-01	2.48e-01	2.22e-01	6.94e-02	2.43e-01	8.30e-01	9.28e-02	4.88e-02	7.78e-02	5.82e-01
GOMF ARGININE BINDING	7	7.37e-01	7.90e-01	0.4280	1.70e-01	-1.47e-02	-9.99e-02	1.62e-01	3.43e-01	1.90e-02	4.36e-01	9.46e-01	6.47e-01	4.58e-01	1.16e-01	9.31e-01
GOMF METHYLATION DEPENDENT PROTEIN BINDING	78	3.95e-06	3.68e-05	0.4280	2.16e-02	1.22e-01	-1.12e-01	3.23e-01	2.26e-01	-1.81e-02	7.42e-01	6.23e-02	8.81e-02	8.38e-07	5.70e-04	7.82e-01
GOBP CMP METABOLIC PROCESS	7	5.29e-01	6.22e-01	0.4280	-2.00e-01	-2.98e-01	7.95e-02	8.55e-02	-1.87e-01	-7.57e-02	3.59e-01	1.72e-01	7.16e-01	6.95e-01	3.92e-01	7.29e-01
GOBP CHORION DEVELOPMENT	8	5.63e-01	6.51e-01	0.4280	-1.61e-01	-2.06e-01	5.33e-02	4.80e-02	-3.23e-01	-7.36e-02	4.31e-01	3.13e-01	7.94e-01	8.14e-01	1.14e-01	7.18e-01
GOMF NUCLEAR ANDROGEN RECEPTOR BINDING	24	2.17e-02	6.30e-02	0.4280	-6.85e-02	-7.75e-02	1.73e-01	2.35e-01	-1.83e-01	2.32e-01	5.62e-01	5.11e-01	1.42e-01	4.67e-02	1.20e-01	4.95e-02
GOBP REGULATION OF ALCOHOL BIOSYNTHETIC PROCESS	35	4.48e-04	2.56e-03	0.4280	-9.09e-02	-8.83e-02	2.75e-01	2.10e-01	-1.53e-01	1.54e-01	3.52e-01	3.66e-01	4.85e-03	3.17e-02	1.17e-01	1.15e-01
GOBP POSITIVE REGULATION OF ORGAN GROWTH	29	2.15e-02	6.26e-02	0.4280	9.13e-02	3.50e-01	1.91e-01	1.22e-01	1.79e-02	-6.05e-03	3.95e-01	1.09e-03	7.53e-02	2.54e-01	8.67e-01	9.55e-01
GOBP REGULATION OF DENDRITIC CELL ANTIGEN PROCESSING AND PRESENTATION	9	4.53e-02	1.09e-01	0.4280	-1.76e-01	7.39e-02	1.74e-01	9.23e-03	7.53e-02	-3.32e-01	3.60e-01	7.01e-01	3.65e-01	9.62e-01	6.96e-01	8.46e-02
GOMF INSULIN RECEPTOR SUBSTRATE BINDING	12	1.32e-01	2.39e-01	0.4270	-2.25e-01	8.95e-02	1.80e-01	1.40e-01	-1.92e-01	1.87e-01	1.77e-01	5.92e-01	2.80e-01	4.00e-01	2.49e-01	2.61e-01
GOMF OMEGA PEPTIDASE ACTIVITY	10	2.35e-01	3.53e-01	0.4270	8.65e-02	-5.22e-02	2.29e-01	4.52e-02	2.41e-01	2.44e-01	6.36e-01	7.75e-01	2.10e-01	8.05e-01	1.87e-01	1.81e-01
GOMF 3 5 CYCLIC AMP PHOSPHODIESTERASE ACTIVITY	18	3.47e-01	4.63e-01	0.4270	5.40e-02	2.81e-01	2.60e-01	5.53e-02	9.17e-02	1.46e-01	6.92e-01	3.90e-02	5.63e-02	6.85e-01	5.01e-01	2.83e-01
GOBP REGULATION OF CELL MATURATION	14	2.85e-01	4.04e-01	0.4270	1.27e-01	-1.16e-01	2.44e-01	2.28e-02	-4.43e-02	3.01e-01	4.10e-01	4.53e-01	1.14e-01	8.82e-01	7.74e-01	5.11e-02
GOBP OOCYTE MATURATION	24	2.71e-02	7.43e-02	0.4270	-1.32e-01	-1.78e-01	2.26e-01	1.45e-01	-1.53e-01	1.94e-01	2.61e-01	1.32e-01	5.57e-02	2.20e-01	1.94e-01	9.98e-02
GOMF INSULIN LIKE GROWTH FACTOR I BINDING	10	4.58e-01	5.63e-01	0.4270	-1.04e-02	5.79e-02	3.59e-01	-1.44e-01	-6.27e-03	1.71e-01	9.55e-01	7.51e-01	4.93e-02	4.31e-01	9.73e-01	3.50e-01
GOBP PHAGOSOME ACIDIFICATION	7	5.86e-01	6.70e-01	0.4270	-3.23e-01	-8.05e-02	-4.02e-03	-5.21e-02	-2.16e-01	-1.48e-01	1.39e-01	7.12e-01	9.85e-01	8.11e-01	3.22e-01	4.98e-01
GOBP POSITIVE REGULATION OF VASCULAR PERMEABILITY	16	5.92e-02	1.34e-01	0.4270	3.61e-02	-2.45e-01	9.04e-04	-1.59e-01	-8.94e-02	-2.96e-01	8.03e-01	8.91e-02	9.95e-01	2.72e-01	5.36e-01	4.06e-02
GOBP NEGATIVE REGULATION OF VASCULAR ASSOCIATED SMOOTH MUSCLE CELL PROLIFERATION	18	1.09e-01	2.08e-01	0.4270	-2.72e-01	-1.94e-01	1.38e-01	-7.97e-02	-2.10e-01	-2.82e-02	4.59e-02	1.54e-01	3.10e-01	5.58e-01	1.23e-01	8.36e-01
GOBP POSITIVE REGULATION OF RETINOIC ACID RECEPTOR SIGNALING PATHWAY	5	5.69e-01	6.56e-01	0.4270	-1.24e-01	-2.18e-01	-1.71e-02	2.11e-01	1.04e-02	-2.72e-01	6.32e-01	3.99e-01	9.47e-01	4.13e-01	9.68e-01	2.92e-01
GOBP LATERAL MESODERM DEVELOPMENT	11	6.61e-02	1.45e-01	0.4270	-2.68e-01	-1.92e-01	8.41e-02	1.31e-01	-1.27e-01	-1.81e-01	1.23e-01	2.70e-01	6.29e-01	4.53e-01	4.64e-01	2.98e-01
GOBP ERBB3 SIGNALING PATHWAY	9	6.61e-01	7.30e-01	0.4270	-2.52e-01	-2.79e-01	-7.40e-02	-3.17e-02	-1.27e-01	-1.34e-01	1.90e-01	1.47e-01	7.01e-01	8.69e-01	5.11e-01	4.88e-01
GOBP POSITIVE REGULATION OF FIBROBLAST APOPTOTIC PROCESS	7	5.94e-01	6.76e-01	0.4270	-3.30e-01	-7.69e-02	1.89e-02	8.49e-03	-2.51e-01	5.83e-02	1.30e-01	7.25e-01	9.31e-01	9.69e-01	2.50e-01	7.90e-01
GOBP POSITIVE REGULATION OF CELLULAR RESPONSE TO INSULIN STIMULUS	21	8.65e-02	1.76e-01	0.4260	-2.95e-01	-1.21e-01	1.71e-01	-7.06e-03	-1.30e-01	1.84e-01	1.92e-02	3.35e-01	1.76e-01	9.55e-01	3.01e-01	1.44e-01
GOMF DELTA CATENIN BINDING	7	6.91e-01	7.55e-01	0.4260	3.23e-01	2.09e-01	8.62e-02	9.10e-02	-1.19e-01	-6.16e-02	1.39e-01	3.38e-01	6.93e-01	6.77e-01	5.87e-01	7.78e-01
GOBP EATING BEHAVIOR	19	5.81e-02	1.32e-01	0.4260	4.07e-02	3.94e-02	5.77e-02	6.28e-02	3.29e-01	2.51e-01	7.59e-01	7.66e-01	6.63e-01	6.36e-01	1.31e-02	5.77e-02
GOBP PTERIDINE CONTAINING COMPOUND METABOLIC PROCESS	31	8.61e-03	3.05e-02	0.4260	-7.51e-02	-3.98e-01	-2.81e-02	2.98e-02	-9.57e-02	8.25e-02	4.69e-01	1.25e-04	7.87e-01	7.74e-01	3.56e-01	4.26e-01
GOBP APOPTOTIC PROCESS INVOLVED IN DEVELOPMENT	23	5.71e-03	2.19e-02	0.4260	1.48e-02	9.55e-03	3.24e-01	2.67e-01	2.84e-04	7.27e-02	9.02e-01	9.37e-01	7.15e-03	2.68e-02	9.98e-01	5.46e-01
GOMF CLATHRIN HEAVY CHAIN BINDING	10	1.55e-01	2.66e-01	0.4260	-3.16e-01	5.59e-02	3.33e-02	2.37e-01	1.10e-01	9.40e-02	8.32e-02	7.60e-01	8.55e-01	1.94e-01	5.47e-01	6.07e-01
GOBP CHROMOSOME SEPARATION	79	3.40e-08	4.44e-07	0.4260	1.02e-01	-2.08e-01	6.24e-02	2.82e-01	-9.89e-04	2.11e-01	1.17e-01	1.42e-03	3.38e-01	1.45e-05	9.88e-01	1.17e-03
GOBP REGULATION OF SYSTEMIC ARTERIAL BLOOD PRESSURE BY HORMONE	22	9.49e-02	1.89e-01	0.4260	-2.06e-01	-6.83e-02	2.56e-01	-4.11e-02	-5.97e-02	2.53e-01	9.44e-02	5.79e-01	3.79e-02	7.38e-01	6.28e-01	4.02e-02
GOBP REGULATION OF MACROPHAGE CHEMOTAXIS	23	6.43e-02	1.42e-01	0.4260	-1.23e-01	-2.46e-01	2.02e-01	4.76e-02	-1.79e-01	1.75e-01	3.07e-01	4.11e-02	9.38e-02	6.93e-01	1.37e-01	1.46e-01
GOBP CYTOKINETIC PROCESS	46	1.51e-04	9.74e-04	0.4260	-1.51e-01	-1.89e-01	1.45e-01	1.86e-01	-1.44e-01	2.17e-01	7.73e-02	2.67e-02	8.97e-02	2.94e-02	9.10e-02	1.09e-02
GOBP FOLIC ACID CONTAINING COMPOUND METABOLIC PROCESS	25	2.38e-02	6.75e-02	0.4260	-5.00e-02	-3.40e-01	3.45e-02	1.24e-01	-7.31e-02	2.04e-01	6.65e-01	3.26e-03	7.66e-01	2.84e-01	5.27e-01	7.78e-02
GOBP RESPONSE TO CAFFEINE	13	2.10e-01	3.27e-01	0.4260	-2.65e-01	-2.49e-01	8.77e-02	4.45e-02	3.52e-02	1.96e-01	9.84e-02	1.20e-01	5.84e-01	7.81e-01	8.26e-01	2.22e-01
GOMF EXCITATORY EXTRACELLULAR LIGAND GATED MONOATOMIC ION CHANNEL ACTIVITY	16	3.76e-01	4.91e-01	0.4260	2.01e-01	4.26e-03	1.90e-01	2.37e-01	-9.10e-03	2.20e-01	1.64e-01	9.76e-01	1.87e-01	1.00e-01	9.50e-01	1.28e-01
GOBP IMMUNE RESPONSE INHIBITING SIGNAL TRANSDUCTION	9	6.16e-01	6.95e-01	0.4260	-2.42e-01	-2.63e-02	5.97e-02	-1.71e-01	3.18e-03	2.99e-01	2.09e-01	8.91e-01	7.57e-01	3.74e-01	9.87e-01	1.21e-01
GOBP NK T CELL ACTIVATION	13	3.53e-01	4.68e-01	0.4260	-3.11e-02	1.11e-01	-5.26e-02	2.43e-01	3.05e-01	-1.16e-01	8.46e-01	4.88e-01	7.43e-01	1.30e-01	5.72e-02	4.68e-01
GOBP ICOSANOID TRANSPORT	35	3.17e-04	1.89e-03	0.4260	-1.39e-01	4.64e-02	3.25e-01	-2.22e-01	-6.51e-02	2.12e-02	1.54e-01	6.35e-01	8.82e-04	2.29e-02	5.05e-01	8.28e-01
GOBP PROTEIN LOCALIZATION TO PHOTORECEPTOR OUTER SEGMENT	5	8.60e-01	8.86e-01	0.4250	-4.42e-02	3.13e-01	-4.31e-02	2.50e-02	2.80e-01	2.83e-02	8.64e-01	2.26e-01	8.67e-01	9.23e-01	2.79e-01	9.13e-01
GOBP NEGATIVE REGULATION OF EPITHELIAL CELL APOPTOTIC PROCESS	40	5.63e-03	2.16e-02	0.4250	-6.30e-02	1.25e-01	2.93e-01	3.94e-02	-1.81e-01	2.03e-01	4.90e-01	1.71e-01	1.34e-03	6.66e-01	4.75e-02	2.63e-02
GOBP SECRETORY GRANULE ORGANIZATION	53	1.19e-04	7.91e-04	0.4250	-2.40e-01	-5.01e-02	2.03e-01	2.26e-02	-1.98e-01	2.00e-01	2.54e-03	5.28e-01	1.04e-02	7.76e-01	1.28e-02	1.16e-02
GOMF ALCOHOL DEHYDROGENASE NAD P PLUS ACTIVITY	13	3.31e-01	4.49e-01	0.4250	-1.38e-01	-8.27e-02	-3.47e-01	1.43e-01	1.09e-01	-4.83e-02	3.88e-01	6.06e-01	3.03e-02	3.73e-01	4.95e-01	7.63e-01
GOMF PRE MRNA 3 SPLICE SITE BINDING	6	4.35e-01	5.43e-01	0.4250	2.51e-01	-1.36e-01	3.52e-02	6.28e-02	2.38e-01	-1.93e-01	2.86e-01	5.63e-01	8.81e-01	7.90e-01	3.13e-01	4.12e-01
GOBP NEGATIVE REGULATION OF LYMPHOCYTE MIGRATION	13	4.66e-01	5.69e-01	0.4250	1.35e-01	1.80e-01	2.35e-01	1.47e-01	-1.29e-01	1.92e-01	3.99e-01	2.61e-01	1.43e-01	3.60e-01	4.19e-01	2.32e-01
GOCC PROTEIN COMPLEX INVOLVED IN CELL MATRIX ADHESION	16	2.69e-02	7.40e-02	0.4250	-3.92e-02	1.66e-01	1.99e-01	-2.80e-01	1.19e-01	-1.40e-01	7.86e-01	2.50e-01	1.68e-01	5.28e-02	4.10e-01	3.31e-01
GOBP REGULATION OF NEUROINFLAMMATORY RESPONSE	27	7.04e-03	2.60e-02	0.4250	1.65e-02	2.44e-01	2.74e-01	-8.15e-02	1.95e-01	3.03e-02	8.82e-01	2.81e-02	1.36e-02	4.63e-01	7.95e-02	7.86e-01
GOCC LAMIN FILAMENT	5	4.50e-01	5.57e-01	0.4250	8.52e-02	-1.29e-01	1.95e-01	2.80e-01	1.07e-01	-1.70e-01	7.42e-01	6.16e-01	4.51e-01	2.78e-01	6.80e-01	5.09e-01
GOBP VIRION ASSEMBLY	33	3.91e-03	1.60e-02	0.4250	-1.27e-01	-2.08e-01	1.34e-01	1.76e-01	-9.43e-03	2.68e-01	2.05e-01	3.82e-02	1.84e-01	7.98e-02	9.25e-01	7.64e-03
GOBP POSITIVE REGULATION OF DENDRITIC SPINE MORPHOGENESIS	15	1.68e-01	2.81e-01	0.4250	-1.76e-01	1.83e-02	-4.55e-02	1.35e-01	3.00e-01	1.97e-01	2.38e-01	9.03e-01	7.60e-01	3.64e-01	4.41e-02	1.87e-01
GOBP REGULATION OF MACROPHAGE DERIVED FOAM CELL DIFFERENTIATION	22	4.17e-02	1.03e-01	0.4250	-2.81e-01	-1.46e-01	1.62e-01	-1.69e-01	-1.55e-01	-3.56e-02	2.24e-02	2.35e-01	1.89e-01	1.69e-01	2.08e-01	7.73e-01
GOBP BEHAVIORAL RESPONSE TO PAIN	13	4.35e-03	1.75e-02	0.4250	-1.23e-01	-2.18e-01	1.99e-01	1.63e-01	-4.13e-02	-2.23e-01	4.41e-01	1.73e-01	2.14e-01	3.09e-01	7.96e-01	1.64e-01
GOBP ARTERY MORPHOGENESIS	43	6.18e-05	4.43e-04	0.4250	-1.42e-01	1.88e-01	3.07e-01	9.08e-02	4.33e-02	1.43e-01	1.06e-01	3.30e-02	4.85e-04	3.03e-01	6.23e-01	1.06e-01
GOBP HEAT GENERATION	13	7.87e-02	1.64e-01	0.4250	-1.57e-01	2.09e-01	1.66e-01	-1.68e-01	2.29e-01	-6.09e-02	3.27e-01	1.92e-01	3.02e-01	2.94e-01	1.52e-01	7.04e-01
GOBP POSITIVE REGULATION OF AUTOPHAGOSOME ASSEMBLY	19	6.56e-03	2.45e-02	0.4240	-2.64e-01	1.76e-01	6.08e-02	1.92e-01	-1.04e-02	1.97e-01	4.64e-02	1.85e-01	6.46e-01	1.46e-01	9.38e-01	1.37e-01
GOCC SODIUM POTASSIUM EXCHANGING ATPASE COMPLEX	8	7.69e-01	8.14e-01	0.4240	2.19e-01	4.30e-02	1.58e-01	3.15e-01	1.89e-02	7.86e-02	2.85e-01	8.33e-01	4.39e-01	1.23e-01	9.26e-01	7.00e-01
GOBP REGULATION OF EXOSOMAL SECRETION	18	2.04e-01	3.20e-01	0.4240	-1.27e-01	-2.22e-01	1.60e-01	5.00e-02	-2.62e-01	1.34e-01	3.50e-01	1.04e-01	2.40e-01	7.13e-01	5.44e-02	3.25e-01
GOBP IMMATURE T CELL PROLIFERATION	9	4.44e-01	5.51e-01	0.4240	1.04e-01	1.99e-01	2.31e-01	-2.14e-01	-6.01e-02	-1.63e-01	5.88e-01	3.01e-01	2.29e-01	2.67e-01	7.55e-01	3.96e-01
GOBP REGULATION OF GAMMA AMINOBUTYRIC ACID SECRETION	6	7.56e-01	8.04e-01	0.4240	2.39e-03	1.79e-01	1.21e-02	1.58e-01	3.04e-01	-1.74e-01	9.92e-01	4.49e-01	9.59e-01	5.03e-01	1.97e-01	4.60e-01
GOBP MITOTIC SPINDLE ASSEMBLY	73	1.42e-07	1.70e-06	0.4240	-1.03e-01	-1.67e-01	1.18e-01	2.18e-01	4.93e-02	2.78e-01	1.29e-01	1.35e-02	8.02e-02	1.29e-03	4.67e-01	3.95e-05
GOBP REGULATION OF ARP2 3 COMPLEX MEDIATED ACTIN NUCLEATION	29	4.43e-02	1.07e-01	0.4240	-2.34e-01	-2.57e-01	1.09e-01	-5.49e-02	-1.98e-01	6.93e-02	2.90e-02	1.65e-02	3.11e-01	6.09e-01	6.54e-02	5.19e-01
GOCC T TUBULE	38	4.54e-02	1.09e-01	0.4230	2.01e-02	1.41e-01	3.15e-01	-7.34e-02	-9.06e-02	2.15e-01	8.30e-01	1.31e-01	7.78e-04	4.34e-01	3.34e-01	2.20e-02
GOBP PROTEIN AUTOPROCESSING	16	2.29e-01	3.47e-01	0.4230	-1.75e-01	-9.85e-02	-3.49e-01	9.03e-02	4.64e-02	-8.42e-02	2.26e-01	4.95e-01	1.58e-02	5.32e-01	7.48e-01	5.60e-01
GOBP PARAXIAL MESODERM DEVELOPMENT	11	2.41e-01	3.59e-01	0.4230	8.07e-02	3.90e-02	-3.76e-02	-1.26e-01	-3.58e-01	-1.60e-01	6.43e-01	8.23e-01	8.29e-01	4.70e-01	3.96e-02	3.58e-01
GOBP NEGATIVE REGULATION OF PEPTIDYL THREONINE PHOSPHORYLATION	16	1.09e-01	2.09e-01	0.4230	-6.19e-02	-1.41e-01	2.07e-01	2.31e-01	-1.92e-01	1.50e-01	6.68e-01	3.28e-01	1.51e-01	1.10e-01	1.84e-01	3.00e-01
GOMF NEUROPEPTIDE ACTIVITY	8	3.69e-01	4.85e-01	0.4230	5.50e-02	-2.95e-01	5.03e-02	2.16e-01	-1.07e-01	-1.68e-01	7.88e-01	1.48e-01	8.06e-01	2.90e-01	5.99e-01	4.09e-01
GOBP CHEMOKINE C C MOTIF LIGAND 5 PRODUCTION	9	3.80e-01	4.94e-01	0.4230	-1.35e-01	3.23e-01	1.37e-01	-3.75e-02	-7.55e-02	1.75e-01	4.84e-01	9.33e-02	4.76e-01	8.46e-01	6.95e-01	3.64e-01
GOCC JUXTAPARANODE REGION OF AXON	9	6.95e-01	7.58e-01	0.4230	2.90e-01	1.28e-01	2.63e-01	8.75e-02	3.93e-02	1.27e-02	1.32e-01	5.07e-01	1.71e-01	6.49e-01	8.38e-01	9.47e-01
GOBP MYOTUBE DIFFERENTIATION INVOLVED IN SKELETAL MUSCLE REGENERATION	6	7.89e-01	8.30e-01	0.4230	2.37e-01	1.91e-01	2.39e-01	-1.37e-01	6.62e-02	7.84e-02	3.15e-01	4.18e-01	3.11e-01	5.62e-01	7.79e-01	7.40e-01
GOCC VESICLE LUMEN	292	1.46e-24	8.91e-23	0.4230	-1.99e-01	-2.03e-01	1.69e-01	-8.08e-03	-1.66e-01	2.03e-01	4.59e-09	2.40e-09	6.33e-07	8.12e-01	1.00e-06	2.27e-09
GOMF FRUCTOSE BINDING	6	5.78e-01	6.64e-01	0.4230	-1.06e-01	-2.88e-01	-2.98e-03	-1.07e-01	-4.17e-02	-2.67e-01	6.54e-01	2.22e-01	9.90e-01	6.48e-01	8.60e-01	2.58e-01
GOMF EPIDERMAL GROWTH FACTOR RECEPTOR BINDING	27	1.59e-03	7.55e-03	0.4230	-1.64e-01	7.26e-02	2.78e-01	1.35e-01	1.53e-01	1.66e-01	1.40e-01	5.14e-01	1.24e-02	2.25e-01	1.68e-01	1.35e-01
GOCC SMOOTH ENDOPLASMIC RETICULUM MEMBRANE	5	8.12e-01	8.48e-01	0.4230	-7.63e-02	-2.08e-02	6.26e-02	1.51e-02	2.81e-02	4.09e-01	7.68e-01	9.36e-01	8.08e-01	9.53e-01	9.13e-01	1.13e-01
GOCC MICROVILLUS MEMBRANE	23	2.36e-01	3.53e-01	0.4230	1.58e-02	1.21e-01	3.32e-01	-3.51e-02	-1.04e-01	2.03e-01	8.95e-01	3.14e-01	5.81e-03	7.71e-01	3.90e-01	9.18e-02
GOBP B CELL RECEPTOR SIGNALING PATHWAY	72	1.97e-04	1.24e-03	0.4220	1.36e-01	1.13e-01	2.72e-01	1.35e-01	-1.22e-01	2.00e-01	4.64e-02	9.63e-02	6.47e-05	4.74e-02	7.43e-02	3.33e-03
GOBP REGULATION OF NATURAL KILLER CELL MEDIATED IMMUNITY	47	2.22e-06	2.18e-05	0.4220	7.47e-02	2.70e-01	8.12e-02	2.28e-01	-7.60e-02	1.89e-01	3.76e-01	1.36e-03	3.36e-01	6.84e-03	3.67e-01	2.53e-02
GOBP NOREPINEPHRINE TRANSPORT	15	1.70e-01	2.83e-01	0.4220	-2.29e-02	-1.09e-01	2.92e-01	-1.94e-01	-2.07e-01	-9.08e-03	8.78e-01	4.65e-01	5.02e-02	1.93e-01	1.64e-01	9.51e-01
GOBP REGULATION OF ODONTOGENESIS	9	7.14e-01	7.72e-01	0.4220	-5.32e-02	-1.40e-01	2.45e-01	-1.34e-02	-1.22e-01	2.85e-01	7.82e-01	4.67e-01	2.03e-01	9.44e-01	5.28e-01	1.39e-01
GOBP POSITIVE REGULATION OF DENDRITIC CELL DIFFERENTIATION	6	8.50e-01	8.79e-01	0.4220	-7.45e-02	-2.31e-01	-2.34e-01	2.79e-02	1.65e-01	-1.91e-01	7.52e-01	3.28e-01	3.20e-01	9.06e-01	4.84e-01	4.17e-01
GOBP REGULATION OF PROTEIN LOCALIZATION TO LYSOSOME	5	6.50e-01	7.22e-01	0.4220	-9.95e-02	1.63e-02	3.41e-01	1.98e-02	1.43e-01	1.77e-01	7.00e-01	9.50e-01	1.87e-01	9.39e-01	5.80e-01	4.94e-01
GOBP HETEROCHROMATIN ORGANIZATION	11	3.00e-01	4.20e-01	0.4220	-1.95e-02	2.63e-01	1.57e-01	1.31e-01	2.43e-01	-8.78e-02	9.11e-01	1.30e-01	3.69e-01	4.53e-01	1.63e-01	6.14e-01
GOBP POSITIVE REGULATION OF DOUBLE STRAND BREAK REPAIR VIA NONHOMOLOGOUS END JOINING	14	2.44e-01	3.63e-01	0.4220	-1.15e-01	-6.87e-02	-2.64e-01	2.74e-01	1.22e-01	-2.05e-02	4.56e-01	6.56e-01	8.75e-02	7.56e-02	4.30e-01	8.94e-01
GOMF NUCLEOTIDASE ACTIVITY	15	3.78e-01	4.92e-01	0.4220	-6.55e-02	-1.81e-01	9.59e-02	-2.73e-01	-1.88e-01	1.49e-01	6.61e-01	2.26e-01	5.20e-01	6.74e-02	2.07e-01	3.18e-01
GOBP RIBONUCLEOSIDE MONOPHOSPHATE BIOSYNTHETIC PROCESS	32	2.99e-03	1.29e-02	0.4220	-1.72e-01	-3.19e-01	-1.01e-01	1.51e-01	1.15e-01	1.74e-02	9.13e-02	1.81e-03	3.21e-01	1.39e-01	2.59e-01	8.65e-01
GOBP NUCLEOSIDE PHOSPHATE BIOSYNTHETIC PROCESS	258	1.63e-24	9.86e-23	0.4220	-1.22e-01	-3.74e-01	-1.20e-01	6.84e-02	-3.73e-02	5.27e-02	7.40e-04	4.46e-25	8.70e-04	5.87e-02	3.02e-01	1.45e-01
GOBP NEGATIVE REGULATION OF STEM CELL PROLIFERATION	15	3.22e-01	4.41e-01	0.4220	1.44e-01	-4.42e-02	2.93e-01	1.69e-01	-1.58e-02	2.01e-01	3.34e-01	7.67e-01	4.97e-02	2.56e-01	9.16e-01	1.78e-01
GOBP NEGATIVE REGULATION OF RESPONSE TO TYPE II INTERFERON	6	4.07e-01	5.19e-01	0.4220	-4.87e-02	-2.17e-01	3.01e-01	1.18e-01	-1.50e-01	-3.27e-02	8.36e-01	3.57e-01	2.01e-01	6.18e-01	5.24e-01	8.90e-01
GOBP POSITIVE REGULATION OF MACROPHAGE MIGRATION	20	1.25e-01	2.30e-01	0.4220	-1.35e-01	-8.42e-02	2.99e-01	-1.38e-01	-1.87e-01	9.53e-02	2.96e-01	5.14e-01	2.07e-02	2.85e-01	1.48e-01	4.61e-01
GOBP REGULATION OF NUCLEAR TRANSCRIBED MRNA CATABOLIC PROCESS NONSENSE MEDIATED DECAY	12	3.78e-01	4.93e-01	0.4220	-4.03e-02	-2.78e-01	-1.62e-01	2.24e-01	-1.01e-01	-1.11e-01	8.09e-01	9.58e-02	3.30e-01	1.80e-01	5.47e-01	5.04e-01
GOBP RESPONSE TO COCAINE	35	6.04e-03	2.28e-02	0.4210	4.58e-02	-6.63e-03	3.35e-01	1.41e-01	1.13e-02	2.07e-01	6.39e-01	9.46e-01	5.96e-04	1.49e-01	9.08e-01	3.37e-02
GOCC NUCLEAR STRESS GRANULE	6	8.47e-01	8.76e-01	0.4210	-1.97e-01	-1.96e-01	1.85e-01	-3.18e-02	-2.24e-01	1.22e-01	4.02e-01	4.06e-01	4.32e-01	8.93e-01	3.43e-01	6.05e-01
GOBP METANEPHRIC GLOMERULUS DEVELOPMENT	9	7.99e-01	8.38e-01	0.4210	-1.94e-01	-1.53e-01	-1.21e-01	-3.00e-01	-9.49e-02	-5.68e-02	3.14e-01	4.27e-01	5.31e-01	1.20e-01	6.22e-01	7.68e-01
GOBP METANEPHRIC NEPHRON MORPHOGENESIS	12	1.74e-01	2.89e-01	0.4210	-1.89e-01	1.27e-01	1.28e-01	-2.82e-01	1.69e-01	3.17e-02	2.56e-01	4.46e-01	4.42e-01	9.09e-02	3.10e-01	8.49e-01
GOBP REGULATION OF RESPIRATORY BURST	16	5.67e-01	6.54e-01	0.4210	-1.72e-01	-2.71e-01	-7.24e-02	-1.29e-01	-2.22e-01	-5.61e-02	2.35e-01	6.07e-02	6.16e-01	3.71e-01	1.24e-01	6.97e-01
GOCC HAUS COMPLEX	8	7.56e-01	8.05e-01	0.4210	-1.23e-01	-3.22e-01	-2.15e-01	8.40e-02	-6.92e-02	-2.96e-03	5.47e-01	1.14e-01	2.92e-01	6.81e-01	7.35e-01	9.88e-01
GOBP LIPID EXPORT FROM CELL	34	1.44e-02	4.59e-02	0.4210	-1.29e-01	7.79e-03	3.27e-01	-1.05e-01	-1.18e-01	1.70e-01	1.95e-01	9.37e-01	9.60e-04	2.90e-01	2.35e-01	8.70e-02
GOBP POSITIVE REGULATION OF RECEPTOR INTERNALIZATION	19	8.29e-02	1.71e-01	0.4210	-3.19e-01	-4.26e-02	1.10e-01	-4.26e-02	-2.36e-01	6.42e-02	1.61e-02	7.48e-01	4.06e-01	7.48e-01	7.49e-02	6.28e-01
GOBP LYMPH NODE DEVELOPMENT	17	1.83e-01	2.97e-01	0.4210	1.05e-01	9.34e-02	6.92e-02	1.68e-01	9.32e-02	3.40e-01	4.55e-01	5.05e-01	6.21e-01	2.30e-01	5.06e-01	1.51e-02
GOMF METALLOCARBOXYPEPTIDASE ACTIVITY	15	3.26e-01	4.45e-01	0.4210	-2.10e-01	-6.14e-02	1.88e-01	-2.72e-01	-8.21e-02	1.14e-01	1.58e-01	6.81e-01	2.08e-01	6.79e-02	5.82e-01	4.43e-01
GOBP AUDITORY RECEPTOR CELL DEVELOPMENT	20	1.22e-01	2.26e-01	0.4210	-7.88e-02	6.62e-02	-1.86e-01	-4.68e-02	-2.61e-02	-3.59e-01	5.42e-01	6.08e-01	1.50e-01	7.17e-01	8.40e-01	5.39e-03
GOMF COMPLEMENT BINDING	16	9.55e-02	1.89e-01	0.4210	-5.66e-02	1.08e-01	2.32e-01	-5.81e-02	-3.14e-01	-8.02e-02	6.95e-01	4.54e-01	1.08e-01	6.87e-01	2.96e-02	5.78e-01
GOBP REGULATION OF RNA EXPORT FROM NUCLEUS	16	6.67e-02	1.46e-01	0.4210	-1.25e-01	1.64e-01	-1.86e-02	3.25e-01	1.41e-01	9.31e-02	3.87e-01	2.55e-01	8.98e-01	2.45e-02	3.30e-01	5.19e-01
GOMF OXIDOREDUCTASE ACTIVITY ACTING ON NAD P H OXYGEN AS ACCEPTOR	12	2.87e-01	4.06e-01	0.4210	-9.56e-02	2.52e-01	2.01e-01	-1.68e-01	1.73e-01	7.39e-02	5.66e-01	1.31e-01	2.28e-01	3.13e-01	2.99e-01	6.58e-01
GOCC CHROMAFFIN GRANULE MEMBRANE	8	5.61e-01	6.50e-01	0.4200	-2.07e-01	3.81e-02	1.33e-01	8.61e-02	1.90e-01	2.67e-01	3.10e-01	8.52e-01	5.15e-01	6.73e-01	3.52e-01	1.92e-01
GOBP DEOXYRIBONUCLEOSIDE METABOLIC PROCESS	10	4.49e-01	5.56e-01	0.4200	-9.14e-02	-3.08e-01	7.06e-02	1.46e-01	-4.68e-02	2.12e-01	6.17e-01	9.16e-02	6.99e-01	4.23e-01	7.98e-01	2.46e-01
GOBP NEPHRIC DUCT DEVELOPMENT	7	6.14e-01	6.93e-01	0.4200	1.05e-01	3.05e-01	1.12e-01	-5.41e-02	-9.50e-02	-2.20e-01	6.30e-01	1.63e-01	6.09e-01	8.04e-01	6.63e-01	3.14e-01
GOBP POSITIVE REGULATION OF PEPTIDYL THREONINE PHOSPHORYLATION	23	1.76e-02	5.34e-02	0.4200	-3.64e-02	-2.37e-01	7.68e-02	2.15e-01	-2.59e-01	1.98e-02	7.62e-01	4.95e-02	5.24e-01	7.47e-02	3.16e-02	8.69e-01
GOMF ATP DEPENDENT CHROMATIN REMODELER ACTIVITY	35	2.28e-02	6.56e-02	0.4200	4.81e-02	2.03e-01	1.78e-01	2.62e-01	1.26e-01	1.29e-01	6.22e-01	3.74e-02	6.85e-02	7.31e-03	1.95e-01	1.85e-01
GOBP PROTOPORPHYRINOGEN IX METABOLIC PROCESS	11	4.24e-01	5.33e-01	0.4200	1.81e-01	-1.26e-01	-7.75e-02	2.26e-01	2.60e-01	5.60e-02	2.98e-01	4.69e-01	6.56e-01	1.94e-01	1.35e-01	7.48e-01
GOBP REGULATION OF PIGMENT CELL DIFFERENTIATION	5	7.60e-01	8.07e-01	0.4200	-7.44e-02	1.79e-02	1.48e-02	-3.33e-01	-5.39e-02	2.39e-01	7.73e-01	9.45e-01	9.54e-01	1.98e-01	8.35e-01	3.55e-01
GOBP RESPONSE TO FOOD	22	2.69e-01	3.88e-01	0.4200	-2.27e-01	-2.71e-01	-1.69e-01	-3.79e-02	-6.35e-02	-1.32e-01	6.49e-02	2.76e-02	1.71e-01	7.58e-01	6.06e-01	2.84e-01
GOBP NEGATIVE REGULATION OF PROTEIN KINASE ACTIVITY BY REGULATION OF PROTEIN PHOSPHORYLATION	6	5.60e-01	6.49e-01	0.4200	-2.22e-01	-1.11e-01	4.71e-02	2.24e-01	2.27e-01	1.06e-01	3.46e-01	6.37e-01	8.42e-01	3.42e-01	3.36e-01	6.54e-01
GOBP POSITIVE REGULATION OF MITOCHONDRIAL MEMBRANE PERMEABILITY	36	2.69e-02	7.40e-02	0.4200	-6.93e-02	-2.21e-01	-2.19e-01	8.40e-02	3.24e-02	-2.59e-01	4.72e-01	2.16e-02	2.32e-02	3.83e-01	7.37e-01	7.21e-03
GOBP SENSORY PERCEPTION OF CHEMICAL STIMULUS	94	3.88e-07	4.33e-06	0.4200	4.49e-02	1.71e-01	2.43e-01	-2.45e-01	-1.51e-01	5.71e-02	4.52e-01	4.17e-03	4.51e-05	4.13e-05	1.13e-02	3.39e-01
GOCC RNA POLYMERASE COMPLEX	100	1.02e-08	1.43e-07	0.4200	-1.75e-01	-3.13e-01	-1.43e-01	1.30e-01	-2.77e-02	9.84e-02	2.45e-03	6.29e-08	1.35e-02	2.51e-02	6.33e-01	8.91e-02
GOMF 3 5 EXONUCLEASE ACTIVITY	58	5.31e-04	2.94e-03	0.4200	-1.05e-01	-1.62e-01	-2.88e-01	1.84e-01	1.26e-01	-7.96e-02	1.67e-01	3.31e-02	1.46e-04	1.53e-02	9.71e-02	2.94e-01
GOCC CYTOPLASMIC DYNEIN COMPLEX	22	4.91e-02	1.16e-01	0.4200	-1.79e-01	-2.06e-01	-1.18e-01	-6.30e-02	-1.16e-01	2.66e-01	1.46e-01	9.49e-02	3.39e-01	6.09e-01	3.48e-01	3.07e-02
GOBP RESPONSE TO INTERFERON BETA	30	3.41e-02	8.82e-02	0.4200	5.21e-02	-1.25e-02	1.23e-01	2.07e-01	8.37e-02	3.29e-01	6.21e-01	9.06e-01	2.43e-01	4.99e-02	4.27e-01	1.79e-03
GOBP REGULATION OF CHROMATIN ORGANIZATION	33	2.22e-02	6.42e-02	0.4200	8.54e-02	1.31e-01	1.17e-01	3.28e-01	6.87e-02	1.59e-01	3.96e-01	1.92e-01	2.44e-01	1.10e-03	4.94e-01	1.13e-01
GOBP DETECTION OF MECHANICAL STIMULUS INVOLVED IN SENSORY PERCEPTION	23	1.18e-01	2.21e-01	0.4200	-1.60e-01	-4.42e-02	-5.41e-03	-3.74e-01	-8.14e-02	-4.26e-02	1.85e-01	7.13e-01	9.64e-01	1.89e-03	4.99e-01	7.24e-01
GOBP POSITIVE REGULATION OF TRANSCRIPTION OF NOTCH RECEPTOR TARGET	7	2.07e-01	3.23e-01	0.4190	-6.53e-02	1.10e-01	3.12e-01	1.92e-01	-6.34e-02	-1.47e-01	7.65e-01	6.13e-01	1.53e-01	3.79e-01	7.71e-01	5.02e-01
GOMF S100 PROTEIN BINDING	12	1.40e-01	2.49e-01	0.4190	-1.46e-01	-7.71e-02	2.61e-01	2.11e-01	-1.56e-01	1.08e-01	3.82e-01	6.44e-01	1.18e-01	2.05e-01	3.50e-01	5.17e-01
GOBP ADHESION OF SYMBIONT TO HOST	10	4.99e-01	5.96e-01	0.4190	1.47e-01	7.58e-02	1.97e-01	1.54e-01	2.73e-01	1.07e-01	4.21e-01	6.78e-01	2.80e-01	4.00e-01	1.35e-01	5.56e-01
GOBP CEREBRAL CORTEX RADIALLY ORIENTED CELL MIGRATION	28	2.98e-02	7.97e-02	0.4190	-2.17e-01	-3.28e-02	1.66e-01	-2.03e-02	-2.79e-01	1.48e-01	4.68e-02	7.64e-01	1.28e-01	8.52e-01	1.07e-02	1.75e-01
GOBP ENDOSOME TO PLASMA MEMBRANE PROTEIN TRANSPORT	16	9.56e-02	1.90e-01	0.4190	-2.08e-01	-2.90e-02	2.59e-01	1.41e-01	-4.52e-02	2.07e-01	1.50e-01	8.41e-01	7.27e-02	3.30e-01	7.54e-01	1.52e-01
GOCC CLEAVAGE FURROW	47	3.16e-04	1.89e-03	0.4190	-1.64e-02	-4.64e-02	1.37e-01	3.13e-01	1.02e-01	2.16e-01	8.46e-01	5.82e-01	1.05e-01	2.10e-04	2.27e-01	1.05e-02
GOCC SWR1 COMPLEX	13	2.07e-01	3.24e-01	0.4190	-1.36e-02	-1.24e-01	9.39e-02	3.29e-01	1.68e-01	1.21e-01	9.32e-01	4.39e-01	5.58e-01	3.99e-02	2.93e-01	4.49e-01
GOCC ORIGIN RECOGNITION COMPLEX	8	3.91e-01	5.04e-01	0.4190	1.25e-02	-2.62e-01	-2.47e-01	9.78e-02	4.64e-03	1.90e-01	9.51e-01	1.99e-01	2.27e-01	6.32e-01	9.82e-01	3.51e-01
GOBP ATRIAL CARDIAC MUSCLE CELL TO AV NODE CELL COMMUNICATION	11	5.04e-01	6.00e-01	0.4190	1.04e-01	2.45e-01	2.96e-01	-1.00e-01	-7.71e-02	-3.07e-02	5.52e-01	1.59e-01	8.91e-02	5.65e-01	6.58e-01	8.60e-01
GOBP REGULATION OF VIRAL GENOME REPLICATION	78	5.42e-08	6.86e-07	0.4190	1.82e-02	-4.78e-02	4.67e-02	2.26e-01	1.17e-02	3.46e-01	7.81e-01	4.66e-01	4.76e-01	5.53e-04	8.59e-01	1.30e-07
GOCC RNA POLYMERASE II HOLOENZYME	70	2.87e-06	2.76e-05	0.4190	-2.26e-01	-2.77e-01	-8.89e-02	1.02e-01	2.83e-02	1.69e-01	1.10e-03	6.11e-05	1.98e-01	1.39e-01	6.83e-01	1.44e-02
GOBP STARTLE RESPONSE	15	3.28e-01	4.46e-01	0.4190	1.76e-02	1.49e-01	5.85e-02	1.40e-01	3.45e-01	1.02e-01	9.06e-01	3.19e-01	6.95e-01	3.48e-01	2.05e-02	4.92e-01
GOBP PROTEIN REFOLDING	23	2.57e-02	7.17e-02	0.4190	-3.19e-02	-2.15e-01	1.14e-01	2.52e-01	6.60e-02	2.17e-01	7.91e-01	7.43e-02	3.45e-01	3.63e-02	5.84e-01	7.16e-02
GOBP NUCLEOBASE METABOLIC PROCESS	33	1.20e-02	3.97e-02	0.4190	-2.22e-01	-3.29e-01	-6.75e-02	7.19e-02	-1.77e-02	8.51e-02	2.71e-02	1.06e-03	5.02e-01	4.75e-01	8.60e-01	3.97e-01
GOBP REGULATION OF ENDOTHELIAL CELL DEVELOPMENT	17	1.53e-02	4.81e-02	0.4180	-2.97e-01	9.22e-02	1.56e-01	-1.88e-01	9.80e-02	-9.53e-02	3.37e-02	5.10e-01	2.67e-01	1.80e-01	4.84e-01	4.97e-01
GOBP VESICLE FUSION TO PLASMA MEMBRANE	16	2.25e-01	3.44e-01	0.4180	1.26e-01	4.22e-02	2.26e-01	1.40e-01	2.18e-01	1.97e-01	3.84e-01	7.70e-01	1.17e-01	3.31e-01	1.31e-01	1.72e-01
GOBP NEGATIVE REGULATION OF VIRAL PROCESS	77	6.72e-09	9.73e-08	0.4180	2.80e-02	-7.58e-02	-1.55e-02	2.60e-01	1.21e-02	3.16e-01	6.71e-01	2.50e-01	8.14e-01	7.76e-05	8.55e-01	1.57e-06
GOBP PROTEIN LOCALIZATION TO PRESYNAPSE	11	1.68e-01	2.81e-01	0.4180	1.65e-01	-7.01e-02	3.48e-01	-1.10e-01	-9.57e-02	-1.56e-02	3.43e-01	6.87e-01	4.56e-02	5.27e-01	5.83e-01	9.29e-01
GOMF PHOSPHOPROTEIN BINDING	87	2.23e-07	2.59e-06	0.4180	-1.42e-02	7.58e-02	2.79e-01	2.10e-01	-3.24e-02	2.14e-01	8.19e-01	2.22e-01	6.94e-06	7.06e-04	6.01e-01	5.45e-04
GOBP RESPONSE TO MURAMYL DIPEPTIDE	21	8.40e-05	5.80e-04	0.4180	-2.50e-01	1.05e-01	1.63e-01	2.88e-02	7.86e-02	-2.61e-01	4.76e-02	4.07e-01	1.97e-01	8.19e-01	5.33e-01	3.85e-02
GOBP REGULATION OF DEOXYRIBONUCLEASE ACTIVITY	10	5.64e-01	6.52e-01	0.4180	-1.37e-01	-3.00e-01	-2.10e-01	7.59e-02	-9.59e-02	8.23e-02	4.55e-01	1.00e-01	2.50e-01	6.78e-01	6.00e-01	6.52e-01
GOBP SPINDLE LOCALIZATION	49	1.83e-04	1.16e-03	0.4180	-2.89e-02	1.92e-02	1.95e-01	2.08e-01	-1.59e-01	2.60e-01	7.27e-01	8.16e-01	1.84e-02	1.19e-02	5.48e-02	1.67e-03
GOBP REGULATION OF RESPONSE TO ENDOPLASMIC RETICULUM STRESS	77	1.02e-06	1.06e-05	0.4180	-2.12e-01	-1.89e-01	1.14e-01	8.23e-02	-2.09e-01	1.75e-01	1.30e-03	4.07e-03	8.48e-02	2.12e-01	1.55e-03	7.84e-03
GOBP REGULATION OF DNA DAMAGE CHECKPOINT	21	3.89e-02	9.75e-02	0.4180	-2.52e-01	-1.68e-01	-1.48e-01	1.87e-01	-9.36e-03	1.60e-01	4.55e-02	1.82e-01	2.40e-01	1.37e-01	9.41e-01	2.04e-01
GOBP ACTIN MEDIATED CELL CONTRACTION	73	3.74e-04	2.19e-03	0.4180	-2.50e-02	7.65e-02	3.05e-01	-9.27e-02	-1.85e-01	1.80e-01	7.12e-01	2.59e-01	6.56e-06	1.71e-01	6.36e-03	7.83e-03
GOBP RESPONSE TO RAPAMYCIN	5	8.40e-01	8.70e-01	0.4180	-5.91e-02	-2.43e-01	8.48e-02	1.28e-01	-2.90e-01	6.45e-02	8.19e-01	3.47e-01	7.43e-01	6.20e-01	2.61e-01	8.03e-01
GOCC ENDONUCLEASE COMPLEX	40	4.38e-03	1.75e-02	0.4180	-1.38e-01	-2.50e-01	-2.65e-01	1.49e-01	-2.72e-02	-1.09e-02	1.32e-01	6.23e-03	3.76e-03	1.03e-01	7.66e-01	9.05e-01
GOBP MEMBRANE REPOLARIZATION	31	1.26e-01	2.30e-01	0.4180	-9.13e-02	8.36e-03	2.54e-01	-1.53e-01	-2.15e-01	1.80e-01	3.79e-01	9.36e-01	1.45e-02	1.40e-01	3.84e-02	8.34e-02
GOBP STRESS GRANULE ASSEMBLY	32	1.60e-03	7.57e-03	0.4180	-1.89e-01	7.41e-02	1.48e-01	1.12e-01	-1.73e-01	2.63e-01	6.47e-02	4.68e-01	1.47e-01	2.71e-01	9.07e-02	1.01e-02
GOMF DYSTROGLYCAN BINDING	9	2.23e-01	3.42e-01	0.4180	7.97e-02	1.49e-01	1.18e-01	1.52e-01	-2.79e-01	-1.76e-01	6.79e-01	4.39e-01	5.41e-01	4.29e-01	1.47e-01	3.61e-01
GOBP LYTIC VACUOLE ORGANIZATION	99	4.03e-11	7.54e-10	0.4180	-3.30e-01	-2.45e-01	-6.36e-03	5.64e-02	4.68e-05	5.09e-02	1.45e-08	2.57e-05	9.13e-01	3.33e-01	9.99e-01	3.81e-01
GOMF NUCLEOSIDE DIPHOSPHATE PHOSPHATASE ACTIVITY	14	4.82e-01	5.83e-01	0.4170	-2.33e-01	-2.02e-01	-2.63e-01	-2.52e-02	-8.91e-02	-3.18e-02	1.31e-01	1.90e-01	8.79e-02	8.70e-01	5.64e-01	8.37e-01
GOMF COENZYME A DIPHOSPHATASE ACTIVITY	5	8.13e-01	8.49e-01	0.4170	1.18e-01	-1.72e-01	2.55e-02	3.57e-01	-4.02e-02	2.54e-02	6.47e-01	5.04e-01	9.21e-01	1.66e-01	8.76e-01	9.22e-01
GOBP IRON COORDINATION ENTITY TRANSPORT	12	5.11e-01	6.06e-01	0.4170	1.35e-01	-1.81e-01	-1.76e-01	2.21e-01	1.53e-01	-1.40e-01	4.17e-01	2.77e-01	2.90e-01	1.85e-01	3.59e-01	4.00e-01
GOBP REGULATION OF RESPONSE TO NUTRIENT LEVELS	21	1.02e-01	1.98e-01	0.4170	-1.67e-01	-4.32e-02	-1.77e-01	-1.53e-01	1.95e-01	-2.28e-01	1.85e-01	7.32e-01	1.61e-01	2.25e-01	1.23e-01	7.07e-02
GOBP PROTEIN FOLDING	195	5.06e-19	1.96e-17	0.4170	-1.90e-01	-3.15e-01	-1.82e-02	1.16e-01	-6.60e-02	1.44e-01	4.52e-06	3.44e-14	6.61e-01	5.16e-03	1.12e-01	5.34e-04
GOCC NPBAF COMPLEX	14	2.12e-02	6.20e-02	0.4170	-7.86e-02	6.17e-02	1.54e-01	2.80e-01	-2.48e-01	-2.12e-02	6.11e-01	6.89e-01	3.19e-01	6.94e-02	1.08e-01	8.91e-01
GOBP REGULATION OF SPHINGOLIPID BIOSYNTHETIC PROCESS	10	6.78e-01	7.45e-01	0.4170	-1.44e-01	-1.85e-01	-2.54e-01	-2.82e-02	-1.73e-01	-1.55e-01	4.30e-01	3.12e-01	1.65e-01	8.77e-01	3.43e-01	3.95e-01
GOCC FLEMMING BODY	30	4.53e-02	1.09e-01	0.4170	-1.60e-01	-1.19e-01	1.45e-01	5.45e-02	-1.31e-01	3.05e-01	1.28e-01	2.59e-01	1.70e-01	6.05e-01	2.16e-01	3.81e-03
GOBP NEGATIVE REGULATION OF OSTEOBLAST DIFFERENTIATION	34	5.55e-02	1.27e-01	0.4170	1.80e-01	1.56e-01	2.54e-01	2.06e-01	-2.79e-02	9.61e-02	6.87e-02	1.15e-01	1.03e-02	3.75e-02	7.78e-01	3.32e-01
GOBP SUBSTRATE DEPENDENT CELL MIGRATION	22	2.18e-01	3.36e-01	0.4170	-3.22e-01	-6.80e-02	-9.72e-03	-1.92e-01	-9.99e-02	1.36e-01	8.83e-03	5.81e-01	9.37e-01	1.19e-01	4.17e-01	2.70e-01
GOBP CEREBRAL CORTEX CELL MIGRATION	36	2.55e-02	7.13e-02	0.4170	-2.68e-01	-4.70e-02	1.18e-01	-1.11e-01	-2.31e-01	1.44e-01	5.47e-03	6.26e-01	2.21e-01	2.49e-01	1.65e-02	1.36e-01
GOMF INOSITOL 1 4 5 TRISPHOSPHATE BINDING	9	7.74e-01	8.17e-01	0.4170	9.52e-03	1.76e-01	2.13e-01	1.10e-01	5.45e-02	2.87e-01	9.61e-01	3.62e-01	2.69e-01	5.68e-01	7.77e-01	1.36e-01
GOBP T CELL EXTRAVASATION	12	1.78e-01	2.93e-01	0.4170	-2.27e-01	-5.92e-03	9.34e-02	2.61e-01	1.17e-01	1.78e-01	1.73e-01	9.72e-01	5.75e-01	1.18e-01	4.84e-01	2.85e-01
GOBP PURINE NUCLEOTIDE TRANSPORT	35	1.26e-01	2.31e-01	0.4170	-1.96e-01	-2.40e-01	-1.59e-01	-1.24e-01	-1.31e-01	-1.41e-01	4.48e-02	1.40e-02	1.04e-01	2.05e-01	1.78e-01	1.49e-01
GOBP POSITIVE REGULATION OF TRIGLYCERIDE METABOLIC PROCESS	15	8.40e-02	1.72e-01	0.4170	-7.09e-02	-2.09e-02	-7.31e-02	2.68e-01	1.10e-01	-2.81e-01	6.34e-01	8.89e-01	6.24e-01	7.18e-02	4.62e-01	5.99e-02
GOCC CORTICAL CYTOSKELETON	92	8.42e-08	1.05e-06	0.4170	5.90e-02	-7.71e-04	2.56e-01	2.52e-01	-6.76e-02	1.91e-01	3.28e-01	9.90e-01	2.19e-05	2.84e-05	2.63e-01	1.59e-03
GOBP RESPONSE TO STEROL DEPLETION	16	4.59e-02	1.10e-01	0.4170	-3.16e-01	-3.89e-02	2.22e-01	2.78e-02	3.19e-02	1.45e-01	2.88e-02	7.88e-01	1.24e-01	8.47e-01	8.25e-01	3.14e-01
GOBP DIOL METABOLIC PROCESS	29	6.17e-02	1.38e-01	0.4160	-1.24e-01	-2.61e-01	6.14e-02	-2.36e-01	-1.74e-01	4.94e-04	2.46e-01	1.51e-02	5.67e-01	2.75e-02	1.06e-01	9.96e-01
GOBP BASEMENT MEMBRANE ASSEMBLY	8	2.41e-01	3.59e-01	0.4160	-1.77e-01	1.46e-01	-2.25e-02	1.05e-02	-2.39e-01	-2.50e-01	3.86e-01	4.74e-01	9.12e-01	9.59e-01	2.41e-01	2.20e-01
GOBP BROWN FAT CELL DIFFERENTIATION	38	9.93e-03	3.41e-02	0.4160	2.81e-03	2.53e-01	2.52e-01	1.10e-01	1.41e-01	1.18e-01	9.76e-01	6.85e-03	7.29e-03	2.42e-01	1.34e-01	2.10e-01
GOCC RSC TYPE COMPLEX	14	6.29e-02	1.40e-01	0.4160	-1.01e-01	3.37e-02	6.98e-02	3.83e-01	-2.98e-02	9.63e-02	5.14e-01	8.27e-01	6.51e-01	1.31e-02	8.47e-01	5.33e-01
GOBP MULTIVESICULAR BODY SORTING PATHWAY	47	9.40e-04	4.83e-03	0.4160	-1.99e-01	-2.27e-01	5.56e-02	6.71e-02	-4.73e-02	2.68e-01	1.80e-02	7.19e-03	5.09e-01	4.26e-01	5.75e-01	1.46e-03
GOBP REGULATION OF STEM CELL DIVISION	9	5.87e-01	6.70e-01	0.4160	1.49e-01	-5.11e-02	3.47e-02	2.87e-01	2.94e-02	2.52e-01	4.38e-01	7.91e-01	8.57e-01	1.36e-01	8.79e-01	1.91e-01
GOMF UBIQUITIN PROTEIN TRANSFERASE ACTIVATOR ACTIVITY	15	1.63e-01	2.76e-01	0.4160	-1.02e-01	-1.27e-01	7.42e-02	2.45e-01	1.75e-01	2.25e-01	4.94e-01	3.95e-01	6.19e-01	1.01e-01	2.41e-01	1.32e-01
GOBP POSITIVE REGULATION OF TRANSLATION	119	8.81e-07	9.29e-06	0.4160	-1.90e-01	-3.01e-01	-1.78e-01	-2.18e-02	-1.08e-01	-4.80e-02	3.42e-04	1.41e-08	8.01e-04	6.81e-01	4.11e-02	3.66e-01
GOBP GLIAL CELL DERIVED NEUROTROPHIC FACTOR RECEPTOR SIGNALING PATHWAY	6	3.46e-01	4.62e-01	0.4160	-2.04e-01	-1.86e-01	4.88e-03	-6.88e-02	2.27e-01	-2.02e-01	3.88e-01	4.31e-01	9.83e-01	7.70e-01	3.36e-01	3.91e-01
GOBP REGULATION OF CORTICOSTEROID HORMONE SECRETION	10	6.45e-01	7.19e-01	0.4160	1.80e-01	-3.37e-02	2.83e-01	1.01e-01	-1.68e-01	1.43e-01	3.24e-01	8.53e-01	1.21e-01	5.79e-01	3.57e-01	4.34e-01
GOBP DNA DEMETHYLATION	20	3.17e-01	4.37e-01	0.4160	1.89e-01	2.27e-01	2.45e-01	5.53e-02	-9.19e-02	1.19e-01	1.44e-01	7.85e-02	5.80e-02	6.68e-01	4.77e-01	3.59e-01
GOCC ASYMMETRIC GLUTAMATERGIC EXCITATORY SYNAPSE	8	7.92e-01	8.33e-01	0.4160	1.90e-01	2.15e-01	1.97e-01	1.52e-01	-7.31e-02	1.53e-01	3.52e-01	2.92e-01	3.36e-01	4.58e-01	7.20e-01	4.54e-01
GOBP NON MOTILE CILIUM ASSEMBLY	59	1.33e-04	8.69e-04	0.4150	-1.24e-01	9.81e-02	-2.35e-01	3.83e-02	2.98e-01	-4.76e-02	9.98e-02	1.93e-01	1.79e-03	6.11e-01	7.60e-05	5.27e-01
GOBP POSITIVE REGULATION OF CHONDROCYTE DIFFERENTIATION	12	4.62e-01	5.66e-01	0.4150	2.99e-01	2.19e-01	1.49e-01	-6.15e-02	-5.24e-02	-7.99e-02	7.27e-02	1.88e-01	3.73e-01	7.12e-01	7.53e-01	6.32e-01
GOMF ACETYLCHOLINE RECEPTOR BINDING	7	1.99e-01	3.15e-01	0.4150	2.77e-02	2.55e-02	1.65e-01	-1.74e-01	3.37e-01	-1.42e-02	8.99e-01	9.07e-01	4.50e-01	4.24e-01	1.23e-01	9.48e-01
GOBP LUNG CELL DIFFERENTIATION	16	1.44e-01	2.54e-01	0.4150	-3.84e-01	-1.16e-01	3.57e-02	-5.01e-02	-8.55e-02	7.32e-04	7.75e-03	4.20e-01	8.05e-01	7.29e-01	5.54e-01	9.96e-01
GOBP EXIT FROM MITOSIS	27	2.82e-02	7.65e-02	0.4150	-1.36e-01	-3.53e-01	-7.81e-02	1.29e-01	-6.86e-02	-3.96e-02	2.22e-01	1.48e-03	4.82e-01	2.44e-01	5.37e-01	7.22e-01
GOBP CENTROMERIC SISTER CHROMATID COHESION	10	5.15e-01	6.09e-01	0.4150	1.05e-01	-1.40e-01	5.82e-02	3.22e-01	4.35e-03	1.87e-01	5.67e-01	4.44e-01	7.50e-01	7.81e-02	9.81e-01	3.06e-01
GOBP AUTOPHAGOSOME MATURATION	65	3.06e-06	2.93e-05	0.4150	-2.47e-01	-2.11e-01	-2.52e-02	1.32e-01	-1.49e-01	1.62e-01	5.67e-04	3.25e-03	7.25e-01	6.56e-02	3.77e-02	2.36e-02
GOMF TRANSCRIPTION COACTIVATOR BINDING	39	1.71e-03	8.02e-03	0.4150	4.99e-02	2.52e-01	2.23e-01	2.33e-01	3.75e-02	2.53e-02	5.90e-01	6.49e-03	1.58e-02	1.18e-02	6.86e-01	7.85e-01
GOCC CALYX OF HELD	11	6.42e-01	7.16e-01	0.4150	5.23e-02	1.10e-01	2.08e-01	1.88e-01	1.77e-01	2.17e-01	7.64e-01	5.27e-01	2.32e-01	2.79e-01	3.08e-01	2.13e-01
GOMF ALL TRANS RETINOL DEHYDROGENASE NADPPLUS ACTIVITY	11	5.47e-01	6.37e-01	0.4150	-8.45e-02	-1.02e-01	-2.75e-01	2.20e-01	1.72e-01	-1.42e-02	6.27e-01	5.56e-01	1.14e-01	2.06e-01	3.22e-01	9.35e-01
GOCC CUL4 RING E3 UBIQUITIN LIGASE COMPLEX	33	1.12e-03	5.61e-03	0.4150	-2.17e-01	-5.81e-02	-2.26e-01	2.54e-01	5.86e-02	-4.90e-02	3.12e-02	5.63e-01	2.48e-02	1.14e-02	5.60e-01	6.26e-01
GOBP ESTABLISHMENT OF SKIN BARRIER	19	1.48e-01	2.59e-01	0.4150	1.86e-01	-3.32e-02	2.75e-01	1.93e-01	-1.34e-01	7.47e-02	1.62e-01	8.02e-01	3.80e-02	1.45e-01	3.12e-01	5.73e-01
GOBP HISTONE MRNA METABOLIC PROCESS	24	1.22e-01	2.26e-01	0.4140	-2.98e-01	-1.92e-01	-1.94e-01	-2.55e-02	2.78e-02	8.26e-02	1.15e-02	1.03e-01	9.91e-02	8.29e-01	8.14e-01	4.84e-01
GOMF SCAVENGER RECEPTOR ACTIVITY	22	3.75e-03	1.55e-02	0.4140	5.89e-02	1.74e-01	1.65e-01	-1.45e-02	2.45e-01	-2.25e-01	6.32e-01	1.57e-01	1.81e-01	9.06e-01	4.71e-02	6.72e-02
GOBP PROTEIN LOCALIZATION TO CELL CORTEX	10	7.48e-01	7.99e-01	0.4140	1.43e-01	1.30e-01	1.12e-02	2.66e-01	2.30e-01	-1.04e-01	4.35e-01	4.77e-01	9.51e-01	1.45e-01	2.09e-01	5.70e-01
GOMF QUINONE BINDING	16	4.34e-01	5.42e-01	0.4140	-4.40e-02	-1.79e-01	-8.50e-02	-2.42e-01	-2.47e-01	-1.06e-01	7.61e-01	2.16e-01	5.56e-01	9.41e-02	8.71e-02	4.65e-01
GOBP MAINTENANCE OF POSTSYNAPTIC SPECIALIZATION STRUCTURE	8	5.76e-01	6.62e-01	0.4140	-1.28e-01	-1.05e-01	3.12e-01	3.78e-02	-1.67e-01	1.33e-01	5.31e-01	6.07e-01	1.26e-01	8.53e-01	4.14e-01	5.16e-01
GOBP MYOBLAST FUSION	37	8.46e-02	1.73e-01	0.4140	1.30e-01	2.00e-01	2.63e-01	2.60e-02	-1.87e-02	2.12e-01	1.72e-01	3.51e-02	5.71e-03	7.84e-01	8.44e-01	2.60e-02
GOMF NEUROPEPTIDE RECEPTOR ACTIVITY	15	3.24e-01	4.42e-01	0.4140	5.03e-02	1.53e-01	3.58e-01	-2.79e-02	-1.15e-01	6.13e-02	7.36e-01	3.06e-01	1.64e-02	8.52e-01	4.42e-01	6.81e-01
GOBP NEGATIVE REGULATION OF LIPID STORAGE	17	1.31e-02	4.27e-02	0.4140	-2.70e-01	-1.95e-02	3.00e-01	-1.03e-02	-8.89e-02	1.44e-02	5.41e-02	8.89e-01	3.21e-02	9.42e-01	5.26e-01	9.18e-01
GOBP APICAL PROTEIN LOCALIZATION	11	6.02e-01	6.83e-01	0.4140	-1.56e-01	-2.02e-01	1.77e-01	-8.61e-02	-2.54e-01	5.52e-02	3.69e-01	2.45e-01	3.10e-01	6.21e-01	1.45e-01	7.51e-01
GOMF AZOLE TRANSMEMBRANE TRANSPORTER ACTIVITY	10	3.15e-01	4.35e-01	0.4140	-5.10e-02	-2.10e-01	2.06e-02	1.86e-01	-2.79e-01	-1.09e-01	7.80e-01	2.50e-01	9.10e-01	3.08e-01	1.27e-01	5.52e-01
GOBP RETINOIC ACID RECEPTOR SIGNALING PATHWAY	22	1.74e-02	5.29e-02	0.4140	3.08e-03	4.66e-02	1.75e-01	3.68e-01	2.04e-02	5.26e-02	9.80e-01	7.05e-01	1.55e-01	2.81e-03	8.69e-01	6.69e-01
GOBP BRADYKININ CATABOLIC PROCESS	6	8.24e-01	8.58e-01	0.4140	-1.77e-01	9.15e-02	8.08e-02	-2.80e-01	-1.75e-01	-1.26e-01	4.53e-01	6.98e-01	7.32e-01	2.35e-01	4.57e-01	5.93e-01
GOBP REGULATION OF CHROMOSOME CONDENSATION	13	2.49e-01	3.68e-01	0.4140	-6.50e-02	-8.99e-02	-3.01e-03	2.18e-01	1.97e-02	3.33e-01	6.85e-01	5.75e-01	9.85e-01	1.73e-01	9.02e-01	3.75e-02
GOCC ENDOPLASMIC RETICULUM GOLGI INTERMEDIATE COMPARTMENT	123	3.96e-14	9.95e-13	0.4140	-2.17e-01	-1.59e-01	1.41e-01	1.73e-01	-6.01e-02	2.13e-01	3.22e-05	2.36e-03	7.10e-03	8.91e-04	2.50e-01	4.33e-05
GOBP DETECTION OF MECHANICAL STIMULUS INVOLVED IN SENSORY PERCEPTION OF PAIN	8	7.60e-01	8.07e-01	0.4140	-1.44e-01	-2.11e-01	7.11e-02	-2.68e-01	-1.64e-01	-5.00e-02	4.82e-01	3.01e-01	7.28e-01	1.90e-01	4.23e-01	8.06e-01
GOBP NEGATIVE REGULATION OF REGULATED SECRETORY PATHWAY	20	5.89e-02	1.33e-01	0.4140	-1.31e-01	1.78e-01	2.46e-01	1.45e-01	-5.66e-02	1.93e-01	3.11e-01	1.68e-01	5.66e-02	2.60e-01	6.61e-01	1.34e-01
GOBP DE NOVO PROTEIN FOLDING	42	1.06e-03	5.36e-03	0.4140	-2.25e-01	-2.74e-01	8.46e-03	1.36e-01	-7.30e-02	1.47e-01	1.16e-02	2.14e-03	9.24e-01	1.27e-01	4.13e-01	9.88e-02
GOBP REGULATION OF RHO PROTEIN SIGNAL TRANSDUCTION	73	8.19e-06	7.04e-05	0.4140	1.14e-01	1.37e-01	2.00e-01	2.95e-01	-2.48e-02	1.10e-01	9.19e-02	4.31e-02	3.20e-03	1.33e-05	7.14e-01	1.04e-01
GOBP POSITIVE REGULATION OF NEUROTRANSMITTER SECRETION	14	2.49e-01	3.68e-01	0.4140	1.92e-03	1.15e-01	1.75e-01	1.44e-01	3.00e-01	1.27e-01	9.90e-01	4.56e-01	2.57e-01	3.51e-01	5.17e-02	4.09e-01
GOBP NUCLEOSIDE TRANSPORT	8	3.03e-01	4.23e-01	0.4140	9.71e-02	-3.00e-01	-9.93e-02	5.30e-02	2.29e-01	8.21e-02	6.35e-01	1.42e-01	6.27e-01	7.95e-01	2.63e-01	6.88e-01
GOBP RENAL SYSTEM PROCESS INVOLVED IN REGULATION OF BLOOD VOLUME	9	7.27e-01	7.82e-01	0.4130	3.25e-01	1.17e-01	1.75e-01	7.51e-02	-1.32e-03	1.24e-01	9.09e-02	5.44e-01	3.64e-01	6.97e-01	9.95e-01	5.21e-01
GOBP PROGESTERONE METABOLIC PROCESS	11	3.72e-01	4.87e-01	0.4130	1.60e-01	1.75e-01	8.44e-02	-5.91e-02	2.12e-01	2.43e-01	3.57e-01	3.15e-01	6.28e-01	7.34e-01	2.23e-01	1.63e-01
GOBP TRANSLATIONAL TERMINATION	16	1.80e-01	2.95e-01	0.4130	-1.05e-01	-2.70e-01	-1.05e-01	1.52e-01	-2.25e-01	4.77e-02	4.69e-01	6.16e-02	4.65e-01	2.93e-01	1.19e-01	7.41e-01
GOMF OXIDOREDUCTASE ACTIVITY ACTING ON NAD P H	80	4.39e-06	4.06e-05	0.4130	-1.32e-01	-3.70e-01	-1.01e-01	-3.81e-02	-6.49e-02	2.95e-02	4.13e-02	1.07e-08	1.19e-01	5.56e-01	3.16e-01	6.48e-01
GOBP EXTRACELLULAR MATRIX CONSTITUENT SECRETION	10	2.06e-01	3.23e-01	0.4130	-1.13e-01	2.66e-03	1.14e-01	8.17e-02	3.56e-01	1.07e-01	5.35e-01	9.88e-01	5.33e-01	6.54e-01	5.13e-02	5.57e-01
GOCC JUNCTIONAL SARCOPLASMIC RETICULUM MEMBRANE	6	8.92e-01	9.12e-01	0.4130	2.23e-01	8.59e-02	2.63e-01	-2.86e-02	-1.34e-01	1.61e-01	3.44e-01	7.16e-01	2.65e-01	9.03e-01	5.71e-01	4.94e-01
GOBP RETROTRANSPOSON SILENCING BY HETEROCHROMATIN FORMATION	7	7.29e-01	7.84e-01	0.4130	-6.75e-02	-1.74e-02	1.17e-01	-2.36e-01	-5.38e-02	3.06e-01	7.57e-01	9.36e-01	5.93e-01	2.80e-01	8.05e-01	1.61e-01
GOBP NUCLEOPHAGY	22	9.40e-02	1.88e-01	0.4130	-1.08e-01	-1.04e-02	-2.22e-01	2.63e-01	1.62e-01	-1.19e-01	3.80e-01	9.32e-01	7.15e-02	3.26e-02	1.89e-01	3.35e-01
GOMF STRUCTURAL CONSTITUENT OF EYE LENS	6	8.16e-01	8.51e-01	0.4130	2.28e-02	2.14e-01	-1.06e-01	-1.52e-01	1.28e-01	-2.71e-01	9.23e-01	3.64e-01	6.54e-01	5.19e-01	5.86e-01	2.50e-01
GOBP LEPTIN MEDIATED SIGNALING PATHWAY	8	6.70e-01	7.37e-01	0.4130	-2.72e-01	5.07e-03	9.37e-02	-4.87e-02	-2.00e-01	2.12e-01	1.82e-01	9.80e-01	6.46e-01	8.12e-01	3.27e-01	2.98e-01
GOBP HEMOSTASIS	192	6.06e-16	1.78e-14	0.4130	-1.12e-01	-1.31e-01	2.74e-01	-1.70e-02	-1.42e-01	2.12e-01	7.56e-03	1.76e-03	5.56e-11	6.86e-01	6.74e-04	3.88e-07
GOCC MLL3 4 COMPLEX	12	3.76e-01	4.91e-01	0.4130	1.21e-02	2.19e-01	5.22e-02	2.90e-01	1.06e-01	1.56e-01	9.42e-01	1.89e-01	7.54e-01	8.20e-02	5.27e-01	3.49e-01
GOCC ORGANELLE ENVELOPE	1171	1.16e-88	1.53e-85	0.4130	-1.71e-01	-3.30e-01	-1.69e-01	2.92e-02	-5.02e-02	5.16e-03	5.34e-23	2.57e-81	1.73e-22	9.21e-02	3.86e-03	7.66e-01
GOBP NEUROTRANSMITTER RECEPTOR LOCALIZATION TO POSTSYNAPTIC SPECIALIZATION MEMBRANE	16	2.71e-01	3.90e-01	0.4130	-8.97e-02	-1.19e-01	-9.78e-02	-6.70e-02	-1.91e-01	-3.13e-01	5.35e-01	4.11e-01	4.98e-01	6.43e-01	1.86e-01	3.04e-02
GOBP ZINC ION IMPORT ACROSS PLASMA MEMBRANE	8	6.50e-01	7.22e-01	0.4130	-1.73e-01	6.81e-02	2.52e-01	8.95e-02	2.42e-02	2.53e-01	3.98e-01	7.39e-01	2.17e-01	6.61e-01	9.06e-01	2.16e-01
GOBP PYRIMIDINE CONTAINING COMPOUND SALVAGE	6	6.53e-01	7.24e-01	0.4130	-1.65e-01	-2.73e-01	3.25e-02	1.08e-02	-1.54e-01	-2.08e-01	4.83e-01	2.47e-01	8.90e-01	9.63e-01	5.13e-01	3.77e-01
GOBP SYNAPTIC VESICLE COATING	5	8.14e-01	8.50e-01	0.4130	-7.40e-02	2.31e-01	6.36e-02	-2.95e-01	2.27e-02	1.41e-01	7.75e-01	3.72e-01	8.05e-01	2.53e-01	9.30e-01	5.84e-01
GOBP REGULATION OF RENAL SYSTEM PROCESS	12	4.83e-01	5.84e-01	0.4130	2.56e-01	-1.24e-02	2.51e-01	8.97e-02	8.79e-03	1.82e-01	1.24e-01	9.41e-01	1.32e-01	5.91e-01	9.58e-01	2.75e-01
GOBP ANIMAL ORGAN MATURATION	22	1.47e-01	2.57e-01	0.4120	-9.98e-02	-3.77e-03	2.72e-01	1.80e-02	-2.39e-01	1.70e-01	4.18e-01	9.76e-01	2.72e-02	8.84e-01	5.26e-02	1.68e-01
GOBP PYRIMIDINE NUCLEOSIDE MONOPHOSPHATE CATABOLIC PROCESS	6	7.60e-01	8.07e-01	0.4120	4.82e-02	-2.99e-01	1.48e-01	2.39e-03	-1.46e-01	1.87e-01	8.38e-01	2.04e-01	5.31e-01	9.92e-01	5.35e-01	4.28e-01
GOBP CELLULAR RESPONSE TO STEROL	19	1.11e-01	2.11e-01	0.4120	-2.06e-02	3.11e-01	1.17e-01	1.85e-01	8.62e-02	1.34e-01	8.77e-01	1.90e-02	3.79e-01	1.63e-01	5.15e-01	3.13e-01
GOBP POSITIVE REGULATION OF STEM CELL DIFFERENTIATION	12	2.82e-01	4.02e-01	0.4120	-1.05e-01	-1.82e-01	-5.00e-02	2.07e-02	-9.96e-02	3.36e-01	5.29e-01	2.75e-01	7.64e-01	9.01e-01	5.50e-01	4.39e-02
GOMF OXIDOREDUCTASE ACTIVITY ACTING ON THE CH NH GROUP OF DONORS NAD OR NADP AS ACCEPTOR	15	2.19e-01	3.37e-01	0.4120	-3.47e-02	-3.72e-01	3.18e-02	5.99e-02	-1.16e-01	1.11e-01	8.16e-01	1.27e-02	8.31e-01	6.88e-01	4.36e-01	4.55e-01
GOBP HEAD MORPHOGENESIS	28	1.10e-01	2.09e-01	0.4120	5.96e-02	1.62e-01	2.76e-01	8.67e-02	-1.30e-01	1.98e-01	5.85e-01	1.37e-01	1.14e-02	4.27e-01	2.34e-01	6.97e-02
GOBP NEGATIVE REGULATION OF PROTEIN DEPHOSPHORYLATION	23	1.31e-01	2.38e-01	0.4120	-2.03e-01	-7.24e-02	1.65e-01	3.57e-02	-1.12e-01	2.87e-01	9.18e-02	5.48e-01	1.72e-01	7.67e-01	3.52e-01	1.72e-02
GOBP MAMMARY GLAND EPITHELIAL CELL DIFFERENTIATION	12	6.36e-01	7.11e-01	0.4120	8.18e-02	2.74e-01	1.07e-01	1.89e-01	1.47e-01	1.38e-01	6.24e-01	9.97e-02	5.22e-01	2.57e-01	3.79e-01	4.06e-01
GOMF POLY A BINDING	20	4.69e-02	1.12e-01	0.4120	-2.71e-01	2.52e-02	-2.85e-01	-8.57e-02	-5.90e-02	-5.96e-02	3.61e-02	8.46e-01	2.71e-02	5.07e-01	6.48e-01	6.45e-01
GOBP NEGATIVE REGULATION OF LONG TERM SYNAPTIC POTENTIATION	10	6.76e-01	7.42e-01	0.4120	-3.76e-02	-1.11e-01	-2.80e-01	1.16e-01	-2.50e-02	-2.52e-01	8.37e-01	5.45e-01	1.25e-01	5.25e-01	8.91e-01	1.67e-01
GOBP NEGATIVE REGULATION OF AMIDE METABOLIC PROCESS	21	2.80e-01	4.00e-01	0.4120	-1.94e-01	-2.50e-01	4.77e-02	-8.22e-02	-2.45e-01	-2.37e-03	1.23e-01	4.71e-02	7.05e-01	5.14e-01	5.17e-02	9.85e-01
GOMF TRANSITION METAL ION TRANSMEMBRANE TRANSPORTER ACTIVITY	38	7.15e-03	2.63e-02	0.4120	-2.37e-01	2.19e-02	2.31e-01	-3.52e-02	-1.32e-01	2.02e-01	1.15e-02	8.15e-01	1.38e-02	7.07e-01	1.58e-01	3.08e-02
GOBP PROTEIN METHYLATION	46	8.64e-03	3.06e-02	0.4120	-1.06e-01	-2.89e-01	-2.61e-01	5.85e-02	-5.53e-03	-5.79e-02	2.14e-01	7.07e-04	2.18e-03	4.92e-01	9.48e-01	4.97e-01
GOBP PHOTOTRANSDUCTION VISIBLE LIGHT	12	1.47e-01	2.57e-01	0.4120	2.50e-01	-4.24e-02	4.31e-02	-2.06e-01	-2.34e-01	7.86e-02	1.34e-01	7.99e-01	7.96e-01	2.17e-01	1.60e-01	6.37e-01
GOBP PYRIMIDINE NUCLEOTIDE METABOLIC PROCESS	49	5.30e-04	2.94e-03	0.4120	-8.60e-02	-3.57e-01	-1.46e-01	6.76e-02	-2.64e-02	8.90e-02	2.98e-01	1.54e-05	7.62e-02	4.13e-01	7.50e-01	2.81e-01
GOMF MOLECULAR CARRIER ACTIVITY	88	5.18e-07	5.70e-06	0.4110	-2.09e-01	-2.95e-01	-1.24e-01	8.43e-02	-1.72e-02	1.25e-01	6.98e-04	1.69e-06	4.42e-02	1.72e-01	7.80e-01	4.28e-02
GOBP TRIPARTITE REGIONAL SUBDIVISION	11	5.18e-01	6.12e-01	0.4110	-6.80e-02	1.78e-01	1.60e-01	5.08e-02	-1.75e-02	3.23e-01	6.96e-01	3.08e-01	3.57e-01	7.70e-01	9.20e-01	6.35e-02
GOBP EPITHELIAL FLUID TRANSPORT	5	7.13e-01	7.72e-01	0.4110	-2.88e-01	1.14e-01	2.25e-01	-1.36e-01	4.03e-02	4.87e-02	2.64e-01	6.60e-01	3.83e-01	5.99e-01	8.76e-01	8.50e-01
GOBP GERMINAL CENTER B CELL DIFFERENTIATION	5	5.03e-01	5.99e-01	0.4110	1.87e-01	-3.12e-01	1.78e-01	-5.20e-02	-1.57e-02	4.16e-02	4.70e-01	2.26e-01	4.90e-01	8.40e-01	9.51e-01	8.72e-01
GOBP ACTIN FILAMENT BASED MOVEMENT	97	6.22e-06	5.54e-05	0.4110	3.31e-02	1.02e-01	3.14e-01	1.07e-02	-1.73e-01	1.70e-01	5.73e-01	8.26e-02	9.02e-08	8.55e-01	3.23e-03	3.89e-03
GOMF DIACYLGLYCEROL BINDING	11	5.41e-02	1.25e-01	0.4110	-1.92e-01	1.56e-01	2.09e-01	2.45e-01	-5.25e-02	-2.53e-02	2.70e-01	3.69e-01	2.29e-01	1.59e-01	7.63e-01	8.85e-01
GOBP CRANIAL NERVE DEVELOPMENT	39	2.58e-03	1.14e-02	0.4110	-5.17e-02	1.46e-01	2.12e-01	2.14e-03	2.26e-01	2.21e-01	5.76e-01	1.15e-01	2.22e-02	9.82e-01	1.45e-02	1.68e-02
GOBP GLYCOSYL COMPOUND BIOSYNTHETIC PROCESS	24	5.89e-02	1.33e-01	0.4110	-4.12e-02	-3.35e-01	-2.27e-01	1.41e-02	5.29e-02	4.90e-03	7.27e-01	4.48e-03	5.38e-02	9.05e-01	6.54e-01	9.67e-01
GOBP NEGATIVE REGULATION OF EXTRINSIC APOPTOTIC SIGNALING PATHWAY VIA DEATH DOMAIN RECEPTORS	22	4.99e-03	1.96e-02	0.4110	-3.04e-01	6.55e-02	2.30e-01	-1.21e-02	-1.36e-01	1.05e-02	1.34e-02	5.95e-01	6.18e-02	9.21e-01	2.71e-01	9.32e-01
GOCC SECONDARY LYSOSOME	21	1.29e-01	2.35e-01	0.4110	-2.91e-01	-4.05e-02	-2.34e-01	1.99e-02	1.56e-01	-4.68e-02	2.08e-02	7.48e-01	6.29e-02	8.75e-01	2.14e-01	7.11e-01
GOBP MITOTIC SISTER CHROMATID SEGREGATION	187	5.94e-19	2.27e-17	0.4100	1.70e-02	-1.98e-01	7.82e-02	2.40e-01	-1.15e-02	2.55e-01	6.88e-01	2.85e-06	6.50e-02	1.51e-08	7.86e-01	1.85e-09
GOBP REGULATION OF NITRIC OXIDE SYNTHASE ACTIVITY	16	6.29e-02	1.40e-01	0.4100	-4.40e-02	2.51e-02	2.60e-01	1.29e-01	2.36e-01	1.61e-01	7.60e-01	8.62e-01	7.17e-02	3.70e-01	1.02e-01	2.66e-01
GOCC MICROTUBULE PLUS END	22	5.74e-02	1.31e-01	0.4100	9.36e-02	-3.46e-02	2.58e-01	2.63e-01	-1.14e-01	9.85e-02	4.47e-01	7.79e-01	3.61e-02	3.28e-02	3.54e-01	4.24e-01
GOBP REGULATION OF DOUBLE STRAND BREAK REPAIR VIA NONHOMOLOGOUS END JOINING	28	4.80e-02	1.14e-01	0.4100	-7.95e-02	-1.03e-01	-2.50e-01	2.60e-01	1.07e-01	-1.01e-01	4.67e-01	3.45e-01	2.21e-02	1.74e-02	3.28e-01	3.55e-01
GOBP RESPONSE TO INTERLEUKIN 12	11	3.85e-01	4.99e-01	0.4100	-3.94e-01	7.69e-03	-3.69e-02	-8.17e-02	-5.45e-02	4.56e-02	2.37e-02	9.65e-01	8.32e-01	6.39e-01	7.54e-01	7.93e-01
GOMF HMG BOX DOMAIN BINDING	8	5.54e-01	6.44e-01	0.4100	6.50e-02	3.01e-01	-7.13e-04	-2.40e-01	1.27e-01	-7.94e-03	7.50e-01	1.41e-01	9.97e-01	2.41e-01	5.33e-01	9.69e-01
GOBP INTERLEUKIN 13 PRODUCTION	17	2.36e-01	3.53e-01	0.4100	-1.28e-01	-9.02e-02	2.24e-01	1.25e-01	-1.30e-01	2.48e-01	3.61e-01	5.20e-01	1.11e-01	3.74e-01	3.55e-01	7.66e-02
GOCC GOLGI CIS CISTERNA	19	1.61e-01	2.74e-01	0.4100	3.34e-02	2.76e-01	5.40e-02	2.60e-01	1.38e-01	3.93e-02	8.01e-01	3.70e-02	6.84e-01	5.02e-02	2.99e-01	7.67e-01
GOBP 3 PHOSPHOADENOSINE 5 PHOSPHOSULFATE METABOLIC PROCESS	13	4.42e-01	5.49e-01	0.4100	-1.28e-01	-1.72e-01	1.18e-01	-6.92e-02	-3.16e-01	-5.91e-02	4.23e-01	2.84e-01	4.60e-01	6.66e-01	4.85e-02	7.12e-01
GOBP NADP METABOLIC PROCESS	40	4.72e-04	2.68e-03	0.4100	-2.19e-01	-3.02e-01	5.51e-02	1.20e-01	-6.87e-02	8.27e-02	1.65e-02	9.53e-04	5.46e-01	1.90e-01	4.52e-01	3.66e-01
GOBP RESPONSE TO UV C	13	3.60e-01	4.76e-01	0.4100	-5.12e-02	2.00e-01	-1.72e-01	2.10e-01	2.24e-01	-4.16e-02	7.49e-01	2.12e-01	2.82e-01	1.91e-01	1.63e-01	7.95e-01
GOBP NEGATIVE REGULATION OF CELLULAR RESPONSE TO GROWTH FACTOR STIMULUS	74	1.75e-05	1.40e-04	0.4100	-1.67e-02	2.31e-01	3.15e-01	-7.29e-04	-3.36e-02	1.17e-01	8.04e-01	5.78e-04	2.77e-06	9.91e-01	6.17e-01	8.12e-02
GOBP RNA SURVEILLANCE	18	2.66e-01	3.85e-01	0.4100	-2.28e-02	-2.09e-01	-3.12e-01	1.20e-01	9.37e-02	-5.49e-02	8.67e-01	1.24e-01	2.19e-02	3.77e-01	4.92e-01	6.87e-01
GOBP REGULATION OF PROTEIN EXPORT FROM NUCLEUS	34	1.35e-02	4.38e-02	0.4100	-1.98e-01	-1.92e-01	1.97e-01	7.20e-03	-1.69e-01	1.57e-01	4.59e-02	5.27e-02	4.72e-02	9.42e-01	8.83e-02	1.13e-01
GOMF ALDO KETO REDUCTASE NADPH ACTIVITY	24	1.98e-01	3.14e-01	0.4100	1.43e-02	-1.29e-01	-2.63e-01	2.12e-01	1.37e-01	-1.35e-01	9.04e-01	2.74e-01	2.60e-02	7.25e-02	2.44e-01	2.51e-01
GOBP CORTICAL CYTOSKELETON ORGANIZATION	49	1.54e-05	1.25e-04	0.4100	-9.71e-02	1.92e-02	3.22e-01	1.67e-01	-4.86e-02	1.55e-01	2.40e-01	8.16e-01	9.50e-05	4.32e-02	5.56e-01	6.10e-02
GOBP REGULATION OF PHOSPHOLIPID BIOSYNTHETIC PROCESS	10	5.20e-01	6.14e-01	0.4100	-3.60e-01	-1.01e-01	7.61e-02	-5.91e-02	-3.72e-02	1.31e-01	4.87e-02	5.80e-01	6.77e-01	7.46e-01	8.39e-01	4.72e-01
GOBP NEGATIVE REGULATION OF INTRACELLULAR ESTROGEN RECEPTOR SIGNALING PATHWAY	12	8.80e-02	1.78e-01	0.4100	-1.58e-01	6.62e-03	-9.82e-02	3.63e-01	-2.21e-02	2.41e-02	3.43e-01	9.68e-01	5.56e-01	2.93e-02	8.94e-01	8.85e-01
GOBP ENERGY DERIVATION BY OXIDATION OF ORGANIC COMPOUNDS	302	1.00e-23	5.49e-22	0.4090	-1.58e-01	-3.49e-01	-1.19e-01	3.41e-02	-6.87e-02	3.37e-02	2.50e-06	1.76e-25	3.57e-04	3.09e-01	4.02e-02	3.14e-01
GOBP RENAL ABSORPTION	22	9.68e-02	1.91e-01	0.4090	1.14e-01	-4.17e-02	1.03e-01	3.25e-01	1.82e-01	6.31e-02	3.56e-01	7.35e-01	4.04e-01	8.39e-03	1.40e-01	6.09e-01
GOBP CALCIUM ION TRANSMEMBRANE TRANSPORT VIA HIGH VOLTAGE GATED CALCIUM CHANNEL	15	2.29e-01	3.47e-01	0.4090	1.27e-01	2.57e-01	2.12e-01	-2.18e-02	-1.88e-01	-7.06e-02	3.95e-01	8.51e-02	1.55e-01	8.84e-01	2.09e-01	6.36e-01
GOBP POSITIVE REGULATION OF CARDIAC EPITHELIAL TO MESENCHYMAL TRANSITION	8	5.81e-01	6.66e-01	0.4090	-9.36e-02	6.46e-02	2.94e-01	1.83e-01	8.28e-03	1.86e-01	6.46e-01	7.52e-01	1.50e-01	3.69e-01	9.68e-01	3.62e-01
GOBP PERIPHERAL NERVOUS SYSTEM NEURON DIFFERENTIATION	6	8.23e-01	8.57e-01	0.4090	8.18e-02	-3.23e-02	1.52e-01	-3.46e-02	-2.20e-01	2.95e-01	7.29e-01	8.91e-01	5.18e-01	8.83e-01	3.50e-01	2.11e-01
GOBP MALE SEX DETERMINATION	6	7.42e-01	7.94e-01	0.4090	-2.63e-02	1.88e-02	-2.20e-01	-1.57e-02	-1.75e-01	-2.95e-01	9.11e-01	9.36e-01	3.50e-01	9.47e-01	4.59e-01	2.10e-01
GOBP POSITIVE REGULATION OF LIPID CATABOLIC PROCESS	17	1.50e-02	4.74e-02	0.4090	7.23e-02	1.37e-01	3.22e-01	3.43e-02	-3.18e-02	-1.93e-01	6.06e-01	3.28e-01	2.13e-02	8.07e-01	8.20e-01	1.68e-01
GOCC MEMBRANE COAT	92	6.75e-12	1.38e-10	0.4090	-2.47e-01	-4.05e-02	9.67e-02	2.14e-01	-5.12e-02	2.17e-01	4.23e-05	5.02e-01	1.09e-01	3.97e-04	3.96e-01	3.17e-04
GOMF RNA POLYMERASE II CTD HEPTAPEPTIDE REPEAT PHOSPHATASE ACTIVITY	7	4.94e-01	5.93e-01	0.4090	-1.74e-01	-1.38e-01	-2.07e-01	2.33e-01	-8.20e-02	1.17e-01	4.24e-01	5.26e-01	3.42e-01	2.85e-01	7.07e-01	5.91e-01
GOBP NUCLEAR MEMBRANE ORGANIZATION	46	9.13e-04	4.71e-03	0.4090	-2.10e-01	-2.54e-01	8.99e-02	8.79e-02	-1.38e-01	1.55e-01	1.36e-02	2.87e-03	2.92e-01	3.02e-01	1.06e-01	6.97e-02
GOBP RIBONUCLEOSIDE DIPHOSPHATE BIOSYNTHETIC PROCESS	10	3.87e-01	5.00e-01	0.4090	1.24e-01	-1.22e-01	7.06e-03	1.73e-01	2.76e-01	1.76e-01	4.98e-01	5.04e-01	9.69e-01	3.44e-01	1.31e-01	3.34e-01
GOBP POSITIVE REGULATION OF COLLATERAL SPROUTING	7	4.78e-01	5.80e-01	0.4090	1.54e-01	1.05e-01	2.18e-01	6.84e-02	-7.91e-02	-2.72e-01	4.81e-01	6.29e-01	3.18e-01	7.54e-01	7.17e-01	2.12e-01
GOBP SMOOTH MUSCLE CELL DIFFERENTIATION	44	1.20e-03	5.96e-03	0.4090	-1.43e-02	2.24e-01	1.97e-02	2.13e-01	2.44e-01	-1.07e-01	8.69e-01	1.01e-02	8.21e-01	1.46e-02	5.07e-03	2.19e-01
GOBP REGULATION OF SISTER CHROMATID SEGREGATION	100	4.85e-09	7.11e-08	0.4090	5.69e-02	-1.49e-01	1.22e-01	2.63e-01	-6.11e-02	2.32e-01	3.25e-01	9.99e-03	3.51e-02	5.30e-06	2.91e-01	6.17e-05
GOBP NEGATIVE REGULATION OF MACROPHAGE ACTIVATION	13	2.24e-01	3.43e-01	0.4090	-2.93e-03	2.82e-01	1.87e-01	1.08e-01	1.77e-01	-9.81e-02	9.85e-01	7.83e-02	2.43e-01	4.99e-01	2.70e-01	5.40e-01
GOBP REGULATION OF GUANYL NUCLEOTIDE EXCHANGE FACTOR ACTIVITY	6	8.55e-01	8.83e-01	0.4090	1.60e-01	2.30e-01	9.49e-02	1.04e-01	7.93e-02	2.49e-01	4.96e-01	3.28e-01	6.87e-01	6.58e-01	7.36e-01	2.91e-01
GOMF CROSSOVER JUNCTION DNA ENDONUCLEASE ACTIVITY	9	6.67e-01	7.35e-01	0.4090	1.92e-01	-1.18e-01	-1.61e-01	6.68e-02	-3.95e-02	-2.90e-01	3.17e-01	5.40e-01	4.04e-01	7.29e-01	8.37e-01	1.32e-01
GOBP CHONDROCYTE DEVELOPMENT	20	1.31e-02	4.26e-02	0.4090	-1.65e-01	2.99e-01	1.68e-01	1.28e-01	-6.02e-03	7.37e-02	2.00e-01	2.06e-02	1.92e-01	3.23e-01	9.63e-01	5.68e-01
GOBP RENAL VESICLE DEVELOPMENT	8	5.95e-01	6.77e-01	0.4090	-8.45e-02	1.04e-01	2.26e-01	-2.93e-01	3.82e-02	1.04e-01	6.79e-01	6.11e-01	2.69e-01	1.51e-01	8.52e-01	6.11e-01
GOMF TRANSLATION INITIATION FACTOR BINDING	29	1.07e-01	2.05e-01	0.4080	-1.16e-01	-2.78e-01	-2.21e-01	9.06e-02	-3.71e-02	-1.32e-01	2.80e-01	9.47e-03	3.94e-02	3.98e-01	7.30e-01	2.19e-01
GOMF WNT RECEPTOR ACTIVITY	13	4.87e-01	5.86e-01	0.4080	-9.64e-03	2.93e-01	1.93e-01	1.15e-01	1.01e-01	1.42e-01	9.52e-01	6.73e-02	2.29e-01	4.74e-01	5.29e-01	3.76e-01
GOCC GBAF COMPLEX	13	4.61e-02	1.10e-01	0.4080	-1.54e-01	-4.13e-02	1.06e-01	3.30e-01	-1.43e-01	1.83e-02	3.36e-01	7.97e-01	5.07e-01	3.92e-02	3.72e-01	9.09e-01
GOBP FORMATION OF EXTRACHROMOSOMAL CIRCULAR DNA	15	1.01e-01	1.97e-01	0.4080	-1.13e-02	-8.80e-02	6.21e-02	3.77e-01	-8.40e-02	7.73e-02	9.40e-01	5.55e-01	6.77e-01	1.16e-02	5.73e-01	6.04e-01
GOBP REGULATION OF DELAYED RECTIFIER POTASSIUM CHANNEL ACTIVITY	13	3.64e-01	4.79e-01	0.4080	6.11e-03	4.77e-02	2.67e-01	-2.74e-01	-6.18e-02	1.20e-01	9.70e-01	7.66e-01	9.55e-02	8.77e-02	7.00e-01	4.55e-01
GOBP NEURON CELLULAR HOMEOSTASIS	48	3.13e-03	1.34e-02	0.4080	-2.97e-01	-1.06e-01	9.79e-02	-4.81e-02	-1.49e-01	1.82e-01	3.72e-04	2.04e-01	2.41e-01	5.64e-01	7.36e-02	2.96e-02
GOBP POSITIVE REGULATION OF T HELPER 2 CELL DIFFERENTIATION	7	4.12e-01	5.23e-01	0.4080	-3.81e-01	-1.41e-03	8.30e-02	1.61e-02	-1.06e-01	-5.19e-02	8.06e-02	9.95e-01	7.04e-01	9.41e-01	6.27e-01	8.12e-01
GOBP PHOSPHATIDYLINOSITOL DEPHOSPHORYLATION	29	9.43e-03	3.27e-02	0.4080	-1.39e-01	2.62e-01	1.66e-01	4.66e-02	-2.71e-02	2.20e-01	1.96e-01	1.48e-02	1.22e-01	6.64e-01	8.01e-01	4.03e-02
GOBP POSITIVE REGULATION OF NUCLEAR CELL CYCLE DNA REPLICATION	7	3.52e-01	4.68e-01	0.4080	-1.81e-01	-9.21e-03	5.15e-02	9.51e-02	-2.87e-01	-1.99e-01	4.06e-01	9.66e-01	8.13e-01	6.63e-01	1.89e-01	3.62e-01
GOBP GLOMERULAR EPITHELIAL CELL DEVELOPMENT	10	2.22e-01	3.40e-01	0.4080	-4.11e-03	1.82e-01	2.23e-01	-4.75e-02	-1.44e-01	-2.46e-01	9.82e-01	3.18e-01	2.23e-01	7.95e-01	4.31e-01	1.77e-01
GOBP VESICLE MEDIATED TRANSPORT BETWEEN ENDOSOMAL COMPARTMENTS	49	2.42e-04	1.49e-03	0.4080	-1.81e-01	-1.53e-01	8.95e-02	1.38e-01	-1.90e-01	2.17e-01	2.88e-02	6.36e-02	2.78e-01	9.56e-02	2.12e-02	8.54e-03
GOBP RESPONSE TO INCREASED OXYGEN LEVELS	20	4.56e-02	1.09e-01	0.4080	-3.13e-01	-2.49e-01	6.77e-02	-2.81e-02	-2.07e-02	2.73e-02	1.54e-02	5.39e-02	6.00e-01	8.28e-01	8.73e-01	8.33e-01
GOCC EXTRINSIC COMPONENT OF POSTSYNAPTIC SPECIALIZATION MEMBRANE	5	9.50e-01	9.59e-01	0.4080	2.39e-01	7.56e-02	1.05e-02	2.68e-01	1.53e-01	8.89e-02	3.54e-01	7.70e-01	9.67e-01	2.99e-01	5.54e-01	7.31e-01
GOBP MICROTUBULE SEVERING	8	7.22e-01	7.79e-01	0.4080	-1.24e-01	-2.23e-01	-1.82e-01	1.28e-01	9.30e-02	-2.07e-01	5.43e-01	2.75e-01	3.72e-01	5.31e-01	6.49e-01	3.10e-01
GOMF TPR DOMAIN BINDING	7	5.03e-01	5.99e-01	0.4080	-1.35e-01	-2.93e-01	1.28e-01	1.59e-01	-1.43e-01	-1.49e-02	5.38e-01	1.79e-01	5.58e-01	4.66e-01	5.14e-01	9.46e-01
GOBP GRANULOCYTE CHEMOTAXIS	89	1.33e-07	1.60e-06	0.4080	-3.71e-02	9.83e-02	3.59e-01	-5.89e-02	-3.62e-02	1.46e-01	5.46e-01	1.09e-01	4.57e-09	3.37e-01	5.55e-01	1.76e-02
GOMF CYCLIC NUCLEOTIDE DEPENDENT PROTEIN KINASE ACTIVITY	7	4.73e-01	5.75e-01	0.4070	-2.29e-01	-3.29e-02	-8.14e-02	2.14e-01	-4.17e-02	2.41e-01	2.93e-01	8.80e-01	7.09e-01	3.26e-01	8.48e-01	2.70e-01
GOBP REGULATION OF CHROMOSOME SEGREGATION	124	2.25e-11	4.36e-10	0.4070	4.05e-02	-1.31e-01	1.22e-01	2.67e-01	-6.55e-02	2.39e-01	4.36e-01	1.17e-02	1.88e-02	2.93e-07	2.08e-01	4.48e-06
GOBP POSITIVE REGULATION OF LAMELLIPODIUM MORPHOGENESIS	7	1.33e-01	2.40e-01	0.4070	-8.87e-02	-1.06e-01	2.34e-01	2.22e-01	-9.70e-03	-2.07e-01	6.84e-01	6.29e-01	2.83e-01	3.09e-01	9.65e-01	3.44e-01
GOBP POSITIVE REGULATION OF BONE MINERALIZATION	31	1.66e-02	5.12e-02	0.4070	-1.79e-01	1.03e-01	-8.30e-02	-2.17e-01	-4.32e-02	-2.60e-01	8.50e-02	3.19e-01	4.24e-01	3.69e-02	6.77e-01	1.22e-02
GOMF 1 PHOSPHATIDYLINOSITOL 4 PHOSPHATE 5 KINASE ACTIVITY	9	3.61e-01	4.77e-01	0.4070	-1.51e-01	1.49e-01	2.28e-01	2.18e-01	8.66e-02	1.19e-01	4.34e-01	4.38e-01	2.37e-01	2.58e-01	6.53e-01	5.36e-01
GOBP NEGATIVE REGULATION OF PEPTIDYL TYROSINE PHOSPHORYLATION	36	3.72e-02	9.44e-02	0.4070	-1.00e-01	3.48e-02	2.66e-01	3.83e-02	-9.35e-02	2.72e-01	2.98e-01	7.18e-01	5.81e-03	6.91e-01	3.32e-01	4.79e-03
GOBP MANNOSE METABOLIC PROCESS	9	4.59e-01	5.64e-01	0.4070	1.57e-03	-2.26e-01	-5.90e-02	3.00e-01	-4.25e-02	-1.40e-01	9.93e-01	2.41e-01	7.59e-01	1.19e-01	8.25e-01	4.67e-01
GOBP KERATAN SULFATE METABOLIC PROCESS	15	2.02e-01	3.18e-01	0.4070	-6.15e-02	-3.73e-02	3.02e-01	1.07e-01	5.58e-02	2.35e-01	6.80e-01	8.03e-01	4.32e-02	4.71e-01	7.09e-01	1.16e-01
GOBP POSITIVE REGULATION OF MEMBRANE PERMEABILITY	39	1.84e-02	5.53e-02	0.4070	-9.28e-02	-2.56e-01	-1.84e-01	6.39e-02	-2.58e-02	-2.31e-01	3.16e-01	5.76e-03	4.67e-02	4.90e-01	7.80e-01	1.27e-02
GOBP POSITIVE REGULATION OF EMBRYONIC DEVELOPMENT	15	9.61e-02	1.90e-01	0.4070	-6.42e-03	3.04e-01	-6.25e-03	2.39e-01	6.48e-02	-1.08e-01	9.66e-01	4.15e-02	9.67e-01	1.09e-01	6.64e-01	4.69e-01
GOBP REGULATION OF PROTEIN DEPHOSPHORYLATION	65	6.61e-05	4.68e-04	0.4070	-9.53e-02	-9.38e-02	2.02e-01	1.16e-01	-1.92e-01	2.38e-01	1.84e-01	1.91e-01	4.92e-03	1.06e-01	7.49e-03	8.88e-04
GOBP NEUROMUSCULAR SYNAPTIC TRANSMISSION	20	1.04e-02	3.55e-02	0.4070	-1.82e-02	1.59e-01	2.42e-01	1.32e-01	2.48e-01	-5.26e-02	8.88e-01	2.18e-01	6.13e-02	3.06e-01	5.52e-02	6.84e-01
GOBP REGULATION OF T CELL RECEPTOR SIGNALING PATHWAY	48	1.12e-02	3.77e-02	0.4070	1.24e-01	1.57e-01	8.04e-02	2.59e-01	1.28e-01	1.87e-01	1.38e-01	5.92e-02	3.35e-01	1.88e-03	1.24e-01	2.49e-02
GOMF ACIDIC AMINO ACID TRANSMEMBRANE TRANSPORTER ACTIVITY	14	3.30e-01	4.48e-01	0.4070	8.65e-02	-1.86e-01	1.84e-01	5.09e-02	-8.96e-02	2.80e-01	5.75e-01	2.28e-01	2.33e-01	7.42e-01	5.62e-01	6.93e-02
GOBP REGULATION OF MACROPHAGE DIFFERENTIATION	18	1.24e-01	2.28e-01	0.4060	-1.79e-01	-1.35e-01	2.52e-01	4.01e-03	-2.10e-01	8.46e-02	1.89e-01	3.23e-01	6.37e-02	9.77e-01	1.22e-01	5.34e-01
GOBP INTERMEMBRANE LIPID TRANSFER	27	4.67e-02	1.12e-01	0.4060	-2.37e-02	8.78e-02	-2.44e-02	3.29e-01	2.18e-01	1.97e-02	8.31e-01	4.29e-01	8.26e-01	3.08e-03	4.98e-02	8.59e-01
GOMF NUCLEAR EXPORT SIGNAL RECEPTOR ACTIVITY	12	3.34e-01	4.52e-01	0.4060	-2.56e-01	-2.16e-01	-9.66e-02	1.63e-01	-1.22e-01	4.41e-02	1.25e-01	1.95e-01	5.62e-01	3.28e-01	4.63e-01	7.91e-01
GOBP NEGATIVE REGULATION OF EPIDERMAL GROWTH FACTOR ACTIVATED RECEPTOR ACTIVITY	12	2.37e-01	3.54e-01	0.4060	-2.31e-01	-3.27e-02	8.43e-02	1.22e-01	-2.11e-01	2.10e-01	1.66e-01	8.45e-01	6.13e-01	4.63e-01	2.05e-01	2.09e-01
GOBP PIRNA PROCESSING	12	1.53e-01	2.63e-01	0.4060	-1.39e-01	1.86e-01	-4.54e-02	-8.71e-02	6.42e-02	3.12e-01	4.05e-01	2.64e-01	7.85e-01	6.01e-01	7.00e-01	6.15e-02
GOCC FICOLIN 1 RICH GRANULE	179	6.77e-16	1.97e-14	0.4060	-2.50e-01	-9.48e-02	1.86e-01	9.35e-03	-7.79e-02	2.29e-01	7.59e-09	2.87e-02	1.79e-05	8.29e-01	7.22e-02	1.24e-07
GOMF ACTIVIN RECEPTOR BINDING	7	4.72e-01	5.74e-01	0.4060	-2.68e-01	1.50e-01	2.59e-01	-4.34e-02	-2.20e-02	3.64e-02	2.20e-01	4.91e-01	2.36e-01	8.43e-01	9.20e-01	8.68e-01
GOBP CELLULAR RESPONSE TO DSRNA	19	8.09e-02	1.68e-01	0.4060	-7.74e-03	-3.96e-02	-3.61e-03	1.97e-01	5.58e-02	3.48e-01	9.53e-01	7.65e-01	9.78e-01	1.38e-01	6.74e-01	8.56e-03
GOBP REGULATION OF MITOTIC CYTOKINESIS	15	4.95e-02	1.16e-01	0.4060	-1.22e-01	-7.13e-02	1.32e-01	3.40e-01	-8.09e-02	7.05e-02	4.14e-01	6.33e-01	3.76e-01	2.25e-02	5.88e-01	6.37e-01
GOBP MAINTENANCE OF GASTROINTESTINAL EPITHELIUM	13	5.59e-01	6.48e-01	0.4060	4.16e-02	1.67e-01	8.56e-02	2.56e-01	2.40e-01	6.80e-02	7.95e-01	2.98e-01	5.93e-01	1.10e-01	1.34e-01	6.71e-01
GOMF PHOSPHATIDYLINOSITOL PHOSPHATE 5 PHOSPHATASE ACTIVITY	12	2.88e-01	4.08e-01	0.4060	-4.80e-02	3.02e-01	8.74e-02	1.05e-01	1.87e-01	-1.33e-01	7.74e-01	7.05e-02	6.00e-01	5.28e-01	2.61e-01	4.27e-01
GOBP INTERFERON MEDIATED SIGNALING PATHWAY	82	8.01e-06	6.92e-05	0.4060	5.15e-02	8.24e-02	1.19e-01	2.78e-01	6.79e-02	2.43e-01	4.20e-01	1.97e-01	6.18e-02	1.33e-05	2.88e-01	1.47e-04
GOBP REGULATION OF NEUROTRANSMITTER RECEPTOR ACTIVITY	26	7.69e-03	2.79e-02	0.4060	8.90e-02	1.08e-01	3.24e-01	-4.83e-02	1.64e-01	1.04e-01	4.32e-01	3.40e-01	4.27e-03	6.70e-01	1.48e-01	3.58e-01
GOBP GOLGI RIBBON FORMATION	11	6.72e-01	7.39e-01	0.4060	4.00e-02	2.95e-01	1.25e-01	1.29e-01	1.53e-01	1.41e-01	8.18e-01	8.98e-02	4.73e-01	4.59e-01	3.79e-01	4.18e-01
GOBP REGULATION OF SKELETAL MUSCLE CONTRACTION	13	6.84e-01	7.49e-01	0.4050	2.64e-01	1.54e-01	1.81e-01	1.28e-01	1.31e-01	6.77e-02	9.98e-02	3.35e-01	2.57e-01	4.25e-01	4.12e-01	6.73e-01
GOBP REGULATION OF EPIDERMAL GROWTH FACTOR ACTIVATED RECEPTOR ACTIVITY	16	2.77e-01	3.96e-01	0.4050	-2.74e-01	-5.33e-02	8.28e-02	-4.89e-02	-2.49e-01	1.24e-01	5.79e-02	7.12e-01	5.67e-01	7.35e-01	8.49e-02	3.90e-01
GOBP ERYTHROCYTE DEVELOPMENT	39	1.71e-02	5.23e-02	0.4050	3.82e-02	3.38e-02	2.79e-01	1.70e-01	-1.01e-01	2.11e-01	6.80e-01	7.15e-01	2.53e-03	6.60e-02	2.74e-01	2.26e-02
GOBP VESICLE TARGETING ROUGH ER TO CIS GOLGI	26	2.90e-02	7.81e-02	0.4050	-1.03e-01	-2.11e-01	2.61e-02	2.18e-01	-9.46e-02	2.29e-01	3.66e-01	6.28e-02	8.18e-01	5.45e-02	4.04e-01	4.34e-02
GOBP VASCULAR ASSOCIATED SMOOTH MUSCLE CELL DIFFERENTIATION	22	6.71e-02	1.46e-01	0.4050	-3.61e-02	2.42e-01	6.12e-03	1.24e-01	2.44e-01	-1.70e-01	7.70e-01	4.90e-02	9.60e-01	3.12e-01	4.72e-02	1.66e-01
GOCC MITOCHONDRION	1529	5.23e-118	4.85e-114	0.4050	-1.38e-01	-3.28e-01	-1.88e-01	4.62e-02	-4.50e-03	-6.97e-03	2.80e-19	8.19e-103	9.39e-35	2.57e-03	7.69e-01	6.50e-01
GOBP REGULATION OF POTASSIUM ION TRANSPORT	59	1.81e-03	8.41e-03	0.4050	-3.94e-02	-8.58e-02	2.68e-01	-1.46e-01	-2.01e-01	1.47e-01	6.01e-01	2.54e-01	3.70e-04	5.21e-02	7.43e-03	5.07e-02
GOBP REGULATION OF PHOSPHOPROTEIN PHOSPHATASE ACTIVITY	36	1.15e-02	3.85e-02	0.4050	-1.46e-01	3.80e-03	2.39e-01	8.82e-02	-1.41e-01	2.42e-01	1.30e-01	9.69e-01	1.32e-02	3.60e-01	1.44e-01	1.20e-02
GOCC CHROMOSOME TELOMERIC REGION	150	5.65e-15	1.51e-13	0.4050	-4.92e-02	-1.42e-01	-1.10e-01	3.09e-01	1.13e-01	1.46e-01	2.99e-01	2.62e-03	1.96e-02	6.77e-11	1.68e-02	2.01e-03
GOBP REGULATION OF FAT CELL PROLIFERATION	7	3.40e-01	4.57e-01	0.4050	-1.34e-01	5.27e-03	-1.27e-01	3.48e-01	-8.32e-02	-3.99e-02	5.38e-01	9.81e-01	5.59e-01	1.10e-01	7.03e-01	8.55e-01
GOMF CHITIN BINDING	6	7.68e-01	8.14e-01	0.4050	2.17e-01	-6.34e-02	-3.23e-02	2.98e-01	-9.93e-02	-1.17e-01	3.58e-01	7.88e-01	8.91e-01	2.07e-01	6.74e-01	6.19e-01
GOBP REGULATION OF PROTEIN LOCALIZATION TO CENTROSOME	12	1.22e-01	2.26e-01	0.4050	3.39e-02	-1.70e-02	8.21e-02	2.03e-01	-3.37e-01	-3.69e-02	8.39e-01	9.19e-01	6.23e-01	2.24e-01	4.32e-02	8.25e-01
GOMF POLY A RNA POLYMERASE ACTIVITY	9	4.85e-01	5.85e-01	0.4050	-3.42e-01	3.02e-02	-1.23e-01	-1.20e-02	1.51e-01	-8.96e-02	7.55e-02	8.75e-01	5.22e-01	9.50e-01	4.33e-01	6.42e-01
GOCC GATOR2 COMPLEX	10	3.68e-01	4.83e-01	0.4050	3.31e-02	-1.20e-01	-6.10e-02	2.39e-01	-3.36e-02	-2.94e-01	8.56e-01	5.12e-01	7.38e-01	1.90e-01	8.54e-01	1.07e-01
GOBP MICROGLIAL CELL MIGRATION	6	8.73e-01	8.96e-01	0.4050	1.29e-01	3.23e-02	3.05e-01	-1.37e-01	-1.39e-01	1.24e-01	5.85e-01	8.91e-01	1.96e-01	5.61e-01	5.54e-01	5.99e-01
GOBP ANDROGEN METABOLIC PROCESS	18	2.61e-01	3.81e-01	0.4050	-9.26e-03	-6.74e-02	6.92e-02	-2.65e-01	-2.60e-01	1.30e-01	9.46e-01	6.20e-01	6.11e-01	5.16e-02	5.64e-02	3.38e-01
GOBP REGULATION OF MITOTIC NUCLEAR DIVISION	104	5.29e-11	9.85e-10	0.4050	7.05e-02	-2.48e-01	7.13e-02	2.50e-01	2.52e-02	1.73e-01	2.14e-01	1.27e-05	2.09e-01	1.10e-05	6.57e-01	2.35e-03
GOBP POSITIVE REGULATION OF PROTEIN MATURATION	21	2.45e-01	3.63e-01	0.4050	-1.21e-01	-1.01e-01	2.59e-01	-6.72e-02	-2.10e-01	1.52e-01	3.36e-01	4.24e-01	3.97e-02	5.94e-01	9.51e-02	2.27e-01
GOBP REGULATION OF AMINO ACID TRANSMEMBRANE TRANSPORT	12	4.97e-01	5.95e-01	0.4050	-2.45e-01	-5.98e-02	5.55e-02	-5.39e-02	-2.37e-01	1.96e-01	1.42e-01	7.20e-01	7.39e-01	7.47e-01	1.55e-01	2.39e-01
GOBP REGULATION OF CELLULAR RESPONSE TO OSMOTIC STRESS	11	6.01e-01	6.82e-01	0.4050	-4.81e-02	-6.93e-03	-1.77e-01	1.34e-01	1.83e-01	-2.81e-01	7.82e-01	9.68e-01	3.10e-01	4.43e-01	2.93e-01	1.06e-01
GOBP REGULATION OF AMINE METABOLIC PROCESS	21	1.91e-03	8.83e-03	0.4050	-2.48e-01	-5.60e-02	1.09e-01	2.32e-01	1.82e-01	1.34e-02	4.90e-02	6.57e-01	3.88e-01	6.54e-02	1.48e-01	9.15e-01
GOMF TELOMERIC DNA BINDING	38	2.00e-03	9.19e-03	0.4050	2.96e-02	-1.20e-01	-1.65e-01	3.44e-01	4.15e-02	3.46e-02	7.52e-01	1.99e-01	7.83e-02	2.42e-04	6.58e-01	7.12e-01
GOBP SPHINGOID METABOLIC PROCESS	21	3.71e-01	4.86e-01	0.4050	-1.03e-01	-1.64e-01	1.29e-01	-2.09e-01	-2.53e-01	4.74e-02	4.14e-01	1.92e-01	3.05e-01	9.81e-02	4.50e-02	7.07e-01
GOBP PEPTIDYL PROLINE HYDROXYLATION	10	4.88e-01	5.88e-01	0.4050	-2.26e-01	-3.04e-01	-9.27e-02	2.52e-02	1.00e-01	3.10e-02	2.15e-01	9.61e-02	6.12e-01	8.90e-01	5.83e-01	8.65e-01
GOMF K48 LINKED DEUBIQUITINASE ACTIVITY	17	2.86e-02	7.72e-02	0.4050	-1.69e-01	2.82e-01	-6.86e-03	-8.43e-03	1.09e-02	2.36e-01	2.28e-01	4.42e-02	9.61e-01	9.52e-01	9.38e-01	9.21e-02
GOMF PROFILIN BINDING	9	2.91e-01	4.11e-01	0.4050	3.00e-02	-4.02e-02	-2.61e-02	2.71e-01	-1.51e-01	2.54e-01	8.76e-01	8.35e-01	8.92e-01	1.59e-01	4.34e-01	1.87e-01
GOCC AMPA GLUTAMATE RECEPTOR COMPLEX	14	1.87e-01	3.02e-01	0.4050	3.17e-01	-3.59e-03	1.67e-01	-5.97e-02	-1.12e-01	-1.40e-01	4.03e-02	9.81e-01	2.80e-01	6.99e-01	4.68e-01	3.64e-01
GOMF CO SMAD BINDING	9	5.74e-01	6.60e-01	0.4050	-2.16e-01	1.75e-01	5.98e-02	-2.20e-01	-1.36e-01	1.25e-01	2.62e-01	3.62e-01	7.56e-01	2.52e-01	4.80e-01	5.15e-01
GOCC SMAD PROTEIN COMPLEX	8	7.58e-01	8.06e-01	0.4040	-3.11e-01	4.48e-02	-3.84e-02	-2.39e-01	-7.33e-02	1.93e-02	1.27e-01	8.26e-01	8.51e-01	2.41e-01	7.20e-01	9.25e-01
GOMF EUKARYOTIC INITIATION FACTOR 4E BINDING	8	3.33e-01	4.51e-01	0.4040	-2.01e-01	-8.09e-02	-6.19e-02	1.95e-01	3.18e-02	-2.71e-01	3.25e-01	6.92e-01	7.62e-01	3.38e-01	8.76e-01	1.84e-01
GOBP BRAIN MORPHOGENESIS	28	9.14e-02	1.84e-01	0.4040	-2.54e-01	2.42e-02	-7.63e-02	-2.97e-01	-5.68e-02	-3.38e-02	1.99e-02	8.24e-01	4.85e-01	6.56e-03	6.03e-01	7.57e-01
GOMF LIGAND GATED CALCIUM CHANNEL ACTIVITY	24	2.31e-01	3.49e-01	0.4040	1.64e-01	2.46e-01	5.57e-02	1.07e-01	2.05e-01	-1.40e-01	1.65e-01	3.71e-02	6.37e-01	3.62e-01	8.20e-02	2.36e-01
GOBP GLUCOSE 6 PHOSPHATE METABOLIC PROCESS	27	2.07e-02	6.09e-02	0.4040	-1.91e-01	-2.07e-01	1.55e-01	1.09e-01	-1.82e-01	1.23e-01	8.55e-02	6.29e-02	1.63e-01	3.25e-01	1.02e-01	2.70e-01
GOBP HISTONE MRNA CATABOLIC PROCESS	15	1.83e-01	2.98e-01	0.4040	-3.47e-01	-1.68e-02	-9.35e-02	-2.25e-02	-2.99e-02	1.80e-01	1.99e-02	9.10e-01	5.31e-01	8.80e-01	8.41e-01	2.27e-01
GOBP TOLL LIKE RECEPTOR 2 SIGNALING PATHWAY	16	1.21e-02	4.00e-02	0.4040	-2.96e-01	1.42e-01	2.11e-01	1.03e-01	1.37e-02	1.05e-02	4.03e-02	3.25e-01	1.43e-01	4.77e-01	9.24e-01	9.42e-01
GOCC AXONEMAL A TUBULE INNER SHEATH	5	8.70e-01	8.94e-01	0.4040	-2.44e-01	-1.32e-01	-1.85e-01	2.55e-02	-1.78e-01	-1.41e-01	3.45e-01	6.08e-01	4.74e-01	9.21e-01	4.91e-01	5.84e-01
GOBP TOLL SIGNALING PATHWAY	11	1.89e-01	3.04e-01	0.4040	-2.26e-01	2.80e-01	1.26e-01	8.11e-02	1.02e-01	2.81e-02	1.95e-01	1.07e-01	4.68e-01	6.41e-01	5.57e-01	8.72e-01
GOBP AROMATIC AMINO ACID FAMILY CATABOLIC PROCESS	13	2.78e-01	3.98e-01	0.4040	-9.11e-03	-2.08e-01	-2.32e-01	6.49e-02	2.43e-01	5.48e-02	9.55e-01	1.95e-01	1.48e-01	6.86e-01	1.29e-01	7.32e-01
GOBP LYMPH VESSEL MORPHOGENESIS	14	3.34e-01	4.51e-01	0.4040	-9.53e-02	2.28e-01	2.52e-01	4.44e-02	1.13e-01	1.55e-01	5.37e-01	1.39e-01	1.03e-01	7.74e-01	4.64e-01	3.16e-01
GOBP RESPONSE TO ELECTRICAL STIMULUS	32	1.73e-03	8.11e-03	0.4040	-6.67e-02	1.05e-01	2.38e-01	-1.28e-01	2.04e-01	1.81e-01	5.14e-01	3.02e-01	2.00e-02	2.09e-01	4.53e-02	7.56e-02
GOBP REGULATION OF MITOCHONDRIAL DEPOLARIZATION	14	4.10e-01	5.20e-01	0.4040	-1.42e-01	-2.10e-01	-7.63e-02	-1.53e-01	-1.72e-01	2.01e-01	3.58e-01	1.74e-01	6.21e-01	3.20e-01	2.67e-01	1.93e-01
GOMF PHOSPHATIDIC ACID BINDING	21	3.43e-02	8.87e-02	0.4040	-1.70e-01	-2.16e-01	1.28e-01	2.03e-01	-1.28e-01	1.16e-01	1.77e-01	8.71e-02	3.09e-01	1.07e-01	3.08e-01	3.57e-01
GOBP LYMPHOCYTE MIGRATION	88	4.06e-06	3.77e-05	0.4040	3.90e-02	8.31e-02	2.40e-01	2.22e-01	-3.93e-02	2.16e-01	5.27e-01	1.78e-01	1.01e-04	3.26e-04	5.24e-01	4.72e-04
GOBP AXON ENSHEATHMENT IN CENTRAL NERVOUS SYSTEM	16	4.51e-01	5.57e-01	0.4040	-1.28e-01	7.89e-02	2.55e-01	-1.09e-01	-1.96e-01	1.58e-01	3.74e-01	5.85e-01	7.74e-02	4.51e-01	1.75e-01	2.73e-01
GOBP POSITIVE REGULATION OF CELL MATURATION	6	8.32e-01	8.65e-01	0.4040	-3.33e-02	-1.36e-02	2.35e-01	-2.08e-01	-2.04e-02	2.51e-01	8.88e-01	9.54e-01	3.20e-01	3.78e-01	9.31e-01	2.86e-01
GOBP PHAGOCYTOSIS ENGULFMENT	45	1.07e-04	7.22e-04	0.4040	-1.36e-01	7.43e-02	2.98e-01	1.29e-01	3.34e-02	1.79e-01	1.14e-01	3.89e-01	5.32e-04	1.33e-01	6.98e-01	3.75e-02
GOBP ENTERIC NERVOUS SYSTEM DEVELOPMENT	6	8.56e-01	8.83e-01	0.4040	-8.57e-02	7.44e-02	2.52e-01	-2.65e-01	-1.20e-01	4.82e-02	7.16e-01	7.52e-01	2.85e-01	2.61e-01	6.12e-01	8.38e-01
GOBP REGULATION OF LEUKOCYTE ADHESION TO VASCULAR ENDOTHELIAL CELL	24	4.71e-02	1.12e-01	0.4040	-1.14e-01	1.10e-01	3.25e-01	-1.38e-01	-9.76e-02	5.96e-02	3.32e-01	3.50e-01	5.85e-03	2.43e-01	4.08e-01	6.13e-01
GOBP VIRAL BUDDING	24	5.57e-02	1.28e-01	0.4040	-1.74e-01	-2.37e-01	2.31e-02	1.25e-01	1.80e-02	2.44e-01	1.39e-01	4.46e-02	8.45e-01	2.88e-01	8.79e-01	3.81e-02
GOBP ENDOSOME ORGANIZATION	95	8.59e-09	1.22e-07	0.4030	-3.12e-01	-1.93e-01	6.39e-02	3.80e-02	-8.19e-02	1.26e-01	1.50e-07	1.13e-03	2.82e-01	5.22e-01	1.68e-01	3.40e-02
GOCC NUCLEAR ENVELOPE LUMEN	10	6.07e-01	6.87e-01	0.4030	-7.61e-02	4.93e-03	1.16e-01	-8.98e-02	-2.50e-01	2.70e-01	6.77e-01	9.78e-01	5.26e-01	6.23e-01	1.72e-01	1.39e-01
GOMF ENDOPEPTIDASE ACTIVATOR ACTIVITY	18	2.32e-01	3.50e-01	0.4030	-2.60e-01	-2.34e-01	3.73e-02	5.02e-02	-8.39e-02	1.70e-01	5.58e-02	8.53e-02	7.84e-01	7.12e-01	5.38e-01	2.12e-01
GOBP MACROPHAGE APOPTOTIC PROCESS	13	5.54e-01	6.44e-01	0.4030	1.32e-01	1.58e-01	-7.62e-02	1.32e-01	2.97e-01	9.27e-02	4.09e-01	3.24e-01	6.34e-01	4.10e-01	6.37e-02	5.63e-01
GOMF LRR DOMAIN BINDING	16	3.21e-01	4.40e-01	0.4030	-7.88e-02	-2.71e-01	3.14e-02	-6.52e-02	-2.46e-01	-1.31e-01	5.85e-01	6.10e-02	8.28e-01	6.52e-01	8.79e-02	3.65e-01
GOCC COPII COATED ER TO GOLGI TRANSPORT VESICLE	89	1.36e-08	1.88e-07	0.4030	-2.98e-01	-2.02e-01	-5.17e-02	1.23e-01	8.22e-03	1.22e-01	1.20e-06	9.72e-04	4.00e-01	4.40e-02	8.93e-01	4.66e-02
GOBP NEGATIVE REGULATION OF PEPTIDYL SERINE PHOSPHORYLATION	21	2.30e-01	3.48e-01	0.4030	-1.13e-01	6.87e-03	1.75e-01	-9.92e-02	-3.08e-01	1.20e-01	3.68e-01	9.57e-01	1.66e-01	4.31e-01	1.46e-02	3.41e-01
GOMF PROTEIN GLUTAMIC ACID LIGASE ACTIVITY	8	6.19e-01	6.98e-01	0.4030	5.44e-02	-1.00e-01	-1.37e-01	-6.54e-03	2.11e-01	-2.93e-01	7.90e-01	6.23e-01	5.02e-01	9.74e-01	3.02e-01	1.51e-01
GOBP POSITIVE REGULATION OF BICELLULAR TIGHT JUNCTION ASSEMBLY	5	8.72e-01	8.96e-01	0.4030	1.19e-01	1.71e-01	3.11e-01	1.34e-01	6.21e-02	1.41e-02	6.44e-01	5.08e-01	2.28e-01	6.04e-01	8.10e-01	9.56e-01
GOBP BEHAVIORAL RESPONSE TO ETHANOL	7	3.79e-01	4.93e-01	0.4030	-7.42e-02	-7.69e-02	-5.53e-02	-1.86e-01	3.24e-01	9.19e-02	7.34e-01	7.25e-01	8.00e-01	3.94e-01	1.38e-01	6.74e-01
GOBP PHAGOCYTOSIS RECOGNITION	17	6.39e-02	1.42e-01	0.4030	-6.01e-02	2.07e-01	5.96e-02	-1.41e-01	2.15e-01	-2.15e-01	6.68e-01	1.39e-01	6.71e-01	3.15e-01	1.24e-01	1.26e-01
GOBP CRANIOFACIAL SUTURE MORPHOGENESIS	11	3.04e-01	4.23e-01	0.4030	-1.77e-01	-8.68e-02	-1.77e-02	1.99e-01	2.77e-01	8.15e-02	3.09e-01	6.18e-01	9.19e-01	2.54e-01	1.11e-01	6.40e-01
GOBP REGULATION OF SISTER CHROMATID COHESION	17	8.15e-02	1.69e-01	0.4030	-1.68e-01	-1.12e-01	-6.12e-02	2.25e-01	-4.67e-02	2.54e-01	2.30e-01	4.23e-01	6.62e-01	1.08e-01	7.39e-01	6.95e-02
GOMF INTERLEUKIN 17 RECEPTOR ACTIVITY	6	7.86e-01	8.28e-01	0.4030	-2.32e-01	-2.22e-01	6.36e-02	4.48e-02	-2.29e-01	-1.63e-02	3.24e-01	3.46e-01	7.87e-01	8.49e-01	3.31e-01	9.45e-01
GOCC AXONAL GROWTH CONE	22	2.53e-01	3.72e-01	0.4020	1.43e-01	2.64e-01	1.14e-01	1.71e-01	1.47e-01	-8.87e-02	2.47e-01	3.18e-02	3.54e-01	1.66e-01	2.31e-01	4.71e-01
GOBP REGULATION OF CILIUM MOVEMENT	20	3.01e-01	4.20e-01	0.4020	-1.35e-01	-5.35e-02	-1.83e-01	-2.03e-01	4.14e-02	-2.54e-01	2.96e-01	6.79e-01	1.56e-01	1.16e-01	7.49e-01	4.94e-02
GOCC I BAND	102	2.85e-05	2.19e-04	0.4020	2.56e-02	2.54e-02	2.76e-01	-9.09e-03	-1.25e-01	2.62e-01	6.55e-01	6.58e-01	1.50e-06	8.74e-01	2.86e-02	4.65e-06
GOBP REGULATION OF PROTEIN GLYCOSYLATION	9	7.70e-01	8.15e-01	0.4020	1.34e-01	8.50e-02	-1.64e-01	1.69e-01	8.17e-02	-2.73e-01	4.86e-01	6.59e-01	3.95e-01	3.79e-01	6.71e-01	1.56e-01
GOBP POSITIVE REGULATION OF INTERFERON ALPHA PRODUCTION	21	2.87e-02	7.75e-02	0.4020	-2.96e-01	1.60e-01	2.48e-02	4.62e-02	1.07e-01	1.85e-01	1.87e-02	2.05e-01	8.44e-01	7.14e-01	3.96e-01	1.42e-01
GOBP T CELL DIFFERENTIATION INVOLVED IN IMMUNE RESPONSE	77	1.47e-05	1.19e-04	0.4020	3.32e-02	2.86e-01	2.12e-01	1.47e-01	3.74e-02	1.06e-01	6.14e-01	1.42e-05	1.31e-03	2.61e-02	5.70e-01	1.09e-01
GOBP ESTABLISHMENT OF ENDOTHELIAL BARRIER	47	3.19e-06	3.04e-05	0.4020	-2.31e-01	2.03e-01	2.54e-01	-2.49e-02	1.94e-02	4.07e-02	6.17e-03	1.62e-02	2.54e-03	7.68e-01	8.18e-01	6.29e-01
GOBP RNA PROCESSING	916	4.92e-66	2.85e-63	0.4020	-1.14e-01	-2.75e-01	-2.51e-01	8.55e-02	-3.70e-03	-5.46e-02	5.23e-09	3.07e-45	6.02e-38	1.16e-05	8.50e-01	5.14e-03
GOBP DEOXYRIBONUCLEOTIDE METABOLIC PROCESS	39	1.63e-03	7.71e-03	0.4020	-5.57e-02	-3.41e-01	-6.30e-02	3.92e-02	-2.77e-02	1.89e-01	5.47e-01	2.27e-04	4.96e-01	6.72e-01	7.64e-01	4.11e-02
GOBP MAINTENANCE OF CELL POLARITY	16	4.59e-01	5.64e-01	0.4020	-7.34e-02	-1.78e-02	2.70e-01	3.90e-02	-1.42e-01	2.48e-01	6.11e-01	9.02e-01	6.16e-02	7.87e-01	3.27e-01	8.64e-02
GOMF OXIDOREDUCTASE ACTIVITY ACTING ON THE CH CH GROUP OF DONORS OXYGEN AS ACCEPTOR	10	5.26e-01	6.19e-01	0.4020	-9.10e-02	-3.18e-01	-1.38e-01	1.44e-01	9.63e-02	-5.14e-02	6.18e-01	8.12e-02	4.49e-01	4.32e-01	5.98e-01	7.78e-01
GOBP POSITIVE REGULATION OF MIRNA METABOLIC PROCESS	55	2.17e-04	1.35e-03	0.4010	4.90e-03	1.66e-01	3.51e-01	-2.56e-02	-1.69e-03	9.87e-02	9.50e-01	3.28e-02	6.76e-06	7.43e-01	9.83e-01	2.06e-01
GOBP NEPHRON TUBULE FORMATION	8	7.61e-01	8.07e-01	0.4010	1.05e-02	2.30e-01	-8.43e-02	4.43e-02	3.12e-01	4.54e-02	9.59e-01	2.61e-01	6.80e-01	8.28e-01	1.27e-01	8.24e-01
GOMF MICROFILAMENT MOTOR ACTIVITY	26	7.83e-02	1.64e-01	0.4010	2.23e-01	1.73e-01	1.74e-01	2.07e-01	-8.42e-02	-3.86e-02	4.92e-02	1.27e-01	1.24e-01	6.82e-02	4.57e-01	7.33e-01
GOBP POSITIVE REGULATION OF MITOCHONDRIAL FUSION	5	7.25e-01	7.81e-01	0.4010	-1.16e-01	-1.33e-01	-2.95e-01	1.70e-01	-5.66e-03	1.16e-01	6.53e-01	6.05e-01	2.53e-01	5.11e-01	9.83e-01	6.52e-01
GOMF UDP XYLOSYLTRANSFERASE ACTIVITY	10	2.18e-01	3.36e-01	0.4010	-3.07e-01	-2.95e-02	9.40e-02	-7.09e-02	2.18e-01	6.80e-02	9.29e-02	8.72e-01	6.07e-01	6.98e-01	2.33e-01	7.10e-01
GOBP NEGATIVE REGULATION OF RNA SPLICING	25	9.91e-02	1.94e-01	0.4010	-1.19e-01	-2.79e-01	-9.28e-02	7.44e-02	-2.16e-01	-8.95e-02	3.02e-01	1.59e-02	4.22e-01	5.20e-01	6.12e-02	4.39e-01
GOBP MODULATION BY HOST OF VIRAL PROCESS	45	1.64e-03	7.76e-03	0.4010	-2.39e-01	-9.40e-02	1.95e-01	2.94e-02	-9.70e-02	2.15e-01	5.46e-03	2.75e-01	2.38e-02	7.33e-01	2.60e-01	1.24e-02
GOBP POSITIVE REGULATION OF LAMELLIPODIUM ORGANIZATION	33	4.10e-03	1.67e-02	0.4010	-2.07e-01	4.74e-02	2.54e-01	9.15e-02	-2.96e-02	2.05e-01	3.96e-02	6.38e-01	1.16e-02	3.63e-01	7.68e-01	4.18e-02
GOMF HISTONE H3K4 METHYLTRANSFERASE ACTIVITY	16	4.67e-01	5.70e-01	0.4010	1.33e-01	1.85e-01	1.77e-01	2.61e-01	7.31e-02	6.05e-02	3.58e-01	2.00e-01	2.19e-01	7.02e-02	6.13e-01	6.75e-01
GOBP REGULATION OF CARDIAC MUSCLE CELL ACTION POTENTIAL	21	3.79e-01	4.93e-01	0.4010	2.50e-02	9.86e-02	2.73e-01	-1.14e-01	-1.05e-01	2.28e-01	8.43e-01	4.34e-01	3.05e-02	3.66e-01	4.05e-01	7.05e-02
GOMF VOLTAGE GATED SODIUM CHANNEL ACTIVITY	17	3.57e-01	4.73e-01	0.4010	7.85e-02	2.50e-01	2.31e-01	-1.52e-01	-1.09e-01	6.14e-02	5.75e-01	7.45e-02	9.90e-02	2.79e-01	4.37e-01	6.61e-01
GOBP GLANDULAR EPITHELIAL CELL DEVELOPMENT	22	8.16e-02	1.69e-01	0.4010	1.53e-02	6.34e-02	3.18e-01	1.82e-01	-7.06e-02	1.30e-01	9.01e-01	6.07e-01	9.71e-03	1.39e-01	5.66e-01	2.93e-01
GOMF PHOTORECEPTOR ACTIVITY	8	6.39e-01	7.13e-01	0.4010	-4.36e-02	3.55e-01	4.88e-02	-1.11e-01	1.14e-01	-7.02e-02	8.31e-01	8.23e-02	8.11e-01	5.85e-01	5.76e-01	7.31e-01
GOBP PEROXISOME ORGANIZATION	36	2.83e-02	7.68e-02	0.4010	-2.28e-01	-2.33e-01	-2.09e-01	2.26e-02	9.72e-02	2.74e-02	1.80e-02	1.56e-02	3.01e-02	8.15e-01	3.13e-01	7.76e-01
GOBP PIGMENT GRANULE ORGANIZATION	36	1.57e-02	4.91e-02	0.4010	-2.40e-01	-8.75e-02	1.16e-01	7.99e-03	-2.00e-02	2.85e-01	1.27e-02	3.64e-01	2.29e-01	9.34e-01	8.36e-01	3.08e-03
GOBP RESPONSE TO GONADOTROPIN	18	4.50e-01	5.56e-01	0.4000	1.14e-01	1.22e-01	2.86e-01	-1.06e-02	2.42e-02	2.24e-01	4.02e-01	3.69e-01	3.58e-02	9.38e-01	8.59e-01	1.00e-01
GOBP INNER EAR RECEPTOR CELL DEVELOPMENT	37	9.94e-03	3.41e-02	0.4000	-1.44e-01	9.62e-02	-1.36e-01	-1.66e-01	4.58e-02	-2.86e-01	1.29e-01	3.11e-01	1.53e-01	7.99e-02	6.30e-01	2.57e-03
GOBP SEMI LUNAR VALVE DEVELOPMENT	29	9.67e-03	3.34e-02	0.4000	-8.91e-02	1.78e-01	3.24e-01	2.54e-02	5.60e-02	1.08e-01	4.06e-01	9.63e-02	2.51e-03	8.13e-01	6.02e-01	3.16e-01
GOBP MAST CELL ACTIVATION INVOLVED IN IMMUNE RESPONSE	48	1.74e-02	5.29e-02	0.4000	-1.87e-02	4.22e-02	2.53e-01	5.23e-02	-9.00e-02	2.88e-01	8.22e-01	6.13e-01	2.39e-03	5.30e-01	2.81e-01	5.50e-04
GOBP ADRENERGIC RECEPTOR SIGNALING PATHWAY	18	1.09e-02	3.68e-02	0.4000	-1.25e-01	2.30e-01	2.14e-01	2.11e-01	-4.71e-03	-3.63e-02	3.60e-01	9.10e-02	1.16e-01	1.20e-01	9.72e-01	7.90e-01
GOBP PLASMA MEMBRANE FUSION	11	4.31e-01	5.40e-01	0.4000	2.04e-01	1.36e-01	3.90e-02	-1.62e-01	-1.01e-01	-2.50e-01	2.42e-01	4.36e-01	8.23e-01	3.52e-01	5.62e-01	1.52e-01
GOCC CHROMAFFIN GRANULE	11	3.82e-01	4.95e-01	0.4000	-1.48e-01	-7.66e-02	1.87e-01	6.25e-02	1.35e-01	2.75e-01	3.97e-01	6.60e-01	2.83e-01	7.20e-01	4.39e-01	1.14e-01
GOBP PURINE NUCLEOSIDE TRANSMEMBRANE TRANSPORT	5	5.42e-01	6.33e-01	0.4000	2.34e-01	-2.80e-01	1.37e-02	-3.86e-02	6.00e-02	1.47e-01	3.64e-01	2.79e-01	9.58e-01	8.81e-01	8.16e-01	5.69e-01
GOBP ANTIBACTERIAL INNATE IMMUNE RESPONSE	7	4.14e-01	5.25e-01	0.4000	-1.42e-01	2.13e-01	2.32e-01	-1.05e-01	-8.55e-03	-1.71e-01	5.15e-01	3.29e-01	2.87e-01	6.29e-01	9.69e-01	4.34e-01
GOBP ACETYL COA METABOLIC PROCESS	28	2.60e-02	7.23e-02	0.4000	-7.67e-02	-2.51e-01	-1.08e-01	2.53e-01	1.08e-01	6.22e-02	4.83e-01	2.14e-02	3.21e-01	2.07e-02	3.24e-01	5.69e-01
GOBP ALPHA BETA T CELL ACTIVATION	169	4.54e-10	7.64e-09	0.4000	7.57e-02	2.23e-01	1.90e-01	1.83e-01	6.38e-02	1.76e-01	8.96e-02	5.74e-07	2.12e-05	4.06e-05	1.52e-01	7.68e-05
GOBP CELLULAR RESPONSE TO ANGIOTENSIN	24	2.30e-01	3.48e-01	0.4000	-8.44e-02	1.16e-01	2.48e-01	-3.78e-02	-1.21e-01	2.48e-01	4.74e-01	3.27e-01	3.51e-02	7.49e-01	3.04e-01	3.52e-02
GOBP PIECEMEAL MICROAUTOPHAGY OF THE NUCLEUS	17	3.00e-01	4.20e-01	0.4000	-1.11e-01	-1.30e-02	-2.34e-01	2.23e-01	1.75e-01	-1.11e-01	4.29e-01	9.26e-01	9.54e-02	1.11e-01	2.11e-01	4.27e-01
GOBP RESPONSE TO ACETYLCHOLINE	28	7.52e-02	1.59e-01	0.4000	-1.16e-01	4.38e-02	2.37e-01	9.04e-02	-8.58e-02	2.70e-01	2.88e-01	6.88e-01	3.01e-02	4.08e-01	4.32e-01	1.34e-02
GOBP REGULATION OF EXTRACELLULAR MATRIX DISASSEMBLY	12	6.51e-01	7.23e-01	0.4000	4.83e-02	1.91e-01	5.85e-02	1.89e-01	2.85e-01	3.22e-02	7.72e-01	2.52e-01	7.26e-01	2.58e-01	8.78e-02	8.47e-01
GOBP REGULATION OF LAMELLIPODIUM ASSEMBLY	34	1.29e-02	4.22e-02	0.4000	-1.66e-01	8.35e-03	2.05e-01	1.23e-01	-1.72e-02	2.73e-01	9.35e-02	9.33e-01	3.84e-02	2.15e-01	8.62e-01	5.84e-03
GOBP SPERM DNA CONDENSATION	11	6.10e-01	6.90e-01	0.4000	-2.10e-01	-1.01e-01	1.83e-02	-2.18e-01	-4.47e-02	2.36e-01	2.29e-01	5.60e-01	9.16e-01	2.10e-01	7.98e-01	1.75e-01
GOBP DENTATE GYRUS DEVELOPMENT	15	4.32e-01	5.40e-01	0.4000	1.23e-01	5.87e-02	2.83e-01	-1.65e-01	-1.17e-01	1.42e-01	4.09e-01	6.94e-01	5.80e-02	2.68e-01	4.32e-01	3.41e-01
GOBP POSITIVE REGULATION OF AMINE TRANSPORT	27	1.36e-01	2.43e-01	0.4000	4.22e-02	1.13e-01	3.07e-01	1.16e-01	2.01e-02	1.92e-01	7.04e-01	3.08e-01	5.78e-03	2.95e-01	8.56e-01	8.37e-02
GOCC CAVEOLA	65	3.29e-03	1.40e-02	0.4000	1.94e-02	1.48e-01	2.97e-01	-4.85e-02	-8.07e-02	2.01e-01	7.87e-01	3.89e-02	3.44e-05	4.99e-01	2.60e-01	5.13e-03
GOMF PROTEIN FOLDING CHAPERONE	58	6.20e-06	5.52e-05	0.4000	-1.07e-01	-2.83e-01	2.15e-02	2.27e-01	1.89e-02	1.25e-01	1.58e-01	1.92e-04	7.77e-01	2.75e-03	8.03e-01	9.95e-02
GOBP MYOBLAST PROLIFERATION	17	3.17e-01	4.37e-01	0.4000	-1.60e-01	1.19e-02	-3.10e-02	-2.19e-01	-2.27e-01	-1.83e-01	2.54e-01	9.32e-01	8.25e-01	1.17e-01	1.05e-01	1.92e-01
GOBP CDP DIACYLGLYCEROL BIOSYNTHETIC PROCESS	13	2.80e-01	3.99e-01	0.4000	-2.20e-01	5.34e-02	2.75e-01	-8.83e-02	1.33e-02	1.58e-01	1.70e-01	7.39e-01	8.62e-02	5.81e-01	9.34e-01	3.24e-01
GOBP NEGATIVE REGULATION OF COAGULATION	38	5.42e-05	3.91e-04	0.4000	3.06e-02	-1.34e-01	3.45e-01	-9.88e-02	-9.70e-02	4.89e-02	7.44e-01	1.53e-01	2.31e-04	2.92e-01	3.01e-01	6.02e-01
GOBP CD4 POSITIVE ALPHA BETA T CELL CYTOKINE PRODUCTION	16	2.36e-01	3.53e-01	0.3990	2.33e-02	2.27e-01	2.23e-01	-1.09e-01	-2.11e-01	-3.63e-02	8.72e-01	1.16e-01	1.22e-01	4.49e-01	1.44e-01	8.01e-01
GOBP OUTER DYNEIN ARM ASSEMBLY	14	2.12e-01	3.30e-01	0.3990	8.03e-02	1.05e-01	9.28e-02	2.53e-01	1.92e-01	-1.81e-01	6.03e-01	4.97e-01	5.48e-01	1.02e-01	2.14e-01	2.41e-01
GOMF L SERINE TRANSMEMBRANE TRANSPORTER ACTIVITY	8	5.83e-01	6.68e-01	0.3990	-5.83e-04	-1.35e-02	1.37e-01	1.39e-01	-2.84e-01	2.02e-01	9.98e-01	9.47e-01	5.01e-01	4.96e-01	1.65e-01	3.23e-01
GOBP PEPTIDYL LYSINE TRIMETHYLATION	10	8.02e-01	8.41e-01	0.3990	-1.37e-01	-2.12e-01	-2.45e-01	1.81e-03	-9.02e-02	-1.65e-01	4.53e-01	2.45e-01	1.79e-01	9.92e-01	6.21e-01	3.67e-01
GOBP CHROMOSOME LOCALIZATION	112	8.43e-10	1.36e-08	0.3990	-9.84e-02	-2.31e-01	6.37e-02	1.65e-01	-8.32e-02	2.41e-01	7.21e-02	2.49e-05	2.44e-01	2.51e-03	1.28e-01	1.03e-05
GOBP RESPONSE TO MUSCLE STRETCH	21	1.01e-01	1.96e-01	0.3990	-3.22e-02	1.88e-01	3.12e-01	7.72e-02	-1.04e-01	9.46e-02	7.98e-01	1.36e-01	1.34e-02	5.41e-01	4.09e-01	4.53e-01
GOMF DAMAGED DNA BINDING	70	1.80e-04	1.15e-03	0.3990	-5.35e-02	-2.21e-01	-2.52e-01	1.73e-01	1.01e-01	-6.15e-02	4.39e-01	1.41e-03	2.61e-04	1.22e-02	1.42e-01	3.73e-01
GOMF FK506 BINDING	10	2.64e-01	3.83e-01	0.3990	-3.72e-02	-3.19e-01	2.06e-01	-1.76e-02	-8.19e-02	7.91e-02	8.38e-01	8.02e-02	2.58e-01	9.23e-01	6.54e-01	6.65e-01
GOBP PYRIMIDINE NUCLEOSIDE MONOPHOSPHATE METABOLIC PROCESS	19	1.79e-01	2.94e-01	0.3990	-5.88e-02	-3.52e-01	-4.84e-02	1.09e-01	-1.31e-01	7.41e-03	6.57e-01	7.83e-03	7.15e-01	4.09e-01	3.21e-01	9.55e-01
GOBP LEUKOTRIENE METABOLIC PROCESS	23	2.05e-01	3.22e-01	0.3990	-3.68e-02	5.70e-02	2.74e-01	-1.61e-01	-2.25e-01	5.42e-02	7.60e-01	6.36e-01	2.28e-02	1.82e-01	6.15e-02	6.53e-01
GOBP REGULATION OF TRANSCRIPTION REGULATORY REGION DNA BINDING	24	9.94e-02	1.95e-01	0.3990	1.83e-02	-1.37e-01	2.90e-01	2.81e-02	-1.73e-01	1.60e-01	8.77e-01	2.47e-01	1.40e-02	8.12e-01	1.44e-01	1.74e-01
GOBP REGULATION OF ENDOCRINE PROCESS	23	2.30e-01	3.48e-01	0.3990	3.83e-02	6.40e-02	2.91e-01	5.67e-02	-1.88e-01	1.74e-01	7.50e-01	5.95e-01	1.58e-02	6.38e-01	1.18e-01	1.48e-01
GOBP POSITIVE REGULATION OF DENDRITIC SPINE DEVELOPMENT	34	4.02e-03	1.64e-02	0.3990	-2.07e-01	6.99e-02	9.86e-02	8.30e-02	2.08e-01	2.27e-01	3.70e-02	4.81e-01	3.20e-01	4.02e-01	3.55e-02	2.20e-02
GOBP ADHERENS JUNCTION ASSEMBLY	12	9.53e-02	1.89e-01	0.3990	-1.91e-01	1.58e-01	2.53e-01	6.17e-02	-1.69e-01	-3.46e-02	2.52e-01	3.43e-01	1.29e-01	7.11e-01	3.10e-01	8.36e-01
GOBP REGULATION OF MONOOXYGENASE ACTIVITY	27	3.08e-02	8.15e-02	0.3990	3.05e-03	7.22e-02	2.71e-01	1.13e-01	1.76e-01	1.92e-01	9.78e-01	5.16e-01	1.50e-02	3.08e-01	1.13e-01	8.46e-02
GOBP TRANSFORMING GROWTH FACTOR BETA PRODUCTION	26	1.06e-01	2.04e-01	0.3990	-2.33e-01	-6.13e-02	1.45e-01	-9.70e-02	-2.60e-01	5.69e-02	4.01e-02	5.88e-01	2.02e-01	3.92e-01	2.17e-02	6.16e-01
GOMF CYCLIC NUCLEOTIDE BINDING	26	9.13e-03	3.19e-02	0.3990	-2.49e-02	-6.48e-02	1.46e-01	2.44e-02	-3.29e-01	-1.54e-01	8.26e-01	5.67e-01	1.98e-01	8.30e-01	3.64e-03	1.73e-01
GOBP SNRNA PROCESSING	27	1.10e-01	2.09e-01	0.3990	-2.99e-02	-1.81e-01	-2.27e-01	2.28e-01	1.30e-01	-6.84e-02	7.88e-01	1.03e-01	4.10e-02	4.06e-02	2.41e-01	5.38e-01
GOBP PROTEIN LOCALIZATION TO MEMBRANE RAFT	8	7.63e-01	8.09e-01	0.3990	-2.58e-01	-6.63e-02	1.92e-01	-7.50e-02	-1.62e-01	1.38e-01	2.07e-01	7.46e-01	3.46e-01	7.14e-01	4.27e-01	4.98e-01
GOBP POSTSYNAPTIC MODULATION OF CHEMICAL SYNAPTIC TRANSMISSION	20	3.53e-01	4.68e-01	0.3990	-3.07e-01	-9.26e-02	-1.79e-02	-1.52e-01	-1.77e-01	3.68e-02	1.75e-02	4.74e-01	8.90e-01	2.40e-01	1.69e-01	7.76e-01
GOCC SNARE COMPLEX	43	5.08e-03	1.99e-02	0.3990	-2.15e-01	-2.50e-01	-1.06e-01	-4.39e-02	1.44e-03	1.92e-01	1.49e-02	4.55e-03	2.27e-01	6.18e-01	9.87e-01	2.91e-02
GOBP CAMP MEDIATED SIGNALING	40	3.51e-02	9.03e-02	0.3980	1.70e-02	2.47e-01	2.45e-01	6.69e-02	3.37e-02	1.78e-01	8.53e-01	6.94e-03	7.25e-03	4.64e-01	7.12e-01	5.11e-02
GOBP POSITIVE REGULATION OF RESPONSE TO TUMOR CELL	11	4.32e-01	5.40e-01	0.3980	-1.47e-01	-3.05e-01	-3.42e-02	1.51e-01	4.36e-02	1.34e-01	3.99e-01	7.95e-02	8.44e-01	3.85e-01	8.02e-01	4.43e-01
GOBP NEGATIVE REGULATION OF AMYLOID PRECURSOR PROTEIN CATABOLIC PROCESS	17	2.47e-01	3.65e-01	0.3980	-1.21e-01	-1.44e-01	2.21e-01	9.88e-04	-2.65e-01	6.45e-02	3.89e-01	3.06e-01	1.15e-01	9.94e-01	5.84e-02	6.45e-01
GOMF FIBRONECTIN BINDING	22	1.37e-02	4.43e-02	0.3980	-2.51e-01	6.76e-02	2.24e-01	-1.85e-01	6.77e-02	3.97e-02	4.12e-02	5.83e-01	6.92e-02	1.32e-01	5.83e-01	7.47e-01
GOBP NEURON PROJECTION MAINTENANCE	10	3.40e-01	4.57e-01	0.3980	-2.17e-01	-1.25e-01	-1.11e-01	1.23e-01	-2.21e-01	-1.39e-01	2.35e-01	4.93e-01	5.43e-01	5.01e-01	2.26e-01	4.48e-01
GOBP RESPONSE TO GROWTH HORMONE	27	7.66e-02	1.61e-01	0.3980	-1.08e-01	1.23e-01	1.71e-01	9.75e-02	3.85e-02	3.02e-01	3.31e-01	2.67e-01	1.24e-01	3.81e-01	7.29e-01	6.59e-03
GOMF CADHERIN BINDING INVOLVED IN CELL CELL ADHESION	14	5.66e-02	1.29e-01	0.3980	-1.18e-01	-2.39e-01	1.96e-01	-4.23e-02	1.09e-01	1.87e-01	4.45e-01	1.21e-01	2.04e-01	7.84e-01	4.82e-01	2.25e-01
GOMF SINGLE STRANDED DNA BINDING	114	2.70e-10	4.68e-09	0.3980	-1.17e-01	-2.57e-01	-2.02e-01	1.66e-01	-2.80e-02	9.54e-02	3.15e-02	2.04e-06	1.93e-04	2.14e-03	6.05e-01	7.87e-02
GOBP FIBROBLAST MIGRATION	50	6.87e-04	3.69e-03	0.3980	-2.38e-01	-1.11e-01	1.31e-01	-9.20e-02	-2.50e-01	-3.64e-02	3.58e-03	1.74e-01	1.10e-01	2.61e-01	2.24e-03	6.56e-01
GOBP CELL JUNCTION MAINTENANCE	35	3.79e-03	1.56e-02	0.3980	6.71e-02	4.36e-02	3.46e-01	1.01e-01	-1.43e-01	3.90e-02	4.92e-01	6.55e-01	3.99e-04	2.99e-01	1.43e-01	6.90e-01
GOMF POLY G BINDING	8	6.26e-01	7.03e-01	0.3980	-2.71e-01	9.07e-03	-5.71e-04	-7.48e-02	-1.87e-01	2.10e-01	1.85e-01	9.65e-01	9.98e-01	7.14e-01	3.59e-01	3.03e-01
GOMF NEUROPEPTIDE BINDING	12	3.35e-01	4.52e-01	0.3980	5.45e-02	2.96e-01	1.25e-01	-7.31e-03	-8.08e-02	2.12e-01	7.44e-01	7.54e-02	4.52e-01	9.65e-01	6.28e-01	2.03e-01
GOBP REGULATION OF REGULATED SECRETORY PATHWAY	97	9.16e-10	1.47e-08	0.3970	-1.57e-01	8.68e-02	2.63e-01	1.29e-01	-1.05e-02	2.00e-01	7.71e-03	1.39e-01	7.52e-06	2.83e-02	8.59e-01	6.62e-04
GOBP IMMUNOGLOBULIN PRODUCTION	151	1.31e-14	3.43e-13	0.3970	-3.74e-03	-2.05e-01	4.08e-02	2.17e-01	-1.04e-01	2.38e-01	9.37e-01	1.40e-05	3.87e-01	4.23e-06	2.72e-02	4.66e-07
GOBP CELLULAR RESPONSE TO VIRUS	52	6.17e-03	2.32e-02	0.3970	2.38e-03	1.77e-01	2.00e-01	1.45e-01	1.38e-01	2.15e-01	9.76e-01	2.74e-02	1.24e-02	7.04e-02	8.56e-02	7.21e-03
GOBP NEURON PROJECTION EXTENSION INVOLVED IN NEURON PROJECTION GUIDANCE	14	1.34e-01	2.41e-01	0.3970	-3.08e-02	2.06e-01	2.96e-01	2.58e-02	1.61e-01	1.59e-03	8.42e-01	1.82e-01	5.48e-02	8.67e-01	2.97e-01	9.92e-01
GOBP NEGATIVE REGULATION OF ERBB SIGNALING PATHWAY	28	2.18e-02	6.32e-02	0.3970	-1.74e-01	-7.66e-02	1.56e-01	1.38e-01	-1.86e-01	2.09e-01	1.11e-01	4.83e-01	1.53e-01	2.08e-01	8.76e-02	5.59e-02
GOBP P BODY ASSEMBLY	23	1.52e-02	4.78e-02	0.3970	-3.43e-02	2.15e-01	1.26e-01	2.65e-01	-4.77e-02	1.49e-01	7.76e-01	7.45e-02	2.97e-01	2.81e-02	6.92e-01	2.15e-01
GOBP DETECTION OF LIGHT STIMULUS INVOLVED IN SENSORY PERCEPTION	15	1.52e-01	2.63e-01	0.3970	8.62e-02	3.66e-01	4.77e-03	-1.27e-01	-1.67e-03	-1.98e-02	5.63e-01	1.42e-02	9.74e-01	3.93e-01	9.91e-01	8.94e-01
GOCC RECEPTOR COMPLEX	386	8.58e-20	3.58e-18	0.3970	1.64e-01	2.21e-01	7.55e-02	1.57e-01	1.95e-01	1.16e-01	3.22e-08	8.41e-14	1.09e-02	1.25e-07	4.57e-11	9.23e-05
GOCC CANONICAL INFLAMMASOME COMPLEX	16	7.21e-02	1.54e-01	0.3970	-2.91e-01	2.08e-01	7.06e-02	9.61e-03	1.50e-01	4.42e-02	4.37e-02	1.50e-01	6.25e-01	9.47e-01	2.98e-01	7.59e-01
GOBP POSITIVE REGULATION OF VOLTAGE GATED CALCIUM CHANNEL ACTIVITY	5	8.96e-01	9.14e-01	0.3970	2.21e-02	5.22e-02	-1.78e-01	-1.36e-01	-1.09e-01	-3.03e-01	9.32e-01	8.40e-01	4.90e-01	5.98e-01	6.72e-01	2.40e-01
GOBP DGMP METABOLIC PROCESS	5	8.87e-01	9.07e-01	0.3970	2.35e-01	-9.80e-04	1.75e-01	2.51e-01	8.74e-02	-2.93e-02	3.62e-01	9.97e-01	4.99e-01	3.31e-01	7.35e-01	9.10e-01
GOMF STRUCTURAL CONSTITUENT OF SKIN EPIDERMIS	9	7.24e-01	7.80e-01	0.3970	-3.08e-01	2.34e-02	7.08e-02	-1.58e-01	-9.19e-02	1.54e-01	1.09e-01	9.03e-01	7.13e-01	4.12e-01	6.33e-01	4.24e-01
GOBP REGULATION OF HAIR CYCLE	15	1.15e-01	2.17e-01	0.3970	-2.51e-01	1.91e-01	1.79e-01	-8.56e-02	1.24e-01	5.85e-02	9.26e-02	2.00e-01	2.30e-01	5.66e-01	4.08e-01	6.95e-01
GOBP NUCLEOSIDE MONOPHOSPHATE CATABOLIC PROCESS	16	2.62e-01	3.82e-01	0.3970	1.14e-01	-8.03e-02	2.57e-01	5.81e-03	3.21e-03	2.68e-01	4.29e-01	5.78e-01	7.49e-02	9.68e-01	9.82e-01	6.35e-02
GOBP EPITHELIAL STRUCTURE MAINTENANCE	21	3.42e-01	4.59e-01	0.3970	8.68e-02	1.07e-01	-1.15e-01	2.79e-01	1.97e-01	-9.21e-02	4.91e-01	3.97e-01	3.60e-01	2.71e-02	1.18e-01	4.65e-01
GOCC HISTONE DEACETYLASE COMPLEX	79	8.80e-06	7.51e-05	0.3970	8.42e-03	1.39e-01	2.71e-02	2.76e-01	2.46e-01	-2.23e-02	8.97e-01	3.32e-02	6.77e-01	2.21e-05	1.57e-04	7.32e-01
GOBP REGULATION OF NON CANONICAL WNT SIGNALING PATHWAY	19	3.85e-01	4.98e-01	0.3960	2.14e-01	1.42e-01	4.00e-02	2.69e-01	8.26e-02	-1.03e-01	1.06e-01	2.83e-01	7.63e-01	4.27e-02	5.33e-01	4.37e-01
GOBP MICROGLIAL CELL MEDIATED CYTOTOXICITY	5	9.07e-01	9.23e-01	0.3960	-4.37e-02	2.91e-01	1.79e-01	7.68e-02	8.50e-02	1.58e-01	8.65e-01	2.59e-01	4.88e-01	7.66e-01	7.42e-01	5.40e-01
GOMF 3 5 RNA HELICASE ACTIVITY	5	7.38e-01	7.91e-01	0.3960	-1.49e-01	1.62e-01	1.98e-01	2.31e-01	5.99e-02	1.13e-01	5.64e-01	5.31e-01	4.43e-01	3.71e-01	8.17e-01	6.62e-01
GOBP PROTEIN TARGETING TO VACUOLE	45	1.81e-04	1.15e-03	0.3960	-2.51e-01	-1.74e-02	9.77e-02	1.47e-01	-4.83e-02	2.46e-01	3.59e-03	8.40e-01	2.57e-01	8.90e-02	5.75e-01	4.29e-03
GOBP ADIPONECTIN ACTIVATED SIGNALING PATHWAY	7	7.92e-01	8.32e-01	0.3960	-2.35e-01	-3.79e-02	-5.72e-02	-1.35e-01	-2.07e-01	-1.89e-01	2.81e-01	8.62e-01	7.93e-01	5.35e-01	3.42e-01	3.86e-01
GOBP RETINA MORPHOGENESIS IN CAMERA TYPE EYE	38	2.22e-02	6.42e-02	0.3960	1.04e-01	2.87e-01	2.44e-01	6.65e-02	1.60e-04	6.54e-03	2.67e-01	2.24e-03	9.15e-03	4.78e-01	9.99e-01	9.44e-01
GOBP INTERMEDIATE FILAMENT ORGANIZATION	23	1.68e-01	2.81e-01	0.3960	-1.89e-01	1.24e-01	1.66e-01	-1.80e-01	-1.76e-01	1.23e-01	1.17e-01	3.02e-01	1.69e-01	1.35e-01	1.45e-01	3.06e-01
GOBP RESPONSE TO DIETARY EXCESS	22	2.04e-01	3.20e-01	0.3960	2.84e-02	1.44e-01	1.15e-01	1.41e-01	2.79e-01	1.58e-01	8.18e-01	2.43e-01	3.51e-01	2.53e-01	2.37e-02	2.00e-01
GOBP REGULATION OF SPINDLE CHECKPOINT	23	7.11e-02	1.53e-01	0.3960	1.36e-01	-1.94e-01	7.17e-02	2.65e-01	-1.73e-03	1.60e-01	2.58e-01	1.08e-01	5.52e-01	2.78e-02	9.89e-01	1.85e-01
GOBP REGULATION OF ATP BIOSYNTHETIC PROCESS	12	3.79e-01	4.93e-01	0.3960	9.67e-04	-2.88e-01	-7.13e-02	2.57e-01	4.94e-02	8.49e-03	9.95e-01	8.39e-02	6.69e-01	1.23e-01	7.67e-01	9.59e-01
GOBP NEGATIVE REGULATION OF HIPPO SIGNALING	21	4.07e-02	1.01e-01	0.3960	-1.22e-01	1.46e-01	2.70e-01	1.57e-01	-6.82e-02	1.35e-01	3.32e-01	2.47e-01	3.21e-02	2.13e-01	5.89e-01	2.83e-01
GOBP EMBRYONIC AXIS SPECIFICATION	26	6.17e-02	1.38e-01	0.3960	-1.29e-01	1.83e-01	1.39e-01	9.93e-02	1.22e-01	2.50e-01	2.55e-01	1.07e-01	2.21e-01	3.81e-01	2.80e-01	2.71e-02
GOBP ASTRAL MICROTUBULE ORGANIZATION	10	6.41e-01	7.15e-01	0.3960	-7.14e-03	2.21e-01	2.56e-01	3.65e-02	-1.38e-01	1.49e-01	9.69e-01	2.26e-01	1.62e-01	8.42e-01	4.49e-01	4.16e-01
GOBP PROTEIN LOCALIZATION TO SITE OF DOUBLE STRAND BREAK	15	2.42e-01	3.60e-01	0.3960	-9.38e-02	-4.89e-02	-2.48e-01	2.53e-01	1.34e-01	4.51e-02	5.29e-01	7.43e-01	9.62e-02	9.03e-02	3.67e-01	7.62e-01
GOBP CELLULAR PIGMENTATION	56	2.48e-04	1.52e-03	0.3960	-2.84e-01	-1.22e-01	1.07e-01	4.54e-03	-2.62e-02	2.21e-01	2.39e-04	1.14e-01	1.65e-01	9.53e-01	7.34e-01	4.18e-03
GOBP POSITIVE REGULATION OF TELOMERE MAINTENANCE VIA TELOMERE LENGTHENING	36	1.79e-02	5.41e-02	0.3960	-2.60e-01	-2.12e-01	-1.66e-01	5.89e-02	-8.51e-02	7.62e-02	6.97e-03	2.77e-02	8.45e-02	5.41e-01	3.77e-01	4.29e-01
GOBP REGULATION OF T CELL CHEMOTAXIS	11	6.72e-01	7.39e-01	0.3960	9.80e-02	-7.09e-02	2.11e-01	6.79e-02	-1.28e-01	2.76e-01	5.74e-01	6.84e-01	2.26e-01	6.97e-01	4.62e-01	1.12e-01
GOBP POSITIVE REGULATION OF DENDRITIC CELL ANTIGEN PROCESSING AND PRESENTATION	5	5.85e-01	6.70e-01	0.3950	3.05e-03	9.12e-02	1.65e-01	2.34e-01	1.32e-01	-2.21e-01	9.91e-01	7.24e-01	5.23e-01	3.65e-01	6.08e-01	3.93e-01
GOBP FACE DEVELOPMENT	38	3.98e-02	9.92e-02	0.3950	-1.54e-02	9.52e-02	2.86e-01	2.80e-02	-1.70e-01	1.88e-01	8.70e-01	3.10e-01	2.26e-03	7.65e-01	6.91e-02	4.50e-02
GOCC RAGULATOR COMPLEX	6	7.88e-01	8.29e-01	0.3950	-2.32e-01	-1.87e-01	1.66e-02	-7.68e-02	9.75e-02	2.28e-01	3.26e-01	4.28e-01	9.44e-01	7.45e-01	6.79e-01	3.33e-01
GOBP RESPONSE TO PROGESTERONE	31	2.66e-03	1.17e-02	0.3950	-2.73e-01	5.20e-02	2.36e-01	6.89e-03	-1.10e-01	1.06e-01	8.48e-03	6.16e-01	2.30e-02	9.47e-01	2.90e-01	3.07e-01
GOBP RESPONSE TO INTERLEUKIN 7	16	2.95e-01	4.14e-01	0.3950	-8.05e-02	-1.85e-01	1.16e-01	1.65e-01	-8.93e-02	2.58e-01	5.77e-01	2.00e-01	4.21e-01	2.52e-01	5.36e-01	7.35e-02
GOBP HEPARIN METABOLIC PROCESS	13	2.87e-01	4.06e-01	0.3950	-3.65e-01	-1.53e-02	-1.29e-01	-2.92e-02	-7.17e-02	8.01e-04	2.26e-02	9.24e-01	4.20e-01	8.55e-01	6.55e-01	9.96e-01
GOMF TESTOSTERONE DEHYDROGENASE NADPLUS ACTIVITY	6	6.12e-01	6.91e-01	0.3950	3.85e-01	-6.27e-02	-2.25e-02	-7.32e-03	5.17e-02	-2.96e-02	1.03e-01	7.90e-01	9.24e-01	9.75e-01	8.26e-01	9.00e-01
GOBP ANTEROGRADE NEURONAL DENSE CORE VESICLE TRANSPORT	6	7.12e-01	7.71e-01	0.3950	1.09e-01	3.31e-01	3.95e-02	-1.24e-01	-1.05e-01	-8.25e-02	6.44e-01	1.60e-01	8.67e-01	5.99e-01	6.56e-01	7.27e-01
GOBP NEUTROPHIL CHEMOTAXIS	69	1.17e-05	9.72e-05	0.3950	-4.79e-02	1.19e-01	3.45e-01	-8.15e-02	-3.26e-02	1.14e-01	4.91e-01	8.68e-02	7.38e-07	2.42e-01	6.40e-01	1.01e-01
GOBP POSITIVE REGULATION OF GLIAL CELL MIGRATION	9	7.86e-01	8.28e-01	0.3950	2.43e-01	2.52e-01	1.21e-01	8.89e-02	1.08e-02	-1.05e-01	2.07e-01	1.91e-01	5.31e-01	6.44e-01	9.55e-01	5.87e-01
GOBP RESPONSE TO ACIDIC PH	17	9.11e-02	1.83e-01	0.3950	-1.34e-01	-1.15e-01	3.04e-02	2.09e-01	2.52e-01	1.28e-01	3.40e-01	4.13e-01	8.28e-01	1.35e-01	7.16e-02	3.60e-01
GOBP POSITIVE REGULATION OF DNA DAMAGE RESPONSE SIGNAL TRANSDUCTION BY P53 CLASS MEDIATOR	14	2.02e-01	3.18e-01	0.3950	-2.01e-01	-1.76e-02	-8.22e-02	-7.53e-02	2.93e-01	1.30e-01	1.93e-01	9.09e-01	5.94e-01	6.26e-01	5.78e-02	4.01e-01
GOBP EMBRYONIC PLACENTA DEVELOPMENT	62	5.71e-06	5.12e-05	0.3950	-9.69e-02	1.28e-01	3.32e-01	5.89e-02	-3.67e-02	1.22e-01	1.87e-01	8.15e-02	6.11e-06	4.23e-01	6.17e-01	9.63e-02
GOBP SARCOPLASMIC RETICULUM CALCIUM ION TRANSPORT	30	1.24e-01	2.29e-01	0.3950	-1.02e-01	-3.87e-02	2.56e-01	-6.17e-03	-1.54e-01	2.33e-01	3.33e-01	7.14e-01	1.51e-02	9.53e-01	1.44e-01	2.70e-02
GOMF HISTONE H3 KINASE ACTIVITY	11	4.04e-01	5.15e-01	0.3950	-1.59e-01	-2.63e-01	2.88e-02	8.70e-02	7.98e-02	2.16e-01	3.61e-01	1.32e-01	8.69e-01	6.17e-01	6.47e-01	2.14e-01
GOMF NUCLEAR LOCALIZATION SEQUENCE BINDING	23	2.34e-03	1.05e-02	0.3950	-3.15e-01	8.48e-02	-3.74e-02	1.83e-01	-1.66e-02	1.19e-01	8.89e-03	4.81e-01	7.56e-01	1.30e-01	8.90e-01	3.23e-01
GOBP CYTOKINE PRODUCTION INVOLVED IN INFLAMMATORY RESPONSE	46	4.48e-06	4.12e-05	0.3950	-1.60e-01	2.18e-01	4.77e-02	1.48e-01	2.01e-01	-1.34e-01	5.99e-02	1.07e-02	5.75e-01	8.20e-02	1.83e-02	1.16e-01
GOBP CARDIOLIPIN BIOSYNTHETIC PROCESS	7	7.60e-01	8.07e-01	0.3940	1.10e-01	-2.49e-01	-1.05e-01	2.39e-01	-1.34e-02	-1.16e-01	6.14e-01	2.54e-01	6.32e-01	2.74e-01	9.51e-01	5.95e-01
GOMF MICROTUBULE PLUS END BINDING	21	5.53e-02	1.27e-01	0.3940	-1.60e-01	5.45e-02	2.21e-01	1.47e-01	-1.44e-01	1.89e-01	2.04e-01	6.65e-01	7.90e-02	2.45e-01	2.53e-01	1.34e-01
GOMF UBIQUITIN UBIQUITIN LIGASE ACTIVITY	14	1.97e-01	3.13e-01	0.3940	-2.59e-01	-1.36e-01	-1.13e-01	9.24e-02	-2.20e-01	-1.08e-02	9.31e-02	3.79e-01	4.64e-01	5.49e-01	1.54e-01	9.44e-01
GOBP POSITIVE REGULATION OF CENTRIOLE ELONGATION	5	6.63e-01	7.32e-01	0.3940	-1.55e-02	2.63e-01	-1.89e-01	1.16e-01	1.45e-01	1.26e-01	9.52e-01	3.09e-01	4.63e-01	6.54e-01	5.75e-01	6.25e-01
GOBP POSITIVE REGULATION OF ANIMAL ORGAN MORPHOGENESIS	18	3.63e-01	4.79e-01	0.3940	-4.14e-02	2.32e-02	2.79e-01	-1.98e-01	-1.13e-01	1.53e-01	7.61e-01	8.65e-01	4.01e-02	1.46e-01	4.08e-01	2.62e-01
GOCC GLIAL CELL PROJECTION	25	7.55e-02	1.60e-01	0.3940	-1.79e-01	7.46e-02	1.30e-01	4.44e-02	-1.77e-02	3.14e-01	1.22e-01	5.19e-01	2.60e-01	7.01e-01	8.79e-01	6.53e-03
GOBP REGULATION OF CELLULAR EXTRAVASATION	33	3.83e-03	1.58e-02	0.3940	-1.72e-01	4.26e-02	2.91e-01	8.83e-02	-5.15e-02	1.70e-01	8.74e-02	6.72e-01	3.83e-03	3.80e-01	6.09e-01	9.06e-02
GOMF NUCLEOBASE CONTAINING COMPOUND TRANSMEMBRANE TRANSPORTER ACTIVITY	50	9.93e-03	3.41e-02	0.3940	-1.94e-01	-2.46e-01	-1.11e-01	-4.02e-02	-1.31e-01	-1.62e-01	1.77e-02	2.67e-03	1.75e-01	6.23e-01	1.08e-01	4.69e-02
GOMF PHOSPHOLIPASE A1 ACTIVITY	14	4.17e-01	5.27e-01	0.3940	1.55e-02	-2.55e-01	-3.97e-02	-1.79e-01	-1.78e-01	-1.58e-01	9.20e-01	9.87e-02	7.97e-01	2.47e-01	2.50e-01	3.05e-01
GOBP POSITIVE REGULATION OF ANTIGEN PROCESSING AND PRESENTATION	6	4.24e-01	5.33e-01	0.3940	-2.45e-02	-6.34e-03	1.44e-01	2.75e-01	1.51e-01	-1.88e-01	9.17e-01	9.79e-01	5.40e-01	2.43e-01	5.23e-01	4.25e-01
GOCC RADIAL SPOKE	6	7.69e-01	8.14e-01	0.3940	-6.09e-02	2.75e-01	2.73e-01	-3.38e-02	-1.20e-02	4.87e-03	7.96e-01	2.43e-01	2.47e-01	8.86e-01	9.59e-01	9.84e-01
GOBP T CELL MEDIATED IMMUNE RESPONSE TO TUMOR CELL	11	6.66e-01	7.34e-01	0.3940	-2.56e-01	-2.04e-01	-2.07e-01	8.87e-04	-5.48e-02	4.64e-02	1.41e-01	2.41e-01	2.35e-01	9.96e-01	7.53e-01	7.90e-01
GOBP REGULATION OF NON MOTILE CILIUM ASSEMBLY	9	8.37e-01	8.68e-01	0.3940	1.44e-01	1.77e-01	-9.75e-02	1.62e-01	2.59e-01	1.73e-02	4.54e-01	3.59e-01	6.12e-01	3.99e-01	1.79e-01	9.28e-01
GOBP GENOMIC IMPRINTING	14	6.12e-01	6.91e-01	0.3940	8.71e-02	1.65e-01	1.02e-01	1.66e-01	2.67e-01	1.04e-01	5.73e-01	2.84e-01	5.07e-01	2.82e-01	8.36e-02	5.00e-01
GOBP TETRAPYRROLE BIOSYNTHETIC PROCESS	33	5.52e-02	1.27e-01	0.3940	-4.35e-02	-3.11e-01	-2.16e-01	4.43e-02	8.13e-03	-8.90e-02	6.66e-01	2.01e-03	3.17e-02	6.60e-01	9.36e-01	3.76e-01
GOBP TELOMERE MAINTENANCE VIA RECOMBINATION	14	3.53e-01	4.68e-01	0.3940	-9.73e-03	-9.35e-02	-2.19e-01	1.61e-01	2.50e-01	9.93e-02	9.50e-01	5.45e-01	1.57e-01	2.98e-01	1.05e-01	5.20e-01
GOBP POSITIVE REGULATION OF CHROMATIN ORGANIZATION	14	4.52e-01	5.58e-01	0.3940	9.44e-02	5.53e-02	-8.02e-03	2.97e-01	1.30e-01	1.95e-01	5.41e-01	7.20e-01	9.59e-01	5.47e-02	3.99e-01	2.07e-01
GOBP POSITIVE REGULATION OF INTERLEUKIN 2 PRODUCTION	32	7.71e-03	2.80e-02	0.3940	-4.49e-02	2.25e-01	1.21e-01	1.96e-01	2.21e-01	-2.68e-02	6.60e-01	2.78e-02	2.37e-01	5.55e-02	3.05e-02	7.93e-01
GOBP PROTEIN LOCALIZATION TO MITOCHONDRION	122	6.68e-08	8.37e-07	0.3940	-1.76e-01	-3.10e-01	-1.54e-01	5.54e-02	-3.32e-02	1.48e-02	7.94e-04	3.37e-09	3.39e-03	2.91e-01	5.27e-01	7.78e-01
GOCC SYNAPTIC CLEFT	10	4.74e-01	5.76e-01	0.3930	1.95e-01	-1.21e-01	-3.52e-03	8.73e-02	-2.34e-01	-2.00e-01	2.87e-01	5.09e-01	9.85e-01	6.33e-01	2.00e-01	2.74e-01
GOBP REGULATION OF SECONDARY METABOLIC PROCESS	11	2.24e-01	3.43e-01	0.3930	-2.17e-01	4.74e-03	8.90e-03	2.79e-01	1.71e-01	2.10e-02	2.13e-01	9.78e-01	9.59e-01	1.09e-01	3.27e-01	9.04e-01
GOBP POSITIVE REGULATION OF NON MOTILE CILIUM ASSEMBLY	6	8.65e-01	8.90e-01	0.3930	-4.33e-02	8.86e-02	-2.48e-02	1.75e-01	3.25e-01	8.96e-02	8.54e-01	7.07e-01	9.16e-01	4.58e-01	1.68e-01	7.04e-01
GOBP PYRIMIDINE RIBONUCLEOTIDE CATABOLIC PROCESS	7	6.94e-01	7.57e-01	0.3930	-2.63e-01	-7.29e-02	1.10e-01	4.53e-02	1.03e-01	2.36e-01	2.29e-01	7.38e-01	6.15e-01	8.36e-01	6.37e-01	2.80e-01
GOMF MONOATOMIC CATION BICARBONATE SYMPORTER ACTIVITY	11	9.44e-02	1.88e-01	0.3930	1.16e-02	3.62e-01	-4.25e-02	8.95e-02	-4.88e-02	1.07e-01	9.47e-01	3.78e-02	8.07e-01	6.07e-01	7.79e-01	5.39e-01
GOBP ISOTYPE SWITCHING TO IGG ISOTYPES	15	2.13e-01	3.31e-01	0.3930	-5.40e-02	-7.29e-02	-4.97e-02	2.66e-01	6.37e-02	2.63e-01	7.17e-01	6.25e-01	7.39e-01	7.48e-02	6.69e-01	7.78e-02
GOBP NEGATIVE REGULATION OF ATP DEPENDENT ACTIVITY	13	5.43e-01	6.33e-01	0.3930	-2.73e-02	1.47e-01	-1.91e-01	1.77e-01	2.50e-01	-4.58e-02	8.65e-01	3.60e-01	2.33e-01	2.70e-01	1.19e-01	7.75e-01
GOBP FATTY ACID DERIVATIVE CATABOLIC PROCESS	16	1.31e-01	2.38e-01	0.3930	5.64e-02	-2.95e-01	1.42e-01	1.51e-01	-1.40e-01	3.98e-02	6.96e-01	4.10e-02	3.25e-01	2.96e-01	3.33e-01	7.83e-01
GOBP REGULATION OF SMALL GTPASE MEDIATED SIGNAL TRANSDUCTION	263	1.37e-18	5.05e-17	0.3930	8.73e-02	1.96e-01	2.08e-01	2.33e-01	6.89e-02	7.69e-02	1.48e-02	4.37e-08	6.63e-09	7.10e-11	5.44e-02	3.19e-02
GOBP PROTEIN TARGETING TO MITOCHONDRION	101	1.95e-06	1.94e-05	0.3930	-1.52e-01	-3.16e-01	-1.62e-01	6.42e-02	-3.56e-02	3.17e-03	8.46e-03	4.13e-08	4.99e-03	2.65e-01	5.37e-01	9.56e-01
GOBP NOSE DEVELOPMENT	7	6.84e-01	7.49e-01	0.3930	7.50e-02	2.23e-01	1.36e-01	3.27e-02	-1.41e-01	2.43e-01	7.31e-01	3.06e-01	5.33e-01	8.81e-01	5.17e-01	2.65e-01
GOBP EGG ACTIVATION	6	5.86e-01	6.70e-01	0.3930	2.12e-01	-1.00e-01	1.06e-01	-8.95e-02	-5.62e-02	-2.78e-01	3.70e-01	6.71e-01	6.54e-01	7.04e-01	8.12e-01	2.39e-01
GOCC SET1C COMPASS COMPLEX	13	3.41e-01	4.58e-01	0.3930	1.08e-01	-6.68e-02	-1.11e-01	3.25e-01	5.65e-02	1.30e-01	4.99e-01	6.77e-01	4.88e-01	4.26e-02	7.24e-01	4.18e-01
GOBP INTEGRIN MEDIATED SIGNALING PATHWAY	96	1.32e-06	1.35e-05	0.3920	-4.69e-02	-1.01e-02	3.02e-01	6.99e-02	-7.07e-02	2.25e-01	4.27e-01	8.64e-01	3.15e-07	2.37e-01	2.31e-01	1.39e-04
GOMF ORGANOPHOSPHATE PHOSPHATE ANTIPORTER ACTIVITY	7	4.27e-01	5.36e-01	0.3920	9.76e-02	7.00e-02	1.48e-01	6.14e-02	3.11e-02	-3.36e-01	6.55e-01	7.49e-01	4.97e-01	7.78e-01	8.87e-01	1.24e-01
GOMF MHC CLASS I PROTEIN BINDING	20	2.43e-02	6.87e-02	0.3920	-7.59e-02	-2.09e-02	-4.70e-02	2.27e-01	-5.18e-02	3.02e-01	5.57e-01	8.72e-01	7.16e-01	7.83e-02	6.89e-01	1.94e-02
GOMF CELL CELL ADHESION MEDIATOR ACTIVITY	33	2.60e-02	7.23e-02	0.3920	-1.77e-01	-1.48e-01	1.94e-01	-1.95e-01	-9.32e-02	1.28e-01	7.93e-02	1.41e-01	5.36e-02	5.29e-02	3.54e-01	2.04e-01
GOBP NEGATIVE REGULATION OF ACTIN FILAMENT BUNDLE ASSEMBLY	26	4.20e-02	1.03e-01	0.3920	-3.62e-02	8.08e-02	2.11e-01	1.27e-01	-2.15e-01	1.97e-01	7.49e-01	4.76e-01	6.23e-02	2.62e-01	5.76e-02	8.18e-02
GOBP NEURONAL SIGNAL TRANSDUCTION	5	7.87e-01	8.29e-01	0.3920	2.97e-01	2.60e-02	5.73e-02	2.09e-02	1.99e-01	1.48e-01	2.51e-01	9.20e-01	8.24e-01	9.36e-01	4.42e-01	5.66e-01
GOMF LNCRNA BINDING	16	2.82e-02	7.65e-02	0.3920	-1.45e-01	1.37e-01	-1.30e-02	3.22e-01	-3.44e-03	1.00e-01	3.15e-01	3.43e-01	9.28e-01	2.57e-02	9.81e-01	4.88e-01
GOBP REGULATION OF PROTEIN CATABOLIC PROCESS IN THE VACUOLE	12	1.91e-01	3.06e-01	0.3920	-7.62e-02	-1.03e-01	3.32e-01	9.97e-02	-4.08e-02	1.24e-01	6.48e-01	5.37e-01	4.63e-02	5.50e-01	8.07e-01	4.57e-01
GOBP REGULATION OF BASEMENT MEMBRANE ORGANIZATION	11	4.70e-01	5.73e-01	0.3920	-1.21e-01	2.66e-01	1.69e-01	-1.97e-01	-1.71e-02	-1.02e-02	4.87e-01	1.26e-01	3.31e-01	2.57e-01	9.22e-01	9.53e-01
GOBP SMOOTH MUSCLE CELL MATRIX ADHESION	5	6.44e-01	7.18e-01	0.3920	1.96e-01	-9.53e-02	1.13e-01	5.64e-02	3.01e-02	-2.99e-01	4.48e-01	7.12e-01	6.61e-01	8.27e-01	9.07e-01	2.47e-01
GOBP REGULATION OF CELL SUBSTRATE JUNCTION ORGANIZATION	56	1.35e-05	1.11e-04	0.3920	-2.37e-01	-3.67e-02	2.48e-01	-1.32e-02	-1.68e-01	7.95e-02	2.15e-03	6.35e-01	1.35e-03	8.64e-01	2.95e-02	3.03e-01
GOBP SULFUR AMINO ACID METABOLIC PROCESS	24	2.65e-01	3.85e-01	0.3920	-2.16e-01	-2.54e-01	-2.04e-01	-1.88e-02	9.72e-04	7.07e-03	6.68e-02	3.09e-02	8.31e-02	8.73e-01	9.93e-01	9.52e-01
GOBP PORPHYRIN CONTAINING COMPOUND METABOLIC PROCESS	47	8.20e-04	4.30e-03	0.3920	-1.39e-02	-3.39e-01	-1.32e-01	4.54e-02	1.30e-02	-1.37e-01	8.69e-01	5.73e-05	1.17e-01	5.90e-01	8.78e-01	1.05e-01
GOBP POSITIVE REGULATION OF VIRAL GENOME REPLICATION	29	2.78e-02	7.58e-02	0.3920	-5.94e-02	-3.24e-02	5.81e-02	2.44e-01	3.81e-02	2.91e-01	5.80e-01	7.63e-01	5.88e-01	2.32e-02	7.23e-01	6.62e-03
GOBP POSITIVE REGULATION OF MONOCYTE EXTRAVASATION	5	5.03e-01	5.99e-01	0.3920	-2.16e-01	2.38e-01	-2.58e-02	8.79e-02	-1.17e-01	-1.68e-01	4.02e-01	3.57e-01	9.20e-01	7.34e-01	6.51e-01	5.16e-01
GOCC ALVEOLAR LAMELLAR BODY	7	7.30e-01	7.84e-01	0.3920	2.27e-01	1.24e-01	2.01e-01	4.00e-02	-1.19e-01	-1.74e-01	2.98e-01	5.71e-01	3.56e-01	8.55e-01	5.86e-01	4.26e-01
GOBP POSITIVE REGULATION OF MRNA PROCESSING	30	1.62e-01	2.75e-01	0.3920	-1.99e-01	-2.34e-01	-2.01e-01	1.87e-02	-8.22e-02	-1.08e-01	5.94e-02	2.65e-02	5.68e-02	8.59e-01	4.36e-01	3.07e-01
GOBP ALCOHOL CATABOLIC PROCESS	25	8.56e-02	1.75e-01	0.3920	-2.55e-01	-2.78e-02	-2.14e-01	2.51e-02	4.69e-02	-1.97e-01	2.74e-02	8.10e-01	6.36e-02	8.28e-01	6.85e-01	8.79e-02
GOBP POSITIVE REGULATION OF GLOMERULAR MESANGIAL CELL PROLIFERATION	6	7.83e-01	8.25e-01	0.3920	-2.60e-01	1.35e-01	-3.56e-02	-2.18e-01	-7.38e-02	1.14e-01	2.69e-01	5.66e-01	8.80e-01	3.55e-01	7.54e-01	6.29e-01
GOBP INTRACELLULAR POTASSIUM ION HOMEOSTASIS	11	6.36e-01	7.11e-01	0.3920	1.62e-01	9.79e-02	1.63e-01	2.94e-01	-1.64e-02	6.39e-02	3.53e-01	5.74e-01	3.49e-01	9.10e-02	9.25e-01	7.14e-01
GOCC RNA POLYMERASE II TRANSCRIPTION REPRESSOR COMPLEX	13	5.56e-01	6.45e-01	0.3920	-2.45e-01	-1.64e-01	8.20e-02	-4.21e-02	-2.34e-01	5.59e-02	1.26e-01	3.07e-01	6.09e-01	7.93e-01	1.44e-01	7.27e-01
GOCC CILIARY TIP	39	1.55e-02	4.84e-02	0.3920	-7.76e-02	5.28e-02	-2.31e-01	1.03e-02	2.97e-01	-5.17e-02	4.02e-01	5.68e-01	1.25e-02	9.12e-01	1.33e-03	5.76e-01
GOBP NEGATIVE REGULATION OF CHROMOSOME ORGANIZATION	94	5.30e-08	6.72e-07	0.3910	4.29e-02	-1.29e-01	1.94e-02	2.83e-01	4.28e-02	2.29e-01	4.72e-01	3.07e-02	7.45e-01	2.16e-06	4.73e-01	1.21e-04
GOBP CELLULAR RESPONSE TO ETHER	6	3.50e-01	4.66e-01	0.3910	-1.99e-01	1.48e-01	1.87e-01	-8.18e-03	9.32e-02	-2.20e-01	3.99e-01	5.31e-01	4.28e-01	9.72e-01	6.92e-01	3.52e-01
GOCC EXOCYST	15	2.11e-01	3.29e-01	0.3910	-2.87e-01	7.49e-02	8.41e-03	1.64e-02	1.47e-01	2.09e-01	5.46e-02	6.15e-01	9.55e-01	9.13e-01	3.25e-01	1.62e-01
GOBP VASCULAR ENDOTHELIAL GROWTH FACTOR PRODUCTION	29	1.49e-03	7.15e-03	0.3910	-3.08e-01	2.01e-01	3.48e-02	-8.26e-02	3.37e-02	-9.31e-02	4.12e-03	6.09e-02	7.46e-01	4.41e-01	7.54e-01	3.86e-01
GOMF SNAP RECEPTOR ACTIVITY	35	1.36e-02	4.40e-02	0.3910	-1.45e-01	-2.81e-01	-1.82e-01	-1.53e-02	3.55e-02	1.36e-01	1.38e-01	4.03e-03	6.21e-02	8.76e-01	7.16e-01	1.65e-01
GOBP SIGNAL TRANSDUCTION INVOLVED IN REGULATION OF GENE EXPRESSION	13	5.09e-01	6.04e-01	0.3910	-4.05e-02	-2.47e-01	1.59e-01	2.58e-02	-1.72e-01	1.87e-01	8.00e-01	1.23e-01	3.22e-01	8.72e-01	2.83e-01	2.44e-01
GOBP HORMONE CATABOLIC PROCESS	6	8.83e-01	9.04e-01	0.3910	-1.78e-01	-2.11e-02	-2.90e-03	-3.28e-01	-6.30e-02	9.69e-02	4.50e-01	9.29e-01	9.90e-01	1.65e-01	7.89e-01	6.81e-01
GOMF FILAMIN BINDING	10	3.16e-01	4.36e-01	0.3910	-2.75e-01	3.50e-02	-4.81e-03	2.18e-01	1.09e-01	1.29e-01	1.33e-01	8.48e-01	9.79e-01	2.32e-01	5.52e-01	4.79e-01
GOMF PHOSPHOLIPID TRANSPORTER ACTIVITY	55	1.32e-03	6.45e-03	0.3910	3.21e-02	1.66e-01	9.15e-02	2.87e-01	1.22e-01	1.35e-01	6.80e-01	3.31e-02	2.40e-01	2.28e-04	1.16e-01	8.44e-02
GOBP ERAD PATHWAY	105	3.31e-08	4.33e-07	0.3910	-2.63e-01	-1.80e-01	5.10e-02	6.14e-02	-1.18e-01	1.75e-01	3.15e-06	1.46e-03	3.67e-01	2.77e-01	3.62e-02	1.93e-03
GOBP REGULATION OF TOLL LIKE RECEPTOR 3 SIGNALING PATHWAY	13	2.55e-01	3.75e-01	0.3910	-3.59e-01	7.44e-02	-1.13e-02	-6.81e-02	-7.32e-02	8.95e-02	2.50e-02	6.42e-01	9.44e-01	6.71e-01	6.47e-01	5.76e-01
GOBP MAINTENANCE OF SYNAPSE STRUCTURE	19	5.05e-02	1.18e-01	0.3910	6.51e-03	2.12e-02	3.05e-01	2.16e-01	-1.00e-01	4.69e-02	9.61e-01	8.73e-01	2.13e-02	1.03e-01	4.48e-01	7.23e-01
GOBP INNER EAR RECEPTOR CELL STEREOCILIUM ORGANIZATION	27	4.41e-02	1.07e-01	0.3910	-1.22e-01	1.51e-01	-1.09e-01	-1.12e-01	1.63e-01	-2.53e-01	2.72e-01	1.73e-01	3.27e-01	3.13e-01	1.43e-01	2.31e-02
GOBP NUCLEOSIDE TRIPHOSPHATE METABOLIC PROCESS	239	4.03e-19	1.59e-17	0.3910	-1.21e-01	-3.46e-01	-7.09e-02	7.29e-02	-7.86e-02	4.27e-02	1.28e-03	3.08e-20	5.90e-02	5.22e-02	3.65e-02	2.56e-01
GOBP DISTAL TUBULE DEVELOPMENT	7	7.75e-01	8.19e-01	0.3910	3.39e-03	1.57e-01	-5.36e-02	1.28e-01	2.03e-01	-2.60e-01	9.88e-01	4.71e-01	8.06e-01	5.56e-01	3.54e-01	2.34e-01
GOBP SISTER CHROMATID SEGREGATION	224	3.42e-20	1.47e-18	0.3900	1.08e-02	-1.63e-01	9.53e-02	2.44e-01	-2.44e-02	2.38e-01	7.81e-01	2.57e-05	1.40e-02	3.28e-10	5.29e-01	8.20e-10
GOMF INTRONIC TRANSCRIPTION REGULATORY REGION SEQUENCE SPECIFIC DNA BINDING	7	8.25e-01	8.59e-01	0.3900	-1.73e-01	-1.05e-01	-1.01e-01	-2.24e-01	-1.89e-01	1.25e-01	4.27e-01	6.30e-01	6.44e-01	3.06e-01	3.87e-01	5.67e-01
GOMF ANNEALING ACTIVITY	10	7.23e-01	7.80e-01	0.3900	1.37e-01	-2.95e-02	1.54e-01	2.14e-01	6.58e-02	2.43e-01	4.55e-01	8.71e-01	4.00e-01	2.40e-01	7.19e-01	1.84e-01
GOBP NUCLEIC ACID CATABOLIC PROCESS	660	6.01e-46	1.46e-43	0.3900	-1.01e-01	-2.87e-01	-2.22e-01	9.05e-02	-1.14e-02	-4.64e-02	8.84e-06	2.66e-36	2.13e-22	7.35e-05	6.18e-01	4.23e-02
GOCC DENSE CORE GRANULE	17	1.31e-01	2.38e-01	0.3900	-1.80e-01	2.86e-01	2.02e-02	-2.04e-02	1.92e-01	2.14e-03	1.98e-01	4.10e-02	8.85e-01	8.84e-01	1.70e-01	9.88e-01
GOBP REGULATION OF ANTIGEN RECEPTOR MEDIATED SIGNALING PATHWAY	66	1.81e-03	8.41e-03	0.3900	1.19e-01	1.78e-01	1.20e-01	2.11e-01	7.68e-02	2.03e-01	9.39e-02	1.23e-02	9.08e-02	3.01e-03	2.81e-01	4.27e-03
GOBP MAINTENANCE OF PROTEIN LOCALIZATION IN ORGANELLE	39	6.82e-03	2.53e-02	0.3900	-1.95e-01	-2.41e-01	5.22e-02	1.13e-01	-7.99e-02	1.85e-01	3.49e-02	9.11e-03	5.73e-01	2.24e-01	3.88e-01	4.57e-02
GOBP MYELOID CELL ACTIVATION INVOLVED IN IMMUNE RESPONSE	86	4.92e-05	3.58e-04	0.3900	-2.37e-02	1.11e-01	2.82e-01	8.51e-02	1.01e-02	2.29e-01	7.03e-01	7.42e-02	6.33e-06	1.73e-01	8.71e-01	2.35e-04
GOMF NUCLEAR VITAMIN D RECEPTOR BINDING	15	4.41e-01	5.48e-01	0.3900	6.71e-03	1.75e-01	1.70e-01	2.03e-01	3.45e-02	2.24e-01	9.64e-01	2.41e-01	2.55e-01	1.73e-01	8.17e-01	1.33e-01
GOBP NUCLEOTIDE TRANSPORT	41	1.05e-01	2.02e-01	0.3900	-1.98e-01	-2.23e-01	-1.28e-01	-1.00e-01	-1.60e-01	-1.07e-01	2.86e-02	1.35e-02	1.56e-01	2.68e-01	7.62e-02	2.38e-01
GOBP REGULATION OF INCLUSION BODY ASSEMBLY	14	3.22e-01	4.41e-01	0.3900	3.00e-02	-7.96e-02	2.52e-01	2.18e-01	-1.13e-01	1.44e-01	8.46e-01	6.06e-01	1.02e-01	1.57e-01	4.62e-01	3.51e-01
GOMF PROTEASE BINDING	113	2.32e-07	2.68e-06	0.3900	-1.58e-01	-8.91e-02	2.27e-01	-4.87e-02	-2.21e-01	1.29e-01	3.62e-03	1.02e-01	3.19e-05	3.72e-01	5.03e-05	1.80e-02
GOMF SOLUTE SODIUM SYMPORTER ACTIVITY	46	3.22e-02	8.42e-02	0.3900	2.34e-01	2.11e-01	1.87e-01	1.28e-01	-2.50e-02	3.28e-02	6.12e-03	1.35e-02	2.80e-02	1.34e-01	7.70e-01	7.00e-01
GOBP LEUKOTRIENE BIOSYNTHETIC PROCESS	13	4.44e-01	5.51e-01	0.3900	-6.40e-02	1.09e-01	3.10e-01	-1.57e-01	-2.61e-02	1.18e-01	6.90e-01	4.94e-01	5.26e-02	3.26e-01	8.70e-01	4.60e-01
GOBP REGULATION OF RECEPTOR LOCALIZATION TO SYNAPSE	19	3.56e-01	4.72e-01	0.3900	-1.78e-01	-1.93e-01	6.72e-03	-6.81e-02	-2.69e-01	-7.56e-02	1.78e-01	1.44e-01	9.60e-01	6.07e-01	4.26e-02	5.68e-01
GOBP AZOLE TRANSMEMBRANE TRANSPORT	11	2.58e-01	3.78e-01	0.3900	-1.09e-01	-1.68e-01	-1.62e-02	1.88e-01	-2.20e-01	-1.67e-01	5.32e-01	3.34e-01	9.26e-01	2.81e-01	2.06e-01	3.39e-01
GOBP POSITIVE REGULATION OF RECEPTOR MEDIATED ENDOCYTOSIS	40	8.77e-03	3.09e-02	0.3900	-1.76e-01	-9.67e-03	2.03e-01	5.25e-02	-1.70e-01	2.19e-01	5.45e-02	9.16e-01	2.64e-02	5.66e-01	6.30e-02	1.64e-02
GOBP CHITIN METABOLIC PROCESS	5	8.94e-01	9.13e-01	0.3900	2.57e-01	8.43e-02	1.06e-01	2.29e-01	-1.23e-01	6.17e-03	3.20e-01	7.44e-01	6.81e-01	3.76e-01	6.34e-01	9.81e-01
GOMF CHITINASE ACTIVITY	5	8.94e-01	9.13e-01	0.3900	2.57e-01	8.43e-02	1.06e-01	2.29e-01	-1.23e-01	6.17e-03	3.20e-01	7.44e-01	6.81e-01	3.76e-01	6.34e-01	9.81e-01
GOBP TRANSCRIPTION BY RNA POLYMERASE I	70	5.49e-06	4.95e-05	0.3890	-8.81e-02	-2.53e-01	-9.85e-02	1.42e-01	-1.16e-01	-1.92e-01	2.03e-01	2.56e-04	1.54e-01	4.01e-02	9.22e-02	5.58e-03
GOMF DNA DIRECTED DNA POLYMERASE ACTIVITY	22	3.06e-01	4.26e-01	0.3890	-1.60e-01	-1.90e-01	-2.40e-01	1.63e-02	1.36e-01	-1.16e-01	1.94e-01	1.23e-01	5.15e-02	8.95e-01	2.69e-01	3.44e-01
GOBP RESPONSE TO ZINC ION STARVATION	8	7.04e-01	7.64e-01	0.3890	-1.07e-02	3.42e-01	6.45e-02	-8.63e-02	1.27e-01	-8.16e-02	9.58e-01	9.40e-02	7.52e-01	6.73e-01	5.34e-01	6.89e-01
GOBP REGULATION OF PEPTIDYL THREONINE PHOSPHORYLATION	36	6.98e-04	3.74e-03	0.3890	-1.40e-02	-1.47e-01	1.43e-01	2.61e-01	-1.99e-01	3.77e-02	8.85e-01	1.26e-01	1.38e-01	6.71e-03	3.90e-02	6.96e-01
GOBP GLUTATHIONE METABOLIC PROCESS	38	2.33e-04	1.44e-03	0.3890	-8.90e-02	-2.95e-01	1.20e-01	-5.76e-02	3.45e-02	1.93e-01	3.43e-01	1.62e-03	1.99e-01	5.39e-01	7.13e-01	3.97e-02
GOBP SYNAPTIC VESICLE LOCALIZATION	48	1.18e-02	3.92e-02	0.3890	-1.28e-01	8.34e-02	1.95e-01	-7.01e-02	-1.50e-01	2.50e-01	1.24e-01	3.18e-01	1.93e-02	4.01e-01	7.22e-02	2.74e-03
GOBP ESTROGEN METABOLIC PROCESS	22	4.38e-01	5.45e-01	0.3890	-1.47e-01	-9.60e-02	7.71e-02	-1.88e-01	-2.59e-01	1.12e-01	2.33e-01	4.36e-01	5.31e-01	1.27e-01	3.57e-02	3.64e-01
GOMF PEPTIDE LYSINE N ACETYLTRANSFERASE ACTIVITY	44	3.25e-06	3.09e-05	0.3890	-5.68e-02	1.34e-01	-5.96e-02	3.49e-01	3.96e-03	-7.21e-02	5.14e-01	1.25e-01	4.94e-01	6.32e-05	9.64e-01	4.08e-01
GOBP HYALURONAN CATABOLIC PROCESS	14	1.29e-01	2.34e-01	0.3890	-7.21e-02	-2.27e-01	9.11e-02	8.90e-02	-2.08e-01	-1.87e-01	6.41e-01	1.41e-01	5.55e-01	5.64e-01	1.77e-01	2.27e-01
GOMF MRNA REGULATORY ELEMENT BINDING TRANSLATION REPRESSOR ACTIVITY	14	5.44e-01	6.35e-01	0.3890	-3.14e-01	-2.15e-02	-4.49e-02	-1.88e-01	-1.17e-01	3.28e-02	4.20e-02	8.89e-01	7.71e-01	2.22e-01	4.49e-01	8.32e-01
GOBP CITRATE METABOLIC PROCESS	5	6.87e-01	7.51e-01	0.3890	-3.37e-01	-4.95e-02	-2.94e-02	5.36e-02	-1.25e-02	-1.78e-01	1.93e-01	8.48e-01	9.09e-01	8.36e-01	9.61e-01	4.91e-01
GOCC POSTSYNAPTIC RECYCLING ENDOSOME	8	7.23e-01	7.80e-01	0.3890	-1.37e-01	-1.56e-01	1.39e-02	4.64e-02	-1.08e-01	3.06e-01	5.01e-01	4.45e-01	9.46e-01	8.20e-01	5.96e-01	1.33e-01
GOMF ORGANOPHOSPHATE ESTER TRANSMEMBRANE TRANSPORTER ACTIVITY	34	4.31e-02	1.05e-01	0.3890	-1.43e-01	-1.55e-01	-1.49e-01	-7.82e-03	-9.16e-02	-2.76e-01	1.48e-01	1.19e-01	1.32e-01	9.37e-01	3.55e-01	5.39e-03
GOBP RELEASE OF CYTOCHROME C FROM MITOCHONDRIA	52	1.34e-02	4.34e-02	0.3890	-1.70e-01	-2.53e-01	-1.52e-01	-1.36e-01	-1.97e-02	-1.28e-01	3.37e-02	1.60e-03	5.75e-02	9.08e-02	8.06e-01	1.12e-01
GOMF U1 SNRNP BINDING	6	8.71e-01	8.95e-01	0.3890	-2.39e-01	-2.35e-01	-1.17e-01	8.12e-02	-7.81e-02	1.12e-01	3.10e-01	3.20e-01	6.20e-01	7.31e-01	7.40e-01	6.36e-01
GOMF NADPH BINDING	16	4.69e-01	5.72e-01	0.3890	-2.55e-01	-1.79e-01	-1.53e-01	-1.57e-01	2.59e-02	7.53e-02	7.78e-02	2.16e-01	2.90e-01	2.76e-01	8.57e-01	6.02e-01
GOBP REGULATION OF INTRINSIC APOPTOTIC SIGNALING PATHWAY BY P53 CLASS MEDIATOR	31	1.65e-01	2.78e-01	0.3890	-2.10e-01	-2.36e-01	-2.20e-01	-2.14e-02	1.72e-02	-4.50e-02	4.26e-02	2.28e-02	3.43e-02	8.37e-01	8.68e-01	6.65e-01
GOBP C TERMINAL PROTEIN LIPIDATION	9	6.86e-01	7.51e-01	0.3890	-8.22e-02	-2.12e-01	-2.25e-01	1.95e-01	-5.69e-02	-8.66e-02	6.69e-01	2.70e-01	2.43e-01	3.12e-01	7.67e-01	6.53e-01
GOBP POSITIVE REGULATION OF EXOSOMAL SECRETION	14	3.77e-01	4.92e-01	0.3890	-1.01e-01	-1.67e-01	2.01e-01	7.57e-02	-2.33e-01	1.11e-01	5.11e-01	2.78e-01	1.92e-01	6.24e-01	1.32e-01	4.72e-01
GOBP HETEROPHILIC CELL CELL ADHESION VIA PLASMA MEMBRANE CELL ADHESION MOLECULES	30	2.11e-02	6.16e-02	0.3890	-8.79e-02	3.08e-01	-2.66e-02	4.90e-02	2.10e-01	-3.16e-02	4.05e-01	3.48e-03	8.01e-01	6.42e-01	4.63e-02	7.64e-01
GOBP TOLERANCE INDUCTION TO SELF ANTIGEN	6	5.04e-01	5.99e-01	0.3890	-1.15e-01	3.60e-02	4.47e-02	2.96e-01	-1.73e-01	1.30e-01	6.25e-01	8.79e-01	8.50e-01	2.10e-01	4.62e-01	5.82e-01
GOBP MITOCHONDRION ORGANIZATION	481	3.77e-33	4.54e-31	0.3890	-1.31e-01	-3.09e-01	-1.89e-01	4.67e-02	-6.68e-03	-1.38e-02	8.64e-07	3.22e-31	1.10e-12	7.94e-02	8.02e-01	6.05e-01
GOMF CULLIN FAMILY PROTEIN BINDING	24	3.82e-02	9.62e-02	0.3880	-1.71e-01	-1.51e-01	-2.16e-01	1.81e-01	3.44e-02	1.34e-01	1.46e-01	2.00e-01	6.68e-02	1.25e-01	7.70e-01	2.55e-01
GOMF MHC PROTEIN BINDING	41	1.11e-04	7.43e-04	0.3880	5.64e-02	1.92e-01	-9.46e-02	2.74e-01	7.38e-02	1.45e-01	5.32e-01	3.31e-02	2.95e-01	2.37e-03	4.13e-01	1.08e-01
GOCC AP 1 ADAPTOR COMPLEX	11	4.82e-01	5.83e-01	0.3880	-1.36e-01	6.64e-02	2.16e-01	1.54e-01	-7.79e-02	2.28e-01	4.35e-01	7.03e-01	2.16e-01	3.77e-01	6.55e-01	1.91e-01
GOBP REGULATION OF CARDIAC MUSCLE CONTRACTION BY REGULATION OF THE RELEASE OF SEQUESTERED CALCIUM ION	16	5.28e-01	6.21e-01	0.3880	-1.36e-01	-2.48e-01	6.05e-02	-1.01e-01	-1.59e-01	1.77e-01	3.46e-01	8.53e-02	6.75e-01	4.84e-01	2.72e-01	2.19e-01
GOBP CELLULAR RESPONSE TO TOPOLOGICALLY INCORRECT PROTEIN	95	3.15e-06	3.01e-05	0.3880	-2.28e-01	-1.67e-01	3.82e-02	-2.12e-03	-2.38e-01	1.12e-01	1.21e-04	5.01e-03	5.20e-01	9.72e-01	6.05e-05	5.87e-02
GOBP RIBONUCLEOSIDE CATABOLIC PROCESS	18	2.37e-01	3.54e-01	0.3880	2.35e-01	1.23e-01	1.06e-01	6.56e-02	3.84e-02	2.52e-01	8.48e-02	3.67e-01	4.35e-01	6.30e-01	7.78e-01	6.43e-02
GOMF POTASSIUM ION TRANSMEMBRANE TRANSPORTER ACTIVITY	95	1.17e-05	9.69e-05	0.3880	1.21e-01	2.28e-01	2.75e-01	-5.53e-02	3.57e-02	6.14e-02	4.12e-02	1.25e-04	3.48e-06	3.52e-01	5.47e-01	3.01e-01
GOBP BRANCHED CHAIN AMINO ACID TRANSPORT	11	4.12e-01	5.22e-01	0.3880	-9.19e-02	-5.34e-02	-2.36e-01	2.21e-01	-3.42e-02	-1.83e-01	5.98e-01	7.59e-01	1.75e-01	2.05e-01	8.44e-01	2.93e-01
GOBP AXONAL FASCICULATION	16	1.69e-01	2.81e-01	0.3880	-3.38e-01	5.66e-02	9.28e-02	-2.64e-02	1.71e-02	1.52e-01	1.91e-02	6.95e-01	5.20e-01	8.55e-01	9.06e-01	2.93e-01
GOCC TRANS GOLGI NETWORK TRANSPORT VESICLE MEMBRANE	18	8.50e-02	1.74e-01	0.3880	-2.32e-01	3.81e-02	1.31e-01	1.76e-01	-1.27e-02	2.16e-01	8.77e-02	7.80e-01	3.35e-01	1.96e-01	9.25e-01	1.13e-01
GOMF ARYLSULFATASE ACTIVITY	10	6.96e-01	7.59e-01	0.3880	-2.48e-01	-3.42e-02	-1.95e-01	-1.10e-01	-1.08e-01	-1.61e-01	1.75e-01	8.52e-01	2.85e-01	5.49e-01	5.54e-01	3.78e-01
GOBP NEGATIVE REGULATION OF MYOBLAST DIFFERENTIATION	17	1.06e-01	2.04e-01	0.3880	1.05e-01	-1.25e-01	-2.09e-01	-1.35e-01	1.96e-01	-1.53e-01	4.53e-01	3.73e-01	1.36e-01	3.37e-01	1.63e-01	2.74e-01
GOBP POSITIVE REGULATION OF POTASSIUM ION TRANSMEMBRANE TRANSPORTER ACTIVITY	12	4.85e-01	5.86e-01	0.3880	1.75e-01	5.54e-02	2.47e-01	-8.30e-02	4.16e-02	2.16e-01	2.93e-01	7.40e-01	1.38e-01	6.18e-01	8.03e-01	1.96e-01
GOBP MITOCHONDRIAL CALCIUM ION HOMEOSTASIS	23	1.44e-01	2.54e-01	0.3880	-1.65e-01	-3.40e-01	-6.01e-02	1.51e-02	-4.15e-02	4.11e-02	1.71e-01	4.73e-03	6.18e-01	9.00e-01	7.30e-01	7.33e-01
GOBP REGULATION OF MEMBRANE LIPID DISTRIBUTION	51	1.86e-02	5.57e-02	0.3870	1.25e-01	1.58e-01	1.74e-01	2.37e-01	5.08e-02	1.43e-01	1.23e-01	5.12e-02	3.16e-02	3.38e-03	5.30e-01	7.69e-02
GOBP GLYCEROL ETHER METABOLIC PROCESS	19	1.47e-01	2.57e-01	0.3870	-2.74e-01	-5.88e-03	1.05e-01	-1.32e-01	9.65e-02	1.92e-01	3.83e-02	9.65e-01	4.28e-01	3.18e-01	4.67e-01	1.47e-01
GOCC INO80 TYPE COMPLEX	27	2.28e-02	6.55e-02	0.3870	-4.43e-02	-1.16e-01	-5.03e-02	3.41e-01	1.19e-01	-4.21e-02	6.90e-01	2.95e-01	6.51e-01	2.17e-03	2.85e-01	7.05e-01
GOMF RNA ENDONUCLEASE ACTIVITY	67	2.09e-03	9.53e-03	0.3870	-5.77e-02	-2.32e-01	-2.61e-01	8.19e-02	3.52e-02	-1.30e-01	4.14e-01	1.03e-03	2.24e-04	2.46e-01	6.18e-01	6.53e-02
GOBP POSITIVE REGULATION OF PATTERN RECOGNITION RECEPTOR SIGNALING PATHWAY	64	1.13e-07	1.38e-06	0.3870	-2.11e-01	1.49e-01	-1.84e-02	2.26e-01	1.52e-01	9.38e-02	3.49e-03	3.98e-02	7.99e-01	1.78e-03	3.56e-02	1.94e-01
GOBP POSITIVE REGULATION OF ERYTHROCYTE DIFFERENTIATION	31	2.57e-02	7.17e-02	0.3870	-1.49e-01	6.32e-03	1.85e-01	1.14e-01	-1.46e-01	2.43e-01	1.51e-01	9.51e-01	7.54e-02	2.70e-01	1.60e-01	1.91e-02
GOBP REGULATION OF CD4 POSITIVE ALPHA BETA T CELL ACTIVATION	74	4.34e-04	2.49e-03	0.3870	8.07e-02	1.77e-01	2.27e-01	1.85e-01	-1.66e-02	1.61e-01	2.30e-01	8.53e-03	7.48e-04	5.86e-03	8.05e-01	1.65e-02
GOBP REGULATION OF TYPE I INTERFERON MEDIATED SIGNALING PATHWAY	41	5.44e-03	2.10e-02	0.3870	3.26e-02	-1.70e-02	3.65e-02	3.08e-01	6.00e-02	2.20e-01	7.18e-01	8.51e-01	6.86e-01	6.52e-04	5.06e-01	1.46e-02
GOBP INTRACELLULAR DISTRIBUTION OF MITOCHONDRIA	7	7.90e-01	8.31e-01	0.3870	-2.74e-01	-1.56e-01	-1.99e-01	4.40e-02	-8.50e-02	4.12e-02	2.10e-01	4.75e-01	3.62e-01	8.40e-01	6.97e-01	8.50e-01
GOCC UNCONVENTIONAL MYOSIN COMPLEX	8	5.63e-01	6.52e-01	0.3870	-1.56e-01	-1.49e-01	2.04e-01	1.51e-01	-1.66e-01	1.05e-01	4.46e-01	4.66e-01	3.18e-01	4.59e-01	4.15e-01	6.06e-01
GOBP BONE MATURATION	19	1.06e-01	2.04e-01	0.3870	-1.43e-01	-4.91e-02	2.25e-01	1.08e-01	-2.26e-01	1.15e-01	2.79e-01	7.11e-01	9.02e-02	4.15e-01	8.75e-02	3.86e-01
GOMF 5 3 DNA HELICASE ACTIVITY	9	6.79e-01	7.45e-01	0.3870	1.17e-01	-1.07e-02	1.11e-01	3.25e-01	-3.66e-02	1.28e-01	5.43e-01	9.55e-01	5.64e-01	9.13e-02	8.49e-01	5.07e-01
GOCC CATENIN COMPLEX	16	5.32e-01	6.25e-01	0.3870	9.46e-02	2.76e-01	4.57e-02	1.88e-01	1.63e-01	2.21e-02	5.13e-01	5.63e-02	7.52e-01	1.92e-01	2.60e-01	8.78e-01
GOBP CERAMIDE TRANSPORT	15	1.07e-01	2.05e-01	0.3870	-2.02e-01	-2.23e-02	8.22e-02	2.83e-01	4.05e-02	1.41e-01	1.75e-01	8.81e-01	5.82e-01	5.81e-02	7.86e-01	3.45e-01
GOCC SPINDLE POLE CENTROSOME	13	2.79e-01	3.99e-01	0.3860	2.07e-02	-2.92e-01	9.69e-03	2.41e-01	3.98e-02	6.25e-02	8.97e-01	6.87e-02	9.52e-01	1.32e-01	8.04e-01	6.96e-01
GOBP ASPARTATE TRANSMEMBRANE TRANSPORT	16	3.32e-01	4.49e-01	0.3860	1.91e-02	-2.85e-01	9.59e-02	4.06e-02	-2.14e-01	1.04e-01	8.95e-01	4.83e-02	5.07e-01	7.78e-01	1.38e-01	4.71e-01
GOBP POSITIVE REGULATION OF ANTIGEN RECEPTOR MEDIATED SIGNALING PATHWAY	27	1.89e-01	3.04e-01	0.3860	1.07e-01	1.65e-01	8.73e-02	2.31e-01	1.07e-01	1.96e-01	3.34e-01	1.38e-01	4.32e-01	3.82e-02	3.36e-01	7.82e-02
GOBP NEGATIVE REGULATION OF GLIAL CELL MIGRATION	6	8.36e-01	8.68e-01	0.3860	1.16e-01	-1.72e-01	1.08e-01	1.06e-01	-2.01e-01	2.07e-01	6.22e-01	4.66e-01	6.47e-01	6.52e-01	3.95e-01	3.79e-01
GOCC EXTRINSIC COMPONENT OF POSTSYNAPTIC MEMBRANE	8	7.11e-01	7.70e-01	0.3860	1.29e-01	1.07e-01	-3.59e-02	3.04e-01	7.40e-02	1.48e-01	5.28e-01	6.02e-01	8.60e-01	1.36e-01	7.17e-01	4.69e-01
GOBP GROWTH PLATE CARTILAGE CHONDROCYTE DIFFERENTIATION	7	7.18e-01	7.76e-01	0.3860	-2.50e-01	1.19e-01	1.89e-01	1.17e-02	-2.79e-02	1.90e-01	2.53e-01	5.85e-01	3.87e-01	9.57e-01	8.98e-01	3.84e-01
GOBP C TERMINAL PROTEIN AMINO ACID MODIFICATION	13	6.01e-01	6.82e-01	0.3860	-2.10e-01	-2.27e-01	-1.98e-01	7.68e-02	-5.91e-02	-6.91e-02	1.89e-01	1.56e-01	2.17e-01	6.31e-01	7.12e-01	6.66e-01
GOMF NUCLEAR RECEPTOR COACTIVATOR ACTIVITY	54	8.51e-05	5.86e-04	0.3860	-4.48e-02	2.93e-02	1.83e-01	2.60e-01	-8.45e-02	1.95e-01	5.69e-01	7.09e-01	2.01e-02	9.53e-04	2.83e-01	1.33e-02
GOBP NEGATIVE REGULATION OF PHOSPHATASE ACTIVITY	17	3.58e-01	4.73e-01	0.3860	-3.05e-01	-7.81e-02	6.78e-02	-5.21e-02	-1.22e-01	1.67e-01	2.96e-02	5.77e-01	6.29e-01	7.10e-01	3.85e-01	2.34e-01
GOMF GENERAL TRANSCRIPTION INITIATION FACTOR ACTIVITY	49	2.98e-03	1.29e-02	0.3860	-2.01e-01	-2.74e-01	-1.42e-01	3.86e-02	6.05e-02	8.97e-02	1.51e-02	8.99e-04	8.46e-02	6.40e-01	4.63e-01	2.77e-01
GOMF MISMATCHED DNA BINDING	14	5.16e-01	6.10e-01	0.3860	-1.44e-01	-2.80e-01	-2.16e-01	-1.83e-02	6.19e-03	5.27e-02	3.51e-01	6.99e-02	1.61e-01	9.06e-01	9.68e-01	7.33e-01
GOBP MEMBRANE INVAGINATION	61	7.38e-06	6.45e-05	0.3860	-1.42e-01	-1.64e-02	2.82e-01	1.17e-01	-3.19e-02	1.84e-01	5.46e-02	8.25e-01	1.37e-04	1.14e-01	6.67e-01	1.29e-02
GOCC SEX CHROMOSOME	33	4.18e-02	1.03e-01	0.3860	-2.25e-01	-1.12e-01	8.61e-02	1.52e-02	-3.69e-02	2.76e-01	2.50e-02	2.67e-01	3.92e-01	8.80e-01	7.14e-01	5.98e-03
GOBP SODIUM DEPENDENT PHOSPHATE TRANSPORT	7	6.29e-01	7.05e-01	0.3860	1.07e-01	1.89e-01	1.28e-01	1.27e-02	-2.48e-01	1.53e-01	6.23e-01	3.87e-01	5.58e-01	9.54e-01	2.56e-01	4.83e-01
GOBP GLOMERULAR EPITHELIUM DEVELOPMENT	19	2.71e-01	3.91e-01	0.3850	9.18e-03	1.51e-01	3.34e-01	-4.22e-03	-7.26e-02	9.60e-02	9.45e-01	2.56e-01	1.18e-02	9.75e-01	5.84e-01	4.69e-01
GOCC MICROFIBRIL	11	5.01e-01	5.98e-01	0.3850	2.63e-01	1.15e-01	1.28e-01	-6.28e-03	-4.08e-02	-2.19e-01	1.31e-01	5.09e-01	4.64e-01	9.71e-01	8.15e-01	2.08e-01
GOBP DITERPENOID BIOSYNTHETIC PROCESS	6	6.49e-01	7.21e-01	0.3850	1.11e-04	7.62e-02	-2.89e-02	1.61e-01	1.11e-02	3.40e-01	1.00e+00	7.47e-01	9.02e-01	4.94e-01	9.62e-01	1.49e-01
GOBP KINETOCHORE ORGANIZATION	20	1.19e-01	2.22e-01	0.3850	6.58e-03	-2.44e-01	-8.26e-02	2.16e-01	6.89e-02	1.74e-01	9.59e-01	5.85e-02	5.23e-01	9.37e-02	5.93e-01	1.78e-01
GOBP RESPONSE TO HYDROXYUREA	11	4.97e-01	5.95e-01	0.3850	-3.55e-02	-2.77e-01	-7.65e-02	2.09e-01	-1.33e-01	5.88e-02	8.38e-01	1.12e-01	6.61e-01	2.30e-01	4.45e-01	7.35e-01
GOBP CELL COMMUNICATION INVOLVED IN CARDIAC CONDUCTION	33	7.34e-02	1.56e-01	0.3850	-8.20e-02	1.18e-02	2.87e-01	-1.17e-01	-1.85e-01	1.07e-01	4.15e-01	9.06e-01	4.38e-03	2.44e-01	6.58e-02	2.88e-01
GOBP NEGATIVE REGULATION OF INTRINSIC APOPTOTIC SIGNALING PATHWAY BY P53 CLASS MEDIATOR	21	3.62e-01	4.77e-01	0.3850	-2.57e-01	-2.09e-01	-1.49e-01	-1.10e-01	2.82e-02	-5.99e-02	4.14e-02	9.74e-02	2.36e-01	3.85e-01	8.23e-01	6.35e-01
GOBP INTRINSIC APOPTOTIC SIGNALING PATHWAY IN RESPONSE TO HYPOXIA	9	3.69e-01	4.84e-01	0.3850	-2.15e-01	-1.15e-01	-4.00e-02	2.40e-01	-1.47e-01	8.98e-02	2.64e-01	5.51e-01	8.35e-01	2.12e-01	4.46e-01	6.41e-01
GOBP THIAMINE TRANSPORT	6	7.60e-01	8.07e-01	0.3850	-2.58e-01	-1.14e-01	-2.24e-01	1.20e-01	-4.27e-02	4.79e-02	2.74e-01	6.27e-01	3.43e-01	6.10e-01	8.56e-01	8.39e-01
GOCC GERM CELL NUCLEUS	52	1.70e-04	1.09e-03	0.3850	-5.56e-02	-1.27e-01	-4.06e-02	3.13e-01	5.16e-02	1.63e-01	4.88e-01	1.12e-01	6.12e-01	9.35e-05	5.20e-01	4.20e-02
GOBP REGULATION OF MESENCHYMAL CELL PROLIFERATION	18	5.06e-01	6.02e-01	0.3850	-7.14e-02	-1.92e-02	2.36e-01	-8.91e-02	-2.42e-01	1.43e-01	6.00e-01	8.88e-01	8.25e-02	5.13e-01	7.57e-02	2.95e-01
GOBP G PROTEIN COUPLED PURINERGIC NUCLEOTIDE RECEPTOR SIGNALING PATHWAY	12	4.50e-01	5.57e-01	0.3850	-2.89e-01	1.38e-01	8.40e-02	-1.67e-01	-1.24e-02	1.02e-01	8.33e-02	4.07e-01	6.14e-01	3.16e-01	9.40e-01	5.41e-01
GOMF G PROTEIN COUPLED PURINERGIC NUCLEOTIDE RECEPTOR ACTIVITY	12	4.50e-01	5.57e-01	0.3850	-2.89e-01	1.38e-01	8.40e-02	-1.67e-01	-1.24e-02	1.02e-01	8.33e-02	4.07e-01	6.14e-01	3.16e-01	9.40e-01	5.41e-01
GOBP TOOTH MINERALIZATION	18	2.03e-01	3.19e-01	0.3850	1.26e-01	2.23e-01	2.23e-01	1.60e-01	-1.63e-02	-8.05e-02	3.53e-01	1.01e-01	1.01e-01	2.41e-01	9.05e-01	5.54e-01
GOBP EMBRYONIC BODY MORPHOGENESIS	11	4.03e-01	5.15e-01	0.3850	6.27e-02	2.54e-01	1.03e-01	5.87e-02	7.11e-02	-2.46e-01	7.19e-01	1.44e-01	5.53e-01	7.36e-01	6.83e-01	1.59e-01
GOBP LOOP OF HENLE DEVELOPMENT	5	7.13e-01	7.72e-01	0.3850	-1.49e-01	9.51e-02	3.67e-02	-6.71e-02	-6.46e-02	-3.27e-01	5.64e-01	7.13e-01	8.87e-01	7.95e-01	8.02e-01	2.06e-01
GOMF MOLECULAR SEQUESTERING ACTIVITY	42	5.89e-04	3.22e-03	0.3840	-5.31e-02	-1.73e-01	2.43e-01	1.58e-01	-1.04e-01	1.41e-01	5.51e-01	5.17e-02	6.36e-03	7.64e-02	2.45e-01	1.13e-01
GOBP BONE TRABECULA MORPHOGENESIS	10	2.40e-01	3.58e-01	0.3840	-2.44e-01	1.43e-01	7.69e-02	-6.28e-02	-1.48e-01	-1.90e-01	1.82e-01	4.33e-01	6.74e-01	7.31e-01	4.19e-01	2.98e-01
GOMF MYOSIN II BINDING	10	1.69e-01	2.81e-01	0.3840	7.71e-04	1.73e-01	2.68e-02	3.13e-01	-1.33e-01	3.79e-02	9.97e-01	3.42e-01	8.83e-01	8.67e-02	4.67e-01	8.36e-01
GOCC SWI SNF COMPLEX	29	2.25e-03	1.01e-02	0.3840	2.51e-02	1.15e-01	1.42e-01	3.10e-01	-1.28e-01	3.24e-02	8.15e-01	2.84e-01	1.87e-01	3.82e-03	2.31e-01	7.63e-01
GOBP SYNAPTIC VESICLE MEMBRANE ORGANIZATION	21	1.05e-01	2.02e-01	0.3840	1.27e-01	-4.55e-02	2.15e-01	1.93e-01	1.54e-01	1.50e-01	3.12e-01	7.18e-01	8.88e-02	1.26e-01	2.23e-01	2.34e-01
GOBP MICROAUTOPHAGY	22	1.29e-01	2.35e-01	0.3840	-7.35e-02	-3.47e-02	-1.84e-01	2.94e-01	1.36e-01	-4.95e-02	5.51e-01	7.78e-01	1.35e-01	1.70e-02	2.70e-01	6.88e-01
GOBP FREE UBIQUITIN CHAIN POLYMERIZATION	9	5.52e-01	6.42e-01	0.3840	1.52e-01	-1.29e-01	6.08e-02	2.65e-01	-1.84e-01	-4.92e-04	4.31e-01	5.02e-01	7.52e-01	1.68e-01	3.38e-01	9.98e-01
GOBP REGULATION OF TOLL LIKE RECEPTOR 4 SIGNALING PATHWAY	26	1.15e-02	3.85e-02	0.3840	-2.66e-01	1.69e-01	-4.80e-02	7.19e-02	2.02e-01	-5.01e-03	1.88e-02	1.37e-01	6.72e-01	5.26e-01	7.42e-02	9.65e-01
GOBP REGULATION OF VESICLE FUSION	17	2.44e-01	3.62e-01	0.3840	1.65e-01	-1.08e-01	1.56e-01	2.19e-01	9.82e-02	1.65e-01	2.39e-01	4.41e-01	2.66e-01	1.19e-01	4.83e-01	2.40e-01
GOMF MANNOSYLTRANSFERASE ACTIVITY	24	2.64e-01	3.83e-01	0.3840	-2.97e-01	-1.34e-01	-1.78e-01	-6.91e-02	-5.71e-02	-4.13e-02	1.18e-02	2.56e-01	1.32e-01	5.58e-01	6.28e-01	7.26e-01
GOBP RESPONSE TO BILE ACID	6	6.65e-01	7.33e-01	0.3840	1.55e-01	1.80e-02	2.74e-02	1.58e-02	2.68e-01	-2.25e-01	5.12e-01	9.39e-01	9.08e-01	9.46e-01	2.56e-01	3.40e-01
GOCC MALE GERM CELL NUCLEUS	43	8.92e-04	4.61e-03	0.3840	-8.28e-02	-1.66e-01	-1.19e-02	2.72e-01	-3.58e-02	1.94e-01	3.48e-01	5.98e-02	8.92e-01	2.02e-03	6.84e-01	2.77e-02
GOBP PEPTIDYL THREONINE MODIFICATION	91	8.38e-10	1.35e-08	0.3840	-1.31e-01	-3.50e-02	2.09e-01	1.90e-01	-1.66e-01	1.48e-01	3.14e-02	5.64e-01	5.63e-04	1.73e-03	6.35e-03	1.48e-02
GOBP PODOSOME ASSEMBLY	18	1.31e-01	2.38e-01	0.3840	-2.18e-01	-2.77e-03	2.15e-01	1.03e-01	-3.90e-03	2.07e-01	1.09e-01	9.84e-01	1.15e-01	4.48e-01	9.77e-01	1.29e-01
GOBP RETINAL GANGLION CELL AXON GUIDANCE	15	2.84e-01	4.04e-01	0.3840	-5.82e-02	2.00e-01	1.20e-01	2.51e-02	2.90e-01	6.91e-02	6.97e-01	1.80e-01	4.20e-01	8.66e-01	5.19e-02	6.43e-01
GOMF IMMUNOGLOBULIN BINDING	19	3.44e-01	4.61e-01	0.3840	4.55e-02	8.68e-02	2.99e-01	-1.17e-01	-2.24e-02	1.83e-01	7.31e-01	5.12e-01	2.38e-02	3.76e-01	8.66e-01	1.66e-01
GOBP PROTEIN TRIMERIZATION	13	4.57e-01	5.62e-01	0.3840	1.20e-01	-1.37e-02	1.18e-01	1.39e-01	2.02e-01	2.42e-01	4.55e-01	9.32e-01	4.63e-01	3.87e-01	2.06e-01	1.31e-01
GOBP DEOXYRIBONUCLEOSIDE MONOPHOSPHATE CATABOLIC PROCESS	11	3.98e-01	5.10e-01	0.3840	2.37e-01	-7.44e-02	2.02e-01	1.14e-01	1.20e-01	1.31e-01	1.74e-01	6.69e-01	2.47e-01	5.13e-01	4.89e-01	4.51e-01
GOBP REGULATION OF SKELETAL MUSCLE ADAPTATION	7	6.03e-01	6.83e-01	0.3830	3.78e-02	1.74e-01	-1.87e-01	-3.55e-03	-1.10e-01	-2.61e-01	8.63e-01	4.26e-01	3.91e-01	9.87e-01	6.13e-01	2.31e-01
GOBP PROTEIN QUALITY CONTROL FOR MISFOLDED OR INCOMPLETELY SYNTHESIZED PROTEINS	25	1.83e-01	2.98e-01	0.3830	-2.27e-01	-2.09e-01	-2.06e-01	5.55e-02	-7.35e-02	-3.58e-02	4.99e-02	7.08e-02	7.47e-02	6.31e-01	5.25e-01	7.57e-01
GOBP LIVER REGENERATION	25	1.51e-01	2.62e-01	0.3830	2.03e-01	-4.93e-02	1.48e-01	2.63e-01	1.32e-02	1.11e-01	7.91e-02	6.70e-01	2.00e-01	2.28e-02	9.09e-01	3.39e-01
GOBP GDP METABOLIC PROCESS	11	7.49e-01	8.00e-01	0.3830	-8.52e-03	7.37e-02	2.56e-01	-1.88e-01	-1.03e-01	1.73e-01	9.61e-01	6.72e-01	1.41e-01	2.79e-01	5.55e-01	3.21e-01
GOBP ASTROCYTE DIFFERENTIATION	62	5.79e-05	4.17e-04	0.3830	-1.29e-01	1.73e-01	2.68e-01	-1.25e-01	-1.04e-01	4.20e-02	7.84e-02	1.83e-02	2.60e-04	8.86e-02	1.55e-01	5.67e-01
GOBP REGULATION OF RESPONSE TO OSMOTIC STRESS	14	6.64e-01	7.32e-01	0.3830	8.45e-02	1.75e-01	-4.44e-02	1.74e-01	2.44e-01	-1.33e-01	5.84e-01	2.58e-01	7.73e-01	2.60e-01	1.14e-01	3.89e-01
GOBP CARDIAC MUSCLE TISSUE MORPHOGENESIS	33	9.93e-02	1.95e-01	0.3830	1.14e-01	2.53e-01	1.18e-01	1.33e-01	7.63e-02	1.81e-01	2.59e-01	1.19e-02	2.40e-01	1.87e-01	4.48e-01	7.23e-02
GOBP COMPLEMENT ACTIVATION ALTERNATIVE PATHWAY	11	7.34e-01	7.88e-01	0.3830	-2.61e-02	-2.38e-01	-4.95e-02	-1.67e-01	-2.20e-01	-1.04e-01	8.81e-01	1.71e-01	7.76e-01	3.36e-01	2.07e-01	5.51e-01
GOBP VISUAL BEHAVIOR	43	3.79e-02	9.58e-02	0.3830	-9.05e-03	1.98e-01	2.48e-01	5.40e-02	2.13e-02	2.06e-01	9.18e-01	2.49e-02	4.84e-03	5.40e-01	8.09e-01	1.92e-02
GOBP NEGATIVE REGULATION OF EXTRACELLULAR MATRIX ORGANIZATION	11	5.42e-01	6.33e-01	0.3830	1.07e-01	5.86e-02	2.09e-01	1.39e-01	2.26e-01	1.35e-01	5.39e-01	7.37e-01	2.31e-01	4.24e-01	1.95e-01	4.40e-01
GOMF SODIUM CHANNEL ACTIVITY	32	1.36e-01	2.44e-01	0.3830	1.78e-01	2.22e-01	2.53e-01	-1.15e-02	5.02e-03	3.96e-02	8.10e-02	2.96e-02	1.34e-02	9.10e-01	9.61e-01	6.99e-01
GOBP NEGATIVE REGULATION OF ORGAN GROWTH	26	2.53e-02	7.09e-02	0.3830	-7.86e-02	-9.31e-02	2.29e-01	4.75e-02	-2.77e-01	-6.54e-03	4.88e-01	4.11e-01	4.30e-02	6.75e-01	1.43e-02	9.54e-01
GOBP RESPONSE TO PROSTAGLANDIN E	19	8.08e-02	1.68e-01	0.3830	-1.54e-01	1.92e-01	2.66e-01	5.48e-02	-5.23e-02	9.60e-02	2.45e-01	1.47e-01	4.43e-02	6.79e-01	6.93e-01	4.69e-01
GOBP REGULATION OF RAC PROTEIN SIGNAL TRANSDUCTION	22	1.83e-01	2.98e-01	0.3830	-4.18e-02	2.57e-01	2.12e-01	3.50e-02	-3.85e-02	1.77e-01	7.35e-01	3.73e-02	8.56e-02	7.76e-01	7.55e-01	1.50e-01
GOBP CELLULAR RESPONSE TO OXIDISED LOW DENSITY LIPOPROTEIN PARTICLE STIMULUS	11	3.37e-01	4.55e-01	0.3830	-1.43e-01	1.63e-01	1.17e-01	1.21e-01	2.64e-01	3.38e-02	4.12e-01	3.49e-01	5.01e-01	4.85e-01	1.29e-01	8.46e-01
GOBP NEGATIVE REGULATION OF INFLAMMASOME MEDIATED SIGNALING PATHWAY	12	2.04e-01	3.20e-01	0.3830	7.26e-03	-2.87e-02	1.30e-02	3.59e-01	-1.20e-01	4.94e-02	9.65e-01	8.63e-01	9.38e-01	3.15e-02	4.72e-01	7.67e-01
GOBP REGULATION OF NUCLEOTIDE BIOSYNTHETIC PROCESS	21	1.25e-01	2.29e-01	0.3830	7.99e-02	-2.17e-01	-5.60e-02	2.67e-01	1.25e-01	5.56e-02	5.26e-01	8.53e-02	6.57e-01	3.45e-02	3.20e-01	6.59e-01
GOBP KERATINIZATION	17	5.67e-01	6.55e-01	0.3830	1.63e-01	1.32e-01	2.67e-01	1.33e-01	1.88e-02	1.14e-01	2.44e-01	3.47e-01	5.66e-02	3.44e-01	8.94e-01	4.14e-01
GOMF DEACETYLASE ACTIVITY	35	9.47e-02	1.88e-01	0.3830	4.84e-02	-8.41e-02	-2.17e-01	2.28e-01	1.38e-01	-1.37e-01	6.21e-01	3.89e-01	2.63e-02	1.95e-02	1.57e-01	1.62e-01
GOBP GRANULOCYTE MIGRATION	110	2.03e-08	2.74e-07	0.3830	-5.08e-02	7.63e-02	3.36e-01	-2.26e-02	-3.64e-02	1.53e-01	3.58e-01	1.67e-01	1.15e-09	6.82e-01	5.10e-01	5.62e-03
GOMF EXONUCLEASE ACTIVITY ACTIVE WITH EITHER RIBO OR DEOXYRIBONUCLEIC ACIDS AND PRODUCING 5 PHOSPHOMONOESTERS	61	7.19e-04	3.84e-03	0.3820	-1.60e-01	-1.71e-01	-2.38e-01	1.60e-01	9.45e-02	-1.77e-02	3.06e-02	2.12e-02	1.28e-03	3.11e-02	2.02e-01	8.11e-01
GOBP NEGATIVE REGULATION OF MACROPHAGE CYTOKINE PRODUCTION	10	6.21e-01	6.99e-01	0.3820	-1.28e-01	2.06e-02	-1.28e-01	1.75e-01	2.68e-01	-1.03e-01	4.82e-01	9.10e-01	4.82e-01	3.39e-01	1.43e-01	5.72e-01
GOBP T CELL MIGRATION	61	6.48e-04	3.50e-03	0.3820	4.68e-02	6.54e-02	2.02e-01	2.65e-01	2.76e-02	1.66e-01	5.28e-01	3.77e-01	6.34e-03	3.37e-04	7.10e-01	2.46e-02
GOBP POSITIVE REGULATION OF B CELL PROLIFERATION	40	7.58e-02	1.60e-01	0.3820	1.07e-01	2.64e-01	2.14e-01	6.22e-02	1.03e-01	6.87e-02	2.43e-01	3.86e-03	1.91e-02	4.96e-01	2.60e-01	4.52e-01
GOBP EXTRAEMBRYONIC MEMBRANE DEVELOPMENT	9	6.71e-01	7.38e-01	0.3820	-9.86e-02	-2.44e-01	7.01e-02	7.33e-02	-2.58e-01	-3.09e-03	6.08e-01	2.05e-01	7.16e-01	7.03e-01	1.80e-01	9.87e-01
GOBP MAINTENANCE OF LENS TRANSPARENCY	6	6.59e-01	7.29e-01	0.3820	-4.15e-03	1.31e-01	5.01e-03	-2.87e-01	2.00e-01	7.85e-02	9.86e-01	5.77e-01	9.83e-01	2.23e-01	3.96e-01	7.39e-01
GOBP PEPTIDYL LYSINE ACETYLATION	20	1.72e-02	5.25e-02	0.3820	1.46e-02	-2.82e-02	2.10e-02	3.06e-01	-2.13e-01	7.42e-02	9.10e-01	8.27e-01	8.71e-01	1.78e-02	9.87e-02	5.66e-01
GOBP NEGATIVE REGULATION OF INTERLEUKIN 6 PRODUCTION	42	8.18e-04	4.29e-03	0.3820	-7.72e-02	2.59e-01	2.23e-01	6.07e-02	-1.00e-01	9.70e-02	3.87e-01	3.67e-03	1.23e-02	4.96e-01	2.61e-01	2.77e-01
GOBP CARDIAC RIGHT VENTRICLE MORPHOGENESIS	12	4.49e-01	5.56e-01	0.3820	1.44e-01	2.15e-01	1.34e-01	-1.06e-01	-1.23e-01	-1.86e-01	3.87e-01	1.96e-01	4.21e-01	5.25e-01	4.61e-01	2.65e-01
GOBP PROTEIN K11 LINKED UBIQUITINATION	36	5.99e-02	1.35e-01	0.3820	-2.06e-01	-2.22e-01	-1.77e-01	-2.28e-03	-1.52e-01	7.95e-03	3.25e-02	2.11e-02	6.63e-02	9.81e-01	1.15e-01	9.34e-01
GOBP DNA DEAMINATION	13	1.21e-01	2.25e-01	0.3820	2.07e-01	-6.58e-02	-4.10e-02	1.31e-01	-9.39e-02	2.67e-01	1.96e-01	6.81e-01	7.98e-01	4.12e-01	5.58e-01	9.61e-02
GOMF CYTOSKELETAL MOTOR ACTIVITY	91	1.18e-04	7.85e-04	0.3820	2.08e-01	6.71e-02	2.19e-01	1.43e-01	-8.41e-02	1.51e-01	6.17e-04	2.68e-01	2.97e-04	1.86e-02	1.66e-01	1.28e-02
GOBP INTRACELLULAR PHOSPHATE ION HOMEOSTASIS	6	6.87e-01	7.51e-01	0.3820	-2.09e-01	-1.05e-03	-1.62e-01	-1.20e-01	-2.45e-01	4.45e-02	3.76e-01	9.96e-01	4.93e-01	6.10e-01	2.99e-01	8.50e-01
GOCC MRE11 COMPLEX	5	8.09e-01	8.46e-01	0.3820	-1.93e-01	1.45e-01	-1.10e-01	-2.39e-01	4.84e-02	1.25e-01	4.54e-01	5.74e-01	6.69e-01	3.54e-01	8.51e-01	6.29e-01
GOBP REGULATION OF CATECHOLAMINE METABOLIC PROCESS	13	5.03e-02	1.18e-01	0.3820	-2.14e-01	-8.90e-03	2.79e-01	8.34e-02	1.06e-01	6.14e-02	1.81e-01	9.56e-01	8.15e-02	6.03e-01	5.09e-01	7.02e-01
GOBP NEGATIVE REGULATION OF CYSTEINE TYPE ENDOPEPTIDASE ACTIVITY INVOLVED IN APOPTOTIC PROCESS	42	2.50e-03	1.11e-02	0.3820	-3.31e-01	-7.84e-02	7.73e-02	-5.17e-02	1.73e-02	1.44e-01	2.01e-04	3.80e-01	3.86e-01	5.62e-01	8.46e-01	1.06e-01
GOBP CHONDROCYTE DIFFERENTIATION INVOLVED IN ENDOCHONDRAL BONE MORPHOGENESIS	11	3.37e-01	4.55e-01	0.3820	-2.04e-01	1.79e-01	-2.32e-02	1.80e-01	1.69e-01	1.02e-01	2.41e-01	3.04e-01	8.94e-01	3.00e-01	3.33e-01	5.58e-01
GOBP PROTEIN TRANSPORT TO VACUOLE INVOLVED IN UBIQUITIN DEPENDENT PROTEIN CATABOLIC PROCESS VIA THE MULTIVESICULAR BODY SORTING PATHWAY	14	2.25e-01	3.44e-01	0.3820	-7.15e-03	-4.68e-02	9.06e-02	3.37e-01	-7.89e-02	1.24e-01	9.63e-01	7.62e-01	5.57e-01	2.90e-02	6.09e-01	4.21e-01
GOBP PROTEIN O LINKED MANNOSYLATION	19	3.10e-01	4.30e-01	0.3820	-1.59e-01	-1.22e-01	-1.80e-01	-7.53e-03	1.16e-01	-2.44e-01	2.31e-01	3.56e-01	1.74e-01	9.55e-01	3.83e-01	6.55e-02
GOMF WW DOMAIN BINDING	18	5.72e-01	6.59e-01	0.3820	1.62e-01	7.67e-02	4.01e-02	2.60e-01	1.98e-01	6.98e-02	2.35e-01	5.73e-01	7.68e-01	5.58e-02	1.45e-01	6.08e-01
GOBP NEURON CELL CELL ADHESION	8	8.57e-01	8.84e-01	0.3820	-1.97e-01	2.75e-02	1.34e-01	-1.23e-01	-1.38e-01	2.32e-01	3.35e-01	8.93e-01	5.10e-01	5.47e-01	4.99e-01	2.56e-01
GOBP POSITIVE REGULATION OF GLUCOSE IMPORT	28	2.88e-02	7.76e-02	0.3820	-2.88e-01	-8.49e-03	1.95e-01	-6.83e-02	-9.25e-02	1.07e-01	8.39e-03	9.38e-01	7.43e-02	5.31e-01	3.97e-01	3.27e-01
GOBP REGULATION OF T HELPER 17 TYPE IMMUNE RESPONSE	30	4.18e-02	1.03e-01	0.3810	1.10e-01	2.97e-01	9.80e-02	1.11e-01	4.72e-02	-1.46e-01	2.95e-01	4.94e-03	3.53e-01	2.91e-01	6.55e-01	1.67e-01
GOBP GOLGI TO VACUOLE TRANSPORT	19	6.87e-02	1.49e-01	0.3810	-2.57e-01	-8.36e-02	2.08e-01	7.47e-02	-8.78e-02	1.26e-01	5.24e-02	5.28e-01	1.16e-01	5.73e-01	5.07e-01	3.42e-01
GOBP RNA 3 URIDYLATION	5	9.01e-01	9.18e-01	0.3810	8.93e-02	2.73e-01	5.66e-02	-1.00e-01	1.17e-01	-1.90e-01	7.29e-01	2.90e-01	8.27e-01	6.98e-01	6.50e-01	4.63e-01
GOCC GTPASE COMPLEX	34	9.95e-02	1.95e-01	0.3810	-1.67e-01	-5.20e-02	1.78e-01	-5.38e-02	-2.20e-01	1.78e-01	9.15e-02	5.99e-01	7.28e-02	5.87e-01	2.64e-02	7.18e-02
GOBP ENDOSOME TO LYSOSOME TRANSPORT	65	4.63e-05	3.40e-04	0.3810	-1.96e-01	-1.23e-01	1.06e-01	1.32e-01	-8.77e-02	2.36e-01	6.31e-03	8.74e-02	1.41e-01	6.57e-02	2.22e-01	9.99e-04
GOBP NEGATIVE REGULATION OF CARDIAC MUSCLE CELL PROLIFERATION	8	5.33e-01	6.25e-01	0.3810	1.12e-01	4.20e-02	2.31e-01	2.65e-01	4.07e-02	-7.43e-02	5.84e-01	8.37e-01	2.57e-01	1.94e-01	8.42e-01	7.16e-01
GOBP POSTREPLICATION REPAIR	36	7.28e-03	2.67e-02	0.3810	-1.14e-01	-1.90e-01	-2.65e-02	9.98e-02	6.32e-02	2.85e-01	2.35e-01	4.84e-02	7.84e-01	3.00e-01	5.11e-01	3.04e-03
GOMF DIACYLGLYCEROL DEPENDENT SERINE THREONINE KINASE ACTIVITY	14	1.58e-01	2.70e-01	0.3810	-2.20e-01	-9.61e-03	1.42e-02	1.13e-01	-1.74e-01	2.31e-01	1.54e-01	9.50e-01	9.27e-01	4.64e-01	2.61e-01	1.34e-01
GOBP NATURAL KILLER CELL MEDIATED IMMUNITY	73	2.84e-06	2.74e-05	0.3810	4.84e-02	1.54e-01	1.36e-01	2.10e-01	-8.66e-02	2.22e-01	4.75e-01	2.27e-02	4.48e-02	1.93e-03	2.01e-01	1.07e-03
GOCC POSTSYNAPTIC SPECIALIZATION MEMBRANE	73	4.87e-04	2.75e-03	0.3810	2.29e-01	2.21e-01	1.42e-01	7.41e-03	1.44e-01	-5.50e-02	7.25e-04	1.09e-03	3.57e-02	9.13e-01	3.38e-02	4.16e-01
GOBP CELLULAR RESPONSE TO NITROSATIVE STRESS	5	8.37e-01	8.68e-01	0.3810	5.14e-02	-1.56e-01	1.72e-01	3.58e-02	7.34e-02	2.86e-01	8.42e-01	5.47e-01	5.06e-01	8.90e-01	7.76e-01	2.68e-01
GOBP ANTIGEN PROCESSING AND PRESENTATION OF PEPTIDE ANTIGEN	62	2.11e-04	1.31e-03	0.3810	-7.71e-02	-7.85e-02	-1.30e-01	1.87e-01	2.83e-01	-3.29e-02	2.94e-01	2.85e-01	7.61e-02	1.09e-02	1.17e-04	6.54e-01
GOBP SERTOLI CELL DEVELOPMENT	11	6.85e-01	7.50e-01	0.3810	-6.08e-02	1.51e-02	1.88e-01	-8.61e-02	8.25e-03	3.13e-01	7.27e-01	9.31e-01	2.79e-01	6.21e-01	9.62e-01	7.21e-02
GOMF DNA DAMAGE SENSOR ACTIVITY	22	1.88e-01	3.03e-01	0.3810	-6.86e-02	-2.91e-01	-2.03e-01	-1.94e-02	-1.11e-01	4.12e-02	5.78e-01	1.80e-02	1.00e-01	8.75e-01	3.68e-01	7.38e-01
GOMF PROTEIN LYSINE DEACETYLASE ACTIVITY	23	2.13e-01	3.31e-01	0.3810	2.02e-02	-1.09e-01	-1.60e-01	2.47e-01	1.20e-01	-1.78e-01	8.67e-01	3.66e-01	1.83e-01	4.03e-02	3.20e-01	1.40e-01
GOBP PYRIMIDINE NUCLEOBASE METABOLIC PROCESS	17	1.08e-01	2.06e-01	0.3810	-2.28e-01	-1.82e-01	9.34e-02	1.83e-01	-1.11e-02	1.31e-01	1.03e-01	1.93e-01	5.05e-01	1.92e-01	9.37e-01	3.49e-01
GOMF LIPID TRANSFER ACTIVITY	44	7.60e-04	4.03e-03	0.3810	-1.84e-02	1.52e-02	5.00e-02	3.37e-01	1.68e-01	-3.54e-03	8.33e-01	8.61e-01	5.66e-01	1.10e-04	5.36e-02	9.68e-01
GOBP NEGATIVE REGULATION OF CALCIUM ION TRANSPORT	41	4.46e-02	1.08e-01	0.3810	-1.83e-01	-2.53e-01	3.99e-02	-1.01e-01	-1.15e-01	1.51e-01	4.32e-02	5.11e-03	6.59e-01	2.65e-01	2.01e-01	9.50e-02
GOBP CELLULAR RESPONSE TO PARATHYROID HORMONE STIMULUS	9	4.58e-01	5.63e-01	0.3810	-2.01e-01	1.99e-01	-1.73e-01	-1.70e-01	-2.53e-02	-7.21e-02	2.96e-01	3.02e-01	3.68e-01	3.76e-01	8.95e-01	7.08e-01
GOBP POSITIVE REGULATION OF MACROPHAGE CYTOKINE PRODUCTION	22	1.15e-02	3.86e-02	0.3810	-1.39e-01	8.72e-02	2.64e-01	8.18e-02	1.80e-01	9.60e-02	2.58e-01	4.79e-01	3.22e-02	5.06e-01	1.44e-01	4.36e-01
GOBP REGULATION OF CHOLESTEROL EFFLUX	27	8.87e-03	3.11e-02	0.3800	9.15e-02	8.36e-02	1.74e-01	2.74e-01	7.88e-02	-1.34e-01	4.11e-01	4.52e-01	1.17e-01	1.39e-02	4.79e-01	2.28e-01
GOBP MAINTENANCE OF PROTEIN LOCATION IN EXTRACELLULAR REGION	6	4.86e-01	5.86e-01	0.3800	1.66e-01	-4.33e-02	2.11e-01	-1.67e-01	-3.03e-03	-2.07e-01	4.82e-01	8.54e-01	3.72e-01	4.79e-01	9.90e-01	3.80e-01
GOBP NEGATIVE REGULATION OF WOUND HEALING	54	7.72e-04	4.08e-03	0.3800	5.86e-02	-2.32e-02	3.29e-01	-6.91e-02	-1.41e-01	8.91e-02	4.57e-01	7.68e-01	2.95e-05	3.80e-01	7.35e-02	2.57e-01
GOBP ACUTE INFLAMMATORY RESPONSE TO ANTIGENIC STIMULUS	26	1.46e-01	2.57e-01	0.3800	1.02e-01	1.06e-01	1.97e-01	-2.12e-03	1.35e-01	2.57e-01	3.66e-01	3.50e-01	8.25e-02	9.85e-01	2.34e-01	2.35e-02
GOBP NEGATIVE REGULATION OF VOLTAGE GATED CALCIUM CHANNEL ACTIVITY	6	8.06e-01	8.44e-01	0.3800	1.63e-01	-6.91e-02	2.20e-01	9.97e-02	1.08e-01	2.08e-01	4.89e-01	7.70e-01	3.51e-01	6.72e-01	6.47e-01	3.79e-01
GOBP NEGATIVE REGULATION OF PHAGOCYTOSIS	20	1.39e-01	2.48e-01	0.3800	-2.30e-01	3.29e-02	1.10e-01	5.97e-02	-8.07e-02	2.61e-01	7.48e-02	7.99e-01	3.93e-01	6.44e-01	5.32e-01	4.33e-02
GOBP URIDINE TRANSMEMBRANE TRANSPORT	5	6.61e-01	7.30e-01	0.3800	1.14e-01	-1.99e-01	2.03e-02	7.00e-02	2.68e-01	1.22e-01	6.59e-01	4.42e-01	9.37e-01	7.86e-01	3.00e-01	6.36e-01
GOBP POSITIVE REGULATION OF VIRAL PROCESS	61	5.00e-05	3.63e-04	0.3800	-1.76e-01	-1.68e-01	4.26e-02	1.85e-01	-3.67e-02	2.18e-01	1.76e-02	2.31e-02	5.65e-01	1.23e-02	6.20e-01	3.18e-03
GOBP REGULATION OF LEUKOCYTE TETHERING OR ROLLING	12	4.52e-01	5.58e-01	0.3800	-2.20e-02	6.93e-02	3.51e-01	-3.50e-03	-2.98e-02	1.21e-01	8.95e-01	6.78e-01	3.50e-02	9.83e-01	8.58e-01	4.69e-01
GOBP REGULATION OF CYTOPLASMIC MRNA PROCESSING BODY ASSEMBLY	8	3.84e-01	4.97e-01	0.3800	-1.67e-01	3.02e-01	-1.31e-01	1.52e-02	3.29e-02	-8.19e-02	4.14e-01	1.39e-01	5.22e-01	9.41e-01	8.72e-01	6.88e-01
GOCC TELOMERASE HOLOENZYME COMPLEX	21	2.12e-01	3.29e-01	0.3800	-2.34e-02	-2.66e-01	-1.78e-01	1.93e-01	5.99e-02	-1.93e-02	8.53e-01	3.50e-02	1.57e-01	1.26e-01	6.35e-01	8.79e-01
GOBP BUNDLE OF HIS CELL TO PURKINJE MYOCYTE COMMUNICATION	8	5.89e-01	6.72e-01	0.3800	-9.27e-02	9.63e-02	2.17e-01	-2.20e-01	-1.10e-01	-1.36e-01	6.50e-01	6.37e-01	2.87e-01	2.82e-01	5.92e-01	5.04e-01
GOBP PYRIMIDINE RIBONUCLEOTIDE METABOLIC PROCESS	28	5.74e-02	1.31e-01	0.3790	-1.59e-01	-3.07e-01	-6.19e-02	9.99e-02	5.08e-03	1.04e-01	1.46e-01	4.98e-03	5.71e-01	3.60e-01	9.63e-01	3.41e-01
GOBP GOLGI VESICLE TRANSPORT	288	3.09e-26	2.24e-24	0.3790	-1.79e-01	-1.17e-01	8.36e-02	1.61e-01	-5.18e-02	2.50e-01	1.67e-07	6.60e-04	1.47e-02	2.57e-06	1.30e-01	2.82e-13
GOBP CHEMICAL SYNAPTIC TRANSMISSION POSTSYNAPTIC	72	3.98e-04	2.31e-03	0.3790	9.29e-02	6.33e-02	1.32e-01	3.00e-01	9.69e-02	1.19e-01	1.73e-01	3.53e-01	5.37e-02	1.04e-05	1.55e-01	7.96e-02
GOMF DOUBLE STRANDED METHYLATED DNA BINDING	5	7.22e-01	7.79e-01	0.3790	1.55e-02	2.35e-01	-1.26e-01	2.59e-01	2.38e-02	-6.82e-02	9.52e-01	3.63e-01	6.25e-01	3.16e-01	9.26e-01	7.92e-01
GOBP REGULATION OF SHORT TERM NEURONAL SYNAPTIC PLASTICITY	11	3.77e-01	4.92e-01	0.3790	-4.04e-02	3.29e-02	1.37e-01	1.61e-01	2.92e-01	1.06e-01	8.16e-01	8.50e-01	4.31e-01	3.56e-01	9.37e-02	5.43e-01
GOMF PHOSPHATIDYLETHANOLAMINE BINDING	13	5.86e-01	6.70e-01	0.3790	-1.56e-01	-2.81e-01	-8.54e-02	-1.25e-03	-9.30e-02	1.56e-01	3.29e-01	7.94e-02	5.94e-01	9.94e-01	5.61e-01	3.31e-01
GOBP REGULATION OF CHONDROCYTE DIFFERENTIATION	28	1.75e-01	2.89e-01	0.3790	5.87e-02	3.03e-01	1.84e-01	-1.48e-02	9.07e-02	7.63e-02	5.91e-01	5.46e-03	9.19e-02	8.92e-01	4.06e-01	4.85e-01
GOBP CEREBELLAR GRANULAR LAYER DEVELOPMENT	9	4.06e-01	5.17e-01	0.3790	-6.53e-02	-5.26e-02	2.82e-01	-1.13e-01	9.93e-02	1.86e-01	7.35e-01	7.85e-01	1.43e-01	5.56e-01	6.06e-01	3.34e-01
GOBP DEFENSE RESPONSE TO FUNGUS	38	9.92e-02	1.94e-01	0.3790	-1.72e-02	-2.51e-02	2.19e-01	-1.57e-02	-1.72e-01	2.55e-01	8.55e-01	7.89e-01	1.97e-02	8.67e-01	6.73e-02	6.51e-03
GOCC NUCLEAR PORE NUCLEAR BASKET	12	4.39e-01	5.46e-01	0.3790	-1.41e-01	-1.10e-01	1.88e-02	1.90e-01	1.49e-01	2.29e-01	3.97e-01	5.08e-01	9.10e-01	2.53e-01	3.70e-01	1.70e-01
GOBP REGULATION OF MYELOID CELL APOPTOTIC PROCESS	26	2.90e-01	4.09e-01	0.3790	1.68e-02	1.78e-01	2.27e-01	6.39e-02	6.47e-02	2.27e-01	8.82e-01	1.15e-01	4.55e-02	5.73e-01	5.68e-01	4.49e-02
GOBP REGULATION OF CYTOKINETIC PROCESS	7	4.96e-01	5.95e-01	0.3790	-1.72e-01	3.02e-03	-2.36e-02	3.19e-01	7.49e-02	-7.45e-02	4.31e-01	9.89e-01	9.14e-01	1.44e-01	7.32e-01	7.33e-01
GOBP REGULATION OF ACTIN FILAMENT BASED MOVEMENT	27	2.51e-01	3.70e-01	0.3790	7.27e-02	1.54e-01	2.94e-01	-3.98e-02	-1.11e-01	1.19e-01	5.13e-01	1.66e-01	8.26e-03	7.20e-01	3.20e-01	2.84e-01
GOBP SNARE COMPLEX ASSEMBLY	20	3.47e-01	4.64e-01	0.3780	-1.05e-02	9.19e-03	-1.32e-01	2.07e-01	2.58e-01	-1.27e-01	9.35e-01	9.43e-01	3.07e-01	1.09e-01	4.58e-02	3.24e-01
GOBP SUPPRESSION OF VIRAL RELEASE BY HOST	15	1.99e-01	3.15e-01	0.3780	-1.16e-02	-1.17e-01	-3.17e-02	3.48e-01	-4.78e-02	7.24e-02	9.38e-01	4.32e-01	8.32e-01	1.98e-02	7.49e-01	6.27e-01
GOBP GALACTOLIPID METABOLIC PROCESS	5	4.38e-01	5.46e-01	0.3780	-1.54e-01	2.42e-01	-6.91e-02	1.24e-01	-1.89e-01	-7.25e-02	5.52e-01	3.49e-01	7.89e-01	6.32e-01	4.65e-01	7.79e-01
GOBP PHAGOSOME LYSOSOME FUSION	12	2.07e-01	3.24e-01	0.3780	-2.96e-01	7.71e-02	3.21e-02	1.39e-01	1.59e-01	6.33e-02	7.60e-02	6.44e-01	8.47e-01	4.03e-01	3.40e-01	7.04e-01
GOBP NEGATIVE REGULATION OF ENDOTHELIAL CELL APOPTOTIC PROCESS	22	8.29e-02	1.71e-01	0.3780	6.75e-02	1.22e-01	3.15e-01	8.42e-02	-1.31e-01	-1.03e-02	5.84e-01	3.23e-01	1.04e-02	4.94e-01	2.89e-01	9.33e-01
GOBP FRUCTOSE 1 6 BISPHOSPHATE METABOLIC PROCESS	8	1.40e-01	2.49e-01	0.3780	-1.23e-02	-2.85e-01	8.53e-02	-1.42e-01	1.85e-01	-1.33e-02	9.52e-01	1.63e-01	6.76e-01	4.88e-01	3.66e-01	9.48e-01
GOMF CARD DOMAIN BINDING	14	3.04e-01	4.24e-01	0.3780	-1.31e-01	2.65e-01	-8.93e-02	5.81e-02	1.97e-01	-7.58e-02	3.96e-01	8.66e-02	5.63e-01	7.07e-01	2.02e-01	6.23e-01
GOBP POSITIVE REGULATION OF PROTEIN TYROSINE KINASE ACTIVITY	19	5.11e-01	6.06e-01	0.3780	1.99e-01	2.76e-01	1.26e-01	8.48e-02	6.29e-02	-1.81e-02	1.33e-01	3.75e-02	3.43e-01	5.22e-01	6.35e-01	8.92e-01
GOBP CELLULAR RESPONSE TO ALKALOID	30	2.51e-02	7.03e-02	0.3780	-1.56e-01	-2.76e-01	1.16e-01	5.63e-02	-7.61e-02	1.42e-01	1.40e-01	8.87e-03	2.73e-01	5.93e-01	4.71e-01	1.79e-01
GOBP RECEPTOR INTERNALIZATION	100	4.45e-05	3.28e-04	0.3780	-1.82e-02	5.76e-02	2.85e-01	1.07e-02	-1.47e-01	1.91e-01	7.54e-01	3.20e-01	8.41e-07	8.53e-01	1.12e-02	9.84e-04
GOMF HORMONE ACTIVITY	38	5.73e-02	1.30e-01	0.3780	1.64e-01	1.27e-01	2.83e-01	1.23e-01	-1.64e-02	6.78e-02	8.09e-02	1.77e-01	2.53e-03	1.90e-01	8.61e-01	4.70e-01
GOBP NEGATIVE REGULATION OF ESTABLISHMENT OF PROTEIN LOCALIZATION	105	4.71e-05	3.44e-04	0.3780	-1.85e-01	-1.47e-01	1.43e-01	-1.25e-01	-1.48e-01	1.70e-01	1.05e-03	9.23e-03	1.15e-02	2.70e-02	8.70e-03	2.55e-03
GOCC INTERCALATED DISC	38	4.18e-02	1.03e-01	0.3780	-7.61e-02	4.48e-02	2.62e-01	-1.64e-01	-1.91e-01	5.57e-02	4.17e-01	6.33e-01	5.14e-03	8.10e-02	4.20e-02	5.52e-01
GOBP MITOTIC CYTOKINESIS	87	5.22e-07	5.72e-06	0.3780	-1.40e-01	-1.51e-01	1.18e-01	1.72e-01	-3.53e-02	2.36e-01	2.44e-02	1.52e-02	5.65e-02	5.49e-03	5.70e-01	1.42e-04
GOBP RESPONSE TO LAMINAR FLUID SHEAR STRESS	13	1.12e-01	2.12e-01	0.3780	-8.59e-02	1.63e-01	2.84e-01	4.73e-02	1.61e-01	-1.53e-02	5.92e-01	3.09e-01	7.65e-02	7.68e-01	3.16e-01	9.24e-01
GOBP ACTIN FILAMENT DEPOLYMERIZATION	54	4.87e-03	1.92e-02	0.3780	2.99e-02	5.36e-02	2.76e-01	1.27e-01	4.22e-02	2.12e-01	7.03e-01	4.96e-01	4.54e-04	1.06e-01	5.91e-01	7.09e-03
GOBP B CELL MEDIATED IMMUNITY	174	2.26e-13	5.27e-12	0.3780	8.37e-02	-1.22e-01	1.39e-01	2.20e-01	-1.03e-01	2.06e-01	5.69e-02	5.52e-03	1.50e-03	5.68e-07	1.96e-02	2.70e-06
GOBP FIBRINOLYSIS	18	5.10e-03	2.00e-02	0.3780	1.47e-02	-8.69e-02	3.15e-01	-1.02e-01	-6.16e-02	-1.46e-01	9.14e-01	5.23e-01	2.05e-02	4.55e-01	6.51e-01	2.85e-01
GOBP REGULATION OF STRESS ACTIVATED PROTEIN KINASE SIGNALING CASCADE	35	8.11e-02	1.68e-01	0.3780	-2.27e-01	-2.16e-01	6.78e-02	-3.31e-02	-1.50e-01	1.28e-01	1.99e-02	2.73e-02	4.88e-01	7.34e-01	1.25e-01	1.91e-01
GOBP NEGATIVE REGULATION OF ADAPTIVE IMMUNE RESPONSE	59	1.92e-02	5.74e-02	0.3780	1.34e-01	2.05e-01	2.18e-01	9.97e-02	-1.09e-02	1.59e-01	7.42e-02	6.55e-03	3.80e-03	1.86e-01	8.84e-01	3.52e-02
GOBP POSITIVE REGULATION OF MYELINATION	15	2.14e-01	3.32e-01	0.3780	-1.34e-01	3.34e-02	2.12e-01	1.25e-01	1.59e-01	1.94e-01	3.71e-01	8.23e-01	1.54e-01	4.01e-01	2.86e-01	1.94e-01
GOBP POSITIVE REGULATION OF CYCLASE ACTIVITY	21	1.44e-01	2.54e-01	0.3780	-1.60e-01	4.10e-02	2.30e-01	-1.24e-01	-2.17e-01	-9.67e-03	2.04e-01	7.45e-01	6.86e-02	3.23e-01	8.55e-02	9.39e-01
GOBP LYSINE METABOLIC PROCESS	6	8.87e-01	9.07e-01	0.3780	-9.30e-02	-9.20e-02	-2.11e-01	-2.24e-01	1.00e-01	-1.43e-01	6.93e-01	6.96e-01	3.71e-01	3.41e-01	6.71e-01	5.44e-01
GOBP POSITIVE REGULATION OF T CELL APOPTOTIC PROCESS	12	2.68e-01	3.88e-01	0.3770	1.77e-01	-1.48e-01	-1.66e-01	1.51e-01	1.28e-01	1.51e-01	2.89e-01	3.73e-01	3.20e-01	3.66e-01	4.43e-01	3.67e-01
GOBP RIG I SIGNALING PATHWAY	24	4.52e-02	1.09e-01	0.3770	-2.04e-01	-1.69e-01	-4.80e-02	2.05e-01	-7.33e-02	1.51e-01	8.43e-02	1.52e-01	6.84e-01	8.21e-02	5.34e-01	2.01e-01
GOBP MAMMARY GLAND ALVEOLUS DEVELOPMENT	15	3.79e-01	4.93e-01	0.3770	-1.16e-01	7.34e-02	2.65e-01	-1.69e-01	7.17e-03	1.57e-01	4.38e-01	6.22e-01	7.54e-02	2.56e-01	9.62e-01	2.93e-01
GOBP VESICLE TARGETING	65	4.61e-05	3.38e-04	0.3770	-2.19e-01	-1.46e-01	2.56e-02	1.23e-01	-8.65e-02	2.23e-01	2.27e-03	4.14e-02	7.22e-01	8.71e-02	2.28e-01	1.84e-03
GOBP GLUCOSE CATABOLIC PROCESS	23	7.72e-02	1.62e-01	0.3770	-3.51e-03	5.55e-02	3.03e-01	1.75e-01	-6.67e-02	1.11e-01	9.77e-01	6.45e-01	1.19e-02	1.46e-01	5.80e-01	3.55e-01
GOBP ALCOHOL BIOSYNTHETIC PROCESS	107	1.38e-08	1.90e-07	0.3770	-8.59e-02	-2.07e-01	1.68e-01	1.28e-01	-1.03e-01	1.92e-01	1.25e-01	2.14e-04	2.63e-03	2.25e-02	6.66e-02	6.09e-04
GOBP REGULATION OF CHOLESTEROL STORAGE	15	2.22e-02	6.43e-02	0.3770	-1.01e-01	3.05e-02	1.92e-01	1.79e-01	2.40e-01	-6.86e-02	4.96e-01	8.38e-01	1.98e-01	2.29e-01	1.08e-01	6.46e-01
GOMF NADPLUS BINDING	17	3.95e-01	5.07e-01	0.3770	-1.13e-01	-2.19e-01	6.78e-02	5.65e-02	-1.26e-01	2.40e-01	4.19e-01	1.18e-01	6.28e-01	6.87e-01	3.67e-01	8.62e-02
GOBP CELLULAR RESPONSE TO ETHANOL	11	3.22e-01	4.41e-01	0.3770	-1.79e-01	2.13e-01	2.24e-01	-1.12e-01	4.23e-02	-2.06e-02	3.04e-01	2.22e-01	1.99e-01	5.19e-01	8.08e-01	9.06e-01
GOBP ISOPRENOID BIOSYNTHETIC PROCESS	22	1.96e-01	3.12e-01	0.3770	-1.89e-01	-1.52e-01	1.04e-01	5.38e-02	-3.85e-02	2.61e-01	1.25e-01	2.16e-01	3.97e-01	6.62e-01	7.54e-01	3.41e-02
GOBP REGULATION OF B CELL PROLIFERATION	59	1.05e-02	3.57e-02	0.3770	7.58e-02	2.05e-01	2.67e-01	7.81e-02	1.91e-02	1.29e-01	3.14e-01	6.36e-03	3.93e-04	2.99e-01	7.99e-01	8.69e-02
GOBP PROTEIN K63 LINKED DEUBIQUITINATION	30	6.60e-02	1.45e-01	0.3770	-1.36e-01	1.90e-01	1.81e-01	-1.82e-02	-1.32e-02	2.33e-01	1.98e-01	7.10e-02	8.58e-02	8.63e-01	9.01e-01	2.74e-02
GOBP MESODERMAL CELL DIFFERENTIATION	17	2.84e-01	4.04e-01	0.3770	-3.62e-02	-1.04e-01	2.88e-01	-1.06e-01	-1.00e-01	1.60e-01	7.96e-01	4.58e-01	3.96e-02	4.48e-01	4.75e-01	2.54e-01
GOBP MEMBRANE DISASSEMBLY	13	3.32e-01	4.50e-01	0.3770	-1.45e-01	-1.19e-01	1.46e-01	2.16e-01	-2.70e-02	1.96e-01	3.66e-01	4.58e-01	3.63e-01	1.78e-01	8.66e-01	2.22e-01
GOBP MANNOSYLATION	26	1.50e-01	2.61e-01	0.3770	-3.19e-01	-1.04e-01	-1.47e-01	-5.65e-02	3.63e-02	-5.50e-02	4.82e-03	3.59e-01	1.94e-01	6.18e-01	7.48e-01	6.27e-01
GOBP PERICENTRIC HETEROCHROMATIN FORMATION	5	8.97e-01	9.15e-01	0.3770	-1.91e-01	-1.37e-01	7.43e-02	-6.27e-02	6.24e-02	2.70e-01	4.59e-01	5.95e-01	7.74e-01	8.08e-01	8.09e-01	2.95e-01
GOBP RESPONSE TO HYPEROXIA	13	3.22e-01	4.41e-01	0.3770	-1.77e-01	-2.33e-01	9.30e-02	-2.13e-01	-4.64e-02	-8.93e-03	2.70e-01	1.46e-01	5.62e-01	1.83e-01	7.72e-01	9.56e-01
GOBP POSITIVE REGULATION OF GLYCOGEN METABOLIC PROCESS	12	1.15e-01	2.16e-01	0.3770	-3.24e-02	-4.20e-02	3.05e-02	1.10e-01	2.19e-01	-2.79e-01	8.46e-01	8.01e-01	8.55e-01	5.11e-01	1.88e-01	9.37e-02
GOBP EPIBOLY	35	5.44e-03	2.10e-02	0.3770	-1.54e-01	2.46e-02	3.06e-01	-8.46e-02	-1.10e-01	6.82e-02	1.14e-01	8.01e-01	1.74e-03	3.86e-01	2.61e-01	4.85e-01
GOBP REVERSE CHOLESTEROL TRANSPORT	13	3.27e-01	4.46e-01	0.3770	1.19e-01	9.81e-02	2.31e-01	2.36e-01	7.34e-02	-5.95e-02	4.56e-01	5.40e-01	1.49e-01	1.40e-01	6.47e-01	7.10e-01
GOBP POSITIVE REGULATION OF T HELPER 17 TYPE IMMUNE RESPONSE	17	2.06e-01	3.23e-01	0.3770	1.19e-02	3.26e-01	6.62e-02	1.02e-01	8.79e-02	-1.13e-01	9.32e-01	1.98e-02	6.36e-01	4.68e-01	5.31e-01	4.20e-01
GOBP ADHERENS JUNCTION ORGANIZATION	40	2.65e-02	7.32e-02	0.3760	3.99e-02	6.55e-02	2.82e-01	1.61e-02	-2.19e-01	8.91e-02	6.62e-01	4.73e-01	2.00e-03	8.60e-01	1.66e-02	3.29e-01
GOBP REGULATION OF ACTIN NUCLEATION	37	2.07e-02	6.09e-02	0.3760	-2.18e-01	-2.40e-01	6.27e-02	-2.88e-03	-1.80e-01	5.17e-03	2.16e-02	1.15e-02	5.09e-01	9.76e-01	5.76e-02	9.57e-01
GOBP NEGATIVE REGULATION OF GLUCOSE IMPORT	11	5.60e-01	6.49e-01	0.3760	-1.50e-01	-1.45e-01	-1.44e-01	-1.63e-01	1.34e-01	-1.81e-01	3.88e-01	4.04e-01	4.08e-01	3.50e-01	4.42e-01	2.98e-01
GOBP VERY LONG CHAIN FATTY ACID CATABOLIC PROCESS	7	8.01e-01	8.39e-01	0.3760	2.97e-02	1.33e-01	8.70e-02	2.93e-01	4.24e-02	1.66e-01	8.92e-01	5.41e-01	6.90e-01	1.79e-01	8.46e-01	4.47e-01
GOCC CLATHRIN VESICLE COAT	31	2.25e-03	1.02e-02	0.3760	-1.89e-01	-5.47e-02	8.21e-02	2.55e-01	-8.73e-02	1.53e-01	6.81e-02	5.98e-01	4.29e-01	1.40e-02	4.00e-01	1.41e-01
GOBP NEUTROPHIL MIGRATION	87	2.87e-06	2.76e-05	0.3760	-6.84e-02	8.36e-02	3.25e-01	-5.29e-02	-4.76e-02	1.38e-01	2.70e-01	1.78e-01	1.60e-07	3.94e-01	4.42e-01	2.59e-02
GOBP RESPONSE TO AMINO ACID STARVATION	53	3.00e-03	1.29e-02	0.3760	-2.23e-01	-1.65e-01	4.71e-02	-2.71e-02	-2.48e-01	-2.53e-03	4.94e-03	3.77e-02	5.54e-01	7.33e-01	1.81e-03	9.75e-01
GOBP LYMPHANGIOGENESIS	11	5.47e-01	6.37e-01	0.3760	-1.49e-01	1.82e-01	2.18e-01	2.36e-02	8.75e-02	1.74e-01	3.93e-01	2.96e-01	2.10e-01	8.92e-01	6.15e-01	3.17e-01
GOBP ORGANISM EMERGENCE FROM PROTECTIVE STRUCTURE	20	1.61e-01	2.74e-01	0.3760	3.99e-02	1.49e-02	2.86e-02	1.73e-01	3.27e-01	4.21e-02	7.57e-01	9.08e-01	8.25e-01	1.80e-01	1.14e-02	7.44e-01
GOBP NEGATIVE REGULATION OF MONOATOMIC ION TRANSMEMBRANE TRANSPORT	61	1.40e-02	4.49e-02	0.3760	-1.84e-01	-1.78e-01	8.71e-02	-1.18e-01	-1.60e-01	1.68e-01	1.28e-02	1.62e-02	2.40e-01	1.10e-01	3.03e-02	2.29e-02
GOBP RESPONSE TO TOPOLOGICALLY INCORRECT PROTEIN	138	7.94e-09	1.13e-07	0.3760	-1.90e-01	-1.54e-01	1.03e-01	3.44e-02	-1.88e-01	1.84e-01	1.13e-04	1.82e-03	3.62e-02	4.85e-01	1.33e-04	1.84e-04
GOMF MANNOSE BINDING	19	1.53e-01	2.64e-01	0.3760	-3.18e-01	3.10e-02	4.13e-02	-1.74e-01	7.39e-02	3.98e-02	1.63e-02	8.15e-01	7.56e-01	1.90e-01	5.77e-01	7.64e-01
GOBP MONOCARBOXYLIC ACID CATABOLIC PROCESS	111	1.40e-06	1.43e-05	0.3760	-1.30e-01	-2.57e-01	-2.09e-01	6.47e-02	9.32e-02	-4.37e-02	1.84e-02	3.02e-06	1.38e-04	2.39e-01	8.97e-02	4.27e-01
GOBP POSITIVE REGULATION OF LYASE ACTIVITY	21	2.65e-01	3.85e-01	0.3760	-1.69e-01	-1.28e-01	1.23e-01	-1.42e-01	-2.38e-01	-6.45e-02	1.80e-01	3.11e-01	3.30e-01	2.60e-01	5.87e-02	6.09e-01
GOBP CELL PROLIFERATION INVOLVED IN KIDNEY DEVELOPMENT	14	4.59e-01	5.64e-01	0.3760	2.32e-01	1.94e-01	1.36e-01	-3.54e-02	-1.23e-02	1.73e-01	1.33e-01	2.09e-01	3.80e-01	8.18e-01	9.37e-01	2.63e-01
GOBP TRABECULA FORMATION	15	1.34e-01	2.41e-01	0.3760	-3.18e-01	4.89e-02	-8.03e-02	-2.97e-02	-1.57e-01	-7.40e-02	3.29e-02	7.43e-01	5.90e-01	8.42e-01	2.92e-01	6.20e-01
GOBP DNA TEMPLATED TRANSCRIPTION TERMINATION	24	8.97e-02	1.81e-01	0.3760	-6.15e-02	-1.03e-03	2.45e-02	2.75e-01	9.77e-02	2.27e-01	6.02e-01	9.93e-01	8.36e-01	1.95e-02	4.07e-01	5.47e-02
GOBP NEGATIVE REGULATION OF ION TRANSMEMBRANE TRANSPORTER ACTIVITY	34	1.10e-01	2.09e-01	0.3750	-1.87e-01	-1.20e-01	1.65e-01	-1.28e-01	-1.11e-01	1.89e-01	5.95e-02	2.25e-01	9.51e-02	1.98e-01	2.64e-01	5.64e-02
GOCC PRESYNAPTIC ACTIVE ZONE CYTOPLASMIC COMPONENT	11	1.51e-01	2.62e-01	0.3750	-1.62e-01	1.67e-02	-6.45e-03	1.74e-01	4.65e-02	-2.86e-01	3.52e-01	9.24e-01	9.70e-01	3.17e-01	7.89e-01	1.00e-01
GOBP NUCLEOTIDE SUGAR BIOSYNTHETIC PROCESS	19	2.88e-01	4.08e-01	0.3750	-1.11e-01	-2.35e-01	-1.39e-01	9.66e-02	-1.73e-01	-1.21e-01	4.02e-01	7.56e-02	2.95e-01	4.66e-01	1.92e-01	3.60e-01
GOBP MITOCHONDRIAL FRAGMENTATION INVOLVED IN APOPTOTIC PROCESS	9	6.90e-01	7.53e-01	0.3750	-2.47e-02	-2.06e-01	-1.42e-01	2.34e-01	1.14e-01	9.86e-02	8.98e-01	2.84e-01	4.60e-01	2.25e-01	5.52e-01	6.09e-01
GOMF INOSITOL 1 4 5 TRISPHOSPHATE 5 PHOSPHATASE ACTIVITY	6	4.92e-01	5.91e-01	0.3750	-4.65e-02	1.50e-01	9.90e-02	2.89e-01	-1.22e-01	-8.81e-02	8.44e-01	5.25e-01	6.74e-01	2.20e-01	6.04e-01	7.09e-01
GOBP REGULATION OF PHOSPHATASE ACTIVITY	47	5.65e-03	2.17e-02	0.3750	-1.42e-01	7.63e-02	2.26e-01	6.71e-02	-3.77e-02	2.41e-01	9.14e-02	3.66e-01	7.46e-03	4.26e-01	6.54e-01	4.29e-03
GOCC MICROBODY MEMBRANE	61	5.52e-04	3.04e-03	0.3750	-2.53e-01	-2.10e-01	-1.08e-01	7.86e-03	6.86e-02	1.27e-01	6.16e-04	4.65e-03	1.44e-01	9.15e-01	3.54e-01	8.59e-02
GOBP REGULATION OF ADENYLATE CYCLASE ACTIVITY	25	4.80e-02	1.14e-01	0.3750	-1.07e-01	1.98e-01	2.44e-01	-9.37e-02	-1.48e-01	-1.09e-02	3.55e-01	8.70e-02	3.49e-02	4.17e-01	1.99e-01	9.25e-01
GOBP PROTEIN DNA COVALENT CROSS LINKING REPAIR	9	7.41e-01	7.93e-01	0.3750	1.14e-02	-2.85e-02	-1.95e-01	2.89e-01	1.34e-01	-1.69e-02	9.53e-01	8.82e-01	3.11e-01	1.33e-01	4.85e-01	9.30e-01
GOMF TESTOSTERONE DEHYDROGENASE NAD P ACTIVITY	8	4.16e-01	5.26e-01	0.3750	3.55e-01	-7.22e-02	5.42e-02	-5.48e-02	3.69e-02	4.87e-02	8.23e-02	7.24e-01	7.90e-01	7.89e-01	8.56e-01	8.11e-01
GOBP NEUROTRANSMITTER RECEPTOR TRANSPORT	19	3.40e-01	4.57e-01	0.3750	5.11e-02	7.43e-02	2.84e-01	1.42e-01	5.30e-02	1.71e-01	7.00e-01	5.75e-01	3.24e-02	2.84e-01	6.89e-01	1.97e-01
GOBP DEOXYRIBONUCLEOSIDE CATABOLIC PROCESS	5	8.43e-01	8.72e-01	0.3750	-1.50e-01	-1.62e-01	2.10e-01	-1.95e-01	-6.87e-02	6.86e-02	5.60e-01	5.30e-01	4.15e-01	4.51e-01	7.90e-01	7.90e-01
GOMF VIRION BINDING	7	6.97e-01	7.59e-01	0.3750	-3.54e-01	-6.09e-02	-1.95e-02	5.55e-02	2.74e-03	8.98e-02	1.05e-01	7.80e-01	9.29e-01	7.99e-01	9.90e-01	6.81e-01
GOBP ANTIFUNGAL INNATE IMMUNE RESPONSE	14	3.09e-01	4.29e-01	0.3750	-2.44e-01	1.11e-01	-5.94e-02	-1.66e-01	9.31e-02	1.70e-01	1.13e-01	4.72e-01	7.00e-01	2.83e-01	5.46e-01	2.71e-01
GOCC CUL2 RING UBIQUITIN LIGASE COMPLEX	21	1.23e-01	2.27e-01	0.3750	-3.30e-01	-3.90e-02	-1.92e-02	7.96e-03	3.51e-02	1.68e-01	8.76e-03	7.57e-01	8.79e-01	9.50e-01	7.81e-01	1.83e-01
GOBP CELL FATE DETERMINATION	22	6.01e-02	1.35e-01	0.3750	-5.95e-02	2.59e-01	1.87e-01	-4.75e-02	1.78e-01	-3.59e-02	6.29e-01	3.57e-02	1.29e-01	7.00e-01	1.49e-01	7.71e-01
GOCC PHAGOPHORE ASSEMBLY SITE MEMBRANE	21	8.59e-02	1.75e-01	0.3750	-8.36e-02	-2.16e-02	-1.64e-01	3.03e-01	6.48e-02	-9.93e-02	5.07e-01	8.64e-01	1.93e-01	1.61e-02	6.07e-01	4.31e-01
GOMF METALLOEXOPEPTIDASE ACTIVITY	47	1.09e-02	3.69e-02	0.3750	-2.82e-01	-1.22e-01	5.43e-02	-1.96e-01	-4.71e-02	5.15e-02	8.30e-04	1.46e-01	5.20e-01	2.03e-02	5.77e-01	5.42e-01
GOBP RNA SPLICING VIA TRANSESTERIFICATION REACTIONS	289	4.84e-19	1.89e-17	0.3750	-1.36e-01	-2.49e-01	-2.22e-01	1.01e-01	1.70e-02	5.13e-03	7.29e-05	3.03e-13	8.53e-11	3.04e-03	6.20e-01	8.81e-01
GOBP VENTRICULAR CARDIAC MUSCLE TISSUE MORPHOGENESIS	28	2.07e-01	3.23e-01	0.3750	4.94e-02	2.28e-01	9.31e-02	1.43e-01	1.59e-01	1.77e-01	6.51e-01	3.66e-02	3.94e-01	1.89e-01	1.46e-01	1.04e-01
GOBP SPINDLE ASSEMBLY	126	1.16e-10	2.07e-09	0.3750	-6.75e-02	-1.38e-01	6.60e-02	2.51e-01	4.21e-02	2.18e-01	1.91e-01	7.29e-03	2.01e-01	1.18e-06	4.14e-01	2.31e-05
GOBP ORGANONITROGEN COMPOUND BIOSYNTHETIC PROCESS	1505	1.10e-94	2.54e-91	0.3750	-1.60e-01	-2.98e-01	-1.48e-01	3.84e-02	-4.78e-02	1.81e-02	3.99e-25	1.22e-83	8.47e-22	1.29e-02	1.97e-03	2.41e-01
GOMF PHOSPHATIDYL PHOSPHOLIPASE B ACTIVITY	10	4.13e-01	5.23e-01	0.3740	4.30e-02	-7.83e-02	2.03e-01	2.89e-01	6.83e-02	5.56e-02	8.14e-01	6.68e-01	2.66e-01	1.14e-01	7.08e-01	7.61e-01
GOCC REPLICATION FORK	74	6.45e-05	4.59e-04	0.3740	7.70e-02	-1.50e-01	-1.41e-01	2.42e-01	1.77e-01	4.88e-02	2.52e-01	2.61e-02	3.63e-02	3.18e-04	8.63e-03	4.68e-01
GOBP ADENYLATE CYCLASE INHIBITING G PROTEIN COUPLED RECEPTOR SIGNALING PATHWAY	49	3.35e-03	1.42e-02	0.3740	-5.25e-02	1.44e-01	2.89e-01	-1.48e-01	-1.25e-02	1.06e-01	5.25e-01	8.13e-02	4.62e-04	7.40e-02	8.80e-01	1.99e-01
GOBP MITOCHONDRIAL FISSION	38	3.07e-02	8.14e-02	0.3740	-2.37e-01	-2.46e-01	-1.11e-01	7.61e-02	-4.16e-02	6.21e-02	1.15e-02	8.66e-03	2.38e-01	4.17e-01	6.57e-01	5.08e-01
GOBP REGULATION OF RELAXATION OF MUSCLE	9	7.37e-01	7.90e-01	0.3740	5.29e-06	2.61e-01	7.21e-02	2.02e-01	1.57e-01	3.91e-02	1.00e+00	1.75e-01	7.08e-01	2.95e-01	4.15e-01	8.39e-01
GOBP ESTABLISHMENT OF EPITHELIAL CELL APICAL BASAL POLARITY	14	5.59e-01	6.48e-01	0.3740	-1.43e-01	-3.07e-02	1.92e-01	-9.16e-02	-6.25e-03	2.71e-01	3.55e-01	8.42e-01	2.13e-01	5.53e-01	9.68e-01	7.93e-02
GOBP NEGATIVE REGULATION OF MONOATOMIC ION TRANSPORT	77	1.93e-03	8.91e-03	0.3740	-1.53e-01	-1.88e-01	1.13e-01	-1.43e-01	-1.64e-01	1.45e-01	2.00e-02	4.34e-03	8.62e-02	3.04e-02	1.29e-02	2.73e-02
GOBP SENSORY PERCEPTION OF TEMPERATURE STIMULUS	15	7.20e-02	1.54e-01	0.3740	-1.26e-01	-2.36e-01	6.65e-02	2.45e-01	-7.36e-03	-6.42e-02	3.98e-01	1.14e-01	6.55e-01	1.01e-01	9.61e-01	6.67e-01
GOCC ISWI TYPE COMPLEX	13	1.61e-01	2.74e-01	0.3740	-2.54e-01	-4.02e-02	-5.81e-02	2.38e-01	-3.57e-02	1.13e-01	1.13e-01	8.02e-01	7.17e-01	1.38e-01	8.24e-01	4.82e-01
GOMF PHOSPHOFRUCTOKINASE ACTIVITY	7	4.82e-01	5.83e-01	0.3740	-2.51e-02	1.27e-01	2.59e-01	-2.11e-02	-1.24e-01	-2.01e-01	9.09e-01	5.62e-01	2.35e-01	9.23e-01	5.70e-01	3.58e-01
GOMF SPECTRIN BINDING	24	2.63e-01	3.83e-01	0.3740	1.37e-01	5.48e-02	2.86e-01	1.56e-02	5.12e-03	1.89e-01	2.45e-01	6.42e-01	1.53e-02	8.95e-01	9.65e-01	1.08e-01
GOBP HIPPOCAMPUS DEVELOPMENT	67	5.15e-03	2.01e-02	0.3740	8.93e-02	1.90e-01	1.89e-01	1.88e-01	1.16e-01	1.07e-01	2.06e-01	7.22e-03	7.57e-03	7.94e-03	1.00e-01	1.31e-01
GOBP REGULATION OF GLUTAMATE SECRETION	13	5.11e-01	6.06e-01	0.3740	7.11e-02	6.82e-02	2.12e-01	2.57e-01	1.01e-01	9.18e-02	6.57e-01	6.70e-01	1.86e-01	1.08e-01	5.27e-01	5.67e-01
GOMF PEPTIDE HORMONE RECEPTOR BINDING	7	5.53e-01	6.43e-01	0.3730	-1.82e-01	-9.73e-02	-1.62e-01	6.83e-02	-2.43e-01	8.22e-02	4.04e-01	6.56e-01	4.59e-01	7.54e-01	2.65e-01	7.07e-01
GOBP PLASMA MEMBRANE PHOSPHOLIPID SCRAMBLING	18	4.59e-01	5.64e-01	0.3730	6.25e-02	1.01e-01	2.11e-01	1.82e-01	1.37e-01	1.70e-01	6.46e-01	4.57e-01	1.22e-01	1.80e-01	3.14e-01	2.12e-01
GOBP ENERGY HOMEOSTASIS	57	3.34e-03	1.41e-02	0.3730	1.68e-02	1.68e-01	5.71e-02	2.42e-01	2.19e-01	3.38e-02	8.27e-01	2.81e-02	4.56e-01	1.60e-03	4.25e-03	6.59e-01
GOBP ACUTE PHASE RESPONSE	26	3.01e-02	8.04e-02	0.3730	-7.40e-02	1.61e-01	2.92e-01	-1.47e-01	-3.23e-02	-1.18e-02	5.14e-01	1.55e-01	1.00e-02	1.95e-01	7.75e-01	9.17e-01
GOBP REGULATION OF VENTRICULAR CARDIAC MUSCLE CELL ACTION POTENTIAL	10	6.65e-01	7.33e-01	0.3730	3.19e-02	5.15e-02	2.95e-01	-1.80e-01	-1.19e-01	4.32e-02	8.61e-01	7.78e-01	1.06e-01	3.25e-01	5.15e-01	8.13e-01
GOBP REGULATION OF HEART RATE BY CARDIAC CONDUCTION	27	1.89e-01	3.04e-01	0.3730	-1.27e-01	2.94e-02	1.47e-01	-2.84e-01	-9.86e-02	1.01e-01	2.54e-01	7.92e-01	1.86e-01	1.07e-02	3.75e-01	3.65e-01
GOBP PURINE CONTAINING COMPOUND SALVAGE	14	4.00e-01	5.12e-01	0.3730	-1.17e-01	-3.06e-01	7.83e-02	-8.48e-02	-8.49e-02	1.05e-01	4.47e-01	4.76e-02	6.12e-01	5.83e-01	5.82e-01	4.94e-01
GOCC GOLGI CISTERNA MEMBRANE	75	6.73e-06	5.92e-05	0.3730	-7.69e-02	8.63e-03	1.51e-01	2.20e-01	-5.97e-02	2.41e-01	2.50e-01	8.97e-01	2.38e-02	9.75e-04	3.71e-01	3.06e-04
GOMF GLUCURONOSYLTRANSFERASE ACTIVITY	14	2.86e-01	4.05e-01	0.3730	-9.11e-02	-2.35e-02	2.15e-01	8.57e-02	-2.71e-01	5.58e-02	5.55e-01	8.79e-01	1.64e-01	5.79e-01	7.92e-02	7.18e-01
GOBP GLUTAMINE FAMILY AMINO ACID BIOSYNTHETIC PROCESS	14	4.60e-01	5.65e-01	0.3730	-2.57e-01	-1.69e-01	1.21e-02	6.51e-02	-5.26e-02	1.93e-01	9.57e-02	2.74e-01	9.37e-01	6.73e-01	7.33e-01	2.12e-01
GOBP VESICLE COATING	39	5.50e-03	2.12e-02	0.3730	-1.29e-01	-1.36e-01	4.59e-02	2.01e-01	-6.39e-02	2.39e-01	1.64e-01	1.42e-01	6.20e-01	2.94e-02	4.90e-01	9.86e-03
GOBP PRIMARY AMINO COMPOUND METABOLIC PROCESS	11	4.19e-01	5.29e-01	0.3730	-1.19e-01	8.68e-02	-4.12e-02	-4.29e-03	3.27e-01	-9.10e-02	4.93e-01	6.18e-01	8.13e-01	9.80e-01	6.03e-02	6.01e-01
GOBP FILOPODIUM ASSEMBLY	56	1.89e-03	8.73e-03	0.3730	-1.10e-01	8.94e-02	2.50e-01	7.49e-02	-2.98e-02	2.23e-01	1.55e-01	2.47e-01	1.22e-03	3.32e-01	7.00e-01	3.85e-03
GOBP B CELL HOMEOSTASIS	34	1.65e-02	5.08e-02	0.3720	-1.80e-01	3.27e-02	2.05e-01	1.02e-01	-7.78e-02	2.16e-01	6.86e-02	7.41e-01	3.88e-02	3.06e-01	4.33e-01	2.90e-02
GOBP CELLULAR RESPONSE TO UV B	12	3.08e-01	4.28e-01	0.3720	2.26e-01	-8.96e-04	1.25e-01	2.83e-02	-4.27e-02	-2.63e-01	1.75e-01	9.96e-01	4.54e-01	8.65e-01	7.98e-01	1.14e-01
GOMF PROTEIN SERINE THREONINE KINASE INHIBITOR ACTIVITY	35	7.96e-03	2.87e-02	0.3720	1.39e-02	-2.79e-01	1.11e-01	1.34e-01	-1.69e-01	4.25e-02	8.87e-01	4.32e-03	2.56e-01	1.69e-01	8.39e-02	6.63e-01
GOBP EXTRACELLULAR VESICLE BIOGENESIS	24	2.91e-01	4.10e-01	0.3720	-1.75e-01	-1.84e-01	1.02e-01	-1.79e-02	-2.16e-01	1.29e-01	1.38e-01	1.18e-01	3.89e-01	8.79e-01	6.69e-02	2.74e-01
GOBP NEGATIVE REGULATION OF TYPE II INTERFERON PRODUCTION	38	8.36e-02	1.72e-01	0.3720	8.99e-02	2.85e-02	3.00e-01	1.07e-02	-1.15e-01	1.63e-01	3.38e-01	7.61e-01	1.39e-03	9.09e-01	2.22e-01	8.26e-02
GOBP NEGATIVE REGULATION OF NUCLEAR TRANSCRIBED MRNA CATABOLIC PROCESS NONSENSE MEDIATED DECAY	7	8.69e-01	8.94e-01	0.3720	-5.35e-02	-2.29e-01	-1.13e-01	-1.81e-02	-9.58e-02	-2.46e-01	8.06e-01	2.93e-01	6.04e-01	9.34e-01	6.61e-01	2.60e-01
GOBP ENTRY OF BACTERIUM INTO HOST CELL	7	4.97e-01	5.95e-01	0.3720	-2.82e-01	4.89e-02	1.50e-01	-1.44e-01	1.04e-01	-4.92e-02	1.96e-01	8.23e-01	4.93e-01	5.10e-01	6.34e-01	8.22e-01
GOBP CEREBELLAR CORTEX FORMATION	18	1.68e-01	2.81e-01	0.3720	-1.52e-01	1.97e-01	7.23e-02	1.75e-02	2.58e-01	6.57e-02	2.64e-01	1.48e-01	5.95e-01	8.98e-01	5.83e-02	6.30e-01
GOBP ATP METABOLIC PROCESS	195	4.55e-14	1.13e-12	0.3720	-9.53e-02	-3.32e-01	-7.50e-02	8.27e-02	-7.81e-02	1.47e-02	2.17e-02	1.23e-15	7.08e-02	4.65e-02	6.01e-02	7.24e-01
GOBP NON PROTEINOGENIC AMINO ACID CATABOLIC PROCESS	14	3.41e-01	4.58e-01	0.3720	-1.37e-01	-1.26e-01	-1.03e-01	9.93e-02	2.42e-01	1.56e-01	3.75e-01	4.16e-01	5.05e-01	5.20e-01	1.16e-01	3.11e-01
GOMF SYNTAXIN 1 BINDING	14	4.71e-01	5.73e-01	0.3720	-2.72e-01	5.68e-03	-3.20e-02	-1.51e-01	-1.54e-01	1.29e-01	7.80e-02	9.71e-01	8.36e-01	3.29e-01	3.19e-01	4.05e-01
GOMF POLY A SPECIFIC RIBONUCLEASE ACTIVITY	13	1.69e-01	2.82e-01	0.3710	-1.36e-01	1.05e-01	1.83e-02	2.48e-01	-2.64e-02	2.14e-01	3.95e-01	5.11e-01	9.09e-01	1.21e-01	8.69e-01	1.82e-01
GOBP HETEROTYPIC CELL CELL ADHESION	50	1.30e-03	6.38e-03	0.3710	-7.55e-02	1.82e-01	2.53e-01	-1.70e-01	3.05e-02	7.17e-02	3.56e-01	2.59e-02	1.94e-03	3.80e-02	7.09e-01	3.80e-01
GOBP STRIATED MUSCLE CELL DEVELOPMENT	48	4.50e-02	1.09e-01	0.3710	6.08e-02	1.13e-01	2.45e-01	6.46e-02	-1.01e-01	2.17e-01	4.66e-01	1.74e-01	3.33e-03	4.39e-01	2.24e-01	9.44e-03
GOBP REGULATION OF DENDRITIC SPINE DEVELOPMENT	49	8.36e-04	4.38e-03	0.3710	-2.11e-01	4.87e-02	1.41e-01	4.16e-02	1.21e-01	2.33e-01	1.06e-02	5.55e-01	8.71e-02	6.14e-01	1.41e-01	4.69e-03
GOCC TERMINAL BOUTON	24	6.14e-02	1.37e-01	0.3710	4.23e-02	3.91e-02	2.32e-01	2.67e-01	-6.00e-02	7.57e-02	7.20e-01	7.40e-01	4.89e-02	2.37e-02	6.11e-01	5.21e-01
GOCC DESMOSOME	18	4.62e-01	5.66e-01	0.3710	2.03e-02	1.02e-01	2.43e-01	-1.63e-01	-1.98e-01	4.64e-02	8.81e-01	4.53e-01	7.42e-02	2.31e-01	1.47e-01	7.33e-01
GOBP PROTEIN LOCALIZATION TO LYSOSOME	52	2.45e-03	1.09e-02	0.3710	-2.10e-01	-1.33e-01	1.13e-01	6.95e-02	-1.19e-01	2.10e-01	8.67e-03	9.79e-02	1.58e-01	3.86e-01	1.38e-01	8.90e-03
GOBP CELL DIFFERENTIATION IN SPINAL CORD	25	2.72e-01	3.91e-01	0.3710	7.74e-02	1.92e-01	-1.28e-01	6.40e-02	1.61e-01	-2.19e-01	5.03e-01	9.64e-02	2.67e-01	5.79e-01	1.63e-01	5.76e-02
GOCC COMPLEX OF COLLAGEN TRIMERS	13	4.08e-01	5.19e-01	0.3710	-1.73e-01	1.92e-01	1.51e-02	-2.30e-01	-8.76e-02	-1.00e-01	2.81e-01	2.30e-01	9.25e-01	1.51e-01	5.84e-01	5.32e-01
GOBP POSITIVE REGULATION OF VASCULAR ASSOCIATED SMOOTH MUSCLE CELL MIGRATION	13	1.24e-01	2.29e-01	0.3710	-2.32e-01	2.59e-01	4.20e-02	4.74e-02	6.21e-02	-9.44e-02	1.48e-01	1.06e-01	7.93e-01	7.67e-01	6.98e-01	5.56e-01
GOBP FOREBRAIN NEURON DEVELOPMENT	16	3.66e-01	4.81e-01	0.3710	9.28e-04	1.37e-01	1.59e-01	2.22e-01	1.94e-01	7.79e-02	9.95e-01	3.41e-01	2.69e-01	1.23e-01	1.79e-01	5.89e-01
GOCC MEDIATOR COMPLEX	37	8.73e-03	3.08e-02	0.3710	3.03e-02	-7.98e-02	-2.94e-02	3.06e-01	3.27e-02	1.86e-01	7.50e-01	4.01e-01	7.57e-01	1.28e-03	7.31e-01	4.99e-02
GOBP POSITIVE REGULATION OF T HELPER CELL DIFFERENTIATION	22	1.93e-02	5.77e-02	0.3710	-2.06e-01	1.09e-01	2.57e-01	8.30e-02	-7.15e-02	7.25e-02	9.38e-02	3.77e-01	3.72e-02	5.00e-01	5.62e-01	5.56e-01
GOBP ESTABLISHMENT OF MITOTIC SPINDLE LOCALIZATION	34	2.46e-02	6.93e-02	0.3710	-1.07e-01	-6.05e-02	1.12e-01	8.78e-02	-2.13e-01	2.38e-01	2.81e-01	5.42e-01	2.57e-01	3.76e-01	3.14e-02	1.64e-02
GOCC MIDBODY	194	3.29e-16	1.00e-14	0.3710	-1.21e-01	-1.33e-01	1.39e-01	1.78e-01	-4.01e-02	2.29e-01	3.76e-03	1.45e-03	8.24e-04	1.95e-05	3.35e-01	3.59e-08
GOMF NUCLEOSOME BINDING	75	3.79e-06	3.55e-05	0.3710	-8.09e-02	-2.90e-01	-4.68e-02	1.97e-01	2.30e-02	7.04e-02	2.26e-01	1.36e-05	4.84e-01	3.19e-03	7.30e-01	2.92e-01
GOBP DEADENYLATION DEPENDENT DECAPPING OF NUCLEAR TRANSCRIBED MRNA	11	4.68e-01	5.71e-01	0.3710	-1.39e-01	-8.83e-02	1.60e-02	5.03e-02	-2.55e-01	2.06e-01	4.26e-01	6.12e-01	9.27e-01	7.73e-01	1.42e-01	2.38e-01
GOBP POSITIVE REGULATION OF VACUOLE ORGANIZATION	24	1.46e-02	4.64e-02	0.3700	-2.60e-01	1.07e-01	1.28e-01	1.21e-01	-5.33e-02	1.56e-01	2.74e-02	3.63e-01	2.78e-01	3.05e-01	6.51e-01	1.87e-01
GOBP REGULATION OF STEROL TRANSPORT	42	8.76e-04	4.55e-03	0.3700	5.76e-02	4.72e-02	2.66e-01	2.34e-01	-7.28e-02	2.73e-02	5.18e-01	5.97e-01	2.88e-03	8.55e-03	4.14e-01	7.60e-01
GOMF OPSIN BINDING	5	8.90e-01	9.10e-01	0.3700	8.93e-02	1.74e-01	1.60e-01	-2.70e-01	-5.41e-03	2.55e-02	7.29e-01	5.00e-01	5.37e-01	2.96e-01	9.83e-01	9.21e-01
GOBP REGULATION OF SYSTEMIC ARTERIAL BLOOD PRESSURE BY RENIN ANGIOTENSIN	15	5.14e-01	6.08e-01	0.3700	-2.73e-01	-5.24e-02	1.03e-01	-1.02e-01	-3.66e-02	1.93e-01	6.75e-02	7.25e-01	4.90e-01	4.95e-01	8.06e-01	1.94e-01
GOBP SYMPATHETIC NERVOUS SYSTEM DEVELOPMENT	9	6.77e-01	7.44e-01	0.3700	-1.14e-01	1.76e-01	1.35e-01	-6.27e-02	2.03e-01	1.72e-01	5.54e-01	3.62e-01	4.84e-01	7.44e-01	2.91e-01	3.72e-01
GOBP REGULATION OF INTRINSIC APOPTOTIC SIGNALING PATHWAY IN RESPONSE TO DNA DAMAGE BY P53 CLASS MEDIATOR	17	6.01e-01	6.81e-01	0.3700	-1.78e-01	-2.55e-01	-1.51e-01	-9.53e-02	-2.06e-02	-8.78e-02	2.03e-01	6.90e-02	2.80e-01	4.96e-01	8.83e-01	5.31e-01
GOCC MALE PRONUCLEUS	7	8.71e-01	8.95e-01	0.3700	-3.02e-01	-1.09e-01	-5.46e-02	-5.98e-02	-1.62e-01	2.64e-02	1.66e-01	6.17e-01	8.02e-01	7.84e-01	4.57e-01	9.04e-01
GOBP POSITIVE REGULATION OF CARTILAGE DEVELOPMENT	18	4.87e-01	5.87e-01	0.3700	1.69e-01	1.62e-01	2.52e-01	-2.90e-02	-1.25e-01	4.69e-02	2.15e-01	2.35e-01	6.42e-02	8.31e-01	3.60e-01	7.31e-01
GOBP CHONDROITIN SULFATE BIOSYNTHETIC PROCESS	16	1.61e-02	5.00e-02	0.3700	-1.05e-01	9.77e-02	1.54e-01	2.06e-01	-1.64e-01	-1.52e-01	4.68e-01	4.98e-01	2.86e-01	1.54e-01	2.55e-01	2.93e-01
GOBP TRANSCRIPTION INITIATION AT RNA POLYMERASE III PROMOTER	8	7.26e-01	7.81e-01	0.3700	-5.16e-03	-2.16e-01	-1.81e-01	1.82e-01	-1.39e-01	-7.00e-02	9.80e-01	2.91e-01	3.76e-01	3.72e-01	4.95e-01	7.32e-01
GOBP REGULATION OF BRANCHING INVOLVED IN URETERIC BUD MORPHOGENESIS	11	6.55e-01	7.26e-01	0.3700	-8.39e-02	2.20e-02	-2.02e-01	-1.65e-01	1.88e-01	-1.60e-01	6.30e-01	8.99e-01	2.46e-01	3.43e-01	2.79e-01	3.59e-01
GOBP POSITIVE REGULATION OF MYOBLAST PROLIFERATION	8	7.49e-01	8.00e-01	0.3690	-7.13e-03	2.18e-01	-9.42e-02	-1.91e-01	7.12e-02	-1.97e-01	9.72e-01	2.86e-01	6.44e-01	3.50e-01	7.27e-01	3.35e-01
GOBP CARDIAC ATRIUM DEVELOPMENT	19	2.39e-01	3.57e-01	0.3690	3.50e-02	8.58e-02	2.71e-01	1.51e-01	1.18e-01	1.34e-01	7.92e-01	5.18e-01	4.09e-02	2.55e-01	3.75e-01	3.14e-01
GOBP PHOSPHATIDYLCHOLINE BIOSYNTHETIC PROCESS	25	2.62e-02	7.26e-02	0.3690	-3.23e-01	-8.42e-02	8.58e-02	1.12e-02	6.60e-02	1.14e-01	5.16e-03	4.66e-01	4.57e-01	9.23e-01	5.68e-01	3.24e-01
GOBP REGULATION OF T CELL MEDIATED IMMUNE RESPONSE TO TUMOR CELL	10	7.01e-01	7.62e-01	0.3690	-2.47e-01	-1.83e-01	-1.41e-01	3.03e-02	-2.04e-03	1.45e-01	1.76e-01	3.17e-01	4.39e-01	8.68e-01	9.91e-01	4.28e-01
GOMF ISOPRENOID BINDING	13	1.70e-01	2.83e-01	0.3690	-5.37e-02	-4.69e-03	1.62e-01	8.49e-02	-2.88e-01	-1.31e-01	7.38e-01	9.77e-01	3.13e-01	5.96e-01	7.24e-02	4.12e-01
GOBP RELAXATION OF MUSCLE	26	9.37e-02	1.87e-01	0.3690	-2.01e-01	-1.22e-01	1.82e-01	5.07e-02	-1.28e-01	1.70e-01	7.62e-02	2.82e-01	1.09e-01	6.54e-01	2.60e-01	1.33e-01
GOMF EXTRACELLULAR LIGAND GATED MONOATOMIC ION CHANNEL ACTIVITY	30	2.83e-01	4.03e-01	0.3690	2.06e-01	1.83e-01	2.19e-01	4.29e-02	4.97e-02	8.96e-02	5.10e-02	8.32e-02	3.77e-02	6.84e-01	6.37e-01	3.96e-01
GOMF SUGAR TRANSMEMBRANE TRANSPORTER ACTIVITY	22	1.27e-01	2.32e-01	0.3690	1.25e-01	7.67e-02	5.39e-02	1.22e-01	2.92e-01	-1.08e-01	3.11e-01	5.33e-01	6.62e-01	3.22e-01	1.77e-02	3.81e-01
GOBP KERATINOCYTE PROLIFERATION	37	1.54e-02	4.84e-02	0.3690	7.57e-02	2.64e-01	2.14e-01	2.01e-03	9.45e-02	-7.77e-02	4.26e-01	5.49e-03	2.43e-02	9.83e-01	3.20e-01	4.14e-01
GOBP PURINE CONTAINING COMPOUND TRANSMEMBRANE TRANSPORT	31	3.32e-01	4.50e-01	0.3690	-1.46e-01	-2.13e-01	-1.73e-01	-9.92e-02	-1.10e-01	-1.32e-01	1.58e-01	4.03e-02	9.52e-02	3.39e-01	2.89e-01	2.04e-01
GOBP CARDIAC EPITHELIAL TO MESENCHYMAL TRANSITION	23	6.16e-02	1.38e-01	0.3690	-1.42e-01	1.48e-01	1.16e-01	2.04e-01	1.48e-01	1.31e-01	2.37e-01	2.20e-01	3.36e-01	9.05e-02	2.19e-01	2.78e-01
GOMF VERY LONG CHAIN FATTY ACID COA LIGASE ACTIVITY	8	6.52e-01	7.23e-01	0.3690	1.48e-01	-1.12e-01	5.79e-02	2.83e-01	-2.69e-02	-1.33e-01	4.69e-01	5.83e-01	7.77e-01	1.66e-01	8.95e-01	5.15e-01
GOBP POSITIVE REGULATION OF SIGNAL TRANSDUCTION BY P53 CLASS MEDIATOR	28	4.17e-02	1.03e-01	0.3690	-6.37e-02	-2.18e-01	-2.04e-01	1.99e-02	2.02e-01	3.68e-02	5.60e-01	4.54e-02	6.11e-02	8.56e-01	6.49e-02	7.36e-01
GOBP SERINE TRANSPORT	9	8.36e-01	8.68e-01	0.3690	-2.26e-02	-3.88e-02	1.95e-01	7.38e-02	-1.51e-01	2.60e-01	9.06e-01	8.40e-01	3.12e-01	7.01e-01	4.31e-01	1.77e-01
GOBP XENOBIOTIC EXPORT FROM CELL	12	3.15e-01	4.35e-01	0.3690	-2.97e-01	-1.29e-01	4.70e-02	-1.48e-01	8.28e-02	-1.50e-02	7.53e-02	4.38e-01	7.78e-01	3.74e-01	6.19e-01	9.28e-01
GOBP REGULATION OF EXOCYTOSIS	139	8.63e-12	1.74e-10	0.3690	-1.81e-01	-2.62e-03	2.27e-01	8.88e-02	-8.57e-02	1.91e-01	2.34e-04	9.57e-01	3.77e-06	7.08e-02	8.12e-02	1.03e-04
GOBP NEGATIVE REGULATION OF UBIQUITIN PROTEIN TRANSFERASE ACTIVITY	15	3.53e-01	4.68e-01	0.3690	-1.29e-01	-2.68e-01	-7.40e-02	1.36e-01	7.26e-02	1.33e-01	3.85e-01	7.18e-02	6.20e-01	3.62e-01	6.26e-01	3.71e-01
GOBP PROTEIN K6 LINKED UBIQUITINATION	16	3.29e-01	4.47e-01	0.3690	-1.09e-01	-2.27e-01	-2.82e-02	1.62e-01	-7.13e-02	2.01e-01	4.52e-01	1.16e-01	8.45e-01	2.62e-01	6.22e-01	1.64e-01
GOBP NEGATIVE REGULATION OF SMOOTH MUSCLE CELL APOPTOTIC PROCESS	11	3.32e-01	4.50e-01	0.3690	1.90e-01	-1.76e-01	8.58e-03	1.47e-01	1.37e-01	-1.68e-01	2.74e-01	3.11e-01	9.61e-01	3.99e-01	4.32e-01	3.36e-01
GOBP NATURAL KILLER CELL MEDIATED IMMUNE RESPONSE TO TUMOR CELL	10	6.63e-01	7.32e-01	0.3680	2.32e-01	-5.58e-02	1.39e-01	1.78e-01	-1.57e-01	5.59e-02	2.04e-01	7.60e-01	4.46e-01	3.30e-01	3.90e-01	7.60e-01
GOCC CHROMOCENTER	13	3.27e-01	4.45e-01	0.3680	-3.55e-03	4.38e-02	-1.45e-02	3.14e-01	2.43e-02	1.85e-01	9.82e-01	7.84e-01	9.28e-01	4.97e-02	8.79e-01	2.49e-01
GOCC ANAPHASE PROMOTING COMPLEX	22	2.05e-01	3.22e-01	0.3680	-3.31e-02	-3.32e-01	-1.45e-01	4.79e-02	-3.49e-02	-1.47e-04	7.88e-01	7.07e-03	2.39e-01	6.98e-01	7.77e-01	9.99e-01
GOMF HEPARAN SULFATE PROTEOGLYCAN BINDING	13	4.64e-01	5.68e-01	0.3680	2.36e-02	7.74e-02	3.42e-01	-1.09e-02	-1.35e-02	1.10e-01	8.83e-01	6.29e-01	3.29e-02	9.46e-01	9.33e-01	4.94e-01
GOBP GLANDULAR EPITHELIAL CELL DIFFERENTIATION	38	3.69e-03	1.53e-02	0.3680	-5.58e-02	1.14e-01	3.05e-01	1.25e-01	-2.44e-02	1.01e-01	5.51e-01	2.23e-01	1.14e-03	1.83e-01	7.94e-01	2.81e-01
GOMF PEPTIDE N ACETYLTRANSFERASE ACTIVITY	48	9.96e-06	8.39e-05	0.3680	-6.69e-02	1.06e-01	-1.09e-01	3.13e-01	1.92e-02	-9.93e-02	4.23e-01	2.05e-01	1.90e-01	1.79e-04	8.18e-01	2.34e-01
GOBP POSITIVE REGULATION OF MACROPHAGE DERIVED FOAM CELL DIFFERENTIATION	11	6.68e-01	7.36e-01	0.3680	-1.82e-01	-8.55e-02	7.94e-02	-2.82e-01	-8.53e-02	-4.52e-02	2.97e-01	6.24e-01	6.48e-01	1.05e-01	6.24e-01	7.95e-01
GOBP RESPONSE TO CGMP	7	7.06e-01	7.66e-01	0.3680	5.90e-03	-1.33e-01	8.37e-02	6.71e-02	-2.87e-01	-1.54e-01	9.78e-01	5.43e-01	7.01e-01	7.58e-01	1.88e-01	4.81e-01
GOMF DISORDERED DOMAIN SPECIFIC BINDING	25	3.61e-02	9.22e-02	0.3680	5.93e-02	-7.12e-02	2.00e-01	2.89e-01	-1.37e-02	5.57e-02	6.08e-01	5.38e-01	8.31e-02	1.24e-02	9.06e-01	6.30e-01
GOBP POSITIVE REGULATION OF LONG TERM SYNAPTIC POTENTIATION	15	2.61e-01	3.81e-01	0.3680	-8.18e-03	-2.39e-01	6.64e-02	2.07e-02	1.73e-02	2.71e-01	9.56e-01	1.09e-01	6.56e-01	8.89e-01	9.08e-01	6.96e-02
GOMF HISTONE MODIFYING ACTIVITY	193	3.74e-16	1.13e-14	0.3680	1.41e-02	1.40e-01	3.31e-02	3.18e-01	1.15e-01	8.47e-03	7.35e-01	7.74e-04	4.28e-01	2.54e-14	5.93e-03	8.39e-01
GOBP RESPONSE TO NITROSATIVE STRESS	9	7.88e-01	8.29e-01	0.3680	-2.04e-01	-2.48e-01	-2.70e-02	-1.29e-01	-1.62e-02	1.21e-01	2.90e-01	1.98e-01	8.88e-01	5.01e-01	9.33e-01	5.29e-01
GOMF U2 SNRNA BINDING	6	7.84e-01	8.26e-01	0.3680	-2.48e-01	-1.16e-01	-7.82e-03	6.17e-02	-2.37e-01	-2.23e-02	2.94e-01	6.21e-01	9.74e-01	7.93e-01	3.16e-01	9.25e-01
GOCC SMN COMPLEX	11	5.17e-01	6.11e-01	0.3680	3.37e-02	-2.67e-01	-1.74e-01	6.35e-02	1.56e-01	-6.55e-02	8.47e-01	1.26e-01	3.17e-01	7.15e-01	3.71e-01	7.07e-01
GOBP OSTEOCLAST DIFFERENTIATION	84	1.03e-05	8.60e-05	0.3680	-8.51e-02	1.68e-01	2.80e-01	2.23e-02	-6.62e-03	1.44e-01	1.78e-01	7.91e-03	9.05e-06	7.24e-01	9.16e-01	2.25e-02
GOBP IRON IMPORT INTO CELL	8	7.42e-01	7.94e-01	0.3670	7.40e-02	2.33e-01	1.21e-01	-1.91e-01	-6.04e-02	1.43e-01	7.17e-01	2.54e-01	5.54e-01	3.48e-01	7.67e-01	4.83e-01
GOBP METANEPHROS MORPHOGENESIS	15	3.23e-01	4.42e-01	0.3670	-8.33e-02	1.45e-01	2.10e-01	-2.30e-01	6.26e-02	7.90e-02	5.77e-01	3.29e-01	1.60e-01	1.24e-01	6.75e-01	5.96e-01
GOBP BICARBONATE TRANSPORT	27	6.76e-02	1.47e-01	0.3670	9.97e-02	2.71e-01	1.64e-01	-1.24e-02	-1.46e-01	5.63e-02	3.70e-01	1.49e-02	1.39e-01	9.11e-01	1.88e-01	6.12e-01
GOBP REGULATION OF ORGANELLE TRANSPORT ALONG MICROTUBULE	9	6.89e-01	7.53e-01	0.3670	2.13e-01	2.83e-02	-2.42e-01	6.08e-02	1.02e-01	-1.26e-01	2.68e-01	8.83e-01	2.08e-01	7.52e-01	5.96e-01	5.13e-01
GOBP CYTOPLASM ORGANIZATION	13	3.08e-01	4.29e-01	0.3670	-2.72e-01	1.69e-01	1.19e-01	-2.09e-02	4.21e-02	1.26e-01	8.90e-02	2.92e-01	4.59e-01	8.96e-01	7.93e-01	4.33e-01
GOBP POSITIVE REGULATION OF CELL SUBSTRATE JUNCTION ORGANIZATION	23	9.00e-03	3.15e-02	0.3670	-2.18e-01	4.06e-02	2.38e-01	5.33e-02	-1.62e-01	-8.90e-03	7.01e-02	7.36e-01	4.86e-02	6.58e-01	1.79e-01	9.41e-01
GOBP BENZENE CONTAINING COMPOUND METABOLIC PROCESS	21	1.31e-01	2.37e-01	0.3670	-5.33e-02	-1.15e-01	-1.71e-01	4.22e-02	2.94e-01	3.07e-02	6.73e-01	3.60e-01	1.76e-01	7.38e-01	1.95e-02	8.08e-01
GOBP POSITIVE REGULATION OF DIGESTIVE SYSTEM PROCESS	9	4.56e-01	5.61e-01	0.3670	-1.28e-01	5.43e-02	2.25e-02	8.28e-02	3.23e-01	-5.82e-02	5.05e-01	7.78e-01	9.07e-01	6.67e-01	9.30e-02	7.62e-01
GOBP POSITIVE REGULATION OF SYNCYTIUM FORMATION BY PLASMA MEMBRANE FUSION	16	4.95e-01	5.93e-01	0.3670	-5.88e-02	1.20e-01	2.79e-01	9.23e-03	2.23e-02	1.96e-01	6.84e-01	4.06e-01	5.34e-02	9.49e-01	8.77e-01	1.75e-01
GOBP INTERLEUKIN 18 MEDIATED SIGNALING PATHWAY	10	2.62e-01	3.82e-01	0.3670	-7.44e-02	2.43e-01	-2.35e-01	-5.55e-02	-1.61e-02	-1.06e-01	6.84e-01	1.83e-01	1.98e-01	7.61e-01	9.30e-01	5.61e-01
GOBP GLUCOCORTICOID METABOLIC PROCESS	13	6.38e-01	7.13e-01	0.3670	1.22e-01	-9.79e-03	9.67e-02	2.99e-01	7.83e-02	1.20e-01	4.45e-01	9.51e-01	5.46e-01	6.16e-02	6.25e-01	4.55e-01
GOBP POSITIVE REGULATION OF TRANSCRIPTION BY RNA POLYMERASE I	32	2.86e-03	1.25e-02	0.3670	-3.15e-02	-1.74e-01	5.26e-03	2.36e-01	-1.64e-01	-1.44e-01	7.58e-01	8.93e-02	9.59e-01	2.10e-02	1.09e-01	1.57e-01
GOBP PORE COMPLEX ASSEMBLY	20	2.38e-01	3.56e-01	0.3660	-2.58e-01	-2.01e-01	-2.13e-02	3.78e-02	2.61e-02	1.57e-01	4.58e-02	1.20e-01	8.69e-01	7.70e-01	8.40e-01	2.23e-01
GOMF HORMONE RECEPTOR BINDING	12	3.34e-01	4.51e-01	0.3660	7.52e-02	1.89e-01	5.00e-02	2.87e-01	-4.71e-02	7.59e-02	6.52e-01	2.57e-01	7.64e-01	8.50e-02	7.78e-01	6.49e-01
GOBP CORONARY VASCULATURE DEVELOPMENT	36	2.49e-03	1.11e-02	0.3660	-1.71e-01	2.17e-01	1.41e-01	1.11e-01	1.37e-01	8.30e-02	7.52e-02	2.44e-02	1.45e-01	2.47e-01	1.54e-01	3.89e-01
GOMF URIDYLYLTRANSFERASE ACTIVITY	7	8.05e-01	8.43e-01	0.3660	-1.08e-01	-7.63e-02	-1.70e-01	3.77e-02	-1.62e-01	-2.45e-01	6.21e-01	7.27e-01	4.36e-01	8.63e-01	4.59e-01	2.61e-01
GOBP REGULATION OF LAMELLIPODIUM MORPHOGENESIS	10	1.60e-01	2.73e-01	0.3660	-8.63e-02	4.95e-02	1.47e-01	1.85e-01	2.12e-01	-1.54e-01	6.37e-01	7.87e-01	4.22e-01	3.12e-01	2.46e-01	3.99e-01
GOBP REGULATION OF COAGULATION	54	4.36e-06	4.03e-05	0.3660	-5.23e-02	-1.49e-01	2.98e-01	-9.92e-02	-6.34e-02	8.16e-02	5.06e-01	5.87e-02	1.53e-04	2.07e-01	4.20e-01	3.00e-01
GOBP REGULATION OF HYDROGEN PEROXIDE BIOSYNTHETIC PROCESS	5	7.84e-01	8.26e-01	0.3660	3.31e-01	-1.10e-01	3.51e-02	-4.27e-02	-4.71e-02	-8.30e-02	1.99e-01	6.71e-01	8.92e-01	8.69e-01	8.55e-01	7.48e-01
GOBP NEGATIVE REGULATION OF NUCLEOTIDE CATABOLIC PROCESS	18	2.37e-01	3.54e-01	0.3660	6.30e-02	1.29e-01	2.72e-01	1.74e-01	-8.57e-02	4.03e-02	6.44e-01	3.44e-01	4.55e-02	2.01e-01	5.29e-01	7.67e-01
GOCC CELL BODY MEMBRANE	18	5.17e-01	6.11e-01	0.3660	1.42e-01	2.18e-01	1.62e-01	-1.93e-02	7.21e-02	1.86e-01	2.97e-01	1.10e-01	2.33e-01	8.87e-01	5.96e-01	1.73e-01
GOBP RESPONSE TO ATP	27	4.02e-03	1.64e-02	0.3660	-1.83e-01	4.76e-02	2.56e-01	-2.34e-02	1.42e-01	1.09e-01	9.99e-02	6.69e-01	2.13e-02	8.33e-01	2.01e-01	3.28e-01
GOBP CARDIAC CONDUCTION	63	8.51e-03	3.03e-02	0.3660	-1.03e-01	7.23e-02	2.40e-01	-9.80e-02	-9.49e-02	2.04e-01	1.56e-01	3.21e-01	9.76e-04	1.78e-01	1.93e-01	5.11e-03
GOBP POSITIVE REGULATION OF PROTEIN BINDING	48	1.18e-02	3.92e-02	0.3660	-9.21e-02	-3.12e-02	2.55e-01	3.88e-02	-1.60e-01	1.79e-01	2.70e-01	7.09e-01	2.20e-03	6.42e-01	5.51e-02	3.20e-02
GOBP NEGATIVE REGULATION OF DEFENSE RESPONSE TO VIRUS	17	2.67e-01	3.86e-01	0.3660	-2.28e-01	-1.56e-01	-1.81e-01	1.54e-01	-3.28e-02	-6.45e-03	1.04e-01	2.65e-01	1.96e-01	2.73e-01	8.15e-01	9.63e-01
GOBP REGULATION OF OSTEOCLAST DIFFERENTIATION	53	4.26e-03	1.72e-02	0.3660	-5.47e-02	2.24e-01	2.57e-01	-2.32e-02	-1.11e-02	1.16e-01	4.91e-01	4.71e-03	1.18e-03	7.71e-01	8.89e-01	1.44e-01
GOMF TRANSMEMBRANE RECEPTOR PROTEIN SERINE THREONINE KINASE ACTIVITY	15	1.52e-01	2.63e-01	0.3660	-2.71e-01	2.26e-01	2.54e-02	-3.46e-02	1.76e-02	8.62e-02	6.97e-02	1.30e-01	8.65e-01	8.16e-01	9.06e-01	5.63e-01
GOBP REGULATION OF RIG I SIGNALING PATHWAY	18	1.81e-01	2.96e-01	0.3660	-1.41e-01	-1.72e-01	-2.45e-02	2.13e-01	-9.29e-02	1.73e-01	3.00e-01	2.07e-01	8.57e-01	1.18e-01	4.95e-01	2.04e-01
GOBP NEGATIVE REGULATION OF TELOMERE MAINTENANCE	36	3.72e-02	9.45e-02	0.3660	-1.46e-02	6.77e-02	-1.58e-01	2.49e-01	2.00e-01	4.38e-02	8.80e-01	4.82e-01	1.01e-01	9.71e-03	3.76e-02	6.49e-01
GOBP REGULATION OF PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR SIGNALING PATHWAY	9	7.84e-01	8.26e-01	0.3660	1.12e-01	5.05e-02	3.13e-01	8.32e-02	-6.58e-02	9.81e-02	5.62e-01	7.93e-01	1.04e-01	6.66e-01	7.33e-01	6.10e-01
GOBP NEGATIVE REGULATION OF DNA DAMAGE RESPONSE SIGNAL TRANSDUCTION BY P53 CLASS MEDIATOR	13	1.22e-01	2.26e-01	0.3660	-2.54e-01	-2.07e-01	1.27e-01	3.06e-02	8.31e-02	5.10e-02	1.13e-01	1.97e-01	4.29e-01	8.49e-01	6.04e-01	7.50e-01
GOBP REGULATION OF SMOOTH MUSCLE CONTRACTION	38	2.93e-02	7.87e-02	0.3650	-1.19e-01	-6.06e-02	2.36e-01	-1.84e-01	-1.54e-01	5.08e-02	2.05e-01	5.18e-01	1.18e-02	4.99e-02	1.01e-01	5.88e-01
GOBP REGULATION OF ENDODEOXYRIBONUCLEASE ACTIVITY	8	6.84e-01	7.49e-01	0.3650	-1.66e-01	-1.60e-01	-2.60e-01	3.38e-02	-8.02e-02	7.23e-02	4.17e-01	4.33e-01	2.03e-01	8.69e-01	6.95e-01	7.23e-01
GOCC SPINDLE MICROTUBULE	77	1.82e-05	1.44e-04	0.3650	-1.87e-01	-2.29e-01	-1.15e-02	1.02e-01	1.53e-02	1.88e-01	4.65e-03	5.03e-04	8.61e-01	1.22e-01	8.16e-01	4.34e-03
GOBP ANAPHASE PROMOTING COMPLEX DEPENDENT CATABOLIC PROCESS	23	2.08e-01	3.24e-01	0.3650	-1.45e-02	-2.99e-01	-1.66e-01	1.13e-01	-5.63e-02	-2.10e-02	9.04e-01	1.30e-02	1.68e-01	3.50e-01	6.40e-01	8.62e-01
GOBP PYRIMIDINE RIBONUCLEOSIDE MONOPHOSPHATE BIOSYNTHETIC PROCESS	11	4.76e-01	5.77e-01	0.3650	-1.31e-01	-2.84e-01	1.84e-02	1.62e-01	-9.55e-02	-1.57e-03	4.51e-01	1.03e-01	9.16e-01	3.53e-01	5.83e-01	9.93e-01
GOBP CELLULAR RESPONSE TO MURAMYL DIPEPTIDE	9	1.54e-01	2.65e-01	0.3650	-1.67e-01	8.54e-02	2.27e-01	3.21e-03	1.93e-01	-9.84e-02	3.86e-01	6.57e-01	2.38e-01	9.87e-01	3.17e-01	6.09e-01
GOBP ARACHIDONIC ACID SECRETION	15	1.14e-01	2.15e-01	0.3650	-2.95e-01	2.45e-02	1.37e-01	-6.45e-02	1.40e-01	5.76e-02	4.79e-02	8.69e-01	3.58e-01	6.65e-01	3.49e-01	6.99e-01
GOBP DEOXYRIBONUCLEOTIDE CATABOLIC PROCESS	25	4.85e-02	1.15e-01	0.3650	-5.09e-03	-3.47e-01	-5.86e-02	-2.27e-02	-2.90e-02	8.81e-02	9.65e-01	2.64e-03	6.12e-01	8.44e-01	8.02e-01	4.46e-01
GOMF THIOLESTER HYDROLASE ACTIVITY	38	4.65e-03	1.85e-02	0.3650	-5.62e-02	-2.80e-01	-9.72e-02	7.26e-02	8.10e-02	1.74e-01	5.49e-01	2.78e-03	3.00e-01	4.39e-01	3.87e-01	6.42e-02
GOCC APICAL CORTEX	6	9.07e-01	9.23e-01	0.3650	1.10e-01	3.17e-01	8.00e-02	2.05e-02	7.10e-02	9.14e-02	6.41e-01	1.78e-01	7.34e-01	9.31e-01	7.63e-01	6.98e-01
GOMF PROTEIN TYROSINE KINASE ACTIVATOR ACTIVITY	22	1.41e-01	2.51e-01	0.3650	-1.53e-01	1.17e-01	2.70e-01	-1.16e-01	-5.67e-02	8.06e-02	2.15e-01	3.43e-01	2.86e-02	3.44e-01	6.45e-01	5.13e-01
GOBP GLOMERULAR MESANGIAL CELL PROLIFERATION	8	8.38e-01	8.69e-01	0.3650	-6.06e-02	1.00e-01	1.41e-01	-1.15e-01	-1.20e-01	2.68e-01	7.67e-01	6.24e-01	4.90e-01	5.73e-01	5.55e-01	1.90e-01
GOCC VCP NPL4 UFD1 AAA ATPASE COMPLEX	8	7.65e-01	8.11e-01	0.3640	-2.08e-01	-2.30e-01	-1.00e-01	1.33e-01	-8.46e-02	-4.45e-02	3.09e-01	2.61e-01	6.23e-01	5.15e-01	6.79e-01	8.28e-01
GOBP CD8 POSITIVE ALPHA BETA T CELL ACTIVATION	26	1.59e-01	2.72e-01	0.3640	8.59e-02	2.11e-01	1.33e-01	4.21e-02	-2.81e-03	2.48e-01	4.48e-01	6.27e-02	2.41e-01	7.10e-01	9.80e-01	2.85e-02
GOCC SARCOLEMMA	110	2.27e-05	1.77e-04	0.3640	-9.69e-02	-3.34e-02	2.38e-01	-1.18e-01	-2.00e-01	1.06e-01	7.92e-02	5.45e-01	1.55e-05	3.26e-02	2.84e-04	5.45e-02
GOBP IRON ION TRANSMEMBRANE TRANSPORT	19	3.52e-01	4.68e-01	0.3640	1.67e-01	8.71e-02	2.19e-01	-5.27e-02	-2.15e-01	3.21e-03	2.06e-01	5.11e-01	9.88e-02	6.91e-01	1.04e-01	9.81e-01
GOBP LACTONE METABOLIC PROCESS	10	4.24e-01	5.33e-01	0.3640	-5.35e-02	1.43e-01	2.30e-02	-4.95e-02	1.99e-01	-2.58e-01	7.69e-01	4.34e-01	9.00e-01	7.86e-01	2.76e-01	1.57e-01
GOBP NEGATIVE REGULATION OF T CELL MEDIATED IMMUNITY	29	1.66e-01	2.79e-01	0.3640	1.83e-01	2.57e-01	1.30e-01	1.15e-01	-2.08e-02	5.12e-02	8.81e-02	1.67e-02	2.27e-01	2.84e-01	8.46e-01	6.33e-01
GOBP DENDRITIC CELL CHEMOTAXIS	22	1.64e-01	2.77e-01	0.3640	1.67e-02	-8.25e-02	2.15e-01	2.08e-01	-1.06e-01	1.57e-01	8.92e-01	5.03e-01	8.06e-02	9.18e-02	3.89e-01	2.02e-01
GOBP PHOSPHOLIPASE C ACTIVATING G PROTEIN COUPLED ACETYLCHOLINE RECEPTOR SIGNALING PATHWAY	6	5.53e-01	6.42e-01	0.3640	-4.39e-02	1.41e-01	1.52e-01	-6.61e-02	1.82e-01	-2.23e-01	8.52e-01	5.49e-01	5.19e-01	7.79e-01	4.40e-01	3.44e-01
GOCC SECRETORY GRANULE	721	4.32e-46	1.08e-43	0.3640	-1.95e-01	-8.30e-02	1.83e-01	-2.24e-02	-1.39e-01	1.85e-01	5.39e-19	1.47e-04	6.68e-17	3.06e-01	1.83e-10	2.43e-17
GOBP I KAPPAB PHOSPHORYLATION	14	1.60e-01	2.72e-01	0.3640	-2.70e-01	2.31e-01	-1.68e-02	-1.09e-04	7.37e-02	-1.73e-02	7.98e-02	1.35e-01	9.13e-01	9.99e-01	6.33e-01	9.11e-01
GOBP DETECTION OF STIMULUS INVOLVED IN SENSORY PERCEPTION OF PAIN	17	1.95e-01	3.12e-01	0.3640	-1.86e-01	-2.79e-01	5.19e-03	1.37e-01	-2.21e-02	2.56e-02	1.84e-01	4.64e-02	9.70e-01	3.29e-01	8.75e-01	8.55e-01
GOBP G PROTEIN COUPLED GLUTAMATE RECEPTOR SIGNALING PATHWAY	7	8.69e-01	8.94e-01	0.3640	-1.41e-01	4.05e-02	-1.52e-01	-9.18e-02	8.99e-02	-2.67e-01	5.19e-01	8.53e-01	4.86e-01	6.74e-01	6.81e-01	2.21e-01
GOBP REGULATION OF MACROPHAGE MIGRATION	36	3.85e-02	9.67e-02	0.3640	-5.76e-02	-1.64e-01	2.27e-01	6.77e-03	-1.90e-01	1.20e-01	5.50e-01	8.91e-02	1.83e-02	9.44e-01	4.90e-02	2.12e-01
GOBP NEGATIVE REGULATION OF G PROTEIN COUPLED RECEPTOR SIGNALING PATHWAY	45	1.01e-01	1.97e-01	0.3630	1.23e-01	2.00e-01	1.56e-01	1.72e-01	7.48e-02	1.32e-01	1.53e-01	2.00e-02	7.01e-02	4.63e-02	3.86e-01	1.26e-01
GOBP NEGATIVE REGULATION OF RECEPTOR SIGNALING PATHWAY VIA STAT	18	2.05e-01	3.21e-01	0.3630	8.79e-03	7.23e-02	2.95e-01	-1.81e-01	-7.77e-04	8.51e-02	9.49e-01	5.95e-01	3.04e-02	1.84e-01	9.95e-01	5.32e-01
GOMF NUCLEAR STEROID RECEPTOR ACTIVITY	18	4.37e-02	1.06e-01	0.3630	-2.24e-01	1.07e-01	4.89e-02	4.40e-02	2.41e-01	-8.95e-02	1.00e-01	4.34e-01	7.20e-01	7.47e-01	7.63e-02	5.11e-01
GOBP REGULATION OF DEPHOSPHORYLATION	89	1.00e-05	8.44e-05	0.3630	-1.07e-01	-3.39e-03	1.77e-01	1.13e-01	-1.25e-01	2.47e-01	8.16e-02	9.56e-01	3.94e-03	6.61e-02	4.22e-02	5.53e-05
GOBP REGULATION OF BMP SIGNALING PATHWAY	66	1.06e-04	7.13e-04	0.3630	-5.80e-02	2.10e-01	2.70e-01	5.34e-02	1.41e-02	9.45e-02	4.15e-01	3.21e-03	1.52e-04	4.53e-01	8.43e-01	1.84e-01
GOBP CARDIAC CELL DEVELOPMENT	57	4.17e-04	2.40e-03	0.3630	-1.56e-01	-1.77e-02	1.67e-01	2.31e-02	-2.60e-01	1.06e-01	4.14e-02	8.17e-01	2.88e-02	7.63e-01	6.86e-04	1.68e-01
GOBP RESPONSE TO FUNGUS	48	4.24e-02	1.04e-01	0.3630	-9.75e-02	-3.72e-03	1.97e-01	-3.41e-02	-1.88e-01	2.17e-01	2.42e-01	9.64e-01	1.82e-02	6.83e-01	2.42e-02	9.35e-03
GOBP BODY FLUID SECRETION	61	8.73e-05	6.00e-04	0.3630	-9.49e-02	3.61e-02	2.08e-01	1.76e-01	1.08e-01	1.89e-01	2.00e-01	6.26e-01	4.94e-03	1.77e-02	1.44e-01	1.08e-02
GOBP POSITIVE REGULATION OF DEFENSE RESPONSE TO BACTERIUM	10	7.45e-02	1.58e-01	0.3630	-1.95e-01	4.88e-02	2.31e-01	2.01e-03	7.98e-02	-1.78e-01	2.87e-01	7.89e-01	2.06e-01	9.91e-01	6.62e-01	3.29e-01
GOBP NEGATIVE REGULATION OF TUMOR NECROSIS FACTOR MEDIATED SIGNALING PATHWAY	20	2.44e-01	3.62e-01	0.3630	-8.68e-02	-4.80e-03	1.30e-01	6.70e-02	1.42e-01	2.87e-01	5.01e-01	9.70e-01	3.13e-01	6.04e-01	2.73e-01	2.60e-02
GOBP NEGATIVE REGULATION OF LIPID CATABOLIC PROCESS	20	2.12e-01	3.30e-01	0.3630	3.42e-02	2.75e-01	1.10e-01	-1.08e-01	1.50e-01	-9.52e-02	7.91e-01	3.35e-02	3.93e-01	4.04e-01	2.47e-01	4.61e-01
GOBP RESPONSE TO PARATHYROID HORMONE	10	4.89e-01	5.88e-01	0.3630	-1.89e-01	1.44e-01	-1.41e-01	-1.91e-01	-1.16e-01	-7.53e-02	3.02e-01	4.31e-01	4.40e-01	2.96e-01	5.24e-01	6.80e-01
GOBP POSITIVE REGULATION OF PROTEIN ACETYLATION	11	1.53e-01	2.64e-01	0.3630	-2.98e-01	1.01e-01	3.89e-02	1.31e-01	-1.13e-01	3.46e-02	8.70e-02	5.61e-01	8.23e-01	4.51e-01	5.17e-01	8.43e-01
GOBP REGULATION OF RECEPTOR RECYCLING	20	3.16e-01	4.36e-01	0.3630	-1.56e-01	-6.38e-02	1.51e-01	7.39e-02	-1.13e-01	2.49e-01	2.26e-01	6.21e-01	2.44e-01	5.67e-01	3.80e-01	5.36e-02
GOBP SULFUR COMPOUND CATABOLIC PROCESS	36	3.35e-02	8.71e-02	0.3630	-1.40e-01	-3.11e-01	-9.58e-02	4.30e-02	-1.05e-02	-6.53e-02	1.45e-01	1.26e-03	3.20e-01	6.55e-01	9.13e-01	4.98e-01
GOBP POLY A PLUS MRNA EXPORT FROM NUCLEUS	20	1.31e-01	2.38e-01	0.3630	-2.44e-01	-2.03e-01	-7.91e-02	1.14e-01	-1.42e-02	-1.06e-01	5.87e-02	1.17e-01	5.40e-01	3.76e-01	9.12e-01	4.10e-01
GOBP GENERATION OF PRECURSOR METABOLITES AND ENERGY	413	4.18e-27	3.23e-25	0.3630	-1.49e-01	-3.03e-01	-7.07e-02	6.20e-02	-8.13e-02	4.70e-02	2.03e-07	4.48e-26	1.38e-02	3.06e-02	4.62e-03	1.01e-01
GOBP FOREBRAIN RADIAL GLIAL CELL DIFFERENTIATION	5	9.75e-01	9.79e-01	0.3630	-2.27e-01	-1.75e-01	-6.70e-02	-1.73e-01	-8.22e-02	9.01e-02	3.80e-01	4.97e-01	7.95e-01	5.02e-01	7.50e-01	7.27e-01
GOBP RHYTHMIC BEHAVIOR	29	1.49e-01	2.59e-01	0.3630	-1.22e-01	2.44e-02	-1.83e-01	9.27e-03	1.66e-01	-2.34e-01	2.54e-01	8.20e-01	8.79e-02	9.31e-01	1.23e-01	2.91e-02
GOCC CYCLIN DEPENDENT PROTEIN KINASE HOLOENZYME COMPLEX	53	7.16e-03	2.64e-02	0.3620	-1.25e-01	-1.41e-01	1.46e-01	6.12e-02	-1.83e-01	1.93e-01	1.14e-01	7.68e-02	6.61e-02	4.41e-01	2.14e-02	1.48e-02
GOBP AGGREPHAGY	16	2.62e-01	3.82e-01	0.3620	-7.06e-03	-1.79e-01	1.67e-01	1.42e-01	-2.23e-01	3.62e-02	9.61e-01	2.15e-01	2.46e-01	3.27e-01	1.22e-01	8.02e-01
GOBP EPIGENETIC PROGRAMMING IN THE ZYGOTIC PRONUCLEI	11	4.96e-02	1.16e-01	0.3620	-1.54e-01	1.79e-01	-8.61e-02	1.80e-01	-1.85e-01	3.53e-02	3.76e-01	3.03e-01	6.21e-01	3.01e-01	2.88e-01	8.39e-01
GOMF MONOAMINE TRANSMEMBRANE TRANSPORTER ACTIVITY	7	7.65e-01	8.11e-01	0.3620	-5.25e-02	-2.25e-01	-1.08e-01	1.55e-01	1.48e-01	-1.43e-01	8.10e-01	3.02e-01	6.21e-01	4.79e-01	4.98e-01	5.14e-01
GOBP LIMBIC SYSTEM DEVELOPMENT	78	3.65e-03	1.52e-02	0.3620	1.01e-01	1.81e-01	1.92e-01	1.72e-01	1.03e-01	1.06e-01	1.24e-01	5.62e-03	3.41e-03	8.67e-03	1.17e-01	1.07e-01
GOBP NEGATIVE REGULATION OF FIBROBLAST PROLIFERATION	31	2.27e-01	3.45e-01	0.3620	1.58e-01	6.79e-02	2.11e-02	2.79e-01	1.46e-01	-4.04e-02	1.28e-01	5.13e-01	8.39e-01	7.09e-03	1.60e-01	6.97e-01
GOBP DENDRITIC CELL MIGRATION	29	1.05e-01	2.03e-01	0.3620	-2.79e-02	2.12e-02	2.66e-01	1.34e-01	-9.22e-02	1.81e-01	7.95e-01	8.44e-01	1.32e-02	2.13e-01	3.90e-01	9.20e-02
GOBP NEGATIVE REGULATION OF RECEPTOR SIGNALING PATHWAY VIA JAK STAT	16	2.63e-01	3.83e-01	0.3620	4.79e-02	8.28e-02	3.23e-01	-1.03e-01	2.11e-02	8.14e-02	7.40e-01	5.66e-01	2.54e-02	4.76e-01	8.84e-01	5.73e-01
GOBP OLIGODENDROCYTE PROGENITOR PROLIFERATION	5	8.22e-01	8.57e-01	0.3620	-2.72e-01	6.65e-02	7.41e-02	4.97e-02	1.78e-01	1.13e-01	2.93e-01	7.97e-01	7.74e-01	8.47e-01	4.90e-01	6.61e-01
GOBP NEGATIVE REGULATION OF OXIDOREDUCTASE ACTIVITY	13	8.10e-01	8.47e-01	0.3620	1.81e-01	1.67e-01	1.73e-01	8.34e-02	1.27e-01	1.32e-01	2.60e-01	2.96e-01	2.81e-01	6.03e-01	4.29e-01	4.11e-01
GOBP NATURAL KILLER CELL DIFFERENTIATION	24	3.76e-01	4.91e-01	0.3620	-7.22e-03	1.56e-01	2.61e-01	-6.87e-02	-1.84e-02	1.82e-01	9.51e-01	1.86e-01	2.67e-02	5.60e-01	8.76e-01	1.23e-01
GOMF CATALYTIC ACTIVITY ACTING ON A NUCLEIC ACID	586	1.70e-37	2.71e-35	0.3620	-9.25e-02	-2.29e-01	-2.09e-01	1.45e-01	6.51e-02	-2.72e-02	1.32e-04	2.81e-21	4.56e-18	1.90e-09	7.09e-03	2.61e-01
GOCC MEMBRANE MICRODOMAIN	237	7.13e-14	1.75e-12	0.3620	-8.06e-02	9.56e-02	2.50e-01	4.37e-02	-7.34e-02	2.13e-01	3.25e-02	1.12e-02	3.45e-11	2.46e-01	5.18e-02	1.55e-08
GOBP MIRNA METABOLIC PROCESS	91	4.76e-05	3.47e-04	0.3620	-2.79e-02	1.75e-01	2.80e-01	1.64e-02	2.02e-03	1.43e-01	6.45e-01	3.91e-03	3.75e-06	7.87e-01	9.73e-01	1.86e-02
GOBP QUATERNARY AMMONIUM GROUP TRANSPORT	12	1.49e-01	2.59e-01	0.3620	-1.83e-01	1.13e-01	1.20e-01	-1.34e-01	1.49e-01	-1.73e-01	2.72e-01	4.97e-01	4.73e-01	4.20e-01	3.72e-01	2.99e-01
GOBP NEGATIVE REGULATION OF DNA REPLICATION	21	1.78e-01	2.93e-01	0.3620	1.32e-03	-1.60e-01	8.69e-02	2.22e-01	5.87e-02	2.12e-01	9.92e-01	2.04e-01	4.91e-01	7.88e-02	6.42e-01	9.26e-02
GOBP INDUCTION OF POSITIVE CHEMOTAXIS	7	4.97e-01	5.95e-01	0.3610	-6.08e-03	-1.41e-02	8.85e-02	2.19e-01	1.93e-01	-1.93e-01	9.78e-01	9.48e-01	6.85e-01	3.16e-01	3.76e-01	3.76e-01
GOCC TRANSCRIPTION PREINITIATION COMPLEX	13	4.86e-01	5.86e-01	0.3610	-1.11e-01	-1.46e-01	6.73e-02	1.85e-01	2.27e-02	2.40e-01	4.87e-01	3.61e-01	6.75e-01	2.48e-01	8.87e-01	1.34e-01
GOMF TRANSMEMBRANE TRANSPORTER BINDING	108	1.00e-04	6.82e-04	0.3610	-1.44e-01	-7.71e-02	1.70e-01	-5.85e-02	-1.94e-01	1.84e-01	9.75e-03	1.66e-01	2.32e-03	2.94e-01	4.81e-04	9.45e-04
GOBP PEPTIDE BIOSYNTHETIC PROCESS	22	4.64e-02	1.11e-01	0.3610	-7.60e-02	-8.70e-02	2.44e-01	5.73e-02	1.13e-01	2.04e-01	5.37e-01	4.80e-01	4.75e-02	6.42e-01	3.61e-01	9.72e-02
GOBP POSITIVE REGULATION OF NK T CELL ACTIVATION	7	9.23e-01	9.35e-01	0.3610	9.61e-03	3.77e-02	-1.60e-01	1.05e-01	1.86e-01	-2.41e-01	9.65e-01	8.63e-01	4.64e-01	6.32e-01	3.94e-01	2.70e-01
GOBP C21 STEROID HORMONE METABOLIC PROCESS	22	3.70e-01	4.86e-01	0.3610	1.69e-01	1.32e-02	2.01e-01	7.93e-02	-1.32e-02	2.34e-01	1.69e-01	9.15e-01	1.02e-01	5.20e-01	9.15e-01	5.77e-02
GOBP V D J RECOMBINATION	18	1.28e-01	2.33e-01	0.3610	-1.66e-01	3.73e-02	-1.11e-01	1.77e-01	1.18e-01	2.10e-01	2.23e-01	7.84e-01	4.14e-01	1.94e-01	3.88e-01	1.23e-01
GOMF MAP KINASE KINASE KINASE KINASE ACTIVITY	6	4.89e-01	5.88e-01	0.3610	-1.45e-01	2.27e-01	-2.17e-01	2.35e-02	-6.62e-02	-7.82e-02	5.38e-01	3.37e-01	3.58e-01	9.21e-01	7.79e-01	7.40e-01
GOCC EXTRINSIC COMPONENT OF ORGANELLE MEMBRANE	24	1.53e-01	2.64e-01	0.3610	-2.22e-01	-1.79e-01	-1.14e-01	6.16e-02	4.91e-02	1.72e-01	5.93e-02	1.29e-01	3.35e-01	6.01e-01	6.77e-01	1.45e-01
GOBP SURFACTANT HOMEOSTASIS	14	6.43e-01	7.17e-01	0.3610	1.38e-01	1.05e-01	-2.23e-03	1.44e-01	2.37e-01	-1.52e-01	3.72e-01	4.97e-01	9.88e-01	3.52e-01	1.24e-01	3.24e-01
GOMF PHOSPHATE ION BINDING	10	5.92e-01	6.75e-01	0.3610	-8.35e-02	-1.65e-01	2.39e-01	-1.33e-01	-1.17e-01	8.61e-02	6.48e-01	3.66e-01	1.91e-01	4.65e-01	5.23e-01	6.37e-01
GOBP REGULATION OF BONE REMODELING	34	1.81e-01	2.96e-01	0.3610	5.08e-02	9.46e-02	2.82e-01	6.09e-02	-2.58e-02	1.87e-01	6.08e-01	3.40e-01	4.47e-03	5.39e-01	7.95e-01	5.96e-02
GOBP POSITIVE REGULATION OF NUCLEOTIDE BIOSYNTHETIC PROCESS	9	5.21e-01	6.15e-01	0.3610	-8.18e-02	-2.02e-01	1.41e-01	1.26e-01	9.96e-02	1.93e-01	6.71e-01	2.94e-01	4.65e-01	5.14e-01	6.05e-01	3.17e-01
GOMF UBIQUITIN PROTEIN TRANSFERASE REGULATOR ACTIVITY	30	4.55e-02	1.09e-01	0.3610	-8.85e-02	-2.95e-01	-1.11e-01	1.13e-01	8.80e-02	4.81e-02	4.01e-01	5.16e-03	2.92e-01	2.83e-01	4.04e-01	6.48e-01
GOBP NEGATIVE REGULATION OF MAP KINASE ACTIVITY	36	7.54e-02	1.60e-01	0.3610	8.87e-02	8.32e-02	3.10e-01	-5.74e-02	-8.27e-02	9.67e-02	3.57e-01	3.87e-01	1.31e-03	5.51e-01	3.91e-01	3.15e-01
GOMF MOLECULAR CONDENSATE SCAFFOLD ACTIVITY	35	1.75e-02	5.32e-02	0.3610	1.06e-03	2.66e-01	-3.81e-02	1.93e-01	1.31e-01	-6.00e-02	9.91e-01	6.49e-03	6.96e-01	4.85e-02	1.80e-01	5.39e-01
GOCC CHITOSOME	16	4.77e-01	5.78e-01	0.3610	-1.66e-01	-7.45e-02	1.92e-01	7.68e-03	-4.03e-02	2.41e-01	2.51e-01	6.06e-01	1.83e-01	9.58e-01	7.80e-01	9.45e-02
GOBP SULFATE TRANSPORT	10	8.51e-01	8.80e-01	0.3600	1.65e-01	7.00e-02	-8.55e-02	1.39e-01	1.39e-01	-2.28e-01	3.67e-01	7.02e-01	6.40e-01	4.48e-01	4.47e-01	2.12e-01
GOMF P53 BINDING	59	1.26e-05	1.03e-04	0.3600	-3.10e-02	2.70e-02	8.11e-03	3.54e-01	5.31e-02	-1.73e-02	6.81e-01	7.20e-01	9.14e-01	2.63e-06	4.81e-01	8.18e-01
GOBP FLAVIN CONTAINING COMPOUND METABOLIC PROCESS	5	7.43e-01	7.95e-01	0.3600	3.62e-02	-2.74e-01	1.01e-01	1.98e-01	6.34e-02	7.90e-03	8.89e-01	2.89e-01	6.97e-01	4.42e-01	8.06e-01	9.76e-01
GOBP RNA TEMPLATED DNA BIOSYNTHETIC PROCESS	69	5.10e-05	3.70e-04	0.3600	-1.60e-01	-1.39e-01	-1.76e-01	1.99e-01	8.17e-02	8.86e-02	2.17e-02	4.59e-02	1.15e-02	4.35e-03	2.41e-01	2.03e-01
GOCC CILIARY TRANSITION ZONE	67	1.46e-04	9.50e-04	0.3600	-7.96e-02	8.43e-02	-2.30e-01	-9.70e-02	2.27e-01	-5.32e-02	2.60e-01	2.33e-01	1.15e-03	1.70e-01	1.34e-03	4.52e-01
GOMF RNA STEM LOOP BINDING	15	1.03e-01	2.00e-01	0.3600	-2.06e-01	8.17e-02	2.69e-01	6.46e-02	-3.87e-02	4.98e-02	1.68e-01	5.84e-01	7.09e-02	6.65e-01	7.95e-01	7.38e-01
GOBP REGULATION OF CELLULAR RESPONSE TO VASCULAR ENDOTHELIAL GROWTH FACTOR STIMULUS	17	4.23e-01	5.32e-01	0.3600	-4.71e-02	1.39e-02	2.76e-01	6.08e-03	1.84e-02	2.25e-01	7.37e-01	9.21e-01	4.87e-02	9.65e-01	8.96e-01	1.08e-01
GOBP BEHAVIORAL RESPONSE TO COCAINE	10	4.48e-01	5.55e-01	0.3600	-3.81e-02	1.11e-02	3.11e-01	4.06e-02	9.46e-02	1.44e-01	8.35e-01	9.52e-01	8.87e-02	8.24e-01	6.04e-01	4.29e-01
GOMF K63 LINKED POLYUBIQUITIN MODIFICATION DEPENDENT PROTEIN BINDING	26	1.39e-01	2.48e-01	0.3600	1.45e-01	1.37e-01	1.12e-01	2.78e-01	-1.18e-02	-1.98e-03	2.02e-01	2.27e-01	3.23e-01	1.42e-02	9.17e-01	9.86e-01
GOBP POSITIVE REGULATION OF HEART RATE	16	4.99e-01	5.96e-01	0.3600	-5.23e-02	1.21e-01	2.53e-01	6.27e-02	6.62e-02	2.00e-01	7.17e-01	4.03e-01	7.97e-02	6.64e-01	6.47e-01	1.67e-01
GOBP CYCLIC GMP AMP TRANSMEMBRANE IMPORT ACROSS PLASMA MEMBRANE	7	9.07e-01	9.23e-01	0.3600	-2.44e-01	-1.45e-01	-1.15e-01	-4.79e-02	-1.19e-01	-1.40e-01	2.65e-01	5.08e-01	5.98e-01	8.26e-01	5.84e-01	5.22e-01
GOCC CUL3 RING UBIQUITIN LIGASE COMPLEX	36	1.97e-04	1.24e-03	0.3600	-8.15e-02	5.29e-02	-3.58e-02	3.25e-01	-5.50e-02	9.93e-02	3.97e-01	5.83e-01	7.10e-01	7.28e-04	5.68e-01	3.03e-01
GOMF ADRENERGIC RECEPTOR BINDING	12	3.49e-01	4.65e-01	0.3600	-1.80e-01	-5.09e-02	2.09e-01	1.60e-01	-2.25e-02	1.57e-01	2.80e-01	7.60e-01	2.10e-01	3.38e-01	8.93e-01	3.45e-01
GOMF CARBOHYDRATE DERIVATIVE TRANSMEMBRANE TRANSPORTER ACTIVITY	51	1.92e-03	8.84e-03	0.3600	-1.31e-01	-1.88e-01	-1.21e-01	7.79e-02	-3.71e-03	-2.37e-01	1.07e-01	1.99e-02	1.35e-01	3.36e-01	9.63e-01	3.42e-03
GOBP MITOTIC SPINDLE ORGANIZATION	130	8.68e-11	1.59e-09	0.3600	-6.67e-02	-1.45e-01	1.35e-01	2.10e-01	3.25e-02	2.01e-01	1.89e-01	4.25e-03	7.99e-03	3.47e-05	5.23e-01	7.46e-05
GOCC ATG12 ATG5 ATG16 COMPLEX	6	6.18e-01	6.97e-01	0.3600	-1.48e-01	2.31e-01	-8.47e-03	1.73e-01	1.26e-02	1.55e-01	5.31e-01	3.28e-01	9.71e-01	4.62e-01	9.57e-01	5.10e-01
GOBP CYTOSKELETON DEPENDENT CYTOKINESIS	112	5.66e-08	7.14e-07	0.3600	-1.43e-01	-1.44e-01	1.09e-01	1.42e-01	-3.79e-02	2.34e-01	8.92e-03	8.62e-03	4.60e-02	9.41e-03	4.89e-01	1.89e-05
GOBP NEGATIVE REGULATION OF CYSTEINE TYPE ENDOPEPTIDASE ACTIVITY	49	2.57e-03	1.14e-02	0.3600	-3.03e-01	-7.82e-02	8.52e-02	-3.91e-02	-5.11e-03	1.50e-01	2.43e-04	3.44e-01	3.02e-01	6.36e-01	9.51e-01	6.91e-02
GOMF QUATERNARY AMMONIUM GROUP BINDING	32	1.29e-02	4.19e-02	0.3590	-1.62e-01	-1.13e-01	1.68e-01	1.75e-01	-4.07e-02	1.72e-01	1.14e-01	2.68e-01	9.93e-02	8.62e-02	6.90e-01	9.24e-02
GOBP PROTEIN KINASE A SIGNALING	27	4.09e-01	5.20e-01	0.3590	1.15e-01	1.34e-01	1.65e-01	1.63e-01	9.01e-02	1.90e-01	3.02e-01	2.29e-01	1.38e-01	1.43e-01	4.18e-01	8.69e-02
GOBP LONG TERM MEMORY	27	1.96e-01	3.12e-01	0.3590	8.79e-02	1.75e-01	1.85e-01	2.19e-01	8.17e-02	4.05e-02	4.29e-01	1.16e-01	9.53e-02	4.86e-02	4.63e-01	7.15e-01
GOBP CELLULAR RESPONSE TO PROSTAGLANDIN STIMULUS	19	9.59e-02	1.90e-01	0.3590	-3.35e-01	5.48e-02	5.00e-02	-1.35e-02	-8.55e-02	6.26e-02	1.15e-02	6.79e-01	7.06e-01	9.19e-01	5.19e-01	6.37e-01
GOBP MEGAKARYOCYTE DIFFERENTIATION	55	2.94e-03	1.27e-02	0.3590	-7.33e-02	-2.03e-01	1.64e-01	6.06e-02	-1.84e-01	1.32e-01	3.47e-01	9.14e-03	3.53e-02	4.37e-01	1.80e-02	8.93e-02
GOBP EOSINOPHIL ACTIVATION	9	6.74e-01	7.41e-01	0.3590	1.34e-02	8.77e-03	-1.17e-01	-4.77e-02	2.85e-01	-1.78e-01	9.45e-01	9.64e-01	5.43e-01	8.04e-01	1.39e-01	3.55e-01
GOBP CHROMATIN LOOPING	14	2.24e-01	3.43e-01	0.3590	-1.06e-01	-4.44e-02	-1.37e-01	5.24e-02	1.16e-01	2.84e-01	4.93e-01	7.74e-01	3.74e-01	7.34e-01	4.50e-01	6.60e-02
GOBP INOSITOL PHOSPHATE METABOLIC PROCESS	32	3.45e-03	1.45e-02	0.3590	-2.51e-01	4.16e-02	1.51e-01	1.36e-01	5.61e-02	1.41e-01	1.40e-02	6.84e-01	1.40e-01	1.84e-01	5.83e-01	1.68e-01
GOBP REGULATION OF MITOCHONDRIAL FUSION	14	6.20e-01	6.98e-01	0.3590	-2.01e-01	-2.34e-01	-1.67e-01	6.52e-02	1.98e-02	3.42e-02	1.93e-01	1.29e-01	2.80e-01	6.73e-01	8.98e-01	8.25e-01
GOBP DOUBLE STRAND BREAK REPAIR VIA NONHOMOLOGOUS END JOINING	70	1.14e-04	7.59e-04	0.3590	-1.23e-01	-1.56e-01	-1.87e-01	1.69e-01	1.26e-01	9.99e-02	7.48e-02	2.42e-02	6.79e-03	1.46e-02	6.89e-02	1.48e-01
GOBP POSITIVE REGULATION OF PROTEIN GLYCOSYLATION	6	9.46e-01	9.55e-01	0.3590	1.29e-01	-3.16e-02	-1.20e-01	1.72e-01	1.41e-01	-2.18e-01	5.85e-01	8.93e-01	6.12e-01	4.66e-01	5.49e-01	3.56e-01
GOBP POSITIVE REGULATION OF COAGULATION	24	5.90e-03	2.24e-02	0.3580	-1.00e-01	-1.04e-01	3.20e-01	-3.33e-02	-6.12e-02	2.27e-02	3.95e-01	3.76e-01	6.73e-03	7.78e-01	6.04e-01	8.47e-01
GOBP POSITIVE REGULATION OF TELOMERE MAINTENANCE	69	5.65e-05	4.07e-04	0.3580	-1.65e-01	-2.04e-01	-1.48e-01	1.80e-01	-5.67e-02	4.67e-02	1.81e-02	3.43e-03	3.29e-02	9.74e-03	4.15e-01	5.02e-01
GOBP DERMATAN SULFATE BIOSYNTHETIC PROCESS	5	8.44e-01	8.73e-01	0.3580	-1.40e-02	-1.32e-01	8.28e-02	1.50e-01	-2.80e-01	-5.23e-02	9.57e-01	6.08e-01	7.49e-01	5.60e-01	2.78e-01	8.39e-01
GOBP CELLULAR RESPONSE TO LIPOPROTEIN PARTICLE STIMULUS	31	3.12e-02	8.23e-02	0.3580	-6.73e-02	-2.75e-02	3.15e-01	1.19e-02	-9.52e-02	1.21e-01	5.16e-01	7.91e-01	2.39e-03	9.09e-01	3.59e-01	2.44e-01
GOCC POSTSYNAPTIC DENSITY MEMBRANE	59	1.12e-02	3.75e-02	0.3580	2.16e-01	2.09e-01	1.04e-01	1.97e-02	1.50e-01	-6.51e-02	4.07e-03	5.46e-03	1.68e-01	7.93e-01	4.65e-02	3.87e-01
GOBP MAMMARY GLAND DEVELOPMENT	95	1.82e-06	1.83e-05	0.3580	-2.69e-02	5.84e-02	2.43e-01	1.89e-01	2.33e-02	1.70e-01	6.51e-01	3.25e-01	4.29e-05	1.43e-03	6.95e-01	4.24e-03
GOBP REGULATION OF EXTRACELLULAR MATRIX ASSEMBLY	17	5.84e-01	6.68e-01	0.3580	8.88e-02	1.99e-01	1.24e-01	2.19e-01	1.27e-01	3.69e-02	5.26e-01	1.56e-01	3.74e-01	1.18e-01	3.66e-01	7.92e-01
GOMF 1 4 ALPHA OLIGOGLUCAN PHOSPHORYLASE ACTIVITY	5	7.87e-01	8.29e-01	0.3580	-7.70e-02	5.35e-02	6.73e-02	-1.14e-02	-2.36e-01	-2.43e-01	7.66e-01	8.36e-01	7.94e-01	9.65e-01	3.61e-01	3.46e-01
GOMF MANNOSIDASE ACTIVITY	15	2.61e-01	3.81e-01	0.3580	-2.07e-01	-1.58e-02	-5.84e-02	2.28e-01	1.53e-01	8.00e-02	1.65e-01	9.16e-01	6.96e-01	1.27e-01	3.04e-01	5.92e-01
GOBP ENDOLYSOSOMAL TOLL LIKE RECEPTOR SIGNALING PATHWAY	48	2.29e-04	1.42e-03	0.3580	-2.55e-01	1.03e-01	3.96e-02	9.13e-02	4.53e-02	2.02e-01	2.26e-03	2.16e-01	6.35e-01	2.74e-01	5.87e-01	1.56e-02
GOBP PURINE RIBONUCLEOTIDE SALVAGE	7	3.69e-01	4.84e-01	0.3580	3.10e-02	-1.47e-01	1.35e-01	1.12e-01	2.74e-01	-9.85e-04	8.87e-01	5.00e-01	5.37e-01	6.09e-01	2.10e-01	9.96e-01
GOCC CATSPER COMPLEX	9	4.07e-01	5.19e-01	0.3580	1.72e-01	5.78e-02	2.34e-01	-8.07e-02	1.84e-01	2.15e-02	3.72e-01	7.64e-01	2.25e-01	6.75e-01	3.40e-01	9.11e-01
GOBP REGULATION OF MYOBLAST PROLIFERATION	9	7.17e-01	7.75e-01	0.3580	-4.24e-02	1.80e-01	-8.22e-02	-1.60e-01	-6.99e-03	-2.48e-01	8.26e-01	3.51e-01	6.69e-01	4.06e-01	9.71e-01	1.97e-01
GOMF SULFATE TRANSMEMBRANE TRANSPORTER ACTIVITY	9	9.00e-01	9.18e-01	0.3580	1.56e-01	1.21e-01	-6.60e-02	1.11e-01	1.94e-01	-1.86e-01	4.18e-01	5.31e-01	7.32e-01	5.63e-01	3.12e-01	3.34e-01
GOMF BHLH TRANSCRIPTION FACTOR BINDING	22	2.88e-01	4.08e-01	0.3580	1.76e-01	6.28e-02	3.56e-02	2.46e-01	8.17e-02	-1.56e-01	1.53e-01	6.10e-01	7.73e-01	4.56e-02	5.07e-01	2.04e-01
GOBP REGULATION OF NUCLEAR DIVISION	117	1.80e-09	2.73e-08	0.3580	4.54e-02	-2.26e-01	6.31e-02	2.13e-01	9.28e-03	1.59e-01	3.96e-01	2.41e-05	2.38e-01	6.91e-05	8.62e-01	2.92e-03
GOMF AMP BINDING	13	2.92e-01	4.11e-01	0.3570	-1.04e-01	-2.59e-01	-1.24e-02	-5.99e-02	-2.31e-02	-2.13e-01	5.14e-01	1.06e-01	9.38e-01	7.08e-01	8.85e-01	1.83e-01
GOMF SPLICING FACTOR BINDING	6	8.61e-01	8.87e-01	0.3570	-1.80e-01	-1.43e-01	6.10e-02	1.06e-01	-2.06e-01	1.32e-01	4.46e-01	5.43e-01	7.96e-01	6.52e-01	3.82e-01	5.75e-01
GOBP NEGATIVE REGULATION OF LIPID LOCALIZATION	33	7.61e-05	5.32e-04	0.3570	-1.62e-01	2.64e-02	2.72e-01	5.10e-02	-1.24e-01	-9.35e-02	1.07e-01	7.93e-01	6.79e-03	6.12e-01	2.19e-01	3.52e-01
GOBP SPERM AXONEME ASSEMBLY	22	8.11e-02	1.68e-01	0.3570	-3.44e-02	1.23e-01	-1.13e-01	-1.71e-01	2.63e-01	1.09e-02	7.80e-01	3.19e-01	3.57e-01	1.66e-01	3.24e-02	9.30e-01
GOBP CONSTITUTIVE HETEROCHROMATIN FORMATION	12	3.89e-01	5.02e-01	0.3570	-1.65e-01	-1.79e-01	1.30e-01	1.26e-01	5.66e-02	1.80e-01	3.22e-01	2.83e-01	4.37e-01	4.50e-01	7.34e-01	2.80e-01
GOBP MUSCLE HYPERTROPHY	66	1.59e-03	7.54e-03	0.3570	-2.58e-02	-3.42e-02	2.40e-01	9.40e-02	-1.62e-01	1.81e-01	7.17e-01	6.31e-01	7.33e-04	1.86e-01	2.27e-02	1.08e-02
GOMF HYDROLASE ACTIVITY ACTING ON CARBON NITROGEN BUT NOT PEPTIDE BONDS IN CYCLIC AMIDINES	31	1.83e-01	2.97e-01	0.3570	1.50e-01	4.15e-02	-5.88e-02	1.88e-01	2.42e-01	7.85e-02	1.47e-01	6.89e-01	5.71e-01	7.02e-02	1.99e-02	4.49e-01
GOMF OXIDOREDUCTASE ACTIVITY ACTING ON METAL IONS	12	7.88e-01	8.29e-01	0.3570	-5.58e-02	-1.49e-01	-2.70e-01	-1.59e-05	-3.78e-02	-1.67e-01	7.38e-01	3.73e-01	1.05e-01	1.00e+00	8.21e-01	3.17e-01
GOBP B CELL PROLIFERATION	79	3.77e-03	1.56e-02	0.3570	7.72e-02	1.62e-01	2.63e-01	6.80e-02	-2.71e-02	1.44e-01	2.35e-01	1.26e-02	5.46e-05	2.96e-01	6.77e-01	2.67e-02
GOMF CHEMOKINE RECEPTOR BINDING	29	1.21e-01	2.25e-01	0.3570	5.08e-02	1.80e-02	2.69e-01	-1.18e-01	-1.95e-01	1.16e-02	6.36e-01	8.67e-01	1.21e-02	2.72e-01	6.93e-02	9.14e-01
GOBP POSITIVE REGULATION OF RESPONSE TO ENDOPLASMIC RETICULUM STRESS	34	1.02e-02	3.48e-02	0.3570	-1.93e-01	-8.49e-02	1.69e-01	1.04e-01	-1.77e-01	1.10e-01	5.17e-02	3.92e-01	8.82e-02	2.93e-01	7.35e-02	2.68e-01
GOMF CELL ADHESION MEDIATOR ACTIVITY	46	2.36e-02	6.72e-02	0.3570	-1.18e-01	-9.65e-02	1.99e-01	-1.86e-01	-1.08e-01	1.35e-01	1.67e-01	2.58e-01	1.96e-02	2.89e-02	2.05e-01	1.13e-01
GOCC VACUOLAR LUMEN	148	5.85e-12	1.21e-10	0.3570	-2.33e-01	-2.20e-01	8.86e-02	4.35e-02	-8.11e-02	8.89e-02	9.41e-07	3.67e-06	6.29e-02	3.61e-01	8.86e-02	6.20e-02
GOCC PRESYNAPTIC CYTOSKELETON	7	6.40e-01	7.14e-01	0.3570	-7.76e-02	-2.30e-02	2.03e-01	2.29e-01	1.29e-01	1.02e-01	7.22e-01	9.16e-01	3.53e-01	2.94e-01	5.53e-01	6.41e-01
GOBP CENTRIOLE CENTRIOLE COHESION	15	2.69e-01	3.88e-01	0.3570	2.95e-02	2.99e-01	-4.44e-02	1.16e-01	1.07e-01	9.79e-02	8.43e-01	4.47e-02	7.66e-01	4.35e-01	4.71e-01	5.11e-01
GOBP CELLULAR OXIDANT DETOXIFICATION	80	4.37e-05	3.23e-04	0.3570	-1.33e-01	-1.94e-01	1.50e-01	2.24e-03	-5.06e-02	2.15e-01	3.93e-02	2.64e-03	2.02e-02	9.72e-01	4.34e-01	8.62e-04
GOCC ESCRT COMPLEX	27	8.42e-02	1.73e-01	0.3560	-1.31e-01	-1.72e-01	4.88e-02	1.78e-01	-4.44e-02	2.11e-01	2.40e-01	1.23e-01	6.60e-01	1.08e-01	6.89e-01	5.82e-02
GOBP POSITIVE REGULATION OF DNA BINDING	29	3.65e-01	4.80e-01	0.3560	-1.26e-01	-1.39e-01	1.17e-01	-1.77e-01	-1.92e-01	1.01e-01	2.40e-01	1.94e-01	2.77e-01	9.94e-02	7.38e-02	3.48e-01
GOBP POLYAMINE TRANSPORT	13	5.07e-01	6.03e-01	0.3560	-2.79e-01	-1.99e-01	1.89e-02	5.49e-05	-9.63e-02	-8.81e-03	8.18e-02	2.14e-01	9.06e-01	1.00e+00	5.48e-01	9.56e-01
GOBP REGULATION OF LYSOSOME ORGANIZATION	12	5.33e-01	6.25e-01	0.3560	-1.70e-01	-2.41e-01	7.68e-02	-5.10e-03	-1.77e-01	-5.30e-02	3.09e-01	1.48e-01	6.45e-01	9.76e-01	2.89e-01	7.50e-01
GOBP REGULATION OF GOLGI ORGANIZATION	17	5.51e-01	6.40e-01	0.3560	-1.68e-01	-1.56e-01	1.63e-01	-7.53e-02	-1.67e-01	1.21e-01	2.31e-01	2.66e-01	2.46e-01	5.91e-01	2.33e-01	3.89e-01
GOCC ER TO GOLGI TRANSPORT VESICLE MEMBRANE	59	2.57e-04	1.57e-03	0.3560	-2.69e-01	-1.62e-01	-8.26e-02	1.28e-01	2.46e-02	6.77e-02	3.49e-04	3.11e-02	2.72e-01	9.02e-02	7.44e-01	3.69e-01
GOBP CYTIDINE METABOLIC PROCESS	12	5.20e-01	6.14e-01	0.3560	2.21e-01	1.03e-01	9.61e-02	5.05e-02	-4.28e-02	2.33e-01	1.85e-01	5.38e-01	5.64e-01	7.62e-01	7.97e-01	1.63e-01
GOBP NEGATIVE REGULATION OF TELOMERE MAINTENANCE VIA TELOMERE LENGTHENING	28	7.99e-02	1.66e-01	0.3560	-7.29e-02	6.18e-02	-1.62e-01	2.44e-01	1.78e-01	2.75e-02	5.04e-01	5.71e-01	1.38e-01	2.57e-02	1.04e-01	8.01e-01
GOMF DYNEIN INTERMEDIATE CHAIN BINDING	33	1.09e-01	2.08e-01	0.3560	1.76e-01	1.10e-01	1.91e-01	-6.05e-02	-1.21e-01	1.71e-01	8.09e-02	2.76e-01	5.76e-02	5.48e-01	2.28e-01	8.90e-02
GOBP ENDODERM FORMATION	46	5.15e-04	2.87e-03	0.3560	-2.39e-01	9.29e-02	2.24e-01	-3.48e-02	-4.20e-02	8.98e-02	5.03e-03	2.76e-01	8.58e-03	6.83e-01	6.22e-01	2.92e-01
GOBP TRANSLESION SYNTHESIS	26	8.46e-02	1.73e-01	0.3560	-6.29e-02	-1.80e-01	-3.44e-02	1.83e-01	1.09e-01	2.09e-01	5.79e-01	1.12e-01	7.61e-01	1.06e-01	3.35e-01	6.45e-02
GOBP T HELPER 2 CELL DIFFERENTIATION	18	4.34e-01	5.42e-01	0.3560	-6.71e-03	1.98e-01	2.72e-01	2.08e-02	-5.59e-02	1.01e-01	9.61e-01	1.46e-01	4.56e-02	8.78e-01	6.81e-01	4.60e-01
GOBP POSITIVE REGULATION OF PHAGOCYTOSIS	58	1.06e-03	5.36e-03	0.3560	-5.21e-02	1.66e-01	2.33e-01	3.40e-02	1.45e-01	1.43e-01	4.93e-01	2.89e-02	2.17e-03	6.54e-01	5.67e-02	6.01e-02
GOBP VASODILATION	35	1.85e-02	5.56e-02	0.3560	-1.46e-01	-2.76e-01	1.00e-01	-6.93e-02	-1.20e-01	2.78e-03	1.36e-01	4.68e-03	3.04e-01	4.78e-01	2.18e-01	9.77e-01
GOBP REGULATION OF CELLULAR RESPONSE TO OXIDATIVE STRESS	21	6.62e-02	1.45e-01	0.3560	-6.16e-02	-1.90e-02	1.83e-01	5.06e-02	2.22e-01	1.94e-01	6.25e-01	8.80e-01	1.47e-01	6.88e-01	7.88e-02	1.24e-01
GOBP NEGATIVE REGULATION OF MACROPHAGE APOPTOTIC PROCESS	7	7.57e-01	8.05e-01	0.3560	1.55e-02	4.58e-02	3.26e-02	1.14e-02	9.56e-02	3.38e-01	9.43e-01	8.34e-01	8.81e-01	9.58e-01	6.61e-01	1.22e-01
GOBP DIACYLGLYCEROL METABOLIC PROCESS	23	9.04e-02	1.82e-01	0.3560	-2.75e-04	2.01e-01	1.07e-01	2.23e-01	1.37e-01	-7.97e-02	9.98e-01	9.51e-02	3.75e-01	6.43e-02	2.54e-01	5.08e-01
GOMF SUMO LIGASE ACTIVITY	13	5.68e-01	6.56e-01	0.3560	-1.15e-01	1.36e-01	-1.25e-01	1.09e-01	2.37e-01	-1.07e-01	4.74e-01	3.97e-01	4.36e-01	4.95e-01	1.39e-01	5.05e-01
GOBP REGULATION OF T HELPER CELL DIFFERENTIATION	40	1.52e-02	4.79e-02	0.3560	5.64e-02	2.18e-01	2.23e-01	1.60e-01	2.66e-02	1.53e-03	5.37e-01	1.71e-02	1.46e-02	8.04e-02	7.71e-01	9.87e-01
GOBP MACROPHAGE CHEMOTAXIS	30	1.01e-01	1.96e-01	0.3560	-1.24e-01	-2.70e-01	9.82e-02	-1.17e-02	-1.45e-01	8.70e-02	2.40e-01	1.05e-02	3.52e-01	9.12e-01	1.70e-01	4.10e-01
GOBP NEGATIVE REGULATION OF INTERLEUKIN 8 PRODUCTION	16	1.79e-01	2.94e-01	0.3560	-3.11e-02	2.11e-01	2.35e-01	1.00e-01	1.21e-01	-3.46e-02	8.30e-01	1.44e-01	1.04e-01	4.89e-01	4.01e-01	8.11e-01
GOMF NUCLEOSIDE TRANSMEMBRANE TRANSPORTER ACTIVITY	8	5.80e-01	6.66e-01	0.3560	2.07e-01	-1.91e-01	-5.26e-02	8.94e-02	1.73e-01	-8.22e-02	3.11e-01	3.49e-01	7.97e-01	6.62e-01	3.98e-01	6.87e-01
GOBP G PROTEIN COUPLED PURINERGIC RECEPTOR SIGNALING PATHWAY	10	8.35e-01	8.67e-01	0.3560	-6.15e-02	-8.33e-02	2.29e-01	3.14e-03	-1.65e-01	1.90e-01	7.36e-01	6.48e-01	2.10e-01	9.86e-01	3.68e-01	2.97e-01
GOBP LIPID GLYCOSYLATION	8	6.54e-01	7.25e-01	0.3560	-6.79e-02	-1.64e-01	1.80e-01	-2.66e-02	-2.28e-01	-1.00e-01	7.40e-01	4.21e-01	3.79e-01	8.96e-01	2.65e-01	6.23e-01
GOBP RESPONSE TO NICOTINE	30	1.43e-01	2.52e-01	0.3560	3.29e-02	6.95e-02	2.81e-01	1.21e-01	7.84e-03	1.64e-01	7.55e-01	5.10e-01	7.64e-03	2.53e-01	9.41e-01	1.21e-01
GOBP LATE ENDOSOME TO VACUOLE TRANSPORT VIA MULTIVESICULAR BODY SORTING PATHWAY	25	1.49e-01	2.59e-01	0.3560	-1.10e-01	-2.12e-01	5.98e-02	1.30e-01	-6.31e-02	2.12e-01	3.43e-01	6.60e-02	6.05e-01	2.59e-01	5.85e-01	6.69e-02
GOBP NEGATIVE REGULATION OF LIPID TRANSPORT	20	5.17e-03	2.01e-02	0.3560	-1.32e-01	-5.27e-02	1.79e-01	8.23e-02	-1.40e-01	-2.19e-01	3.09e-01	6.83e-01	1.66e-01	5.24e-01	2.78e-01	9.01e-02
GOBP PEROXISOMAL TRANSPORT	21	3.97e-01	5.09e-01	0.3560	-1.90e-01	-1.44e-01	-2.22e-01	5.50e-02	1.25e-01	-3.67e-02	1.32e-01	2.52e-01	7.76e-02	6.62e-01	3.20e-01	7.71e-01
GOMF METAL CATION MONOATOMIC CATION ANTIPORTER ACTIVITY	31	3.15e-02	8.28e-02	0.3550	-2.51e-01	4.56e-02	1.97e-01	-3.25e-02	-5.98e-02	1.34e-01	1.56e-02	6.60e-01	5.78e-02	7.54e-01	5.64e-01	1.97e-01
GOBP OVULATION CYCLE	48	8.70e-03	3.08e-02	0.3550	-1.07e-01	1.06e-01	2.45e-01	6.70e-02	-4.79e-02	1.92e-01	1.98e-01	2.05e-01	3.34e-03	4.22e-01	5.66e-01	2.14e-02
GOBP POSITIVE REGULATION OF VASOCONSTRICTION	19	3.68e-01	4.83e-01	0.3550	-3.71e-02	7.55e-02	3.01e-01	-7.16e-02	-2.21e-02	1.52e-01	7.80e-01	5.69e-01	2.33e-02	5.89e-01	8.67e-01	2.50e-01
GOBP REGULATION OF UBIQUITIN PROTEIN TRANSFERASE ACTIVITY	35	1.75e-02	5.32e-02	0.3550	-1.39e-01	-2.57e-01	5.30e-03	1.59e-01	8.67e-03	1.24e-01	1.55e-01	8.60e-03	9.57e-01	1.03e-01	9.29e-01	2.03e-01
GOBP INNER DYNEIN ARM ASSEMBLY	12	3.93e-01	5.06e-01	0.3550	1.86e-01	7.21e-02	1.39e-01	9.44e-04	-4.12e-02	-2.56e-01	2.65e-01	6.65e-01	4.05e-01	9.95e-01	8.05e-01	1.25e-01
GOCC PROTEIN COMPLEX INVOLVED IN CELL ADHESION	50	5.05e-03	1.98e-02	0.3550	-6.03e-03	8.00e-02	2.95e-01	-1.35e-01	-1.95e-02	1.20e-01	9.41e-01	3.28e-01	3.14e-04	9.84e-02	8.12e-01	1.43e-01
GOBP NUCLEAR ENVELOPE ORGANIZATION	56	1.06e-03	5.36e-03	0.3550	-2.00e-01	-1.96e-01	8.91e-02	9.12e-02	-1.10e-01	1.39e-01	9.71e-03	1.11e-02	2.49e-01	2.38e-01	1.54e-01	7.23e-02
GOBP POSTSYNAPTIC MEMBRANE ORGANIZATION	28	2.13e-01	3.31e-01	0.3550	9.47e-02	7.93e-02	1.66e-01	1.91e-01	1.81e-01	1.20e-01	3.86e-01	4.68e-01	1.29e-01	8.07e-02	9.76e-02	2.73e-01
GOBP REGULATION OF MITOCHONDRIAL MEMBRANE POTENTIAL	63	6.71e-04	3.62e-03	0.3550	-1.21e-01	-3.06e-01	-1.10e-01	4.61e-02	3.20e-02	4.80e-02	9.55e-02	2.63e-05	1.30e-01	5.26e-01	6.61e-01	5.10e-01
GOBP PROTEIN TARGETING TO MEMBRANE	107	1.94e-05	1.53e-04	0.3550	-1.41e-01	-2.02e-01	5.11e-02	2.33e-02	-1.86e-01	1.66e-01	1.16e-02	3.13e-04	3.61e-01	6.78e-01	8.75e-04	2.97e-03
GOBP NEURAL NUCLEUS DEVELOPMENT	51	2.64e-02	7.30e-02	0.3550	-2.30e-01	-1.56e-01	3.41e-02	-2.88e-02	-1.55e-01	1.52e-01	4.56e-03	5.45e-02	6.73e-01	7.22e-01	5.63e-02	6.00e-02
GOBP REGULATION OF MOTOR NEURON APOPTOTIC PROCESS	14	6.03e-01	6.83e-01	0.3550	-7.90e-02	4.30e-03	-9.01e-03	-3.18e-01	-1.13e-01	-7.58e-02	6.09e-01	9.78e-01	9.53e-01	3.93e-02	4.66e-01	6.23e-01
GOCC GOLGI CISTERNA	98	1.36e-07	1.63e-06	0.3550	-9.83e-02	-1.31e-02	1.35e-01	2.12e-01	-6.21e-02	2.21e-01	9.28e-02	8.22e-01	2.10e-02	2.85e-04	2.88e-01	1.53e-04
GOBP REGULATION OF DEVELOPMENT HETEROCHRONIC	10	4.93e-01	5.92e-01	0.3550	-2.87e-01	-5.49e-02	7.90e-02	-1.61e-01	8.84e-02	2.15e-02	1.16e-01	7.64e-01	6.65e-01	3.77e-01	6.28e-01	9.06e-01
GOBP POSITIVE REGULATION OF ALPHA BETA T CELL DIFFERENTIATION	49	1.07e-03	5.39e-03	0.3550	-9.89e-02	9.89e-02	2.38e-01	1.61e-01	-1.38e-02	1.54e-01	2.31e-01	2.31e-01	4.01e-03	5.11e-02	8.67e-01	6.29e-02
GOBP LATE ENDOSOME TO GOLGI TRANSPORT	5	9.07e-01	9.23e-01	0.3550	-1.54e-02	7.20e-02	4.82e-02	1.56e-01	3.46e-02	3.04e-01	9.52e-01	7.80e-01	8.52e-01	5.46e-01	8.93e-01	2.39e-01
GOCC GUANYL NUCLEOTIDE EXCHANGE FACTOR COMPLEX	23	1.68e-01	2.81e-01	0.3550	-2.44e-01	-8.50e-03	9.97e-02	1.38e-03	5.05e-02	2.31e-01	4.27e-02	9.44e-01	4.08e-01	9.91e-01	6.75e-01	5.48e-02
GOBP LAMELLIPODIUM MORPHOGENESIS	17	3.50e-02	9.00e-02	0.3550	-1.51e-01	-2.85e-02	1.76e-01	1.67e-01	2.03e-01	4.27e-02	2.81e-01	8.39e-01	2.08e-01	2.33e-01	1.47e-01	7.60e-01
GOBP REGULATION OF T CELL APOPTOTIC PROCESS	36	1.40e-01	2.49e-01	0.3540	1.32e-01	8.83e-02	4.57e-02	2.08e-01	1.45e-01	1.84e-01	1.71e-01	3.59e-01	6.35e-01	3.06e-02	1.31e-01	5.61e-02
GOCC MITOTIC SPINDLE POLE	38	7.21e-03	2.65e-02	0.3540	-9.84e-02	-4.20e-02	8.17e-02	2.56e-01	1.40e-01	1.49e-01	2.94e-01	6.54e-01	3.83e-01	6.31e-03	1.35e-01	1.11e-01
GOBP MICROTUBULE CYTOSKELETON ORGANIZATION INVOLVED IN MITOSIS	158	6.55e-12	1.35e-10	0.3540	-8.42e-02	-1.44e-01	1.39e-01	1.80e-01	-2.18e-02	2.14e-01	6.78e-02	1.82e-03	2.57e-03	9.50e-05	6.36e-01	3.54e-06
GOBP REGULATION OF DEFENSE RESPONSE TO BACTERIUM	14	9.74e-02	1.92e-01	0.3540	-6.21e-02	1.16e-01	3.16e-01	8.65e-03	-2.31e-02	-8.72e-02	6.88e-01	4.51e-01	4.09e-02	9.55e-01	8.81e-01	5.72e-01
GOMF 2 OXOGLUTARATE DEPENDENT DIOXYGENASE ACTIVITY	55	1.30e-05	1.07e-04	0.3540	-1.02e-01	7.94e-02	3.62e-03	3.17e-01	8.74e-02	-9.27e-03	1.92e-01	3.09e-01	9.63e-01	4.64e-05	2.62e-01	9.05e-01
GOMF HISTONE METHYLTRANSFERASE BINDING	13	5.39e-01	6.30e-01	0.3540	-1.63e-01	-1.54e-01	-6.90e-02	1.78e-02	-2.04e-01	-1.68e-01	3.10e-01	3.35e-01	6.67e-01	9.12e-01	2.03e-01	2.94e-01
GOMF CADHERIN BINDING	294	1.69e-22	8.72e-21	0.3540	-1.32e-01	-1.30e-01	1.64e-01	1.29e-01	-1.06e-01	1.90e-01	9.55e-05	1.31e-04	1.28e-06	1.37e-04	1.80e-03	2.25e-08
GOBP REGULATION OF HEART GROWTH	42	1.03e-02	3.51e-02	0.3540	4.78e-02	2.01e-01	2.14e-01	1.80e-01	-4.13e-02	5.01e-02	5.92e-01	2.44e-02	1.64e-02	4.31e-02	6.43e-01	5.74e-01
GOBP REGULATION OF MITOCHONDRIAL MEMBRANE PERMEABILITY	49	4.42e-02	1.07e-01	0.3540	-7.73e-02	-2.19e-01	-1.84e-01	3.03e-02	1.22e-03	-1.91e-01	3.49e-01	8.03e-03	2.56e-02	7.13e-01	9.88e-01	2.10e-02
GOMF DNA HELICASE ACTIVITY	59	7.11e-04	3.80e-03	0.3540	6.88e-02	-8.91e-02	-2.08e-02	3.27e-01	2.99e-02	6.35e-02	3.60e-01	2.36e-01	7.82e-01	1.38e-05	6.91e-01	3.99e-01
GOBP PYRIMIDINE NUCLEOSIDE METABOLIC PROCESS	23	2.47e-01	3.66e-01	0.3540	8.76e-02	-8.65e-02	1.34e-01	1.05e-01	-8.45e-02	2.72e-01	4.67e-01	4.73e-01	2.66e-01	3.85e-01	4.83e-01	2.41e-02
GOBP REGULATION OF MODIFICATION OF SYNAPTIC STRUCTURE	12	6.54e-01	7.25e-01	0.3530	-1.42e-01	1.96e-02	-1.54e-01	-4.66e-02	2.79e-02	-2.79e-01	3.95e-01	9.06e-01	3.57e-01	7.80e-01	8.67e-01	9.43e-02
GOBP VASCULAR ASSOCIATED SMOOTH MUSCLE CELL DEVELOPMENT	8	7.16e-01	7.75e-01	0.3530	5.49e-02	2.26e-01	1.47e-01	1.83e-02	1.67e-01	-1.45e-01	7.88e-01	2.68e-01	4.71e-01	9.28e-01	4.14e-01	4.78e-01
GOBP MYELOID DENDRITIC CELL ACTIVATION	25	3.17e-01	4.37e-01	0.3530	-1.95e-02	1.01e-01	2.07e-01	2.17e-02	-1.35e-01	2.29e-01	8.66e-01	3.84e-01	7.27e-02	8.51e-01	2.42e-01	4.72e-02
GOBP REGULATION OF ANTIGEN PROCESSING AND PRESENTATION	17	4.39e-02	1.07e-01	0.3530	-1.12e-01	-6.02e-02	7.27e-03	1.30e-01	9.64e-02	-2.87e-01	4.23e-01	6.67e-01	9.59e-01	3.55e-01	4.92e-01	4.04e-02
GOBP CATECHOL CONTAINING COMPOUND BIOSYNTHETIC PROCESS	13	5.33e-01	6.25e-01	0.3530	-1.92e-01	-4.93e-02	1.74e-01	-6.61e-02	3.97e-02	2.22e-01	2.30e-01	7.58e-01	2.77e-01	6.80e-01	8.04e-01	1.66e-01
GOBP CORTICAL ACTIN CYTOSKELETON ORGANIZATION	41	9.32e-04	4.80e-03	0.3530	-7.46e-02	4.22e-02	2.83e-01	1.66e-01	-1.69e-02	9.72e-02	4.09e-01	6.40e-01	1.69e-03	6.65e-02	8.51e-01	2.82e-01
GOBP REGULATION OF HIPPO SIGNALING	33	5.39e-03	2.08e-02	0.3530	-9.83e-02	1.45e-01	2.51e-01	1.59e-01	-1.00e-03	7.49e-02	3.28e-01	1.49e-01	1.25e-02	1.14e-01	9.92e-01	4.56e-01
GOMF METAL DEPENDENT DEUBIQUITINASE ACTIVITY	12	6.53e-01	7.24e-01	0.3530	-2.13e-01	-2.18e-01	-6.56e-02	-4.65e-03	3.17e-02	1.62e-01	2.01e-01	1.90e-01	6.94e-01	9.78e-01	8.49e-01	3.33e-01
GOCC DENDRITIC GROWTH CONE	9	6.34e-01	7.10e-01	0.3530	1.19e-01	1.34e-01	2.04e-01	1.59e-01	1.19e-01	-1.07e-01	5.36e-01	4.87e-01	2.89e-01	4.09e-01	5.35e-01	5.79e-01
GOBP TRANSPORT OF VIRUS	20	1.38e-01	2.46e-01	0.3530	-1.43e-01	1.69e-02	-1.54e-01	-1.07e-02	2.21e-01	1.77e-01	2.68e-01	8.96e-01	2.34e-01	9.34e-01	8.69e-02	1.71e-01
GOMF PROTEIN SEQUESTERING ACTIVITY	26	1.55e-02	4.84e-02	0.3530	-1.01e-01	-1.32e-01	2.84e-01	4.85e-02	-9.60e-02	7.04e-02	3.71e-01	2.44e-01	1.23e-02	6.69e-01	3.97e-01	5.34e-01
GOMF PHOSPHATIDYLINOSITOL PHOSPHATE PHOSPHATASE ACTIVITY	27	2.29e-02	6.58e-02	0.3530	-2.05e-01	2.28e-01	1.14e-01	4.46e-02	2.85e-02	1.22e-01	6.50e-02	4.07e-02	3.06e-01	6.88e-01	7.97e-01	2.71e-01
GOBP RETROGRADE TRANSPORT ENDOSOME TO GOLGI	99	1.50e-07	1.78e-06	0.3530	-2.03e-01	-1.09e-01	4.88e-02	1.24e-01	-1.25e-01	1.96e-01	4.97e-04	6.10e-02	4.02e-01	3.35e-02	3.19e-02	7.45e-04
GOBP REGULATION OF IRON ION TRANSPORT	7	8.07e-01	8.45e-01	0.3530	-6.80e-03	1.21e-01	-2.63e-01	-1.91e-02	1.96e-01	-4.40e-02	9.75e-01	5.80e-01	2.28e-01	9.30e-01	3.69e-01	8.40e-01
GOBP FUCOSYLATION	13	6.92e-01	7.56e-01	0.3530	4.18e-02	-4.98e-02	-1.73e-01	1.30e-01	2.57e-02	-2.70e-01	7.94e-01	7.56e-01	2.81e-01	4.17e-01	8.72e-01	9.17e-02
GOCC GABA ERGIC SYNAPSE	37	3.17e-02	8.33e-02	0.3530	1.27e-01	7.85e-02	1.48e-01	-1.51e-01	-2.25e-01	-8.27e-02	1.80e-01	4.09e-01	1.19e-01	1.12e-01	1.79e-02	3.84e-01
GOCC PROTEIN LIPID COMPLEX	23	1.38e-01	2.46e-01	0.3530	2.29e-02	-1.15e-01	2.45e-01	1.33e-01	-1.92e-02	1.81e-01	8.49e-01	3.41e-01	4.19e-02	2.69e-01	8.73e-01	1.33e-01
GOBP MEMBRANE PROTEIN ECTODOMAIN PROTEOLYSIS	46	8.76e-04	4.55e-03	0.3530	-1.39e-01	-3.29e-02	2.64e-01	-1.53e-03	-1.82e-01	3.36e-02	1.03e-01	6.99e-01	1.94e-03	9.86e-01	3.26e-02	6.93e-01
GOBP REGULATION OF TRANSCRIPTION BY RNA POLYMERASE I	44	2.51e-04	1.54e-03	0.3530	-2.48e-02	-1.89e-01	3.65e-02	2.07e-01	-1.56e-01	-1.41e-01	7.76e-01	3.00e-02	6.75e-01	1.75e-02	7.43e-02	1.07e-01
GOBP REGULATION OF TRIGLYCERIDE BIOSYNTHETIC PROCESS	18	9.09e-02	1.83e-01	0.3530	-1.26e-01	1.43e-02	-3.14e-02	1.58e-01	1.94e-01	-2.11e-01	3.55e-01	9.17e-01	8.18e-01	2.45e-01	1.54e-01	1.21e-01
GOBP PEPTIDYL LYSINE MONOMETHYLATION	9	5.92e-01	6.74e-01	0.3530	-1.66e-01	-2.49e-01	-8.48e-02	1.99e-02	1.49e-01	-7.24e-02	3.89e-01	1.96e-01	6.60e-01	9.18e-01	4.40e-01	7.07e-01
GOBP SUBSTRATE ADHESION DEPENDENT CELL SPREADING	85	1.03e-06	1.08e-05	0.3530	-1.38e-01	-1.12e-01	2.38e-01	3.05e-02	-1.68e-01	8.25e-02	2.80e-02	7.36e-02	1.46e-04	6.26e-01	7.36e-03	1.89e-01
GOBP NEGATIVE REGULATION OF CYTOKINE PRODUCTION INVOLVED IN INFLAMMATORY RESPONSE	20	8.64e-03	3.06e-02	0.3530	-1.76e-01	1.01e-01	8.90e-02	2.01e-01	1.08e-01	-1.53e-01	1.72e-01	4.34e-01	4.91e-01	1.20e-01	4.05e-01	2.36e-01
GOBP VASCULAR ENDOTHELIAL CELL PROLIFERATION	21	3.80e-01	4.94e-01	0.3530	-7.13e-02	1.68e-01	1.80e-01	-1.90e-01	-1.25e-01	8.31e-02	5.72e-01	1.84e-01	1.53e-01	1.31e-01	3.22e-01	5.10e-01
GOMF 7SK SNRNA BINDING	9	6.47e-01	7.19e-01	0.3530	-1.56e-01	-8.91e-02	-1.46e-01	1.65e-01	-1.44e-02	-2.08e-01	4.17e-01	6.44e-01	4.49e-01	3.91e-01	9.40e-01	2.79e-01
GOBP NUCLEOBASE CONTAINING SMALL MOLECULE BIOSYNTHETIC PROCESS	18	1.44e-01	2.54e-01	0.3530	8.96e-02	-2.92e-01	-1.07e-01	9.06e-02	1.04e-01	2.69e-02	5.11e-01	3.22e-02	4.32e-01	5.06e-01	4.45e-01	8.43e-01
GOBP NEGATIVE REGULATION OF NEURON PROJECTION REGENERATION	14	1.01e-01	1.97e-01	0.3520	2.15e-02	3.23e-01	-1.24e-01	-5.42e-02	-2.34e-02	-2.55e-02	8.89e-01	3.65e-02	4.21e-01	7.25e-01	8.80e-01	8.69e-01
GOBP FIBROBLAST GROWTH FACTOR PRODUCTION	7	4.98e-01	5.95e-01	0.3520	-5.28e-02	-4.15e-02	3.10e-01	-7.51e-02	9.67e-02	9.36e-02	8.09e-01	8.49e-01	1.56e-01	7.31e-01	6.58e-01	6.68e-01
GOBP POSITIVE REGULATION OF OSSIFICATION	36	1.11e-02	3.75e-02	0.3520	-2.05e-01	1.39e-01	-1.15e-02	-1.70e-01	-7.54e-02	-1.67e-01	3.29e-02	1.49e-01	9.05e-01	7.71e-02	4.34e-01	8.33e-02
GOBP NEGATIVE REGULATION OF CARDIAC MUSCLE TISSUE GROWTH	18	1.55e-01	2.66e-01	0.3520	3.01e-02	-9.41e-02	2.00e-01	2.10e-01	-1.72e-01	2.45e-02	8.25e-01	4.89e-01	1.41e-01	1.23e-01	2.06e-01	8.57e-01
GOBP POSITIVE REGULATION OF VASCULATURE DEVELOPMENT	131	4.87e-07	5.38e-06	0.3520	-3.94e-02	6.83e-02	2.90e-01	2.05e-02	-4.86e-02	1.77e-01	4.36e-01	1.77e-01	1.01e-08	6.86e-01	3.37e-01	4.83e-04
GOBP GUANINE NUCLEOTIDE TRANSPORT	10	7.33e-01	7.87e-01	0.3520	-2.30e-01	-1.65e-01	-3.29e-02	-2.72e-02	-1.64e-01	-1.24e-01	2.08e-01	3.66e-01	8.57e-01	8.82e-01	3.70e-01	4.97e-01
GOCC ACTIN FILAMENT BUNDLE	73	3.40e-04	2.01e-03	0.3520	-7.44e-02	-7.17e-02	1.86e-01	1.37e-01	-9.15e-02	2.27e-01	2.72e-01	2.89e-01	6.04e-03	4.23e-02	1.76e-01	7.89e-04
GOBP VESICLE TETHERING	32	4.85e-02	1.15e-01	0.3520	-2.24e-01	-1.24e-01	-5.63e-02	5.86e-02	5.64e-02	2.21e-01	2.87e-02	2.24e-01	5.81e-01	5.66e-01	5.81e-01	3.04e-02
GOBP CARDIAC CONDUCTION SYSTEM DEVELOPMENT	16	2.32e-01	3.50e-01	0.3520	-1.36e-01	1.75e-01	1.87e-01	-1.17e-02	-1.89e-01	6.43e-02	3.46e-01	2.25e-01	1.95e-01	9.36e-01	1.91e-01	6.56e-01
GOBP POSITIVE REGULATION OF PROTEIN AUTOPHOSPHORYLATION	22	4.86e-01	5.86e-01	0.3520	-2.59e-01	-7.85e-02	-1.26e-02	-1.56e-01	-1.26e-01	1.02e-01	3.55e-02	5.24e-01	9.18e-01	2.04e-01	3.06e-01	4.08e-01
GOMF STRUCTURAL CONSTITUENT OF MUSCLE	30	2.22e-01	3.40e-01	0.3520	1.52e-01	4.70e-02	2.28e-01	1.77e-02	-1.76e-01	1.25e-01	1.49e-01	6.56e-01	3.09e-02	8.67e-01	9.55e-02	2.37e-01
GOBP PHOSPHATIDYLINOSITOL PHOSPHATE BIOSYNTHETIC PROCESS	61	1.53e-04	9.89e-04	0.3520	-1.30e-01	1.76e-01	9.17e-02	1.54e-01	1.76e-01	1.14e-01	8.00e-02	1.75e-02	2.16e-01	3.71e-02	1.73e-02	1.24e-01
GOBP MEMBRANE REPOLARIZATION DURING ACTION POTENTIAL	17	6.60e-01	7.29e-01	0.3520	-8.34e-02	-4.21e-03	1.81e-01	-1.71e-01	-1.19e-01	2.02e-01	5.52e-01	9.76e-01	1.97e-01	2.23e-01	3.96e-01	1.49e-01
GOBP CYCLIC NUCLEOTIDE METABOLIC PROCESS	29	9.61e-02	1.90e-01	0.3520	-6.14e-02	1.69e-01	2.37e-01	1.09e-01	5.40e-02	1.43e-01	5.67e-01	1.16e-01	2.71e-02	3.09e-01	6.15e-01	1.82e-01
GOBP LUNG ALVEOLUS DEVELOPMENT	34	1.79e-02	5.41e-02	0.3520	-1.45e-01	-2.12e-02	4.64e-02	1.29e-01	2.21e-01	1.87e-01	1.43e-01	8.31e-01	6.40e-01	1.94e-01	2.59e-02	5.92e-02
GOBP REGULATION OF TRANSLATION AT SYNAPSE	8	7.43e-01	7.95e-01	0.3520	-2.53e-01	-8.92e-02	-6.56e-02	1.12e-01	1.29e-01	1.35e-01	2.15e-01	6.62e-01	7.48e-01	5.82e-01	5.28e-01	5.09e-01
GOBP SNRNA TRANSCRIPTION BY RNA POLYMERASE III	9	6.82e-01	7.47e-01	0.3520	2.40e-01	1.02e-01	-3.12e-02	1.07e-01	1.26e-01	1.66e-01	2.13e-01	5.97e-01	8.71e-01	5.78e-01	5.14e-01	3.87e-01
GOCC HETEROCHROMATIN	74	1.09e-03	5.49e-03	0.3520	5.85e-02	-3.64e-02	-6.99e-02	2.93e-01	1.68e-01	-1.75e-02	3.85e-01	5.88e-01	2.98e-01	1.34e-05	1.26e-02	7.95e-01
GOBP REGULATION OF TRIGLYCERIDE METABOLIC PROCESS	31	2.20e-03	9.97e-03	0.3520	-1.41e-01	9.06e-03	6.50e-02	2.65e-01	1.67e-01	-3.41e-02	1.75e-01	9.30e-01	5.31e-01	1.06e-02	1.07e-01	7.42e-01
GOBP REGULATION OF TYPE B PANCREATIC CELL DEVELOPMENT	7	6.64e-01	7.32e-01	0.3520	-2.51e-01	-6.04e-02	-4.01e-04	3.31e-02	-1.84e-01	-1.49e-01	2.51e-01	7.82e-01	9.99e-01	8.79e-01	3.99e-01	4.96e-01
GOBP MONOACYLGLYCEROL BIOSYNTHETIC PROCESS	6	7.04e-01	7.64e-01	0.3520	-1.51e-01	1.34e-01	6.26e-02	-4.49e-02	2.58e-01	-1.03e-01	5.22e-01	5.70e-01	7.91e-01	8.49e-01	2.75e-01	6.63e-01
GOMF CARNITINE O ACYLTRANSFERASE ACTIVITY	6	6.60e-01	7.29e-01	0.3510	8.55e-02	-1.86e-02	1.23e-01	8.43e-02	3.06e-01	-9.04e-03	7.17e-01	9.37e-01	6.01e-01	7.21e-01	1.95e-01	9.69e-01
GOBP MITOTIC RECOMBINATION	23	1.51e-01	2.62e-01	0.3510	1.46e-02	-1.33e-01	-1.23e-01	1.70e-01	2.06e-01	1.39e-01	9.04e-01	2.71e-01	3.07e-01	1.59e-01	8.75e-02	2.49e-01
GOBP DETECTION OF STIMULUS INVOLVED IN SENSORY PERCEPTION	110	4.56e-06	4.18e-05	0.3510	-2.13e-02	1.27e-01	1.63e-01	-2.58e-01	-1.11e-01	3.56e-02	7.00e-01	2.17e-02	3.18e-03	2.82e-06	4.38e-02	5.19e-01
GOMF RACEMASE AND EPIMERASE ACTIVITY	17	5.61e-01	6.49e-01	0.3510	-8.52e-02	-2.60e-01	-1.96e-01	6.04e-02	4.49e-02	-6.79e-02	5.43e-01	6.37e-02	1.62e-01	6.67e-01	7.49e-01	6.28e-01
GOBP STRESS INDUCED PREMATURE SENESCENCE	7	8.38e-01	8.69e-01	0.3510	-5.56e-02	1.67e-01	4.65e-03	-2.62e-01	-1.06e-01	-1.12e-01	7.99e-01	4.45e-01	9.83e-01	2.30e-01	6.28e-01	6.07e-01
GOBP NEGATIVE REGULATION OF NON CANONICAL NF KAPPAB SIGNAL TRANSDUCTION	24	1.27e-01	2.32e-01	0.3510	-6.32e-02	2.73e-01	2.07e-01	-7.47e-03	2.41e-02	3.41e-02	5.92e-01	2.05e-02	7.91e-02	9.49e-01	8.38e-01	7.73e-01
GOBP SYNAPTIC VESICLE CYTOSKELETAL TRANSPORT	19	2.13e-01	3.31e-01	0.3510	-1.20e-01	-3.65e-02	-2.24e-02	-1.95e-01	-8.05e-02	2.50e-01	3.66e-01	7.83e-01	8.66e-01	1.42e-01	5.43e-01	5.88e-02
GOBP POSITIVE REGULATION OF DEPHOSPHORYLATION	46	3.51e-02	9.02e-02	0.3510	-4.01e-02	-7.88e-02	2.16e-01	6.77e-02	-1.62e-01	1.95e-01	6.38e-01	3.55e-01	1.13e-02	4.27e-01	5.79e-02	2.21e-02
GOBP T CELL ACTIVATION INVOLVED IN IMMUNE RESPONSE	99	8.06e-06	6.96e-05	0.3510	1.62e-03	2.23e-01	1.79e-01	1.63e-01	8.35e-02	8.78e-02	9.78e-01	1.27e-04	2.07e-03	4.94e-03	1.51e-01	1.31e-01
GOBP NEGATIVE REGULATION OF SMALL GTPASE MEDIATED SIGNAL TRANSDUCTION	48	2.88e-02	7.76e-02	0.3510	1.70e-02	1.40e-01	2.60e-01	1.14e-01	-1.65e-02	1.49e-01	8.38e-01	9.34e-02	1.80e-03	1.72e-01	8.43e-01	7.51e-02
GOBP MAMMARY GLAND EPITHELIAL CELL PROLIFERATION	23	1.80e-01	2.95e-01	0.3510	3.12e-02	5.54e-02	2.42e-01	2.17e-01	-2.48e-02	1.14e-01	7.96e-01	6.46e-01	4.48e-02	7.18e-02	8.37e-01	3.45e-01
GOBP RENAL SYSTEM VASCULATURE DEVELOPMENT	22	3.51e-01	4.67e-01	0.3510	-1.46e-01	6.71e-02	1.99e-01	-1.14e-01	-1.93e-03	2.11e-01	2.37e-01	5.86e-01	1.06e-01	3.55e-01	9.87e-01	8.63e-02
GOMF MYOSIN BINDING	53	5.03e-03	1.97e-02	0.3510	-6.67e-02	-2.35e-02	2.01e-01	1.49e-01	-9.68e-02	2.14e-01	4.01e-01	7.67e-01	1.14e-02	6.02e-02	2.23e-01	6.94e-03
GOBP CLATHRIN COAT ASSEMBLY	17	1.24e-01	2.29e-01	0.3510	-2.19e-01	2.62e-02	-1.04e-01	2.37e-01	8.68e-02	-3.34e-03	1.18e-01	8.52e-01	4.58e-01	9.14e-02	5.35e-01	9.81e-01
GOBP NEGATIVE REGULATION OF GLIOGENESIS	27	1.77e-01	2.92e-01	0.3510	1.04e-01	1.70e-01	2.54e-01	1.34e-01	2.63e-03	2.03e-02	3.50e-01	1.25e-01	2.21e-02	2.29e-01	9.81e-01	8.55e-01
GOCC CHLORIDE CHANNEL COMPLEX	27	2.22e-01	3.40e-01	0.3510	-1.79e-02	1.10e-02	1.43e-01	-2.44e-01	-2.00e-01	-4.77e-02	8.72e-01	9.21e-01	1.99e-01	2.79e-02	7.20e-02	6.68e-01
GOBP MITOTIC NUCLEAR DIVISION	258	1.12e-20	5.03e-19	0.3500	-1.90e-02	-2.23e-01	4.47e-02	2.08e-01	-6.12e-03	1.66e-01	5.99e-01	7.34e-10	2.16e-01	8.56e-09	8.66e-01	4.48e-06
GOBP DOUBLE STRAND BREAK REPAIR VIA SINGLE STRAND ANNEALING	8	8.18e-01	8.53e-01	0.3500	2.90e-02	-1.30e-01	-6.13e-02	2.66e-01	1.74e-01	4.16e-03	8.87e-01	5.23e-01	7.64e-01	1.92e-01	3.94e-01	9.84e-01
GOBP PURINE DEOXYRIBONUCLEOTIDE METABOLIC PROCESS	15	3.33e-01	4.51e-01	0.3500	-3.16e-02	-2.49e-01	8.33e-02	4.88e-02	1.34e-02	2.24e-01	8.32e-01	9.50e-02	5.76e-01	7.43e-01	9.28e-01	1.33e-01
GOBP CELLULAR RESPONSE TO VASCULAR ENDOTHELIAL GROWTH FACTOR STIMULUS	46	1.46e-03	7.06e-03	0.3500	-8.65e-02	8.51e-03	2.88e-01	5.86e-02	3.80e-02	1.66e-01	3.10e-01	9.20e-01	7.35e-04	4.92e-01	6.56e-01	5.18e-02
GOBP NEGATIVE REGULATION OF PEPTIDYL CYSTEINE S NITROSYLATION	6	8.41e-01	8.71e-01	0.3500	-1.83e-01	1.46e-01	3.47e-03	-1.69e-02	1.14e-01	2.34e-01	4.38e-01	5.36e-01	9.88e-01	9.43e-01	6.28e-01	3.21e-01
GOMF QUATERNARY AMMONIUM GROUP TRANSMEMBRANE TRANSPORTER ACTIVITY	8	2.99e-01	4.18e-01	0.3500	-8.78e-02	1.22e-01	2.56e-01	7.98e-03	2.13e-02	-1.85e-01	6.67e-01	5.51e-01	2.10e-01	9.69e-01	9.17e-01	3.66e-01
GOBP WALKING BEHAVIOR	22	9.33e-02	1.87e-01	0.3500	-1.43e-01	-3.49e-02	-3.79e-02	-2.74e-02	-3.02e-01	-8.72e-02	2.46e-01	7.77e-01	7.58e-01	8.24e-01	1.42e-02	4.79e-01
GOBP NEGATIVE REGULATION OF EPIDERMAL GROWTH FACTOR RECEPTOR SIGNALING PATHWAY	24	7.91e-02	1.65e-01	0.3500	-1.28e-01	-4.01e-02	1.21e-01	1.45e-01	-2.00e-01	1.70e-01	2.79e-01	7.34e-01	3.03e-01	2.18e-01	9.05e-02	1.49e-01
GOBP AMYLOID FIBRIL FORMATION	36	6.26e-02	1.39e-01	0.3500	-1.15e-01	-2.28e-01	5.71e-02	8.34e-02	-1.25e-01	1.78e-01	2.34e-01	1.81e-02	5.54e-01	3.87e-01	1.94e-01	6.45e-02
GOBP STEROID HORMONE SECRETION	18	4.23e-01	5.31e-01	0.3500	4.88e-02	-1.55e-02	2.46e-01	8.86e-02	-2.02e-01	1.04e-01	7.20e-01	9.10e-01	7.08e-02	5.15e-01	1.38e-01	4.45e-01
GOBP NON PROTEINOGENIC AMINO ACID BIOSYNTHETIC PROCESS	13	5.87e-01	6.70e-01	0.3500	-1.66e-01	1.53e-02	1.93e-01	6.81e-02	-5.23e-02	2.24e-01	3.01e-01	9.24e-01	2.29e-01	6.71e-01	7.44e-01	1.61e-01
GOCC CORTICAL ACTIN CYTOSKELETON	67	7.05e-04	3.78e-03	0.3500	6.34e-02	1.77e-02	2.04e-01	2.38e-01	-4.25e-02	1.34e-01	3.70e-01	8.02e-01	3.95e-03	7.42e-04	5.48e-01	5.75e-02
GOBP REGULATION OF ALPHA BETA T CELL ACTIVATION	107	9.33e-05	6.37e-04	0.3500	5.84e-02	1.69e-01	2.12e-01	1.61e-01	3.17e-02	1.37e-01	2.97e-01	2.59e-03	1.54e-04	4.09e-03	5.71e-01	1.45e-02
GOMF OXIDOREDUCTASE ACTIVITY ACTING ON A SULFUR GROUP OF DONORS OXYGEN AS ACCEPTOR	11	6.80e-01	7.46e-01	0.3490	-2.37e-01	-1.13e-01	6.01e-02	4.82e-02	-2.51e-02	2.16e-01	1.74e-01	5.16e-01	7.30e-01	7.82e-01	8.86e-01	2.14e-01
GOBP NEGATIVE REGULATION OF PROTEIN LOCALIZATION TO NUCLEUS	31	8.20e-02	1.70e-01	0.3490	-1.19e-01	-1.70e-02	1.60e-01	7.68e-02	-1.87e-01	2.03e-01	2.51e-01	8.70e-01	1.23e-01	4.59e-01	7.23e-02	5.01e-02
GOBP REGULATION OF VASOCONSTRICTION	38	8.20e-02	1.69e-01	0.3490	-1.59e-02	1.39e-01	2.60e-01	-1.46e-01	-5.44e-02	1.02e-01	8.65e-01	1.38e-01	5.47e-03	1.19e-01	5.62e-01	2.79e-01
GOBP CELLULAR RESPONSE TO REACTIVE NITROGEN SPECIES	14	1.51e-01	2.62e-01	0.3490	-2.16e-01	-3.11e-02	2.16e-01	1.32e-01	-8.00e-02	6.36e-02	1.62e-01	8.40e-01	1.62e-01	3.93e-01	6.04e-01	6.80e-01
GOBP CELLULAR RESPONSE TO GAMMA RADIATION	24	2.35e-01	3.53e-01	0.3490	-9.06e-02	-2.53e-01	-1.42e-01	1.53e-01	-5.34e-02	-5.67e-02	4.42e-01	3.17e-02	2.29e-01	1.94e-01	6.51e-01	6.31e-01
GOBP REGULATION OF TRANSMISSION OF NERVE IMPULSE	8	8.37e-01	8.68e-01	0.3490	-2.44e-01	1.94e-02	-1.39e-01	-1.02e-01	3.95e-02	-1.75e-01	2.32e-01	9.24e-01	4.97e-01	6.16e-01	8.47e-01	3.91e-01
GOMF RNA NUCLEASE ACTIVITY	117	8.07e-06	6.97e-05	0.3490	-1.16e-01	-2.06e-01	-2.27e-01	1.11e-01	3.20e-02	-3.83e-02	3.09e-02	1.21e-04	2.28e-05	3.77e-02	5.50e-01	4.74e-01
GOMF PROTEIN HETERODIMERIZATION ACTIVITY	235	1.36e-12	3.00e-11	0.3490	-1.55e-01	-2.03e-01	1.25e-01	-3.86e-02	-1.62e-01	1.15e-01	4.24e-05	8.14e-08	9.80e-04	3.09e-01	1.82e-05	2.42e-03
GOMF DNA POLYMERASE ACTIVITY	28	2.04e-01	3.20e-01	0.3490	-1.09e-01	-1.94e-01	-2.02e-01	1.07e-01	1.38e-01	-2.75e-02	3.20e-01	7.53e-02	6.38e-02	3.26e-01	2.05e-01	8.01e-01
GOMF STRUCTURAL CONSTITUENT OF CYTOSKELETON	78	3.00e-03	1.29e-02	0.3490	1.42e-02	1.87e-02	2.51e-01	5.05e-02	-3.48e-02	2.33e-01	8.28e-01	7.75e-01	1.25e-04	4.41e-01	5.95e-01	3.69e-04
GOMF GLUTATHIONE TRANSFERASE ACTIVITY	20	6.48e-02	1.43e-01	0.3490	-5.63e-02	-2.49e-01	6.00e-02	-2.22e-01	3.69e-03	6.06e-02	6.63e-01	5.42e-02	6.42e-01	8.50e-02	9.77e-01	6.39e-01
GOBP REGULATION OF POLYSACCHARIDE BIOSYNTHETIC PROCESS	28	1.57e-01	2.69e-01	0.3490	9.57e-02	5.18e-02	7.01e-02	2.96e-01	1.28e-01	-2.66e-02	3.81e-01	6.35e-01	5.21e-01	6.67e-03	2.40e-01	8.08e-01
GOBP REGULATION OF HEART RATE	63	1.73e-02	5.29e-02	0.3490	-1.12e-01	-6.90e-02	2.06e-01	-1.14e-01	-1.40e-01	1.72e-01	1.25e-01	3.44e-01	4.75e-03	1.17e-01	5.53e-02	1.81e-02
GOMF THIOESTERASE BINDING	10	7.59e-01	8.07e-01	0.3490	1.90e-01	-7.26e-03	-5.06e-02	1.48e-01	2.40e-03	-2.47e-01	2.97e-01	9.68e-01	7.82e-01	4.19e-01	9.90e-01	1.76e-01
GOBP POSITIVE REGULATION OF MONOOXYGENASE ACTIVITY	20	1.33e-02	4.31e-02	0.3490	-1.35e-01	-4.61e-02	1.80e-01	7.78e-02	2.40e-01	6.87e-02	2.95e-01	7.21e-01	1.62e-01	5.47e-01	6.28e-02	5.95e-01
GOBP REGULATION OF PROTEIN DEUBIQUITINATION	10	6.87e-01	7.51e-01	0.3490	-1.05e-01	-2.24e-02	1.27e-01	1.73e-01	1.10e-01	2.27e-01	5.64e-01	9.03e-01	4.86e-01	3.42e-01	5.48e-01	2.14e-01
GOBP VASCULAR ASSOCIATED SMOOTH MUSCLE CELL MIGRATION	22	3.83e-02	9.63e-02	0.3490	-2.85e-01	3.66e-02	7.49e-02	-4.65e-02	-1.38e-01	-1.11e-01	2.08e-02	7.66e-01	5.43e-01	7.06e-01	2.62e-01	3.68e-01
GOCC CCR4 NOT COMPLEX	16	4.48e-01	5.55e-01	0.3480	-1.80e-01	7.51e-02	1.30e-01	-1.10e-03	-9.21e-02	2.41e-01	2.13e-01	6.03e-01	3.68e-01	9.94e-01	5.23e-01	9.51e-02
GOBP ESTABLISHMENT OF PROTEIN LOCALIZATION TO VACUOLE	58	3.70e-04	2.16e-03	0.3480	-2.00e-01	-2.51e-02	1.15e-01	1.20e-01	-8.12e-02	2.16e-01	8.44e-03	7.41e-01	1.31e-01	1.14e-01	2.85e-01	4.42e-03
GOBP POSITIVE REGULATION OF INTERLEUKIN 1 ALPHA PRODUCTION	5	6.89e-01	7.53e-01	0.3480	-1.44e-03	-1.39e-01	-5.70e-02	-1.49e-01	2.58e-01	9.86e-02	9.96e-01	5.90e-01	8.25e-01	5.65e-01	3.17e-01	7.03e-01
GOBP POSITIVE REGULATION OF MITOTIC NUCLEAR DIVISION	33	8.05e-03	2.90e-02	0.3480	5.92e-02	-1.68e-01	4.72e-02	2.08e-01	2.00e-01	6.42e-02	5.56e-01	9.52e-02	6.39e-01	3.88e-02	4.68e-02	5.24e-01
GOCC LYSOSOMAL LUMEN	73	5.06e-07	5.57e-06	0.3480	-2.50e-01	-2.16e-01	-2.19e-02	2.75e-02	8.35e-02	-6.18e-02	2.27e-04	1.38e-03	7.46e-01	6.85e-01	2.17e-01	3.61e-01
GOBP COBALAMIN TRANSPORT	8	5.74e-01	6.61e-01	0.3480	2.52e-01	-1.46e-01	1.66e-01	6.37e-02	-3.17e-02	-6.35e-02	2.18e-01	4.75e-01	4.17e-01	7.55e-01	8.77e-01	7.56e-01
GOBP CHONDROITIN SULFATE METABOLIC PROCESS	22	1.10e-02	3.70e-02	0.3480	-2.09e-01	-1.31e-02	1.15e-01	1.13e-01	-2.09e-01	-8.90e-02	9.04e-02	9.15e-01	3.50e-01	3.61e-01	8.99e-02	4.70e-01
GOBP VASCULAR ASSOCIATED SMOOTH MUSCLE CELL APOPTOTIC PROCESS	9	7.24e-01	7.81e-01	0.3480	-7.83e-02	-6.08e-02	1.76e-01	1.11e-01	-2.30e-01	1.23e-01	6.84e-01	7.52e-01	3.61e-01	5.63e-01	2.32e-01	5.24e-01
GOBP CGAS STING SIGNALING PATHWAY	18	3.70e-01	4.85e-01	0.3480	3.29e-02	-2.12e-01	-1.44e-01	1.78e-01	-9.27e-02	-1.18e-01	8.09e-01	1.20e-01	2.89e-01	1.91e-01	4.96e-01	3.85e-01
GOBP CYCLIC NUCLEOTIDE BIOSYNTHETIC PROCESS	13	6.87e-01	7.51e-01	0.3480	-4.29e-02	2.42e-03	2.27e-01	-4.20e-02	-2.46e-01	7.29e-02	7.89e-01	9.88e-01	1.57e-01	7.93e-01	1.24e-01	6.49e-01
GOBP REGULATION OF INTRACELLULAR ESTROGEN RECEPTOR SIGNALING PATHWAY	29	1.40e-02	4.49e-02	0.3480	-1.03e-01	4.99e-02	-8.65e-02	2.68e-01	6.58e-02	1.55e-01	3.37e-01	6.42e-01	4.20e-01	1.25e-02	5.40e-01	1.47e-01
GOBP ACTION POTENTIAL	109	7.98e-05	5.55e-04	0.3480	4.39e-02	9.25e-02	2.76e-01	-1.02e-01	-7.91e-02	1.32e-01	4.28e-01	9.53e-02	6.28e-07	6.62e-02	1.54e-01	1.72e-02
GOBP ESTABLISHMENT OR MAINTENANCE OF MONOPOLAR CELL POLARITY	21	3.11e-01	4.31e-01	0.3480	-1.20e-02	4.11e-02	2.32e-01	9.39e-02	1.05e-01	2.13e-01	9.24e-01	7.44e-01	6.57e-02	4.56e-01	4.06e-01	9.09e-02
GOMF TITIN BINDING	9	8.41e-01	8.71e-01	0.3480	2.64e-01	6.28e-02	3.50e-03	1.63e-01	1.11e-01	9.12e-02	1.71e-01	7.44e-01	9.85e-01	3.96e-01	5.65e-01	6.36e-01
GOBP GLIAL CELL PROLIFERATION	42	1.36e-02	4.38e-02	0.3480	-1.70e-01	9.36e-02	2.24e-01	-1.90e-02	2.95e-02	1.79e-01	5.73e-02	2.94e-01	1.21e-02	8.31e-01	7.41e-01	4.48e-02
GOMF NEUROTRANSMITTER TRANSMEMBRANE TRANSPORTER ACTIVITY	12	5.11e-01	6.06e-01	0.3480	1.42e-01	1.77e-01	2.06e-01	-1.27e-01	8.20e-02	-6.41e-02	3.95e-01	2.88e-01	2.17e-01	4.48e-01	6.23e-01	7.01e-01
GOBP REGULATION OF EXTRINSIC APOPTOTIC SIGNALING PATHWAY VIA DEATH DOMAIN RECEPTORS	36	8.26e-04	4.33e-03	0.3470	-2.70e-01	4.03e-02	1.98e-01	-8.16e-02	-1.08e-02	-8.62e-03	5.06e-03	6.76e-01	3.95e-02	3.97e-01	9.10e-01	9.29e-01
GOBP CHROMOSOME CONDENSATION	37	3.23e-02	8.45e-02	0.3470	4.58e-02	-1.42e-01	9.17e-02	2.36e-01	-2.28e-02	1.83e-01	6.30e-01	1.34e-01	3.34e-01	1.28e-02	8.10e-01	5.39e-02
GOBP RESPONSE TO AUDITORY STIMULUS	19	9.38e-02	1.87e-01	0.3470	2.45e-01	4.88e-02	2.44e-02	-2.99e-02	1.58e-01	1.78e-01	6.49e-02	7.13e-01	8.54e-01	8.22e-01	2.32e-01	1.78e-01
GOBP REGULATION OF KILLING OF CELLS OF ANOTHER ORGANISM	7	8.21e-01	8.55e-01	0.3470	4.07e-02	2.35e-01	9.83e-03	-3.99e-02	2.92e-02	-2.47e-01	8.52e-01	2.81e-01	9.64e-01	8.55e-01	8.94e-01	2.58e-01
GOBP TYPE B PANCREATIC CELL DIFFERENTIATION	16	2.97e-01	4.17e-01	0.3470	-1.02e-01	-1.11e-01	1.63e-01	3.92e-02	-2.62e-01	-2.51e-02	4.78e-01	4.42e-01	2.59e-01	7.86e-01	6.91e-02	8.62e-01
GOMF GALACTOSYLTRANSFERASE ACTIVITY	26	2.25e-02	6.48e-02	0.3470	-7.34e-02	-2.61e-03	1.77e-01	2.27e-01	-1.59e-01	8.25e-02	5.17e-01	9.82e-01	1.19e-01	4.49e-02	1.60e-01	4.66e-01
GOBP REGULATION OF COMPLEMENT ACTIVATION	17	4.50e-01	5.57e-01	0.3470	-3.60e-02	6.82e-02	1.77e-01	-2.01e-01	7.63e-03	2.06e-01	7.97e-01	6.26e-01	2.06e-01	1.51e-01	9.57e-01	1.41e-01
GOBP MAMMARY GLAND EPITHELIUM DEVELOPMENT	52	3.39e-02	8.79e-02	0.3470	7.68e-02	1.33e-01	1.86e-01	2.06e-01	8.60e-02	1.11e-01	3.38e-01	9.71e-02	2.07e-02	1.00e-02	2.83e-01	1.66e-01
GOMF S ADENOSYLMETHIONINE DEPENDENT METHYLTRANSFERASE ACTIVITY	149	6.83e-07	7.39e-06	0.3470	-7.79e-02	-2.01e-01	-2.28e-01	9.61e-02	8.21e-02	-7.38e-02	1.01e-01	2.19e-05	1.54e-06	4.28e-02	8.36e-02	1.20e-01
GOBP GLYCOPHAGY	12	2.43e-01	3.61e-01	0.3460	-2.02e-01	5.60e-02	-1.32e-01	2.39e-01	2.86e-02	-2.58e-02	2.26e-01	7.37e-01	4.29e-01	1.51e-01	8.64e-01	8.77e-01
GOBP B CELL PROLIFERATION INVOLVED IN IMMUNE RESPONSE	6	9.02e-01	9.19e-01	0.3460	-1.35e-01	1.22e-01	1.20e-01	-1.06e-01	-1.86e-01	1.63e-01	5.66e-01	6.06e-01	6.10e-01	6.53e-01	4.30e-01	4.89e-01
GOMF LIGASE ACTIVITY	156	1.93e-09	2.92e-08	0.3460	-1.36e-01	-2.74e-01	-1.30e-01	8.41e-02	4.92e-02	3.63e-03	3.36e-03	3.47e-09	5.16e-03	6.98e-02	2.89e-01	9.38e-01
GOBP NEGATIVE REGULATION OF CARDIAC MUSCLE ADAPTATION	6	8.58e-01	8.84e-01	0.3460	2.67e-01	-1.63e-02	1.86e-01	1.60e-03	-9.68e-02	-6.59e-02	2.57e-01	9.45e-01	4.30e-01	9.95e-01	6.81e-01	7.80e-01
GOBP RESPONSE TO SALT STRESS	19	4.50e-02	1.09e-01	0.3460	-3.53e-02	4.67e-02	1.92e-01	1.10e-01	2.59e-01	1.87e-02	7.90e-01	7.24e-01	1.47e-01	4.08e-01	5.04e-02	8.88e-01
GOBP REGULATION OF INFLAMMASOME MEDIATED SIGNALING PATHWAY	34	9.47e-04	4.86e-03	0.3460	-1.97e-01	1.61e-01	5.82e-02	1.38e-01	-7.01e-02	1.67e-01	4.70e-02	1.05e-01	5.57e-01	1.64e-01	4.79e-01	9.14e-02
GOMF ADENYLATE CYCLASE ACTIVITY	11	7.53e-01	8.03e-01	0.3460	-3.20e-02	1.01e-01	2.64e-01	-1.53e-02	-1.72e-01	9.51e-02	8.54e-01	5.61e-01	1.29e-01	9.30e-01	3.23e-01	5.85e-01
GOBP IONOTROPIC GLUTAMATE RECEPTOR SIGNALING PATHWAY	14	2.94e-01	4.14e-01	0.3460	-1.83e-01	1.72e-01	-8.67e-02	1.20e-01	1.52e-01	-1.09e-01	2.36e-01	2.65e-01	5.74e-01	4.38e-01	3.26e-01	4.80e-01
GOBP SECONDARY METABOLITE BIOSYNTHETIC PROCESS	17	4.71e-01	5.73e-01	0.3460	-1.04e-01	9.93e-03	-1.43e-01	1.82e-01	2.35e-01	5.74e-03	4.58e-01	9.44e-01	3.06e-01	1.94e-01	9.34e-02	9.67e-01
GOMF DOUBLE STRANDED RNA BINDING	70	8.34e-05	5.76e-04	0.3460	-2.01e-01	-7.90e-02	4.54e-02	1.10e-01	-8.00e-02	2.29e-01	3.59e-03	2.53e-01	5.11e-01	1.11e-01	2.47e-01	9.28e-04
GOBP TRABECULA MORPHOGENESIS	31	2.45e-02	6.91e-02	0.3460	-8.07e-02	2.48e-01	1.09e-01	1.13e-01	5.96e-03	1.64e-01	4.37e-01	1.68e-02	2.93e-01	2.77e-01	9.54e-01	1.14e-01
GOMF PHOSPHATIDYLINOSITOL TRISPHOSPHATE PHOSPHATASE ACTIVITY	7	4.79e-01	5.81e-01	0.3460	-1.76e-01	7.05e-02	3.49e-02	8.20e-02	1.65e-02	-2.75e-01	4.19e-01	7.47e-01	8.73e-01	7.07e-01	9.40e-01	2.08e-01
GOBP DETOXIFICATION	116	9.95e-07	1.04e-05	0.3460	-1.28e-01	-1.89e-01	1.39e-01	-2.04e-02	-6.05e-02	2.10e-01	1.70e-02	4.42e-04	9.76e-03	7.04e-01	2.60e-01	9.23e-05
GOBP RESPONSE TO ALKALOID	71	1.14e-04	7.61e-04	0.3460	-7.97e-02	-1.11e-01	2.09e-01	1.25e-01	-3.72e-02	2.01e-01	2.45e-01	1.06e-01	2.32e-03	6.79e-02	5.88e-01	3.48e-03
GOBP FLUID TRANSPORT	20	4.51e-01	5.57e-01	0.3460	-1.98e-01	-1.56e-01	2.42e-02	-3.90e-02	-2.33e-01	2.95e-04	1.26e-01	2.28e-01	8.52e-01	7.63e-01	7.15e-02	9.98e-01
GOMF FRUCTOSE 6 PHOSPHATE BINDING	5	7.96e-01	8.35e-01	0.3460	1.77e-01	-1.36e-01	7.28e-03	-9.23e-02	3.00e-02	-2.45e-01	4.92e-01	6.00e-01	9.78e-01	7.21e-01	9.08e-01	3.42e-01
GOBP NEGATIVE REGULATION OF MYOTUBE DIFFERENTIATION	12	1.62e-01	2.75e-01	0.3460	-2.94e-02	-1.48e-01	1.47e-01	2.52e-01	-3.08e-02	-1.04e-01	8.60e-01	3.75e-01	3.79e-01	1.31e-01	8.54e-01	5.33e-01
GOBP POSITIVE REGULATION OF CHROMOSOME ORGANIZATION	106	2.67e-08	3.56e-07	0.3460	-8.96e-02	-1.63e-01	-1.21e-01	2.45e-01	-1.15e-02	9.82e-02	1.11e-01	3.71e-03	3.09e-02	1.26e-05	8.38e-01	8.06e-02
GOBP REGULATION OF SYSTEMIC ARTERIAL BLOOD PRESSURE MEDIATED BY A CHEMICAL SIGNAL	27	1.26e-01	2.31e-01	0.3450	-2.13e-01	-6.37e-02	1.89e-01	-2.88e-02	-3.86e-02	1.78e-01	5.52e-02	5.67e-01	8.86e-02	7.96e-01	7.28e-01	1.09e-01
GOBP CYTOKINESIS	166	2.41e-11	4.64e-10	0.3450	-1.17e-01	-1.27e-01	1.10e-01	1.60e-01	-4.63e-02	2.23e-01	9.49e-03	4.71e-03	1.49e-02	3.90e-04	3.04e-01	6.99e-07
GOBP CELLULAR COMPONENT MAINTENANCE	55	1.69e-03	7.96e-03	0.3450	-9.34e-03	-2.26e-03	2.91e-01	2.95e-02	-1.73e-01	6.06e-02	9.05e-01	9.77e-01	1.92e-04	7.05e-01	2.62e-02	4.37e-01
GOBP DNA DOUBLE STRAND BREAK PROCESSING	20	2.82e-01	4.02e-01	0.3450	-6.38e-02	-1.75e-02	3.26e-02	1.59e-01	9.52e-02	2.82e-01	6.21e-01	8.92e-01	8.01e-01	2.18e-01	4.61e-01	2.93e-02
GOBP REGULATION OF CARDIAC EPITHELIAL TO MESENCHYMAL TRANSITION	11	7.45e-01	7.96e-01	0.3450	4.67e-03	6.54e-02	1.03e-01	2.57e-01	1.27e-01	1.49e-01	9.79e-01	7.07e-01	5.56e-01	1.40e-01	4.67e-01	3.92e-01
GOCC CONDENSED CHROMOSOME CENTROMERIC REGION	176	1.15e-12	2.54e-11	0.3450	-9.04e-02	-1.68e-01	1.70e-02	1.73e-01	-6.50e-02	2.19e-01	3.87e-02	1.22e-04	6.97e-01	7.29e-05	1.37e-01	5.15e-07
GOBP REGULATION OF LYMPHOCYTE MIGRATION	59	7.15e-03	2.64e-02	0.3450	2.28e-02	4.93e-02	2.06e-01	1.79e-01	-6.32e-02	1.94e-01	7.62e-01	5.13e-01	6.19e-03	1.77e-02	4.01e-01	9.81e-03
GOMF 1 PHOSPHATIDYLINOSITOL 3 KINASE REGULATOR ACTIVITY	14	4.89e-01	5.88e-01	0.3450	-7.12e-02	2.95e-01	3.37e-02	-3.90e-02	1.53e-01	2.13e-02	6.45e-01	5.57e-02	8.27e-01	8.00e-01	3.20e-01	8.90e-01
GOBP MAINTENANCE OF PROTEIN LOCATION IN CELL	59	2.60e-03	1.15e-02	0.3450	-1.97e-01	-1.80e-01	2.58e-02	7.96e-02	-5.56e-02	1.94e-01	9.00e-03	1.67e-02	7.32e-01	2.90e-01	4.60e-01	9.92e-03
GOBP REGULATION OF URINE VOLUME	14	7.87e-01	8.29e-01	0.3450	1.63e-01	1.90e-01	3.14e-02	1.20e-01	1.60e-01	-1.24e-01	2.91e-01	2.20e-01	8.39e-01	4.37e-01	3.00e-01	4.22e-01
GOBP MEMBRANE PROTEIN PROTEOLYSIS	58	1.17e-03	5.83e-03	0.3450	-1.40e-01	-1.00e-01	2.08e-01	-1.21e-02	-2.08e-01	5.03e-02	6.56e-02	1.86e-01	6.09e-03	8.73e-01	6.22e-03	5.08e-01
GOBP MITOCHONDRIAL GENOME MAINTENANCE	29	8.03e-02	1.67e-01	0.3450	-5.64e-02	-1.22e-01	-2.23e-01	2.23e-01	3.08e-02	-1.23e-02	5.99e-01	2.56e-01	3.75e-02	3.76e-02	7.74e-01	9.09e-01
GOBP P38MAPK CASCADE	46	4.17e-03	1.69e-02	0.3440	-6.02e-02	2.08e-01	2.62e-01	1.78e-02	4.31e-03	5.22e-02	4.80e-01	1.45e-02	2.13e-03	8.35e-01	9.60e-01	5.40e-01
GOMF VITAMIN TRANSMEMBRANE TRANSPORTER ACTIVITY	23	3.74e-01	4.89e-01	0.3440	1.57e-01	1.10e-01	7.61e-02	1.95e-01	1.64e-01	-1.05e-01	1.93e-01	3.59e-01	5.28e-01	1.06e-01	1.72e-01	3.85e-01
GOCC CAJAL BODY	61	1.58e-02	4.94e-02	0.3440	-1.38e-01	-1.97e-01	-2.42e-01	1.90e-02	1.56e-02	-3.44e-02	6.28e-02	7.63e-03	1.05e-03	7.97e-01	8.33e-01	6.42e-01
GOBP PHAGOLYSOSOME ASSEMBLY	16	2.22e-01	3.40e-01	0.3440	-3.25e-01	-4.83e-02	6.78e-03	2.88e-02	8.81e-02	4.43e-02	2.44e-02	7.38e-01	9.63e-01	8.42e-01	5.42e-01	7.59e-01
GOMF PROTEIN LIPID COMPLEX BINDING	23	8.59e-03	3.05e-02	0.3440	-1.89e-02	5.65e-02	3.19e-01	7.39e-02	8.59e-02	-1.07e-02	8.75e-01	6.39e-01	8.00e-03	5.39e-01	4.76e-01	9.30e-01
GOMF G QUADRUPLEX DNA BINDING	11	5.27e-01	6.20e-01	0.3440	5.61e-02	-3.78e-02	-1.32e-01	2.92e-01	3.10e-02	1.01e-01	7.47e-01	8.28e-01	4.49e-01	9.33e-02	8.59e-01	5.62e-01
GOBP SPINAL CORD PATTERNING	5	9.68e-01	9.73e-01	0.3440	2.71e-01	8.92e-02	1.63e-01	8.28e-02	-4.93e-02	3.15e-02	2.94e-01	7.30e-01	5.27e-01	7.49e-01	8.49e-01	9.03e-01
GOMF CYCLIN DEPENDENT PROTEIN SERINE THREONINE KINASE REGULATOR ACTIVITY	46	3.05e-02	8.10e-02	0.3440	-1.15e-01	-2.28e-01	1.36e-02	4.84e-02	-1.46e-01	1.71e-01	1.77e-01	7.45e-03	8.73e-01	5.70e-01	8.58e-02	4.49e-02
GOBP CELLULAR RESPONSE TO CADMIUM ION	27	2.65e-01	3.84e-01	0.3440	2.18e-02	-8.18e-02	2.38e-01	-7.55e-02	-2.02e-01	9.21e-02	8.44e-01	4.62e-01	3.26e-02	4.97e-01	6.99e-02	4.08e-01
GOBP REGULATION OF AUTOPHAGOSOME ASSEMBLY	47	1.53e-04	9.90e-04	0.3440	-2.89e-01	9.60e-02	-3.64e-02	8.40e-02	4.74e-02	1.23e-01	6.08e-04	2.55e-01	6.66e-01	3.19e-01	5.74e-01	1.46e-01
GOBP REGULATION OF KERATINOCYTE PROLIFERATION	31	1.41e-01	2.50e-01	0.3440	7.50e-02	2.42e-01	1.94e-01	7.00e-02	1.05e-01	-2.08e-02	4.70e-01	1.97e-02	6.13e-02	5.00e-01	3.10e-01	8.41e-01
GOBP ENDOSOMAL LUMEN ACIDIFICATION	14	1.78e-01	2.93e-01	0.3440	-2.44e-01	-1.68e-01	1.43e-01	8.88e-02	-1.48e-02	4.71e-02	1.15e-01	2.77e-01	3.53e-01	5.65e-01	9.24e-01	7.60e-01
GOBP IMMUNE RESPONSE REGULATING CELL SURFACE RECEPTOR SIGNALING PATHWAY INVOLVED IN PHAGOCYTOSIS	21	3.17e-02	8.32e-02	0.3440	-2.21e-01	1.47e-01	5.57e-02	1.84e-01	1.99e-02	1.02e-01	7.97e-02	2.43e-01	6.59e-01	1.43e-01	8.75e-01	4.18e-01
GOBP RENAL WATER HOMEOSTASIS	15	6.07e-01	6.87e-01	0.3440	-1.02e-01	7.24e-03	-2.13e-01	1.01e-01	8.84e-02	-2.11e-01	4.95e-01	9.61e-01	1.53e-01	4.98e-01	5.53e-01	1.57e-01
GOBP AXIS SPECIFICATION	57	2.17e-02	6.30e-02	0.3440	2.02e-02	2.22e-01	1.12e-01	1.04e-01	1.89e-01	9.74e-02	7.92e-01	3.78e-03	1.42e-01	1.73e-01	1.37e-02	2.03e-01
GOBP NEGATIVE REGULATION OF REACTIVE OXYGEN SPECIES METABOLIC PROCESS	35	3.31e-02	8.63e-02	0.3440	-1.69e-01	-1.54e-01	-1.26e-02	8.79e-02	-1.96e-01	1.39e-01	8.28e-02	1.14e-01	8.97e-01	3.68e-01	4.45e-02	1.55e-01
GOBP CARBOHYDRATE DERIVATIVE TRANSPORT	80	1.46e-04	9.47e-04	0.3440	-1.56e-01	-2.18e-01	-1.32e-01	6.09e-02	4.01e-02	-1.54e-01	1.57e-02	7.70e-04	4.19e-02	3.47e-01	5.35e-01	1.70e-02
GOCC MULTIVESICULAR BODY	53	1.15e-03	5.71e-03	0.3440	2.61e-02	-1.48e-01	2.26e-01	1.10e-01	-2.59e-02	1.78e-01	7.42e-01	6.16e-02	4.46e-03	1.64e-01	7.44e-01	2.52e-02
GOBP POSITIVE REGULATION OF STRESS ACTIVATED PROTEIN KINASE SIGNALING CASCADE	18	3.97e-01	5.09e-01	0.3440	-2.60e-01	-5.79e-02	7.80e-02	5.82e-03	-7.21e-02	1.90e-01	5.64e-02	6.71e-01	5.67e-01	9.66e-01	5.96e-01	1.63e-01
GOMF ATP DEPENDENT ACTIVITY ACTING ON RNA	72	1.01e-04	6.85e-04	0.3440	-2.06e-01	-1.27e-01	-1.70e-01	1.55e-01	1.45e-02	-8.11e-02	2.57e-03	6.20e-02	1.25e-02	2.32e-02	8.32e-01	2.34e-01
GOBP DISACCHARIDE METABOLIC PROCESS	6	7.06e-01	7.66e-01	0.3440	-1.19e-01	1.24e-01	8.12e-02	-7.70e-02	-4.02e-02	-2.73e-01	6.13e-01	5.98e-01	7.31e-01	7.44e-01	8.64e-01	2.48e-01
GOMF RNA EXONUCLEASE ACTIVITY PRODUCING 5 PHOSPHOMONOESTERS	40	1.65e-02	5.10e-02	0.3440	-2.18e-01	-1.32e-01	-1.77e-01	1.16e-01	2.90e-02	8.59e-02	1.71e-02	1.48e-01	5.24e-02	2.03e-01	7.51e-01	3.47e-01
GOMF RNA POLYMERASE II CORE PROMOTER SEQUENCE SPECIFIC DNA BINDING	19	3.73e-01	4.88e-01	0.3440	-1.21e-01	3.61e-02	1.50e-01	-2.82e-02	9.84e-02	2.63e-01	3.60e-01	7.86e-01	2.59e-01	8.31e-01	4.58e-01	4.71e-02
GOBP NEGATIVE REGULATION OF CYTOSOLIC CALCIUM ION CONCENTRATION	6	9.25e-01	9.37e-01	0.3430	6.28e-02	6.47e-02	1.51e-01	-1.26e-01	-2.66e-01	1.44e-02	7.90e-01	7.84e-01	5.22e-01	5.93e-01	2.59e-01	9.51e-01
GOMF PEPTIDASE ACTIVATOR ACTIVITY INVOLVED IN APOPTOTIC PROCESS	24	9.60e-02	1.90e-01	0.3430	-1.60e-01	-1.49e-02	-1.64e-01	-5.57e-02	2.03e-01	1.44e-01	1.74e-01	8.99e-01	1.63e-01	6.36e-01	8.56e-02	2.21e-01
GOBP T CELL DIFFERENTIATION IN THYMUS	78	2.06e-03	9.43e-03	0.3430	6.01e-02	2.39e-01	3.54e-02	1.61e-01	1.54e-01	7.92e-02	3.59e-01	2.66e-04	5.89e-01	1.38e-02	1.90e-02	2.27e-01
GOBP POSITIVE REGULATION OF FAT CELL DIFFERENTIATION	45	1.42e-03	6.88e-03	0.3430	-7.60e-02	2.43e-01	2.05e-01	4.47e-02	9.62e-02	-6.30e-03	3.78e-01	4.87e-03	1.76e-02	6.04e-01	2.64e-01	9.42e-01
GOBP COMMISSURAL NEURON AXON GUIDANCE	10	4.73e-01	5.75e-01	0.3430	-1.59e-01	7.02e-02	1.03e-01	1.62e-01	2.19e-01	5.52e-02	3.85e-01	7.01e-01	5.73e-01	3.75e-01	2.31e-01	7.62e-01
GOMF OXIDOREDUCTASE ACTIVITY ACTING ON SINGLE DONORS WITH INCORPORATION OF MOLECULAR OXYGEN	19	1.05e-01	2.03e-01	0.3430	1.18e-01	-4.45e-02	9.83e-02	-2.73e-01	-6.33e-02	1.16e-01	3.75e-01	7.37e-01	4.58e-01	3.91e-02	6.33e-01	3.81e-01
GOBP PIGMENT BIOSYNTHETIC PROCESS	45	6.34e-02	1.41e-01	0.3430	-8.79e-02	-1.96e-01	-2.19e-01	1.15e-01	7.86e-02	-6.53e-02	3.08e-01	2.30e-02	1.10e-02	1.81e-01	3.62e-01	4.49e-01
GOBP PROTEIN MONOUBIQUITINATION	48	1.93e-02	5.76e-02	0.3430	-4.96e-04	-4.64e-02	1.23e-01	1.70e-01	6.38e-02	2.60e-01	9.95e-01	5.78e-01	1.39e-01	4.18e-02	4.45e-01	1.86e-03
GOMF ANTIOXIDANT ACTIVITY	69	1.26e-03	6.19e-03	0.3430	-1.30e-01	-1.95e-01	1.42e-01	1.40e-02	-1.02e-01	1.78e-01	6.25e-02	5.06e-03	4.13e-02	8.40e-01	1.42e-01	1.04e-02
GOBP REGULATION OF TRANSLATION	333	3.00e-16	9.15e-15	0.3430	-2.02e-01	-2.25e-01	-1.33e-01	2.80e-02	-8.89e-02	-4.26e-03	2.39e-10	1.82e-12	3.19e-05	3.81e-01	5.29e-03	8.94e-01
GOBP CHONDROITIN SULFATE PROTEOGLYCAN METABOLIC PROCESS	27	1.83e-02	5.50e-02	0.3430	-1.83e-01	-6.10e-02	1.08e-01	6.38e-02	-2.48e-01	-5.81e-02	1.00e-01	5.84e-01	3.31e-01	5.66e-01	2.60e-02	6.01e-01
GOBP REGULATION OF GLYCOGEN BIOSYNTHETIC PROCESS	21	4.51e-01	5.57e-01	0.3430	1.39e-01	1.14e-01	9.40e-02	2.49e-01	1.09e-01	-4.72e-02	2.71e-01	3.65e-01	4.56e-01	4.78e-02	3.86e-01	7.08e-01
GOBP ENDOCARDIAL CUSHION DEVELOPMENT	28	2.59e-02	7.21e-02	0.3430	-2.03e-01	1.62e-01	1.40e-01	8.92e-02	1.02e-01	1.10e-01	6.32e-02	1.39e-01	2.00e-01	4.14e-01	3.50e-01	3.12e-01
GOMF CYCLOSPORIN A BINDING	16	5.34e-01	6.26e-01	0.3430	-2.96e-01	-1.07e-01	-5.74e-02	-3.49e-02	-1.80e-02	1.16e-01	4.02e-02	4.60e-01	6.91e-01	8.09e-01	9.01e-01	4.22e-01
GOBP GLYCOSPHINGOLIPID METABOLIC PROCESS	49	4.56e-03	1.82e-02	0.3430	-2.45e-01	1.56e-02	1.76e-01	-5.02e-02	-1.07e-01	1.11e-01	3.06e-03	8.50e-01	3.30e-02	5.43e-01	1.93e-01	1.80e-01
GOBP POSITIVE REGULATION OF TRANSCRIPTION ELONGATION BY RNA POLYMERASE II	49	4.63e-03	1.84e-02	0.3430	9.06e-02	-2.89e-02	-3.41e-02	3.27e-01	1.26e-02	-1.22e-02	2.73e-01	7.27e-01	6.79e-01	7.55e-05	8.79e-01	8.83e-01
GOBP POSITIVE REGULATION OF BIOMINERAL TISSUE DEVELOPMENT	37	4.05e-02	1.00e-01	0.3430	-1.03e-01	7.80e-02	-6.32e-02	-1.70e-01	-7.13e-02	-2.50e-01	2.77e-01	4.12e-01	5.06e-01	7.38e-02	4.53e-01	8.43e-03
GOCC CHROMOSOME CENTROMERIC REGION	242	1.32e-17	4.46e-16	0.3430	-1.10e-01	-1.61e-01	1.06e-02	1.58e-01	-6.87e-02	2.23e-01	3.30e-03	1.70e-05	7.77e-01	2.38e-05	6.59e-02	2.23e-09
GOBP RESPONSE TO PLATELET DERIVED GROWTH FACTOR	21	2.02e-01	3.19e-01	0.3420	-3.58e-02	2.82e-02	1.23e-01	2.35e-01	-5.86e-02	2.03e-01	7.76e-01	8.23e-01	3.29e-01	6.21e-02	6.42e-01	1.07e-01
GOMF PRIMARY ACTIVE TRANSMEMBRANE TRANSPORTER ACTIVITY	142	4.24e-08	5.45e-07	0.3420	-7.42e-02	-2.92e-01	-4.22e-02	6.36e-02	-1.41e-01	-2.74e-02	1.27e-01	1.87e-09	3.86e-01	1.91e-01	3.68e-03	5.74e-01
GOBP POSITIVE REGULATION OF SECONDARY METABOLITE BIOSYNTHETIC PROCESS	7	8.42e-01	8.72e-01	0.3420	-2.34e-01	4.66e-02	-1.50e-01	3.52e-02	1.90e-01	1.43e-03	2.83e-01	8.31e-01	4.91e-01	8.72e-01	3.83e-01	9.95e-01
GOBP INTEGRATED STRESS RESPONSE SIGNALING	47	4.79e-02	1.14e-01	0.3420	-1.80e-01	-6.81e-02	1.62e-01	-1.17e-01	-1.91e-01	6.01e-02	3.28e-02	4.19e-01	5.40e-02	1.66e-01	2.33e-02	4.76e-01
GOBP RNA 3 END PROCESSING	85	4.73e-04	2.69e-03	0.3420	-1.64e-01	-1.85e-01	-2.05e-01	8.80e-02	8.06e-02	-3.76e-03	8.96e-03	3.23e-03	1.11e-03	1.61e-01	1.99e-01	9.52e-01
GOCC PHOSPHATASE COMPLEX	49	9.65e-04	4.93e-03	0.3420	-1.11e-01	1.84e-01	8.50e-02	7.90e-02	-1.70e-02	2.39e-01	1.79e-01	2.57e-02	3.03e-01	3.39e-01	8.37e-01	3.79e-03
GOMF CERAMIDE BINDING	18	3.20e-01	4.40e-01	0.3420	-2.71e-01	-1.47e-01	-2.47e-02	5.46e-02	5.60e-02	1.24e-01	4.65e-02	2.80e-01	8.56e-01	6.88e-01	6.81e-01	3.63e-01
GOMF INTRACELLULARLY GATED CALCIUM CHANNEL ACTIVITY	17	5.83e-01	6.68e-01	0.3420	1.59e-01	1.48e-01	1.24e-01	1.85e-01	1.17e-01	-8.12e-02	2.56e-01	2.91e-01	3.77e-01	1.87e-01	4.02e-01	5.62e-01
GOBP RETINAL ROD CELL DIFFERENTIATION	10	6.31e-01	7.07e-01	0.3420	-6.31e-02	2.49e-01	-7.45e-02	-1.07e-01	3.00e-02	-1.83e-01	7.30e-01	1.74e-01	6.83e-01	5.57e-01	8.69e-01	3.17e-01
GOCC CLATHRIN COAT	46	3.38e-04	2.00e-03	0.3420	-2.02e-01	2.31e-02	4.39e-02	2.13e-01	3.02e-03	1.68e-01	1.77e-02	7.87e-01	6.06e-01	1.23e-02	9.72e-01	4.88e-02
GOBP L ASCORBIC ACID METABOLIC PROCESS	9	4.52e-01	5.58e-01	0.3420	1.47e-02	1.12e-01	1.18e-01	4.58e-02	2.37e-01	-1.80e-01	9.39e-01	5.60e-01	5.39e-01	8.12e-01	2.19e-01	3.51e-01
GOBP NEGATIVE REGULATION OF TRANSPORTER ACTIVITY	42	1.14e-01	2.15e-01	0.3420	-1.90e-01	-9.42e-02	1.37e-01	-1.29e-01	-1.03e-01	1.62e-01	3.33e-02	2.91e-01	1.25e-01	1.48e-01	2.47e-01	6.98e-02
GOBP NEGATIVE REGULATION OF CELL MATRIX ADHESION	28	1.39e-01	2.48e-01	0.3420	-1.22e-01	-1.67e-02	2.28e-01	-1.09e-01	-1.94e-01	1.73e-02	2.65e-01	8.78e-01	3.65e-02	3.18e-01	7.58e-02	8.74e-01
GOMF LIPID TRANSMEMBRANE TRANSPORTER ACTIVITY	27	1.54e-01	2.65e-01	0.3420	1.06e-01	5.05e-02	2.71e-01	1.36e-01	-9.49e-02	5.08e-02	3.42e-01	6.50e-01	1.50e-02	2.23e-01	3.93e-01	6.48e-01
GOMF HISTONE METHYLTRANSFERASE ACTIVITY	62	9.39e-03	3.26e-02	0.3420	8.58e-02	5.31e-02	-6.77e-02	2.84e-01	1.29e-01	-7.03e-02	2.43e-01	4.70e-01	3.56e-01	1.10e-04	8.01e-02	3.39e-01
GOCC HISTONE METHYLTRANSFERASE COMPLEX	67	3.19e-04	1.90e-03	0.3420	4.77e-02	-1.14e-02	-7.94e-02	3.22e-01	5.48e-02	-3.87e-02	4.99e-01	8.72e-01	2.61e-01	5.18e-06	4.38e-01	5.83e-01
GOCC CD40 RECEPTOR COMPLEX	11	8.43e-01	8.72e-01	0.3420	9.72e-03	2.55e-04	-2.32e-01	1.53e-01	1.76e-01	-9.30e-02	9.55e-01	9.99e-01	1.83e-01	3.79e-01	3.13e-01	5.93e-01
GOBP MIGRACYTOSIS	5	9.12e-01	9.27e-01	0.3420	-9.05e-02	1.12e-01	2.59e-01	-1.23e-01	5.18e-02	1.05e-01	7.26e-01	6.65e-01	3.15e-01	6.33e-01	8.41e-01	6.85e-01
GOBP REGULATION OF MUSCLE HYPERTROPHY	45	1.97e-02	5.85e-02	0.3420	-8.09e-02	5.98e-03	2.30e-01	9.03e-02	-1.42e-01	1.70e-01	3.48e-01	9.45e-01	7.59e-03	2.95e-01	9.95e-02	4.81e-02
GOBP TETRAPYRROLE METABOLIC PROCESS	56	1.24e-03	6.13e-03	0.3420	2.34e-02	-2.65e-01	-1.39e-01	8.13e-02	1.02e-01	-9.67e-02	7.62e-01	5.92e-04	7.12e-02	2.92e-01	1.87e-01	2.11e-01
GOBP REGULATION OF VIRAL PROCESS	143	6.20e-10	1.03e-08	0.3420	-7.62e-02	-1.11e-01	3.30e-02	1.76e-01	-3.02e-02	2.56e-01	1.16e-01	2.19e-02	4.95e-01	2.89e-04	5.33e-01	1.18e-07
GOBP REGULATION OF CYCLIN DEPENDENT PROTEIN KINASE ACTIVITY	66	6.69e-04	3.61e-03	0.3420	-8.25e-02	-2.17e-01	7.84e-02	1.27e-01	-1.55e-01	1.28e-01	2.46e-01	2.25e-03	2.71e-01	7.46e-02	2.96e-02	7.17e-02
GOBP VESICLE DOCKING INVOLVED IN EXOCYTOSIS	30	4.48e-02	1.08e-01	0.3420	-2.57e-01	1.88e-02	3.93e-02	6.40e-02	3.29e-02	2.09e-01	1.48e-02	8.58e-01	7.10e-01	5.44e-01	7.55e-01	4.79e-02
GOBP REGULATION OF TRANSLATIONAL ELONGATION	12	5.88e-01	6.71e-01	0.3420	-6.23e-02	-2.31e-01	-8.71e-02	1.84e-01	-8.27e-02	1.04e-01	7.08e-01	1.65e-01	6.01e-01	2.68e-01	6.20e-01	5.33e-01
GOBP POSITIVE REGULATION OF STEROL TRANSPORT	26	3.09e-02	8.17e-02	0.3420	4.38e-02	5.53e-02	1.99e-01	2.65e-01	2.23e-02	-3.79e-02	6.99e-01	6.26e-01	7.92e-02	1.93e-02	8.44e-01	7.38e-01
GOBP CHONDROCYTE DIFFERENTIATION	75	2.37e-06	2.32e-05	0.3420	-1.08e-01	2.89e-01	1.27e-01	4.49e-02	1.41e-02	5.79e-02	1.07e-01	1.54e-05	5.65e-02	5.01e-01	8.33e-01	3.86e-01
GOBP REGULATION OF DNA TEMPLATED DNA REPLICATION	47	5.62e-03	2.16e-02	0.3420	1.21e-01	-1.82e-01	-4.19e-02	2.54e-01	-5.26e-02	3.40e-03	1.53e-01	3.10e-02	6.19e-01	2.58e-03	5.33e-01	9.68e-01
GOBP REGULATION OF SPROUTING ANGIOGENESIS	33	2.11e-02	6.18e-02	0.3420	-7.42e-02	1.61e-01	2.77e-01	1.79e-02	-8.60e-02	3.34e-02	4.61e-01	1.10e-01	5.97e-03	8.59e-01	3.93e-01	7.40e-01
GOBP NADH OXIDATION	6	8.44e-01	8.73e-01	0.3410	-2.10e-01	1.05e-01	-3.75e-02	2.97e-02	1.30e-01	2.06e-01	3.73e-01	6.57e-01	8.74e-01	9.00e-01	5.80e-01	3.83e-01
GOBP NAD CATABOLIC PROCESS	19	6.22e-02	1.38e-01	0.3410	-1.03e-01	-5.84e-02	2.93e-01	9.70e-02	-6.90e-02	5.25e-02	4.36e-01	6.60e-01	2.73e-02	4.64e-01	6.03e-01	6.92e-01
GOBP VITAMIN BIOSYNTHETIC PROCESS	21	2.76e-01	3.96e-01	0.3410	-1.30e-01	-1.31e-01	-1.54e-01	-2.38e-02	1.86e-01	-1.53e-01	3.01e-01	2.97e-01	2.22e-01	8.50e-01	1.40e-01	2.24e-01
GOBP RESPONSE TO IMMOBILIZATION STRESS	18	4.05e-02	1.00e-01	0.3410	-2.12e-01	-9.43e-02	9.58e-03	1.65e-01	-2.77e-02	-1.86e-01	1.20e-01	4.88e-01	9.44e-01	2.26e-01	8.39e-01	1.71e-01
GOBP CELLULAR RESPONSE TO SALT STRESS	13	2.10e-01	3.27e-01	0.3410	-1.40e-01	7.81e-02	1.59e-01	4.29e-02	2.49e-01	3.89e-02	3.81e-01	6.26e-01	3.20e-01	7.89e-01	1.20e-01	8.08e-01
GOBP REGULATION OF TRANSLATION AT POSTSYNAPSE	5	8.94e-01	9.13e-01	0.3410	-1.87e-01	-9.12e-02	-1.21e-01	1.11e-01	-3.57e-02	-2.11e-01	4.68e-01	7.24e-01	6.41e-01	6.66e-01	8.90e-01	4.13e-01
GOMF MINOR GROOVE OF ADENINE THYMINE RICH DNA BINDING	8	7.33e-01	7.87e-01	0.3410	-2.39e-01	1.71e-01	7.35e-02	-9.63e-02	1.02e-01	6.94e-02	2.41e-01	4.03e-01	7.19e-01	6.37e-01	6.19e-01	7.34e-01
GOCC INNER KINETOCHORE	19	1.10e-01	2.09e-01	0.3410	6.37e-02	-2.54e-01	-1.14e-01	1.10e-03	-6.53e-02	1.75e-01	6.31e-01	5.53e-02	3.91e-01	9.93e-01	6.22e-01	1.88e-01
GOBP POSITIVE REGULATION OF DNA REPLICATION	39	1.79e-03	8.33e-03	0.3410	-8.17e-02	-7.94e-02	1.45e-01	2.29e-01	-1.58e-01	6.90e-02	3.77e-01	3.91e-01	1.17e-01	1.33e-02	8.78e-02	4.56e-01
GOBP NEGATIVE REGULATION OF MACROAUTOPHAGY	35	3.83e-04	2.23e-03	0.3410	-1.84e-01	1.18e-01	-2.93e-02	2.54e-01	4.02e-02	-4.14e-02	6.02e-02	2.28e-01	7.64e-01	9.35e-03	6.81e-01	6.72e-01
GOBP DEFINITIVE HEMOPOIESIS	19	3.94e-01	5.07e-01	0.3410	3.29e-02	-8.70e-02	1.54e-01	1.18e-01	-2.11e-01	1.58e-01	8.04e-01	5.12e-01	2.44e-01	3.74e-01	1.10e-01	2.32e-01
GOMF LIPID PHOSPHATASE ACTIVITY	15	5.19e-01	6.13e-01	0.3410	8.60e-02	-5.96e-02	-1.21e-01	9.13e-02	-9.13e-02	-2.72e-01	5.64e-01	6.89e-01	4.16e-01	5.40e-01	5.40e-01	6.85e-02
GOMF CLATHRIN BINDING	41	6.65e-03	2.48e-02	0.3410	-1.18e-01	1.46e-01	-8.76e-03	2.08e-01	1.49e-01	1.24e-01	1.91e-01	1.07e-01	9.23e-01	2.12e-02	9.80e-02	1.70e-01
GOBP REGULATION OF MICROTUBULE NUCLEATION	19	5.60e-01	6.49e-01	0.3410	4.82e-02	4.74e-02	-7.65e-02	2.37e-01	1.98e-01	-1.02e-01	7.16e-01	7.20e-01	5.64e-01	7.42e-02	1.35e-01	4.39e-01
GOMF O ACYLTRANSFERASE ACTIVITY	45	1.22e-02	4.01e-02	0.3410	-1.77e-01	9.43e-04	2.15e-01	-1.57e-01	-3.60e-02	1.12e-01	3.95e-02	9.91e-01	1.27e-02	6.86e-02	6.76e-01	1.94e-01
GOCC MICROBODY	128	2.53e-07	2.90e-06	0.3410	-2.01e-01	-2.24e-01	-1.20e-01	7.21e-03	8.22e-02	6.35e-02	8.25e-05	1.20e-05	1.93e-02	8.88e-01	1.08e-01	2.15e-01
GOBP POSITIVE REGULATION OF ADIPOSE TISSUE DEVELOPMENT	9	6.83e-01	7.48e-01	0.3400	-8.96e-02	2.40e-01	1.75e-01	-3.82e-02	-1.25e-01	5.26e-02	6.42e-01	2.13e-01	3.64e-01	8.43e-01	5.17e-01	7.85e-01
GOBP INDOLE CONTAINING COMPOUND METABOLIC PROCESS	18	2.85e-01	4.05e-01	0.3400	-1.27e-01	4.17e-02	-7.76e-02	9.81e-03	3.03e-01	6.75e-03	3.52e-01	7.59e-01	5.69e-01	9.43e-01	2.60e-02	9.60e-01
GOMF HYALURONIC ACID BINDING	16	9.22e-02	1.85e-01	0.3400	-2.40e-01	1.50e-01	1.22e-01	-8.33e-05	1.32e-01	-5.77e-02	9.64e-02	2.97e-01	3.99e-01	1.00e+00	3.61e-01	6.90e-01
GOBP POSITIVE REGULATION OF HEMOGLOBIN BIOSYNTHETIC PROCESS	5	8.83e-01	9.04e-01	0.3400	2.08e-02	5.10e-02	1.43e-01	-2.24e-01	-8.52e-02	-1.87e-01	9.36e-01	8.43e-01	5.79e-01	3.86e-01	7.41e-01	4.70e-01
GOBP PROTEIN POLYGLUTAMYLATION	10	6.51e-01	7.23e-01	0.3400	-1.56e-02	-1.49e-01	-1.44e-01	-8.34e-02	1.65e-01	-1.96e-01	9.32e-01	4.15e-01	4.31e-01	6.48e-01	3.66e-01	2.83e-01
GOBP POSITIVE REGULATION OF SMOOTH MUSCLE CELL MIGRATION	32	4.76e-02	1.13e-01	0.3400	-8.60e-02	2.29e-01	1.40e-01	1.09e-01	3.39e-02	1.52e-01	4.00e-01	2.50e-02	1.69e-01	2.86e-01	7.40e-01	1.37e-01
GOMF SPHINGOSINE 1 PHOSPHATE PHOSPHATASE ACTIVITY	7	8.80e-01	9.02e-01	0.3400	3.04e-02	-1.00e-01	-7.37e-02	-1.41e-01	-6.54e-02	-2.74e-01	8.89e-01	6.46e-01	7.35e-01	5.19e-01	7.65e-01	2.09e-01
GOBP MEMORY	90	3.18e-04	1.90e-03	0.3400	-6.65e-02	6.55e-02	2.43e-01	6.08e-02	-3.63e-02	2.07e-01	2.76e-01	2.83e-01	6.85e-05	3.19e-01	5.52e-01	6.83e-04
GOBP DEOXYRIBONUCLEOSIDE MONOPHOSPHATE METABOLIC PROCESS	21	2.13e-01	3.31e-01	0.3400	3.55e-02	-2.64e-01	8.34e-02	7.90e-02	-8.75e-02	1.54e-01	7.78e-01	3.61e-02	5.08e-01	5.31e-01	4.88e-01	2.22e-01
GOBP BLASTOCYST GROWTH	20	2.74e-01	3.94e-01	0.3400	-8.18e-02	-3.10e-02	5.24e-02	1.41e-01	-1.13e-02	2.92e-01	5.26e-01	8.10e-01	6.85e-01	2.74e-01	9.30e-01	2.40e-02
GOMF NUCLEAR ESTROGEN RECEPTOR BINDING	35	1.03e-02	3.51e-02	0.3400	-6.55e-02	3.98e-02	1.77e-01	2.31e-01	-9.08e-02	1.30e-01	5.03e-01	6.83e-01	7.07e-02	1.81e-02	3.53e-01	1.84e-01
GOMF SUMO BINDING	17	5.14e-01	6.08e-01	0.3400	6.75e-02	1.07e-01	3.85e-02	2.66e-01	7.97e-02	1.44e-01	6.30e-01	4.46e-01	7.83e-01	5.75e-02	5.69e-01	3.02e-01
GOBP INTERMEDIATE FILAMENT BASED PROCESS	43	9.81e-02	1.93e-01	0.3400	-1.15e-01	7.66e-02	1.66e-01	-1.22e-01	-1.59e-01	1.70e-01	1.91e-01	3.85e-01	5.92e-02	1.68e-01	7.20e-02	5.44e-02
GOBP NAD BIOSYNTHESIS VIA NICOTINAMIDE RIBOSIDE SALVAGE PATHWAY	7	9.34e-01	9.45e-01	0.3400	-4.93e-02	5.77e-02	2.04e-01	3.17e-02	-1.40e-01	2.18e-01	8.21e-01	7.92e-01	3.49e-01	8.85e-01	5.22e-01	3.19e-01
GOBP ANTIGEN PROCESSING AND PRESENTATION OF PEPTIDE ANTIGEN VIA MHC CLASS I	32	5.83e-02	1.32e-01	0.3390	-1.29e-01	-1.88e-02	-5.09e-02	1.71e-01	1.87e-01	1.77e-01	2.05e-01	8.54e-01	6.19e-01	9.36e-02	6.76e-02	8.30e-02
GOBP RNA SPLICING	423	5.67e-24	3.26e-22	0.3390	-1.17e-01	-2.06e-01	-2.11e-01	1.20e-01	2.55e-02	-3.53e-03	3.89e-05	4.04e-13	1.05e-13	2.49e-05	3.69e-01	9.01e-01
GOMF EXOPEPTIDASE ACTIVITY	76	1.37e-03	6.70e-03	0.3390	-2.49e-01	-1.69e-01	-8.31e-02	-1.27e-01	3.66e-02	-1.68e-02	1.74e-04	1.07e-02	2.10e-01	5.64e-02	5.82e-01	8.00e-01
GOBP NEGATIVE REGULATION OF FATTY ACID METABOLIC PROCESS	25	2.68e-01	3.87e-01	0.3390	4.01e-02	2.16e-01	1.32e-01	1.47e-01	1.91e-02	1.66e-01	7.28e-01	6.19e-02	2.55e-01	2.03e-01	8.69e-01	1.50e-01
GOMF ENDONUCLEASE ACTIVITY	118	5.08e-05	3.69e-04	0.3390	-4.64e-02	-2.08e-01	-2.23e-01	7.05e-02	7.46e-02	-9.66e-02	3.84e-01	9.69e-05	2.75e-05	1.86e-01	1.61e-01	6.99e-02
GOMF PYRIMIDINE NUCLEOBASE TRANSMEMBRANE TRANSPORTER ACTIVITY	6	8.67e-01	8.92e-01	0.3390	4.87e-02	-2.21e-02	1.82e-01	-5.77e-02	9.98e-02	2.56e-01	8.36e-01	9.25e-01	4.39e-01	8.07e-01	6.72e-01	2.77e-01
GOBP DETECTION OF OTHER ORGANISM	18	2.61e-01	3.81e-01	0.3390	-2.34e-01	1.11e-01	-3.40e-02	-1.45e-01	-8.84e-02	-1.35e-01	8.62e-02	4.15e-01	8.03e-01	2.87e-01	5.16e-01	3.22e-01
GOBP CELLULAR RESPONSE TO LEPTIN STIMULUS	13	4.99e-01	5.96e-01	0.3390	-2.37e-01	-8.37e-02	1.40e-01	5.03e-02	-1.25e-01	1.18e-01	1.38e-01	6.01e-01	3.84e-01	7.53e-01	4.36e-01	4.60e-01
GOBP STRIATED MUSCLE ADAPTATION	28	1.21e-01	2.25e-01	0.3390	2.11e-01	1.30e-01	7.53e-02	1.93e-01	-9.35e-02	-4.53e-02	5.32e-02	2.36e-01	4.90e-01	7.79e-02	3.92e-01	6.78e-01
GOBP POSITIVE REGULATION OF UBIQUITIN PROTEIN TRANSFERASE ACTIVITY	18	2.62e-01	3.82e-01	0.3390	-1.29e-01	-2.53e-01	3.62e-02	1.51e-01	-1.43e-02	9.93e-02	3.43e-01	6.35e-02	7.90e-01	2.66e-01	9.16e-01	4.66e-01
GOBP RESPONSE TO MUSCLE ACTIVITY	20	1.00e-01	1.96e-01	0.3390	-1.76e-02	-1.92e-01	2.17e-01	1.17e-01	-1.24e-01	3.66e-02	8.92e-01	1.37e-01	9.26e-02	3.64e-01	3.38e-01	7.77e-01
GOBP REGULATION OF BICELLULAR TIGHT JUNCTION ASSEMBLY	17	2.26e-01	3.44e-01	0.3390	-4.22e-02	2.44e-01	2.19e-01	-1.73e-02	2.06e-02	-6.81e-02	7.63e-01	8.13e-02	1.18e-01	9.02e-01	8.83e-01	6.27e-01
GOBP REGULATION OF TOLL LIKE RECEPTOR SIGNALING PATHWAY	32	1.66e-01	2.79e-01	0.3390	-2.17e-02	1.70e-01	1.61e-01	9.17e-02	7.66e-03	2.26e-01	8.32e-01	9.56e-02	1.15e-01	3.69e-01	9.40e-01	2.71e-02
GOBP FORELIMB MORPHOGENESIS	19	2.06e-01	3.23e-01	0.3390	-1.77e-01	1.04e-01	2.40e-01	-6.40e-02	-9.39e-02	4.45e-02	1.80e-01	4.33e-01	7.03e-02	6.29e-01	4.79e-01	7.37e-01
GOBP NEURONAL STEM CELL POPULATION MAINTENANCE	19	2.62e-01	3.82e-01	0.3390	-8.60e-02	8.06e-02	2.33e-01	6.58e-02	1.21e-01	1.65e-01	5.16e-01	5.43e-01	7.85e-02	6.20e-01	3.60e-01	2.12e-01
GOBP NADH METABOLIC PROCESS	30	1.49e-02	4.72e-02	0.3390	-1.86e-01	-1.77e-01	1.77e-01	7.44e-02	-8.07e-02	7.18e-02	7.73e-02	9.34e-02	9.32e-02	4.80e-01	4.44e-01	4.96e-01
GOBP SISTER CHROMATID COHESION	55	2.03e-03	9.32e-03	0.3390	-5.74e-02	-1.73e-02	3.80e-02	2.28e-01	4.40e-02	2.36e-01	4.61e-01	8.24e-01	6.26e-01	3.43e-03	5.73e-01	2.48e-03
GOBP SYNAPSE MATURATION	24	3.83e-01	4.96e-01	0.3390	-1.20e-01	4.45e-02	1.94e-01	-9.07e-03	-1.24e-01	2.12e-01	3.08e-01	7.06e-01	9.97e-02	9.39e-01	2.92e-01	7.21e-02
GOBP CELLULAR RESPONSE TO INTERFERON BETA	23	3.09e-01	4.29e-01	0.3380	2.54e-03	4.47e-03	1.09e-01	9.40e-02	5.73e-04	3.06e-01	9.83e-01	9.70e-01	3.64e-01	4.35e-01	9.96e-01	1.10e-02
GOCC GOLGI LUMEN	57	2.02e-03	9.28e-03	0.3380	6.14e-02	1.69e-03	2.72e-01	1.11e-01	-1.42e-01	6.40e-02	4.23e-01	9.82e-01	3.74e-04	1.47e-01	6.42e-02	4.03e-01
GOBP RESPONSE TO NERVE GROWTH FACTOR	37	3.57e-03	1.49e-02	0.3380	-2.02e-01	1.16e-01	1.56e-01	1.06e-01	-7.23e-02	1.39e-01	3.37e-02	2.22e-01	9.99e-02	2.67e-01	4.46e-01	1.42e-01
GOBP SLEEP	13	4.54e-01	5.59e-01	0.3380	-2.55e-02	5.79e-03	-2.40e-01	1.12e-01	-7.22e-02	-1.96e-01	8.74e-01	9.71e-01	1.34e-01	4.84e-01	6.52e-01	2.22e-01
GOBP TOLL LIKE RECEPTOR SIGNALING PATHWAY	74	1.27e-04	8.34e-04	0.3380	-1.39e-01	1.81e-01	1.17e-01	4.23e-02	5.42e-02	2.09e-01	3.80e-02	7.23e-03	8.19e-02	5.29e-01	4.20e-01	1.85e-03
GOBP REGULATION OF CELL CYCLE CHECKPOINT	44	9.16e-03	3.20e-02	0.3380	-4.92e-02	-1.82e-01	-3.32e-02	2.28e-01	-5.38e-03	1.60e-01	5.73e-01	3.70e-02	7.03e-01	8.81e-03	9.51e-01	6.61e-02
GOCC CHROMOSOMAL REGION	370	5.53e-29	4.93e-27	0.3380	-7.72e-02	-1.45e-01	-3.46e-02	2.24e-01	2.04e-03	1.89e-01	1.08e-02	1.56e-06	2.53e-01	1.32e-13	9.46e-01	4.43e-10
GOBP MYELOID LEUKOCYTE MEDIATED IMMUNITY	97	1.03e-04	6.96e-04	0.3380	-2.64e-02	7.23e-02	2.59e-01	9.06e-02	-5.38e-02	1.73e-01	6.53e-01	2.18e-01	1.01e-05	1.23e-01	3.60e-01	3.25e-03
GOBP DENDRITE EXTENSION	25	3.27e-01	4.46e-01	0.3380	7.19e-02	2.26e-01	2.00e-01	2.04e-02	1.28e-01	3.32e-02	5.34e-01	5.04e-02	8.38e-02	8.60e-01	2.68e-01	7.74e-01
GOBP POSITIVE REGULATION OF LIPID STORAGE	19	1.42e-02	4.53e-02	0.3380	-4.65e-02	6.13e-02	2.36e-01	5.46e-02	2.14e-01	-6.15e-02	7.26e-01	6.44e-01	7.52e-02	6.81e-01	1.07e-01	6.43e-01
GOCC CELL DIVISION SITE	66	3.18e-04	1.90e-03	0.3380	-3.75e-02	-5.73e-02	7.95e-02	2.69e-01	9.30e-02	1.48e-01	5.98e-01	4.21e-01	2.64e-01	1.56e-04	1.92e-01	3.75e-02
GOCC X CHROMOSOME	13	5.93e-01	6.75e-01	0.3380	-1.79e-01	-1.03e-01	1.88e-01	-1.11e-01	-3.93e-02	1.49e-01	2.64e-01	5.21e-01	2.41e-01	4.89e-01	8.06e-01	3.52e-01
GOBP NEGATIVE REGULATION OF CELLULAR CATABOLIC PROCESS	100	1.48e-10	2.62e-09	0.3370	-1.02e-01	1.35e-01	1.42e-01	2.10e-01	-9.10e-02	1.11e-01	7.70e-02	1.97e-02	1.39e-02	2.78e-04	1.16e-01	5.42e-02
GOBP POSITIVE REGULATION OF OSTEOBLAST DIFFERENTIATION	45	4.83e-02	1.14e-01	0.3370	-2.47e-01	-1.67e-02	4.39e-02	-1.42e-01	-1.74e-01	1.24e-02	4.07e-03	8.47e-01	6.10e-01	1.00e-01	4.37e-02	8.85e-01
GOBP APOPTOTIC DNA FRAGMENTATION	15	4.89e-01	5.88e-01	0.3370	-2.42e-01	-2.07e-01	-7.14e-02	6.72e-02	4.66e-02	2.81e-02	1.05e-01	1.64e-01	6.32e-01	6.52e-01	7.55e-01	8.50e-01
GOBP DICARBOXYLIC ACID METABOLIC PROCESS	77	1.45e-04	9.40e-04	0.3370	-1.83e-01	-2.46e-01	-3.25e-02	-1.26e-02	3.73e-02	1.30e-01	5.41e-03	1.84e-04	6.22e-01	8.48e-01	5.71e-01	4.85e-02
GOCC VESICLE TETHERING COMPLEX	65	2.68e-04	1.63e-03	0.3370	-1.39e-01	-1.07e-01	-3.34e-02	2.01e-01	1.35e-01	1.51e-01	5.22e-02	1.34e-01	6.41e-01	4.96e-03	5.89e-02	3.51e-02
GOBP RELEASE OF SEQUESTERED CALCIUM ION INTO CYTOSOL BY ENDOPLASMIC RETICULUM	29	3.11e-01	4.31e-01	0.3370	-7.47e-02	-3.42e-02	2.16e-01	5.24e-03	-8.75e-02	2.29e-01	4.86e-01	7.50e-01	4.36e-02	9.61e-01	4.15e-01	3.27e-02
GOBP METHYLATION	200	4.74e-09	6.97e-08	0.3370	-3.88e-02	-2.17e-01	-2.21e-01	8.04e-02	4.11e-02	-8.84e-02	3.44e-01	1.16e-07	6.69e-08	4.99e-02	3.16e-01	3.11e-02
GOBP CELL SUBSTRATE JUNCTION ORGANIZATION	87	9.64e-07	1.01e-05	0.3370	-1.15e-01	-5.18e-03	2.60e-01	3.08e-02	-1.70e-01	5.55e-02	6.29e-02	9.33e-01	2.77e-05	6.20e-01	6.22e-03	3.71e-01
GOBP REGULATION OF MEMBRANE PERMEABILITY	58	1.73e-02	5.29e-02	0.3370	-9.52e-02	-2.38e-01	-1.39e-01	2.32e-02	-3.36e-02	-1.65e-01	2.10e-01	1.72e-03	6.79e-02	7.60e-01	6.58e-01	2.99e-02
GOBP MACROPHAGE CYTOKINE PRODUCTION	33	5.53e-03	2.13e-02	0.3370	-1.23e-01	3.64e-02	1.93e-01	1.24e-01	1.80e-01	1.10e-01	2.21e-01	7.18e-01	5.49e-02	2.16e-01	7.40e-02	2.74e-01
GOMF SODIUM ION TRANSMEMBRANE TRANSPORTER ACTIVITY	104	7.69e-04	4.07e-03	0.3370	1.43e-01	2.06e-01	2.07e-01	7.97e-02	1.48e-02	3.46e-02	1.19e-02	2.90e-04	2.56e-04	1.60e-01	7.95e-01	5.42e-01
GOBP STRIATED MUSCLE CELL PROLIFERATION	54	1.45e-03	7.02e-03	0.3370	-9.04e-02	1.84e-01	1.72e-01	1.34e-01	-2.60e-03	1.54e-01	2.50e-01	1.94e-02	2.88e-02	8.81e-02	9.74e-01	4.96e-02
GOMF CATALYTIC ACTIVITY ACTING ON A GLYCOPROTEIN	18	4.39e-01	5.46e-01	0.3370	-1.12e-01	-2.02e-01	7.47e-02	9.77e-02	-1.67e-01	1.31e-01	4.12e-01	1.38e-01	5.83e-01	4.73e-01	2.21e-01	3.36e-01
GOBP POSITIVE REGULATION OF SYNAPSE ASSEMBLY	37	1.22e-01	2.26e-01	0.3370	5.35e-02	2.88e-01	5.11e-02	4.88e-02	1.49e-01	-2.33e-02	5.73e-01	2.44e-03	5.90e-01	6.08e-01	1.17e-01	8.06e-01
GOBP CELL CYCLE CHECKPOINT SIGNALING	187	8.20e-13	1.83e-11	0.3370	-1.59e-02	-1.37e-01	1.10e-02	2.53e-01	3.88e-02	1.70e-01	7.07e-01	1.27e-03	7.95e-01	2.47e-09	3.60e-01	6.25e-05
GOMF ANGIOTENSIN RECEPTOR BINDING	7	6.51e-01	7.23e-01	0.3370	-2.29e-01	8.06e-02	2.03e-02	1.02e-01	2.01e-01	-5.71e-02	2.95e-01	7.12e-01	9.26e-01	6.40e-01	3.57e-01	7.93e-01
GOBP POSITIVE REGULATION OF GLUCOSE TRANSMEMBRANE TRANSPORT	33	3.83e-02	9.63e-02	0.3360	-2.45e-01	4.97e-02	1.81e-01	-7.16e-02	-6.41e-02	9.15e-02	1.47e-02	6.21e-01	7.14e-02	4.76e-01	5.24e-01	3.63e-01
GOBP SPHINGOLIPID BIOSYNTHETIC PROCESS	90	1.28e-03	6.26e-03	0.3360	-1.04e-01	8.36e-03	1.54e-01	-5.05e-02	-1.69e-01	2.18e-01	8.82e-02	8.91e-01	1.13e-02	4.08e-01	5.73e-03	3.53e-04
GOBP ANATOMICAL STRUCTURE ARRANGEMENT	12	7.19e-01	7.77e-01	0.3360	1.37e-02	1.79e-01	9.26e-03	3.01e-02	2.52e-01	1.27e-01	9.35e-01	2.83e-01	9.56e-01	8.57e-01	1.30e-01	4.46e-01
GOBP OVULATION CYCLE PROCESS	33	8.14e-02	1.69e-01	0.3360	-1.12e-01	1.32e-01	2.44e-01	1.78e-02	-5.61e-02	1.41e-01	2.67e-01	1.89e-01	1.51e-02	8.60e-01	5.77e-01	1.60e-01
GOBP NEGATIVE REGULATION OF INTRACELLULAR STEROID HORMONE RECEPTOR SIGNALING PATHWAY	28	6.83e-03	2.53e-02	0.3360	-1.30e-01	-2.71e-03	1.09e-01	2.47e-01	-1.38e-01	6.58e-02	2.32e-01	9.80e-01	3.18e-01	2.39e-02	2.07e-01	5.47e-01
GOBP DNA ALKYLATION REPAIR	12	5.81e-01	6.66e-01	0.3360	3.06e-02	-1.87e-01	-3.76e-02	2.65e-01	-4.87e-02	5.70e-02	8.54e-01	2.63e-01	8.22e-01	1.12e-01	7.70e-01	7.33e-01
GOBP NEUROTRANSMITTER RECEPTOR TRANSPORT TO PLASMA MEMBRANE	14	6.15e-01	6.93e-01	0.3360	-3.41e-03	1.07e-01	1.59e-01	1.91e-01	1.61e-01	1.17e-01	9.82e-01	4.87e-01	3.03e-01	2.16e-01	2.96e-01	4.48e-01
GOMF UBIQUITIN MODIFIED HISTONE READER ACTIVITY	7	5.91e-01	6.74e-01	0.3360	-2.45e-01	-6.86e-02	8.97e-02	9.16e-02	-1.56e-01	-8.72e-02	2.62e-01	7.53e-01	6.81e-01	6.75e-01	4.74e-01	6.90e-01
GOBP GLIAL CELL MIGRATION	51	2.27e-02	6.53e-02	0.3360	-1.09e-01	-5.77e-02	1.90e-01	-7.43e-02	-2.34e-01	3.68e-02	1.77e-01	4.76e-01	1.92e-02	3.58e-01	3.79e-03	6.49e-01
GOMF KINASE INHIBITOR ACTIVITY	72	2.83e-03	1.24e-02	0.3360	-7.23e-02	-1.52e-01	1.84e-01	-1.27e-02	-1.19e-01	1.91e-01	2.89e-01	2.59e-02	6.87e-03	8.52e-01	8.20e-02	5.05e-03
GOBP POSITIVE REGULATION OF AXON EXTENSION	30	5.01e-03	1.97e-02	0.3360	-1.32e-01	1.62e-01	1.65e-01	1.75e-01	1.06e-01	-1.01e-02	2.10e-01	1.24e-01	1.18e-01	9.80e-02	3.14e-01	9.23e-01
GOCC MLL1 2 COMPLEX	32	5.18e-02	1.20e-01	0.3360	7.93e-02	-1.22e-01	-8.29e-02	2.88e-01	-4.02e-02	-2.21e-02	4.38e-01	2.34e-01	4.17e-01	4.82e-03	6.94e-01	8.29e-01
GOBP PURINE NUCLEOTIDE SALVAGE	10	5.22e-01	6.15e-01	0.3360	-1.07e-01	-3.05e-01	4.91e-02	6.30e-02	1.45e-02	4.40e-02	5.57e-01	9.52e-02	7.88e-01	7.30e-01	9.37e-01	8.10e-01
GOBP GLOMERULAR MESANGIUM DEVELOPMENT	11	8.08e-01	8.45e-01	0.3360	9.39e-02	1.78e-01	1.71e-01	1.50e-02	-9.09e-02	1.86e-01	5.90e-01	3.05e-01	3.26e-01	9.32e-01	6.02e-01	2.86e-01
GOMF POTASSIUM CHANNEL ACTIVITY	70	1.64e-03	7.75e-03	0.3360	1.21e-01	1.68e-01	2.39e-01	-1.11e-01	-2.56e-03	2.50e-02	8.05e-02	1.52e-02	5.39e-04	1.09e-01	9.70e-01	7.17e-01
GOBP REGULATION OF ALPHA BETA T CELL DIFFERENTIATION	68	1.48e-03	7.09e-03	0.3360	1.41e-02	1.75e-01	2.34e-01	1.34e-01	-9.99e-03	9.56e-02	8.41e-01	1.28e-02	8.26e-04	5.59e-02	8.87e-01	1.73e-01
GOBP ESTABLISHMENT OF SPINDLE ORIENTATION	34	1.15e-01	2.16e-01	0.3360	-7.12e-03	-4.01e-02	1.71e-01	9.61e-02	-1.96e-01	1.85e-01	9.43e-01	6.86e-01	8.37e-02	3.32e-01	4.81e-02	6.19e-02
GOBP MYELOID CELL APOPTOTIC PROCESS	32	1.98e-01	3.14e-01	0.3360	1.01e-03	1.52e-01	1.76e-01	1.42e-01	1.30e-01	1.48e-01	9.92e-01	1.38e-01	8.55e-02	1.66e-01	2.02e-01	1.47e-01
GOBP EOSINOPHIL MEDIATED IMMUNITY	9	8.06e-01	8.44e-01	0.3360	-1.40e-01	-5.97e-02	-1.26e-01	-1.26e-01	1.22e-01	-2.08e-01	4.67e-01	7.57e-01	5.13e-01	5.14e-01	5.26e-01	2.81e-01
GOBP ACUTE INFLAMMATORY RESPONSE	77	8.16e-05	5.65e-04	0.3360	-4.23e-02	8.15e-02	2.78e-01	-9.17e-02	3.48e-02	1.33e-01	5.21e-01	2.16e-01	2.50e-05	1.64e-01	5.98e-01	4.43e-02
GOMF FIBROBLAST GROWTH FACTOR RECEPTOR BINDING	11	7.36e-01	7.90e-01	0.3360	-6.13e-02	2.28e-02	-3.83e-02	-2.57e-01	-2.01e-01	-3.10e-02	7.25e-01	8.96e-01	8.26e-01	1.41e-01	2.49e-01	8.59e-01
GOMF PROTEIN CONTAINING COMPLEX DESTABILIZING ACTIVITY	12	3.79e-01	4.93e-01	0.3360	-2.03e-01	2.12e-03	-7.85e-02	1.37e-01	1.13e-01	-1.83e-01	2.23e-01	9.90e-01	6.38e-01	4.11e-01	4.97e-01	2.71e-01
GOBP EPITHELIAL CELL PROLIFERATION INVOLVED IN LUNG MORPHOGENESIS	6	7.98e-01	8.37e-01	0.3360	3.97e-02	-2.69e-01	8.35e-02	-1.49e-01	-9.60e-02	-4.14e-03	8.66e-01	2.53e-01	7.23e-01	5.26e-01	6.84e-01	9.86e-01
GOCC OUTER MEMBRANE	226	1.99e-08	2.69e-07	0.3360	-1.92e-01	-2.26e-01	-1.36e-01	-3.79e-02	-6.90e-02	-7.20e-03	6.90e-07	4.66e-09	4.12e-04	3.26e-01	7.42e-02	8.52e-01
GOBP PROTEIN LOCALIZATION TO VACUOLE	78	3.74e-05	2.81e-04	0.3360	-1.62e-01	-4.99e-02	1.25e-01	1.44e-01	-6.83e-02	2.07e-01	1.35e-02	4.46e-01	5.63e-02	2.75e-02	2.97e-01	1.56e-03
GOBP WOUND HEALING	336	9.29e-20	3.86e-18	0.3360	-1.23e-01	-8.59e-02	2.30e-01	-3.38e-02	-1.24e-01	1.43e-01	1.03e-04	6.80e-03	3.79e-13	2.87e-01	9.61e-05	6.50e-06
GOBP REGULATION OF UNSATURATED FATTY ACID BIOSYNTHETIC PROCESS	9	2.03e-01	3.20e-01	0.3360	-1.25e-01	2.38e-03	1.83e-01	-6.45e-02	2.34e-01	-6.79e-02	5.16e-01	9.90e-01	3.42e-01	7.38e-01	2.24e-01	7.24e-01
GOBP PEPTIDE CATABOLIC PROCESS	17	4.26e-01	5.34e-01	0.3360	-1.42e-01	2.08e-01	1.26e-01	-1.50e-01	4.25e-02	9.30e-02	3.10e-01	1.37e-01	3.69e-01	2.83e-01	7.62e-01	5.07e-01
GOBP REGULATION OF FATTY ACID OXIDATION	27	1.36e-01	2.43e-01	0.3360	8.89e-02	1.32e-01	-1.09e-01	8.23e-02	-1.74e-02	-2.61e-01	4.24e-01	2.35e-01	3.27e-01	4.59e-01	8.76e-01	1.87e-02
GOBP POSITIVE REGULATION OF PLASMA MEMBRANE BOUNDED CELL PROJECTION ASSEMBLY	96	6.97e-06	6.12e-05	0.3360	-8.63e-02	8.35e-02	1.33e-01	1.91e-01	7.91e-02	1.94e-01	1.44e-01	1.57e-01	2.38e-02	1.21e-03	1.81e-01	1.03e-03
GOMF CORECEPTOR ACTIVITY	47	1.89e-02	5.66e-02	0.3360	-5.38e-02	5.30e-02	1.24e-01	1.59e-01	-7.78e-03	2.57e-01	5.23e-01	5.29e-01	1.41e-01	5.94e-02	9.26e-01	2.29e-03
GOBP ORGAN GROWTH	116	4.21e-08	5.41e-07	0.3350	-8.89e-02	1.23e-01	2.04e-01	1.40e-01	-5.22e-02	1.59e-01	9.83e-02	2.16e-02	1.44e-04	8.99e-03	3.31e-01	3.16e-03
GOMF ACETYLGLUCOSAMINYLTRANSFERASE ACTIVITY	37	9.00e-02	1.81e-01	0.3350	-2.58e-01	-1.51e-01	-8.70e-02	-1.11e-02	-9.63e-02	-7.89e-02	6.67e-03	1.11e-01	3.60e-01	9.07e-01	3.11e-01	4.06e-01
GOBP REGULATION OF CD4 POSITIVE ALPHA BETA T CELL DIFFERENTIATION	53	8.69e-03	3.07e-02	0.3350	2.72e-02	1.99e-01	2.15e-01	1.47e-01	3.68e-02	5.55e-02	7.32e-01	1.22e-02	6.83e-03	6.48e-02	6.43e-01	4.84e-01
GOBP NEGATIVE REGULATION OF SPROUTING ANGIOGENESIS	10	3.46e-01	4.63e-01	0.3350	-1.85e-01	1.51e-01	2.21e-01	3.14e-04	7.33e-02	-2.87e-02	3.10e-01	4.08e-01	2.25e-01	9.99e-01	6.88e-01	8.75e-01
GOBP EXCITATORY SYNAPSE ASSEMBLY	24	1.01e-01	1.96e-01	0.3350	-9.84e-02	-1.27e-01	2.47e-01	-9.26e-02	-1.22e-01	4.43e-02	4.04e-01	2.83e-01	3.59e-02	4.32e-01	3.01e-01	7.07e-01
GOBP MODULATION OF EXCITATORY POSTSYNAPTIC POTENTIAL	33	1.09e-01	2.08e-01	0.3350	1.88e-02	6.12e-02	1.44e-01	2.53e-01	8.61e-02	1.27e-01	8.52e-01	5.43e-01	1.53e-01	1.19e-02	3.92e-01	2.07e-01
GOMF THIAMINE TRANSMEMBRANE TRANSPORTER ACTIVITY	5	9.68e-01	9.73e-01	0.3350	-1.24e-01	-1.50e-01	-8.35e-02	-5.47e-02	-2.48e-01	-5.03e-02	6.31e-01	5.60e-01	7.46e-01	8.32e-01	3.36e-01	8.46e-01
GOMF TRANSFORMING GROWTH FACTOR BETA RECEPTOR ACTIVITY	11	4.15e-01	5.26e-01	0.3350	-2.14e-01	2.29e-01	5.88e-02	2.44e-02	3.60e-03	1.00e-01	2.20e-01	1.89e-01	7.36e-01	8.88e-01	9.83e-01	5.66e-01
GOBP TYPE II INTERFERON MEDIATED SIGNALING PATHWAY	25	4.33e-01	5.41e-01	0.3350	1.40e-02	1.51e-01	2.09e-01	1.10e-01	3.81e-02	1.79e-01	9.04e-01	1.92e-01	7.08e-02	3.40e-01	7.42e-01	1.21e-01
GOBP REGULATION OF CELL GROWTH INVOLVED IN CARDIAC MUSCLE CELL DEVELOPMENT	12	6.63e-01	7.32e-01	0.3350	-2.49e-02	-7.09e-02	2.19e-01	8.81e-02	-2.01e-01	1.01e-01	8.81e-01	6.71e-01	1.89e-01	5.97e-01	2.27e-01	5.44e-01
GOBP MAINTENANCE OF CENTROSOME LOCATION	6	5.72e-01	6.59e-01	0.3350	-3.28e-02	1.08e-01	-8.97e-02	7.95e-02	-5.60e-02	2.86e-01	8.89e-01	6.47e-01	7.04e-01	7.36e-01	8.12e-01	2.25e-01
GOBP NEGATIVE REGULATION OF CARBOHYDRATE METABOLIC PROCESS	48	8.85e-03	3.11e-02	0.3350	7.14e-02	1.21e-01	1.85e-01	2.36e-01	4.67e-02	1.08e-02	3.92e-01	1.46e-01	2.63e-02	4.74e-03	5.76e-01	8.97e-01
GOMF PYRIMIDINE NUCLEOSIDE TRANSMEMBRANE TRANSPORTER ACTIVITY	6	8.16e-01	8.51e-01	0.3350	2.60e-01	-8.66e-02	8.39e-02	1.06e-01	1.23e-01	-5.96e-02	2.70e-01	7.13e-01	7.22e-01	6.54e-01	6.02e-01	8.00e-01
GOMF RNA CAP BINDING	18	4.21e-01	5.30e-01	0.3350	-1.93e-01	-1.73e-01	-1.40e-02	7.93e-02	-1.48e-01	1.28e-01	1.56e-01	2.04e-01	9.18e-01	5.60e-01	2.76e-01	3.48e-01
GOCC BLOOD MICROPARTICLE	105	1.17e-06	1.22e-05	0.3350	6.35e-02	-1.54e-01	1.47e-01	1.80e-01	-1.33e-01	1.12e-01	2.61e-01	6.38e-03	9.02e-03	1.43e-03	1.90e-02	4.80e-02
GOBP DNA CONFORMATION CHANGE	88	7.17e-06	6.28e-05	0.3350	-1.51e-02	-1.48e-01	1.24e-02	2.64e-01	-1.54e-02	1.40e-01	8.06e-01	1.62e-02	8.40e-01	1.82e-05	8.03e-01	2.36e-02
GOBP VESICLE ORGANIZATION	327	3.91e-22	1.95e-20	0.3350	-2.06e-01	-1.12e-01	1.21e-01	6.74e-02	-6.14e-02	1.85e-01	1.42e-10	5.18e-04	1.78e-04	3.63e-02	5.64e-02	9.65e-09
GOBP NLS BEARING PROTEIN IMPORT INTO NUCLEUS	19	2.49e-01	3.68e-01	0.3350	-2.85e-01	-7.03e-03	-8.49e-02	-4.44e-02	-8.33e-02	1.21e-01	3.16e-02	9.58e-01	5.22e-01	7.37e-01	5.30e-01	3.61e-01
GOBP POSITIVE REGULATION OF MEMBRANE DEPOLARIZATION	7	7.51e-01	8.01e-01	0.3350	-1.20e-01	-1.72e-01	-6.67e-02	-3.78e-02	1.95e-01	1.54e-01	5.83e-01	4.30e-01	7.60e-01	8.62e-01	3.71e-01	4.79e-01
GOCC AXON CYTOPLASM	58	2.21e-02	6.40e-02	0.3350	-9.60e-02	-1.33e-02	1.49e-01	4.01e-03	-5.95e-02	2.77e-01	2.06e-01	8.61e-01	4.94e-02	9.58e-01	4.33e-01	2.64e-04
GOMF NUCLEOSIDE MONOPHOSPHATE KINASE ACTIVITY	19	3.45e-01	4.61e-01	0.3340	6.61e-03	-1.05e-01	1.19e-01	-1.67e-01	-8.11e-02	2.28e-01	9.60e-01	4.28e-01	3.69e-01	2.07e-01	5.40e-01	8.51e-02
GOBP REGULATION OF DOPAMINE SECRETION	12	8.31e-01	8.64e-01	0.3340	1.18e-01	2.52e-01	1.65e-01	7.40e-02	4.01e-02	1.28e-02	4.78e-01	1.31e-01	3.24e-01	6.57e-01	8.10e-01	9.39e-01
GOMF ATPASE COUPLED MONOATOMIC CATION TRANSMEMBRANE TRANSPORTER ACTIVITY	41	1.44e-03	6.97e-03	0.3340	-1.78e-01	2.65e-02	2.33e-01	1.08e-01	-4.21e-02	1.08e-01	4.89e-02	7.69e-01	9.70e-03	2.31e-01	6.41e-01	2.33e-01
GOBP NUCLEAR PORE LOCALIZATION	5	7.74e-01	8.17e-01	0.3340	-2.07e-01	-1.54e-01	9.79e-03	1.68e-01	8.02e-02	-1.03e-01	4.22e-01	5.52e-01	9.70e-01	5.16e-01	7.56e-01	6.91e-01
GOBP AMINO ACID BETAINE METABOLIC PROCESS	13	6.06e-01	6.86e-01	0.3340	-3.89e-02	3.52e-02	1.82e-01	-1.62e-01	4.75e-02	2.18e-01	8.08e-01	8.26e-01	2.57e-01	3.11e-01	7.67e-01	1.74e-01
GOBP NEGATIVE REGULATION OF CHEMOKINE MEDIATED SIGNALING PATHWAY	6	9.32e-01	9.43e-01	0.3340	1.17e-01	-1.91e-02	1.74e-01	1.63e-02	1.44e-02	2.59e-01	6.20e-01	9.35e-01	4.61e-01	9.45e-01	9.51e-01	2.72e-01
GOBP NEGATIVE REGULATION OF TRANSMEMBRANE TRANSPORT	90	1.79e-03	8.34e-03	0.3340	-2.17e-01	-1.92e-01	3.07e-02	-1.15e-01	-1.05e-01	4.61e-02	3.63e-04	1.63e-03	6.15e-01	5.83e-02	8.40e-02	4.50e-01
GOBP EYE PHOTORECEPTOR CELL DIFFERENTIATION	30	4.45e-02	1.08e-01	0.3340	-8.27e-02	2.02e-01	1.50e-01	-1.51e-01	-7.80e-02	-1.12e-01	4.33e-01	5.55e-02	1.55e-01	1.52e-01	4.59e-01	2.88e-01
GOMF AMINOPEPTIDASE ACTIVITY	35	1.11e-01	2.10e-01	0.3340	-1.89e-01	-1.62e-01	-1.50e-01	2.73e-03	9.99e-02	-1.30e-01	5.30e-02	9.67e-02	1.23e-01	9.78e-01	3.07e-01	1.82e-01
GOBP CIRCADIAN SLEEP WAKE CYCLE SLEEP	10	9.07e-01	9.23e-01	0.3340	1.17e-01	1.90e-01	-2.85e-02	1.81e-01	1.52e-01	-7.03e-02	5.22e-01	2.97e-01	8.76e-01	3.22e-01	4.05e-01	7.00e-01
GOBP REGULATION OF POSTSYNAPTIC DENSITY ORGANIZATION	11	5.29e-01	6.21e-01	0.3340	-2.65e-01	-1.80e-01	1.29e-02	7.22e-02	-5.36e-02	-2.81e-02	1.28e-01	3.02e-01	9.41e-01	6.78e-01	7.58e-01	8.72e-01
GOBP ANIMAL ORGAN FORMATION	35	8.27e-02	1.71e-01	0.3340	-1.15e-01	2.25e-02	2.65e-01	-5.73e-02	-9.98e-02	1.20e-01	2.40e-01	8.18e-01	6.70e-03	5.57e-01	3.07e-01	2.18e-01
GOMF STORE OPERATED CALCIUM CHANNEL ACTIVITY	7	7.50e-01	8.00e-01	0.3340	2.97e-01	6.80e-02	-2.24e-02	9.85e-02	-6.62e-02	6.62e-02	1.74e-01	7.56e-01	9.18e-01	6.52e-01	7.62e-01	7.62e-01
GOBP NUCLEAR CHROMOSOME SEGREGATION	287	7.65e-20	3.21e-18	0.3340	-3.72e-02	-1.71e-01	5.75e-02	2.03e-01	-3.10e-02	1.88e-01	2.79e-01	5.96e-07	9.36e-02	3.42e-09	3.66e-01	4.02e-08
GOBP REGULATION OF CARDIAC MUSCLE ADAPTATION	9	6.49e-01	7.22e-01	0.3340	1.44e-01	2.11e-01	7.79e-02	1.54e-01	-1.26e-01	2.61e-02	4.54e-01	2.74e-01	6.86e-01	4.24e-01	5.12e-01	8.92e-01
GOBP REGULATION OF CYTOKINESIS	78	3.19e-05	2.42e-04	0.3340	-6.27e-02	-1.09e-01	1.08e-01	2.31e-01	-4.74e-02	1.69e-01	3.38e-01	9.46e-02	1.00e-01	4.30e-04	4.69e-01	9.89e-03
GOBP REGULATION OF HUMORAL IMMUNE RESPONSE	31	1.37e-01	2.45e-01	0.3340	7.45e-02	1.21e-01	2.28e-01	-9.47e-03	1.38e-01	1.43e-01	4.73e-01	2.45e-01	2.82e-02	9.27e-01	1.83e-01	1.70e-01
GOBP NEGATIVE REGULATION OF INTERLEUKIN 2 PRODUCTION	28	2.07e-01	3.23e-01	0.3340	1.87e-01	1.69e-01	1.53e-01	1.15e-01	-1.05e-01	-8.22e-03	8.59e-02	1.22e-01	1.60e-01	2.93e-01	3.38e-01	9.40e-01
GOBP REGULATION OF FIBROBLAST GROWTH FACTOR RECEPTOR SIGNALING PATHWAY	23	3.40e-01	4.57e-01	0.3340	-2.15e-02	-5.42e-02	1.23e-01	-1.02e-01	-2.81e-01	-5.75e-02	8.58e-01	6.53e-01	3.06e-01	3.99e-01	1.95e-02	6.33e-01
GOBP PEPTIDE CROSS LINKING	16	2.98e-01	4.18e-01	0.3340	4.42e-02	-4.70e-02	2.40e-01	-2.06e-01	-7.93e-02	2.84e-02	7.59e-01	7.45e-01	9.61e-02	1.54e-01	5.83e-01	8.44e-01
GOMF MITOGEN ACTIVATED PROTEIN KINASE P38 BINDING	7	8.10e-01	8.47e-01	0.3340	2.45e-02	4.17e-02	-7.05e-02	1.67e-01	-1.06e-02	-2.75e-01	9.11e-01	8.49e-01	7.47e-01	4.43e-01	9.61e-01	2.07e-01
GOBP REGULATION OF DNA DAMAGE RESPONSE SIGNAL TRANSDUCTION BY P53 CLASS MEDIATOR	33	5.26e-02	1.22e-01	0.3330	-2.65e-01	-1.48e-01	-4.10e-02	-3.74e-02	1.06e-01	6.69e-02	8.31e-03	1.41e-01	6.83e-01	7.10e-01	2.93e-01	5.06e-01
GOBP VIRAL GENOME REPLICATION	117	5.78e-08	7.28e-07	0.3330	-5.59e-02	-6.77e-02	3.42e-02	1.92e-01	-3.14e-02	2.54e-01	2.97e-01	2.06e-01	5.23e-01	3.43e-04	5.58e-01	2.06e-06
GOBP MICROTUBULE ANCHORING AT MICROTUBULE ORGANIZING CENTER	13	6.35e-01	7.11e-01	0.3330	7.89e-02	3.07e-01	4.68e-02	6.77e-02	5.98e-02	1.13e-02	6.22e-01	5.51e-02	7.70e-01	6.72e-01	7.09e-01	9.44e-01
GOBP NUCLEOSIDE BISPHOSPHATE BIOSYNTHETIC PROCESS	54	3.25e-03	1.38e-02	0.3330	-1.40e-01	-1.61e-01	3.26e-02	1.53e-01	1.45e-02	2.03e-01	7.62e-02	4.10e-02	6.79e-01	5.16e-02	8.54e-01	1.00e-02
GOBP NEGATIVE REGULATION OF COLD INDUCED THERMOGENESIS	40	3.09e-02	8.17e-02	0.3330	-2.82e-01	-1.93e-02	2.44e-03	-1.26e-01	-9.11e-02	-8.19e-02	2.01e-03	8.32e-01	9.79e-01	1.66e-01	3.19e-01	3.70e-01
GOBP PHOSPHOLIPID TRANSPORT	83	4.97e-04	2.79e-03	0.3330	4.61e-02	7.80e-02	1.60e-01	2.39e-01	9.28e-02	1.08e-01	4.68e-01	2.19e-01	1.20e-02	1.67e-04	1.44e-01	8.97e-02
GOBP PROTEIN DEPOLYMERIZATION	101	4.73e-05	3.45e-04	0.3330	6.67e-03	5.13e-02	2.24e-01	1.69e-01	2.12e-02	1.70e-01	9.08e-01	3.73e-01	9.77e-05	3.32e-03	7.12e-01	3.14e-03
GOBP REGULATION OF PROTEIN TARGETING TO MEMBRANE	30	1.06e-01	2.04e-01	0.3330	-7.69e-02	-1.42e-01	7.42e-02	1.08e-01	-2.18e-01	1.42e-01	4.66e-01	1.79e-01	4.82e-01	3.04e-01	3.89e-02	1.77e-01
GOMF G PROTEIN COUPLED RECEPTOR KINASE ACTIVITY	6	7.49e-01	8.00e-01	0.3330	5.76e-02	-1.17e-01	1.27e-01	1.40e-01	-1.62e-01	-1.79e-01	8.07e-01	6.19e-01	5.91e-01	5.52e-01	4.92e-01	4.49e-01
GOMF PHOSPHATASE ACTIVATOR ACTIVITY	18	4.44e-01	5.51e-01	0.3330	-2.56e-01	-1.08e-02	8.69e-02	-4.25e-02	-1.23e-01	1.44e-01	5.98e-02	9.36e-01	5.23e-01	7.55e-01	3.68e-01	2.91e-01
GOBP ENDOTHELIAL CELL DEVELOPMENT	57	7.03e-05	4.97e-04	0.3330	-1.86e-01	1.43e-01	2.23e-01	1.87e-03	3.43e-02	6.92e-02	1.50e-02	6.18e-02	3.62e-03	9.81e-01	6.54e-01	3.66e-01
GOBP REGULATION OF CARDIAC CONDUCTION	18	5.83e-01	6.68e-01	0.3330	-7.43e-02	1.14e-01	2.48e-01	-9.21e-02	-8.02e-02	1.26e-01	5.85e-01	4.01e-01	6.87e-02	4.99e-01	5.56e-01	3.56e-01
GOCC ACTOMYOSIN	74	1.00e-03	5.10e-03	0.3330	-8.55e-02	-9.85e-02	1.61e-01	1.11e-01	-1.12e-01	2.07e-01	2.03e-01	1.43e-01	1.66e-02	9.90e-02	9.59e-02	2.06e-03
GOBP REGULATION OF BODY FLUID LEVELS	279	8.25e-17	2.65e-15	0.3330	-9.54e-02	-7.66e-02	2.32e-01	3.74e-02	-6.94e-02	1.89e-01	6.09e-03	2.76e-02	2.57e-11	2.82e-01	4.60e-02	5.79e-08
GOBP REGULATION OF NMDA RECEPTOR ACTIVITY	10	5.09e-01	6.04e-01	0.3330	-2.66e-04	-2.98e-02	2.65e-01	-1.72e-01	2.29e-02	9.63e-02	9.99e-01	8.70e-01	1.46e-01	3.48e-01	9.00e-01	5.98e-01
GOBP ERYTHROCYTE MATURATION	19	3.30e-01	4.48e-01	0.3320	1.28e-01	-6.24e-02	1.23e-01	2.52e-01	-9.52e-02	4.77e-02	3.33e-01	6.38e-01	3.53e-01	5.68e-02	4.72e-01	7.19e-01
GOBP POSITIVE REGULATION OF DNA TEMPLATED TRANSCRIPTION ELONGATION	58	1.11e-03	5.59e-03	0.3320	5.12e-02	-1.49e-02	-8.11e-02	3.15e-01	2.47e-02	-3.36e-02	5.00e-01	8.45e-01	2.85e-01	3.28e-05	7.45e-01	6.58e-01
GOBP FOCAL ADHESION ASSEMBLY	70	2.66e-05	2.06e-04	0.3320	-1.35e-01	-5.48e-02	2.29e-01	-6.27e-03	-1.92e-01	8.26e-03	5.14e-02	4.28e-01	9.22e-04	9.28e-01	5.49e-03	9.05e-01
GOBP REGULATION OF POLYSACCHARIDE METABOLIC PROCESS	33	9.71e-02	1.92e-01	0.3320	9.35e-02	5.78e-03	4.60e-02	2.43e-01	1.95e-01	-5.00e-02	3.53e-01	9.54e-01	6.47e-01	1.56e-02	5.29e-02	6.19e-01
GOBP RESPONSE TO AMPHETAMINE	24	3.84e-02	9.64e-02	0.3320	-7.67e-02	5.28e-02	2.61e-01	-1.01e-01	1.20e-01	9.55e-02	5.16e-01	6.54e-01	2.70e-02	3.91e-01	3.08e-01	4.18e-01
GOBP POSITIVE REGULATION OF URINE VOLUME	7	7.73e-01	8.17e-01	0.3320	8.45e-02	-1.29e-01	7.66e-02	2.56e-01	1.20e-01	-2.71e-02	6.99e-01	5.55e-01	7.26e-01	2.40e-01	5.82e-01	9.01e-01
GOBP POSITIVE REGULATION OF MEIOTIC NUCLEAR DIVISION	7	6.96e-01	7.58e-01	0.3320	-1.22e-01	-1.24e-01	-1.97e-01	1.02e-02	-1.23e-01	1.62e-01	5.77e-01	5.70e-01	3.67e-01	9.63e-01	5.74e-01	4.57e-01
GOCC PHOTORECEPTOR CONNECTING CILIUM	35	1.33e-01	2.40e-01	0.3320	-1.38e-01	-9.59e-03	-2.34e-01	-6.92e-02	1.64e-01	-6.91e-02	1.59e-01	9.22e-01	1.64e-02	4.79e-01	9.38e-02	4.79e-01
GOBP RETICULOPHAGY	20	3.46e-01	4.62e-01	0.3320	-1.10e-01	-7.40e-02	-1.84e-01	2.11e-01	1.19e-01	1.08e-02	3.94e-01	5.67e-01	1.54e-01	1.02e-01	3.58e-01	9.33e-01
GOBP ELASTIC FIBER ASSEMBLY	9	7.10e-01	7.70e-01	0.3320	1.57e-01	1.36e-01	5.33e-02	-1.43e-01	9.48e-02	-1.88e-01	4.16e-01	4.81e-01	7.82e-01	4.59e-01	6.22e-01	3.30e-01
GOMF CHLORIDE CHANNEL REGULATOR ACTIVITY	12	3.09e-01	4.29e-01	0.3320	-3.75e-03	-2.83e-01	-5.67e-02	-1.25e-01	7.60e-02	7.56e-02	9.82e-01	8.98e-02	7.34e-01	4.54e-01	6.49e-01	6.50e-01
GOBP FRUCTOSE METABOLIC PROCESS	13	2.28e-01	3.46e-01	0.3320	-2.57e-01	-5.19e-02	-7.21e-04	6.18e-04	1.46e-01	-1.42e-01	1.08e-01	7.46e-01	9.96e-01	9.97e-01	3.62e-01	3.77e-01
GOMF RNA EXONUCLEASE ACTIVITY	45	2.99e-02	7.99e-02	0.3320	-1.70e-01	-1.50e-01	-2.00e-01	1.10e-01	6.90e-02	4.19e-02	4.80e-02	8.07e-02	2.04e-02	2.01e-01	4.23e-01	6.27e-01
GOBP POSITIVE REGULATION OF CILIUM ASSEMBLY	27	2.44e-01	3.63e-01	0.3320	-7.16e-03	1.57e-01	-8.21e-02	2.09e-01	1.81e-01	-4.58e-02	9.49e-01	1.58e-01	4.60e-01	5.99e-02	1.03e-01	6.80e-01
GOBP NEGATIVE REGULATION OF T CELL RECEPTOR SIGNALING PATHWAY	25	2.25e-01	3.44e-01	0.3320	8.00e-02	1.73e-01	2.25e-02	2.32e-01	6.60e-02	1.22e-01	4.89e-01	1.34e-01	8.46e-01	4.43e-02	5.68e-01	2.91e-01
GOBP INTRINSIC APOPTOTIC SIGNALING PATHWAY IN RESPONSE TO OXIDATIVE STRESS	52	8.87e-03	3.11e-02	0.3320	-1.68e-01	-1.75e-01	3.74e-02	9.81e-02	-1.38e-01	1.45e-01	3.58e-02	2.92e-02	6.41e-01	2.21e-01	8.48e-02	6.99e-02
GOCC SARCOPLASMIC RETICULUM	58	4.36e-03	1.75e-02	0.3320	-5.17e-02	7.14e-02	2.14e-01	1.59e-01	-8.84e-03	1.77e-01	4.95e-01	3.47e-01	4.78e-03	3.66e-02	9.07e-01	2.00e-02
GOBP VACUOLE ORGANIZATION	218	1.03e-15	2.90e-14	0.3320	-2.90e-01	-1.43e-01	-1.61e-02	4.79e-02	-2.18e-02	4.91e-02	1.46e-13	2.88e-04	6.81e-01	2.23e-01	5.80e-01	2.12e-01
GOCC CARBOXY TERMINAL DOMAIN PROTEIN KINASE COMPLEX	20	3.51e-01	4.67e-01	0.3320	-3.00e-01	-2.76e-02	1.20e-02	-5.72e-02	-1.87e-02	1.25e-01	2.03e-02	8.31e-01	9.26e-01	6.58e-01	8.85e-01	3.32e-01
GOBP NEGATIVE REGULATION OF PROTEIN LOCALIZATION	176	1.02e-07	1.25e-06	0.3320	-1.98e-01	-1.07e-01	1.25e-01	-5.22e-02	-1.55e-01	1.30e-01	5.93e-06	1.46e-02	4.14e-03	2.32e-01	3.85e-04	2.88e-03
GOMF DNA NUCLEASE ACTIVITY	63	7.92e-03	2.86e-02	0.3320	2.75e-02	-1.52e-01	-1.72e-01	1.39e-01	1.74e-01	-8.43e-02	7.06e-01	3.74e-02	1.85e-02	5.67e-02	1.67e-02	2.47e-01
GOBP MRNA TRANSCRIPTION	48	2.23e-05	1.74e-04	0.3310	-2.79e-01	3.27e-02	1.45e-01	8.99e-02	1.63e-03	3.94e-02	8.12e-04	6.95e-01	8.15e-02	2.81e-01	9.84e-01	6.37e-01
GOBP CELLULAR RESPONSE TO RETINOIC ACID	41	7.48e-03	2.73e-02	0.3310	-1.63e-01	1.93e-03	2.04e-01	7.59e-02	6.42e-02	1.78e-01	7.16e-02	9.83e-01	2.36e-02	4.00e-01	4.77e-01	4.81e-02
GOBP REGULATION OF SYNAPTIC VESICLE EXOCYTOSIS	34	2.82e-02	7.66e-02	0.3310	-2.56e-01	4.99e-02	1.15e-01	3.17e-02	-1.05e-02	1.66e-01	9.86e-03	6.15e-01	2.44e-01	7.49e-01	9.15e-01	9.39e-02
GOBP NEGATIVE REGULATION OF CELL KILLING	26	1.17e-01	2.20e-01	0.3310	-5.54e-02	1.31e-01	1.08e-01	2.20e-01	2.43e-02	1.70e-01	6.25e-01	2.46e-01	3.42e-01	5.20e-02	8.30e-01	1.34e-01
GOBP POST EMBRYONIC DEVELOPMENT	77	6.18e-06	5.52e-05	0.3310	-1.44e-01	1.95e-01	2.10e-01	3.19e-02	3.21e-03	7.74e-02	2.88e-02	3.10e-03	1.46e-03	6.28e-01	9.61e-01	2.40e-01
GOBP ADENYLATE CYCLASE MODULATING G PROTEIN COUPLED RECEPTOR SIGNALING PATHWAY	152	1.25e-06	1.29e-05	0.3310	-4.76e-03	1.48e-01	2.64e-01	-4.89e-03	-3.88e-02	1.29e-01	9.19e-01	1.59e-03	1.95e-08	9.17e-01	4.10e-01	6.18e-03
GOBP EXTRACELLULAR REGULATION OF SIGNAL TRANSDUCTION	11	6.11e-01	6.90e-01	0.3310	3.32e-02	1.02e-03	2.30e-01	-2.18e-01	-9.18e-02	-8.68e-03	8.49e-01	9.95e-01	1.87e-01	2.11e-01	5.98e-01	9.60e-01
GOBP ACROSOME REACTION	21	6.15e-01	6.94e-01	0.3310	9.63e-02	1.61e-01	1.03e-01	2.01e-01	1.49e-01	3.77e-02	4.45e-01	2.02e-01	4.12e-01	1.11e-01	2.37e-01	7.65e-01
GOBP PYRIMIDINE NUCLEOTIDE CATABOLIC PROCESS	19	2.84e-01	4.04e-01	0.3310	-1.57e-02	-2.70e-01	-1.22e-01	8.88e-02	6.63e-02	9.63e-02	9.06e-01	4.16e-02	3.55e-01	5.03e-01	6.17e-01	4.67e-01
GOBP INTERLEUKIN 17A MEDIATED SIGNALING PATHWAY	5	8.63e-01	8.89e-01	0.3310	-3.12e-01	8.17e-03	6.31e-02	2.50e-02	-7.38e-02	4.75e-02	2.27e-01	9.75e-01	8.07e-01	9.23e-01	7.75e-01	8.54e-01
GOMF SIRNA BINDING	10	5.35e-01	6.26e-01	0.3310	-1.74e-01	1.71e-01	-5.23e-02	1.62e-01	1.26e-01	7.48e-02	3.41e-01	3.50e-01	7.75e-01	3.76e-01	4.91e-01	6.82e-01
GOMF INTRACELLULARLY CALCIUM GATED CHLORIDE CHANNEL ACTIVITY	12	3.90e-01	5.03e-01	0.3310	4.99e-02	6.65e-02	2.67e-01	3.73e-02	1.63e-01	5.81e-02	7.65e-01	6.90e-01	1.09e-01	8.23e-01	3.28e-01	7.27e-01
GOBP POSITIVE REGULATION OF BLOOD CIRCULATION	24	3.23e-01	4.42e-01	0.3310	1.09e-02	5.84e-02	2.52e-01	8.19e-02	6.29e-02	1.79e-01	9.27e-01	6.20e-01	3.28e-02	4.87e-01	5.94e-01	1.29e-01
GOBP COLUMNAR CUBOIDAL EPITHELIAL CELL DEVELOPMENT	33	1.12e-01	2.12e-01	0.3310	-1.43e-02	2.10e-02	2.89e-01	4.33e-02	-6.71e-02	1.38e-01	8.87e-01	8.35e-01	4.09e-03	6.67e-01	5.05e-01	1.70e-01
GOBP POSTSYNAPTIC CYTOSKELETON ORGANIZATION	11	7.95e-01	8.34e-01	0.3310	1.14e-02	7.81e-02	1.75e-01	7.20e-02	-1.43e-01	2.17e-01	9.48e-01	6.54e-01	3.14e-01	6.79e-01	4.12e-01	2.13e-01
GOBP DECIDUALIZATION	17	2.26e-01	3.45e-01	0.3310	-1.09e-01	2.03e-02	-5.18e-02	-7.09e-03	1.75e-01	-2.53e-01	4.35e-01	8.85e-01	7.11e-01	9.60e-01	2.12e-01	7.14e-02
GOBP CARDIAC MUSCLE CONTRACTION	97	8.96e-04	4.63e-03	0.3310	-4.85e-02	8.18e-02	2.53e-01	-7.41e-02	-1.10e-01	1.37e-01	4.09e-01	1.64e-01	1.63e-05	2.07e-01	6.18e-02	2.01e-02
GOMF LIPOPOLYSACCHARIDE BINDING	28	9.82e-02	1.93e-01	0.3310	-1.96e-01	-1.31e-01	1.29e-01	-1.71e-01	-1.11e-02	8.97e-02	7.28e-02	2.30e-01	2.39e-01	1.18e-01	9.19e-01	4.11e-01
GOBP FC RECEPTOR SIGNALING PATHWAY	55	3.26e-03	1.39e-02	0.3310	-7.25e-02	2.56e-01	1.13e-01	8.04e-02	9.17e-02	1.03e-01	3.53e-01	1.00e-03	1.47e-01	3.03e-01	2.39e-01	1.86e-01
GOBP PIGMENT METABOLIC PROCESS	58	1.11e-02	3.74e-02	0.3310	-3.54e-02	-2.26e-01	-1.60e-01	1.04e-01	7.75e-02	-1.22e-01	6.41e-01	2.97e-03	3.54e-02	1.70e-01	3.07e-01	1.09e-01
GOMF METALLOAMINOPEPTIDASE ACTIVITY	23	2.39e-01	3.56e-01	0.3310	-2.67e-01	-1.13e-01	-5.30e-02	-1.15e-01	5.67e-02	-7.52e-02	2.64e-02	3.46e-01	6.60e-01	3.39e-01	6.38e-01	5.32e-01
GOBP ONE CARBON COMPOUND TRANSPORT	16	6.57e-01	7.28e-01	0.3310	8.47e-02	2.24e-03	1.70e-01	-6.52e-02	-2.14e-01	1.52e-01	5.57e-01	9.88e-01	2.40e-01	6.51e-01	1.38e-01	2.92e-01
GOBP BINDING OF SPERM TO ZONA PELLUCIDA	20	1.75e-01	2.89e-01	0.3300	-7.88e-02	-2.69e-01	8.65e-02	1.19e-01	-9.04e-02	2.77e-02	5.42e-01	3.72e-02	5.03e-01	3.57e-01	4.84e-01	8.30e-01
GOMF OXYSTEROL BINDING	14	4.21e-01	5.31e-01	0.3300	-2.27e-01	-5.04e-02	-2.97e-03	1.71e-02	-2.27e-01	5.65e-02	1.41e-01	7.44e-01	9.85e-01	9.12e-01	1.41e-01	7.14e-01
GOBP REGULATION OF NADP METABOLIC PROCESS	8	3.47e-01	4.64e-01	0.3300	-5.20e-02	-1.04e-01	1.24e-01	1.55e-01	-1.51e-02	-2.37e-01	7.99e-01	6.11e-01	5.45e-01	4.47e-01	9.41e-01	2.46e-01
GOBP SULFUR AMINO ACID BIOSYNTHETIC PROCESS	13	7.78e-01	8.21e-01	0.3300	-7.02e-02	-2.01e-01	-1.78e-01	-5.55e-02	5.40e-02	-1.61e-01	6.61e-01	2.09e-01	2.67e-01	7.29e-01	7.36e-01	3.14e-01
GOBP REGULATION OF SKELETAL MUSCLE TISSUE DEVELOPMENT	16	4.25e-01	5.34e-01	0.3300	1.76e-01	2.71e-01	8.68e-03	-3.86e-02	-6.77e-03	-5.42e-02	2.23e-01	6.04e-02	9.52e-01	7.89e-01	9.63e-01	7.07e-01
GOBP EPITHELIAL CELL APOPTOTIC PROCESS	104	2.23e-04	1.38e-03	0.3300	-5.48e-02	4.83e-02	2.48e-01	3.02e-02	-8.58e-02	1.84e-01	3.35e-01	3.95e-01	1.24e-05	5.95e-01	1.31e-01	1.18e-03
GOBP REGULATION OF CELL PROLIFERATION INVOLVED IN KIDNEY DEVELOPMENT	11	6.53e-01	7.24e-01	0.3300	1.52e-01	6.59e-02	1.10e-01	-2.10e-01	-1.54e-01	3.72e-02	3.84e-01	7.05e-01	5.28e-01	2.27e-01	3.75e-01	8.31e-01
GOBP CATECHOLAMINE SECRETION	29	3.97e-01	5.09e-01	0.3300	6.65e-02	1.13e-01	2.51e-01	-6.28e-02	-1.09e-01	1.14e-01	5.35e-01	2.93e-01	1.94e-02	5.58e-01	3.09e-01	2.89e-01
GOBP PROTEIN LOCALIZATION TO CHROMOSOME	115	1.11e-07	1.36e-06	0.3300	-4.51e-02	-1.66e-01	-1.71e-02	2.31e-01	-2.61e-02	1.57e-01	4.04e-01	2.09e-03	7.52e-01	1.84e-05	6.28e-01	3.57e-03
GOBP NUCLEAR TRANSCRIBED MRNA POLY A TAIL SHORTENING	32	5.47e-02	1.26e-01	0.3300	-8.33e-02	1.71e-01	-1.79e-02	1.74e-01	1.49e-01	1.40e-01	4.15e-01	9.42e-02	8.61e-01	8.82e-02	1.44e-01	1.69e-01
GOBP NEURON FATE SPECIFICATION	9	5.93e-01	6.76e-01	0.3300	-1.66e-02	-2.18e-01	-2.05e-02	1.34e-01	1.10e-02	-2.06e-01	9.31e-01	2.58e-01	9.15e-01	4.86e-01	9.54e-01	2.84e-01
GOBP MRNA PROCESSING	455	1.04e-24	6.42e-23	0.3300	-1.24e-01	-2.00e-01	-1.94e-01	1.25e-01	1.77e-02	-3.52e-03	6.09e-06	2.43e-13	1.43e-12	5.35e-06	5.17e-01	8.98e-01
GOMF GPI ANCHOR BINDING	5	9.09e-01	9.25e-01	0.3300	1.03e-01	3.84e-02	-1.21e-01	-1.62e-02	2.84e-01	3.43e-02	6.90e-01	8.82e-01	6.40e-01	9.50e-01	2.72e-01	8.94e-01
GOBP RESPONSE TO UV B	19	3.06e-01	4.27e-01	0.3300	2.17e-01	3.57e-02	4.15e-02	2.73e-02	4.22e-02	-2.37e-01	1.01e-01	7.88e-01	7.54e-01	8.37e-01	7.50e-01	7.39e-02
GOBP POSITIVE REGULATION OF EXTRACELLULAR MATRIX ORGANIZATION	25	2.26e-01	3.44e-01	0.3300	-2.35e-02	1.66e-01	1.29e-01	2.07e-01	1.02e-01	1.01e-01	8.39e-01	1.50e-01	2.63e-01	7.27e-02	3.78e-01	3.81e-01
GOMF THIOL OXIDASE ACTIVITY	6	8.27e-01	8.61e-01	0.3300	-2.14e-01	-2.84e-02	1.74e-01	-4.44e-03	-1.78e-01	-1.97e-03	3.63e-01	9.04e-01	4.61e-01	9.85e-01	4.50e-01	9.93e-01
GOMF TELOMERASE RNA BINDING	22	3.22e-01	4.41e-01	0.3300	-1.84e-01	-1.47e-01	-1.66e-01	1.11e-01	9.28e-02	6.89e-02	1.35e-01	2.34e-01	1.79e-01	3.66e-01	4.51e-01	5.76e-01
GOBP CARDIOLIPIN METABOLIC PROCESS	14	6.66e-01	7.34e-01	0.3300	-1.63e-03	-2.26e-01	-1.65e-01	1.65e-01	3.09e-02	-4.33e-02	9.92e-01	1.43e-01	2.84e-01	2.85e-01	8.42e-01	7.79e-01
GOMF ADENYLYLTRANSFERASE ACTIVITY	27	1.34e-01	2.41e-01	0.3300	-1.44e-01	-1.03e-01	-7.46e-02	1.59e-01	1.45e-01	1.59e-01	1.96e-01	3.54e-01	5.02e-01	1.52e-01	1.92e-01	1.52e-01
GOMF NUCLEOTIDE RECEPTOR ACTIVITY	17	4.15e-01	5.25e-01	0.3290	-1.91e-01	2.04e-02	1.44e-01	-1.93e-01	3.41e-02	1.12e-01	1.72e-01	8.84e-01	3.05e-01	1.69e-01	8.08e-01	4.23e-01
GOBP PURINE NUCLEOSIDE BIOSYNTHETIC PROCESS	11	4.63e-01	5.67e-01	0.3290	-4.53e-02	-2.64e-01	-5.79e-02	-1.30e-01	6.19e-02	1.12e-01	7.95e-01	1.29e-01	7.40e-01	4.54e-01	7.22e-01	5.19e-01
GOBP MONOCYTE CHEMOTAXIS	34	4.26e-02	1.04e-01	0.3290	-1.16e-01	-6.04e-02	8.84e-02	-2.63e-01	1.60e-02	1.18e-01	2.41e-01	5.42e-01	3.72e-01	7.96e-03	8.72e-01	2.32e-01
GOBP REGULATION OF MULTICELLULAR ORGANISM GROWTH	46	1.16e-02	3.87e-02	0.3290	-7.37e-02	7.35e-02	4.37e-02	2.41e-01	1.29e-01	1.44e-01	3.87e-01	3.88e-01	6.08e-01	4.62e-03	1.31e-01	9.03e-02
GOBP POTASSIUM ION TRANSPORT	148	3.51e-07	3.94e-06	0.3290	1.37e-02	1.11e-01	2.83e-01	-6.72e-02	-6.47e-02	8.64e-02	7.73e-01	2.03e-02	2.92e-09	1.59e-01	1.74e-01	6.98e-02
GOBP NEGATIVE REGULATION OF MEMBRANE PERMEABILITY	18	6.89e-01	7.53e-01	0.3290	9.19e-03	-9.64e-02	-1.97e-01	-4.07e-02	6.12e-03	-2.42e-01	9.46e-01	4.79e-01	1.49e-01	7.65e-01	9.64e-01	7.51e-02
GOBP PYRIMIDINE RIBONUCLEOSIDE MONOPHOSPHATE METABOLIC PROCESS	14	4.09e-01	5.20e-01	0.3290	-7.58e-02	-2.46e-01	1.19e-02	1.93e-01	-6.56e-02	-1.76e-02	6.24e-01	1.10e-01	9.38e-01	2.12e-01	6.71e-01	9.09e-01
GOBP PURINE DEOXYRIBONUCLEOSIDE MONOPHOSPHATE METABOLIC PROCESS	10	7.59e-01	8.07e-01	0.3290	9.61e-02	-8.95e-02	1.88e-01	1.46e-01	4.27e-02	1.81e-01	5.99e-01	6.24e-01	3.04e-01	4.25e-01	8.15e-01	3.21e-01
GOCC INTEGRATOR COMPLEX	16	5.03e-01	5.99e-01	0.3290	-3.60e-02	2.00e-02	7.74e-02	2.51e-01	1.32e-01	1.42e-01	8.03e-01	8.90e-01	5.92e-01	8.16e-02	3.61e-01	3.27e-01
GOBP POSITIVE REGULATION OF CELL CYCLE G2 M PHASE TRANSITION	29	2.69e-01	3.89e-01	0.3290	-1.53e-01	-2.46e-01	-1.45e-01	4.51e-02	4.15e-03	3.59e-02	1.53e-01	2.18e-02	1.78e-01	6.75e-01	9.69e-01	7.38e-01
GOMF OXIDOREDUCTASE ACTIVITY ACTING ON THE CH NH GROUP OF DONORS	23	6.44e-02	1.42e-01	0.3290	9.81e-02	-2.64e-01	9.50e-04	1.13e-01	9.03e-02	8.85e-02	4.15e-01	2.82e-02	9.94e-01	3.48e-01	4.53e-01	4.63e-01
GOBP INTERLEUKIN 1 MEDIATED SIGNALING PATHWAY	26	3.34e-02	8.70e-02	0.3290	-2.43e-01	5.43e-02	1.19e-01	-1.14e-01	-7.48e-02	-1.16e-01	3.19e-02	6.32e-01	2.92e-01	3.15e-01	5.09e-01	3.07e-01
GOBP ACID SECRETION	28	2.15e-01	3.32e-01	0.3290	-2.38e-02	2.78e-01	1.29e-01	-6.91e-03	8.10e-02	8.58e-02	8.27e-01	1.10e-02	2.37e-01	9.50e-01	4.58e-01	4.32e-01
GOBP MOTOR NEURON APOPTOTIC PROCESS	19	6.41e-01	7.15e-01	0.3290	-7.86e-02	1.41e-02	1.15e-01	-2.39e-01	-1.55e-01	8.56e-02	5.53e-01	9.15e-01	3.84e-01	7.09e-02	2.42e-01	5.18e-01
GOBP GENITALIA DEVELOPMENT	26	3.49e-01	4.65e-01	0.3290	-5.93e-02	-4.04e-02	2.10e-01	-8.62e-02	-4.44e-02	2.23e-01	6.00e-01	7.21e-01	6.37e-02	4.47e-01	6.95e-01	4.95e-02
GOBP NEGATIVE REGULATION OF RESPONSE TO WOUNDING	74	3.90e-03	1.60e-02	0.3290	2.67e-02	4.75e-02	2.76e-01	-4.21e-02	-1.39e-01	8.76e-02	6.92e-01	4.80e-01	3.95e-05	5.32e-01	3.81e-02	1.93e-01
GOBP REGULATED EXOCYTOSIS	176	3.20e-11	6.05e-10	0.3290	-1.02e-01	8.89e-02	2.19e-01	1.06e-01	2.73e-02	1.72e-01	1.95e-02	4.18e-02	5.10e-07	1.50e-02	5.32e-01	8.35e-05
GOMF VOLTAGE GATED CHLORIDE CHANNEL ACTIVITY	8	5.82e-01	6.67e-01	0.3290	-5.49e-02	1.97e-02	1.18e-01	-1.04e-01	-7.77e-02	-2.72e-01	7.88e-01	9.23e-01	5.64e-01	6.11e-01	7.04e-01	1.83e-01
GOBP BODY MORPHOGENESIS	39	1.01e-01	1.96e-01	0.3280	6.05e-02	1.88e-01	2.28e-01	7.89e-02	-7.33e-02	7.29e-02	5.13e-01	4.18e-02	1.39e-02	3.94e-01	4.28e-01	4.31e-01
GOCC METHYLTRANSFERASE COMPLEX	98	7.53e-06	6.57e-05	0.3280	9.81e-03	-1.36e-01	-1.42e-01	2.60e-01	3.98e-03	-3.56e-02	8.67e-01	1.99e-02	1.49e-02	8.64e-06	9.46e-01	5.42e-01
GOBP PROTEIN LOCALIZATION TO CILIUM	62	2.78e-03	1.22e-02	0.3280	-8.23e-02	1.46e-01	-1.53e-01	-1.21e-02	2.36e-01	-1.52e-02	2.62e-01	4.66e-02	3.74e-02	8.70e-01	1.29e-03	8.36e-01
GOBP MYELOID DENDRITIC CELL DIFFERENTIATION	16	7.31e-01	7.85e-01	0.3280	-2.10e-02	7.30e-02	2.31e-01	4.08e-02	-9.03e-02	1.96e-01	8.84e-01	6.13e-01	1.09e-01	7.78e-01	5.32e-01	1.74e-01
GOBP MODULATION BY HOST OF VIRAL GENOME REPLICATION	23	4.71e-01	5.73e-01	0.3280	-2.14e-01	-8.36e-02	7.29e-02	-5.32e-02	-1.05e-01	1.89e-01	7.53e-02	4.88e-01	5.45e-01	6.58e-01	3.83e-01	1.17e-01
GOMF PROTEIN PHOSPHATASE 1 BINDING	23	5.10e-01	6.05e-01	0.3280	7.93e-02	1.23e-01	1.40e-01	1.47e-01	1.84e-01	1.04e-01	5.10e-01	3.06e-01	2.44e-01	2.21e-01	1.27e-01	3.89e-01
GOBP NEGATIVE REGULATION OF CHEMOKINE PRODUCTION	20	2.52e-01	3.71e-01	0.3280	-1.79e-01	-1.98e-02	-6.93e-03	1.57e-01	9.86e-02	2.01e-01	1.65e-01	8.78e-01	9.57e-01	2.25e-01	4.45e-01	1.19e-01
GOBP PROTEIN LOCALIZATION TO CHROMATIN	48	1.55e-02	4.86e-02	0.3280	7.34e-02	-5.43e-02	1.37e-01	2.29e-01	-9.61e-02	1.37e-01	3.79e-01	5.15e-01	1.02e-01	6.07e-03	2.49e-01	9.99e-02
GOBP INTRACELLULAR OXYGEN HOMEOSTASIS	7	8.68e-01	8.93e-01	0.3280	-6.88e-02	2.57e-01	1.62e-01	-5.94e-02	7.96e-02	1.66e-02	7.52e-01	2.38e-01	4.58e-01	7.85e-01	7.15e-01	9.39e-01
GOBP EPITHELIAL CELL DIFFERENTIATION INVOLVED IN PROSTATE GLAND DEVELOPMENT	7	8.77e-01	8.99e-01	0.3280	5.38e-02	1.01e-01	2.01e-01	1.71e-01	1.49e-01	4.83e-02	8.05e-01	6.45e-01	3.57e-01	4.33e-01	4.95e-01	8.25e-01
GOBP RESPONSE TO MANGANESE ION	16	5.47e-01	6.37e-01	0.3280	-1.49e-01	1.01e-01	1.82e-01	-1.79e-01	-9.63e-02	2.40e-02	3.02e-01	4.83e-01	2.09e-01	2.16e-01	5.05e-01	8.68e-01
GOMF KINESIN BINDING	39	1.54e-01	2.65e-01	0.3280	5.86e-02	1.09e-01	1.43e-01	2.05e-01	1.36e-01	1.05e-01	5.27e-01	2.37e-01	1.22e-01	2.70e-02	1.42e-01	2.57e-01
GOBP PYRIMIDINE NUCLEOSIDE CATABOLIC PROCESS	15	6.59e-01	7.29e-01	0.3280	1.22e-01	4.54e-02	1.58e-01	-5.46e-03	-1.08e-01	2.32e-01	4.13e-01	7.61e-01	2.90e-01	9.71e-01	4.69e-01	1.20e-01
GOBP AXO DENDRITIC TRANSPORT	72	5.06e-03	1.98e-02	0.3270	-1.13e-01	4.55e-02	1.45e-01	-9.32e-03	-7.33e-02	2.57e-01	9.75e-02	5.04e-01	3.31e-02	8.91e-01	2.82e-01	1.66e-04
GOBP NEGATIVE REGULATION OF GLYCOPROTEIN METABOLIC PROCESS	13	6.93e-01	7.56e-01	0.3270	-1.08e-02	1.48e-01	2.69e-01	4.74e-02	-2.39e-02	9.92e-02	9.46e-01	3.55e-01	9.27e-02	7.67e-01	8.81e-01	5.36e-01
GOBP NEGATIVE REGULATION OF CELLULAR RESPIRATION	8	6.84e-01	7.49e-01	0.3270	1.09e-01	-4.54e-02	-4.36e-02	-2.87e-01	-7.82e-02	-5.38e-02	5.94e-01	8.24e-01	8.31e-01	1.60e-01	7.02e-01	7.92e-01
GOBP CALCIUM ION TRANSPORT INTO CYTOSOL	17	4.52e-01	5.58e-01	0.3270	1.39e-01	-1.17e-01	1.96e-01	-4.57e-02	-1.37e-01	1.22e-01	3.20e-01	4.05e-01	1.62e-01	7.44e-01	3.28e-01	3.84e-01
GOBP REGULATION OF SIGNALING RECEPTOR ACTIVITY	72	3.75e-03	1.55e-02	0.3270	-1.21e-03	1.09e-01	2.46e-01	-4.51e-02	5.47e-02	1.72e-01	9.86e-01	1.09e-01	3.08e-04	5.08e-01	4.22e-01	1.15e-02
GOBP HIPPO SIGNALING	46	1.47e-03	7.09e-03	0.3270	-1.17e-01	1.99e-01	1.95e-01	1.03e-01	-1.47e-02	7.09e-02	1.71e-01	1.97e-02	2.22e-02	2.27e-01	8.63e-01	4.06e-01
GOBP KINETOCHORE ASSEMBLY	16	4.16e-01	5.26e-01	0.3270	7.11e-02	-2.19e-01	-5.35e-02	1.89e-01	8.33e-02	9.28e-02	6.23e-01	1.30e-01	7.11e-01	1.91e-01	5.64e-01	5.20e-01
GOBP REGULATION OF RECEPTOR BINDING	11	6.96e-01	7.59e-01	0.3270	1.91e-01	1.34e-01	1.06e-01	1.19e-01	-1.10e-01	-1.23e-01	2.73e-01	4.42e-01	5.43e-01	4.96e-01	5.27e-01	4.79e-01
GOBP CELL VOLUME HOMEOSTASIS	31	7.05e-02	1.52e-01	0.3270	5.96e-02	1.59e-01	2.19e-01	1.33e-01	1.09e-01	-2.18e-02	5.66e-01	1.25e-01	3.51e-02	1.99e-01	2.93e-01	8.33e-01
GOBP CHEMOSENSORY BEHAVIOR	13	7.58e-01	8.06e-01	0.3270	1.69e-01	3.31e-02	1.78e-01	8.06e-02	-1.51e-01	1.28e-01	2.92e-01	8.37e-01	2.67e-01	6.15e-01	3.47e-01	4.23e-01
GOMF GROWTH FACTOR RECEPTOR BINDING	90	8.51e-05	5.86e-04	0.3270	-1.53e-01	6.62e-02	2.28e-01	-2.20e-02	-4.56e-02	1.57e-01	1.24e-02	2.78e-01	1.86e-04	7.19e-01	4.55e-01	9.99e-03
GOBP MESENCHYMAL CELL PROLIFERATION	21	6.03e-01	6.83e-01	0.3270	5.40e-03	2.83e-02	2.35e-01	-6.90e-02	-1.83e-01	1.12e-01	9.66e-01	8.22e-01	6.27e-02	5.84e-01	1.46e-01	3.74e-01
GOBP OLEFINIC COMPOUND BIOSYNTHETIC PROCESS	18	5.84e-01	6.69e-01	0.3270	1.63e-01	2.89e-03	1.57e-01	1.79e-01	-8.26e-02	1.29e-01	2.32e-01	9.83e-01	2.49e-01	1.88e-01	5.44e-01	3.42e-01
GOBP POLYOL BIOSYNTHETIC PROCESS	48	2.36e-02	6.71e-02	0.3270	-2.04e-01	-1.91e-01	8.14e-02	-8.38e-04	-6.42e-02	1.34e-01	1.45e-02	2.22e-02	3.29e-01	9.92e-01	4.41e-01	1.08e-01
GOBP TELOMERE MAINTENANCE	154	1.37e-09	2.13e-08	0.3270	-6.38e-02	-1.66e-01	-1.33e-01	2.28e-01	4.12e-02	6.34e-02	1.72e-01	3.92e-04	4.53e-03	1.05e-06	3.77e-01	1.75e-01
GOBP NEUROTRANSMITTER RECEPTOR INTERNALIZATION	26	3.98e-01	5.10e-01	0.3270	1.03e-01	-1.15e-02	2.15e-01	1.29e-01	-3.32e-02	1.79e-01	3.62e-01	9.19e-01	5.76e-02	2.56e-01	7.69e-01	1.15e-01
GOBP CHOLANGIOCYTE PROLIFERATION	5	9.56e-01	9.64e-01	0.3270	-7.83e-02	1.13e-01	-1.00e-01	6.11e-02	2.14e-01	-1.68e-01	7.62e-01	6.61e-01	6.98e-01	8.13e-01	4.08e-01	5.16e-01
GOBP REGULATION OF POSTSYNAPTIC MEMBRANE POTENTIAL	84	4.12e-03	1.67e-02	0.3270	1.01e-01	1.02e-01	1.39e-01	2.27e-01	9.57e-02	7.74e-02	1.10e-01	1.06e-01	2.75e-02	3.23e-04	1.29e-01	2.20e-01
GOCC POSTSYNAPTIC ENDOSOME	12	6.87e-01	7.51e-01	0.3260	-2.25e-01	-1.03e-01	-2.61e-03	4.44e-02	-8.50e-02	1.90e-01	1.77e-01	5.39e-01	9.88e-01	7.90e-01	6.10e-01	2.54e-01
GOBP POSITIVE REGULATION OF MYOBLAST DIFFERENTIATION	33	5.13e-04	2.86e-03	0.3260	-1.39e-01	1.05e-01	8.06e-02	2.20e-01	-1.43e-01	2.88e-02	1.67e-01	2.97e-01	4.23e-01	2.86e-02	1.56e-01	7.75e-01
GOBP POSITIVE REGULATION OF POTASSIUM ION TRANSPORT	29	2.21e-01	3.40e-01	0.3260	1.11e-02	-2.54e-02	1.70e-01	-2.21e-01	-1.12e-01	1.24e-01	9.18e-01	8.13e-01	1.13e-01	3.96e-02	2.95e-01	2.46e-01
GOMF CALCIUM DEPENDENT PHOSPHOLIPID BINDING	38	2.81e-01	4.01e-01	0.3260	-1.61e-01	-1.22e-01	9.82e-02	-1.64e-01	-1.39e-01	9.99e-02	8.64e-02	1.94e-01	2.95e-01	8.02e-02	1.38e-01	2.87e-01
GOBP REGULATION OF CD40 SIGNALING PATHWAY	5	9.43e-01	9.53e-01	0.3260	1.89e-01	6.86e-02	1.33e-02	3.47e-02	-7.66e-02	-2.42e-01	4.63e-01	7.90e-01	9.59e-01	8.93e-01	7.67e-01	3.48e-01
GOBP URETER DEVELOPMENT	7	8.07e-01	8.45e-01	0.3260	-1.46e-02	-5.80e-02	-2.14e-02	-3.15e-01	-4.49e-03	-5.58e-02	9.47e-01	7.90e-01	9.22e-01	1.49e-01	9.84e-01	7.98e-01
GOMF TUMOR NECROSIS FACTOR RECEPTOR BINDING	30	1.10e-01	2.09e-01	0.3260	3.76e-02	3.49e-02	-1.72e-01	-3.87e-02	2.66e-01	-4.28e-02	7.21e-01	7.40e-01	1.03e-01	7.14e-01	1.17e-02	6.85e-01
GOBP POSITIVE REGULATION OF WOUND HEALING	44	1.33e-03	6.47e-03	0.3260	-1.20e-01	-8.44e-02	2.58e-01	-5.93e-02	-1.22e-01	3.87e-03	1.69e-01	3.33e-01	3.09e-03	4.96e-01	1.62e-01	9.65e-01
GOMF FRIZZLED BINDING	25	1.94e-01	3.11e-01	0.3260	8.40e-02	1.90e-01	1.24e-01	9.56e-02	1.45e-01	-1.32e-01	4.67e-01	1.01e-01	2.83e-01	4.08e-01	2.09e-01	2.52e-01
GOMF HISTONE BINDING	226	8.99e-12	1.81e-10	0.3260	1.10e-02	1.22e-02	-7.32e-02	2.67e-01	1.56e-01	7.01e-02	7.77e-01	7.52e-01	5.78e-02	4.54e-12	5.61e-05	6.96e-02
GOMF BH DOMAIN BINDING	10	7.88e-01	8.29e-01	0.3260	1.69e-01	6.84e-02	1.46e-01	-6.46e-02	-2.15e-01	3.48e-02	3.56e-01	7.08e-01	4.25e-01	7.23e-01	2.39e-01	8.49e-01
GOBP POSITIVE REGULATION OF TRANSLATIONAL INITIATION	22	4.20e-01	5.30e-01	0.3260	-2.50e-01	-1.52e-01	3.31e-02	-8.16e-02	-1.12e-01	-7.94e-03	4.22e-02	2.18e-01	7.88e-01	5.08e-01	3.64e-01	9.49e-01
GOBP GASTRIC ACID SECRETION	9	8.31e-01	8.64e-01	0.3250	-7.34e-02	1.82e-01	6.53e-02	4.23e-02	1.38e-01	2.06e-01	7.03e-01	3.44e-01	7.35e-01	8.26e-01	4.75e-01	2.85e-01
GOBP REGULATION OF ESTABLISHMENT OR MAINTENANCE OF CELL POLARITY	23	5.70e-02	1.30e-01	0.3250	-2.63e-01	3.68e-02	4.52e-02	5.47e-02	-1.55e-01	7.98e-02	2.93e-02	7.60e-01	7.07e-01	6.50e-01	1.97e-01	5.07e-01
GOBP MESENCHYME MORPHOGENESIS	31	1.77e-01	2.92e-01	0.3250	-4.41e-02	1.25e-01	1.71e-01	1.50e-01	2.77e-02	1.89e-01	6.71e-01	2.28e-01	9.92e-02	1.48e-01	7.89e-01	6.88e-02
GOCC SEPTIN CYTOSKELETON	15	5.72e-01	6.59e-01	0.3250	-1.70e-01	-2.11e-01	-4.65e-02	2.36e-02	3.89e-02	1.68e-01	2.55e-01	1.57e-01	7.55e-01	8.74e-01	7.94e-01	2.60e-01
GOBP FATTY ACID ELONGATION	13	8.54e-01	8.82e-01	0.3250	-2.16e-01	-1.14e-01	-2.18e-02	-1.30e-01	-1.26e-01	1.15e-01	1.78e-01	4.78e-01	8.92e-01	4.18e-01	4.31e-01	4.75e-01
GOBP ESTABLISHMENT OF MITOCHONDRION LOCALIZATION MICROTUBULE MEDIATED	22	4.32e-01	5.41e-01	0.3250	-2.67e-01	-7.67e-02	5.17e-02	-8.82e-02	-4.31e-02	1.28e-01	3.03e-02	5.33e-01	6.74e-01	4.74e-01	7.26e-01	2.98e-01
GOBP INCLUSION BODY ASSEMBLY	20	1.81e-01	2.96e-01	0.3250	6.98e-02	-4.40e-02	2.67e-01	1.49e-01	-6.71e-02	3.48e-02	5.89e-01	7.33e-01	3.89e-02	2.50e-01	6.04e-01	7.88e-01
GOMF METHYL CPG BINDING	22	2.31e-01	3.49e-01	0.3250	8.80e-02	3.32e-02	-7.60e-02	2.99e-01	1.36e-02	-3.76e-02	4.75e-01	7.88e-01	5.37e-01	1.51e-02	9.12e-01	7.60e-01
GOBP ENDOSOMAL TRANSPORT	270	4.95e-19	1.92e-17	0.3250	-1.85e-01	-8.11e-02	1.01e-01	1.27e-01	-6.02e-02	1.86e-01	1.59e-07	2.18e-02	4.18e-03	3.20e-04	8.86e-02	1.34e-07
GOBP REGULATION OF VASCULATURE DEVELOPMENT	225	9.42e-12	1.89e-10	0.3250	-2.65e-02	1.05e-01	2.64e-01	6.43e-02	-9.36e-03	1.42e-01	4.93e-01	6.72e-03	9.40e-12	9.67e-02	8.09e-01	2.31e-04
GOBP CELL DIFFERENTIATION INVOLVED IN KIDNEY DEVELOPMENT	36	1.29e-01	2.35e-01	0.3250	9.02e-02	2.37e-01	2.00e-01	-2.17e-02	2.73e-03	-2.93e-02	3.49e-01	1.38e-02	3.78e-02	8.22e-01	9.77e-01	7.61e-01
GOBP POSITIVE REGULATION OF AXONOGENESIS	61	1.37e-04	8.97e-04	0.3250	-1.31e-02	1.81e-01	1.26e-01	1.98e-01	1.11e-01	-7.29e-02	8.59e-01	1.47e-02	8.97e-02	7.36e-03	1.32e-01	3.25e-01
GOBP MITOTIC CELL CYCLE CHECKPOINT SIGNALING	141	6.85e-09	9.91e-08	0.3250	-8.06e-03	-1.68e-01	4.62e-03	2.37e-01	1.85e-02	1.43e-01	8.69e-01	5.55e-04	9.24e-01	1.14e-06	7.05e-01	3.34e-03
GOCC NUCLEAR PORE	94	2.07e-05	1.63e-04	0.3250	-2.01e-01	-1.77e-01	-1.09e-01	1.41e-01	1.97e-02	3.79e-02	7.35e-04	3.04e-03	6.73e-02	1.79e-02	7.41e-01	5.25e-01
GOMF DEAMINASE ACTIVITY	29	4.93e-01	5.92e-01	0.3250	1.57e-01	1.16e-01	1.02e-02	1.59e-01	1.94e-01	6.53e-02	1.44e-01	2.80e-01	9.24e-01	1.38e-01	7.03e-02	5.43e-01
GOBP RESPONSE TO LIGHT INTENSITY	12	6.85e-01	7.49e-01	0.3250	1.06e-01	2.31e-01	8.31e-02	-1.57e-01	-2.25e-02	-9.50e-02	5.25e-01	1.66e-01	6.18e-01	3.48e-01	8.93e-01	5.69e-01
GOBP REGULATION OF NUCLEOTIDE EXCISION REPAIR	26	3.17e-02	8.32e-02	0.3250	-3.12e-02	-1.22e-02	1.17e-01	2.59e-01	-1.47e-01	4.00e-02	7.83e-01	9.15e-01	3.01e-01	2.21e-02	1.93e-01	7.24e-01
GOBP METANEPHRIC GLOMERULUS VASCULATURE DEVELOPMENT	6	8.93e-01	9.13e-01	0.3250	5.87e-02	-8.14e-02	-1.21e-01	-2.44e-01	-9.44e-02	-1.10e-01	8.04e-01	7.30e-01	6.08e-01	3.00e-01	6.89e-01	6.40e-01
GOBP REGULATION OF CALCIUM ION DEPENDENT EXOCYTOSIS	23	5.63e-02	1.29e-01	0.3250	-9.26e-02	-3.66e-02	1.71e-01	1.90e-01	1.44e-01	9.61e-02	4.42e-01	7.61e-01	1.55e-01	1.15e-01	2.31e-01	4.25e-01
GOMF ADP BINDING	35	3.40e-03	1.43e-02	0.3250	-2.10e-01	-1.48e-01	3.94e-02	1.19e-01	-1.16e-01	-1.01e-01	3.17e-02	1.30e-01	6.87e-01	2.22e-01	2.36e-01	3.00e-01
GOBP NEGATIVE REGULATION OF OXIDATIVE STRESS INDUCED INTRINSIC APOPTOTIC SIGNALING PATHWAY	26	1.23e-01	2.27e-01	0.3240	-1.33e-01	-1.83e-01	-8.13e-02	1.51e-01	-1.25e-01	-9.63e-02	2.40e-01	1.07e-01	4.73e-01	1.84e-01	2.72e-01	3.95e-01
GOCC SAGA TYPE COMPLEX	37	9.68e-02	1.91e-01	0.3240	-1.94e-01	-1.78e-01	-1.54e-01	1.10e-01	-6.57e-05	-1.68e-02	4.13e-02	6.17e-02	1.04e-01	2.48e-01	9.99e-01	8.60e-01
GOBP SPINDLE ORGANIZATION	192	4.13e-13	9.47e-12	0.3240	-4.19e-02	-1.49e-01	8.51e-02	2.20e-01	1.79e-02	1.59e-01	3.17e-01	3.77e-04	4.20e-02	1.49e-07	6.69e-01	1.43e-04
GOMF ABC TYPE TRANSPORTER ACTIVITY	39	1.31e-01	2.37e-01	0.3240	1.71e-01	1.11e-01	2.08e-01	1.29e-01	-5.95e-02	1.01e-02	6.43e-02	2.30e-01	2.47e-02	1.64e-01	5.20e-01	9.13e-01
GOBP POSITIVE REGULATION OF GLYCOGEN BIOSYNTHETIC PROCESS	11	1.86e-01	3.01e-01	0.3240	-5.31e-02	1.57e-03	1.02e-01	8.10e-02	1.75e-01	-2.33e-01	7.61e-01	9.93e-01	5.58e-01	6.42e-01	3.14e-01	1.80e-01
GOBP CELLULAR METABOLIC COMPOUND SALVAGE	28	1.18e-01	2.20e-01	0.3240	-8.52e-02	-2.89e-01	-8.85e-02	1.79e-02	4.31e-02	-6.61e-02	4.35e-01	8.17e-03	4.18e-01	8.70e-01	6.93e-01	5.45e-01
GOBP PROTEIN LOCALIZATION TO CELL CELL JUNCTION	20	2.21e-01	3.39e-01	0.3240	-2.43e-01	-8.40e-03	6.18e-02	2.23e-02	-1.76e-01	1.03e-01	6.01e-02	9.48e-01	6.32e-01	8.63e-01	1.73e-01	4.26e-01
GOBP PROTEIN TARGETING	298	6.33e-15	1.68e-13	0.3240	-1.86e-01	-2.13e-01	-2.13e-02	4.57e-02	-9.07e-02	1.19e-01	3.33e-08	2.58e-10	5.27e-01	1.75e-01	7.08e-03	4.03e-04
GOBP CELLULAR RESPONSE TO MINERALOCORTICOID STIMULUS	10	9.73e-02	1.92e-01	0.3240	-5.58e-03	-8.90e-02	2.29e-01	3.33e-03	9.98e-02	-1.85e-01	9.76e-01	6.26e-01	2.10e-01	9.85e-01	5.85e-01	3.10e-01
GOMF TYPE I TRANSFORMING GROWTH FACTOR BETA RECEPTOR BINDING	10	7.73e-01	8.17e-01	0.3240	-1.76e-01	4.93e-02	2.12e-01	-2.64e-02	-2.34e-02	1.58e-01	3.35e-01	7.87e-01	2.46e-01	8.85e-01	8.98e-01	3.86e-01
GOMF GAMMA TUBULIN BINDING	33	2.80e-02	7.62e-02	0.3240	-1.02e-01	1.69e-01	7.19e-03	1.21e-01	1.95e-01	-1.14e-01	3.11e-01	9.31e-02	9.43e-01	2.29e-01	5.20e-02	2.59e-01
GOBP CHAPERONE COFACTOR DEPENDENT PROTEIN REFOLDING	32	4.32e-02	1.05e-01	0.3240	-1.37e-01	-1.70e-01	7.77e-02	1.84e-01	-3.00e-02	1.28e-01	1.81e-01	9.56e-02	4.47e-01	7.14e-02	7.69e-01	2.12e-01
GOBP ANTERIOR POSTERIOR AXIS SPECIFICATION	30	2.91e-01	4.10e-01	0.3240	-6.08e-02	1.36e-01	1.80e-01	3.99e-02	2.93e-02	2.19e-01	5.65e-01	1.98e-01	8.88e-02	7.05e-01	7.81e-01	3.79e-02
GOBP POSITIVE REGULATION OF DEFENSE RESPONSE TO VIRUS BY HOST	27	3.72e-01	4.87e-01	0.3240	3.90e-02	5.05e-02	9.60e-02	1.77e-01	1.32e-01	2.06e-01	7.26e-01	6.50e-01	3.88e-01	1.11e-01	2.35e-01	6.35e-02
GOBP BONE REMODELING	63	3.67e-03	1.52e-02	0.3240	-6.78e-02	1.19e-01	2.47e-01	6.07e-02	-4.80e-02	1.37e-01	3.52e-01	1.04e-01	6.81e-04	4.05e-01	5.10e-01	5.98e-02
GOBP TELOMERE ORGANIZATION	168	9.65e-11	1.74e-09	0.3230	-7.46e-02	-1.81e-01	-9.43e-02	2.24e-01	1.48e-02	8.36e-02	9.53e-02	5.33e-05	3.50e-02	5.28e-07	7.41e-01	6.15e-02
GOBP NEURON REMODELING	9	7.28e-01	7.83e-01	0.3230	-6.41e-02	-1.14e-01	-8.23e-02	-8.69e-03	8.48e-02	-2.71e-01	7.39e-01	5.53e-01	6.69e-01	9.64e-01	6.59e-01	1.59e-01
GOBP VENTRICULAR SEPTUM MORPHOGENESIS	30	3.13e-01	4.33e-01	0.3230	1.97e-02	1.71e-01	2.10e-01	1.08e-01	1.57e-02	1.38e-01	8.52e-01	1.05e-01	4.70e-02	3.06e-01	8.82e-01	1.90e-01
GOBP REGULATION OF MEMBRANE LIPID METABOLIC PROCESS	14	8.35e-01	8.67e-01	0.3230	-1.98e-01	-1.54e-01	-1.44e-01	-7.87e-02	-6.36e-03	-1.20e-01	1.99e-01	3.19e-01	3.51e-01	6.10e-01	9.67e-01	4.36e-01
GOBP POSITIVE REGULATION BY HOST OF VIRAL TRANSCRIPTION	16	3.09e-01	4.30e-01	0.3230	-1.09e-01	3.53e-02	9.37e-02	2.48e-01	1.16e-01	8.77e-02	4.51e-01	8.07e-01	5.17e-01	8.62e-02	4.22e-01	5.44e-01
GOBP NOREPINEPHRINE METABOLIC PROCESS	8	8.48e-01	8.76e-01	0.3230	1.18e-01	1.96e-01	9.95e-02	1.05e-01	-5.49e-02	1.67e-01	5.62e-01	3.36e-01	6.26e-01	6.06e-01	7.88e-01	4.14e-01
GOBP DNA SYNTHESIS INVOLVED IN DNA REPAIR	40	5.00e-02	1.17e-01	0.3230	-9.19e-02	-2.10e-01	-1.22e-01	1.63e-01	7.72e-02	6.74e-02	3.14e-01	2.18e-02	1.82e-01	7.45e-02	3.98e-01	4.61e-01
GOBP VENTRICULAR CARDIAC MUSCLE TISSUE DEVELOPMENT	37	1.93e-01	3.09e-01	0.3230	2.72e-02	1.84e-01	1.42e-01	1.33e-01	5.56e-02	1.70e-01	7.75e-01	5.29e-02	1.35e-01	1.61e-01	5.58e-01	7.38e-02
GOMF MRNA 3 UTR BINDING	89	4.91e-03	1.94e-02	0.3230	-1.90e-01	-1.15e-01	-1.89e-01	-6.64e-02	-8.16e-02	-9.10e-02	1.94e-03	6.15e-02	2.08e-03	2.79e-01	1.84e-01	1.38e-01
GOBP AMYLOID PRECURSOR PROTEIN CATABOLIC PROCESS	52	2.01e-03	9.22e-03	0.3230	-1.97e-01	-5.52e-02	1.66e-01	1.63e-02	-1.81e-01	4.39e-02	1.40e-02	4.91e-01	3.87e-02	8.39e-01	2.40e-02	5.84e-01
GOBP T CELL RECEPTOR SIGNALING PATHWAY	139	3.06e-05	2.33e-04	0.3230	8.61e-02	1.34e-01	1.48e-05	2.28e-01	1.44e-01	7.76e-02	7.98e-02	6.20e-03	1.00e+00	3.50e-06	3.34e-03	1.14e-01
GOBP POSITIVE REGULATION OF NEUROTRANSMITTER TRANSPORT	18	2.42e-01	3.60e-01	0.3230	4.88e-02	3.25e-02	1.79e-01	5.78e-02	2.26e-01	1.18e-01	7.20e-01	8.11e-01	1.87e-01	6.71e-01	9.64e-02	3.87e-01
GOBP CELL ACTIVATION INVOLVED IN IMMUNE RESPONSE	264	1.83e-11	3.58e-10	0.3230	8.40e-03	1.37e-01	1.90e-01	1.40e-01	4.46e-02	1.66e-01	8.14e-01	1.25e-04	1.04e-07	9.04e-05	2.12e-01	3.56e-06
GOBP REGULATION OF RECEPTOR SIGNALING PATHWAY VIA STAT	66	1.70e-02	5.22e-02	0.3230	2.85e-02	1.53e-01	1.83e-01	-1.78e-02	1.09e-01	1.85e-01	6.89e-01	3.18e-02	1.01e-02	8.03e-01	1.27e-01	9.30e-03
GOBP NEGATIVE REGULATION OF AXON EXTENSION	25	5.04e-01	5.99e-01	0.3230	8.43e-02	2.01e-01	1.93e-01	7.38e-02	9.97e-02	6.25e-02	4.66e-01	8.19e-02	9.48e-02	5.23e-01	3.88e-01	5.89e-01
GOBP SALIVA SECRETION	6	9.22e-01	9.34e-01	0.3220	2.92e-02	2.66e-01	4.53e-02	-1.44e-01	9.69e-02	8.69e-03	9.01e-01	2.59e-01	8.48e-01	5.41e-01	6.81e-01	9.71e-01
GOMF SOLUTE MONOATOMIC CATION SYMPORTER ACTIVITY	76	6.44e-03	2.41e-02	0.3220	1.22e-01	1.73e-01	1.96e-01	1.41e-01	-2.42e-03	2.82e-02	6.61e-02	8.96e-03	3.11e-03	3.42e-02	9.71e-01	6.71e-01
GOBP AMP METABOLIC PROCESS	21	1.07e-01	2.05e-01	0.3220	-8.93e-02	-2.48e-01	-6.79e-02	-3.84e-02	1.58e-01	5.74e-02	4.79e-01	4.91e-02	5.90e-01	7.61e-01	2.09e-01	6.49e-01
GOBP DIACYLGLYCEROL BIOSYNTHETIC PROCESS	7	8.10e-01	8.47e-01	0.3220	9.67e-02	1.35e-01	1.77e-01	1.57e-01	5.53e-02	-1.32e-01	6.58e-01	5.37e-01	4.17e-01	4.73e-01	8.00e-01	5.46e-01
GOCC PARANODE REGION OF AXON	10	6.75e-01	7.41e-01	0.3220	2.58e-01	1.81e-02	3.57e-02	-3.33e-02	-1.69e-01	-7.98e-02	1.58e-01	9.21e-01	8.45e-01	8.55e-01	3.56e-01	6.62e-01
GOBP INNER EAR MORPHOGENESIS	58	6.18e-02	1.38e-01	0.3220	9.17e-02	1.91e-01	-6.79e-02	5.38e-02	2.08e-01	-8.96e-02	2.27e-01	1.17e-02	3.71e-01	4.78e-01	6.14e-03	2.38e-01
GOBP REGULATION OF EXTRACELLULAR MATRIX ORGANIZATION	53	5.17e-02	1.20e-01	0.3220	4.17e-02	1.95e-01	1.92e-01	9.78e-02	1.05e-01	8.06e-02	5.99e-01	1.40e-02	1.54e-02	2.18e-01	1.88e-01	3.10e-01
GOMF PROTEIN MEMBRANE ADAPTOR ACTIVITY	37	8.43e-02	1.73e-01	0.3220	-1.50e-02	1.25e-01	1.82e-01	1.87e-01	6.61e-02	1.25e-01	8.74e-01	1.89e-01	5.55e-02	4.96e-02	4.87e-01	1.87e-01
GOBP HEART FORMATION	19	3.18e-01	4.37e-01	0.3220	-1.40e-01	1.35e-01	2.30e-01	-1.79e-02	2.34e-02	1.11e-01	2.90e-01	3.09e-01	8.29e-02	8.93e-01	8.60e-01	4.02e-01
GOBP L ALPHA AMINO ACID TRANSMEMBRANE TRANSPORT	52	1.84e-02	5.53e-02	0.3220	-1.30e-01	-2.05e-01	-5.27e-02	6.70e-02	-1.93e-01	-2.13e-03	1.04e-01	1.05e-02	5.11e-01	4.04e-01	1.58e-02	9.79e-01
GOBP NEGATIVE REGULATION OF SIGNALING RECEPTOR ACTIVITY	22	4.65e-01	5.69e-01	0.3220	-1.72e-01	7.32e-02	1.42e-01	-1.22e-01	-2.81e-02	1.82e-01	1.63e-01	5.52e-01	2.50e-01	3.23e-01	8.19e-01	1.40e-01
GOBP REGULATION OF HEMATOPOIETIC STEM CELL DIFFERENTIATION	15	2.33e-01	3.51e-01	0.3220	-8.73e-02	2.12e-01	1.59e-01	1.73e-02	-1.49e-01	-5.68e-02	5.58e-01	1.55e-01	2.86e-01	9.08e-01	3.17e-01	7.03e-01
GOBP NEUTROPHIL MEDIATED IMMUNITY	32	1.63e-02	5.04e-02	0.3220	-1.19e-01	6.19e-03	2.63e-01	7.09e-02	-1.12e-01	5.17e-02	2.43e-01	9.52e-01	1.00e-02	4.88e-01	2.73e-01	6.13e-01
GOBP REGULATION OF OXIDATIVE STRESS INDUCED INTRINSIC APOPTOTIC SIGNALING PATHWAY	35	3.59e-02	9.19e-02	0.3220	-1.77e-01	-1.87e-01	-6.25e-03	1.18e-01	-1.52e-01	-1.77e-02	6.94e-02	5.56e-02	9.49e-01	2.29e-01	1.20e-01	8.56e-01
GOBP NEGATIVE REGULATION OF CELL DEVELOPMENT	185	1.86e-08	2.53e-07	0.3220	3.12e-02	1.51e-01	2.60e-01	3.57e-02	-6.12e-02	8.38e-02	4.64e-01	3.85e-04	1.01e-09	4.02e-01	1.51e-01	4.94e-02
GOBP CELL PROLIFERATION IN FOREBRAIN	16	5.72e-01	6.59e-01	0.3220	2.72e-02	2.19e-01	1.26e-01	-2.75e-02	-3.14e-02	1.93e-01	8.51e-01	1.29e-01	3.83e-01	8.49e-01	8.28e-01	1.82e-01
GOMF EXONUCLEASE ACTIVITY	87	1.39e-03	6.75e-03	0.3220	-8.28e-02	-1.28e-01	-2.15e-01	1.14e-01	1.44e-01	-2.17e-02	1.82e-01	3.96e-02	5.21e-04	6.69e-02	2.01e-02	7.27e-01
GOBP REGULATION OF CHROMATIN BINDING	10	8.34e-01	8.66e-01	0.3220	5.79e-02	4.89e-02	1.29e-01	2.60e-01	6.91e-02	9.45e-02	7.51e-01	7.89e-01	4.78e-01	1.55e-01	7.05e-01	6.05e-01
GOBP DIGESTIVE SYSTEM DEVELOPMENT	77	5.72e-04	3.15e-03	0.3220	-7.34e-02	1.34e-01	2.53e-01	-6.86e-02	7.33e-03	1.06e-01	2.65e-01	4.18e-02	1.21e-04	2.98e-01	9.11e-01	1.08e-01
GOBP POSITIVE REGULATION OF PROTEIN KINASE C SIGNALING	7	5.95e-01	6.77e-01	0.3220	7.21e-02	-1.45e-01	2.55e-01	1.11e-01	1.15e-02	7.75e-03	7.41e-01	5.07e-01	2.43e-01	6.12e-01	9.58e-01	9.72e-01
GOBP EXCRETION	13	3.17e-01	4.37e-01	0.3220	6.50e-02	-4.78e-03	1.44e-01	2.22e-01	1.33e-01	-1.07e-01	6.85e-01	9.76e-01	3.67e-01	1.66e-01	4.05e-01	5.06e-01
GOBP CELLULAR RESPONSE TO GLUCOCORTICOID STIMULUS	39	1.45e-01	2.55e-01	0.3220	-2.04e-01	-1.27e-01	1.01e-01	-1.26e-01	-1.36e-01	3.13e-02	2.73e-02	1.70e-01	2.74e-01	1.73e-01	1.41e-01	7.35e-01
GOBP REGULATION OF NUCLEAR TRANSCRIBED MRNA POLY A TAIL SHORTENING	15	2.66e-01	3.86e-01	0.3220	-1.90e-01	2.51e-01	3.13e-02	1.46e-02	5.09e-02	2.53e-02	2.02e-01	9.28e-02	8.34e-01	9.22e-01	7.33e-01	8.65e-01
GOBP ENDOCYTIC RECYCLING	79	9.07e-06	7.70e-05	0.3220	-1.17e-01	2.94e-02	1.85e-01	1.85e-01	2.01e-02	1.42e-01	7.30e-02	6.52e-01	4.51e-03	4.51e-03	7.58e-01	2.88e-02
GOBP CHONDROCYTE PROLIFERATION	15	1.60e-01	2.73e-01	0.3220	-1.15e-01	1.99e-01	1.07e-01	7.30e-02	-1.79e-01	4.42e-02	4.41e-01	1.82e-01	4.75e-01	6.24e-01	2.31e-01	7.67e-01
GOMF HISTONE ACETYLTRANSFERASE BINDING	22	3.77e-01	4.92e-01	0.3220	-1.35e-01	-5.66e-02	5.78e-02	3.44e-03	-1.30e-01	2.48e-01	2.73e-01	6.46e-01	6.39e-01	9.78e-01	2.91e-01	4.38e-02
GOBP REGULATION OF MICROGLIAL CELL ACTIVATION	14	6.69e-01	7.37e-01	0.3210	-3.00e-02	1.37e-01	1.93e-01	7.76e-02	1.43e-01	1.43e-01	8.46e-01	3.76e-01	2.12e-01	6.15e-01	3.56e-01	3.56e-01
GOBP CELLULAR RESPONSE TO FATTY ACID	24	2.31e-02	6.61e-02	0.3210	-1.29e-03	1.17e-01	1.61e-01	-2.25e-02	2.29e-01	-1.02e-01	9.91e-01	3.19e-01	1.71e-01	8.48e-01	5.20e-02	3.87e-01
GOBP FATTY ACID CATABOLIC PROCESS	96	1.85e-04	1.17e-03	0.3210	-7.66e-02	-2.31e-01	-1.66e-01	7.91e-02	9.57e-02	-3.22e-02	1.95e-01	9.01e-05	5.04e-03	1.80e-01	1.05e-01	5.86e-01
GOMF DNA ENDONUCLEASE ACTIVITY	41	3.77e-02	9.54e-02	0.3210	2.16e-02	-1.21e-01	-1.55e-01	8.91e-02	2.37e-01	-6.12e-03	8.11e-01	1.82e-01	8.53e-02	3.24e-01	8.67e-03	9.46e-01
GOMF ENDODEOXYRIBONUCLEASE ACTIVITY PRODUCING 5 PHOSPHOMONOESTERS	14	7.23e-01	7.80e-01	0.3210	1.94e-01	-3.62e-02	3.56e-02	2.37e-01	7.35e-02	-3.66e-02	2.09e-01	8.14e-01	8.18e-01	1.24e-01	6.34e-01	8.13e-01
GOBP SOMITOGENESIS	38	1.97e-01	3.13e-01	0.3210	1.34e-01	1.80e-01	5.39e-02	1.91e-01	6.96e-02	9.18e-02	1.53e-01	5.46e-02	5.66e-01	4.12e-02	4.58e-01	3.27e-01
GOMF FLAP ENDONUCLEASE ACTIVITY	8	8.56e-01	8.83e-01	0.3210	1.69e-01	-5.35e-02	-4.64e-02	2.24e-01	-5.61e-02	-1.28e-01	4.09e-01	7.93e-01	8.20e-01	2.73e-01	7.83e-01	5.29e-01
GOBP POSITIVE REGULATION OF T CELL MIGRATION	29	1.44e-01	2.54e-01	0.3210	-7.43e-02	-1.07e-01	4.49e-02	1.87e-01	4.96e-02	2.16e-01	4.89e-01	3.19e-01	6.76e-01	8.16e-02	6.44e-01	4.38e-02
GOMF OXIDOREDUCTASE ACTIVITY ACTING ON CH OH GROUP OF DONORS	105	1.02e-03	5.17e-03	0.3210	-1.67e-01	-1.92e-01	-1.88e-01	3.33e-02	-9.39e-03	-4.60e-02	3.15e-03	6.91e-04	8.92e-04	5.56e-01	8.68e-01	4.16e-01
GOBP DOPAMINE METABOLIC PROCESS	24	4.45e-02	1.08e-01	0.3210	-1.31e-01	1.82e-03	1.81e-01	1.65e-01	1.30e-01	9.38e-02	2.66e-01	9.88e-01	1.25e-01	1.61e-01	2.71e-01	4.26e-01
GOBP REGULATION OF CELL FATE COMMITMENT	29	2.24e-01	3.43e-01	0.3210	8.27e-02	1.08e-01	4.94e-02	2.71e-01	8.62e-02	-3.07e-02	4.41e-01	3.14e-01	6.45e-01	1.14e-02	4.22e-01	7.75e-01
GOBP RESPONSE TO ACID CHEMICAL	103	2.77e-05	2.14e-04	0.3210	-6.90e-02	5.85e-02	2.13e-01	1.05e-01	5.26e-02	1.88e-01	2.26e-01	3.05e-01	1.85e-04	6.48e-02	3.57e-01	9.56e-04
GOBP KERATINOCYTE DIFFERENTIATION	87	7.52e-05	5.27e-04	0.3210	-1.39e-01	6.27e-02	2.37e-01	-1.20e-04	-9.24e-02	1.23e-01	2.49e-02	3.12e-01	1.36e-04	9.98e-01	1.36e-01	4.74e-02
GOBP PODOCYTE CELL MIGRATION	7	8.71e-01	8.95e-01	0.3210	-1.52e-01	-1.92e-01	-5.82e-02	2.20e-02	-6.03e-02	-1.89e-01	4.87e-01	3.80e-01	7.90e-01	9.20e-01	7.82e-01	3.87e-01
GOBP SKELETAL MUSCLE CONTRACTION	33	3.60e-01	4.76e-01	0.3210	1.93e-01	1.48e-01	1.64e-01	4.93e-02	9.94e-02	6.70e-02	5.51e-02	1.42e-01	1.02e-01	6.24e-01	3.23e-01	5.05e-01
GOBP EMBRYONIC HEART TUBE DEVELOPMENT	52	5.97e-04	3.27e-03	0.3210	-1.21e-01	1.18e-01	1.42e-01	1.16e-01	1.92e-01	6.04e-02	1.32e-01	1.40e-01	7.66e-02	1.48e-01	1.65e-02	4.51e-01
GOBP REGULATION OF MEIOTIC NUCLEAR DIVISION	18	3.96e-01	5.09e-01	0.3210	3.54e-03	-9.96e-02	5.73e-02	1.10e-01	-1.61e-01	2.27e-01	9.79e-01	4.65e-01	6.74e-01	4.17e-01	2.37e-01	9.60e-02
GOBP PANCREAS DEVELOPMENT	42	9.07e-02	1.82e-01	0.3200	-1.86e-01	-5.13e-02	1.47e-01	-8.64e-02	-1.83e-01	5.53e-02	3.67e-02	5.65e-01	1.00e-01	3.33e-01	4.06e-02	5.35e-01
GOBP REGULATION OF DNA TEMPLATED TRANSCRIPTION ELONGATION	98	1.72e-05	1.38e-04	0.3200	6.06e-02	-6.05e-02	-3.77e-02	3.04e-01	3.48e-02	2.21e-03	3.00e-01	3.01e-01	5.19e-01	1.89e-07	5.52e-01	9.70e-01
GOBP SELF PROTEOLYSIS	9	8.96e-01	9.14e-01	0.3200	4.52e-02	2.58e-01	1.28e-02	1.05e-01	1.50e-01	-1.53e-02	8.14e-01	1.80e-01	9.47e-01	5.85e-01	4.36e-01	9.37e-01
GOCC CELL SUBSTRATE JUNCTION	395	5.66e-22	2.80e-20	0.3200	-1.49e-01	-1.48e-01	1.39e-01	4.55e-02	-1.15e-01	1.55e-01	3.87e-07	4.68e-07	2.00e-06	1.21e-01	9.37e-05	1.31e-07
GOBP LEUKOCYTE MIGRATION	309	6.96e-16	2.02e-14	0.3200	-2.17e-02	5.39e-02	2.56e-01	8.63e-02	-3.47e-02	1.57e-01	5.12e-01	1.04e-01	8.79e-15	9.12e-03	2.94e-01	2.12e-06
GOBP REGULATION OF GLYCOGEN METABOLIC PROCESS	26	2.87e-01	4.06e-01	0.3200	1.28e-01	4.39e-02	5.89e-02	1.91e-01	1.97e-01	-7.29e-02	2.60e-01	6.98e-01	6.03e-01	9.13e-02	8.22e-02	5.20e-01
GOBP CHONDROITIN SULFATE PROTEOGLYCAN BIOSYNTHETIC PROCESS	21	4.38e-02	1.06e-01	0.3200	-9.63e-02	9.84e-03	1.36e-01	1.21e-01	-2.25e-01	-9.71e-02	4.45e-01	9.38e-01	2.82e-01	3.37e-01	7.47e-02	4.41e-01
GOBP POSITIVE REGULATION OF MYELOID LEUKOCYTE MEDIATED IMMUNITY	20	1.42e-01	2.52e-01	0.3200	-1.90e-01	1.74e-02	2.27e-01	1.46e-02	3.77e-02	1.13e-01	1.42e-01	8.93e-01	7.84e-02	9.10e-01	7.71e-01	3.81e-01
GOBP AMINE TRANSPORT	56	3.91e-02	9.79e-02	0.3200	-8.58e-02	2.61e-02	2.27e-01	-3.53e-02	-1.55e-01	1.32e-01	2.66e-01	7.36e-01	3.30e-03	6.48e-01	4.50e-02	8.70e-02
GOBP NEGATIVE REGULATION OF CENTRIOLE REPLICATION	7	8.68e-01	8.93e-01	0.3200	1.31e-01	1.51e-01	-8.39e-02	1.12e-01	1.57e-01	1.34e-01	5.49e-01	4.89e-01	7.01e-01	6.06e-01	4.72e-01	5.38e-01
GOMF POLY PURINE TRACT BINDING	26	4.29e-02	1.05e-01	0.3200	-2.36e-01	3.11e-02	-1.85e-01	-4.06e-02	-9.42e-02	3.00e-02	3.76e-02	7.84e-01	1.02e-01	7.20e-01	4.06e-01	7.91e-01
GOCC DNA REPAIR COMPLEX	22	2.37e-01	3.55e-01	0.3200	-1.14e-01	-3.33e-02	-4.98e-02	1.88e-01	1.02e-01	1.99e-01	3.55e-01	7.87e-01	6.86e-01	1.26e-01	4.07e-01	1.06e-01
GOBP PROTEIN LOCALIZATION TO AXON	8	9.11e-01	9.26e-01	0.3200	2.87e-01	8.26e-02	4.18e-02	9.90e-02	3.28e-02	6.47e-03	1.59e-01	6.86e-01	8.38e-01	6.28e-01	8.72e-01	9.75e-01
GOBP ENGULFMENT OF APOPTOTIC CELL	11	2.27e-01	3.46e-01	0.3200	1.25e-04	4.69e-02	2.97e-01	2.29e-02	2.76e-02	-1.02e-01	9.99e-01	7.88e-01	8.79e-02	8.95e-01	8.74e-01	5.59e-01
GOBP DNA CATABOLIC PROCESS	27	1.68e-01	2.81e-01	0.3190	-4.61e-02	-2.22e-01	-8.52e-02	1.97e-01	5.76e-02	-3.49e-02	6.78e-01	4.55e-02	4.43e-01	7.69e-02	6.05e-01	7.54e-01
GOBP DISRUPTION OF ANATOMICAL STRUCTURE IN ANOTHER ORGANISM	54	2.00e-02	5.92e-02	0.3190	1.75e-01	-6.30e-02	1.61e-01	9.25e-02	-1.34e-01	1.22e-01	2.63e-02	4.23e-01	4.04e-02	2.40e-01	8.83e-02	1.21e-01
GOBP REGULATION OF CHOLESTEROL METABOLIC PROCESS	26	1.11e-01	2.11e-01	0.3190	-4.21e-02	-1.65e-01	5.35e-02	2.45e-01	4.02e-02	9.04e-02	7.10e-01	1.45e-01	6.37e-01	3.03e-02	7.23e-01	4.25e-01
GOBP REGULATION OF MAMMARY GLAND EPITHELIAL CELL PROLIFERATION	14	6.35e-01	7.11e-01	0.3190	1.19e-01	-3.90e-02	9.89e-02	2.73e-01	-3.51e-03	4.17e-02	4.42e-01	8.01e-01	5.22e-01	7.66e-02	9.82e-01	7.87e-01
GOBP POSITIVE REGULATION OF INFLAMMATORY RESPONSE	119	3.54e-05	2.67e-04	0.3190	-8.93e-02	1.01e-01	2.13e-01	-7.15e-02	2.16e-02	1.81e-01	9.25e-02	5.67e-02	6.07e-05	1.78e-01	6.85e-01	6.45e-04
GOCC SECRETORY VESICLE	844	5.34e-43	1.05e-40	0.3190	-1.71e-01	-7.15e-02	1.63e-01	-4.81e-03	-1.11e-01	1.69e-01	2.84e-17	4.21e-04	1.07e-15	8.12e-01	4.45e-08	6.89e-17
GOCC CONDENSED CHROMOSOME	259	1.41e-16	4.40e-15	0.3190	-7.05e-02	-1.52e-01	3.76e-03	1.69e-01	-4.43e-02	2.07e-01	5.07e-02	2.46e-05	9.17e-01	2.73e-06	2.19e-01	9.02e-09
GOBP REGULATION OF CAMP MEDIATED SIGNALING	14	8.39e-01	8.70e-01	0.3190	2.18e-01	1.20e-01	1.13e-01	1.49e-01	6.44e-03	6.66e-02	1.58e-01	4.35e-01	4.63e-01	3.33e-01	9.67e-01	6.66e-01
GOBP WNT SIGNALING PATHWAY PLANAR CELL POLARITY PATHWAY	38	2.78e-01	3.98e-01	0.3190	1.58e-01	1.07e-01	1.85e-01	1.61e-01	2.91e-02	6.41e-02	9.14e-02	2.56e-01	4.82e-02	8.52e-02	7.56e-01	4.94e-01
GOMF N ACETYLTRANSFERASE ACTIVITY	61	1.06e-04	7.14e-04	0.3190	-7.61e-02	4.59e-02	-1.51e-01	2.33e-01	2.00e-02	-1.28e-01	3.04e-01	5.35e-01	4.14e-02	1.67e-03	7.88e-01	8.35e-02
GOBP REGULATION OF AXON EXTENSION	63	2.37e-04	1.46e-03	0.3190	-2.89e-02	1.93e-01	1.47e-01	1.79e-01	9.65e-02	-2.04e-02	6.91e-01	8.10e-03	4.35e-02	1.38e-02	1.85e-01	7.80e-01
GOBP REGULATION OF PLASMA LIPOPROTEIN PARTICLE LEVELS	54	3.83e-05	2.87e-04	0.3190	-6.74e-02	6.45e-02	2.66e-01	1.37e-01	4.60e-02	3.25e-02	3.92e-01	4.12e-01	7.10e-04	8.16e-02	5.59e-01	6.80e-01
GOBP REGULATION OF RUFFLE ASSEMBLY	28	2.78e-02	7.58e-02	0.3190	-3.60e-02	-1.93e-01	-7.07e-03	1.50e-01	-3.22e-03	-2.01e-01	7.42e-01	7.67e-02	9.48e-01	1.68e-01	9.76e-01	6.63e-02
GOBP 2 OXOGLUTARATE METABOLIC PROCESS	14	4.21e-01	5.30e-01	0.3190	-4.73e-02	-2.03e-01	-1.35e-01	1.63e-04	1.63e-01	1.16e-01	7.60e-01	1.89e-01	3.83e-01	9.99e-01	2.90e-01	4.54e-01
GOBP TERTIARY ALCOHOL METABOLIC PROCESS	13	7.10e-01	7.70e-01	0.3180	7.98e-03	4.23e-03	-1.52e-01	2.30e-01	1.51e-01	4.76e-02	9.60e-01	9.79e-01	3.41e-01	1.50e-01	3.47e-01	7.66e-01
GOBP FORMATION OF PRIMARY GERM LAYER	91	3.58e-05	2.69e-04	0.3180	-5.60e-02	5.42e-02	2.81e-01	3.18e-02	-6.21e-02	1.08e-01	3.56e-01	3.72e-01	3.67e-06	6.01e-01	3.06e-01	7.56e-02
GOBP PYRIMIDINE CONTAINING COMPOUND TRANSMEMBRANE TRANSPORT	13	8.86e-01	9.07e-01	0.3180	-1.49e-01	-1.65e-01	3.71e-02	-1.30e-01	-1.41e-01	1.16e-01	3.52e-01	3.02e-01	8.17e-01	4.15e-01	3.79e-01	4.68e-01
GOBP REGULATION OF SODIUM ION TRANSMEMBRANE TRANSPORT	43	1.63e-01	2.76e-01	0.3180	-3.93e-02	3.91e-02	2.35e-01	-1.26e-03	-1.25e-01	1.66e-01	6.55e-01	6.57e-01	7.69e-03	9.89e-01	1.57e-01	5.97e-02
GOBP REGULATION OF MONOCYTE CHEMOTAXIS	21	2.70e-01	3.89e-01	0.3180	-1.55e-01	-6.98e-03	3.90e-02	-1.86e-01	9.50e-02	1.80e-01	2.20e-01	9.56e-01	7.57e-01	1.41e-01	4.51e-01	1.54e-01
GOBP DNA TEMPLATED DNA REPLICATION	159	1.17e-08	1.63e-07	0.3180	4.78e-02	-1.40e-01	-7.88e-02	2.47e-01	8.04e-02	7.39e-02	2.98e-01	2.33e-03	8.64e-02	7.19e-08	8.04e-02	1.08e-01
GOBP ENDOCRINE SYSTEM DEVELOPMENT	71	4.09e-03	1.66e-02	0.3180	-1.14e-01	1.40e-02	2.25e-01	-4.90e-03	-1.35e-01	1.38e-01	9.60e-02	8.38e-01	1.02e-03	9.43e-01	4.92e-02	4.49e-02
GOBP REGULATION OF LAMELLIPODIUM ORGANIZATION	45	5.89e-03	2.24e-02	0.3180	-1.66e-01	1.80e-03	1.81e-01	1.19e-01	1.51e-02	1.62e-01	5.39e-02	9.83e-01	3.52e-02	1.66e-01	8.61e-01	6.01e-02
GOBP CYTOSOLIC TRANSPORT	133	5.64e-09	8.21e-08	0.3180	-1.88e-01	-4.86e-02	6.93e-02	1.06e-01	-1.23e-01	1.80e-01	1.81e-04	3.33e-01	1.68e-01	3.55e-02	1.46e-02	3.34e-04
GOBP NUCLEOTIDE SALVAGE	16	1.15e-01	2.16e-01	0.3180	-7.57e-02	-2.68e-01	9.35e-02	7.73e-02	-1.66e-02	-9.29e-02	6.00e-01	6.35e-02	5.17e-01	5.92e-01	9.09e-01	5.20e-01
GOBP CELLULAR ALDEHYDE METABOLIC PROCESS	56	1.45e-02	4.60e-02	0.3180	-1.23e-01	-2.14e-01	-1.38e-01	8.81e-02	9.20e-02	-7.18e-02	1.12e-01	5.71e-03	7.32e-02	2.54e-01	2.34e-01	3.53e-01
GOBP PIGMENT CELL DIFFERENTIATION	24	2.67e-01	3.87e-01	0.3180	-2.31e-01	5.90e-02	6.25e-02	-9.64e-02	5.83e-02	1.66e-01	4.97e-02	6.17e-01	5.96e-01	4.13e-01	6.21e-01	1.60e-01
GOBP POSITIVE REGULATION OF ISOTYPE SWITCHING	28	2.18e-01	3.36e-01	0.3180	-4.00e-02	1.11e-02	-1.41e-01	2.12e-01	1.73e-01	6.90e-02	7.14e-01	9.19e-01	1.98e-01	5.22e-02	1.14e-01	5.27e-01
GOCC MUSCLE MYOSIN COMPLEX	6	8.54e-01	8.82e-01	0.3180	2.33e-01	4.07e-02	1.33e-01	-1.56e-02	6.37e-02	-1.53e-01	3.24e-01	8.63e-01	5.73e-01	9.47e-01	7.87e-01	5.17e-01
GOMF CHROMATIN PROTEIN ADAPTOR ACTIVITY	30	2.37e-01	3.54e-01	0.3180	2.60e-02	-4.72e-02	-8.99e-02	2.68e-01	1.24e-01	-5.13e-02	8.05e-01	6.55e-01	3.94e-01	1.10e-02	2.41e-01	6.27e-01
GOBP NEGATIVE REGULATION OF PROTEASOMAL PROTEIN CATABOLIC PROCESS	50	5.12e-02	1.19e-01	0.3180	-2.03e-01	-1.67e-01	-3.37e-02	1.20e-02	-1.11e-01	1.35e-01	1.30e-02	4.07e-02	6.80e-01	8.83e-01	1.74e-01	9.97e-02
GOCC DEATH INDUCING SIGNALING COMPLEX	9	8.52e-01	8.80e-01	0.3180	-1.99e-01	-1.12e-01	-2.51e-02	3.78e-03	-1.39e-01	1.70e-01	3.01e-01	5.62e-01	8.96e-01	9.84e-01	4.70e-01	3.78e-01
GOBP VACUOLAR LOCALIZATION	76	3.02e-03	1.30e-02	0.3180	-2.93e-02	-5.85e-02	1.87e-01	1.12e-01	-1.13e-01	1.90e-01	6.59e-01	3.78e-01	4.80e-03	9.10e-02	8.86e-02	4.11e-03
GOBP PEPTIDYL THREONINE DEPHOSPHORYLATION	16	6.09e-01	6.89e-01	0.3180	-1.20e-01	-1.85e-01	1.04e-01	5.24e-02	-7.58e-02	1.82e-01	4.07e-01	2.00e-01	4.73e-01	7.17e-01	6.00e-01	2.08e-01
GOBP INTRACELLULAR STEROL TRANSPORT	31	2.86e-02	7.73e-02	0.3180	-1.52e-01	-7.21e-02	1.48e-01	1.63e-01	-1.22e-01	9.62e-02	1.43e-01	4.87e-01	1.55e-01	1.17e-01	2.38e-01	3.54e-01
GOBP NEGATIVE REGULATION OF SIGNAL TRANSDUCTION IN ABSENCE OF LIGAND	24	1.89e-01	3.05e-01	0.3180	1.53e-01	-5.79e-02	2.31e-01	4.03e-02	2.24e-02	1.36e-01	1.94e-01	6.24e-01	5.01e-02	7.33e-01	8.50e-01	2.49e-01
GOBP SPINAL CORD DEVELOPMENT	60	9.87e-02	1.94e-01	0.3170	1.31e-01	1.52e-01	-3.61e-02	9.78e-02	1.98e-01	-1.01e-01	7.85e-02	4.17e-02	6.29e-01	1.90e-01	7.90e-03	1.74e-01
GOMF SUMO TRANSFERASE ACTIVITY	24	2.73e-01	3.93e-01	0.3170	-2.60e-02	-5.39e-02	-1.27e-01	2.21e-01	5.72e-02	-1.70e-01	8.26e-01	6.48e-01	2.81e-01	6.14e-02	6.28e-01	1.48e-01
GOBP MACROPHAGE DIFFERENTIATION	51	3.30e-03	1.40e-02	0.3170	-2.81e-01	-8.26e-02	8.96e-02	-4.86e-02	-6.57e-02	1.81e-02	5.20e-04	3.07e-01	2.69e-01	5.49e-01	4.17e-01	8.23e-01
GOMF FAD BINDING	36	3.33e-02	8.66e-02	0.3170	-2.16e-01	-1.03e-02	1.70e-01	-4.52e-04	2.77e-02	1.55e-01	2.46e-02	9.14e-01	7.73e-02	9.96e-01	7.74e-01	1.07e-01
GOCC VOLTAGE GATED CALCIUM CHANNEL COMPLEX	31	1.54e-01	2.65e-01	0.3170	8.31e-02	2.12e-01	1.42e-01	-3.59e-03	1.52e-01	-7.18e-02	4.23e-01	4.09e-02	1.70e-01	9.72e-01	1.42e-01	4.89e-01
GOMF TRANSFERASE ACTIVITY TRANSFERRING ONE CARBON GROUPS	196	1.02e-07	1.25e-06	0.3170	-3.42e-02	-1.75e-01	-2.17e-01	1.01e-01	7.19e-02	-7.80e-02	4.10e-01	2.32e-05	1.54e-07	1.47e-02	8.27e-02	5.98e-02
GOBP SERINE FAMILY AMINO ACID BIOSYNTHETIC PROCESS	13	6.26e-01	7.03e-01	0.3170	1.21e-01	-1.44e-01	1.59e-01	1.40e-01	-1.25e-01	6.89e-02	4.51e-01	3.68e-01	3.21e-01	3.83e-01	4.34e-01	6.67e-01
GOBP REGULATION OF CHROMOSOME ORGANIZATION	241	2.11e-15	5.80e-14	0.3170	3.83e-03	-1.12e-01	-5.28e-03	2.51e-01	2.87e-03	1.58e-01	9.18e-01	2.75e-03	8.88e-01	1.93e-11	9.39e-01	2.40e-05
GOBP BLASTOCYST FORMATION	36	6.14e-03	2.32e-02	0.3170	-1.40e-01	3.71e-02	4.62e-02	2.62e-01	2.40e-02	9.14e-02	1.47e-01	7.00e-01	6.31e-01	6.56e-03	8.03e-01	3.43e-01
GOBP OUTFLOW TRACT MORPHOGENESIS	47	1.73e-03	8.12e-03	0.3170	-1.36e-01	1.21e-01	1.85e-01	1.18e-01	1.07e-01	8.84e-02	1.06e-01	1.50e-01	2.85e-02	1.62e-01	2.05e-01	2.94e-01
GOBP RECEPTOR CLUSTERING	45	4.55e-02	1.09e-01	0.3170	6.35e-02	8.85e-03	2.04e-01	1.71e-01	7.98e-02	1.38e-01	4.61e-01	9.18e-01	1.79e-02	4.75e-02	3.54e-01	1.08e-01
GOBP AMINE BIOSYNTHETIC PROCESS	29	2.88e-01	4.07e-01	0.3170	-1.75e-01	-2.31e-01	3.09e-02	-4.35e-02	-7.27e-02	9.04e-02	1.04e-01	3.10e-02	7.73e-01	6.85e-01	4.98e-01	4.00e-01
GOBP EMBRYONIC PATTERN SPECIFICATION	46	8.71e-02	1.77e-01	0.3170	-2.37e-02	1.67e-01	1.57e-01	-4.45e-03	1.20e-01	1.81e-01	7.81e-01	5.06e-02	6.49e-02	9.58e-01	1.60e-01	3.34e-02
GOBP RESPONSE TO INTERLEUKIN 18	11	5.71e-01	6.59e-01	0.3170	-1.58e-01	1.45e-01	-1.44e-01	-1.36e-01	-7.28e-02	-9.89e-02	3.65e-01	4.04e-01	4.09e-01	4.34e-01	6.76e-01	5.70e-01
GOBP MALE MEIOSIS I	17	6.69e-01	7.36e-01	0.3170	-1.46e-03	-1.05e-02	1.26e-01	-9.32e-02	-1.82e-01	2.06e-01	9.92e-01	9.40e-01	3.70e-01	5.06e-01	1.93e-01	1.42e-01
GOCC B WICH COMPLEX	7	7.29e-01	7.84e-01	0.3170	-2.87e-01	-4.37e-02	3.13e-02	8.41e-02	-8.79e-02	1.54e-03	1.88e-01	8.41e-01	8.86e-01	7.00e-01	6.87e-01	9.94e-01
GOMF I SMAD BINDING	16	1.52e-01	2.62e-01	0.3170	-2.64e-01	1.51e-01	5.19e-02	3.87e-02	-5.61e-02	2.10e-02	6.74e-02	2.97e-01	7.19e-01	7.89e-01	6.98e-01	8.84e-01
GOCC RIPOPTOSOME	6	6.93e-01	7.56e-01	0.3160	-1.82e-01	9.25e-02	7.34e-02	1.68e-01	-1.40e-01	7.17e-02	4.41e-01	6.95e-01	7.56e-01	4.76e-01	5.51e-01	7.61e-01
GOBP PROTEIN HETEROTETRAMERIZATION	13	4.96e-01	5.94e-01	0.3160	3.15e-02	-1.67e-01	-2.22e-01	1.37e-01	-4.17e-02	3.87e-02	8.44e-01	2.98e-01	1.66e-01	3.91e-01	7.95e-01	8.09e-01
GOBP NEGATIVE REGULATION OF PEPTIDASE ACTIVITY	83	1.67e-04	1.07e-03	0.3160	-2.74e-01	-5.78e-02	7.37e-02	-2.75e-02	-2.66e-02	1.22e-01	1.64e-05	3.63e-01	2.46e-01	6.65e-01	6.76e-01	5.45e-02
GOBP ORGANELLE FUSION	145	2.26e-08	3.03e-07	0.3160	-1.57e-01	-2.14e-01	-3.05e-02	1.07e-01	3.33e-02	1.26e-01	1.10e-03	8.48e-06	5.26e-01	2.56e-02	4.89e-01	8.90e-03
GOBP TELOMERE CAPPING	37	1.35e-02	4.38e-02	0.3160	-9.15e-02	1.60e-02	-2.19e-01	2.01e-01	4.51e-02	-2.90e-02	3.35e-01	8.67e-01	2.14e-02	3.40e-02	6.35e-01	7.60e-01
GOBP REGULATION OF B CELL DIFFERENTIATION	32	1.32e-01	2.39e-01	0.3160	1.02e-01	2.08e-01	1.43e-01	7.57e-02	-1.06e-01	9.23e-02	3.18e-01	4.14e-02	1.60e-01	4.59e-01	2.99e-01	3.66e-01
GOCC EXTRINSIC COMPONENT OF CYTOPLASMIC SIDE OF PLASMA MEMBRANE	43	4.32e-02	1.05e-01	0.3160	-4.82e-02	1.02e-01	2.34e-01	9.36e-02	-8.21e-02	1.30e-01	5.84e-01	2.48e-01	8.00e-03	2.88e-01	3.52e-01	1.40e-01
GOMF MICROTUBULE MINUS END BINDING	14	4.83e-01	5.84e-01	0.3160	-8.63e-04	1.86e-01	8.85e-02	1.19e-01	1.59e-01	-1.33e-01	9.96e-01	2.28e-01	5.66e-01	4.41e-01	3.03e-01	3.88e-01
GOBP POINTED END ACTIN FILAMENT CAPPING	5	8.62e-01	8.88e-01	0.3160	1.31e-01	1.78e-01	-1.57e-01	-1.86e-02	1.44e-01	7.12e-02	6.12e-01	4.90e-01	5.44e-01	9.43e-01	5.77e-01	7.83e-01
GOCC STRIATED MUSCLE THIN FILAMENT	14	6.12e-01	6.91e-01	0.3160	-1.21e-01	-1.12e-01	3.95e-03	-1.46e-01	-7.48e-03	2.26e-01	4.35e-01	4.67e-01	9.80e-01	3.45e-01	9.61e-01	1.43e-01
GOBP REGULATION OF PROTEIN LOCALIZATION TO CELL SURFACE	34	2.35e-01	3.53e-01	0.3160	-1.88e-01	-7.59e-02	-1.34e-01	-5.96e-02	-3.44e-02	-1.89e-01	5.76e-02	4.44e-01	1.77e-01	5.47e-01	7.28e-01	5.60e-02
GOBP EMBRYONIC FORELIMB MORPHOGENESIS	15	3.86e-01	5.00e-01	0.3160	-1.69e-02	2.37e-01	1.73e-01	8.89e-02	2.92e-02	-6.61e-02	9.10e-01	1.11e-01	2.47e-01	5.51e-01	8.45e-01	6.58e-01
GOBP PROTEOGLYCAN BIOSYNTHETIC PROCESS	50	4.49e-04	2.56e-03	0.3160	-1.12e-01	-1.29e-02	9.57e-02	1.53e-01	-2.15e-01	9.08e-02	1.71e-01	8.75e-01	2.42e-01	6.18e-02	8.54e-03	2.67e-01
GOBP FATTY ACID BETA OXIDATION	70	4.75e-03	1.88e-02	0.3160	-6.36e-02	-2.22e-01	-1.72e-01	9.50e-02	8.75e-02	-1.56e-03	3.58e-01	1.35e-03	1.26e-02	1.69e-01	2.05e-01	9.82e-01
GOBP INTERSTRAND CROSS LINK REPAIR	40	1.34e-01	2.42e-01	0.3160	-1.57e-02	-1.17e-01	-1.95e-01	1.42e-01	1.65e-01	-1.59e-02	8.64e-01	2.01e-01	3.27e-02	1.20e-01	7.16e-02	8.62e-01
GOMF SIGNALING RECEPTOR INHIBITOR ACTIVITY	13	8.30e-01	8.63e-01	0.3150	4.66e-02	5.03e-02	1.61e-01	2.77e-02	-1.66e-02	2.60e-01	7.71e-01	7.54e-01	3.14e-01	8.63e-01	9.18e-01	1.04e-01
GOBP SPONTANEOUS SYNAPTIC TRANSMISSION	12	6.48e-01	7.21e-01	0.3150	-1.94e-01	-6.85e-02	-4.39e-02	1.05e-01	1.53e-01	1.45e-01	2.45e-01	6.81e-01	7.92e-01	5.30e-01	3.59e-01	3.85e-01
GOBP CENTROMERE COMPLEX ASSEMBLY	29	1.30e-01	2.36e-01	0.3150	8.55e-02	-1.72e-01	2.85e-03	1.89e-01	4.22e-02	1.59e-01	4.25e-01	1.09e-01	9.79e-01	7.81e-02	6.94e-01	1.39e-01
GOBP REGULATION OF MUCUS SECRETION	7	6.24e-01	7.01e-01	0.3150	-4.94e-03	-1.79e-01	1.69e-01	1.65e-01	-7.19e-02	-7.94e-02	9.82e-01	4.12e-01	4.38e-01	4.49e-01	7.42e-01	7.16e-01
GOMF NAD DEPENDENT PROTEIN LYSINE DEACETYLASE ACTIVITY	7	8.69e-01	8.94e-01	0.3150	1.39e-02	-1.98e-01	-5.07e-02	1.99e-01	-1.13e-01	6.95e-02	9.49e-01	3.63e-01	8.16e-01	3.61e-01	6.05e-01	7.50e-01
GOBP POLARIZED EPITHELIAL CELL DIFFERENTIATION	20	5.01e-01	5.98e-01	0.3150	-1.76e-01	-1.57e-02	1.47e-01	-1.26e-02	-1.21e-02	2.15e-01	1.73e-01	9.03e-01	2.56e-01	9.22e-01	9.25e-01	9.53e-02
GOBP POSTSYNAPSE ASSEMBLY	29	3.19e-01	4.38e-01	0.3150	9.88e-03	1.41e-01	1.39e-01	1.60e-01	1.50e-01	1.09e-01	9.27e-01	1.89e-01	1.94e-01	1.35e-01	1.63e-01	3.08e-01
GOBP UBIQUITIN DEPENDENT PROTEIN CATABOLIC PROCESS VIA THE MULTIVESICULAR BODY SORTING PATHWAY	35	6.80e-02	1.48e-01	0.3150	-8.88e-02	-1.92e-01	5.56e-02	1.67e-01	-7.88e-02	1.32e-01	3.63e-01	4.97e-02	5.69e-01	8.70e-02	4.20e-01	1.75e-01
GOBP PHOSPHOLIPASE C ACTIVATING G PROTEIN COUPLED RECEPTOR SIGNALING PATHWAY	69	1.54e-02	4.82e-02	0.3150	4.91e-02	1.89e-01	2.20e-01	2.69e-02	7.58e-02	8.05e-02	4.81e-01	6.52e-03	1.61e-03	6.99e-01	2.76e-01	2.48e-01
GOBP NEGATIVE REGULATION OF PROTEIN TYROSINE KINASE ACTIVITY	18	4.72e-01	5.74e-01	0.3150	-1.23e-01	-2.42e-02	1.34e-01	4.67e-02	-2.06e-01	1.44e-01	3.65e-01	8.59e-01	3.24e-01	7.31e-01	1.30e-01	2.89e-01
GOBP NEURAL CREST FORMATION	10	5.84e-01	6.69e-01	0.3150	-1.57e-01	-7.57e-02	-6.00e-02	2.55e-01	1.47e-02	-7.10e-03	3.91e-01	6.79e-01	7.42e-01	1.62e-01	9.36e-01	9.69e-01
GOBP PHOTORECEPTOR CELL MAINTENANCE	30	1.66e-01	2.79e-01	0.3150	-3.56e-02	1.08e-01	-1.87e-01	-1.03e-01	1.85e-01	-8.21e-02	7.36e-01	3.05e-01	7.69e-02	3.31e-01	7.98e-02	4.36e-01
GOBP EMBRYONIC HEART TUBE MORPHOGENESIS	45	4.69e-03	1.86e-02	0.3150	-1.03e-01	1.09e-01	8.56e-02	9.88e-02	2.43e-01	2.79e-02	2.34e-01	2.04e-01	3.20e-01	2.51e-01	4.88e-03	7.46e-01
GOBP RESPONSE TO OXYGEN GLUCOSE DEPRIVATION	7	9.32e-01	9.43e-01	0.3150	-1.17e-01	-1.87e-01	-7.68e-03	4.56e-02	-1.93e-01	1.05e-01	5.93e-01	3.91e-01	9.72e-01	8.34e-01	3.76e-01	6.31e-01
GOBP NEGATIVE REGULATION OF KERATINOCYTE PROLIFERATION	19	7.09e-01	7.69e-01	0.3150	5.02e-02	1.48e-01	2.10e-01	8.45e-02	6.82e-02	1.37e-01	7.05e-01	2.63e-01	1.13e-01	5.24e-01	6.07e-01	3.02e-01
GOBP REGULATION OF LIPID STORAGE	41	2.95e-05	2.25e-04	0.3150	-1.39e-01	5.41e-02	2.36e-01	5.92e-02	1.30e-01	-2.71e-02	1.23e-01	5.49e-01	9.00e-03	5.12e-01	1.50e-01	7.64e-01
GOBP PYROPTOSIS	33	6.05e-02	1.36e-01	0.3150	-2.14e-01	9.16e-04	-5.19e-02	7.73e-02	1.08e-01	1.81e-01	3.30e-02	9.93e-01	6.06e-01	4.42e-01	2.81e-01	7.26e-02
GOMF STEROID DEHYDROGENASE ACTIVITY	28	4.86e-01	5.86e-01	0.3150	-1.06e-01	-2.00e-01	-1.53e-01	-1.07e-01	-1.12e-01	-1.87e-02	3.30e-01	6.76e-02	1.60e-01	3.27e-01	3.06e-01	8.64e-01
GOBP DEFENSE RESPONSE TO GRAM POSITIVE BACTERIUM	73	1.12e-03	5.62e-03	0.3150	-1.21e-01	-2.10e-01	1.07e-01	-6.29e-02	-1.57e-01	-1.39e-02	7.31e-02	1.94e-03	1.15e-01	3.53e-01	2.03e-02	8.38e-01
GOBP CELLULAR RESPONSE TO TOXIC SUBSTANCE	109	3.02e-05	2.31e-04	0.3150	-1.07e-01	-1.52e-01	1.45e-01	-2.57e-02	-3.98e-02	2.03e-01	5.33e-02	6.17e-03	8.80e-03	6.44e-01	4.72e-01	2.57e-04
GOMF CALCIUM CHANNEL REGULATOR ACTIVITY	34	5.30e-02	1.22e-01	0.3140	-1.60e-01	-1.14e-01	1.44e-01	1.10e-01	-2.16e-02	1.64e-01	1.07e-01	2.48e-01	1.45e-01	2.66e-01	8.28e-01	9.83e-02
GOBP NEUROBLAST PROLIFERATION	49	2.79e-02	7.60e-02	0.3140	-3.20e-02	2.18e-01	1.43e-01	1.17e-01	9.82e-02	8.19e-02	6.98e-01	8.33e-03	8.40e-02	1.57e-01	2.34e-01	3.21e-01
GOBP REGULATION OF APOPTOTIC DNA FRAGMENTATION	8	7.74e-01	8.17e-01	0.3140	-1.16e-01	-2.13e-01	3.69e-02	1.87e-01	-1.81e-02	5.47e-02	5.69e-01	2.96e-01	8.57e-01	3.59e-01	9.29e-01	7.89e-01
GOBP MITOTIC G2 M TRANSITION CHECKPOINT	54	7.73e-03	2.80e-02	0.3140	-1.50e-01	-1.56e-01	-3.86e-02	1.39e-01	3.58e-02	1.73e-01	5.73e-02	4.68e-02	6.24e-01	7.76e-02	6.49e-01	2.78e-02
GOBP MYELOID LEUKOCYTE DIFFERENTIATION	188	1.01e-11	2.01e-10	0.3140	-1.22e-01	3.15e-02	2.33e-01	6.68e-02	-6.00e-02	1.43e-01	3.99e-03	4.57e-01	3.49e-08	1.14e-01	1.56e-01	7.10e-04
GOBP BONE MORPHOGENESIS	62	6.14e-03	2.32e-02	0.3140	-2.28e-04	1.40e-01	1.05e-01	2.18e-01	1.36e-01	4.76e-02	9.98e-01	5.70e-02	1.52e-01	3.04e-03	6.40e-02	5.17e-01
GOBP ANTIVIRAL INNATE IMMUNE RESPONSE	49	3.74e-02	9.47e-02	0.3140	-1.24e-01	-1.45e-01	-2.38e-01	3.98e-02	6.13e-02	2.47e-02	1.34e-01	7.95e-02	3.99e-03	6.29e-01	4.58e-01	7.65e-01
GOCC NUCLEOLUS	971	1.28e-48	3.70e-46	0.3140	-8.18e-02	-2.22e-01	-1.59e-01	1.29e-01	7.49e-03	-1.66e-02	1.63e-05	7.33e-32	4.31e-17	8.55e-12	6.93e-01	3.82e-01
GOMF G PROTEIN BETA GAMMA SUBUNIT COMPLEX BINDING	18	4.54e-01	5.60e-01	0.3140	-2.30e-01	-3.91e-02	1.23e-01	-7.00e-02	-1.54e-01	2.02e-02	9.10e-02	7.74e-01	3.68e-01	6.07e-01	2.57e-01	8.82e-01
GOBP NATURAL KILLER CELL ACTIVATION	72	9.48e-03	3.28e-02	0.3140	5.58e-02	1.49e-01	1.68e-01	1.02e-01	-6.22e-02	1.75e-01	4.13e-01	2.83e-02	1.39e-02	1.34e-01	3.61e-01	1.00e-02
GOBP AORTIC VALVE MORPHOGENESIS	23	2.74e-01	3.93e-01	0.3140	-2.56e-02	1.28e-01	2.76e-01	-3.00e-02	4.27e-03	6.82e-02	8.32e-01	2.89e-01	2.20e-02	8.03e-01	9.72e-01	5.71e-01
GOBP METANEPHRIC EPITHELIUM DEVELOPMENT	14	5.85e-01	6.69e-01	0.3140	-7.26e-02	1.28e-01	-7.87e-02	-2.17e-01	1.19e-01	-9.72e-02	6.38e-01	4.08e-01	6.10e-01	1.60e-01	4.39e-01	5.29e-01
GOBP REGULATION OF T CELL MIGRATION	41	7.78e-02	1.63e-01	0.3140	-3.29e-04	-3.53e-02	1.27e-01	2.02e-01	-1.43e-02	2.00e-01	9.97e-01	6.95e-01	1.58e-01	2.53e-02	8.74e-01	2.65e-02
GOBP NEURAL TUBE FORMATION	86	6.62e-06	5.86e-05	0.3140	-7.19e-02	1.38e-01	3.54e-02	1.94e-01	1.78e-01	-6.30e-02	2.49e-01	2.70e-02	5.70e-01	1.89e-03	4.40e-03	3.13e-01
GOBP DOPAMINE TRANSPORT	25	5.84e-01	6.69e-01	0.3140	1.96e-01	1.01e-01	1.55e-01	1.09e-01	-1.49e-02	1.18e-01	8.94e-02	3.81e-01	1.81e-01	3.47e-01	8.97e-01	3.08e-01
GOCC SARCOPLASMIC RETICULUM MEMBRANE	30	3.75e-01	4.90e-01	0.3140	1.46e-02	4.94e-02	2.02e-01	1.07e-01	-6.58e-02	1.99e-01	8.90e-01	6.40e-01	5.60e-02	3.10e-01	5.33e-01	5.98e-02
GOBP MRNA EXPORT FROM NUCLEUS	67	4.00e-05	2.98e-04	0.3140	-1.43e-01	-1.12e-01	-6.94e-02	2.38e-01	-5.62e-02	3.08e-02	4.27e-02	1.12e-01	3.26e-01	7.68e-04	4.26e-01	6.63e-01
GOMF OXIDOREDUCTASE ACTIVITY ACTING ON THE CH CH GROUP OF DONORS	56	3.31e-03	1.40e-02	0.3140	-7.53e-02	-2.52e-01	-1.03e-01	7.45e-02	1.14e-01	-1.30e-02	3.29e-01	1.11e-03	1.80e-01	3.35e-01	1.40e-01	8.66e-01
GOBP NEGATIVE REGULATION OF DNA BINDING	24	2.33e-01	3.51e-01	0.3140	3.07e-03	-1.23e-01	1.98e-02	1.27e-01	-3.22e-02	2.57e-01	9.79e-01	2.99e-01	8.66e-01	2.82e-01	7.85e-01	2.96e-02
GOBP SEX CHROMOSOME DOSAGE COMPENSATION	17	3.20e-01	4.40e-01	0.3140	-2.77e-01	3.49e-02	3.77e-02	-7.93e-03	-1.13e-01	7.91e-02	4.82e-02	8.03e-01	7.88e-01	9.55e-01	4.19e-01	5.72e-01
GOCC GOLGI STACK	127	1.93e-08	2.62e-07	0.3140	-1.35e-01	-9.28e-03	1.11e-01	1.69e-01	-5.88e-02	1.89e-01	8.51e-03	8.57e-01	3.15e-02	1.00e-03	2.53e-01	2.33e-04
GOBP PUTRESCINE METABOLIC PROCESS	8	7.56e-01	8.05e-01	0.3140	-1.24e-01	-2.03e-01	8.58e-02	-1.00e-01	4.79e-02	1.49e-01	5.45e-01	3.20e-01	6.74e-01	6.24e-01	8.14e-01	4.65e-01
GOBP NEUROTRANSMITTER UPTAKE	30	3.40e-01	4.57e-01	0.3140	9.72e-02	-5.07e-02	1.93e-01	-1.21e-02	-1.36e-01	1.74e-01	3.57e-01	6.31e-01	6.66e-02	9.09e-01	1.96e-01	9.98e-02
GOBP MICROTUBULE NUCLEATION	45	2.61e-02	7.26e-02	0.3130	-1.93e-02	9.82e-02	-5.62e-02	2.48e-01	1.33e-01	-7.78e-02	8.23e-01	2.54e-01	5.15e-01	4.02e-03	1.24e-01	3.67e-01
GOBP L AMINO ACID BIOSYNTHETIC PROCESS	49	5.33e-02	1.23e-01	0.3130	-1.16e-01	-2.78e-01	-6.26e-02	-1.30e-02	-4.76e-02	3.46e-02	1.59e-01	7.68e-04	4.49e-01	8.75e-01	5.64e-01	6.75e-01
GOBP HAIR CELL DIFFERENTIATION	34	3.09e-02	8.17e-02	0.3130	-6.81e-02	1.11e-01	-3.36e-02	5.04e-03	6.06e-02	-2.76e-01	4.92e-01	2.61e-01	7.34e-01	9.59e-01	5.41e-01	5.30e-03
GOCC TRANSCRIPTION FACTOR TFTC COMPLEX	18	2.53e-01	3.72e-01	0.3130	-8.29e-02	-6.69e-02	5.84e-02	2.76e-01	-1.14e-02	8.47e-02	5.42e-01	6.23e-01	6.68e-01	4.28e-02	9.33e-01	5.34e-01
GOBP PROTEIN LIPID COMPLEX ORGANIZATION	35	2.32e-02	6.62e-02	0.3130	-1.63e-02	9.98e-02	2.42e-01	1.65e-01	2.78e-02	3.97e-02	8.67e-01	3.07e-01	1.34e-02	9.17e-02	7.76e-01	6.84e-01
GOMF GDP DISSOCIATION INHIBITOR ACTIVITY	15	7.94e-01	8.34e-01	0.3130	-2.26e-01	-1.17e-01	-9.58e-02	-7.10e-02	-1.33e-01	-3.59e-02	1.30e-01	4.32e-01	5.20e-01	6.34e-01	3.72e-01	8.10e-01
GOMF DOLICHYL PHOSPHATE MANNOSE PROTEIN MANNOSYLTRANSFERASE ACTIVITY	8	7.94e-01	8.34e-01	0.3130	-1.60e-01	5.55e-02	1.49e-02	-2.11e-01	7.31e-02	-1.39e-01	4.34e-01	7.86e-01	9.42e-01	3.01e-01	7.20e-01	4.95e-01
GOBP FATTY ACID DERIVATIVE BIOSYNTHETIC PROCESS	41	1.94e-01	3.11e-01	0.3130	-3.01e-02	-9.32e-02	1.70e-01	-5.37e-02	-1.10e-01	2.11e-01	7.39e-01	3.02e-01	5.94e-02	5.52e-01	2.21e-01	1.96e-02
GOBP CARDIOCYTE DIFFERENTIATION	98	1.17e-05	9.69e-05	0.3130	-1.88e-01	-2.88e-02	1.70e-01	3.02e-02	-1.37e-01	1.16e-01	1.29e-03	6.23e-01	3.67e-03	6.05e-01	1.95e-02	4.79e-02
GOMF OLIGOSACCHARIDE BINDING	9	7.85e-01	8.27e-01	0.3130	-1.03e-01	-2.82e-01	1.03e-02	1.42e-03	-4.79e-03	8.64e-02	5.94e-01	1.42e-01	9.57e-01	9.94e-01	9.80e-01	6.54e-01
GOBP KETONE BIOSYNTHETIC PROCESS	37	1.28e-01	2.33e-01	0.3130	-3.89e-02	-2.45e-01	-1.43e-01	1.17e-01	-4.71e-02	-3.67e-03	6.82e-01	9.85e-03	1.33e-01	2.19e-01	6.20e-01	9.69e-01
GOBP REGULATION OF LIPOPOLYSACCHARIDE MEDIATED SIGNALING PATHWAY	23	4.52e-02	1.09e-01	0.3130	-1.70e-01	-1.30e-01	1.58e-01	-1.40e-01	6.51e-02	5.56e-02	1.58e-01	2.80e-01	1.89e-01	2.44e-01	5.89e-01	6.44e-01
GOBP REGULATION OF MITOCHONDRIAL FISSION	28	2.55e-01	3.75e-01	0.3130	-1.81e-01	-1.97e-01	-4.69e-02	7.61e-02	-2.92e-02	1.31e-01	9.74e-02	7.06e-02	6.67e-01	4.86e-01	7.89e-01	2.29e-01
GOBP SODIUM ION IMPORT ACROSS PLASMA MEMBRANE	16	5.33e-01	6.25e-01	0.3130	4.26e-02	8.66e-02	2.31e-01	1.57e-01	7.49e-02	7.00e-02	7.68e-01	5.49e-01	1.10e-01	2.77e-01	6.04e-01	6.28e-01
GOBP POST EMBRYONIC CAMERA TYPE EYE DEVELOPMENT	7	5.85e-01	6.69e-01	0.3130	-1.82e-01	5.06e-02	9.55e-02	3.79e-02	2.09e-01	-8.96e-02	4.04e-01	8.17e-01	6.62e-01	8.62e-01	3.39e-01	6.81e-01
GOCC SITE OF DNA DAMAGE	125	1.24e-06	1.28e-05	0.3130	-1.14e-01	-1.48e-01	-1.66e-01	1.71e-01	5.43e-02	5.46e-02	2.77e-02	4.24e-03	1.36e-03	9.40e-04	2.94e-01	2.92e-01
GOBP PROTEIN OXIDATION	10	8.18e-01	8.53e-01	0.3130	-1.89e-01	-1.08e-01	-1.11e-01	-7.29e-02	9.56e-02	-1.53e-01	3.00e-01	5.53e-01	5.42e-01	6.90e-01	6.01e-01	4.03e-01
GOMF PHOSPHORUS OXYGEN LYASE ACTIVITY	17	6.74e-01	7.41e-01	0.3130	-1.01e-01	3.25e-02	2.21e-01	-4.95e-02	-3.43e-02	1.84e-01	4.69e-01	8.16e-01	1.14e-01	7.24e-01	8.07e-01	1.89e-01
GOBP POSITIVE REGULATION OF RELEASE OF SEQUESTERED CALCIUM ION INTO CYTOSOL	27	3.45e-01	4.62e-01	0.3130	1.38e-01	-4.53e-02	1.80e-01	4.50e-02	-1.75e-01	1.08e-01	2.13e-01	6.84e-01	1.06e-01	6.86e-01	1.16e-01	3.31e-01
GOBP CELLULAR COMPONENT ASSEMBLY INVOLVED IN MORPHOGENESIS	90	3.56e-03	1.49e-02	0.3120	-1.37e-02	9.24e-02	2.20e-01	2.41e-02	-1.22e-01	1.59e-01	8.23e-01	1.30e-01	3.14e-04	6.92e-01	4.54e-02	9.31e-03
GOBP PURINE DEOXYRIBONUCLEOTIDE CATABOLIC PROCESS	9	5.23e-01	6.16e-01	0.3120	1.26e-02	-2.80e-01	6.25e-02	-3.89e-02	5.67e-02	1.03e-01	9.48e-01	1.46e-01	7.45e-01	8.40e-01	7.68e-01	5.92e-01
GOBP POSTSYNAPTIC NEUROTRANSMITTER RECEPTOR INTERNALIZATION	24	4.51e-01	5.57e-01	0.3120	7.54e-02	-4.13e-03	1.78e-01	1.91e-01	-5.56e-03	1.54e-01	5.23e-01	9.72e-01	1.32e-01	1.05e-01	9.62e-01	1.92e-01
GOBP PEPTIDYL TYROSINE DEPHOSPHORYLATION	26	1.15e-01	2.17e-01	0.3120	-1.52e-02	1.14e-01	2.80e-01	6.68e-02	-2.17e-02	3.17e-02	8.93e-01	3.13e-01	1.35e-02	5.55e-01	8.48e-01	7.80e-01
GOBP CELLULAR RESPONSE TO PH	17	5.03e-01	5.99e-01	0.3120	1.35e-01	5.52e-02	1.10e-01	2.10e-01	1.03e-01	-9.77e-02	3.35e-01	6.94e-01	4.33e-01	1.34e-01	4.60e-01	4.86e-01
GOBP NEGATIVE REGULATION OF ENDOTHELIAL CELL PROLIFERATION	28	4.02e-02	9.99e-02	0.3120	-6.42e-02	-9.67e-02	1.47e-01	-2.43e-01	-3.29e-02	-4.54e-02	5.56e-01	3.76e-01	1.77e-01	2.60e-02	7.63e-01	6.77e-01
GOBP POSITIVE REGULATION OF PROTEIN UBIQUITINATION	97	5.02e-05	3.64e-04	0.3120	-2.10e-01	-1.24e-01	-1.24e-02	7.50e-02	-5.11e-02	1.72e-01	3.59e-04	3.47e-02	8.33e-01	2.02e-01	3.84e-01	3.44e-03
GOBP NEGATIVE REGULATION OF SMOOTHENED SIGNALING PATHWAY	30	8.65e-02	1.76e-01	0.3120	4.59e-02	1.82e-01	-7.87e-02	2.24e-01	7.37e-02	-1.84e-03	6.63e-01	8.47e-02	4.55e-01	3.34e-02	4.85e-01	9.86e-01
GOBP PHOSPHATE ION HOMEOSTASIS	12	8.18e-01	8.53e-01	0.3120	1.43e-01	2.43e-01	9.97e-02	-2.00e-02	2.46e-02	8.04e-02	3.91e-01	1.44e-01	5.50e-01	9.04e-01	8.83e-01	6.30e-01
GOMF SULFOTRANSFERASE ACTIVITY	29	1.08e-01	2.06e-01	0.3120	1.14e-01	5.33e-02	1.25e-01	1.90e-01	-1.65e-01	4.95e-02	2.90e-01	6.19e-01	2.46e-01	7.59e-02	1.24e-01	6.44e-01
GOCC ORGANELLE MEMBRANE CONTACT SITE	46	3.95e-02	9.86e-02	0.3120	-1.97e-01	-1.45e-01	-1.67e-01	9.19e-02	-3.52e-03	3.64e-02	2.11e-02	8.93e-02	5.04e-02	2.81e-01	9.67e-01	6.70e-01
GOBP AMYLOID BETA METABOLIC PROCESS	49	2.69e-02	7.39e-02	0.3120	-2.02e-01	-1.04e-01	8.18e-02	-3.38e-02	-1.94e-01	-2.07e-03	1.42e-02	2.09e-01	3.22e-01	6.82e-01	1.90e-02	9.80e-01
GOMF GUANYL NUCLEOTIDE EXCHANGE FACTOR ACTIVITY	209	1.74e-10	3.05e-09	0.3110	4.15e-02	1.64e-01	1.67e-01	1.86e-01	6.49e-02	3.90e-02	3.01e-01	4.33e-05	3.20e-05	3.40e-06	1.06e-01	3.31e-01
GOBP MITOCHONDRION ENDOPLASMIC RETICULUM MEMBRANE TETHERING	7	5.62e-01	6.50e-01	0.3110	-2.64e-01	-2.30e-02	8.33e-02	1.14e-01	9.70e-03	-8.18e-02	2.27e-01	9.16e-01	7.03e-01	6.01e-01	9.65e-01	7.08e-01
GOCC PRC1 COMPLEX	16	4.30e-01	5.39e-01	0.3110	-1.36e-01	-1.08e-01	-9.60e-02	9.67e-02	1.52e-01	-1.59e-01	3.46e-01	4.56e-01	5.06e-01	5.03e-01	2.93e-01	2.71e-01
GOMF HSP90 PROTEIN BINDING	38	1.14e-01	2.15e-01	0.3110	7.81e-02	-1.88e-02	6.71e-02	2.70e-01	1.04e-01	4.66e-02	4.05e-01	8.41e-01	4.74e-01	3.95e-03	2.67e-01	6.19e-01
GOBP GLUTAMATE METABOLIC PROCESS	25	3.20e-01	4.40e-01	0.3110	-1.60e-01	-7.66e-02	1.11e-01	3.22e-02	1.45e-02	2.28e-01	1.66e-01	5.07e-01	3.35e-01	7.81e-01	9.00e-01	4.87e-02
GOBP POSITIVE REGULATION OF CD4 POSITIVE ALPHA BETA T CELL ACTIVATION	43	1.34e-02	4.36e-02	0.3110	-2.55e-02	1.10e-01	1.72e-01	2.22e-01	2.63e-02	6.95e-02	7.72e-01	2.11e-01	5.15e-02	1.19e-02	7.65e-01	4.30e-01
GOBP TELOMERE MAINTENANCE VIA TELOMERE LENGTHENING	78	4.15e-04	2.39e-03	0.3110	-1.20e-01	-1.44e-01	-1.50e-01	1.79e-01	4.66e-02	7.13e-02	6.63e-02	2.78e-02	2.24e-02	6.23e-03	4.77e-01	2.76e-01
GOBP NEGATIVE REGULATION OF MUSCLE HYPERTROPHY	22	1.14e-01	2.16e-01	0.3110	-6.41e-02	-6.00e-02	2.02e-01	1.69e-01	-1.35e-01	3.95e-02	6.03e-01	6.26e-01	1.01e-01	1.70e-01	2.72e-01	7.48e-01
GOBP BLASTODERM SEGMENTATION	14	7.25e-01	7.81e-01	0.3110	-6.62e-02	1.46e-01	1.08e-01	6.54e-02	8.89e-02	2.18e-01	6.68e-01	3.46e-01	4.84e-01	6.72e-01	5.65e-01	1.58e-01
GOBP NUCLEOSOME ORGANIZATION	92	5.21e-05	3.77e-04	0.3110	-1.07e-01	-1.53e-01	7.24e-02	1.48e-01	-1.14e-01	1.47e-01	7.49e-02	1.12e-02	2.30e-01	1.43e-02	5.83e-02	1.45e-02
GOBP REGULATION OF CLATHRIN DEPENDENT ENDOCYTOSIS	16	7.99e-01	8.38e-01	0.3110	4.81e-02	1.84e-01	5.16e-02	1.39e-01	1.80e-01	7.85e-02	7.39e-01	2.02e-01	7.21e-01	3.34e-01	2.13e-01	5.86e-01
GOBP NEGATIVE REGULATION OF AUTOPHAGY	82	1.55e-07	1.84e-06	0.3110	-8.40e-02	1.12e-01	1.13e-01	2.33e-01	-6.59e-02	7.52e-02	1.88e-01	8.05e-02	7.61e-02	2.58e-04	3.02e-01	2.39e-01
GOBP MYELOID LEUKOCYTE ACTIVATION	205	5.25e-09	7.66e-08	0.3110	-5.13e-02	9.57e-02	2.23e-01	7.14e-02	-3.28e-02	1.71e-01	2.06e-01	1.82e-02	3.96e-08	7.80e-02	4.18e-01	2.36e-05
GOBP REGULATION OF TUBE SIZE	94	5.46e-04	3.02e-03	0.3110	-1.22e-01	-6.41e-02	1.97e-01	-1.30e-01	-1.35e-01	6.48e-02	4.15e-02	2.83e-01	9.72e-04	2.97e-02	2.41e-02	2.78e-01
GOMF MITOGEN ACTIVATED PROTEIN KINASE KINASE BINDING	10	6.77e-01	7.44e-01	0.3110	9.20e-03	2.20e-01	1.56e-01	6.71e-03	9.04e-02	-1.25e-01	9.60e-01	2.28e-01	3.94e-01	9.71e-01	6.21e-01	4.92e-01
GOMF PROTEIN SERINE THREONINE TYROSINE KINASE ACTIVITY	39	3.15e-02	8.29e-02	0.3110	-8.72e-02	4.83e-02	1.11e-01	2.17e-01	1.03e-01	1.30e-01	3.46e-01	6.02e-01	2.31e-01	1.92e-02	2.67e-01	1.59e-01
GOBP NEGATIVE REGULATION OF NOTCH SIGNALING PATHWAY	26	6.70e-02	1.46e-01	0.3110	3.96e-02	7.84e-02	8.87e-02	1.69e-01	1.48e-01	-1.75e-01	7.27e-01	4.89e-01	4.34e-01	1.35e-01	1.90e-01	1.23e-01
GOBP CELL CHEMOTAXIS	233	9.89e-10	1.58e-08	0.3110	2.96e-02	5.13e-02	2.66e-01	3.87e-02	-6.54e-02	1.29e-01	4.36e-01	1.77e-01	2.57e-12	3.09e-01	8.55e-02	7.02e-04
GOBP RESPONSE TO STEROL	27	1.03e-01	2.00e-01	0.3110	-5.02e-02	2.19e-01	1.03e-01	1.66e-01	2.23e-02	8.67e-02	6.51e-01	4.85e-02	3.56e-01	1.36e-01	8.41e-01	4.35e-01
GOBP NEURAL TUBE DEVELOPMENT	126	3.26e-08	4.27e-07	0.3110	-7.29e-02	1.55e-01	1.92e-02	1.77e-01	1.80e-01	-5.84e-02	1.58e-01	2.66e-03	7.09e-01	6.11e-04	4.92e-04	2.57e-01
GOBP PROTEIN SUMOYLATION	62	8.23e-03	2.95e-02	0.3110	-1.01e-01	-6.47e-02	-1.80e-01	1.80e-01	1.32e-01	1.23e-02	1.68e-01	3.79e-01	1.44e-02	1.43e-02	7.20e-02	8.67e-01
GOBP NEUROEPITHELIAL CELL DIFFERENTIATION	25	1.42e-01	2.51e-01	0.3110	-4.57e-02	-1.44e-01	1.71e-01	5.26e-02	-2.03e-01	-2.09e-02	6.92e-01	2.12e-01	1.39e-01	6.49e-01	7.85e-02	8.57e-01
GOBP ANIMAL ORGAN REGENERATION	57	8.71e-03	3.08e-02	0.3110	1.05e-01	-9.78e-03	2.35e-01	1.54e-01	-3.21e-02	7.34e-02	1.69e-01	8.98e-01	2.14e-03	4.41e-02	6.75e-01	3.38e-01
GOBP POSITIVE REGULATION OF VASCULAR ENDOTHELIAL GROWTH FACTOR SIGNALING PATHWAY	5	9.53e-01	9.61e-01	0.3110	-4.91e-02	1.30e-01	9.22e-03	-2.65e-01	-8.27e-02	2.46e-03	8.49e-01	6.15e-01	9.72e-01	3.04e-01	7.49e-01	9.92e-01
GOMF STRUCTURAL MOLECULE ACTIVITY	525	1.29e-25	8.71e-24	0.3110	-5.97e-02	-2.83e-01	-1.01e-01	8.86e-03	-5.15e-02	-1.37e-02	1.94e-02	1.30e-28	7.77e-05	7.29e-01	4.38e-02	5.93e-01
GOBP RNA POLYMERASE II PREINITIATION COMPLEX ASSEMBLY	53	1.49e-02	4.73e-02	0.3110	-6.83e-02	-1.76e-01	-1.35e-01	1.77e-01	6.68e-02	8.24e-02	3.90e-01	2.70e-02	8.80e-02	2.54e-02	4.00e-01	3.00e-01
GOMF PROTEIN HORMONE RECEPTOR ACTIVITY	15	4.37e-01	5.45e-01	0.3110	-1.64e-01	1.07e-02	2.07e-01	6.66e-02	-1.08e-01	1.04e-01	2.71e-01	9.43e-01	1.65e-01	6.55e-01	4.71e-01	4.87e-01
GOBP POSITIVE REGULATION OF INTERFERON BETA PRODUCTION	39	1.99e-02	5.90e-02	0.3110	-1.87e-01	-2.34e-02	-6.67e-02	6.29e-02	2.84e-02	2.28e-01	4.37e-02	8.01e-01	4.71e-01	4.96e-01	7.59e-01	1.38e-02
GOBP NEGATIVE REGULATION OF GLUCOSE TRANSMEMBRANE TRANSPORT	16	1.85e-01	3.00e-01	0.3110	-1.75e-01	-1.81e-01	2.61e-02	-1.30e-01	1.09e-01	-6.22e-02	2.25e-01	2.11e-01	8.56e-01	3.68e-01	4.52e-01	6.67e-01
GOBP REGULATION OF POSTSYNAPTIC DENSITY ASSEMBLY	8	7.34e-01	7.88e-01	0.3110	-1.88e-01	-1.35e-01	-5.72e-02	1.24e-01	3.64e-02	-1.52e-01	3.58e-01	5.09e-01	7.79e-01	5.43e-01	8.58e-01	4.57e-01
GOBP SOMATIC STEM CELL DIVISION	9	9.54e-01	9.62e-01	0.3110	6.66e-02	1.28e-01	-6.38e-02	1.44e-01	2.18e-01	-5.65e-02	7.29e-01	5.06e-01	7.40e-01	4.54e-01	2.57e-01	7.69e-01
GOBP POSITIVE REGULATION OF T CELL CYTOKINE PRODUCTION	25	1.84e-01	2.99e-01	0.3110	-9.81e-02	1.13e-01	1.05e-01	-7.88e-02	-2.31e-01	5.82e-02	3.96e-01	3.27e-01	3.62e-01	4.95e-01	4.58e-02	6.14e-01
GOBP POSITIVE REGULATION OF CALCIUM ION IMPORT	19	4.53e-01	5.58e-01	0.3100	1.03e-01	1.48e-01	2.25e-01	-5.68e-02	-7.49e-02	-6.50e-02	4.37e-01	2.63e-01	8.95e-02	6.68e-01	5.72e-01	6.24e-01
GOBP NUCLEUS ORGANIZATION	139	4.98e-09	7.28e-08	0.3100	-2.29e-01	-1.12e-01	2.71e-02	1.10e-01	-6.47e-02	1.20e-01	3.23e-06	2.31e-02	5.81e-01	2.45e-02	1.88e-01	1.47e-02
GOBP N ACETYLGLUCOSAMINE METABOLIC PROCESS	14	7.22e-01	7.79e-01	0.3100	4.97e-03	3.36e-02	-1.21e-01	2.48e-01	1.36e-01	-1.15e-02	9.74e-01	8.27e-01	4.33e-01	1.08e-01	3.77e-01	9.41e-01
GOMF NOTCH BINDING	19	6.31e-01	7.07e-01	0.3100	9.74e-02	1.48e-01	1.53e-01	1.87e-01	7.77e-02	1.35e-02	4.63e-01	2.64e-01	2.47e-01	1.58e-01	5.57e-01	9.19e-01
GOBP CELLULAR RESPONSE TO IRON ION	7	9.23e-01	9.35e-01	0.3100	2.27e-01	7.78e-02	-1.26e-01	3.51e-02	7.84e-02	-1.23e-01	2.98e-01	7.22e-01	5.63e-01	8.72e-01	7.19e-01	5.72e-01
GOBP REGULATION OF CARDIOCYTE DIFFERENTIATION	15	4.48e-01	5.55e-01	0.3100	-2.50e-01	-9.49e-02	-6.87e-02	5.98e-02	1.20e-01	-4.43e-02	9.37e-02	5.24e-01	6.45e-01	6.88e-01	4.21e-01	7.66e-01
GOBP NEGATIVE REGULATION OF CELL CYCLE G2 M PHASE TRANSITION	67	2.03e-03	9.31e-03	0.3100	-1.60e-01	-1.76e-01	-2.34e-02	1.34e-01	-1.38e-02	1.44e-01	2.33e-02	1.26e-02	7.41e-01	5.84e-02	8.45e-01	4.16e-02
GOBP REGULATION OF WOUND HEALING	96	1.71e-05	1.37e-04	0.3100	-6.88e-02	-7.57e-02	2.45e-01	-8.08e-02	-1.28e-01	5.21e-02	2.44e-01	2.00e-01	3.34e-05	1.71e-01	3.02e-02	3.78e-01
GOMF MODIFICATION DEPENDENT PROTEIN BINDING	181	2.77e-08	3.68e-07	0.3100	3.95e-02	7.94e-02	-1.62e-02	2.70e-01	1.23e-01	-2.53e-03	3.60e-01	6.56e-02	7.08e-01	3.83e-10	4.26e-03	9.53e-01
GOBP NEGATIVE REGULATION OF PROTEIN CONTAINING COMPLEX DISASSEMBLY	71	2.01e-02	5.93e-02	0.3100	5.09e-02	1.17e-01	2.15e-01	1.32e-01	2.31e-02	1.25e-01	4.58e-01	8.81e-02	1.77e-03	5.39e-02	7.36e-01	6.92e-02
GOBP 3 UTR MEDIATED MRNA DESTABILIZATION	18	2.33e-01	3.51e-01	0.3100	4.92e-02	1.19e-01	7.35e-02	3.69e-02	-9.28e-02	-2.53e-01	7.18e-01	3.80e-01	5.89e-01	7.87e-01	4.96e-01	6.35e-02
GOBP POSITIVE REGULATION OF RESPONSE TO CYTOKINE STIMULUS	60	1.74e-02	5.29e-02	0.3100	-1.66e-02	1.08e-01	1.66e-01	1.72e-01	6.43e-02	1.50e-01	8.24e-01	1.49e-01	2.60e-02	2.10e-02	3.89e-01	4.41e-02
GOBP ENTEROENDOCRINE CELL DIFFERENTIATION	20	2.48e-01	3.67e-01	0.3100	-8.03e-02	-1.33e-01	1.46e-01	9.65e-02	-2.02e-01	2.07e-03	5.34e-01	3.03e-01	2.57e-01	4.55e-01	1.17e-01	9.87e-01
GOMF L GLUTAMATE TRANSMEMBRANE TRANSPORTER ACTIVITY	10	7.81e-01	8.24e-01	0.3090	1.09e-01	-9.29e-02	1.42e-01	-1.20e-02	-3.21e-02	2.32e-01	5.52e-01	6.11e-01	4.38e-01	9.47e-01	8.60e-01	2.03e-01
GOBP POSITIVE REGULATION OF TRANSPORTER ACTIVITY	69	4.68e-02	1.12e-01	0.3090	5.91e-02	1.34e-01	1.65e-01	7.38e-02	1.15e-01	1.69e-01	3.96e-01	5.47e-02	1.81e-02	2.89e-01	9.85e-02	1.51e-02
GOBP MUSCLE ORGAN MORPHOGENESIS	42	2.03e-01	3.19e-01	0.3090	8.83e-02	1.85e-01	1.12e-01	1.24e-01	4.71e-02	1.54e-01	3.22e-01	3.82e-02	2.10e-01	1.66e-01	5.98e-01	8.38e-02
GOBP MEMBRANE DOCKING	74	5.81e-04	3.18e-03	0.3090	-2.64e-01	-6.10e-02	4.42e-02	1.88e-02	-5.86e-03	1.42e-01	8.87e-05	3.65e-01	5.11e-01	7.79e-01	9.31e-01	3.47e-02
GOBP VASOCONSTRICTION	48	7.36e-02	1.57e-01	0.3090	-7.41e-02	3.40e-02	2.16e-01	-1.63e-01	-9.90e-02	7.52e-02	3.74e-01	6.83e-01	9.48e-03	5.02e-02	2.35e-01	3.67e-01
GOBP SPHINGOLIPID METABOLIC PROCESS	137	2.28e-04	1.41e-03	0.3090	-1.74e-01	-8.78e-02	1.07e-01	-7.14e-02	-1.40e-01	1.47e-01	4.50e-04	7.61e-02	3.07e-02	1.49e-01	4.77e-03	2.90e-03
GOMF NUCLEASE ACTIVITY	204	2.78e-08	3.69e-07	0.3090	-6.69e-02	-1.65e-01	-2.00e-01	1.16e-01	9.80e-02	-3.21e-02	9.95e-02	4.98e-05	8.91e-07	4.21e-03	1.59e-02	4.30e-01
GOCC COP9 SIGNALOSOME	36	1.84e-01	2.99e-01	0.3090	8.92e-02	-1.26e-01	-1.35e-01	2.12e-01	8.25e-02	-4.18e-02	3.54e-01	1.91e-01	1.63e-01	2.74e-02	3.92e-01	6.64e-01
GOBP POSITIVE REGULATION OF LIPID TRANSPORT	62	6.65e-03	2.48e-02	0.3090	-1.22e-03	7.73e-02	2.65e-01	6.96e-02	1.63e-02	1.19e-01	9.87e-01	2.93e-01	3.03e-04	3.43e-01	8.24e-01	1.06e-01
GOBP PHAGOCYTOSIS	207	6.38e-14	1.57e-12	0.3090	-1.52e-01	3.85e-02	1.97e-01	8.88e-02	6.67e-03	1.55e-01	1.69e-04	3.40e-01	9.78e-07	2.77e-02	8.69e-01	1.16e-04
GOBP RESPONSE TO ENDOPLASMIC RETICULUM STRESS	240	8.27e-14	2.02e-12	0.3090	-2.01e-01	-9.39e-02	8.26e-02	7.31e-02	-1.02e-01	1.55e-01	8.68e-08	1.22e-02	2.75e-02	5.12e-02	6.76e-03	3.61e-05
GOMF NEUTRAL L AMINO ACID TRANSMEMBRANE TRANSPORTER ACTIVITY	29	1.47e-01	2.57e-01	0.3090	6.36e-02	-6.20e-02	8.51e-02	7.93e-02	-2.22e-01	1.58e-01	5.53e-01	5.63e-01	4.28e-01	4.60e-01	3.86e-02	1.42e-01
GOBP FOREBRAIN NEURON DIFFERENTIATION	26	1.59e-01	2.72e-01	0.3090	-1.14e-01	1.14e-01	1.71e-01	8.11e-02	1.34e-01	1.25e-01	3.14e-01	3.14e-01	1.31e-01	4.74e-01	2.37e-01	2.70e-01
GOBP NEURAL RETINA DEVELOPMENT	44	4.18e-02	1.03e-01	0.3090	3.71e-02	2.47e-01	1.77e-01	2.31e-03	-2.50e-03	-4.27e-02	6.70e-01	4.60e-03	4.24e-02	9.79e-01	9.77e-01	6.24e-01
GOBP METANEPHRIC NEPHRON DEVELOPMENT	20	3.24e-01	4.43e-01	0.3090	-1.56e-01	1.26e-02	4.45e-02	-2.57e-01	5.36e-02	-1.40e-02	2.28e-01	9.22e-01	7.31e-01	4.67e-02	6.78e-01	9.14e-01
GOBP POSITIVE REGULATION OF OXIDOREDUCTASE ACTIVITY	30	1.08e-02	3.66e-02	0.3090	-1.42e-01	-1.36e-01	1.53e-01	8.82e-02	1.18e-01	1.09e-01	1.78e-01	1.99e-01	1.48e-01	4.03e-01	2.63e-01	3.02e-01
GOMF L AMINO ACID TRANSMEMBRANE TRANSPORTER ACTIVITY	46	1.77e-02	5.36e-02	0.3090	-3.80e-02	-1.90e-01	-2.92e-02	1.36e-01	-1.93e-01	3.31e-02	6.56e-01	2.57e-02	7.32e-01	1.11e-01	2.32e-02	6.98e-01
GOBP LIPID IMPORT INTO CELL	18	8.35e-02	1.72e-01	0.3090	-1.64e-01	-2.11e-04	2.54e-01	-5.01e-02	-2.55e-02	-3.26e-02	2.29e-01	9.99e-01	6.24e-02	7.13e-01	8.51e-01	8.11e-01
GOBP RESPONSE TO ESTRADIOL	82	4.98e-04	2.79e-03	0.3090	-5.77e-02	2.57e-02	2.67e-01	1.50e-02	-3.66e-02	1.37e-01	3.67e-01	6.87e-01	2.96e-05	8.15e-01	5.67e-01	3.24e-02
GOBP ADAPTIVE IMMUNE RESPONSE	616	7.04e-25	4.44e-23	0.3090	9.57e-02	5.33e-02	7.14e-02	2.12e-01	7.63e-02	1.66e-01	5.05e-05	2.39e-02	2.49e-03	3.02e-19	1.23e-03	2.01e-12
GOBP REGULATION OF ACTIVIN RECEPTOR SIGNALING PATHWAY	20	3.40e-02	8.80e-02	0.3090	-1.39e-01	1.15e-01	1.77e-01	1.62e-01	-1.84e-02	-6.88e-02	2.82e-01	3.73e-01	1.70e-01	2.11e-01	8.87e-01	5.94e-01
GOBP DOUBLE STRAND BREAK REPAIR	293	1.13e-16	3.55e-15	0.3080	-4.02e-02	-1.12e-01	-1.01e-01	2.49e-01	7.95e-02	4.99e-02	2.37e-01	1.02e-03	2.95e-03	2.12e-13	1.92e-02	1.42e-01
GOBP GOLGI TO PLASMA MEMBRANE PROTEIN TRANSPORT	39	5.84e-02	1.32e-01	0.3080	-9.39e-02	3.22e-03	8.63e-02	6.11e-02	1.62e-01	2.21e-01	3.10e-01	9.72e-01	3.51e-01	5.09e-01	8.05e-02	1.68e-02
GOBP AMYLOID PRECURSOR PROTEIN METABOLIC PROCESS	67	2.61e-03	1.15e-02	0.3080	-1.78e-01	-9.11e-02	1.19e-01	2.39e-02	-1.87e-01	7.47e-02	1.16e-02	1.97e-01	9.35e-02	7.35e-01	8.27e-03	2.90e-01
GOMF CYCLIC NUCLEOTIDE PHOSPHODIESTERASE ACTIVITY	21	5.65e-01	6.53e-01	0.3080	-3.95e-02	1.33e-01	1.72e-01	9.25e-02	2.62e-02	1.92e-01	7.54e-01	2.91e-01	1.73e-01	4.63e-01	8.36e-01	1.27e-01
GOCC CIS GOLGI NETWORK	60	2.64e-03	1.16e-02	0.3080	-9.99e-02	6.05e-02	8.95e-02	1.46e-01	-2.34e-02	2.27e-01	1.81e-01	4.17e-01	2.31e-01	5.12e-02	7.54e-01	2.33e-03
GOBP VESICLE MEDIATED TRANSPORT TO THE PLASMA MEMBRANE	138	6.81e-08	8.52e-07	0.3080	-1.10e-01	4.63e-02	1.40e-01	1.52e-01	7.93e-02	1.78e-01	2.53e-02	3.48e-01	4.62e-03	1.99e-03	1.08e-01	3.07e-04
GOBP LEUKOCYTE CHEMOTAXIS	178	3.04e-08	4.00e-07	0.3080	-1.37e-02	4.54e-02	2.69e-01	2.66e-02	-4.26e-02	1.33e-01	7.52e-01	2.97e-01	5.63e-10	5.41e-01	3.27e-01	2.21e-03
GOBP NEGATIVE REGULATION OF PROTEIN CATABOLIC PROCESS	101	1.86e-04	1.18e-03	0.3080	-1.65e-01	-1.41e-01	7.47e-02	5.07e-02	-1.50e-01	1.31e-01	4.11e-03	1.42e-02	1.95e-01	3.78e-01	9.22e-03	2.31e-02
GOBP ENTRAINMENT OF CIRCADIAN CLOCK	24	2.31e-01	3.49e-01	0.3080	5.75e-02	4.15e-02	2.96e-02	2.73e-01	6.73e-02	-9.91e-02	6.26e-01	7.25e-01	8.02e-01	2.05e-02	5.68e-01	4.01e-01
GOBP POSITIVE REGULATION OF CYTOSOLIC CALCIUM ION CONCENTRATION	118	1.95e-04	1.23e-03	0.3080	3.37e-02	4.38e-02	2.62e-01	2.26e-02	-3.65e-02	1.45e-01	5.28e-01	4.11e-01	8.50e-07	6.71e-01	4.93e-01	6.43e-03
GOBP NEGATIVE REGULATION OF NEURON DIFFERENTIATION	44	1.25e-01	2.30e-01	0.3080	-1.23e-01	5.15e-02	1.90e-01	-1.70e-02	-8.86e-02	1.81e-01	1.57e-01	5.54e-01	2.96e-02	8.46e-01	3.09e-01	3.75e-02
GOMF EPHRIN RECEPTOR BINDING	24	4.72e-02	1.12e-01	0.3080	-1.15e-01	1.44e-01	1.21e-01	1.24e-01	-1.54e-01	8.37e-02	3.28e-01	2.23e-01	3.05e-01	2.92e-01	1.91e-01	4.78e-01
GOBP DNA DAMAGE RESPONSE SIGNAL TRANSDUCTION BY P53 CLASS MEDIATOR RESULTING IN CELL CYCLE ARREST	17	4.38e-01	5.45e-01	0.3080	8.17e-02	-1.05e-01	-2.71e-03	2.35e-01	8.77e-02	-1.18e-01	5.60e-01	4.52e-01	9.85e-01	9.28e-02	5.31e-01	4.01e-01
GOBP POSITIVE REGULATION OF VASCULAR ASSOCIATED SMOOTH MUSCLE CELL PROLIFERATION	31	5.24e-02	1.21e-01	0.3080	-9.07e-02	2.10e-01	2.05e-01	6.65e-04	-1.49e-02	-2.91e-03	3.82e-01	4.26e-02	4.82e-02	9.95e-01	8.86e-01	9.78e-01
GOBP LYMPHOCYTE ACTIVATION INVOLVED IN IMMUNE RESPONSE	184	7.57e-07	8.09e-06	0.3080	3.20e-02	1.40e-01	1.51e-01	1.68e-01	5.84e-02	1.41e-01	4.55e-01	1.10e-03	4.05e-04	8.60e-05	1.72e-01	1.01e-03
GOBP REGULATION OF SMOOTHENED SIGNALING PATHWAY	69	1.74e-03	8.17e-03	0.3080	-1.64e-02	2.08e-01	-7.38e-02	1.51e-01	1.51e-01	1.24e-02	8.13e-01	2.82e-03	2.89e-01	3.03e-02	3.00e-02	8.59e-01
GOCC INTRACELLULAR PROTEIN CONTAINING COMPLEX	845	1.88e-48	5.28e-46	0.3080	-1.61e-01	-1.88e-01	-9.55e-02	1.29e-01	-2.53e-02	8.37e-02	1.80e-15	1.69e-20	2.45e-06	2.17e-10	2.12e-01	3.63e-05
GOBP AXONAL TRANSPORT	61	3.91e-02	9.80e-02	0.3070	-9.47e-02	3.07e-02	1.41e-01	-8.36e-03	-5.93e-02	2.47e-01	2.01e-01	6.78e-01	5.75e-02	9.10e-01	4.23e-01	8.34e-04
GOMF PROTEIN TYROSINE SERINE THREONINE PHOSPHATASE ACTIVITY	21	3.22e-01	4.41e-01	0.3070	-2.66e-02	1.16e-01	-8.14e-02	7.59e-02	5.39e-02	-2.55e-01	8.33e-01	3.57e-01	5.19e-01	5.47e-01	6.69e-01	4.32e-02
GOBP NEGATIVE REGULATION OF VASCULATURE DEVELOPMENT	78	5.39e-04	2.98e-03	0.3070	-2.66e-02	1.59e-01	2.08e-01	7.74e-02	1.16e-01	7.63e-02	6.84e-01	1.52e-02	1.51e-03	2.37e-01	7.69e-02	2.44e-01
GOBP FATTY ACYL COA BIOSYNTHETIC PROCESS	25	5.11e-01	6.06e-01	0.3070	-9.07e-02	-1.33e-01	1.41e-01	-2.37e-02	-1.10e-01	1.89e-01	4.33e-01	2.50e-01	2.23e-01	8.37e-01	3.41e-01	1.01e-01
GOBP VACUOLAR TRANSPORT	156	3.76e-10	6.40e-09	0.3070	-2.02e-01	-4.05e-02	7.96e-02	1.20e-01	-2.73e-02	1.74e-01	1.30e-05	3.83e-01	8.64e-02	9.60e-03	5.56e-01	1.83e-04
GOBP REGULATION OF PROTON TRANSPORT	15	3.57e-01	4.73e-01	0.3070	-5.66e-03	-2.17e-01	1.38e-01	3.94e-02	3.17e-02	1.60e-01	9.70e-01	1.46e-01	3.54e-01	7.92e-01	8.32e-01	2.85e-01
GOBP POSITIVE REGULATION OF CD4 POSITIVE ALPHA BETA T CELL DIFFERENTIATION	34	4.44e-03	1.77e-02	0.3070	-1.20e-01	7.14e-02	2.00e-01	1.67e-01	7.95e-02	2.49e-02	2.27e-01	4.71e-01	4.38e-02	9.25e-02	4.22e-01	8.01e-01
GOMF PHOSPHOLIPASE C ACTIVITY	23	6.24e-01	7.01e-01	0.3070	6.45e-02	1.78e-01	1.89e-01	1.05e-01	1.94e-02	1.05e-01	5.92e-01	1.39e-01	1.17e-01	3.82e-01	8.72e-01	3.83e-01
GOBP INTRACELLULAR LIPID TRANSPORT	44	1.97e-02	5.87e-02	0.3070	-7.74e-02	2.96e-02	1.16e-01	2.23e-01	7.11e-02	1.38e-01	3.75e-01	7.34e-01	1.85e-01	1.05e-02	4.14e-01	1.13e-01
GOBP 5 PHOSPHORIBOSE 1 DIPHOSPHATE METABOLIC PROCESS	5	8.86e-01	9.07e-01	0.3060	-6.08e-02	-8.61e-02	-1.36e-01	1.14e-02	7.76e-02	2.41e-01	8.14e-01	7.39e-01	5.98e-01	9.65e-01	7.64e-01	3.51e-01
GOBP REGULATION OF LIPID TRANSPORT	100	3.91e-06	3.65e-05	0.3060	-4.78e-02	2.32e-02	2.63e-01	8.85e-02	-7.71e-02	8.91e-02	4.09e-01	6.89e-01	5.33e-06	1.26e-01	1.83e-01	1.24e-01
GOMF PHOSPHATIDYLINOSITOL 3 KINASE BINDING	22	1.52e-01	2.63e-01	0.3060	-2.10e-01	-5.79e-02	1.73e-01	6.17e-02	-7.65e-02	8.27e-02	8.78e-02	6.38e-01	1.61e-01	6.16e-01	5.34e-01	5.02e-01
GOBP POSITIVE REGULATION OF INSULIN SECRETION INVOLVED IN CELLULAR RESPONSE TO GLUCOSE STIMULUS	22	3.14e-01	4.34e-01	0.3060	-1.87e-01	-3.07e-04	-1.55e-01	1.28e-01	1.21e-01	-6.02e-02	1.28e-01	9.98e-01	2.07e-01	2.99e-01	3.27e-01	6.25e-01
GOBP PHENOL CONTAINING COMPOUND BIOSYNTHETIC PROCESS	30	8.30e-02	1.71e-01	0.3060	-2.01e-01	2.19e-02	1.64e-02	7.21e-02	1.86e-01	1.14e-01	5.70e-02	8.36e-01	8.76e-01	4.94e-01	7.80e-02	2.80e-01
GOBP COCHLEA DEVELOPMENT	27	2.06e-01	3.23e-01	0.3060	-8.06e-02	1.09e-01	1.95e-02	1.39e-01	1.13e-01	2.07e-01	4.68e-01	3.25e-01	8.61e-01	2.10e-01	3.11e-01	6.30e-02
GOCC LIPID DROPLET	87	1.47e-04	9.51e-04	0.3060	-1.08e-01	-8.36e-02	2.00e-01	7.15e-02	-1.16e-01	1.28e-01	8.26e-02	1.78e-01	1.24e-03	2.49e-01	6.08e-02	3.96e-02
GOBP MACROPHAGE MIGRATION	44	1.00e-01	1.96e-01	0.3060	-7.19e-02	-1.82e-01	1.35e-01	-1.25e-02	-1.75e-01	7.97e-02	4.10e-01	3.71e-02	1.21e-01	8.86e-01	4.45e-02	3.60e-01
GOBP FATTY ACYL COA METABOLIC PROCESS	38	3.11e-01	4.31e-01	0.3060	-8.18e-02	-1.32e-01	1.38e-01	-5.58e-02	-1.60e-01	1.48e-01	3.83e-01	1.58e-01	1.42e-01	5.52e-01	8.80e-02	1.15e-01
GOBP APOPTOTIC CELL CLEARANCE	41	1.58e-03	7.50e-03	0.3060	-1.89e-01	-4.44e-02	2.25e-01	-5.06e-02	1.30e-02	5.23e-02	3.65e-02	6.23e-01	1.28e-02	5.75e-01	8.86e-01	5.62e-01
GOMF ATPASE ACTIVATOR ACTIVITY	26	1.33e-01	2.40e-01	0.3060	-7.86e-02	-2.31e-01	5.68e-02	-3.38e-03	3.84e-02	1.72e-01	4.88e-01	4.19e-02	6.16e-01	9.76e-01	7.35e-01	1.29e-01
GOBP LIPOPOLYSACCHARIDE MEDIATED SIGNALING PATHWAY	50	1.79e-03	8.34e-03	0.3060	-2.09e-01	-1.74e-03	1.93e-01	-6.99e-02	2.57e-02	8.46e-02	1.07e-02	9.83e-01	1.81e-02	3.93e-01	7.54e-01	3.01e-01
GOBP G PROTEIN COUPLED RECEPTOR SIGNALING PATHWAY COUPLED TO CYCLIC NUCLEOTIDE SECOND MESSENGER	23	5.79e-01	6.64e-01	0.3060	9.58e-03	1.76e-01	2.19e-01	-6.26e-02	-2.88e-02	9.93e-02	9.37e-01	1.44e-01	6.96e-02	6.03e-01	8.11e-01	4.10e-01
GOBP NEGATIVE REGULATION OF CYTOPLASMIC PATTERN RECOGNITION RECEPTOR SIGNALING PATHWAY	48	1.11e-02	3.74e-02	0.3060	-1.80e-01	-1.35e-01	-7.82e-02	1.74e-01	-3.46e-04	8.10e-02	3.12e-02	1.05e-01	3.48e-01	3.72e-02	9.97e-01	3.32e-01
GOBP HIGH DENSITY LIPOPROTEIN PARTICLE REMODELING	12	2.82e-01	4.02e-01	0.3060	1.09e-02	-5.31e-02	9.44e-02	1.15e-01	-1.91e-02	-2.61e-01	9.48e-01	7.50e-01	5.71e-01	4.90e-01	9.09e-01	1.18e-01
GOBP SKELETAL MUSCLE CELL DIFFERENTIATION	51	1.88e-03	8.70e-03	0.3060	-1.84e-02	1.41e-01	4.35e-02	-9.13e-02	1.97e-01	-1.55e-01	8.20e-01	8.07e-02	5.91e-01	2.59e-01	1.49e-02	5.54e-02
GOBP NEGATIVE CHEMOTAXIS	33	1.48e-01	2.59e-01	0.3060	9.09e-03	2.18e-01	2.07e-01	-3.49e-02	-4.26e-02	-8.04e-03	9.28e-01	3.03e-02	3.99e-02	7.29e-01	6.72e-01	9.36e-01
GOBP PEPTIDYL PROLINE HYDROXYLATION TO 4 HYDROXY L PROLINE	7	8.52e-01	8.80e-01	0.3060	-2.01e-01	-2.20e-01	1.42e-02	-4.05e-02	-3.38e-03	-5.34e-02	3.57e-01	3.14e-01	9.48e-01	8.53e-01	9.88e-01	8.07e-01
GOMF PEPTIDYL PROLINE 4 DIOXYGENASE ACTIVITY	7	8.52e-01	8.80e-01	0.3060	-2.01e-01	-2.20e-01	1.42e-02	-4.05e-02	-3.38e-03	-5.34e-02	3.57e-01	3.14e-01	9.48e-01	8.53e-01	9.88e-01	8.07e-01
GOBP CHROMOSOME ORGANIZATION	567	1.34e-34	1.75e-32	0.3050	-2.36e-02	-1.54e-01	-6.28e-04	2.17e-01	8.59e-03	1.47e-01	3.38e-01	3.22e-10	9.80e-01	8.29e-19	7.27e-01	2.36e-09
GOBP EPOXIDE METABOLIC PROCESS	5	9.81e-01	9.84e-01	0.3050	1.19e-01	7.05e-02	-4.99e-02	6.78e-02	2.08e-01	-1.54e-01	6.44e-01	7.85e-01	8.47e-01	7.93e-01	4.20e-01	5.51e-01
GOBP POSITIVE REGULATION OF PROTEIN TARGETING TO MEMBRANE	26	2.34e-01	3.52e-01	0.3050	-8.77e-02	-1.02e-01	7.16e-02	1.21e-01	-1.66e-01	1.67e-01	4.39e-01	3.70e-01	5.28e-01	2.85e-01	1.42e-01	1.41e-01
GOBP RESPONSE TO FORSKOLIN	10	6.92e-01	7.56e-01	0.3050	3.37e-02	1.09e-01	7.15e-02	-8.05e-02	-2.60e-01	2.87e-02	8.54e-01	5.50e-01	6.96e-01	6.60e-01	1.54e-01	8.75e-01
GOBP ENDOMEMBRANE SYSTEM ORGANIZATION	523	2.37e-30	2.36e-28	0.3050	-1.55e-01	-9.82e-02	1.36e-01	8.47e-02	-9.08e-02	1.60e-01	1.20e-09	1.22e-04	9.61e-08	9.28e-04	3.83e-04	4.27e-10
GOBP PARKIN MEDIATED STIMULATION OF MITOPHAGY IN RESPONSE TO MITOCHONDRIAL DEPOLARIZATION	6	9.65e-01	9.71e-01	0.3050	-1.29e-01	-8.68e-02	-1.95e-01	-1.68e-01	-4.37e-02	-2.80e-02	5.85e-01	7.13e-01	4.07e-01	4.76e-01	8.53e-01	9.05e-01
GOBP NEGATIVE REGULATION OF CALCIUM ION TRANSMEMBRANE TRANSPORTER ACTIVITY	15	5.92e-01	6.75e-01	0.3050	-1.30e-01	-2.11e-01	2.94e-02	-7.42e-02	1.06e-02	1.60e-01	3.83e-01	1.58e-01	8.44e-01	6.19e-01	9.43e-01	2.85e-01
GOBP FOAM CELL DIFFERENTIATION	29	9.11e-02	1.83e-01	0.3050	-2.06e-01	-8.51e-02	1.57e-01	-1.23e-01	-6.10e-02	7.51e-03	5.47e-02	4.27e-01	1.44e-01	2.52e-01	5.69e-01	9.44e-01
GOBP VITAMIN K METABOLIC PROCESS	10	7.28e-01	7.83e-01	0.3050	6.52e-02	-9.88e-02	-2.64e-01	3.79e-03	9.21e-02	-2.82e-02	7.21e-01	5.88e-01	1.48e-01	9.83e-01	6.14e-01	8.77e-01
GOMF NEUROPEPTIDE RECEPTOR BINDING	10	7.97e-01	8.36e-01	0.3050	1.55e-01	-8.09e-02	2.60e-02	2.03e-01	1.21e-01	-7.80e-02	3.96e-01	6.58e-01	8.87e-01	2.66e-01	5.08e-01	6.69e-01
GOBP TERPENOID BIOSYNTHETIC PROCESS	10	8.34e-01	8.66e-01	0.3050	-2.32e-02	-3.50e-02	5.94e-02	1.05e-01	9.24e-02	2.61e-01	8.99e-01	8.48e-01	7.45e-01	5.65e-01	6.13e-01	1.53e-01
GOMF HEXOSYLTRANSFERASE ACTIVITY	155	3.28e-07	3.70e-06	0.3050	-2.23e-01	-9.57e-02	5.56e-02	-1.14e-02	-1.61e-01	6.92e-02	1.58e-06	3.98e-02	2.32e-01	8.07e-01	5.39e-04	1.37e-01
GOBP REGULATION OF GRANULOCYTE CHEMOTAXIS	41	3.81e-02	9.60e-02	0.3050	-1.04e-01	1.26e-02	2.45e-01	-5.79e-02	5.28e-03	1.37e-01	2.50e-01	8.89e-01	6.73e-03	5.21e-01	9.53e-01	1.29e-01
GOBP FAT SOLUBLE VITAMIN CATABOLIC PROCESS	5	9.15e-01	9.29e-01	0.3050	-2.78e-02	3.70e-03	-2.23e-01	-1.82e-01	9.47e-02	-1.42e-02	9.14e-01	9.89e-01	3.87e-01	4.81e-01	7.14e-01	9.56e-01
GOCC MYOFILAMENT	17	4.67e-01	5.70e-01	0.3050	3.22e-02	4.71e-02	3.74e-02	2.07e-02	1.26e-01	2.68e-01	8.18e-01	7.37e-01	7.90e-01	8.82e-01	3.69e-01	5.54e-02
GOBP CRANIAL SKELETAL SYSTEM DEVELOPMENT	45	1.08e-02	3.65e-02	0.3050	-6.48e-02	9.20e-02	8.57e-02	2.47e-01	6.83e-02	8.59e-02	4.52e-01	2.86e-01	3.20e-01	4.20e-03	4.28e-01	3.19e-01
GOMF BRANCHED CHAIN AMINO ACID TRANSMEMBRANE TRANSPORTER ACTIVITY	8	6.15e-01	6.94e-01	0.3050	-5.13e-02	-9.94e-03	-6.29e-02	2.69e-01	-1.16e-01	-2.17e-02	8.02e-01	9.61e-01	7.58e-01	1.88e-01	5.72e-01	9.15e-01
GOBP CELLULAR RESPONSE TO ESTRADIOL STIMULUS	28	2.10e-01	3.27e-01	0.3050	6.79e-02	4.32e-02	2.81e-01	-1.84e-02	-1.48e-02	8.27e-02	5.34e-01	6.92e-01	1.01e-02	8.66e-01	8.92e-01	4.49e-01
GOCC CYTOPLASMIC SIDE OF PLASMA MEMBRANE	143	3.98e-06	3.70e-05	0.3050	1.34e-03	1.18e-01	2.01e-01	1.19e-01	-6.53e-02	1.42e-01	9.78e-01	1.49e-02	3.36e-05	1.42e-02	1.78e-01	3.39e-03
GOBP RECEPTOR METABOLIC PROCESS	65	6.61e-04	3.57e-03	0.3050	-1.53e-01	-8.56e-02	1.36e-01	1.30e-01	-1.06e-01	1.25e-01	3.29e-02	2.33e-01	5.87e-02	6.95e-02	1.40e-01	8.24e-02
GOBP HEPATICOBILIARY SYSTEM DEVELOPMENT	110	7.98e-06	6.91e-05	0.3050	-3.70e-02	8.38e-02	2.21e-01	1.45e-01	-6.21e-03	1.20e-01	5.03e-01	1.29e-01	6.08e-05	8.58e-03	9.10e-01	3.01e-02
GOBP DETECTION OF BIOTIC STIMULUS	31	6.12e-02	1.37e-01	0.3050	-1.60e-01	2.23e-01	8.14e-02	-7.05e-02	7.28e-02	-2.06e-02	1.23e-01	3.16e-02	4.33e-01	4.97e-01	4.83e-01	8.43e-01
GOBP REGULATION OF PIGMENTATION	12	8.60e-01	8.86e-01	0.3040	-2.01e-01	-7.65e-03	8.29e-02	-9.95e-02	-1.46e-01	1.19e-01	2.29e-01	9.63e-01	6.19e-01	5.51e-01	3.80e-01	4.74e-01
GOMF GUANYL RIBONUCLEOTIDE BINDING	337	4.79e-14	1.19e-12	0.3040	-1.83e-01	-1.87e-01	7.53e-03	1.38e-02	-8.76e-02	1.29e-01	8.32e-09	3.95e-09	8.12e-01	6.63e-01	5.71e-03	4.90e-05
GOBP INTESTINAL ABSORPTION	30	1.82e-01	2.97e-01	0.3040	2.37e-02	1.43e-01	2.41e-01	8.99e-02	5.44e-02	5.04e-02	8.23e-01	1.74e-01	2.25e-02	3.94e-01	6.06e-01	6.33e-01
GOBP RESPONSE TO VITAMIN E	7	8.35e-01	8.67e-01	0.3040	-1.35e-01	-1.33e-01	-5.91e-02	1.98e-01	-1.02e-01	5.99e-02	5.35e-01	5.42e-01	7.87e-01	3.65e-01	6.41e-01	7.84e-01
GOBP CHROMOSOME SEGREGATION	387	7.49e-23	3.97e-21	0.3040	-2.51e-02	-1.50e-01	3.87e-02	2.07e-01	-1.70e-02	1.58e-01	3.97e-01	4.37e-07	1.92e-01	2.63e-12	5.65e-01	9.81e-08
GOBP POSITIVE REGULATION OF DNA REPAIR	122	1.10e-06	1.15e-05	0.3040	-5.23e-02	-1.12e-01	-9.43e-02	2.56e-01	5.31e-02	1.81e-02	3.18e-01	3.27e-02	7.22e-02	1.08e-06	3.11e-01	7.30e-01
GOBP NEUROPEPTIDE SIGNALING PATHWAY	41	1.47e-01	2.57e-01	0.3040	8.04e-02	1.33e-01	2.09e-01	1.45e-01	-1.52e-02	5.99e-02	3.73e-01	1.41e-01	2.05e-02	1.09e-01	8.66e-01	5.07e-01
GOBP REGULATION OF PHOSPHOLIPID METABOLIC PROCESS	24	8.06e-02	1.68e-01	0.3040	-2.44e-01	1.06e-01	-3.95e-02	1.01e-01	6.60e-02	7.57e-02	3.86e-02	3.70e-01	7.37e-01	3.92e-01	5.75e-01	5.21e-01
GOBP POSITIVE REGULATION OF JUN KINASE ACTIVITY	25	3.17e-01	4.36e-01	0.3040	-6.63e-02	1.43e-01	-6.02e-02	4.97e-02	2.09e-01	-1.33e-01	5.66e-01	2.14e-01	6.02e-01	6.67e-01	7.02e-02	2.50e-01
GOBP POSITIVE REGULATION OF PHOSPHOLIPASE ACTIVITY	28	2.49e-01	3.68e-01	0.3040	4.42e-02	-3.79e-02	1.61e-01	1.15e-01	-1.99e-01	1.02e-01	6.85e-01	7.28e-01	1.40e-01	2.94e-01	6.88e-02	3.49e-01
GOBP NEGATIVE REGULATION OF LEUKOCYTE APOPTOTIC PROCESS	48	1.73e-01	2.87e-01	0.3040	5.01e-02	3.92e-02	1.71e-01	1.08e-01	-1.28e-02	2.18e-01	5.48e-01	6.38e-01	4.08e-02	1.95e-01	8.78e-01	9.08e-03
GOBP T HELPER 1 TYPE IMMUNE RESPONSE	44	1.15e-02	3.86e-02	0.3040	-5.76e-02	1.39e-01	2.34e-01	3.57e-02	-1.16e-01	1.70e-02	5.09e-01	1.10e-01	7.31e-03	6.82e-01	1.83e-01	8.45e-01
GOBP VASCULAR ENDOTHELIAL GROWTH FACTOR SIGNALING PATHWAY	31	1.82e-01	2.96e-01	0.3040	-6.01e-02	-3.90e-02	2.47e-01	7.94e-03	-4.00e-02	1.57e-01	5.62e-01	7.07e-01	1.75e-02	9.39e-01	7.00e-01	1.29e-01
GOMF DEATH RECEPTOR BINDING	17	5.27e-01	6.19e-01	0.3040	-9.33e-02	-3.40e-02	1.03e-01	1.79e-01	2.91e-02	1.98e-01	5.05e-01	8.08e-01	4.64e-01	2.02e-01	8.35e-01	1.58e-01
GOBP REGULATION OF XENOPHAGY	9	8.09e-01	8.46e-01	0.3040	2.16e-02	2.41e-01	7.28e-02	2.86e-02	6.40e-02	-1.54e-01	9.11e-01	2.11e-01	7.05e-01	8.82e-01	7.40e-01	4.24e-01
GOBP POSITIVE REGULATION OF NEURAL PRECURSOR CELL PROLIFERATION	34	2.53e-01	3.73e-01	0.3040	7.80e-03	9.87e-02	2.20e-01	1.14e-01	3.30e-02	1.41e-01	9.37e-01	3.19e-01	2.61e-02	2.49e-01	7.39e-01	1.56e-01
GOBP PROTEIN LOCALIZATION TO GOLGI APPARATUS	29	2.62e-01	3.82e-01	0.3040	-1.15e-02	1.60e-01	1.10e-01	1.34e-01	2.27e-02	1.90e-01	9.15e-01	1.37e-01	3.07e-01	2.13e-01	8.32e-01	7.59e-02
GOMF INOSITOL PHOSPHATE PHOSPHATASE ACTIVITY	18	4.86e-01	5.86e-01	0.3040	-1.97e-02	1.15e-01	1.78e-01	1.60e-01	1.19e-01	8.42e-02	8.85e-01	4.00e-01	1.90e-01	2.39e-01	3.82e-01	5.36e-01
GOBP EMBRYONIC HEMOPOIESIS	21	5.47e-01	6.37e-01	0.3040	-4.11e-02	-7.42e-02	2.18e-01	4.72e-03	-7.47e-02	1.79e-01	7.44e-01	5.56e-01	8.39e-02	9.70e-01	5.54e-01	1.56e-01
GOBP RESPONSE TO ISOQUINOLINE ALKALOID	7	7.82e-01	8.24e-01	0.3040	-2.85e-01	3.54e-02	1.22e-02	4.91e-03	9.51e-02	-2.34e-02	1.92e-01	8.71e-01	9.56e-01	9.82e-01	6.63e-01	9.15e-01
GOBP POSTSYNAPTIC DENSITY ASSEMBLY	16	4.26e-01	5.34e-01	0.3040	-7.77e-02	-1.30e-01	2.10e-01	7.45e-02	-3.39e-02	1.36e-01	5.91e-01	3.69e-01	1.46e-01	6.06e-01	8.14e-01	3.46e-01
GOBP POSITIVE REGULATION OF GTPASE ACTIVITY	170	4.52e-09	6.66e-08	0.3040	4.14e-02	1.17e-01	2.38e-01	1.16e-01	-7.04e-02	4.04e-02	3.52e-01	8.78e-03	8.31e-08	8.86e-03	1.14e-01	3.64e-01
GOBP RESPONSE TO TYPE II INTERFERON	103	8.14e-05	5.64e-04	0.3040	-6.88e-02	3.23e-02	1.38e-01	1.49e-01	9.79e-02	1.89e-01	2.28e-01	5.71e-01	1.58e-02	9.19e-03	8.60e-02	9.11e-04
GOMF CIS TRANS ISOMERASE ACTIVITY	36	4.08e-02	1.01e-01	0.3030	-1.41e-01	-2.34e-01	1.92e-02	-1.99e-02	5.70e-02	1.16e-01	1.42e-01	1.52e-02	8.42e-01	8.36e-01	5.54e-01	2.30e-01
GOBP TUBULIN DEACETYLATION	22	5.94e-01	6.76e-01	0.3030	-1.11e-01	-4.75e-02	-1.80e-01	6.59e-02	1.63e-01	-1.20e-01	3.68e-01	7.00e-01	1.44e-01	5.93e-01	1.86e-01	3.31e-01
GOMF FMN BINDING	12	8.11e-01	8.48e-01	0.3030	3.61e-02	-1.45e-01	-1.22e-01	1.89e-01	3.50e-02	-1.33e-01	8.29e-01	3.84e-01	4.65e-01	2.56e-01	8.34e-01	4.24e-01
GOMF INTRACELLULARLY LIGAND GATED MONOATOMIC ION CHANNEL ACTIVITY	23	2.12e-01	3.29e-01	0.3030	1.09e-01	1.34e-01	1.57e-01	3.25e-02	-1.03e-01	-1.61e-01	3.65e-01	2.65e-01	1.93e-01	7.87e-01	3.93e-01	1.82e-01
GOBP REGULATION OF PHAGOCYTOSIS	83	1.06e-03	5.36e-03	0.3030	-7.03e-02	1.12e-01	2.01e-01	2.55e-02	9.28e-02	1.58e-01	2.68e-01	7.68e-02	1.58e-03	6.89e-01	1.44e-01	1.29e-02
GOMF PYRUVATE DEHYDROGENASE ACETYL TRANSFERRING KINASE ACTIVITY	5	9.06e-01	9.23e-01	0.3030	-9.01e-02	-5.52e-02	7.60e-02	2.47e-01	1.07e-01	5.13e-02	7.27e-01	8.31e-01	7.68e-01	3.39e-01	6.77e-01	8.43e-01
GOCC CENTRIOLE	150	1.79e-05	1.43e-04	0.3030	1.08e-03	5.58e-02	-9.29e-02	1.54e-01	2.35e-01	3.74e-02	9.82e-01	2.39e-01	4.97e-02	1.11e-03	7.01e-07	4.29e-01
GOMF ACTIN FILAMENT BINDING	177	1.88e-08	2.56e-07	0.3030	-1.22e-02	-3.99e-02	2.17e-01	1.10e-01	-1.11e-01	1.36e-01	7.79e-01	3.60e-01	6.02e-07	1.14e-02	1.05e-02	1.86e-03
GOBP RESPONSE TO MAGNESIUM ION	16	3.13e-01	4.33e-01	0.3030	-1.87e-01	-1.42e-01	7.05e-02	-7.89e-02	-6.85e-02	-1.44e-01	1.95e-01	3.24e-01	6.25e-01	5.85e-01	6.35e-01	3.18e-01
GOBP STRIATED MUSCLE CONTRACTION	129	1.60e-04	1.03e-03	0.3030	-2.52e-02	7.61e-02	2.44e-01	-7.90e-02	-6.63e-02	1.23e-01	6.21e-01	1.36e-01	1.66e-06	1.21e-01	1.94e-01	1.56e-02
GOCC LAMELLIPODIUM MEMBRANE	17	3.99e-01	5.11e-01	0.3030	-1.22e-01	1.00e-01	2.20e-01	-1.11e-03	8.05e-02	1.10e-01	3.85e-01	4.74e-01	1.16e-01	9.94e-01	5.66e-01	4.31e-01
GOBP SPERM FLAGELLUM ASSEMBLY	33	6.57e-02	1.44e-01	0.3030	3.95e-02	1.60e-01	-6.09e-02	-1.82e-01	1.61e-01	-4.29e-02	6.94e-01	1.11e-01	5.45e-01	7.07e-02	1.09e-01	6.69e-01
GOBP REGULATION OF SUPEROXIDE ANION GENERATION	17	4.71e-01	5.73e-01	0.3030	-1.05e-01	1.15e-02	-1.22e-01	1.77e-01	9.80e-02	-1.59e-01	4.54e-01	9.34e-01	3.85e-01	2.08e-01	4.84e-01	2.58e-01
GOBP POSITIVE REGULATION OF B CELL RECEPTOR SIGNALING PATHWAY	8	4.67e-01	5.70e-01	0.3030	-5.36e-02	1.54e-01	1.12e-02	1.07e-01	-2.27e-01	4.66e-02	7.93e-01	4.52e-01	9.56e-01	5.99e-01	2.66e-01	8.19e-01
GOBP NEGATIVE REGULATION OF INTERLEUKIN 1 PRODUCTION	28	2.82e-02	7.66e-02	0.3030	-6.06e-02	1.77e-01	1.84e-01	1.36e-01	2.71e-02	-6.23e-02	5.79e-01	1.05e-01	9.23e-02	2.14e-01	8.04e-01	5.68e-01
GOBP PROTEIN MATURATION	453	3.10e-22	1.56e-20	0.3030	-1.46e-01	-2.32e-01	-6.97e-03	6.36e-02	-6.91e-02	8.75e-02	9.93e-08	2.41e-17	7.99e-01	2.03e-02	1.17e-02	1.42e-03
GOBP NEUROFILAMENT CYTOSKELETON ORGANIZATION	9	4.84e-01	5.85e-01	0.3030	4.13e-02	7.99e-03	-7.46e-02	3.75e-02	-5.17e-02	2.83e-01	8.30e-01	9.67e-01	6.98e-01	8.46e-01	7.88e-01	1.41e-01
GOBP POSITIVE CHEMOTAXIS	38	2.15e-01	3.32e-01	0.3030	-5.43e-03	-1.85e-01	-2.62e-02	-1.53e-01	-1.81e-01	-2.98e-02	9.54e-01	4.87e-02	7.80e-01	1.04e-01	5.37e-02	7.50e-01
GOBP REGULATION OF BONE RESORPTION	30	4.75e-01	5.77e-01	0.3030	8.94e-02	9.75e-02	2.23e-01	9.82e-02	2.13e-02	1.21e-01	3.96e-01	3.55e-01	3.47e-02	3.52e-01	8.40e-01	2.53e-01
GOBP THIOESTER BIOSYNTHETIC PROCESS	44	5.08e-02	1.19e-01	0.3030	-1.42e-01	-1.26e-01	2.35e-02	1.09e-01	-1.52e-02	2.08e-01	1.04e-01	1.48e-01	7.88e-01	2.13e-01	8.61e-01	1.71e-02
GOMF ESTRADIOL 17 BETA DEHYDROGENASE NAD P ACTIVITY	15	7.59e-01	8.07e-01	0.3030	-7.19e-02	-1.27e-01	-1.87e-01	-8.18e-02	-1.44e-01	-9.06e-02	6.30e-01	3.96e-01	2.10e-01	5.83e-01	3.35e-01	5.44e-01
GOBP B CELL APOPTOTIC PROCESS	25	4.29e-01	5.37e-01	0.3030	3.32e-03	-3.77e-02	2.38e-01	3.95e-02	-1.29e-01	1.23e-01	9.77e-01	7.44e-01	3.92e-02	7.32e-01	2.63e-01	2.87e-01
GOBP MACROPHAGE ACTIVATION INVOLVED IN IMMUNE RESPONSE	17	6.26e-01	7.03e-01	0.3030	-1.13e-02	1.56e-01	1.76e-01	6.92e-02	1.47e-01	9.77e-02	9.36e-01	2.64e-01	2.08e-01	6.21e-01	2.95e-01	4.86e-01
GOBP POSITIVE REGULATION OF CELLULAR RESPONSE TO TRANSFORMING GROWTH FACTOR BETA STIMULUS	25	1.32e-01	2.38e-01	0.3030	-5.69e-02	1.77e-02	2.27e-01	3.37e-02	-1.88e-01	-1.60e-02	6.22e-01	8.78e-01	4.99e-02	7.71e-01	1.04e-01	8.90e-01
GOBP SEQUESTERING OF CALCIUM ION	103	3.69e-05	2.77e-04	0.3020	3.84e-02	-5.11e-02	2.21e-01	1.35e-01	-1.07e-01	9.52e-02	5.01e-01	3.70e-01	1.10e-04	1.80e-02	6.05e-02	9.49e-02
GOBP POSITIVE REGULATION OF ALPHA BETA T CELL ACTIVATION	67	6.97e-04	3.74e-03	0.3020	-5.03e-02	1.13e-01	1.77e-01	1.85e-01	-1.30e-02	1.03e-01	4.77e-01	1.09e-01	1.25e-02	8.92e-03	8.54e-01	1.45e-01
GOBP ESTABLISHMENT OF EPITHELIAL CELL POLARITY	28	3.64e-01	4.80e-01	0.3020	3.36e-02	1.44e-01	2.04e-01	1.38e-01	3.20e-02	8.73e-02	7.58e-01	1.87e-01	6.15e-02	2.06e-01	7.69e-01	4.24e-01
GOBP POSITIVE REGULATION OF CIRCADIAN RHYTHM	10	5.85e-01	6.69e-01	0.3020	-1.76e-01	2.13e-01	-5.89e-02	6.41e-02	8.20e-02	-1.84e-02	3.35e-01	2.42e-01	7.47e-01	7.26e-01	6.54e-01	9.20e-01
GOBP IMP METABOLIC PROCESS	16	5.08e-01	6.03e-01	0.3020	-4.73e-02	-1.92e-01	-6.95e-02	1.46e-01	1.52e-01	5.62e-02	7.43e-01	1.85e-01	6.30e-01	3.12e-01	2.93e-01	6.97e-01
GOBP NEGATIVE REGULATION OF TOLL LIKE RECEPTOR 4 SIGNALING PATHWAY	10	6.19e-01	6.97e-01	0.3020	-2.25e-01	9.27e-02	-5.63e-03	7.62e-02	1.60e-01	-2.42e-02	2.18e-01	6.12e-01	9.75e-01	6.76e-01	3.82e-01	8.94e-01
GOBP MYELOID LEUKOCYTE MIGRATION	174	1.95e-08	2.64e-07	0.3020	-7.39e-02	2.86e-02	2.54e-01	-1.13e-03	-4.61e-02	1.36e-01	9.26e-02	5.15e-01	7.71e-09	9.79e-01	2.95e-01	1.99e-03
GOBP ERBB2 SIGNALING PATHWAY	18	1.24e-01	2.29e-01	0.3020	-2.26e-01	-1.11e-01	8.85e-02	-5.23e-02	-1.07e-02	-1.31e-01	9.71e-02	4.14e-01	5.16e-01	7.01e-01	9.37e-01	3.36e-01
GOMF RECEPTOR ANTAGONIST ACTIVITY	8	9.54e-01	9.62e-01	0.3020	1.32e-01	8.25e-02	2.10e-01	8.28e-02	-9.72e-02	8.05e-02	5.19e-01	6.86e-01	3.03e-01	6.85e-01	6.34e-01	6.93e-01
GOBP FATTY ACID DERIVATIVE METABOLIC PROCESS	64	5.91e-02	1.34e-01	0.3020	-4.95e-02	-1.21e-01	1.59e-01	-6.74e-02	-1.53e-01	1.44e-01	4.94e-01	9.44e-02	2.77e-02	3.51e-01	3.45e-02	4.61e-02
GOBP REGULATION OF SODIUM ION TRANSPORT	61	2.59e-02	7.21e-02	0.3020	-5.86e-02	-1.48e-02	2.43e-01	-4.35e-02	-1.19e-01	1.12e-01	4.29e-01	8.42e-01	1.05e-03	5.57e-01	1.08e-01	1.31e-01
GOBP REGULATION OF GLUTAMATE RECEPTOR SIGNALING PATHWAY	6	8.03e-01	8.41e-01	0.3020	1.21e-01	1.78e-01	-1.03e-01	-1.08e-01	-1.17e-01	-9.35e-02	6.09e-01	4.49e-01	6.64e-01	6.47e-01	6.19e-01	6.92e-01
GOBP METANEPHRIC TUBULE DEVELOPMENT	13	6.15e-01	6.94e-01	0.3020	-4.55e-02	1.43e-01	-1.77e-02	-2.41e-01	9.78e-02	-2.93e-02	7.76e-01	3.74e-01	9.12e-01	1.33e-01	5.41e-01	8.55e-01
GOBP POSITIVE REGULATION OF TRANSCRIPTION BY RNA POLYMERASE III	18	2.30e-01	3.49e-01	0.3020	-2.73e-02	8.21e-02	1.18e-01	2.04e-01	-1.43e-01	8.70e-02	8.41e-01	5.46e-01	3.86e-01	1.34e-01	2.94e-01	5.23e-01
GOCC CATALYTIC COMPLEX	1589	4.96e-84	3.83e-81	0.3020	-1.58e-01	-1.95e-01	-8.60e-02	1.18e-01	-4.41e-02	6.93e-02	1.15e-25	1.57e-38	1.13e-08	5.19e-15	3.44e-03	4.21e-06
GOBP BONE RESORPTION	49	3.70e-02	9.41e-02	0.3020	-1.36e-02	9.33e-02	2.36e-01	1.13e-01	-3.89e-02	1.09e-01	8.69e-01	2.58e-01	4.23e-03	1.71e-01	6.38e-01	1.86e-01
GOBP DETERMINATION OF ADULT LIFESPAN	27	1.69e-01	2.81e-01	0.3010	-5.00e-02	-3.00e-02	-1.73e-01	2.14e-01	7.26e-03	-1.09e-01	6.53e-01	7.88e-01	1.19e-01	5.48e-02	9.48e-01	3.28e-01
GOBP POSITIVE REGULATION OF ERBB SIGNALING PATHWAY	26	1.10e-01	2.09e-01	0.3010	-2.70e-02	3.52e-02	2.92e-01	-1.45e-02	-1.88e-02	5.38e-02	8.12e-01	7.56e-01	9.92e-03	8.98e-01	8.68e-01	6.35e-01
GOBP LYSOSOMAL TRANSPORT	123	3.00e-08	3.94e-07	0.3010	-2.11e-01	-4.47e-02	7.73e-02	1.27e-01	-3.21e-02	1.45e-01	5.31e-05	3.92e-01	1.39e-01	1.46e-02	5.39e-01	5.54e-03
GOBP HYPOTHALAMUS DEVELOPMENT	12	4.79e-01	5.81e-01	0.3010	-7.54e-02	-1.15e-01	6.31e-02	1.72e-01	1.87e-01	5.74e-02	6.51e-01	4.89e-01	7.05e-01	3.04e-01	2.61e-01	7.31e-01
GOBP SPERM CAPACITATION	11	6.58e-01	7.28e-01	0.3010	-4.21e-02	2.01e-01	2.14e-01	-1.08e-02	-3.44e-02	-4.11e-02	8.09e-01	2.49e-01	2.20e-01	9.51e-01	8.43e-01	8.13e-01
GOCC SITE OF DOUBLE STRAND BREAK	94	4.12e-05	3.06e-04	0.3010	-1.18e-01	-1.34e-01	-9.32e-02	1.87e-01	2.81e-02	1.21e-01	4.77e-02	2.53e-02	1.18e-01	1.75e-03	6.38e-01	4.30e-02
GOBP SEMINIFEROUS TUBULE DEVELOPMENT	14	6.70e-01	7.37e-01	0.3010	-3.08e-02	4.46e-02	8.41e-02	-3.20e-02	-9.72e-02	2.65e-01	8.42e-01	7.73e-01	5.86e-01	8.36e-01	5.29e-01	8.61e-02
GOCC KERATIN FILAMENT	14	6.16e-01	6.95e-01	0.3010	-1.41e-01	-2.96e-02	1.66e-01	1.09e-01	-2.00e-02	1.73e-01	3.60e-01	8.48e-01	2.81e-01	4.80e-01	8.97e-01	2.63e-01
GOCC POLE PLASM	16	2.99e-01	4.19e-01	0.3010	-9.91e-02	1.83e-01	2.62e-02	3.03e-02	-3.82e-02	2.11e-01	4.93e-01	2.06e-01	8.56e-01	8.34e-01	7.91e-01	1.44e-01
GOMF G PROTEIN COUPLED GLUTAMATE RECEPTOR BINDING	8	9.62e-01	9.69e-01	0.3010	-8.00e-02	-7.34e-02	6.13e-02	-1.77e-01	-1.64e-01	1.29e-01	6.95e-01	7.19e-01	7.64e-01	3.85e-01	4.22e-01	5.27e-01
GOBP ANOIKIS	29	1.13e-01	2.13e-01	0.3010	6.85e-02	-5.65e-02	1.04e-01	2.57e-01	-7.65e-02	1.10e-02	5.23e-01	5.99e-01	3.33e-01	1.67e-02	4.76e-01	9.19e-01
GOBP RESPONSE TO CADMIUM ION	48	1.36e-02	4.40e-02	0.3010	-1.46e-01	-1.75e-01	1.55e-01	1.05e-03	-8.71e-02	8.34e-02	7.98e-02	3.62e-02	6.28e-02	9.90e-01	2.97e-01	3.17e-01
GOMF PROTEIN FOLDING CHAPERONE BINDING	119	1.35e-05	1.11e-04	0.3010	-1.04e-01	-2.40e-01	1.18e-02	6.80e-02	-4.32e-02	1.24e-01	5.02e-02	6.07e-06	8.23e-01	2.00e-01	4.16e-01	1.94e-02
GOBP POSITIVE REGULATION OF NERVOUS SYSTEM PROCESS	22	1.82e-01	2.96e-01	0.3010	-1.13e-01	2.81e-02	1.98e-01	1.14e-01	9.73e-02	1.24e-01	3.60e-01	8.20e-01	1.08e-01	3.53e-01	4.30e-01	3.15e-01
GOBP RETINA HOMEOSTASIS	37	7.78e-02	1.63e-01	0.3010	-6.99e-02	8.84e-02	-1.65e-01	-1.75e-01	1.24e-01	-6.74e-02	4.62e-01	3.52e-01	8.20e-02	6.55e-02	1.93e-01	4.78e-01
GOBP PHOTOTRANSDUCTION	27	4.76e-01	5.78e-01	0.3010	1.37e-01	1.99e-01	1.09e-01	-3.04e-02	1.09e-01	8.47e-02	2.17e-01	7.32e-02	3.27e-01	7.84e-01	3.27e-01	4.46e-01
GOBP CERAMIDE BIOSYNTHETIC PROCESS	55	6.28e-02	1.40e-01	0.3010	-7.75e-02	-9.29e-03	1.27e-01	-1.63e-03	-1.58e-01	2.08e-01	3.20e-01	9.05e-01	1.05e-01	9.83e-01	4.25e-02	7.62e-03
GOBP CHOLESTEROL STORAGE	21	2.63e-02	7.29e-02	0.3010	-2.08e-01	1.74e-02	1.32e-01	3.53e-02	1.59e-01	-5.50e-02	9.96e-02	8.90e-01	2.96e-01	7.79e-01	2.07e-01	6.62e-01
GOBP REGULATION OF POSTSYNAPTIC SPECIALIZATION ASSEMBLY	10	9.33e-01	9.44e-01	0.3010	1.23e-03	6.46e-02	-1.43e-01	1.42e-01	1.80e-01	-1.14e-01	9.95e-01	7.23e-01	4.33e-01	4.37e-01	3.23e-01	5.33e-01
GOBP REGULATION OF MICROTUBULE BASED MOVEMENT	35	3.28e-01	4.46e-01	0.3000	6.46e-03	-2.12e-02	-2.00e-01	-7.31e-02	9.73e-02	-1.87e-01	9.47e-01	8.28e-01	4.07e-02	4.54e-01	3.19e-01	5.54e-02
GOBP DETECTION OF LIGHT STIMULUS	41	1.24e-01	2.28e-01	0.3000	1.48e-01	2.32e-01	3.33e-02	-4.40e-02	1.04e-01	2.30e-02	1.01e-01	1.01e-02	7.12e-01	6.26e-01	2.49e-01	7.99e-01
GOBP CELL DIVISION	564	4.02e-30	3.93e-28	0.3000	-7.27e-02	-1.27e-01	8.31e-02	1.44e-01	-3.42e-02	2.01e-01	3.17e-03	2.78e-07	7.47e-04	5.69e-09	1.65e-01	3.62e-16
GOBP GOLGI ORGANIZATION	145	2.07e-07	2.41e-06	0.3000	-1.42e-01	2.61e-02	1.22e-01	8.70e-02	-5.76e-02	2.08e-01	3.08e-03	5.87e-01	1.10e-02	7.06e-02	2.31e-01	1.48e-05
GOBP TYPE B PANCREATIC CELL PROLIFERATION	22	5.33e-02	1.23e-01	0.3000	3.73e-03	-3.47e-02	2.01e-01	-1.30e-01	-6.38e-02	-1.66e-01	9.76e-01	7.78e-01	1.02e-01	2.93e-01	6.05e-01	1.77e-01
GOBP NEGATIVE REGULATION OF EPITHELIAL CELL DIFFERENTIATION	26	5.40e-02	1.24e-01	0.3000	-3.57e-02	1.23e-01	2.38e-01	4.55e-02	1.23e-01	-5.84e-03	7.53e-01	2.78e-01	3.58e-02	6.88e-01	2.77e-01	9.59e-01
GOBP PROTEIN DEPHOSPHORYLATION	178	3.44e-09	5.12e-08	0.3000	-1.42e-01	-2.06e-02	1.33e-01	8.02e-02	-1.21e-01	1.76e-01	1.12e-03	6.35e-01	2.21e-03	6.50e-02	5.54e-03	5.03e-05
GOCC RNAI EFFECTOR COMPLEX	31	7.78e-02	1.63e-01	0.3000	-2.17e-01	1.35e-01	1.31e-01	-7.41e-02	-4.96e-03	4.71e-02	3.62e-02	1.94e-01	2.09e-01	4.75e-01	9.62e-01	6.50e-01
GOBP CENTROSOME SEPARATION	15	7.49e-01	8.00e-01	0.3000	6.05e-03	-1.48e-01	1.33e-01	5.45e-02	-1.39e-01	1.68e-01	9.68e-01	3.21e-01	3.74e-01	7.15e-01	3.52e-01	2.59e-01
GOMF NUCLEOBASE CONTAINING COMPOUND KINASE ACTIVITY	39	1.70e-01	2.83e-01	0.3000	-9.93e-02	-2.54e-01	-5.13e-02	2.22e-03	-6.57e-02	9.31e-02	2.83e-01	6.03e-03	5.79e-01	9.81e-01	4.78e-01	3.15e-01
GOBP REGULATION OF RELEASE OF SEQUESTERED CALCIUM ION INTO CYTOSOL	58	2.94e-02	7.90e-02	0.3000	-4.77e-03	-9.20e-02	1.82e-01	6.47e-02	-1.77e-01	1.13e-01	9.50e-01	2.26e-01	1.63e-02	3.94e-01	1.98e-02	1.36e-01
GOBP ODONTOGENESIS OF DENTIN CONTAINING TOOTH	51	6.47e-02	1.43e-01	0.3000	6.16e-02	7.87e-02	2.47e-01	8.93e-02	-6.60e-02	8.10e-02	4.47e-01	3.31e-01	2.26e-03	2.70e-01	4.15e-01	3.17e-01
GOBP POSITIVE REGULATION OF CELLULAR SENESCENCE	11	8.19e-01	8.54e-01	0.3000	-8.31e-02	-1.47e-01	3.56e-02	9.47e-02	-9.99e-02	2.03e-01	6.33e-01	3.99e-01	8.38e-01	5.86e-01	5.66e-01	2.43e-01
GOBP CELLULAR RESPONSE TO ESTROGEN STIMULUS	16	5.83e-01	6.68e-01	0.3000	-9.53e-02	1.20e-01	1.62e-01	7.35e-02	1.21e-01	1.42e-01	5.09e-01	4.05e-01	2.62e-01	6.11e-01	4.00e-01	3.27e-01
GOBP CHEMOKINE C X C MOTIF LIGAND 2 PRODUCTION	17	7.25e-01	7.81e-01	0.3000	-1.54e-01	-1.17e-02	-1.88e-01	-1.33e-01	7.65e-02	-8.54e-02	2.72e-01	9.34e-01	1.79e-01	3.44e-01	5.85e-01	5.42e-01
GOBP CELLULAR RESPONSE TO TYPE II INTERFERON	84	2.22e-03	1.00e-02	0.3000	-6.47e-02	8.41e-02	1.65e-01	1.14e-01	5.83e-02	1.87e-01	3.06e-01	1.83e-01	8.76e-03	7.05e-02	3.56e-01	3.10e-03
GOCC CLATHRIN ADAPTOR COMPLEX	25	1.20e-01	2.24e-01	0.3000	-1.45e-01	-6.99e-02	3.05e-02	2.30e-01	1.00e-03	1.01e-01	2.09e-01	5.45e-01	7.92e-01	4.65e-02	9.93e-01	3.84e-01
GOBP LIGAND GATED ION CHANNEL SIGNALING PATHWAY	22	4.20e-01	5.29e-01	0.3000	3.05e-02	2.15e-01	7.98e-03	-9.49e-03	1.07e-01	-1.76e-01	8.04e-01	8.07e-02	9.48e-01	9.39e-01	3.85e-01	1.52e-01
GOBP UBIQUITIN RECYCLING	13	7.37e-01	7.90e-01	0.3000	-6.56e-02	-6.20e-02	1.58e-01	1.30e-01	-1.11e-01	1.65e-01	6.82e-01	6.99e-01	3.24e-01	4.16e-01	4.88e-01	3.02e-01
GOBP LUNG ASSOCIATED MESENCHYME DEVELOPMENT	7	7.81e-01	8.24e-01	0.3000	-4.11e-02	-1.91e-01	1.61e-01	8.63e-02	-1.30e-01	-3.64e-02	8.51e-01	3.82e-01	4.60e-01	6.92e-01	5.50e-01	8.68e-01
GOBP HUMORAL IMMUNE RESPONSE MEDIATED BY CIRCULATING IMMUNOGLOBULIN	47	1.91e-02	5.71e-02	0.3000	8.78e-02	1.12e-02	1.76e-01	2.17e-01	6.15e-02	1.65e-02	2.98e-01	8.95e-01	3.73e-02	1.01e-02	4.66e-01	8.45e-01
GOBP INNER CELL MASS CELL PROLIFERATION	14	5.42e-01	6.33e-01	0.3000	1.95e-02	-5.41e-02	5.07e-02	1.81e-01	-1.52e-01	1.67e-01	8.99e-01	7.26e-01	7.43e-01	2.40e-01	3.26e-01	2.79e-01
GOBP INORGANIC ION IMPORT ACROSS PLASMA MEMBRANE	79	4.83e-03	1.91e-02	0.3000	-3.31e-03	1.81e-01	2.22e-01	1.36e-02	3.45e-02	7.87e-02	9.59e-01	5.41e-03	6.40e-04	8.35e-01	5.96e-01	2.26e-01
GOBP RESPONSE TO SALT	20	5.41e-01	6.33e-01	0.2990	6.91e-02	-1.09e-01	-9.70e-02	2.26e-02	-9.48e-02	-2.32e-01	5.93e-01	3.97e-01	4.53e-01	8.61e-01	4.63e-01	7.19e-02
GOCC SWI SNF SUPERFAMILY TYPE COMPLEX	90	9.33e-06	7.90e-05	0.2990	-1.88e-02	1.19e-02	3.45e-02	2.94e-01	3.12e-02	2.53e-02	7.58e-01	8.45e-01	5.72e-01	1.44e-06	6.09e-01	6.78e-01
GOBP PRO B CELL DIFFERENTIATION	11	6.58e-01	7.28e-01	0.2990	-1.88e-01	1.83e-01	1.20e-01	-2.15e-02	4.33e-02	6.43e-02	2.81e-01	2.93e-01	4.91e-01	9.02e-01	8.03e-01	7.12e-01
GOBP ESTABLISHMENT OF PROTEIN LOCALIZATION TO MEMBRANE	250	6.98e-11	1.28e-09	0.2990	-1.64e-01	-2.05e-01	-1.20e-02	5.08e-02	-6.28e-02	1.19e-01	8.44e-06	2.43e-08	7.44e-01	1.67e-01	8.76e-02	1.16e-03
GOBP POSITIVE REGULATION OF SMOOTH MUSCLE CELL DIFFERENTIATION	14	4.22e-01	5.31e-01	0.2990	-1.36e-01	-1.77e-03	-4.68e-02	4.65e-02	3.78e-02	-2.56e-01	3.80e-01	9.91e-01	7.62e-01	7.63e-01	8.06e-01	9.75e-02
GOBP NEGATIVE REGULATION OF TYPE I INTERFERON PRODUCTION	42	8.81e-02	1.79e-01	0.2990	-3.01e-02	-2.22e-03	-3.98e-02	2.44e-01	1.46e-01	7.80e-02	7.36e-01	9.80e-01	6.55e-01	6.15e-03	1.01e-01	3.81e-01
GOBP KERATINOCYTE APOPTOTIC PROCESS	6	9.21e-01	9.34e-01	0.2990	7.93e-02	1.60e-01	1.29e-01	1.67e-01	2.85e-02	-1.12e-01	7.36e-01	4.98e-01	5.84e-01	4.79e-01	9.04e-01	6.36e-01
GOBP REGULATION OF MEGAKARYOCYTE DIFFERENTIATION	27	3.95e-01	5.07e-01	0.2990	-1.34e-01	-2.06e-01	8.56e-03	4.54e-02	-8.64e-02	1.40e-01	2.27e-01	6.43e-02	9.39e-01	6.83e-01	4.37e-01	2.08e-01
GOBP POSITIVE REGULATION OF CALCINEURIN MEDIATED SIGNALING	16	7.68e-01	8.14e-01	0.2990	1.08e-01	3.70e-02	2.36e-01	8.89e-02	-3.43e-02	1.09e-01	4.57e-01	7.98e-01	1.03e-01	5.38e-01	8.12e-01	4.49e-01
GOMF ISOMERASE ACTIVITY	151	1.28e-07	1.54e-06	0.2990	-1.03e-01	-2.63e-01	-3.40e-02	7.18e-02	-1.11e-02	5.71e-02	2.93e-02	2.38e-08	4.70e-01	1.28e-01	8.14e-01	2.26e-01
GOCC ATPASE COMPLEX	140	3.73e-09	5.54e-08	0.2990	-1.26e-01	-1.74e-01	1.43e-03	1.97e-01	-5.59e-02	4.15e-02	1.03e-02	3.81e-04	9.77e-01	5.96e-05	2.54e-01	3.97e-01
GOBP PHOSPHOLIPID HOMEOSTASIS	13	6.59e-01	7.29e-01	0.2990	8.44e-02	2.43e-01	6.57e-02	1.18e-01	-1.59e-02	-6.84e-02	5.98e-01	1.29e-01	6.82e-01	4.63e-01	9.21e-01	6.69e-01
GOBP POSITIVE REGULATION OF NEURON DIFFERENTIATION	48	2.62e-01	3.82e-01	0.2990	1.24e-01	1.48e-01	1.33e-01	1.18e-01	1.35e-01	4.63e-02	1.38e-01	7.52e-02	1.11e-01	1.56e-01	1.06e-01	5.79e-01
GOBP MORPHOGENESIS OF AN ENDOTHELIUM	13	8.26e-01	8.60e-01	0.2990	-1.66e-01	-1.17e-01	1.26e-01	-1.04e-01	-1.40e-01	4.32e-02	3.01e-01	4.64e-01	4.31e-01	5.18e-01	3.80e-01	7.87e-01
GOBP ENDOCYTOSIS INVOLVED IN VIRAL ENTRY INTO HOST CELL	11	6.90e-01	7.53e-01	0.2990	9.48e-03	9.20e-02	1.16e-02	-4.26e-02	1.55e-01	2.34e-01	9.57e-01	5.97e-01	9.47e-01	8.07e-01	3.74e-01	1.78e-01
GOBP REGULATION OF P38MAPK CASCADE	34	4.24e-02	1.04e-01	0.2990	1.14e-02	2.01e-01	1.89e-01	2.49e-02	5.60e-02	-9.69e-02	9.08e-01	4.27e-02	5.64e-02	8.02e-01	5.72e-01	3.28e-01
GOMF WIDE PORE CHANNEL ACTIVITY	17	7.03e-01	7.64e-01	0.2990	-1.43e-01	-2.02e-01	-5.47e-02	2.72e-02	-9.67e-02	1.23e-01	3.09e-01	1.49e-01	6.96e-01	8.46e-01	4.90e-01	3.82e-01
GOBP DEFENSE RESPONSE TO GRAM NEGATIVE BACTERIUM	47	2.98e-02	7.97e-02	0.2990	-8.21e-02	-2.07e-01	1.01e-01	6.40e-02	-1.53e-01	3.95e-02	3.30e-01	1.39e-02	2.30e-01	4.48e-01	6.90e-02	6.39e-01
GOBP NEGATIVE REGULATION OF LIPID BIOSYNTHETIC PROCESS	43	6.90e-02	1.49e-01	0.2990	-1.79e-02	-4.98e-02	2.21e-01	9.56e-02	-1.75e-02	1.68e-01	8.39e-01	5.72e-01	1.23e-02	2.78e-01	8.43e-01	5.68e-02
GOBP NEGATIVE REGULATION OF CYSTEINE TYPE ENDOPEPTIDASE ACTIVITY INVOLVED IN APOPTOTIC SIGNALING PATHWAY	5	7.37e-01	7.90e-01	0.2990	-1.52e-02	-1.38e-01	5.63e-02	3.03e-02	1.51e-01	-2.07e-01	9.53e-01	5.93e-01	8.28e-01	9.07e-01	5.58e-01	4.23e-01
GOBP PHAGOSOME MATURATION	27	1.97e-01	3.13e-01	0.2990	-2.65e-01	-5.07e-02	8.55e-02	-2.81e-02	-2.35e-02	8.91e-02	1.73e-02	6.49e-01	4.42e-01	8.00e-01	8.32e-01	4.23e-01
GOBP DNA INTEGRITY CHECKPOINT SIGNALING	132	5.04e-07	5.56e-06	0.2990	-4.86e-02	-9.53e-02	-2.13e-02	2.42e-01	5.93e-02	1.22e-01	3.35e-01	5.86e-02	6.72e-01	1.52e-06	2.39e-01	1.53e-02
GOBP DETECTION OF EXTERNAL BIOTIC STIMULUS	23	2.22e-01	3.41e-01	0.2990	-1.35e-01	1.75e-01	6.23e-03	-1.18e-01	5.95e-02	-1.51e-01	2.63e-01	1.45e-01	9.59e-01	3.29e-01	6.22e-01	2.10e-01
GOBP REGULATION OF STEROID BIOSYNTHETIC PROCESS	52	1.64e-02	5.07e-02	0.2980	1.38e-02	-2.44e-03	2.42e-01	1.29e-01	-6.05e-03	1.17e-01	8.63e-01	9.76e-01	2.55e-03	1.09e-01	9.40e-01	1.43e-01
GOCC AP TYPE MEMBRANE COAT ADAPTOR COMPLEX	39	1.93e-02	5.77e-02	0.2980	-1.81e-01	-4.15e-02	2.31e-02	1.91e-01	1.83e-02	1.32e-01	5.04e-02	6.54e-01	8.03e-01	3.95e-02	8.44e-01	1.55e-01
GOBP POSITIVE REGULATION OF DENDRITIC CELL CYTOKINE PRODUCTION	11	7.20e-01	7.77e-01	0.2980	-2.05e-01	1.23e-01	-6.80e-02	-1.29e-01	-3.87e-02	-9.38e-02	2.38e-01	4.79e-01	6.96e-01	4.59e-01	8.24e-01	5.90e-01
GOBP REGULATION OF SODIUM ION TRANSMEMBRANE TRANSPORTER ACTIVITY	34	4.28e-01	5.37e-01	0.2980	-2.27e-02	-1.58e-03	2.16e-01	-2.36e-02	-1.22e-01	1.62e-01	8.19e-01	9.87e-01	2.93e-02	8.11e-01	2.18e-01	1.02e-01
GOBP G1 TO G0 TRANSITION INVOLVED IN CELL DIFFERENTIATION	5	9.66e-01	9.72e-01	0.2980	-6.50e-02	1.26e-01	5.73e-02	-2.56e-01	-1.03e-02	-2.41e-03	8.01e-01	6.26e-01	8.25e-01	3.22e-01	9.68e-01	9.93e-01
GOMF HISTONE DEACETYLASE BINDING	102	3.38e-06	3.20e-05	0.2980	2.62e-03	7.68e-02	7.52e-02	2.40e-01	1.29e-01	-5.67e-02	9.64e-01	1.80e-01	1.89e-01	2.84e-05	2.44e-02	3.22e-01
GOBP VASCULAR PROCESS IN CIRCULATORY SYSTEM	186	2.86e-08	3.77e-07	0.2980	-6.68e-02	8.24e-03	2.49e-01	-2.99e-02	-9.88e-02	1.09e-01	1.16e-01	8.46e-01	4.95e-09	4.82e-01	2.02e-02	1.03e-02
GOMF CARGO RECEPTOR ACTIVITY	64	2.92e-05	2.23e-04	0.2980	-5.49e-02	2.79e-02	2.72e-01	9.86e-02	-1.52e-02	3.12e-02	4.47e-01	6.99e-01	1.65e-04	1.73e-01	8.34e-01	6.66e-01
GOBP REGULATION OF CYCLASE ACTIVITY	31	9.81e-02	1.93e-01	0.2980	-1.03e-01	1.71e-01	1.93e-01	-6.05e-02	-9.03e-02	-4.09e-03	3.19e-01	1.00e-01	6.29e-02	5.60e-01	3.84e-01	9.69e-01
GOBP REGULATION OF ERAD PATHWAY	23	3.24e-01	4.43e-01	0.2980	-1.95e-01	-1.91e-01	-4.17e-02	9.57e-02	3.17e-02	4.68e-02	1.05e-01	1.13e-01	7.29e-01	4.27e-01	7.92e-01	6.98e-01
GOBP SYNAPTIC TRANSMISSION GLUTAMATERGIC	65	2.66e-02	7.34e-02	0.2980	-3.63e-02	1.56e-01	1.76e-01	-4.01e-02	8.39e-02	1.53e-01	6.13e-01	2.98e-02	1.41e-02	5.76e-01	2.42e-01	3.31e-02
GOBP MIRNA CATABOLIC PROCESS	16	7.95e-01	8.34e-01	0.2980	-1.45e-01	-7.64e-02	5.43e-02	-1.50e-01	-6.98e-02	1.77e-01	3.14e-01	5.97e-01	7.07e-01	2.98e-01	6.29e-01	2.21e-01
GOMF CYSTEINE TYPE ENDOPEPTIDASE REGULATOR ACTIVITY INVOLVED IN APOPTOTIC PROCESS	38	7.18e-02	1.54e-01	0.2980	-1.23e-01	1.37e-02	1.88e-02	-2.86e-02	1.15e-02	2.68e-01	1.88e-01	8.84e-01	8.41e-01	7.60e-01	9.02e-01	4.24e-03
GOMF MONOSACCHARIDE BINDING	66	7.09e-04	3.80e-03	0.2980	-1.50e-01	-1.91e-01	1.31e-01	-2.26e-02	-2.30e-02	1.06e-01	3.45e-02	7.25e-03	6.62e-02	7.51e-01	7.46e-01	1.37e-01
GOBP POSITIVE REGULATION OF STRIATED MUSCLE CELL DIFFERENTIATION	23	4.00e-01	5.12e-01	0.2970	8.97e-02	1.59e-01	-1.28e-02	1.47e-01	4.29e-02	-1.78e-01	4.57e-01	1.87e-01	9.16e-01	2.23e-01	7.22e-01	1.40e-01
GOBP GLUCOSAMINE CONTAINING COMPOUND CATABOLIC PROCESS	8	8.31e-01	8.64e-01	0.2970	9.54e-02	-5.08e-02	-8.12e-02	7.63e-02	-1.91e-01	-1.67e-01	6.40e-01	8.03e-01	6.91e-01	7.09e-01	3.49e-01	4.14e-01
GOBP POSITIVE REGULATION OF NEURON MIGRATION	17	1.62e-01	2.75e-01	0.2970	-9.97e-02	-1.13e-02	1.88e-01	1.95e-01	-7.25e-02	5.58e-03	4.77e-01	9.36e-01	1.80e-01	1.65e-01	6.05e-01	9.68e-01
GOMF PHOSPHATASE INHIBITOR ACTIVITY	35	1.46e-01	2.55e-01	0.2970	2.78e-02	-7.79e-02	9.00e-02	1.03e-01	7.42e-02	2.40e-01	7.76e-01	4.25e-01	3.57e-01	2.93e-01	4.47e-01	1.41e-02
GOBP POSITIVE REGULATION OF LIPID LOCALIZATION	80	1.20e-04	7.96e-04	0.2970	-8.72e-03	7.89e-02	2.60e-01	6.28e-02	6.15e-02	8.10e-02	8.93e-01	2.22e-01	5.63e-05	3.32e-01	3.42e-01	2.11e-01
GOBP T HELPER 2 CELL CYTOKINE PRODUCTION	10	8.92e-01	9.12e-01	0.2970	1.39e-01	2.17e-01	1.22e-01	7.19e-02	-4.35e-02	3.60e-03	4.46e-01	2.35e-01	5.03e-01	6.94e-01	8.12e-01	9.84e-01
GOBP GOLGI TO PLASMA MEMBRANE TRANSPORT	60	1.02e-02	3.48e-02	0.2970	-1.25e-01	1.93e-02	8.92e-02	9.82e-02	1.06e-01	2.09e-01	9.49e-02	7.96e-01	2.32e-01	1.88e-01	1.54e-01	5.17e-03
GOBP NEGATIVE REGULATION OF CARDIAC MUSCLE CELL DIFFERENTIATION	7	8.91e-01	9.11e-01	0.2970	-1.26e-01	2.66e-02	-1.02e-02	2.01e-01	1.53e-01	8.89e-02	5.63e-01	9.03e-01	9.63e-01	3.58e-01	4.83e-01	6.84e-01
GOMF PALMITOYLTRANSFERASE ACTIVITY	35	3.83e-01	4.96e-01	0.2970	-8.08e-02	-1.23e-01	8.58e-02	-1.10e-01	-2.17e-01	-1.16e-02	4.08e-01	2.09e-01	3.80e-01	2.61e-01	2.62e-02	9.06e-01
GOBP RETROGRADE TRANSPORT VESICLE RECYCLING WITHIN GOLGI	9	8.87e-01	9.07e-01	0.2970	-1.19e-01	-6.31e-02	-1.66e-01	1.05e-01	1.68e-01	5.54e-02	5.37e-01	7.43e-01	3.87e-01	5.85e-01	3.82e-01	7.73e-01
GOBP FC GAMMA RECEPTOR SIGNALING PATHWAY	33	7.01e-02	1.51e-01	0.2970	-1.11e-01	2.09e-01	9.42e-02	1.01e-01	6.72e-02	9.21e-02	2.69e-01	3.73e-02	3.49e-01	3.16e-01	5.04e-01	3.60e-01
GOCC COATED VESICLE	277	3.57e-18	1.27e-16	0.2970	-2.04e-01	-1.15e-01	5.18e-02	1.25e-01	-3.29e-02	1.19e-01	5.02e-09	9.94e-04	1.38e-01	3.62e-04	3.46e-01	6.59e-04
GOBP PROSTANOID BIOSYNTHETIC PROCESS	22	5.08e-02	1.19e-01	0.2970	-1.69e-01	-1.34e-01	1.21e-01	-1.30e-02	1.46e-01	7.51e-02	1.70e-01	2.78e-01	3.24e-01	9.16e-01	2.36e-01	5.42e-01
GOBP MEMBRANE BIOGENESIS	53	1.72e-02	5.27e-02	0.2970	-1.05e-01	-1.83e-01	1.27e-01	6.81e-02	-1.12e-01	1.01e-01	1.88e-01	2.09e-02	1.09e-01	3.91e-01	1.57e-01	2.02e-01
GOBP MAINTENANCE OF BLOOD BRAIN BARRIER	31	3.31e-01	4.49e-01	0.2970	-1.92e-01	2.47e-02	1.27e-01	-1.43e-01	-1.02e-01	6.37e-02	6.47e-02	8.12e-01	2.20e-01	1.70e-01	3.28e-01	5.39e-01
GOBP COLLATERAL SPROUTING	24	1.09e-01	2.08e-01	0.2970	-1.83e-02	1.05e-01	2.53e-01	1.14e-01	7.05e-03	-4.38e-03	8.77e-01	3.73e-01	3.21e-02	3.36e-01	9.52e-01	9.70e-01
GOBP NEGATIVE REGULATION OF MUSCLE ADAPTATION	8	7.55e-01	8.04e-01	0.2970	2.60e-01	-6.71e-02	1.01e-01	-1.58e-02	2.60e-03	-7.59e-02	2.03e-01	7.43e-01	6.22e-01	9.38e-01	9.90e-01	7.10e-01
GOBP AMINO ACID METABOLIC PROCESS	248	5.62e-11	1.04e-09	0.2970	-1.13e-01	-2.36e-01	-1.26e-01	2.71e-02	5.64e-02	6.73e-03	2.27e-03	1.58e-10	6.42e-04	4.63e-01	1.27e-01	8.55e-01
GOBP ESTROGEN BIOSYNTHETIC PROCESS	8	9.21e-01	9.34e-01	0.2970	-4.05e-02	-1.12e-01	-1.59e-01	-1.04e-01	-1.77e-01	-8.01e-02	8.43e-01	5.83e-01	4.35e-01	6.11e-01	3.86e-01	6.95e-01
GOBP EAR MORPHOGENESIS	69	5.42e-02	1.25e-01	0.2970	5.32e-02	1.72e-01	-6.11e-02	6.36e-02	2.09e-01	-6.60e-02	4.45e-01	1.37e-02	3.80e-01	3.61e-01	2.70e-03	3.43e-01
GOBP AXONEMAL DYNEIN COMPLEX ASSEMBLY	25	3.06e-01	4.26e-01	0.2970	1.63e-01	1.08e-01	8.15e-02	4.54e-02	8.67e-02	-1.83e-01	1.58e-01	3.51e-01	4.80e-01	6.94e-01	4.53e-01	1.13e-01
GOCC MAIN AXON	47	1.42e-01	2.52e-01	0.2970	1.85e-01	1.22e-01	7.34e-02	5.75e-02	1.68e-01	-4.38e-02	2.78e-02	1.48e-01	3.84e-01	4.96e-01	4.66e-02	6.03e-01
GOCC LATERAL ELEMENT	11	5.92e-01	6.75e-01	0.2970	-5.61e-02	1.06e-02	-5.92e-02	9.92e-02	2.98e-02	2.66e-01	7.47e-01	9.52e-01	7.34e-01	5.69e-01	8.64e-01	1.27e-01
GOBP POSITIVE REGULATION OF POST TRANSLATIONAL PROTEIN MODIFICATION	119	8.34e-06	7.16e-05	0.2970	-2.05e-01	-1.28e-01	-1.87e-02	8.32e-02	-5.77e-02	1.38e-01	1.15e-04	1.58e-02	7.25e-01	1.17e-01	2.77e-01	9.19e-03
GOBP RNA LOCALIZATION	191	9.35e-10	1.50e-08	0.2970	-1.50e-01	-1.71e-01	-1.07e-01	1.54e-01	-3.86e-03	3.62e-02	3.59e-04	4.76e-05	1.08e-02	2.44e-04	9.27e-01	3.89e-01
GOCC PHAGOCYTIC VESICLE MEMBRANE	76	3.12e-04	1.87e-03	0.2970	-2.74e-01	-3.58e-02	-4.07e-02	4.17e-02	4.16e-02	8.14e-02	3.68e-05	5.90e-01	5.40e-01	5.30e-01	5.31e-01	2.20e-01
GOBP POSITIVE REGULATION OF LEUKOCYTE CHEMOTAXIS	70	4.72e-03	1.87e-02	0.2970	-3.40e-02	-3.71e-02	2.26e-01	8.09e-02	-2.38e-02	1.65e-01	6.23e-01	5.92e-01	1.06e-03	2.42e-01	7.31e-01	1.72e-02
GOBP MATERNAL PLACENTA DEVELOPMENT	25	8.43e-02	1.73e-01	0.2960	-1.85e-01	-4.50e-02	-2.16e-02	-1.58e-02	4.75e-02	-2.21e-01	1.10e-01	6.97e-01	8.51e-01	8.91e-01	6.81e-01	5.59e-02
GOBP REGULATION OF GLUCOCORTICOID SECRETION	7	9.62e-01	9.68e-01	0.2960	1.01e-01	1.24e-01	1.26e-01	1.63e-01	-2.67e-02	1.39e-01	6.45e-01	5.69e-01	5.65e-01	4.56e-01	9.03e-01	5.25e-01
GOBP MEMBRANE RAFT ORGANIZATION	22	4.68e-01	5.71e-01	0.2960	3.67e-02	-7.99e-02	1.78e-01	1.52e-01	-5.50e-02	1.49e-01	7.65e-01	5.16e-01	1.48e-01	2.18e-01	6.55e-01	2.25e-01
GOBP DNA TEMPLATED DNA REPLICATION MAINTENANCE OF FIDELITY	57	5.65e-02	1.29e-01	0.2960	8.16e-02	-2.21e-02	2.64e-02	2.44e-01	1.22e-01	7.42e-02	2.87e-01	7.73e-01	7.31e-01	1.44e-03	1.12e-01	3.33e-01
GOBP AROMATIC AMINO ACID METABOLIC PROCESS	24	2.50e-01	3.68e-01	0.2960	-3.40e-02	-1.43e-01	-1.73e-01	-6.48e-03	1.86e-01	3.56e-02	7.73e-01	2.24e-01	1.42e-01	9.56e-01	1.15e-01	7.63e-01
GOBP NUCLEUS LOCALIZATION	29	9.89e-02	1.94e-01	0.2960	8.87e-03	1.71e-01	1.91e-01	1.39e-01	-5.12e-02	-1.31e-02	9.34e-01	1.12e-01	7.53e-02	1.95e-01	6.33e-01	9.03e-01
GOBP MAINTENANCE OF PROTEIN LOCATION IN NUCLEUS	22	4.63e-01	5.67e-01	0.2960	-1.17e-01	-2.39e-01	-5.74e-02	6.68e-02	-3.16e-04	9.48e-02	3.41e-01	5.25e-02	6.41e-01	5.88e-01	9.98e-01	4.41e-01
GOBP PRESYNAPTIC MODULATION OF CHEMICAL SYNAPTIC TRANSMISSION	24	2.06e-01	3.23e-01	0.2960	-2.23e-01	-9.40e-02	3.36e-02	8.13e-02	8.29e-02	1.20e-01	5.86e-02	4.25e-01	7.76e-01	4.90e-01	4.82e-01	3.10e-01
GOCC NUCLEAR OUTER MEMBRANE ENDOPLASMIC RETICULUM MEMBRANE NETWORK	1022	1.12e-47	3.05e-45	0.2960	-1.96e-01	-1.51e-01	2.90e-02	3.81e-02	-9.35e-02	1.23e-01	2.75e-26	3.18e-16	1.17e-01	3.97e-02	4.35e-07	2.92e-11
GOBP REGULATION OF CYSTEINE TYPE ENDOPEPTIDASE ACTIVITY INVOLVED IN APOPTOTIC SIGNALING PATHWAY	10	6.64e-01	7.32e-01	0.2960	-1.25e-01	-2.42e-01	6.85e-02	-3.93e-02	-5.41e-02	-6.24e-02	4.94e-01	1.84e-01	7.07e-01	8.30e-01	7.67e-01	7.33e-01
GOBP NEGATIVE REGULATION OF VIRAL TRANSCRIPTION	14	5.07e-01	6.02e-01	0.2960	-7.58e-02	2.93e-02	7.55e-02	2.56e-01	7.93e-02	5.89e-02	6.23e-01	8.50e-01	6.25e-01	9.76e-02	6.07e-01	7.03e-01
GOBP HOMOPHILIC CELL ADHESION VIA PLASMA MEMBRANE ADHESION MOLECULES	81	3.09e-02	8.17e-02	0.2960	3.16e-02	1.58e-01	1.97e-01	-5.57e-02	-1.84e-02	1.38e-01	6.23e-01	1.40e-02	2.13e-03	3.86e-01	7.74e-01	3.15e-02
GOCC NEURON PROJECTION CYTOPLASM	78	1.20e-02	3.96e-02	0.2960	-8.68e-02	1.74e-02	1.30e-01	2.50e-02	-3.65e-02	2.46e-01	1.85e-01	7.91e-01	4.65e-02	7.03e-01	5.78e-01	1.70e-04
GOBP CARNITINE METABOLIC PROCESS	11	7.18e-01	7.76e-01	0.2960	-5.63e-02	-3.33e-02	1.53e-01	-9.49e-02	8.95e-02	2.07e-01	7.46e-01	8.48e-01	3.81e-01	5.86e-01	6.07e-01	2.35e-01
GOBP LONG CHAIN FATTY ACID TRANSPORT	47	6.22e-04	3.38e-03	0.2960	-8.18e-02	1.26e-02	2.57e-01	5.24e-02	8.29e-02	7.16e-02	3.32e-01	8.81e-01	2.34e-03	5.34e-01	3.25e-01	3.96e-01
GOMF SOLUTE PROTON SYMPORTER ACTIVITY	19	9.42e-02	1.88e-01	0.2960	-1.82e-01	-6.45e-02	1.24e-01	1.84e-01	-3.15e-02	8.74e-04	1.71e-01	6.27e-01	3.51e-01	1.64e-01	8.12e-01	9.95e-01
GOMF RIBOSOMAL PROTEIN S6 KINASE ACTIVITY	7	9.18e-01	9.32e-01	0.2960	-1.42e-02	-1.07e-01	-9.34e-02	2.45e-01	4.95e-02	6.62e-02	9.48e-01	6.24e-01	6.69e-01	2.61e-01	8.21e-01	7.62e-01
GOMF PROTEIN PHOSPHATASE BINDING	129	2.04e-05	1.61e-04	0.2960	-1.60e-03	5.88e-02	1.76e-01	1.81e-01	2.62e-02	1.41e-01	9.75e-01	2.49e-01	5.74e-04	3.99e-04	6.08e-01	5.80e-03
GOBP HYPEROSMOTIC RESPONSE	24	1.45e-01	2.55e-01	0.2950	-1.17e-01	6.93e-02	1.60e-01	1.72e-01	-4.05e-02	1.11e-01	3.23e-01	5.57e-01	1.76e-01	1.45e-01	7.31e-01	3.48e-01
GOMF VOLTAGE GATED MONOATOMIC CATION CHANNEL ACTIVITY	86	3.38e-03	1.43e-02	0.2950	1.35e-01	1.74e-01	1.83e-01	-6.44e-02	2.57e-02	-1.48e-02	3.01e-02	5.17e-03	3.33e-03	3.02e-01	6.81e-01	8.12e-01
GOBP MORPHOGENESIS OF A BRANCHING STRUCTURE	127	6.44e-05	4.58e-04	0.2950	2.16e-03	1.29e-01	2.41e-01	3.28e-02	-6.42e-02	8.61e-02	9.66e-01	1.18e-02	2.80e-06	5.23e-01	2.11e-01	9.39e-02
GOBP B CELL DIFFERENTIATION	124	5.15e-04	2.87e-03	0.2950	6.52e-02	1.18e-01	2.09e-01	1.20e-01	-2.47e-02	1.02e-01	2.10e-01	2.31e-02	5.93e-05	2.10e-02	6.34e-01	4.94e-02
GOBP POSITIVE REGULATION OF LYMPHOCYTE MIGRATION	35	2.41e-01	3.59e-01	0.2950	-8.49e-03	-5.34e-02	1.48e-01	1.31e-01	-8.34e-02	1.96e-01	9.31e-01	5.85e-01	1.29e-01	1.81e-01	3.93e-01	4.52e-02
GOBP EPITHELIAL CELL DIFFERENTIATION INVOLVED IN KIDNEY DEVELOPMENT	31	2.45e-01	3.63e-01	0.2950	4.85e-02	1.94e-01	1.97e-01	-7.74e-02	-3.71e-02	-3.37e-02	6.40e-01	6.14e-02	5.81e-02	4.56e-01	7.21e-01	7.45e-01
GOBP MICROTUBULE ORGANIZING CENTER LOCALIZATION	30	9.86e-02	1.94e-01	0.2950	-8.16e-02	1.46e-01	6.91e-02	5.42e-02	-4.92e-02	2.22e-01	4.39e-01	1.68e-01	5.12e-01	6.07e-01	6.41e-01	3.54e-02
GOMF ARACHIDONATE COA LIGASE ACTIVITY	9	9.28e-01	9.40e-01	0.2950	-5.07e-02	9.44e-02	1.85e-01	5.03e-02	-7.06e-02	1.85e-01	7.92e-01	6.24e-01	3.38e-01	7.94e-01	7.14e-01	3.37e-01
GOBP SKELETAL MUSCLE ACETYLCHOLINE GATED CHANNEL CLUSTERING	10	8.62e-01	8.88e-01	0.2950	1.21e-01	-7.66e-02	-9.28e-02	2.39e-01	3.05e-02	3.37e-03	5.07e-01	6.75e-01	6.12e-01	1.91e-01	8.67e-01	9.85e-01
GOBP THYROID GLAND DEVELOPMENT	18	1.27e-01	2.32e-01	0.2950	-2.05e-01	-9.89e-02	1.55e-01	3.42e-03	-7.58e-02	-7.55e-02	1.32e-01	4.67e-01	2.56e-01	9.80e-01	5.78e-01	5.79e-01
GOBP NEGATIVE REGULATION OF UBIQUITIN DEPENDENT PROTEIN CATABOLIC PROCESS	49	2.68e-02	7.39e-02	0.2950	-1.77e-01	-1.61e-01	-5.79e-02	1.15e-01	-8.90e-02	7.24e-02	3.17e-02	5.18e-02	4.83e-01	1.63e-01	2.81e-01	3.80e-01
GOBP CERAMIDE METABOLIC PROCESS	85	1.48e-02	4.69e-02	0.2950	-1.53e-01	-8.28e-02	1.22e-01	-3.64e-02	-1.31e-01	1.53e-01	1.50e-02	1.87e-01	5.12e-02	5.62e-01	3.68e-02	1.47e-02
GOBP REGULATION OF MEMBRANE DEPOLARIZATION	32	4.03e-01	5.15e-01	0.2950	-7.74e-03	-1.15e-01	7.01e-02	-1.09e-01	-2.19e-01	9.58e-02	9.40e-01	2.61e-01	4.92e-01	2.86e-01	3.23e-02	3.48e-01
GOBP TYPE B PANCREATIC CELL DEVELOPMENT	14	4.62e-01	5.66e-01	0.2950	-9.84e-03	-1.01e-01	1.21e-01	1.71e-01	-1.80e-01	-2.31e-02	9.49e-01	5.15e-01	4.31e-01	2.68e-01	2.44e-01	8.81e-01
GOBP POSITIVE REGULATION OF NEUROBLAST PROLIFERATION	19	3.12e-01	4.33e-01	0.2950	-6.07e-02	1.06e-01	2.23e-01	1.14e-01	7.23e-02	6.56e-02	6.47e-01	4.22e-01	9.29e-02	3.92e-01	5.85e-01	6.20e-01
GOBP REGULATION OF RAS PROTEIN SIGNAL TRANSDUCTION	40	6.96e-02	1.50e-01	0.2950	-6.20e-03	4.47e-02	2.17e-01	1.16e-01	9.06e-02	1.28e-01	9.46e-01	6.24e-01	1.78e-02	2.04e-01	3.21e-01	1.62e-01
GOMF PROTEIN TYROSINE KINASE ACTIVITY	115	4.03e-04	2.33e-03	0.2950	-3.98e-03	1.08e-01	1.84e-01	1.14e-01	-4.04e-02	1.63e-01	9.41e-01	4.58e-02	6.45e-04	3.45e-02	4.55e-01	2.47e-03
GOBP ORGANOPHOSPHATE BIOSYNTHETIC PROCESS	523	7.69e-26	5.40e-24	0.2950	-1.86e-01	-2.05e-01	-6.19e-02	5.94e-02	2.05e-02	5.03e-02	3.07e-13	1.20e-15	1.55e-02	2.01e-02	4.23e-01	4.93e-02
GOBP AORTA MORPHOGENESIS	20	1.50e-01	2.61e-01	0.2950	-1.22e-01	1.38e-01	1.99e-01	8.73e-02	-7.40e-02	9.40e-03	3.43e-01	2.85e-01	1.24e-01	4.99e-01	5.67e-01	9.42e-01
GOBP POSITIVE REGULATION OF FATTY ACID BIOSYNTHETIC PROCESS	15	2.89e-01	4.09e-01	0.2950	-9.47e-02	1.03e-01	1.41e-01	-4.35e-02	2.13e-01	-9.18e-03	5.25e-01	4.91e-01	3.44e-01	7.71e-01	1.53e-01	9.51e-01
GOBP HEMATOPOIETIC STEM CELL DIFFERENTIATION	32	1.07e-01	2.05e-01	0.2940	3.79e-02	2.05e-01	9.69e-02	1.83e-01	-5.64e-03	3.55e-03	7.11e-01	4.44e-02	3.43e-01	7.27e-02	9.56e-01	9.72e-01
GOBP VIRAL GENE EXPRESSION	95	6.52e-05	4.63e-04	0.2940	-1.31e-01	-1.54e-01	2.40e-02	1.59e-01	-5.47e-02	1.29e-01	2.73e-02	9.46e-03	6.86e-01	7.28e-03	3.57e-01	2.92e-02
GOBP ICOSANOID BIOSYNTHETIC PROCESS	39	1.52e-02	4.78e-02	0.2940	-1.68e-01	-4.47e-02	1.71e-01	-6.28e-02	8.36e-02	1.28e-01	6.97e-02	6.29e-01	6.49e-02	4.97e-01	3.66e-01	1.68e-01
GOBP POSITIVE REGULATION OF MONONUCLEAR CELL MIGRATION	76	6.31e-03	2.37e-02	0.2940	-1.06e-01	-1.06e-01	1.69e-01	3.27e-02	-9.96e-02	1.56e-01	1.09e-01	1.11e-01	1.07e-02	6.23e-01	1.33e-01	1.86e-02
GOBP INTRACELLULAR PROTEIN TRANSPORT	620	1.40e-33	1.75e-31	0.2940	-2.30e-01	-1.20e-01	1.71e-02	5.17e-02	-7.69e-02	1.02e-01	1.36e-22	3.73e-07	4.67e-01	2.81e-02	1.09e-03	1.34e-05
GOBP RESPONSE TO ANGIOTENSIN	30	3.64e-01	4.79e-01	0.2940	-1.15e-01	1.31e-01	1.34e-01	-1.34e-01	-7.44e-02	1.20e-01	2.75e-01	2.14e-01	2.02e-01	2.02e-01	4.81e-01	2.56e-01
GOCC EXTRINSIC COMPONENT OF SYNAPTIC MEMBRANE	12	5.94e-01	6.76e-01	0.2940	-1.13e-02	1.56e-01	-9.25e-02	2.15e-01	7.54e-02	3.80e-02	9.46e-01	3.51e-01	5.79e-01	1.96e-01	6.51e-01	8.20e-01
GOBP POSITIVE REGULATION OF NON CANONICAL NF KAPPAB SIGNAL TRANSDUCTION	56	9.92e-04	5.05e-03	0.2940	-1.82e-01	6.56e-02	3.86e-02	8.92e-02	1.96e-01	3.20e-02	1.85e-02	3.96e-01	6.17e-01	2.48e-01	1.11e-02	6.79e-01
GOBP NEGATIVE REGULATION OF GLUCONEOGENESIS	15	5.10e-01	6.05e-01	0.2940	8.85e-02	5.33e-02	1.30e-01	1.85e-01	1.29e-01	-8.86e-02	5.53e-01	7.21e-01	3.83e-01	2.14e-01	3.87e-01	5.52e-01
GOBP RESPONSE TO FRUCTOSE	9	5.12e-01	6.06e-01	0.2940	-1.41e-02	-2.61e-02	2.92e-01	-6.37e-03	2.09e-02	1.99e-03	9.42e-01	8.92e-01	1.30e-01	9.74e-01	9.13e-01	9.92e-01
GOBP POSITIVE REGULATION OF TELOMERE CAPPING	15	2.21e-01	3.40e-01	0.2940	-1.29e-01	3.72e-02	-1.30e-01	1.24e-01	-1.45e-01	-1.23e-01	3.87e-01	8.03e-01	3.83e-01	4.07e-01	3.31e-01	4.11e-01
GOBP REGULATION OF ALTERNATIVE MRNA SPLICING VIA SPLICEOSOME	47	1.52e-01	2.62e-01	0.2940	-1.89e-01	-7.82e-02	2.99e-03	-7.08e-02	-1.73e-01	9.80e-02	2.51e-02	3.54e-01	9.72e-01	4.01e-01	4.05e-02	2.45e-01
GOBP REGULATION OF CELL MIGRATION INVOLVED IN SPROUTING ANGIOGENESIS	29	1.86e-02	5.57e-02	0.2940	-1.44e-01	-5.81e-02	5.66e-02	-1.12e-01	3.70e-02	-2.12e-01	1.81e-01	5.88e-01	5.98e-01	2.97e-01	7.30e-01	4.77e-02
GOBP ATRIAL SEPTUM MORPHOGENESIS	7	6.59e-01	7.29e-01	0.2940	7.02e-03	-8.73e-02	2.50e-01	3.25e-02	-8.36e-02	-8.85e-02	9.74e-01	6.89e-01	2.51e-01	8.82e-01	7.02e-01	6.85e-01
GOBP NEGATIVE REGULATION OF SMALL MOLECULE METABOLIC PROCESS	80	4.66e-03	1.85e-02	0.2940	6.41e-02	1.13e-01	1.51e-01	2.06e-01	3.74e-02	4.97e-02	3.22e-01	8.13e-02	1.93e-02	1.41e-03	5.64e-01	4.42e-01
GOCC ACTIN FILAMENT	94	2.07e-04	1.30e-03	0.2940	-3.84e-02	-4.32e-02	2.13e-01	1.14e-01	-9.00e-02	1.28e-01	5.20e-01	4.69e-01	3.59e-04	5.69e-02	1.32e-01	3.16e-02
GOBP DENDRITIC CELL CYTOKINE PRODUCTION	16	3.78e-01	4.93e-01	0.2940	-1.17e-01	2.44e-01	1.63e-02	6.22e-02	6.24e-02	6.98e-02	4.16e-01	9.13e-02	9.10e-01	6.67e-01	6.66e-01	6.29e-01
GOBP ADENYLATE CYCLASE ACTIVATING G PROTEIN COUPLED RECEPTOR SIGNALING PATHWAY	97	3.50e-03	1.46e-02	0.2930	2.55e-02	1.32e-01	2.18e-01	7.84e-02	-4.42e-02	1.12e-01	6.65e-01	2.51e-02	2.12e-04	1.82e-01	4.52e-01	5.60e-02
GOBP REGULATION OF AUTOPHAGY OF MITOCHONDRION IN RESPONSE TO MITOCHONDRIAL DEPOLARIZATION	14	7.20e-01	7.77e-01	0.2930	-4.80e-02	-1.49e-01	-1.89e-01	1.43e-01	-4.69e-02	-5.44e-02	7.56e-01	3.34e-01	2.20e-01	3.53e-01	7.61e-01	7.24e-01
GOBP APOPTOTIC MITOCHONDRIAL CHANGES	95	7.80e-03	2.82e-02	0.2930	-1.29e-01	-2.27e-01	-1.19e-01	-3.51e-02	-1.29e-02	-5.08e-02	3.03e-02	1.34e-04	4.58e-02	5.54e-01	8.28e-01	3.92e-01
GOBP HYDROGEN PEROXIDE CATABOLIC PROCESS	26	4.46e-01	5.53e-01	0.2930	3.73e-02	-8.89e-02	1.39e-01	1.15e-01	-1.02e-01	1.84e-01	7.42e-01	4.33e-01	2.21e-01	3.09e-01	3.66e-01	1.05e-01
GOBP NEGATIVE REGULATION OF RECEPTOR INTERNALIZATION	13	9.11e-01	9.26e-01	0.2930	1.04e-01	1.89e-01	1.73e-01	7.37e-02	2.97e-02	5.66e-02	5.16e-01	2.38e-01	2.81e-01	6.46e-01	8.53e-01	7.24e-01
GOBP SECONDARY METABOLIC PROCESS	34	2.74e-01	3.94e-01	0.2930	-4.25e-02	5.44e-02	-1.11e-01	1.50e-01	2.12e-01	3.86e-02	6.68e-01	5.83e-01	2.63e-01	1.31e-01	3.24e-02	6.97e-01
GOBP ORGANIC ACID CATABOLIC PROCESS	206	1.22e-07	1.47e-06	0.2930	-9.53e-02	-1.92e-01	-1.75e-01	2.49e-02	8.88e-02	-2.76e-02	1.84e-02	2.04e-06	1.44e-05	5.38e-01	2.81e-02	4.95e-01
GOBP EXOCYTOSIS	281	4.70e-14	1.17e-12	0.2930	-1.38e-01	3.32e-02	1.75e-01	6.18e-02	-2.36e-02	1.76e-01	7.04e-05	3.38e-01	4.63e-07	7.46e-02	4.96e-01	4.13e-07
GOMF LIPID TRANSPORTER ACTIVITY	115	3.65e-04	2.14e-03	0.2930	7.38e-02	1.20e-01	1.52e-01	1.95e-01	1.29e-02	6.92e-02	1.72e-01	2.64e-02	4.88e-03	3.09e-04	8.11e-01	2.00e-01
GOBP RESPONSE TO AMINE	35	7.75e-02	1.63e-01	0.2930	-3.70e-02	5.27e-02	2.27e-01	-1.65e-02	1.04e-01	1.38e-01	7.05e-01	5.90e-01	2.02e-02	8.66e-01	2.89e-01	1.57e-01
GOBP ORGANIC HYDROXY COMPOUND CATABOLIC PROCESS	38	2.03e-01	3.19e-01	0.2930	-1.44e-01	-6.96e-02	-1.52e-01	3.24e-02	9.25e-03	-1.90e-01	1.24e-01	4.58e-01	1.06e-01	7.30e-01	9.21e-01	4.32e-02
GOBP REGULATION OF PROTEIN ACETYLATION	18	3.76e-01	4.91e-01	0.2930	-2.26e-01	-6.40e-02	6.03e-04	1.10e-01	-6.84e-02	1.17e-01	9.72e-02	6.38e-01	9.96e-01	4.17e-01	6.16e-01	3.89e-01
GOBP EXOCYTIC PROCESS	66	1.69e-02	5.19e-02	0.2930	-1.61e-01	-1.51e-02	1.03e-01	2.48e-02	-3.58e-02	2.16e-01	2.34e-02	8.32e-01	1.46e-01	7.28e-01	6.15e-01	2.37e-03
GOBP RIBOSE PHOSPHATE METABOLIC PROCESS	420	1.29e-19	5.27e-18	0.2930	-1.26e-01	-2.48e-01	-3.39e-02	5.07e-02	-3.33e-02	6.00e-02	9.36e-06	3.10e-18	2.33e-01	7.49e-02	2.42e-01	3.49e-02
GOBP TRANSCRIPTION BY RNA POLYMERASE III	61	2.01e-02	5.94e-02	0.2930	-7.65e-02	-1.70e-01	-1.66e-01	1.21e-01	-7.27e-02	-5.73e-02	3.02e-01	2.18e-02	2.45e-02	1.02e-01	3.26e-01	4.39e-01
GOBP DNA REPLICATION	266	1.51e-13	3.55e-12	0.2930	-9.76e-03	-1.64e-01	-7.77e-02	2.15e-01	3.75e-02	6.82e-02	7.84e-01	3.87e-06	2.92e-02	1.47e-09	2.93e-01	5.55e-02
GOMF PDZ DOMAIN BINDING	67	4.28e-04	2.46e-03	0.2930	-1.43e-01	1.84e-01	1.71e-01	-3.77e-02	-1.04e-03	1.79e-02	4.27e-02	9.02e-03	1.53e-02	5.93e-01	9.88e-01	8.00e-01
GOBP POST GOLGI VESICLE MEDIATED TRANSPORT	103	1.02e-04	6.94e-04	0.2930	-1.50e-01	1.65e-03	1.17e-01	8.79e-02	-1.64e-02	2.03e-01	8.33e-03	9.77e-01	3.95e-02	1.23e-01	7.74e-01	3.76e-04
GOBP MRNA 3 END PROCESSING	39	8.30e-02	1.71e-01	0.2920	-2.15e-01	-8.20e-02	-1.11e-01	9.81e-02	8.61e-02	5.69e-02	2.02e-02	3.76e-01	2.29e-01	2.89e-01	3.52e-01	5.38e-01
GOBP NEGATIVE REGULATION OF MICROTUBULE POLYMERIZATION OR DEPOLYMERIZATION	32	9.88e-02	1.94e-01	0.2920	7.29e-02	1.20e-01	8.04e-02	2.35e-01	-1.81e-02	-6.04e-02	4.75e-01	2.39e-01	4.31e-01	2.12e-02	8.59e-01	5.55e-01
GOBP EPIGENETIC PROGRAMMING OF GENE EXPRESSION	25	3.52e-01	4.68e-01	0.2920	3.85e-02	1.57e-01	7.74e-03	2.26e-01	7.57e-02	5.10e-02	7.39e-01	1.74e-01	9.47e-01	5.07e-02	5.12e-01	6.59e-01
GOBP DETECTION OF VISIBLE LIGHT	31	8.28e-02	1.71e-01	0.2920	1.29e-01	1.84e-01	1.92e-02	-1.77e-01	-5.62e-02	-4.35e-03	2.13e-01	7.62e-02	8.54e-01	8.79e-02	5.88e-01	9.67e-01
GOCC BRUSH BORDER MEMBRANE	41	4.86e-02	1.15e-01	0.2920	-2.82e-02	8.20e-02	2.23e-01	-1.24e-03	1.15e-01	1.24e-01	7.55e-01	3.63e-01	1.37e-02	9.89e-01	2.04e-01	1.70e-01
GOBP HETEROCHROMATIN FORMATION	110	1.65e-05	1.33e-04	0.2920	-5.77e-02	1.50e-02	8.60e-02	2.22e-01	4.85e-02	1.51e-01	2.96e-01	7.86e-01	1.19e-01	5.73e-05	3.79e-01	6.24e-03
GOMF DICARBOXYLIC ACID TRANSMEMBRANE TRANSPORTER ACTIVITY	20	3.80e-01	4.94e-01	0.2920	7.63e-02	-2.06e-01	-3.97e-02	1.56e-01	2.35e-02	-1.03e-01	5.55e-01	1.11e-01	7.59e-01	2.27e-01	8.55e-01	4.26e-01
GOBP REGULATION OF SYNCYTIUM FORMATION BY PLASMA MEMBRANE FUSION	20	6.81e-01	7.47e-01	0.2920	-5.86e-02	8.91e-02	1.79e-01	-7.62e-02	1.99e-02	1.88e-01	6.50e-01	4.90e-01	1.65e-01	5.55e-01	8.77e-01	1.44e-01
GOMF INOSITOL TETRAKISPHOSPHATE PHOSPHATASE ACTIVITY	7	8.15e-01	8.50e-01	0.2920	-1.26e-01	-1.17e-01	9.74e-02	1.10e-01	-1.80e-01	-4.52e-02	5.65e-01	5.92e-01	6.55e-01	6.14e-01	4.11e-01	8.36e-01
GOBP INTRACELLULAR MRNA LOCALIZATION	15	2.68e-01	3.87e-01	0.2920	-9.19e-02	1.80e-01	7.45e-02	1.46e-02	-1.16e-01	-1.58e-01	5.38e-01	2.27e-01	6.17e-01	9.22e-01	4.37e-01	2.88e-01
GOBP POSITIVE REGULATION OF DNA RECOMBINATION	72	8.29e-03	2.96e-02	0.2920	-5.12e-02	-2.40e-02	-1.33e-01	2.16e-01	1.26e-01	-3.85e-02	4.52e-01	7.24e-01	5.06e-02	1.51e-03	6.37e-02	5.72e-01
GOBP RNA EXPORT FROM NUCLEUS	87	9.04e-06	7.69e-05	0.2920	-1.17e-01	-9.45e-02	-7.61e-02	2.36e-01	-3.00e-02	-5.15e-04	5.89e-02	1.28e-01	2.20e-01	1.39e-04	6.28e-01	9.93e-01
GOBP OOCYTE DIFFERENTIATION	43	7.13e-02	1.53e-01	0.2920	-1.05e-01	-1.11e-01	1.29e-01	1.15e-01	-8.09e-02	1.60e-01	2.34e-01	2.10e-01	1.43e-01	1.93e-01	3.59e-01	6.97e-02
GOBP ORGANELLE MEMBRANE FUSION	106	2.71e-05	2.09e-04	0.2920	-1.21e-01	-1.47e-01	1.67e-02	1.29e-01	6.20e-02	1.67e-01	3.07e-02	8.91e-03	7.66e-01	2.16e-02	2.70e-01	2.92e-03
GOBP STRIATUM DEVELOPMENT	18	1.33e-01	2.40e-01	0.2920	-1.42e-01	1.96e-01	-1.23e-01	-7.60e-02	-1.76e-02	7.28e-02	2.98e-01	1.49e-01	3.66e-01	5.76e-01	8.97e-01	5.93e-01
GOBP SUBPALLIUM DEVELOPMENT	18	1.33e-01	2.40e-01	0.2920	-1.42e-01	1.96e-01	-1.23e-01	-7.60e-02	-1.76e-02	7.28e-02	2.98e-01	1.49e-01	3.66e-01	5.76e-01	8.97e-01	5.93e-01
GOBP AMIDE CATABOLIC PROCESS	11	8.57e-01	8.84e-01	0.2920	6.98e-02	-1.51e-01	-1.32e-01	4.17e-02	6.66e-02	-1.85e-01	6.88e-01	3.87e-01	4.50e-01	8.11e-01	7.02e-01	2.89e-01
GOBP POSITIVE REGULATION OF NITRIC OXIDE METABOLIC PROCESS	34	7.38e-03	2.70e-02	0.2920	-8.26e-02	1.03e-01	2.07e-01	-1.15e-01	8.63e-02	-6.49e-02	4.04e-01	3.00e-01	3.64e-02	2.48e-01	3.84e-01	5.12e-01
GOBP POSITIVE REGULATION OF CYTOKINESIS	38	6.14e-02	1.37e-01	0.2920	-6.46e-02	-1.28e-01	1.20e-01	1.77e-01	-5.90e-02	1.23e-01	4.91e-01	1.71e-01	2.02e-01	5.84e-02	5.29e-01	1.89e-01
GOBP REGULATION OF VACUOLE ORGANIZATION	58	1.61e-03	7.64e-03	0.2920	-2.73e-01	2.41e-02	-3.21e-03	3.86e-02	1.22e-02	9.13e-02	3.22e-04	7.51e-01	9.66e-01	6.11e-01	8.73e-01	2.29e-01
GOBP DNA REPAIR	573	4.36e-29	3.96e-27	0.2920	-5.41e-02	-1.17e-01	-1.13e-01	2.19e-01	8.03e-02	3.23e-02	2.70e-02	1.65e-06	3.58e-06	2.87e-19	1.02e-03	1.87e-01
GOBP POSITIVE REGULATION OF STEM CELL POPULATION MAINTENANCE	42	7.89e-03	2.85e-02	0.2920	-6.44e-02	2.77e-02	1.06e-02	2.77e-01	-3.97e-03	5.71e-02	4.70e-01	7.56e-01	9.05e-01	1.90e-03	9.65e-01	5.22e-01
GOBP DIENCEPHALON DEVELOPMENT	37	2.68e-01	3.88e-01	0.2920	3.75e-02	2.14e-01	1.51e-01	-6.43e-02	8.29e-02	6.44e-02	6.93e-01	2.45e-02	1.12e-01	4.98e-01	3.83e-01	4.98e-01
GOCC CYTOPLASMIC STRESS GRANULE	82	7.79e-04	4.12e-03	0.2910	-2.02e-01	-6.61e-02	4.28e-02	4.77e-02	-1.25e-01	1.42e-01	1.60e-03	3.01e-01	5.03e-01	4.55e-01	5.09e-02	2.58e-02
GOBP PROTEIN DESTABILIZATION	48	3.43e-03	1.44e-02	0.2910	-6.97e-02	-3.36e-03	9.68e-02	2.38e-01	-7.89e-02	8.94e-02	4.03e-01	9.68e-01	2.46e-01	4.40e-03	3.44e-01	2.84e-01
GOBP PROTEIN DNA COMPLEX ASSEMBLY	176	1.29e-08	1.78e-07	0.2910	-5.24e-02	-1.96e-01	-1.17e-02	1.47e-01	-3.80e-02	1.44e-01	2.31e-01	7.64e-06	7.88e-01	7.64e-04	3.84e-01	9.95e-04
GOBP POSITIVE REGULATION OF EPIDERMIS DEVELOPMENT	24	4.80e-01	5.82e-01	0.2910	9.33e-02	1.02e-01	1.45e-01	1.91e-01	8.96e-02	-3.40e-03	4.29e-01	3.86e-01	2.19e-01	1.05e-01	4.47e-01	9.77e-01
GOBP GLOMERULAR BASEMENT MEMBRANE DEVELOPMENT	9	8.86e-01	9.07e-01	0.2910	-6.17e-02	3.11e-02	-6.63e-02	-1.02e-01	-2.14e-02	-2.55e-01	7.49e-01	8.71e-01	7.31e-01	5.97e-01	9.11e-01	1.86e-01
GOBP PROTEIN AUTOUBIQUITINATION	70	1.22e-02	4.01e-02	0.2910	-2.04e-01	-1.22e-01	-4.66e-02	6.38e-03	-1.16e-01	1.13e-01	3.19e-03	7.77e-02	5.00e-01	9.26e-01	9.27e-02	1.03e-01
GOMF GLYCOLIPID BINDING	23	3.79e-01	4.93e-01	0.2910	-1.95e-01	-1.20e-01	3.71e-02	-1.69e-02	6.02e-02	1.65e-01	1.06e-01	3.19e-01	7.58e-01	8.89e-01	6.17e-01	1.71e-01
GOBP NEGATIVE REGULATION OF CELL FATE COMMITMENT	5	9.16e-01	9.30e-01	0.2910	-1.99e-01	-1.82e-01	9.90e-02	1.71e-02	-4.16e-02	4.19e-03	4.41e-01	4.80e-01	7.01e-01	9.47e-01	8.72e-01	9.87e-01
GOBP REGULATION OF PH	82	3.64e-04	2.13e-03	0.2910	-2.65e-01	-5.59e-02	6.27e-03	2.70e-02	4.97e-03	1.02e-01	3.30e-05	3.82e-01	9.22e-01	6.73e-01	9.38e-01	1.09e-01
GOBP ORGANELLE DISASSEMBLY	171	5.19e-07	5.70e-06	0.2910	-1.52e-01	-1.85e-01	-1.25e-01	9.78e-02	-1.28e-02	4.37e-02	6.03e-04	2.88e-05	4.93e-03	2.73e-02	7.73e-01	3.24e-01
GOMF GTPASE ACTIVITY	284	2.96e-10	5.10e-09	0.2910	-1.90e-01	-1.38e-01	2.54e-02	-7.40e-03	-9.36e-02	1.41e-01	3.36e-08	6.13e-05	4.61e-01	8.30e-01	6.65e-03	4.54e-05
GOBP CYCLIC NUCLEOTIDE TRANSPORT	10	8.39e-01	8.70e-01	0.2910	-1.56e-01	-1.18e-01	6.85e-02	1.91e-02	-2.03e-01	1.12e-03	3.93e-01	5.18e-01	7.07e-01	9.17e-01	2.66e-01	9.95e-01
GOBP MECHANORECEPTOR DIFFERENTIATION	48	2.61e-02	7.26e-02	0.2910	-9.02e-02	1.22e-01	-3.46e-02	-1.24e-01	6.72e-02	-2.01e-01	2.80e-01	1.43e-01	6.79e-01	1.38e-01	4.21e-01	1.59e-02
GOBP PROTEIN K48 LINKED UBIQUITINATION	97	8.98e-04	4.64e-03	0.2910	-2.19e-01	-1.20e-01	-7.59e-02	7.50e-03	-5.19e-02	1.16e-01	1.88e-04	4.05e-02	1.96e-01	8.98e-01	3.77e-01	4.85e-02
GOBP ORGANELLE FISSION	416	1.57e-22	8.17e-21	0.2910	-5.88e-02	-1.90e-01	1.02e-02	1.59e-01	-8.78e-04	1.40e-01	3.98e-02	2.79e-11	7.20e-01	2.85e-08	9.75e-01	9.72e-07
GOBP NEGATIVE REGULATION OF PROTEIN LOCALIZATION TO MICROTUBULE	5	9.72e-01	9.76e-01	0.2910	-8.65e-02	2.80e-02	7.68e-02	1.05e-02	1.15e-01	2.39e-01	7.38e-01	9.14e-01	7.66e-01	9.68e-01	6.57e-01	3.55e-01
GOBP RESPONSE TO ISCHEMIA	47	3.39e-02	8.79e-02	0.2910	-9.55e-02	7.57e-02	1.78e-01	1.01e-01	7.90e-02	1.47e-01	2.57e-01	3.69e-01	3.50e-02	2.30e-01	3.49e-01	8.15e-02
GOBP REGULATION OF CELL SHAPE	116	4.74e-06	4.33e-05	0.2910	-1.15e-01	-2.53e-02	1.99e-01	4.00e-02	-1.53e-01	7.66e-02	3.30e-02	6.38e-01	2.06e-04	4.57e-01	4.38e-03	1.54e-01
GOBP REGULATION OF HEART RATE BY CHEMICAL SIGNAL	5	9.77e-01	9.80e-01	0.2910	-1.07e-01	-6.09e-02	2.00e-01	1.50e-02	-1.01e-01	1.38e-01	6.78e-01	8.14e-01	4.39e-01	9.54e-01	6.97e-01	5.94e-01
GOBP PROTEIN AUTOPHOSPHORYLATION	170	4.86e-08	6.19e-07	0.2910	-5.14e-02	1.49e-01	1.67e-01	1.13e-01	-1.61e-02	1.36e-01	2.48e-01	7.75e-04	1.72e-04	1.10e-02	7.18e-01	2.19e-03
GOBP POSITIVE REGULATION OF CATION CHANNEL ACTIVITY	34	4.07e-01	5.19e-01	0.2910	9.91e-02	5.68e-02	1.69e-01	-1.20e-02	-5.75e-02	1.99e-01	3.17e-01	5.66e-01	8.90e-02	9.04e-01	5.62e-01	4.49e-02
GOBP PLASMA LIPOPROTEIN PARTICLE CLEARANCE	29	1.75e-02	5.31e-02	0.2900	-3.17e-02	3.72e-02	2.77e-01	6.79e-02	2.58e-02	-1.04e-02	7.68e-01	7.29e-01	9.88e-03	5.27e-01	8.10e-01	9.23e-01
GOBP REGULATION OF CARDIAC MUSCLE CONTRACTION BY CALCIUM ION SIGNALING	20	6.46e-01	7.19e-01	0.2900	-1.12e-01	-1.25e-01	1.44e-01	-2.21e-02	-7.72e-02	1.70e-01	3.86e-01	3.34e-01	2.64e-01	8.64e-01	5.50e-01	1.87e-01
GOBP POSITIVE REGULATION OF CELL PROLIFERATION INVOLVED IN KIDNEY DEVELOPMENT	8	9.17e-01	9.31e-01	0.2900	1.88e-02	1.32e-01	9.52e-02	-1.93e-01	-1.15e-01	8.43e-02	9.27e-01	5.20e-01	6.41e-01	3.44e-01	5.72e-01	6.80e-01
GOBP MOLTING CYCLE	67	4.39e-02	1.07e-01	0.2900	3.23e-02	1.48e-01	1.80e-01	8.75e-02	1.07e-01	9.93e-02	6.48e-01	3.58e-02	1.09e-02	2.15e-01	1.30e-01	1.60e-01
GOBP REGULATION OF ANOIKIS	19	4.37e-01	5.45e-01	0.2900	2.40e-02	-1.19e-01	1.47e-01	1.80e-01	-9.60e-02	7.85e-02	8.56e-01	3.69e-01	2.66e-01	1.74e-01	4.69e-01	5.54e-01
GOBP REGULATION OF NEUROTRANSMITTER SECRETION	63	6.66e-03	2.48e-02	0.2900	-1.09e-01	8.93e-02	1.89e-01	5.01e-02	6.73e-02	1.47e-01	1.33e-01	2.21e-01	9.41e-03	4.92e-01	3.55e-01	4.41e-02
GOCC SAGA COMPLEX	23	3.76e-01	4.91e-01	0.2900	-1.12e-03	-1.56e-01	-7.66e-02	2.29e-01	5.15e-04	-3.93e-02	9.93e-01	1.96e-01	5.25e-01	5.70e-02	9.97e-01	7.44e-01
GOBP ANTIGEN RECEPTOR MEDIATED SIGNALING PATHWAY	196	2.86e-06	2.75e-05	0.2900	1.00e-01	1.25e-01	6.79e-02	1.92e-01	5.75e-02	1.17e-01	1.58e-02	2.49e-03	1.01e-01	3.51e-06	1.65e-01	4.75e-03
GOBP ARTERY DEVELOPMENT	68	2.30e-04	1.42e-03	0.2900	-1.60e-01	1.23e-01	1.93e-01	3.37e-02	6.80e-03	7.05e-02	2.25e-02	7.89e-02	5.91e-03	6.31e-01	9.23e-01	3.15e-01
GOCC FILOPODIUM	83	3.91e-03	1.60e-02	0.2900	-1.01e-01	1.01e-01	1.54e-01	-2.22e-02	-1.22e-01	1.57e-01	1.11e-01	1.12e-01	1.51e-02	7.26e-01	5.55e-02	1.33e-02
GOBP REGULATION OF NEUTROPHIL MIGRATION	39	1.21e-02	3.99e-02	0.2900	-1.33e-01	4.17e-04	2.37e-01	-6.92e-02	2.32e-02	7.09e-02	1.51e-01	9.96e-01	1.05e-02	4.54e-01	8.02e-01	4.43e-01
GOBP CELLULAR RESPONSE TO LAMINAR FLUID SHEAR STRESS	6	7.46e-01	7.97e-01	0.2900	-5.87e-04	-1.18e-01	2.57e-01	-1.09e-03	-5.20e-02	-3.55e-02	9.98e-01	6.17e-01	2.75e-01	9.96e-01	8.25e-01	8.80e-01
GOBP REGULATION OF NERVOUS SYSTEM PROCESS	82	4.32e-04	2.48e-03	0.2900	-6.45e-02	2.58e-02	2.02e-01	1.11e-01	6.75e-02	1.48e-01	3.12e-01	6.87e-01	1.59e-03	8.28e-02	2.91e-01	2.09e-02
GOBP RESPONSE TO FATTY ACID	42	8.64e-04	4.50e-03	0.2900	-8.72e-02	1.94e-02	2.45e-01	-6.52e-02	1.03e-01	3.87e-02	3.28e-01	8.28e-01	6.09e-03	4.65e-01	2.49e-01	6.65e-01
GOBP NEGATIVE REGULATION OF EPITHELIAL TO MESENCHYMAL TRANSITION	28	4.96e-01	5.95e-01	0.2900	3.10e-02	6.74e-02	2.05e-01	1.19e-02	-1.59e-01	1.04e-01	7.77e-01	5.37e-01	5.99e-02	9.13e-01	1.44e-01	3.43e-01
GOMF CATALYTIC ACTIVITY ACTING ON DNA	234	1.36e-09	2.12e-08	0.2900	1.20e-03	-9.96e-02	-1.13e-01	2.18e-01	1.16e-01	1.71e-02	9.75e-01	8.67e-03	2.82e-03	9.36e-09	2.27e-03	6.52e-01
GOBP PROGRAMMED CELL DEATH INVOLVED IN CELL DEVELOPMENT	17	7.73e-01	8.17e-01	0.2900	1.22e-01	1.62e-01	1.67e-01	-6.53e-02	-8.43e-02	5.96e-02	3.84e-01	2.48e-01	2.32e-01	6.41e-01	5.47e-01	6.71e-01
GOBP REGULATION OF POST TRANSLATIONAL PROTEIN MODIFICATION	227	3.07e-11	5.84e-10	0.2900	-1.74e-01	-1.70e-01	-6.51e-02	1.23e-01	-2.47e-02	7.10e-02	6.55e-06	1.08e-05	9.12e-02	1.42e-03	5.22e-01	6.56e-02
GOBP PROTEASOMAL PROTEIN CATABOLIC PROCESS	491	1.65e-26	1.22e-24	0.2900	-1.94e-01	-1.35e-01	-1.53e-02	1.00e-01	-5.44e-02	1.21e-01	1.70e-13	3.13e-07	5.61e-01	1.45e-04	3.91e-02	4.18e-06
GOBP CELL SURFACE PATTERN RECOGNITION RECEPTOR SIGNALING PATHWAY	63	2.99e-04	1.79e-03	0.2890	-2.44e-01	1.16e-01	4.66e-02	-5.50e-03	8.99e-02	2.08e-02	7.95e-04	1.12e-01	5.22e-01	9.40e-01	2.17e-01	7.75e-01
GOBP NON CANONICAL WNT SIGNALING PATHWAY	53	5.98e-02	1.35e-01	0.2890	9.56e-02	1.53e-01	1.92e-01	1.13e-01	-3.88e-02	4.43e-03	2.28e-01	5.44e-02	1.55e-02	1.53e-01	6.25e-01	9.56e-01
GOBP NEGATIVE REGULATION OF CANONICAL WNT SIGNALING PATHWAY	91	7.03e-03	2.60e-02	0.2890	7.65e-02	1.36e-01	1.25e-01	1.89e-01	2.82e-02	8.39e-02	2.07e-01	2.49e-02	3.88e-02	1.80e-03	6.42e-01	1.67e-01
GOBP POSITIVE REGULATION OF NUCLEAR DIVISION	40	4.24e-02	1.04e-01	0.2890	2.75e-02	-1.60e-01	4.43e-03	1.73e-01	1.44e-01	8.14e-02	7.63e-01	7.94e-02	9.61e-01	5.79e-02	1.16e-01	3.73e-01
GOBP REGULATION OF ERBB SIGNALING PATHWAY	61	3.03e-02	8.06e-02	0.2890	-5.96e-02	-5.54e-02	1.99e-01	5.68e-02	-1.21e-01	1.40e-01	4.21e-01	4.55e-01	7.10e-03	4.43e-01	1.02e-01	5.94e-02
GOBP PLASMA MEMBRANE ORGANIZATION	125	2.58e-05	2.00e-04	0.2890	1.23e-02	-6.56e-02	2.29e-01	5.97e-02	-8.60e-02	1.25e-01	8.13e-01	2.06e-01	9.64e-06	2.49e-01	9.70e-02	1.54e-02
GOBP INTERFERON BETA PRODUCTION	57	6.72e-03	2.50e-02	0.2890	-1.31e-01	5.82e-02	-6.28e-02	1.32e-01	1.38e-01	1.51e-01	8.73e-02	4.47e-01	4.12e-01	8.51e-02	7.09e-02	4.93e-02
GOBP REGULATION OF MUSCLE TISSUE DEVELOPMENT	28	3.22e-01	4.41e-01	0.2890	2.12e-01	1.91e-01	4.22e-02	-1.02e-02	-1.00e-02	-1.76e-02	5.25e-02	8.01e-02	6.99e-01	9.25e-01	9.27e-01	8.72e-01
GOBP POSITIVE REGULATION OF ORGANELLE ASSEMBLY	81	6.61e-06	5.85e-05	0.2890	-1.85e-01	1.37e-01	1.11e-02	1.36e-01	7.13e-02	8.41e-02	4.07e-03	3.34e-02	8.63e-01	3.42e-02	2.67e-01	1.91e-01
GOBP CEREBELLAR CORTEX DEVELOPMENT	40	8.95e-02	1.81e-01	0.2890	-6.14e-03	1.06e-01	1.67e-01	1.70e-01	1.04e-01	6.87e-02	9.46e-01	2.47e-01	6.77e-02	6.28e-02	2.54e-01	4.52e-01
GOCC TRANSPORT VESICLE	336	5.41e-17	1.77e-15	0.2890	-1.82e-01	-7.33e-02	7.76e-02	7.65e-02	-5.24e-02	1.75e-01	1.00e-08	2.09e-02	1.45e-02	1.60e-02	9.86e-02	3.81e-08
GOBP REGULATION OF EPITHELIAL CELL DIFFERENTIATION INVOLVED IN KIDNEY DEVELOPMENT	8	8.17e-01	8.53e-01	0.2890	-8.87e-03	2.48e-01	-2.50e-02	-1.45e-01	-8.30e-03	-8.95e-03	9.65e-01	2.24e-01	9.03e-01	4.78e-01	9.68e-01	9.65e-01
GOMF PHOSPHOLIPID SCRAMBLASE ACTIVITY	11	7.72e-01	8.17e-01	0.2890	-6.51e-02	4.19e-02	4.37e-02	2.25e-01	6.20e-02	1.45e-01	7.08e-01	8.10e-01	8.02e-01	1.97e-01	7.22e-01	4.04e-01
GOBP MYELIN MAINTENANCE	15	2.64e-01	3.84e-01	0.2890	-4.40e-02	-1.75e-01	1.12e-01	1.92e-01	3.47e-02	-1.83e-02	7.68e-01	2.39e-01	4.54e-01	1.99e-01	8.16e-01	9.03e-01
GOCC NEUROTRANSMITTER RECEPTOR COMPLEX	24	4.08e-01	5.19e-01	0.2890	2.41e-01	6.71e-02	1.06e-01	1.71e-02	1.50e-02	-9.50e-02	4.10e-02	5.69e-01	3.68e-01	8.84e-01	8.99e-01	4.20e-01
GOBP HEMATOPOIETIC STEM CELL PROLIFERATION	28	1.47e-01	2.57e-01	0.2890	-2.86e-02	1.97e-01	-1.03e-01	1.46e-01	1.09e-01	-3.26e-03	7.94e-01	7.12e-02	3.44e-01	1.83e-01	3.17e-01	9.76e-01
GOBP RADIAL GLIAL CELL DIFFERENTIATION	8	8.95e-01	9.13e-01	0.2890	-9.06e-02	-1.67e-01	-8.61e-02	1.19e-01	7.09e-03	1.60e-01	6.57e-01	4.14e-01	6.73e-01	5.59e-01	9.72e-01	4.32e-01
GOBP LOW DENSITY LIPOPROTEIN PARTICLE CLEARANCE	20	5.78e-02	1.31e-01	0.2890	-1.08e-01	1.71e-02	2.50e-01	1.29e-02	9.43e-02	9.03e-03	4.04e-01	8.95e-01	5.33e-02	9.21e-01	4.65e-01	9.44e-01
GOBP CELLULAR RESPONSE TO ARSENIC CONTAINING SUBSTANCE	17	3.18e-01	4.37e-01	0.2890	-1.41e-01	-3.43e-03	1.82e-01	-1.14e-01	-9.70e-02	-8.96e-02	3.16e-01	9.80e-01	1.94e-01	4.15e-01	4.88e-01	5.23e-01
GOBP POSITIVE REGULATION OF DOUBLE STRAND BREAK REPAIR VIA HOMOLOGOUS RECOMBINATION	41	8.40e-02	1.72e-01	0.2890	-5.06e-02	-5.98e-02	-1.01e-01	2.30e-01	8.47e-02	-8.28e-02	5.75e-01	5.07e-01	2.61e-01	1.08e-02	3.48e-01	3.59e-01
GOCC CONTRACTILE MUSCLE FIBER	175	7.77e-05	5.42e-04	0.2890	-2.14e-02	-2.10e-02	1.77e-01	-7.15e-03	-9.22e-02	2.06e-01	6.25e-01	6.32e-01	5.52e-05	8.70e-01	3.53e-02	2.46e-06
GOBP REGULATION OF CELL MATRIX ADHESION	98	1.10e-03	5.50e-03	0.2890	-6.86e-02	-8.25e-03	2.18e-01	-9.69e-03	-1.52e-01	8.91e-02	2.40e-01	8.88e-01	1.93e-04	8.68e-01	9.47e-03	1.28e-01
GOBP ACTIVATION OF GTPASE ACTIVITY	90	6.19e-05	4.43e-04	0.2890	6.78e-02	1.37e-01	1.43e-01	1.87e-01	-2.51e-03	-6.93e-02	2.66e-01	2.48e-02	1.94e-02	2.21e-03	9.67e-01	2.56e-01
GOBP NEGATIVE REGULATION OF DOUBLE STRAND BREAK REPAIR VIA HOMOLOGOUS RECOMBINATION	26	1.17e-01	2.19e-01	0.2890	-8.39e-02	4.23e-03	7.12e-02	2.49e-01	-2.37e-02	9.20e-02	4.59e-01	9.70e-01	5.30e-01	2.79e-02	8.35e-01	4.17e-01
GOBP REGULATION OF PROTEIN DEPOLYMERIZATION	75	9.45e-03	3.28e-02	0.2880	-1.35e-02	4.96e-02	2.18e-01	1.01e-01	1.79e-02	1.50e-01	8.40e-01	4.58e-01	1.08e-03	1.32e-01	7.89e-01	2.48e-02
GOBP T CELL APOPTOTIC PROCESS	53	1.08e-01	2.06e-01	0.2880	6.87e-02	1.72e-03	1.09e-02	2.04e-01	1.45e-01	1.24e-01	3.87e-01	9.83e-01	8.91e-01	1.00e-02	6.76e-02	1.18e-01
GOBP NEGATIVE REGULATION OF AMINE TRANSPORT	14	8.22e-01	8.56e-01	0.2880	-9.00e-02	-3.24e-02	6.98e-03	-1.84e-01	-1.33e-01	-1.50e-01	5.60e-01	8.34e-01	9.64e-01	2.33e-01	3.91e-01	3.32e-01
GOBP INTERLEUKIN 8 PRODUCTION	67	5.22e-04	2.91e-03	0.2880	-9.88e-02	2.26e-01	1.18e-01	1.18e-02	8.46e-02	-3.26e-02	1.62e-01	1.39e-03	9.47e-02	8.67e-01	2.31e-01	6.45e-01
GOBP ACTIVATION INDUCED CELL DEATH OF T CELLS	9	8.53e-01	8.81e-01	0.2880	-5.11e-02	-2.49e-01	2.88e-02	1.95e-02	-1.16e-01	-6.06e-02	7.91e-01	1.95e-01	8.81e-01	9.20e-01	5.48e-01	7.53e-01
GOBP POSTSYNAPSE TO NUCLEUS SIGNALING PATHWAY	5	8.62e-01	8.88e-01	0.2880	-1.30e-01	1.23e-01	1.03e-01	1.44e-01	1.19e-01	-7.51e-02	6.15e-01	6.33e-01	6.90e-01	5.78e-01	6.46e-01	7.71e-01
GOMF PROTEOGLYCAN BINDING	28	2.32e-01	3.50e-01	0.2880	-2.27e-01	-2.60e-02	-1.49e-02	-1.47e-01	4.83e-02	-8.04e-02	3.76e-02	8.11e-01	8.91e-01	1.77e-01	6.58e-01	4.61e-01
GOBP MEIOTIC CHROMOSOME SEGREGATION	68	7.07e-03	2.61e-02	0.2880	-8.70e-02	-1.72e-01	-1.22e-02	1.18e-01	-4.96e-02	1.71e-01	2.15e-01	1.42e-02	8.61e-01	9.17e-02	4.80e-01	1.47e-02
GOBP REGULATION OF PROTEIN MATURATION	55	1.21e-02	3.99e-02	0.2880	-1.50e-01	-5.37e-02	2.04e-01	-1.68e-02	-8.57e-02	9.23e-02	5.51e-02	4.91e-01	8.96e-03	8.29e-01	2.71e-01	2.36e-01
GOBP NUCLEOBASE CONTAINING SMALL MOLECULE METABOLIC PROCESS	592	1.00e-25	6.91e-24	0.2880	-1.22e-01	-2.40e-01	-5.77e-02	5.26e-02	-2.88e-02	5.68e-02	3.67e-07	1.60e-23	1.64e-02	2.88e-02	2.31e-01	1.82e-02
GOBP PROTEIN TARGETING TO VACUOLE INVOLVED IN AUTOPHAGY	6	9.42e-01	9.52e-01	0.2880	4.10e-02	-1.86e-01	4.09e-03	1.50e-01	-1.53e-01	1.80e-02	8.62e-01	4.29e-01	9.86e-01	5.24e-01	5.15e-01	9.39e-01
GOBP CARBOHYDRATE DERIVATIVE BIOSYNTHETIC PROCESS	577	3.29e-25	2.13e-23	0.2880	-1.54e-01	-2.14e-01	-3.60e-02	6.48e-02	-4.95e-02	7.31e-02	2.70e-10	1.48e-18	1.39e-01	7.86e-03	4.24e-02	2.69e-03
GOBP RESPONSE TO LEPTIN	17	3.60e-01	4.75e-01	0.2880	-2.44e-01	-4.31e-02	1.02e-01	-6.57e-02	6.33e-02	5.27e-02	8.19e-02	7.58e-01	4.66e-01	6.39e-01	6.51e-01	7.07e-01
GOBP C4 DICARBOXYLATE TRANSPORT	23	3.63e-01	4.78e-01	0.2880	1.55e-02	-2.07e-01	2.75e-03	1.76e-01	-8.01e-02	4.73e-02	8.98e-01	8.50e-02	9.82e-01	1.45e-01	5.06e-01	6.95e-01
GOBP CELLULAR RESPONSE TO DEXAMETHASONE STIMULUS	20	5.97e-01	6.79e-01	0.2880	-1.60e-01	-1.50e-01	-1.73e-02	-2.41e-02	1.90e-04	1.84e-01	2.16e-01	2.46e-01	8.94e-01	8.52e-01	9.99e-01	1.54e-01
GOBP REGULATION OF NEUROTRANSMITTER TRANSPORT	74	1.02e-02	3.49e-02	0.2870	-7.75e-02	6.93e-02	2.12e-01	2.01e-02	1.36e-02	1.61e-01	2.49e-01	3.03e-01	1.57e-03	7.65e-01	8.40e-01	1.64e-02
GOBP MITOCHONDRIAL DEPOLARIZATION	18	7.76e-01	8.19e-01	0.2870	-1.37e-01	-1.82e-01	-1.53e-01	-7.83e-02	-1.89e-02	2.77e-02	3.16e-01	1.81e-01	2.61e-01	5.65e-01	8.89e-01	8.39e-01
GOCC TROPONIN COMPLEX	5	9.17e-01	9.31e-01	0.2870	-6.28e-02	-1.30e-01	-8.37e-02	-1.46e-01	9.41e-02	1.57e-01	8.08e-01	6.16e-01	7.46e-01	5.71e-01	7.16e-01	5.44e-01
GOBP NEGATIVE REGULATION OF PHOSPHATIDYLINOSITOL 3 KINASE PROTEIN KINASE B SIGNAL TRANSDUCTION	48	7.26e-02	1.55e-01	0.2870	-1.67e-01	-1.04e-01	3.52e-02	-3.81e-02	-1.95e-01	-5.56e-02	4.54e-02	2.15e-01	6.73e-01	6.48e-01	1.92e-02	5.05e-01
GOBP REGULATION OF FATTY ACID BIOSYNTHETIC PROCESS	34	1.41e-01	2.50e-01	0.2870	-4.14e-02	-1.49e-02	2.24e-01	7.59e-02	2.66e-02	1.54e-01	6.76e-01	8.80e-01	2.36e-02	4.44e-01	7.88e-01	1.19e-01
GOBP REGULATION OF EXTENT OF CELL GROWTH	77	2.77e-05	2.14e-04	0.2870	-3.85e-02	1.74e-01	1.68e-01	1.41e-01	3.29e-02	-3.77e-02	5.60e-01	8.21e-03	1.09e-02	3.19e-02	6.18e-01	5.68e-01
GOBP CENTRAL NERVOUS SYSTEM NEURON DIFFERENTIATION	106	2.53e-04	1.55e-03	0.2870	-2.28e-02	2.21e-01	1.07e-01	9.49e-02	1.04e-01	4.34e-02	6.86e-01	8.54e-05	5.70e-02	9.14e-02	6.46e-02	4.40e-01
GOBP SYNAPTIC VESICLE RECYCLING	69	1.67e-03	7.86e-03	0.2870	-2.79e-02	-3.68e-03	2.03e-01	1.55e-01	-8.63e-02	9.42e-02	6.89e-01	9.58e-01	3.51e-03	2.61e-02	2.15e-01	1.76e-01
GOBP VASCULOGENESIS	54	2.83e-02	7.67e-02	0.2870	3.97e-02	1.72e-01	1.60e-01	1.48e-01	6.12e-02	-1.16e-02	6.14e-01	2.91e-02	4.21e-02	6.02e-02	4.37e-01	8.83e-01
GOBP RAS PROTEIN SIGNAL TRANSDUCTION	107	1.56e-04	1.01e-03	0.2870	-2.35e-02	6.47e-02	2.43e-01	5.99e-02	-8.05e-02	9.20e-02	6.75e-01	2.47e-01	1.41e-05	2.85e-01	1.50e-01	1.00e-01
GOBP POSITIVE REGULATION OF NEURON PROJECTION DEVELOPMENT	118	2.20e-06	2.17e-05	0.2870	-7.94e-02	9.72e-02	1.85e-01	1.40e-01	1.77e-02	1.11e-01	1.37e-01	6.83e-02	5.21e-04	8.57e-03	7.40e-01	3.69e-02
GOBP CELLULAR RESPONSE TO VITAMIN D	17	3.15e-01	4.35e-01	0.2870	-1.40e-01	1.29e-01	5.64e-02	-5.06e-02	1.80e-01	-9.00e-02	3.19e-01	3.58e-01	6.87e-01	7.18e-01	1.99e-01	5.20e-01
GOBP RECEPTOR MEDIATED ENDOCYTOSIS	210	7.09e-09	1.02e-07	0.2870	-5.20e-02	4.85e-02	2.25e-01	7.02e-02	-4.25e-02	1.40e-01	1.94e-01	2.26e-01	1.79e-08	7.94e-02	2.88e-01	4.69e-04
GOCC BCL 2 FAMILY PROTEIN COMPLEX	10	7.95e-01	8.35e-01	0.2870	-1.01e-01	-1.93e-01	9.68e-02	-2.46e-02	-1.46e-01	-5.91e-02	5.79e-01	2.91e-01	5.96e-01	8.93e-01	4.26e-01	7.46e-01
GOCC PRONUCLEUS	12	6.78e-01	7.44e-01	0.2870	3.91e-02	-5.77e-02	1.55e-01	2.25e-01	-2.56e-02	4.28e-02	8.15e-01	7.29e-01	3.52e-01	1.77e-01	8.78e-01	7.98e-01
GOBP NEGATIVE REGULATION OF SUBSTRATE ADHESION DEPENDENT CELL SPREADING	12	7.44e-01	7.96e-01	0.2870	-2.96e-02	-2.25e-01	1.05e-01	-8.03e-03	-1.40e-01	3.84e-03	8.59e-01	1.77e-01	5.29e-01	9.62e-01	4.02e-01	9.82e-01
GOBP POSITIVE REGULATION OF GENE EXPRESSION EPIGENETIC	52	3.62e-02	9.25e-02	0.2870	1.09e-01	2.46e-02	-2.28e-03	2.57e-01	2.43e-03	-6.08e-02	1.76e-01	7.59e-01	9.77e-01	1.35e-03	9.76e-01	4.48e-01
GOBP POSITIVE REGULATION OF TELOMERASE ACTIVITY	27	3.40e-01	4.57e-01	0.2870	-1.91e-01	-1.25e-01	-1.49e-01	8.40e-02	-2.81e-02	5.72e-03	8.66e-02	2.62e-01	1.79e-01	4.50e-01	8.01e-01	9.59e-01
GOMF ATPASE REGULATOR ACTIVITY	47	2.59e-02	7.22e-02	0.2860	-9.56e-02	-1.68e-01	7.96e-02	1.38e-01	8.16e-03	1.39e-01	2.57e-01	4.58e-02	3.45e-01	1.03e-01	9.23e-01	9.99e-02
GOBP ENDOCRINE HORMONE SECRETION	37	1.54e-01	2.65e-01	0.2860	-4.72e-03	2.10e-01	1.83e-01	-5.87e-02	-2.75e-02	-9.23e-03	9.60e-01	2.69e-02	5.39e-02	5.37e-01	7.72e-01	9.23e-01
GOBP RESPONSE TO COLD	34	4.67e-02	1.11e-01	0.2860	-7.81e-02	1.27e-02	1.22e-01	2.01e-01	1.28e-01	6.46e-02	4.31e-01	8.98e-01	2.18e-01	4.29e-02	1.95e-01	5.15e-01
GOMF 14 3 3 PROTEIN BINDING	32	3.61e-02	9.22e-02	0.2860	-4.72e-02	-5.12e-02	4.01e-02	6.52e-02	-1.68e-01	-2.07e-01	6.44e-01	6.16e-01	6.95e-01	5.23e-01	9.94e-02	4.24e-02
GOBP NEGATIVE REGULATION OF NATURAL KILLER CELL MEDIATED IMMUNITY	19	1.74e-01	2.89e-01	0.2860	-1.04e-01	-5.92e-02	-5.51e-02	2.07e-01	-1.47e-01	-4.28e-04	4.33e-01	6.55e-01	6.77e-01	1.18e-01	2.66e-01	9.97e-01
GOBP NEGATIVE REGULATION OF CELLULAR RESPONSE TO INSULIN STIMULUS	37	6.74e-03	2.50e-02	0.2860	-2.12e-02	5.74e-02	2.30e-01	1.46e-01	-4.37e-02	-4.29e-02	8.23e-01	5.46e-01	1.54e-02	1.23e-01	6.46e-01	6.52e-01
GOBP VITAMIN TRANSPORT	35	2.20e-01	3.39e-01	0.2860	6.36e-02	8.45e-02	2.50e-02	1.35e-01	2.02e-01	-1.06e-01	5.15e-01	3.87e-01	7.98e-01	1.68e-01	3.88e-02	2.78e-01
GOBP REPLACEMENT OSSIFICATION	21	3.76e-01	4.91e-01	0.2860	-2.58e-02	6.00e-03	-6.86e-02	8.49e-02	2.00e-02	-2.62e-01	8.38e-01	9.62e-01	5.86e-01	5.01e-01	8.74e-01	3.74e-02
GOBP SODIUM ION TRANSMEMBRANE TRANSPORT	126	1.24e-03	6.13e-03	0.2860	8.67e-02	1.62e-01	2.03e-01	5.05e-02	-3.62e-02	5.63e-02	9.28e-02	1.70e-03	8.49e-05	3.28e-01	4.82e-01	2.75e-01
GOBP XENOPHAGY	14	7.11e-01	7.70e-01	0.2860	2.26e-02	2.22e-01	1.69e-02	1.39e-01	8.51e-02	-7.17e-02	8.84e-01	1.50e-01	9.13e-01	3.69e-01	5.82e-01	6.43e-01
GOCC COATED VESICLE MEMBRANE	175	1.31e-10	2.32e-09	0.2860	-1.95e-01	-1.08e-01	5.02e-02	1.28e-01	-4.95e-02	1.03e-01	8.46e-06	1.39e-02	2.52e-01	3.39e-03	2.59e-01	1.85e-02
GOBP POSITIVE REGULATION OF BINDING	95	4.82e-03	1.91e-02	0.2860	-8.84e-02	-1.01e-01	1.54e-01	2.07e-02	-1.31e-01	1.50e-01	1.36e-01	8.97e-02	9.52e-03	7.27e-01	2.75e-02	1.14e-02
GOMF CHROMATIN INSULATOR SEQUENCE BINDING	5	9.94e-01	9.95e-01	0.2860	1.31e-01	6.58e-02	-7.46e-02	1.74e-01	1.53e-01	-3.46e-02	6.12e-01	7.99e-01	7.73e-01	5.01e-01	5.54e-01	8.93e-01
GOBP ARACHIDONIC ACID METABOLIC PROCESS	38	1.81e-01	2.96e-01	0.2860	-3.10e-02	-1.51e-01	-1.20e-01	-1.42e-01	2.22e-02	-1.52e-01	7.41e-01	1.08e-01	2.01e-01	1.31e-01	8.13e-01	1.05e-01
GOBP EXPORT ACROSS PLASMA MEMBRANE	53	1.08e-01	2.06e-01	0.2860	-1.25e-01	-7.50e-02	1.48e-01	4.47e-03	-8.44e-02	1.77e-01	1.14e-01	3.45e-01	6.28e-02	9.55e-01	2.88e-01	2.58e-02
GOBP NEGATIVE REGULATION OF RAS PROTEIN SIGNAL TRANSDUCTION	22	2.35e-01	3.53e-01	0.2860	-8.76e-02	-6.04e-02	2.13e-01	1.17e-01	-4.18e-02	9.86e-02	4.77e-01	6.24e-01	8.43e-02	3.43e-01	7.34e-01	4.23e-01
GOBP POSITIVE REGULATION OF GLYCOPROTEIN METABOLIC PROCESS	20	4.07e-01	5.18e-01	0.2860	-1.65e-01	7.44e-02	1.77e-01	-6.31e-02	-1.14e-01	2.59e-02	2.01e-01	5.65e-01	1.71e-01	6.25e-01	3.78e-01	8.41e-01
GOMF MRNA BINDING	305	1.08e-10	1.93e-09	0.2860	-1.67e-01	-1.81e-01	-1.03e-01	3.58e-02	-9.28e-02	-1.22e-02	4.95e-07	5.27e-08	1.91e-03	2.83e-01	5.31e-03	7.13e-01
GOBP DENDRITIC CELL DIFFERENTIATION	40	1.34e-01	2.41e-01	0.2860	-7.43e-02	-9.14e-02	1.94e-01	-1.23e-02	-3.92e-02	1.68e-01	4.16e-01	3.17e-01	3.37e-02	8.93e-01	6.68e-01	6.54e-02
GOBP DORSAL VENTRAL PATTERN FORMATION	46	6.22e-02	1.38e-01	0.2860	7.08e-02	1.69e-01	3.33e-02	-6.99e-02	1.66e-01	-1.19e-01	4.06e-01	4.68e-02	6.96e-01	4.12e-01	5.08e-02	1.63e-01
GOMF GTPASE INHIBITOR ACTIVITY	11	6.02e-01	6.82e-01	0.2850	-5.15e-02	1.95e-02	7.56e-02	2.24e-01	-1.19e-01	9.35e-02	7.67e-01	9.11e-01	6.64e-01	1.99e-01	4.96e-01	5.91e-01
GOBP TRANSCRIPTION PREINITIATION COMPLEX ASSEMBLY	65	1.29e-02	4.22e-02	0.2850	-4.02e-02	-1.44e-01	-1.16e-01	2.00e-01	5.95e-02	4.59e-02	5.76e-01	4.46e-02	1.06e-01	5.35e-03	4.07e-01	5.22e-01
GOBP NEGATIVE REGULATION OF GTPASE ACTIVITY	19	1.01e-01	1.96e-01	0.2850	-3.56e-02	7.69e-02	-7.68e-02	2.44e-01	-9.15e-02	-1.42e-02	7.88e-01	5.62e-01	5.62e-01	6.53e-02	4.90e-01	9.15e-01
GOBP REGULATION OF CD8 POSITIVE ALPHA BETA T CELL ACTIVATION	19	7.93e-01	8.33e-01	0.2850	1.35e-02	1.43e-01	1.75e-01	6.62e-02	1.88e-02	1.59e-01	9.19e-01	2.79e-01	1.88e-01	6.17e-01	8.87e-01	2.30e-01
GOMF ACYLGLYCEROL LIPASE ACTIVITY	14	5.14e-01	6.08e-01	0.2850	-1.11e-01	-1.62e-01	-3.07e-02	1.21e-01	1.65e-01	-8.42e-03	4.72e-01	2.95e-01	8.42e-01	4.33e-01	2.86e-01	9.56e-01
GOBP NEUROTRANSMITTER REUPTAKE	21	4.85e-01	5.86e-01	0.2850	4.88e-02	-1.97e-01	1.06e-01	-4.51e-02	-1.39e-01	8.55e-02	6.99e-01	1.18e-01	4.02e-01	7.20e-01	2.68e-01	4.98e-01
GOBP PSEUDOPODIUM ORGANIZATION	13	3.00e-01	4.19e-01	0.2850	-2.22e-01	-1.92e-02	1.73e-01	3.61e-02	1.37e-02	-5.41e-03	1.66e-01	9.05e-01	2.80e-01	8.22e-01	9.32e-01	9.73e-01
GOBP STEM CELL PROLIFERATION	73	4.32e-02	1.05e-01	0.2850	6.43e-02	1.30e-01	9.20e-02	1.98e-01	9.86e-02	5.31e-02	3.42e-01	5.44e-02	1.74e-01	3.52e-03	1.45e-01	4.32e-01
GOBP 3 UTR MEDIATED MRNA STABILIZATION	18	1.60e-01	2.72e-01	0.2850	-1.27e-01	2.13e-01	8.27e-02	8.94e-02	-6.79e-02	-1.73e-02	3.51e-01	1.18e-01	5.44e-01	5.12e-01	6.18e-01	8.99e-01
GOBP REGULATION OF LIPID LOCALIZATION	122	6.13e-08	7.69e-07	0.2850	-6.41e-02	3.14e-02	2.57e-01	6.70e-02	-3.55e-02	6.31e-02	2.22e-01	5.49e-01	9.07e-07	2.02e-01	4.98e-01	2.29e-01
GOMF NUCLEOTIDYLTRANSFERASE ACTIVITY	132	4.00e-05	2.98e-04	0.2850	-1.22e-01	-1.74e-01	-1.39e-01	1.17e-01	3.24e-02	4.37e-02	1.59e-02	5.55e-04	5.84e-03	2.05e-02	5.20e-01	3.86e-01
GOBP COLLAGEN BIOSYNTHETIC PROCESS	29	2.31e-01	3.49e-01	0.2840	-3.47e-02	2.42e-02	-4.25e-02	2.41e-01	1.24e-01	-6.29e-02	7.46e-01	8.21e-01	6.92e-01	2.48e-02	2.48e-01	5.57e-01
GOBP POSITIVE REGULATION OF MULTICELLULAR ORGANISM GROWTH	20	6.54e-01	7.25e-01	0.2840	3.74e-02	1.21e-01	6.01e-02	5.50e-02	1.36e-01	1.99e-01	7.72e-01	3.48e-01	6.42e-01	6.70e-01	2.92e-01	1.23e-01
GOBP REGULATION OF LONG TERM NEURONAL SYNAPTIC PLASTICITY	20	5.62e-01	6.50e-01	0.2840	-2.05e-01	-9.98e-02	6.49e-02	-4.05e-03	3.35e-03	1.58e-01	1.13e-01	4.40e-01	6.16e-01	9.75e-01	9.79e-01	2.22e-01
GOBP POSITIVE REGULATION OF ERAD PATHWAY	16	4.38e-01	5.46e-01	0.2840	-1.24e-01	-1.73e-01	2.56e-02	1.82e-01	2.84e-02	3.29e-02	3.89e-01	2.32e-01	8.59e-01	2.08e-01	8.44e-01	8.20e-01
GOBP REGULATION OF B CELL APOPTOTIC PROCESS	19	7.20e-01	7.78e-01	0.2840	7.45e-02	-3.83e-03	1.83e-01	-5.22e-02	-1.93e-01	4.47e-02	5.74e-01	9.77e-01	1.68e-01	6.93e-01	1.46e-01	7.36e-01
GOMF MAGNESIUM ION TRANSMEMBRANE TRANSPORTER ACTIVITY	16	8.93e-01	9.12e-01	0.2840	1.17e-01	1.89e-01	9.49e-02	1.18e-01	9.05e-02	1.34e-02	4.18e-01	1.90e-01	5.11e-01	4.13e-01	5.31e-01	9.26e-01
GOBP REGULATION OF MYELINATION	37	7.42e-03	2.71e-02	0.2840	-1.88e-01	-6.45e-02	1.23e-01	1.23e-01	8.46e-02	6.30e-02	4.83e-02	4.97e-01	1.97e-01	1.96e-01	3.73e-01	5.07e-01
GOBP REGULATION OF DNA REPAIR	208	8.85e-11	1.61e-09	0.2840	-5.11e-02	-1.07e-01	-7.89e-02	2.43e-01	3.74e-02	1.00e-02	2.04e-01	7.96e-03	4.97e-02	1.60e-09	3.52e-01	8.03e-01
GOBP REGULATION OF MYELOID LEUKOCYTE DIFFERENTIATION	94	1.19e-03	5.92e-03	0.2840	-5.24e-02	7.70e-02	2.29e-01	4.54e-02	-6.81e-02	1.13e-01	3.80e-01	1.97e-01	1.25e-04	4.47e-01	2.54e-01	5.78e-02
GOMF G PROTEIN COUPLED RECEPTOR ACTIVITY	281	9.62e-10	1.54e-08	0.2840	5.78e-02	1.68e-01	1.94e-01	-8.75e-02	-5.38e-02	2.92e-02	9.56e-02	1.33e-06	2.13e-08	1.16e-02	1.21e-01	4.00e-01
GOBP RESPONSE TO PURINE CONTAINING COMPOUND	108	6.64e-06	5.87e-05	0.2840	-1.78e-01	4.62e-02	1.90e-01	-3.70e-02	-3.59e-03	9.57e-02	1.40e-03	4.06e-01	6.39e-04	5.06e-01	9.49e-01	8.59e-02
GOBP VASCULAR ASSOCIATED SMOOTH MUSCLE CONTRACTION	15	7.70e-01	8.15e-01	0.2840	-1.69e-01	6.20e-02	1.36e-01	-1.47e-01	-4.76e-02	7.64e-02	2.58e-01	6.78e-01	3.62e-01	3.25e-01	7.50e-01	6.08e-01
GOBP L AMINO ACID CATABOLIC PROCESS	50	2.30e-02	6.60e-02	0.2840	1.16e-03	-2.36e-01	-1.26e-01	6.30e-03	8.34e-02	-4.22e-02	9.89e-01	3.86e-03	1.23e-01	9.39e-01	3.07e-01	6.06e-01
GOBP NEGATIVE REGULATION OF STEM CELL DIFFERENTIATION	21	2.96e-01	4.15e-01	0.2840	-3.07e-02	1.85e-01	1.91e-01	7.40e-02	-5.81e-02	-8.29e-03	8.08e-01	1.43e-01	1.30e-01	5.57e-01	6.45e-01	9.48e-01
GOMF PHOSPHOTRANSFERASE ACTIVITY PHOSPHATE GROUP AS ACCEPTOR	32	2.26e-01	3.44e-01	0.2840	-8.23e-02	-2.38e-01	-8.49e-02	-1.38e-02	1.42e-02	9.73e-02	4.20e-01	1.99e-02	4.06e-01	8.92e-01	8.89e-01	3.41e-01
GOBP MITOTIC DNA INTEGRITY CHECKPOINT SIGNALING	85	8.66e-04	4.51e-03	0.2840	-3.42e-02	-1.14e-01	-4.23e-02	2.37e-01	6.00e-02	6.75e-02	5.86e-01	6.89e-02	5.01e-01	1.57e-04	3.39e-01	2.82e-01
GOBP DNA TEMPLATED TRANSCRIPTION ELONGATION	130	4.05e-06	3.76e-05	0.2830	-8.52e-03	-1.23e-01	-5.79e-02	2.47e-01	2.75e-02	1.49e-02	8.67e-01	1.55e-02	2.54e-01	1.19e-06	5.89e-01	7.69e-01
GOMF COBALAMIN BINDING	9	7.05e-01	7.65e-01	0.2830	-6.97e-02	-7.77e-02	-1.12e-01	-6.97e-02	-2.45e-02	2.27e-01	7.17e-01	6.87e-01	5.61e-01	7.17e-01	8.99e-01	2.39e-01
GOBP CELLULAR HYPEROSMOTIC RESPONSE	18	2.55e-01	3.74e-01	0.2830	-1.38e-01	3.00e-02	1.49e-01	1.66e-01	-7.67e-02	6.95e-02	3.10e-01	8.26e-01	2.74e-01	2.24e-01	5.73e-01	6.10e-01
GOMF CALCIUM DEPENDENT CYSTEINE TYPE ENDOPEPTIDASE ACTIVITY	13	5.30e-01	6.22e-01	0.2830	2.51e-03	-3.89e-02	-7.88e-02	1.46e-01	-1.69e-01	-1.50e-01	9.88e-01	8.08e-01	6.23e-01	3.61e-01	2.91e-01	3.48e-01
GOBP PYRIMIDINE CONTAINING COMPOUND METABOLIC PROCESS	82	2.43e-03	1.09e-02	0.2830	-6.91e-02	-2.12e-01	-3.46e-02	9.24e-02	-2.88e-02	1.42e-01	2.80e-01	9.16e-04	5.88e-01	1.48e-01	6.52e-01	2.65e-02
GOBP REGULATION OF NEUTROPHIL CHEMOTAXIS	29	8.42e-02	1.73e-01	0.2830	-1.01e-01	4.15e-02	2.37e-01	-9.20e-02	3.00e-02	5.29e-02	3.46e-01	6.99e-01	2.72e-02	3.91e-01	7.80e-01	6.22e-01
GOBP STRESS ACTIVATED PROTEIN KINASE SIGNALING CASCADE	50	5.13e-02	1.19e-01	0.2830	-2.01e-01	-3.01e-02	1.09e-01	1.87e-02	-5.35e-02	1.54e-01	1.40e-02	7.13e-01	1.83e-01	8.19e-01	5.12e-01	5.89e-02
GOBP NEUTRAL LIPID CATABOLIC PROCESS	26	4.20e-01	5.30e-01	0.2830	-3.20e-02	5.47e-02	2.21e-01	4.96e-02	-1.23e-01	9.72e-02	7.77e-01	6.29e-01	5.07e-02	6.62e-01	2.76e-01	3.91e-01
GOBP POSITIVE REGULATION OF SMOOTH MUSCLE CELL PROLIFERATION	69	5.73e-04	3.15e-03	0.2830	-1.23e-01	1.57e-01	1.80e-01	4.31e-02	-4.35e-02	6.22e-02	7.61e-02	2.38e-02	9.56e-03	5.36e-01	5.32e-01	3.71e-01
GOMF LYSINE N METHYLTRANSFERASE ACTIVITY	58	1.32e-01	2.38e-01	0.2830	7.81e-02	5.61e-03	-8.83e-02	2.14e-01	1.16e-01	-8.26e-02	3.03e-01	9.41e-01	2.45e-01	4.79e-03	1.25e-01	2.77e-01
GOBP REGULATION OF CYTOPLASMIC PATTERN RECOGNITION RECEPTOR SIGNALING PATHWAY	106	2.58e-07	2.96e-06	0.2830	-2.00e-01	8.91e-03	-2.97e-02	1.51e-01	2.36e-03	1.28e-01	3.70e-04	8.74e-01	5.97e-01	7.24e-03	9.67e-01	2.31e-02
GOMF CDP ALCOHOL PHOSPHATIDYLTRANSFERASE ACTIVITY	8	9.15e-01	9.30e-01	0.2830	-2.09e-01	-4.76e-02	1.46e-02	-8.79e-02	7.75e-02	1.43e-01	3.07e-01	8.16e-01	9.43e-01	6.67e-01	7.04e-01	4.85e-01
GOBP NERVE DEVELOPMENT	58	4.13e-02	1.02e-01	0.2830	-9.40e-02	6.73e-02	1.80e-01	-1.18e-02	5.74e-02	1.76e-01	2.16e-01	3.75e-01	1.80e-02	8.77e-01	4.50e-01	2.03e-02
GOBP REGULATION OF NATURAL KILLER CELL MEDIATED IMMUNE RESPONSE TO TUMOR CELL	9	8.79e-01	9.01e-01	0.2830	1.89e-01	-5.31e-02	1.04e-01	1.07e-01	-1.35e-01	-3.51e-02	3.27e-01	7.83e-01	5.90e-01	5.79e-01	4.83e-01	8.55e-01
GOBP INFLAMMASOME MEDIATED SIGNALING PATHWAY	38	6.43e-03	2.41e-02	0.2830	-1.71e-01	1.53e-01	6.47e-02	1.24e-01	-3.56e-02	8.04e-02	6.76e-02	1.03e-01	4.90e-01	1.86e-01	7.04e-01	3.91e-01
GOBP RECOMBINATIONAL REPAIR	182	1.83e-08	2.51e-07	0.2830	-3.94e-02	-1.12e-01	-1.08e-01	2.24e-01	4.89e-02	3.78e-02	3.60e-01	9.38e-03	1.17e-02	1.76e-07	2.55e-01	3.79e-01
GOBP ACTIVIN RECEPTOR SIGNALING PATHWAY	34	1.22e-02	4.01e-02	0.2830	-1.63e-01	1.21e-01	1.29e-01	1.46e-01	9.18e-03	2.68e-02	1.00e-01	2.21e-01	1.94e-01	1.41e-01	9.26e-01	7.87e-01
GOBP GLYCOPROTEIN CATABOLIC PROCESS	29	1.96e-01	3.12e-01	0.2830	-2.25e-01	-6.45e-02	-7.56e-02	1.01e-01	7.45e-02	6.02e-02	3.61e-02	5.48e-01	4.81e-01	3.44e-01	4.88e-01	5.75e-01
GOBP GRANULOCYTE ACTIVATION	45	9.80e-02	1.93e-01	0.2830	-6.12e-02	8.82e-02	2.32e-01	2.11e-02	-5.37e-02	1.05e-01	4.78e-01	3.06e-01	6.98e-03	8.07e-01	5.33e-01	2.24e-01
GOBP REGULATION OF CELL CYCLE G2 M PHASE TRANSITION	109	3.17e-04	1.89e-03	0.2830	-1.36e-01	-1.92e-01	-9.45e-02	1.10e-01	1.23e-02	5.89e-02	1.44e-02	5.50e-04	8.82e-02	4.66e-02	8.25e-01	2.88e-01
GOBP PROTEIN EXPORT FROM NUCLEUS	58	1.48e-02	4.70e-02	0.2830	-1.75e-01	-1.91e-01	5.86e-02	2.62e-02	-8.75e-02	2.78e-02	2.09e-02	1.19e-02	4.41e-01	7.30e-01	2.49e-01	7.14e-01
GOMF CHLORIDE TRANSMEMBRANE TRANSPORTER ACTIVITY	68	2.62e-02	7.26e-02	0.2820	1.37e-01	1.56e-01	1.86e-01	-1.52e-02	5.13e-03	-3.93e-02	5.02e-02	2.59e-02	7.87e-03	8.29e-01	9.42e-01	5.75e-01
GOBP VENTRICULAR SYSTEM DEVELOPMENT	28	1.31e-01	2.37e-01	0.2820	-4.43e-02	2.23e-01	5.04e-02	1.37e-01	2.53e-02	7.71e-02	6.85e-01	4.07e-02	6.44e-01	2.10e-01	8.17e-01	4.80e-01
GOBP FEMALE SEX DIFFERENTIATION	77	1.23e-02	4.04e-02	0.2820	-8.84e-02	-5.78e-02	1.92e-01	5.57e-03	-1.35e-01	1.16e-01	1.80e-01	3.81e-01	3.59e-03	9.33e-01	4.03e-02	7.81e-02
GOBP MODULATION OF MICROTUBULE CYTOSKELETON INVOLVED IN CEREBRAL CORTEX RADIAL GLIA GUIDED MIGRATION	5	9.77e-01	9.81e-01	0.2820	2.50e-03	1.90e-02	-1.32e-02	-1.68e-01	-9.47e-02	-2.05e-01	9.92e-01	9.41e-01	9.59e-01	5.16e-01	7.14e-01	4.27e-01
GOBP SIGNALING RECEPTOR LIGAND PRECURSOR PROCESSING	28	3.89e-01	5.02e-01	0.2820	-1.24e-01	6.41e-02	1.31e-01	-1.11e-01	4.65e-02	1.69e-01	2.57e-01	5.57e-01	2.30e-01	3.09e-01	6.70e-01	1.22e-01
GOBP RESPONSE TO DSRNA	36	4.62e-01	5.66e-01	0.2820	-1.91e-01	-1.25e-01	4.16e-02	-7.84e-02	-1.03e-01	9.58e-02	4.77e-02	1.95e-01	6.66e-01	4.16e-01	2.85e-01	3.20e-01
GOBP VIRAL PROCESS	372	2.04e-18	7.44e-17	0.2820	-1.10e-01	-9.97e-02	6.41e-02	1.41e-01	-4.23e-02	1.78e-01	2.55e-04	9.68e-04	3.38e-02	3.22e-06	1.61e-01	3.59e-09
GOBP RESPONSE TO X RAY	26	2.31e-01	3.49e-01	0.2820	-1.19e-01	3.73e-02	-9.21e-02	4.48e-02	1.49e-01	1.77e-01	2.94e-01	7.42e-01	4.16e-01	6.92e-01	1.89e-01	1.18e-01
GOBP HOMOLOGOUS RECOMBINATION	50	2.45e-02	6.91e-02	0.2820	-5.92e-02	-8.70e-02	-8.92e-02	1.49e-01	8.09e-02	1.78e-01	4.69e-01	2.87e-01	2.75e-01	6.80e-02	3.22e-01	2.95e-02
GOBP ETHER METABOLIC PROCESS	24	2.83e-01	4.03e-01	0.2820	-1.92e-01	1.00e-02	7.27e-02	-9.07e-02	1.20e-01	1.20e-01	1.03e-01	9.32e-01	5.38e-01	4.42e-01	3.10e-01	3.08e-01
GOBP RESPONSE TO PAIN	21	9.50e-02	1.89e-01	0.2820	5.99e-03	-1.75e-01	1.89e-01	1.12e-01	-4.12e-03	9.98e-03	9.62e-01	1.64e-01	1.33e-01	3.73e-01	9.74e-01	9.37e-01
GOBP NEURON INTRINSIC APOPTOTIC SIGNALING PATHWAY IN RESPONSE TO OXIDATIVE STRESS	18	2.07e-01	3.24e-01	0.2820	-1.68e-01	7.46e-02	1.35e-01	1.58e-01	2.16e-02	4.34e-02	2.17e-01	5.84e-01	3.20e-01	2.46e-01	8.74e-01	7.50e-01
GOMF GENERAL TRANSCRIPTION INITIATION FACTOR BINDING	51	1.26e-01	2.31e-01	0.2820	-2.11e-01	-1.63e-01	-8.30e-02	-9.84e-03	1.46e-02	3.15e-02	9.05e-03	4.42e-02	3.05e-01	9.03e-01	8.57e-01	6.97e-01
GOMF UBIQUITIN LIKE LIGASE SUBSTRATE ADAPTOR ACTIVITY	55	7.04e-03	2.60e-02	0.2810	-1.15e-01	-2.33e-02	-8.60e-02	2.26e-01	7.86e-02	-2.63e-02	1.42e-01	7.65e-01	2.70e-01	3.67e-03	3.13e-01	7.36e-01
GOBP POSITIVE REGULATION OF INFLAMMATORY RESPONSE TO ANTIGENIC STIMULUS	13	4.95e-01	5.94e-01	0.2810	5.32e-03	-1.02e-01	2.55e-02	-8.15e-03	1.91e-01	1.78e-01	9.73e-01	5.26e-01	8.73e-01	9.59e-01	2.33e-01	2.67e-01
GOBP NUCLEAR MIGRATION	24	1.78e-01	2.93e-01	0.2810	-7.20e-02	1.68e-01	2.02e-01	6.97e-02	-6.41e-03	1.40e-03	5.42e-01	1.54e-01	8.68e-02	5.54e-01	9.57e-01	9.90e-01
GOBP VESICLE DOCKING	49	3.27e-02	8.54e-02	0.2810	-2.13e-01	-4.14e-03	7.30e-04	3.73e-02	7.76e-02	1.62e-01	9.79e-03	9.60e-01	9.93e-01	6.52e-01	3.47e-01	4.99e-02
GOBP LONG TERM SYNAPTIC DEPRESSION	23	3.01e-01	4.20e-01	0.2810	4.18e-02	8.25e-02	1.99e-01	1.67e-01	5.39e-02	1.65e-03	7.29e-01	4.94e-01	9.82e-02	1.65e-01	6.54e-01	9.89e-01
GOBP ESTABLISHMENT OF ORGANELLE LOCALIZATION	420	5.44e-17	1.77e-15	0.2810	-1.12e-01	-9.38e-02	9.26e-02	7.06e-02	-9.82e-02	1.86e-01	8.32e-05	9.77e-04	1.14e-03	1.31e-02	5.58e-04	6.16e-11
GOMF FUCOSYLTRANSFERASE ACTIVITY	9	9.07e-01	9.23e-01	0.2810	2.24e-02	9.33e-02	-1.81e-01	2.39e-02	2.20e-02	-1.90e-01	9.07e-01	6.28e-01	3.47e-01	9.01e-01	9.09e-01	3.24e-01
GOBP NEGATIVE REGULATION OF LYMPHOCYTE ACTIVATION	139	1.15e-03	5.71e-03	0.2810	1.09e-02	2.87e-02	2.01e-01	5.27e-02	-6.89e-02	1.74e-01	8.25e-01	5.60e-01	4.36e-05	2.83e-01	1.61e-01	4.02e-04
GOBP UTERUS DEVELOPMENT	15	6.19e-01	6.97e-01	0.2810	-4.47e-02	1.54e-01	1.76e-01	9.08e-02	1.11e-01	4.29e-02	7.64e-01	3.02e-01	2.39e-01	5.43e-01	4.58e-01	7.73e-01
GOBP NEGATIVE REGULATION OF ENDOCYTOSIS	57	3.49e-03	1.46e-02	0.2810	-2.00e-01	2.65e-02	1.26e-01	6.67e-02	4.73e-02	1.25e-01	8.98e-03	7.29e-01	1.01e-01	3.84e-01	5.37e-01	1.02e-01
GOBP RHO PROTEIN SIGNAL TRANSDUCTION	120	1.48e-05	1.20e-04	0.2810	1.12e-02	7.02e-02	1.97e-01	1.50e-01	-8.21e-02	7.57e-02	8.33e-01	1.84e-01	1.91e-04	4.50e-03	1.20e-01	1.52e-01
GOBP REGULATION OF MITOTIC SPINDLE ASSEMBLY	22	4.23e-01	5.31e-01	0.2810	-1.55e-01	-8.29e-02	-1.41e-02	9.71e-02	1.11e-01	1.62e-01	2.09e-01	5.01e-01	9.09e-01	4.31e-01	3.66e-01	1.90e-01
GOCC ENDOPLASMIC RETICULUM LUMEN	225	6.33e-13	1.43e-11	0.2810	-2.03e-01	-1.04e-01	1.15e-01	4.04e-02	-2.96e-02	1.05e-01	1.58e-07	7.01e-03	2.89e-03	2.96e-01	4.44e-01	6.49e-03
GOBP NEGATIVE REGULATION OF INTERLEUKIN 1 BETA PRODUCTION	23	1.46e-01	2.56e-01	0.2810	-1.23e-01	1.26e-01	3.20e-02	1.24e-01	1.43e-01	-1.06e-01	3.09e-01	2.97e-01	7.91e-01	3.05e-01	2.35e-01	3.77e-01
GOBP NEGATIVE REGULATION OF LEUKOCYTE MIGRATION	41	2.90e-01	4.10e-01	0.2810	5.04e-02	1.26e-01	2.09e-01	5.58e-02	-7.60e-02	8.92e-02	5.77e-01	1.62e-01	2.07e-02	5.37e-01	4.00e-01	3.23e-01
GOBP POSITIVE REGULATION OF T HELPER 2 CELL CYTOKINE PRODUCTION	8	9.60e-01	9.67e-01	0.2810	2.70e-02	1.84e-01	4.91e-02	3.34e-02	1.70e-01	1.08e-01	8.95e-01	3.66e-01	8.10e-01	8.70e-01	4.05e-01	5.95e-01
GOMF ACYL COA BINDING	19	3.35e-01	4.52e-01	0.2810	-1.11e-01	-1.80e-01	-3.09e-02	-5.00e-02	1.36e-01	1.11e-01	4.02e-01	1.75e-01	8.16e-01	7.06e-01	3.05e-01	4.04e-01
GOBP PROTEOLYSIS INVOLVED IN PROTEIN CATABOLIC PROCESS	704	8.82e-36	1.22e-33	0.2810	-1.90e-01	-1.30e-01	-1.59e-02	9.29e-02	-5.75e-02	1.16e-01	7.62e-18	3.83e-09	4.74e-01	2.69e-05	9.36e-03	1.62e-07
GOMF FATTY ACID DERIVATIVE BINDING	17	3.52e-01	4.68e-01	0.2810	-2.34e-02	-2.05e-01	-8.87e-02	-7.52e-02	9.38e-02	1.18e-01	8.67e-01	1.43e-01	5.27e-01	5.92e-01	5.03e-01	4.01e-01
GOBP CELLULAR RESPONSE TO CALCIUM ION	55	3.07e-02	8.14e-02	0.2810	-9.11e-02	1.19e-01	1.92e-01	-1.76e-02	6.86e-02	1.20e-01	2.42e-01	1.26e-01	1.39e-02	8.21e-01	3.79e-01	1.23e-01
GOBP PHOSPHATE ION TRANSPORT	21	3.62e-01	4.77e-01	0.2810	-4.78e-02	9.99e-02	-1.16e-01	9.78e-02	1.00e-02	-2.08e-01	7.05e-01	4.28e-01	3.58e-01	4.38e-01	9.36e-01	9.84e-02
GOBP REGULATION OF PROTEIN UBIQUITINATION	180	4.54e-08	5.81e-07	0.2810	-1.76e-01	-1.55e-01	-4.58e-02	1.06e-01	-2.43e-02	9.91e-02	4.66e-05	3.45e-04	2.90e-01	1.39e-02	5.74e-01	2.19e-02
GOBP RENAL SODIUM EXCRETION	6	8.82e-01	9.04e-01	0.2800	-3.84e-02	-7.46e-02	1.78e-01	-1.34e-01	6.03e-02	1.35e-01	8.71e-01	7.52e-01	4.50e-01	5.68e-01	7.98e-01	5.67e-01
GOBP NUCLEOSIDE MONOPHOSPHATE METABOLIC PROCESS	69	4.44e-03	1.77e-02	0.2800	-6.52e-02	-2.46e-01	-1.67e-02	5.36e-02	7.28e-03	1.03e-01	3.49e-01	4.02e-04	8.11e-01	4.41e-01	9.17e-01	1.41e-01
GOMF TRANSMEMBRANE RECEPTOR PROTEIN TYROSINE KINASE ADAPTOR ACTIVITY	16	3.94e-01	5.07e-01	0.2800	4.78e-02	8.63e-02	1.77e-01	1.07e-01	-1.19e-01	-1.09e-01	7.40e-01	5.50e-01	2.21e-01	4.57e-01	4.08e-01	4.50e-01
GOBP REGULATION OF HYDROGEN PEROXIDE METABOLIC PROCESS	14	5.52e-01	6.42e-01	0.2800	1.91e-01	-1.60e-01	8.97e-02	7.23e-02	-1.45e-02	5.52e-02	2.15e-01	3.01e-01	5.61e-01	6.39e-01	9.25e-01	7.21e-01
GOBP MYELOID CELL DIFFERENTIATION	369	5.50e-18	1.93e-16	0.2800	-1.08e-01	-6.52e-03	1.73e-01	9.27e-02	-7.94e-02	1.49e-01	3.79e-04	8.30e-01	1.19e-08	2.23e-03	8.79e-03	9.14e-07
GOBP PLATELET DERIVED GROWTH FACTOR RECEPTOR SIGNALING PATHWAY	47	5.91e-02	1.34e-01	0.2800	-1.07e-01	1.10e-02	2.06e-01	4.96e-02	-8.51e-02	1.22e-01	2.06e-01	8.96e-01	1.45e-02	5.56e-01	3.13e-01	1.48e-01
GOBP MIDDLE EAR MORPHOGENESIS	9	9.08e-01	9.24e-01	0.2800	-1.75e-01	-1.60e-01	-9.83e-02	5.83e-02	9.18e-02	2.69e-02	3.64e-01	4.05e-01	6.10e-01	7.62e-01	6.33e-01	8.89e-01
GOMF PHOSPHATIDYLINOSITOL 5 PHOSPHATE BINDING	18	5.12e-01	6.06e-01	0.2800	-4.81e-04	-3.29e-03	2.23e-01	-1.53e-01	-4.15e-02	5.81e-02	9.97e-01	9.81e-01	1.01e-01	2.61e-01	7.60e-01	6.70e-01
GOBP LEUKOCYTE APOPTOTIC PROCESS	105	1.93e-03	8.90e-03	0.2800	-7.72e-03	2.82e-02	1.28e-01	1.40e-01	9.25e-02	1.82e-01	8.91e-01	6.17e-01	2.37e-02	1.34e-02	1.01e-01	1.26e-03
GOBP REGULATION OF RYANODINE SENSITIVE CALCIUM RELEASE CHANNEL ACTIVITY	18	8.25e-01	8.58e-01	0.2800	-1.26e-01	-1.01e-01	6.09e-02	-6.40e-02	-1.16e-01	1.76e-01	3.57e-01	4.56e-01	6.55e-01	6.38e-01	3.93e-01	1.96e-01
GOCC POSTSYNAPTIC MEMBRANE	158	2.50e-04	1.54e-03	0.2800	1.03e-01	1.76e-01	1.79e-01	4.22e-03	5.81e-02	3.84e-02	2.56e-02	1.35e-04	1.07e-04	9.27e-01	2.07e-01	4.05e-01
GOBP ECTOPIC GERM CELL PROGRAMMED CELL DEATH	11	7.19e-01	7.77e-01	0.2800	6.98e-02	1.15e-01	-8.71e-02	-1.95e-02	-1.22e-01	-1.94e-01	6.89e-01	5.09e-01	6.17e-01	9.11e-01	4.85e-01	2.66e-01
GOBP NEGATIVE REGULATION OF DNA RECOMBINATION	45	1.08e-01	2.06e-01	0.2800	-2.46e-02	-1.54e-01	9.76e-02	1.14e-01	-7.87e-02	1.59e-01	7.75e-01	7.43e-02	2.57e-01	1.85e-01	3.61e-01	6.48e-02
GOBP NEGATIVE REGULATION OF EXTRINSIC APOPTOTIC SIGNALING PATHWAY	73	1.48e-03	7.09e-03	0.2800	-1.46e-01	-3.76e-02	2.06e-01	-1.79e-02	-5.06e-02	1.02e-01	3.15e-02	5.79e-01	2.32e-03	7.91e-01	4.55e-01	1.33e-01
GOBP ENDODERM DEVELOPMENT	63	1.44e-03	6.99e-03	0.2800	-1.07e-01	1.62e-01	1.88e-01	5.73e-02	7.08e-03	4.68e-02	1.42e-01	2.66e-02	1.00e-02	4.32e-01	9.23e-01	5.21e-01
GOBP SKELETAL MUSCLE TISSUE GROWTH	6	7.11e-01	7.70e-01	0.2800	1.34e-01	1.15e-02	-7.47e-02	-9.65e-02	-7.24e-02	2.00e-01	5.69e-01	9.61e-01	7.51e-01	6.82e-01	7.59e-01	3.97e-01
GOBP MITOTIC G1 S TRANSITION CHECKPOINT SIGNALING	28	2.79e-01	3.98e-01	0.2800	6.18e-02	-1.16e-01	-3.77e-02	2.32e-01	-1.30e-02	-7.31e-02	5.71e-01	2.87e-01	7.30e-01	3.34e-02	9.05e-01	5.03e-01
GOBP CELLULAR COMPONENT DISASSEMBLY INVOLVED IN EXECUTION PHASE OF APOPTOSIS	28	2.47e-01	3.65e-01	0.2800	5.71e-03	-1.59e-01	-4.33e-02	2.01e-01	8.93e-02	-5.26e-02	9.58e-01	1.47e-01	6.92e-01	6.56e-02	4.13e-01	6.30e-01
GOCC PML BODY	103	3.91e-05	2.92e-04	0.2800	-7.11e-02	2.49e-02	1.26e-01	1.86e-01	-3.29e-02	1.45e-01	2.12e-01	6.63e-01	2.70e-02	1.13e-03	5.64e-01	1.10e-02
GOBP NEGATIVE REGULATION OF TRANSPORT	317	3.20e-12	6.80e-11	0.2800	-1.87e-01	-7.12e-02	1.19e-01	-3.80e-02	-5.84e-02	1.38e-01	1.12e-08	2.93e-02	2.63e-04	2.44e-01	7.39e-02	2.24e-05
GOBP PURINE CONTAINING COMPOUND METABOLIC PROCESS	489	1.25e-19	5.14e-18	0.2790	-1.29e-01	-2.33e-01	-5.18e-02	3.69e-02	-2.45e-02	5.04e-02	1.03e-06	1.09e-18	4.99e-02	1.63e-01	3.53e-01	5.62e-02
GOBP REGULATION OF ADIPOSE TISSUE DEVELOPMENT	13	6.61e-01	7.30e-01	0.2790	-1.16e-01	1.34e-01	1.47e-01	-4.32e-02	-1.52e-01	8.82e-03	4.70e-01	4.03e-01	3.57e-01	7.87e-01	3.43e-01	9.56e-01
GOBP STEROL TRANSPORT	85	7.47e-05	5.24e-04	0.2790	-2.56e-02	2.17e-02	2.15e-01	1.47e-01	-7.88e-02	5.22e-02	6.83e-01	7.29e-01	6.09e-04	1.89e-02	2.09e-01	4.06e-01
GOBP TAXIS	341	1.29e-12	2.85e-11	0.2790	1.24e-02	7.20e-02	2.42e-01	4.05e-02	-3.44e-02	1.07e-01	6.95e-01	2.24e-02	1.74e-14	1.98e-01	2.75e-01	6.80e-04
GOBP LIPID DROPLET ORGANIZATION	30	1.84e-01	2.99e-01	0.2790	-1.75e-01	-7.13e-02	1.71e-01	-3.93e-03	-6.75e-02	9.17e-02	9.78e-02	4.99e-01	1.04e-01	9.70e-01	5.22e-01	3.85e-01
GOBP DIGESTIVE SYSTEM PROCESS	69	2.21e-02	6.41e-02	0.2790	-9.09e-03	1.38e-01	1.43e-01	1.30e-01	1.20e-01	8.44e-02	8.96e-01	4.77e-02	3.95e-02	6.22e-02	8.56e-02	2.26e-01
GOBP EPITHELIAL TUBE FORMATION	104	1.86e-05	1.47e-04	0.2790	-5.70e-02	1.51e-01	6.14e-02	1.35e-01	1.67e-01	-4.66e-02	3.15e-01	7.77e-03	2.80e-01	1.76e-02	3.35e-03	4.12e-01
GOBP POSITIVE REGULATION OF ATP DEPENDENT ACTIVITY	36	1.74e-01	2.88e-01	0.2790	-7.82e-02	-4.94e-02	4.21e-02	5.60e-02	9.08e-02	2.37e-01	4.17e-01	6.08e-01	6.62e-01	5.61e-01	3.46e-01	1.39e-02
GOBP AUTONOMIC NERVOUS SYSTEM DEVELOPMENT	23	1.63e-01	2.75e-01	0.2790	-8.01e-02	8.90e-02	1.48e-01	-1.28e-01	1.56e-01	3.04e-02	5.06e-01	4.60e-01	2.19e-01	2.89e-01	1.96e-01	8.01e-01
GOMF TRANSFORMING GROWTH FACTOR BETA BINDING	22	2.58e-01	3.78e-01	0.2790	-1.55e-01	2.26e-02	2.01e-01	1.65e-02	3.70e-02	1.06e-01	2.07e-01	8.54e-01	1.03e-01	8.93e-01	7.64e-01	3.89e-01
GOBP POSITIVE REGULATION OF MUSCLE CONTRACTION	36	5.56e-02	1.27e-01	0.2790	-4.41e-02	3.77e-02	2.11e-01	-1.71e-01	-1.84e-02	-7.36e-03	6.47e-01	6.95e-01	2.83e-02	7.50e-02	8.49e-01	9.39e-01
GOBP LIPID STORAGE	73	2.29e-07	2.65e-06	0.2790	-1.41e-01	4.73e-02	2.07e-01	-4.09e-02	1.00e-01	-2.96e-02	3.73e-02	4.85e-01	2.20e-03	5.46e-01	1.38e-01	6.62e-01
GOBP RESPONSE TO ETHER	13	4.78e-01	5.80e-01	0.2790	-1.54e-01	-2.72e-02	1.52e-01	-7.89e-02	-1.02e-01	-1.17e-01	3.37e-01	8.65e-01	3.43e-01	6.22e-01	5.26e-01	4.64e-01
GOBP RESPONSE TO EPIDERMAL GROWTH FACTOR	37	7.62e-03	2.77e-02	0.2790	-2.24e-01	-2.11e-02	3.73e-02	1.26e-01	-9.73e-02	-1.18e-02	1.83e-02	8.24e-01	6.95e-01	1.83e-01	3.06e-01	9.01e-01
GOBP NEGATIVE REGULATION OF STRIATED MUSCLE CELL DIFFERENTIATION	29	1.00e-01	1.96e-01	0.2790	-5.85e-02	-1.16e-01	1.32e-01	1.82e-01	-9.27e-02	3.99e-02	5.85e-01	2.78e-01	2.19e-01	8.99e-02	3.88e-01	7.10e-01
GOBP REGULATION OF GASTRULATION	13	7.42e-01	7.94e-01	0.2790	-2.81e-02	1.27e-01	-1.16e-01	3.64e-02	1.95e-02	-2.13e-01	8.61e-01	4.29e-01	4.67e-01	8.20e-01	9.03e-01	1.83e-01
GOCC RUFFLE	166	2.18e-08	2.93e-07	0.2790	-1.20e-01	3.81e-02	2.02e-01	5.97e-02	-6.41e-02	1.15e-01	7.41e-03	3.97e-01	7.44e-06	1.85e-01	1.54e-01	1.03e-02
GOMF CARBON OXYGEN LYASE ACTIVITY	65	7.46e-02	1.58e-01	0.2790	-4.50e-02	-2.11e-01	-1.56e-01	4.43e-02	-4.43e-02	-5.33e-02	5.30e-01	3.30e-03	2.95e-02	5.37e-01	5.37e-01	4.58e-01
GOBP REGULATION OF TELOMERE MAINTENANCE	104	7.58e-05	5.30e-04	0.2780	-8.12e-02	-1.07e-01	-1.27e-01	1.93e-01	3.53e-02	6.97e-02	1.52e-01	6.01e-02	2.56e-02	6.55e-04	5.34e-01	2.19e-01
GOBP MITRAL VALVE DEVELOPMENT	11	8.57e-01	8.84e-01	0.2780	1.23e-01	1.49e-01	1.61e-01	8.51e-02	-1.90e-02	-8.22e-02	4.79e-01	3.92e-01	3.56e-01	6.25e-01	9.13e-01	6.37e-01
GOBP MORPHOGENESIS OF AN EPITHELIAL SHEET	49	3.57e-03	1.49e-02	0.2780	-8.78e-02	7.36e-02	2.53e-01	-9.76e-03	-1.11e-02	1.63e-02	2.88e-01	3.73e-01	2.20e-03	9.06e-01	8.93e-01	8.43e-01
GOBP ERBB SIGNALING PATHWAY	106	7.85e-05	5.47e-04	0.2780	-1.52e-01	-5.53e-02	1.68e-01	3.25e-02	-1.10e-01	9.99e-02	6.81e-03	3.26e-01	2.85e-03	5.64e-01	4.96e-02	7.56e-02
GOBP HOMOLOGOUS CHROMOSOME PAIRING AT MEIOSIS	34	4.28e-01	5.37e-01	0.2780	-1.90e-01	-1.08e-01	-1.58e-01	1.11e-02	1.84e-02	-6.65e-02	5.57e-02	2.76e-01	1.11e-01	9.11e-01	8.52e-01	5.02e-01
GOBP NEGATIVE REGULATION OF STRIATED MUSCLE CELL APOPTOTIC PROCESS	19	6.01e-01	6.82e-01	0.2780	-1.54e-02	-4.80e-02	9.54e-02	1.46e-01	-1.01e-01	1.85e-01	9.08e-01	7.17e-01	4.72e-01	2.72e-01	4.46e-01	1.62e-01
GOMF CYCLIN DEPENDENT PROTEIN SERINE THREONINE KINASE INHIBITOR ACTIVITY	12	7.28e-01	7.83e-01	0.2780	8.34e-02	-1.75e-01	1.52e-01	6.06e-02	-8.12e-02	8.03e-02	6.17e-01	2.95e-01	3.61e-01	7.16e-01	6.26e-01	6.30e-01
GOBP REGULATION OF CARTILAGE DEVELOPMENT	40	2.60e-01	3.81e-01	0.2780	-4.00e-03	2.00e-01	1.36e-01	6.49e-02	9.40e-02	7.53e-02	9.65e-01	2.82e-02	1.38e-01	4.77e-01	3.03e-01	4.10e-01
GOBP GLOMERULUS DEVELOPMENT	51	1.97e-01	3.13e-01	0.2780	-7.24e-02	9.04e-02	1.65e-01	-1.17e-01	-1.18e-01	9.48e-02	3.71e-01	2.64e-01	4.14e-02	1.49e-01	1.44e-01	2.42e-01
GOBP NEGATIVE REGULATION OF SMOOTH MUSCLE CELL MIGRATION	16	1.80e-01	2.95e-01	0.2780	-1.70e-01	1.07e-01	1.56e-01	2.82e-02	-2.53e-02	-1.06e-01	2.38e-01	4.60e-01	2.81e-01	8.45e-01	8.61e-01	4.63e-01
GOBP LIPOSACCHARIDE METABOLIC PROCESS	88	1.05e-03	5.32e-03	0.2780	-2.60e-01	-8.64e-02	-3.22e-02	-1.61e-02	2.04e-02	1.75e-02	2.42e-05	1.61e-01	6.01e-01	7.93e-01	7.41e-01	7.77e-01
GOCC PERICENTRIC HETEROCHROMATIN	28	2.79e-01	3.99e-01	0.2780	-2.22e-02	-3.53e-02	-5.97e-02	2.33e-01	9.24e-02	-9.63e-02	8.39e-01	7.47e-01	5.85e-01	3.30e-02	3.98e-01	3.78e-01
GOBP POSITIVE REGULATION OF INTERLEUKIN 1 BETA PRODUCTION	54	8.58e-03	3.05e-02	0.2780	-2.40e-01	5.85e-02	8.60e-02	-9.31e-02	-1.72e-02	-1.18e-03	2.31e-03	4.57e-01	2.75e-01	2.37e-01	8.27e-01	9.88e-01
GOMF SMAD BINDING	65	1.65e-03	7.77e-03	0.2780	-1.74e-01	6.63e-02	1.27e-01	3.13e-02	-1.30e-01	9.17e-02	1.51e-02	3.55e-01	7.57e-02	6.63e-01	7.05e-02	2.01e-01
GOBP ESTABLISHMENT OF PROTEIN LOCALIZATION TO ORGANELLE	419	2.15e-18	7.82e-17	0.2780	-1.75e-01	-1.69e-01	-2.03e-02	7.96e-02	-6.94e-02	7.84e-02	7.49e-10	2.67e-09	4.76e-01	5.20e-03	1.49e-02	5.91e-03
GOBP POSITIVE REGULATION OF EPITHELIAL TO MESENCHYMAL TRANSITION	44	1.81e-01	2.96e-01	0.2780	1.31e-01	1.00e-01	1.14e-01	1.18e-01	1.46e-01	-4.30e-02	1.34e-01	2.50e-01	1.92e-01	1.76e-01	9.33e-02	6.22e-01
GOMF MAP KINASE SCAFFOLD ACTIVITY	12	6.97e-01	7.60e-01	0.2780	3.34e-02	1.14e-01	1.81e-01	2.33e-02	-1.53e-01	-7.89e-02	8.41e-01	4.94e-01	2.78e-01	8.89e-01	3.58e-01	6.36e-01
GOMF PHOSPHOLIPASE BINDING	21	5.06e-01	6.02e-01	0.2780	-1.28e-02	1.07e-01	7.77e-02	3.30e-02	-2.16e-02	2.40e-01	9.19e-01	3.95e-01	5.38e-01	7.94e-01	8.64e-01	5.65e-02
GOCC MEIOTIC COHESIN COMPLEX	6	9.45e-01	9.54e-01	0.2780	-5.01e-02	6.32e-02	2.20e-02	2.18e-01	5.58e-02	1.39e-01	8.32e-01	7.89e-01	9.26e-01	3.55e-01	8.13e-01	5.54e-01
GOMF TESTOSTERONE 17 BETA DEHYDROGENASE NADPPLUS ACTIVITY	6	9.77e-01	9.81e-01	0.2780	1.47e-01	2.44e-02	2.39e-03	1.21e-01	1.78e-01	9.19e-02	5.32e-01	9.18e-01	9.92e-01	6.09e-01	4.50e-01	6.97e-01
GOBP CIRCULATORY SYSTEM PROCESS	409	2.31e-14	5.88e-13	0.2780	-6.83e-02	9.85e-03	2.18e-01	-2.85e-02	-8.41e-02	1.30e-01	1.78e-02	7.33e-01	4.25e-14	3.24e-01	3.53e-03	6.07e-06
GOBP PEPTIDYL LYSINE MODIFICATION	138	1.80e-04	1.14e-03	0.2770	-9.83e-02	-1.27e-01	-1.73e-01	1.26e-01	4.92e-02	-5.49e-02	4.62e-02	1.01e-02	4.45e-04	1.07e-02	3.19e-01	2.66e-01
GOBP POSITIVE REGULATION OF TYPE I INTERFERON PRODUCTION	70	4.95e-04	2.78e-03	0.2770	-1.69e-01	7.48e-02	-4.10e-02	8.99e-02	6.16e-02	1.71e-01	1.46e-02	2.79e-01	5.53e-01	1.94e-01	3.73e-01	1.33e-02
GOBP REGULATION OF DENDRITIC CELL DIFFERENTIATION	13	4.85e-01	5.85e-01	0.2770	1.39e-02	-1.30e-01	-9.29e-02	-9.27e-02	1.98e-01	-5.97e-02	9.31e-01	4.18e-01	5.62e-01	5.63e-01	2.17e-01	7.09e-01
GOBP POSITIVE REGULATION OF RESPONSE TO WOUNDING	55	2.96e-03	1.28e-02	0.2770	-1.13e-01	-1.99e-02	2.32e-01	-2.77e-02	-9.44e-02	1.52e-02	1.46e-01	7.98e-01	2.92e-03	7.22e-01	2.26e-01	8.46e-01
GOBP RETINOIC ACID METABOLIC PROCESS	12	9.19e-01	9.32e-01	0.2770	2.64e-02	1.44e-01	1.43e-01	-1.31e-02	8.59e-02	1.65e-01	8.74e-01	3.89e-01	3.90e-01	9.38e-01	6.06e-01	3.21e-01
GOMF PHOSPHOTRANSFERASE ACTIVITY FOR OTHER SUBSTITUTED PHOSPHATE GROUPS	22	2.57e-01	3.77e-01	0.2770	-2.67e-01	-2.32e-02	-1.58e-03	-1.11e-02	-1.69e-02	-6.90e-02	3.04e-02	8.51e-01	9.90e-01	9.28e-01	8.91e-01	5.75e-01
GOBP REGULATION OF VESICLE MEDIATED TRANSPORT	418	9.40e-20	3.89e-18	0.2770	-1.03e-01	5.71e-03	1.73e-01	9.87e-02	-3.21e-02	1.60e-01	3.19e-04	8.41e-01	1.41e-09	5.39e-04	2.60e-01	2.05e-08
GOBP GLYCOSAMINOGLYCAN CATABOLIC PROCESS	25	9.75e-02	1.92e-01	0.2770	-7.49e-02	-1.91e-01	8.81e-02	-4.30e-02	-7.41e-02	-1.39e-01	5.17e-01	9.79e-02	4.46e-01	7.10e-01	5.21e-01	2.28e-01
GOBP RESPIRATORY GASEOUS EXCHANGE BY RESPIRATORY SYSTEM	60	1.69e-02	5.20e-02	0.2770	-7.40e-02	7.79e-02	1.13e-01	1.44e-01	1.32e-01	1.20e-01	3.21e-01	2.97e-01	1.30e-01	5.42e-02	7.72e-02	1.09e-01
GOBP AMIDE BIOSYNTHETIC PROCESS	130	2.50e-04	1.54e-03	0.2770	-8.20e-02	-7.78e-02	9.79e-02	6.71e-02	-7.47e-02	2.10e-01	1.06e-01	1.26e-01	5.40e-02	1.87e-01	1.42e-01	3.44e-05
GOBP REGULATION OF SPINDLE ASSEMBLY	31	3.12e-01	4.32e-01	0.2770	-6.75e-02	4.75e-02	4.73e-03	1.27e-01	1.76e-01	1.50e-01	5.15e-01	6.47e-01	9.64e-01	2.20e-01	8.99e-02	1.47e-01
GOBP STEM CELL DIVISION	28	4.85e-01	5.85e-01	0.2770	-1.21e-01	-6.28e-02	1.01e-01	1.80e-02	-2.40e-02	2.17e-01	2.67e-01	5.65e-01	3.54e-01	8.69e-01	8.26e-01	4.73e-02
GOCC PROTEIN PHOSPHATASE TYPE 2A COMPLEX	17	2.85e-01	4.05e-01	0.2770	-6.61e-02	1.65e-01	-3.91e-02	-4.62e-02	6.80e-03	2.04e-01	6.37e-01	2.40e-01	7.80e-01	7.42e-01	9.61e-01	1.46e-01
GOBP REGULATION OF MEIOTIC CELL CYCLE	46	1.91e-01	3.07e-01	0.2770	-5.93e-02	-2.35e-01	-4.88e-02	1.61e-02	-1.15e-01	4.29e-02	4.87e-01	5.80e-03	5.67e-01	8.51e-01	1.77e-01	6.15e-01
GOMF FOUR WAY JUNCTION DNA BINDING	18	5.64e-01	6.52e-01	0.2760	-1.40e-01	-9.98e-02	-9.28e-02	1.74e-01	6.17e-02	6.42e-02	3.03e-01	4.63e-01	4.96e-01	2.02e-01	6.51e-01	6.37e-01
GOBP PROTEASOME MEDIATED UBIQUITIN DEPENDENT PROTEIN CATABOLIC PROCESS	374	9.83e-19	3.69e-17	0.2760	-1.70e-01	-1.32e-01	-1.63e-02	1.15e-01	-6.00e-02	1.14e-01	1.52e-08	1.22e-05	5.88e-01	1.36e-04	4.63e-02	1.63e-04
GOBP NEGATIVE REGULATION OF RESPONSE TO CYTOKINE STIMULUS	68	1.75e-02	5.31e-02	0.2760	-5.75e-02	-1.48e-02	6.31e-02	1.27e-01	1.07e-01	2.03e-01	4.13e-01	8.33e-01	3.68e-01	7.06e-02	1.28e-01	3.73e-03
GOMF DEATH RECEPTOR ACTIVITY	12	7.72e-01	8.16e-01	0.2760	7.64e-02	1.60e-01	9.16e-02	-1.07e-01	3.34e-02	-1.54e-01	6.47e-01	3.36e-01	5.83e-01	5.21e-01	8.41e-01	3.54e-01
GOBP MYELOID LEUKOCYTE CYTOKINE PRODUCTION	45	1.60e-02	4.98e-02	0.2760	-1.47e-01	7.24e-02	1.87e-01	4.51e-02	5.99e-02	9.43e-02	8.78e-02	4.01e-01	3.01e-02	6.01e-01	4.87e-01	2.74e-01
GOMF GATED CHANNEL ACTIVITY	185	6.97e-06	6.12e-05	0.2760	1.38e-01	1.50e-01	1.81e-01	-2.85e-02	3.66e-02	1.07e-02	1.26e-03	4.50e-04	2.20e-05	5.04e-01	3.91e-01	8.02e-01
GOBP GMP METABOLIC PROCESS	26	3.75e-01	4.90e-01	0.2760	-1.12e-01	-2.47e-01	-7.76e-03	-7.68e-03	-1.72e-02	4.68e-02	3.22e-01	2.92e-02	9.45e-01	9.46e-01	8.79e-01	6.80e-01
GOCC PROTEIN KINASE COMPLEX	136	4.43e-06	4.08e-05	0.2760	-1.44e-01	-8.54e-02	6.94e-02	7.83e-02	-1.53e-01	1.17e-01	3.68e-03	8.56e-02	1.62e-01	1.15e-01	2.05e-03	1.82e-02
GOBP NODAL SIGNALING PATHWAY	12	6.00e-01	6.81e-01	0.2760	-4.52e-02	-1.65e-02	1.25e-02	2.70e-01	-7.98e-03	-2.63e-02	7.86e-01	9.21e-01	9.40e-01	1.05e-01	9.62e-01	8.75e-01
GOBP REGULATION OF RECEPTOR MEDIATED ENDOCYTOSIS	87	5.01e-03	1.97e-02	0.2760	-8.94e-02	7.59e-02	1.75e-01	5.84e-02	-3.77e-02	1.64e-01	1.50e-01	2.21e-01	4.69e-03	3.47e-01	5.44e-01	8.30e-03
GOBP PIGMENTATION	86	1.81e-03	8.41e-03	0.2760	-2.11e-01	-2.90e-02	7.65e-02	8.90e-03	3.95e-03	1.58e-01	7.22e-04	6.42e-01	2.20e-01	8.87e-01	9.50e-01	1.15e-02
GOBP NEGATIVE REGULATION OF PROTEASOMAL UBIQUITIN DEPENDENT PROTEIN CATABOLIC PROCESS	34	2.02e-01	3.19e-01	0.2760	-1.69e-01	-1.16e-01	-2.83e-02	5.53e-02	-1.44e-01	9.80e-02	8.82e-02	2.43e-01	7.75e-01	5.77e-01	1.47e-01	3.23e-01
GOBP EPIDERMAL GROWTH FACTOR RECEPTOR SIGNALING PATHWAY	89	5.50e-04	3.04e-03	0.2760	-1.09e-01	-6.47e-03	1.93e-01	6.48e-02	-1.06e-01	1.07e-01	7.52e-02	9.16e-01	1.68e-03	2.91e-01	8.34e-02	8.06e-02
GOCC MANCHETTE	18	5.39e-01	6.30e-01	0.2760	-5.08e-04	5.70e-02	-1.62e-01	-6.91e-02	2.04e-01	-3.19e-03	9.97e-01	6.76e-01	2.34e-01	6.12e-01	1.33e-01	9.81e-01
GOBP REGULATION OF PROTEIN AUTOPHOSPHORYLATION	33	2.26e-01	3.44e-01	0.2760	-2.18e-01	6.01e-02	5.71e-02	-6.32e-02	-5.21e-02	1.22e-01	3.02e-02	5.51e-01	5.71e-01	5.30e-01	6.04e-01	2.25e-01
GOBP INNATE IMMUNE RESPONSE ACTIVATING CELL SURFACE RECEPTOR SIGNALING PATHWAY	83	2.85e-05	2.19e-04	0.2760	-1.60e-01	2.05e-01	5.75e-02	2.47e-02	1.27e-02	6.36e-02	1.15e-02	1.23e-03	3.65e-01	6.97e-01	8.42e-01	3.17e-01
GOBP CELLULAR RESPONSE TO MACROPHAGE COLONY STIMULATING FACTOR STIMULUS	11	5.20e-01	6.13e-01	0.2760	-1.07e-01	2.55e-02	1.02e-01	2.29e-01	-3.11e-02	2.24e-03	5.38e-01	8.83e-01	5.60e-01	1.88e-01	8.58e-01	9.90e-01
GOBP ENDOTHELIAL CELL CHEMOTAXIS	19	3.09e-02	8.16e-02	0.2760	-3.68e-02	-7.65e-02	1.95e-01	-5.86e-02	4.05e-02	-1.60e-01	7.81e-01	5.64e-01	1.41e-01	6.58e-01	7.60e-01	2.27e-01
GOCC NUCLEAR INNER MEMBRANE	49	9.27e-03	3.23e-02	0.2760	-2.67e-01	2.57e-02	-1.82e-02	2.64e-02	-2.60e-02	4.99e-02	1.25e-03	7.56e-01	8.26e-01	7.49e-01	7.53e-01	5.45e-01
GOBP POSITIVE REGULATION OF CELL PROJECTION ORGANIZATION	287	1.08e-15	3.04e-14	0.2750	-6.07e-02	1.15e-01	1.60e-01	1.57e-01	4.36e-02	8.44e-02	7.71e-02	8.42e-04	3.32e-06	4.85e-06	2.04e-01	1.39e-02
GOCC NUCLEAR PROTEIN CONTAINING COMPLEX	1190	8.61e-55	3.47e-52	0.2750	-6.58e-02	-1.44e-01	-1.04e-01	1.92e-01	4.89e-02	2.08e-02	1.34e-04	6.62e-17	1.35e-09	4.79e-29	4.51e-03	2.27e-01
GOBP RECEPTOR RECYCLING	41	1.62e-01	2.75e-01	0.2750	-1.46e-01	-9.43e-02	7.13e-02	7.18e-02	-9.60e-02	1.62e-01	1.07e-01	2.96e-01	4.30e-01	4.26e-01	2.87e-01	7.30e-02
GOBP PROTEIN CONTAINING COMPLEX DISASSEMBLY	233	2.08e-12	4.54e-11	0.2750	-9.32e-02	-5.40e-02	1.02e-01	1.80e-01	-3.75e-02	1.41e-01	1.43e-02	1.56e-01	7.15e-03	2.23e-06	3.25e-01	2.09e-04
GOBP NEGATIVE REGULATION OF PROTEOLYSIS INVOLVED IN PROTEIN CATABOLIC PROCESS	65	2.97e-02	7.96e-02	0.2750	-1.77e-01	-1.53e-01	-5.71e-02	5.75e-02	-8.81e-02	8.07e-02	1.36e-02	3.24e-02	4.26e-01	4.23e-01	2.19e-01	2.61e-01
GOMF NF KAPPAB BINDING	29	1.38e-01	2.46e-01	0.2750	-1.10e-01	-2.25e-01	-7.30e-03	1.04e-01	3.81e-02	-1.73e-02	3.04e-01	3.56e-02	9.46e-01	3.31e-01	7.23e-01	8.72e-01
GOBP RESPONSE TO FLUID SHEAR STRESS	28	2.28e-03	1.03e-02	0.2750	-1.46e-01	-3.62e-02	1.61e-01	3.00e-02	1.13e-01	-1.16e-01	1.81e-01	7.40e-01	1.40e-01	7.83e-01	3.00e-01	2.90e-01
GOBP B CELL ACTIVATION INVOLVED IN IMMUNE RESPONSE	80	4.42e-02	1.07e-01	0.2750	5.98e-02	5.41e-02	1.33e-01	1.59e-01	1.50e-02	1.61e-01	3.55e-01	4.03e-01	3.96e-02	1.39e-02	8.17e-01	1.28e-02
GOBP LACTATE METABOLIC PROCESS	15	4.30e-01	5.38e-01	0.2750	-8.43e-02	-1.45e-02	-1.35e-01	2.17e-01	-1.01e-02	5.43e-02	5.72e-01	9.23e-01	3.65e-01	1.46e-01	9.46e-01	7.16e-01
GOBP POSITIVE REGULATION OF SMOOTHENED SIGNALING PATHWAY	26	3.67e-01	4.82e-01	0.2750	-9.66e-02	1.65e-01	-3.48e-02	7.83e-02	1.77e-01	2.32e-02	3.94e-01	1.46e-01	7.58e-01	4.90e-01	1.19e-01	8.38e-01
GOBP REGULATION OF RESPONSE TO WOUNDING	131	2.95e-05	2.25e-04	0.2750	-7.47e-02	-4.93e-03	2.17e-01	-6.11e-02	-1.31e-01	4.25e-02	1.40e-01	9.22e-01	1.73e-05	2.27e-01	9.82e-03	4.00e-01
GOMF DNA SECONDARY STRUCTURE BINDING	35	1.93e-01	3.09e-01	0.2750	-1.11e-01	-4.87e-02	-8.40e-02	1.68e-01	1.34e-01	8.75e-02	2.56e-01	6.18e-01	3.90e-01	8.53e-02	1.72e-01	3.71e-01
GOMF RNA POLYMERASE CORE ENZYME BINDING	41	1.62e-02	5.01e-02	0.2750	-1.30e-01	1.20e-02	-2.61e-02	2.24e-01	1.18e-02	8.54e-02	1.51e-01	8.94e-01	7.73e-01	1.29e-02	8.96e-01	3.44e-01
GOBP POSTSYNAPTIC SIGNAL TRANSDUCTION	30	2.03e-01	3.19e-01	0.2750	-9.07e-02	3.62e-02	1.60e-01	1.31e-01	-7.73e-02	1.31e-01	3.90e-01	7.31e-01	1.28e-01	2.16e-01	4.64e-01	2.15e-01
GOBP POSITIVE REGULATION OF PROTEIN LOCALIZATION TO CILIUM	6	9.81e-01	9.84e-01	0.2750	1.27e-03	1.41e-01	-1.14e-01	5.08e-02	1.27e-01	-1.54e-01	9.96e-01	5.50e-01	6.29e-01	8.29e-01	5.91e-01	5.13e-01
GOBP REGULATION OF ORGANIC ACID TRANSPORT	54	6.87e-03	2.54e-02	0.2750	-1.32e-01	1.02e-01	2.08e-01	-1.00e-02	-5.30e-02	3.63e-02	9.28e-02	1.93e-01	8.28e-03	8.99e-01	5.00e-01	6.45e-01
GOBP UDP GLUCOSE METABOLIC PROCESS	6	9.48e-01	9.57e-01	0.2740	-2.20e-01	2.47e-02	6.98e-02	2.12e-02	-2.66e-02	1.42e-01	3.50e-01	9.17e-01	7.67e-01	9.28e-01	9.10e-01	5.46e-01
GOBP RESPONSE TO CAMP	58	3.89e-03	1.60e-02	0.2740	-1.47e-01	1.10e-01	1.79e-01	-5.27e-02	-8.22e-02	-5.10e-03	5.34e-02	1.47e-01	1.82e-02	4.88e-01	2.79e-01	9.46e-01
GOBP PYRIDINE CONTAINING COMPOUND BIOSYNTHETIC PROCESS	27	4.03e-01	5.15e-01	0.2740	-7.07e-02	4.37e-02	-1.11e-01	5.36e-02	2.22e-01	6.36e-02	5.25e-01	6.94e-01	3.18e-01	6.30e-01	4.62e-02	5.67e-01
GOBP REGULATION OF DNA CATABOLIC PROCESS	9	8.78e-01	9.00e-01	0.2740	-5.34e-02	-9.54e-02	5.70e-02	1.96e-01	6.79e-02	1.30e-01	7.81e-01	6.20e-01	7.67e-01	3.08e-01	7.24e-01	4.99e-01
GOBP SERINE FAMILY AMINO ACID METABOLIC PROCESS	26	3.05e-01	4.25e-01	0.2740	1.29e-01	-1.63e-01	3.09e-02	1.77e-01	4.09e-03	7.53e-03	2.56e-01	1.51e-01	7.85e-01	1.19e-01	9.71e-01	9.47e-01
GOCC CELL CELL CONTACT ZONE	60	3.54e-02	9.09e-02	0.2740	-7.06e-02	5.46e-02	2.10e-01	-8.27e-02	-1.24e-01	2.75e-02	3.44e-01	4.64e-01	4.87e-03	2.68e-01	9.56e-02	7.13e-01
GOBP POSITIVE REGULATION OF CELL CYCLE PHASE TRANSITION	98	3.50e-04	2.06e-03	0.2740	-8.27e-02	-1.96e-01	-1.64e-03	1.48e-01	-3.49e-02	8.20e-02	1.57e-01	7.91e-04	9.78e-01	1.13e-02	5.50e-01	1.61e-01
GOBP REGULATION OF ORGAN GROWTH	62	1.46e-03	7.03e-03	0.2740	-2.77e-02	1.39e-01	1.74e-01	1.07e-01	-1.15e-01	1.23e-02	7.06e-01	5.77e-02	1.81e-02	1.43e-01	1.19e-01	8.67e-01
GOBP INTERLEUKIN 2 PRODUCTION	60	4.29e-02	1.05e-01	0.2740	6.41e-02	1.79e-01	1.10e-01	1.42e-01	6.55e-02	-5.00e-02	3.90e-01	1.67e-02	1.42e-01	5.63e-02	3.80e-01	5.03e-01
GOBP REGULATION OF CELLULAR RESPONSE TO INSULIN STIMULUS	64	8.08e-04	4.25e-03	0.2740	-1.36e-01	4.18e-02	1.98e-01	9.22e-02	-9.67e-03	8.52e-02	6.04e-02	5.63e-01	6.22e-03	2.02e-01	8.94e-01	2.38e-01
GOMF CYSTEINE TYPE ENDOPEPTIDASE ACTIVITY	75	2.49e-03	1.11e-02	0.2740	-2.03e-01	-3.52e-02	-5.09e-02	7.47e-02	8.99e-02	1.29e-01	2.40e-03	5.98e-01	4.46e-01	2.63e-01	1.78e-01	5.42e-02
GOBP NEGATIVE REGULATION OF RESPONSE TO TUMOR CELL	8	9.44e-01	9.53e-01	0.2740	1.67e-01	1.76e-01	4.39e-02	1.17e-01	-2.42e-02	-4.82e-03	4.12e-01	3.89e-01	8.30e-01	5.67e-01	9.06e-01	9.81e-01
GOMF MONOATOMIC ANION CHANNEL ACTIVITY	55	6.80e-02	1.48e-01	0.2740	2.13e-02	-2.63e-02	1.08e-01	-1.99e-01	-1.44e-01	-4.59e-02	7.84e-01	7.36e-01	1.67e-01	1.07e-02	6.54e-02	5.56e-01
GOMF HISTONE H3K36 METHYLTRANSFERASE ACTIVITY	11	6.38e-01	7.13e-01	0.2740	-1.87e-01	3.64e-02	1.58e-02	1.72e-01	2.42e-02	9.12e-02	2.83e-01	8.35e-01	9.28e-01	3.23e-01	8.89e-01	6.01e-01
GOBP VIRAL LIFE CYCLE	274	3.02e-12	6.43e-11	0.2740	-1.03e-01	-9.07e-02	6.61e-02	1.36e-01	-3.54e-02	1.79e-01	3.44e-03	9.78e-03	5.99e-02	1.09e-04	3.13e-01	3.22e-07
GOBP CAMERA TYPE EYE PHOTORECEPTOR CELL DIFFERENTIATION	19	4.84e-01	5.85e-01	0.2740	2.07e-02	1.80e-01	1.54e-01	-7.41e-02	-1.76e-02	-1.12e-01	8.76e-01	1.73e-01	2.45e-01	5.76e-01	8.95e-01	3.99e-01
GOBP VESICLE CYTOSKELETAL TRAFFICKING	57	2.00e-02	5.93e-02	0.2740	-1.54e-02	1.27e-01	9.05e-02	3.98e-02	-7.11e-02	2.09e-01	8.40e-01	9.68e-02	2.37e-01	6.03e-01	3.53e-01	6.30e-03
GOMF CELL ADHESION MOLECULE BINDING	450	2.96e-20	1.28e-18	0.2740	-1.13e-01	-8.71e-02	1.59e-01	6.09e-02	-8.46e-02	1.36e-01	3.76e-05	1.54e-03	7.54e-09	2.68e-02	2.10e-03	8.00e-07
GOBP NEGATIVE REGULATION OF TRANSCRIPTION BY RNA POLYMERASE I	11	5.18e-01	6.12e-01	0.2740	-1.00e-01	-1.49e-01	1.09e-01	1.67e-01	-3.90e-02	-3.92e-02	5.66e-01	3.93e-01	5.30e-01	3.38e-01	8.23e-01	8.22e-01
GOBP REGULATION OF COLLAGEN FIBRIL ORGANIZATION	8	6.93e-01	7.56e-01	0.2740	-2.00e-02	-1.34e-01	2.25e-01	5.15e-02	1.66e-02	5.50e-02	9.22e-01	5.10e-01	2.71e-01	8.01e-01	9.35e-01	7.88e-01
GOMF N METHYLTRANSFERASE ACTIVITY	90	1.93e-02	5.75e-02	0.2740	-2.69e-02	-8.62e-02	-1.64e-01	1.50e-01	1.15e-01	-6.55e-02	6.59e-01	1.57e-01	7.29e-03	1.41e-02	5.83e-02	2.83e-01
GOBP LYSOSOMAL PROTEIN CATABOLIC PROCESS	20	3.36e-01	4.53e-01	0.2740	-2.11e-01	-1.25e-01	5.98e-02	5.10e-02	5.60e-02	7.63e-02	1.03e-01	3.35e-01	6.43e-01	6.93e-01	6.65e-01	5.55e-01
GOBP STRIATED MUSCLE TISSUE DEVELOPMENT	166	1.93e-06	1.93e-05	0.2740	-1.12e-02	8.78e-02	1.98e-01	9.08e-02	-9.59e-02	1.01e-01	8.03e-01	5.09e-02	1.02e-05	4.36e-02	3.30e-02	2.44e-02
GOMF UBIQUITIN LIKE PROTEIN READER ACTIVITY	20	6.88e-01	7.53e-01	0.2740	-2.40e-02	-8.15e-02	-1.27e-01	1.45e-01	6.77e-02	-1.62e-01	8.52e-01	5.28e-01	3.27e-01	2.63e-01	6.00e-01	2.11e-01
GOBP VITAMIN D METABOLIC PROCESS	13	4.66e-01	5.69e-01	0.2740	2.37e-02	8.32e-02	8.93e-02	-1.21e-01	1.73e-01	-1.23e-01	8.82e-01	6.03e-01	5.77e-01	4.50e-01	2.81e-01	4.44e-01
GOBP CELL DIFFERENTIATION INVOLVED IN METANEPHROS DEVELOPMENT	9	8.18e-01	8.53e-01	0.2740	-7.34e-02	1.50e-01	-1.10e-01	-1.77e-01	-3.41e-02	-5.04e-02	7.03e-01	4.37e-01	5.69e-01	3.58e-01	8.60e-01	7.94e-01
GOBP MOLTING CYCLE PROCESS	57	1.49e-01	2.60e-01	0.2740	3.68e-02	1.07e-01	1.40e-01	1.01e-01	1.33e-01	1.19e-01	6.31e-01	1.61e-01	6.71e-02	1.86e-01	8.17e-02	1.19e-01
GOMF DYNEIN HEAVY CHAIN BINDING	13	6.11e-01	6.90e-01	0.2740	4.74e-02	-1.30e-01	-1.05e-01	-1.73e-01	-1.14e-01	3.99e-02	7.67e-01	4.16e-01	5.14e-01	2.79e-01	4.77e-01	8.03e-01
GOBP CELL FATE COMMITMENT	156	1.54e-04	9.95e-04	0.2730	4.65e-02	1.61e-01	1.75e-01	1.03e-01	2.81e-02	6.75e-02	3.16e-01	5.17e-04	1.61e-04	2.60e-02	5.44e-01	1.46e-01
GOBP GLAND DEVELOPMENT	302	5.10e-15	1.37e-13	0.2730	-7.16e-02	2.27e-02	2.00e-01	1.12e-01	-2.39e-02	1.26e-01	3.24e-02	4.98e-01	2.09e-09	7.90e-04	4.75e-01	1.75e-04
GOBP POSITIVE REGULATION OF RECEPTOR SIGNALING PATHWAY VIA STAT	35	2.86e-01	4.05e-01	0.2730	-5.04e-02	1.24e-01	7.93e-02	-1.47e-02	1.04e-01	1.99e-01	6.06e-01	2.06e-01	4.17e-01	8.80e-01	2.88e-01	4.14e-02
GOBP VESICLE MEDIATED TRANSPORT IN SYNAPSE	174	1.61e-07	1.90e-06	0.2730	-9.81e-02	-1.18e-04	1.49e-01	1.22e-01	-2.53e-02	1.66e-01	2.56e-02	9.98e-01	7.21e-04	5.57e-03	5.65e-01	1.60e-04
GOBP REGULATION OF RECEPTOR INTERNALIZATION	50	9.93e-02	1.95e-01	0.2730	-4.96e-02	7.87e-02	2.06e-01	6.90e-02	-5.32e-02	1.26e-01	5.44e-01	3.36e-01	1.16e-02	3.99e-01	5.15e-01	1.23e-01
GOBP REGULATION OF LEUKOCYTE APOPTOTIC PROCESS	79	6.72e-02	1.47e-01	0.2730	2.24e-02	8.93e-02	1.46e-01	8.93e-02	5.38e-02	1.84e-01	7.31e-01	1.70e-01	2.44e-02	1.70e-01	4.08e-01	4.69e-03
GOBP TOLL LIKE RECEPTOR 4 SIGNALING PATHWAY	53	3.77e-03	1.56e-02	0.2730	-2.49e-01	7.12e-02	3.47e-02	2.13e-02	6.74e-02	3.66e-02	1.71e-03	3.70e-01	6.62e-01	7.88e-01	3.96e-01	6.45e-01
GOBP REGULATION OF BLOOD CIRCULATION	160	5.17e-05	3.75e-04	0.2730	-6.90e-02	3.36e-02	2.15e-01	-7.06e-02	-7.45e-02	1.10e-01	1.32e-01	4.63e-01	2.80e-06	1.23e-01	1.04e-01	1.64e-02
GOBP REGULATION OF BILE ACID METABOLIC PROCESS	8	9.01e-01	9.18e-01	0.2730	-5.12e-02	1.23e-01	-1.44e-03	-5.04e-02	2.31e-01	-2.93e-02	8.02e-01	5.47e-01	9.94e-01	8.05e-01	2.58e-01	8.86e-01
GOBP REGULATION OF CALCIUM ION IMPORT	31	1.97e-01	3.13e-01	0.2730	-7.20e-02	1.20e-01	1.79e-01	-7.91e-02	-1.24e-01	-3.63e-02	4.88e-01	2.49e-01	8.40e-02	4.46e-01	2.34e-01	7.26e-01
GOBP PROTEIN KINASE C ACTIVATING G PROTEIN COUPLED RECEPTOR SIGNALING PATHWAY	17	7.00e-01	7.61e-01	0.2730	7.00e-02	1.26e-01	1.30e-01	1.92e-01	2.61e-03	1.33e-02	6.17e-01	3.70e-01	3.54e-01	1.72e-01	9.85e-01	9.24e-01
GOBP MRNA MODIFICATION	19	7.99e-01	8.38e-01	0.2730	-1.69e-01	-1.42e-01	-3.22e-02	-2.61e-02	-1.29e-01	8.43e-02	2.01e-01	2.83e-01	8.08e-01	8.44e-01	3.30e-01	5.25e-01
GOBP AMINO ACID CATABOLIC PROCESS	82	2.63e-03	1.16e-02	0.2730	-6.33e-02	-1.93e-01	-1.42e-01	5.14e-03	1.10e-01	2.90e-02	3.21e-01	2.56e-03	2.61e-02	9.36e-01	8.38e-02	6.50e-01
GOBP MITOTIC G2 DNA DAMAGE CHECKPOINT SIGNALING	37	1.75e-01	2.90e-01	0.2730	-1.44e-01	-1.57e-01	-6.05e-02	1.31e-01	2.48e-02	8.64e-02	1.30e-01	9.82e-02	5.24e-01	1.67e-01	7.94e-01	3.63e-01
GOBP POSITIVE REGULATION OF PHOSPHATIDYLINOSITOL 3 KINASE PROTEIN KINASE B SIGNAL TRANSDUCTION	134	1.54e-03	7.36e-03	0.2730	-8.37e-02	-6.33e-02	1.66e-01	-3.35e-02	-1.40e-01	1.23e-01	9.42e-02	2.06e-01	9.18e-04	5.03e-01	5.05e-03	1.43e-02
GOBP POLYSACCHARIDE BIOSYNTHETIC PROCESS	49	2.67e-02	7.35e-02	0.2730	-7.33e-02	-6.17e-03	1.51e-01	1.77e-01	-1.69e-02	1.21e-01	3.75e-01	9.40e-01	6.81e-02	3.23e-02	8.38e-01	1.42e-01
GOBP EPITHELIAL CELL DEVELOPMENT	161	1.16e-07	1.41e-06	0.2730	-8.86e-02	9.09e-02	2.22e-01	2.57e-02	-2.20e-02	8.79e-02	5.25e-02	4.66e-02	1.16e-06	5.73e-01	6.30e-01	5.42e-02
GOBP REGULATION OF MICROTUBULE BINDING	7	9.19e-01	9.32e-01	0.2720	-1.03e-01	3.56e-02	8.90e-02	-4.73e-02	-2.24e-01	-4.60e-02	6.37e-01	8.70e-01	6.83e-01	8.28e-01	3.06e-01	8.33e-01
GOBP MUCUS SECRETION	12	5.57e-01	6.46e-01	0.2720	-1.33e-01	-1.95e-01	6.85e-02	7.41e-02	-5.47e-02	-7.25e-02	4.26e-01	2.42e-01	6.81e-01	6.57e-01	7.43e-01	6.64e-01
GOBP REGULATION OF CYSTEINE TYPE ENDOPEPTIDASE ACTIVITY	162	1.25e-04	8.23e-04	0.2720	-2.05e-01	-7.59e-02	5.46e-02	-7.13e-02	-6.57e-02	1.19e-01	6.89e-06	9.56e-02	2.31e-01	1.18e-01	1.49e-01	9.22e-03
GOCC PLASMA MEMBRANE PROTEIN COMPLEX	522	7.92e-12	1.61e-10	0.2720	1.10e-01	1.32e-01	7.78e-02	1.26e-01	1.07e-01	1.06e-01	1.64e-05	2.68e-07	2.35e-03	9.00e-07	2.84e-05	3.36e-05
GOMF LIGAND GATED CHANNEL ACTIVITY	99	2.35e-03	1.05e-02	0.2720	1.42e-01	1.28e-01	1.88e-01	6.73e-03	3.23e-02	-2.83e-02	1.43e-02	2.81e-02	1.19e-03	9.08e-01	5.78e-01	6.27e-01
GOBP MEIOTIC CELL CYCLE PROCESS	153	4.79e-06	4.37e-05	0.2720	-1.64e-03	-9.71e-02	4.30e-02	1.78e-01	1.65e-02	1.75e-01	9.72e-01	3.81e-02	3.58e-01	1.45e-04	7.24e-01	1.81e-04
GOBP POSITIVE REGULATION OF STEM CELL PROLIFERATION	24	4.50e-01	5.56e-01	0.2720	-2.23e-01	-5.87e-02	-1.17e-01	2.63e-02	-1.25e-02	-7.82e-02	5.86e-02	6.19e-01	3.19e-01	8.23e-01	9.16e-01	5.07e-01
GOBP POSITIVE REGULATION OF PROTEOLYSIS INVOLVED IN PROTEIN CATABOLIC PROCESS	119	3.32e-06	3.15e-05	0.2720	-1.48e-01	-1.41e-01	7.77e-02	1.26e-01	-3.67e-02	9.39e-02	5.17e-03	7.99e-03	1.43e-01	1.76e-02	4.90e-01	7.69e-02
GOMF OXIDOREDUCTASE ACTIVITY ACTING ON PAIRED DONORS WITH INCORPORATION OR REDUCTION OF MOLECULAR OXYGEN REDUCED FLAVIN OR FLAVOPROTEIN AS ONE DONOR AND INCORPORATION OF ONE ATOM OF OXYGEN	19	6.98e-01	7.60e-01	0.2720	1.36e-01	1.70e-01	1.12e-01	-5.34e-02	9.65e-02	-4.16e-02	3.06e-01	1.99e-01	3.98e-01	6.87e-01	4.66e-01	7.54e-01
GOBP REGULATION OF VASCULAR PERMEABILITY	33	2.21e-01	3.40e-01	0.2720	1.51e-02	-2.39e-02	2.13e-01	-4.08e-02	-1.61e-01	-1.18e-02	8.81e-01	8.12e-01	3.44e-02	6.85e-01	1.09e-01	9.07e-01
GOBP ENDOPLASMIC RETICULUM CALCIUM ION HOMEOSTASIS	25	2.87e-01	4.06e-01	0.2720	-8.13e-02	-1.20e-01	1.04e-01	1.32e-01	-1.47e-01	5.46e-02	4.82e-01	3.00e-01	3.70e-01	2.52e-01	2.03e-01	6.37e-01
GOBP NEGATIVE REGULATION OF CILIUM ASSEMBLY	20	5.04e-01	6.00e-01	0.2720	-2.56e-02	1.14e-01	-6.33e-03	1.25e-01	9.02e-02	1.91e-01	8.43e-01	3.78e-01	9.61e-01	3.33e-01	4.85e-01	1.40e-01
GOBP REGULATION OF OSSIFICATION	85	5.29e-04	2.94e-03	0.2720	-1.04e-01	1.81e-01	1.68e-01	-2.87e-02	-1.37e-02	3.24e-02	9.59e-02	4.00e-03	7.44e-03	6.47e-01	8.27e-01	6.06e-01
GOBP REGULATION OF GTPASE ACTIVITY	229	2.09e-09	3.15e-08	0.2720	3.46e-02	1.26e-01	1.98e-01	1.16e-01	-4.46e-02	4.40e-02	3.67e-01	1.00e-03	2.39e-07	2.50e-03	2.45e-01	2.52e-01
GOBP ALDEHYDE BIOSYNTHETIC PROCESS	13	6.94e-01	7.57e-01	0.2720	5.38e-02	-6.21e-02	4.89e-02	2.49e-01	-4.69e-02	-2.21e-02	7.37e-01	6.98e-01	7.60e-01	1.20e-01	7.70e-01	8.90e-01
GOMF CYCLIN DEPENDENT PROTEIN KINASE ACTIVITY	26	1.86e-01	3.01e-01	0.2720	-2.35e-02	5.31e-02	1.49e-01	2.17e-01	1.54e-02	2.79e-02	8.35e-01	6.39e-01	1.89e-01	5.51e-02	8.92e-01	8.06e-01
GOMF PROTEIN SERINE THREONINE KINASE ACTIVATOR ACTIVITY	65	2.45e-02	6.91e-02	0.2720	-2.04e-01	-3.82e-02	-6.25e-03	-3.65e-02	-1.32e-01	1.08e-01	4.37e-03	5.94e-01	9.31e-01	6.11e-01	6.59e-02	1.32e-01
GOBP PROTEIN LOCALIZATION TO MICROTUBULE	17	4.54e-01	5.60e-01	0.2720	-2.38e-01	5.49e-02	-2.90e-02	6.14e-02	5.68e-02	7.89e-02	8.94e-02	6.95e-01	8.36e-01	6.61e-01	6.85e-01	5.73e-01
GOBP MEMBRANE FUSION	144	1.46e-05	1.19e-04	0.2710	-1.25e-01	-1.22e-01	5.92e-02	7.85e-02	-5.25e-05	1.83e-01	9.71e-03	1.18e-02	2.20e-01	1.04e-01	9.99e-01	1.44e-04
GOMF PROLINE RICH REGION BINDING	15	6.59e-01	7.29e-01	0.2710	-4.51e-02	-7.02e-02	2.66e-02	2.34e-02	1.14e-01	2.29e-01	7.62e-01	6.38e-01	8.58e-01	8.75e-01	4.43e-01	1.25e-01
GOBP RESPONSE TO PROSTAGLANDIN	26	1.30e-01	2.35e-01	0.2710	-1.90e-01	1.18e-01	1.07e-01	5.53e-02	-6.04e-02	7.41e-02	9.33e-02	2.98e-01	3.46e-01	6.25e-01	5.94e-01	5.13e-01
GOBP NEGATIVE REGULATION OF TRANSFORMING GROWTH FACTOR BETA RECEPTOR SIGNALING PATHWAY	79	1.41e-03	6.83e-03	0.2710	-4.07e-02	7.33e-02	1.81e-01	1.45e-01	-6.02e-02	9.58e-02	5.31e-01	2.60e-01	5.46e-03	2.56e-02	3.55e-01	1.41e-01
GOBP ICOSANOID CATABOLIC PROCESS	7	9.37e-01	9.47e-01	0.2710	-4.67e-02	-1.10e-01	1.68e-01	-8.25e-02	-1.54e-01	-2.27e-02	8.31e-01	6.16e-01	4.41e-01	7.06e-01	4.79e-01	9.17e-01
GOBP DNA BIOSYNTHETIC PROCESS	174	8.04e-07	8.52e-06	0.2710	-7.50e-02	-1.50e-01	-1.18e-01	1.62e-01	5.07e-02	5.06e-02	8.79e-02	6.27e-04	7.18e-03	2.23e-04	2.49e-01	2.50e-01
GOBP MICROTUBULE DEPOLYMERIZATION	38	2.37e-01	3.54e-01	0.2710	9.02e-03	5.68e-02	1.27e-01	1.99e-01	4.12e-02	1.13e-01	9.23e-01	5.44e-01	1.77e-01	3.34e-02	6.60e-01	2.28e-01
GOBP PEPTIDYL SERINE MODIFICATION	223	1.38e-10	2.45e-09	0.2710	-8.00e-02	1.28e-01	1.51e-01	1.04e-01	-2.44e-02	1.29e-01	3.96e-02	1.01e-03	9.97e-05	7.63e-03	5.30e-01	9.08e-04
GOBP EXTRACELLULAR MATRIX DISASSEMBLY	44	2.26e-02	6.52e-02	0.2710	-3.68e-02	1.24e-01	2.06e-01	1.15e-01	2.89e-02	1.48e-02	6.73e-01	1.54e-01	1.79e-02	1.88e-01	7.40e-01	8.65e-01
GOBP HYDROGEN PEROXIDE BIOSYNTHETIC PROCESS	12	6.24e-01	7.01e-01	0.2710	2.30e-01	-2.85e-02	1.00e-01	-9.24e-02	-1.65e-02	3.24e-02	1.68e-01	8.64e-01	5.47e-01	5.80e-01	9.21e-01	8.46e-01
GOBP NEGATIVE REGULATION OF CELL ACTIVATION	178	1.21e-04	7.97e-04	0.2710	-7.45e-03	1.34e-02	2.07e-01	2.30e-02	-7.33e-02	1.57e-01	8.64e-01	7.57e-01	1.94e-06	5.97e-01	9.15e-02	3.09e-04
GOBP CELLULAR RESPONSE TO AMYLOID BETA	32	1.48e-01	2.58e-01	0.2710	-1.06e-01	2.07e-01	6.19e-02	3.81e-02	1.18e-01	-5.60e-03	2.98e-01	4.25e-02	5.45e-01	7.09e-01	2.49e-01	9.56e-01
GOBP NEGATIVE REGULATION OF PROTEIN MATURATION	23	1.57e-01	2.69e-01	0.2710	-1.19e-01	-1.14e-01	2.04e-01	2.01e-02	-3.88e-02	4.93e-02	3.22e-01	3.46e-01	8.96e-02	8.67e-01	7.47e-01	6.82e-01
GOCC STEREOCILIUM BUNDLE	50	2.51e-01	3.70e-01	0.2710	-5.11e-02	-6.49e-02	-1.46e-01	-1.56e-01	-3.01e-02	-1.42e-01	5.32e-01	4.27e-01	7.49e-02	5.65e-02	7.13e-01	8.33e-02
GOBP MALE MEIOTIC NUCLEAR DIVISION	33	1.35e-01	2.43e-01	0.2710	-5.65e-02	-4.01e-02	-3.04e-03	-9.26e-02	-1.73e-02	2.44e-01	5.74e-01	6.90e-01	9.76e-01	3.57e-01	8.64e-01	1.52e-02
GOBP REGULATION OF PROTEIN LOCALIZATION TO SYNAPSE	19	3.81e-01	4.94e-01	0.2710	4.98e-02	9.04e-02	9.63e-02	-2.52e-02	-6.90e-02	-2.19e-01	7.07e-01	4.95e-01	4.67e-01	8.49e-01	6.03e-01	9.86e-02
GOCC NUCLEAR CHROMOSOME	218	1.36e-09	2.12e-08	0.2710	-3.25e-02	-1.16e-01	-2.40e-02	2.09e-01	4.42e-02	1.12e-01	4.09e-01	3.06e-03	5.41e-01	1.11e-07	2.61e-01	4.32e-03
GOBP ENDOCRINE PROCESS	58	4.83e-02	1.14e-01	0.2710	-9.25e-02	1.00e-01	2.07e-01	-4.48e-02	-4.67e-02	8.69e-02	2.23e-01	1.87e-01	6.38e-03	5.55e-01	5.39e-01	2.52e-01
GOMF POLY PYRIMIDINE TRACT BINDING	24	2.81e-01	4.01e-01	0.2700	-2.02e-01	-5.74e-02	-2.79e-02	7.67e-02	-1.12e-01	9.89e-02	8.68e-02	6.26e-01	8.13e-01	5.16e-01	3.41e-01	4.01e-01
GOCC NUCLEAR PERIPHERY	141	1.90e-08	2.59e-07	0.2700	-6.76e-02	-2.61e-02	1.02e-01	2.28e-01	-4.66e-04	7.28e-02	1.66e-01	5.92e-01	3.61e-02	2.84e-06	9.92e-01	1.36e-01
GOBP DENDRITIC SPINE DEVELOPMENT	83	2.80e-03	1.22e-02	0.2700	-1.61e-01	7.23e-02	1.34e-01	-4.29e-03	4.23e-02	1.49e-01	1.14e-02	2.55e-01	3.51e-02	9.46e-01	5.05e-01	1.86e-02
GOBP REGULATION OF TELOMERE MAINTENANCE VIA TELOMERE LENGTHENING	61	9.97e-03	3.42e-02	0.2700	-1.32e-01	-8.08e-02	-1.40e-01	1.57e-01	3.15e-02	6.28e-02	7.47e-02	2.75e-01	5.85e-02	3.42e-02	6.70e-01	3.97e-01
GOMF SOLUTE INORGANIC ANION ANTIPORTER ACTIVITY	23	7.16e-01	7.75e-01	0.2700	1.04e-01	2.07e-01	3.79e-02	8.64e-02	7.87e-02	-6.62e-02	3.87e-01	8.60e-02	7.53e-01	4.73e-01	5.13e-01	5.82e-01
GOBP PROTEIN LOCALIZATION TO MICROTUBULE ORGANIZING CENTER	37	1.71e-01	2.84e-01	0.2700	-1.92e-02	7.78e-02	9.23e-02	1.64e-01	-2.71e-02	1.75e-01	8.40e-01	4.13e-01	3.31e-01	8.42e-02	7.76e-01	6.60e-02
GOBP REGULATION OF UBIQUITIN DEPENDENT PROTEIN CATABOLIC PROCESS	155	1.93e-07	2.25e-06	0.2700	-1.78e-01	-1.31e-01	3.91e-02	1.03e-01	-7.29e-02	8.28e-02	1.28e-04	5.05e-03	4.02e-01	2.72e-02	1.18e-01	7.53e-02
GOMF SPHINGOLIPID BINDING	26	4.70e-01	5.73e-01	0.2700	-1.53e-01	-7.07e-02	3.74e-02	1.44e-03	3.22e-02	2.05e-01	1.76e-01	5.33e-01	7.41e-01	9.90e-01	7.76e-01	7.02e-02
GOBP LEUKOCYTE HOMEOSTASIS	100	2.65e-04	1.62e-03	0.2700	-1.22e-01	-4.37e-02	1.43e-01	9.92e-02	5.94e-03	1.61e-01	3.56e-02	4.50e-01	1.32e-02	8.65e-02	9.18e-01	5.45e-03
GOBP LEUKOCYTE MEDIATED IMMUNITY	406	5.40e-16	1.59e-14	0.2700	1.25e-02	-3.08e-03	1.16e-01	1.65e-01	-6.10e-02	1.68e-01	6.67e-01	9.15e-01	5.70e-05	1.10e-08	3.50e-02	6.14e-09
GOBP POSITIVE REGULATION OF MYELOID LEUKOCYTE CYTOKINE PRODUCTION INVOLVED IN IMMUNE RESPONSE	32	5.98e-02	1.35e-01	0.2700	-1.63e-01	7.76e-02	1.89e-01	6.55e-05	4.60e-02	4.92e-02	1.10e-01	4.48e-01	6.36e-02	9.99e-01	6.52e-01	6.30e-01
GOMF NUCLEAR RECEPTOR BINDING	123	4.86e-06	4.43e-05	0.2700	-4.35e-02	5.35e-02	1.51e-01	1.88e-01	-1.43e-02	9.84e-02	4.05e-01	3.05e-01	3.76e-03	3.08e-04	7.84e-01	5.94e-02
GOBP NEGATIVE REGULATION OF SIGNAL TRANSDUCTION BY P53 CLASS MEDIATOR	30	4.36e-01	5.44e-01	0.2700	-1.82e-01	-1.16e-01	-1.21e-01	-1.30e-02	1.04e-01	-2.70e-02	8.43e-02	2.73e-01	2.50e-01	9.02e-01	3.23e-01	7.98e-01
GOBP POSITIVE REGULATION OF EXTRACELLULAR MATRIX ASSEMBLY	13	8.30e-01	8.63e-01	0.2700	-2.94e-02	1.07e-01	1.54e-02	1.74e-01	1.73e-01	-4.11e-03	8.54e-01	5.02e-01	9.24e-01	2.78e-01	2.79e-01	9.80e-01
GOBP COLUMNAR CUBOIDAL EPITHELIAL CELL DIFFERENTIATION	70	4.73e-03	1.88e-02	0.2700	-6.47e-02	-2.12e-03	2.26e-01	2.02e-02	-1.20e-01	5.39e-02	3.49e-01	9.76e-01	1.08e-03	7.70e-01	8.28e-02	4.36e-01
GOBP NEGATIVE REGULATION OF POST TRANSLATIONAL PROTEIN MODIFICATION	83	3.21e-03	1.37e-02	0.2700	-1.15e-01	-1.47e-01	-9.57e-02	1.64e-01	4.40e-02	-8.44e-03	6.97e-02	2.06e-02	1.32e-01	9.88e-03	4.89e-01	8.94e-01
GOBP GLYCOSYL COMPOUND METABOLIC PROCESS	73	4.62e-02	1.11e-01	0.2700	-1.22e-01	-2.03e-01	-1.07e-01	-3.30e-02	-1.69e-02	6.39e-02	7.16e-02	2.75e-03	1.14e-01	6.26e-01	8.02e-01	3.45e-01
GOBP NEUROINFLAMMATORY RESPONSE	63	3.46e-03	1.45e-02	0.2700	-1.03e-01	1.46e-01	1.78e-01	-7.27e-02	5.99e-02	1.56e-02	1.56e-01	4.46e-02	1.45e-02	3.18e-01	4.11e-01	8.30e-01
GOCC ACETYLTRANSFERASE COMPLEX	94	7.80e-06	6.79e-05	0.2700	-1.75e-01	-6.45e-02	-9.18e-02	1.60e-01	-6.08e-02	-1.90e-02	3.43e-03	2.80e-01	1.24e-01	7.23e-03	3.08e-01	7.50e-01
GOBP TRIGLYCERIDE METABOLIC PROCESS	75	5.28e-04	2.93e-03	0.2700	-1.73e-01	8.37e-02	1.63e-01	3.44e-02	1.26e-03	8.99e-02	9.60e-03	2.10e-01	1.46e-02	6.07e-01	9.85e-01	1.78e-01
GOBP NEGATIVE REGULATION OF LEUKOCYTE MEDIATED IMMUNITY	64	7.91e-02	1.65e-01	0.2700	6.38e-02	1.52e-01	1.10e-01	1.52e-01	1.25e-02	1.02e-01	3.78e-01	3.56e-02	1.29e-01	3.59e-02	8.63e-01	1.58e-01
GOBP MAINTENANCE OF PROTEIN LOCATION	78	7.61e-03	2.77e-02	0.2700	-1.43e-01	-1.56e-01	5.36e-02	7.32e-02	-4.29e-02	1.34e-01	2.95e-02	1.72e-02	4.13e-01	2.64e-01	5.13e-01	4.08e-02
GOBP ACTIVATION OF PHOSPHOLIPASE C ACTIVITY	16	3.80e-01	4.94e-01	0.2690	-7.48e-02	-5.31e-02	1.01e-01	1.60e-01	-1.67e-01	-2.17e-02	6.04e-01	7.13e-01	4.83e-01	2.68e-01	2.47e-01	8.81e-01
GOMF TRANSCRIPTION COREGULATOR BINDING	103	5.57e-06	5.00e-05	0.2690	-2.03e-03	7.76e-02	8.41e-02	2.18e-01	7.83e-02	-7.55e-02	9.72e-01	1.74e-01	1.40e-01	1.30e-04	1.70e-01	1.85e-01
GOBP RESPIRATORY BURST INVOLVED IN DEFENSE RESPONSE	14	4.78e-01	5.80e-01	0.2690	7.54e-04	-5.24e-02	2.25e-01	-4.64e-02	6.98e-02	1.10e-01	9.96e-01	7.34e-01	1.45e-01	7.64e-01	6.51e-01	4.76e-01
GOMF DNA BINDING TRANSCRIPTION REPRESSOR ACTIVITY	198	6.56e-07	7.13e-06	0.2690	5.73e-02	1.81e-01	8.01e-02	1.46e-01	7.99e-02	-4.70e-02	1.65e-01	1.12e-05	5.19e-02	3.81e-04	5.27e-02	2.54e-01
GOCC SPINDLE	395	1.07e-18	4.00e-17	0.2690	-8.22e-02	-1.44e-01	2.36e-03	1.66e-01	3.24e-02	1.28e-01	5.04e-03	8.95e-07	9.36e-01	1.51e-08	2.69e-01	1.27e-05
GOBP NEGATIVE REGULATION OF PROTEIN BINDING	58	7.50e-02	1.59e-01	0.2690	-6.09e-02	-1.80e-01	-1.39e-01	1.25e-01	-2.90e-02	-2.59e-02	4.23e-01	1.76e-02	6.81e-02	9.98e-02	7.03e-01	7.33e-01
GOMF UDP GLYCOSYLTRANSFERASE ACTIVITY	107	2.23e-04	1.38e-03	0.2690	-1.82e-01	-7.33e-02	1.04e-01	2.55e-02	-1.26e-01	7.95e-02	1.12e-03	1.90e-01	6.23e-02	6.49e-01	2.38e-02	1.55e-01
GOBP POSITIVE REGULATION OF REPRODUCTIVE PROCESS	48	2.97e-02	7.95e-02	0.2690	-1.19e-01	-9.37e-02	1.77e-01	5.46e-02	-9.72e-02	7.63e-02	1.55e-01	2.61e-01	3.41e-02	5.13e-01	2.44e-01	3.60e-01
GOBP REGULATION OF GLUCOSE IMPORT	45	7.93e-02	1.65e-01	0.2690	-2.31e-01	-5.28e-02	7.30e-02	-9.82e-02	-3.61e-02	6.58e-03	7.42e-03	5.40e-01	3.97e-01	2.54e-01	6.75e-01	9.39e-01
GOBP ACTIVATED T CELL PROLIFERATION	40	1.00e-01	1.96e-01	0.2690	-5.51e-02	-9.29e-02	1.10e-01	1.54e-01	-1.19e-01	1.03e-01	5.47e-01	3.09e-01	2.29e-01	9.20e-02	1.91e-01	2.62e-01
GOBP POSITIVE REGULATION OF VASCULAR ENDOTHELIAL CELL PROLIFERATION	14	7.14e-01	7.72e-01	0.2690	-1.59e-01	1.07e-01	-1.11e-02	-1.37e-01	-1.16e-01	-5.50e-02	3.03e-01	4.88e-01	9.43e-01	3.74e-01	4.51e-01	7.22e-01
GOBP REGULATION OF MONONUCLEAR CELL MIGRATION	118	7.64e-04	4.05e-03	0.2690	-5.94e-02	-5.82e-02	1.78e-01	5.94e-02	-9.85e-02	1.42e-01	2.65e-01	2.75e-01	8.22e-04	2.65e-01	6.45e-02	7.69e-03
GOBP NEGATIVE REGULATION OF PROTEIN UBIQUITINATION	70	1.04e-02	3.54e-02	0.2690	-1.23e-01	-1.56e-01	-7.82e-02	1.57e-01	1.82e-02	3.85e-02	7.51e-02	2.36e-02	2.58e-01	2.34e-02	7.93e-01	5.78e-01
GOBP PHOSPHATIDYLSERINE METABOLIC PROCESS	19	6.56e-01	7.26e-01	0.2690	2.90e-02	1.01e-01	7.69e-03	1.74e-01	1.34e-01	-1.14e-01	8.27e-01	4.46e-01	9.54e-01	1.90e-01	3.13e-01	3.89e-01
GOBP REGULATION OF EXTRINSIC APOPTOTIC SIGNALING PATHWAY IN ABSENCE OF LIGAND	33	1.95e-01	3.11e-01	0.2690	5.78e-02	-1.39e-01	1.76e-01	2.92e-02	-6.21e-02	1.17e-01	5.66e-01	1.66e-01	8.06e-02	7.72e-01	5.37e-01	2.44e-01
GOBP NEGATIVE REGULATION OF INFLAMMATORY RESPONSE TO ANTIGENIC STIMULUS	24	3.32e-01	4.50e-01	0.2680	-7.32e-02	1.74e-02	1.60e-01	5.44e-02	-1.91e-01	3.85e-02	5.35e-01	8.83e-01	1.75e-01	6.44e-01	1.06e-01	7.44e-01
GOBP NEGATIVE REGULATION OF B CELL APOPTOTIC PROCESS	14	7.54e-01	8.04e-01	0.2680	1.47e-01	-6.89e-02	9.71e-02	-6.19e-02	-1.75e-01	-4.36e-02	3.42e-01	6.55e-01	5.29e-01	6.88e-01	2.57e-01	7.78e-01
GOBP NEGATIVE REGULATION OF PRODUCTION OF MOLECULAR MEDIATOR OF IMMUNE RESPONSE	38	2.84e-01	4.04e-01	0.2680	1.21e-01	1.51e-01	1.47e-01	6.26e-03	-1.14e-01	6.77e-05	1.96e-01	1.07e-01	1.17e-01	9.47e-01	2.25e-01	9.99e-01
GOBP PROSTANOID METABOLIC PROCESS	38	9.04e-03	3.16e-02	0.2680	-1.74e-01	-1.59e-01	7.96e-02	-4.42e-02	9.02e-02	1.36e-02	6.38e-02	9.03e-02	3.96e-01	6.37e-01	3.36e-01	8.85e-01
GOBP COMPLEMENT ACTIVATION CLASSICAL PATHWAY	33	1.65e-01	2.78e-01	0.2680	-3.72e-02	-1.28e-01	1.36e-01	1.46e-01	-8.01e-02	8.83e-02	7.12e-01	2.02e-01	1.75e-01	1.47e-01	4.26e-01	3.80e-01
GOBP REGULATION OF PROTEIN LOCALIZATION TO CILIUM	10	9.33e-01	9.44e-01	0.2680	-1.14e-01	-1.46e-02	-2.00e-01	-7.37e-02	1.01e-01	-5.58e-02	5.32e-01	9.36e-01	2.73e-01	6.86e-01	5.82e-01	7.60e-01
GOBP PHOTORECEPTOR CELL DIFFERENTIATION	41	7.30e-02	1.56e-01	0.2680	-5.40e-02	2.29e-01	7.28e-02	-6.45e-02	2.06e-02	-8.27e-02	5.50e-01	1.13e-02	4.20e-01	4.75e-01	8.20e-01	3.59e-01
GOBP POSITIVE REGULATION OF NEUTROPHIL MIGRATION	29	1.54e-01	2.65e-01	0.2680	-1.21e-01	-8.11e-02	2.01e-01	8.95e-03	-2.12e-02	9.90e-02	2.59e-01	4.50e-01	6.12e-02	9.34e-01	8.43e-01	3.56e-01
GOBP INTERLEUKIN 12 PRODUCTION	56	6.40e-02	1.42e-01	0.2680	-1.37e-01	6.75e-02	1.45e-01	1.71e-02	-1.41e-02	1.64e-01	7.56e-02	3.83e-01	5.97e-02	8.25e-01	8.55e-01	3.39e-02
GOBP POSITIVE REGULATION OF OSTEOCLAST DIFFERENTIATION	19	5.27e-01	6.20e-01	0.2680	-1.30e-01	2.01e-01	4.01e-02	-8.78e-02	7.10e-02	1.25e-02	3.28e-01	1.29e-01	7.62e-01	5.08e-01	5.92e-01	9.25e-01
GOBP CARDIAC MUSCLE CELL DIFFERENTIATION	78	2.06e-03	9.42e-03	0.2680	-1.22e-01	-2.05e-02	1.48e-01	7.72e-02	-1.35e-01	1.01e-01	6.18e-02	7.54e-01	2.37e-02	2.38e-01	3.91e-02	1.21e-01
GOMF STEROID DEHYDROGENASE ACTIVITY ACTING ON THE CH OH GROUP OF DONORS NAD OR NADP AS ACCEPTOR	23	6.05e-01	6.85e-01	0.2680	-1.22e-02	-1.54e-01	-1.54e-01	-3.53e-02	-1.37e-01	-6.44e-02	9.19e-01	2.01e-01	2.02e-01	7.69e-01	2.54e-01	5.93e-01
GOBP INSULIN RECEPTOR SIGNALING PATHWAY	108	3.20e-07	3.62e-06	0.2680	-1.53e-01	5.40e-02	1.77e-01	9.26e-02	-5.05e-02	5.71e-02	6.11e-03	3.33e-01	1.52e-03	9.66e-02	3.64e-01	3.05e-01
GOBP CYTOPLASMIC SEQUESTERING OF PROTEIN	14	6.41e-01	7.15e-01	0.2680	-3.07e-02	-1.23e-01	8.54e-02	2.08e-01	2.05e-02	6.90e-02	8.42e-01	4.26e-01	5.80e-01	1.78e-01	8.94e-01	6.55e-01
GOBP MEMBRANE LIPID METABOLIC PROCESS	179	8.67e-05	5.96e-04	0.2680	-1.98e-01	-1.12e-01	3.40e-02	-5.69e-02	-7.49e-02	9.91e-02	4.84e-06	9.46e-03	4.33e-01	1.90e-01	8.40e-02	2.22e-02
GOCC PHAGOCYTIC VESICLE	137	8.56e-07	9.04e-06	0.2680	-2.31e-01	-1.68e-02	6.30e-02	3.77e-02	-3.99e-02	1.05e-01	3.07e-06	7.34e-01	2.03e-01	4.46e-01	4.20e-01	3.32e-02
GOBP POSITIVE REGULATION OF INTRINSIC APOPTOTIC SIGNALING PATHWAY	53	9.88e-02	1.94e-01	0.2680	-7.47e-02	-2.12e-01	-2.37e-02	7.06e-02	-1.25e-01	-8.36e-04	3.47e-01	7.65e-03	7.65e-01	3.74e-01	1.15e-01	9.92e-01
GOBP MODIFICATION DEPENDENT MACROMOLECULE CATABOLIC PROCESS	580	2.42e-28	2.00e-26	0.2680	-1.66e-01	-1.22e-01	-2.05e-03	1.14e-01	-6.11e-02	1.12e-01	9.41e-12	5.36e-07	9.33e-01	2.74e-06	1.20e-02	3.95e-06
GOBP SYNAPTIC VESICLE PRIMING	15	6.61e-01	7.30e-01	0.2680	-5.63e-02	-2.02e-03	7.22e-02	2.14e-01	-6.97e-03	1.32e-01	7.06e-01	9.89e-01	6.28e-01	1.51e-01	9.63e-01	3.77e-01
GOMF PHOSPHATASE REGULATOR ACTIVITY	88	2.27e-02	6.53e-02	0.2670	-4.17e-02	3.79e-02	1.25e-01	3.98e-02	-2.17e-02	2.25e-01	4.99e-01	5.38e-01	4.35e-02	5.19e-01	7.25e-01	2.57e-04
GOCC SARCOPLASM	73	3.20e-03	1.36e-02	0.2670	-6.57e-02	5.60e-02	1.47e-01	1.62e-01	-3.27e-02	1.23e-01	3.32e-01	4.08e-01	2.98e-02	1.69e-02	6.29e-01	6.82e-02
GOBP REGULATION OF MACROPHAGE APOPTOTIC PROCESS	10	7.57e-01	8.05e-01	0.2670	2.81e-02	1.20e-01	-1.18e-01	-3.15e-02	1.69e-01	1.13e-01	8.78e-01	5.12e-01	5.18e-01	8.63e-01	3.54e-01	5.36e-01
GOBP REGULATION OF LEUKOCYTE MIGRATION	181	5.07e-08	6.45e-07	0.2670	-4.91e-02	-5.65e-03	2.13e-01	8.98e-02	-1.93e-02	1.23e-01	2.54e-01	8.96e-01	7.66e-07	3.72e-02	6.55e-01	4.23e-03
GOBP POSITIVE REGULATION OF ACTIN FILAMENT POLYMERIZATION	44	8.15e-03	2.92e-02	0.2670	-1.59e-01	-7.68e-02	1.80e-01	1.22e-02	-8.73e-02	-5.20e-03	6.78e-02	3.78e-01	3.87e-02	8.88e-01	3.16e-01	9.52e-01
GOMF METAL ION TRANSMEMBRANE TRANSPORTER ACTIVITY	297	3.77e-08	4.89e-07	0.2670	6.47e-02	1.57e-01	1.98e-01	2.71e-02	1.16e-03	5.46e-02	5.52e-02	3.41e-06	4.75e-09	4.22e-01	9.73e-01	1.06e-01
GOMF HEXOSE TRANSMEMBRANE TRANSPORTER ACTIVITY	18	4.61e-01	5.66e-01	0.2670	8.57e-02	4.45e-02	2.76e-02	1.00e-02	2.02e-01	-1.43e-01	5.29e-01	7.44e-01	8.39e-01	9.41e-01	1.38e-01	2.95e-01
GOBP SYNCYTIUM FORMATION	49	3.87e-01	5.00e-01	0.2670	5.14e-02	1.35e-01	1.79e-01	3.88e-02	-6.97e-03	1.30e-01	5.33e-01	1.02e-01	3.00e-02	6.38e-01	9.33e-01	1.16e-01
GOBP MOTOR BEHAVIOR	18	3.73e-01	4.88e-01	0.2670	-2.11e-01	1.31e-01	-1.84e-02	5.63e-02	7.30e-02	3.16e-02	1.22e-01	3.36e-01	8.92e-01	6.79e-01	5.92e-01	8.17e-01
GOBP NEGATIVE REGULATION OF BLOOD PRESSURE	31	1.62e-01	2.74e-01	0.2670	-1.21e-01	1.31e-01	8.63e-02	-1.28e-01	1.26e-01	4.13e-03	2.44e-01	2.07e-01	4.06e-01	2.19e-01	2.25e-01	9.68e-01
GOMF DNA BINDING TRANSCRIPTION FACTOR ACTIVITY	1022	5.78e-37	8.64e-35	0.2670	-2.33e-02	1.25e-01	6.50e-03	1.58e-01	1.66e-01	5.17e-02	2.08e-01	1.52e-11	7.26e-01	1.21e-17	3.28e-19	5.20e-03
GOMF PEPTIDASE ACTIVATOR ACTIVITY	56	5.31e-02	1.23e-01	0.2670	-1.97e-01	-9.20e-02	-6.11e-02	2.02e-02	6.99e-02	1.23e-01	1.09e-02	2.34e-01	4.29e-01	7.94e-01	3.65e-01	1.11e-01
GOBP POSITIVE REGULATION OF CARDIAC MUSCLE CONTRACTION	6	9.87e-01	9.88e-01	0.2670	-2.26e-02	-6.20e-02	-1.35e-01	-1.14e-01	2.27e-02	-1.87e-01	9.24e-01	7.92e-01	5.66e-01	6.29e-01	9.23e-01	4.27e-01
GOBP REGULATION OF DNA REPLICATION	118	2.66e-05	2.06e-04	0.2670	-4.48e-02	-1.38e-01	-2.24e-02	2.03e-01	-4.43e-02	8.14e-02	4.00e-01	9.71e-03	6.74e-01	1.43e-04	4.06e-01	1.27e-01
GOBP POSITIVE REGULATION OF PROTEIN CONTAINING COMPLEX DISASSEMBLY	32	6.89e-02	1.49e-01	0.2670	-1.46e-01	-8.54e-02	1.40e-01	1.04e-01	-1.06e-01	2.73e-02	1.53e-01	4.03e-01	1.70e-01	3.06e-01	2.99e-01	7.89e-01
GOBP PROTEIN IMPORT	9	8.97e-01	9.15e-01	0.2670	8.45e-02	-1.66e-01	-2.48e-02	1.61e-01	-9.85e-02	-1.02e-02	6.61e-01	3.89e-01	8.98e-01	4.02e-01	6.09e-01	9.58e-01
GOBP PEPTIDE METABOLIC PROCESS	64	1.86e-02	5.57e-02	0.2670	-1.65e-01	-1.04e-01	7.37e-02	-3.66e-02	4.24e-02	1.56e-01	2.21e-02	1.50e-01	3.08e-01	6.13e-01	5.58e-01	3.10e-02
GOCC CELL CORTEX REGION	27	1.25e-01	2.30e-01	0.2670	-1.10e-01	1.39e-01	-5.45e-03	1.33e-01	8.92e-02	-1.18e-01	3.22e-01	2.10e-01	9.61e-01	2.32e-01	4.23e-01	2.89e-01
GOMF OXIDOREDUCTASE ACTIVITY	590	2.35e-20	1.03e-18	0.2670	-1.24e-01	-2.22e-01	-6.48e-02	2.30e-02	-2.18e-02	3.65e-02	2.64e-07	3.59e-20	7.19e-03	3.40e-01	3.65e-01	1.30e-01
GOMF CHLORIDE CHANNEL ACTIVITY	42	1.51e-01	2.62e-01	0.2660	1.12e-01	8.32e-02	1.65e-01	-1.33e-01	-7.41e-02	-3.69e-02	2.11e-01	3.51e-01	6.43e-02	1.37e-01	4.06e-01	6.79e-01
GOBP MRNA TRANSPORT	123	3.40e-06	3.21e-05	0.2660	-1.37e-01	-8.24e-02	-9.19e-02	1.91e-01	1.98e-02	-1.36e-02	8.88e-03	1.15e-01	7.85e-02	2.54e-04	7.05e-01	7.95e-01
GOBP POSITIVE REGULATION OF UBIQUITIN DEPENDENT PROTEIN CATABOLIC PROCESS	96	3.06e-05	2.33e-04	0.2660	-1.36e-01	-1.24e-01	9.68e-02	1.38e-01	-6.04e-02	6.96e-02	2.09e-02	3.63e-02	1.01e-01	1.91e-02	3.07e-01	2.39e-01
GOBP MACROAUTOPHAGY	344	6.95e-18	2.42e-16	0.2660	-2.19e-01	-8.26e-02	6.26e-03	7.96e-02	-5.51e-02	8.31e-02	3.22e-12	8.48e-03	8.42e-01	1.12e-02	7.94e-02	8.10e-03
GOBP POSTSYNAPTIC SPECIALIZATION ORGANIZATION	34	3.97e-01	5.09e-01	0.2660	-1.09e-02	5.62e-03	2.14e-01	3.33e-02	-1.15e-01	1.03e-01	9.12e-01	9.55e-01	3.06e-02	7.37e-01	2.46e-01	3.00e-01
GOBP REGULATION OF PROTEOLYSIS INVOLVED IN PROTEIN CATABOLIC PROCESS	209	7.22e-09	1.04e-07	0.2660	-1.73e-01	-1.47e-01	1.51e-02	8.97e-02	-4.55e-02	9.49e-02	1.63e-05	2.53e-04	7.07e-01	2.53e-02	2.57e-01	1.80e-02
GOBP POSITIVE REGULATION OF CELL DIVISION	68	5.35e-03	2.07e-02	0.2660	-6.43e-02	-1.07e-01	1.76e-01	7.14e-02	-1.36e-02	1.38e-01	3.59e-01	1.27e-01	1.20e-02	3.09e-01	8.46e-01	4.96e-02
GOBP CEREBELLAR CORTEX MORPHOGENESIS	27	4.16e-01	5.26e-01	0.2660	-5.47e-02	1.67e-01	1.50e-01	5.35e-03	1.13e-01	7.07e-02	6.23e-01	1.34e-01	1.79e-01	9.62e-01	3.11e-01	5.25e-01
GOBP ESTABLISHMENT OF CELL POLARITY	130	6.56e-05	4.65e-04	0.2660	-5.52e-02	8.28e-02	1.77e-01	7.97e-02	-8.98e-02	1.23e-01	2.77e-01	1.03e-01	4.78e-04	1.17e-01	7.71e-02	1.58e-02
GOBP INTERLEUKIN 10 PRODUCTION	53	9.91e-02	1.94e-01	0.2660	-4.08e-02	5.70e-02	6.35e-02	1.64e-01	9.73e-02	1.59e-01	6.08e-01	4.73e-01	4.24e-01	3.86e-02	2.21e-01	4.48e-02
GOBP REGULATION OF HEART CONTRACTION	129	5.10e-04	2.85e-03	0.2660	-9.32e-02	1.45e-02	2.02e-01	-6.26e-02	-6.95e-02	1.10e-01	6.76e-02	7.76e-01	7.15e-05	2.20e-01	1.73e-01	3.11e-02
GOBP AMYLOID PRECURSOR PROTEIN BIOSYNTHETIC PROCESS	13	7.14e-01	7.72e-01	0.2660	-7.04e-02	4.02e-03	9.64e-02	1.33e-01	-1.38e-01	1.41e-01	6.60e-01	9.80e-01	5.47e-01	4.08e-01	3.89e-01	3.80e-01
GOMF E BOX BINDING	32	8.75e-03	3.08e-02	0.2660	1.03e-01	-2.56e-02	1.62e-01	1.06e-02	8.14e-02	-1.63e-01	3.12e-01	8.02e-01	1.14e-01	9.18e-01	4.25e-01	1.11e-01
GOBP NEUROTRANSMITTER RECEPTOR TRANSPORT ENDOSOME TO POSTSYNAPTIC MEMBRANE	10	8.24e-01	8.58e-01	0.2660	-1.10e-01	3.91e-02	1.30e-01	1.29e-01	9.91e-02	1.17e-01	5.46e-01	8.30e-01	4.76e-01	4.81e-01	5.88e-01	5.22e-01
GOBP CENTRIOLE ASSEMBLY	45	1.80e-01	2.95e-01	0.2660	2.43e-02	6.35e-03	-1.30e-01	6.49e-02	2.20e-01	2.09e-02	7.78e-01	9.41e-01	1.32e-01	4.51e-01	1.06e-02	8.08e-01
GOCC TRANSFERASE COMPLEX	789	4.06e-39	6.71e-37	0.2660	-1.57e-01	-1.28e-01	-6.84e-02	1.29e-01	-4.39e-02	7.92e-02	7.45e-14	8.48e-10	1.10e-03	7.23e-10	3.61e-02	1.57e-04
GOMF CYCLIN BINDING	30	2.25e-01	3.44e-01	0.2660	7.85e-02	-2.08e-02	3.39e-02	2.27e-01	3.31e-03	-1.06e-01	4.57e-01	8.44e-01	7.48e-01	3.14e-02	9.75e-01	3.14e-01
GOBP SENSORY PERCEPTION OF BITTER TASTE	15	4.39e-01	5.46e-01	0.2660	1.39e-01	1.59e-01	-1.19e-01	-9.69e-02	-2.66e-03	-4.72e-02	3.50e-01	2.87e-01	4.23e-01	5.16e-01	9.86e-01	7.52e-01
GOBP REGULATION OF CELLULAR RESPONSE TO GROWTH FACTOR STIMULUS	224	1.78e-09	2.71e-08	0.2650	-3.95e-02	1.38e-01	2.02e-01	6.29e-02	-9.59e-03	6.98e-02	3.09e-01	3.66e-04	1.82e-07	1.05e-01	8.05e-01	7.20e-02
GOBP NEGATIVE REGULATION OF MITOTIC CELL CYCLE PHASE TRANSITION	171	4.20e-07	4.68e-06	0.2650	-4.56e-02	-1.50e-01	-2.66e-03	1.69e-01	-2.15e-02	1.30e-01	3.03e-01	7.28e-04	9.52e-01	1.36e-04	6.27e-01	3.39e-03
GOCC MYOSIN COMPLEX	39	2.27e-01	3.46e-01	0.2650	1.34e-01	7.18e-02	1.35e-01	1.52e-01	-7.51e-02	-1.64e-02	1.47e-01	4.38e-01	1.44e-01	1.02e-01	4.17e-01	8.59e-01
GOBP CAVEOLIN MEDIATED ENDOCYTOSIS	9	5.50e-01	6.40e-01	0.2650	-1.27e-01	-1.78e-01	6.97e-02	1.70e-02	7.05e-02	-1.12e-01	5.11e-01	3.55e-01	7.17e-01	9.29e-01	7.14e-01	5.61e-01
GOBP POSITIVE REGULATION OF ESTABLISHMENT OF PROTEIN LOCALIZATION TO MITOCHONDRION	32	1.79e-01	2.94e-01	0.2650	-7.98e-02	-1.02e-01	7.67e-02	1.86e-01	-4.47e-02	1.06e-01	4.35e-01	3.18e-01	4.53e-01	6.90e-02	6.62e-01	3.01e-01
GOBP REGULATION OF AXONOGENESIS	113	7.66e-06	6.67e-05	0.2650	-3.84e-03	1.76e-01	1.65e-01	9.94e-02	2.15e-02	-4.27e-02	9.44e-01	1.25e-03	2.44e-03	6.79e-02	6.94e-01	4.33e-01
GOBP CELL CELL ADHESION MEDIATED BY CADHERIN	31	5.41e-01	6.33e-01	0.2650	1.61e-01	1.09e-01	1.66e-01	3.21e-02	5.76e-02	2.12e-02	1.21e-01	2.92e-01	1.09e-01	7.57e-01	5.79e-01	8.38e-01
GOBP NEGATIVE REGULATION OF OXIDATIVE STRESS INDUCED NEURON INTRINSIC APOPTOTIC SIGNALING PATHWAY	12	4.42e-01	5.50e-01	0.2650	-1.93e-01	1.59e-02	9.90e-02	1.14e-01	-9.33e-02	-3.60e-02	2.47e-01	9.24e-01	5.53e-01	4.94e-01	5.76e-01	8.29e-01
GOBP MITOTIC CELL CYCLE PROCESS	688	3.53e-32	3.85e-30	0.2650	-6.10e-02	-1.34e-01	3.86e-02	1.71e-01	-2.23e-02	1.32e-01	6.39e-03	2.29e-09	8.43e-02	2.15e-14	3.20e-01	3.66e-09
GOBP RESPONSE TO DEXAMETHASONE	30	2.66e-01	3.85e-01	0.2650	-2.14e-01	-7.93e-02	3.86e-02	-7.02e-02	6.36e-02	8.61e-02	4.20e-02	4.52e-01	7.14e-01	5.06e-01	5.47e-01	4.14e-01
GOBP SEROTONIN UPTAKE	10	8.94e-01	9.13e-01	0.2650	8.72e-02	-1.35e-01	1.39e-01	6.44e-02	-1.26e-01	6.92e-02	6.33e-01	4.58e-01	4.47e-01	7.24e-01	4.89e-01	7.05e-01
GOBP NEGATIVE REGULATION OF SMOOTH MUSCLE CELL PROLIFERATION	38	5.22e-03	2.03e-02	0.2650	-1.64e-01	-2.58e-02	1.48e-01	-4.97e-02	-4.75e-02	-1.26e-01	7.99e-02	7.83e-01	1.14e-01	5.96e-01	6.13e-01	1.79e-01
GOMF LYASE ACTIVITY	169	9.34e-05	6.37e-04	0.2650	-8.20e-02	-1.96e-01	-1.37e-01	7.32e-02	-2.24e-05	-2.44e-02	6.60e-02	1.05e-05	2.07e-03	1.01e-01	1.00e+00	5.84e-01
GOBP POST TRANSCRIPTIONAL REGULATION OF GENE EXPRESSION	494	7.11e-16	2.06e-14	0.2650	-1.59e-01	-1.69e-01	-9.73e-02	4.54e-02	-6.96e-02	1.65e-03	1.56e-09	1.28e-10	2.15e-04	8.41e-02	8.12e-03	9.50e-01
GOBP MULTICELLULAR ORGANISMAL LEVEL IRON ION HOMEOSTASIS	23	2.60e-01	3.80e-01	0.2650	-6.09e-02	1.56e-01	1.03e-01	-2.21e-02	-1.75e-01	-2.21e-02	6.13e-01	1.95e-01	3.94e-01	8.54e-01	1.47e-01	8.54e-01
GOCC SIN3 TYPE COMPLEX	22	3.26e-01	4.45e-01	0.2650	-1.79e-01	6.24e-02	-8.17e-03	1.32e-01	1.12e-01	6.35e-02	1.45e-01	6.13e-01	9.47e-01	2.85e-01	3.62e-01	6.06e-01
GOBP T CELL DIFFERENTIATION	279	2.66e-09	3.99e-08	0.2650	1.38e-02	1.80e-01	9.95e-02	1.33e-01	6.10e-02	8.01e-02	6.92e-01	2.46e-07	4.25e-03	1.39e-04	7.97e-02	2.14e-02
GOCC POSTSYNAPTIC CYTOSOL	12	7.55e-01	8.04e-01	0.2650	4.83e-02	-8.42e-02	-5.47e-02	1.99e-01	-9.95e-02	-9.01e-02	7.72e-01	6.14e-01	7.43e-01	2.33e-01	5.51e-01	5.89e-01
GOBP REGULATION OF MUSCLE ADAPTATION	63	2.61e-02	7.26e-02	0.2650	-3.83e-02	-1.30e-02	1.94e-01	6.67e-02	-1.42e-01	7.83e-02	5.99e-01	8.59e-01	7.75e-03	3.60e-01	5.13e-02	2.83e-01
GOBP REGULATION OF SUPEROXIDE METABOLIC PROCESS	23	4.22e-01	5.31e-01	0.2640	-1.21e-01	3.78e-02	-8.04e-03	9.79e-02	2.05e-01	4.49e-02	3.14e-01	7.54e-01	9.47e-01	4.16e-01	8.85e-02	7.09e-01
GOCC EXTRINSIC COMPONENT OF PLASMA MEMBRANE	76	5.84e-03	2.23e-02	0.2640	-1.48e-02	1.62e-01	1.27e-01	1.41e-01	-2.97e-03	8.70e-02	8.24e-01	1.46e-02	5.63e-02	3.39e-02	9.64e-01	1.90e-01
GOBP DEVELOPMENT OF PRIMARY FEMALE SEXUAL CHARACTERISTICS	70	2.28e-02	6.56e-02	0.2640	-5.86e-02	-3.61e-02	1.82e-01	4.54e-02	-1.48e-01	8.95e-02	3.97e-01	6.01e-01	8.29e-03	5.12e-01	3.26e-02	1.96e-01
GOBP NEGATIVE REGULATION OF OSTEOBLAST PROLIFERATION	9	9.19e-01	9.32e-01	0.2640	6.96e-02	1.75e-01	4.04e-02	-1.08e-01	1.02e-01	-1.03e-01	7.18e-01	3.62e-01	8.34e-01	5.76e-01	5.95e-01	5.94e-01
GOBP PHOSPHATIDYLGLYCEROL BIOSYNTHETIC PROCESS	9	8.16e-01	8.51e-01	0.2640	-2.81e-02	-6.23e-02	1.53e-04	2.34e-01	4.00e-02	-9.39e-02	8.84e-01	7.46e-01	9.99e-01	2.24e-01	8.36e-01	6.26e-01
GOBP REGULATION OF AMYLOID PRECURSOR PROTEIN CATABOLIC PROCESS	39	6.65e-02	1.46e-01	0.2640	-1.54e-01	-3.10e-02	1.66e-01	1.09e-02	-1.30e-01	2.30e-02	9.53e-02	7.37e-01	7.26e-02	9.06e-01	1.62e-01	8.03e-01
GOBP REGULATION OF PHOSPHOLIPASE ACTIVITY	37	3.21e-01	4.40e-01	0.2640	5.92e-03	-3.76e-03	1.60e-01	2.21e-02	-1.97e-01	7.08e-02	9.50e-01	9.68e-01	9.22e-02	8.16e-01	3.85e-02	4.56e-01
GOBP REGULATION OF PHOSPHOLIPASE C ACTIVITY	27	3.57e-01	4.73e-01	0.2640	5.62e-02	3.56e-02	1.64e-01	1.19e-01	-1.53e-01	3.05e-02	6.13e-01	7.49e-01	1.40e-01	2.84e-01	1.69e-01	7.84e-01
GOBP PHOSPHOLIPID CATABOLIC PROCESS	46	2.39e-01	3.57e-01	0.2640	1.84e-02	8.57e-02	1.76e-01	1.30e-01	3.87e-02	1.14e-01	8.29e-01	3.15e-01	3.92e-02	1.28e-01	6.50e-01	1.82e-01
GOBP EMBRYO IMPLANTATION	42	4.52e-02	1.09e-01	0.2640	-1.37e-01	-7.62e-02	1.83e-01	1.85e-02	-1.07e-02	1.07e-01	1.24e-01	3.93e-01	4.04e-02	8.35e-01	9.05e-01	2.32e-01
GOCC AUTOPHAGOSOME MEMBRANE	50	1.49e-01	2.60e-01	0.2640	-1.66e-01	-1.25e-01	4.10e-03	3.32e-02	-1.06e-01	1.19e-01	4.22e-02	1.26e-01	9.60e-01	6.84e-01	1.95e-01	1.45e-01
GOBP G PROTEIN COUPLED ACETYLCHOLINE RECEPTOR SIGNALING PATHWAY	16	8.51e-01	8.80e-01	0.2640	-2.15e-01	-4.35e-02	2.22e-02	-8.15e-02	-6.74e-02	1.01e-01	1.37e-01	7.63e-01	8.78e-01	5.73e-01	6.41e-01	4.86e-01
GOBP MYOTUBE CELL DEVELOPMENT	29	5.11e-01	6.06e-01	0.2640	4.80e-02	3.75e-02	1.06e-01	-1.38e-01	-1.88e-01	1.37e-02	6.55e-01	7.27e-01	3.21e-01	1.98e-01	7.94e-02	8.98e-01
GOBP REGULATION OF PROTEIN TARGETING	72	1.12e-02	3.77e-02	0.2640	-1.16e-01	-1.37e-01	4.30e-02	1.13e-01	-9.74e-02	1.14e-01	8.77e-02	4.37e-02	5.28e-01	9.69e-02	1.53e-01	9.32e-02
GOBP TYPE 2 IMMUNE RESPONSE	38	2.95e-01	4.15e-01	0.2640	4.19e-03	1.38e-01	1.96e-01	3.74e-02	-7.70e-02	6.84e-02	9.64e-01	1.40e-01	3.65e-02	6.90e-01	4.11e-01	4.66e-01
GOMF CALCIUM DEPENDENT PROTEIN BINDING	57	8.56e-02	1.75e-01	0.2640	-1.06e-01	-5.22e-02	1.60e-01	3.30e-02	-4.22e-02	1.65e-01	1.67e-01	4.95e-01	3.72e-02	6.66e-01	5.82e-01	3.10e-02
GOBP GLUTAMINE FAMILY AMINO ACID CATABOLIC PROCESS	18	5.43e-01	6.34e-01	0.2640	-3.77e-02	-1.44e-01	1.59e-01	-1.80e-02	-6.41e-03	1.48e-01	7.82e-01	2.90e-01	2.44e-01	8.95e-01	9.62e-01	2.79e-01
GOBP ESTABLISHMENT OF MITOCHONDRION LOCALIZATION	28	5.26e-01	6.19e-01	0.2640	-1.95e-01	-4.12e-02	9.66e-02	-7.27e-02	-4.34e-02	1.15e-01	7.43e-02	7.06e-01	3.76e-01	5.06e-01	6.91e-01	2.90e-01
GOBP PHOTOPERIODISM	24	2.93e-01	4.13e-01	0.2640	5.11e-02	3.46e-03	2.83e-02	2.03e-01	1.64e-02	-1.57e-01	6.65e-01	9.77e-01	8.10e-01	8.53e-02	8.89e-01	1.83e-01
GOMF SINGLE STRANDED RNA BINDING	74	1.12e-03	5.59e-03	0.2640	-1.79e-01	-1.84e-02	-9.07e-02	1.29e-01	4.23e-02	1.02e-01	7.90e-03	7.84e-01	1.78e-01	5.44e-02	5.29e-01	1.28e-01
GOBP SMOOTHENED SIGNALING PATHWAY	118	7.57e-05	5.30e-04	0.2640	-7.88e-02	1.79e-01	-2.97e-02	8.47e-02	1.45e-01	4.68e-02	1.39e-01	7.94e-04	5.77e-01	1.12e-01	6.52e-03	3.80e-01
GOBP POSITIVE REGULATION OF ENDOTHELIAL CELL APOPTOTIC PROCESS	16	4.71e-01	5.73e-01	0.2640	-6.96e-02	-2.34e-02	1.12e-02	8.92e-05	2.47e-01	5.43e-02	6.30e-01	8.71e-01	9.38e-01	1.00e+00	8.72e-02	7.07e-01
GOBP NEGATIVE REGULATION OF CELL CYCLE PROCESS	272	8.46e-12	1.71e-10	0.2630	-4.83e-02	-1.10e-01	3.32e-03	1.87e-01	8.60e-03	1.41e-01	1.70e-01	1.73e-03	9.25e-01	1.11e-07	8.07e-01	6.34e-05
GOBP REGULATION OF PROTEIN CONTAINING COMPLEX DISASSEMBLY	111	1.14e-04	7.61e-04	0.2630	-2.89e-02	3.01e-02	1.72e-01	1.59e-01	-4.85e-02	1.02e-01	5.99e-01	5.84e-01	1.79e-03	3.74e-03	3.78e-01	6.27e-02
GOBP RESPONSE TO PH	26	2.82e-01	4.02e-01	0.2630	-5.32e-03	-3.05e-02	8.65e-02	1.75e-01	1.66e-01	5.25e-02	9.63e-01	7.88e-01	4.45e-01	1.23e-01	1.43e-01	6.43e-01
GOBP CHLORIDE TRANSPORT	75	4.47e-02	1.08e-01	0.2630	1.12e-01	1.26e-01	2.00e-01	-1.97e-02	8.86e-03	2.15e-02	9.35e-02	5.87e-02	2.78e-03	7.68e-01	8.94e-01	7.48e-01
GOBP REGULATION OF PROTEIN DEACETYLATION	28	4.32e-01	5.41e-01	0.2630	-1.68e-01	3.06e-03	-1.21e-01	1.72e-02	1.16e-01	-1.13e-01	1.24e-01	9.78e-01	2.67e-01	8.75e-01	2.89e-01	3.01e-01
GOBP CATECHOLAMINE TRANSPORT	38	5.26e-01	6.19e-01	0.2630	9.78e-02	6.67e-02	2.03e-01	8.62e-03	-6.03e-02	1.02e-01	2.97e-01	4.77e-01	3.04e-02	9.27e-01	5.20e-01	2.77e-01
GOCC POTASSIUM CHANNEL COMPLEX	60	5.82e-02	1.32e-01	0.2630	1.54e-01	7.31e-02	1.80e-01	-4.85e-02	2.75e-02	7.00e-02	3.97e-02	3.28e-01	1.60e-02	5.16e-01	7.13e-01	3.48e-01
GOBP SKELETAL MUSCLE SATELLITE CELL DIFFERENTIATION	8	9.66e-01	9.72e-01	0.2630	-1.33e-01	-1.47e-01	4.29e-02	1.59e-02	-6.23e-02	1.54e-01	5.14e-01	4.71e-01	8.34e-01	9.38e-01	7.60e-01	4.49e-01
GOBP VESICLE LOCALIZATION	194	1.31e-07	1.57e-06	0.2630	-1.35e-01	-3.08e-02	8.43e-02	7.03e-02	-9.62e-02	1.70e-01	1.23e-03	4.60e-01	4.30e-02	9.13e-02	2.09e-02	4.45e-05
GOBP REGULATION OF MACROAUTOPHAGY	172	6.75e-10	1.11e-08	0.2630	-2.01e-01	-2.78e-02	6.71e-02	9.75e-02	-7.24e-02	9.29e-02	5.16e-06	5.29e-01	1.29e-01	2.74e-02	1.02e-01	3.55e-02
GOBP ANTEROGRADE AXONAL TRANSPORT	47	2.93e-01	4.12e-01	0.2630	-4.61e-02	7.64e-03	1.23e-01	-7.14e-02	-4.33e-02	2.12e-01	5.85e-01	9.28e-01	1.46e-01	3.97e-01	6.08e-01	1.18e-02
GOBP POSITIVE REGULATION OF GLUCONEOGENESIS	17	2.46e-01	3.64e-01	0.2630	-1.90e-01	2.43e-02	-5.37e-02	1.45e-01	-9.19e-02	-1.54e-02	1.75e-01	8.62e-01	7.01e-01	3.01e-01	5.12e-01	9.12e-01
GOBP REGULATION OF CELL KILLING	97	1.21e-04	8.00e-04	0.2630	-3.07e-03	1.59e-01	3.46e-02	1.71e-01	1.46e-02	1.15e-01	9.58e-01	6.97e-03	5.56e-01	3.56e-03	8.04e-01	4.95e-02
GOBP POSITIVE REGULATION OF B CELL DIFFERENTIATION	16	7.16e-01	7.74e-01	0.2630	-1.39e-02	8.21e-02	1.32e-01	1.48e-01	-6.75e-02	1.36e-01	9.23e-01	5.70e-01	3.60e-01	3.06e-01	6.40e-01	3.48e-01
GOBP AORTA DEVELOPMENT	43	3.00e-02	8.00e-02	0.2630	-1.99e-01	8.57e-02	1.16e-01	-4.55e-02	-8.09e-02	-9.61e-03	2.40e-02	3.31e-01	1.88e-01	6.05e-01	3.59e-01	9.13e-01
GOBP REGULATION OF VIRAL TRANSCRIPTION	18	5.13e-01	6.07e-01	0.2630	-9.63e-02	-1.43e-02	7.61e-02	2.03e-01	4.14e-02	1.04e-01	4.79e-01	9.16e-01	5.76e-01	1.35e-01	7.61e-01	4.47e-01
GOCC LATE ENDOSOME	278	1.44e-11	2.84e-10	0.2630	-1.64e-01	-1.10e-01	6.68e-02	7.41e-02	-3.26e-02	1.39e-01	2.70e-06	1.60e-03	5.55e-02	3.35e-02	3.49e-01	7.04e-05
GOBP GLUCOSAMINE CONTAINING COMPOUND METABOLIC PROCESS	20	6.76e-01	7.43e-01	0.2630	4.78e-02	5.69e-02	-7.84e-02	2.26e-01	7.73e-02	-2.06e-02	7.11e-01	6.60e-01	5.44e-01	8.05e-02	5.49e-01	8.74e-01
GOBP POSITIVE REGULATION OF SECRETION	224	1.40e-09	2.17e-08	0.2630	-1.39e-01	5.48e-03	1.82e-01	1.51e-02	-6.01e-02	1.13e-01	3.23e-04	8.88e-01	2.82e-06	6.98e-01	1.21e-01	3.64e-03
GOBP FEEDING BEHAVIOR	47	1.74e-01	2.88e-01	0.2630	-1.98e-02	5.51e-02	9.79e-02	-2.69e-02	6.08e-02	2.27e-01	8.15e-01	5.13e-01	2.46e-01	7.50e-01	4.71e-01	7.09e-03
GOBP 4 HYDROXYPROLINE METABOLIC PROCESS	10	7.15e-01	7.73e-01	0.2620	-1.47e-01	-2.01e-01	8.16e-02	1.49e-02	7.48e-03	8.61e-03	4.21e-01	2.72e-01	6.55e-01	9.35e-01	9.67e-01	9.62e-01
GOBP REGULATION OF POTASSIUM ION EXPORT ACROSS PLASMA MEMBRANE	6	9.84e-01	9.86e-01	0.2620	-8.54e-02	-2.17e-01	-2.16e-02	-1.75e-02	-1.07e-01	-4.77e-02	7.17e-01	3.57e-01	9.27e-01	9.41e-01	6.51e-01	8.40e-01
GOMF PROTEIN SERINE KINASE ACTIVITY	328	1.18e-16	3.69e-15	0.2620	-4.80e-02	1.50e-01	1.26e-01	1.52e-01	2.40e-02	6.69e-02	1.35e-01	2.96e-06	8.48e-05	2.36e-06	4.55e-01	3.72e-02
GOBP POSITIVE REGULATION OF CHEMOKINE PRODUCTION	59	1.96e-02	5.83e-02	0.2620	-1.92e-01	9.20e-02	-1.91e-02	-1.18e-01	5.04e-02	-8.10e-02	1.07e-02	2.22e-01	8.00e-01	1.16e-01	5.03e-01	2.82e-01
GOBP REGULATION OF ENDOTHELIAL CELL DIFFERENTIATION	31	2.45e-02	6.90e-02	0.2620	-1.67e-01	3.25e-02	1.95e-01	1.39e-03	-2.07e-02	-3.59e-02	1.08e-01	7.54e-01	5.97e-02	9.89e-01	8.42e-01	7.30e-01
GOBP CELLULAR RESPONSE TO STARVATION	150	1.58e-07	1.87e-06	0.2620	-2.01e-01	-5.70e-02	4.50e-02	3.14e-02	-1.48e-01	8.73e-03	2.14e-05	2.28e-01	3.42e-01	5.07e-01	1.74e-03	8.54e-01
GOBP POSITIVE REGULATION OF INTERLEUKIN 8 PRODUCTION	50	1.60e-02	4.96e-02	0.2620	-1.25e-01	2.04e-01	9.45e-02	-2.43e-02	3.84e-02	-2.68e-02	1.27e-01	1.27e-02	2.48e-01	7.66e-01	6.38e-01	7.43e-01
GOBP PROTEIN CONTAINING COMPLEX REMODELING	20	5.45e-01	6.35e-01	0.2620	-3.84e-02	2.95e-02	2.27e-01	-8.90e-03	-1.19e-01	2.30e-02	7.66e-01	8.19e-01	7.86e-02	9.45e-01	3.57e-01	8.59e-01
GOBP POSITIVE REGULATION OF NEURON PROJECTION REGENERATION	9	6.88e-01	7.53e-01	0.2620	-1.63e-01	1.52e-01	6.96e-02	1.69e-02	-9.86e-02	-6.54e-02	3.98e-01	4.30e-01	7.18e-01	9.30e-01	6.09e-01	7.34e-01
GOCC CONDENSED NUCLEAR CHROMOSOME	66	6.26e-03	2.35e-02	0.2620	2.89e-04	-7.59e-02	-2.01e-02	1.99e-01	-4.69e-02	1.44e-01	9.97e-01	2.86e-01	7.78e-01	5.17e-03	5.10e-01	4.32e-02
GOBP HEART PROCESS	166	9.37e-05	6.39e-04	0.2620	-9.68e-02	-7.25e-03	1.88e-01	-4.13e-02	-8.65e-02	1.22e-01	3.15e-02	8.72e-01	2.95e-05	3.59e-01	5.44e-02	6.91e-03
GOMF DNA BINDING TRANSCRIPTION ACTIVATOR ACTIVITY	319	8.14e-13	1.82e-11	0.2620	-1.82e-02	1.62e-01	1.25e-01	1.27e-01	9.47e-02	3.87e-02	5.76e-01	6.87e-07	1.25e-04	9.89e-05	3.64e-03	2.35e-01
GOBP REGULATION OF CELL DIVISION	143	1.40e-05	1.14e-04	0.2620	-3.12e-02	-1.31e-01	1.04e-01	1.40e-01	-4.25e-02	1.35e-01	5.20e-01	6.79e-03	3.24e-02	3.79e-03	3.80e-01	5.32e-03
GOMF PROTEIN METHYLTRANSFERASE ACTIVITY	87	2.08e-02	6.11e-02	0.2620	3.87e-02	-2.88e-02	-1.13e-01	2.10e-01	9.40e-02	-2.35e-02	5.33e-01	6.43e-01	6.73e-02	7.18e-04	1.30e-01	7.04e-01
GOBP MESENCHYMAL CELL MIGRATION	31	2.07e-02	6.08e-02	0.2620	-1.13e-01	1.32e-01	1.46e-01	6.43e-02	2.50e-02	-1.10e-01	2.75e-01	2.05e-01	1.59e-01	5.35e-01	8.10e-01	2.87e-01
GOCC H4 H2A HISTONE ACETYLTRANSFERASE COMPLEX	24	5.02e-01	5.99e-01	0.2620	-1.75e-01	-1.64e-01	1.44e-02	4.74e-02	-9.19e-02	1.48e-02	1.38e-01	1.65e-01	9.03e-01	6.88e-01	4.36e-01	9.00e-01
GOMF ATP DEPENDENT ACTIVITY ACTING ON DNA	117	1.40e-04	9.13e-04	0.2620	-3.08e-03	-3.55e-02	-1.14e-02	2.34e-01	3.72e-02	1.04e-01	9.54e-01	5.08e-01	8.32e-01	1.21e-05	4.87e-01	5.14e-02
GOBP MYELOID CELL HOMEOSTASIS	163	2.95e-07	3.35e-06	0.2620	-1.03e-01	-2.88e-02	1.52e-01	1.17e-01	-6.05e-02	1.29e-01	2.27e-02	5.25e-01	8.19e-04	9.96e-03	1.83e-01	4.64e-03
GOMF PHOSPHATASE BINDING	169	1.02e-05	8.58e-05	0.2620	2.51e-04	6.86e-02	1.29e-01	1.78e-01	1.74e-02	1.22e-01	9.96e-01	1.24e-01	3.69e-03	6.48e-05	6.97e-01	6.08e-03
GOMF G QUADRUPLEX RNA BINDING	8	9.23e-01	9.35e-01	0.2620	-1.92e-01	-2.34e-02	-1.09e-01	-5.33e-02	1.84e-02	1.26e-01	3.47e-01	9.09e-01	5.92e-01	7.94e-01	9.28e-01	5.37e-01
GOBP NEGATIVE REGULATION OF CALCINEURIN MEDIATED SIGNALING	13	7.37e-01	7.90e-01	0.2620	-3.87e-02	1.65e-02	1.31e-01	2.69e-02	-2.21e-01	-1.02e-02	8.09e-01	9.18e-01	4.13e-01	8.67e-01	1.69e-01	9.49e-01
GOBP EYE MORPHOGENESIS	98	1.96e-04	1.23e-03	0.2620	-6.75e-02	1.98e-01	1.50e-01	3.25e-02	2.86e-02	1.65e-02	2.48e-01	6.89e-04	1.05e-02	5.79e-01	6.24e-01	7.78e-01
GOBP DETECTION OF MECHANICAL STIMULUS	36	3.97e-01	5.09e-01	0.2610	-1.70e-02	2.70e-02	8.76e-02	-2.11e-01	-1.22e-01	-1.60e-02	8.60e-01	7.79e-01	3.63e-01	2.83e-02	2.07e-01	8.68e-01
GOBP POSITIVE REGULATION OF CALCIUM MEDIATED SIGNALING	40	4.00e-01	5.12e-01	0.2610	1.12e-01	7.52e-02	2.06e-01	4.16e-02	1.37e-02	7.72e-02	2.22e-01	4.11e-01	2.42e-02	6.49e-01	8.81e-01	3.98e-01
GOBP BASEMENT MEMBRANE ORGANIZATION	30	5.12e-01	6.07e-01	0.2610	-1.29e-01	-2.17e-02	1.09e-01	-1.78e-01	-8.73e-02	6.05e-03	2.20e-01	8.37e-01	3.03e-01	9.18e-02	4.08e-01	9.54e-01
GOBP MORPHOGENESIS OF EMBRYONIC EPITHELIUM	107	1.73e-04	1.11e-03	0.2610	-3.15e-02	1.51e-01	6.31e-02	1.36e-01	1.42e-01	-4.22e-02	5.73e-01	6.99e-03	2.59e-01	1.50e-02	1.11e-02	4.50e-01
GOBP REGULATION OF DOUBLE STRAND BREAK REPAIR	133	4.51e-06	4.13e-05	0.2610	-3.27e-02	-8.07e-02	-4.62e-02	2.42e-01	1.08e-02	9.73e-03	5.15e-01	1.08e-01	3.58e-01	1.50e-06	8.30e-01	8.46e-01
GOBP LYMPHOCYTE MEDIATED IMMUNITY	324	2.26e-12	4.91e-11	0.2610	3.27e-02	-2.16e-02	8.57e-02	1.75e-01	-5.99e-02	1.59e-01	3.11e-01	5.03e-01	8.06e-03	6.19e-08	6.40e-02	9.20e-07
GOBP RESPONSE TO WOUNDING	440	8.14e-18	2.83e-16	0.2610	-1.22e-01	-4.73e-02	1.85e-01	-2.90e-02	-8.92e-02	9.10e-02	1.23e-05	8.93e-02	3.19e-11	2.97e-01	1.34e-03	1.06e-03
GOBP POSITIVE REGULATION OF EPITHELIAL CELL DIFFERENTIATION	43	3.73e-02	9.46e-02	0.2610	-7.13e-03	-2.92e-02	1.79e-01	1.56e-01	-1.01e-01	2.52e-02	9.36e-01	7.41e-01	4.25e-02	7.64e-02	2.50e-01	7.75e-01
GOCC SCF UBIQUITIN LIGASE COMPLEX	59	3.31e-02	8.64e-02	0.2610	-7.78e-02	-1.34e-01	-3.35e-02	1.27e-01	-2.87e-02	1.61e-01	3.02e-01	7.41e-02	6.57e-01	9.18e-02	7.03e-01	3.23e-02
GOMF GTPASE BINDING	291	3.92e-18	1.39e-16	0.2610	-1.30e-01	5.36e-02	1.37e-01	1.45e-01	1.85e-02	9.00e-02	1.33e-04	1.16e-01	5.76e-05	2.08e-05	5.87e-01	8.24e-03
GOBP NEURONAL ACTION POTENTIAL	17	5.03e-01	5.99e-01	0.2610	1.11e-01	4.98e-02	1.64e-01	3.83e-02	1.58e-01	-4.40e-03	4.28e-01	7.22e-01	2.42e-01	7.84e-01	2.60e-01	9.75e-01
GOBP NEGATIVE REGULATION OF PROGRAMMED NECROTIC CELL DEATH	16	6.51e-01	7.23e-01	0.2610	1.35e-01	4.63e-02	-1.19e-01	1.71e-01	-1.57e-02	-6.21e-02	3.48e-01	7.49e-01	4.11e-01	2.36e-01	9.14e-01	6.67e-01
GOMF PHOSPHORIC DIESTER HYDROLASE ACTIVITY	73	6.08e-02	1.36e-01	0.2610	-8.48e-03	1.41e-01	8.62e-02	1.25e-01	1.19e-01	1.04e-01	9.00e-01	3.68e-02	2.03e-01	6.49e-02	7.87e-02	1.26e-01
GOMF ACTIN MONOMER BINDING	25	4.51e-01	5.57e-01	0.2610	1.13e-02	-1.30e-01	1.07e-01	1.39e-01	4.53e-03	1.43e-01	9.22e-01	2.62e-01	3.56e-01	2.30e-01	9.69e-01	2.16e-01
GOMF MODIFIED AMINO ACID TRANSMEMBRANE TRANSPORTER ACTIVITY	25	2.92e-01	4.11e-01	0.2610	-1.83e-02	-1.87e-01	1.14e-01	5.14e-02	-1.28e-01	-2.57e-02	8.74e-01	1.06e-01	3.23e-01	6.57e-01	2.69e-01	8.24e-01
GOCC BASOLATERAL PLASMA MEMBRANE	186	1.82e-07	2.13e-06	0.2600	-1.40e-02	1.40e-01	2.04e-01	4.62e-02	-5.64e-02	3.79e-02	7.41e-01	1.03e-03	1.69e-06	2.77e-01	1.85e-01	3.73e-01
GOCC FIBRILLAR CENTER	138	7.97e-06	6.91e-05	0.2600	-4.69e-02	-1.30e-01	-6.14e-02	2.11e-01	1.27e-02	-2.17e-02	3.42e-01	8.61e-03	2.13e-01	1.90e-05	7.97e-01	6.60e-01
GOBP CELLULAR RESPONSE TO PEPTIDE HORMONE STIMULUS	243	7.73e-12	1.57e-10	0.2600	-1.31e-01	7.99e-02	1.75e-01	4.85e-02	-3.02e-02	1.01e-01	4.53e-04	3.20e-02	2.49e-06	1.93e-01	4.18e-01	6.70e-03
GOMF CHROMATIN DNA BINDING	111	1.76e-05	1.41e-04	0.2600	-6.31e-02	-1.10e-01	8.98e-02	1.91e-01	-2.16e-02	8.03e-02	2.51e-01	4.51e-02	1.02e-01	4.98e-04	6.94e-01	1.44e-01
GOCC CULLIN RING UBIQUITIN LIGASE COMPLEX	167	9.63e-08	1.18e-06	0.2600	-1.20e-01	-9.71e-02	-9.82e-02	1.75e-01	4.25e-03	6.04e-02	7.54e-03	3.04e-02	2.86e-02	9.72e-05	9.25e-01	1.78e-01
GOBP SOMITE DEVELOPMENT	51	3.00e-01	4.19e-01	0.2600	1.01e-01	1.43e-01	1.44e-02	1.66e-01	8.57e-02	4.20e-02	2.10e-01	7.81e-02	8.59e-01	4.02e-02	2.90e-01	6.04e-01
GOBP NEGATIVE REGULATION OF TRANSMEMBRANE RECEPTOR PROTEIN SERINE THREONINE KINASE SIGNALING PATHWAY	114	1.03e-04	6.95e-04	0.2600	-6.98e-02	9.27e-02	1.80e-01	9.88e-02	-4.09e-02	1.01e-01	1.98e-01	8.75e-02	9.07e-04	6.85e-02	4.51e-01	6.20e-02
GOBP PURINERGIC NUCLEOTIDE RECEPTOR SIGNALING PATHWAY	27	5.54e-01	6.44e-01	0.2600	-1.06e-01	6.29e-03	1.72e-01	-9.01e-02	-1.97e-02	1.35e-01	3.41e-01	9.55e-01	1.22e-01	4.18e-01	8.59e-01	2.26e-01
GOBP ACTIVATION OF INNATE IMMUNE RESPONSE	274	5.08e-16	1.50e-14	0.2600	-1.74e-01	8.39e-02	2.76e-02	8.43e-02	4.61e-03	1.49e-01	6.93e-07	1.69e-02	4.31e-01	1.63e-02	8.96e-01	2.22e-05
GOCC CLATHRIN COATED PIT	69	3.90e-04	2.26e-03	0.2600	-1.22e-01	-2.05e-02	1.47e-01	1.48e-01	-7.40e-02	5.50e-02	8.05e-02	7.68e-01	3.41e-02	3.34e-02	2.88e-01	4.29e-01
GOBP REGULATION OF GENE SILENCING BY REGULATORY NCRNA	24	5.40e-01	6.31e-01	0.2600	4.15e-02	1.16e-01	-5.56e-02	1.84e-01	1.01e-01	7.15e-02	7.25e-01	3.26e-01	6.38e-01	1.18e-01	3.94e-01	5.44e-01
GOBP MYELIN ASSEMBLY	21	7.72e-01	8.16e-01	0.2600	-1.73e-01	-5.98e-02	6.52e-02	-1.50e-01	-8.46e-02	7.33e-03	1.70e-01	6.35e-01	6.05e-01	2.35e-01	5.02e-01	9.54e-01
GOBP REGULATION OF CARDIAC MUSCLE CONTRACTION	52	1.63e-01	2.75e-01	0.2590	-7.96e-02	1.56e-02	1.99e-01	-8.22e-02	-8.35e-02	8.55e-02	3.21e-01	8.46e-01	1.29e-02	3.05e-01	2.97e-01	2.86e-01
GOMF NADP BINDING	45	1.55e-01	2.66e-01	0.2590	-2.24e-01	-1.01e-01	3.14e-02	-5.44e-02	-9.55e-03	5.25e-02	9.23e-03	2.41e-01	7.16e-01	5.28e-01	9.12e-01	5.42e-01
GOMF SODIUM CHANNEL REGULATOR ACTIVITY	32	5.07e-01	6.02e-01	0.2590	-9.03e-02	-1.39e-01	-5.81e-02	-1.79e-01	-5.74e-02	3.15e-02	3.77e-01	1.74e-01	5.70e-01	7.90e-02	5.74e-01	7.58e-01
GOBP REGULATION OF SPINDLE ORGANIZATION	45	1.64e-01	2.77e-01	0.2590	-3.54e-02	-1.48e-03	8.54e-03	1.99e-01	1.11e-01	1.19e-01	6.81e-01	9.86e-01	9.21e-01	2.11e-02	1.96e-01	1.69e-01
GOBP CELL CYCLE G2 M PHASE TRANSITION	143	2.34e-05	1.82e-04	0.2590	-1.11e-01	-1.59e-01	-6.30e-02	1.39e-01	-7.42e-03	7.85e-02	2.15e-02	1.05e-03	1.94e-01	3.98e-03	8.78e-01	1.05e-01
GOCC ACTIN CYTOSKELETON	419	1.46e-15	4.07e-14	0.2590	-3.30e-02	-1.63e-02	1.88e-01	8.71e-02	-9.48e-02	1.18e-01	2.47e-01	5.67e-01	4.16e-11	2.25e-03	8.71e-04	3.32e-05
GOCC ORGANELLE SUBCOMPARTMENT	1283	1.51e-50	4.82e-48	0.2590	-1.80e-01	-1.15e-01	2.52e-02	5.38e-02	-6.67e-02	1.16e-01	2.56e-27	4.66e-12	1.29e-01	1.22e-03	6.06e-05	2.65e-12
GOBP POSITIVE REGULATION OF LEUKOCYTE MIGRATION	115	4.13e-05	3.06e-04	0.2590	-9.52e-02	-7.90e-02	1.81e-01	6.49e-02	-4.24e-02	1.14e-01	7.78e-02	1.43e-01	8.11e-04	2.29e-01	4.33e-01	3.43e-02
GOBP MIDBRAIN DEVELOPMENT	64	3.74e-02	9.47e-02	0.2590	-2.32e-01	-5.52e-02	3.32e-02	-2.27e-02	-2.67e-02	8.84e-02	1.32e-03	4.45e-01	6.46e-01	7.54e-01	7.12e-01	2.21e-01
GOBP NATURAL KILLER CELL PROLIFERATION	12	9.12e-01	9.27e-01	0.2590	-2.10e-01	-6.96e-02	-1.26e-01	-2.16e-02	4.31e-02	6.84e-03	2.09e-01	6.77e-01	4.50e-01	8.97e-01	7.96e-01	9.67e-01
GOBP CALCIUM ION REGULATED EXOCYTOSIS	41	2.24e-02	6.47e-02	0.2590	-9.29e-02	-2.19e-02	1.52e-01	8.76e-02	1.36e-01	9.30e-02	3.03e-01	8.08e-01	9.27e-02	3.32e-01	1.31e-01	3.03e-01
GOMF MANGANESE ION BINDING	61	3.81e-03	1.57e-02	0.2590	-2.12e-01	-1.32e-01	4.88e-02	1.20e-02	3.87e-02	2.75e-02	4.22e-03	7.53e-02	5.10e-01	8.72e-01	6.01e-01	7.10e-01
GOBP CIRCADIAN SLEEP WAKE CYCLE	12	9.25e-01	9.37e-01	0.2590	-3.17e-02	1.13e-01	-9.22e-02	8.39e-02	1.81e-01	-6.92e-02	8.49e-01	4.99e-01	5.80e-01	6.15e-01	2.76e-01	6.78e-01
GOBP PROTEIN PROCESSING	180	7.05e-05	4.97e-04	0.2590	-1.90e-01	-1.32e-01	2.96e-02	-3.37e-02	-9.30e-02	5.19e-02	1.09e-05	2.23e-03	4.94e-01	4.35e-01	3.15e-02	2.29e-01
GOBP PROTEIN DEUBIQUITINATION	82	4.90e-04	2.76e-03	0.2590	-1.64e-01	1.38e-01	5.33e-02	4.36e-02	1.57e-02	1.26e-01	1.00e-02	3.12e-02	4.04e-01	4.95e-01	8.06e-01	4.82e-02
GOBP NEGATIVE REGULATION OF RECEPTOR MEDIATED ENDOCYTOSIS	23	3.56e-01	4.72e-01	0.2590	-1.68e-01	1.01e-01	1.53e-01	-1.71e-03	-2.60e-02	6.49e-02	1.63e-01	4.02e-01	2.03e-01	9.89e-01	8.29e-01	5.90e-01
GOBP REGULATION OF CARDIAC MUSCLE CELL ACTION POTENTIAL INVOLVED IN REGULATION OF CONTRACTION	5	9.58e-01	9.65e-01	0.2590	1.08e-01	1.64e-01	-4.89e-02	1.30e-01	2.82e-02	9.09e-02	6.76e-01	5.26e-01	8.50e-01	6.15e-01	9.13e-01	7.25e-01
GOBP EPITHELIAL CELL PROLIFERATION INVOLVED IN PROSTATE GLAND DEVELOPMENT	9	7.96e-01	8.36e-01	0.2580	-2.65e-02	-1.06e-01	5.82e-02	1.53e-01	1.64e-01	3.36e-02	8.91e-01	5.83e-01	7.63e-01	4.26e-01	3.94e-01	8.61e-01
GOCC PRESYNAPTIC ACTIVE ZONE	54	1.81e-02	5.47e-02	0.2580	1.63e-02	1.67e-01	1.20e-01	5.03e-02	9.20e-02	-1.15e-01	8.36e-01	3.38e-02	1.28e-01	5.22e-01	2.42e-01	1.43e-01
GOBP REGULATION OF PROTEASOMAL PROTEIN CATABOLIC PROCESS	175	6.11e-07	6.65e-06	0.2580	-1.76e-01	-1.35e-01	1.22e-02	8.60e-02	-3.97e-02	9.17e-02	5.95e-05	2.07e-03	7.81e-01	4.96e-02	3.65e-01	3.63e-02
GOBP REGULATION OF ANDROGEN RECEPTOR SIGNALING PATHWAY	23	4.56e-01	5.61e-01	0.2580	4.80e-02	-2.14e-02	1.00e-01	2.21e-01	-5.77e-02	4.22e-02	6.90e-01	8.59e-01	4.07e-01	6.65e-02	6.32e-01	7.26e-01
GOBP ANTIGEN PROCESSING AND PRESENTATION	103	4.77e-04	2.71e-03	0.2580	-1.50e-01	-1.12e-01	-8.20e-02	1.18e-01	1.00e-01	-2.96e-02	8.36e-03	5.01e-02	1.51e-01	3.86e-02	7.81e-02	6.04e-01
GOBP ENDOTHELIAL CELL APOPTOTIC PROCESS	44	3.50e-02	9.00e-02	0.2580	-5.82e-02	8.93e-02	2.34e-01	-8.71e-03	-2.14e-03	1.92e-02	5.04e-01	3.05e-01	7.17e-03	9.20e-01	9.80e-01	8.26e-01
GOBP GLUTAMATE RECEPTOR SIGNALING PATHWAY	31	1.60e-01	2.72e-01	0.2580	-1.72e-01	1.50e-01	-3.70e-02	-5.08e-02	3.51e-02	-9.66e-02	9.65e-02	1.49e-01	7.21e-01	6.24e-01	7.35e-01	3.52e-01
GOBP REGULATION OF PATTERN RECOGNITION RECEPTOR SIGNALING PATHWAY	154	3.83e-09	5.67e-08	0.2580	-1.73e-01	5.88e-02	1.48e-03	1.43e-01	3.74e-02	1.07e-01	2.10e-04	2.08e-01	9.75e-01	2.20e-03	4.23e-01	2.22e-02
GOBP BIOLOGICAL PROCESS INVOLVED IN INTRASPECIES INTERACTION BETWEEN ORGANISMS	36	1.95e-01	3.11e-01	0.2580	-3.49e-02	8.31e-02	1.51e-01	1.61e-01	-1.25e-02	9.77e-02	7.17e-01	3.88e-01	1.16e-01	9.45e-02	8.97e-01	3.10e-01
GOBP MUSCLE CELL PROLIFERATION	159	2.26e-08	3.03e-07	0.2580	-1.17e-01	1.13e-01	1.76e-01	5.75e-02	-4.09e-02	6.45e-02	1.08e-02	1.40e-02	1.27e-04	2.11e-01	3.74e-01	1.61e-01
GOBP SNRNA METABOLIC PROCESS	56	1.19e-01	2.22e-01	0.2580	-4.08e-02	-1.38e-01	-1.43e-01	1.10e-01	1.15e-01	1.35e-02	5.97e-01	7.51e-02	6.44e-02	1.53e-01	1.36e-01	8.62e-01
GOMF MONOOXYGENASE ACTIVITY	55	9.04e-02	1.82e-01	0.2580	1.47e-01	9.72e-02	1.55e-01	-3.68e-02	8.35e-02	5.62e-02	5.99e-02	2.12e-01	4.63e-02	6.37e-01	2.84e-01	4.71e-01
GOBP VENTRICULAR SEPTUM DEVELOPMENT	52	7.69e-02	1.62e-01	0.2580	-6.37e-02	1.17e-01	1.74e-01	8.46e-02	2.09e-02	1.04e-01	4.27e-01	1.45e-01	2.96e-02	2.91e-01	7.94e-01	1.94e-01
GOMF OXIDOREDUCTASE ACTIVITY ACTING ON PEROXIDE AS ACCEPTOR	49	1.73e-01	2.87e-01	0.2580	-7.37e-02	-1.71e-01	6.89e-02	2.24e-02	-6.08e-02	1.51e-01	3.72e-01	3.80e-02	4.04e-01	7.86e-01	4.62e-01	6.78e-02
GOBP CELL MIGRATION INVOLVED IN SPROUTING ANGIOGENESIS	41	6.75e-03	2.50e-02	0.2580	-1.10e-01	6.28e-02	1.37e-01	-1.21e-01	8.57e-02	-9.73e-02	2.22e-01	4.87e-01	1.29e-01	1.78e-01	3.42e-01	2.81e-01
GOCC TRANSCRIPTION REPRESSOR COMPLEX	66	9.35e-04	4.81e-03	0.2580	-1.51e-01	3.08e-04	9.44e-02	1.58e-01	-4.97e-02	8.57e-02	3.36e-02	9.97e-01	1.85e-01	2.68e-02	4.85e-01	2.28e-01
GOMF ANDROSTAN 3 ALPHA 17 BETA DIOL DEHYDROGENASE ACTIVITY	7	8.75e-01	8.98e-01	0.2580	8.14e-02	2.72e-02	-1.60e-01	1.27e-01	7.66e-02	1.07e-01	7.09e-01	9.01e-01	4.63e-01	5.61e-01	7.26e-01	6.24e-01
GOMF TRANSFORMING GROWTH FACTOR BETA RECEPTOR BINDING	22	5.74e-01	6.61e-01	0.2580	-1.01e-01	1.49e-01	1.58e-01	-1.49e-02	-3.14e-02	8.88e-02	4.14e-01	2.27e-01	1.99e-01	9.03e-01	7.99e-01	4.71e-01
GOBP REGULATION OF DNA BINDING	60	9.58e-02	1.90e-01	0.2580	-3.08e-03	-1.32e-01	1.27e-01	5.53e-02	-9.79e-02	1.42e-01	9.67e-01	7.79e-02	8.78e-02	4.59e-01	1.90e-01	5.71e-02
GOBP NEGATIVE REGULATION OF LEUKOCYTE CELL CELL ADHESION	116	8.29e-03	2.96e-02	0.2580	7.95e-03	5.43e-02	1.67e-01	9.29e-02	-5.08e-02	1.55e-01	8.82e-01	3.13e-01	1.85e-03	8.39e-02	3.45e-01	3.84e-03
GOBP SECRETION BY TISSUE	29	4.50e-01	5.57e-01	0.2580	8.35e-03	5.52e-02	1.15e-01	1.95e-01	6.98e-02	8.29e-02	9.38e-01	6.07e-01	2.82e-01	6.88e-02	5.15e-01	4.40e-01
GOMF SEQUENCE SPECIFIC DNA BINDING	1229	5.47e-43	1.06e-40	0.2580	-1.45e-02	9.84e-02	3.85e-03	1.87e-01	1.36e-01	5.43e-02	3.94e-01	6.61e-09	8.21e-01	3.08e-28	9.31e-16	1.37e-03
GOBP POSITIVE REGULATION OF TRANSMEMBRANE TRANSPORT	152	4.01e-03	1.64e-02	0.2570	-2.35e-02	3.56e-02	1.83e-01	-2.03e-02	-7.44e-02	1.58e-01	6.18e-01	4.49e-01	9.54e-05	6.66e-01	1.13e-01	7.84e-04
GOBP NUCLEAR EXPORT	161	2.04e-07	2.38e-06	0.2570	-1.53e-01	-1.40e-01	-3.62e-02	1.42e-01	-4.09e-02	1.15e-02	7.98e-04	2.13e-03	4.28e-01	1.95e-03	3.71e-01	8.02e-01
GOBP POSITIVE REGULATION OF PROTEIN EXPORT FROM NUCLEUS	19	2.56e-01	3.76e-01	0.2570	-1.79e-01	-6.05e-02	1.63e-01	1.94e-02	-5.75e-02	-1.54e-02	1.77e-01	6.48e-01	2.18e-01	8.83e-01	6.65e-01	9.07e-01
GOCC CILIARY ROOTLET	14	7.31e-01	7.85e-01	0.2570	-8.68e-02	9.10e-02	4.06e-02	-1.65e-01	1.22e-01	8.17e-02	5.74e-01	5.55e-01	7.93e-01	2.86e-01	4.29e-01	5.97e-01
GOMF N ACYLTRANSFERASE ACTIVITY	77	3.10e-03	1.33e-02	0.2570	-2.90e-02	7.93e-03	-1.34e-01	1.99e-01	2.13e-02	-8.42e-02	6.60e-01	9.04e-01	4.14e-02	2.53e-03	7.47e-01	2.02e-01
GOMF RECEPTOR SERINE THREONINE KINASE BINDING	16	8.30e-01	8.63e-01	0.2570	-1.02e-01	1.02e-02	1.83e-01	-6.92e-03	-7.19e-02	1.29e-01	4.78e-01	9.44e-01	2.04e-01	9.62e-01	6.18e-01	3.70e-01
GOMF TRANSLATION REPRESSOR ACTIVITY	36	5.85e-01	6.70e-01	0.2570	-1.72e-01	-1.19e-01	-1.38e-01	-3.69e-02	1.81e-02	-4.06e-02	7.46e-02	2.15e-01	1.53e-01	7.02e-01	8.51e-01	6.73e-01
GOBP PROTEIN CATABOLIC PROCESS	900	3.75e-39	6.32e-37	0.2570	-1.76e-01	-1.20e-01	4.13e-03	8.80e-02	-5.29e-02	1.01e-01	3.32e-19	1.17e-09	8.34e-01	7.61e-06	7.15e-03	2.90e-07
GOBP RESPONSE TO ORGANOPHOSPHORUS	96	1.18e-04	7.82e-04	0.2570	-1.46e-01	6.21e-02	1.89e-01	-4.35e-02	-1.51e-04	5.61e-02	1.34e-02	2.93e-01	1.36e-03	4.62e-01	9.98e-01	3.42e-01
GOBP ISOPRENOID METABOLIC PROCESS	91	1.14e-02	3.82e-02	0.2570	-1.45e-01	-1.89e-01	-7.49e-02	6.29e-03	3.46e-02	5.17e-02	1.72e-02	1.86e-03	2.17e-01	9.17e-01	5.68e-01	3.94e-01
GOMF PHOSPHOLIPASE A2 ACTIVITY	22	4.55e-01	5.60e-01	0.2570	-1.51e-01	-1.96e-01	8.00e-03	-1.34e-02	4.35e-02	5.13e-02	2.21e-01	1.11e-01	9.48e-01	9.14e-01	7.24e-01	6.77e-01
GOBP POSITIVE REGULATION OF GLIOGENESIS	53	3.35e-02	8.70e-02	0.2570	-1.33e-01	1.23e-01	1.26e-01	-2.30e-02	1.03e-01	7.72e-02	9.36e-02	1.21e-01	1.14e-01	7.72e-01	1.93e-01	3.31e-01
GOBP TESTOSTERONE BIOSYNTHETIC PROCESS	7	9.70e-01	9.75e-01	0.2570	6.69e-02	-5.97e-02	4.13e-02	1.66e-01	1.06e-01	1.31e-01	7.59e-01	7.85e-01	8.50e-01	4.46e-01	6.28e-01	5.47e-01
GOBP ESTABLISHMENT OF RNA LOCALIZATION	153	1.00e-06	1.05e-05	0.2570	-1.30e-01	-1.08e-01	-7.61e-02	1.71e-01	2.64e-03	4.69e-02	5.55e-03	2.11e-02	1.04e-01	2.60e-04	9.55e-01	3.17e-01
GOBP SKELETAL MUSCLE ADAPTATION	10	7.71e-01	8.16e-01	0.2560	3.21e-02	2.02e-01	1.24e-02	-3.20e-03	-1.06e-01	-1.13e-01	8.60e-01	2.69e-01	9.46e-01	9.86e-01	5.63e-01	5.38e-01
GOCC EARLY ENDOSOME MEMBRANE	172	8.44e-09	1.20e-07	0.2560	-1.82e-01	6.08e-02	6.80e-02	8.65e-02	2.39e-02	1.28e-01	3.84e-05	1.69e-01	1.24e-01	5.03e-02	5.89e-01	3.92e-03
GOBP REGULATION OF LEUKOCYTE CHEMOTAXIS	96	7.18e-03	2.64e-02	0.2560	-5.20e-02	-5.42e-03	2.05e-01	2.35e-02	-4.06e-02	1.37e-01	3.78e-01	9.27e-01	5.11e-04	6.91e-01	4.92e-01	2.07e-02
GOBP NEURON FATE COMMITMENT	26	1.20e-01	2.24e-01	0.2560	-1.29e-01	6.41e-02	1.83e-01	1.01e-01	2.38e-02	3.10e-02	2.56e-01	5.72e-01	1.07e-01	3.73e-01	8.34e-01	7.85e-01
GOBP MULTICELLULAR ORGANISM GROWTH	117	5.85e-04	3.21e-03	0.2560	-5.20e-02	8.41e-02	6.00e-02	1.65e-01	1.22e-01	1.01e-01	3.32e-01	1.16e-01	2.62e-01	2.07e-03	2.24e-02	5.97e-02
GOBP INTRINSIC APOPTOTIC SIGNALING PATHWAY IN RESPONSE TO OSMOTIC STRESS	8	9.71e-01	9.75e-01	0.2560	-2.25e-02	-3.34e-02	-1.79e-01	-1.13e-01	-2.73e-02	-1.36e-01	9.12e-01	8.70e-01	3.80e-01	5.81e-01	8.94e-01	5.05e-01
GOMF ACETYLTRANSFERASE ACTIVITY	85	3.53e-04	2.08e-03	0.2560	-1.12e-01	-8.60e-03	-1.11e-01	1.98e-01	3.58e-02	-1.32e-02	7.43e-02	8.91e-01	7.80e-02	1.58e-03	5.68e-01	8.34e-01
GOBP INFLAMMATORY RESPONSE TO ANTIGENIC STIMULUS	66	7.91e-02	1.65e-01	0.2560	-4.79e-02	9.08e-02	1.86e-01	1.45e-04	3.85e-02	1.37e-01	5.01e-01	2.02e-01	8.79e-03	9.98e-01	5.89e-01	5.40e-02
GOCC NEURON PROJECTION MEMBRANE	35	1.49e-01	2.59e-01	0.2560	1.14e-01	9.56e-02	1.66e-01	-8.02e-02	9.64e-02	6.71e-04	2.43e-01	3.28e-01	8.83e-02	4.12e-01	3.24e-01	9.95e-01
GOMF UBIQUITIN LIKE PROTEIN LIGASE BINDING	301	1.16e-11	2.30e-10	0.2560	-1.58e-01	-9.25e-02	3.70e-02	8.14e-02	-3.84e-02	1.50e-01	2.39e-06	5.78e-03	2.70e-01	1.52e-02	2.52e-01	7.41e-06
GOCC RUFFLE MEMBRANE	88	5.86e-04	3.21e-03	0.2560	-9.83e-03	3.44e-02	1.77e-01	1.72e-01	1.18e-02	5.53e-02	8.73e-01	5.77e-01	4.03e-03	5.25e-03	8.49e-01	3.70e-01
GOBP RESPONSE TO RETINOIC ACID	67	2.31e-03	1.04e-02	0.2560	-6.08e-02	1.33e-02	2.03e-01	1.24e-01	-1.85e-02	6.75e-02	3.90e-01	8.51e-01	4.01e-03	7.82e-02	7.94e-01	3.40e-01
GOBP RESPONSE TO OXIDATIVE STRESS	343	5.66e-10	9.44e-09	0.2560	-1.76e-01	-1.56e-01	-3.49e-03	6.95e-03	-7.81e-02	6.44e-02	2.22e-08	6.85e-07	9.12e-01	8.25e-01	1.30e-02	4.04e-02
GOBP GOLGI TO ENDOSOME TRANSPORT	17	6.56e-01	7.26e-01	0.2560	-1.15e-01	3.95e-03	6.20e-02	4.75e-02	-1.42e-01	1.62e-01	4.13e-01	9.78e-01	6.58e-01	7.34e-01	3.12e-01	2.48e-01
GOBP POSITIVE REGULATION OF CALCIUM ION TRANSPORT	83	3.95e-02	9.86e-02	0.2560	5.19e-02	6.02e-02	2.07e-01	3.93e-02	-1.01e-01	6.66e-02	4.14e-01	3.43e-01	1.09e-03	5.36e-01	1.12e-01	2.94e-01
GOCC TRANSFERASE COMPLEX TRANSFERRING PHOSPHORUS CONTAINING GROUPS	274	2.30e-11	4.44e-10	0.2560	-1.36e-01	-1.41e-01	-1.89e-02	1.27e-01	-4.76e-02	9.17e-02	1.13e-04	5.93e-05	5.90e-01	2.92e-04	1.75e-01	8.99e-03
GOCC ACROSOMAL MEMBRANE	18	7.71e-01	8.16e-01	0.2560	6.02e-02	1.30e-01	1.80e-01	1.07e-01	-2.27e-02	2.56e-02	6.58e-01	3.40e-01	1.86e-01	4.33e-01	8.67e-01	8.51e-01
GOBP ORGANIC HYDROXY COMPOUND BIOSYNTHETIC PROCESS	180	7.65e-07	8.15e-06	0.2560	-1.11e-01	-1.28e-01	1.11e-01	5.95e-02	-2.97e-02	1.40e-01	9.91e-03	2.96e-03	9.89e-03	1.69e-01	4.92e-01	1.18e-03
GOBP POSITIVE REGULATION OF LIPASE ACTIVITY	33	3.11e-01	4.31e-01	0.2560	2.87e-02	-9.85e-02	1.08e-01	1.12e-01	-1.64e-01	6.08e-02	7.76e-01	3.28e-01	2.82e-01	2.66e-01	1.03e-01	5.46e-01
GOBP SKIN EPIDERMIS DEVELOPMENT	76	7.43e-02	1.58e-01	0.2560	4.18e-02	4.79e-02	1.69e-01	1.17e-01	4.86e-02	1.29e-01	5.29e-01	4.71e-01	1.07e-02	7.74e-02	4.64e-01	5.23e-02
GOBP GLYCOSYLATION	210	6.07e-07	6.62e-06	0.2560	-1.94e-01	-9.97e-02	2.95e-02	2.09e-02	-7.82e-02	1.02e-01	1.23e-06	1.28e-02	4.61e-01	6.02e-01	5.09e-02	1.12e-02
GOBP THIAMINE CONTAINING COMPOUND METABOLIC PROCESS	7	9.66e-01	9.72e-01	0.2560	-1.37e-01	-6.20e-03	-1.54e-01	9.17e-02	1.20e-01	-9.21e-03	5.30e-01	9.77e-01	4.80e-01	6.74e-01	5.84e-01	9.66e-01
GOBP POSITIVE REGULATION OF MORPHOGENESIS OF AN EPITHELIUM	24	6.82e-01	7.47e-01	0.2560	1.18e-01	1.55e-01	1.39e-01	6.93e-03	8.58e-02	-3.13e-02	3.18e-01	1.90e-01	2.40e-01	9.53e-01	4.67e-01	7.91e-01
GOBP REGULATION OF NATURAL KILLER CELL ACTIVATION	36	6.63e-01	7.31e-01	0.2560	1.48e-01	1.47e-01	1.28e-01	5.33e-02	1.74e-02	4.80e-02	1.24e-01	1.28e-01	1.83e-01	5.80e-01	8.56e-01	6.18e-01
GOBP INTRACELLULAR IRON ION HOMEOSTASIS	64	9.58e-02	1.90e-01	0.2560	-1.42e-01	-1.71e-01	-8.85e-02	5.80e-02	-5.78e-02	-3.93e-02	5.01e-02	1.81e-02	2.21e-01	4.22e-01	4.24e-01	5.86e-01
GOCC HIPPOCAMPAL MOSSY FIBER TO CA3 SYNAPSE	23	6.74e-01	7.41e-01	0.2560	-2.02e-01	-8.33e-02	3.83e-02	-1.15e-01	-1.95e-02	4.80e-02	9.32e-02	4.89e-01	7.50e-01	3.38e-01	8.71e-01	6.90e-01
GOBP NEGATIVE REGULATION OF DNA REPAIR	39	1.22e-01	2.26e-01	0.2560	-4.40e-02	-8.62e-02	-6.64e-02	2.16e-01	2.79e-03	-6.94e-02	6.34e-01	3.52e-01	4.73e-01	1.95e-02	9.76e-01	4.53e-01
GOBP MESODERM DEVELOPMENT	83	6.06e-03	2.29e-02	0.2560	2.64e-02	2.85e-02	1.92e-01	1.38e-01	-5.88e-02	6.62e-02	6.78e-01	6.54e-01	2.51e-03	2.94e-02	3.54e-01	2.97e-01
GOBP ORGANIC HYDROXY COMPOUND TRANSPORT	183	1.54e-05	1.25e-04	0.2550	-1.19e-02	1.48e-02	2.12e-01	3.09e-02	-1.02e-01	9.14e-02	7.81e-01	7.30e-01	7.23e-07	4.70e-01	1.68e-02	3.30e-02
GOBP POSITIVE REGULATION OF ENDOCYTOSIS	124	6.59e-04	3.56e-03	0.2550	-5.60e-02	7.79e-02	1.84e-01	7.30e-02	-2.83e-03	1.29e-01	2.81e-01	1.34e-01	3.93e-04	1.60e-01	9.57e-01	1.29e-02
GOBP POSITIVE REGULATION OF MONOATOMIC ION TRANSPORT	149	3.43e-03	1.44e-02	0.2550	1.45e-02	3.96e-02	2.03e-01	-4.79e-02	-8.47e-02	1.13e-01	7.60e-01	4.04e-01	1.90e-05	3.13e-01	7.42e-02	1.74e-02
GOCC ADHERENS JUNCTION	148	2.64e-06	2.56e-05	0.2550	-1.20e-02	8.98e-02	2.24e-01	4.02e-02	-6.73e-02	2.20e-02	8.01e-01	5.94e-02	2.50e-06	3.99e-01	1.58e-01	6.44e-01
GOCC LATE ENDOSOME MEMBRANE	160	3.93e-06	3.67e-05	0.2550	-1.47e-01	-1.21e-01	3.86e-02	9.79e-02	-6.83e-03	1.33e-01	1.33e-03	8.37e-03	3.99e-01	3.26e-02	8.81e-01	3.66e-03
GOBP PHOTORECEPTOR CELL DEVELOPMENT	33	1.87e-01	3.03e-01	0.2550	-5.43e-02	1.89e-01	2.52e-02	-9.04e-02	-3.43e-02	-1.28e-01	5.89e-01	6.04e-02	8.02e-01	3.69e-01	7.33e-01	2.02e-01
GOBP POSITIVE REGULATION OF DOUBLE STRAND BREAK REPAIR	86	1.44e-03	6.96e-03	0.2550	-3.39e-02	-6.43e-02	-6.28e-02	2.36e-01	1.48e-02	1.63e-03	5.87e-01	3.03e-01	3.14e-01	1.59e-04	8.13e-01	9.79e-01
GOMF CHROMATIN BINDING	514	1.32e-23	7.21e-22	0.2550	-1.85e-02	1.45e-02	3.43e-02	2.40e-01	5.55e-02	4.97e-02	4.73e-01	5.74e-01	1.83e-01	1.13e-20	3.14e-02	5.37e-02
GOBP POSITIVE REGULATION OF LYMPHOCYTE APOPTOTIC PROCESS	15	6.46e-01	7.19e-01	0.2550	1.57e-01	-7.03e-02	-7.75e-02	1.44e-01	2.52e-03	9.35e-02	2.94e-01	6.37e-01	6.03e-01	3.35e-01	9.87e-01	5.31e-01
GOBP RESPONSE TO IRON ION	23	4.86e-01	5.86e-01	0.2550	-6.70e-02	-2.64e-02	5.58e-02	7.17e-03	-2.34e-01	4.34e-02	5.78e-01	8.27e-01	6.43e-01	9.53e-01	5.23e-02	7.18e-01
GOMF CYTOSKELETAL ANCHOR ACTIVITY	22	7.24e-01	7.81e-01	0.2550	-4.24e-02	-5.25e-02	1.82e-01	-2.15e-02	-4.79e-02	1.56e-01	7.31e-01	6.70e-01	1.40e-01	8.61e-01	6.97e-01	2.04e-01
GOBP ENDOCYTOSIS	584	3.99e-25	2.57e-23	0.2550	-8.29e-02	2.90e-02	1.74e-01	9.94e-02	-1.08e-02	1.30e-01	6.25e-04	2.31e-01	7.31e-13	4.09e-05	6.56e-01	7.71e-08
GOMF PHOSPHATIDYLINOSITOL 4 PHOSPHATE BINDING	27	4.81e-01	5.82e-01	0.2550	-1.38e-01	8.17e-02	1.48e-01	-7.52e-02	1.71e-02	1.05e-01	2.13e-01	4.63e-01	1.83e-01	4.99e-01	8.77e-01	3.43e-01
GOBP POSITIVE REGULATION OF G1 S TRANSITION OF MITOTIC CELL CYCLE	41	1.78e-01	2.92e-01	0.2550	-1.40e-01	-1.67e-01	4.23e-02	6.08e-02	-1.24e-02	1.08e-01	1.21e-01	6.42e-02	6.39e-01	5.00e-01	8.91e-01	2.32e-01
GOBP HUMORAL IMMUNE RESPONSE	164	1.71e-06	1.72e-05	0.2540	2.76e-02	-1.11e-01	1.80e-01	-1.68e-02	-1.36e-01	2.56e-02	5.43e-01	1.41e-02	7.28e-05	7.11e-01	2.67e-03	5.72e-01
GOCC NUCLEAR OUTER MEMBRANE	26	6.11e-01	6.91e-01	0.2540	1.07e-01	7.54e-02	1.02e-01	1.86e-01	4.15e-02	-2.81e-02	3.43e-01	5.06e-01	3.68e-01	1.01e-01	7.14e-01	8.04e-01
GOBP REGULATION OF INSULIN RECEPTOR SIGNALING PATHWAY	59	2.92e-03	1.27e-02	0.2540	-9.30e-02	1.76e-02	1.98e-01	1.13e-01	8.70e-04	6.10e-02	2.17e-01	8.15e-01	8.47e-03	1.34e-01	9.91e-01	4.18e-01
GOBP PERIPHERAL NERVOUS SYSTEM AXON ENSHEATHMENT	23	3.14e-01	4.34e-01	0.2540	4.17e-03	-9.84e-02	4.46e-02	2.17e-01	-5.73e-02	-4.93e-02	9.72e-01	4.14e-01	7.11e-01	7.12e-02	6.34e-01	6.83e-01
GOBP REGULATION OF TUMOR NECROSIS FACTOR MEDIATED SIGNALING PATHWAY	54	1.76e-02	5.34e-02	0.2540	-1.19e-01	1.34e-01	5.87e-02	1.19e-01	1.17e-01	3.32e-02	1.31e-01	8.87e-02	4.56e-01	1.29e-01	1.36e-01	6.73e-01
GOCC IMMUNOLOGICAL SYNAPSE	45	5.65e-02	1.29e-01	0.2540	2.02e-02	9.83e-02	2.20e-02	2.03e-01	-1.28e-02	1.13e-01	8.15e-01	2.54e-01	7.99e-01	1.86e-02	8.82e-01	1.89e-01
GOBP MAGNESIUM ION TRANSPORT	17	9.01e-01	9.18e-01	0.2540	1.23e-01	1.82e-01	8.21e-02	8.69e-02	3.20e-02	2.80e-02	3.79e-01	1.93e-01	5.58e-01	5.35e-01	8.19e-01	8.42e-01
GOCC ENDOSOME MEMBRANE	513	3.02e-26	2.21e-24	0.2540	-1.68e-01	-3.84e-02	8.82e-02	1.07e-01	-2.47e-02	1.23e-01	8.28e-11	1.37e-01	6.35e-04	3.29e-05	3.39e-01	1.83e-06
GOCC GOLGI TRANSPORT COMPLEX	10	9.34e-01	9.45e-01	0.2540	-8.56e-02	-1.21e-01	-1.32e-01	1.27e-01	8.82e-02	3.36e-02	6.39e-01	5.08e-01	4.69e-01	4.86e-01	6.29e-01	8.54e-01
GOBP REGULATION OF ACROSOME REACTION	7	8.60e-01	8.86e-01	0.2540	-1.01e-01	3.93e-02	-5.72e-02	2.10e-01	2.79e-03	-7.25e-02	6.43e-01	8.57e-01	7.93e-01	3.35e-01	9.90e-01	7.40e-01
GOMF OXIDOREDUCTASE ACTIVITY ACTING ON PAIRED DONORS WITH INCORPORATION OR REDUCTION OF MOLECULAR OXYGEN NAD P H AS ONE DONOR AND INCORPORATION OF ONE ATOM OF OXYGEN	22	7.56e-01	8.05e-01	0.2540	1.14e-01	1.25e-01	1.02e-01	2.32e-02	1.53e-01	3.97e-02	3.55e-01	3.11e-01	4.09e-01	8.50e-01	2.14e-01	7.47e-01
GOBP REGULATION OF EPITHELIAL CELL APOPTOTIC PROCESS	76	5.95e-02	1.34e-01	0.2540	-2.94e-02	7.62e-02	2.06e-01	1.45e-02	-5.41e-02	1.10e-01	6.57e-01	2.51e-01	1.87e-03	8.27e-01	4.14e-01	9.75e-02
GOBP POLYSACCHARIDE CATABOLIC PROCESS	25	2.35e-01	3.53e-01	0.2540	2.14e-02	1.22e-01	7.68e-02	1.86e-01	-8.68e-02	2.87e-02	8.53e-01	2.90e-01	5.06e-01	1.07e-01	4.53e-01	8.04e-01
GOBP NEGATIVE REGULATION OF HYDROLASE ACTIVITY	140	3.31e-05	2.51e-04	0.2540	-2.04e-01	-2.57e-02	6.27e-02	1.04e-02	-8.32e-02	1.05e-01	2.96e-05	6.00e-01	2.00e-01	8.32e-01	8.91e-02	3.25e-02
GOBP DETECTION OF STIMULUS	196	1.76e-05	1.41e-04	0.2540	-6.57e-04	1.16e-01	1.47e-01	-1.56e-01	-6.32e-02	3.31e-02	9.87e-01	5.17e-03	3.88e-04	1.71e-04	1.27e-01	4.24e-01
GOBP PRODUCTION OF MOLECULAR MEDIATOR OF IMMUNE RESPONSE	250	9.95e-09	1.40e-07	0.2540	-5.74e-02	-9.53e-02	7.71e-02	1.20e-01	-7.68e-02	1.60e-01	1.18e-01	9.44e-03	3.58e-02	1.07e-03	3.66e-02	1.27e-05
GOBP REGULATION OF RESPONSE TO OXIDATIVE STRESS	31	1.36e-01	2.43e-01	0.2540	-1.69e-01	-1.10e-01	7.73e-02	3.12e-02	8.81e-02	9.37e-02	1.02e-01	2.89e-01	4.57e-01	7.64e-01	3.96e-01	3.66e-01
GOBP POSITIVE REGULATION OF DEVELOPMENTAL GROWTH	114	1.76e-03	8.24e-03	0.2540	3.33e-02	1.75e-01	1.40e-01	1.05e-01	4.63e-02	4.30e-03	5.40e-01	1.28e-03	9.75e-03	5.38e-02	3.93e-01	9.37e-01
GOBP MODULATION OF PROCESS OF ANOTHER ORGANISM	12	6.35e-01	7.11e-01	0.2540	-1.60e-01	8.98e-02	5.86e-02	-1.57e-02	-1.43e-01	-8.02e-02	3.36e-01	5.90e-01	7.25e-01	9.25e-01	3.91e-01	6.31e-01
GOMF CYCLASE ACTIVITY	15	9.19e-01	9.32e-01	0.2540	-1.15e-01	-3.82e-02	1.28e-01	-9.49e-02	-1.42e-01	6.33e-02	4.41e-01	7.98e-01	3.90e-01	5.25e-01	3.41e-01	6.71e-01
GOBP DEVELOPMENTAL GROWTH INVOLVED IN MORPHOGENESIS	170	2.15e-06	2.13e-05	0.2530	6.77e-05	1.32e-01	1.71e-01	1.19e-01	4.60e-02	3.74e-02	9.99e-01	3.02e-03	1.25e-04	7.26e-03	3.01e-01	4.01e-01
GOBP REGULATION OF SYSTEM PROCESS	363	1.46e-12	3.20e-11	0.2530	-3.57e-02	2.51e-02	2.14e-01	3.73e-02	-2.91e-02	1.19e-01	2.43e-01	4.11e-01	2.36e-12	2.23e-01	3.42e-01	9.84e-05
GOMF TRANSCRIPTION REGULATOR ACTIVITY	1476	1.71e-51	5.85e-49	0.2530	-1.89e-02	9.68e-02	9.95e-03	1.86e-01	1.32e-01	4.78e-02	2.24e-01	5.18e-10	5.23e-01	7.10e-33	1.89e-17	2.17e-03
GOBP CELL CYCLE PHASE TRANSITION	484	1.83e-21	8.82e-20	0.2530	-6.20e-02	-1.14e-01	1.07e-02	1.86e-01	-1.68e-02	1.10e-01	1.96e-02	1.67e-05	6.87e-01	2.29e-12	5.28e-01	3.18e-05
GOBP REGULATION OF OLIGODENDROCYTE DIFFERENTIATION	28	6.76e-02	1.47e-01	0.2530	-1.06e-01	4.92e-02	2.21e-01	3.52e-02	-1.34e-02	-1.86e-02	3.30e-01	6.52e-01	4.34e-02	7.47e-01	9.02e-01	8.65e-01
GOBP POSITIVE REGULATION OF CELL SUBSTRATE ADHESION	95	5.49e-04	3.03e-03	0.2530	-6.27e-02	-1.12e-02	1.84e-01	1.14e-01	-7.08e-02	9.03e-02	2.91e-01	8.50e-01	1.89e-03	5.58e-02	2.33e-01	1.28e-01
GOBP ESTABLISHMENT OR MAINTENANCE OF CELL POLARITY	192	2.89e-06	2.78e-05	0.2530	-6.35e-02	4.69e-02	1.65e-01	5.34e-02	-1.12e-01	1.23e-01	1.29e-01	2.63e-01	7.88e-05	2.02e-01	7.56e-03	3.18e-03
GOCC VESICLE MEMBRANE	1064	1.27e-46	3.27e-44	0.2530	-1.52e-01	-5.46e-03	1.20e-01	6.82e-02	-4.27e-02	1.43e-01	6.70e-17	7.64e-01	4.64e-11	1.73e-04	1.87e-02	3.92e-15
GOBP VIRAL RNA GENOME REPLICATION	28	3.38e-01	4.56e-01	0.2530	5.58e-02	-6.23e-02	-1.17e-02	2.20e-01	-5.17e-02	7.63e-02	6.09e-01	5.68e-01	9.15e-01	4.38e-02	6.36e-01	4.85e-01
GOCC DENDRITE CYTOPLASM	23	8.10e-01	8.47e-01	0.2530	3.14e-02	1.04e-01	1.45e-01	-2.80e-02	-1.55e-02	1.74e-01	7.95e-01	3.88e-01	2.30e-01	8.16e-01	8.97e-01	1.48e-01
GOMF HELICASE ACTIVITY	146	3.57e-06	3.36e-05	0.2530	-5.67e-02	-4.34e-02	-5.16e-02	2.30e-01	5.52e-02	1.38e-02	2.37e-01	3.66e-01	2.82e-01	1.54e-06	2.50e-01	7.74e-01
GOBP ALTERNATIVE MRNA SPLICING VIA SPLICEOSOME	65	7.10e-02	1.53e-01	0.2530	-1.58e-01	-9.16e-02	-4.88e-03	-1.14e-03	-1.54e-01	8.40e-02	2.75e-02	2.02e-01	9.46e-01	9.87e-01	3.21e-02	2.41e-01
GOBP AUTOPHAGOSOME ORGANIZATION	118	1.09e-05	9.10e-05	0.2530	-2.37e-01	-3.58e-02	-2.02e-02	5.65e-02	-3.98e-02	3.70e-02	8.61e-06	5.02e-01	7.05e-01	2.89e-01	4.55e-01	4.87e-01
GOBP NEGATIVE REGULATION OF MONONUCLEAR CELL MIGRATION	28	5.21e-01	6.14e-01	0.2530	4.33e-02	-1.63e-02	1.16e-01	-2.71e-03	-2.17e-01	3.74e-02	6.92e-01	8.81e-01	2.86e-01	9.80e-01	4.73e-02	7.32e-01
GOBP CELLULAR RESPONSE TO VITAMIN	21	2.79e-01	3.99e-01	0.2530	-1.49e-01	8.09e-02	7.68e-02	-8.95e-02	1.32e-01	-6.13e-02	2.36e-01	5.21e-01	5.42e-01	4.78e-01	2.94e-01	6.27e-01
GOBP SULFUR COMPOUND BIOSYNTHETIC PROCESS	139	6.34e-05	4.52e-04	0.2530	-1.49e-01	-1.34e-01	2.07e-02	9.15e-02	-2.71e-02	1.20e-01	2.42e-03	6.53e-03	6.74e-01	6.25e-02	5.81e-01	1.47e-02
GOBP RUFFLE ASSEMBLY	40	2.76e-02	7.54e-02	0.2530	-7.24e-02	-1.38e-01	-1.05e-03	1.40e-01	4.10e-02	-1.36e-01	4.28e-01	1.32e-01	9.91e-01	1.26e-01	6.53e-01	1.36e-01
GOBP NEUROTRANSMITTER SECRETION	108	6.36e-04	3.45e-03	0.2530	-1.19e-01	6.82e-02	1.46e-01	1.45e-02	7.29e-02	1.36e-01	3.33e-02	2.21e-01	8.85e-03	7.95e-01	1.90e-01	1.49e-02
GOBP REGULATION OF CELL SUBSTRATE ADHESION	172	1.86e-06	1.87e-05	0.2530	-6.20e-02	2.52e-02	2.09e-01	3.88e-02	-8.76e-02	8.16e-02	1.61e-01	5.68e-01	2.34e-06	3.80e-01	4.76e-02	6.49e-02
GOBP ASSOCIATIVE LEARNING	61	3.76e-02	9.52e-02	0.2530	-6.75e-02	8.28e-02	1.59e-01	1.06e-01	5.68e-02	1.12e-01	3.62e-01	2.64e-01	3.16e-02	1.51e-01	4.43e-01	1.29e-01
GOMF MITOGEN ACTIVATED PROTEIN KINASE BINDING	29	2.74e-02	7.51e-02	0.2530	-1.52e-01	8.57e-02	1.26e-01	8.80e-02	4.83e-02	-8.62e-02	1.57e-01	4.25e-01	2.39e-01	4.12e-01	6.53e-01	4.22e-01
GOBP PHOSPHATIDYLCHOLINE METABOLIC PROCESS	59	5.91e-03	2.24e-02	0.2530	-1.51e-01	2.84e-02	9.08e-02	9.17e-02	1.32e-01	7.83e-02	4.49e-02	7.06e-01	2.28e-01	2.23e-01	7.98e-02	2.98e-01
GOBP PROTEOGLYCAN METABOLIC PROCESS	65	1.14e-03	5.67e-03	0.2520	-1.70e-01	-4.00e-02	-1.65e-02	9.11e-02	-1.56e-01	-1.34e-02	1.77e-02	5.77e-01	8.18e-01	2.04e-01	2.92e-02	8.51e-01
GOMF LAMIN BINDING	14	7.03e-01	7.64e-01	0.2520	-1.92e-01	5.73e-02	1.38e-02	5.84e-02	1.18e-01	7.61e-02	2.12e-01	7.10e-01	9.29e-01	7.05e-01	4.43e-01	6.22e-01
GOBP TRANSPOSITION	26	5.07e-01	6.03e-01	0.2520	-2.12e-04	-4.36e-02	2.56e-02	1.06e-01	1.24e-01	1.86e-01	9.99e-01	7.01e-01	8.21e-01	3.49e-01	2.74e-01	1.01e-01
GOMF LOW DENSITY LIPOPROTEIN PARTICLE BINDING	14	2.68e-01	3.88e-01	0.2520	-5.99e-02	-2.77e-03	2.17e-01	-5.61e-02	9.10e-02	-4.15e-02	6.98e-01	9.86e-01	1.60e-01	7.16e-01	5.56e-01	7.88e-01
GOBP REGULATION OF SIGNAL TRANSDUCTION BY P53 CLASS MEDIATOR	99	9.86e-03	3.39e-02	0.2520	-1.55e-01	-1.43e-01	-1.12e-01	6.11e-02	5.50e-02	5.63e-03	7.86e-03	1.39e-02	5.40e-02	2.94e-01	3.44e-01	9.23e-01
GOBP IMMUNE EFFECTOR PROCESS	592	1.52e-18	5.59e-17	0.2520	6.97e-03	2.31e-02	1.37e-01	1.42e-01	-3.59e-02	1.52e-01	7.72e-01	3.37e-01	1.32e-08	3.94e-09	1.36e-01	2.78e-10
GOBP INTRACELLULAR TRANSPORT	1243	5.54e-56	2.44e-53	0.2520	-1.73e-01	-9.23e-02	1.91e-02	1.01e-01	-3.15e-02	1.17e-01	1.19e-24	4.47e-08	2.57e-01	2.49e-09	6.18e-02	3.66e-12
GOBP POSITIVE REGULATION OF NEURON APOPTOTIC PROCESS	50	1.77e-02	5.36e-02	0.2520	-1.78e-01	-3.81e-03	1.34e-01	7.69e-02	2.09e-03	9.00e-02	2.97e-02	9.63e-01	1.01e-01	3.47e-01	9.80e-01	2.71e-01
GOBP DEVELOPMENTAL PIGMENTATION	32	3.50e-01	4.66e-01	0.2520	-2.11e-01	1.62e-02	3.15e-02	-2.93e-02	1.91e-02	1.29e-01	3.92e-02	8.74e-01	7.58e-01	7.75e-01	8.52e-01	2.05e-01
GOBP RESPIRATORY BURST	35	3.39e-01	4.56e-01	0.2520	-7.94e-02	-5.71e-02	1.82e-01	-5.84e-02	-3.86e-02	1.26e-01	4.17e-01	5.59e-01	6.20e-02	5.50e-01	6.93e-01	1.96e-01
GOBP NUCLEOBASE CONTAINING COMPOUND TRANSPORT	212	2.52e-07	2.89e-06	0.2520	-1.45e-01	-1.50e-01	-8.88e-02	1.04e-01	-3.43e-02	1.74e-03	2.65e-04	1.66e-04	2.59e-02	8.85e-03	3.89e-01	9.65e-01
GOBP CELLULAR RESPONSE TO FLUID SHEAR STRESS	15	4.06e-01	5.18e-01	0.2520	-1.35e-01	-1.07e-01	1.33e-01	-2.80e-02	-7.01e-02	-1.01e-01	3.64e-01	4.71e-01	3.71e-01	8.51e-01	6.38e-01	4.99e-01
GOCC COLLAGEN TRIMER	45	4.79e-02	1.14e-01	0.2520	-4.85e-02	5.96e-02	2.21e-01	-3.69e-02	5.52e-02	6.67e-02	5.74e-01	4.89e-01	1.04e-02	6.68e-01	5.22e-01	4.39e-01
GOBP REGULATION OF DOUBLE STRAND BREAK REPAIR VIA HOMOLOGOUS RECOMBINATION	79	1.78e-03	8.30e-03	0.2520	-7.33e-02	-7.88e-02	-4.71e-02	2.23e-01	7.17e-03	3.67e-03	2.60e-01	2.26e-01	4.69e-01	6.23e-04	9.12e-01	9.55e-01
GOBP BIOLOGICAL PROCESS INVOLVED IN INTERACTION WITH HOST	166	4.11e-07	4.58e-06	0.2520	-1.22e-01	-9.74e-02	9.28e-02	1.24e-01	-3.09e-02	1.18e-01	6.61e-03	3.03e-02	3.91e-02	5.79e-03	4.93e-01	8.49e-03
GOBP NEGATIVE REGULATION OF LEUKOCYTE CHEMOTAXIS	19	7.04e-01	7.65e-01	0.2520	7.27e-02	8.87e-02	8.82e-02	-1.15e-01	-1.70e-01	1.57e-02	5.83e-01	5.03e-01	5.05e-01	3.85e-01	1.99e-01	9.06e-01
GOBP HYDROGEN PEROXIDE METABOLIC PROCESS	44	2.07e-01	3.24e-01	0.2520	6.36e-02	-1.29e-01	1.18e-01	5.96e-02	-7.01e-02	1.43e-01	4.66e-01	1.40e-01	1.76e-01	4.94e-01	4.21e-01	1.02e-01
GOBP REGULATION OF NEURON MIGRATION	32	2.03e-01	3.19e-01	0.2520	-2.48e-02	1.45e-01	1.33e-01	1.53e-01	6.33e-03	2.41e-02	8.08e-01	1.56e-01	1.93e-01	1.34e-01	9.51e-01	8.13e-01
GOBP GLIAL CELL ACTIVATION	45	3.18e-02	8.34e-02	0.2520	-1.43e-01	1.02e-01	1.54e-01	-7.80e-02	5.12e-02	5.18e-03	9.61e-02	2.35e-01	7.48e-02	3.66e-01	5.52e-01	9.52e-01
GOBP STEM CELL DEVELOPMENT	52	6.89e-03	2.55e-02	0.2520	-1.36e-01	1.04e-01	1.71e-01	-2.14e-02	-5.49e-02	-3.34e-02	8.99e-02	1.93e-01	3.26e-02	7.89e-01	4.93e-01	6.77e-01
GOBP PHOSPHOLIPID DEPHOSPHORYLATION	39	2.20e-01	3.39e-01	0.2510	-4.10e-02	1.78e-01	1.31e-01	5.60e-02	-2.58e-02	9.50e-02	6.58e-01	5.50e-02	1.56e-01	5.45e-01	7.80e-01	3.05e-01
GOBP LENS DEVELOPMENT IN CAMERA TYPE EYE	56	5.19e-02	1.20e-01	0.2510	-5.01e-02	1.80e-01	1.44e-01	6.47e-02	2.46e-02	5.17e-02	5.17e-01	1.96e-02	6.24e-02	4.02e-01	7.50e-01	5.04e-01
GOBP NEGATIVE REGULATION OF T CELL MEDIATED IMMUNE RESPONSE TO TUMOR CELL	5	9.58e-01	9.65e-01	0.2510	1.80e-02	2.14e-01	-8.07e-02	-9.48e-02	3.37e-02	-1.87e-02	9.45e-01	4.07e-01	7.55e-01	7.14e-01	8.96e-01	9.42e-01
GOBP POSITIVE REGULATION OF NATURAL KILLER CELL ACTIVATION	19	8.58e-01	8.84e-01	0.2510	-7.48e-02	-4.99e-02	-1.61e-01	3.02e-02	1.42e-01	-8.99e-02	5.72e-01	7.07e-01	2.25e-01	8.20e-01	2.83e-01	4.98e-01
GOBP REGULATION OF STEM CELL DIFFERENTIATION	67	9.84e-02	1.94e-01	0.2510	4.52e-02	9.38e-02	1.09e-01	1.81e-01	3.50e-02	8.06e-02	5.23e-01	1.84e-01	1.24e-01	1.03e-02	6.20e-01	2.54e-01
GOBP UNSATURATED FATTY ACID BIOSYNTHETIC PROCESS	40	2.37e-02	6.72e-02	0.2510	-1.04e-01	-7.85e-02	1.50e-01	-1.03e-02	1.08e-01	1.09e-01	2.55e-01	3.90e-01	1.00e-01	9.10e-01	2.39e-01	2.32e-01
GOBP IMMUNE RESPONSE REGULATING CELL SURFACE RECEPTOR SIGNALING PATHWAY	327	1.31e-09	2.06e-08	0.2510	1.20e-02	1.50e-01	9.13e-02	1.26e-01	4.62e-02	1.19e-01	7.10e-01	3.24e-06	4.57e-03	8.82e-05	1.51e-01	2.13e-04
GOBP ION CHANNEL MODULATING G PROTEIN COUPLED RECEPTOR SIGNALING PATHWAY	8	9.50e-01	9.59e-01	0.2510	6.98e-02	1.02e-01	-5.98e-03	2.01e-03	2.73e-02	-2.17e-01	7.33e-01	6.16e-01	9.77e-01	9.92e-01	8.94e-01	2.89e-01
GOBP CENTROSOME DUPLICATION	71	2.76e-02	7.54e-02	0.2510	-8.90e-02	-2.83e-02	-1.39e-01	4.72e-02	1.68e-01	6.60e-02	1.95e-01	6.80e-01	4.24e-02	4.92e-01	1.41e-02	3.36e-01
GOBP ORGANELLE LOCALIZATION	532	5.55e-19	2.13e-17	0.2510	-1.02e-01	-8.06e-02	7.59e-02	8.84e-02	-8.29e-02	1.60e-01	5.77e-05	1.48e-03	2.74e-03	4.89e-04	1.08e-03	2.51e-10
GOBP REGULATION OF CENTRIOLE REPLICATION	22	5.12e-01	6.07e-01	0.2510	2.87e-02	7.37e-02	-1.57e-01	2.27e-02	1.72e-01	4.47e-02	8.16e-01	5.50e-01	2.03e-01	8.54e-01	1.62e-01	7.17e-01
GOBP NEGATIVE REGULATION OF HORMONE SECRETION	49	1.34e-02	4.36e-02	0.2510	-7.97e-02	6.18e-02	1.58e-01	-1.57e-01	4.20e-02	-3.99e-02	3.35e-01	4.54e-01	5.64e-02	5.72e-02	6.11e-01	6.29e-01
GOBP MONONUCLEAR CELL MIGRATION	178	4.02e-05	2.99e-04	0.2510	-4.73e-02	-5.75e-03	1.82e-01	6.35e-02	-6.53e-02	1.39e-01	2.76e-01	8.95e-01	2.78e-05	1.44e-01	1.33e-01	1.41e-03
GOBP POSITIVE REGULATION OF BLOOD VESSEL ENDOTHELIAL CELL MIGRATION	47	1.77e-03	8.28e-03	0.2510	-2.08e-01	-5.58e-02	1.19e-01	2.40e-02	2.30e-02	-3.62e-02	1.37e-02	5.08e-01	1.57e-01	7.76e-01	7.85e-01	6.67e-01
GOBP BIOLOGICAL PROCESS INVOLVED IN INTERACTION WITH SYMBIONT	97	7.12e-04	3.80e-03	0.2510	-9.91e-02	-9.91e-02	1.51e-01	7.40e-02	-8.82e-02	8.59e-02	9.18e-02	9.18e-02	1.04e-02	2.08e-01	1.33e-01	1.44e-01
GOBP MITOTIC CELL CYCLE	810	1.98e-33	2.45e-31	0.2510	-6.41e-02	-1.19e-01	4.82e-02	1.54e-01	-1.93e-02	1.35e-01	1.93e-03	9.39e-09	1.99e-02	8.51e-14	3.50e-01	6.60e-11
GOBP REGULATION OF MITOCHONDRION ORGANIZATION	139	2.54e-04	1.55e-03	0.2510	-1.07e-01	-1.99e-01	-6.75e-02	6.30e-02	-1.42e-02	-5.44e-02	2.87e-02	5.04e-05	1.70e-01	2.00e-01	7.73e-01	2.69e-01
GOBP GANGLIOSIDE METABOLIC PROCESS	21	4.90e-01	5.89e-01	0.2510	-1.78e-01	-6.45e-02	1.17e-01	5.15e-02	-1.83e-02	1.03e-01	1.59e-01	6.09e-01	3.54e-01	6.83e-01	8.85e-01	4.15e-01
GOBP NEGATIVE REGULATION OF SECRETION	124	4.35e-04	2.50e-03	0.2510	-9.70e-02	3.00e-02	1.92e-01	-1.43e-02	-4.74e-03	1.25e-01	6.22e-02	5.64e-01	2.28e-04	7.84e-01	9.27e-01	1.63e-02
GOBP MACROPHAGE ACTIVATION	91	3.13e-03	1.34e-02	0.2500	-4.39e-02	1.05e-01	1.79e-01	1.00e-01	3.03e-02	8.37e-02	4.69e-01	8.49e-02	3.25e-03	9.78e-02	6.18e-01	1.68e-01
GOCC NUCLEAR UBIQUITIN LIGASE COMPLEX	45	2.36e-01	3.54e-01	0.2500	-9.71e-02	-1.86e-01	-9.76e-02	7.99e-02	4.99e-02	-1.06e-02	2.60e-01	3.04e-02	2.57e-01	3.54e-01	5.62e-01	9.02e-01
GOBP DEVELOPMENTAL MATURATION	229	2.56e-08	3.42e-07	0.2500	-9.00e-02	-3.50e-02	1.65e-01	6.74e-02	-8.96e-02	1.16e-01	1.90e-02	3.62e-01	1.62e-05	7.89e-02	1.95e-02	2.51e-03
GOBP CELLULAR RESPONSE TO ACIDIC PH	10	7.54e-01	8.04e-01	0.2500	-1.37e-01	-8.91e-02	1.64e-01	3.58e-02	-8.82e-02	8.09e-04	4.53e-01	6.26e-01	3.69e-01	8.45e-01	6.29e-01	9.96e-01
GOBP REGULATION OF ESTABLISHMENT OF PLANAR POLARITY	10	7.26e-01	7.81e-01	0.2500	-1.52e-01	4.46e-02	3.21e-02	1.28e-01	1.32e-01	-5.11e-02	4.06e-01	8.07e-01	8.61e-01	4.82e-01	4.69e-01	7.80e-01
GOBP RUFFLE ORGANIZATION	51	3.94e-03	1.61e-02	0.2500	-6.06e-02	-1.10e-01	2.01e-02	1.63e-01	4.86e-02	-1.32e-01	4.54e-01	1.74e-01	8.04e-01	4.37e-02	5.48e-01	1.03e-01
GOBP OLIGOSACCHARIDE BIOSYNTHETIC PROCESS	21	7.26e-01	7.81e-01	0.2500	-5.27e-02	1.89e-02	1.97e-01	2.59e-02	-1.49e-02	1.40e-01	6.76e-01	8.81e-01	1.18e-01	8.37e-01	9.06e-01	2.65e-01
GOBP ENDOTHELIUM DEVELOPMENT	106	3.33e-05	2.52e-04	0.2500	-1.62e-01	4.39e-02	1.70e-01	1.26e-02	-1.67e-03	7.31e-02	3.93e-03	4.35e-01	2.51e-03	8.23e-01	9.76e-01	1.93e-01
GOBP MITOTIC CELL CYCLE PHASE TRANSITION	397	4.57e-16	1.36e-14	0.2500	-7.29e-02	-1.44e-01	3.61e-03	1.53e-01	-4.38e-02	1.05e-01	1.27e-02	8.32e-07	9.02e-01	1.60e-07	1.34e-01	3.35e-04
GOMF PROTEIN RNA ADAPTOR ACTIVITY	20	7.27e-01	7.82e-01	0.2500	-1.94e-01	-8.89e-02	1.83e-02	1.31e-03	-1.17e-01	5.39e-02	1.33e-01	4.91e-01	8.87e-01	9.92e-01	3.65e-01	6.77e-01
GOBP MRNA METABOLIC PROCESS	674	3.32e-24	1.96e-22	0.2500	-1.16e-01	-1.42e-01	-1.15e-01	1.24e-01	6.24e-03	1.87e-02	2.70e-07	3.73e-10	3.62e-07	4.26e-08	7.83e-01	4.09e-01
GOCC PERINUCLEAR REGION OF CYTOPLASM	616	3.80e-26	2.73e-24	0.2500	-8.42e-02	9.71e-04	1.31e-01	1.35e-01	-1.94e-02	1.40e-01	3.61e-04	9.67e-01	2.90e-08	9.97e-09	4.10e-01	3.17e-09
GOBP REGULATION OF MYELOID CELL DIFFERENTIATION	168	1.47e-05	1.19e-04	0.2500	-9.29e-02	2.88e-02	1.70e-01	5.23e-02	-7.55e-02	1.25e-01	3.77e-02	5.20e-01	1.46e-04	2.42e-01	9.15e-02	5.12e-03
GOBP AUTOPHAGY OF MITOCHONDRION	100	9.10e-03	3.18e-02	0.2500	-1.07e-01	-1.13e-01	-1.46e-01	1.20e-01	3.57e-02	-3.56e-02	6.54e-02	5.15e-02	1.16e-02	3.79e-02	5.37e-01	5.39e-01
GOBP POSITIVE REGULATION OF DNA BIOSYNTHETIC PROCESS	63	7.68e-02	1.62e-01	0.2500	-1.22e-01	-1.54e-01	-1.01e-01	7.35e-02	5.56e-02	7.23e-02	9.37e-02	3.49e-02	1.67e-01	3.13e-01	4.45e-01	3.21e-01
GOBP RESPONSE TO ZINC ION	31	7.57e-02	1.60e-01	0.2500	2.51e-02	-1.95e-02	1.77e-01	7.33e-03	1.52e-01	8.29e-02	8.09e-01	8.51e-01	8.84e-02	9.44e-01	1.42e-01	4.25e-01
GOBP MAINTENANCE OF ORGANELLE LOCATION	12	6.97e-01	7.59e-01	0.2500	5.87e-02	-2.74e-02	-4.59e-02	1.51e-01	-5.25e-02	1.75e-01	7.25e-01	8.69e-01	7.83e-01	3.66e-01	7.53e-01	2.94e-01
GOBP REGULATION OF DNA TEMPLATED TRANSCRIPTION INITIATION	76	8.53e-03	3.03e-02	0.2500	-1.21e-01	-8.65e-02	-9.76e-02	1.70e-01	4.07e-02	-6.00e-03	6.82e-02	1.92e-01	1.41e-01	1.03e-02	5.39e-01	9.28e-01
GOBP DNA MODIFICATION	39	1.70e-01	2.83e-01	0.2500	1.91e-01	5.25e-05	-6.49e-02	1.36e-01	-4.60e-02	-3.25e-02	3.93e-02	1.00e+00	4.83e-01	1.41e-01	6.19e-01	7.25e-01
GOBP INTERLEUKIN 12 MEDIATED SIGNALING PATHWAY	8	8.75e-01	8.98e-01	0.2500	-2.22e-01	6.60e-02	-4.59e-02	2.60e-02	-5.95e-04	7.67e-02	2.77e-01	7.46e-01	8.22e-01	8.99e-01	9.98e-01	7.07e-01
GOBP REGULATION OF MUSCLE CONTRACTION	114	1.77e-03	8.28e-03	0.2490	-4.04e-02	-4.49e-03	2.08e-01	-8.36e-02	-7.57e-02	6.85e-02	4.56e-01	9.34e-01	1.28e-04	1.23e-01	1.63e-01	2.07e-01
GOMF NADPLUS PROTEIN ADP RIBOSYLTRANSFERASE ACTIVITY	24	1.61e-01	2.73e-01	0.2490	-3.77e-02	-3.15e-03	-3.59e-02	9.63e-02	-1.41e-01	1.74e-01	7.49e-01	9.79e-01	7.61e-01	4.14e-01	2.33e-01	1.39e-01
GOBP REGULATION OF BIOLOGICAL PROCESS INVOLVED IN SYMBIOTIC INTERACTION	46	5.33e-02	1.23e-01	0.2490	-7.67e-02	-1.22e-01	6.66e-02	1.71e-01	-7.05e-02	5.25e-02	3.68e-01	1.53e-01	4.35e-01	4.48e-02	4.08e-01	5.38e-01
GOBP STRESS FIBER ASSEMBLY	94	4.78e-04	2.71e-03	0.2490	-8.98e-02	3.20e-02	1.26e-01	1.56e-01	4.83e-02	1.02e-01	1.33e-01	5.92e-01	3.48e-02	8.92e-03	4.18e-01	8.75e-02
GOBP NUCLEOTIDE SUGAR METABOLIC PROCESS	38	2.34e-01	3.52e-01	0.2490	-1.13e-01	-1.46e-01	-6.04e-02	1.00e-01	-1.19e-01	-1.35e-02	2.27e-01	1.19e-01	5.19e-01	2.86e-01	2.06e-01	8.86e-01
GOBP MUSCLE CELL DEVELOPMENT	129	1.89e-03	8.73e-03	0.2490	-5.09e-03	4.23e-02	1.66e-01	1.68e-02	-1.60e-01	8.29e-02	9.21e-01	4.06e-01	1.14e-03	7.42e-01	1.72e-03	1.04e-01
GOBP MUSCLE ADAPTATION	78	5.03e-03	1.97e-02	0.2490	1.64e-02	1.53e-02	2.10e-01	8.23e-02	-1.01e-01	2.48e-02	8.02e-01	8.16e-01	1.36e-03	2.09e-01	1.25e-01	7.05e-01
GOBP REGULATION OF CATION CHANNEL ACTIVITY	69	2.12e-01	3.29e-01	0.2490	-1.04e-02	4.48e-02	1.78e-01	-8.33e-02	-6.87e-02	1.28e-01	8.81e-01	5.20e-01	1.04e-02	2.32e-01	3.23e-01	6.60e-02
GOBP POSITIVE REGULATION OF CELL JUNCTION ASSEMBLY	66	7.27e-02	1.55e-01	0.2490	7.89e-03	1.87e-01	1.62e-01	5.77e-03	2.10e-02	1.91e-02	9.12e-01	8.61e-03	2.33e-02	9.35e-01	7.68e-01	7.88e-01
GOBP VESICLE MEDIATED TRANSPORT	1319	8.99e-56	3.79e-53	0.2490	-1.16e-01	-7.74e-03	1.17e-01	1.10e-01	-8.36e-03	1.50e-01	1.31e-12	6.37e-01	1.19e-12	2.02e-11	6.11e-01	6.05e-20
GOMF TRANSCRIPTION REGULATOR INHIBITOR ACTIVITY	24	8.52e-01	8.80e-01	0.2490	1.38e-01	9.53e-02	1.19e-01	1.00e-01	8.57e-02	4.61e-02	2.41e-01	4.19e-01	3.12e-01	3.96e-01	4.67e-01	6.96e-01
GOCC EARLY ENDOSOME	384	1.93e-17	6.42e-16	0.2490	-1.44e-01	-1.26e-02	1.17e-01	9.25e-02	-5.61e-02	1.25e-01	1.22e-06	6.72e-01	8.69e-05	1.87e-03	5.93e-02	2.67e-05
GOBP LINOLEIC ACID METABOLIC PROCESS	13	5.87e-01	6.70e-01	0.2490	-1.31e-01	1.39e-02	5.47e-02	3.84e-04	2.04e-01	8.45e-04	4.13e-01	9.31e-01	7.33e-01	9.98e-01	2.04e-01	9.96e-01
GOBP TISSUE REMODELING	123	4.80e-06	4.37e-05	0.2490	-1.06e-01	8.66e-02	1.86e-01	6.76e-02	-2.29e-02	5.97e-02	4.20e-02	9.74e-02	3.79e-04	1.95e-01	6.61e-01	2.53e-01
GOBP POSITIVE REGULATION OF SPROUTING ANGIOGENESIS	18	6.58e-01	7.28e-01	0.2490	-1.05e-01	1.26e-01	1.69e-01	-2.37e-02	-6.18e-02	4.45e-02	4.42e-01	3.55e-01	2.14e-01	8.62e-01	6.50e-01	7.44e-01
GOCC MRNA CLEAVAGE AND POLYADENYLATION SPECIFICITY FACTOR COMPLEX	17	5.47e-01	6.37e-01	0.2490	-6.14e-02	-8.99e-02	-2.06e-02	1.70e-01	-1.33e-01	5.45e-02	6.61e-01	5.21e-01	8.83e-01	2.25e-01	3.43e-01	6.97e-01
GOBP ACTIN POLYMERIZATION OR DEPOLYMERIZATION	176	6.80e-07	7.36e-06	0.2490	-1.12e-01	-2.15e-02	1.73e-01	5.26e-02	-2.14e-02	1.25e-01	1.04e-02	6.22e-01	7.75e-05	2.29e-01	6.25e-01	4.11e-03
GOBP POSITIVE REGULATION OF MITOTIC CELL CYCLE	112	5.56e-04	3.06e-03	0.2490	-1.07e-01	-1.68e-01	2.30e-02	1.12e-01	-1.93e-02	9.37e-02	5.08e-02	2.13e-03	6.74e-01	4.14e-02	7.25e-01	8.66e-02
GOMF IMMUNE RECEPTOR ACTIVITY	124	2.17e-02	6.30e-02	0.2480	1.79e-02	1.06e-01	1.66e-01	5.12e-02	-6.59e-03	1.42e-01	7.31e-01	4.20e-02	1.46e-03	3.24e-01	8.99e-01	6.31e-03
GOMF EXTRACELLULAR MATRIX STRUCTURAL CONSTITUENT CONFERRING TENSILE STRENGTH	26	7.00e-01	7.61e-01	0.2480	1.94e-02	1.91e-01	1.44e-01	-2.08e-03	7.98e-04	6.55e-02	8.64e-01	9.20e-02	2.05e-01	9.85e-01	9.94e-01	5.63e-01
GOMF TRANSCRIPTION COREGULATOR ACTIVITY	456	6.30e-20	2.65e-18	0.2480	-3.44e-03	3.05e-02	1.56e-02	2.40e-01	4.24e-02	3.13e-02	9.00e-01	2.64e-01	5.69e-01	1.38e-18	1.21e-01	2.52e-01
GOBP NEGATIVE REGULATION OF PROTEIN SERINE THREONINE KINASE ACTIVITY	73	2.94e-02	7.89e-02	0.2480	1.02e-03	-1.12e-02	2.13e-01	6.04e-02	-3.62e-02	1.07e-01	9.88e-01	8.68e-01	1.69e-03	3.72e-01	5.93e-01	1.14e-01
GOMF TROPOMYOSIN BINDING	12	9.22e-01	9.35e-01	0.2480	-3.40e-02	-1.12e-01	-1.94e-01	-7.25e-02	3.83e-02	-5.75e-02	8.39e-01	5.00e-01	2.43e-01	6.63e-01	8.18e-01	7.30e-01
GOBP REGULATION OF ERYTHROCYTE DIFFERENTIATION	43	9.91e-02	1.94e-01	0.2480	-1.16e-01	1.81e-02	1.52e-01	7.55e-02	-1.05e-01	8.96e-02	1.89e-01	8.37e-01	8.45e-02	3.92e-01	2.32e-01	3.09e-01
GOBP NEGATIVE REGULATION OF CELL SUBSTRATE ADHESION	48	1.36e-01	2.44e-01	0.2480	-3.43e-02	4.10e-02	1.90e-01	-8.17e-02	-1.26e-01	-1.64e-02	6.81e-01	6.23e-01	2.30e-02	3.28e-01	1.31e-01	8.45e-01
GOMF PHOSPHATE TRANSMEMBRANE TRANSPORTER ACTIVITY	14	7.38e-01	7.90e-01	0.2480	-3.28e-02	4.93e-02	-3.64e-02	3.11e-02	7.71e-03	-2.36e-01	8.32e-01	7.49e-01	8.14e-01	8.40e-01	9.60e-01	1.26e-01
GOBP CELL PROJECTION MORPHOGENESIS	475	8.31e-18	2.87e-16	0.2480	-4.97e-02	1.42e-01	1.59e-01	7.49e-02	3.17e-02	8.30e-02	6.36e-02	1.06e-07	2.76e-09	5.17e-03	2.37e-01	1.96e-03
GOBP REGULATORY NCRNA PROCESSING	57	1.75e-02	5.32e-02	0.2480	-1.43e-01	5.79e-02	2.37e-02	4.37e-02	-5.64e-02	1.79e-01	6.21e-02	4.49e-01	7.57e-01	5.68e-01	4.62e-01	1.92e-02
GOBP PHOSPHATIDIC ACID METABOLIC PROCESS	30	1.28e-01	2.33e-01	0.2480	-2.39e-01	5.30e-02	-1.08e-02	4.08e-02	4.10e-03	-7.97e-03	2.37e-02	6.15e-01	9.18e-01	6.99e-01	9.69e-01	9.40e-01
GOBP PROTEIN TRANSPORT	1227	3.71e-52	1.32e-49	0.2480	-1.85e-01	-8.62e-02	3.16e-02	7.40e-02	-2.29e-02	1.13e-01	9.00e-28	3.89e-07	6.25e-02	1.33e-05	1.77e-01	2.58e-11
GOMF TRANSMEMBRANE RECEPTOR PROTEIN SERINE THREONINE KINASE BINDING	13	7.54e-01	8.04e-01	0.2480	-1.36e-01	9.33e-02	1.51e-01	3.22e-02	5.96e-02	8.42e-02	3.97e-01	5.60e-01	3.46e-01	8.41e-01	7.10e-01	5.99e-01
GOBP HEART VALVE DEVELOPMENT	49	1.45e-02	4.62e-02	0.2480	-1.13e-01	1.18e-01	1.85e-01	1.74e-02	-5.42e-03	1.08e-03	1.69e-01	1.52e-01	2.48e-02	8.33e-01	9.48e-01	9.90e-01
GOCC INTERCELLULAR BRIDGE	79	3.92e-03	1.61e-02	0.2480	8.98e-03	-1.32e-01	6.58e-02	1.91e-01	6.05e-03	5.52e-02	8.90e-01	4.28e-02	3.12e-01	3.26e-03	9.26e-01	3.96e-01
GOBP CAMERA TYPE EYE MORPHOGENESIS	80	1.00e-03	5.10e-03	0.2480	-5.97e-02	1.78e-01	1.40e-01	6.75e-02	4.22e-02	-1.97e-02	3.56e-01	5.92e-03	3.06e-02	2.97e-01	5.14e-01	7.61e-01
GOMF PROTEIN PHOSPHATASE 2A BINDING	26	5.90e-01	6.73e-01	0.2480	2.57e-02	-3.39e-02	1.43e-01	1.41e-01	-7.88e-02	1.15e-01	8.21e-01	7.65e-01	2.07e-01	2.13e-01	4.87e-01	3.11e-01
GOBP POSITIVE REGULATION OF SIGNALING RECEPTOR ACTIVITY	21	4.96e-01	5.94e-01	0.2480	-1.11e-01	1.57e-01	9.50e-02	-2.56e-02	1.21e-01	9.69e-03	3.78e-01	2.12e-01	4.51e-01	8.39e-01	3.36e-01	9.39e-01
GOBP DEFENSE RESPONSE TO VIRUS	264	3.02e-11	5.77e-10	0.2480	-8.97e-02	-4.70e-02	-7.43e-02	1.36e-01	6.45e-02	1.52e-01	1.22e-02	1.88e-01	3.78e-02	1.50e-04	7.11e-02	2.08e-05
GOBP REGULATION OF CELL CYCLE PHASE TRANSITION	391	3.84e-16	1.16e-14	0.2480	-6.58e-02	-1.22e-01	-1.54e-02	1.84e-01	5.20e-03	9.09e-02	2.57e-02	3.39e-05	6.01e-01	4.69e-10	8.60e-01	2.03e-03
GOBP CARBOHYDRATE DERIVATIVE METABOLIC PROCESS	936	2.58e-30	2.55e-28	0.2480	-1.53e-01	-1.75e-01	-1.94e-02	4.02e-02	-3.69e-02	6.48e-02	2.46e-15	1.36e-19	3.16e-01	3.71e-02	5.60e-02	7.88e-04
GOMF ATPASE BINDING	69	1.43e-01	2.53e-01	0.2480	-1.85e-01	-1.18e-01	-2.66e-02	-2.42e-02	-7.05e-02	8.30e-02	7.83e-03	9.01e-02	7.02e-01	7.29e-01	3.11e-01	2.33e-01
GOBP N ACETYLNEURAMINATE METABOLIC PROCESS	11	7.54e-01	8.04e-01	0.2480	-1.71e-02	-2.50e-02	-6.25e-02	1.90e-01	-8.58e-02	-1.14e-01	9.22e-01	8.86e-01	7.20e-01	2.75e-01	6.22e-01	5.12e-01
GOBP PROTEIN KINASE C SIGNALING	25	6.04e-01	6.84e-01	0.2480	-1.54e-02	1.40e-01	1.16e-01	1.35e-01	4.98e-02	8.57e-02	8.94e-01	2.27e-01	3.16e-01	2.42e-01	6.67e-01	4.58e-01
GOBP REGULATION OF LYMPHOID PROGENITOR CELL DIFFERENTIATION	11	8.73e-01	8.96e-01	0.2480	-5.29e-02	1.49e-01	5.41e-02	-5.60e-02	1.74e-01	2.07e-03	7.61e-01	3.93e-01	7.56e-01	7.48e-01	3.17e-01	9.91e-01
GOBP PROTEIN LOCALIZATION TO ORGANELLE	870	6.90e-36	9.84e-34	0.2480	-1.48e-01	-1.17e-01	5.81e-03	1.09e-01	-3.94e-02	1.11e-01	1.43e-13	4.87e-09	7.71e-01	4.40e-08	4.89e-02	3.17e-08
GOBP NEGATIVE REGULATION OF TOR SIGNALING	65	1.25e-04	8.26e-04	0.2470	-1.28e-01	8.93e-02	6.94e-02	1.76e-01	-2.96e-02	-1.35e-02	7.36e-02	2.13e-01	3.33e-01	1.42e-02	6.80e-01	8.51e-01
GOBP IMPORT INTO CELL	731	2.25e-30	2.26e-28	0.2470	-7.32e-02	4.00e-02	1.79e-01	9.31e-02	-1.20e-02	1.15e-01	7.62e-04	6.56e-02	1.56e-16	1.83e-05	5.79e-01	1.08e-07
GOBP MESONEPHROS DEVELOPMENT	60	1.36e-01	2.43e-01	0.2470	-5.23e-02	3.70e-03	1.91e-01	-9.83e-02	-9.25e-02	6.14e-02	4.84e-01	9.60e-01	1.05e-02	1.88e-01	2.15e-01	4.11e-01
GOBP LIPID DROPLET FORMATION	12	6.81e-01	7.46e-01	0.2470	-1.30e-01	-5.20e-02	1.79e-01	-8.21e-02	-4.96e-02	-1.94e-02	4.36e-01	7.55e-01	2.83e-01	6.22e-01	7.66e-01	9.07e-01
GOBP REGULATION OF INFLAMMATORY RESPONSE	306	3.09e-08	4.05e-07	0.2470	-3.35e-02	1.20e-01	1.75e-01	1.03e-02	3.56e-02	1.18e-01	3.14e-01	3.20e-04	1.52e-07	7.57e-01	2.85e-01	3.89e-04
GOBP RESPONSE TO ESTROGEN	45	5.57e-02	1.28e-01	0.2470	-1.11e-01	-4.97e-03	1.88e-01	-1.15e-02	4.40e-02	1.06e-01	1.97e-01	9.54e-01	2.88e-02	8.94e-01	6.10e-01	2.19e-01
GOBP CELLULAR RESPONSE TO CORTICOSTEROID STIMULUS	47	1.72e-01	2.85e-01	0.2470	-1.64e-01	-1.14e-01	8.97e-02	-8.57e-02	-7.53e-02	1.35e-02	5.20e-02	1.75e-01	2.87e-01	3.10e-01	3.72e-01	8.73e-01
GOBP REGULATION OF INNATE IMMUNE RESPONSE	399	2.43e-18	8.80e-17	0.2470	-1.22e-01	7.05e-02	6.46e-02	9.69e-02	-1.19e-02	1.66e-01	2.74e-05	1.57e-02	2.69e-02	8.94e-04	6.85e-01	1.36e-08
GOBP CELL PROLIFERATION IN HINDBRAIN	9	9.00e-01	9.18e-01	0.2470	3.61e-03	9.87e-02	9.35e-02	-1.17e-01	-6.26e-02	-1.58e-01	9.85e-01	6.08e-01	6.27e-01	5.42e-01	7.45e-01	4.12e-01
GOBP NEGATIVE REGULATION OF MAPK CASCADE	130	7.03e-04	3.77e-03	0.2470	4.31e-02	1.06e-01	1.80e-01	1.06e-01	5.62e-02	3.77e-02	3.96e-01	3.72e-02	4.08e-04	3.71e-02	2.68e-01	4.58e-01
GOBP ESTABLISHMENT OF PROTEIN LOCALIZATION	1486	9.53e-59	4.65e-56	0.2470	-1.76e-01	-1.10e-01	2.62e-02	7.07e-02	-3.71e-02	1.06e-01	9.86e-30	1.70e-12	9.20e-02	5.30e-06	1.70e-02	1.09e-11
GOBP POSITIVE REGULATION OF POST TRANSCRIPTIONAL GENE SILENCING	11	7.47e-01	7.99e-01	0.2470	-1.62e-01	1.37e-01	-2.37e-03	5.63e-02	1.97e-02	1.12e-01	3.53e-01	4.33e-01	9.89e-01	7.47e-01	9.10e-01	5.20e-01
GOBP DETECTION OF BACTERIUM	15	7.49e-01	8.00e-01	0.2470	-1.42e-01	3.40e-02	-4.85e-02	-5.74e-02	-5.53e-02	-1.76e-01	3.40e-01	8.19e-01	7.45e-01	7.01e-01	7.11e-01	2.38e-01
GOBP REGULATION OF EXCITATORY SYNAPSE ASSEMBLY	11	5.53e-01	6.43e-01	0.2470	-1.94e-01	-9.24e-02	8.62e-02	3.02e-02	3.43e-02	-7.27e-02	2.65e-01	5.96e-01	6.21e-01	8.62e-01	8.44e-01	6.76e-01
GOBP IMPORT ACROSS PLASMA MEMBRANE	137	1.83e-05	1.45e-04	0.2470	-8.21e-02	9.61e-02	2.02e-01	7.61e-03	-3.52e-02	5.47e-02	9.70e-02	5.21e-02	4.65e-05	8.78e-01	4.77e-01	2.69e-01
GOBP PYRIDINE NUCLEOTIDE BIOSYNTHETIC PROCESS	24	5.52e-01	6.42e-01	0.2470	-8.97e-02	4.58e-02	-1.17e-01	2.62e-02	1.77e-01	7.20e-02	4.47e-01	6.98e-01	3.23e-01	8.24e-01	1.34e-01	5.42e-01
GOMF CARBOXYLIC ESTER HYDROLASE ACTIVITY	113	1.69e-03	7.97e-03	0.2470	-1.14e-01	-1.79e-01	-7.34e-02	8.08e-02	5.43e-02	3.16e-02	3.69e-02	1.00e-03	1.78e-01	1.38e-01	3.18e-01	5.62e-01
GOMF GLUTATHIONE PEROXIDASE ACTIVITY	18	6.57e-01	7.28e-01	0.2470	-4.58e-02	-2.29e-01	-1.71e-02	-1.87e-02	2.11e-03	7.64e-02	7.37e-01	9.31e-02	9.00e-01	8.91e-01	9.88e-01	5.75e-01
GOCC SITE OF POLARIZED GROWTH	137	8.82e-06	7.52e-05	0.2470	-7.35e-02	1.44e-01	1.15e-01	1.12e-01	8.32e-02	4.34e-02	1.38e-01	3.50e-03	2.01e-02	2.39e-02	9.26e-02	3.81e-01
GOBP POSITIVE REGULATION OF CELL MATRIX ADHESION	44	1.97e-01	3.13e-01	0.2470	-6.56e-04	-8.46e-02	1.61e-01	6.57e-02	-1.41e-01	5.93e-02	9.94e-01	3.32e-01	6.48e-02	4.51e-01	1.05e-01	4.96e-01
GOBP POSITIVE REGULATION OF LEUKOCYTE APOPTOTIC PROCESS	25	8.13e-01	8.49e-01	0.2460	4.16e-02	1.58e-01	1.04e-01	4.35e-02	8.69e-02	1.18e-01	7.19e-01	1.73e-01	3.67e-01	7.07e-01	4.52e-01	3.08e-01
GOBP NON MEMBRANE BOUNDED ORGANELLE ASSEMBLY	368	3.06e-14	7.77e-13	0.2460	-5.82e-02	-1.26e-01	1.95e-02	1.61e-01	-1.84e-02	1.21e-01	5.51e-02	3.38e-05	5.20e-01	1.07e-07	5.45e-01	6.47e-05
GOCC GOLGI MEMBRANE	599	2.18e-26	1.61e-24	0.2460	-1.69e-01	-3.70e-02	7.24e-02	8.21e-02	-4.63e-02	1.29e-01	1.70e-12	1.22e-01	2.49e-03	6.07e-04	5.29e-02	6.60e-08
GOBP RAB PROTEIN SIGNAL TRANSDUCTION	22	5.33e-01	6.25e-01	0.2460	-4.54e-02	-3.78e-02	3.95e-02	1.46e-01	-7.85e-02	1.68e-01	7.12e-01	7.59e-01	7.49e-01	2.36e-01	5.24e-01	1.73e-01
GOBP POSITIVE REGULATION OF POTASSIUM ION TRANSMEMBRANE TRANSPORT	23	5.75e-01	6.62e-01	0.2460	9.21e-02	2.53e-02	1.22e-01	-1.61e-01	-6.47e-02	8.05e-02	4.45e-01	8.34e-01	3.11e-01	1.81e-01	5.91e-01	5.04e-01
GOMF SCAFFOLD PROTEIN BINDING	58	5.60e-02	1.28e-01	0.2460	-1.25e-01	3.17e-03	1.38e-01	7.76e-02	-1.31e-02	1.41e-01	1.00e-01	9.67e-01	7.00e-02	3.07e-01	8.63e-01	6.30e-02
GOBP AXONEME ASSEMBLY	66	1.27e-01	2.33e-01	0.2460	8.88e-02	1.47e-01	5.22e-02	5.29e-03	1.65e-01	-3.37e-02	2.12e-01	3.85e-02	4.63e-01	9.41e-01	2.06e-02	6.36e-01
GOBP REGULATION OF PEPTIDASE ACTIVITY	231	1.71e-06	1.72e-05	0.2460	-2.03e-01	-6.01e-02	4.40e-02	-3.68e-02	-5.92e-02	9.46e-02	1.04e-07	1.15e-01	2.49e-01	3.35e-01	1.21e-01	1.33e-02
GOBP RESPONSE TO TOXIC SUBSTANCE	193	1.31e-05	1.08e-04	0.2460	-6.33e-02	-1.18e-01	1.32e-01	-9.01e-03	-5.05e-02	1.51e-01	1.30e-01	4.83e-03	1.59e-03	8.29e-01	2.26e-01	3.04e-04
GOBP REGULATION OF INTRACELLULAR STEROID HORMONE RECEPTOR SIGNALING PATHWAY	58	8.89e-03	3.12e-02	0.2460	-7.86e-02	-1.46e-03	1.32e-02	2.13e-01	-2.73e-02	9.06e-02	3.01e-01	9.85e-01	8.61e-01	5.06e-03	7.19e-01	2.33e-01
GOBP ESTABLISHMENT OF PROTEIN LOCALIZATION TO PLASMA MEMBRANE	61	5.23e-02	1.21e-01	0.2460	-9.43e-02	2.58e-02	1.22e-01	6.50e-02	9.35e-02	1.52e-01	2.03e-01	7.27e-01	9.92e-02	3.80e-01	2.07e-01	4.03e-02
GOBP REGULATION OF CYSTEINE TYPE ENDOPEPTIDASE ACTIVITY INVOLVED IN APOPTOTIC PROCESS	141	1.28e-03	6.29e-03	0.2460	-2.07e-01	-5.87e-02	2.96e-02	-6.74e-02	-2.74e-02	8.98e-02	2.23e-05	2.29e-01	5.44e-01	1.67e-01	5.75e-01	6.56e-02
GOMF COA LIGASE ACTIVITY	23	7.38e-01	7.91e-01	0.2460	4.66e-02	2.10e-01	1.15e-01	2.17e-03	2.66e-02	-1.51e-03	6.99e-01	8.10e-02	3.38e-01	9.86e-01	8.26e-01	9.90e-01
GOBP GLYCOPROTEIN BIOSYNTHETIC PROCESS	267	2.80e-09	4.20e-08	0.2460	-1.63e-01	-5.56e-02	7.65e-02	4.31e-02	-9.03e-02	1.21e-01	4.30e-06	1.18e-01	3.15e-02	2.25e-01	1.11e-02	6.45e-04
GOBP RESPONSE TO HYDROGEN PEROXIDE	88	1.94e-04	1.22e-03	0.2460	-1.54e-01	-3.75e-02	1.44e-01	7.83e-02	-7.22e-02	5.53e-02	1.23e-02	5.44e-01	1.95e-02	2.04e-01	2.42e-01	3.70e-01
GOBP POSITIVE REGULATION OF ALPHA BETA T CELL PROLIFERATION	23	1.28e-01	2.34e-01	0.2460	-9.35e-02	3.19e-02	-4.30e-02	1.44e-01	-1.48e-01	-7.90e-02	4.38e-01	7.91e-01	7.21e-01	2.33e-01	2.20e-01	5.12e-01
GOBP REGULATION OF CIRCADIAN RHYTHM	88	8.44e-06	7.23e-05	0.2460	-1.24e-01	2.15e-02	-7.99e-04	1.91e-01	1.82e-02	-8.65e-02	4.39e-02	7.28e-01	9.90e-01	1.91e-03	7.68e-01	1.61e-01
GOBP SMALL GTPASE MEDIATED SIGNAL TRANSDUCTION	442	1.12e-16	3.52e-15	0.2460	-9.08e-03	9.78e-02	1.70e-01	1.29e-01	-7.30e-03	7.12e-02	7.43e-01	4.24e-04	9.40e-10	3.15e-06	7.93e-01	1.03e-02
GOBP AXON EXTENSION	84	2.70e-04	1.64e-03	0.2460	-6.92e-02	1.52e-01	1.31e-01	9.69e-02	7.12e-02	-2.86e-02	2.73e-01	1.59e-02	3.83e-02	1.25e-01	2.59e-01	6.50e-01
GOBP RESPONSE TO VITAMIN D	27	2.20e-01	3.39e-01	0.2460	-1.04e-01	1.10e-01	6.78e-02	-9.44e-02	1.33e-01	-7.81e-02	3.48e-01	3.22e-01	5.42e-01	3.96e-01	2.32e-01	4.82e-01
GOMF HYDROLASE ACTIVITY ACTING ON CARBON NITROGEN BUT NOT PEPTIDE BONDS IN CYCLIC AMIDES	11	9.00e-01	9.18e-01	0.2450	-1.90e-01	-8.43e-02	-8.25e-02	2.30e-02	7.71e-02	-6.04e-02	2.75e-01	6.28e-01	6.36e-01	8.95e-01	6.58e-01	7.29e-01
GOBP DNA METABOLIC PROCESS	910	1.71e-34	2.17e-32	0.2450	-4.65e-02	-1.22e-01	-7.13e-02	1.83e-01	4.09e-02	5.36e-02	1.74e-02	4.37e-10	2.67e-04	7.52e-21	3.68e-02	6.17e-03
GOMF BASAL TRANSCRIPTION MACHINERY BINDING	58	6.14e-02	1.37e-01	0.2450	-1.10e-01	-7.02e-02	-1.19e-02	1.33e-01	6.08e-02	1.47e-01	1.47e-01	3.55e-01	8.76e-01	7.94e-02	4.23e-01	5.31e-02
GOCC SYNAPTONEMAL STRUCTURE	29	4.58e-01	5.63e-01	0.2450	-8.07e-02	-1.28e-01	-2.07e-02	8.29e-02	-5.75e-02	1.63e-01	4.52e-01	2.32e-01	8.47e-01	4.40e-01	5.92e-01	1.28e-01
GOBP POSITIVE REGULATION OF CELL CYCLE	268	7.17e-11	1.32e-09	0.2450	-9.72e-02	-8.94e-02	6.58e-02	1.49e-01	-2.33e-02	1.25e-01	6.19e-03	1.18e-02	6.38e-02	2.67e-05	5.12e-01	4.20e-04
GOBP MEMBRANE ORGANIZATION	692	1.45e-28	1.24e-26	0.2450	-1.17e-01	-1.20e-01	6.25e-02	1.14e-01	-2.05e-02	1.22e-01	1.72e-07	6.87e-08	5.13e-03	3.42e-07	3.57e-01	4.78e-08
GOBP REGULATION OF MRNA SPLICING VIA SPLICEOSOME	96	5.37e-03	2.08e-02	0.2450	-1.47e-01	-1.25e-01	-7.91e-02	5.72e-02	-1.13e-01	2.74e-02	1.27e-02	3.47e-02	1.80e-01	3.33e-01	5.65e-02	6.43e-01
GOBP NEGATIVE REGULATION OF INNATE IMMUNE RESPONSE	80	1.89e-02	5.66e-02	0.2450	-7.40e-02	-1.40e-01	-7.68e-03	9.27e-02	-8.62e-02	1.38e-01	2.53e-01	3.00e-02	9.05e-01	1.52e-01	1.83e-01	3.34e-02
GOBP NEGATIVE REGULATION OF GENE EXPRESSION EPIGENETIC	140	3.29e-05	2.49e-04	0.2450	-4.70e-02	-1.02e-03	4.04e-02	2.10e-01	5.24e-02	9.78e-02	3.37e-01	9.83e-01	4.09e-01	1.84e-05	2.84e-01	4.59e-02
GOBP LEUKOCYTE CELL CELL ADHESION	353	3.34e-10	5.72e-09	0.2450	-4.91e-03	8.81e-02	1.57e-01	1.21e-01	2.08e-02	1.11e-01	8.74e-01	4.45e-03	3.71e-07	9.20e-05	5.03e-01	3.35e-04
GOBP RESPONSE TO AMYLOID BETA	35	1.97e-01	3.13e-01	0.2450	-1.09e-01	1.80e-01	8.71e-02	9.10e-03	8.81e-02	1.68e-02	2.64e-01	6.52e-02	3.72e-01	9.26e-01	3.67e-01	8.64e-01
GOBP NEGATIVE REGULATION OF PEPTIDE SECRETION	36	6.47e-02	1.43e-01	0.2450	-6.15e-02	-1.62e-02	1.40e-01	-1.87e-01	3.72e-02	-6.77e-03	5.23e-01	8.66e-01	1.46e-01	5.22e-02	6.99e-01	9.44e-01
GOBP CYSTEINE METABOLIC PROCESS	9	8.56e-01	8.83e-01	0.2450	4.85e-03	-1.97e-01	8.19e-02	9.43e-02	-6.96e-02	-2.75e-02	9.80e-01	3.06e-01	6.71e-01	6.24e-01	7.18e-01	8.86e-01
GOBP POSITIVE REGULATION OF ACTIVATED T CELL PROLIFERATION	19	7.53e-01	8.03e-01	0.2450	-6.00e-02	-1.85e-01	-9.38e-03	7.81e-02	-1.27e-01	1.92e-03	6.51e-01	1.63e-01	9.44e-01	5.56e-01	3.39e-01	9.88e-01
GOBP POSITIVE REGULATION OF RESPONSE TO BIOTIC STIMULUS	347	2.10e-16	6.47e-15	0.2450	-1.41e-01	7.51e-02	5.82e-02	9.64e-02	5.78e-03	1.48e-01	6.86e-06	1.62e-02	6.25e-02	2.05e-03	8.53e-01	2.25e-06
GOBP NEGATIVE REGULATION OF ACTIN FILAMENT POLYMERIZATION	57	3.19e-01	4.39e-01	0.2450	9.52e-03	4.28e-02	1.59e-01	7.09e-02	-1.47e-03	1.67e-01	9.01e-01	5.76e-01	3.79e-02	3.54e-01	9.85e-01	2.97e-02
GOBP PROTEIN CATABOLIC PROCESS IN THE VACUOLE	22	3.31e-01	4.49e-01	0.2450	-1.54e-01	-1.28e-01	9.11e-02	8.56e-02	2.65e-02	5.95e-02	2.11e-01	3.00e-01	4.60e-01	4.87e-01	8.30e-01	6.29e-01
GOBP HYALURONAN METABOLIC PROCESS	29	3.19e-02	8.36e-02	0.2450	-1.64e-01	-2.42e-02	6.96e-02	8.88e-02	4.26e-03	-1.40e-01	1.26e-01	8.22e-01	5.16e-01	4.08e-01	9.68e-01	1.92e-01
GOBP POSITIVE REGULATION OF PROTEASOMAL PROTEIN CATABOLIC PROCESS	100	2.72e-04	1.65e-03	0.2450	-1.46e-01	-1.16e-01	6.36e-02	1.20e-01	-2.60e-02	7.77e-02	1.16e-02	4.58e-02	2.72e-01	3.75e-02	6.54e-01	1.79e-01
GOBP POSITIVE REGULATION OF FIBROBLAST PROLIFERATION	44	2.10e-02	6.14e-02	0.2450	-9.51e-02	-1.73e-01	9.00e-02	1.09e-01	1.22e-02	2.35e-02	2.75e-01	4.65e-02	3.02e-01	2.09e-01	8.88e-01	7.88e-01
GOBP TUBE FORMATION	116	1.91e-05	1.51e-04	0.2450	-7.45e-02	1.17e-01	7.78e-02	1.16e-01	1.44e-01	-2.44e-02	1.66e-01	2.93e-02	1.48e-01	3.15e-02	7.59e-03	6.50e-01
GOBP NEGATIVE REGULATION OF LEUKOCYTE PROLIFERATION	82	4.35e-02	1.06e-01	0.2450	-3.89e-02	1.79e-02	1.82e-01	6.45e-02	-3.18e-02	1.40e-01	5.42e-01	7.80e-01	4.30e-03	3.13e-01	6.18e-01	2.84e-02
GOBP G PROTEIN COUPLED RECEPTOR SIGNALING PATHWAY	562	3.42e-15	9.24e-14	0.2450	3.99e-03	1.07e-01	2.00e-01	-1.88e-02	-6.06e-02	6.50e-02	8.72e-01	1.51e-05	4.54e-16	4.46e-01	1.41e-02	8.45e-03
GOBP POSITIVE REGULATION OF CELL CYCLE PROCESS	212	3.63e-08	4.73e-07	0.2450	-7.46e-02	-1.15e-01	3.63e-02	1.63e-01	-2.13e-02	1.12e-01	6.13e-02	3.90e-03	3.63e-01	4.09e-05	5.93e-01	4.95e-03
GOBP PHOSPHOLIPID BIOSYNTHETIC PROCESS	227	2.17e-11	4.21e-10	0.2450	-2.29e-01	-2.26e-02	4.36e-03	4.79e-02	5.63e-02	3.42e-02	2.58e-09	5.57e-01	9.10e-01	2.14e-01	1.44e-01	3.75e-01
GOBP MAINTENANCE OF LOCATION IN CELL	185	3.94e-06	3.67e-05	0.2440	-6.37e-02	-1.11e-01	1.19e-01	9.13e-02	-9.43e-02	1.09e-01	1.35e-01	9.32e-03	5.16e-03	3.23e-02	2.70e-02	1.03e-02
GOBP NEGATIVE REGULATION OF DNA BIOSYNTHETIC PROCESS	29	4.98e-01	5.96e-01	0.2440	-4.88e-02	-3.29e-02	-8.92e-02	1.83e-01	1.08e-01	5.75e-02	6.49e-01	7.59e-01	4.06e-01	8.84e-02	3.15e-01	5.92e-01
GOBP POSITIVE REGULATION OF CALCIUM ION TRANSMEMBRANE TRANSPORTER ACTIVITY	25	6.69e-01	7.37e-01	0.2440	-1.16e-02	1.48e-01	1.09e-01	7.45e-02	7.29e-03	1.42e-01	9.20e-01	1.99e-01	3.46e-01	5.19e-01	9.50e-01	2.19e-01
GOBP REGULATION OF MITOTIC CELL CYCLE PHASE TRANSITION	309	1.80e-11	3.53e-10	0.2440	-7.87e-02	-1.55e-01	-2.78e-02	1.49e-01	-1.91e-02	7.80e-02	1.74e-02	2.80e-06	4.01e-01	6.31e-06	5.65e-01	1.84e-02
GOBP MODIFICATION OF POSTSYNAPTIC ACTIN CYTOSKELETON	9	8.96e-01	9.14e-01	0.2440	1.16e-02	-2.36e-01	1.71e-02	-9.25e-03	-5.56e-02	-2.24e-02	9.52e-01	2.21e-01	9.29e-01	9.62e-01	7.73e-01	9.07e-01
GOBP PURINE RIBONUCLEOSIDE METABOLIC PROCESS	21	7.42e-01	7.94e-01	0.2440	-1.29e-01	-3.11e-02	1.13e-02	-7.77e-02	-4.94e-02	1.83e-01	3.05e-01	8.05e-01	9.28e-01	5.38e-01	6.95e-01	1.47e-01
GOMF BMP RECEPTOR BINDING	6	9.88e-01	9.89e-01	0.2440	1.84e-02	2.65e-02	2.53e-02	1.20e-01	1.55e-01	1.40e-01	9.38e-01	9.10e-01	9.14e-01	6.10e-01	5.11e-01	5.53e-01
GOBP NEGATIVE REGULATION OF DEVELOPMENTAL GROWTH	72	8.62e-03	3.05e-02	0.2440	1.02e-02	9.13e-02	2.09e-01	8.44e-02	-1.79e-02	1.18e-02	8.81e-01	1.80e-01	2.18e-03	2.16e-01	7.93e-01	8.63e-01
GOBP SEX DETERMINATION	10	8.80e-01	9.02e-01	0.2440	6.57e-02	6.79e-03	8.55e-02	-1.05e-01	-9.74e-02	-1.66e-01	7.19e-01	9.70e-01	6.40e-01	5.66e-01	5.94e-01	3.64e-01
GOBP MUSCLE CONTRACTION	233	4.90e-06	4.46e-05	0.2440	-4.59e-02	2.91e-02	2.01e-01	-4.62e-02	-7.25e-02	9.41e-02	2.28e-01	4.44e-01	1.24e-07	2.25e-01	5.67e-02	1.33e-02
GOBP L AMINO ACID METABOLIC PROCESS	141	2.70e-03	1.19e-02	0.2440	-9.05e-02	-1.98e-01	-1.09e-01	-1.34e-02	8.08e-03	-5.20e-03	6.35e-02	4.86e-05	2.55e-02	7.84e-01	8.68e-01	9.15e-01
GOCC UBIQUITIN LIGASE COMPLEX	291	3.97e-13	9.14e-12	0.2440	-1.50e-01	-7.35e-02	-4.82e-02	1.39e-01	-1.13e-02	9.93e-02	1.07e-05	3.10e-02	1.58e-01	4.46e-05	7.40e-01	3.57e-03
GOBP REGULATION OF ACTIN FILAMENT BUNDLE ASSEMBLY	86	1.14e-03	5.66e-03	0.2440	-1.17e-01	2.30e-02	1.20e-01	1.33e-01	4.14e-02	1.07e-01	5.97e-02	7.12e-01	5.52e-02	3.26e-02	5.07e-01	8.65e-02
GOBP PRE MIRNA PROCESSING	15	7.37e-01	7.90e-01	0.2440	-1.72e-01	1.30e-01	4.09e-02	-5.08e-02	-1.03e-02	9.30e-02	2.47e-01	3.85e-01	7.84e-01	7.33e-01	9.45e-01	5.33e-01
GOBP PRESYNAPSE ORGANIZATION	29	1.51e-01	2.62e-01	0.2440	-6.73e-02	1.85e-01	9.47e-02	1.36e-02	-6.47e-02	-8.74e-02	5.30e-01	8.55e-02	3.78e-01	8.99e-01	5.47e-01	4.15e-01
GOBP GLUTAMATE SECRETION	19	7.17e-01	7.75e-01	0.2440	2.57e-03	1.08e-01	8.03e-02	1.45e-01	1.43e-01	-1.30e-02	9.85e-01	4.16e-01	5.44e-01	2.75e-01	2.81e-01	9.22e-01
GOBP RESPONSE TO TEMPERATURE STIMULUS	130	2.05e-06	2.03e-05	0.2440	-6.59e-02	-5.81e-02	1.25e-01	1.44e-01	8.36e-02	9.15e-02	1.94e-01	2.52e-01	1.35e-02	4.61e-03	9.98e-02	7.17e-02
GOCC TRANSPORT VESICLE MEMBRANE	187	2.92e-07	3.33e-06	0.2440	-1.62e-01	-4.70e-02	7.30e-02	8.72e-02	-2.63e-02	1.32e-01	1.35e-04	2.68e-01	8.52e-02	3.99e-02	5.36e-01	1.80e-03
GOBP CELLULAR RESPONSE TO OXIDATIVE STRESS	217	7.99e-06	6.91e-05	0.2440	-1.62e-01	-1.33e-01	2.89e-02	1.71e-02	-6.86e-02	9.98e-02	4.10e-05	7.46e-04	4.64e-01	6.65e-01	8.18e-02	1.13e-02
GOCC VACUOLAR MEMBRANE	459	4.95e-20	2.09e-18	0.2440	-1.89e-01	-9.11e-02	4.41e-02	7.03e-02	-5.41e-02	7.57e-02	4.02e-12	8.25e-04	1.05e-01	9.87e-03	4.72e-02	5.47e-03
GOBP POSITIVE REGULATION OF MICROTUBULE POLYMERIZATION OR DEPOLYMERIZATION	32	2.34e-01	3.52e-01	0.2440	-1.25e-01	9.60e-02	3.78e-02	1.33e-01	8.93e-02	8.81e-02	2.22e-01	3.48e-01	7.12e-01	1.94e-01	3.82e-01	3.89e-01
GOBP REGULATION OF GLIAL CELL MIGRATION	17	8.57e-01	8.84e-01	0.2440	1.33e-01	4.90e-02	1.65e-01	9.53e-02	-5.31e-02	1.23e-02	3.42e-01	7.27e-01	2.38e-01	4.96e-01	7.05e-01	9.30e-01
GOBP CALCINEURIN MEDIATED SIGNALING	39	2.59e-01	3.79e-01	0.2440	5.71e-02	1.53e-01	1.29e-01	1.09e-01	-6.37e-02	1.98e-02	5.37e-01	9.79e-02	1.65e-01	2.41e-01	4.92e-01	8.30e-01
GOBP POSITIVE REGULATION OF CYSTEINE TYPE ENDOPEPTIDASE ACTIVITY	114	3.73e-02	9.46e-02	0.2440	-1.61e-01	-6.57e-02	5.70e-02	-8.36e-02	-8.45e-02	1.09e-01	3.03e-03	2.25e-01	2.93e-01	1.23e-01	1.19e-01	4.40e-02
GOBP MULTICELLULAR ORGANISMAL LEVEL WATER HOMEOSTASIS	19	6.31e-01	7.07e-01	0.2440	-1.34e-01	4.72e-02	-9.93e-02	1.15e-01	1.05e-01	-7.27e-02	3.14e-01	7.22e-01	4.54e-01	3.87e-01	4.27e-01	5.83e-01
GOBP POSITIVE REGULATION OF EXTRINSIC APOPTOTIC SIGNALING PATHWAY	44	4.84e-02	1.14e-01	0.2440	-1.75e-01	-3.98e-02	7.54e-02	1.50e-02	1.16e-01	8.91e-02	4.49e-02	6.48e-01	3.87e-01	8.63e-01	1.83e-01	3.06e-01
GOBP STEROID BIOSYNTHETIC PROCESS	128	1.48e-03	7.09e-03	0.2440	-3.66e-02	-1.25e-01	1.25e-01	4.85e-02	-6.85e-02	1.40e-01	4.75e-01	1.46e-02	1.44e-02	3.43e-01	1.81e-01	6.08e-03
GOBP NEGATIVE REGULATION OF NUCLEOTIDE METABOLIC PROCESS	25	4.15e-01	5.25e-01	0.2440	3.80e-02	7.48e-02	1.52e-01	1.68e-01	-3.13e-02	-9.46e-03	7.42e-01	5.17e-01	1.89e-01	1.46e-01	7.86e-01	9.35e-01
GOBP NEGATIVE REGULATION OF CARDIOCYTE DIFFERENTIATION	8	9.53e-01	9.61e-01	0.2440	-1.29e-01	-3.92e-03	4.48e-02	6.35e-02	9.42e-02	1.66e-01	5.26e-01	9.85e-01	8.26e-01	7.56e-01	6.45e-01	4.16e-01
GOBP COLLAGEN FIBRIL ORGANIZATION	45	1.74e-02	5.29e-02	0.2440	-1.97e-01	9.58e-02	2.08e-02	8.71e-02	5.75e-02	-9.64e-05	2.22e-02	2.66e-01	8.09e-01	3.12e-01	5.04e-01	9.99e-01
GOBP INTRINSIC APOPTOTIC SIGNALING PATHWAY IN RESPONSE TO ENDOPLASMIC RETICULUM STRESS	58	4.74e-03	1.88e-02	0.2430	-1.03e-01	-1.96e-02	7.26e-02	1.46e-01	-1.41e-01	4.19e-02	1.76e-01	7.96e-01	3.39e-01	5.42e-02	6.27e-02	5.81e-01
GOBP CARDIAC VENTRICLE MORPHOGENESIS	40	3.32e-01	4.50e-01	0.2430	-2.96e-02	1.63e-01	8.71e-02	1.03e-01	8.90e-02	7.48e-02	7.46e-01	7.40e-02	3.41e-01	2.59e-01	3.30e-01	4.13e-01
GOBP LUNG MORPHOGENESIS	35	2.90e-01	4.10e-01	0.2430	-5.58e-02	-6.89e-03	1.76e-01	-9.18e-02	-1.26e-01	-2.68e-02	5.68e-01	9.44e-01	7.14e-02	3.47e-01	1.96e-01	7.84e-01
GOBP REGULATION OF CELLULAR RESPONSE TO TRANSFORMING GROWTH FACTOR BETA STIMULUS	118	1.86e-04	1.18e-03	0.2430	-5.08e-02	9.24e-02	1.70e-01	9.58e-02	-6.39e-02	7.64e-02	3.40e-01	8.32e-02	1.39e-03	7.23e-02	2.31e-01	1.52e-01
GOBP VIRAL TRANSCRIPTION	47	1.20e-01	2.24e-01	0.2430	-3.87e-02	-1.45e-02	8.42e-02	1.97e-01	2.68e-02	1.04e-01	6.46e-01	8.64e-01	3.18e-01	1.95e-02	7.50e-01	2.15e-01
GOBP REGULATION OF SPONTANEOUS SYNAPTIC TRANSMISSION	6	9.71e-01	9.75e-01	0.2430	-1.51e-01	-5.21e-02	-5.72e-03	1.15e-01	4.85e-02	1.34e-01	5.22e-01	8.25e-01	9.81e-01	6.26e-01	8.37e-01	5.68e-01
GOBP NEGATIVE REGULATION OF PROTEOLYSIS	169	6.52e-06	5.79e-05	0.2430	-2.08e-01	-8.16e-02	2.78e-02	2.88e-02	-4.13e-02	7.69e-02	3.06e-06	6.72e-02	5.33e-01	5.18e-01	3.54e-01	8.45e-02
GOMF RNA POLYMERASE BINDING	56	8.97e-03	3.14e-02	0.2430	-1.53e-01	-4.69e-03	-2.29e-02	1.46e-01	-3.70e-02	1.12e-01	4.81e-02	9.52e-01	7.67e-01	5.83e-02	6.32e-01	1.47e-01
GOBP REGULATION OF GLUCOSE TRANSMEMBRANE TRANSPORT	60	2.15e-02	6.27e-02	0.2430	-2.05e-01	-2.37e-02	1.01e-01	-6.75e-02	6.11e-03	4.08e-02	5.98e-03	7.51e-01	1.75e-01	3.66e-01	9.35e-01	5.85e-01
GOMF RNA POLYMERASE II GENERAL TRANSCRIPTION INITIATION FACTOR BINDING	23	5.49e-01	6.39e-01	0.2430	-7.79e-02	-1.58e-01	-3.99e-02	-1.50e-02	4.47e-02	1.55e-01	5.18e-01	1.89e-01	7.40e-01	9.01e-01	7.10e-01	1.97e-01
GOBP REGULATION OF MACROPHAGE ACTIVATION	47	2.01e-01	3.17e-01	0.2430	1.23e-02	1.31e-01	1.75e-01	8.78e-02	4.44e-02	3.79e-02	8.84e-01	1.19e-01	3.84e-02	2.98e-01	5.99e-01	6.53e-01
GOBP T CELL CYTOKINE PRODUCTION	35	1.71e-01	2.85e-01	0.2430	-4.07e-02	1.28e-01	1.05e-01	-2.95e-02	-1.67e-01	-3.27e-02	6.77e-01	1.89e-01	2.81e-01	7.62e-01	8.81e-02	7.37e-01
GOMF CIS REGULATORY REGION SEQUENCE SPECIFIC DNA BINDING	870	1.76e-25	1.18e-23	0.2430	-1.04e-02	1.24e-01	3.55e-02	1.47e-01	1.36e-01	4.50e-02	6.02e-01	5.39e-10	7.54e-02	1.96e-13	9.20e-12	2.44e-02
GOCC PRESYNAPTIC CYTOSOL	12	8.65e-01	8.90e-01	0.2430	-1.55e-01	-4.28e-02	-2.56e-02	6.10e-02	1.01e-02	1.69e-01	3.54e-01	7.97e-01	8.78e-01	7.15e-01	9.52e-01	3.09e-01
GOBP CD40 SIGNALING PATHWAY	14	7.62e-01	8.09e-01	0.2430	-1.32e-02	-1.32e-01	-5.11e-02	1.16e-01	1.16e-01	-1.09e-01	9.32e-01	3.93e-01	7.41e-01	4.54e-01	4.52e-01	4.80e-01
GOBP POSITIVE REGULATION OF REACTIVE OXYGEN SPECIES METABOLIC PROCESS	57	2.99e-02	7.99e-02	0.2430	-8.79e-02	1.12e-01	1.37e-01	8.30e-02	9.58e-02	6.10e-02	2.51e-01	1.43e-01	7.35e-02	2.78e-01	2.11e-01	4.26e-01
GOBP LOCOMOTORY EXPLORATION BEHAVIOR	12	9.05e-01	9.22e-01	0.2420	-9.19e-02	-7.04e-03	1.60e-01	-5.77e-02	1.66e-02	1.45e-01	5.82e-01	9.66e-01	3.38e-01	7.29e-01	9.21e-01	3.83e-01
GOBP DNA DAMAGE RESPONSE	844	1.71e-32	1.94e-30	0.2420	-6.43e-02	-9.04e-02	-6.54e-02	1.93e-01	6.20e-02	3.40e-02	1.52e-03	8.35e-06	1.25e-03	1.75e-21	2.24e-03	9.35e-02
GOBP GLUTAMINE METABOLIC PROCESS	25	5.99e-01	6.81e-01	0.2420	-2.04e-01	-6.55e-02	-7.38e-02	1.73e-02	4.58e-02	7.13e-02	7.77e-02	5.71e-01	5.23e-01	8.81e-01	6.92e-01	5.37e-01
GOBP NEGATIVE REGULATION OF WNT SIGNALING PATHWAY	115	3.42e-03	1.44e-02	0.2420	3.48e-02	1.19e-01	1.13e-01	1.61e-01	3.30e-03	6.80e-02	5.19e-01	2.77e-02	3.60e-02	2.84e-03	9.51e-01	2.08e-01
GOBP EMBRYONIC APPENDAGE MORPHOGENESIS	73	8.68e-02	1.77e-01	0.2420	7.18e-02	1.92e-01	8.14e-02	9.77e-02	2.43e-02	4.50e-03	2.89e-01	4.60e-03	2.29e-01	1.49e-01	7.19e-01	9.47e-01
GOMF SERINE TYPE ENDOPEPTIDASE INHIBITOR ACTIVITY	51	6.36e-02	1.41e-01	0.2420	-1.91e-01	1.04e-01	-3.13e-02	-9.59e-02	-2.87e-02	2.49e-02	1.85e-02	2.00e-01	6.99e-01	2.36e-01	7.23e-01	7.58e-01
GOBP ACTIN FILAMENT BUNDLE ORGANIZATION	139	2.79e-05	2.15e-04	0.2420	-6.27e-02	1.13e-02	1.39e-01	1.43e-01	4.63e-02	1.12e-01	2.02e-01	8.17e-01	4.56e-03	3.53e-03	3.46e-01	2.29e-02
GOBP REGULATION OF INTRACELLULAR PROTEIN TRANSPORT	135	1.14e-03	5.70e-03	0.2420	-1.67e-01	-8.26e-02	8.21e-02	1.65e-03	-6.20e-02	1.16e-01	8.14e-04	9.77e-02	9.95e-02	9.74e-01	2.13e-01	2.02e-02
GOBP TRAIL ACTIVATED APOPTOTIC SIGNALING PATHWAY	9	8.96e-01	9.14e-01	0.2420	-1.22e-01	1.76e-01	-2.16e-03	1.91e-02	1.06e-01	-3.27e-02	5.27e-01	3.60e-01	9.91e-01	9.21e-01	5.81e-01	8.65e-01
GOBP REGULATION OF REPRODUCTIVE PROCESS	123	7.66e-04	4.06e-03	0.2420	-8.03e-02	-1.55e-01	1.12e-01	9.14e-03	-1.14e-01	5.05e-02	1.24e-01	3.02e-03	3.13e-02	8.61e-01	2.93e-02	3.33e-01
GOBP REGULATION OF TRANSPORTER ACTIVITY	161	2.64e-03	1.16e-02	0.2420	-1.00e-02	6.69e-02	1.80e-01	-4.45e-02	-5.61e-03	1.41e-01	8.27e-01	1.43e-01	8.41e-05	3.30e-01	9.02e-01	2.07e-03
GOBP TYPE I INTERFERON PRODUCTION	118	9.07e-05	6.22e-04	0.2420	-1.14e-01	3.38e-02	-6.32e-02	1.47e-01	8.93e-02	1.04e-01	3.20e-02	5.26e-01	2.36e-01	5.78e-03	9.39e-02	5.12e-02
GOBP POSITIVE REGULATION OF JNK CASCADE	82	3.64e-03	1.52e-02	0.2420	-3.73e-02	1.86e-01	1.34e-01	5.98e-02	3.01e-02	-1.02e-02	5.60e-01	3.54e-03	3.62e-02	3.49e-01	6.38e-01	8.73e-01
GOBP SMOOTH MUSCLE CONTRACTION	66	6.17e-02	1.38e-01	0.2420	-1.36e-01	-2.14e-02	1.48e-01	-7.54e-02	-1.05e-01	3.27e-02	5.55e-02	7.63e-01	3.79e-02	2.89e-01	1.42e-01	6.46e-01
GOBP REGULATION OF DENDRITE DEVELOPMENT	76	1.24e-02	4.07e-02	0.2420	2.46e-02	1.62e-01	9.77e-02	1.33e-01	4.12e-02	-4.99e-02	7.11e-01	1.43e-02	1.41e-01	4.44e-02	5.34e-01	4.52e-01
GOMF CARBON NITROGEN LYASE ACTIVITY	12	8.37e-01	8.68e-01	0.2420	3.93e-02	-1.23e-01	2.69e-03	9.49e-02	9.85e-02	1.52e-01	8.14e-01	4.62e-01	9.87e-01	5.69e-01	5.55e-01	3.61e-01
GOBP REGULATION OF ENDOCYTOSIS	236	9.39e-08	1.16e-06	0.2420	-6.74e-02	3.98e-02	1.59e-01	9.23e-02	2.20e-02	1.35e-01	7.43e-02	2.93e-01	2.60e-05	1.47e-02	5.60e-01	3.68e-04
GOBP REGULATION OF CELL SIZE	149	4.42e-08	5.67e-07	0.2420	-4.99e-02	9.20e-02	1.66e-01	1.38e-01	2.84e-02	4.80e-03	2.93e-01	5.25e-02	4.60e-04	3.70e-03	5.50e-01	9.19e-01
GOBP POSITIVE REGULATION OF DEFENSE RESPONSE	430	7.80e-17	2.51e-15	0.2420	-1.16e-01	8.74e-02	8.67e-02	7.12e-02	3.33e-03	1.57e-01	3.54e-05	1.89e-03	2.06e-03	1.14e-02	9.06e-01	2.41e-08
GOBP SOMATIC DIVERSIFICATION OF IMMUNE RECEPTORS	76	1.81e-02	5.47e-02	0.2420	-4.86e-02	5.02e-04	1.32e-03	1.49e-01	5.06e-02	1.76e-01	4.64e-01	9.94e-01	9.84e-01	2.44e-02	4.46e-01	7.85e-03
GOBP SCF DEPENDENT PROTEASOMAL UBIQUITIN DEPENDENT PROTEIN CATABOLIC PROCESS	42	2.57e-02	7.17e-02	0.2410	-1.03e-01	-3.14e-02	-1.50e-01	8.83e-02	-2.89e-02	1.25e-01	2.50e-01	7.25e-01	9.31e-02	3.22e-01	7.46e-01	1.59e-01
GOBP DNA RECOMBINATION	307	9.99e-11	1.79e-09	0.2410	-4.44e-02	-9.89e-02	-9.01e-02	1.86e-01	4.19e-02	4.40e-02	1.81e-01	2.90e-03	6.67e-03	1.95e-08	2.07e-01	1.85e-01
GOBP LIPID OXIDATION	97	3.55e-02	9.09e-02	0.2410	-7.99e-02	-1.48e-01	-1.54e-01	3.82e-02	6.75e-02	-9.63e-03	1.74e-01	1.16e-02	8.74e-03	5.16e-01	2.51e-01	8.70e-01
GOBP FAT SOLUBLE VITAMIN BIOSYNTHETIC PROCESS	10	7.23e-01	7.80e-01	0.2410	1.64e-02	4.96e-02	7.63e-02	-1.22e-01	1.41e-01	-1.22e-01	9.28e-01	7.86e-01	6.76e-01	5.04e-01	4.39e-01	5.06e-01
GOBP REGULATION OF STRIATED MUSCLE CONTRACTION	66	6.95e-02	1.50e-01	0.2410	-1.09e-03	7.16e-02	2.16e-01	-2.32e-02	3.64e-03	7.75e-02	9.88e-01	3.15e-01	2.46e-03	7.44e-01	9.59e-01	2.76e-01
GOBP CELL CELL JUNCTION ORGANIZATION	158	3.90e-04	2.26e-03	0.2410	-1.75e-03	8.29e-02	2.09e-01	1.78e-02	-2.48e-02	8.02e-02	9.70e-01	7.22e-02	5.58e-06	7.00e-01	5.90e-01	8.21e-02
GOMF PROTEIN SERINE THREONINE KINASE ACTIVITY	382	2.44e-18	8.80e-17	0.2410	-5.59e-02	1.32e-01	1.15e-01	1.44e-01	5.02e-03	5.61e-02	6.08e-02	9.02e-06	1.08e-04	1.26e-06	8.66e-01	5.99e-02
GOMF ERBB 3 CLASS RECEPTOR BINDING	5	9.84e-01	9.86e-01	0.2410	1.29e-01	1.32e-01	-1.06e-01	9.29e-02	4.28e-02	-4.80e-02	6.19e-01	6.09e-01	6.82e-01	7.19e-01	8.68e-01	8.52e-01
GOBP DEFENSE RESPONSE TO BACTERIUM	208	1.40e-04	9.10e-04	0.2410	-6.03e-02	-3.32e-02	1.53e-01	1.52e-02	-1.04e-01	1.38e-01	1.34e-01	4.09e-01	1.50e-04	7.06e-01	9.83e-03	6.23e-04
GOBP REGULATION OF AMINO ACID TRANSPORT	29	3.54e-01	4.70e-01	0.2410	-8.90e-02	5.57e-02	1.09e-01	1.35e-01	-2.67e-02	1.27e-01	4.07e-01	6.04e-01	3.08e-01	2.10e-01	8.03e-01	2.37e-01
GOBP CYTOPLASMIC PATTERN RECOGNITION RECEPTOR SIGNALING PATHWAY	157	6.07e-08	7.63e-07	0.2410	-1.83e-01	3.38e-02	-3.07e-03	1.14e-01	1.97e-02	9.89e-02	7.52e-05	4.65e-01	9.47e-01	1.34e-02	6.70e-01	3.24e-02
GOMF ENZYME SUBSTRATE ADAPTOR ACTIVITY	68	2.18e-03	9.88e-03	0.2410	-1.31e-01	1.27e-02	-4.25e-02	1.90e-01	1.82e-02	4.67e-02	6.17e-02	8.56e-01	5.45e-01	6.61e-03	7.95e-01	5.05e-01
GOBP POSITIVE REGULATION OF NERVOUS SYSTEM DEVELOPMENT	210	1.68e-07	1.98e-06	0.2410	-4.72e-02	1.57e-01	1.16e-01	7.11e-02	1.08e-01	3.03e-02	2.38e-01	8.89e-05	3.84e-03	7.56e-02	7.01e-03	4.49e-01
GOBP REGULATION OF LONG TERM SYNAPTIC POTENTIATION	33	5.73e-01	6.60e-01	0.2410	-1.31e-01	-1.43e-01	-1.28e-03	1.57e-02	-5.89e-02	1.28e-01	1.93e-01	1.54e-01	9.90e-01	8.76e-01	5.58e-01	2.02e-01
GOBP POSITIVE REGULATION OF SMOOTH MUSCLE CELL APOPTOTIC PROCESS	13	8.85e-01	9.06e-01	0.2410	5.68e-02	-1.00e-01	7.66e-02	-1.25e-01	-1.48e-01	-3.48e-02	7.23e-01	5.31e-01	6.32e-01	4.36e-01	3.55e-01	8.28e-01
GOBP PROTEIN LOCALIZATION TO SYNAPSE	59	7.98e-02	1.66e-01	0.2400	3.96e-02	6.28e-02	2.13e-01	6.24e-02	1.65e-02	5.22e-02	5.99e-01	4.04e-01	4.67e-03	4.07e-01	8.26e-01	4.88e-01
GOBP SYNAPTIC VESICLE EXOCYTOSIS	71	2.16e-02	6.29e-02	0.2400	-1.07e-01	4.13e-02	1.06e-01	1.03e-01	7.31e-02	1.32e-01	1.18e-01	5.47e-01	1.22e-01	1.35e-01	2.87e-01	5.51e-02
GOBP CELL KILLING	175	2.40e-04	1.47e-03	0.2400	3.97e-02	4.54e-02	9.96e-02	1.28e-01	-3.23e-02	1.64e-01	3.65e-01	3.00e-01	2.30e-02	3.58e-03	4.61e-01	1.87e-04
GOBP POSITIVE REGULATION OF NUCLEOTIDE CATABOLIC PROCESS	15	7.54e-01	8.04e-01	0.2400	4.59e-02	4.45e-02	4.83e-02	-9.47e-02	-1.78e-01	1.04e-01	7.58e-01	7.65e-01	7.46e-01	5.25e-01	2.33e-01	4.88e-01
GOBP REGULATION OF STRIATED MUSCLE TISSUE DEVELOPMENT	13	8.65e-01	8.90e-01	0.2400	2.33e-01	2.23e-02	2.19e-02	3.72e-02	-1.49e-02	-2.73e-02	1.46e-01	8.89e-01	8.91e-01	8.16e-01	9.26e-01	8.65e-01
GOCC CYTOPLASMIC SIDE OF ENDOPLASMIC RETICULUM MEMBRANE	19	8.97e-01	9.15e-01	0.2400	-6.63e-02	-1.67e-01	-6.50e-02	-3.69e-02	-1.40e-01	-7.91e-03	6.17e-01	2.06e-01	6.24e-01	7.81e-01	2.91e-01	9.52e-01
GOBP POSITIVE REGULATION OF FATTY ACID METABOLIC PROCESS	28	2.18e-01	3.36e-01	0.2400	2.71e-02	1.19e-01	1.18e-01	-1.09e-02	4.56e-02	-1.62e-01	8.04e-01	2.74e-01	2.78e-01	9.20e-01	6.76e-01	1.37e-01
GOMF HORMONE BINDING	53	8.92e-02	1.80e-01	0.2400	-1.60e-01	-8.11e-03	1.34e-01	-1.43e-02	-1.05e-01	5.44e-02	4.43e-02	9.19e-01	9.22e-02	8.57e-01	1.88e-01	4.93e-01
GOMF PROTEIN KINASE ACTIVITY	499	1.51e-19	6.11e-18	0.2400	-3.79e-02	1.16e-01	1.36e-01	1.27e-01	-1.11e-02	8.78e-02	1.47e-01	8.89e-06	1.95e-07	1.10e-06	6.70e-01	7.92e-04
GOBP CHROMOSOME ORGANIZATION INVOLVED IN MEIOTIC CELL CYCLE	46	2.21e-01	3.40e-01	0.2400	-1.19e-01	-7.65e-02	-1.62e-01	8.00e-02	6.04e-02	3.58e-02	1.63e-01	3.69e-01	5.75e-02	3.48e-01	4.78e-01	6.74e-01
GOBP ESTABLISHMENT OF LOCALIZATION IN CELL	1700	1.11e-65	6.03e-63	0.2400	-1.51e-01	-8.19e-02	5.22e-02	9.04e-02	-3.36e-02	1.27e-01	5.59e-25	2.01e-08	3.49e-04	6.00e-10	2.16e-02	3.48e-18
GOMF TRANSPORTER REGULATOR ACTIVITY	112	3.88e-02	9.73e-02	0.2400	-1.18e-01	-1.27e-01	5.86e-02	-4.79e-02	-8.77e-02	1.18e-01	3.04e-02	1.99e-02	2.84e-01	3.81e-01	1.09e-01	3.16e-02
GOBP POSITIVE REGULATION OF TUMOR NECROSIS FACTOR SUPERFAMILY CYTOKINE PRODUCTION	98	1.13e-03	5.62e-03	0.2400	-1.34e-01	8.31e-02	1.13e-01	7.14e-02	4.49e-02	1.13e-01	2.20e-02	1.55e-01	5.36e-02	2.22e-01	4.42e-01	5.31e-02
GOBP ACTOMYOSIN STRUCTURE ORGANIZATION	163	6.32e-05	4.51e-04	0.2400	-1.85e-02	6.35e-02	1.44e-01	1.44e-01	-9.03e-04	1.08e-01	6.84e-01	1.62e-01	1.49e-03	1.54e-03	9.84e-01	1.76e-02
GOBP CARTILAGE DEVELOPMENT	126	1.11e-04	7.43e-04	0.2400	-4.60e-02	2.03e-01	9.32e-02	5.87e-02	4.46e-02	9.36e-03	3.73e-01	8.41e-05	7.09e-02	2.56e-01	3.87e-01	8.56e-01
GOMF ACTIN BINDING	357	2.75e-12	5.86e-11	0.2400	-3.57e-02	-2.83e-02	1.59e-01	1.08e-01	-8.38e-02	1.07e-01	2.47e-01	3.58e-01	2.48e-07	4.61e-04	6.54e-03	5.31e-04
GOBP SUPEROXIDE ANION GENERATION	32	2.51e-01	3.70e-01	0.2400	1.30e-02	8.36e-02	2.84e-02	-1.07e-01	6.58e-02	-1.83e-01	8.99e-01	4.13e-01	7.81e-01	2.94e-01	5.19e-01	7.25e-02
GOBP POSITIVE REGULATION OF CELL MIGRATION INVOLVED IN SPROUTING ANGIOGENESIS	16	3.98e-01	5.10e-01	0.2400	-7.98e-02	3.52e-02	5.18e-02	-6.54e-04	9.76e-02	-1.94e-01	5.80e-01	8.08e-01	7.20e-01	9.96e-01	4.99e-01	1.79e-01
GOBP REGULATION OF DEVELOPMENTAL GROWTH	219	3.76e-09	5.57e-08	0.2400	-1.23e-02	1.35e-01	1.47e-01	1.30e-01	-8.83e-03	1.97e-02	7.54e-01	5.93e-04	1.71e-04	9.13e-04	8.22e-01	6.16e-01
GOBP NEGATIVE REGULATION OF MUSCLE CELL APOPTOTIC PROCESS	34	3.15e-01	4.35e-01	0.2390	9.05e-02	-7.67e-02	1.20e-01	1.61e-01	-5.15e-02	2.25e-02	3.61e-01	4.39e-01	2.26e-01	1.05e-01	6.03e-01	8.21e-01
GOMF BETA TUBULIN BINDING	36	4.71e-01	5.73e-01	0.2390	-1.22e-01	-7.05e-02	2.26e-02	-7.30e-03	-1.39e-01	1.32e-01	2.05e-01	4.64e-01	8.15e-01	9.40e-01	1.48e-01	1.69e-01
GOBP REGULATION OF JNK CASCADE	120	1.43e-03	6.93e-03	0.2390	-8.29e-03	1.83e-01	1.10e-01	9.18e-02	4.65e-02	3.17e-02	8.75e-01	5.33e-04	3.72e-02	8.24e-02	3.79e-01	5.49e-01
GOBP REGULATION OF PROTEIN LOCALIZATION TO PLASMA MEMBRANE	89	3.40e-03	1.43e-02	0.2390	-1.65e-01	-1.00e-01	8.18e-02	5.00e-02	-8.97e-02	5.39e-02	7.24e-03	1.03e-01	1.82e-01	4.15e-01	1.44e-01	3.80e-01
GOBP NEGATIVE REGULATION OF REPRODUCTIVE PROCESS	42	1.89e-01	3.04e-01	0.2390	1.29e-02	-1.38e-01	1.05e-01	1.31e-01	-4.61e-02	8.79e-02	8.85e-01	1.22e-01	2.39e-01	1.42e-01	6.05e-01	3.24e-01
GOBP LEARNING	108	1.37e-03	6.68e-03	0.2390	-1.28e-01	5.37e-02	1.54e-01	2.80e-02	-3.81e-02	1.09e-01	2.12e-02	3.35e-01	5.73e-03	6.15e-01	4.94e-01	4.94e-02
GOBP REGULATION OF ACTIN FILAMENT BASED PROCESS	313	5.64e-12	1.17e-10	0.2390	-7.17e-02	2.01e-02	1.83e-01	7.99e-02	-1.57e-02	1.08e-01	2.93e-02	5.40e-01	2.57e-08	1.51e-02	6.34e-01	1.06e-03
GOBP NEGATIVE REGULATION OF INFLAMMATORY RESPONSE	129	3.10e-05	2.36e-04	0.2390	-5.42e-02	1.42e-01	1.70e-01	6.63e-02	-2.81e-03	2.85e-02	2.88e-01	5.49e-03	8.42e-04	1.93e-01	9.56e-01	5.77e-01
GOMF CARBOHYDRATE KINASE ACTIVITY	21	4.32e-01	5.40e-01	0.2390	-1.26e-01	-8.59e-02	1.40e-01	7.08e-02	-9.12e-02	2.92e-02	3.17e-01	4.96e-01	2.66e-01	5.75e-01	4.69e-01	8.17e-01
GOBP POSITIVE REGULATION OF INTERLEUKIN 1 PRODUCTION	63	4.98e-02	1.17e-01	0.2390	-2.09e-01	2.43e-02	6.83e-02	-8.09e-02	-2.71e-02	3.29e-02	4.18e-03	7.39e-01	3.49e-01	2.67e-01	7.10e-01	6.52e-01
GOBP REGULATION OF NUCLEOCYTOPLASMIC TRANSPORT	104	1.63e-03	7.73e-03	0.2390	-1.73e-01	-7.68e-02	8.43e-02	4.00e-02	-1.98e-02	1.10e-01	2.29e-03	1.76e-01	1.37e-01	4.81e-01	7.27e-01	5.20e-02
GOBP MACROMOLECULE CATABOLIC PROCESS	1246	1.86e-47	4.92e-45	0.2390	-1.54e-01	-1.25e-01	-1.20e-02	9.68e-02	-5.25e-02	7.53e-02	6.76e-20	1.49e-13	4.76e-01	9.45e-09	1.85e-03	7.92e-06
GOMF FIBROBLAST GROWTH FACTOR BINDING	19	6.72e-01	7.39e-01	0.2390	-8.37e-02	-5.12e-03	-7.01e-02	1.25e-02	-4.99e-02	-2.06e-01	5.28e-01	9.69e-01	5.97e-01	9.25e-01	7.07e-01	1.20e-01
GOBP NEGATIVE REGULATION OF PHOSPHORUS METABOLIC PROCESS	304	6.44e-10	1.07e-08	0.2390	-1.02e-01	-1.11e-02	1.59e-01	4.26e-02	-8.03e-02	1.13e-01	2.18e-03	7.40e-01	1.76e-06	2.01e-01	1.61e-02	6.73e-04
GOBP NEGATIVE REGULATION OF PHOSPHORYLATION	249	1.92e-07	2.24e-06	0.2390	-1.11e-01	-1.90e-02	1.57e-01	1.72e-02	-8.29e-02	1.12e-01	2.52e-03	6.06e-01	1.98e-05	6.41e-01	2.43e-02	2.40e-03
GOBP MACROMOLECULE DEACYLATION	56	1.95e-01	3.11e-01	0.2390	-9.12e-02	-1.14e-01	-1.17e-01	9.95e-02	1.05e-01	-3.28e-02	2.38e-01	1.39e-01	1.30e-01	1.98e-01	1.74e-01	6.71e-01
GOBP VASCULAR ASSOCIATED SMOOTH MUSCLE CELL PROLIFERATION	51	1.99e-02	5.91e-02	0.2390	-1.50e-01	1.59e-02	1.69e-01	-2.14e-02	-7.25e-02	-6.39e-03	6.34e-02	8.44e-01	3.74e-02	7.91e-01	3.71e-01	9.37e-01
GOBP CELLULAR RESPONSE TO NUTRIENT LEVELS	205	8.07e-10	1.31e-08	0.2390	-1.84e-01	-3.89e-02	5.06e-02	2.95e-02	-1.34e-01	-1.82e-02	5.58e-06	3.37e-01	2.12e-01	4.67e-01	9.78e-04	6.53e-01
GOBP STEROL METABOLIC PROCESS	112	2.11e-03	9.62e-03	0.2390	1.77e-04	-7.32e-02	1.28e-01	1.41e-01	-7.50e-03	1.24e-01	9.97e-01	1.81e-01	1.96e-02	9.82e-03	8.91e-01	2.37e-02
GOBP VENTRAL SPINAL CORD DEVELOPMENT	24	8.10e-01	8.47e-01	0.2390	1.20e-01	1.30e-01	-3.67e-02	9.47e-02	5.93e-02	-1.09e-01	3.10e-01	2.70e-01	7.56e-01	4.22e-01	6.15e-01	3.56e-01
GOBP REGULATION OF SYNAPTIC TRANSMISSION GLUTAMATERGIC	44	3.16e-01	4.36e-01	0.2390	-1.05e-02	1.29e-01	1.42e-01	-9.45e-02	6.10e-02	8.61e-02	9.04e-01	1.38e-01	1.04e-01	2.78e-01	4.84e-01	3.23e-01
GOBP CELLULAR RESPONSE TO KETONE	82	3.23e-02	8.45e-02	0.2380	-1.96e-01	-1.80e-02	6.45e-02	-3.37e-02	-4.83e-02	1.02e-01	2.11e-03	7.79e-01	3.13e-01	5.97e-01	4.50e-01	1.11e-01
GOCC PINOSOME	9	8.19e-01	8.54e-01	0.2380	-1.72e-01	1.50e-01	6.46e-02	2.48e-02	-5.70e-03	-1.72e-03	3.73e-01	4.35e-01	7.37e-01	8.98e-01	9.76e-01	9.93e-01
GOBP AMIDE METABOLIC PROCESS	359	1.48e-08	2.03e-07	0.2380	-1.34e-01	-1.40e-01	5.64e-02	-2.17e-02	-7.67e-02	9.95e-02	1.37e-05	5.53e-06	6.66e-02	4.80e-01	1.26e-02	1.21e-03
GOBP PROTEIN K48 LINKED DEUBIQUITINATION	25	1.56e-01	2.68e-01	0.2380	-1.67e-01	1.55e-01	1.88e-02	5.62e-02	-3.11e-02	-1.18e-02	1.48e-01	1.79e-01	8.71e-01	6.27e-01	7.88e-01	9.18e-01
GOBP POSTSYNAPTIC SPECIALIZATION ASSEMBLY	21	8.43e-01	8.72e-01	0.2380	3.08e-02	3.21e-02	1.55e-01	1.15e-01	-2.15e-02	1.31e-01	8.07e-01	7.99e-01	2.20e-01	3.62e-01	8.65e-01	3.00e-01
GOBP POSITIVE REGULATION OF ACTIN FILAMENT BUNDLE ASSEMBLY	49	2.64e-02	7.30e-02	0.2380	-1.15e-01	-2.55e-02	7.77e-02	1.52e-01	1.04e-01	5.33e-02	1.63e-01	7.57e-01	3.47e-01	6.65e-02	2.06e-01	5.19e-01
GOBP CELL MORPHOGENESIS	715	3.10e-25	2.02e-23	0.2380	-6.15e-02	9.92e-02	1.69e-01	6.77e-02	-5.05e-03	9.89e-02	5.10e-03	6.33e-06	1.32e-14	2.05e-03	8.18e-01	6.74e-06
GOCC 9PLUS0 NON MOTILE CILIUM	90	2.99e-02	7.99e-02	0.2380	-1.75e-01	-2.13e-03	-9.99e-02	-1.16e-01	4.90e-02	1.17e-02	4.11e-03	9.72e-01	1.02e-01	5.70e-02	4.22e-01	8.48e-01
GOBP POSITIVE REGULATION OF MITOPHAGY IN RESPONSE TO MITOCHONDRIAL DEPOLARIZATION	10	9.48e-01	9.57e-01	0.2380	9.93e-02	-3.43e-02	-1.73e-01	8.76e-02	7.17e-02	-5.43e-02	5.87e-01	8.51e-01	3.45e-01	6.32e-01	6.94e-01	7.66e-01
GOMF PEPTIDE RECEPTOR ACTIVITY	59	2.31e-01	3.49e-01	0.2380	4.77e-02	7.80e-02	1.70e-01	3.34e-02	-1.16e-01	6.81e-02	5.26e-01	3.00e-01	2.37e-02	6.57e-01	1.23e-01	3.66e-01
GOBP RETINA DEVELOPMENT IN CAMERA TYPE EYE	102	1.09e-03	5.49e-03	0.2380	-8.75e-02	1.42e-01	1.61e-01	8.52e-03	-2.52e-02	4.60e-02	1.27e-01	1.32e-02	4.95e-03	8.82e-01	6.60e-01	4.22e-01
GOBP NEURON PROJECTION GUIDANCE	141	8.00e-04	4.21e-03	0.2380	-2.49e-02	1.62e-01	1.59e-01	2.49e-02	1.76e-02	5.86e-02	6.10e-01	8.68e-04	1.14e-03	6.10e-01	7.18e-01	2.29e-01
GOBP PURINE NUCLEOBASE TRANSMEMBRANE TRANSPORT	7	9.85e-01	9.86e-01	0.2380	7.41e-02	1.00e-01	2.16e-02	3.36e-02	1.80e-01	8.36e-02	7.34e-01	6.47e-01	9.21e-01	8.78e-01	4.09e-01	7.02e-01
GOBP PROTEIN CONTAINING COMPLEX ASSEMBLY	1381	1.33e-44	2.87e-42	0.2380	-9.94e-02	-1.77e-01	-5.80e-02	9.63e-02	-2.48e-03	5.16e-02	6.15e-10	2.70e-28	3.04e-04	2.08e-09	8.78e-01	1.33e-03
GOBP RIBONUCLEOSIDE METABOLIC PROCESS	34	4.58e-01	5.63e-01	0.2380	-1.33e-02	-7.29e-03	6.80e-02	-5.76e-02	-7.49e-02	2.07e-01	8.93e-01	9.41e-01	4.93e-01	5.61e-01	4.50e-01	3.70e-02
GOBP VESICLE TRANSPORT ALONG MICROTUBULE	44	9.34e-02	1.87e-01	0.2380	-4.56e-02	1.14e-01	2.92e-02	1.61e-02	-2.24e-02	1.99e-01	6.00e-01	1.90e-01	7.38e-01	8.54e-01	7.97e-01	2.21e-02
GOBP POSITIVE REGULATION OF NOTCH SIGNALING PATHWAY	37	4.35e-01	5.43e-01	0.2380	-5.01e-02	5.53e-02	-2.46e-02	1.24e-01	1.78e-01	5.72e-02	5.98e-01	5.60e-01	7.95e-01	1.91e-01	6.15e-02	5.47e-01
GOBP REGULATION OF NEURON PROJECTION REGENERATION	27	2.71e-01	3.90e-01	0.2380	-8.44e-02	1.69e-01	-1.76e-02	-8.28e-02	-8.95e-02	-7.54e-02	4.48e-01	1.29e-01	8.74e-01	4.57e-01	4.21e-01	4.98e-01
GOBP NEGATIVE REGULATION OF CYCLIN DEPENDENT PROTEIN SERINE THREONINE KINASE ACTIVITY	18	7.31e-01	7.85e-01	0.2370	-5.92e-03	-5.49e-02	-3.14e-02	1.82e-01	1.13e-01	-8.05e-02	9.65e-01	6.87e-01	8.17e-01	1.82e-01	4.05e-01	5.55e-01
GOBP NEGATIVE REGULATION OF PROTEIN POLYMERIZATION	69	2.32e-01	3.50e-01	0.2370	4.46e-02	3.67e-02	1.56e-01	9.45e-02	-3.87e-02	1.36e-01	5.22e-01	5.99e-01	2.55e-02	1.75e-01	5.79e-01	5.14e-02
GOBP FEMALE GAMETE GENERATION	108	8.58e-03	3.05e-02	0.2370	-1.26e-01	-9.40e-02	4.63e-02	5.44e-02	-5.73e-02	1.52e-01	2.36e-02	9.16e-02	4.05e-01	3.28e-01	3.03e-01	6.26e-03
GOBP REGULATION OF ACTIN FILAMENT LENGTH	137	1.94e-04	1.22e-03	0.2370	-8.19e-02	-9.18e-03	1.79e-01	5.41e-02	-2.99e-02	1.17e-01	9.79e-02	8.53e-01	3.06e-04	2.74e-01	5.46e-01	1.77e-02
GOBP REGULATION OF BEHAVIOR	48	2.49e-01	3.68e-01	0.2370	-3.22e-02	1.57e-01	2.19e-02	3.65e-02	1.70e-01	-8.70e-03	6.99e-01	6.04e-02	7.93e-01	6.62e-01	4.18e-02	9.17e-01
GOBP PROTEIN LOCALIZATION TO CYTOSKELETON	58	3.02e-02	8.05e-02	0.2370	-7.32e-02	5.73e-02	6.30e-02	1.74e-01	-7.17e-04	1.15e-01	3.35e-01	4.50e-01	4.07e-01	2.16e-02	9.92e-01	1.29e-01
GOBP TRIGLYCERIDE BIOSYNTHETIC PROCESS	35	1.44e-01	2.53e-01	0.2370	-2.08e-01	6.90e-02	7.38e-02	-5.14e-02	1.41e-03	-1.58e-02	3.34e-02	4.80e-01	4.50e-01	5.99e-01	9.88e-01	8.71e-01
GOBP OOGENESIS	70	8.59e-02	1.75e-01	0.2370	-1.68e-01	-1.00e-01	4.08e-02	2.21e-02	-5.75e-02	1.12e-01	1.51e-02	1.47e-01	5.55e-01	7.49e-01	4.06e-01	1.06e-01
GOBP REGULATION OF CYTOSOLIC CALCIUM ION CONCENTRATION	32	4.03e-01	5.14e-01	0.2370	-4.09e-02	1.10e-01	1.92e-01	3.37e-02	-4.01e-02	5.31e-02	6.89e-01	2.82e-01	6.00e-02	7.42e-01	6.95e-01	6.03e-01
GOBP R LOOP PROCESSING	9	9.04e-01	9.21e-01	0.2370	-1.24e-01	-3.08e-02	-2.98e-02	5.68e-02	-5.90e-02	1.80e-01	5.20e-01	8.73e-01	8.77e-01	7.68e-01	7.59e-01	3.50e-01
GOBP TYROSINE PHOSPHORYLATION OF STAT PROTEIN	48	9.00e-02	1.81e-01	0.2370	-4.51e-02	1.18e-02	8.46e-02	-1.82e-01	5.15e-02	1.06e-01	5.89e-01	8.87e-01	3.11e-01	2.94e-02	5.37e-01	2.05e-01
GOCC APICAL PART OF CELL	311	5.21e-07	5.72e-06	0.2370	-2.96e-02	8.95e-02	1.81e-01	7.77e-03	-3.68e-02	1.15e-01	3.70e-01	6.67e-03	4.36e-08	8.14e-01	2.64e-01	4.78e-04
GOMF G PROTEIN ALPHA SUBUNIT BINDING	21	4.10e-01	5.21e-01	0.2370	-1.25e-01	8.27e-02	1.76e-01	3.61e-02	7.81e-03	3.64e-02	3.21e-01	5.12e-01	1.63e-01	7.74e-01	9.51e-01	7.73e-01
GOBP CELLULAR RESPONSE TO BIOTIC STIMULUS	211	1.35e-10	2.39e-09	0.2370	-1.09e-01	2.42e-02	1.91e-01	5.00e-02	5.24e-03	6.88e-02	6.21e-03	5.45e-01	1.81e-06	2.11e-01	8.96e-01	8.52e-02
GOBP INORGANIC ANION TRANSMEMBRANE TRANSPORT	80	2.13e-02	6.21e-02	0.2370	1.02e-01	1.24e-01	1.56e-01	6.03e-03	4.07e-02	-6.58e-02	1.14e-01	5.48e-02	1.62e-02	9.26e-01	5.29e-01	3.09e-01
GOMF PRE MRNA BINDING	36	7.44e-01	7.96e-01	0.2370	-1.37e-01	-1.24e-01	-6.12e-02	-6.39e-02	-1.11e-01	-4.31e-02	1.56e-01	1.97e-01	5.25e-01	5.07e-01	2.49e-01	6.54e-01
GOBP RESPONSE TO MOLECULE OF BACTERIAL ORIGIN	286	4.31e-12	9.02e-11	0.2370	-6.98e-02	1.16e-02	2.09e-01	5.96e-03	-3.48e-03	8.47e-02	4.24e-02	7.36e-01	1.10e-09	8.62e-01	9.19e-01	1.37e-02
GOBP FATTY ACID TRANSPORT	76	1.19e-04	7.91e-04	0.2370	-7.93e-02	3.52e-02	2.14e-01	-6.89e-03	4.88e-02	9.96e-03	2.32e-01	5.96e-01	1.23e-03	9.17e-01	4.62e-01	8.81e-01
GOBP INTRACELLULAR TRIGLYCERIDE HOMEOSTASIS	9	7.24e-01	7.80e-01	0.2370	-1.95e-02	1.16e-01	-1.16e-01	3.43e-02	3.83e-02	1.62e-01	9.19e-01	5.48e-01	5.47e-01	8.59e-01	8.42e-01	4.01e-01
GOBP POSITIVE REGULATION OF MONOATOMIC ION TRANSMEMBRANE TRANSPORT	106	8.32e-02	1.71e-01	0.2370	7.74e-02	4.17e-02	1.71e-01	1.78e-02	-3.70e-02	1.32e-01	1.69e-01	4.58e-01	2.33e-03	7.52e-01	5.10e-01	1.92e-02
GOBP REGULATION OF CELLULAR RESPONSE TO HYPOXIA	14	6.94e-01	7.57e-01	0.2370	-4.42e-02	2.22e-02	6.08e-02	1.95e-01	-7.31e-02	8.11e-02	7.75e-01	8.85e-01	6.94e-01	2.07e-01	6.36e-01	5.99e-01
GOBP TONGUE DEVELOPMENT	10	7.05e-01	7.65e-01	0.2370	-1.33e-01	1.55e-01	-8.29e-02	-2.45e-02	-3.05e-02	7.59e-02	4.67e-01	3.95e-01	6.50e-01	8.93e-01	8.67e-01	6.78e-01
GOBP MEIOSIS I CELL CYCLE PROCESS	98	5.90e-03	2.24e-02	0.2370	1.92e-02	-1.12e-01	5.22e-04	1.51e-01	-4.88e-04	1.42e-01	7.42e-01	5.52e-02	9.93e-01	9.78e-03	9.93e-01	1.50e-02
GOMF PROTEIN TYROSINE PHOSPHATASE ACTIVITY	79	6.41e-02	1.42e-01	0.2360	-7.16e-02	1.65e-02	1.74e-01	1.66e-02	-9.01e-02	1.10e-01	2.71e-01	8.00e-01	7.64e-03	7.98e-01	1.66e-01	9.24e-02
GOBP PROTEIN POLYUBIQUITINATION	251	4.94e-10	8.29e-09	0.2360	-2.00e-01	-4.49e-02	-3.99e-02	7.00e-02	-7.56e-03	8.65e-02	5.08e-08	2.21e-01	2.76e-01	5.61e-02	8.37e-01	1.83e-02
GOBP POSITIVE REGULATION OF TYROSINE PHOSPHORYLATION OF STAT PROTEIN	38	1.36e-01	2.44e-01	0.2360	-6.47e-02	-4.89e-02	-2.14e-03	-2.12e-01	6.40e-02	2.05e-02	4.90e-01	6.02e-01	9.82e-01	2.40e-02	4.95e-01	8.27e-01
GOMF TRANSFERRIN RECEPTOR BINDING	10	8.98e-01	9.16e-01	0.2360	-2.20e-01	-3.00e-02	-3.98e-02	1.23e-03	-4.78e-02	-4.96e-02	2.27e-01	8.69e-01	8.27e-01	9.95e-01	7.93e-01	7.86e-01
GOBP NEGATIVE REGULATION OF RNA CATABOLIC PROCESS	70	8.66e-02	1.76e-01	0.2360	-1.66e-01	-1.38e-01	-4.31e-02	4.56e-02	-6.78e-02	2.64e-02	1.62e-02	4.62e-02	5.33e-01	5.10e-01	3.26e-01	7.02e-01
GOBP NEGATIVE REGULATION OF CELL CELL ADHESION	161	9.97e-04	5.07e-03	0.2360	-3.49e-03	3.21e-02	1.84e-01	7.18e-02	-3.95e-02	1.19e-01	9.39e-01	4.82e-01	5.59e-05	1.16e-01	3.87e-01	9.18e-03
GOBP POSITIVE REGULATION OF OSTEOBLAST PROLIFERATION	10	8.19e-01	8.53e-01	0.2360	-5.27e-02	-3.84e-02	2.10e-01	4.94e-03	-8.53e-02	-4.63e-03	7.73e-01	8.33e-01	2.50e-01	9.78e-01	6.41e-01	9.80e-01
GOBP LAMELLIPODIUM ASSEMBLY	63	1.49e-01	2.60e-01	0.2360	-1.40e-01	-4.33e-02	1.06e-01	9.17e-03	-7.41e-02	1.32e-01	5.48e-02	5.52e-01	1.46e-01	9.00e-01	3.09e-01	6.99e-02
GOBP REGULATION OF ACTOMYOSIN STRUCTURE ORGANIZATION	81	9.49e-04	4.87e-03	0.2360	-1.21e-01	4.79e-02	9.28e-02	1.53e-01	4.84e-02	6.58e-02	5.91e-02	4.57e-01	1.49e-01	1.75e-02	4.51e-01	3.06e-01
GOBP IMMUNE RESPONSE REGULATING SIGNALING PATHWAY	508	8.96e-19	3.38e-17	0.2360	-5.29e-02	1.18e-01	7.66e-02	1.20e-01	2.02e-02	1.35e-01	4.13e-02	5.15e-06	3.14e-03	3.48e-06	4.36e-01	2.11e-07
GOBP RESPONSE TO BMP	103	5.12e-04	2.86e-03	0.2360	-9.07e-02	1.50e-01	1.51e-01	2.31e-02	-1.60e-02	3.51e-02	1.12e-01	8.58e-03	7.97e-03	6.86e-01	7.79e-01	5.38e-01
GOBP MUSCLE SYSTEM PROCESS	303	2.72e-08	3.62e-07	0.2360	-4.53e-02	1.47e-02	2.00e-01	-2.46e-02	-7.17e-02	8.70e-02	1.75e-01	6.59e-01	2.15e-09	4.61e-01	3.20e-02	9.22e-03
GOCC PRESYNAPTIC MEMBRANE	99	3.65e-04	2.14e-03	0.2360	-3.73e-02	1.72e-01	8.32e-02	6.40e-02	7.67e-02	-8.69e-02	5.22e-01	3.07e-03	1.52e-01	2.71e-01	1.87e-01	1.35e-01
GOMF TRANSCRIPTION COACTIVATOR ACTIVITY	250	2.11e-10	3.67e-09	0.2360	-2.50e-02	1.66e-02	2.33e-02	2.27e-01	2.13e-02	4.65e-02	4.96e-01	6.52e-01	5.25e-01	6.62e-10	5.62e-01	2.06e-01
GOBP T CELL ACTIVATION	497	4.49e-13	1.03e-11	0.2360	3.10e-03	1.13e-01	9.07e-02	1.42e-01	5.68e-02	1.06e-01	9.06e-01	1.71e-05	5.35e-04	6.10e-08	3.01e-02	5.56e-05
GOBP REGULATION OF BONE MINERALIZATION	57	2.73e-02	7.48e-02	0.2350	-1.14e-01	1.37e-01	7.32e-02	-9.43e-02	-1.40e-02	-9.62e-02	1.35e-01	7.46e-02	3.39e-01	2.18e-01	8.55e-01	2.09e-01
GOBP SEROTONIN TRANSPORT	16	7.60e-01	8.07e-01	0.2350	7.97e-02	-5.52e-02	1.73e-01	-9.17e-02	-8.28e-02	2.76e-02	5.81e-01	7.02e-01	2.30e-01	5.26e-01	5.66e-01	8.48e-01
GOMF LIGAND GATED MONOATOMIC CATION CHANNEL ACTIVITY	77	7.22e-02	1.54e-01	0.2350	1.34e-01	1.10e-01	1.52e-01	1.95e-02	2.50e-02	-3.86e-02	4.28e-02	9.50e-02	2.15e-02	7.67e-01	7.05e-01	5.58e-01
GOMF DINUCLEOTIDE PHOSPHATASE ACTIVITY	7	9.04e-01	9.21e-01	0.2350	1.13e-01	-1.20e-02	-1.61e-01	1.64e-02	-1.04e-01	-7.32e-02	6.04e-01	9.56e-01	4.60e-01	9.40e-01	6.35e-01	7.37e-01
GOBP PLACENTA DEVELOPMENT	108	2.69e-05	2.08e-04	0.2350	-1.02e-01	5.99e-02	1.88e-01	5.98e-02	-3.36e-02	3.34e-02	6.60e-02	2.82e-01	7.24e-04	2.83e-01	5.46e-01	5.48e-01
GOBP REGULATION OF DENDRITE MORPHOGENESIS	51	6.06e-02	1.36e-01	0.2350	-4.55e-02	1.56e-01	1.01e-01	1.29e-01	4.47e-02	1.16e-02	5.74e-01	5.42e-02	2.11e-01	1.12e-01	5.81e-01	8.87e-01
GOBP BRANCHING MORPHOGENESIS OF AN EPITHELIAL TUBE	94	6.12e-03	2.31e-02	0.2350	1.03e-02	7.78e-02	2.06e-01	6.68e-02	-2.67e-02	3.88e-02	8.63e-01	1.93e-01	5.56e-04	2.63e-01	6.55e-01	5.16e-01
GOBP REGULATION OF MYOTUBE DIFFERENTIATION	29	2.13e-01	3.31e-01	0.2350	7.62e-02	1.91e-02	1.10e-01	1.10e-01	-4.09e-02	-1.52e-01	4.77e-01	8.59e-01	3.04e-01	3.06e-01	7.03e-01	1.56e-01
GOBP THYMUS DEVELOPMENT	38	4.18e-02	1.03e-01	0.2350	-1.68e-01	6.34e-02	6.95e-02	1.28e-01	4.24e-02	1.14e-02	7.33e-02	4.99e-01	4.58e-01	1.74e-01	6.51e-01	9.03e-01
GOBP LEUKOCYTE MEDIATED CYTOTOXICITY	128	4.08e-04	2.35e-03	0.2350	-7.62e-03	3.44e-02	6.07e-02	1.71e-01	-2.19e-02	1.43e-01	8.82e-01	5.02e-01	2.35e-01	8.35e-04	6.69e-01	5.07e-03
GOBP PURINE NUCLEOSIDE MONOPHOSPHATE METABOLIC PROCESS	41	1.42e-01	2.51e-01	0.2350	-8.70e-02	-1.96e-01	2.78e-02	-4.01e-02	2.66e-02	7.86e-02	3.35e-01	3.00e-02	7.58e-01	6.57e-01	7.68e-01	3.84e-01
GOBP REGULATION OF PROTEASOMAL UBIQUITIN DEPENDENT PROTEIN CATABOLIC PROCESS	118	2.56e-04	1.57e-03	0.2350	-1.65e-01	-1.01e-01	2.16e-02	9.51e-02	-6.68e-02	6.09e-02	1.96e-03	5.71e-02	6.86e-01	7.44e-02	2.10e-01	2.53e-01
GOBP BLASTOCYST DEVELOPMENT	96	3.20e-03	1.36e-02	0.2350	-1.10e-01	-1.87e-02	1.43e-02	1.36e-01	1.16e-01	1.03e-01	6.16e-02	7.51e-01	8.08e-01	2.16e-02	4.87e-02	8.27e-02
GOBP NEGATIVE REGULATION OF SUPRAMOLECULAR FIBER ORGANIZATION	135	2.98e-03	1.29e-02	0.2350	1.14e-02	1.93e-02	1.43e-01	1.33e-01	-3.58e-02	1.24e-01	8.19e-01	6.98e-01	4.24e-03	7.76e-03	4.73e-01	1.26e-02
GOBP EPHRIN RECEPTOR SIGNALING PATHWAY	40	1.47e-01	2.57e-01	0.2350	-4.02e-02	1.46e-01	7.00e-02	9.31e-02	-3.92e-02	1.31e-01	6.60e-01	1.11e-01	4.44e-01	3.08e-01	6.68e-01	1.50e-01
GOBP ESTABLISHMENT OR MAINTENANCE OF BIPOLAR CELL POLARITY	48	4.53e-01	5.59e-01	0.2350	-4.41e-02	-6.11e-02	1.24e-01	1.10e-02	-1.29e-01	1.32e-01	5.97e-01	4.64e-01	1.38e-01	8.95e-01	1.22e-01	1.13e-01
GOBP REGULATION OF CHEMOTAXIS	153	9.67e-04	4.94e-03	0.2350	2.41e-03	1.62e-02	1.94e-01	5.34e-02	-1.28e-02	1.20e-01	9.59e-01	7.30e-01	3.52e-05	2.54e-01	7.85e-01	1.07e-02
GOBP SIGNAL TRANSDUCTION IN RESPONSE TO DNA DAMAGE	181	1.36e-06	1.40e-05	0.2350	-9.53e-02	-6.30e-02	-8.39e-03	1.75e-01	5.13e-02	9.27e-02	2.70e-02	1.44e-01	8.46e-01	4.73e-05	2.34e-01	3.14e-02
GOBP REGULATION OF ACTIN FILAMENT ORGANIZATION	230	1.63e-09	2.50e-08	0.2350	-1.14e-01	-1.17e-02	1.54e-01	8.14e-02	-3.35e-03	1.08e-01	2.81e-03	7.61e-01	5.82e-05	3.36e-02	9.30e-01	4.95e-03
GOBP ALPHA AMINO ACID METABOLIC PROCESS	169	3.38e-04	2.00e-03	0.2350	-9.39e-02	-1.84e-01	-1.00e-01	-4.80e-03	2.80e-02	3.84e-02	3.53e-02	3.55e-05	2.49e-02	9.14e-01	5.31e-01	3.89e-01
GOCC GAMMA TUBULIN COMPLEX	19	8.41e-01	8.71e-01	0.2350	-5.43e-03	-7.94e-02	-1.01e-01	9.41e-02	8.93e-02	-1.47e-01	9.67e-01	5.49e-01	4.48e-01	4.78e-01	5.01e-01	2.66e-01
GOBP POSITIVE REGULATION OF KERATINOCYTE DIFFERENTIATION	14	7.98e-01	8.37e-01	0.2350	-3.47e-03	6.41e-02	1.23e-01	1.49e-01	1.14e-01	1.59e-02	9.82e-01	6.78e-01	4.24e-01	3.33e-01	4.59e-01	9.18e-01
GOBP LIPOPROTEIN BIOSYNTHETIC PROCESS	94	5.65e-02	1.29e-01	0.2340	-1.23e-01	-1.45e-01	-1.25e-01	5.31e-02	-1.31e-02	-1.03e-02	3.86e-02	1.50e-02	3.66e-02	3.74e-01	8.26e-01	8.64e-01
GOBP REGULATION OF TELOMERE CAPPING	24	2.16e-01	3.33e-01	0.2340	-3.02e-02	1.02e-01	-1.28e-01	1.65e-01	1.89e-03	2.26e-04	7.98e-01	3.87e-01	2.76e-01	1.62e-01	9.87e-01	9.98e-01
GOBP SEGMENTATION	59	3.14e-01	4.34e-01	0.2340	4.61e-02	1.47e-01	1.87e-02	1.12e-01	1.13e-01	7.43e-02	5.41e-01	5.07e-02	8.04e-01	1.37e-01	1.34e-01	3.23e-01
GOBP REGULATION OF CELL CYCLE PROCESS	629	2.53e-24	1.52e-22	0.2340	-6.24e-02	-1.03e-01	1.16e-02	1.77e-01	-1.14e-03	9.49e-02	7.64e-03	1.13e-05	6.19e-01	3.49e-14	9.61e-01	4.89e-05
GOBP PROTEIN LOCALIZATION TO PERINUCLEAR REGION OF CYTOPLASM	7	9.52e-01	9.61e-01	0.2340	-2.65e-02	-9.91e-02	-6.87e-02	4.14e-02	1.76e-01	-8.37e-02	9.03e-01	6.50e-01	7.53e-01	8.50e-01	4.20e-01	7.01e-01
GOBP EMBRYONIC SKELETAL SYSTEM MORPHOGENESIS	43	2.40e-01	3.58e-01	0.2340	-1.28e-02	1.00e-01	-3.08e-02	1.84e-01	9.22e-02	-3.53e-02	8.84e-01	2.55e-01	7.26e-01	3.66e-02	2.96e-01	6.88e-01
GOBP NUCLEOTIDE EXCISION REPAIR	80	2.09e-02	6.13e-02	0.2340	-1.31e-01	-9.56e-02	-8.69e-02	1.34e-01	5.43e-02	1.22e-02	4.33e-02	1.40e-01	1.79e-01	3.80e-02	4.01e-01	8.50e-01
GOMF ENDOPEPTIDASE REGULATOR ACTIVITY	108	1.32e-02	4.29e-02	0.2340	-1.71e-01	-4.88e-02	4.69e-02	-4.82e-03	-5.34e-02	1.35e-01	2.18e-03	3.81e-01	4.00e-01	9.31e-01	3.38e-01	1.52e-02
GOMF TRANSFERASE ACTIVITY TRANSFERRING NITROGENOUS GROUPS	20	6.05e-01	6.85e-01	0.2340	3.18e-02	-3.92e-02	1.17e-01	4.52e-02	1.27e-01	1.43e-01	8.05e-01	7.61e-01	3.67e-01	7.26e-01	3.25e-01	2.68e-01
GOBP CELLULAR RESPONSE TO INSULIN STIMULUS	177	3.78e-08	4.89e-07	0.2340	-1.52e-01	5.95e-02	1.32e-01	6.29e-02	-2.80e-02	7.74e-02	4.88e-04	1.72e-01	2.43e-03	1.49e-01	5.20e-01	7.59e-02
GOBP GASTRULATION	144	1.64e-05	1.32e-04	0.2340	-6.81e-02	5.65e-02	1.86e-01	7.51e-02	-4.98e-02	6.64e-02	1.58e-01	2.42e-01	1.21e-04	1.20e-01	3.02e-01	1.69e-01
GOBP NEGATIVE REGULATION OF CHEMOTAXIS	37	4.83e-01	5.84e-01	0.2340	8.90e-02	1.29e-01	1.62e-01	-1.44e-02	6.09e-02	8.23e-03	3.49e-01	1.74e-01	8.84e-02	8.79e-01	5.22e-01	9.31e-01
GOBP REGULATION OF OSTEOBLAST DIFFERENTIATION	88	1.64e-02	5.08e-02	0.2340	-6.64e-02	5.81e-02	1.55e-01	3.38e-03	-1.39e-01	5.95e-02	2.82e-01	3.46e-01	1.20e-02	9.56e-01	2.38e-02	3.35e-01
GOBP CELLULAR RESPONSE TO CAMP	37	3.59e-01	4.75e-01	0.2340	-8.74e-02	9.31e-02	1.42e-01	-8.21e-02	-1.08e-01	3.10e-03	3.58e-01	3.27e-01	1.36e-01	3.87e-01	2.57e-01	9.74e-01
GOCC MITOTIC SPINDLE MICROTUBULE	14	7.27e-01	7.82e-01	0.2340	-1.28e-01	-1.28e-01	-1.84e-02	1.34e-01	-1.60e-03	-5.77e-02	4.06e-01	4.06e-01	9.05e-01	3.84e-01	9.92e-01	7.09e-01
GOBP POSITIVE REGULATION OF NEUROGENESIS	182	7.96e-07	8.45e-06	0.2340	-7.56e-02	1.29e-01	1.19e-01	7.76e-02	9.78e-02	4.90e-02	7.88e-02	2.63e-03	5.61e-03	7.09e-02	2.28e-02	2.54e-01
GOBP REGULATION OF STEM CELL POPULATION MAINTENANCE	59	1.59e-02	4.95e-02	0.2340	-3.44e-02	-1.80e-02	-3.63e-02	2.24e-01	-1.94e-02	-3.34e-02	6.48e-01	8.11e-01	6.29e-01	2.90e-03	7.96e-01	6.57e-01
GOBP NEUROMUSCULAR PROCESS	111	1.21e-02	3.99e-02	0.2340	-3.55e-02	1.12e-01	9.20e-02	7.73e-02	1.24e-01	1.04e-01	5.18e-01	4.11e-02	9.41e-02	1.60e-01	2.36e-02	5.83e-02
GOBP POLYOL METABOLIC PROCESS	88	2.03e-03	9.31e-03	0.2340	-2.07e-01	-7.12e-02	4.97e-02	-2.33e-02	4.35e-02	4.35e-02	8.11e-04	2.48e-01	4.20e-01	7.06e-01	4.81e-01	4.80e-01
GOCC BRUSH BORDER	79	1.15e-01	2.16e-01	0.2340	2.58e-02	3.75e-02	1.94e-01	4.86e-02	-2.29e-02	1.09e-01	6.92e-01	5.65e-01	2.85e-03	4.55e-01	7.25e-01	9.43e-02
GOBP CELLULAR RESPONSE TO UV	82	4.61e-02	1.10e-01	0.2330	-7.37e-02	-1.70e-01	-4.73e-02	5.56e-02	-9.75e-02	-7.29e-02	2.48e-01	7.73e-03	4.59e-01	3.84e-01	1.27e-01	2.54e-01
GOBP POSITIVE REGULATION OF NATURAL KILLER CELL MEDIATED IMMUNE RESPONSE TO TUMOR CELL	6	9.82e-01	9.85e-01	0.2330	7.48e-02	-1.35e-01	2.98e-02	-7.47e-02	-1.42e-01	-6.19e-02	7.51e-01	5.66e-01	8.99e-01	7.51e-01	5.46e-01	7.93e-01
GOBP CELL FATE SPECIFICATION	49	4.03e-01	5.14e-01	0.2330	5.99e-02	1.26e-01	7.91e-02	1.41e-01	9.43e-02	-9.65e-03	4.68e-01	1.28e-01	3.38e-01	8.84e-02	2.53e-01	9.07e-01
GOBP REGULATION OF RESPONSE TO TUMOR CELL	21	7.94e-01	8.34e-01	0.2330	-9.51e-02	-1.73e-01	-3.45e-02	6.30e-02	-7.01e-02	7.28e-02	4.51e-01	1.69e-01	7.84e-01	6.17e-01	5.78e-01	5.63e-01
GOBP REGULATION OF BLOOD PRESSURE	119	1.39e-02	4.46e-02	0.2330	-4.45e-02	2.70e-02	1.82e-01	-3.86e-03	-1.75e-02	1.36e-01	4.02e-01	6.11e-01	6.20e-04	9.42e-01	7.41e-01	1.05e-02
GOBP GLYCOPROTEIN METABOLIC PROCESS	312	9.65e-11	1.74e-09	0.2330	-1.80e-01	-6.96e-02	4.32e-02	4.47e-02	-7.49e-02	8.78e-02	4.52e-08	3.45e-02	1.90e-01	1.74e-01	2.30e-02	7.67e-03
GOMF TRANSCRIPTION COREPRESSOR ACTIVITY	176	1.95e-06	1.94e-05	0.2330	4.00e-03	3.08e-02	3.50e-02	2.25e-01	4.05e-02	-5.85e-04	9.27e-01	4.80e-01	4.24e-01	2.67e-07	3.54e-01	9.89e-01
GOBP REGULATION OF T CELL MEDIATED CYTOTOXICITY	42	3.77e-01	4.92e-01	0.2330	-6.23e-02	-1.26e-01	-1.30e-01	1.21e-01	-1.54e-02	-5.25e-02	4.85e-01	1.57e-01	1.45e-01	1.74e-01	8.63e-01	5.56e-01
GOBP PROCESS UTILIZING AUTOPHAGIC MECHANISM	552	6.65e-24	3.70e-22	0.2330	-1.54e-01	-5.70e-02	4.04e-02	1.07e-01	-6.65e-02	1.00e-01	6.71e-10	2.20e-02	1.05e-01	1.74e-05	7.61e-03	5.85e-05
GOMF CORE PROMOTER SEQUENCE SPECIFIC DNA BINDING	39	2.74e-01	3.94e-01	0.2330	-7.23e-02	3.14e-02	5.18e-02	1.62e-01	9.85e-02	9.78e-02	4.35e-01	7.34e-01	5.76e-01	8.04e-02	2.87e-01	2.91e-01
GOBP SENSORY ORGAN MORPHOGENESIS	163	2.59e-04	1.58e-03	0.2330	-1.21e-02	1.90e-01	7.12e-02	4.23e-02	1.07e-01	-3.08e-03	7.89e-01	2.95e-05	1.17e-01	3.51e-01	1.88e-02	9.46e-01
GOBP SECRETION	705	6.08e-24	3.44e-22	0.2330	-9.77e-02	3.07e-02	1.57e-01	5.38e-02	-1.30e-02	1.26e-01	9.96e-06	1.65e-01	1.06e-12	1.49e-02	5.55e-01	1.11e-08
GOBP NEGATIVE REGULATION OF PROTEIN SECRETION	54	1.15e-01	2.16e-01	0.2330	-5.53e-02	9.76e-03	1.61e-01	-1.49e-01	-5.58e-02	5.51e-03	4.82e-01	9.01e-01	4.13e-02	5.83e-02	4.78e-01	9.44e-01
GOMF AMYLOID BETA BINDING	70	1.03e-01	1.99e-01	0.2330	-1.41e-01	-8.48e-02	9.85e-02	1.94e-04	-5.46e-02	1.20e-01	4.12e-02	2.20e-01	1.54e-01	9.98e-01	4.30e-01	8.17e-02
GOBP GLUCAN BIOSYNTHETIC PROCESS	34	3.89e-01	5.02e-01	0.2330	-2.76e-02	1.71e-02	1.35e-01	1.51e-01	3.92e-02	1.03e-01	7.80e-01	8.63e-01	1.74e-01	1.27e-01	6.92e-01	2.97e-01
GOBP ENDOCHONDRAL BONE MORPHOGENESIS	38	6.50e-02	1.43e-01	0.2330	-1.15e-01	1.45e-01	6.56e-02	8.87e-02	6.83e-02	-5.61e-02	2.21e-01	1.21e-01	4.84e-01	3.44e-01	4.67e-01	5.49e-01
GOBP TOLL LIKE RECEPTOR 3 SIGNALING PATHWAY	26	5.74e-01	6.60e-01	0.2330	-1.99e-01	3.12e-02	2.73e-02	-3.59e-02	-2.23e-02	1.06e-01	7.97e-02	7.83e-01	8.09e-01	7.51e-01	8.44e-01	3.49e-01
GOBP REACTIVE NITROGEN SPECIES METABOLIC PROCESS	69	4.29e-02	1.05e-01	0.2330	-1.49e-01	1.40e-02	1.36e-01	-1.02e-01	-3.67e-02	3.79e-02	3.19e-02	8.41e-01	5.10e-02	1.42e-01	5.98e-01	5.87e-01
GOBP REGULATION OF ANIMAL ORGAN MORPHOGENESIS	50	3.31e-01	4.49e-01	0.2330	-6.62e-02	4.29e-02	1.57e-01	-1.25e-01	-4.32e-02	7.73e-02	4.18e-01	6.00e-01	5.51e-02	1.28e-01	5.97e-01	3.44e-01
GOBP DOPAMINE RECEPTOR SIGNALING PATHWAY	28	1.88e-01	3.03e-01	0.2330	-1.36e-01	6.13e-02	1.13e-01	1.16e-01	-5.90e-02	4.67e-02	2.14e-01	5.74e-01	3.00e-01	2.89e-01	5.89e-01	6.69e-01
GOCC CLATHRIN COATED VESICLE	180	2.82e-08	3.74e-07	0.2330	-1.58e-01	-7.01e-02	7.89e-02	1.11e-01	-1.43e-02	7.26e-02	2.47e-04	1.05e-01	6.79e-02	1.01e-02	7.41e-01	9.30e-02
GOMF INTRAMOLECULAR TRANSFERASE ACTIVITY	25	6.31e-01	7.07e-01	0.2330	-1.94e-02	-1.61e-01	-9.70e-02	1.07e-01	4.98e-02	6.59e-02	8.67e-01	1.63e-01	4.01e-01	3.54e-01	6.67e-01	5.69e-01
GOMF CARBOHYDRATE TRANSMEMBRANE TRANSPORTER ACTIVITY	31	3.38e-01	4.55e-01	0.2320	7.17e-02	9.68e-02	8.09e-02	3.66e-03	1.60e-01	-8.52e-02	4.90e-01	3.51e-01	4.35e-01	9.72e-01	1.23e-01	4.11e-01
GOBP REGULATION OF PROTEOLYSIS	496	9.84e-16	2.79e-14	0.2320	-1.82e-01	-8.60e-02	5.21e-02	1.71e-02	-5.03e-02	8.92e-02	4.01e-12	1.04e-03	4.71e-02	5.15e-01	5.51e-02	6.71e-04
GOCC ENDOSOME	927	2.83e-37	4.30e-35	0.2320	-1.30e-01	-4.07e-02	9.36e-02	1.05e-01	-2.92e-02	1.22e-01	2.36e-11	3.57e-02	1.40e-06	6.22e-08	1.32e-01	2.96e-10
GOBP REGULATION OF LYMPHOCYTE DIFFERENTIATION	191	4.06e-04	2.35e-03	0.2320	3.90e-02	1.37e-01	1.14e-01	1.23e-01	2.53e-02	6.98e-02	3.52e-01	1.09e-03	6.38e-03	3.47e-03	5.46e-01	9.63e-02
GOBP CELL CYCLE PROCESS	1101	1.38e-40	2.36e-38	0.2320	-5.42e-02	-1.02e-01	1.23e-02	1.70e-01	-2.31e-03	1.07e-01	2.45e-03	1.13e-08	4.91e-01	1.72e-21	8.97e-01	1.91e-09
GOCC CYTOPLASMIC SIDE OF MEMBRANE	183	6.28e-05	4.49e-04	0.2320	-3.02e-02	4.33e-02	1.35e-01	1.00e-01	-7.06e-02	1.33e-01	4.81e-01	3.13e-01	1.59e-03	1.94e-02	9.97e-02	1.90e-03
GOBP PROTEIN DEACETYLATION	41	3.68e-01	4.84e-01	0.2320	-6.75e-02	-5.89e-02	-9.85e-02	1.24e-01	9.90e-02	-1.05e-01	4.55e-01	5.14e-01	2.75e-01	1.71e-01	2.73e-01	2.44e-01
GOMF PRE MRNA INTRONIC BINDING	11	7.68e-01	8.13e-01	0.2320	-1.76e-01	6.03e-02	-1.05e-01	-2.85e-02	-6.84e-02	5.20e-02	3.12e-01	7.29e-01	5.48e-01	8.70e-01	6.94e-01	7.65e-01
GOBP N GLYCAN PROCESSING	15	7.59e-01	8.07e-01	0.2320	-8.64e-02	8.38e-02	1.75e-01	5.78e-02	2.07e-02	7.03e-02	5.62e-01	5.74e-01	2.41e-01	6.98e-01	8.90e-01	6.38e-01
GOBP NEGATIVE REGULATION OF CELL DIFFERENTIATION	451	3.47e-14	8.78e-13	0.2320	-3.23e-02	6.36e-02	1.85e-01	5.71e-02	-7.22e-02	7.74e-02	2.40e-01	2.08e-02	1.71e-11	3.79e-02	8.60e-03	4.84e-03
GOBP CHOLESTEROL EFFLUX	40	1.32e-02	4.28e-02	0.2320	-5.31e-02	5.81e-02	1.09e-01	1.20e-01	2.54e-02	-1.44e-01	5.62e-01	5.25e-01	2.33e-01	1.91e-01	7.81e-01	1.16e-01
GOBP MULTICELLULAR ORGANISMAL MOVEMENT	44	6.45e-01	7.19e-01	0.2320	7.84e-02	8.71e-02	1.41e-01	6.49e-02	5.73e-02	1.11e-01	3.68e-01	3.18e-01	1.04e-01	4.56e-01	5.10e-01	2.01e-01
GOCC SPERM MIDPIECE	34	4.93e-01	5.92e-01	0.2320	-1.52e-02	7.44e-03	-1.63e-01	-9.99e-02	9.79e-02	-8.52e-02	8.78e-01	9.40e-01	1.01e-01	3.13e-01	3.23e-01	3.90e-01
GOBP PROTEIN MODIFICATION BY SMALL PROTEIN REMOVAL	102	6.58e-04	3.55e-03	0.2310	-1.93e-01	4.72e-02	-2.08e-02	2.69e-02	2.00e-02	1.12e-01	7.59e-04	4.10e-01	7.17e-01	6.39e-01	7.27e-01	5.05e-02
GOBP ALPHA BETA T CELL PROLIFERATION	44	2.21e-01	3.39e-01	0.2310	-5.09e-03	7.80e-02	1.08e-01	1.54e-01	-3.98e-02	1.03e-01	9.53e-01	3.71e-01	2.17e-01	7.72e-02	6.48e-01	2.39e-01
GOBP REGULATION OF CELL JUNCTION ASSEMBLY	154	4.92e-07	5.43e-06	0.2310	-1.22e-01	1.23e-01	1.49e-01	-1.21e-02	-3.26e-02	-2.11e-04	9.10e-03	8.53e-03	1.37e-03	7.95e-01	4.85e-01	9.96e-01
GOBP REGULATION OF JUN KINASE ACTIVITY	36	3.42e-01	4.59e-01	0.2310	-6.75e-02	1.16e-01	-1.65e-02	-2.55e-02	1.73e-01	-6.58e-02	4.83e-01	2.27e-01	8.64e-01	7.91e-01	7.17e-02	4.95e-01
GOMF SYMPORTER ACTIVITY	101	5.10e-02	1.19e-01	0.2310	7.74e-02	1.30e-01	1.54e-01	8.02e-02	1.42e-02	1.66e-02	1.79e-01	2.45e-02	7.46e-03	1.64e-01	8.05e-01	7.73e-01
GOBP MONOCARBOXYLIC ACID TRANSPORT	113	5.31e-04	2.94e-03	0.2310	-2.73e-02	5.80e-02	2.13e-01	-2.22e-03	1.93e-02	5.97e-02	6.16e-01	2.87e-01	9.19e-05	9.68e-01	7.23e-01	2.73e-01
GOBP PHOSPHATIDYLINOSITOL BIOSYNTHETIC PROCESS	119	2.03e-04	1.27e-03	0.2310	-1.27e-01	6.13e-02	-1.77e-02	1.25e-01	1.32e-01	1.79e-02	1.69e-02	2.48e-01	7.39e-01	1.89e-02	1.29e-02	7.36e-01
GOBP CARDIAC SEPTUM MORPHOGENESIS	45	2.67e-01	3.86e-01	0.2310	-4.18e-02	1.50e-01	1.35e-01	3.82e-02	7.95e-02	5.52e-02	6.28e-01	8.12e-02	1.17e-01	6.57e-01	3.56e-01	5.22e-01
GOCC H4 HISTONE ACETYLTRANSFERASE COMPLEX	37	1.05e-01	2.02e-01	0.2310	-1.47e-01	-6.20e-02	-2.02e-02	1.39e-01	-9.13e-02	3.51e-04	1.23e-01	5.14e-01	8.31e-01	1.44e-01	3.37e-01	9.97e-01
GOBP HAIR FOLLICLE MATURATION	9	7.50e-01	8.00e-01	0.2310	-1.28e-01	5.32e-02	6.48e-02	1.21e-01	7.70e-02	-9.63e-02	5.06e-01	7.82e-01	7.36e-01	5.29e-01	6.89e-01	6.17e-01
GOCC VACUOLE	773	1.88e-30	1.94e-28	0.2310	-1.75e-01	-9.77e-02	4.13e-02	6.80e-02	-4.97e-02	6.71e-02	1.46e-16	3.84e-06	5.07e-02	1.30e-03	1.87e-02	1.51e-03
GOBP POSITIVE REGULATION OF STRESS FIBER ASSEMBLY	41	9.55e-02	1.89e-01	0.2310	-1.61e-01	-2.07e-02	-9.77e-03	1.23e-01	1.09e-01	-6.22e-03	7.52e-02	8.19e-01	9.14e-01	1.73e-01	2.28e-01	9.45e-01
GOBP POSITIVE REGULATION OF CELL ADHESION MEDIATED BY INTEGRIN	16	7.26e-01	7.81e-01	0.2310	-7.45e-02	-8.47e-02	1.39e-01	9.17e-02	1.59e-02	1.12e-01	6.06e-01	5.58e-01	3.35e-01	5.25e-01	9.13e-01	4.38e-01
GOBP STEROID HORMONE BIOSYNTHETIC PROCESS	28	7.40e-01	7.93e-01	0.2310	9.39e-03	-7.24e-02	1.18e-01	2.87e-02	-1.44e-01	1.12e-01	9.31e-01	5.07e-01	2.79e-01	7.93e-01	1.88e-01	3.07e-01
GOBP PROTEIN DNA COMPLEX ORGANIZATION	784	2.58e-28	2.11e-26	0.2310	-2.88e-02	-2.42e-02	-1.74e-02	2.12e-01	5.37e-02	5.85e-02	1.70e-01	2.49e-01	4.09e-01	4.57e-24	1.06e-02	5.37e-03
GOBP REGULATION OF MUSCLE SYSTEM PROCESS	168	3.06e-04	1.83e-03	0.2300	-4.71e-02	-5.49e-03	1.93e-01	-2.53e-02	-8.24e-02	7.97e-02	2.93e-01	9.02e-01	1.65e-05	5.71e-01	6.56e-02	7.49e-02
GOBP RESPONSE TO VIRUS	344	1.15e-11	2.29e-10	0.2300	-8.35e-02	-5.09e-02	-7.55e-03	1.30e-01	3.36e-02	1.59e-01	7.78e-03	1.05e-01	8.10e-01	3.40e-05	2.84e-01	3.84e-07
GOBP REGULATION OF STORE OPERATED CALCIUM ENTRY	12	8.94e-01	9.13e-01	0.2300	-8.77e-02	1.07e-01	1.32e-01	-7.39e-03	-1.08e-01	7.03e-02	5.99e-01	5.22e-01	4.30e-01	9.65e-01	5.18e-01	6.73e-01
GOBP POSITIVE REGULATION OF INTERLEUKIN 10 PRODUCTION	36	2.39e-01	3.57e-01	0.2300	-1.29e-01	8.63e-02	2.70e-02	9.35e-02	4.77e-02	1.31e-01	1.81e-01	3.70e-01	7.79e-01	3.32e-01	6.21e-01	1.72e-01
GOBP NEGATIVE REGULATION OF NEURON APOPTOTIC PROCESS	112	1.36e-02	4.38e-02	0.2300	-8.82e-02	1.36e-02	9.81e-02	5.21e-02	-1.28e-02	1.80e-01	1.07e-01	8.04e-01	7.30e-02	3.41e-01	8.15e-01	9.71e-04
GOBP SOMATIC DIVERSIFICATION OF IMMUNOGLOBULINS	65	5.54e-02	1.27e-01	0.2300	-3.90e-02	-3.57e-02	-3.40e-03	1.49e-01	1.61e-02	1.66e-01	5.87e-01	6.19e-01	9.62e-01	3.76e-02	8.22e-01	2.03e-02
GOBP AMINE CATABOLIC PROCESS	16	6.51e-01	7.23e-01	0.2300	-3.27e-02	-1.76e-01	1.43e-02	-1.38e-02	-3.24e-02	-1.39e-01	8.21e-01	2.23e-01	9.21e-01	9.24e-01	8.22e-01	3.34e-01
GOBP REGULATION OF PROTEIN SERINE THREONINE KINASE ACTIVITY	216	5.13e-06	4.65e-05	0.2300	-6.70e-02	-8.26e-02	1.47e-01	3.57e-02	-1.05e-01	8.85e-02	8.99e-02	3.65e-02	2.06e-04	3.66e-01	7.64e-03	2.51e-02
GOBP NEGATIVE REGULATION OF TUMOR NECROSIS FACTOR SUPERFAMILY CYTOKINE PRODUCTION	54	1.69e-01	2.82e-01	0.2300	-3.03e-02	6.73e-02	1.64e-01	1.01e-01	2.93e-02	9.76e-02	7.00e-01	3.92e-01	3.70e-02	2.00e-01	7.10e-01	2.15e-01
GOBP AMINO ACID TRANSMEMBRANE TRANSPORT	71	1.42e-01	2.51e-01	0.2300	-9.71e-02	-1.15e-01	1.06e-02	-6.34e-03	-1.73e-01	-8.16e-03	1.57e-01	9.27e-02	8.77e-01	9.26e-01	1.16e-02	9.05e-01
GOBP MUCOPOLYSACCHARIDE METABOLIC PROCESS	76	3.21e-04	1.91e-03	0.2300	-1.87e-01	-2.24e-02	9.26e-02	7.43e-02	-5.70e-02	-1.05e-02	4.83e-03	7.36e-01	1.63e-01	2.63e-01	3.90e-01	8.74e-01
GOBP CELLULAR RESPONSE TO MOLECULE OF BACTERIAL ORIGIN	184	4.09e-09	6.04e-08	0.2300	-8.79e-02	1.59e-02	1.95e-01	4.88e-02	2.37e-02	6.21e-02	3.98e-02	7.10e-01	4.91e-06	2.53e-01	5.79e-01	1.46e-01
GOBP REGULATION OF ESTABLISHMENT OF PROTEIN LOCALIZATION TO MITOCHONDRION	44	1.71e-01	2.84e-01	0.2300	-1.20e-01	-9.03e-02	5.20e-02	1.24e-01	1.50e-02	1.10e-01	1.68e-01	3.00e-01	5.51e-01	1.55e-01	8.63e-01	2.08e-01
GOBP POSITIVE REGULATION OF PROTEIN CATABOLIC PROCESS	182	3.31e-09	4.93e-08	0.2300	-1.41e-01	-6.25e-02	1.26e-01	9.73e-02	-2.93e-02	5.51e-02	1.04e-03	1.46e-01	3.48e-03	2.37e-02	4.96e-01	1.99e-01
GOBP MITOPHAGY	66	1.50e-01	2.60e-01	0.2300	-9.93e-02	-1.15e-01	-1.14e-01	9.89e-02	4.58e-02	-7.00e-02	1.63e-01	1.06e-01	1.10e-01	1.64e-01	5.20e-01	3.26e-01
GOBP INNATE IMMUNE RESPONSE	782	1.51e-25	1.02e-23	0.2300	-8.35e-02	1.65e-02	7.83e-02	1.07e-01	-6.47e-03	1.67e-01	7.17e-05	4.32e-01	1.98e-04	3.47e-07	7.59e-01	1.89e-15
GOMF HYDROLASE ACTIVITY HYDROLYZING O GLYCOSYL COMPOUNDS	70	8.88e-02	1.80e-01	0.2300	-1.35e-01	-9.09e-02	-7.43e-02	-1.45e-03	-2.20e-02	-1.43e-01	5.08e-02	1.89e-01	2.82e-01	9.83e-01	7.50e-01	3.91e-02
GOBP SKIN DEVELOPMENT	177	6.65e-06	5.87e-05	0.2300	-7.71e-02	3.73e-02	1.71e-01	7.56e-02	-1.42e-02	1.02e-01	7.69e-02	3.93e-01	8.68e-05	8.26e-02	7.45e-01	1.97e-02
GOBP REGULATION OF CELLULAR RESPIRATION	44	2.30e-01	3.49e-01	0.2300	-9.90e-02	-1.12e-01	-1.80e-02	6.94e-02	8.80e-02	1.32e-01	2.56e-01	1.97e-01	8.36e-01	4.26e-01	3.12e-01	1.29e-01
GOBP ACTIN FILAMENT BASED PROCESS	647	4.84e-21	2.27e-19	0.2300	-3.79e-02	3.55e-02	1.81e-01	7.91e-02	-4.63e-02	9.39e-02	1.01e-01	1.23e-01	3.56e-15	6.02e-04	4.48e-02	4.62e-05
GOBP REGULATION OF LEUKOCYTE MEDIATED IMMUNITY	225	2.80e-06	2.71e-05	0.2300	-2.30e-02	1.13e-01	8.79e-02	1.25e-01	2.27e-02	1.25e-01	5.53e-01	3.57e-03	2.32e-02	1.22e-03	5.57e-01	1.25e-03
GOBP POSITIVE REGULATION OF PROTEIN SERINE THREONINE KINASE ACTIVITY	102	2.34e-02	6.69e-02	0.2300	-1.46e-01	-5.81e-02	8.83e-02	-7.98e-02	-1.17e-01	1.13e-03	1.07e-02	3.11e-01	1.23e-01	1.64e-01	4.04e-02	9.84e-01
GOBP ORGANOPHOSPHATE METABOLIC PROCESS	887	3.77e-28	3.07e-26	0.2300	-1.41e-01	-1.63e-01	-3.23e-02	5.75e-02	1.12e-02	4.18e-02	1.10e-12	1.68e-16	1.03e-01	3.71e-03	5.73e-01	3.50e-02
GOCC EXTRINSIC COMPONENT OF MEMBRANE	142	3.95e-05	2.95e-04	0.2300	-7.19e-02	1.21e-01	6.05e-02	1.43e-01	7.19e-02	6.03e-02	1.39e-01	1.29e-02	2.13e-01	3.27e-03	1.39e-01	2.15e-01
GOBP GLYCEROPHOSPHOLIPID CATABOLIC PROCESS	28	6.84e-01	7.49e-01	0.2290	6.74e-02	6.53e-02	1.19e-01	1.03e-01	1.29e-01	4.82e-02	5.37e-01	5.50e-01	2.76e-01	3.43e-01	2.37e-01	6.59e-01
GOBP ORGANELLE TRANSPORT ALONG MICROTUBULE	84	4.28e-02	1.05e-01	0.2290	-8.90e-02	4.55e-03	6.10e-02	3.65e-02	-3.19e-02	1.96e-01	1.59e-01	9.43e-01	3.34e-01	5.63e-01	6.13e-01	1.86e-03
GOBP CHROMATIN REMODELING	563	5.38e-21	2.51e-19	0.2290	-2.57e-02	1.03e-03	1.54e-02	2.16e-01	4.37e-02	5.72e-02	2.97e-01	9.67e-01	5.33e-01	2.10e-18	7.66e-02	2.04e-02
GOBP NEGATIVE REGULATION OF LYMPHOCYTE APOPTOTIC PROCESS	34	6.82e-01	7.47e-01	0.2290	9.48e-02	4.74e-02	1.12e-01	9.96e-02	-4.62e-02	1.29e-01	3.39e-01	6.32e-01	2.59e-01	3.15e-01	6.41e-01	1.92e-01
GOCC CILIARY BASAL BODY	152	2.04e-03	9.34e-03	0.2290	-7.14e-02	1.03e-03	-1.18e-01	7.88e-02	1.65e-01	-4.85e-03	1.29e-01	9.82e-01	1.23e-02	9.36e-02	4.30e-04	9.18e-01
GOBP MODULATION BY SYMBIONT OF ENTRY INTO HOST	42	1.74e-01	2.88e-01	0.2290	-6.00e-02	-1.14e-01	3.36e-02	1.72e-01	-4.41e-02	5.76e-02	5.01e-01	2.01e-01	7.06e-01	5.38e-02	6.21e-01	5.19e-01
GOBP NUCLEOSIDE DIPHOSPHATE CATABOLIC PROCESS	87	2.89e-03	1.26e-02	0.2290	-1.10e-01	-5.31e-02	1.21e-01	1.10e-01	-6.36e-02	8.18e-02	7.49e-02	3.92e-01	5.14e-02	7.54e-02	3.05e-01	1.87e-01
GOBP CYTOKINE MEDIATED SIGNALING PATHWAY	393	6.68e-10	1.10e-08	0.2290	-3.33e-02	6.21e-02	1.58e-01	7.99e-02	8.42e-03	1.27e-01	2.57e-01	3.46e-02	7.79e-08	6.59e-03	7.75e-01	1.52e-05
GOBP PROTEIN HOMOTETRAMERIZATION	51	1.12e-01	2.12e-01	0.2290	-1.77e-01	-1.12e-01	-4.53e-02	6.68e-02	-1.17e-03	-4.71e-02	2.92e-02	1.66e-01	5.76e-01	4.10e-01	9.88e-01	5.61e-01
GOBP SPLEEN DEVELOPMENT	30	1.65e-01	2.78e-01	0.2290	-1.17e-01	-1.73e-02	1.19e-01	6.25e-02	-1.37e-01	-4.18e-02	2.68e-01	8.69e-01	2.60e-01	5.54e-01	1.94e-01	6.92e-01
GOMF ATPASE COUPLED TRANSMEMBRANE TRANSPORTER ACTIVITY	76	1.30e-02	4.24e-02	0.2290	-8.21e-03	5.45e-02	1.77e-01	1.17e-01	-5.62e-02	3.73e-02	9.02e-01	4.12e-01	7.69e-03	7.90e-02	3.97e-01	5.75e-01
GOBP NEGATIVE REGULATION OF LIPID METABOLIC PROCESS	71	8.76e-02	1.78e-01	0.2290	1.05e-02	8.85e-02	1.82e-01	5.83e-02	5.18e-02	7.22e-02	8.79e-01	1.97e-01	7.97e-03	3.95e-01	4.51e-01	2.93e-01
GOBP BIOLOGICAL PROCESS INVOLVED IN SYMBIOTIC INTERACTION	254	1.62e-09	2.48e-08	0.2290	-1.05e-01	-8.68e-02	1.05e-01	1.07e-01	-4.33e-02	9.75e-02	4.13e-03	1.72e-02	3.87e-03	3.33e-03	2.34e-01	7.48e-03
GOBP RESPONSE TO KETONE	158	1.04e-04	7.01e-04	0.2290	-1.26e-01	-1.54e-02	1.53e-01	7.18e-03	-5.45e-02	9.88e-02	6.10e-03	7.39e-01	9.20e-04	8.76e-01	2.37e-01	3.21e-02
GOBP LEUKOCYTE DIFFERENTIATION	526	1.22e-14	3.22e-13	0.2290	-3.60e-02	8.54e-02	1.57e-01	8.19e-02	-1.37e-02	1.10e-01	1.58e-01	8.06e-04	7.35e-10	1.31e-03	5.91e-01	1.51e-05
GOBP REGULATION OF PROTEIN CATABOLIC PROCESS	323	1.24e-12	2.75e-11	0.2290	-1.50e-01	-9.22e-02	8.18e-02	7.60e-02	-5.94e-02	7.27e-02	3.60e-06	4.40e-03	1.16e-02	1.88e-02	6.66e-02	2.47e-02
GOBP CELLULAR RESPONSE TO ACID CHEMICAL	71	1.53e-01	2.64e-01	0.2290	-2.08e-02	5.77e-02	1.62e-01	7.88e-02	1.76e-03	1.27e-01	7.62e-01	4.00e-01	1.84e-02	2.51e-01	9.80e-01	6.46e-02
GOBP LYMPHOCYTE DIFFERENTIATION	375	1.61e-08	2.21e-07	0.2290	2.05e-02	1.17e-01	1.34e-01	1.06e-01	2.83e-04	9.42e-02	4.96e-01	1.02e-04	8.30e-06	4.14e-04	9.92e-01	1.74e-03
GOBP SMALL MOLECULE CATABOLIC PROCESS	310	5.05e-07	5.57e-06	0.2290	-8.84e-02	-1.52e-01	-1.22e-01	4.76e-02	6.18e-02	-1.24e-02	7.44e-03	4.07e-06	2.10e-04	1.49e-01	6.16e-02	7.07e-01
GOCC MYELIN SHEATH	40	4.36e-01	5.44e-01	0.2280	-9.92e-02	-1.30e-01	-5.04e-02	3.00e-02	-1.48e-01	-2.10e-03	2.77e-01	1.54e-01	5.81e-01	7.43e-01	1.05e-01	9.82e-01
GOMF SYNTAXIN BINDING	51	1.95e-01	3.11e-01	0.2280	-1.80e-01	-9.36e-02	-2.94e-02	4.49e-02	-6.88e-02	5.87e-02	2.64e-02	2.47e-01	7.17e-01	5.79e-01	3.95e-01	4.68e-01
GOBP CELL MORPHOGENESIS INVOLVED IN NEURON DIFFERENTIATION	412	1.47e-13	3.47e-12	0.2280	-3.80e-02	1.52e-01	1.41e-01	6.80e-02	2.46e-02	5.10e-02	1.86e-01	1.23e-07	9.66e-07	1.80e-02	3.92e-01	7.59e-02
GOMF TUMOR NECROSIS FACTOR RECEPTOR SUPERFAMILY BINDING	44	3.72e-01	4.87e-01	0.2280	-1.03e-02	2.81e-02	-8.28e-02	5.00e-02	2.03e-01	2.71e-02	9.06e-01	7.47e-01	3.42e-01	5.66e-01	1.99e-02	7.56e-01
GOBP REGULATION OF SECRETION	436	1.27e-14	3.32e-13	0.2280	-9.54e-02	1.93e-02	1.70e-01	3.96e-02	-3.61e-02	1.05e-01	6.37e-04	4.89e-01	1.23e-09	1.56e-01	1.97e-01	1.81e-04
GOBP COGNITION	227	1.92e-06	1.92e-05	0.2280	-1.33e-01	5.89e-02	1.15e-01	6.54e-03	-2.62e-04	1.33e-01	5.80e-04	1.26e-01	2.77e-03	8.65e-01	9.95e-01	5.50e-04
GOBP REGULATION OF GLYCOPROTEIN METABOLIC PROCESS	39	4.53e-01	5.58e-01	0.2280	-8.25e-02	4.20e-02	1.65e-01	-4.26e-02	-1.05e-01	5.81e-02	3.73e-01	6.50e-01	7.48e-02	6.45e-01	2.55e-01	5.30e-01
GOBP NUCLEAR TRANSCRIBED MRNA CATABOLIC PROCESS DEADENYLATION DEPENDENT DECAY	60	3.30e-02	8.62e-02	0.2280	-1.68e-01	1.29e-02	-9.29e-02	5.82e-02	4.29e-02	9.83e-02	2.41e-02	8.63e-01	2.14e-01	4.35e-01	5.66e-01	1.88e-01
GOBP ACTIN FILAMENT ORGANIZATION	384	1.53e-13	3.58e-12	0.2280	-8.56e-02	-6.42e-03	1.56e-01	8.45e-02	-2.71e-02	1.12e-01	3.98e-03	8.29e-01	1.60e-07	4.47e-03	3.63e-01	1.71e-04
GOBP POSITIVE REGULATION OF AMYLOID BETA FORMATION	18	6.64e-01	7.32e-01	0.2280	-1.47e-01	4.09e-02	1.47e-01	-6.79e-02	-5.03e-02	1.62e-03	2.80e-01	7.64e-01	2.82e-01	6.18e-01	7.12e-01	9.91e-01
GOCC MRNA CLEAVAGE FACTOR COMPLEX	22	4.52e-01	5.58e-01	0.2280	-1.15e-01	-5.96e-02	-3.79e-02	1.68e-01	-5.88e-02	4.34e-02	3.49e-01	6.29e-01	7.59e-01	1.72e-01	6.33e-01	7.24e-01
GOBP NEGATIVE REGULATION OF MRNA METABOLIC PROCESS	79	1.99e-02	5.91e-02	0.2280	-1.36e-01	-1.26e-01	-1.29e-02	5.82e-02	-1.07e-01	-5.05e-02	3.65e-02	5.36e-02	8.43e-01	3.71e-01	9.87e-02	4.38e-01
GOMF PHOSPHATIDYLINOSITOL 3 5 BISPHOSPHATE BINDING	23	5.42e-01	6.33e-01	0.2280	4.78e-02	-4.03e-02	1.35e-01	5.54e-02	-1.52e-01	-5.85e-02	6.92e-01	7.38e-01	2.62e-01	6.45e-01	2.06e-01	6.27e-01
GOBP NEGATIVE REGULATION OF NERVOUS SYSTEM DEVELOPMENT	94	5.60e-03	2.15e-02	0.2280	-4.63e-02	1.32e-01	1.76e-01	-4.54e-03	-3.58e-02	1.40e-02	4.38e-01	2.68e-02	3.27e-03	9.39e-01	5.49e-01	8.15e-01
GOBP REGULATION OF ATP DEPENDENT ACTIVITY	55	1.81e-01	2.96e-01	0.2280	-2.14e-02	9.60e-03	-6.63e-02	9.87e-02	1.57e-01	1.12e-01	7.84e-01	9.02e-01	3.95e-01	2.06e-01	4.44e-02	1.49e-01
GOMF LAMININ BINDING	23	7.26e-01	7.82e-01	0.2280	-1.11e-01	-6.04e-02	3.42e-02	-1.55e-01	-5.68e-02	-8.62e-02	3.58e-01	6.16e-01	7.77e-01	1.98e-01	6.37e-01	4.74e-01
GOBP FUCOSE CATABOLIC PROCESS	6	9.88e-01	9.89e-01	0.2270	1.94e-02	5.82e-03	6.66e-04	-1.15e-01	-1.69e-01	-9.75e-02	9.34e-01	9.80e-01	9.98e-01	6.27e-01	4.72e-01	6.79e-01
GOBP NEUROTRANSMITTER TRANSPORT	146	2.57e-03	1.14e-02	0.2270	-6.41e-02	6.24e-02	1.65e-01	-1.71e-02	1.73e-02	1.26e-01	1.81e-01	1.93e-01	5.88e-04	7.22e-01	7.18e-01	8.34e-03
GOCC NEURON PROJECTION TERMINUS	79	2.18e-01	3.37e-01	0.2270	9.38e-02	5.92e-02	1.60e-01	8.75e-02	-2.34e-02	7.47e-02	1.49e-01	3.63e-01	1.39e-02	1.79e-01	7.19e-01	2.51e-01
GOBP NEGATIVE REGULATION OF JUN KINASE ACTIVITY	11	9.31e-01	9.43e-01	0.2270	4.48e-03	8.43e-02	9.48e-02	-1.80e-01	1.09e-03	5.63e-02	9.79e-01	6.28e-01	5.86e-01	3.01e-01	9.95e-01	7.47e-01
GOMF CALCIUM ION BINDING	463	4.26e-10	7.21e-09	0.2270	-3.37e-02	8.30e-02	1.72e-01	-1.99e-03	-1.38e-03	1.19e-01	2.15e-01	2.22e-03	2.33e-10	9.42e-01	9.59e-01	1.18e-05
GOMF UBIQUITIN LIKE PROTEIN PEPTIDASE ACTIVITY	106	3.06e-04	1.83e-03	0.2270	-1.92e-01	9.02e-02	-1.38e-02	1.46e-02	3.66e-02	7.01e-02	6.34e-04	1.09e-01	8.06e-01	7.95e-01	5.15e-01	2.13e-01
GOCC BASAL PART OF CELL	224	1.56e-07	1.84e-06	0.2270	-2.98e-02	1.34e-01	1.72e-01	4.04e-02	-3.18e-02	2.55e-02	4.42e-01	5.59e-04	9.24e-06	2.98e-01	4.12e-01	5.10e-01
GOBP REGULATION OF ANATOMICAL STRUCTURE MORPHOGENESIS	640	4.06e-20	1.74e-18	0.2270	-4.78e-02	8.25e-02	1.77e-01	5.68e-02	-1.32e-02	8.75e-02	3.92e-02	3.74e-04	1.84e-14	1.42e-02	5.69e-01	1.60e-04
GOBP TELENCEPHALON DEVELOPMENT	200	6.22e-05	4.45e-04	0.2270	-3.84e-02	1.20e-01	1.41e-01	6.74e-02	3.67e-02	9.93e-02	3.49e-01	3.39e-03	5.74e-04	1.00e-01	3.70e-01	1.55e-02
GOCC PCG PROTEIN COMPLEX	45	1.17e-01	2.19e-01	0.2270	-1.25e-01	-6.83e-02	-5.47e-02	1.24e-01	6.91e-02	-9.03e-02	1.48e-01	4.28e-01	5.26e-01	1.49e-01	4.23e-01	2.95e-01
GOBP ANDROGEN RECEPTOR SIGNALING PATHWAY	41	5.07e-01	6.03e-01	0.2270	4.71e-02	-7.46e-03	1.46e-01	1.17e-01	-4.74e-02	1.10e-01	6.02e-01	9.34e-01	1.06e-01	1.95e-01	5.99e-01	2.23e-01
GOBP ACYL COA METABOLIC PROCESS	84	3.57e-02	9.14e-02	0.2270	-1.01e-01	-1.64e-01	-7.32e-03	2.25e-02	1.41e-02	1.17e-01	1.09e-01	9.52e-03	9.08e-01	7.21e-01	8.23e-01	6.27e-02
GOBP POSITIVE REGULATION OF DNA METABOLIC PROCESS	272	9.75e-10	1.56e-08	0.2270	-5.50e-02	-8.50e-02	-3.69e-02	1.95e-01	8.17e-03	4.47e-02	1.18e-01	1.59e-02	2.94e-01	3.34e-08	8.17e-01	2.04e-01
GOBP NEGATIVE REGULATION OF T CELL PROLIFERATION	63	1.03e-01	2.00e-01	0.2270	-3.05e-02	-6.67e-02	1.34e-01	1.06e-01	-7.84e-02	1.03e-01	6.76e-01	3.60e-01	6.49e-02	1.46e-01	2.82e-01	1.56e-01
GOBP PYRUVATE METABOLIC PROCESS	101	2.19e-03	9.91e-03	0.2270	-1.05e-01	-1.02e-01	8.32e-02	1.13e-01	-5.27e-02	8.63e-02	6.72e-02	7.56e-02	1.49e-01	4.94e-02	3.60e-01	1.34e-01
GOBP BONE DEVELOPMENT	148	1.34e-06	1.38e-05	0.2270	-1.07e-01	3.90e-02	1.18e-01	1.16e-01	8.48e-02	6.37e-02	2.50e-02	4.13e-01	1.32e-02	1.52e-02	7.51e-02	1.81e-01
GOBP POSITIVE REGULATION OF COLLAGEN METABOLIC PROCESS	19	7.84e-01	8.26e-01	0.2270	-4.60e-02	-9.67e-02	6.69e-02	9.25e-02	-1.39e-01	8.72e-02	7.28e-01	4.66e-01	6.14e-01	4.85e-01	2.94e-01	5.11e-01
GOBP RENAL TUBULAR SECRETION	8	9.17e-01	9.31e-01	0.2270	4.46e-03	5.03e-02	1.40e-01	2.76e-03	1.63e-01	5.30e-02	9.83e-01	8.06e-01	4.93e-01	9.89e-01	4.26e-01	7.95e-01
GOBP CELLULAR RESPONSE TO INORGANIC SUBSTANCE	164	3.19e-04	1.90e-03	0.2270	-3.94e-02	-3.49e-03	1.56e-01	8.43e-02	1.12e-02	1.35e-01	3.84e-01	9.39e-01	5.80e-04	6.26e-02	8.04e-01	2.77e-03
GOBP ORGANONITROGEN COMPOUND CATABOLIC PROCESS	1266	3.81e-41	6.67e-39	0.2270	-1.42e-01	-1.22e-01	1.93e-02	7.71e-02	-3.50e-02	9.28e-02	1.81e-17	2.54e-13	2.49e-01	4.11e-06	3.65e-02	2.92e-08
GOMF AMIDE TRANSMEMBRANE TRANSPORTER ACTIVITY	29	5.28e-01	6.20e-01	0.2270	-3.19e-02	-1.48e-01	8.22e-02	-2.80e-02	-1.37e-01	-4.58e-02	7.66e-01	1.68e-01	4.43e-01	7.94e-01	2.02e-01	6.70e-01
GOBP TRANSFORMING GROWTH FACTOR BETA RECEPTOR SIGNALING PATHWAY	168	2.46e-05	1.91e-04	0.2260	-6.63e-02	5.80e-02	1.60e-01	8.16e-02	-5.35e-02	9.09e-02	1.38e-01	1.95e-01	3.33e-04	6.82e-02	2.32e-01	4.21e-02
GOBP NEGATIVE REGULATION OF TRANSLATION	114	5.25e-03	2.04e-02	0.2260	-2.04e-01	-6.85e-02	-4.00e-02	9.18e-03	-4.79e-02	3.24e-02	1.70e-04	2.06e-01	4.61e-01	8.66e-01	3.77e-01	5.50e-01
GOBP TRANSCRIPTION INITIATION AT RNA POLYMERASE II PROMOTER	146	3.60e-04	2.12e-03	0.2260	-4.24e-02	-9.40e-02	-6.45e-02	1.85e-01	4.27e-02	2.21e-02	3.77e-01	5.01e-02	1.78e-01	1.17e-04	3.73e-01	6.45e-01
GOBP REGULATION OF PROTEIN LOCALIZATION TO NUCLEUS	124	4.77e-04	2.71e-03	0.2260	-9.20e-02	-6.72e-02	7.55e-02	1.33e-01	-5.58e-02	1.08e-01	7.70e-02	1.96e-01	1.47e-01	1.08e-02	2.83e-01	3.71e-02
GOBP RESPONSE TO INSULIN	225	1.53e-09	2.36e-08	0.2260	-1.51e-01	7.04e-02	1.27e-01	4.12e-02	-1.88e-02	7.20e-02	9.74e-05	6.88e-02	1.02e-03	2.87e-01	6.28e-01	6.28e-02
GOBP POSITIVE REGULATION OF CHEMOTAXIS	103	1.71e-02	5.23e-02	0.2260	-1.13e-02	-3.56e-02	1.68e-01	7.65e-02	-3.68e-02	1.20e-01	8.43e-01	5.33e-01	3.24e-03	1.80e-01	5.19e-01	3.60e-02
GOBP REGULATION OF MITOTIC CELL CYCLE	448	1.46e-15	4.07e-14	0.2260	-6.93e-02	-1.10e-01	1.32e-02	1.59e-01	8.05e-03	9.21e-02	1.19e-02	6.33e-05	6.32e-01	7.71e-09	7.70e-01	8.33e-04
GOBP REGULATION OF SYSTEMIC ARTERIAL BLOOD PRESSURE	61	3.11e-01	4.31e-01	0.2260	-1.76e-03	9.86e-02	1.81e-01	-2.18e-02	-4.72e-02	7.59e-02	9.81e-01	1.83e-01	1.44e-02	7.68e-01	5.24e-01	3.05e-01
GOBP MEMBRANE LIPID BIOSYNTHETIC PROCESS	125	1.48e-02	4.70e-02	0.2260	-1.44e-01	-5.89e-02	3.40e-02	-1.45e-02	-7.41e-02	1.41e-01	5.50e-03	2.55e-01	5.12e-01	7.79e-01	1.53e-01	6.33e-03
GOCC LATERAL PLASMA MEMBRANE	50	6.76e-02	1.47e-01	0.2260	-5.14e-02	1.38e-02	1.41e-01	9.86e-02	-1.33e-01	3.08e-02	5.30e-01	8.66e-01	8.53e-02	2.28e-01	1.04e-01	7.06e-01
GOBP MODULATION BY HOST OF SYMBIONT PROCESS	76	2.26e-02	6.52e-02	0.2260	-1.25e-01	-3.50e-02	1.37e-01	5.49e-02	-4.71e-02	1.00e-01	6.03e-02	5.98e-01	3.82e-02	4.08e-01	4.77e-01	1.31e-01
GOBP POSITIVE REGULATION OF T CELL MEDIATED IMMUNITY	59	1.99e-01	3.15e-01	0.2260	-1.19e-01	-1.06e-01	-9.68e-02	3.43e-02	-1.02e-01	-6.72e-02	1.14e-01	1.58e-01	1.99e-01	6.49e-01	1.75e-01	3.72e-01
GOBP ACYLGLYCEROL HOMEOSTASIS	27	7.73e-01	8.17e-01	0.2260	9.07e-02	3.28e-02	1.33e-01	8.86e-02	-9.16e-02	8.73e-02	4.15e-01	7.68e-01	2.31e-01	4.26e-01	4.10e-01	4.32e-01
GOBP RESPONSE TO NITROGEN COMPOUND	836	4.48e-33	5.32e-31	0.2260	-1.45e-01	1.63e-03	1.33e-01	4.52e-02	-3.23e-02	9.65e-02	1.26e-12	9.36e-01	7.27e-11	2.67e-02	1.12e-01	2.18e-06
GOCC AGGRESOME	30	7.42e-01	7.94e-01	0.2260	1.47e-01	1.12e-01	8.75e-02	5.52e-02	3.02e-02	-7.09e-02	1.64e-01	2.86e-01	4.07e-01	6.01e-01	7.75e-01	5.01e-01
GOBP TRANSITION METAL ION TRANSPORT	83	3.78e-02	9.56e-02	0.2250	-8.00e-02	-2.14e-02	1.46e-01	6.90e-02	-6.16e-02	1.19e-01	2.08e-01	7.36e-01	2.18e-02	2.77e-01	3.32e-01	6.06e-02
GOBP APICAL JUNCTION ASSEMBLY	54	5.10e-02	1.19e-01	0.2250	-1.68e-01	3.05e-02	1.28e-01	-5.14e-02	-4.87e-02	2.97e-03	3.22e-02	6.98e-01	1.03e-01	5.13e-01	5.36e-01	9.70e-01
GOMF TRANSMEMBRANE RECEPTOR PROTEIN TYROSINE KINASE ACTIVITY	40	6.43e-01	7.17e-01	0.2250	3.58e-02	9.68e-02	9.61e-02	1.31e-01	6.34e-02	9.80e-02	6.96e-01	2.90e-01	2.93e-01	1.51e-01	4.88e-01	2.84e-01
GOBP NEGATIVE REGULATION OF TORC1 SIGNALING	46	1.38e-02	4.45e-02	0.2250	-1.27e-01	4.90e-02	7.62e-02	1.38e-01	-8.58e-02	1.73e-03	1.38e-01	5.65e-01	3.72e-01	1.04e-01	3.14e-01	9.84e-01
GOBP REGULATION OF TRANS SYNAPTIC SIGNALING	334	1.15e-09	1.82e-08	0.2250	-7.01e-02	5.87e-02	1.63e-01	5.57e-02	-4.51e-04	1.13e-01	2.76e-02	6.51e-02	3.13e-07	8.01e-02	9.89e-01	3.96e-04
GOBP L GLUTAMATE TRANSMEMBRANE TRANSPORT	22	7.64e-01	8.10e-01	0.2250	9.33e-03	-1.70e-01	2.26e-02	2.61e-02	-1.01e-01	1.01e-01	9.40e-01	1.66e-01	8.54e-01	8.32e-01	4.11e-01	4.14e-01
GOBP RESPONSE TO UV A	7	9.84e-01	9.86e-01	0.2250	3.48e-02	-9.25e-02	8.43e-02	-9.20e-02	-1.53e-01	-4.38e-02	8.73e-01	6.72e-01	6.99e-01	6.73e-01	4.83e-01	8.41e-01
GOBP CALCIUM DEPENDENT CELL CELL ADHESION VIA PLASMA MEMBRANE CELL ADHESION MOLECULES	23	6.21e-01	6.99e-01	0.2250	2.90e-02	4.04e-02	6.22e-02	-9.59e-02	5.63e-03	1.87e-01	8.10e-01	7.37e-01	6.05e-01	4.26e-01	9.63e-01	1.20e-01
GOBP NEURAL CREST CELL DIFFERENTIATION	54	7.62e-03	2.77e-02	0.2250	-1.86e-01	8.43e-02	8.39e-02	3.41e-02	3.62e-03	-2.62e-02	1.80e-02	2.84e-01	2.86e-01	6.65e-01	9.63e-01	7.39e-01
GOBP HEMATOPOIETIC STEM CELL HOMEOSTASIS	22	3.88e-01	5.01e-01	0.2250	-8.34e-02	2.70e-02	1.05e-02	1.20e-01	-1.06e-01	1.30e-01	4.98e-01	8.26e-01	9.32e-01	3.29e-01	3.88e-01	2.89e-01
GOBP NEGATIVE REGULATION OF MUSCLE CELL DIFFERENTIATION	48	2.96e-02	7.94e-02	0.2250	-5.70e-02	2.02e-02	5.43e-02	2.07e-01	1.03e-02	-3.28e-02	4.94e-01	8.09e-01	5.15e-01	1.31e-02	9.02e-01	6.95e-01
GOBP NEGATIVE REGULATION OF MITOTIC CELL CYCLE	211	2.19e-06	2.16e-05	0.2250	-4.75e-02	-1.17e-01	3.32e-04	1.56e-01	-6.13e-03	1.02e-01	2.34e-01	3.50e-03	9.93e-01	9.57e-05	8.78e-01	1.07e-02
GOBP MUSCLE TISSUE DEVELOPMENT	281	7.17e-06	6.28e-05	0.2250	2.48e-03	8.94e-02	1.80e-01	2.64e-02	-5.19e-02	8.17e-02	9.43e-01	9.91e-03	2.01e-07	4.46e-01	1.34e-01	1.85e-02
GOBP PROTEIN LOCALIZATION TO CELL JUNCTION	86	3.99e-02	9.94e-02	0.2250	-3.28e-02	6.28e-02	1.90e-01	3.08e-02	-3.93e-03	9.09e-02	5.99e-01	3.14e-01	2.27e-03	6.22e-01	9.50e-01	1.45e-01
GOBP DEFENSE RESPONSE TO TUMOR CELL	12	6.38e-01	7.13e-01	0.2250	-1.53e-01	7.96e-02	6.00e-02	1.12e-01	3.64e-02	-5.76e-02	3.59e-01	6.33e-01	7.19e-01	5.02e-01	8.27e-01	7.30e-01
GOBP NEGATIVE REGULATION OF CYTOKINE PRODUCTION INVOLVED IN IMMUNE RESPONSE	29	6.31e-01	7.07e-01	0.2250	9.26e-02	1.50e-01	1.11e-01	5.29e-02	-4.00e-02	-5.33e-02	3.88e-01	1.62e-01	3.02e-01	6.22e-01	7.09e-01	6.20e-01
GOBP CELL SURFACE RECEPTOR SIGNALING PATHWAY VIA STAT	116	1.82e-02	5.48e-02	0.2250	-3.27e-02	1.13e-01	1.26e-01	-3.12e-02	7.77e-02	1.17e-01	5.43e-01	3.52e-02	1.94e-02	5.61e-01	1.48e-01	2.89e-02
GOBP NEURON PROJECTION REGENERATION	45	2.07e-01	3.23e-01	0.2250	-7.30e-02	1.30e-01	2.35e-02	-1.27e-01	-9.95e-02	-3.95e-02	3.97e-01	1.30e-01	7.85e-01	1.40e-01	2.48e-01	6.46e-01
GOBP RESPONSE TO TRANSFORMING GROWTH FACTOR BETA	215	1.50e-06	1.53e-05	0.2250	-5.47e-02	1.04e-01	1.52e-01	6.38e-02	-4.97e-02	8.33e-02	1.67e-01	8.50e-03	1.20e-04	1.07e-01	2.10e-01	3.52e-02
GOBP CELL SUBSTRATE ADHESION	286	2.09e-09	3.15e-08	0.2250	-3.25e-02	2.49e-02	1.98e-01	5.08e-02	-5.04e-02	6.65e-02	3.45e-01	4.68e-01	8.24e-09	1.40e-01	1.43e-01	5.30e-02
GOMF NUCLEOSIDE TRIPHOSPHATASE REGULATOR ACTIVITY	450	1.13e-16	3.55e-15	0.2250	8.78e-03	1.07e-01	1.37e-01	1.42e-01	6.39e-03	7.34e-03	7.50e-01	1.00e-04	6.50e-07	2.57e-07	8.16e-01	7.90e-01
GOBP REGULATION OF OXIDOREDUCTASE ACTIVITY	48	6.15e-02	1.37e-01	0.2250	-1.67e-02	-3.78e-02	1.33e-01	1.07e-01	1.17e-01	7.74e-02	8.41e-01	6.51e-01	1.12e-01	2.00e-01	1.61e-01	3.54e-01
GOBP FOREBRAIN DEVELOPMENT	283	2.93e-07	3.33e-06	0.2240	-5.63e-02	1.40e-01	1.16e-01	4.04e-02	3.81e-02	1.05e-01	1.03e-01	4.90e-05	8.14e-04	2.42e-01	2.71e-01	2.31e-03
GOBP REGULATION OF CALCIUM ION TRANSMEMBRANE TRANSPORT	121	1.56e-02	4.88e-02	0.2240	-2.69e-02	-6.57e-02	1.37e-01	2.20e-02	-1.42e-01	7.71e-02	6.09e-01	2.12e-01	9.33e-03	6.76e-01	6.94e-03	1.43e-01
GOBP CALCIUM ION TRANSMEMBRANE IMPORT INTO CYTOSOL	133	2.43e-03	1.09e-02	0.2240	2.72e-02	1.23e-02	1.77e-01	8.93e-02	-7.92e-02	6.38e-02	5.88e-01	8.07e-01	4.38e-04	7.54e-02	1.15e-01	2.04e-01
GOBP EMBRYONIC CRANIAL SKELETON MORPHOGENESIS	26	4.18e-01	5.28e-01	0.2240	-5.00e-02	1.28e-01	8.52e-02	1.49e-01	9.43e-03	4.12e-02	6.59e-01	2.57e-01	4.52e-01	1.87e-01	9.34e-01	7.16e-01
GOCC RNA N6 METHYLADENOSINE METHYLTRANSFERASE COMPLEX	9	8.68e-01	8.93e-01	0.2240	-1.51e-01	5.91e-02	1.14e-02	3.87e-02	-1.10e-01	1.02e-01	4.33e-01	7.59e-01	9.53e-01	8.41e-01	5.68e-01	5.97e-01
GOCC SPINDLE POLE	171	1.41e-05	1.15e-04	0.2240	-8.76e-02	-1.46e-01	-4.91e-03	1.25e-01	4.16e-02	6.17e-02	4.81e-02	9.63e-04	9.12e-01	4.73e-03	3.49e-01	1.64e-01
GOBP REGULATION OF RESPONSE TO CYTOKINE STIMULUS	153	9.22e-05	6.31e-04	0.2240	-7.70e-02	3.64e-02	1.02e-01	1.34e-01	4.02e-02	1.15e-01	1.00e-01	4.37e-01	2.96e-02	4.29e-03	3.90e-01	1.43e-02
GOBP APPENDAGE DEVELOPMENT	117	2.11e-02	6.18e-02	0.2240	2.64e-02	1.54e-01	1.08e-01	1.01e-01	3.60e-02	5.08e-02	6.22e-01	3.94e-03	4.35e-02	5.83e-02	5.01e-01	3.43e-01
GOBP PROTEIN MODIFICATION BY SMALL PROTEIN CONJUGATION	749	1.75e-28	1.48e-26	0.2240	-1.40e-01	-7.20e-02	-7.38e-02	1.24e-01	4.70e-03	6.92e-02	7.29e-11	8.03e-04	5.95e-04	8.73e-09	8.27e-01	1.27e-03
GOBP EPIDERMAL CELL DIFFERENTIATION	130	1.44e-05	1.17e-04	0.2240	-1.08e-01	9.64e-02	1.68e-01	6.76e-03	-2.81e-02	1.14e-02	3.31e-02	5.78e-02	9.28e-04	8.94e-01	5.80e-01	8.22e-01
GOBP G PROTEIN COUPLED OPIOID RECEPTOR SIGNALING PATHWAY	7	8.58e-01	8.85e-01	0.2240	2.92e-02	-3.91e-02	9.34e-02	1.00e-01	8.67e-02	-1.47e-01	8.93e-01	8.58e-01	6.69e-01	6.46e-01	6.91e-01	5.01e-01
GOBP MULTI MULTICELLULAR ORGANISM PROCESS	142	1.21e-04	7.97e-04	0.2240	-1.11e-01	-9.72e-03	1.70e-01	-6.87e-02	-4.73e-02	4.44e-02	2.26e-02	8.42e-01	4.67e-04	1.58e-01	3.30e-01	3.61e-01
GOBP NEGATIVE REGULATION OF STEM CELL POPULATION MAINTENANCE	21	7.42e-01	7.94e-01	0.2240	-1.41e-01	-1.74e-02	-1.17e-01	9.01e-02	8.99e-02	-2.46e-03	2.62e-01	8.90e-01	3.52e-01	4.75e-01	4.76e-01	9.84e-01
GOBP ERYTHROCYTE HOMEOSTASIS	133	3.58e-04	2.10e-03	0.2240	-8.66e-02	-9.67e-03	1.18e-01	1.10e-01	-6.16e-02	1.13e-01	8.47e-02	8.47e-01	1.85e-02	2.85e-02	2.20e-01	2.47e-02
GOBP POSITIVE REGULATION OF RESPONSE TO EXTERNAL STIMULUS	528	4.78e-16	1.42e-14	0.2240	-9.82e-02	6.10e-02	1.09e-01	6.89e-02	-2.17e-03	1.42e-01	1.13e-04	1.65e-02	1.89e-05	6.82e-03	9.32e-01	2.23e-08
GOBP CELL CELL ADHESION	705	1.81e-15	4.99e-14	0.2240	-6.32e-03	7.32e-02	1.78e-01	4.11e-02	-2.10e-02	1.05e-01	7.75e-01	9.40e-04	8.36e-16	6.31e-02	3.43e-01	2.17e-06
GOBP REGULATION OF PROTEIN BINDING	109	2.49e-03	1.11e-02	0.2240	-1.62e-02	-1.22e-01	7.57e-02	1.42e-01	-6.82e-02	6.61e-02	7.70e-01	2.74e-02	1.72e-01	1.05e-02	2.19e-01	2.33e-01
GOMF GLYCOSYLTRANSFERASE ACTIVITY	217	2.09e-05	1.64e-04	0.2240	-1.62e-01	-4.83e-02	5.41e-02	4.12e-03	-9.68e-02	9.65e-02	4.10e-05	2.20e-01	1.69e-01	9.17e-01	1.40e-02	1.43e-02
GOBP REGULATION OF SYNAPSE ASSEMBLY	78	6.56e-03	2.45e-02	0.2240	-7.62e-02	1.92e-01	5.94e-02	3.95e-02	4.25e-02	-2.34e-02	2.45e-01	3.39e-03	3.64e-01	5.46e-01	5.16e-01	7.21e-01
GOBP INTRACELLULAR ESTROGEN RECEPTOR SIGNALING PATHWAY	47	1.05e-01	2.02e-01	0.2240	-6.57e-02	-1.70e-02	1.64e-02	1.59e-01	-5.41e-02	1.31e-01	4.36e-01	8.40e-01	8.46e-01	5.97e-02	5.21e-01	1.22e-01
GOBP BILE ACID BIOSYNTHETIC PROCESS	27	6.45e-01	7.18e-01	0.2240	-9.76e-02	1.21e-01	6.03e-02	-3.89e-02	6.75e-02	1.27e-01	3.80e-01	2.78e-01	5.88e-01	7.26e-01	5.44e-01	2.52e-01
GOBP NEGATIVE REGULATION OF AXONOGENESIS	40	2.09e-01	3.25e-01	0.2240	-2.26e-02	1.10e-01	1.82e-01	-3.26e-02	-4.69e-02	-3.55e-02	8.05e-01	2.31e-01	4.68e-02	7.21e-01	6.08e-01	6.98e-01
GOBP POSITIVE REGULATION OF INTERLEUKIN 4 PRODUCTION	25	3.55e-01	4.70e-01	0.2240	-1.09e-02	1.89e-02	-3.87e-02	2.15e-01	-3.99e-02	1.29e-02	9.25e-01	8.70e-01	7.38e-01	6.26e-02	7.30e-01	9.11e-01
GOBP NEGATIVE REGULATION OF JNK CASCADE	32	7.06e-01	7.66e-01	0.2240	2.12e-02	1.60e-01	1.22e-01	5.82e-02	5.96e-02	4.48e-02	8.36e-01	1.16e-01	2.32e-01	5.69e-01	5.59e-01	6.61e-01
GOBP LYMPHOCYTE HOMEOSTASIS	73	9.04e-02	1.82e-01	0.2240	-6.77e-02	-5.28e-02	7.70e-02	1.04e-01	-1.14e-02	1.60e-01	3.17e-01	4.35e-01	2.55e-01	1.24e-01	8.67e-01	1.79e-02
GOBP REGULATION OF NEUROBLAST PROLIFERATION	28	4.86e-01	5.86e-01	0.2230	-9.46e-02	1.25e-01	9.49e-02	5.80e-02	9.79e-02	5.88e-02	3.86e-01	2.53e-01	3.85e-01	5.95e-01	3.70e-01	5.91e-01
GOBP POSITIVE REGULATION OF CELL CYCLE G1 S PHASE TRANSITION	51	1.12e-01	2.12e-01	0.2230	-6.68e-02	-1.14e-01	6.86e-02	1.45e-01	-9.07e-03	8.27e-02	4.10e-01	1.60e-01	3.96e-01	7.40e-02	9.11e-01	3.07e-01
GOBP RIBONUCLEOSIDE MONOPHOSPHATE METABOLIC PROCESS	55	6.60e-02	1.45e-01	0.2230	-9.07e-02	-1.85e-01	2.94e-02	2.96e-02	3.27e-02	6.78e-02	2.44e-01	1.75e-02	7.06e-01	7.04e-01	6.75e-01	3.84e-01
GOBP NON PROTEINOGENIC AMINO ACID METABOLIC PROCESS	56	6.60e-02	1.45e-01	0.2230	-1.13e-01	-1.08e-01	8.63e-02	4.91e-02	4.67e-02	1.16e-01	1.45e-01	1.61e-01	2.64e-01	5.25e-01	5.46e-01	1.33e-01
GOBP REGULATION OF DEFENSE RESPONSE	675	4.61e-20	1.97e-18	0.2230	-8.58e-02	8.01e-02	9.49e-02	6.89e-02	1.18e-02	1.49e-01	1.44e-04	3.91e-04	2.66e-05	2.27e-03	6.02e-01	4.09e-11
GOBP CELLULAR RESPONSE TO PEPTIDE	12	4.35e-01	5.43e-01	0.2230	-1.13e-01	-7.69e-02	1.19e-01	8.59e-03	8.02e-02	-1.02e-01	4.98e-01	6.45e-01	4.75e-01	9.59e-01	6.30e-01	5.39e-01
GOBP AMINOGLYCAN CATABOLIC PROCESS	30	1.93e-01	3.09e-01	0.2230	-1.96e-02	-1.45e-01	9.12e-02	2.33e-03	-8.23e-02	-1.15e-01	8.53e-01	1.68e-01	3.87e-01	9.82e-01	4.36e-01	2.75e-01
GOBP CHEMOKINE PRODUCTION	78	1.21e-02	3.99e-02	0.2230	-1.84e-01	8.61e-02	3.45e-02	-8.01e-02	1.50e-02	-2.42e-02	4.87e-03	1.88e-01	5.98e-01	2.21e-01	8.19e-01	7.12e-01
GOMF CYTOKINE ACTIVITY	112	9.31e-05	6.36e-04	0.2230	7.77e-02	5.75e-02	1.58e-01	-1.02e-01	1.99e-02	-6.89e-02	1.56e-01	2.93e-01	3.83e-03	6.32e-02	7.17e-01	2.08e-01
GOCC RIBONUCLEOPROTEIN GRANULE	237	6.95e-07	7.50e-06	0.2230	-1.29e-01	-7.84e-02	8.47e-03	7.34e-02	-6.11e-02	1.34e-01	6.49e-04	3.76e-02	8.22e-01	5.16e-02	1.05e-01	3.83e-04
GOCC NUCLEAR ENVELOPE	450	3.30e-13	7.62e-12	0.2230	-1.63e-01	-1.13e-01	-1.97e-02	6.30e-02	-2.47e-02	7.40e-02	3.02e-09	4.04e-05	4.75e-01	2.20e-02	3.69e-01	7.18e-03
GOMF GLUTAMATE RECEPTOR BINDING	33	7.50e-01	8.00e-01	0.2230	-1.88e-02	1.11e-01	1.35e-01	-8.50e-03	-2.32e-03	1.37e-01	8.52e-01	2.71e-01	1.78e-01	9.33e-01	9.82e-01	1.73e-01
GOBP CANONICAL WNT SIGNALING PATHWAY	232	2.55e-06	2.48e-05	0.2230	-2.20e-02	1.44e-01	7.64e-02	1.22e-01	7.26e-02	4.98e-02	5.64e-01	1.53e-04	4.51e-02	1.38e-03	5.67e-02	1.91e-01
GOBP HEART VALVE MORPHOGENESIS	40	1.74e-01	2.89e-01	0.2230	-5.75e-02	1.44e-01	1.55e-01	-2.29e-02	2.41e-02	-2.70e-02	5.29e-01	1.15e-01	9.07e-02	8.02e-01	7.92e-01	7.68e-01
GOBP REGULATION OF CELL FATE SPECIFICATION	20	8.21e-01	8.56e-01	0.2230	2.37e-02	5.54e-02	4.35e-02	1.87e-01	9.52e-02	3.17e-03	8.55e-01	6.68e-01	7.36e-01	1.47e-01	4.61e-01	9.80e-01
GOBP REGULATION OF TRANSMEMBRANE TRANSPORT	333	1.21e-06	1.25e-05	0.2230	-7.78e-02	-2.20e-02	1.53e-01	-3.75e-02	-8.91e-02	1.02e-01	1.47e-02	4.91e-01	1.57e-06	2.40e-01	5.22e-03	1.38e-03
GOBP INTERLEUKIN 17 PRODUCTION	32	6.43e-01	7.17e-01	0.2230	-2.34e-02	-1.18e-01	1.55e-02	-6.00e-02	-1.47e-01	-9.92e-02	8.19e-01	2.49e-01	8.79e-01	5.57e-01	1.50e-01	3.31e-01
GOBP CYTOPLASMIC SEQUESTERING OF TRANSCRIPTION FACTOR	8	8.80e-01	9.01e-01	0.2230	6.56e-03	-6.33e-02	5.99e-02	1.46e-01	-3.74e-02	-1.39e-01	9.74e-01	7.56e-01	7.69e-01	4.75e-01	8.55e-01	4.96e-01
GOBP N TERMINAL PROTEIN AMINO ACID MODIFICATION	24	6.20e-01	6.98e-01	0.2230	2.22e-03	-1.18e-01	-9.02e-02	2.20e-02	-1.63e-01	-1.40e-02	9.85e-01	3.15e-01	4.44e-01	8.52e-01	1.66e-01	9.05e-01
GOBP REGULATION OF LYASE ACTIVITY	33	4.18e-01	5.28e-01	0.2230	-1.13e-01	3.37e-02	1.13e-01	-8.16e-02	-1.20e-01	-4.35e-02	2.62e-01	7.37e-01	2.60e-01	4.17e-01	2.35e-01	6.65e-01
GOBP T CELL HOMEOSTASIS	43	3.24e-01	4.42e-01	0.2220	-1.73e-02	-1.37e-01	1.95e-02	7.69e-02	-5.91e-03	1.55e-01	8.45e-01	1.20e-01	8.25e-01	3.83e-01	9.47e-01	7.85e-02
GOBP POSITIVE REGULATION OF WNT SIGNALING PATHWAY	112	6.29e-04	3.41e-03	0.2220	-6.45e-02	1.08e-01	1.16e-01	1.18e-01	-2.02e-02	7.73e-02	2.38e-01	4.91e-02	3.41e-02	3.10e-02	7.12e-01	1.57e-01
GOBP REGULATION OF RESPONSE TO BIOTIC STIMULUS	468	1.01e-16	3.19e-15	0.2220	-1.15e-01	5.56e-02	5.31e-02	8.63e-02	5.14e-03	1.51e-01	1.88e-05	3.94e-02	4.91e-02	1.38e-03	8.49e-01	2.26e-08
GOBP SMOOTH MUSCLE CELL PROLIFERATION	114	1.16e-04	7.74e-04	0.2220	-1.23e-01	8.24e-02	1.59e-01	5.69e-03	-4.07e-02	2.06e-02	2.29e-02	1.29e-01	3.31e-03	9.16e-01	4.53e-01	7.04e-01
GOBP CELLULAR RESPONSE TO CHEMICAL STRESS	273	3.77e-07	4.22e-06	0.2220	-1.56e-01	-1.03e-01	4.52e-02	3.12e-02	-5.49e-02	9.18e-02	8.85e-06	3.49e-03	1.99e-01	3.74e-01	1.19e-01	9.05e-03
GOBP REGULATION OF HEMOGLOBIN BIOSYNTHETIC PROCESS	7	9.90e-01	9.91e-01	0.2220	1.98e-02	-7.11e-03	1.33e-01	-1.34e-01	-1.11e-01	3.34e-02	9.28e-01	9.74e-01	5.42e-01	5.40e-01	6.12e-01	8.78e-01
GOBP MOTOR NEURON AXON GUIDANCE	18	8.70e-01	8.94e-01	0.2220	3.05e-02	1.81e-01	1.77e-02	-4.84e-02	9.73e-02	-5.88e-02	8.23e-01	1.83e-01	8.97e-01	7.22e-01	4.75e-01	6.66e-01
GOBP FIBROBLAST GROWTH FACTOR RECEPTOR SIGNALING PATHWAY	53	4.08e-01	5.19e-01	0.2220	-5.59e-02	5.23e-02	1.36e-01	-2.74e-02	-1.16e-01	1.04e-01	4.81e-01	5.10e-01	8.64e-02	7.30e-01	1.44e-01	1.92e-01
GOCC MITOTIC SPINDLE	169	5.98e-05	4.29e-04	0.2220	-4.61e-02	-1.20e-01	3.18e-02	1.45e-01	7.89e-03	1.03e-01	3.01e-01	7.03e-03	4.76e-01	1.15e-03	8.59e-01	2.07e-02
GOBP DENDRITE MORPHOGENESIS	111	2.51e-03	1.11e-02	0.2220	-8.75e-02	1.31e-01	1.24e-01	3.60e-02	-2.33e-02	8.52e-02	1.11e-01	1.74e-02	2.35e-02	5.13e-01	6.72e-01	1.21e-01
GOCC MICROTUBULE ASSOCIATED COMPLEX	136	5.09e-03	1.99e-02	0.2220	1.80e-03	-7.95e-02	8.53e-02	1.01e-01	-6.42e-02	1.46e-01	9.71e-01	1.10e-01	8.58e-02	4.15e-02	1.96e-01	3.29e-03
GOBP CALCIUM ION IMPORT ACROSS PLASMA MEMBRANE	30	5.23e-01	6.16e-01	0.2220	-6.12e-02	1.65e-01	1.20e-01	-2.46e-02	-3.91e-02	4.09e-02	5.62e-01	1.18e-01	2.54e-01	8.16e-01	7.11e-01	6.98e-01
GOBP MODIFICATION OF SYNAPTIC STRUCTURE	24	7.77e-01	8.20e-01	0.2220	-7.28e-02	-6.76e-02	1.24e-01	-8.67e-02	-1.28e-01	1.87e-03	5.37e-01	5.67e-01	2.92e-01	4.62e-01	2.77e-01	9.87e-01
GOBP HOMEOSTASIS OF NUMBER OF CELLS	288	3.96e-08	5.12e-07	0.2220	-8.11e-02	1.01e-02	1.19e-01	9.39e-02	-3.19e-02	1.36e-01	1.79e-02	7.68e-01	5.24e-04	6.13e-03	3.51e-01	7.02e-05
GOBP L AMINO ACID TRANSPORT	70	6.44e-02	1.42e-01	0.2220	-1.12e-01	-8.50e-02	2.41e-02	5.58e-02	-1.48e-01	6.22e-02	1.06e-01	2.19e-01	7.28e-01	4.20e-01	3.25e-02	3.68e-01
GOBP REGULATION OF DNA METABOLIC PROCESS	462	1.53e-15	4.23e-14	0.2220	-4.92e-02	-9.81e-02	-3.09e-02	1.78e-01	1.57e-03	6.54e-02	6.99e-02	3.02e-04	2.56e-01	4.93e-11	9.54e-01	1.60e-02
GOBP INTRINSIC APOPTOTIC SIGNALING PATHWAY IN RESPONSE TO DNA DAMAGE	96	3.05e-03	1.31e-02	0.2220	-2.25e-02	-2.80e-02	6.57e-02	1.90e-01	8.00e-02	2.98e-02	7.03e-01	6.35e-01	2.66e-01	1.27e-03	1.76e-01	6.14e-01
GOBP REGULATION OF MICROTUBULE DEPOLYMERIZATION	25	2.48e-01	3.67e-01	0.2220	-8.87e-02	9.52e-02	1.05e-01	1.43e-01	1.25e-02	-2.76e-02	4.43e-01	4.10e-01	3.65e-01	2.17e-01	9.14e-01	8.11e-01
GOBP EXPORT FROM CELL	673	7.15e-21	3.27e-19	0.2220	-1.03e-01	1.19e-02	1.49e-01	4.27e-02	-2.62e-02	1.16e-01	5.43e-06	5.97e-01	3.94e-11	5.90e-02	2.48e-01	2.64e-07
GOBP BLOOD VESSEL MORPHOGENESIS	460	3.36e-16	1.02e-14	0.2220	-9.02e-02	5.57e-02	1.77e-01	2.12e-02	-3.81e-02	6.90e-02	9.15e-04	4.09e-02	8.69e-11	4.36e-01	1.61e-01	1.12e-02
GOBP DEPHOSPHORYLATION	243	4.78e-07	5.31e-06	0.2210	-1.03e-01	7.79e-03	1.06e-01	8.01e-02	-4.66e-02	1.36e-01	5.57e-03	8.34e-01	4.26e-03	3.16e-02	2.11e-01	2.69e-04
GOMF LYSOPHOSPHOLIPASE ACTIVITY	24	6.13e-01	6.92e-01	0.2210	-6.18e-02	-1.33e-01	8.01e-02	6.58e-02	2.27e-02	1.28e-01	6.00e-01	2.61e-01	4.97e-01	5.77e-01	8.47e-01	2.77e-01
GOBP GLYCEROPHOSPHOLIPID BIOSYNTHETIC PROCESS	190	4.13e-08	5.33e-07	0.2210	-1.85e-01	2.21e-02	-1.86e-03	7.49e-02	9.18e-02	1.85e-02	1.11e-05	6.00e-01	9.65e-01	7.50e-02	2.92e-02	6.60e-01
GOBP DIGESTION	75	3.83e-02	9.64e-02	0.2210	-5.83e-02	1.11e-01	1.23e-01	9.05e-02	7.56e-02	6.58e-02	3.83e-01	9.70e-02	6.55e-02	1.76e-01	2.58e-01	3.25e-01
GOBP RESPONSE TO IONIZING RADIATION	127	1.26e-03	6.22e-03	0.2210	-6.85e-02	-6.03e-02	-7.53e-02	1.68e-01	5.42e-02	6.24e-02	1.82e-01	2.40e-01	1.43e-01	1.08e-03	2.92e-01	2.25e-01
GOBP NEGATIVE REGULATION OF ORGANELLE ASSEMBLY	45	3.54e-02	9.09e-02	0.2210	-8.90e-02	2.79e-02	-1.16e-01	6.20e-02	1.79e-02	1.50e-01	3.02e-01	7.46e-01	1.77e-01	4.72e-01	8.35e-01	8.11e-02
GOBP ONE CARBON METABOLIC PROCESS	32	3.97e-01	5.09e-01	0.2210	7.21e-02	-9.38e-02	5.26e-02	1.43e-01	-1.01e-01	-4.07e-02	4.80e-01	3.59e-01	6.06e-01	1.62e-01	3.24e-01	6.90e-01
GOBP RESPONSE TO PEPTIDE HORMONE	333	6.38e-13	1.43e-11	0.2210	-1.34e-01	6.94e-02	1.37e-01	3.56e-02	-1.79e-03	7.90e-02	2.64e-05	2.95e-02	1.80e-05	2.64e-01	9.55e-01	1.33e-02
GOBP NEGATIVE REGULATION OF DNA METABOLIC PROCESS	122	3.02e-03	1.30e-02	0.2210	-2.41e-02	-1.18e-01	-2.57e-02	1.65e-01	3.48e-02	7.33e-02	6.46e-01	2.48e-02	6.24e-01	1.63e-03	5.07e-01	1.62e-01
GOMF PHOSPHATIDYLINOSITOL 4 5 BISPHOSPHATE PHOSPHATASE ACTIVITY	11	7.71e-01	8.16e-01	0.2210	-1.47e-01	7.77e-02	-2.64e-02	5.39e-02	-2.07e-02	-1.32e-01	3.99e-01	6.56e-01	8.80e-01	7.57e-01	9.06e-01	4.49e-01
GOBP REGULATION OF CELL PROJECTION ASSEMBLY	200	8.67e-06	7.42e-05	0.2210	-8.13e-02	3.55e-02	1.24e-01	1.00e-01	1.62e-02	1.24e-01	4.75e-02	3.87e-01	2.51e-03	1.47e-02	6.93e-01	2.49e-03
GOBP STRIATED MUSCLE CELL APOPTOTIC PROCESS	32	3.19e-01	4.39e-01	0.2210	-1.11e-01	5.83e-02	-2.13e-02	1.51e-01	7.03e-02	7.03e-02	2.79e-01	5.68e-01	8.35e-01	1.38e-01	4.91e-01	4.91e-01
GOMF PROTEIN SERINE THREONINE PHOSPHATASE ACTIVITY	84	9.93e-03	3.41e-02	0.2210	-1.74e-01	-8.06e-02	-3.83e-02	8.34e-02	-5.74e-02	1.34e-02	5.70e-03	2.01e-01	5.44e-01	1.86e-01	3.63e-01	8.31e-01
GOBP NITROGEN COMPOUND TRANSPORT	1585	2.08e-52	8.05e-50	0.2210	-1.62e-01	-8.50e-02	2.91e-02	6.80e-02	-3.16e-02	9.42e-02	5.22e-27	1.74e-08	5.34e-02	6.51e-06	3.64e-02	4.06e-10
GOBP EPITHELIAL TO MESENCHYMAL TRANSITION	128	1.48e-03	7.10e-03	0.2210	-2.59e-02	1.28e-01	1.54e-01	7.39e-02	-7.47e-03	4.96e-02	6.12e-01	1.26e-02	2.55e-03	1.49e-01	8.84e-01	3.33e-01
GOBP NEURAL PRECURSOR CELL PROLIFERATION	113	1.36e-02	4.39e-02	0.2210	-5.33e-02	1.04e-01	6.76e-02	9.09e-02	1.06e-01	1.06e-01	3.28e-01	5.74e-02	2.15e-01	9.51e-02	5.24e-02	5.13e-02
GOBP HEART MORPHOGENESIS	169	8.13e-05	5.64e-04	0.2210	-5.23e-02	1.19e-01	1.21e-01	8.74e-02	7.09e-02	6.64e-02	2.41e-01	7.48e-03	6.55e-03	5.00e-02	1.12e-01	1.37e-01
GOBP SYNAPTONEMAL COMPLEX ORGANIZATION	19	8.64e-01	8.89e-01	0.2210	-8.12e-02	-1.07e-01	4.34e-02	5.36e-02	-1.05e-01	1.21e-01	5.40e-01	4.18e-01	7.44e-01	6.86e-01	4.26e-01	3.60e-01
GOBP SPERM EGG RECOGNITION	27	5.24e-01	6.17e-01	0.2210	-1.84e-02	-1.83e-01	2.26e-02	1.58e-02	-8.60e-02	-8.22e-02	8.69e-01	9.99e-02	8.39e-01	8.87e-01	4.39e-01	4.60e-01
GOMF NUCLEOBASE TRANSMEMBRANE TRANSPORTER ACTIVITY	10	9.78e-01	9.81e-01	0.2210	1.41e-01	3.67e-02	-5.56e-02	7.41e-02	1.38e-01	-7.22e-03	4.42e-01	8.41e-01	7.61e-01	6.85e-01	4.51e-01	9.68e-01
GOBP NEGATIVE REGULATION OF CALCIUM MEDIATED SIGNALING	19	7.33e-01	7.87e-01	0.2210	-4.37e-02	4.67e-02	1.32e-01	1.18e-01	-7.40e-02	8.80e-02	7.42e-01	7.25e-01	3.19e-01	3.74e-01	5.76e-01	5.07e-01
GOBP RESPONSE TO L GLUTAMATE	15	9.16e-01	9.30e-01	0.2200	-1.37e-02	-4.42e-02	-9.40e-02	8.20e-02	1.76e-01	6.96e-03	9.27e-01	7.67e-01	5.28e-01	5.83e-01	2.39e-01	9.63e-01
GOBP L GLUTAMATE IMPORT	31	7.72e-01	8.17e-01	0.2200	-6.45e-02	6.00e-03	1.18e-01	-3.08e-02	-2.25e-02	1.70e-01	5.34e-01	9.54e-01	2.56e-01	7.67e-01	8.28e-01	1.01e-01
GOBP REGULATORY NCRNA MEDIATED GENE SILENCING	134	2.84e-03	1.24e-02	0.2200	-7.82e-02	4.98e-02	7.74e-02	4.99e-02	-2.73e-02	1.75e-01	1.18e-01	3.20e-01	1.22e-01	3.18e-01	5.85e-01	4.53e-04
GOBP CELL CELL ADHESION VIA PLASMA MEMBRANE ADHESION MOLECULES	146	2.89e-03	1.26e-02	0.2200	-1.28e-02	1.66e-01	1.31e-01	-5.45e-02	-1.03e-02	2.30e-02	7.89e-01	5.17e-04	6.33e-03	2.56e-01	8.29e-01	6.31e-01
GOBP REGULATION OF PROTEIN LOCALIZATION TO MEMBRANE	149	4.09e-04	2.36e-03	0.2200	-1.37e-01	-8.12e-02	4.79e-02	6.43e-02	-9.42e-02	8.87e-02	3.88e-03	8.70e-02	3.13e-01	1.76e-01	4.71e-02	6.17e-02
GOBP CYTOPLASMIC MICROTUBULE ORGANIZATION	57	5.05e-02	1.18e-01	0.2200	-6.16e-02	1.27e-01	1.62e-02	7.36e-02	1.03e-01	-1.11e-01	4.21e-01	9.76e-02	8.32e-01	3.37e-01	1.77e-01	1.48e-01
GOBP REGULATION OF BINDING	195	4.09e-05	3.04e-04	0.2200	-2.21e-02	-1.16e-01	7.92e-02	1.12e-01	-6.02e-02	1.10e-01	5.94e-01	5.16e-03	5.67e-02	6.92e-03	1.47e-01	8.19e-03
GOMF JUN KINASE BINDING	11	9.12e-01	9.27e-01	0.2200	-3.86e-02	-6.87e-02	-4.26e-02	-1.09e-01	4.45e-02	-1.63e-01	8.25e-01	6.93e-01	8.07e-01	5.32e-01	7.99e-01	3.48e-01
GOBP POSITIVE REGULATION OF INTERLEUKIN 13 PRODUCTION	13	8.74e-01	8.96e-01	0.2200	-1.27e-01	-5.09e-02	4.60e-02	4.31e-02	-1.56e-01	4.03e-02	4.28e-01	7.51e-01	7.74e-01	7.88e-01	3.32e-01	8.01e-01
GOBP SYNAPSE ASSEMBLY	129	1.78e-03	8.31e-03	0.2200	-7.04e-02	1.48e-01	1.30e-01	-1.09e-02	-3.25e-02	5.96e-02	1.67e-01	3.69e-03	1.11e-02	8.31e-01	5.24e-01	2.42e-01
GOBP CALCIUM MEDIATED SIGNALING	177	1.36e-02	4.40e-02	0.2200	6.39e-02	9.56e-02	1.57e-01	5.29e-02	-2.50e-02	8.42e-02	1.42e-01	2.82e-02	3.16e-04	2.25e-01	5.65e-01	5.33e-02
GOBP ADAPTIVE IMMUNE RESPONSE BASED ON SOMATIC RECOMBINATION OF IMMUNE RECEPTORS BUILT FROM IMMUNOGLOBULIN SUPERFAMILY DOMAINS	334	4.61e-08	5.89e-07	0.2200	1.68e-02	5.62e-03	1.09e-01	1.46e-01	-3.35e-02	1.18e-01	5.97e-01	8.60e-01	6.27e-04	4.74e-06	2.92e-01	2.24e-04
GOMF VOLTAGE GATED CHANNEL ACTIVITY	105	1.83e-02	5.51e-02	0.2200	8.11e-02	1.42e-01	1.14e-01	-6.99e-02	4.17e-02	-4.48e-02	1.51e-01	1.19e-02	4.41e-02	2.16e-01	4.60e-01	4.28e-01
GOBP REGULATION OF MONOATOMIC ION TRANSPORT	317	6.44e-06	5.72e-05	0.2200	-3.88e-02	-1.44e-02	1.62e-01	-4.54e-02	-1.12e-01	7.56e-02	2.35e-01	6.60e-01	7.46e-07	1.64e-01	5.89e-04	2.07e-02
GOBP CELLULAR COMPONENT DISASSEMBLY	477	1.46e-17	4.89e-16	0.2200	-9.26e-02	-7.02e-02	4.92e-02	1.52e-01	-9.89e-03	9.52e-02	5.32e-04	8.62e-03	6.59e-02	1.27e-08	7.12e-01	3.72e-04
GOBP RESPONSE TO PEPTIDE	19	2.98e-01	4.17e-01	0.2200	-5.02e-02	-1.75e-01	1.11e-01	2.40e-02	4.63e-02	-6.75e-03	7.05e-01	1.87e-01	4.02e-01	8.56e-01	7.27e-01	9.59e-01
GOBP REGULATION OF MRNA PROCESSING	118	3.36e-03	1.42e-02	0.2200	-1.30e-01	-1.08e-01	-8.38e-02	8.23e-02	-7.45e-02	-1.18e-02	1.45e-02	4.20e-02	1.16e-01	1.23e-01	1.62e-01	8.24e-01
GOBP PHOSPHATIDYLINOSITOL METABOLIC PROCESS	147	7.30e-05	5.13e-04	0.2190	-1.11e-01	1.01e-01	-1.34e-03	9.85e-02	1.24e-01	2.22e-02	2.03e-02	3.49e-02	9.78e-01	3.92e-02	9.19e-03	6.42e-01
GOBP POSITIVE REGULATION OF PROTEASOMAL UBIQUITIN DEPENDENT PROTEIN CATABOLIC PROCESS	73	1.03e-02	3.51e-02	0.2190	-1.25e-01	-9.88e-02	6.01e-02	1.26e-01	-3.73e-02	4.46e-02	6.56e-02	1.44e-01	3.74e-01	6.30e-02	5.82e-01	5.10e-01
GOBP AXON DEVELOPMENT	350	1.52e-10	2.67e-09	0.2190	-4.08e-02	1.37e-01	1.41e-01	6.68e-02	2.11e-02	5.44e-02	1.90e-01	1.14e-05	5.61e-06	3.19e-02	4.98e-01	8.02e-02
GOBP ROOF OF MOUTH DEVELOPMENT	61	2.04e-01	3.20e-01	0.2190	-2.23e-02	1.64e-01	1.12e-01	3.64e-02	7.10e-02	4.11e-02	7.63e-01	2.65e-02	1.31e-01	6.23e-01	3.37e-01	5.78e-01
GOBP CELLULAR RESPONSE TO HYDROGEN PEROXIDE	62	5.93e-03	2.25e-02	0.2190	-1.45e-01	-1.33e-02	7.46e-02	1.44e-01	-5.95e-03	2.63e-02	4.89e-02	8.57e-01	3.09e-01	5.06e-02	9.35e-01	7.20e-01
GOMF ORGANIC CATION TRANSMEMBRANE TRANSPORTER ACTIVITY	52	9.52e-02	1.89e-01	0.2190	-1.22e-01	-1.00e-01	6.07e-03	1.08e-01	-1.06e-01	1.39e-02	1.30e-01	2.11e-01	9.40e-01	1.76e-01	1.87e-01	8.63e-01
GOCC TRANS GOLGI NETWORK MEMBRANE	99	4.20e-03	1.70e-02	0.2190	-1.55e-01	-5.41e-02	-5.65e-02	1.20e-01	4.86e-02	3.50e-02	7.77e-03	3.52e-01	3.31e-01	3.98e-02	4.04e-01	5.48e-01
GOCC CATION CHANNEL COMPLEX	131	6.13e-03	2.32e-02	0.2190	8.80e-02	7.85e-02	1.69e-01	-5.48e-02	1.72e-02	4.62e-02	8.22e-02	1.21e-01	8.23e-04	2.79e-01	7.33e-01	3.61e-01
GOBP HOMOCYSTEINE METABOLIC PROCESS	9	9.53e-01	9.61e-01	0.2190	3.87e-02	-1.27e-01	-1.87e-02	1.52e-01	-3.67e-02	-7.35e-02	8.41e-01	5.08e-01	9.23e-01	4.29e-01	8.49e-01	7.03e-01
GOBP CLATHRIN DEPENDENT ENDOCYTOSIS	46	1.35e-01	2.43e-01	0.2190	-1.38e-01	-3.45e-02	4.59e-02	1.28e-01	-7.56e-03	9.60e-02	1.06e-01	6.85e-01	5.90e-01	1.33e-01	9.29e-01	2.60e-01
GOBP RESPONSE TO ANTIBIOTIC	36	3.93e-01	5.06e-01	0.2190	-2.40e-02	6.49e-02	8.95e-03	1.10e-01	1.61e-01	-7.19e-02	8.03e-01	5.01e-01	9.26e-01	2.53e-01	9.55e-02	4.55e-01
GOBP SULFUR COMPOUND METABOLIC PROCESS	259	6.66e-06	5.88e-05	0.2190	-1.42e-01	-1.50e-01	-2.54e-02	2.93e-02	-1.35e-02	5.95e-02	8.14e-05	3.40e-05	4.82e-01	4.16e-01	7.08e-01	9.96e-02
GOBP REGULATION OF RESPONSE TO EXTERNAL STIMULUS	874	5.93e-21	2.75e-19	0.2190	-6.44e-02	6.03e-02	1.30e-01	5.37e-02	-5.31e-03	1.42e-01	1.24e-03	2.52e-03	7.10e-11	7.08e-03	7.90e-01	9.86e-13
GOMF HEAT SHOCK PROTEIN BINDING	116	2.96e-03	1.28e-02	0.2190	-4.11e-02	-6.92e-02	5.42e-02	1.56e-01	5.83e-02	1.03e-01	4.45e-01	1.98e-01	3.14e-01	3.75e-03	2.78e-01	5.42e-02
GOBP REGULATION OF CARBOHYDRATE BIOSYNTHETIC PROCESS	80	4.45e-03	1.78e-02	0.2190	-6.24e-02	5.39e-02	8.64e-02	1.70e-01	6.69e-02	1.54e-02	3.34e-01	4.05e-01	1.81e-01	8.72e-03	3.01e-01	8.12e-01
GOBP REGULATION OF CELL ADHESION	639	4.58e-18	1.62e-16	0.2180	-2.89e-02	6.79e-02	1.76e-01	6.41e-02	-2.62e-02	7.98e-02	2.13e-01	3.43e-03	2.73e-14	5.70e-03	2.59e-01	5.79e-04
GOBP MEMBRANE DEPOLARIZATION	59	3.94e-01	5.07e-01	0.2180	4.10e-02	-3.38e-02	1.36e-01	-2.55e-02	-1.44e-01	6.96e-02	5.86e-01	6.53e-01	7.12e-02	7.35e-01	5.55e-02	3.55e-01
GOMF RNA 7 METHYLGUANOSINE CAP BINDING	12	9.07e-01	9.23e-01	0.2180	-5.09e-02	9.25e-03	1.12e-01	1.10e-01	-9.87e-02	1.03e-01	7.60e-01	9.56e-01	5.04e-01	5.10e-01	5.54e-01	5.36e-01
GOBP REGULATION OF PEPTIDYL SERINE PHOSPHORYLATION	78	1.66e-01	2.79e-01	0.2180	-4.17e-02	5.18e-02	1.63e-01	-2.27e-02	-1.02e-01	7.39e-02	5.24e-01	4.29e-01	1.27e-02	7.29e-01	1.18e-01	2.59e-01
GOBP MONONUCLEAR CELL DIFFERENTIATION	450	8.81e-11	1.61e-09	0.2180	-1.50e-02	9.40e-02	1.43e-01	9.09e-02	-1.26e-02	9.84e-02	5.85e-01	6.37e-04	2.15e-07	9.53e-04	6.47e-01	3.47e-04
GOBP T CELL MEDIATED CYTOTOXICITY	52	2.34e-01	3.52e-01	0.2180	-1.04e-01	-1.12e-01	-1.13e-01	9.32e-02	-6.62e-03	5.16e-02	1.95e-01	1.62e-01	1.58e-01	2.45e-01	9.34e-01	5.20e-01
GOBP TIGHT JUNCTION ORGANIZATION	57	3.93e-02	9.83e-02	0.2180	-1.30e-01	8.49e-02	1.49e-01	-3.52e-02	-6.76e-03	7.17e-03	8.99e-02	2.68e-01	5.23e-02	6.45e-01	9.30e-01	9.25e-01
GOBP STEM CELL DIFFERENTIATION	167	1.69e-04	1.08e-03	0.2180	-1.41e-02	1.27e-01	1.13e-01	1.23e-01	2.88e-02	4.99e-02	7.53e-01	4.62e-03	1.16e-02	6.31e-03	5.21e-01	2.66e-01
GOMF CYTOSKELETAL PROTEIN BINDING	830	8.29e-23	4.37e-21	0.2180	-5.07e-02	-8.61e-03	1.20e-01	1.08e-01	-3.39e-02	1.32e-01	1.32e-02	6.74e-01	3.77e-09	1.26e-07	9.71e-02	9.49e-11
GOMF GROWTH FACTOR ACTIVITY	75	1.15e-02	3.83e-02	0.2180	2.65e-02	7.56e-03	1.97e-01	-7.38e-02	-4.54e-02	-1.60e-02	6.91e-01	9.10e-01	3.12e-03	2.69e-01	4.96e-01	8.11e-01
GOBP POSITIVE REGULATION OF ENDOTHELIAL CELL PROLIFERATION	67	1.52e-02	4.78e-02	0.2180	-4.79e-02	-1.33e-02	1.66e-01	8.99e-02	6.02e-02	7.65e-02	4.98e-01	8.50e-01	1.90e-02	2.03e-01	3.95e-01	2.79e-01
GOMF S ACYLTRANSFERASE ACTIVITY	29	6.25e-01	7.02e-01	0.2180	-9.96e-02	-8.79e-02	2.84e-02	-3.66e-02	-1.39e-01	-9.16e-02	3.53e-01	4.13e-01	7.91e-01	7.33e-01	1.96e-01	3.93e-01
GOMF GTPASE ACTIVATOR ACTIVITY	252	4.59e-10	7.71e-09	0.2180	-3.50e-03	9.15e-02	1.52e-01	1.23e-01	-2.52e-02	-9.07e-03	9.24e-01	1.24e-02	3.18e-05	7.83e-04	4.92e-01	8.04e-01
GOBP BIOLOGICAL PROCESS INVOLVED IN INTERSPECIES INTERACTION BETWEEN ORGANISMS	1364	1.73e-37	2.71e-35	0.2180	-7.54e-02	-3.58e-03	9.68e-02	9.78e-02	9.63e-05	1.51e-01	3.13e-06	8.25e-01	2.06e-09	1.43e-09	9.95e-01	1.08e-20
GOBP BLOOD VESSEL ENDOTHELIAL CELL MIGRATION	97	1.48e-05	1.20e-04	0.2180	-9.51e-02	4.37e-02	1.67e-01	-1.89e-04	9.15e-02	-4.79e-03	1.05e-01	4.57e-01	4.42e-03	9.97e-01	1.19e-01	9.35e-01
GOCC CELL CORTEX	264	2.83e-08	3.74e-07	0.2180	-5.27e-02	-1.34e-02	1.01e-01	1.45e-01	-3.79e-02	1.08e-01	1.40e-01	7.07e-01	4.92e-03	4.85e-05	2.89e-01	2.48e-03
GOBP NON CANONICAL NF KAPPAB SIGNAL TRANSDUCTION	110	2.17e-03	9.87e-03	0.2170	-8.51e-02	1.35e-01	2.28e-02	4.88e-02	1.34e-01	-2.84e-02	1.23e-01	1.44e-02	6.79e-01	3.77e-01	1.49e-02	6.07e-01
GOMF TRANSCRIPTION COREPRESSOR BINDING	46	1.98e-01	3.14e-01	0.2170	1.24e-02	-8.11e-03	2.15e-02	1.98e-01	6.43e-02	-5.48e-02	8.84e-01	9.24e-01	8.01e-01	1.99e-02	4.50e-01	5.20e-01
GOBP REGULATION OF REACTIVE OXYGEN SPECIES BIOSYNTHETIC PROCESS	33	7.67e-01	8.13e-01	0.2170	-7.18e-02	-9.57e-03	1.29e-01	-1.41e-02	-5.24e-02	1.50e-01	4.75e-01	9.24e-01	2.01e-01	8.89e-01	6.02e-01	1.36e-01
GOBP DICARBOXYLIC ACID CATABOLIC PROCESS	14	9.04e-01	9.21e-01	0.2170	-4.60e-02	-2.02e-01	-3.56e-02	-2.27e-02	-1.53e-02	4.55e-02	7.65e-01	1.90e-01	8.17e-01	8.83e-01	9.21e-01	7.68e-01
GOBP RESPONSE TO MINERALOCORTICOID	30	2.43e-02	6.87e-02	0.2170	-2.44e-02	-7.21e-02	1.46e-01	-6.42e-02	7.91e-02	-9.89e-02	8.17e-01	4.94e-01	1.67e-01	5.43e-01	4.53e-01	3.48e-01
GOBP NEUTRAL LIPID METABOLIC PROCESS	100	5.56e-04	3.06e-03	0.2170	-1.18e-01	8.07e-02	1.31e-01	7.72e-02	3.10e-02	5.09e-02	4.07e-02	1.63e-01	2.39e-02	1.82e-01	5.92e-01	3.79e-01
GOBP NUCLEOSIDE BISPHOSPHATE METABOLIC PROCESS	108	1.71e-02	5.23e-02	0.2170	-1.20e-01	-1.54e-01	-1.25e-02	3.54e-02	9.24e-03	8.70e-02	3.09e-02	5.79e-03	8.22e-01	5.25e-01	8.68e-01	1.18e-01
GOBP CELLULAR RESPONSE TO ALCOHOL	83	2.54e-03	1.13e-02	0.2170	-1.11e-01	1.02e-01	1.40e-01	6.12e-02	2.78e-03	3.15e-02	8.01e-02	1.07e-01	2.76e-02	3.36e-01	9.65e-01	6.20e-01
GOBP REGULATION OF MONOATOMIC ION TRANSMEMBRANE TRANSPORT	230	6.43e-04	3.48e-03	0.2170	-3.97e-02	-2.38e-02	1.53e-01	-1.84e-02	-1.09e-01	9.62e-02	3.00e-01	5.35e-01	6.36e-05	6.31e-01	4.34e-03	1.20e-02
GOBP REGULATION OF PROTEIN LOCALIZATION TO CELL PERIPHERY	114	1.28e-03	6.29e-03	0.2170	-1.61e-01	-9.11e-02	2.88e-02	6.39e-02	-8.76e-02	2.06e-02	3.07e-03	9.29e-02	5.96e-01	2.39e-01	1.06e-01	7.04e-01
GOBP REGULATION OF PROTEIN TYROSINE KINASE ACTIVITY	40	3.71e-01	4.86e-01	0.2170	-2.63e-02	1.24e-01	1.15e-01	8.94e-02	-3.42e-02	9.22e-02	7.74e-01	1.73e-01	2.09e-01	3.28e-01	7.08e-01	3.13e-01
GOBP ATP EXPORT	6	9.81e-01	9.84e-01	0.2170	8.88e-02	-1.05e-01	-1.34e-01	3.29e-02	9.51e-02	-7.97e-03	7.06e-01	6.57e-01	5.70e-01	8.89e-01	6.87e-01	9.73e-01
GOBP CATECHOL CONTAINING COMPOUND METABOLIC PROCESS	33	2.43e-01	3.61e-01	0.2170	-1.37e-01	1.51e-02	1.59e-01	1.75e-02	-1.17e-02	4.82e-02	1.73e-01	8.80e-01	1.15e-01	8.62e-01	9.07e-01	6.32e-01
GOBP REGULATION OF AUTOPHAGY	333	6.68e-13	1.50e-11	0.2170	-1.26e-01	-2.05e-02	7.09e-02	1.09e-01	-7.12e-02	9.31e-02	7.59e-05	5.21e-01	2.62e-02	6.41e-04	2.56e-02	3.52e-03
GOMF DIOXYGENASE ACTIVITY	81	2.79e-02	7.60e-02	0.2170	-3.91e-02	6.98e-03	5.96e-04	1.94e-01	8.70e-02	9.12e-03	5.43e-01	9.14e-01	9.93e-01	2.54e-03	1.76e-01	8.87e-01
GOBP LUNG EPITHELIUM DEVELOPMENT	27	2.56e-01	3.75e-01	0.2170	-1.98e-01	-3.20e-02	7.04e-02	-1.35e-03	8.53e-03	-4.14e-02	7.53e-02	7.74e-01	5.27e-01	9.90e-01	9.39e-01	7.09e-01
GOBP LOCOMOTOR RHYTHM	11	8.07e-01	8.45e-01	0.2160	-1.04e-01	-7.32e-02	5.01e-02	-3.56e-02	-4.10e-02	-1.59e-01	5.50e-01	6.74e-01	7.74e-01	8.38e-01	8.14e-01	3.62e-01
GOMF MOLECULAR TRANSDUCER ACTIVITY	782	4.23e-16	1.26e-14	0.2160	-6.25e-03	1.46e-01	1.42e-01	-4.67e-03	3.78e-03	7.21e-02	7.66e-01	3.86e-12	1.32e-11	8.24e-01	8.57e-01	6.07e-04
GOBP SOMATIC STEM CELL POPULATION MAINTENANCE	50	4.80e-01	5.81e-01	0.2160	2.97e-02	1.40e-01	-1.44e-02	1.03e-01	1.18e-01	3.82e-02	7.16e-01	8.70e-02	8.60e-01	2.06e-01	1.48e-01	6.40e-01
GOMF ALPHA TUBULIN BINDING	38	4.11e-01	5.22e-01	0.2160	-3.80e-02	4.68e-02	1.19e-02	1.45e-01	5.52e-02	1.38e-01	6.85e-01	6.17e-01	8.99e-01	1.22e-01	5.56e-01	1.42e-01
GOMF DYNEIN LIGHT INTERMEDIATE CHAIN BINDING	26	7.67e-01	8.13e-01	0.2160	7.32e-02	1.60e-01	9.88e-02	-6.84e-02	-1.60e-02	-3.56e-02	5.18e-01	1.59e-01	3.83e-01	5.46e-01	8.87e-01	7.53e-01
GOBP REGULATION OF MAP KINASE ACTIVITY	106	1.25e-02	4.08e-02	0.2160	-1.41e-02	4.12e-02	1.93e-01	-4.77e-02	-7.03e-02	2.41e-02	8.02e-01	4.64e-01	6.09e-04	3.97e-01	2.11e-01	6.68e-01
GOBP REGULATION OF MORPHOGENESIS OF AN EPITHELIUM	38	3.58e-01	4.74e-01	0.2160	8.84e-02	8.98e-02	9.33e-02	-1.48e-01	3.39e-03	-1.92e-02	3.45e-01	3.38e-01	3.20e-01	1.15e-01	9.71e-01	8.37e-01
GOBP FIBROBLAST PROLIFERATION	91	3.19e-03	1.36e-02	0.2160	-3.26e-02	-1.24e-01	4.20e-02	1.62e-01	4.45e-02	2.41e-02	5.91e-01	4.17e-02	4.89e-01	7.68e-03	4.64e-01	6.91e-01
GOBP TUMOR NECROSIS FACTOR SUPERFAMILY CYTOKINE PRODUCTION	155	2.69e-04	1.64e-03	0.2160	-9.86e-02	6.32e-02	1.19e-01	6.77e-02	3.66e-02	1.14e-01	3.42e-02	1.74e-01	1.09e-02	1.46e-01	4.32e-01	1.41e-02
GOMF OXIDOREDUCTASE ACTIVITY ACTING ON THE CH CH GROUP OF DONORS NAD OR NADP AS ACCEPTOR	28	2.82e-01	4.02e-01	0.2160	-1.99e-03	-1.94e-01	-1.92e-02	1.56e-02	9.09e-02	-3.89e-03	9.85e-01	7.49e-02	8.60e-01	8.86e-01	4.05e-01	9.72e-01
GOBP POSITIVE REGULATION OF GRANULOCYTE CHEMOTAXIS	22	3.42e-01	4.59e-01	0.2160	-1.44e-02	-3.75e-02	2.04e-01	4.80e-02	2.36e-02	2.09e-02	9.07e-01	7.61e-01	9.69e-02	6.97e-01	8.48e-01	8.66e-01
GOBP ODONTOGENESIS	73	1.75e-01	2.90e-01	0.2160	3.99e-02	8.67e-02	1.75e-01	6.55e-02	-1.32e-02	4.89e-02	5.55e-01	2.00e-01	9.63e-03	3.33e-01	8.45e-01	4.70e-01
GOBP CELL SURFACE RECEPTOR PROTEIN TYROSINE KINASE SIGNALING PATHWAY	474	2.03e-14	5.20e-13	0.2160	-6.12e-02	5.84e-02	1.69e-01	5.37e-02	-4.57e-02	7.84e-02	2.25e-02	2.95e-02	3.24e-10	4.54e-02	8.87e-02	3.47e-03
GOBP REGULATION OF TRANSCRIPTION BY GLUCOSE	9	9.68e-01	9.73e-01	0.2160	3.38e-02	9.00e-02	-1.76e-02	1.86e-01	5.09e-02	-1.03e-02	8.61e-01	6.40e-01	9.27e-01	3.35e-01	7.91e-01	9.57e-01
GOCC TRANSCRIPTION ELONGATION FACTOR COMPLEX	50	1.42e-01	2.51e-01	0.2160	-6.60e-02	-5.29e-02	5.83e-02	1.69e-01	-9.96e-03	8.58e-02	4.19e-01	5.18e-01	4.76e-01	3.84e-02	9.03e-01	2.94e-01
GOBP REGULATION OF LYMPHOCYTE APOPTOTIC PROCESS	54	5.00e-01	5.97e-01	0.2160	8.98e-02	6.45e-02	6.58e-02	1.13e-01	3.35e-02	1.27e-01	2.54e-01	4.12e-01	4.03e-01	1.50e-01	6.70e-01	1.06e-01
GOBP REGULATION OF LIPASE ACTIVITY	46	3.92e-01	5.06e-01	0.2160	-6.92e-03	-4.74e-02	1.47e-01	1.67e-02	-1.45e-01	3.79e-02	9.35e-01	5.78e-01	8.50e-02	8.44e-01	8.84e-02	6.56e-01
GOBP REGULATION OF NEURAL PRECURSOR CELL PROLIFERATION	62	2.13e-01	3.30e-01	0.2160	-4.97e-02	4.60e-02	1.36e-01	7.93e-02	3.25e-02	1.27e-01	4.98e-01	5.31e-01	6.42e-02	2.80e-01	6.58e-01	8.29e-02
GOCC AXONEMAL MICROTUBULE	22	8.28e-01	8.61e-01	0.2160	-1.21e-01	-8.60e-02	-9.70e-02	-1.00e-01	7.13e-02	-6.67e-03	3.27e-01	4.85e-01	4.31e-01	4.15e-01	5.63e-01	9.57e-01
GOBP MICROTUBULE ANCHORING	24	3.99e-01	5.11e-01	0.2160	-2.22e-02	1.50e-01	5.56e-02	1.02e-01	-7.49e-02	6.59e-02	8.51e-01	2.03e-01	6.37e-01	3.85e-01	5.25e-01	5.76e-01
GOBP GLYCOLIPID BIOSYNTHETIC PROCESS	63	6.79e-02	1.48e-01	0.2160	-1.68e-01	1.10e-02	-1.03e-02	6.48e-02	6.25e-02	9.98e-02	2.10e-02	8.80e-01	8.87e-01	3.74e-01	3.91e-01	1.71e-01
GOBP REGULATION OF CELL CYCLE	940	2.86e-32	3.20e-30	0.2160	-6.59e-02	-7.64e-02	2.60e-02	1.66e-01	-2.48e-03	9.11e-02	6.29e-04	7.30e-05	1.77e-01	7.87e-18	8.98e-01	2.28e-06
GOBP NUCLEAR TRANSPORT	308	6.70e-11	1.23e-09	0.2160	-1.58e-01	-9.33e-02	-2.86e-02	1.06e-01	-2.66e-02	1.51e-02	1.91e-06	4.87e-03	3.89e-01	1.41e-03	4.23e-01	6.49e-01
GOBP IMMUNE RESPONSE TO TUMOR CELL	25	6.43e-01	7.17e-01	0.2160	1.64e-02	-1.05e-01	-6.63e-02	1.69e-01	-2.94e-02	4.01e-02	8.87e-01	3.65e-01	5.66e-01	1.44e-01	7.99e-01	7.29e-01
GOBP ATRIOVENTRICULAR VALVE DEVELOPMENT	18	8.07e-01	8.45e-01	0.2160	-7.88e-02	1.20e-01	1.48e-01	-1.07e-02	-4.33e-02	4.50e-02	5.63e-01	3.77e-01	2.78e-01	9.37e-01	7.50e-01	7.41e-01
GOBP CELL MATRIX ADHESION	188	1.03e-05	8.60e-05	0.2160	-3.11e-02	1.36e-02	1.93e-01	3.60e-02	-6.81e-02	4.77e-02	4.62e-01	7.48e-01	5.16e-06	3.95e-01	1.07e-01	2.60e-01
GOBP SENSORY PERCEPTION OF PAIN	49	4.07e-01	5.18e-01	0.2160	-1.47e-02	3.22e-02	1.89e-01	6.13e-03	-4.27e-02	8.79e-02	8.59e-01	6.96e-01	2.22e-02	9.41e-01	6.05e-01	2.87e-01
GOBP MONOAMINE TRANSPORT	49	4.44e-01	5.51e-01	0.2160	4.73e-02	1.91e-02	1.83e-01	-4.69e-02	-6.91e-02	5.95e-02	5.67e-01	8.17e-01	2.70e-02	5.70e-01	4.03e-01	4.71e-01
GOBP REGULATION OF EPIDERMIS DEVELOPMENT	45	9.01e-02	1.81e-01	0.2160	-2.35e-02	6.47e-02	1.14e-01	1.22e-01	1.14e-01	-3.09e-02	7.85e-01	4.53e-01	1.86e-01	1.57e-01	1.87e-01	7.20e-01
GOMF PHOSPHOPROTEIN PHOSPHATASE ACTIVITY	147	3.58e-04	2.10e-03	0.2160	-1.32e-01	-3.96e-02	7.96e-02	6.58e-02	-8.24e-02	9.98e-02	5.68e-03	4.08e-01	9.58e-02	1.69e-01	8.45e-02	3.68e-02
GOBP RESPONSE TO GROWTH FACTOR	521	8.89e-17	2.82e-15	0.2150	-7.27e-02	8.47e-02	1.61e-01	4.68e-02	-2.33e-02	7.24e-02	4.55e-03	9.48e-04	2.96e-10	6.78e-02	3.63e-01	4.72e-03
GOBP NUCLEOSIDE PHOSPHATE CATABOLIC PROCESS	156	2.68e-04	1.63e-03	0.2150	-8.08e-02	-1.17e-01	9.18e-02	7.23e-02	-2.26e-02	1.10e-01	8.17e-02	1.18e-02	4.79e-02	1.19e-01	6.26e-01	1.77e-02
GOMF MONOATOMIC ANION TRANSMEMBRANE TRANSPORTER ACTIVITY	89	8.42e-02	1.73e-01	0.2150	1.07e-01	1.06e-01	1.42e-01	-3.33e-02	-3.77e-02	-3.18e-02	8.21e-02	8.28e-02	2.06e-02	5.87e-01	5.39e-01	6.04e-01
GOBP PROTEIN LOCALIZATION TO NUCLEUS	279	1.92e-10	3.37e-09	0.2150	-1.20e-01	-7.01e-02	2.36e-02	1.40e-01	-4.14e-02	7.13e-02	5.90e-04	4.41e-02	4.98e-01	5.43e-05	2.34e-01	4.03e-02
GOBP NEGATIVE REGULATION OF CELL CYCLE	336	6.73e-10	1.11e-08	0.2150	-4.60e-02	-9.39e-02	5.35e-03	1.63e-01	1.03e-02	9.30e-02	1.48e-01	3.12e-03	8.66e-01	2.82e-07	7.46e-01	3.41e-03
GOBP PRIMARY MIRNA PROCESSING	16	9.32e-01	9.43e-01	0.2150	-7.26e-02	-6.50e-02	-5.40e-02	-7.53e-02	-1.65e-01	-3.23e-02	6.15e-01	6.53e-01	7.09e-01	6.02e-01	2.54e-01	8.23e-01
GOBP REGULATION OF CELL PROJECTION ORGANIZATION	548	1.82e-16	5.61e-15	0.2150	-4.88e-02	9.00e-02	1.45e-01	8.96e-02	1.56e-03	8.24e-02	5.08e-02	3.15e-04	6.94e-09	3.37e-04	9.50e-01	9.72e-04
GOBP EXECUTION PHASE OF APOPTOSIS	66	7.03e-02	1.51e-01	0.2150	-2.80e-02	-4.49e-02	5.13e-02	1.88e-01	2.71e-02	6.77e-02	6.94e-01	5.28e-01	4.71e-01	8.14e-03	7.03e-01	3.42e-01
GOBP GASTRULATION WITH MOUTH FORMING SECOND	21	3.73e-01	4.88e-01	0.2150	-1.17e-01	5.53e-02	8.83e-02	1.90e-02	-9.37e-02	-1.12e-01	3.52e-01	6.61e-01	4.84e-01	8.80e-01	4.57e-01	3.76e-01
GOBP REGULATION OF CELLULAR RESPONSE TO STRESS	471	2.61e-16	7.98e-15	0.2150	-1.26e-01	-9.97e-02	3.61e-03	1.26e-01	-1.72e-02	6.48e-02	2.73e-06	2.11e-04	8.93e-01	2.98e-06	5.23e-01	1.60e-02
GOBP CELL CYCLE	1403	5.26e-45	1.19e-42	0.2150	-5.73e-02	-8.41e-02	2.13e-02	1.59e-01	-4.83e-03	1.00e-01	3.29e-04	1.35e-07	1.82e-01	2.10e-23	7.62e-01	3.50e-10
GOBP ANATOMICAL STRUCTURE FORMATION INVOLVED IN MORPHOGENESIS	855	9.76e-27	7.36e-25	0.2140	-6.36e-02	6.74e-02	1.64e-01	5.87e-02	-8.77e-03	8.33e-02	1.61e-03	8.31e-04	3.62e-16	3.57e-03	6.63e-01	3.62e-05
GOBP LIPID LOCALIZATION	350	1.89e-11	3.69e-10	0.2140	-2.27e-02	4.93e-02	1.77e-01	8.93e-02	1.28e-02	6.11e-02	4.67e-01	1.13e-01	1.39e-08	4.10e-03	6.80e-01	4.97e-02
GOBP PROTEIN HETEROOLIGOMERIZATION	22	6.26e-01	7.03e-01	0.2140	6.22e-02	-1.15e-01	-3.81e-02	9.60e-02	-9.42e-02	9.66e-02	6.14e-01	3.50e-01	7.57e-01	4.36e-01	4.45e-01	4.33e-01
GOBP MODIFIED AMINO ACID TRANSPORT	32	4.80e-02	1.14e-01	0.2140	-1.24e-01	-8.27e-02	1.44e-01	-1.07e-02	4.20e-02	-3.44e-02	2.26e-01	4.18e-01	1.58e-01	9.17e-01	6.81e-01	7.36e-01
GOBP NAD METABOLIC PROCESS	57	7.63e-02	1.61e-01	0.2140	-1.62e-01	-8.20e-02	2.80e-02	7.12e-02	5.17e-02	6.65e-02	3.43e-02	2.84e-01	7.15e-01	3.53e-01	5.00e-01	3.85e-01
GOBP PROTEIN K63 LINKED UBIQUITINATION	65	1.42e-01	2.51e-01	0.2140	-1.84e-01	-7.12e-02	-6.18e-02	3.58e-02	2.00e-02	3.87e-02	1.03e-02	3.21e-01	3.89e-01	6.18e-01	7.80e-01	5.90e-01
GOBP POSITIVE REGULATION OF CELL MORPHOGENESIS	32	5.35e-01	6.26e-01	0.2140	-4.65e-02	1.32e-01	7.47e-02	1.09e-01	7.86e-02	5.23e-02	6.49e-01	1.96e-01	4.65e-01	2.87e-01	4.42e-01	6.08e-01
GOBP MALE SEX DIFFERENTIATION	118	1.11e-01	2.10e-01	0.2140	-6.56e-02	2.61e-02	1.24e-01	-7.22e-02	-8.50e-02	1.14e-01	2.18e-01	6.25e-01	1.99e-02	1.76e-01	1.11e-01	3.21e-02
GOBP NEURON PROJECTION EXTENSION	123	9.63e-04	4.92e-03	0.2140	-3.92e-02	1.30e-01	1.18e-01	8.92e-02	7.37e-02	1.15e-02	4.52e-01	1.27e-02	2.43e-02	8.77e-02	1.58e-01	8.26e-01
GOBP NEGATIVE REGULATION OF BLOOD VESSEL ENDOTHELIAL CELL MIGRATION	29	5.03e-02	1.18e-01	0.2140	-2.47e-02	-2.30e-02	1.68e-01	-6.24e-02	9.24e-02	-6.26e-02	8.18e-01	8.30e-01	1.17e-01	5.61e-01	3.89e-01	5.60e-01
GOBP REGULATION OF LEUKOCYTE DIFFERENTIATION	275	9.26e-06	7.86e-05	0.2140	4.50e-03	1.12e-01	1.48e-01	7.85e-02	-1.00e-04	7.09e-02	8.98e-01	1.34e-03	2.38e-05	2.52e-02	9.98e-01	4.30e-02
GOCC AUTOPHAGOSOME	107	9.33e-04	4.80e-03	0.2140	-1.28e-01	-5.76e-02	-4.56e-02	1.47e-01	-2.17e-02	4.47e-02	2.27e-02	3.03e-01	4.15e-01	8.60e-03	6.99e-01	4.25e-01
GOCC LEADING EDGE MEMBRANE	139	7.41e-04	3.94e-03	0.2140	9.86e-03	5.66e-02	1.92e-01	5.89e-02	8.27e-03	4.55e-02	8.41e-01	2.49e-01	9.37e-05	2.31e-01	8.66e-01	3.55e-01
GOBP POSITIVE REGULATION OF B CELL MEDIATED IMMUNITY	40	6.34e-01	7.10e-01	0.2140	3.07e-02	2.31e-02	-6.81e-02	9.93e-02	1.69e-01	3.38e-02	7.37e-01	8.00e-01	4.56e-01	2.77e-01	6.42e-02	7.11e-01
GOBP AMINO ACID BIOSYNTHETIC PROCESS	62	1.67e-01	2.79e-01	0.2140	-8.92e-02	-1.83e-01	-4.98e-02	2.35e-02	3.04e-02	1.83e-02	2.25e-01	1.27e-02	4.98e-01	7.49e-01	6.79e-01	8.03e-01
GOBP CELLULAR RESPONSE TO HEAT	56	2.11e-02	6.18e-02	0.2140	-1.22e-01	-4.15e-02	1.20e-01	8.06e-02	6.64e-02	6.21e-02	1.15e-01	5.91e-01	1.21e-01	2.97e-01	3.90e-01	4.21e-01
GOBP SMOOTH MUSCLE CELL MIGRATION	59	9.87e-02	1.94e-01	0.2140	-2.52e-02	1.31e-01	1.57e-01	5.14e-02	-2.20e-02	1.04e-02	7.37e-01	8.22e-02	3.70e-02	4.95e-01	7.70e-01	8.91e-01
GOBP GOLGI LOCALIZATION	13	9.21e-01	9.34e-01	0.2140	2.11e-02	-4.36e-02	7.13e-02	-1.00e-02	-1.86e-01	-5.78e-02	8.95e-01	7.85e-01	6.56e-01	9.50e-01	2.45e-01	7.18e-01
GOBP POSITIVE REGULATION OF INTERLEUKIN 6 PRODUCTION	83	1.12e-03	5.62e-03	0.2130	-1.71e-01	7.77e-02	6.30e-02	3.18e-02	7.24e-02	-1.27e-02	7.17e-03	2.21e-01	3.21e-01	6.16e-01	2.54e-01	8.41e-01
GOBP REGULATION OF CALCINEURIN MEDIATED SIGNALING	33	6.02e-01	6.83e-01	0.2130	2.59e-02	6.79e-02	1.66e-01	4.71e-02	-9.80e-02	3.22e-02	7.97e-01	5.00e-01	9.97e-02	6.39e-01	3.30e-01	7.49e-01
GOBP REGULATION OF FAT CELL DIFFERENTIATION	94	1.27e-03	6.23e-03	0.2130	-1.94e-02	1.34e-01	1.35e-01	-2.41e-03	2.84e-02	-8.95e-02	7.45e-01	2.43e-02	2.35e-02	9.68e-01	6.34e-01	1.34e-01
GOBP SKELETAL MUSCLE ORGAN DEVELOPMENT	121	2.80e-02	7.62e-02	0.2130	6.77e-02	1.22e-01	1.56e-01	-2.17e-02	3.11e-02	1.59e-02	1.99e-01	2.05e-02	3.02e-03	6.80e-01	5.55e-01	7.63e-01
GOMF SH3 DOMAIN BINDING	109	2.45e-03	1.09e-02	0.2130	-7.35e-02	6.68e-02	1.29e-01	9.27e-02	-5.74e-02	8.40e-02	1.85e-01	2.28e-01	1.99e-02	9.46e-02	3.00e-01	1.30e-01
GOBP INSULIN LIKE GROWTH FACTOR RECEPTOR SIGNALING PATHWAY	40	1.60e-01	2.73e-01	0.2130	-2.70e-02	1.43e-01	1.19e-01	1.66e-03	-1.80e-02	-9.83e-02	7.67e-01	1.17e-01	1.91e-01	9.86e-01	8.44e-01	2.82e-01
GOMF SMALL MOLECULE SENSOR ACTIVITY	44	3.81e-01	4.94e-01	0.2130	-9.00e-02	-1.24e-01	-2.69e-02	5.96e-02	3.14e-02	1.30e-01	3.02e-01	1.56e-01	7.57e-01	4.94e-01	7.19e-01	1.37e-01
GOBP CELL ACTIVATION	945	2.58e-21	1.23e-19	0.2130	-2.22e-02	3.34e-02	1.39e-01	9.28e-02	-1.97e-02	1.24e-01	2.47e-01	8.26e-02	4.02e-13	1.36e-06	3.05e-01	1.01e-10
GOMF PROTEIN DIMERIZATION ACTIVITY	820	2.91e-22	1.48e-20	0.2130	-1.14e-01	-1.36e-01	2.72e-02	5.56e-02	-1.47e-02	9.99e-02	2.90e-08	4.15e-11	1.86e-01	6.91e-03	4.74e-01	1.19e-06
GOBP XENOBIOTIC TRANSMEMBRANE TRANSPORT	15	7.52e-01	8.02e-01	0.2130	-4.69e-02	-6.62e-02	1.65e-01	-1.00e-01	-2.31e-02	3.04e-02	7.53e-01	6.57e-01	2.68e-01	5.01e-01	8.77e-01	8.39e-01
GOBP PROTEIN ACETYLATION	50	8.60e-02	1.75e-01	0.2130	-1.41e-02	-4.01e-02	-1.34e-02	1.94e-01	-6.97e-02	2.86e-02	8.63e-01	6.24e-01	8.70e-01	1.75e-02	3.94e-01	7.26e-01
GOMF CALMODULIN DEPENDENT PROTEIN KINASE ACTIVITY	19	5.76e-01	6.62e-01	0.2130	-6.55e-02	-5.94e-02	-1.17e-02	1.58e-01	-5.84e-02	-9.54e-02	6.21e-01	6.54e-01	9.30e-01	2.34e-01	6.59e-01	4.71e-01
GOMF MICROTUBULE BINDING	253	2.89e-05	2.21e-04	0.2130	-1.70e-02	2.22e-03	8.97e-02	1.19e-01	-1.17e-03	1.51e-01	6.41e-01	9.52e-01	1.40e-02	1.10e-03	9.75e-01	3.60e-05
GOBP REGULATION OF OXIDATIVE PHOSPHORYLATION	22	8.41e-01	8.71e-01	0.2130	2.28e-02	-1.54e-01	2.11e-02	-4.05e-02	-1.38e-01	9.80e-03	8.53e-01	2.13e-01	8.64e-01	7.42e-01	2.64e-01	9.37e-01
GOBP ANATOMICAL STRUCTURE MATURATION	175	1.74e-04	1.11e-03	0.2130	-5.49e-02	-3.00e-02	1.44e-01	6.85e-02	-9.65e-02	8.13e-02	2.10e-01	4.94e-01	1.03e-03	1.18e-01	2.77e-02	6.36e-02
GOMF KINASE ACTIVITY	648	1.69e-22	8.72e-21	0.2130	-6.11e-02	7.33e-02	1.04e-01	1.35e-01	1.09e-02	8.26e-02	8.01e-03	1.46e-03	5.74e-06	4.54e-09	6.38e-01	3.34e-04
GOBP REGULATION OF TISSUE REMODELING	52	4.26e-01	5.35e-01	0.2130	-2.44e-02	4.91e-02	1.52e-01	4.00e-02	-8.34e-02	1.03e-01	7.61e-01	5.40e-01	5.86e-02	6.18e-01	2.98e-01	1.98e-01
GOBP RENAL SYSTEM PROCESS INVOLVED IN REGULATION OF SYSTEMIC ARTERIAL BLOOD PRESSURE	15	9.58e-01	9.65e-01	0.2130	2.78e-02	-5.77e-02	1.04e-01	-3.09e-02	-1.22e-01	1.20e-01	8.52e-01	6.99e-01	4.86e-01	8.36e-01	4.12e-01	4.21e-01
GOBP REGULATION OF NEUROGENESIS	271	7.89e-08	9.84e-07	0.2130	-4.77e-02	1.18e-01	1.46e-01	6.26e-02	2.57e-02	5.43e-02	1.76e-01	8.04e-04	3.43e-05	7.63e-02	4.66e-01	1.24e-01
GOBP JNK CASCADE	151	9.55e-04	4.89e-03	0.2120	-2.08e-02	1.73e-01	7.72e-02	7.34e-02	4.41e-02	3.64e-02	6.59e-01	2.41e-04	1.01e-01	1.19e-01	3.50e-01	4.40e-01
GOBP REGULATION OF CELLULAR CATABOLIC PROCESS	402	2.26e-15	6.19e-14	0.2120	-1.24e-01	-7.34e-03	9.23e-02	9.22e-02	-7.98e-02	7.93e-02	2.12e-05	8.01e-01	1.49e-03	1.51e-03	6.03e-03	6.41e-03
GOBP RESPONSE TO HEAT	83	3.37e-03	1.42e-02	0.2120	-2.37e-02	-6.54e-02	1.16e-01	1.19e-01	9.19e-02	6.46e-02	7.09e-01	3.03e-01	6.85e-02	6.08e-02	1.48e-01	3.09e-01
GOBP CELL CYCLE G1 S PHASE TRANSITION	212	1.27e-06	1.30e-05	0.2120	-8.03e-02	-7.70e-02	4.20e-02	1.41e-01	-5.44e-02	8.95e-02	4.40e-02	5.33e-02	2.92e-01	3.99e-04	1.72e-01	2.48e-02
GOBP RESPONSE TO MECHANICAL STIMULUS	169	1.12e-03	5.61e-03	0.2120	-5.88e-02	6.01e-02	1.60e-01	-9.42e-02	-3.95e-02	4.49e-02	1.87e-01	1.78e-01	3.44e-04	3.46e-02	3.75e-01	3.14e-01
GOBP POSITIVE REGULATION OF MYELOID CELL DIFFERENTIATION	82	4.75e-02	1.13e-01	0.2120	-1.46e-01	-3.63e-02	6.71e-02	4.62e-02	-6.87e-02	1.05e-01	2.26e-02	5.70e-01	2.94e-01	4.70e-01	2.82e-01	9.88e-02
GOBP MOTILE CILIUM ASSEMBLY	53	1.57e-01	2.69e-01	0.2120	3.03e-02	8.95e-02	-4.51e-02	-1.41e-01	9.95e-02	-6.40e-02	7.03e-01	2.60e-01	5.70e-01	7.48e-02	2.10e-01	4.20e-01
GOBP REGULATION OF NEURON PROJECTION DEVELOPMENT	340	4.24e-11	7.90e-10	0.2120	-4.90e-02	1.12e-01	1.48e-01	7.75e-02	-8.75e-03	4.74e-02	1.20e-01	4.05e-04	2.92e-06	1.41e-02	7.82e-01	1.34e-01
GOMF RNA POLYMERASE II SPECIFIC DNA BINDING TRANSCRIPTION FACTOR BINDING	287	6.51e-11	1.20e-09	0.2120	-5.37e-02	8.61e-03	1.10e-01	1.63e-01	3.40e-03	5.76e-02	1.18e-01	8.02e-01	1.31e-03	2.07e-06	9.21e-01	9.34e-02
GOBP REGULATION OF ISOTYPE SWITCHING	37	3.54e-01	4.69e-01	0.2120	-1.44e-02	1.05e-02	-8.48e-02	1.80e-01	4.63e-02	5.30e-02	8.80e-01	9.12e-01	3.72e-01	5.77e-02	6.26e-01	5.77e-01
GOBP RESPONSE TO STARVATION	183	3.43e-06	3.24e-05	0.2120	-1.60e-01	-5.51e-02	3.07e-02	3.67e-02	-1.18e-01	-7.86e-03	1.89e-04	1.98e-01	4.74e-01	3.92e-01	5.87e-03	8.55e-01
GOBP POSITIVE REGULATION OF IMMUNOGLOBULIN PRODUCTION	47	3.50e-01	4.66e-01	0.2120	-3.08e-02	-1.47e-02	-7.88e-02	1.72e-01	8.23e-02	3.64e-02	7.15e-01	8.62e-01	3.50e-01	4.18e-02	3.29e-01	6.66e-01
GOBP WNT SIGNALING PATHWAY	341	1.23e-09	1.93e-08	0.2120	-2.28e-02	1.09e-01	1.01e-01	1.30e-01	1.50e-02	7.02e-02	4.70e-01	5.26e-04	1.30e-03	3.47e-05	6.34e-01	2.59e-02
GOBP POSITIVE REGULATION OF MAP KINASE ACTIVITY	65	1.12e-01	2.12e-01	0.2120	-7.60e-02	2.89e-02	1.25e-01	-9.79e-02	-1.04e-01	-4.63e-02	2.90e-01	6.87e-01	8.09e-02	1.72e-01	1.46e-01	5.19e-01
GOCC RNA POLYMERASE II TRANSCRIPTION REGULATOR COMPLEX	217	7.22e-07	7.75e-06	0.2120	-6.16e-02	-1.00e-02	1.11e-01	1.31e-01	4.90e-02	9.45e-02	1.18e-01	8.00e-01	4.78e-03	8.48e-04	2.13e-01	1.64e-02
GOBP REGULATION OF DEFENSE RESPONSE TO VIRUS BY HOST	37	5.43e-01	6.33e-01	0.2120	-2.31e-02	5.81e-02	1.16e-01	9.42e-02	9.65e-02	9.69e-02	8.08e-01	5.41e-01	2.24e-01	3.22e-01	3.10e-01	3.08e-01
GOBP CELL ADHESION	1112	1.24e-25	8.47e-24	0.2120	-8.55e-03	6.59e-02	1.76e-01	4.44e-02	-3.19e-02	7.91e-02	6.31e-01	2.14e-04	3.15e-23	1.26e-02	7.27e-02	8.65e-06
GOBP DEFENSE RESPONSE TO OTHER ORGANISM	966	6.85e-26	4.89e-24	0.2120	-7.94e-02	6.21e-03	8.18e-02	9.37e-02	-1.32e-02	1.51e-01	2.99e-05	7.44e-01	1.69e-05	8.25e-07	4.86e-01	2.03e-15
GOBP MOTOR NEURON MIGRATION	7	9.45e-01	9.55e-01	0.2110	-7.87e-02	7.16e-02	1.50e-01	-3.50e-02	9.62e-02	2.29e-02	7.18e-01	7.43e-01	4.93e-01	8.73e-01	6.60e-01	9.17e-01
GOMF PHOSPHATIDYLINOSITOL PHOSPHATE BINDING	154	1.80e-04	1.14e-03	0.2110	-9.11e-02	4.15e-02	1.38e-01	7.70e-02	-2.60e-02	9.49e-02	5.11e-02	3.74e-01	3.09e-03	9.94e-02	5.78e-01	4.21e-02
GOBP PYRIDINE CONTAINING COMPOUND METABOLIC PROCESS	150	5.02e-05	3.64e-04	0.2110	-1.11e-01	-1.05e-01	5.98e-02	1.17e-01	-1.67e-02	6.34e-02	1.95e-02	2.67e-02	2.06e-01	1.36e-02	7.24e-01	1.80e-01
GOBP LIPOPROTEIN METABOLIC PROCESS	120	2.41e-02	6.81e-02	0.2110	-1.20e-01	-1.20e-01	-9.92e-02	6.23e-02	3.37e-02	3.12e-02	2.34e-02	2.27e-02	6.06e-02	2.39e-01	5.23e-01	5.55e-01
GOBP REGULATION OF INTRACELLULAR TRANSPORT	236	8.10e-06	6.98e-05	0.2110	-1.15e-01	-5.26e-02	7.11e-02	7.01e-02	-2.66e-02	1.34e-01	2.32e-03	1.64e-01	5.99e-02	6.35e-02	4.81e-01	3.89e-04
GOMF TRANSMEMBRANE RECEPTOR PROTEIN KINASE ACTIVITY	55	2.45e-01	3.63e-01	0.2110	-4.79e-02	1.32e-01	7.69e-02	8.61e-02	5.10e-02	9.49e-02	5.39e-01	9.01e-02	3.24e-01	2.69e-01	5.13e-01	2.24e-01
GOBP REGULATION OF CELL CELL ADHESION	406	1.52e-09	2.34e-08	0.2110	-1.21e-02	7.13e-02	1.62e-01	7.84e-02	1.07e-02	8.30e-02	6.76e-01	1.37e-02	2.13e-08	6.73e-03	7.11e-01	4.11e-03
GOBP INTERLEUKIN 6 PRODUCTION	130	1.25e-05	1.03e-04	0.2110	-1.42e-01	1.07e-01	1.00e-01	5.01e-02	-4.66e-03	2.08e-02	5.26e-03	3.46e-02	4.84e-02	3.24e-01	9.27e-01	6.83e-01
GOBP LOCALIZATION WITHIN MEMBRANE	590	7.13e-16	2.06e-14	0.2110	-1.31e-01	-8.76e-02	5.42e-02	5.95e-02	-4.28e-02	1.07e-01	5.31e-08	2.79e-04	2.44e-02	1.36e-02	7.57e-02	9.13e-06
GOCC SYNAPTIC VESICLE MEMBRANE	94	3.60e-02	9.19e-02	0.2110	-9.23e-02	-4.67e-02	9.27e-02	7.56e-02	5.45e-03	1.40e-01	1.22e-01	4.34e-01	1.20e-01	2.05e-01	9.27e-01	1.90e-02
GOBP CELL JUNCTION ORGANIZATION	541	6.09e-15	1.62e-13	0.2110	-4.46e-02	8.56e-02	1.70e-01	2.89e-02	-4.75e-02	5.84e-02	7.64e-02	6.63e-04	1.55e-11	2.51e-01	5.90e-02	2.02e-02
GOBP REGULATION OF PRESYNAPSE ORGANIZATION	19	7.25e-01	7.81e-01	0.2110	-1.83e-02	1.49e-01	1.14e-01	-2.50e-02	-5.78e-02	-7.17e-02	8.90e-01	2.62e-01	3.89e-01	8.50e-01	6.63e-01	5.89e-01
GOBP CELL JUNCTION ASSEMBLY	311	9.43e-09	1.32e-07	0.2110	-5.52e-02	9.60e-02	1.69e-01	-6.97e-03	-4.82e-02	3.54e-02	9.42e-02	3.62e-03	2.85e-07	8.33e-01	1.44e-01	2.83e-01
GOBP MESODERMAL CELL FATE SPECIFICATION	5	9.83e-01	9.85e-01	0.2110	-1.17e-01	-4.99e-02	-1.67e-02	1.07e-02	-2.10e-02	-1.66e-01	6.52e-01	8.47e-01	9.49e-01	9.67e-01	9.35e-01	5.20e-01
GOBP REGULATION OF CELL MORPHOGENESIS	203	5.96e-07	6.50e-06	0.2110	-5.69e-02	6.25e-02	1.66e-01	7.82e-02	-4.18e-02	4.53e-02	1.62e-01	1.25e-01	4.71e-05	5.48e-02	3.05e-01	2.66e-01
GOBP POSITIVE REGULATION OF CALCIUM ION TRANSMEMBRANE TRANSPORT	56	4.72e-01	5.74e-01	0.2110	4.65e-02	1.99e-02	1.61e-01	3.49e-02	-9.25e-02	7.85e-02	5.47e-01	7.97e-01	3.68e-02	6.52e-01	2.31e-01	3.10e-01
GOBP RETINOL METABOLIC PROCESS	28	7.71e-01	8.16e-01	0.2110	1.38e-02	1.20e-01	4.65e-02	4.77e-02	7.29e-02	1.42e-01	8.99e-01	2.72e-01	6.71e-01	6.62e-01	5.04e-01	1.94e-01
GOBP RESPONSE TO MACROPHAGE COLONY STIMULATING FACTOR	14	7.33e-01	7.87e-01	0.2110	3.45e-02	3.82e-02	1.32e-01	1.08e-01	8.72e-02	-7.21e-02	8.23e-01	8.05e-01	3.94e-01	4.84e-01	5.72e-01	6.40e-01
GOBP CELLULAR RESPONSE TO NITROGEN COMPOUND	491	4.51e-18	1.59e-16	0.2110	-1.20e-01	4.66e-02	1.27e-01	6.86e-02	-1.06e-02	8.30e-02	5.59e-06	7.72e-02	1.42e-06	9.28e-03	6.88e-01	1.64e-03
GOMF AMIDE BINDING	198	2.93e-04	1.76e-03	0.2110	-1.61e-01	-1.18e-01	-6.81e-03	-8.46e-03	8.78e-03	6.50e-02	9.31e-05	4.11e-03	8.69e-01	8.37e-01	8.31e-01	1.15e-01
GOCC EXTERNAL SIDE OF PLASMA MEMBRANE	315	1.84e-04	1.17e-03	0.2110	2.49e-02	1.02e-01	1.48e-01	-3.85e-02	-3.21e-02	9.54e-02	4.48e-01	1.95e-03	6.59e-06	2.41e-01	3.27e-01	3.61e-03
GOBP POSITIVE REGULATION OF LYMPHOCYTE DIFFERENTIATION	123	4.30e-03	1.73e-02	0.2110	-3.95e-02	9.86e-02	1.20e-01	1.10e-01	8.49e-03	8.11e-02	4.49e-01	5.89e-02	2.16e-02	3.60e-02	8.71e-01	1.20e-01
GOBP POSITIVE REGULATION OF INTERLEUKIN 12 PRODUCTION	36	5.69e-01	6.56e-01	0.2100	-1.34e-01	3.39e-02	8.97e-02	-3.26e-02	2.21e-02	1.24e-01	1.63e-01	7.25e-01	3.52e-01	7.35e-01	8.18e-01	1.96e-01
GOBP POST TRANSLATIONAL PROTEIN MODIFICATION	882	1.99e-30	2.02e-28	0.2100	-1.36e-01	-6.30e-02	-6.35e-02	1.14e-01	-3.76e-03	6.93e-02	7.36e-12	1.52e-03	1.39e-03	9.89e-09	8.50e-01	4.84e-04
GOBP MHC CLASS II BIOSYNTHETIC PROCESS	19	9.35e-01	9.46e-01	0.2100	-1.29e-01	-6.06e-02	2.26e-02	-8.10e-02	-4.50e-02	1.22e-01	3.31e-01	6.47e-01	8.65e-01	5.41e-01	7.34e-01	3.57e-01
GOBP CANONICAL NF KAPPAB SIGNAL TRANSDUCTION	276	1.56e-06	1.59e-05	0.2100	-4.26e-02	9.73e-02	5.49e-02	1.21e-01	9.83e-02	7.54e-02	2.24e-01	5.39e-03	1.17e-01	5.57e-04	4.95e-03	3.12e-02
GOMF CARBON SULFUR LYASE ACTIVITY	13	8.95e-01	9.14e-01	0.2100	4.17e-02	-1.41e-01	-8.21e-02	-1.74e-02	6.46e-02	-1.06e-01	7.94e-01	3.78e-01	6.08e-01	9.14e-01	6.87e-01	5.08e-01
GOBP POSITIVE REGULATION OF PROTEIN LOCALIZATION TO NUCLEUS	81	1.84e-02	5.54e-02	0.2100	-7.13e-02	-6.37e-02	4.76e-02	1.66e-01	1.79e-02	6.89e-02	2.67e-01	3.22e-01	4.59e-01	9.64e-03	7.81e-01	2.84e-01
GOBP NEGATIVE REGULATION OF HEMATOPOIETIC PROGENITOR CELL DIFFERENTIATION	11	8.64e-01	8.89e-01	0.2100	-9.23e-02	1.16e-01	9.58e-02	3.23e-02	1.08e-01	-2.14e-02	5.96e-01	5.07e-01	5.82e-01	8.53e-01	5.37e-01	9.02e-01
GOBP POSITIVE REGULATION OF ORGANELLE ORGANIZATION	444	5.10e-15	1.37e-13	0.2100	-1.30e-01	-7.79e-02	-1.20e-02	1.31e-01	8.17e-03	6.27e-02	2.83e-06	4.89e-03	6.66e-01	2.35e-06	7.68e-01	2.36e-02
GOBP REGULATION OF SUPRAMOLECULAR FIBER ORGANIZATION	331	2.24e-11	4.35e-10	0.2100	-9.13e-02	-2.77e-02	1.28e-01	9.99e-02	-1.05e-02	9.21e-02	4.33e-03	3.87e-01	6.08e-05	1.79e-03	7.43e-01	3.99e-03
GOBP GLUCOSE IMPORT	58	1.03e-01	2.00e-01	0.2100	-1.94e-01	-9.93e-04	6.15e-02	-4.77e-02	-1.76e-02	1.09e-02	1.07e-02	9.90e-01	4.18e-01	5.30e-01	8.17e-01	8.86e-01
GOBP SMALL MOLECULE METABOLIC PROCESS	1484	3.10e-35	4.16e-33	0.2100	-1.12e-01	-1.66e-01	-4.45e-02	3.09e-02	7.38e-03	2.83e-02	4.61e-13	9.98e-27	4.17e-03	4.70e-02	6.35e-01	6.90e-02
GOBP LAMELLIPODIUM ORGANIZATION	81	3.75e-02	9.48e-02	0.2100	-1.35e-01	-7.11e-02	9.49e-02	4.35e-02	-1.89e-02	9.76e-02	3.59e-02	2.69e-01	1.40e-01	4.99e-01	7.69e-01	1.29e-01
GOMF EXOGENOUS PROTEIN BINDING	67	1.65e-02	5.09e-02	0.2100	-5.97e-02	3.77e-02	1.74e-01	8.74e-02	1.36e-03	3.25e-02	3.98e-01	5.94e-01	1.37e-02	2.16e-01	9.85e-01	6.45e-01
GOBP REGULATION OF CELLULAR COMPONENT SIZE	309	1.06e-10	1.89e-09	0.2100	-6.45e-02	2.36e-02	1.59e-01	9.15e-02	7.78e-03	7.47e-02	5.13e-02	4.75e-01	1.54e-06	5.71e-03	8.14e-01	2.40e-02
GOBP ACTIVATION OF IMMUNE RESPONSE	511	4.15e-16	1.24e-14	0.2100	-5.51e-02	9.00e-02	5.66e-02	1.27e-01	1.84e-02	1.14e-01	3.32e-02	4.97e-04	2.85e-02	8.17e-07	4.77e-01	9.97e-06
GOBP REGULATION OF TELOMERASE ACTIVITY	40	2.90e-01	4.09e-01	0.2100	-5.75e-02	-6.76e-02	-1.32e-01	1.24e-01	6.63e-03	5.60e-02	5.29e-01	4.60e-01	1.48e-01	1.74e-01	9.42e-01	5.40e-01
GOMF CYTOKINE RECEPTOR ACTIVITY	78	3.03e-01	4.22e-01	0.2100	3.58e-03	8.43e-02	1.50e-01	7.58e-03	-6.60e-02	1.00e-01	9.56e-01	1.98e-01	2.24e-02	9.08e-01	3.13e-01	1.27e-01
GOBP POLYSACCHARIDE METABOLIC PROCESS	86	7.15e-03	2.63e-02	0.2100	-9.54e-02	2.25e-02	1.14e-01	1.16e-01	-4.35e-02	7.63e-02	1.26e-01	7.19e-01	6.65e-02	6.30e-02	4.85e-01	2.21e-01
GOBP NEGATIVE REGULATION OF TOLL LIKE RECEPTOR SIGNALING PATHWAY	19	5.79e-01	6.64e-01	0.2100	-1.46e-01	-2.08e-02	3.64e-02	9.63e-02	-1.07e-01	1.61e-02	2.71e-01	8.75e-01	7.83e-01	4.68e-01	4.21e-01	9.04e-01
GOBP RETINAL METABOLIC PROCESS	12	9.70e-01	9.75e-01	0.2090	4.77e-02	1.19e-01	-6.23e-02	5.17e-02	1.42e-01	2.23e-02	7.75e-01	4.75e-01	7.09e-01	7.57e-01	3.93e-01	8.94e-01
GOBP REGULATION OF GLIOGENESIS	76	4.49e-02	1.08e-01	0.2090	-5.15e-02	1.17e-01	1.47e-01	2.01e-02	6.20e-02	3.69e-02	4.38e-01	7.67e-02	2.63e-02	7.62e-01	3.50e-01	5.78e-01
GOBP REGULATION OF GLIAL CELL DIFFERENTIATION	50	1.35e-01	2.43e-01	0.2090	-1.63e-02	8.37e-02	1.84e-01	4.97e-02	7.90e-03	1.02e-02	8.42e-01	3.06e-01	2.44e-02	5.44e-01	9.23e-01	9.00e-01
GOCC DISTAL AXON	194	4.31e-05	3.19e-04	0.2090	-1.44e-02	9.90e-02	1.28e-01	1.20e-01	3.13e-02	4.47e-02	7.29e-01	1.74e-02	2.18e-03	3.84e-03	4.52e-01	2.83e-01
GOBP NEGATIVE REGULATION OF EPITHELIAL CELL MIGRATION	53	5.07e-02	1.19e-01	0.2090	-8.59e-02	-6.51e-02	1.45e-01	-9.80e-02	-3.36e-02	-1.78e-02	2.79e-01	4.12e-01	6.77e-02	2.17e-01	6.73e-01	8.23e-01
GOBP BLOOD VESSEL REMODELING	32	2.89e-01	4.09e-01	0.2090	-1.26e-01	2.63e-02	1.43e-01	4.72e-02	-5.64e-02	3.24e-02	2.16e-01	7.97e-01	1.60e-01	6.44e-01	5.81e-01	7.51e-01
GOBP POSITIVE REGULATION OF AMYLOID PRECURSOR PROTEIN CATABOLIC PROCESS	23	4.80e-01	5.81e-01	0.2090	-1.28e-01	7.83e-02	1.45e-01	-1.12e-02	-1.25e-02	-4.63e-03	2.90e-01	5.16e-01	2.29e-01	9.26e-01	9.17e-01	9.69e-01
GOMF POLYUBIQUITIN MODIFICATION DEPENDENT PROTEIN BINDING	56	1.41e-01	2.50e-01	0.2090	1.38e-02	-3.32e-02	1.46e-02	2.03e-01	1.73e-02	-2.15e-02	8.59e-01	6.67e-01	8.50e-01	8.44e-03	8.22e-01	7.81e-01
GOBP CELLULAR RESPONSE TO EXTERNAL STIMULUS	65	2.89e-02	7.78e-02	0.2090	-1.13e-01	1.16e-01	1.30e-01	1.03e-02	-9.50e-03	1.19e-02	1.15e-01	1.04e-01	6.96e-02	8.85e-01	8.95e-01	8.68e-01
GOBP LYMPHOCYTE APOPTOTIC PROCESS	75	2.26e-01	3.44e-01	0.2090	2.52e-02	-3.59e-03	6.34e-02	1.37e-01	6.28e-02	1.27e-01	7.06e-01	9.57e-01	3.42e-01	4.00e-02	3.47e-01	5.69e-02
GOCC PHOTORECEPTOR INNER SEGMENT	47	2.40e-01	3.58e-01	0.2090	5.06e-02	1.36e-01	-6.81e-02	-1.09e-01	4.68e-02	-6.19e-02	5.48e-01	1.07e-01	4.19e-01	1.96e-01	5.79e-01	4.63e-01
GOBP CALCIUM ION HOMEOSTASIS	229	1.85e-06	1.86e-05	0.2090	-6.67e-02	-6.42e-02	1.49e-01	4.40e-02	-7.83e-02	6.80e-02	8.22e-02	9.42e-02	9.93e-05	2.52e-01	4.11e-02	7.64e-02
GOBP GLUTAMINE TRANSPORT	8	8.72e-01	8.96e-01	0.2090	1.46e-01	-1.05e-01	-9.76e-03	-7.94e-02	2.10e-02	6.61e-02	4.76e-01	6.06e-01	9.62e-01	6.97e-01	9.18e-01	7.46e-01
GOMF L GLUTAMINE TRANSMEMBRANE TRANSPORTER ACTIVITY	8	8.72e-01	8.96e-01	0.2090	1.46e-01	-1.05e-01	-9.76e-03	-7.94e-02	2.10e-02	6.61e-02	4.76e-01	6.06e-01	9.62e-01	6.97e-01	9.18e-01	7.46e-01
GOBP SYNAPTIC SIGNALING	517	8.57e-13	1.90e-11	0.2090	-6.91e-02	5.70e-02	1.46e-01	4.30e-02	1.32e-02	1.10e-01	7.15e-03	2.65e-02	1.25e-08	9.44e-02	6.07e-01	1.94e-05
GOBP VASCULATURE DEVELOPMENT	550	8.77e-18	3.02e-16	0.2090	-1.05e-01	5.21e-02	1.57e-01	6.63e-03	-3.90e-02	6.07e-02	2.54e-05	3.69e-02	3.35e-10	7.90e-01	1.18e-01	1.50e-02
GOBP MEIOTIC CELL CYCLE	211	4.30e-05	3.18e-04	0.2090	-3.08e-02	-9.56e-02	6.76e-03	1.30e-01	8.84e-03	1.28e-01	4.41e-01	1.67e-02	8.66e-01	1.17e-03	8.25e-01	1.30e-03
GOBP ENDOCRINE PANCREAS DEVELOPMENT	23	3.65e-01	4.80e-01	0.2090	-1.40e-01	-3.93e-02	7.52e-02	7.91e-02	-8.74e-02	-5.42e-02	2.47e-01	7.45e-01	5.32e-01	5.12e-01	4.68e-01	6.53e-01
GOBP NEGATIVE REGULATION OF BINDING	88	4.65e-02	1.11e-01	0.2090	-4.21e-02	-1.39e-01	-7.50e-02	1.02e-01	-3.49e-02	7.19e-02	4.95e-01	2.45e-02	2.24e-01	9.71e-02	5.72e-01	2.44e-01
GOBP REGULATION OF CALCIUM MEDIATED SIGNALING	73	4.09e-01	5.19e-01	0.2090	1.46e-02	5.19e-02	1.43e-01	4.50e-02	-2.64e-02	1.32e-01	8.29e-01	4.43e-01	3.49e-02	5.06e-01	6.97e-01	5.10e-02
GOBP UROGENITAL SYSTEM DEVELOPMENT	42	3.41e-01	4.58e-01	0.2080	1.80e-02	-2.85e-02	1.07e-01	9.11e-02	1.06e-01	1.07e-01	8.40e-01	7.49e-01	2.29e-01	3.07e-01	2.36e-01	2.32e-01
GOBP CARDIAC CHAMBER MORPHOGENESIS	72	1.28e-01	2.34e-01	0.2080	-4.06e-02	1.01e-01	1.11e-01	8.29e-02	8.30e-02	7.37e-02	5.51e-01	1.38e-01	1.03e-01	2.24e-01	2.23e-01	2.80e-01
GOBP REGULATION OF NERVOUS SYSTEM DEVELOPMENT	324	4.67e-09	6.86e-08	0.2080	-4.69e-02	1.17e-01	1.38e-01	6.19e-02	4.35e-02	5.23e-02	1.47e-01	2.85e-04	1.97e-05	5.53e-02	1.78e-01	1.06e-01
GOBP CELLULAR RESPONSE TO IONIZING RADIATION	64	9.71e-02	1.92e-01	0.2080	-1.09e-01	-7.70e-02	-8.92e-02	1.26e-01	-2.28e-03	4.32e-02	1.32e-01	2.87e-01	2.17e-01	8.19e-02	9.75e-01	5.50e-01
GOBP MIRNA PROCESSING	41	1.52e-01	2.63e-01	0.2080	-1.11e-01	7.65e-02	6.67e-02	9.15e-02	-6.63e-02	8.93e-02	2.18e-01	3.97e-01	4.60e-01	3.11e-01	4.62e-01	3.23e-01
GOBP NEGATIVE REGULATION OF IMMUNE EFFECTOR PROCESS	109	1.22e-01	2.26e-01	0.2080	3.24e-02	1.10e-01	1.41e-01	4.13e-02	-3.79e-02	8.49e-02	5.59e-01	4.71e-02	1.10e-02	4.56e-01	4.94e-01	1.26e-01
GOBP RESPONSE TO FIBROBLAST GROWTH FACTOR	75	2.93e-01	4.13e-01	0.2080	-5.97e-02	4.47e-02	1.15e-01	-1.13e-01	-1.04e-01	3.17e-02	3.72e-01	5.03e-01	8.47e-02	9.09e-02	1.20e-01	6.35e-01
GOBP MESENCHYMAL CELL DIFFERENTIATION	173	3.88e-05	2.90e-04	0.2080	-4.68e-02	1.30e-01	1.42e-01	5.74e-02	2.16e-04	2.84e-02	2.88e-01	3.14e-03	1.30e-03	1.93e-01	9.96e-01	5.19e-01
GOBP NUCLEOBASE TRANSPORT	12	9.17e-01	9.31e-01	0.2080	6.34e-02	-1.03e-01	-1.19e-01	6.51e-02	9.37e-02	3.92e-02	7.04e-01	5.36e-01	4.77e-01	6.96e-01	5.74e-01	8.14e-01
GOCC CELL CELL JUNCTION	382	3.76e-09	5.57e-08	0.2080	-9.70e-03	9.89e-02	1.72e-01	3.17e-02	-3.16e-02	4.43e-02	7.45e-01	9.04e-04	8.56e-09	2.87e-01	2.89e-01	1.37e-01
GOBP RESPONSE TO ACTIVITY	59	3.69e-02	9.38e-02	0.2080	-2.01e-02	-4.40e-02	1.86e-01	6.63e-02	-3.33e-02	3.16e-02	7.89e-01	5.59e-01	1.37e-02	3.78e-01	6.58e-01	6.74e-01
GOBP REGULATION OF ANATOMICAL STRUCTURE SIZE	393	5.28e-12	1.10e-10	0.2080	-7.83e-02	1.12e-02	1.68e-01	3.78e-02	-2.84e-02	8.07e-02	7.70e-03	7.03e-01	1.08e-08	1.98e-01	3.34e-01	6.06e-03
GOBP CELL MATURATION	129	4.43e-03	1.77e-02	0.2080	-5.31e-02	-7.97e-02	1.37e-01	4.36e-02	-9.34e-02	6.80e-02	2.98e-01	1.18e-01	7.16e-03	3.93e-01	6.70e-02	1.82e-01
GOBP NEGATIVE REGULATION OF CANONICAL NF KAPPAB SIGNAL TRANSDUCTION	53	3.94e-01	5.07e-01	0.2080	-5.46e-02	1.17e-01	1.09e-01	1.96e-02	5.44e-02	1.06e-01	4.92e-01	1.41e-01	1.69e-01	8.05e-01	4.93e-01	1.82e-01
GOBP INTRACELLULAR RECEPTOR SIGNALING PATHWAY	315	1.23e-13	2.93e-12	0.2080	-1.43e-01	3.84e-02	4.20e-02	1.25e-01	2.46e-02	5.64e-02	1.26e-05	2.42e-01	2.00e-01	1.33e-04	4.53e-01	8.54e-02
GOMF KINASE REGULATOR ACTIVITY	244	1.19e-04	7.89e-04	0.2080	-1.25e-01	-7.50e-02	6.47e-02	1.58e-02	-7.66e-02	1.08e-01	7.80e-04	4.36e-02	8.18e-02	6.71e-01	3.95e-02	3.81e-03
GOMF DEUBIQUITINASE ACTIVITY	93	3.23e-03	1.37e-02	0.2080	-1.53e-01	1.16e-01	2.76e-02	2.30e-02	1.10e-02	6.81e-02	1.07e-02	5.22e-02	6.45e-01	7.01e-01	8.55e-01	2.56e-01
GOMF MONOCARBOXYLIC ACID TRANSMEMBRANE TRANSPORTER ACTIVITY	45	6.79e-01	7.45e-01	0.2070	1.08e-01	7.56e-02	1.26e-01	8.86e-02	-2.58e-02	3.63e-02	2.10e-01	3.80e-01	1.45e-01	3.04e-01	7.64e-01	6.74e-01
GOBP LYMPHOCYTE ACTIVATION	699	1.82e-14	4.68e-13	0.2070	-9.60e-05	7.16e-02	1.04e-01	1.21e-01	1.23e-02	1.10e-01	9.97e-01	1.27e-03	2.87e-06	5.25e-08	5.79e-01	6.53e-07
GOBP STRIATED MUSCLE CELL DIFFERENTIATION	208	3.30e-04	1.95e-03	0.2070	-2.61e-02	2.51e-02	1.60e-01	4.76e-02	-7.95e-02	8.50e-02	5.17e-01	5.33e-01	6.67e-05	2.37e-01	4.83e-02	3.45e-02
GOBP RNA CATABOLIC PROCESS	278	4.21e-07	4.68e-06	0.2070	-9.51e-02	-1.19e-01	-7.11e-02	1.16e-01	-3.18e-02	1.50e-02	6.37e-03	6.74e-04	4.13e-02	8.82e-04	3.61e-01	6.66e-01
GOBP POSITIVE REGULATION OF CELL GROWTH	122	8.14e-06	7.01e-05	0.2070	-1.06e-01	1.19e-02	1.15e-01	1.34e-01	-1.35e-02	1.17e-02	4.36e-02	8.21e-01	2.80e-02	1.08e-02	7.97e-01	8.23e-01
GOBP REGULATION OF CATABOLIC PROCESS	902	4.39e-32	4.73e-30	0.2070	-1.33e-01	-6.40e-02	5.21e-02	9.98e-02	-5.90e-02	6.98e-02	1.35e-11	1.13e-03	8.00e-03	3.81e-07	2.68e-03	3.84e-04
GOBP ENZYME LINKED RECEPTOR PROTEIN SIGNALING PATHWAY	719	1.90e-20	8.45e-19	0.2070	-4.96e-02	6.61e-02	1.62e-01	5.54e-02	-4.25e-02	6.86e-02	2.35e-02	2.56e-03	1.26e-13	1.14e-02	5.25e-02	1.74e-03
GOBP EXTRACELLULAR TRANSPORT	34	5.12e-01	6.07e-01	0.2070	-4.81e-02	6.00e-02	2.07e-02	-1.68e-01	1.92e-02	-8.77e-02	6.27e-01	5.45e-01	8.35e-01	8.94e-02	8.47e-01	3.76e-01
GOMF POTASSIUM CHANNEL REGULATOR ACTIVITY	35	6.34e-01	7.10e-01	0.2070	-1.55e-01	-3.15e-02	7.32e-02	-4.90e-02	-9.98e-03	9.86e-02	1.12e-01	7.47e-01	4.54e-01	6.16e-01	9.19e-01	3.13e-01
GOBP TISSUE MORPHOGENESIS	407	6.24e-10	1.04e-08	0.2070	-1.84e-02	1.04e-01	1.55e-01	5.56e-02	3.36e-02	5.66e-02	5.25e-01	3.27e-04	7.41e-08	5.45e-02	2.45e-01	5.02e-02
GOBP POSITIVE REGULATION OF PROTEOLYSIS	298	1.21e-07	1.46e-06	0.2070	-1.51e-01	-7.61e-02	7.62e-02	1.59e-02	-4.74e-02	7.57e-02	7.11e-06	2.39e-02	2.36e-02	6.38e-01	1.60e-01	2.46e-02
GOBP EPIGENETIC REGULATION OF GENE EXPRESSION	223	5.01e-06	4.54e-05	0.2070	-2.17e-02	3.56e-03	3.58e-02	1.88e-01	3.22e-02	6.66e-02	5.76e-01	9.27e-01	3.58e-01	1.27e-06	4.07e-01	8.67e-02
GOBP NEGATIVE REGULATION OF CYTOKINE PRODUCTION	252	7.63e-07	8.15e-06	0.2060	-4.45e-02	3.19e-02	1.21e-01	1.23e-01	4.56e-02	8.88e-02	2.24e-01	3.84e-01	9.31e-04	8.13e-04	2.12e-01	1.52e-02
GOMF INTEGRIN BINDING	115	4.85e-03	1.92e-02	0.2060	-6.73e-02	-6.07e-02	1.58e-01	-5.19e-02	-7.48e-02	3.29e-02	2.13e-01	2.61e-01	3.37e-03	3.36e-01	1.66e-01	5.42e-01
GOBP EXTRACELLULAR MATRIX ASSEMBLY	37	7.60e-01	8.07e-01	0.2060	8.31e-02	1.37e-01	8.81e-02	7.37e-02	5.51e-02	-2.74e-02	3.82e-01	1.50e-01	3.54e-01	4.38e-01	5.62e-01	7.73e-01
GOMF MITOGEN ACTIVATED PROTEIN KINASE KINASE KINASE BINDING	15	6.53e-01	7.25e-01	0.2060	-1.23e-01	3.79e-02	3.52e-02	2.70e-02	1.17e-01	-1.02e-01	4.08e-01	7.99e-01	8.14e-01	8.56e-01	4.33e-01	4.96e-01
GOBP RNA STABILIZATION	59	1.79e-01	2.94e-01	0.2060	-1.51e-01	-9.97e-02	-3.06e-02	7.54e-02	-4.16e-02	3.51e-02	4.42e-02	1.85e-01	6.84e-01	3.17e-01	5.80e-01	6.41e-01
GOBP REGULATION OF NEURON APOPTOTIC PROCESS	174	8.83e-04	4.58e-03	0.2060	-7.47e-02	1.02e-02	1.01e-01	8.03e-02	3.20e-02	1.38e-01	8.90e-02	8.17e-01	2.10e-02	6.77e-02	4.67e-01	1.71e-03
GOBP REGULATION OF TRANSPORT	1226	3.31e-29	3.04e-27	0.2060	-8.24e-02	-1.38e-03	1.36e-01	4.10e-02	-3.91e-02	1.17e-01	1.24e-06	9.35e-01	9.12e-16	1.58e-02	2.12e-02	4.77e-12
GOBP NEUTRAL LIPID BIOSYNTHETIC PROCESS	43	6.35e-02	1.41e-01	0.2060	-1.75e-01	4.83e-02	6.20e-02	9.22e-03	4.95e-02	-5.40e-02	4.65e-02	5.84e-01	4.82e-01	9.17e-01	5.75e-01	5.40e-01
GOBP DEVELOPMENTAL CELL GROWTH	166	4.30e-05	3.18e-04	0.2060	-5.54e-02	8.97e-02	1.41e-01	9.38e-02	-8.50e-03	5.08e-02	2.18e-01	4.63e-02	1.75e-03	3.70e-02	8.50e-01	2.59e-01
GOMF MOLECULAR FUNCTION INHIBITOR ACTIVITY	364	2.60e-06	2.53e-05	0.2060	-8.17e-02	-1.22e-01	5.57e-02	-9.04e-03	-6.46e-02	1.16e-01	7.41e-03	6.50e-05	6.78e-02	7.67e-01	3.44e-02	1.43e-04
GOBP REGULATION OF TYPE 2 IMMUNE RESPONSE	30	6.01e-01	6.81e-01	0.2060	-9.62e-02	5.76e-02	1.23e-01	-4.96e-02	-1.11e-01	3.17e-03	3.62e-01	5.85e-01	2.45e-01	6.38e-01	2.93e-01	9.76e-01
GOCC RECYCLING ENDOSOME MEMBRANE	98	4.14e-03	1.68e-02	0.2060	-1.24e-01	8.46e-03	7.98e-02	1.11e-01	-7.79e-03	9.04e-02	3.43e-02	8.85e-01	1.72e-01	5.77e-02	8.94e-01	1.22e-01
GOBP NEGATIVE REGULATION OF IMMUNE RESPONSE	172	2.29e-03	1.03e-02	0.2060	-3.31e-02	1.40e-03	1.04e-01	7.73e-02	-8.05e-02	1.34e-01	4.54e-01	9.75e-01	1.87e-02	8.03e-02	6.86e-02	2.46e-03
GOBP RESPONSE TO CYTOKINE	738	6.14e-19	2.33e-17	0.2050	-6.16e-02	2.49e-02	1.28e-01	8.77e-02	1.19e-02	1.16e-01	4.42e-03	2.50e-01	3.03e-09	5.06e-05	5.83e-01	7.72e-08
GOBP NEGATIVE REGULATION OF LYMPHOCYTE MEDIATED IMMUNITY	55	3.98e-01	5.10e-01	0.2050	5.95e-02	1.18e-01	8.70e-02	1.03e-01	-2.42e-02	7.72e-02	4.45e-01	1.30e-01	2.64e-01	1.86e-01	7.56e-01	3.22e-01
GOBP REGULATION OF MUSCLE ORGAN DEVELOPMENT	16	8.16e-01	8.51e-01	0.2050	1.56e-01	2.22e-02	-7.68e-02	7.76e-02	5.12e-02	5.19e-02	2.79e-01	8.78e-01	5.95e-01	5.91e-01	7.23e-01	7.19e-01
GOBP REGULATION OF EXTRINSIC APOPTOTIC SIGNALING PATHWAY	123	7.60e-04	4.03e-03	0.2050	-1.24e-01	-4.83e-02	1.31e-01	1.33e-02	7.75e-03	8.40e-02	1.72e-02	3.55e-01	1.24e-02	7.99e-01	8.82e-01	1.08e-01
GOBP POSITIVE REGULATION OF DNA TEMPLATED TRANSCRIPTION INITIATION	65	1.22e-01	2.26e-01	0.2050	-8.72e-02	-7.20e-02	-4.80e-02	1.53e-01	5.16e-02	3.32e-02	2.24e-01	3.16e-01	5.04e-01	3.34e-02	4.72e-01	6.43e-01
GOBP NEGATIVE REGULATION OF PROTEIN METABOLIC PROCESS	667	2.04e-19	8.17e-18	0.2050	-1.51e-01	-5.89e-02	6.32e-02	5.06e-02	-3.79e-02	8.90e-02	3.29e-11	9.51e-03	5.38e-03	2.60e-02	9.51e-02	8.97e-05
GOBP LIPID CATABOLIC PROCESS	262	3.40e-06	3.21e-05	0.2050	-1.44e-01	-1.37e-01	-3.45e-02	3.42e-03	3.68e-02	1.09e-02	6.27e-05	1.36e-04	3.36e-01	9.24e-01	3.05e-01	7.61e-01
GOCC INCLUSION BODY	64	4.36e-01	5.44e-01	0.2050	3.51e-02	1.04e-01	1.33e-01	6.29e-02	-3.08e-02	8.60e-02	6.27e-01	1.50e-01	6.58e-02	3.84e-01	6.70e-01	2.34e-01
GOBP PALLIUM DEVELOPMENT	140	1.05e-02	3.59e-02	0.2050	-2.22e-02	9.70e-02	1.32e-01	8.19e-02	2.39e-02	8.57e-02	6.50e-01	4.75e-02	6.92e-03	9.42e-02	6.25e-01	7.99e-02
GOBP POSITIVE REGULATION OF PROTEIN LOCALIZATION TO MEMBRANE	89	1.58e-02	4.94e-02	0.2050	-1.30e-01	5.35e-03	6.75e-02	8.57e-02	-3.89e-02	1.08e-01	3.40e-02	9.31e-01	2.71e-01	1.63e-01	5.26e-01	7.81e-02
GOCC PHOTORECEPTOR OUTER SEGMENT MEMBRANE	12	8.82e-01	9.04e-01	0.2050	-8.81e-02	3.97e-02	-2.07e-02	-6.25e-02	-1.65e-01	3.20e-02	5.97e-01	8.12e-01	9.01e-01	7.08e-01	3.22e-01	8.48e-01
GOBP NEGATIVE REGULATION OF CATABOLIC PROCESS	301	1.02e-10	1.83e-09	0.2050	-1.36e-01	-4.05e-02	5.16e-02	1.00e-01	-6.73e-02	6.61e-02	4.68e-05	2.27e-01	1.24e-01	2.77e-03	4.46e-02	4.85e-02
GOBP NEGATIVE REGULATION OF PROTEIN CONTAINING COMPLEX ASSEMBLY	124	4.49e-03	1.79e-02	0.2040	-5.31e-02	-1.60e-02	9.44e-02	1.31e-01	-3.51e-02	1.07e-01	3.07e-01	7.58e-01	6.94e-02	1.17e-02	5.00e-01	4.00e-02
GOBP REGULATION OF NON CANONICAL NF KAPPAB SIGNAL TRANSDUCTION	84	1.50e-02	4.73e-02	0.2040	-9.70e-02	9.12e-02	6.54e-02	5.80e-02	1.27e-01	2.09e-02	1.24e-01	1.49e-01	3.00e-01	3.58e-01	4.50e-02	7.41e-01
GOBP POSITIVE REGULATION OF PEPTIDASE ACTIVITY	143	2.87e-02	7.76e-02	0.2040	-1.58e-01	-4.16e-02	4.13e-02	-5.14e-02	-5.76e-02	8.53e-02	1.07e-03	3.90e-01	3.94e-01	2.89e-01	2.35e-01	7.81e-02
GOBP REGULATION OF T CELL ACTIVATION	330	9.86e-06	8.32e-05	0.2040	1.43e-02	8.30e-02	8.35e-02	1.33e-01	6.29e-02	7.85e-02	6.55e-01	9.61e-03	9.17e-03	3.48e-05	4.96e-02	1.43e-02
GOBP PROTEIN PALMITOYLATION	30	8.11e-01	8.47e-01	0.2040	-3.15e-02	-3.42e-02	-5.42e-02	-9.68e-02	-1.20e-01	-1.14e-01	7.65e-01	7.46e-01	6.08e-01	3.59e-01	2.56e-01	2.82e-01
GOBP MAINTENANCE OF LOCATION	271	1.15e-08	1.60e-07	0.2040	-6.81e-02	-6.17e-02	1.47e-01	6.80e-02	-3.11e-02	7.79e-02	5.36e-02	8.03e-02	3.21e-05	5.40e-02	3.78e-01	2.72e-02
GOBP HEMOPOIESIS	814	1.49e-19	6.04e-18	0.2040	-4.41e-02	5.49e-02	1.22e-01	9.29e-02	-2.06e-02	1.13e-01	3.25e-02	7.83e-03	3.59e-09	6.70e-06	3.18e-01	4.13e-08
GOBP NEGATIVE REGULATION OF KINASE ACTIVITY	148	1.45e-03	6.99e-03	0.2040	-5.73e-02	1.50e-03	1.58e-01	5.52e-02	-2.75e-03	1.01e-01	2.29e-01	9.75e-01	8.97e-04	2.46e-01	9.54e-01	3.33e-02
GOMF ACTIVE MONOATOMIC ION TRANSMEMBRANE TRANSPORTER ACTIVITY	218	8.90e-06	7.57e-05	0.2040	-7.11e-02	-1.36e-01	6.68e-02	6.61e-02	-9.23e-02	2.75e-02	7.05e-02	5.45e-04	8.93e-02	9.27e-02	1.89e-02	4.84e-01
GOBP CELL CELL SIGNALING	833	2.01e-19	8.11e-18	0.2040	-5.47e-02	6.63e-02	1.56e-01	2.38e-02	7.78e-03	9.58e-02	7.41e-03	1.16e-03	1.84e-14	2.44e-01	7.03e-01	2.67e-06
GOBP REGULATION OF KETONE BIOSYNTHETIC PROCESS	17	8.57e-01	8.84e-01	0.2040	-3.48e-03	-1.39e-02	6.84e-02	8.63e-02	-1.32e-01	1.08e-01	9.80e-01	9.21e-01	6.25e-01	5.38e-01	3.45e-01	4.39e-01
GOBP REGULATION OF NEURONAL SYNAPTIC PLASTICITY	42	3.57e-01	4.72e-01	0.2040	-7.97e-02	-1.45e-02	9.57e-02	5.64e-02	8.60e-02	1.24e-01	3.72e-01	8.71e-01	2.83e-01	5.27e-01	3.35e-01	1.66e-01
GOMF VOLUME SENSITIVE ANION CHANNEL ACTIVITY	8	9.53e-01	9.61e-01	0.2040	1.21e-02	8.42e-02	7.25e-02	1.54e-01	1.52e-02	-7.07e-02	9.53e-01	6.80e-01	7.22e-01	4.49e-01	9.41e-01	7.29e-01
GOBP METANEPHROS DEVELOPMENT	44	6.32e-01	7.07e-01	0.2040	2.16e-02	8.04e-02	1.21e-01	-1.11e-01	-8.27e-02	2.89e-02	8.04e-01	3.56e-01	1.65e-01	2.03e-01	3.42e-01	7.40e-01
GOBP REGULATION OF DENDRITE EXTENSION	17	7.91e-01	8.32e-01	0.2040	3.65e-02	9.36e-02	1.58e-01	2.59e-02	7.08e-02	-3.11e-02	7.94e-01	5.04e-01	2.61e-01	8.54e-01	6.13e-01	8.24e-01
GOBP SODIUM ION TRANSPORT	163	1.20e-03	5.96e-03	0.2040	2.21e-02	8.60e-02	1.82e-01	-8.35e-03	-1.88e-02	1.45e-02	6.26e-01	5.82e-02	6.23e-05	8.54e-01	6.79e-01	7.50e-01
GOBP REGULATION OF B CELL MEDIATED IMMUNITY	59	5.75e-01	6.61e-01	0.2040	5.44e-02	6.44e-02	4.66e-02	1.09e-01	1.06e-01	9.60e-02	4.70e-01	3.92e-01	5.36e-01	1.48e-01	1.60e-01	2.02e-01
GOBP NUCLEOSIDE DIPHOSPHATE METABOLIC PROCESS	112	9.11e-03	3.18e-02	0.2040	-7.86e-02	-6.09e-02	1.00e-01	9.96e-02	-3.20e-02	1.03e-01	1.51e-01	2.66e-01	6.66e-02	6.87e-02	5.59e-01	5.96e-02
GOBP REGULATION OF NITRIC OXIDE METABOLIC PROCESS	52	5.49e-02	1.26e-01	0.2040	-7.53e-02	8.53e-02	1.48e-01	-5.15e-02	5.71e-02	-2.53e-02	3.48e-01	2.87e-01	6.41e-02	5.21e-01	4.77e-01	7.53e-01
GOBP CELLULAR RESPONSE TO ORGANIC SUBSTANCE	1508	1.08e-42	1.99e-40	0.2040	-9.48e-02	6.88e-03	1.26e-01	6.80e-02	-1.93e-02	1.08e-01	7.86e-10	6.56e-01	3.09e-16	1.04e-05	2.10e-01	2.98e-12
GOBP RESPIRATORY SYSTEM PROCESS	33	5.34e-01	6.26e-01	0.2040	-8.29e-02	3.92e-02	7.41e-02	1.17e-01	4.80e-02	1.08e-01	4.10e-01	6.97e-01	4.61e-01	2.44e-01	6.33e-01	2.85e-01
GOBP POSITIVE REGULATION OF CELL DEVELOPMENT	359	1.51e-10	2.66e-09	0.2040	-7.11e-02	1.01e-01	1.17e-01	7.80e-02	4.65e-02	6.46e-02	2.07e-02	9.89e-04	1.35e-04	1.12e-02	1.30e-01	3.57e-02
GOBP SKELETAL SYSTEM MORPHOGENESIS	135	2.14e-04	1.33e-03	0.2040	-6.79e-02	1.31e-01	5.59e-02	1.08e-01	6.89e-02	-9.78e-03	1.73e-01	8.49e-03	2.62e-01	3.04e-02	1.67e-01	8.45e-01
GOBP PEPTIDYL TYROSINE MODIFICATION	203	1.47e-03	7.06e-03	0.2040	-2.64e-02	5.06e-02	1.66e-01	2.35e-02	-3.23e-02	9.45e-02	5.17e-01	2.14e-01	4.41e-05	5.64e-01	4.28e-01	2.02e-02
GOBP POSITIVE REGULATION OF CANONICAL NF KAPPAB SIGNAL TRANSDUCTION	191	9.49e-05	6.46e-04	0.2040	-8.82e-02	6.97e-02	5.46e-02	9.43e-02	8.04e-02	1.02e-01	3.56e-02	9.69e-02	1.93e-01	2.46e-02	5.53e-02	1.48e-02
GOBP INFLAMMATORY RESPONSE	652	1.84e-17	6.12e-16	0.2030	-7.45e-02	7.05e-02	1.53e-01	1.58e-02	1.70e-02	8.32e-02	1.18e-03	2.15e-03	2.67e-11	4.91e-01	4.60e-01	2.92e-04
GOBP POSITIVE REGULATION OF CANONICAL WNT SIGNALING PATHWAY	84	4.88e-03	1.93e-02	0.2030	-1.00e-01	1.09e-01	5.22e-02	1.21e-01	2.27e-02	4.06e-02	1.12e-01	8.46e-02	4.08e-01	5.59e-02	7.19e-01	5.20e-01
GOBP GLYCEROLIPID BIOSYNTHETIC PROCESS	223	8.56e-09	1.21e-07	0.2030	-1.70e-01	2.39e-02	1.36e-02	7.23e-02	8.08e-02	6.51e-03	1.25e-05	5.39e-01	7.26e-01	6.30e-02	3.77e-02	8.67e-01
GOBP REGULATION OF HEMATOPOIETIC PROGENITOR CELL DIFFERENTIATION	35	3.53e-01	4.69e-01	0.2030	-9.80e-02	1.23e-01	1.23e-01	2.30e-02	2.08e-02	2.60e-02	3.16e-01	2.09e-01	2.09e-01	8.14e-01	8.31e-01	7.90e-01
GOBP NEGATIVE REGULATION OF PROGRAMMED CELL DEATH	689	8.84e-17	2.81e-15	0.2030	-1.07e-01	-6.18e-02	6.87e-02	6.58e-02	-1.75e-02	1.29e-01	1.69e-06	5.72e-03	2.11e-03	3.26e-03	4.34e-01	8.43e-09
GOMF PROTEIN KINASE C BINDING	46	6.77e-02	1.47e-01	0.2030	-1.29e-01	-9.86e-02	8.77e-02	-4.76e-02	-2.03e-02	-6.64e-02	1.30e-01	2.47e-01	3.03e-01	5.76e-01	8.12e-01	4.36e-01
GOBP REACTIVE OXYGEN SPECIES BIOSYNTHETIC PROCESS	44	7.13e-01	7.72e-01	0.2030	-3.60e-02	-1.24e-02	1.28e-01	-3.45e-02	-4.28e-02	1.43e-01	6.79e-01	8.87e-01	1.43e-01	6.92e-01	6.24e-01	1.02e-01
GOBP CELLULAR RESPONSE TO STRESS	1627	1.60e-49	4.79e-47	0.2030	-1.25e-01	-8.99e-02	-9.76e-03	1.15e-01	3.59e-03	6.39e-02	4.88e-17	1.56e-09	5.13e-01	1.06e-14	8.10e-01	1.82e-05
GOBP CONNECTIVE TISSUE DEVELOPMENT	194	2.21e-05	1.73e-04	0.2030	-5.25e-02	1.56e-01	1.09e-01	3.68e-02	2.25e-02	1.77e-02	2.07e-01	1.80e-04	8.87e-03	3.76e-01	5.89e-01	6.71e-01
GOBP NEURON PROJECTION ORGANIZATION	79	6.56e-02	1.44e-01	0.2030	-1.12e-01	5.55e-02	1.09e-01	3.73e-02	-4.56e-02	1.01e-01	8.63e-02	3.94e-01	9.43e-02	5.66e-01	4.84e-01	1.20e-01
GOBP EMBRYO DEVELOPMENT ENDING IN BIRTH OR EGG HATCHING	488	2.28e-17	7.54e-16	0.2030	-6.08e-02	4.18e-02	4.89e-02	1.71e-01	5.60e-02	2.69e-02	2.15e-02	1.14e-01	6.45e-02	8.77e-11	3.43e-02	3.09e-01
GOBP ANTERIOR POSTERIOR PATTERN SPECIFICATION	115	8.46e-02	1.73e-01	0.2030	2.48e-02	1.53e-01	4.59e-02	7.24e-02	7.51e-02	6.25e-02	6.45e-01	4.48e-03	3.95e-01	1.80e-01	1.64e-01	2.47e-01
GOMF INORGANIC ANION TRANSMEMBRANE TRANSPORTER ACTIVITY	101	4.21e-02	1.03e-01	0.2030	1.00e-01	1.08e-01	1.10e-01	5.97e-03	-1.85e-03	-8.51e-02	8.17e-02	6.16e-02	5.57e-02	9.17e-01	9.74e-01	1.40e-01
GOBP CELLULAR RESPONSE TO HORMONE STIMULUS	466	6.08e-16	1.78e-14	0.2030	-1.28e-01	2.12e-02	1.17e-01	6.02e-02	-2.46e-02	7.85e-02	2.05e-06	4.34e-01	1.50e-05	2.59e-02	3.63e-01	3.71e-03
GOBP POSITIVE REGULATION OF CELLULAR COMPONENT BIOGENESIS	417	3.88e-13	8.96e-12	0.2030	-8.18e-02	6.13e-02	6.96e-02	1.30e-01	3.55e-02	8.64e-02	4.20e-03	3.17e-02	1.47e-02	5.01e-06	2.14e-01	2.48e-03
GOBP ENUCLEATE ERYTHROCYTE DIFFERENTIATION	12	7.23e-01	7.80e-01	0.2020	-1.05e-01	3.54e-03	1.45e-01	-4.50e-03	-4.57e-02	-8.24e-02	5.30e-01	9.83e-01	3.83e-01	9.78e-01	7.84e-01	6.21e-01
GOMF HYDROLASE ACTIVITY ACTING ON ACID ANHYDRIDES	711	5.51e-18	1.93e-16	0.2020	-8.63e-02	-1.10e-01	1.27e-02	9.94e-02	-3.84e-02	9.97e-02	8.93e-05	6.22e-07	5.63e-01	6.32e-06	8.09e-02	6.00e-06
GOBP SEX DIFFERENTIATION	186	5.16e-03	2.01e-02	0.2020	-7.24e-02	1.24e-02	1.42e-01	-7.28e-03	-5.39e-02	1.12e-01	8.87e-02	7.71e-01	8.72e-04	8.64e-01	2.05e-01	8.37e-03
GOBP CARDIAC VENTRICLE DEVELOPMENT	79	2.10e-02	6.15e-02	0.2020	-1.11e-01	6.18e-02	1.36e-01	4.36e-02	-3.59e-02	5.34e-02	8.75e-02	3.42e-01	3.61e-02	5.03e-01	5.81e-01	4.12e-01
GOBP N TERMINAL PROTEIN AMINO ACID ACETYLATION	14	7.32e-01	7.86e-01	0.2020	5.86e-02	5.57e-02	-2.35e-02	1.20e-01	-1.33e-01	-4.18e-02	7.04e-01	7.18e-01	8.79e-01	4.37e-01	3.90e-01	7.87e-01
GOBP APPENDAGE MORPHOGENESIS	92	6.53e-02	1.44e-01	0.2020	-1.91e-02	1.53e-01	1.18e-01	3.61e-02	2.26e-03	4.00e-02	7.51e-01	1.11e-02	4.98e-02	5.49e-01	9.70e-01	5.07e-01
GOBP NEGATIVE REGULATION OF CYTOSKELETON ORGANIZATION	135	1.23e-02	4.04e-02	0.2020	9.36e-03	7.87e-02	9.84e-02	1.30e-01	-9.23e-03	8.79e-02	8.51e-01	1.15e-01	4.83e-02	8.97e-03	8.53e-01	7.80e-02
GOMF R SMAD BINDING	22	8.53e-01	8.81e-01	0.2020	1.84e-03	1.07e-01	1.50e-01	1.24e-02	-7.39e-02	3.36e-02	9.88e-01	3.85e-01	2.23e-01	9.20e-01	5.48e-01	7.85e-01
GOBP PRODUCTION OF MOLECULAR MEDIATOR INVOLVED IN INFLAMMATORY RESPONSE	73	1.23e-02	4.04e-02	0.2020	-1.49e-01	8.35e-02	7.73e-02	-5.16e-03	7.41e-02	-5.48e-03	2.76e-02	2.18e-01	2.53e-01	9.39e-01	2.74e-01	9.35e-01
GOBP HEART DEVELOPMENT	420	2.36e-13	5.48e-12	0.2020	-6.28e-02	8.03e-02	1.37e-01	9.01e-02	1.68e-03	5.81e-02	2.74e-02	4.78e-03	1.41e-06	1.54e-03	9.53e-01	4.13e-02
GOMF GROWTH FACTOR BINDING	104	6.79e-02	1.48e-01	0.2020	-3.45e-02	1.67e-02	1.66e-01	4.88e-03	-8.25e-02	6.95e-02	5.44e-01	7.68e-01	3.44e-03	9.32e-01	1.46e-01	2.20e-01
GOBP NUCLEOSIDE METABOLIC PROCESS	52	3.10e-01	4.30e-01	0.2020	-1.88e-02	-1.21e-01	8.98e-03	1.40e-03	-3.45e-02	1.56e-01	8.15e-01	1.31e-01	9.11e-01	9.86e-01	6.67e-01	5.16e-02
GOBP ORGANOPHOSPHATE CATABOLIC PROCESS	204	3.59e-05	2.70e-04	0.2020	-5.38e-02	-7.65e-02	1.07e-01	9.58e-02	-1.04e-02	1.05e-01	1.85e-01	5.97e-02	8.15e-03	1.83e-02	7.97e-01	9.71e-03
GOBP NEGATIVE REGULATION OF SYNAPTIC TRANSMISSION	34	3.37e-01	4.55e-01	0.2010	-2.47e-02	1.21e-01	1.51e-01	2.51e-02	8.55e-03	-4.36e-02	8.03e-01	2.23e-01	1.28e-01	8.00e-01	9.31e-01	6.60e-01
GOBP MORPHOGENESIS OF A POLARIZED EPITHELIUM	48	3.78e-01	4.93e-01	0.2010	-7.81e-02	1.04e-01	1.03e-01	1.65e-02	-3.91e-02	1.06e-01	3.49e-01	2.13e-01	2.15e-01	8.44e-01	6.39e-01	2.05e-01
GOBP POSTSYNAPSE ORGANIZATION	149	5.76e-03	2.20e-02	0.2010	-6.22e-02	8.64e-02	1.16e-01	5.82e-02	1.49e-02	1.10e-01	1.90e-01	6.88e-02	1.41e-02	2.20e-01	7.54e-01	2.08e-02
GOBP NEGATIVE REGULATION OF NEUROBLAST PROLIFERATION	8	9.84e-01	9.86e-01	0.2010	-7.77e-02	1.18e-01	4.20e-02	-6.23e-03	9.22e-02	1.02e-01	7.04e-01	5.64e-01	8.37e-01	9.76e-01	6.52e-01	6.18e-01
GOBP G0 TO G1 TRANSITION	35	1.72e-01	2.86e-01	0.2010	-9.91e-02	-3.88e-02	4.06e-02	1.24e-01	-9.80e-02	-4.97e-02	3.10e-01	6.91e-01	6.78e-01	2.03e-01	3.16e-01	6.11e-01
GOBP MONOSACCHARIDE BIOSYNTHETIC PROCESS	81	1.19e-02	3.93e-02	0.2010	-1.37e-01	-6.82e-02	-1.56e-02	1.13e-01	5.81e-02	-2.80e-02	3.37e-02	2.89e-01	8.08e-01	7.84e-02	3.66e-01	6.63e-01
GOBP AMINOGLYCAN BIOSYNTHETIC PROCESS	65	5.43e-02	1.25e-01	0.2010	5.23e-03	-6.24e-03	1.22e-01	1.31e-01	-9.02e-02	2.18e-03	9.42e-01	9.31e-01	8.77e-02	6.72e-02	2.09e-01	9.76e-01
GOBP REGULATION OF DNA BIOSYNTHETIC PROCESS	106	2.83e-02	7.68e-02	0.2010	-6.64e-02	-9.58e-02	-8.70e-02	1.19e-01	3.21e-02	6.38e-02	2.37e-01	8.84e-02	1.22e-01	3.44e-02	5.68e-01	2.56e-01
GOBP RESPONSE TO GAMMA RADIATION	46	4.30e-01	5.38e-01	0.2010	-4.23e-03	-4.59e-02	-4.90e-02	1.74e-01	5.04e-02	5.46e-02	9.60e-01	5.90e-01	5.65e-01	4.10e-02	5.54e-01	5.22e-01
GOBP REGULATION OF DENDRITIC SPINE MORPHOGENESIS	35	5.38e-01	6.29e-01	0.2010	-1.69e-01	4.87e-02	-1.55e-02	-5.56e-02	5.10e-03	7.74e-02	8.32e-02	6.18e-01	8.74e-01	5.69e-01	9.58e-01	4.28e-01
GOBP ENSHEATHMENT OF NEURONS	131	1.05e-03	5.32e-03	0.2010	-1.59e-01	-1.12e-01	3.56e-02	1.25e-02	-3.45e-02	-1.18e-02	1.73e-03	2.74e-02	4.82e-01	8.05e-01	4.96e-01	8.15e-01
GOBP REGULATION OF COLLAGEN METABOLIC PROCESS	25	6.79e-01	7.45e-01	0.2010	-2.41e-02	-1.29e-01	7.42e-02	9.65e-02	-8.70e-02	2.54e-02	8.35e-01	2.63e-01	5.21e-01	4.04e-01	4.52e-01	8.26e-01
GOBP EPITHELIAL TUBE MORPHOGENESIS	232	2.61e-07	2.99e-06	0.2010	-2.99e-02	9.56e-02	1.16e-01	9.43e-02	8.87e-02	-4.61e-04	4.33e-01	1.22e-02	2.27e-03	1.34e-02	2.00e-02	9.90e-01
GOCC SYNAPTIC MEMBRANE	237	1.26e-04	8.27e-04	0.2010	3.23e-02	1.41e-01	1.21e-01	3.73e-02	5.56e-02	-1.29e-02	3.91e-01	1.82e-04	1.31e-03	3.22e-01	1.40e-01	7.33e-01
GOBP IMMUNE SYSTEM DEVELOPMENT	172	6.79e-04	3.65e-03	0.2010	-6.38e-02	1.28e-02	8.36e-02	1.04e-01	-3.34e-02	1.31e-01	1.49e-01	7.73e-01	5.85e-02	1.84e-02	4.50e-01	3.09e-03
GOBP POSITIVE REGULATION OF CYTOKINE PRODUCTION INVOLVED IN IMMUNE RESPONSE	76	6.26e-02	1.39e-01	0.2010	-1.27e-01	4.99e-02	1.05e-01	-4.52e-02	-9.31e-02	4.89e-03	5.56e-02	4.52e-01	1.15e-01	4.96e-01	1.61e-01	9.41e-01
GOBP XENOBIOTIC TRANSPORT	37	4.65e-01	5.68e-01	0.2010	-1.67e-02	5.69e-02	1.85e-01	2.30e-02	-4.11e-03	4.48e-02	8.60e-01	5.49e-01	5.14e-02	8.09e-01	9.66e-01	6.38e-01
GOBP NEGATIVE REGULATION OF EPITHELIAL CELL PROLIFERATION	97	5.88e-02	1.33e-01	0.2010	-7.66e-03	4.72e-02	1.83e-01	-2.84e-02	-3.11e-02	5.08e-02	8.96e-01	4.22e-01	1.80e-03	6.29e-01	5.97e-01	3.87e-01
GOCC MONOATOMIC ION CHANNEL COMPLEX	208	1.40e-03	6.82e-03	0.2010	7.76e-02	8.72e-02	1.56e-01	-4.31e-02	-1.23e-02	1.95e-02	5.39e-02	3.01e-02	1.08e-04	2.84e-01	7.59e-01	6.27e-01
GOCC ENDOCYTIC VESICLE MEMBRANE	167	1.19e-05	9.88e-05	0.2010	-1.81e-01	-3.14e-02	-5.83e-03	3.16e-02	7.33e-02	-1.64e-02	5.68e-05	4.84e-01	8.97e-01	4.81e-01	1.02e-01	7.15e-01
GOMF CYSTEINE TYPE PEPTIDASE ACTIVITY	150	4.90e-04	2.76e-03	0.2010	-1.71e-01	1.73e-02	-1.62e-02	3.51e-02	4.90e-02	8.24e-02	2.98e-04	7.14e-01	7.31e-01	4.58e-01	3.01e-01	8.16e-02
GOBP RESPONSE TO CORTICOSTEROID	110	7.23e-04	3.86e-03	0.2010	-3.24e-02	-2.30e-02	1.75e-01	-8.45e-02	-3.03e-02	-2.64e-03	5.57e-01	6.77e-01	1.53e-03	1.26e-01	5.83e-01	9.62e-01
GOMF ATP HYDROLYSIS ACTIVITY	374	8.28e-10	1.34e-08	0.2010	-1.67e-02	-4.47e-02	3.28e-02	1.73e-01	-5.64e-03	8.37e-02	5.78e-01	1.38e-01	2.76e-01	9.67e-09	8.52e-01	5.45e-03
GOCC TRIGLYCERIDE RICH PLASMA LIPOPROTEIN PARTICLE	11	9.42e-01	9.52e-01	0.2010	1.10e-02	2.96e-02	1.84e-01	5.99e-02	-4.39e-03	4.17e-02	9.50e-01	8.65e-01	2.91e-01	7.31e-01	9.80e-01	8.11e-01
GOMF MONOATOMIC ION GATED CHANNEL ACTIVITY	20	4.72e-01	5.74e-01	0.2010	1.01e-01	-6.92e-02	4.49e-02	-2.79e-02	7.75e-02	-1.28e-01	4.32e-01	5.92e-01	7.28e-01	8.29e-01	5.49e-01	3.22e-01
GOBP PROTEOLYSIS	1307	3.45e-32	3.81e-30	0.2010	-1.54e-01	-8.20e-02	6.75e-03	4.39e-02	-4.17e-02	7.76e-02	8.72e-21	6.49e-07	6.82e-01	7.75e-03	1.14e-02	2.48e-06
GOBP REGULATION OF TRANSMEMBRANE RECEPTOR PROTEIN SERINE THREONINE KINASE SIGNALING PATHWAY	197	4.03e-06	3.75e-05	0.2000	-4.89e-02	9.64e-02	1.44e-01	6.99e-02	-4.44e-02	2.75e-02	2.37e-01	1.96e-02	4.72e-04	9.06e-02	2.82e-01	5.05e-01
GOBP RESPONSE TO OSMOTIC STRESS	74	3.30e-03	1.40e-02	0.2000	-7.73e-02	2.78e-02	1.27e-01	1.14e-01	-6.27e-02	-1.78e-02	2.50e-01	6.79e-01	5.90e-02	8.96e-02	3.51e-01	7.91e-01
GOBP NEURON MIGRATION	125	1.96e-04	1.23e-03	0.2000	-1.23e-01	9.65e-02	1.05e-01	2.84e-02	-5.84e-02	2.32e-02	1.78e-02	6.26e-02	4.28e-02	5.84e-01	2.60e-01	6.54e-01
GOBP DNA TEMPLATED TRANSCRIPTION INITIATION	182	4.97e-04	2.79e-03	0.2000	-5.65e-02	-8.16e-02	-7.12e-02	1.53e-01	4.03e-02	1.08e-02	1.89e-01	5.77e-02	9.76e-02	3.72e-04	3.48e-01	8.03e-01
GOMF MOLECULAR ADAPTOR ACTIVITY	1071	7.88e-36	1.11e-33	0.2000	-5.62e-02	-2.77e-02	2.84e-02	1.77e-01	3.26e-04	6.30e-02	1.91e-03	1.27e-01	1.17e-01	1.27e-22	9.86e-01	4.99e-04
GOCC CELL PROJECTION MEMBRANE	270	1.51e-05	1.22e-04	0.2000	-3.28e-02	7.99e-02	1.53e-01	3.58e-02	3.22e-02	8.32e-02	3.54e-01	2.38e-02	1.56e-05	3.11e-01	3.63e-01	1.86e-02
GOBP REGULATION OF KIDNEY DEVELOPMENT	19	8.83e-01	9.04e-01	0.2000	7.68e-02	1.27e-01	5.00e-02	-6.73e-02	9.80e-02	3.56e-02	5.62e-01	3.36e-01	7.06e-01	6.12e-01	4.60e-01	7.88e-01
GOBP TISSUE REGENERATION	55	3.25e-01	4.43e-01	0.2000	-3.04e-02	6.69e-02	1.16e-01	-1.04e-01	-9.24e-02	-4.28e-02	6.97e-01	3.91e-01	1.38e-01	1.81e-01	2.36e-01	5.83e-01
GOCC CLATHRIN COATED VESICLE MEMBRANE	111	3.83e-04	2.23e-03	0.2000	-1.33e-01	-6.72e-02	5.56e-02	1.19e-01	4.46e-03	2.50e-02	1.55e-02	2.21e-01	3.11e-01	3.10e-02	9.35e-01	6.49e-01
GOBP MRNA METHYLGUANOSINE CAP DECAPPING	16	7.84e-01	8.26e-01	0.2000	-6.77e-03	1.24e-02	3.10e-02	9.31e-02	-1.30e-01	1.16e-01	9.63e-01	9.32e-01	8.30e-01	5.19e-01	3.69e-01	4.23e-01
GOBP NEPHRON TUBULE EPITHELIAL CELL DIFFERENTIATION	8	9.70e-01	9.75e-01	0.2000	-9.87e-02	1.07e-01	-6.57e-02	-1.15e-01	-2.67e-02	-2.35e-02	6.29e-01	6.00e-01	7.48e-01	5.74e-01	8.96e-01	9.09e-01
GOBP NEURON DEVELOPMENT	826	3.69e-22	1.85e-20	0.2000	-6.42e-02	1.01e-01	1.32e-01	5.38e-02	9.26e-03	7.29e-02	1.73e-03	7.95e-07	1.32e-10	8.68e-03	6.52e-01	3.74e-04
GOBP SENSORY PERCEPTION OF LIGHT STIMULUS	116	3.96e-02	9.89e-02	0.2000	-8.37e-02	4.92e-02	-1.07e-01	-6.82e-02	-3.40e-03	-1.20e-01	1.19e-01	3.60e-01	4.60e-02	2.05e-01	9.50e-01	2.57e-02
GOBP VERY LONG CHAIN FATTY ACID METABOLIC PROCESS	33	7.29e-01	7.84e-01	0.2000	-4.81e-02	-7.07e-02	3.80e-02	-1.97e-02	-4.81e-02	1.69e-01	6.32e-01	4.82e-01	7.06e-01	8.45e-01	6.32e-01	9.34e-02
GOBP REGULATION OF INTRINSIC APOPTOTIC SIGNALING PATHWAY	158	1.90e-03	8.78e-03	0.2000	-1.08e-01	-1.39e-01	1.44e-02	4.99e-02	-8.00e-02	3.17e-03	1.94e-02	2.66e-03	7.55e-01	2.79e-01	8.27e-02	9.45e-01
GOBP RESPONSE TO LIPID	689	7.16e-21	3.27e-19	0.2000	-7.00e-02	1.64e-02	1.66e-01	3.54e-02	-1.15e-02	7.49e-02	1.74e-03	4.62e-01	9.58e-14	1.13e-01	6.07e-01	8.09e-04
GOBP SYNAPSE ORGANIZATION	335	8.76e-08	1.09e-06	0.2000	-6.69e-02	8.44e-02	1.45e-01	1.61e-02	-4.82e-02	6.93e-02	3.54e-02	7.93e-03	5.48e-06	6.13e-01	1.30e-01	2.92e-02
GOCC PLASMA MEMBRANE REGION	872	1.30e-17	4.40e-16	0.2000	-1.75e-02	9.49e-02	1.52e-01	4.19e-02	-2.64e-03	7.43e-02	3.80e-01	2.00e-06	2.18e-14	3.59e-02	8.95e-01	1.97e-04
GOBP REGULATION OF PROTEIN IMPORT INTO NUCLEUS	49	3.00e-01	4.19e-01	0.2000	-1.68e-01	-4.60e-02	4.86e-02	1.93e-02	1.14e-03	8.13e-02	4.14e-02	5.78e-01	5.56e-01	8.15e-01	9.89e-01	3.25e-01
GOBP RESPONSE TO REACTIVE OXYGEN SPECIES	169	9.52e-04	4.88e-03	0.2000	-1.56e-01	-1.01e-01	3.81e-02	6.90e-03	-5.75e-02	2.55e-02	4.77e-04	2.41e-02	3.93e-01	8.77e-01	1.97e-01	5.67e-01
GOBP REGULATION OF FIBROBLAST PROLIFERATION	76	1.43e-02	4.58e-02	0.1990	-2.48e-02	-7.83e-02	6.11e-02	1.62e-01	5.45e-02	-2.38e-03	7.09e-01	2.38e-01	3.57e-01	1.44e-02	4.12e-01	9.71e-01
GOBP POSITIVE REGULATION OF PROTEIN LOCALIZATION TO PLASMA MEMBRANE	50	5.36e-02	1.24e-01	0.1990	-1.71e-01	1.13e-02	7.63e-02	6.56e-02	-1.48e-02	8.84e-03	3.66e-02	8.90e-01	3.51e-01	4.23e-01	8.57e-01	9.14e-01
GOBP POSITIVE REGULATION OF TRANSPORT	655	1.35e-14	3.51e-13	0.1990	-7.33e-02	3.08e-02	1.41e-01	3.83e-02	-2.34e-02	1.07e-01	1.38e-03	1.79e-01	7.54e-10	9.44e-02	3.07e-01	2.84e-06
GOBP COLLAGEN METABOLIC PROCESS	73	1.86e-02	5.58e-02	0.1990	-2.02e-02	-3.95e-02	3.42e-02	1.71e-01	5.81e-02	-6.35e-02	7.65e-01	5.60e-01	6.14e-01	1.16e-02	3.91e-01	3.48e-01
GOBP POSITIVE REGULATION OF LEUKOCYTE CELL CELL ADHESION	240	3.77e-05	2.82e-04	0.1990	-1.23e-02	7.71e-02	1.05e-01	1.24e-01	6.29e-02	5.72e-02	7.43e-01	3.96e-02	5.19e-03	9.25e-04	9.32e-02	1.27e-01
GOBP FOREBRAIN GENERATION OF NEURONS	33	6.10e-01	6.90e-01	0.1990	-9.58e-02	4.08e-02	1.12e-01	5.11e-02	2.79e-02	1.14e-01	3.41e-01	6.85e-01	2.65e-01	6.12e-01	7.82e-01	2.59e-01
GOMF MAGNESIUM ION BINDING	210	6.19e-06	5.52e-05	0.1990	-1.22e-01	-5.86e-02	2.92e-02	1.05e-01	4.83e-02	8.45e-02	2.24e-03	1.43e-01	4.66e-01	9.02e-03	2.28e-01	3.49e-02
GOCC CILIARY PLASM	120	5.03e-02	1.18e-01	0.1990	-5.32e-03	1.27e-01	-5.14e-02	3.00e-04	1.43e-01	-2.19e-02	9.20e-01	1.62e-02	3.31e-01	9.95e-01	6.93e-03	6.78e-01
GOBP HEMATOPOIETIC PROGENITOR CELL DIFFERENTIATION	114	2.73e-03	1.20e-02	0.1990	-1.19e-01	5.40e-02	5.00e-02	1.02e-01	2.94e-02	9.47e-02	2.86e-02	3.20e-01	3.57e-01	6.10e-02	5.88e-01	8.08e-02
GOBP NEGATIVE REGULATION OF RESPONSE TO BIOTIC STIMULUS	109	3.13e-02	8.24e-02	0.1990	-7.24e-02	-1.09e-01	-7.47e-03	8.58e-02	-4.93e-02	1.13e-01	1.92e-01	5.00e-02	8.93e-01	1.22e-01	3.74e-01	4.18e-02
GOBP PHOSPHORYLATION	1119	1.35e-31	1.42e-29	0.1990	-6.94e-02	3.59e-02	1.23e-01	9.71e-02	-3.16e-03	9.50e-02	9.02e-05	4.32e-02	4.60e-12	4.38e-08	8.59e-01	8.34e-08
GOBP NEUROMUSCULAR PROCESS CONTROLLING BALANCE	38	3.59e-01	4.75e-01	0.1990	-1.07e-01	1.21e-01	-3.20e-02	6.20e-02	9.15e-02	-1.76e-02	2.54e-01	1.97e-01	7.33e-01	5.09e-01	3.29e-01	8.51e-01
GOBP MUSCLE CELL MIGRATION	68	1.06e-01	2.03e-01	0.1990	-7.99e-02	8.94e-02	1.41e-01	3.04e-02	-3.20e-02	5.83e-02	2.55e-01	2.03e-01	4.44e-02	6.64e-01	6.48e-01	4.06e-01
GOMF HYDRO LYASE ACTIVITY	50	6.62e-01	7.31e-01	0.1990	-3.43e-02	-1.54e-01	-8.98e-02	-3.13e-02	-5.52e-02	-5.19e-02	6.75e-01	6.02e-02	2.72e-01	7.02e-01	4.99e-01	5.26e-01
GOBP RESPONSE TO LEUKEMIA INHIBITORY FACTOR	86	9.70e-02	1.92e-01	0.1990	-1.60e-01	5.39e-03	7.38e-02	-4.83e-02	-1.37e-02	7.73e-02	1.04e-02	9.31e-01	2.37e-01	4.39e-01	8.26e-01	2.15e-01
GOMF PROTEIN HOMODIMERIZATION ACTIVITY	579	1.36e-14	3.52e-13	0.1990	-1.04e-01	-1.05e-01	3.78e-03	8.55e-02	2.97e-02	9.69e-02	1.78e-05	1.66e-05	8.77e-01	4.40e-04	2.22e-01	6.81e-05
GOBP REGULATION OF NOTCH SIGNALING PATHWAY	73	1.05e-01	2.02e-01	0.1990	-2.79e-02	6.98e-02	3.10e-02	9.65e-02	1.51e-01	-2.66e-02	6.80e-01	3.02e-01	6.47e-01	1.54e-01	2.57e-02	6.94e-01
GOBP MITOCHONDRION LOCALIZATION	45	2.61e-01	3.81e-01	0.1990	-1.73e-01	-1.71e-02	-1.55e-02	2.42e-02	-8.40e-02	3.48e-02	4.43e-02	8.43e-01	8.57e-01	7.78e-01	3.30e-01	6.86e-01
GOMF TRANSFERASE ACTIVITY TRANSFERRING SULPHUR CONTAINING GROUPS	46	3.19e-01	4.38e-01	0.1980	6.91e-02	-7.79e-02	-2.02e-02	1.46e-01	-8.16e-02	5.19e-03	4.17e-01	3.61e-01	8.13e-01	8.56e-02	3.38e-01	9.51e-01
GOBP POSITIVE REGULATION OF PROTEIN IMPORT INTO NUCLEUS	34	2.82e-01	4.02e-01	0.1980	-5.63e-02	5.11e-02	5.45e-02	1.26e-01	1.06e-01	-6.03e-02	5.70e-01	6.06e-01	5.83e-01	2.04e-01	2.87e-01	5.43e-01
GOBP OSTEOBLAST DIFFERENTIATION	161	1.06e-03	5.36e-03	0.1980	-1.03e-01	5.01e-02	1.35e-01	1.05e-02	-4.37e-02	7.74e-02	2.40e-02	2.73e-01	3.15e-03	8.18e-01	3.39e-01	9.00e-02
GOBP HINDBRAIN MORPHOGENESIS	36	4.62e-01	5.66e-01	0.1980	-5.69e-02	1.26e-01	1.25e-01	1.78e-02	6.15e-02	2.16e-02	5.55e-01	1.91e-01	1.94e-01	8.54e-01	5.23e-01	8.22e-01
GOBP REGULATION OF MICROTUBULE CYTOSKELETON ORGANIZATION	141	5.94e-03	2.25e-02	0.1980	-3.29e-02	5.76e-02	5.82e-02	1.42e-01	4.31e-02	9.79e-02	5.00e-01	2.38e-01	2.33e-01	3.67e-03	3.77e-01	4.48e-02
GOMF STEROL BINDING	57	4.08e-02	1.01e-01	0.1980	-1.36e-01	7.63e-02	8.88e-02	7.82e-02	-4.27e-03	3.00e-02	7.54e-02	3.19e-01	2.46e-01	3.07e-01	9.56e-01	6.95e-01
GOBP EXTERNAL ENCAPSULATING STRUCTURE ORGANIZATION	222	5.23e-06	4.73e-05	0.1980	-8.48e-03	1.39e-01	1.33e-01	4.36e-02	4.13e-03	-2.06e-02	8.28e-01	3.67e-04	6.63e-04	2.63e-01	9.16e-01	5.97e-01
GOBP NEGATIVE REGULATION OF IMMUNE SYSTEM PROCESS	428	7.31e-08	9.13e-07	0.1980	-3.54e-02	1.14e-02	1.11e-01	7.49e-02	-4.97e-02	1.32e-01	2.09e-01	6.86e-01	8.73e-05	7.86e-03	7.78e-02	2.70e-06
GOBP CELL CELL JUNCTION ASSEMBLY	106	3.17e-02	8.32e-02	0.1980	-2.37e-02	8.31e-02	1.70e-01	-4.16e-02	-1.28e-02	3.06e-02	6.73e-01	1.40e-01	2.54e-03	4.59e-01	8.21e-01	5.86e-01
GOBP OVARIAN FOLLICLE DEVELOPMENT	39	2.37e-01	3.55e-01	0.1980	-5.74e-02	-9.35e-02	6.45e-02	5.98e-02	-1.12e-01	-8.27e-02	5.35e-01	3.12e-01	4.86e-01	5.18e-01	2.28e-01	3.71e-01
GOBP SCHWANN CELL DIFFERENTIATION	43	1.17e-01	2.20e-01	0.1980	-3.63e-02	-4.99e-02	3.91e-02	1.64e-01	1.62e-02	-8.17e-02	6.80e-01	5.72e-01	6.58e-01	6.33e-02	8.54e-01	3.54e-01
GOMF SIGNALING ADAPTOR ACTIVITY	113	1.75e-03	8.20e-03	0.1980	-5.37e-02	7.06e-02	1.17e-01	9.23e-02	-8.40e-02	4.34e-02	3.24e-01	1.95e-01	3.16e-02	9.02e-02	1.23e-01	4.25e-01
GOBP POSITIVE REGULATION OF HYDROLASE ACTIVITY	372	1.13e-08	1.58e-07	0.1970	-5.12e-02	3.67e-02	1.54e-01	4.30e-02	-6.66e-02	7.00e-02	9.01e-02	2.24e-01	3.17e-07	1.54e-01	2.75e-02	2.04e-02
GOBP RENAL FILTRATION	24	8.56e-01	8.83e-01	0.1970	-2.49e-02	-1.05e-01	8.04e-03	8.73e-04	-1.61e-01	-3.63e-02	8.33e-01	3.74e-01	9.46e-01	9.94e-01	1.72e-01	7.59e-01
GOBP RESPONSE TO HORMONE	646	2.83e-21	1.35e-19	0.1970	-1.27e-01	9.59e-03	1.26e-01	3.96e-02	-1.55e-02	7.21e-02	4.02e-08	6.78e-01	4.98e-08	8.60e-02	5.01e-01	1.79e-03
GOBP KIDNEY EPITHELIUM DEVELOPMENT	92	1.25e-01	2.30e-01	0.1970	2.01e-02	9.34e-02	1.58e-01	-4.53e-02	-5.09e-02	8.49e-03	7.39e-01	1.21e-01	8.63e-03	4.53e-01	3.99e-01	8.88e-01
GOBP CELLULAR RESPONSE TO OSMOTIC STRESS	49	1.13e-01	2.14e-01	0.1970	-1.45e-01	1.88e-02	9.46e-02	7.52e-02	-5.69e-03	5.26e-02	7.81e-02	8.20e-01	2.52e-01	3.62e-01	9.45e-01	5.24e-01
GOBP REGULATION OF CANONICAL WNT SIGNALING PATHWAY	188	5.82e-05	4.18e-04	0.1970	-4.05e-02	1.09e-01	6.79e-02	1.25e-01	1.69e-02	7.00e-02	3.39e-01	1.02e-02	1.09e-01	3.08e-03	6.90e-01	9.81e-02
GOBP OSSIFICATION	290	2.34e-09	3.52e-08	0.1970	-1.24e-01	5.81e-02	1.30e-01	1.76e-02	-1.24e-02	5.08e-02	2.69e-04	8.86e-02	1.33e-04	6.06e-01	7.16e-01	1.37e-01
GOBP NEGATIVE REGULATION OF DEVELOPMENTAL PROCESS	634	2.54e-16	7.78e-15	0.1970	-3.46e-02	5.77e-02	1.62e-01	5.46e-02	-4.55e-02	5.63e-02	1.37e-01	1.31e-02	3.69e-12	1.91e-02	5.07e-02	1.56e-02
GOBP EMBRYONIC SKELETAL SYSTEM DEVELOPMENT	59	7.34e-02	1.56e-01	0.1970	-6.99e-02	9.03e-02	-1.70e-02	1.45e-01	5.46e-02	-3.78e-02	3.53e-01	2.30e-01	8.22e-01	5.33e-02	4.68e-01	6.16e-01
GOBP SYMBIONT ENTRY INTO HOST	132	4.94e-04	2.77e-03	0.1970	-9.86e-02	-2.83e-02	9.60e-02	1.16e-01	2.14e-03	7.44e-02	5.04e-02	5.74e-01	5.69e-02	2.10e-02	9.66e-01	1.40e-01
GOCC DENDRITE TERMINUS	12	8.74e-01	8.96e-01	0.1970	-1.24e-01	-1.41e-02	1.12e-01	3.54e-02	6.61e-02	7.13e-02	4.56e-01	9.33e-01	5.03e-01	8.32e-01	6.92e-01	6.69e-01
GOBP POSITIVE REGULATION OF MITOPHAGY	15	9.36e-01	9.47e-01	0.1970	3.35e-03	-3.24e-02	1.31e-01	7.65e-02	-1.02e-01	6.52e-02	9.82e-01	8.28e-01	3.79e-01	6.08e-01	4.94e-01	6.62e-01
GOBP B CELL ACTIVATION	239	1.09e-04	7.31e-04	0.1970	4.85e-03	4.97e-02	1.33e-01	1.02e-01	-4.80e-02	7.73e-02	8.97e-01	1.86e-01	4.10e-04	6.66e-03	2.01e-01	3.95e-02
GOMF PEPTIDASE REGULATOR ACTIVITY	150	8.88e-03	3.12e-02	0.1970	-1.56e-01	-4.17e-02	3.61e-03	-4.43e-03	1.36e-03	1.12e-01	9.99e-04	3.78e-01	9.39e-01	9.25e-01	9.77e-01	1.76e-02
GOMF ACID THIOL LIGASE ACTIVITY	27	8.38e-01	8.69e-01	0.1970	1.66e-03	8.29e-02	1.33e-01	-1.28e-02	6.94e-02	9.55e-02	9.88e-01	4.56e-01	2.32e-01	9.08e-01	5.33e-01	3.91e-01
GOBP REGULATION OF CENTROSOME CYCLE	51	4.86e-01	5.86e-01	0.1960	-9.85e-02	-5.62e-02	-1.31e-01	1.71e-03	9.06e-02	1.99e-02	2.24e-01	4.88e-01	1.07e-01	9.83e-01	2.63e-01	8.06e-01
GOCC CLATHRIN COATED ENDOCYTIC VESICLE MEMBRANE	56	3.39e-02	8.78e-02	0.1960	-1.23e-01	-7.64e-02	6.38e-03	6.52e-02	5.15e-02	-1.03e-01	1.11e-01	3.23e-01	9.34e-01	3.98e-01	5.05e-01	1.83e-01
GOBP REGULATION OF WNT SIGNALING PATHWAY	245	1.35e-06	1.38e-05	0.1960	-4.88e-02	8.96e-02	9.67e-02	1.06e-01	-2.48e-02	8.29e-02	1.89e-01	1.58e-02	9.17e-03	4.21e-03	5.04e-01	2.55e-02
GOBP REGULATION OF AUTOPHAGY OF MITOCHONDRION	42	2.67e-01	3.86e-01	0.1960	-7.08e-03	-6.92e-02	2.39e-02	1.69e-01	4.91e-02	-4.43e-02	9.37e-01	4.37e-01	7.89e-01	5.74e-02	5.82e-01	6.19e-01
GOMF MYOSIN PHOSPHATASE ACTIVITY	65	2.34e-01	3.52e-01	0.1960	-1.47e-01	-1.01e-01	-5.23e-02	5.93e-02	-1.73e-02	6.39e-03	4.07e-02	1.58e-01	4.66e-01	4.08e-01	8.09e-01	9.29e-01
GOBP REGULATION OF ESTABLISHMENT OF PROTEIN LOCALIZATION	436	7.18e-10	1.18e-08	0.1960	-1.11e-01	-7.75e-02	7.97e-02	4.78e-02	-4.72e-02	9.57e-02	6.99e-05	5.56e-03	4.34e-03	8.71e-02	9.11e-02	6.12e-04
GOBP DETECTION OF CHEMICAL STIMULUS INVOLVED IN SENSORY PERCEPTION OF TASTE	15	8.62e-01	8.88e-01	0.1960	-5.76e-02	6.42e-02	-9.16e-02	-1.41e-01	-4.95e-02	-8.92e-03	6.99e-01	6.67e-01	5.39e-01	3.43e-01	7.40e-01	9.52e-01
GOBP METENCEPHALON DEVELOPMENT	87	6.36e-03	2.39e-02	0.1960	-2.82e-02	7.98e-02	8.22e-02	1.53e-01	-3.36e-02	4.01e-03	6.49e-01	1.98e-01	1.85e-01	1.39e-02	5.88e-01	9.48e-01
GOBP IMMUNOGLOBULIN PRODUCTION INVOLVED IN IMMUNOGLOBULIN MEDIATED IMMUNE RESPONSE	56	2.24e-01	3.43e-01	0.1960	-2.08e-02	-1.14e-03	1.25e-02	9.98e-02	-1.45e-02	1.66e-01	7.88e-01	9.88e-01	8.71e-01	1.96e-01	8.51e-01	3.17e-02
GOMF PHOSPHATIDYLINOSITOL 4 5 BISPHOSPHATE 5 PHOSPHATASE ACTIVITY	9	8.93e-01	9.12e-01	0.1960	-8.86e-02	1.27e-01	3.45e-02	6.29e-02	-1.56e-02	-9.38e-02	6.45e-01	5.09e-01	8.58e-01	7.44e-01	9.35e-01	6.26e-01
GOBP RESPONSE TO CALCIUM ION	98	7.53e-02	1.60e-01	0.1950	-1.20e-01	3.52e-03	1.20e-01	-2.97e-02	-4.14e-02	8.19e-02	3.94e-02	9.52e-01	4.02e-02	6.12e-01	4.78e-01	1.61e-01
GOBP L SERINE METABOLIC PROCESS	11	8.72e-01	8.95e-01	0.1950	1.47e-01	-8.94e-02	1.31e-02	-3.19e-02	3.49e-02	-7.78e-02	3.97e-01	6.07e-01	9.40e-01	8.55e-01	8.41e-01	6.55e-01
GOBP REGULATION OF ORGANELLE ORGANIZATION	1060	8.45e-30	7.91e-28	0.1950	-7.59e-02	-6.30e-02	5.20e-02	1.30e-01	-9.16e-03	9.30e-02	3.05e-05	5.37e-04	4.27e-03	7.56e-13	6.15e-01	3.18e-07
GOCC AXON	465	5.00e-10	8.36e-09	0.1950	-3.85e-02	9.85e-02	1.23e-01	7.23e-02	2.49e-02	7.74e-02	1.55e-01	2.76e-04	5.54e-06	7.58e-03	3.57e-01	4.26e-03
GOBP REGULATION OF TRANSCRIPTION BY RNA POLYMERASE III	30	3.02e-01	4.22e-01	0.1950	-8.30e-02	3.30e-04	-1.09e-01	1.03e-01	-8.57e-02	-4.01e-02	4.32e-01	9.98e-01	3.03e-01	3.31e-01	4.17e-01	7.04e-01
GOCC P BODY	96	8.05e-02	1.67e-01	0.1950	-2.22e-02	5.13e-03	4.33e-02	1.41e-01	3.11e-02	1.22e-01	7.07e-01	9.31e-01	4.63e-01	1.67e-02	5.99e-01	3.95e-02
GOBP PROTEIN O LINKED GLYCOSYLATION	86	1.92e-02	5.74e-02	0.1950	-1.22e-01	1.50e-02	1.24e-01	2.73e-02	3.19e-02	7.53e-02	5.00e-02	8.10e-01	4.61e-02	6.62e-01	6.09e-01	2.28e-01
GOCC CILIARY MEMBRANE	62	2.20e-01	3.39e-01	0.1950	-1.04e-01	7.29e-02	-4.48e-02	-1.48e-02	1.33e-01	4.60e-02	1.56e-01	3.21e-01	5.41e-01	8.41e-01	7.12e-02	5.31e-01
GOBP DENDRITIC SPINE MORPHOGENESIS	49	3.40e-01	4.57e-01	0.1950	-1.19e-01	9.74e-02	4.47e-02	1.78e-03	5.56e-02	9.64e-02	1.49e-01	2.38e-01	5.88e-01	9.83e-01	5.01e-01	2.43e-01
GOBP POSITIVE REGULATION OF CELL CELL ADHESION	272	9.31e-06	7.89e-05	0.1950	-5.36e-03	7.86e-02	1.39e-01	9.26e-02	3.29e-02	5.35e-02	8.79e-01	2.56e-02	7.94e-05	8.57e-03	3.50e-01	1.29e-01
GOBP REGULATION OF G PROTEIN COUPLED RECEPTOR SIGNALING PATHWAY	105	2.06e-01	3.23e-01	0.1950	1.49e-02	2.22e-02	1.19e-01	7.31e-02	-1.96e-02	1.32e-01	7.92e-01	6.95e-01	3.51e-02	1.96e-01	7.29e-01	1.94e-02
GOBP IMPORT INTO NUCLEUS	152	4.81e-05	3.50e-04	0.1950	-1.64e-01	-3.21e-02	-2.42e-02	8.70e-02	-4.19e-02	7.16e-03	4.66e-04	4.95e-01	6.07e-01	6.42e-02	3.73e-01	8.79e-01
GOBP NUCLEAR TRANSCRIBED MRNA CATABOLIC PROCESS NONSENSE MEDIATED DECAY	40	4.33e-01	5.41e-01	0.1950	-3.68e-02	-9.38e-02	-7.23e-02	1.44e-01	-4.47e-02	4.08e-03	6.87e-01	3.05e-01	4.29e-01	1.16e-01	6.25e-01	9.64e-01
GOCC TRANSCRIPTION REGULATOR COMPLEX	404	3.89e-12	8.25e-11	0.1950	-4.14e-02	1.40e-02	8.05e-02	1.61e-01	3.79e-02	4.90e-02	1.53e-01	6.29e-01	5.49e-03	3.10e-08	1.91e-01	9.08e-02
GOMF SIGNALING RECEPTOR COMPLEX ADAPTOR ACTIVITY	47	1.88e-01	3.03e-01	0.1950	-8.32e-02	-1.27e-03	8.26e-02	7.60e-02	-1.32e-01	3.31e-02	3.24e-01	9.88e-01	3.27e-01	3.67e-01	1.18e-01	6.94e-01
GOBP RESPONSE TO BACTERIUM	519	9.26e-11	1.68e-09	0.1950	-5.57e-02	-1.05e-02	1.37e-01	3.68e-02	2.65e-03	1.21e-01	3.01e-02	6.84e-01	8.35e-08	1.52e-01	9.18e-01	2.62e-06
GOBP EMBRYONIC ORGAN MORPHOGENESIS	167	3.85e-03	1.58e-02	0.1950	-1.55e-02	1.19e-01	3.36e-02	8.90e-02	1.19e-01	-1.89e-02	7.29e-01	8.01e-03	4.53e-01	4.71e-02	7.92e-03	6.73e-01
GOBP REGULATION OF HYDROLASE ACTIVITY	566	1.94e-13	4.53e-12	0.1950	-8.88e-02	1.97e-02	1.26e-01	4.38e-02	-5.68e-02	9.29e-02	3.05e-04	4.24e-01	2.89e-07	7.49e-02	2.09e-02	1.59e-04
GOBP RHYTHMIC PROCESS	224	6.59e-09	9.57e-08	0.1950	-1.14e-01	4.80e-02	1.19e-01	8.63e-02	-1.56e-02	3.00e-02	3.41e-03	2.15e-01	2.14e-03	2.61e-02	6.88e-01	4.40e-01
GOBP POSITIVE REGULATION OF MHC CLASS II BIOSYNTHETIC PROCESS	14	9.51e-01	9.60e-01	0.1950	-3.79e-02	1.20e-01	-1.32e-02	2.12e-02	1.31e-01	6.67e-02	8.06e-01	4.39e-01	9.32e-01	8.91e-01	3.96e-01	6.66e-01
GOBP MESENCHYME DEVELOPMENT	209	1.18e-05	9.81e-05	0.1950	-3.68e-02	1.25e-01	1.21e-01	7.64e-02	1.01e-02	1.91e-02	3.59e-01	1.82e-03	2.59e-03	5.71e-02	8.01e-01	6.33e-01
GOBP POSITIVE REGULATION OF OLIGODENDROCYTE DIFFERENTIATION	19	5.89e-01	6.73e-01	0.1950	-1.06e-01	9.79e-02	6.48e-02	6.66e-03	-4.87e-02	-1.02e-01	4.24e-01	4.60e-01	6.25e-01	9.60e-01	7.13e-01	4.41e-01
GOCC LAMELLIPODIUM	178	3.79e-06	3.55e-05	0.1950	-1.49e-01	-3.62e-02	1.00e-01	4.73e-02	-2.10e-02	4.05e-02	6.01e-04	4.05e-01	2.12e-02	2.77e-01	6.30e-01	3.52e-01
GOBP CALCIUM ION IMPORT	57	1.94e-01	3.11e-01	0.1950	-4.68e-02	9.26e-02	1.50e-01	-4.81e-02	-4.57e-02	-1.76e-02	5.41e-01	2.26e-01	5.07e-02	5.30e-01	5.50e-01	8.19e-01
GOBP ESTABLISHMENT OF TISSUE POLARITY	27	5.51e-01	6.40e-01	0.1950	-9.05e-02	1.54e-01	2.28e-03	-5.68e-02	-1.99e-02	4.85e-02	4.16e-01	1.66e-01	9.84e-01	6.09e-01	8.58e-01	6.62e-01
GOCC NON MOTILE CILIUM	118	3.66e-02	9.33e-02	0.1940	-1.41e-01	-5.19e-03	-6.54e-02	-9.01e-02	6.83e-02	3.07e-02	8.33e-03	9.22e-01	2.20e-01	9.09e-02	2.00e-01	5.64e-01
GOBP SIGNAL RELEASE	342	1.68e-07	1.98e-06	0.1940	-8.09e-02	5.63e-02	1.46e-01	-2.64e-02	3.11e-03	7.72e-02	1.01e-02	7.39e-02	3.43e-06	4.02e-01	9.21e-01	1.42e-02
GOCC ANCHORING JUNCTION	730	1.14e-17	3.91e-16	0.1940	-7.98e-02	-3.92e-02	1.30e-01	4.00e-02	-7.29e-02	7.70e-02	2.42e-04	7.13e-02	2.07e-09	6.59e-02	7.99e-04	3.98e-04
GOBP RESPONSE TO OXYGEN LEVELS	261	6.68e-09	9.69e-08	0.1940	-9.42e-02	-7.04e-02	1.22e-01	7.36e-02	-2.68e-02	5.34e-02	8.83e-03	5.03e-02	6.85e-04	4.06e-02	4.57e-01	1.37e-01
GOBP REGULATION OF PROTEIN TRANSPORT	346	1.54e-07	1.83e-06	0.1940	-1.14e-01	-5.78e-02	1.00e-01	2.47e-02	-4.01e-02	9.53e-02	2.64e-04	6.46e-02	1.39e-03	4.30e-01	2.00e-01	2.33e-03
GOBP POSITIVE REGULATION OF CELL ADHESION	392	7.61e-10	1.24e-08	0.1940	-1.89e-02	6.78e-02	1.50e-01	8.76e-02	4.52e-03	4.92e-02	5.20e-01	2.12e-02	3.34e-07	2.91e-03	8.78e-01	9.46e-02
GOBP IN UTERO EMBRYONIC DEVELOPMENT	319	1.14e-09	1.81e-08	0.1940	-5.51e-02	9.17e-03	5.80e-02	1.64e-01	5.06e-02	4.12e-02	9.06e-02	7.78e-01	7.49e-02	4.76e-07	1.20e-01	2.06e-01
GOBP POSITIVE REGULATION OF GENE EXPRESSION VIA CHROMOSOMAL CPG ISLAND DEMETHYLATION	13	9.90e-01	9.91e-01	0.1940	7.23e-02	1.18e-01	3.22e-02	9.55e-02	9.09e-02	-1.21e-02	6.52e-01	4.63e-01	8.41e-01	5.51e-01	5.70e-01	9.40e-01
GOBP CELLULAR LIPID CATABOLIC PROCESS	194	4.39e-04	2.52e-03	0.1940	-1.24e-01	-1.41e-01	-1.55e-02	1.85e-02	2.28e-02	3.38e-02	2.91e-03	6.90e-04	7.10e-01	6.56e-01	5.83e-01	4.17e-01
GOBP REGULATION OF ORGANELLE ASSEMBLY	226	6.01e-06	5.38e-05	0.1940	-8.89e-02	5.90e-02	2.01e-02	1.14e-01	4.98e-02	1.02e-01	2.13e-02	1.27e-01	6.02e-01	3.23e-03	1.97e-01	8.39e-03
GOBP PEPTIDYL L CYSTEINE S PALMITOYLATION	22	8.90e-01	9.10e-01	0.1940	5.70e-02	-2.77e-02	-8.37e-02	-6.53e-02	-4.52e-02	-1.42e-01	6.43e-01	8.22e-01	4.97e-01	5.96e-01	7.13e-01	2.48e-01
GOBP REGULATION OF DNA RECOMBINATION	130	6.21e-03	2.34e-02	0.1940	-4.82e-02	-7.83e-02	-4.98e-02	1.61e-01	1.19e-02	2.06e-02	3.43e-01	1.23e-01	3.27e-01	1.48e-03	8.15e-01	6.85e-01
GOBP EMBRYONIC ORGAN DEVELOPMENT	284	1.67e-06	1.68e-05	0.1940	-5.90e-03	8.85e-02	1.12e-01	1.01e-01	7.98e-02	2.30e-02	8.64e-01	1.03e-02	1.21e-03	3.32e-03	2.08e-02	5.05e-01
GOBP POSITIVE REGULATION OF MACROAUTOPHAGY	81	5.11e-03	2.00e-02	0.1940	-1.21e-01	3.57e-02	6.62e-02	1.09e-01	-6.20e-02	3.76e-02	6.03e-02	5.79e-01	3.03e-01	8.86e-02	3.35e-01	5.58e-01
GOBP NEGATIVE REGULATION OF NF KAPPAB TRANSCRIPTION FACTOR ACTIVITY	68	3.39e-01	4.57e-01	0.1940	-1.27e-01	-2.12e-02	8.60e-02	-1.65e-02	-4.82e-02	1.04e-01	6.91e-02	7.63e-01	2.20e-01	8.14e-01	4.92e-01	1.39e-01
GOBP REGULATION OF CYTOSKELETON ORGANIZATION	443	6.50e-12	1.34e-10	0.1930	-7.08e-02	1.61e-02	1.14e-01	1.02e-01	1.92e-02	9.13e-02	1.07e-02	5.62e-01	3.91e-05	2.30e-04	4.88e-01	9.85e-04
GOCC ENDOCYTIC VESICLE	302	3.78e-11	7.09e-10	0.1930	-1.28e-01	1.21e-03	9.04e-02	9.59e-02	2.21e-02	5.50e-02	1.25e-04	9.71e-01	6.89e-03	4.14e-03	5.10e-01	1.00e-01
GOBP PURINE CONTAINING COMPOUND CATABOLIC PROCESS	134	2.81e-03	1.23e-02	0.1930	-6.38e-02	-8.83e-02	9.74e-02	9.05e-02	-1.34e-02	8.75e-02	2.03e-01	7.77e-02	5.16e-02	7.06e-02	7.88e-01	8.05e-02
GOBP SENSORY PERCEPTION OF TASTE	26	8.81e-01	9.03e-01	0.1930	1.01e-01	1.25e-01	-3.04e-02	1.17e-02	1.02e-01	-1.40e-02	3.72e-01	2.72e-01	7.89e-01	9.17e-01	3.69e-01	9.02e-01
GOCC PHOTORECEPTOR OUTER SEGMENT	60	3.54e-01	4.70e-01	0.1930	-1.26e-01	3.57e-02	-3.03e-02	-1.28e-01	-1.94e-02	4.81e-02	9.05e-02	6.32e-01	6.85e-01	8.55e-02	7.95e-01	5.20e-01
GOBP NEGATIVE REGULATION OF NEURON PROJECTION DEVELOPMENT	102	3.94e-02	9.85e-02	0.1930	-5.86e-02	6.18e-02	1.47e-01	4.86e-02	-2.39e-02	7.51e-02	3.07e-01	2.81e-01	1.06e-02	3.96e-01	6.77e-01	1.90e-01
GOBP CIRCULATORY SYSTEM DEVELOPMENT	824	5.07e-24	2.94e-22	0.1930	-7.85e-02	5.84e-02	1.47e-01	4.38e-02	-2.12e-02	5.98e-02	1.30e-04	4.42e-03	6.36e-13	3.27e-02	3.01e-01	3.56e-03
GOBP SKELETAL MUSCLE TISSUE REGENERATION	34	5.48e-01	6.38e-01	0.1930	-1.53e-02	2.82e-02	6.41e-02	-1.36e-01	-4.14e-02	-1.09e-01	8.77e-01	7.76e-01	5.18e-01	1.69e-01	6.76e-01	2.72e-01
GOBP POSITIVE REGULATION OF SMAD PROTEIN SIGNAL TRANSDUCTION	30	5.73e-01	6.60e-01	0.1930	-7.53e-02	6.19e-02	-1.13e-01	5.67e-02	8.42e-03	-1.08e-01	4.75e-01	5.58e-01	2.85e-01	5.91e-01	9.36e-01	3.05e-01
GOCC CYTOPLASMIC MICROTUBULE	76	2.57e-01	3.77e-01	0.1930	-1.09e-01	-6.17e-02	1.95e-02	1.45e-02	-6.49e-02	1.29e-01	9.97e-02	3.53e-01	7.68e-01	8.27e-01	3.28e-01	5.19e-02
GOBP POSITIVE REGULATION OF PROTEIN LOCALIZATION TO CELL PERIPHERY	61	2.76e-02	7.54e-02	0.1930	-1.60e-01	3.81e-02	3.71e-02	9.04e-02	-1.18e-02	1.78e-02	3.03e-02	6.07e-01	6.16e-01	2.22e-01	8.74e-01	8.10e-01
GOCC CELL LEADING EDGE	363	3.71e-11	6.98e-10	0.1930	-9.44e-02	2.00e-02	1.35e-01	6.79e-02	-2.24e-02	6.65e-02	2.01e-03	5.13e-01	9.53e-06	2.64e-02	4.65e-01	2.96e-02
GOBP REGULATION OF HEMOPOIESIS	352	1.11e-06	1.16e-05	0.1930	-1.97e-02	7.98e-02	1.30e-01	7.59e-02	-2.44e-02	8.38e-02	5.25e-01	1.01e-02	2.67e-05	1.44e-02	4.32e-01	6.91e-03
GOBP POSITIVE REGULATION OF EPITHELIAL CELL PROLIFERATION	136	4.61e-04	2.63e-03	0.1930	-4.00e-02	5.29e-02	1.78e-01	2.01e-02	4.47e-03	2.30e-02	4.20e-01	2.87e-01	3.32e-04	6.86e-01	9.28e-01	6.44e-01
GOCC GOLGI APPARATUS SUBCOMPARTMENT	338	1.81e-09	2.75e-08	0.1930	-1.24e-01	-4.97e-03	2.31e-02	9.95e-02	5.11e-03	1.06e-01	9.05e-05	8.75e-01	4.65e-01	1.67e-03	8.72e-01	8.16e-04
GOBP REGULATION OF PROTEIN CONTAINING COMPLEX ASSEMBLY	367	4.07e-11	7.60e-10	0.1920	-1.11e-01	-2.08e-02	7.73e-02	1.06e-01	-1.43e-02	8.26e-02	2.64e-04	4.93e-01	1.10e-02	4.73e-04	6.39e-01	6.58e-03
GOBP SUPRAMOLECULAR FIBER ORGANIZATION	667	1.17e-17	3.99e-16	0.1920	-7.55e-02	2.42e-03	1.20e-01	8.81e-02	-2.35e-02	9.25e-02	8.85e-04	9.15e-01	1.22e-07	1.06e-04	3.01e-01	4.63e-05
GOBP CELLULAR RESPONSE TO INTERLEUKIN 1	64	2.18e-02	6.33e-02	0.1920	-7.31e-02	7.19e-02	1.57e-01	-1.62e-02	2.09e-02	-3.33e-02	3.12e-01	3.20e-01	2.97e-02	8.23e-01	7.73e-01	6.45e-01
GOBP POSITIVE REGULATION OF TRANSCRIPTION BY RNA POLYMERASE II	937	4.85e-29	4.37e-27	0.1920	-4.67e-02	8.32e-02	6.55e-02	1.42e-01	5.38e-02	2.09e-02	1.54e-02	1.63e-05	6.81e-04	1.67e-13	5.33e-03	2.78e-01
GOCC PHAGOCYTIC CUP	27	5.44e-01	6.35e-01	0.1920	-1.83e-01	1.32e-02	4.69e-02	-2.90e-02	5.19e-03	-1.94e-02	1.01e-01	9.06e-01	6.73e-01	7.94e-01	9.63e-01	8.62e-01
GOBP LEUKOCYTE ACTIVATION INVOLVED IN INFLAMMATORY RESPONSE	41	2.69e-01	3.88e-01	0.1920	-1.38e-01	7.22e-02	1.02e-01	-1.40e-02	3.89e-02	2.43e-02	1.26e-01	4.24e-01	2.59e-01	8.77e-01	6.67e-01	7.88e-01
GOBP BONE MINERALIZATION	89	1.07e-02	3.64e-02	0.1920	-1.20e-01	6.61e-02	5.84e-02	-8.31e-02	1.62e-02	-8.73e-02	5.08e-02	2.81e-01	3.41e-01	1.75e-01	7.92e-01	1.55e-01
GOBP CELLULAR MODIFIED AMINO ACID METABOLIC PROCESS	141	1.58e-03	7.50e-03	0.1920	-7.61e-02	-1.42e-01	4.66e-02	5.39e-03	2.44e-02	8.97e-02	1.19e-01	3.53e-03	3.39e-01	9.12e-01	6.17e-01	6.61e-02
GOBP CELLULAR RESPONSE TO NUTRIENT	39	2.21e-01	3.39e-01	0.1920	-1.05e-01	8.81e-02	1.28e-01	-8.30e-03	-2.44e-02	-3.13e-02	2.59e-01	3.41e-01	1.65e-01	9.28e-01	7.92e-01	7.35e-01
GOBP MICROTUBULE POLYMERIZATION OR DEPOLYMERIZATION	120	4.14e-03	1.68e-02	0.1920	-2.81e-02	2.43e-02	3.63e-02	1.81e-01	2.32e-02	2.95e-02	5.95e-01	6.45e-01	4.93e-01	6.20e-04	6.61e-01	5.77e-01
GOCC MICROVILLUS	72	4.98e-01	5.95e-01	0.1920	-6.50e-02	-6.32e-02	9.72e-02	-6.89e-02	-1.08e-01	5.32e-02	3.40e-01	3.54e-01	1.54e-01	3.12e-01	1.15e-01	4.35e-01
GOBP POSITIVE REGULATION OF IMMUNE RESPONSE	672	1.35e-18	4.98e-17	0.1920	-6.05e-02	6.75e-02	4.49e-02	1.29e-01	2.44e-02	9.68e-02	7.56e-03	2.85e-03	4.72e-02	1.24e-08	2.82e-01	1.88e-05
GOBP RESPONSE TO ETHANOL	84	5.46e-03	2.11e-02	0.1920	-8.81e-02	-4.92e-02	1.34e-01	3.05e-02	5.77e-02	6.63e-02	1.63e-01	4.36e-01	3.37e-02	6.29e-01	3.60e-01	2.94e-01
GOBP RESPONSE TO ENDOGENOUS STIMULUS	1211	2.68e-36	3.94e-34	0.1920	-8.85e-02	3.10e-02	1.40e-01	5.63e-02	-1.99e-02	6.91e-02	2.24e-07	6.99e-02	2.25e-16	9.85e-04	2.43e-01	5.28e-05
GOBP AMEBOIDAL TYPE CELL MIGRATION	328	2.67e-12	5.71e-11	0.1920	-6.84e-02	5.81e-02	1.67e-01	2.90e-02	-1.12e-02	4.09e-03	3.33e-02	7.04e-02	2.18e-07	3.67e-01	7.27e-01	8.99e-01
GOCC LOW DENSITY LIPOPROTEIN PARTICLE	9	9.55e-01	9.63e-01	0.1920	7.50e-03	-5.04e-02	8.25e-02	1.50e-01	6.75e-02	1.72e-02	9.69e-01	7.93e-01	6.68e-01	4.36e-01	7.26e-01	9.29e-01
GOCC FEMALE PRONUCLEUS	9	8.73e-01	8.96e-01	0.1920	-1.05e-01	6.71e-02	5.84e-02	8.56e-02	-8.66e-02	-5.49e-02	5.87e-01	7.27e-01	7.62e-01	6.56e-01	6.53e-01	7.75e-01
GOBP CELLULAR SENESCENCE	90	4.08e-02	1.01e-01	0.1910	-1.10e-01	-4.05e-02	9.52e-02	7.15e-02	-1.93e-02	9.14e-02	7.11e-02	5.07e-01	1.19e-01	2.41e-01	7.51e-01	1.34e-01
GOBP INTERLEUKIN 4 PRODUCTION	31	5.54e-01	6.44e-01	0.1910	-2.61e-05	-7.98e-02	-4.15e-03	1.56e-01	-7.57e-02	-9.95e-03	1.00e+00	4.42e-01	9.68e-01	1.32e-01	4.66e-01	9.24e-01
GOMF VOLTAGE GATED CALCIUM CHANNEL ACTIVITY	31	6.86e-01	7.50e-01	0.1910	2.42e-02	6.80e-02	4.74e-03	-1.20e-01	3.44e-03	-1.30e-01	8.15e-01	5.12e-01	9.64e-01	2.48e-01	9.74e-01	2.09e-01
GOBP NEGATIVE REGULATION OF APOPTOTIC SIGNALING PATHWAY	194	1.35e-04	8.80e-04	0.1910	-1.40e-01	-9.80e-02	6.66e-02	4.55e-03	-3.58e-02	3.97e-02	7.48e-04	1.86e-02	1.10e-01	9.13e-01	3.90e-01	3.41e-01
GOBP REGULATION OF IMMUNE EFFECTOR PROCESS	337	1.27e-05	1.05e-04	0.1910	-1.59e-02	9.16e-02	1.04e-01	8.69e-02	2.16e-02	9.59e-02	6.15e-01	3.87e-03	1.07e-03	6.10e-03	4.96e-01	2.50e-03
GOBP CARBOHYDRATE BIOSYNTHETIC PROCESS	166	2.07e-05	1.63e-04	0.1910	-8.47e-02	-2.87e-02	7.87e-02	1.42e-01	2.71e-03	4.65e-02	5.99e-02	5.23e-01	8.03e-02	1.57e-03	9.52e-01	3.01e-01
GOBP HOMOLOGOUS CHROMOSOME SEGREGATION	45	5.60e-01	6.49e-01	0.1910	-9.39e-02	-1.16e-01	-8.24e-02	4.40e-02	-1.16e-03	7.49e-02	2.76e-01	1.79e-01	3.39e-01	6.09e-01	9.89e-01	3.85e-01
GOBP RAC PROTEIN SIGNAL TRANSDUCTION	45	3.93e-01	5.06e-01	0.1910	-6.01e-02	1.15e-01	1.03e-01	3.44e-02	-4.95e-02	7.35e-02	4.86e-01	1.80e-01	2.32e-01	6.90e-01	5.66e-01	3.94e-01
GOMF DNA BINDING TRANSCRIPTION FACTOR BINDING	401	1.29e-13	3.06e-12	0.1910	-3.81e-02	-1.39e-03	9.19e-02	1.60e-01	-1.58e-02	2.90e-02	1.91e-01	9.62e-01	1.60e-03	3.83e-08	5.86e-01	3.20e-01
GOMF KINASE ACTIVATOR ACTIVITY	122	2.27e-02	6.54e-02	0.1910	-1.17e-01	2.71e-02	7.53e-02	6.16e-03	-7.78e-02	1.02e-01	2.51e-02	6.05e-01	1.51e-01	9.06e-01	1.38e-01	5.28e-02
GOBP DEFENSE RESPONSE	1403	1.36e-29	1.26e-27	0.1910	-7.75e-02	1.26e-02	9.40e-02	7.04e-02	-1.53e-03	1.29e-01	1.17e-06	4.31e-01	3.79e-09	1.03e-05	9.24e-01	6.15e-16
GOBP POSITIVE REGULATION OF CELL KILLING	65	3.74e-03	1.55e-02	0.1910	-3.06e-02	7.37e-02	-9.81e-02	1.31e-01	-4.96e-02	3.00e-02	6.70e-01	3.04e-01	1.71e-01	6.75e-02	4.89e-01	6.76e-01
GOBP REGULATION OF IMMUNE RESPONSE	836	2.17e-21	1.04e-19	0.1910	-6.17e-02	5.95e-02	6.91e-02	1.10e-01	3.81e-03	1.10e-01	2.44e-03	3.51e-03	6.91e-04	5.89e-08	8.52e-01	7.07e-08
GOBP REGULATION OF EPITHELIAL CELL DIFFERENTIATION	104	3.53e-03	1.47e-02	0.1910	-5.26e-02	7.29e-02	1.56e-01	4.94e-02	3.47e-02	1.68e-02	3.54e-01	1.99e-01	5.92e-03	3.84e-01	5.41e-01	7.67e-01
GOBP REGULATION OF EPITHELIAL CELL MIGRATION	186	1.79e-07	2.11e-06	0.1910	-7.78e-02	1.09e-02	1.73e-01	-2.53e-03	-1.64e-02	-4.37e-03	6.72e-02	7.98e-01	4.78e-05	9.53e-01	7.00e-01	9.18e-01
GOBP FAT CELL DIFFERENTIATION	176	3.50e-05	2.64e-04	0.1910	-5.56e-02	1.14e-01	1.18e-01	3.22e-03	7.87e-02	-1.07e-02	2.03e-01	9.22e-03	6.80e-03	9.41e-01	7.17e-02	8.06e-01
GOMF NADPLUS PROTEIN CYSTEINE ADP RIBOSYLTRANSFERASE ACTIVITY	6	9.91e-01	9.92e-01	0.1910	-9.60e-02	-2.79e-02	-1.22e-01	-6.97e-02	-8.05e-02	1.07e-02	6.84e-01	9.06e-01	6.05e-01	7.68e-01	7.33e-01	9.64e-01
GOBP AMINO SUGAR METABOLIC PROCESS	36	3.89e-01	5.02e-01	0.1910	-4.48e-02	9.33e-03	-9.53e-02	3.06e-02	-1.08e-01	-1.12e-01	6.42e-01	9.23e-01	3.22e-01	7.51e-01	2.62e-01	2.45e-01
GOBP CELL SURFACE RECEPTOR PROTEIN SERINE THREONINE KINASE SIGNALING PATHWAY	268	1.64e-06	1.65e-05	0.1910	-4.58e-02	7.52e-02	1.42e-01	6.21e-02	-4.17e-02	5.25e-02	1.97e-01	3.40e-02	6.19e-05	8.02e-02	2.40e-01	1.39e-01
GOBP PEPTIDYL CYSTEINE MODIFICATION	40	8.13e-01	8.50e-01	0.1910	-7.22e-02	-2.23e-03	4.66e-02	-1.06e-01	-1.08e-01	7.70e-02	4.30e-01	9.80e-01	6.10e-01	2.45e-01	2.36e-01	4.00e-01
GOBP MYOTUBE DIFFERENTIATION	96	9.62e-02	1.90e-01	0.1910	2.92e-02	7.10e-02	1.69e-01	2.30e-03	-4.32e-02	1.27e-02	6.22e-01	2.30e-01	4.32e-03	9.69e-01	4.64e-01	8.30e-01
GOMF EXTRACELLULAR MATRIX STRUCTURAL CONSTITUENT	93	2.88e-02	7.77e-02	0.1910	4.48e-02	1.02e-01	1.21e-01	-5.92e-02	5.08e-02	-5.59e-02	4.55e-01	8.96e-02	4.32e-02	3.24e-01	3.97e-01	3.52e-01
GOBP REGULATION OF EPITHELIAL TO MESENCHYMAL TRANSITION	81	2.35e-01	3.53e-01	0.1900	7.27e-02	1.15e-01	1.16e-01	5.64e-02	9.29e-03	-3.28e-02	2.58e-01	7.28e-02	7.20e-02	3.80e-01	8.85e-01	6.10e-01
GOBP NEGATIVE REGULATION OF CELL ADHESION	239	5.80e-04	3.18e-03	0.1900	-2.64e-02	3.50e-02	1.54e-01	1.57e-02	-7.85e-02	6.57e-02	4.83e-01	3.52e-01	4.24e-05	6.76e-01	3.66e-02	8.03e-02
GOBP PROTEIN LOCALIZATION TO CELL SURFACE	58	5.09e-01	6.04e-01	0.1900	-1.10e-01	-7.65e-02	-1.71e-02	-6.88e-02	-6.94e-02	-9.19e-02	1.47e-01	3.14e-01	8.22e-01	3.65e-01	3.61e-01	2.26e-01
GOBP SPROUTING ANGIOGENESIS	98	1.83e-02	5.52e-02	0.1900	-3.29e-02	7.74e-02	1.70e-01	4.16e-03	-9.82e-03	1.18e-02	5.74e-01	1.85e-01	3.65e-03	9.43e-01	8.67e-01	8.39e-01
GOBP MORPHOGENESIS OF AN EPITHELIUM	341	8.68e-09	1.23e-07	0.1900	-4.21e-02	9.49e-02	1.46e-01	3.89e-02	3.75e-02	3.57e-02	1.81e-01	2.60e-03	3.87e-06	2.17e-01	2.34e-01	2.58e-01
GOBP REGULATION OF REACTIVE OXYGEN SPECIES METABOLIC PROCESS	119	3.46e-02	8.93e-02	0.1900	-1.10e-01	-1.51e-02	8.09e-02	3.72e-02	6.86e-03	1.26e-01	3.87e-02	7.76e-01	1.27e-01	4.84e-01	8.97e-01	1.75e-02
GOBP ANIMAL ORGAN MORPHOGENESIS	645	6.39e-13	1.43e-11	0.1900	-2.05e-02	1.17e-01	1.21e-01	5.62e-02	3.90e-02	5.01e-02	3.76e-01	3.66e-07	1.43e-07	1.50e-02	9.09e-02	3.01e-02
GOBP NEGATIVE REGULATION OF PROTEIN MODIFICATION PROCESS	345	8.50e-08	1.06e-06	0.1900	-1.17e-01	-5.21e-02	7.51e-02	5.91e-02	-3.63e-02	9.63e-02	1.95e-04	9.67e-02	1.65e-02	5.95e-02	2.47e-01	2.12e-03
GOBP SMALL MOLECULE BIOSYNTHETIC PROCESS	476	5.93e-12	1.22e-10	0.1900	-1.01e-01	-1.27e-01	2.82e-02	6.39e-02	1.01e-02	6.78e-02	1.50e-04	1.98e-06	2.91e-01	1.69e-02	7.06e-01	1.13e-02
GOBP POSITIVE REGULATION OF CELLULAR COMPONENT ORGANIZATION	911	3.73e-27	2.91e-25	0.1900	-8.12e-02	3.04e-02	7.94e-02	1.24e-01	1.25e-02	8.19e-02	3.28e-05	1.20e-01	4.90e-05	2.25e-10	5.23e-01	2.83e-05
GOMF PROTEIN CONTAINING COMPLEX BINDING	1471	1.55e-44	3.27e-42	0.1900	-8.04e-02	-7.70e-02	4.59e-02	1.34e-01	-2.11e-02	5.67e-02	2.53e-07	8.01e-07	3.31e-03	1.07e-17	1.77e-01	2.80e-04
GOMF UBIQUITIN LIKE PROTEIN LIGASE ACTIVITY	318	6.63e-11	1.22e-09	0.1900	-1.05e-01	2.05e-02	5.12e-03	1.33e-01	-1.20e-02	8.15e-02	1.30e-03	5.29e-01	8.75e-01	4.40e-05	7.13e-01	1.24e-02
GOBP REGULATION OF PEPTIDYL TYROSINE PHOSPHORYLATION	161	6.81e-03	2.53e-02	0.1900	-5.54e-02	4.14e-02	1.58e-01	-5.38e-03	-3.22e-02	7.23e-02	2.25e-01	3.65e-01	5.51e-04	9.06e-01	4.81e-01	1.13e-01
GOBP ENDOTHELIAL CELL PROLIFERATION	117	2.49e-03	1.11e-02	0.1900	-7.79e-02	-4.06e-03	1.58e-01	-5.30e-02	8.08e-03	4.61e-02	1.45e-01	9.40e-01	3.23e-03	3.22e-01	8.80e-01	3.89e-01
GOBP REGULATION OF POSTSYNAPSE ORGANIZATION	82	8.99e-02	1.81e-01	0.1900	-1.46e-01	7.10e-02	5.29e-02	-2.63e-02	1.32e-02	7.59e-02	2.19e-02	2.66e-01	4.07e-01	6.81e-01	8.36e-01	2.35e-01
GOBP CARBOHYDRATE PHOSPHORYLATION	23	5.06e-01	6.02e-01	0.1890	-1.38e-01	-4.46e-02	4.85e-02	1.08e-01	-2.46e-02	-1.63e-02	2.53e-01	7.12e-01	6.87e-01	3.70e-01	8.38e-01	8.92e-01
GOCC TIGHT JUNCTION	95	1.25e-02	4.09e-02	0.1890	-1.94e-02	1.49e-01	5.08e-02	1.02e-02	-1.68e-02	-1.02e-01	7.44e-01	1.22e-02	3.92e-01	8.64e-01	7.77e-01	8.69e-02
GOCC DENDRITIC SHAFT	32	4.55e-01	5.60e-01	0.1890	-1.08e-02	1.13e-01	8.51e-02	9.46e-02	3.79e-02	-7.23e-02	9.16e-01	2.67e-01	4.05e-01	3.54e-01	7.10e-01	4.79e-01
GOBP PYRIDINE CONTAINING COMPOUND CATABOLIC PROCESS	86	1.80e-02	5.45e-02	0.1890	-4.14e-02	-3.89e-02	1.09e-01	1.32e-01	-4.65e-02	3.29e-02	5.07e-01	5.33e-01	8.00e-02	3.44e-02	4.56e-01	5.98e-01
GOBP CORTICOSTEROID HORMONE SECRETION	12	9.46e-01	9.56e-01	0.1890	8.03e-02	-1.01e-01	9.71e-02	7.53e-02	-6.19e-02	1.67e-02	6.30e-01	5.46e-01	5.60e-01	6.51e-01	7.10e-01	9.20e-01
GOBP MAINTENANCE OF CELL NUMBER	150	3.85e-03	1.58e-02	0.1890	-4.30e-02	6.36e-02	2.30e-02	1.45e-01	8.03e-02	4.25e-02	3.63e-01	1.79e-01	6.27e-01	2.13e-03	8.97e-02	3.69e-01
GOBP CALCIUM ION TRANSMEMBRANE TRANSPORT	245	1.78e-04	1.13e-03	0.1890	-2.16e-02	-1.65e-02	1.49e-01	2.71e-02	-9.50e-02	5.53e-02	5.61e-01	6.56e-01	5.84e-05	4.65e-01	1.05e-02	1.36e-01
GOBP SENSORY SYSTEM DEVELOPMENT	251	2.42e-06	2.36e-05	0.1890	-6.08e-02	1.30e-01	1.15e-01	2.00e-02	3.28e-02	1.71e-02	9.72e-02	3.89e-04	1.64e-03	5.85e-01	3.71e-01	6.41e-01
GOMF OXIDOREDUCTASE ACTIVITY ACTING ON PAIRED DONORS WITH INCORPORATION OR REDUCTION OF MOLECULAR OXYGEN	122	2.47e-02	6.94e-02	0.1890	-1.02e-02	5.09e-02	8.95e-02	1.18e-01	9.33e-02	4.84e-02	8.46e-01	3.32e-01	8.77e-02	2.43e-02	7.51e-02	3.55e-01
GOBP SNRNA TRANSCRIPTION BY RNA POLYMERASE II	15	9.36e-01	9.47e-01	0.1890	5.09e-02	1.29e-02	5.75e-02	4.98e-02	1.40e-01	8.72e-02	7.33e-01	9.31e-01	7.00e-01	7.38e-01	3.49e-01	5.59e-01
GOBP MONOSACCHARIDE METABOLIC PROCESS	213	8.81e-08	1.09e-06	0.1890	-1.16e-01	-6.88e-02	5.74e-03	1.04e-01	6.76e-02	-4.49e-02	3.58e-03	8.37e-02	8.85e-01	8.80e-03	8.92e-02	2.59e-01
GOBP RESPONSE TO ORGANIC CYCLIC COMPOUND	655	1.20e-17	4.07e-16	0.1890	-1.10e-01	6.03e-03	1.30e-01	1.86e-02	-1.08e-02	7.69e-02	1.43e-06	7.93e-01	1.33e-08	4.18e-01	6.37e-01	7.90e-04
GOBP BILE ACID METABOLIC PROCESS	35	7.37e-01	7.90e-01	0.1880	-4.03e-02	1.10e-01	5.45e-02	7.85e-04	5.82e-02	1.24e-01	6.80e-01	2.58e-01	5.77e-01	9.94e-01	5.51e-01	2.05e-01
GOCC EUCHROMATIN	49	3.64e-01	4.79e-01	0.1880	-1.24e-01	-1.44e-03	-5.27e-02	7.71e-02	7.85e-02	7.28e-02	1.33e-01	9.86e-01	5.24e-01	3.51e-01	3.42e-01	3.78e-01
GOBP PROTEIN POLYMERIZATION	258	1.13e-05	9.45e-05	0.1880	-6.49e-02	-1.82e-02	1.18e-01	8.47e-02	-2.40e-02	9.58e-02	7.26e-02	6.14e-01	1.08e-03	1.92e-02	5.07e-01	8.08e-03
GOBP EPIDERMIS DEVELOPMENT	212	2.92e-07	3.32e-06	0.1880	-1.05e-01	5.06e-02	1.32e-01	5.81e-02	-4.99e-03	3.16e-02	8.72e-03	2.04e-01	9.24e-04	1.45e-01	9.00e-01	4.28e-01
GOBP INTRINSIC APOPTOTIC SIGNALING PATHWAY IN RESPONSE TO DNA DAMAGE BY P53 CLASS MEDIATOR	43	4.21e-01	5.30e-01	0.1880	-8.29e-03	-8.48e-02	6.16e-02	1.47e-01	-8.94e-03	5.15e-02	9.25e-01	3.36e-01	4.85e-01	9.59e-02	9.19e-01	5.59e-01
GOBP INTERLEUKIN 1 PRODUCTION	95	1.94e-02	5.78e-02	0.1880	-1.40e-01	3.63e-02	1.10e-01	-3.36e-02	-2.94e-02	1.90e-02	1.87e-02	5.41e-01	6.36e-02	5.71e-01	6.20e-01	7.49e-01
GOCC NUCLEAR BODY	781	6.45e-21	2.97e-19	0.1880	-7.41e-02	-4.18e-02	-3.91e-02	1.56e-01	3.34e-02	3.34e-02	4.31e-04	4.69e-02	6.33e-02	1.37e-13	1.13e-01	1.12e-01
GOBP REGULATION OF PROTEIN STABILITY	291	7.06e-07	7.61e-06	0.1870	-1.14e-01	-9.79e-02	-2.85e-03	9.65e-02	-3.68e-02	4.34e-02	8.22e-04	4.05e-03	9.33e-01	4.65e-03	2.80e-01	2.03e-01
GOBP STEROL HOMEOSTASIS	65	2.72e-01	3.91e-01	0.1870	3.02e-02	2.35e-02	1.37e-01	1.11e-01	-2.92e-02	4.21e-02	6.74e-01	7.43e-01	5.60e-02	1.23e-01	6.84e-01	5.57e-01
GOBP POSITIVE REGULATION OF CYTOSKELETON ORGANIZATION	152	1.51e-04	9.75e-04	0.1870	-1.22e-01	-8.98e-03	9.17e-02	7.48e-02	3.98e-02	6.65e-02	9.22e-03	8.49e-01	5.09e-02	1.12e-01	3.97e-01	1.57e-01
GOMF PHOSPHATIDYLINOSITOL 3 4 5 TRISPHOSPHATE BINDING	36	6.71e-01	7.39e-01	0.1870	-5.57e-03	4.07e-02	1.37e-01	5.65e-02	-9.32e-02	5.30e-02	9.54e-01	6.72e-01	1.56e-01	5.58e-01	3.33e-01	5.82e-01
GOBP THYROID HORMONE METABOLIC PROCESS	16	9.46e-01	9.55e-01	0.1870	-4.65e-02	9.10e-02	5.88e-02	-1.43e-01	-2.43e-02	-1.52e-02	7.47e-01	5.29e-01	6.84e-01	3.24e-01	8.66e-01	9.16e-01
GOBP CELLULAR CATABOLIC PROCESS	983	5.00e-23	2.66e-21	0.1870	-1.36e-01	-8.08e-02	1.73e-02	6.14e-02	-2.37e-02	7.25e-02	4.63e-13	1.81e-05	3.58e-01	1.12e-03	2.09e-01	1.22e-04
GOBP POSITIVE REGULATION OF GLUCOSE METABOLIC PROCESS	34	3.20e-01	4.40e-01	0.1870	-1.03e-01	-5.47e-03	-7.69e-03	6.87e-02	6.79e-02	-1.22e-01	2.97e-01	9.56e-01	9.38e-01	4.88e-01	4.93e-01	2.18e-01
GOBP SIGNAL TRANSDUCTION IN ABSENCE OF LIGAND	52	3.23e-01	4.42e-01	0.1870	1.03e-02	-1.05e-01	1.26e-01	9.21e-03	-8.41e-02	3.10e-02	8.98e-01	1.92e-01	1.17e-01	9.09e-01	2.94e-01	6.99e-01
GOBP CYTOKINE PRODUCTION INVOLVED IN IMMUNE RESPONSE	109	1.25e-02	4.10e-02	0.1870	-8.90e-02	7.56e-02	1.34e-01	-5.26e-03	-5.26e-02	2.26e-02	1.09e-01	1.73e-01	1.54e-02	9.24e-01	3.42e-01	6.83e-01
GOBP DEVELOPMENT OF PRIMARY SEXUAL CHARACTERISTICS	159	2.73e-02	7.48e-02	0.1870	-7.28e-02	1.31e-02	1.29e-01	-1.54e-03	-5.28e-02	9.96e-02	1.13e-01	7.75e-01	4.85e-03	9.73e-01	2.51e-01	3.03e-02
GOBP FATTY ACID METABOLIC PROCESS	313	3.78e-07	4.22e-06	0.1870	-1.07e-01	-1.40e-01	-1.92e-02	5.98e-03	4.89e-02	3.40e-02	1.17e-03	2.06e-05	5.59e-01	8.56e-01	1.37e-01	3.01e-01
GOBP REGULATION OF CELL CYCLE G1 S PHASE TRANSITION	163	4.13e-04	2.38e-03	0.1870	-8.56e-02	-8.11e-02	8.41e-03	1.32e-01	-3.80e-02	4.36e-02	5.94e-02	7.41e-02	8.53e-01	3.53e-03	4.03e-01	3.37e-01
GOBP REGULATION OF MEMBRANE POTENTIAL	298	2.84e-04	1.72e-03	0.1870	2.82e-02	1.31e-02	1.51e-01	5.31e-02	-1.65e-02	8.92e-02	4.02e-01	6.98e-01	7.28e-06	1.15e-01	6.24e-01	8.07e-03
GOBP NEURON APOPTOTIC PROCESS	215	3.19e-04	1.90e-03	0.1870	-7.61e-02	-1.54e-02	8.30e-02	7.87e-02	3.59e-02	1.20e-01	5.45e-02	6.97e-01	3.61e-02	4.67e-02	3.64e-01	2.40e-03
GOBP REGULATION OF SMAD PROTEIN SIGNAL TRANSDUCTION	48	6.83e-01	7.48e-01	0.1870	2.59e-02	9.10e-02	7.58e-02	1.10e-01	2.79e-02	8.48e-02	7.56e-01	2.75e-01	3.64e-01	1.86e-01	7.38e-01	3.09e-01
GOBP CELLULAR RESPONSE TO OXYGEN LEVELS	131	4.19e-03	1.70e-02	0.1870	-1.45e-01	-5.18e-02	7.48e-02	3.43e-02	-3.39e-02	5.75e-02	4.29e-03	3.06e-01	1.39e-01	4.98e-01	5.03e-01	2.56e-01
GOBP RESPONSE TO NUTRIENT	120	2.80e-02	7.61e-02	0.1870	-5.18e-02	6.30e-02	1.51e-01	3.13e-03	-5.69e-02	4.49e-02	3.27e-01	2.33e-01	4.21e-03	9.53e-01	2.82e-01	3.96e-01
GOBP REGULATION OF PROGRAMMED NECROTIC CELL DEATH	30	3.97e-01	5.09e-01	0.1860	4.81e-02	7.29e-02	-5.57e-02	1.35e-01	-1.80e-02	7.36e-02	6.48e-01	4.89e-01	5.98e-01	2.00e-01	8.64e-01	4.86e-01
GOBP REGULATION OF PROTEIN KINASE C SIGNALING	15	6.79e-01	7.45e-01	0.1860	-7.39e-02	5.63e-02	1.14e-01	6.61e-03	9.28e-02	-6.59e-02	6.20e-01	7.06e-01	4.43e-01	9.65e-01	5.34e-01	6.58e-01
GOBP MONOACYLGLYCEROL METABOLIC PROCESS	13	9.05e-01	9.22e-01	0.1860	-3.94e-02	-1.22e-01	-1.26e-02	-7.54e-02	1.83e-02	-1.10e-01	8.06e-01	4.47e-01	9.37e-01	6.38e-01	9.09e-01	4.91e-01
GOBP HEMATOPOIETIC OR LYMPHOID ORGAN DEVELOPMENT	77	4.56e-02	1.09e-01	0.1860	-8.91e-02	7.18e-02	9.22e-02	9.66e-02	3.57e-02	4.99e-02	1.76e-01	2.76e-01	1.62e-01	1.43e-01	5.89e-01	4.49e-01
GOBP CARDIAC SEPTUM DEVELOPMENT	74	1.19e-01	2.22e-01	0.1860	-5.04e-02	1.17e-01	9.41e-02	7.17e-02	6.18e-02	2.61e-02	4.53e-01	8.30e-02	1.62e-01	2.86e-01	3.58e-01	6.97e-01
GOBP NEGATIVE REGULATION BY HOST OF VIRAL TRANSCRIPTION	12	8.64e-01	8.89e-01	0.1860	1.69e-01	-5.86e-02	-1.13e-03	-4.18e-02	3.02e-02	3.24e-03	3.11e-01	7.25e-01	9.95e-01	8.02e-01	8.56e-01	9.85e-01
GOCC CENTROSOME	680	1.28e-14	3.34e-13	0.1860	-7.36e-02	-2.71e-02	-2.10e-02	1.12e-01	9.34e-02	8.17e-02	1.07e-03	2.29e-01	3.50e-01	6.07e-07	3.29e-05	2.85e-04
GOCC CENTRIOLAR SATELLITE	115	8.91e-02	1.80e-01	0.1860	-7.11e-04	6.63e-02	-2.40e-02	8.55e-02	1.18e-01	9.14e-02	9.89e-01	2.19e-01	6.56e-01	1.13e-01	2.87e-02	9.03e-02
GOMF PHOSPHATIDYLINOSITOL 3 4 BISPHOSPHATE BINDING	24	7.75e-01	8.19e-01	0.1860	6.97e-02	9.84e-02	5.86e-02	6.33e-02	-4.96e-02	-1.01e-01	5.55e-01	4.04e-01	6.19e-01	5.91e-01	6.74e-01	3.93e-01
GOBP EXPLORATION BEHAVIOR	22	9.06e-01	9.23e-01	0.1860	-5.22e-02	3.60e-02	1.16e-01	5.79e-02	9.30e-03	1.17e-01	6.72e-01	7.70e-01	3.45e-01	6.39e-01	9.40e-01	3.44e-01
GOBP POSITIVE REGULATION OF LOCOMOTION	449	4.20e-12	8.82e-11	0.1860	-6.49e-02	5.25e-02	1.53e-01	3.50e-02	-3.51e-02	4.15e-02	1.85e-02	5.64e-02	2.74e-08	2.04e-01	2.02e-01	1.32e-01
GOBP FEAR RESPONSE	31	5.65e-01	6.53e-01	0.1860	1.69e-02	-8.00e-02	8.41e-02	-8.79e-03	5.24e-02	1.34e-01	8.70e-01	4.41e-01	4.18e-01	9.33e-01	6.13e-01	1.97e-01
GOBP REGULATION OF IMMUNE SYSTEM PROCESS	1326	1.06e-27	8.40e-26	0.1860	-4.87e-02	3.31e-02	9.91e-02	9.73e-02	-8.37e-03	1.08e-01	2.95e-03	4.36e-02	1.44e-09	2.81e-09	6.09e-01	3.96e-11
GOBP POSITIVE REGULATION OF LIPID BIOSYNTHETIC PROCESS	63	3.08e-02	8.15e-02	0.1860	-9.44e-03	6.95e-02	9.88e-02	5.95e-02	7.34e-02	-1.04e-01	8.97e-01	3.40e-01	1.75e-01	4.14e-01	3.14e-01	1.52e-01
GOBP REGULATION OF CELL DEVELOPMENT	646	1.20e-13	2.88e-12	0.1860	-3.46e-02	9.32e-02	1.26e-01	6.88e-02	3.82e-03	6.40e-02	1.34e-01	5.31e-05	5.29e-08	2.87e-03	8.69e-01	5.57e-03
GOBP REGULATION OF RESPONSE TO STRESS	1179	1.50e-28	1.28e-26	0.1860	-9.87e-02	-8.43e-03	6.36e-02	8.94e-02	-7.57e-03	1.12e-01	1.18e-08	6.26e-01	2.36e-04	2.38e-07	6.62e-01	9.20e-11
GOBP REGULATION OF KINASE ACTIVITY	423	2.01e-08	2.72e-07	0.1860	-6.66e-02	-3.71e-02	1.01e-01	7.62e-02	-2.02e-02	1.11e-01	1.88e-02	1.91e-01	3.88e-04	7.18e-03	4.77e-01	9.18e-05
GOBP REGULATION OF BIOMINERAL TISSUE DEVELOPMENT	69	9.03e-02	1.82e-01	0.1860	-6.06e-02	1.10e-01	1.02e-01	-5.70e-02	-2.87e-02	-6.32e-02	3.84e-01	1.13e-01	1.41e-01	4.13e-01	6.80e-01	3.64e-01
GOBP GENERATION OF NEURONS	1047	2.97e-25	1.95e-23	0.1860	-5.29e-02	9.83e-02	1.15e-01	6.91e-02	1.69e-02	5.97e-02	3.84e-03	7.76e-08	2.79e-10	1.59e-04	3.57e-01	1.10e-03
GOMF MONOCARBOXYLIC ACID BINDING	48	2.26e-01	3.44e-01	0.1860	-1.16e-01	1.24e-01	-2.20e-02	3.96e-02	5.61e-02	2.02e-02	1.64e-01	1.38e-01	7.92e-01	6.35e-01	5.01e-01	8.09e-01
GOBP REGULATION OF CELLULAR COMPONENT BIOGENESIS	844	2.22e-24	1.34e-22	0.1860	-9.35e-02	3.25e-02	8.53e-02	1.02e-01	-1.97e-03	8.28e-02	4.01e-06	1.09e-01	2.62e-05	4.41e-07	9.23e-01	4.47e-05
GOMF CARBOHYDRATE BINDING	216	1.27e-04	8.34e-04	0.1860	-1.03e-01	-3.26e-02	9.80e-02	5.51e-02	-8.20e-03	1.00e-01	8.96e-03	4.10e-01	1.31e-02	1.63e-01	8.36e-01	1.14e-02
GOBP ORGANIC ACID METABOLIC PROCESS	739	2.33e-12	5.03e-11	0.1850	-1.25e-01	-1.31e-01	-2.94e-02	-1.98e-03	-3.89e-04	2.74e-02	7.47e-09	1.34e-09	1.74e-01	9.27e-01	9.86e-01	2.04e-01
GOBP NEGATIVE REGULATION OF INTRINSIC APOPTOTIC SIGNALING PATHWAY	94	6.90e-02	1.49e-01	0.1850	-1.31e-01	-1.18e-01	3.48e-03	2.77e-02	-4.41e-02	-2.01e-02	2.77e-02	4.74e-02	9.54e-01	6.43e-01	4.60e-01	7.36e-01
GOCC NUCLEAR SPECK	388	3.78e-10	6.43e-09	0.1850	-9.63e-02	-3.90e-02	-6.72e-02	1.36e-01	2.26e-02	-1.15e-03	1.14e-03	1.87e-01	2.31e-02	4.07e-06	4.44e-01	9.69e-01
GOBP REGULATION OF GROWTH	450	4.43e-14	1.11e-12	0.1850	-3.00e-02	3.67e-02	1.02e-01	1.32e-01	-5.62e-02	3.13e-02	2.75e-01	1.82e-01	2.05e-04	1.47e-06	4.12e-02	2.55e-01
GOBP POSITIVE REGULATION OF PROTEIN METABOLIC PROCESS	1014	6.14e-24	3.45e-22	0.1850	-1.32e-01	-6.67e-02	5.83e-02	4.62e-02	-4.26e-02	7.26e-02	1.44e-12	3.33e-04	1.71e-03	1.30e-02	2.20e-02	9.34e-05
GOBP TOR SIGNALING	154	3.03e-05	2.31e-04	0.1850	-8.43e-02	5.26e-02	6.83e-02	1.39e-01	4.16e-03	2.22e-02	7.12e-02	2.60e-01	1.43e-01	2.94e-03	9.29e-01	6.35e-01
GOBP MULTICELLULAR ORGANISMAL RESPONSE TO STRESS	60	8.22e-02	1.70e-01	0.1850	-2.76e-02	-9.22e-02	1.50e-01	-4.99e-04	-1.84e-02	4.61e-02	7.12e-01	2.17e-01	4.43e-02	9.95e-01	8.05e-01	5.37e-01
GOBP REGULATION OF INFLAMMATORY RESPONSE TO ANTIGENIC STIMULUS	39	7.51e-01	8.01e-01	0.1850	-4.70e-02	-2.54e-03	1.34e-01	2.10e-02	-2.68e-02	1.13e-01	6.12e-01	9.78e-01	1.46e-01	8.21e-01	7.72e-01	2.21e-01
GOBP CARBOHYDRATE DERIVATIVE CATABOLIC PROCESS	237	2.28e-05	1.78e-04	0.1850	-1.04e-01	-1.19e-01	5.22e-02	5.00e-02	-1.80e-02	5.98e-02	5.60e-03	1.59e-03	1.67e-01	1.85e-01	6.33e-01	1.13e-01
GOBP REGULATION OF PROTEIN POLYMERIZATION	179	1.09e-03	5.50e-03	0.1850	-5.17e-02	-1.15e-02	1.38e-01	6.75e-02	-3.40e-02	8.11e-02	2.33e-01	7.91e-01	1.42e-03	1.20e-01	4.33e-01	6.13e-02
GOBP REGULATION OF LIPID CATABOLIC PROCESS	44	9.41e-02	1.88e-01	0.1850	-3.31e-02	6.92e-02	1.07e-01	1.44e-02	4.81e-02	-1.19e-01	7.04e-01	4.27e-01	2.19e-01	8.69e-01	5.81e-01	1.71e-01
GOBP NEGATIVE REGULATION OF MULTICELLULAR ORGANISMAL PROCESS	831	1.46e-19	5.97e-18	0.1850	-4.78e-02	4.13e-02	1.53e-01	4.52e-02	-1.04e-02	6.67e-02	1.92e-02	4.33e-02	5.97e-14	2.69e-02	6.12e-01	1.09e-03
GOBP REGULATION OF STEROID METABOLIC PROCESS	68	1.97e-01	3.13e-01	0.1850	8.18e-03	-1.89e-02	1.33e-01	1.04e-01	1.76e-02	6.97e-02	9.07e-01	7.88e-01	5.82e-02	1.37e-01	8.01e-01	3.20e-01
GOBP POSITIVE REGULATION OF IMMUNE SYSTEM PROCESS	937	1.12e-20	5.03e-19	0.1850	-5.98e-02	4.67e-02	8.74e-02	9.68e-02	-3.86e-04	1.06e-01	1.95e-03	1.56e-02	5.90e-06	5.29e-07	9.84e-01	3.50e-08
GOBP ORGANIC CATION TRANSPORT	78	1.38e-01	2.46e-01	0.1840	-1.45e-01	-4.48e-02	5.98e-02	6.58e-03	-7.99e-02	3.28e-02	2.71e-02	4.94e-01	3.61e-01	9.20e-01	2.22e-01	6.17e-01
GOBP CELLULAR RESPONSE TO LIGHT STIMULUS	100	1.90e-01	3.06e-01	0.1840	-2.87e-02	-1.38e-01	-1.42e-02	9.96e-03	-1.12e-01	-3.54e-02	6.20e-01	1.72e-02	8.06e-01	8.63e-01	5.21e-02	5.41e-01
GOBP ORGANIC CYCLIC COMPOUND CATABOLIC PROCESS	540	2.88e-11	5.52e-10	0.1840	-7.59e-02	-1.29e-01	-2.71e-02	1.00e-01	-1.03e-02	2.81e-02	2.56e-03	3.06e-07	2.81e-01	6.89e-05	6.84e-01	2.64e-01
GOBP TUBE MORPHOGENESIS	639	9.99e-19	3.74e-17	0.1840	-7.57e-02	6.70e-02	1.43e-01	4.11e-02	-3.45e-03	4.07e-02	1.09e-03	3.89e-03	7.20e-10	7.65e-02	8.82e-01	7.94e-02
GOBP DEVELOPMENTAL GROWTH	477	4.14e-12	8.73e-11	0.1840	-5.74e-02	8.39e-02	1.14e-01	8.45e-02	2.29e-03	5.82e-02	3.17e-02	1.70e-03	1.85e-05	1.57e-03	9.32e-01	2.96e-02
GOBP REGULATION OF OSTEOBLAST PROLIFERATION	22	7.80e-01	8.23e-01	0.1840	2.09e-02	3.39e-02	1.53e-01	-8.70e-02	-3.01e-02	-2.51e-02	8.65e-01	7.83e-01	2.16e-01	4.80e-01	8.07e-01	8.38e-01
GOBP NEGATIVE REGULATION OF ORGANELLE ORGANIZATION	322	2.27e-06	2.22e-05	0.1840	-2.61e-02	-4.27e-02	1.73e-02	1.35e-01	4.98e-03	1.14e-01	4.21e-01	1.88e-01	5.94e-01	3.31e-05	8.78e-01	4.41e-04
GOBP PROTEIN LOCALIZATION TO PLASMA MEMBRANE	242	1.18e-05	9.76e-05	0.1840	-1.09e-01	-4.18e-03	1.18e-01	3.61e-02	-4.24e-02	7.10e-02	3.47e-03	9.11e-01	1.62e-03	3.34e-01	2.57e-01	5.70e-02
GOBP POSITIVE REGULATION OF LIPID METABOLIC PROCESS	87	9.20e-03	3.21e-02	0.1840	2.00e-02	6.30e-02	1.06e-01	8.35e-02	4.22e-02	-9.78e-02	7.48e-01	3.10e-01	8.76e-02	1.78e-01	4.96e-01	1.15e-01
GOBP INTRACELLULAR SIGNALING CASSETTE	1552	1.38e-32	1.57e-30	0.1840	-4.47e-02	7.43e-02	1.27e-01	6.51e-02	-2.51e-03	7.68e-02	3.34e-03	1.07e-06	5.33e-17	1.92e-05	8.69e-01	4.61e-07
GOBP CILIUM MOVEMENT	127	3.08e-02	8.16e-02	0.1840	2.46e-02	1.18e-01	-6.05e-03	-8.83e-02	8.12e-02	-7.04e-02	6.33e-01	2.16e-02	9.06e-01	8.58e-02	1.14e-01	1.71e-01
GOMF MIRNA BINDING	37	8.14e-01	8.50e-01	0.1840	-9.71e-02	-1.68e-03	9.26e-02	-2.37e-02	-7.43e-02	9.92e-02	3.07e-01	9.86e-01	3.30e-01	8.03e-01	4.34e-01	2.97e-01
GOBP CELLULAR RESPONSE TO OXYGEN CONTAINING COMPOUND	893	2.49e-25	1.65e-23	0.1840	-9.46e-02	2.28e-02	1.21e-01	6.52e-02	1.75e-03	7.33e-02	1.63e-06	2.47e-01	7.53e-10	9.57e-04	9.29e-01	2.06e-04
GOMF HYDROLASE ACTIVITY ACTING ON CARBON NITROGEN BUT NOT PEPTIDE BONDS IN LINEAR AMIDES	69	2.05e-01	3.21e-01	0.1840	-5.00e-02	-1.04e-01	-8.39e-02	1.53e-02	9.94e-02	5.89e-02	4.72e-01	1.37e-01	2.28e-01	8.26e-01	1.54e-01	3.98e-01
GOBP GLYCEROPHOSPHOLIPID METABOLIC PROCESS	267	9.41e-08	1.16e-06	0.1840	-1.44e-01	2.49e-02	-3.34e-03	7.14e-02	8.53e-02	1.13e-02	5.19e-05	4.84e-01	9.25e-01	4.46e-02	1.65e-02	7.50e-01
GOCC PROTEIN DNA COMPLEX	1029	6.88e-28	5.50e-26	0.1840	-3.19e-02	1.68e-02	1.73e-02	1.73e-01	4.82e-02	5.32e-03	8.39e-02	3.62e-01	3.47e-01	6.99e-21	8.95e-03	7.73e-01
GOBP REGULATION OF LYMPHOCYTE MEDIATED IMMUNITY	172	1.96e-03	9.02e-03	0.1840	-7.67e-03	9.93e-02	2.59e-02	1.18e-01	2.90e-02	9.16e-02	8.62e-01	2.47e-02	5.59e-01	7.48e-03	5.11e-01	3.82e-02
GOMF ENZYME INHIBITOR ACTIVITY	276	2.55e-04	1.56e-03	0.1840	-7.63e-02	-1.01e-01	6.45e-02	2.74e-02	-4.32e-02	1.05e-01	2.91e-02	3.93e-03	6.51e-02	4.33e-01	2.17e-01	2.79e-03
GOBP RESPONSE TO OXYGEN CONTAINING COMPOUND	1244	2.78e-36	4.02e-34	0.1840	-9.17e-02	1.04e-02	1.31e-01	5.98e-02	-1.29e-02	6.61e-02	5.48e-08	5.40e-01	9.23e-15	3.92e-04	4.43e-01	8.90e-05
GOCC DENDRITE MEMBRANE	20	6.29e-01	7.06e-01	0.1830	-3.04e-02	-1.39e-02	6.56e-02	-1.35e-01	4.84e-02	-8.73e-02	8.14e-01	9.14e-01	6.11e-01	2.96e-01	7.08e-01	4.99e-01
GOBP ADULT LOCOMOTORY BEHAVIOR	52	1.53e-01	2.64e-01	0.1830	-1.30e-02	5.51e-02	8.45e-02	1.47e-01	-4.00e-02	-9.80e-03	8.71e-01	4.92e-01	2.92e-01	6.68e-02	6.18e-01	9.03e-01
GOBP REGULATION OF PROTEIN MODIFICATION PROCESS	990	7.26e-24	4.01e-22	0.1830	-9.94e-02	-4.82e-02	6.75e-02	8.62e-02	-2.93e-02	9.26e-02	1.23e-07	1.04e-02	3.29e-04	4.45e-06	1.19e-01	8.42e-07
GOBP REGULATION OF MULTICELLULAR ORGANISMAL DEVELOPMENT	1059	9.34e-25	5.81e-23	0.1830	-4.21e-02	8.03e-02	1.34e-01	6.62e-02	-9.54e-04	5.59e-02	2.06e-02	1.02e-05	2.00e-13	2.78e-04	9.58e-01	2.12e-03
GOBP CELLULAR RESPONSE TO LIPID	469	9.30e-14	2.25e-12	0.1830	-8.92e-02	1.12e-02	1.38e-01	4.97e-02	3.90e-03	6.29e-02	9.35e-04	6.78e-01	3.03e-07	6.51e-02	8.85e-01	1.96e-02
GOMF PURINE NUCLEOTIDE BINDING	1718	1.42e-43	2.93e-41	0.1830	-8.02e-02	-4.23e-02	5.08e-02	1.22e-01	-2.72e-03	8.81e-02	3.39e-08	3.63e-03	4.78e-04	3.34e-17	8.51e-01	1.34e-09
GOBP REGULATION OF CALCIUM ION TRANSPORT	180	8.29e-03	2.96e-02	0.1830	-2.32e-02	-1.60e-02	1.37e-01	1.54e-02	-1.06e-01	4.99e-02	5.91e-01	7.11e-01	1.50e-03	7.21e-01	1.46e-02	2.49e-01
GOBP RESPONSE TO TUMOR NECROSIS FACTOR	187	2.53e-05	1.97e-04	0.1830	-8.98e-02	5.19e-02	5.02e-02	7.09e-02	1.23e-01	6.59e-03	3.42e-02	2.21e-01	2.37e-01	9.48e-02	3.72e-03	8.77e-01
GOBP OLIGOSACCHARIDE METABOLIC PROCESS	46	1.83e-01	2.98e-01	0.1830	-1.38e-01	5.06e-02	4.93e-02	-1.10e-02	9.30e-02	-2.40e-02	1.05e-01	5.52e-01	5.63e-01	8.98e-01	2.75e-01	7.79e-01
GOCC GOLGI APPARATUS	1377	2.77e-37	4.28e-35	0.1830	-1.25e-01	-1.43e-02	5.44e-02	7.87e-02	-2.92e-02	8.70e-02	7.23e-15	3.76e-01	7.17e-04	9.88e-07	6.93e-02	6.37e-08
GOBP LOCOMOTION	937	5.81e-24	3.32e-22	0.1830	-6.15e-02	4.11e-02	1.53e-01	3.28e-02	-2.71e-02	5.18e-02	1.44e-03	3.30e-02	1.93e-15	8.88e-02	1.61e-01	7.23e-03
GOBP GLYCEROLIPID CATABOLIC PROCESS	48	4.54e-01	5.59e-01	0.1830	-1.02e-02	6.50e-02	1.55e-01	4.78e-02	2.28e-02	4.70e-02	9.03e-01	4.36e-01	6.27e-02	5.67e-01	7.85e-01	5.74e-01
GOBP REGULATION OF SYNAPTIC PLASTICITY	144	3.77e-03	1.56e-02	0.1830	-7.89e-02	4.46e-02	9.41e-02	8.78e-02	4.69e-02	8.03e-02	1.02e-01	3.56e-01	5.14e-02	6.89e-02	3.31e-01	9.64e-02
GOBP POSITIVE REGULATION OF EPITHELIAL CELL MIGRATION	127	1.06e-04	7.14e-04	0.1830	-9.97e-02	9.00e-03	1.49e-01	1.36e-02	-2.70e-02	-1.25e-02	5.24e-02	8.61e-01	3.64e-03	7.92e-01	5.99e-01	8.08e-01
GOBP GLYCEROLIPID METABOLIC PROCESS	326	4.55e-10	7.66e-09	0.1830	-1.37e-01	3.81e-02	2.11e-02	7.55e-02	8.07e-02	2.10e-02	2.03e-05	2.37e-01	5.13e-01	1.91e-02	1.23e-02	5.14e-01
GOBP APOPTOTIC PROCESS	1538	4.65e-35	6.16e-33	0.1830	-9.10e-02	-5.69e-02	6.43e-02	8.63e-02	-6.22e-03	1.01e-01	2.65e-09	1.96e-04	2.63e-05	1.66e-08	6.84e-01	3.34e-11
GOBP EMBRYONIC MORPHOGENESIS	411	1.10e-09	1.75e-08	0.1830	-3.55e-02	1.15e-01	1.11e-01	6.95e-02	3.46e-02	2.23e-02	2.17e-01	6.03e-05	1.15e-04	1.56e-02	2.30e-01	4.39e-01
GOMF MONOATOMIC CATION CHANNEL ACTIVITY	211	4.23e-03	1.71e-02	0.1830	7.85e-02	4.47e-02	1.52e-01	-2.04e-02	-3.08e-02	2.63e-02	4.93e-02	2.63e-01	1.38e-04	6.10e-01	4.40e-01	5.10e-01
GOBP POSITIVE REGULATION OF INTERLEUKIN 17 PRODUCTION	20	9.69e-01	9.74e-01	0.1830	3.37e-02	3.90e-02	-8.87e-02	3.12e-02	6.88e-02	-1.31e-01	7.94e-01	7.63e-01	4.92e-01	8.09e-01	5.94e-01	3.11e-01
GOBP RENAL SYSTEM PROCESS	81	2.90e-01	4.10e-01	0.1830	3.72e-02	2.30e-02	3.97e-02	1.61e-01	5.78e-02	2.20e-02	5.63e-01	7.21e-01	5.37e-01	1.21e-02	3.68e-01	7.32e-01
GOBP REGULATION OF PHOSPHORUS METABOLIC PROCESS	893	2.62e-20	1.14e-18	0.1830	-8.06e-02	-8.43e-03	1.08e-01	7.33e-02	-2.37e-02	9.56e-02	4.48e-05	6.69e-01	4.42e-08	2.04e-04	2.30e-01	1.27e-06
GOMF AMINOACYLTRANSFERASE ACTIVITY	429	4.93e-13	1.12e-11	0.1830	-1.11e-01	2.17e-03	-5.84e-03	1.10e-01	-1.97e-02	9.24e-02	8.27e-05	9.39e-01	8.36e-01	9.68e-05	4.84e-01	1.03e-03
GOMF ATP DEPENDENT ACTIVITY	511	1.02e-11	2.04e-10	0.1820	-3.23e-02	-3.24e-02	3.61e-02	1.50e-01	-1.15e-02	8.43e-02	2.11e-01	2.10e-01	1.62e-01	5.79e-09	6.56e-01	1.12e-03
GOMF TUBULIN BINDING	342	3.79e-06	3.55e-05	0.1820	-4.38e-02	4.45e-03	4.96e-02	1.13e-01	2.64e-02	1.24e-01	1.64e-01	8.88e-01	1.15e-01	3.33e-04	4.03e-01	8.08e-05
GOBP REGULATION OF INTRINSIC APOPTOTIC SIGNALING PATHWAY IN RESPONSE TO DNA DAMAGE	35	4.53e-01	5.59e-01	0.1820	-9.45e-02	-1.43e-01	4.00e-03	3.70e-02	1.91e-02	-4.30e-02	3.33e-01	1.42e-01	9.67e-01	7.05e-01	8.45e-01	6.60e-01
GOBP CELLULAR RESPONSE TO REACTIVE OXYGEN SPECIES	129	3.13e-02	8.24e-02	0.1820	-1.48e-01	-9.08e-02	3.14e-03	2.31e-02	-1.13e-02	4.66e-02	3.65e-03	7.50e-02	9.51e-01	6.51e-01	8.25e-01	3.61e-01
GOBP REGULATION OF GLUCONEOGENESIS	44	2.06e-01	3.23e-01	0.1820	-1.30e-01	4.96e-02	2.40e-02	1.01e-01	5.18e-02	3.69e-03	1.35e-01	5.69e-01	7.83e-01	2.44e-01	5.52e-01	9.66e-01
GOBP POSITIVE REGULATION OF ERK1 AND ERK2 CASCADE	125	2.70e-03	1.19e-02	0.1820	-9.84e-02	-9.72e-03	1.29e-01	4.45e-02	1.40e-02	6.68e-02	5.74e-02	8.51e-01	1.30e-02	3.90e-01	7.87e-01	1.97e-01
GOBP POSITIVE REGULATION OF SYNAPTIC TRANSMISSION	106	1.84e-01	2.98e-01	0.1820	-2.91e-02	6.01e-02	1.19e-01	3.71e-02	3.84e-02	1.08e-01	6.04e-01	2.85e-01	3.49e-02	5.09e-01	4.95e-01	5.55e-02
GOBP EAR DEVELOPMENT	127	1.03e-01	1.99e-01	0.1820	-2.48e-03	1.28e-01	2.15e-02	5.84e-02	1.12e-01	-1.39e-03	9.61e-01	1.25e-02	6.75e-01	2.56e-01	2.90e-02	9.78e-01
GOBP REGULATION OF SYNAPSE STRUCTURE OR ACTIVITY	179	2.00e-04	1.25e-03	0.1810	-8.36e-02	1.19e-01	9.66e-02	1.18e-02	-3.71e-02	3.00e-02	5.36e-02	6.12e-03	2.58e-02	7.85e-01	3.91e-01	4.88e-01
GOBP CYTOPLASMIC SEQUESTERING OF NF KAPPAB	6	9.94e-01	9.95e-01	0.1810	-1.72e-02	-1.04e-01	9.77e-02	3.37e-02	-1.04e-01	1.75e-02	9.42e-01	6.60e-01	6.78e-01	8.86e-01	6.60e-01	9.41e-01
GOMF REGULATORY RNA BINDING	46	5.82e-01	6.67e-01	0.1810	-1.41e-01	1.40e-02	3.92e-02	-2.50e-02	-5.40e-02	8.85e-02	9.92e-02	8.69e-01	6.45e-01	7.69e-01	5.27e-01	2.99e-01
GOBP EPITHELIAL CELL DIFFERENTIATION	455	3.13e-11	5.95e-10	0.1810	-7.27e-02	4.31e-02	1.44e-01	3.10e-02	5.91e-03	6.26e-02	7.93e-03	1.15e-01	1.35e-07	2.57e-01	8.29e-01	2.23e-02
GOBP NEGATIVE REGULATION OF GROWTH	175	6.20e-04	3.37e-03	0.1810	-3.19e-02	1.09e-02	1.32e-01	8.91e-02	-6.34e-02	4.73e-02	4.67e-01	8.04e-01	2.56e-03	4.20e-02	1.48e-01	2.80e-01
GOCC MICROTUBULE ORGANIZING CENTER	795	1.00e-15	2.83e-14	0.1810	-6.10e-02	-1.21e-02	-2.04e-02	1.17e-01	1.05e-01	6.28e-02	3.46e-03	5.61e-01	3.27e-01	2.35e-08	5.11e-07	2.61e-03
GOBP SNRNA TRANSCRIPTION	19	9.28e-01	9.40e-01	0.1810	7.11e-02	1.51e-02	6.64e-02	4.79e-02	1.11e-01	9.23e-02	5.92e-01	9.09e-01	6.17e-01	7.17e-01	4.03e-01	4.86e-01
GOBP POSITIVE REGULATION OF RNA SPLICING	41	2.68e-01	3.87e-01	0.1810	-1.21e-01	-2.76e-02	-3.92e-02	1.13e-01	-5.32e-02	-1.06e-02	1.79e-01	7.60e-01	6.64e-01	2.10e-01	5.56e-01	9.07e-01
GOBP POSITIVE REGULATION OF PROTEIN DEACETYLATION	7	9.71e-01	9.75e-01	0.1810	-1.32e-01	-6.46e-02	9.26e-02	1.64e-02	-4.59e-02	-1.34e-02	5.45e-01	7.67e-01	6.72e-01	9.40e-01	8.33e-01	9.51e-01
GOMF CALCIUM ION TRANSMEMBRANE TRANSPORTER ACTIVITY	104	5.67e-02	1.29e-01	0.1810	-3.25e-03	1.25e-01	1.28e-01	1.48e-02	-2.20e-02	-9.87e-03	9.54e-01	2.78e-02	2.45e-02	7.95e-01	6.99e-01	8.62e-01
GOBP POSITIVE REGULATION OF PHOSPHORUS METABOLIC PROCESS	523	7.90e-10	1.29e-08	0.1810	-8.02e-02	1.37e-02	1.18e-01	3.98e-02	-1.95e-02	1.01e-01	1.70e-03	5.92e-01	3.88e-06	1.19e-01	4.45e-01	8.21e-05
GOBP POSITIVE REGULATION OF NF KAPPAB TRANSCRIPTION FACTOR ACTIVITY	117	9.98e-02	1.95e-01	0.1810	-6.84e-02	8.48e-02	9.44e-02	5.37e-03	1.80e-03	1.09e-01	2.01e-01	1.13e-01	7.78e-02	9.20e-01	9.73e-01	4.21e-02
GOBP REGULATION OF INTRACELLULAR SIGNAL TRANSDUCTION	1485	1.04e-31	1.10e-29	0.1810	-4.52e-02	4.66e-02	1.10e-01	9.61e-02	1.13e-02	8.32e-02	3.66e-03	2.73e-03	1.42e-12	6.09e-10	4.68e-01	8.56e-08
GOBP STEROID HORMONE MEDIATED SIGNALING PATHWAY	113	8.70e-03	3.08e-02	0.1810	-1.06e-01	-2.77e-02	4.18e-02	1.18e-01	-1.45e-02	6.98e-02	5.24e-02	6.11e-01	4.43e-01	3.08e-02	7.90e-01	2.00e-01
GOBP POSITIVE REGULATION OF RNA METABOLIC PROCESS	1456	9.25e-43	1.75e-40	0.1800	-5.02e-02	4.45e-02	4.51e-02	1.56e-01	3.78e-02	2.02e-02	1.38e-03	4.59e-03	4.01e-03	3.18e-23	1.59e-02	1.97e-01
GOBP MONOATOMIC ANION TRANSPORT	114	1.62e-01	2.74e-01	0.1800	5.34e-02	8.43e-02	1.45e-01	-2.71e-02	-7.85e-03	2.65e-02	3.25e-01	1.20e-01	7.38e-03	6.17e-01	8.85e-01	6.25e-01
GOBP INORGANIC ANION TRANSPORT	111	1.31e-01	2.37e-01	0.1800	7.96e-02	1.14e-01	1.03e-01	1.84e-02	2.16e-03	-4.84e-02	1.48e-01	3.83e-02	6.16e-02	7.37e-01	9.69e-01	3.79e-01
GOBP PHOSPHOLIPID METABOLIC PROCESS	326	1.58e-09	2.42e-08	0.1800	-1.61e-01	-2.81e-02	1.43e-02	5.84e-02	4.10e-02	2.16e-02	5.76e-07	3.84e-01	6.56e-01	6.99e-02	2.03e-01	5.02e-01
GOBP DNA DAMAGE RESPONSE SIGNAL TRANSDUCTION BY P53 CLASS MEDIATOR	67	1.43e-01	2.53e-01	0.1800	-1.01e-01	-6.33e-02	5.50e-02	9.11e-02	3.54e-02	7.55e-02	1.53e-01	3.71e-01	4.36e-01	1.97e-01	6.17e-01	2.85e-01
GOBP UNSATURATED FATTY ACID METABOLIC PROCESS	82	7.64e-03	2.78e-02	0.1800	-8.57e-02	-1.22e-01	2.42e-02	-5.70e-02	7.66e-02	-2.19e-02	1.80e-01	5.57e-02	7.05e-01	3.72e-01	2.31e-01	7.31e-01
GOBP REGULATION OF CILIUM ASSEMBLY	89	2.15e-01	3.33e-01	0.1800	-2.25e-03	6.02e-02	5.35e-02	1.28e-01	3.32e-02	9.19e-02	9.71e-01	3.26e-01	3.83e-01	3.67e-02	5.88e-01	1.34e-01
GOBP HORMONE BIOSYNTHETIC PROCESS	44	7.22e-01	7.79e-01	0.1800	2.75e-02	4.87e-02	1.50e-01	-3.53e-04	-7.58e-02	3.19e-02	7.52e-01	5.76e-01	8.48e-02	9.97e-01	3.84e-01	7.15e-01
GOBP POSITIVE REGULATION OF BONE RESORPTION	13	9.67e-01	9.73e-01	0.1800	-6.09e-03	-8.00e-03	5.26e-02	1.55e-02	-1.15e-01	1.27e-01	9.70e-01	9.60e-01	7.43e-01	9.23e-01	4.73e-01	4.29e-01
GOCC CELL SURFACE	652	4.74e-08	6.04e-07	0.1800	-3.05e-02	3.61e-02	1.37e-01	-8.81e-03	-3.22e-02	1.01e-01	1.84e-01	1.16e-01	2.23e-09	7.01e-01	1.61e-01	1.13e-05
GOBP ADIPOSE TISSUE DEVELOPMENT	55	2.93e-01	4.13e-01	0.1800	-9.74e-02	6.96e-02	1.21e-01	2.27e-03	1.51e-02	5.52e-02	2.11e-01	3.72e-01	1.19e-01	9.77e-01	8.47e-01	4.79e-01
GOBP PROTEIN LOCALIZATION TO EXTRACELLULAR REGION	280	2.42e-07	2.79e-06	0.1800	-9.66e-02	-1.00e-02	1.26e-01	5.10e-02	-9.57e-03	6.63e-02	5.41e-03	7.73e-01	2.94e-04	1.42e-01	7.83e-01	5.62e-02
GOBP NEUROMUSCULAR PROCESS CONTROLLING POSTURE	12	9.88e-01	9.89e-01	0.1800	-6.56e-02	-5.58e-02	-1.11e-01	7.23e-02	4.46e-02	-7.38e-02	6.94e-01	7.38e-01	5.07e-01	6.65e-01	7.89e-01	6.58e-01
GOBP NEGATIVE REGULATION OF INTRACELLULAR SIGNAL TRANSDUCTION	485	2.31e-12	5.00e-11	0.1800	-5.48e-02	5.83e-02	1.21e-01	9.09e-02	-2.27e-03	5.38e-02	3.88e-02	2.79e-02	4.73e-06	6.11e-04	9.32e-01	4.26e-02
GOBP PROSTATE GLAND DEVELOPMENT	30	7.55e-01	8.04e-01	0.1800	2.96e-03	-4.35e-02	3.65e-02	1.21e-01	1.02e-01	6.23e-02	9.78e-01	6.80e-01	7.29e-01	2.51e-01	3.32e-01	5.55e-01
GOMF TRANSCRIPTION FACTOR BINDING	513	7.96e-16	2.29e-14	0.1800	-4.60e-02	-1.36e-02	5.76e-02	1.62e-01	9.85e-03	1.60e-02	7.44e-02	5.99e-01	2.57e-02	3.32e-10	7.03e-01	5.35e-01
GOBP POSITIVE REGULATION OF SIGNALING	1386	1.28e-28	1.11e-26	0.1790	-5.91e-02	5.93e-02	9.87e-02	8.07e-02	3.24e-02	8.88e-02	2.32e-04	2.17e-04	7.62e-10	4.86e-07	4.32e-02	3.05e-08
GOBP REGULATION OF STRIATED MUSCLE CELL DIFFERENTIATION	58	1.39e-01	2.48e-01	0.1790	2.94e-02	-6.05e-03	5.30e-02	1.41e-01	-1.62e-02	-9.07e-02	6.98e-01	9.36e-01	4.85e-01	6.37e-02	8.31e-01	2.32e-01
GOBP REGULATION OF CELLULAR LOCALIZATION	806	3.19e-18	1.15e-16	0.1790	-1.05e-01	-4.70e-02	5.81e-02	7.62e-02	-4.52e-02	8.64e-02	3.68e-07	2.35e-02	5.11e-03	2.36e-04	2.92e-02	3.10e-05
GOBP TISSUE MIGRATION	247	9.49e-08	1.17e-06	0.1790	-6.66e-02	5.73e-02	1.55e-01	-9.27e-03	8.93e-03	-3.37e-04	7.16e-02	1.21e-01	2.64e-05	8.02e-01	8.09e-01	9.93e-01
GOBP BEHAVIOR	431	1.42e-07	1.69e-06	0.1790	-1.02e-01	5.21e-02	9.86e-02	-1.59e-03	-1.33e-02	9.49e-02	2.93e-04	6.35e-02	4.50e-04	9.55e-01	6.37e-01	7.30e-04
GOBP INTRINSIC APOPTOTIC SIGNALING PATHWAY BY P53 CLASS MEDIATOR	76	2.20e-01	3.38e-01	0.1790	-2.39e-02	-1.35e-01	-4.63e-02	9.29e-02	2.27e-02	-4.27e-02	7.19e-01	4.15e-02	4.86e-01	1.62e-01	7.33e-01	5.20e-01
GOBP REGULATION OF RNA SPLICING	167	2.91e-04	1.75e-03	0.1790	-1.06e-01	-5.40e-02	-6.50e-02	9.33e-02	-6.70e-02	1.75e-02	1.79e-02	2.29e-01	1.47e-01	3.75e-02	1.35e-01	6.97e-01
GOBP CEREBRAL CORTEX DEVELOPMENT	98	1.03e-01	1.99e-01	0.1790	-1.02e-01	5.55e-02	9.48e-02	1.51e-02	-1.92e-02	9.38e-02	8.02e-02	3.43e-01	1.05e-01	7.97e-01	7.42e-01	1.09e-01
GOMF ADENYL NUCLEOTIDE BINDING	1424	1.20e-35	1.63e-33	0.1790	-5.72e-02	-1.20e-02	6.06e-02	1.39e-01	1.21e-02	7.29e-02	3.05e-04	4.49e-01	1.31e-04	1.56e-18	4.47e-01	4.18e-06
GOBP CELLULAR KETONE METABOLIC PROCESS	161	2.03e-02	5.98e-02	0.1790	-6.07e-02	-8.43e-02	-7.45e-02	8.93e-02	8.49e-02	-1.92e-02	1.84e-01	6.49e-02	1.03e-01	5.05e-02	6.32e-02	6.74e-01
GOBP CILIUM ORGANIZATION	368	2.18e-05	1.71e-04	0.1780	-3.78e-02	6.05e-02	-6.01e-02	3.56e-02	1.48e-01	5.00e-03	2.13e-01	4.62e-02	4.78e-02	2.41e-01	1.11e-06	8.69e-01
GOBP CELL MOTILITY	1276	8.41e-30	7.91e-28	0.1780	-5.50e-02	5.57e-02	1.45e-01	3.86e-02	-2.46e-02	5.12e-02	9.76e-04	8.38e-04	3.73e-18	2.07e-02	1.40e-01	2.14e-03
GOBP MONOATOMIC CATION TRANSMEMBRANE TRANSPORT	600	9.12e-11	1.66e-09	0.1780	-1.52e-02	-4.09e-02	1.38e-01	2.42e-02	-8.67e-02	5.12e-02	5.25e-01	8.74e-02	7.44e-09	3.12e-01	2.86e-04	3.21e-02
GOBP REGULATION OF LYMPHOCYTE ACTIVATION	442	4.51e-06	4.13e-05	0.1780	1.25e-02	6.80e-02	8.89e-02	1.13e-01	3.62e-02	7.05e-02	6.52e-01	1.43e-02	1.35e-03	4.70e-05	1.92e-01	1.11e-02
GOBP REGULATION OF PHOSPHORYLATION	760	8.13e-16	2.33e-14	0.1780	-7.90e-02	-1.12e-02	1.12e-01	5.92e-02	-2.24e-02	9.36e-02	2.12e-04	5.99e-01	1.44e-07	5.54e-03	2.94e-01	1.14e-05
GOMF PHOSPHATIDYLINOSITOL BISPHOSPHATE BINDING	85	1.72e-01	2.86e-01	0.1780	-9.14e-03	-1.07e-02	1.25e-01	9.55e-02	-3.97e-02	7.27e-02	8.84e-01	8.65e-01	4.72e-02	1.28e-01	5.27e-01	2.47e-01
GOBP IRON ION TRANSPORT	49	7.39e-01	7.91e-01	0.1780	7.82e-02	7.86e-02	1.04e-01	8.21e-02	-3.09e-02	3.02e-02	3.44e-01	3.41e-01	2.09e-01	3.20e-01	7.08e-01	7.14e-01
GOMF TRANSFERASE ACTIVITY TRANSFERRING PHOSPHORUS CONTAINING GROUPS	801	3.37e-21	1.59e-19	0.1780	-7.36e-02	2.89e-02	5.66e-02	1.29e-01	1.64e-02	7.25e-02	4.01e-04	1.65e-01	6.50e-03	5.29e-10	4.32e-01	4.89e-04
GOBP MONOSACCHARIDE CATABOLIC PROCESS	42	3.10e-01	4.31e-01	0.1780	-4.44e-02	-6.51e-02	9.24e-02	1.25e-01	-2.72e-02	2.04e-02	6.18e-01	4.66e-01	3.00e-01	1.60e-01	7.61e-01	8.19e-01
GOBP ALCOHOL METABOLIC PROCESS	281	4.91e-06	4.46e-05	0.1780	-9.49e-02	-1.08e-01	3.25e-02	7.72e-02	2.99e-03	6.22e-02	6.22e-03	1.80e-03	3.49e-01	2.60e-02	9.31e-01	7.27e-02
GOBP SULFUR COMPOUND TRANSPORT	47	4.02e-01	5.14e-01	0.1780	2.42e-02	-5.64e-02	1.28e-02	1.60e-01	-2.82e-02	-3.40e-02	7.74e-01	5.04e-01	8.80e-01	5.72e-02	7.38e-01	6.87e-01
GOMF HYDROLASE ACTIVITY HYDROLYZING N GLYCOSYL COMPOUNDS	36	7.01e-01	7.62e-01	0.1780	-6.41e-02	-6.69e-02	-9.09e-02	9.42e-02	4.69e-02	6.06e-02	5.05e-01	4.87e-01	3.45e-01	3.28e-01	6.27e-01	5.29e-01
GOCC CLATHRIN COATED ENDOCYTIC VESICLE	69	5.29e-02	1.22e-01	0.1780	-9.16e-02	-5.86e-02	-1.21e-02	5.37e-02	7.14e-02	-1.08e-01	1.89e-01	4.00e-01	8.62e-01	4.40e-01	3.05e-01	1.22e-01
GOBP RNA DECAPPING	19	9.37e-01	9.47e-01	0.1780	-7.95e-02	-9.43e-02	-4.77e-02	2.40e-02	-1.16e-01	2.40e-03	5.49e-01	4.77e-01	7.19e-01	8.56e-01	3.81e-01	9.86e-01
GOBP POSITIVE REGULATION OF MULTICELLULAR ORGANISMAL PROCESS	1273	7.29e-26	5.16e-24	0.1770	-4.43e-02	7.23e-02	1.19e-01	7.07e-02	3.33e-03	7.12e-02	7.94e-03	1.48e-05	8.96e-13	2.28e-05	8.42e-01	1.99e-05
GOBP ADULT BEHAVIOR	95	1.29e-01	2.35e-01	0.1770	-4.19e-03	9.65e-02	1.17e-01	8.42e-02	9.61e-03	3.59e-02	9.44e-01	1.04e-01	4.87e-02	1.56e-01	8.71e-01	5.46e-01
GOBP NEGATIVE REGULATION OF LIPOPOLYSACCHARIDE MEDIATED SIGNALING PATHWAY	10	9.14e-01	9.29e-01	0.1770	-7.33e-02	-1.03e-02	1.58e-01	-1.36e-02	2.25e-02	1.99e-02	6.88e-01	9.55e-01	3.88e-01	9.41e-01	9.02e-01	9.13e-01
GOBP REACTIVE OXYGEN SPECIES METABOLIC PROCESS	191	6.28e-03	2.36e-02	0.1770	-7.49e-02	-7.53e-02	9.13e-02	-1.11e-03	-1.87e-02	1.07e-01	7.42e-02	7.28e-02	2.96e-02	9.79e-01	6.56e-01	1.06e-02
GOBP BIOGENIC AMINE METABOLIC PROCESS	70	1.86e-01	3.02e-01	0.1770	-1.24e-01	-7.18e-02	-3.96e-02	-1.21e-04	9.39e-02	-2.09e-02	7.19e-02	2.99e-01	5.66e-01	9.99e-01	1.75e-01	7.62e-01
GOBP RESPONSE TO ALCOHOL	191	5.20e-06	4.71e-05	0.1770	-7.68e-02	1.73e-03	1.30e-01	8.30e-02	1.71e-02	3.65e-02	6.71e-02	9.67e-01	1.90e-03	4.78e-02	6.83e-01	3.84e-01
GOBP NOTCH SIGNALING PATHWAY	128	2.71e-04	1.64e-03	0.1770	-7.68e-02	2.82e-02	6.25e-02	9.01e-02	1.07e-01	-3.49e-02	1.33e-01	5.81e-01	2.22e-01	7.83e-02	3.65e-02	4.95e-01
GOBP REGULATION OF EMBRYONIC DEVELOPMENT	78	3.04e-02	8.08e-02	0.1770	-1.25e-01	-2.02e-02	-2.56e-02	7.72e-02	-2.57e-02	-9.06e-02	5.72e-02	7.57e-01	6.96e-01	2.39e-01	6.95e-01	1.67e-01
GOMF PEPTIDE HORMONE BINDING	26	9.07e-01	9.23e-01	0.1770	-6.18e-02	3.00e-02	6.51e-02	-8.02e-02	-1.26e-01	1.58e-03	5.85e-01	7.91e-01	5.66e-01	4.79e-01	2.67e-01	9.89e-01
GOBP POSITIVE REGULATION OF PROTEIN MODIFICATION PROCESS	594	5.36e-12	1.11e-10	0.1770	-9.79e-02	-2.65e-02	8.64e-02	5.81e-02	-3.74e-02	9.33e-02	4.63e-05	2.70e-01	3.26e-04	1.56e-02	1.20e-01	1.02e-04
GOBP POSITIVE REGULATION OF NUCLEOCYTOPLASMIC TRANSPORT	57	4.46e-02	1.08e-01	0.1770	-1.50e-01	-1.77e-02	5.80e-02	4.61e-02	3.96e-02	-3.77e-02	5.05e-02	8.17e-01	4.49e-01	5.47e-01	6.06e-01	6.22e-01
GOMF LIGASE ACTIVITY FORMING CARBON SULFUR BONDS	37	6.77e-01	7.43e-01	0.1770	-9.40e-02	-1.85e-02	2.90e-02	-2.21e-03	7.72e-02	1.23e-01	3.22e-01	8.46e-01	7.60e-01	9.81e-01	4.17e-01	1.95e-01
GOBP REGULATION OF APOPTOTIC SIGNALING PATHWAY	322	1.58e-06	1.60e-05	0.1770	-1.25e-01	-9.77e-02	4.99e-02	2.33e-02	-2.37e-02	4.90e-02	1.15e-04	2.58e-03	1.24e-01	4.73e-01	4.64e-01	1.31e-01
GOBP TYPE II INTERFERON PRODUCTION	105	8.91e-02	1.80e-01	0.1770	3.08e-03	6.07e-02	1.26e-01	9.24e-02	-3.01e-02	4.63e-02	9.56e-01	2.83e-01	2.57e-02	1.02e-01	5.94e-01	4.13e-01
GOBP CALCIUM ION TRANSPORT	313	2.57e-05	1.99e-04	0.1760	-3.88e-02	-1.89e-02	1.41e-01	1.82e-02	-7.59e-02	5.56e-02	2.38e-01	5.66e-01	1.74e-05	5.81e-01	2.09e-02	9.06e-02
GOCC MICROTUBULE CYTOSKELETON	1233	4.83e-25	3.07e-23	0.1760	-6.28e-02	-3.85e-02	-5.51e-03	1.25e-01	6.44e-02	7.62e-02	2.13e-04	2.32e-02	7.45e-01	1.71e-13	1.43e-04	6.91e-06
GOBP COLLAGEN CATABOLIC PROCESS	31	4.81e-01	5.82e-01	0.1760	2.78e-03	-1.20e-03	1.29e-01	1.70e-02	-8.57e-02	-8.19e-02	9.79e-01	9.91e-01	2.14e-01	8.70e-01	4.09e-01	4.30e-01
GOBP RESPONSE TO VITAMIN	60	1.13e-01	2.13e-01	0.1760	-6.76e-02	6.95e-02	1.38e-01	-1.64e-02	4.87e-02	1.84e-03	3.65e-01	3.52e-01	6.53e-02	8.26e-01	5.14e-01	9.80e-01
GOBP REGULATION OF DEFENSE RESPONSE TO VIRUS	57	3.77e-01	4.92e-01	0.1760	-7.63e-02	-3.87e-03	-2.29e-02	1.17e-01	7.08e-02	7.69e-02	3.19e-01	9.60e-01	7.65e-01	1.27e-01	3.55e-01	3.15e-01
GOMF PHOSPHATIDYLINOSITOL 4 5 BISPHOSPHATE BINDING	67	4.71e-01	5.73e-01	0.1760	-1.73e-02	5.65e-03	1.18e-01	7.47e-02	-1.75e-02	1.04e-01	8.07e-01	9.36e-01	9.39e-02	2.90e-01	8.05e-01	1.43e-01
GOBP MYELOID DENDRITIC CELL CYTOKINE PRODUCTION	6	9.95e-01	9.95e-01	0.1760	-9.75e-02	-3.55e-02	4.39e-02	8.50e-02	-1.64e-02	1.03e-01	6.79e-01	8.80e-01	8.52e-01	7.19e-01	9.45e-01	6.61e-01
GOCC MOTILE CILIUM	181	3.05e-03	1.31e-02	0.1760	1.60e-02	5.54e-02	-8.35e-02	-5.62e-02	1.30e-01	-2.13e-02	7.11e-01	1.99e-01	5.27e-02	1.92e-01	2.53e-03	6.22e-01
GOCC NEUROMUSCULAR JUNCTION	58	2.65e-01	3.85e-01	0.1760	-5.88e-02	5.49e-02	1.43e-01	2.19e-02	-5.12e-02	2.59e-02	4.38e-01	4.70e-01	5.89e-02	7.73e-01	5.00e-01	7.33e-01
GOBP POSITIVE REGULATION OF GROWTH	183	1.58e-05	1.27e-04	0.1750	-5.76e-02	6.15e-02	8.95e-02	1.25e-01	-4.06e-03	7.66e-03	1.79e-01	1.51e-01	3.68e-02	3.57e-03	9.25e-01	8.58e-01
GOCC NUCLEAR MEMBRANE	282	2.00e-06	1.98e-05	0.1750	-1.15e-01	-3.10e-02	2.14e-02	9.98e-02	8.43e-03	7.85e-02	9.18e-04	3.71e-01	5.36e-01	3.93e-03	8.08e-01	2.33e-02
GOBP NEGATIVE REGULATION OF CATALYTIC ACTIVITY	336	2.02e-06	2.00e-05	0.1750	-9.47e-02	2.20e-03	9.64e-02	5.29e-02	-4.77e-03	9.85e-02	2.87e-03	9.45e-01	2.40e-03	9.59e-02	8.81e-01	1.92e-03
GOBP POSITIVE REGULATION OF ENDOTHELIAL CELL MIGRATION	88	5.13e-03	2.00e-02	0.1750	-1.14e-01	-8.00e-02	1.01e-01	-5.80e-03	-1.61e-02	-2.95e-02	6.47e-02	1.94e-01	1.01e-01	9.25e-01	7.94e-01	6.32e-01
GOBP PURINE NUCLEOSIDE METABOLIC PROCESS	26	8.56e-01	8.84e-01	0.1750	-8.51e-02	-8.32e-02	-6.46e-02	-6.92e-02	1.53e-02	8.60e-02	4.52e-01	4.63e-01	5.69e-01	5.41e-01	8.92e-01	4.48e-01
GOBP INORGANIC ION HOMEOSTASIS	386	5.33e-08	6.74e-07	0.1750	-5.75e-02	-3.66e-02	1.22e-01	6.43e-02	-3.72e-02	7.50e-02	5.24e-02	2.17e-01	3.80e-05	3.01e-02	2.10e-01	1.14e-02
GOBP NEUROGENESIS	1236	1.80e-28	1.50e-26	0.1750	-5.90e-02	7.88e-02	1.15e-01	6.66e-02	6.73e-03	5.70e-02	4.95e-04	3.18e-06	9.51e-12	8.26e-05	6.91e-01	7.57e-04
GOMF XENOBIOTIC TRANSMEMBRANE TRANSPORTER ACTIVITY	24	5.33e-01	6.25e-01	0.1750	-1.34e-02	3.31e-02	8.63e-02	1.04e-01	3.88e-02	-9.79e-02	9.09e-01	7.79e-01	4.64e-01	3.76e-01	7.42e-01	4.06e-01
GOBP ERK1 AND ERK2 CASCADE	220	5.95e-06	5.33e-05	0.1750	-9.90e-02	-6.15e-03	1.20e-01	5.02e-02	1.85e-02	5.98e-02	1.14e-02	8.75e-01	2.15e-03	1.99e-01	6.36e-01	1.26e-01
GOBP MAPK CASCADE	573	3.05e-11	5.81e-10	0.1750	-6.24e-02	6.10e-02	1.23e-01	4.65e-02	7.28e-03	7.51e-02	1.08e-02	1.27e-02	4.58e-07	5.72e-02	7.66e-01	2.15e-03
GOBP MULTICELLULAR ORGANISMAL LEVEL CHEMICAL HOMEOSTASIS	55	3.32e-01	4.49e-01	0.1750	-5.00e-02	1.02e-01	-2.27e-02	6.24e-02	7.16e-02	-9.00e-02	5.21e-01	1.89e-01	7.71e-01	4.23e-01	3.59e-01	2.48e-01
GOBP NEGATIVE REGULATION OF NEURAL PRECURSOR CELL PROLIFERATION	19	9.57e-01	9.64e-01	0.1750	-1.35e-02	4.55e-02	1.64e-02	1.17e-01	1.02e-01	6.27e-02	9.19e-01	7.31e-01	9.02e-01	3.79e-01	4.39e-01	6.36e-01
GOBP POSITIVE REGULATION OF CATABOLIC PROCESS	476	2.25e-14	5.73e-13	0.1750	-1.09e-01	-3.16e-02	6.08e-02	9.94e-02	-5.46e-02	3.50e-02	5.00e-05	2.39e-01	2.32e-02	2.04e-04	4.14e-02	1.91e-01
GOBP NUCLEAR TRANSCRIBED MRNA CATABOLIC PROCESS	121	2.76e-02	7.54e-02	0.1750	-9.52e-02	-4.90e-02	-7.55e-02	1.07e-01	2.09e-02	3.65e-02	7.05e-02	3.52e-01	1.51e-01	4.11e-02	6.91e-01	4.88e-01
GOBP MONOATOMIC ION TRANSMEMBRANE TRANSPORT	706	5.31e-11	9.85e-10	0.1750	1.42e-03	-1.69e-02	1.44e-01	2.28e-02	-7.55e-02	5.74e-02	9.49e-01	4.44e-01	7.60e-11	3.03e-01	6.31e-04	9.42e-03
GOCC EXOCYTIC VESICLE	172	8.59e-03	3.05e-02	0.1750	-9.26e-02	-2.61e-02	6.84e-02	6.16e-02	-1.96e-02	1.11e-01	3.62e-02	5.54e-01	1.22e-01	1.64e-01	6.57e-01	1.19e-02
GOBP GLUTAMINE FAMILY AMINO ACID METABOLIC PROCESS	58	4.59e-01	5.64e-01	0.1750	-8.79e-02	-6.00e-02	9.98e-03	6.12e-02	2.30e-02	1.21e-01	2.47e-01	4.29e-01	8.95e-01	4.20e-01	7.61e-01	1.10e-01
GOBP ICOSANOID METABOLIC PROCESS	84	5.81e-02	1.32e-01	0.1740	-1.03e-01	-9.79e-02	4.04e-02	-8.82e-02	1.17e-02	-2.27e-02	1.02e-01	1.21e-01	5.22e-01	1.62e-01	8.53e-01	7.19e-01
GOBP POSITIVE REGULATION OF TYPE 2 IMMUNE RESPONSE	17	9.13e-01	9.28e-01	0.1740	-9.84e-02	1.16e-01	8.80e-03	-3.26e-02	7.58e-02	-1.32e-02	4.82e-01	4.06e-01	9.50e-01	8.16e-01	5.89e-01	9.25e-01
GOBP GROWTH	688	2.84e-17	9.33e-16	0.1740	-5.25e-02	4.48e-02	1.03e-01	1.03e-01	-2.97e-02	5.66e-02	1.90e-02	4.55e-02	4.03e-06	3.80e-06	1.84e-01	1.15e-02
GOBP MICROTUBULE BUNDLE FORMATION	90	4.41e-01	5.48e-01	0.1740	6.30e-02	1.07e-01	7.98e-02	3.86e-02	8.27e-02	-2.78e-03	3.01e-01	7.94e-02	1.91e-01	5.27e-01	1.75e-01	9.64e-01
GOBP REGULATION OF CELL GROWTH	318	1.41e-09	2.19e-08	0.1730	-3.66e-02	2.86e-02	9.00e-02	1.35e-01	-3.91e-02	8.74e-03	2.63e-01	3.80e-01	5.81e-03	3.50e-05	2.31e-01	7.89e-01
GOBP GLUCOSE METABOLIC PROCESS	161	1.44e-04	9.38e-04	0.1730	-1.16e-01	-4.36e-02	1.61e-02	1.05e-01	5.88e-02	-5.57e-03	1.13e-02	3.40e-01	7.24e-01	2.16e-02	1.98e-01	9.03e-01
GOBP STORE OPERATED CALCIUM ENTRY	19	7.68e-01	8.14e-01	0.1730	4.52e-03	8.94e-02	5.21e-02	8.17e-02	-1.11e-01	1.75e-02	9.73e-01	5.00e-01	6.94e-01	5.38e-01	4.01e-01	8.95e-01
GOBP CARDIAC CHAMBER DEVELOPMENT	104	2.62e-02	7.26e-02	0.1730	-6.60e-02	8.95e-02	9.25e-02	8.34e-02	3.04e-02	3.54e-02	2.45e-01	1.15e-01	1.03e-01	1.42e-01	5.92e-01	5.32e-01
GOBP REGULATION OF CELL ACTIVATION	542	1.34e-07	1.61e-06	0.1730	8.43e-04	4.61e-02	1.21e-01	8.30e-02	9.73e-03	7.90e-02	9.73e-01	6.67e-02	1.44e-06	9.52e-04	6.99e-01	1.67e-03
GOBP RESPONSE TO UV	141	1.41e-02	4.51e-02	0.1730	-6.25e-02	-8.48e-02	-5.01e-02	1.25e-01	-1.56e-03	-2.61e-02	2.00e-01	8.21e-02	3.05e-01	1.02e-02	9.74e-01	5.93e-01
GOCC COLLAGEN CONTAINING EXTRACELLULAR MATRIX	263	6.70e-07	7.28e-06	0.1730	-3.79e-02	-4.33e-02	1.46e-01	-5.26e-02	-4.98e-02	-2.06e-03	2.91e-01	2.27e-01	4.44e-05	1.42e-01	1.64e-01	9.54e-01
GOBP CELLULAR RESPONSE TO ORGANIC CYCLIC COMPOUND	414	1.52e-09	2.34e-08	0.1730	-1.17e-01	3.46e-03	8.44e-02	5.63e-02	-1.23e-02	7.69e-02	4.74e-05	9.04e-01	3.24e-03	4.97e-02	6.68e-01	7.26e-03
GOBP POSITIVE REGULATION OF APOPTOTIC SIGNALING PATHWAY	119	4.11e-02	1.02e-01	0.1730	-1.23e-01	-9.36e-02	2.26e-02	4.27e-02	6.27e-03	6.03e-02	2.04e-02	7.77e-02	6.70e-01	4.21e-01	9.06e-01	2.56e-01
GOBP NEGATIVE REGULATION OF TRANSFERASE ACTIVITY	177	3.85e-03	1.58e-02	0.1730	-4.84e-02	-3.15e-02	1.13e-01	6.46e-02	1.37e-02	9.72e-02	2.67e-01	4.70e-01	9.49e-03	1.38e-01	7.53e-01	2.57e-02
GOBP MONOCARBOXYLIC ACID METABOLIC PROCESS	492	1.36e-08	1.88e-07	0.1730	-1.17e-01	-1.18e-01	-9.84e-03	1.77e-02	1.77e-02	3.82e-02	8.44e-06	7.47e-06	7.09e-01	5.01e-01	5.02e-01	1.47e-01
GOBP EPITHELIAL CELL PROLIFERATION	307	1.42e-06	1.45e-05	0.1730	-7.17e-02	4.97e-02	1.39e-01	-3.47e-02	-3.80e-02	1.31e-02	3.07e-02	1.34e-01	2.76e-05	2.95e-01	2.52e-01	6.94e-01
GOBP NEUTRAL AMINO ACID TRANSPORT	40	6.60e-01	7.30e-01	0.1730	-5.07e-03	-4.93e-02	3.56e-02	3.74e-02	-1.41e-01	6.85e-02	9.56e-01	5.90e-01	6.97e-01	6.82e-01	1.22e-01	4.54e-01
GOBP POSITIVE REGULATION OF TOR SIGNALING	68	2.27e-01	3.46e-01	0.1730	-2.90e-03	2.16e-02	9.39e-02	1.38e-01	-8.77e-03	3.65e-02	9.67e-01	7.58e-01	1.81e-01	4.90e-02	9.00e-01	6.03e-01
GOBP EXTRINSIC APOPTOTIC SIGNALING PATHWAY VIA DEATH DOMAIN RECEPTORS	71	8.32e-02	1.71e-01	0.1720	-1.55e-01	-2.45e-02	5.57e-02	-2.74e-02	-1.46e-02	-3.43e-02	2.43e-02	7.21e-01	4.17e-01	6.90e-01	8.32e-01	6.18e-01
GOMF G PROTEIN COUPLED RECEPTOR BINDING	166	9.81e-03	3.38e-02	0.1720	1.54e-02	9.08e-02	1.37e-01	2.54e-02	4.13e-02	1.18e-02	7.32e-01	4.36e-02	2.33e-03	5.73e-01	3.59e-01	7.93e-01
GOMF UBIQUITIN BINDING	102	1.74e-02	5.29e-02	0.1720	-1.05e-01	-8.68e-02	3.04e-02	9.97e-02	-4.91e-03	1.28e-02	6.58e-02	1.30e-01	5.95e-01	8.19e-02	9.32e-01	8.23e-01
GOBP REGULATION OF LIPID BIOSYNTHETIC PROCESS	131	5.73e-04	3.15e-03	0.1720	-4.06e-02	-1.05e-02	1.34e-01	9.51e-02	2.36e-02	1.86e-02	4.22e-01	8.35e-01	8.06e-03	6.03e-02	6.41e-01	7.14e-01
GOBP REGULATION OF POSTSYNAPTIC MEMBRANE NEUROTRANSMITTER RECEPTOR LEVELS	75	4.34e-01	5.42e-01	0.1720	5.64e-02	8.20e-02	1.10e-01	8.02e-02	3.48e-02	4.22e-04	3.98e-01	2.19e-01	9.94e-02	2.30e-01	6.03e-01	9.95e-01
GOBP CARBOHYDRATE CATABOLIC PROCESS	142	1.27e-03	6.23e-03	0.1720	-7.57e-02	-2.31e-02	7.06e-02	1.29e-01	-6.50e-03	4.13e-02	1.19e-01	6.34e-01	1.46e-01	7.97e-03	8.94e-01	3.95e-01
GOBP REGULATION OF PROGRAMMED CELL DEATH	1188	6.66e-24	3.70e-22	0.1720	-9.74e-02	-5.46e-02	6.26e-02	6.75e-02	-9.64e-03	9.25e-02	1.58e-08	1.54e-03	2.85e-04	9.12e-05	5.76e-01	7.95e-08
GOMF SIGNALING RECEPTOR REGULATOR ACTIVITY	255	1.94e-05	1.54e-04	0.1720	5.08e-02	6.38e-02	1.48e-01	-6.67e-03	1.36e-02	-2.74e-02	1.63e-01	7.97e-02	4.67e-05	8.54e-01	7.08e-01	4.51e-01
GOBP NEGATIVE REGULATION OF RNA BIOSYNTHETIC PROCESS	980	2.57e-22	1.31e-20	0.1720	-1.68e-02	2.26e-02	2.98e-02	1.61e-01	4.39e-02	1.52e-03	3.73e-01	2.31e-01	1.15e-01	1.56e-17	2.00e-02	9.36e-01
GOBP POSITIVE REGULATION OF PROTEIN CONTAINING COMPLEX ASSEMBLY	174	5.40e-04	2.99e-03	0.1720	-1.47e-01	-2.18e-02	2.73e-02	6.24e-02	5.89e-03	5.12e-02	7.99e-04	6.21e-01	5.34e-01	1.56e-01	8.93e-01	2.44e-01
GOMF IONOTROPIC GLUTAMATE RECEPTOR BINDING	19	9.46e-01	9.55e-01	0.1720	-1.44e-01	1.86e-02	3.39e-02	-7.32e-02	-4.32e-03	4.49e-02	2.79e-01	8.88e-01	7.98e-01	5.81e-01	9.74e-01	7.35e-01
GOCC SUPRAMOLECULAR COMPLEX	1042	3.38e-18	1.21e-16	0.1720	-4.90e-02	-6.71e-02	4.87e-02	9.27e-02	-2.74e-02	1.04e-01	7.54e-03	2.53e-04	7.94e-03	4.33e-07	1.36e-01	1.35e-08
GOBP POSITIVE REGULATION OF PROTEIN POLYMERIZATION	78	2.02e-02	5.95e-02	0.1710	-1.17e-01	-3.50e-04	9.27e-02	8.29e-02	9.73e-04	1.39e-02	7.36e-02	9.96e-01	1.57e-01	2.06e-01	9.88e-01	8.31e-01
GOBP CARBOHYDRATE HOMEOSTASIS	191	1.45e-03	7.02e-03	0.1710	-4.47e-02	1.12e-02	1.28e-01	7.06e-02	-4.46e-02	6.12e-02	2.87e-01	7.90e-01	2.20e-03	9.23e-02	2.88e-01	1.45e-01
GOBP AMINE METABOLIC PROCESS	81	1.06e-01	2.03e-01	0.1710	-1.31e-01	-2.86e-02	-2.05e-02	-3.02e-03	1.04e-01	-1.28e-02	4.16e-02	6.57e-01	7.50e-01	9.63e-01	1.07e-01	8.43e-01
GOBP POSITIVE REGULATION OF MAPK CASCADE	331	2.50e-06	2.44e-05	0.1710	-4.72e-02	7.24e-02	1.33e-01	3.68e-02	1.25e-02	4.99e-02	1.40e-01	2.36e-02	3.08e-05	2.51e-01	6.97e-01	1.19e-01
GOBP REGULATION OF KERATINOCYTE DIFFERENTIATION	26	6.01e-01	6.82e-01	0.1710	-6.72e-02	2.22e-02	1.13e-01	9.08e-02	5.27e-02	2.01e-02	5.53e-01	8.45e-01	3.19e-01	4.23e-01	6.42e-01	8.59e-01
GOBP HORMONE MEDIATED SIGNALING PATHWAY	145	1.20e-03	5.97e-03	0.1710	-1.45e-01	-2.31e-02	1.26e-02	8.30e-02	5.64e-03	2.60e-02	2.66e-03	6.32e-01	7.93e-01	8.45e-02	9.07e-01	5.88e-01
GOBP GLUCAN METABOLIC PROCESS	69	1.35e-01	2.43e-01	0.1710	-9.28e-02	4.07e-02	9.14e-02	7.93e-02	-2.59e-02	5.98e-02	1.82e-01	5.59e-01	1.89e-01	2.55e-01	7.10e-01	3.90e-01
GOBP CELLULAR HOMEOSTASIS	632	1.15e-13	2.76e-12	0.1710	-1.07e-01	-6.85e-02	7.28e-02	5.21e-02	-4.28e-02	5.69e-02	4.72e-06	3.29e-03	1.80e-03	2.56e-02	6.64e-02	1.47e-02
GOBP NEGATIVE REGULATION OF CELL GROWTH	139	3.89e-03	1.60e-02	0.1710	-5.37e-02	4.08e-02	1.06e-01	9.46e-02	-4.83e-02	4.47e-02	2.74e-01	4.07e-01	3.03e-02	5.42e-02	3.26e-01	3.63e-01
GOCC SIDE OF MEMBRANE	574	1.58e-05	1.28e-04	0.1710	9.32e-03	5.91e-02	1.23e-01	2.09e-02	-3.65e-02	9.28e-02	7.03e-01	1.56e-02	4.69e-07	3.92e-01	1.36e-01	1.47e-04
GOBP REGULATION OF CATALYTIC ACTIVITY	1106	8.60e-21	3.91e-19	0.1700	-7.42e-02	-1.92e-02	8.98e-02	7.18e-02	-3.16e-02	9.48e-02	3.16e-05	2.82e-01	4.81e-07	5.72e-05	7.64e-02	1.06e-07
GOBP INTRINSIC APOPTOTIC SIGNALING PATHWAY	279	1.05e-05	8.81e-05	0.1700	-9.46e-02	-8.09e-02	2.46e-02	9.86e-02	-1.05e-02	5.60e-02	6.53e-03	2.01e-02	4.80e-01	4.62e-03	7.62e-01	1.07e-01
GOBP POSITIVE REGULATION OF PROTEIN LOCALIZATION	408	1.11e-09	1.76e-08	0.1700	-7.84e-02	-3.74e-03	5.83e-02	1.22e-01	1.98e-02	6.50e-02	6.60e-03	8.97e-01	4.35e-02	2.39e-05	4.94e-01	2.42e-02
GOBP DITERPENOID METABOLIC PROCESS	48	5.11e-01	6.06e-01	0.1700	-8.66e-02	7.92e-03	-1.93e-02	1.32e-02	1.36e-01	4.82e-02	2.99e-01	9.24e-01	8.17e-01	8.74e-01	1.02e-01	5.63e-01
GOBP REGULATION OF GLUCOSE METABOLIC PROCESS	84	2.48e-02	6.95e-02	0.1700	-6.66e-02	5.04e-02	4.45e-02	1.04e-01	7.96e-02	-5.32e-02	2.91e-01	4.25e-01	4.81e-01	9.82e-02	2.07e-01	4.00e-01
GOBP MICROTUBULE POLYMERIZATION	88	6.37e-02	1.41e-01	0.1700	-1.66e-02	3.82e-02	1.84e-02	1.64e-01	7.47e-03	3.44e-03	7.87e-01	5.35e-01	7.66e-01	7.92e-03	9.04e-01	9.56e-01
GOBP GLUCOCORTICOID SECRETION	9	9.96e-01	9.96e-01	0.1700	-1.48e-02	-1.53e-04	-8.78e-02	1.15e-01	8.36e-02	-2.86e-02	9.39e-01	9.99e-01	6.48e-01	5.51e-01	6.64e-01	8.82e-01
GOBP SIGNAL TRANSDUCTION BY P53 CLASS MEDIATOR	161	1.41e-02	4.51e-02	0.1700	-5.68e-02	-1.05e-01	-4.25e-02	1.10e-01	2.47e-02	-3.79e-03	2.14e-01	2.12e-02	3.52e-01	1.59e-02	5.89e-01	9.34e-01
GOBP REGULATORY T CELL DIFFERENTIATION	36	8.55e-01	8.83e-01	0.1700	1.06e-01	2.14e-02	2.04e-02	6.57e-02	1.06e-01	3.24e-02	2.69e-01	8.24e-01	8.32e-01	4.95e-01	2.70e-01	7.36e-01
GOBP POSITIVE REGULATION OF MEIOTIC CELL CYCLE	14	9.69e-01	9.74e-01	0.1700	-4.48e-03	-1.29e-01	-5.42e-02	3.23e-02	-7.71e-02	4.81e-02	9.77e-01	4.04e-01	7.25e-01	8.34e-01	6.17e-01	7.55e-01
GOBP POSITIVE REGULATION OF MRNA METABOLIC PROCESS	129	8.66e-03	3.06e-02	0.1700	-1.34e-01	-2.08e-02	-6.51e-02	7.43e-02	-9.06e-03	2.19e-02	8.35e-03	6.83e-01	2.02e-01	1.45e-01	8.59e-01	6.68e-01
GOBP NEGATIVE REGULATION OF CELLULAR COMPONENT ORGANIZATION	596	5.21e-12	1.09e-10	0.1700	-7.75e-02	-1.41e-02	7.05e-02	9.50e-02	-8.42e-03	9.25e-02	1.24e-03	5.56e-01	3.28e-03	7.48e-05	7.26e-01	1.15e-04
GOBP RESPONSE TO XENOBIOTIC STIMULUS	301	1.94e-06	1.93e-05	0.1700	-6.30e-02	1.66e-03	1.38e-01	3.99e-02	-2.52e-03	6.55e-02	6.02e-02	9.60e-01	3.95e-05	2.34e-01	9.40e-01	5.07e-02
GOBP LEUKOCYTE PROLIFERATION	283	8.43e-04	4.41e-03	0.1700	-1.68e-02	2.79e-02	1.25e-01	5.59e-02	2.09e-02	9.19e-02	6.26e-01	4.20e-01	2.83e-04	1.06e-01	5.45e-01	7.82e-03
GOBP LENS FIBER CELL DEVELOPMENT	10	9.97e-01	9.97e-01	0.1700	-1.15e-01	-7.11e-02	-4.55e-03	-5.43e-02	-8.49e-02	-1.62e-02	5.28e-01	6.97e-01	9.80e-01	7.66e-01	6.42e-01	9.29e-01
GOBP POSITIVE REGULATION OF TRANSMEMBRANE RECEPTOR PROTEIN SERINE THREONINE KINASE SIGNALING PATHWAY	72	3.72e-02	9.44e-02	0.1690	-3.06e-02	7.38e-02	1.01e-01	5.88e-02	-5.25e-02	-7.72e-02	6.54e-01	2.79e-01	1.39e-01	3.88e-01	4.41e-01	2.58e-01
GOMF STEROID BINDING	79	6.95e-02	1.50e-01	0.1690	-1.26e-01	4.10e-02	7.97e-02	1.69e-02	-6.46e-02	1.77e-02	5.28e-02	5.29e-01	2.20e-01	7.95e-01	3.21e-01	7.86e-01
GOBP NEPHRON EPITHELIUM DEVELOPMENT	73	4.45e-01	5.52e-01	0.1690	3.70e-02	9.60e-02	1.31e-01	5.05e-03	-3.16e-02	5.51e-04	5.85e-01	1.56e-01	5.38e-02	9.41e-01	6.41e-01	9.94e-01
GOBP REGULATION OF STEM CELL PROLIFERATION	48	5.35e-01	6.26e-01	0.1690	-2.33e-02	4.55e-02	7.18e-02	1.29e-01	4.61e-02	4.58e-02	7.80e-01	5.86e-01	3.89e-01	1.22e-01	5.80e-01	5.83e-01
GOMF METALLOENDOPEPTIDASE ACTIVITY	70	5.78e-01	6.64e-01	0.1690	8.83e-02	1.15e-01	7.70e-02	2.22e-02	-5.98e-03	-3.29e-02	2.02e-01	9.52e-02	2.65e-01	7.49e-01	9.31e-01	6.34e-01
GOBP TISSUE HOMEOSTASIS	190	3.05e-02	8.11e-02	0.1690	-1.57e-02	1.12e-01	1.07e-01	7.18e-03	3.52e-02	5.70e-02	7.10e-01	7.98e-03	1.12e-02	8.65e-01	4.02e-01	1.75e-01
GOCC APICAL JUNCTION COMPLEX	112	5.14e-03	2.01e-02	0.1690	-5.30e-02	1.19e-01	7.03e-02	1.65e-02	-2.91e-02	-7.46e-02	3.33e-01	2.94e-02	1.99e-01	7.63e-01	5.94e-01	1.73e-01
GOMF PROMOTER SPECIFIC CHROMATIN BINDING	57	4.88e-01	5.88e-01	0.1690	1.16e-02	8.99e-02	5.45e-02	1.21e-01	5.17e-02	-1.22e-02	8.80e-01	2.40e-01	4.77e-01	1.15e-01	4.99e-01	8.74e-01
GOBP POSITIVE REGULATION OF HEMOPOIESIS	164	2.59e-03	1.15e-02	0.1690	-7.88e-02	6.61e-02	9.69e-02	6.84e-02	5.43e-03	6.25e-02	8.17e-02	1.44e-01	3.22e-02	1.31e-01	9.04e-01	1.67e-01
GOBP THYROID HORMONE GENERATION	13	9.48e-01	9.57e-01	0.1690	-7.92e-02	-4.52e-02	-1.20e-02	-8.72e-02	4.41e-02	-1.03e-01	6.21e-01	7.78e-01	9.40e-01	5.86e-01	7.83e-01	5.21e-01
GOBP REGULATION OF CARBOHYDRATE CATABOLIC PROCESS	53	4.68e-01	5.70e-01	0.1690	3.93e-02	3.87e-02	7.99e-02	1.38e-01	-5.55e-03	-7.70e-03	6.21e-01	6.26e-01	3.14e-01	8.21e-02	9.44e-01	9.23e-01
GOBP CELL GROWTH	376	3.13e-10	5.38e-09	0.1690	-4.90e-02	3.21e-02	8.53e-02	1.25e-01	-3.61e-02	3.17e-02	1.03e-01	2.85e-01	4.50e-03	3.32e-05	2.29e-01	2.91e-01
GOBP SENSORY ORGAN DEVELOPMENT	357	3.90e-06	3.65e-05	0.1690	-2.74e-02	1.32e-01	7.24e-02	4.72e-02	5.22e-02	9.27e-03	3.73e-01	1.73e-05	1.89e-02	1.25e-01	9.01e-02	7.64e-01
GOMF HYDROLASE ACTIVITY ACTING ON GLYCOSYL BONDS	106	2.26e-01	3.45e-01	0.1690	-1.04e-01	-7.89e-02	-8.04e-02	4.03e-02	-1.61e-04	-5.79e-02	6.32e-02	1.61e-01	1.53e-01	4.73e-01	9.98e-01	3.03e-01
GOMF CHOLESTEROL BINDING	44	2.39e-01	3.57e-01	0.1690	-8.89e-02	3.82e-02	1.17e-01	7.32e-02	2.83e-03	9.12e-03	3.08e-01	6.61e-01	1.79e-01	4.01e-01	9.74e-01	9.17e-01
GOBP MONOATOMIC ION HOMEOSTASIS	455	2.99e-09	4.47e-08	0.1690	-8.94e-02	-4.76e-02	9.26e-02	5.86e-02	-3.28e-02	7.15e-02	1.08e-03	8.22e-02	7.17e-04	3.24e-02	2.31e-01	8.93e-03
GOMF CYTOKINE RECEPTOR BINDING	162	8.45e-03	3.01e-02	0.1690	-5.62e-02	8.49e-02	1.24e-01	-2.60e-02	2.81e-02	3.54e-02	2.17e-01	6.24e-02	6.55e-03	5.68e-01	5.38e-01	4.36e-01
GOBP COMPLEMENT ACTIVATION	45	4.34e-01	5.42e-01	0.1680	-1.66e-02	-1.17e-01	7.79e-02	2.11e-02	-8.31e-02	-3.25e-02	8.47e-01	1.76e-01	3.66e-01	8.06e-01	3.35e-01	7.06e-01
GOBP REGULATION OF AMIDE METABOLIC PROCESS	59	1.67e-01	2.80e-01	0.1680	-1.28e-01	-6.70e-02	3.80e-02	5.48e-02	-4.87e-02	-2.54e-02	8.92e-02	3.73e-01	6.13e-01	4.66e-01	5.18e-01	7.36e-01
GOMF PHOSPHATIDYLINOSITOL 3 PHOSPHATE BINDING	42	4.55e-01	5.60e-01	0.1680	-1.02e-02	4.40e-02	1.49e-01	5.84e-02	-2.51e-02	1.83e-03	9.09e-01	6.22e-01	9.45e-02	5.13e-01	7.78e-01	9.84e-01
GOBP REGULATION OF MITOPHAGY	35	4.64e-01	5.68e-01	0.1680	-1.23e-02	-9.21e-03	7.91e-02	1.37e-01	4.89e-02	-2.46e-02	9.00e-01	9.25e-01	4.18e-01	1.61e-01	6.16e-01	8.01e-01
GOBP PROTEIN TETRAMERIZATION	78	2.75e-01	3.94e-01	0.1680	-8.39e-02	-8.32e-02	-5.85e-02	9.10e-02	3.73e-02	-3.44e-02	2.00e-01	2.04e-01	3.72e-01	1.65e-01	5.69e-01	5.99e-01
GOBP REPRODUCTIVE SYSTEM DEVELOPMENT	208	9.68e-03	3.34e-02	0.1680	-8.14e-02	2.50e-03	1.06e-01	9.99e-03	-1.96e-02	9.92e-02	4.31e-02	9.50e-01	8.30e-03	8.04e-01	6.26e-01	1.36e-02
GOBP NEGATIVE REGULATION OF LOCOMOTION	253	4.15e-05	3.08e-04	0.1680	-7.91e-02	1.67e-02	1.29e-01	2.38e-02	-4.96e-02	4.37e-02	3.03e-02	6.47e-01	3.96e-04	5.15e-01	1.74e-01	2.31e-01
GOBP POSITIVE REGULATION OF PEPTIDYL TYROSINE PHOSPHORYLATION	114	5.08e-02	1.19e-01	0.1680	-6.91e-03	7.88e-02	1.42e-01	-9.23e-05	3.60e-02	1.82e-02	8.99e-01	1.46e-01	8.65e-03	9.99e-01	5.07e-01	7.37e-01
GOBP HORMONE METABOLIC PROCESS	143	1.73e-01	2.88e-01	0.1680	-3.24e-02	3.93e-02	1.17e-01	-1.09e-02	1.07e-03	1.09e-01	5.04e-01	4.17e-01	1.59e-02	8.22e-01	9.82e-01	2.50e-02
GOBP MUSCLE ORGAN DEVELOPMENT	239	4.47e-02	1.08e-01	0.1680	6.15e-02	1.10e-01	9.32e-02	6.00e-03	4.92e-02	3.40e-02	1.02e-01	3.46e-03	1.31e-02	8.73e-01	1.91e-01	3.65e-01
GOBP REGULATION OF MRNA METABOLIC PROCESS	267	4.40e-06	4.06e-05	0.1680	-1.08e-01	-5.55e-02	-3.21e-02	1.01e-01	-4.45e-02	1.49e-02	2.41e-03	1.19e-01	3.67e-01	4.61e-03	2.11e-01	6.74e-01
GOMF FLAVIN ADENINE DINUCLEOTIDE BINDING	78	1.00e-01	1.96e-01	0.1680	-7.98e-02	-1.25e-01	2.72e-02	6.49e-03	5.07e-02	5.30e-02	2.23e-01	5.68e-02	6.78e-01	9.21e-01	4.39e-01	4.19e-01
GOBP TEMPERATURE HOMEOSTASIS	143	5.17e-04	2.88e-03	0.1670	-1.35e-01	-1.95e-02	6.54e-02	-1.04e-02	-4.04e-02	-5.78e-02	5.21e-03	6.88e-01	1.77e-01	8.30e-01	4.04e-01	2.33e-01
GOBP POSITIVE REGULATION OF DEVELOPMENTAL PROCESS	985	4.86e-20	2.07e-18	0.1670	-4.44e-02	7.65e-02	1.04e-01	7.76e-02	3.28e-02	4.80e-02	1.83e-02	4.91e-05	3.36e-08	3.82e-05	8.18e-02	1.08e-02
GOBP NEGATIVE REGULATION OF DEFENSE RESPONSE	212	5.56e-04	3.06e-03	0.1670	-6.29e-02	4.03e-02	8.96e-02	9.08e-02	-1.45e-02	7.73e-02	1.15e-01	3.12e-01	2.46e-02	2.26e-02	7.16e-01	5.25e-02
GOBP RESPONSE TO INORGANIC SUBSTANCE	392	2.87e-07	3.28e-06	0.1670	-7.26e-02	-3.85e-02	9.77e-02	6.50e-02	-1.28e-02	8.57e-02	1.37e-02	1.91e-01	9.03e-04	2.73e-02	6.63e-01	3.59e-03
GOBP PHENOL CONTAINING COMPOUND METABOLIC PROCESS	70	1.22e-01	2.26e-01	0.1670	-1.25e-01	4.14e-02	6.77e-02	3.10e-02	6.03e-02	3.83e-02	7.07e-02	5.50e-01	3.27e-01	6.54e-01	3.83e-01	5.79e-01
GOMF ANTIPORTER ACTIVITY	108	7.79e-02	1.63e-01	0.1670	-1.27e-01	-8.03e-02	1.16e-02	3.11e-02	-6.46e-02	-5.34e-03	2.25e-02	1.49e-01	8.35e-01	5.77e-01	2.46e-01	9.24e-01
GOBP STEROID METABOLIC PROCESS	223	4.29e-03	1.73e-02	0.1670	-1.21e-02	-5.29e-02	9.03e-02	8.55e-02	-2.62e-02	9.39e-02	7.56e-01	1.73e-01	2.02e-02	2.79e-02	5.00e-01	1.57e-02
GOBP REGULATION OF MICROTUBULE POLYMERIZATION OR DEPOLYMERIZATION	83	7.75e-02	1.63e-01	0.1670	-4.00e-02	3.38e-02	3.99e-02	1.52e-01	2.14e-02	1.16e-02	5.29e-01	5.94e-01	5.30e-01	1.70e-02	7.36e-01	8.55e-01
GOBP PERIPHERAL NERVOUS SYSTEM DEVELOPMENT	62	1.46e-01	2.56e-01	0.1670	-3.07e-02	-3.62e-02	2.97e-02	1.29e-01	7.66e-02	-4.58e-02	6.76e-01	6.23e-01	6.86e-01	7.78e-02	2.97e-01	5.33e-01
GOBP POSITIVE REGULATION OF MRNA CATABOLIC PROCESS	101	1.45e-02	4.61e-02	0.1670	-1.19e-01	3.88e-02	-2.81e-02	9.13e-02	5.00e-03	5.60e-02	3.95e-02	5.01e-01	6.26e-01	1.13e-01	9.31e-01	3.30e-01
GOBP LIPID BIOSYNTHETIC PROCESS	593	2.70e-11	5.19e-10	0.1670	-1.13e-01	-4.18e-02	7.17e-02	3.62e-02	-2.85e-03	8.25e-02	2.63e-06	8.21e-02	2.85e-03	1.33e-01	9.06e-01	5.99e-04
GOBP POSITIVE REGULATION OF IMMUNE EFFECTOR PROCESS	222	5.41e-04	2.99e-03	0.1670	-5.14e-02	8.13e-02	6.79e-02	9.26e-02	1.62e-02	7.13e-02	1.87e-01	3.69e-02	8.15e-02	1.74e-02	6.78e-01	6.71e-02
GOBP RECEPTOR LOCALIZATION TO SYNAPSE	47	7.57e-01	8.06e-01	0.1670	-1.14e-02	2.67e-02	1.44e-01	-2.11e-02	-5.51e-02	5.18e-02	8.92e-01	7.52e-01	8.76e-02	8.02e-01	5.13e-01	5.39e-01
GOBP NEGATIVE REGULATION OF RESPONSE TO EXTERNAL STIMULUS	313	2.47e-04	1.52e-03	0.1670	-3.18e-02	4.58e-02	1.26e-01	5.10e-02	-8.47e-03	7.82e-02	3.34e-01	1.63e-01	1.28e-04	1.21e-01	7.97e-01	1.74e-02
GOMF KINASE BINDING	691	1.50e-13	3.54e-12	0.1670	-4.48e-02	1.18e-02	9.10e-02	1.08e-01	-4.44e-03	7.47e-02	4.48e-02	5.98e-01	4.59e-05	1.25e-06	8.42e-01	8.20e-04
GOBP NEGATIVE REGULATION OF GENE EXPRESSION	945	3.93e-21	1.85e-19	0.1660	-8.32e-02	-2.33e-02	5.00e-02	1.10e-01	-2.15e-04	7.47e-02	1.50e-05	2.26e-01	9.31e-03	9.48e-09	9.91e-01	1.01e-04
GOBP TUBE DEVELOPMENT	787	2.60e-20	1.14e-18	0.1660	-8.44e-02	5.11e-02	1.25e-01	3.46e-02	-3.80e-03	3.42e-02	5.77e-05	1.49e-02	2.74e-09	9.93e-02	8.56e-01	1.03e-01
GOBP MONOATOMIC CATION TRANSPORT	731	2.40e-12	5.15e-11	0.1660	-3.26e-02	-3.77e-02	1.33e-01	1.59e-02	-6.81e-02	5.12e-02	1.34e-01	8.30e-02	9.88e-10	4.66e-01	1.74e-03	1.85e-02
GOMF ORGANIC ACID BINDING	137	1.66e-02	5.12e-02	0.1660	-5.17e-02	-2.05e-02	4.99e-02	1.25e-01	5.37e-02	5.96e-02	2.96e-01	6.79e-01	3.13e-01	1.16e-02	2.78e-01	2.28e-01
GOCC EXTERNAL ENCAPSULATING STRUCTURE	343	2.57e-08	3.43e-07	0.1660	2.61e-02	7.81e-03	1.58e-01	-1.17e-02	-3.63e-02	-1.96e-02	4.06e-01	8.04e-01	4.80e-07	7.10e-01	2.48e-01	5.33e-01
GOBP REGULATION OF TRANSFERASE ACTIVITY	520	2.27e-08	3.04e-07	0.1660	-6.35e-02	-6.55e-02	5.42e-02	7.99e-02	-1.55e-02	9.82e-02	1.33e-02	1.06e-02	3.45e-02	1.82e-03	5.45e-01	1.28e-04
GOMF DEAD H BOX RNA HELICASE BINDING	7	9.83e-01	9.85e-01	0.1660	-1.09e-01	-8.49e-04	-6.00e-03	2.28e-02	-4.46e-02	-1.14e-01	6.17e-01	9.97e-01	9.78e-01	9.17e-01	8.38e-01	6.00e-01
GOBP WATER SOLUBLE VITAMIN METABOLIC PROCESS	59	3.29e-01	4.47e-01	0.1660	-4.02e-02	-1.10e-01	-3.75e-02	5.08e-02	9.93e-02	-3.65e-03	5.93e-01	1.45e-01	6.18e-01	5.00e-01	1.87e-01	9.61e-01
GOBP DENDRITE DEVELOPMENT	187	1.89e-03	8.73e-03	0.1660	-5.75e-02	9.32e-02	1.08e-01	4.65e-02	7.24e-04	4.12e-02	1.75e-01	2.80e-02	1.10e-02	2.72e-01	9.86e-01	3.31e-01
GOBP RESPONSE TO STEROID HORMONE	251	9.36e-06	7.92e-05	0.1660	-8.01e-02	-6.16e-03	1.31e-01	3.46e-02	-3.24e-02	4.01e-02	2.89e-02	8.67e-01	3.52e-04	3.45e-01	3.76e-01	2.74e-01
GOMF PHOSPHATASE ACTIVITY	230	5.39e-04	2.98e-03	0.1660	-9.40e-02	-3.34e-02	7.32e-02	5.78e-02	-6.26e-02	6.99e-02	1.40e-02	3.83e-01	5.58e-02	1.31e-01	1.02e-01	6.78e-02
GOBP POSITIVE REGULATION OF GLIAL CELL DIFFERENTIATION	32	4.51e-01	5.57e-01	0.1660	-9.12e-02	4.54e-02	1.26e-01	1.50e-02	-2.03e-02	-2.38e-02	3.72e-01	6.57e-01	2.18e-01	8.83e-01	8.43e-01	8.16e-01
GOBP TORC1 SIGNALING	100	7.46e-03	2.73e-02	0.1660	-6.00e-02	3.05e-02	7.69e-02	1.20e-01	-5.19e-02	-3.02e-03	3.00e-01	5.99e-01	1.84e-01	3.88e-02	3.70e-01	9.58e-01
GOCC MEMBRANE PROTEIN COMPLEX	1108	8.82e-18	3.03e-16	0.1660	-5.56e-02	-8.70e-02	5.30e-03	7.90e-02	-6.49e-03	1.02e-01	1.81e-03	1.04e-06	7.66e-01	9.20e-06	7.16e-01	9.47e-09
GOCC SPERM CONNECTING PIECE	9	9.86e-01	9.88e-01	0.1660	-7.19e-02	1.16e-01	1.69e-02	-5.02e-02	6.01e-03	7.77e-02	7.09e-01	5.48e-01	9.30e-01	7.94e-01	9.75e-01	6.87e-01
GOBP POSITIVE REGULATION OF HORMONE SECRETION	95	2.40e-01	3.58e-01	0.1660	-1.19e-01	-3.88e-02	7.78e-02	-3.03e-02	-4.41e-02	5.28e-02	4.49e-02	5.13e-01	1.90e-01	6.10e-01	4.58e-01	3.74e-01
GOMF UBIQUITIN LIKE PROTEIN BINDING	121	1.23e-02	4.03e-02	0.1650	-1.02e-01	-6.30e-02	3.09e-02	1.05e-01	-2.49e-03	3.25e-02	5.25e-02	2.32e-01	5.57e-01	4.65e-02	9.62e-01	5.37e-01
GOBP NEGATIVE REGULATION OF CELL PROJECTION ORGANIZATION	146	1.55e-02	4.86e-02	0.1650	-6.83e-02	5.72e-02	1.13e-01	2.82e-02	-5.87e-02	4.84e-02	1.54e-01	2.33e-01	1.84e-02	5.57e-01	2.21e-01	3.13e-01
GOBP POSITIVE REGULATION OF MOLECULAR FUNCTION	952	1.52e-15	4.21e-14	0.1650	-5.49e-02	6.96e-03	1.05e-01	6.43e-02	-3.22e-02	8.94e-02	4.15e-03	7.16e-01	4.10e-08	7.79e-04	9.26e-02	3.04e-06
GOBP CILIUM OR FLAGELLUM DEPENDENT CELL MOTILITY	102	1.58e-01	2.70e-01	0.1650	8.65e-03	9.33e-02	-1.52e-02	-1.04e-01	4.14e-02	-7.49e-02	8.80e-01	1.03e-01	7.91e-01	6.84e-02	4.70e-01	1.91e-01
GOMF PROTEIN DOMAIN SPECIFIC BINDING	568	1.01e-13	2.44e-12	0.1650	-1.03e-01	1.30e-02	9.20e-02	6.17e-02	-3.52e-02	5.37e-02	2.67e-05	5.97e-01	1.80e-04	1.21e-02	1.51e-01	2.87e-02
GOBP PROTEIN STABILIZATION	188	2.31e-03	1.04e-02	0.1650	-1.11e-01	-7.00e-02	-3.00e-02	9.28e-02	1.38e-02	1.64e-02	8.66e-03	9.82e-02	4.78e-01	2.83e-02	7.44e-01	6.99e-01
GOBP HINDBRAIN DEVELOPMENT	116	3.86e-02	9.69e-02	0.1650	-2.79e-02	9.75e-02	8.87e-02	8.79e-02	-1.17e-02	3.34e-02	6.04e-01	6.97e-02	9.88e-02	1.02e-01	8.28e-01	5.34e-01
GOCC RECYCLING ENDOSOME	184	1.27e-03	6.25e-03	0.1650	-8.74e-02	-5.67e-03	8.83e-02	8.03e-02	-4.40e-03	7.19e-02	4.08e-02	8.94e-01	3.89e-02	6.02e-02	9.18e-01	9.24e-02
GOBP POSITIVE REGULATION OF CELLULAR CATABOLIC PROCESS	193	1.14e-05	9.49e-05	0.1640	-9.19e-02	1.16e-03	6.89e-02	7.76e-02	-8.76e-02	-1.22e-02	2.78e-02	9.78e-01	9.90e-02	6.29e-02	3.59e-02	7.70e-01
GOBP CELLULAR LIPID METABOLIC PROCESS	800	8.18e-16	2.34e-14	0.1640	-1.36e-01	-6.70e-02	1.18e-02	2.14e-02	3.64e-02	4.55e-02	5.92e-11	1.28e-03	5.70e-01	3.03e-01	8.06e-02	2.87e-02
GOBP POSITIVE REGULATION OF NUCLEOTIDE METABOLIC PROCESS	26	9.37e-01	9.47e-01	0.1640	-2.62e-02	-2.43e-02	5.69e-02	1.52e-02	-2.75e-02	1.47e-01	8.17e-01	8.30e-01	6.16e-01	8.93e-01	8.08e-01	1.95e-01
GOBP REGULATION OF MOLECULAR FUNCTION	1565	1.23e-24	7.52e-23	0.1640	-5.13e-02	-3.88e-03	9.48e-02	7.32e-02	-2.07e-02	9.76e-02	7.15e-04	7.98e-01	4.10e-10	1.39e-06	1.73e-01	1.23e-10
GOMF PHOSPHATIDYLSERINE BINDING	52	7.59e-01	8.07e-01	0.1640	-1.07e-01	-4.63e-03	6.10e-02	-9.09e-02	-5.46e-02	2.23e-02	1.83e-01	9.54e-01	4.47e-01	2.57e-01	4.96e-01	7.81e-01
GOBP FATTY ACID BIOSYNTHETIC PROCESS	126	3.40e-02	8.80e-02	0.1640	-8.80e-02	-5.15e-02	8.14e-02	3.17e-02	2.72e-02	8.99e-02	8.82e-02	3.19e-01	1.15e-01	5.39e-01	5.98e-01	8.15e-02
GOBP NEGATIVE REGULATION OF TRANSCRIPTION BY RNA POLYMERASE II	699	8.32e-16	2.37e-14	0.1640	-6.25e-03	5.20e-02	5.61e-02	1.38e-01	3.51e-02	-2.55e-02	7.78e-01	1.92e-02	1.15e-02	5.43e-10	1.14e-01	2.51e-01
GOMF CALMODULIN BINDING	151	6.60e-02	1.45e-01	0.1630	2.17e-02	7.79e-02	1.28e-01	5.54e-02	-1.13e-02	2.54e-02	6.46e-01	9.87e-02	6.70e-03	2.40e-01	8.11e-01	5.90e-01
GOBP POSITIVE REGULATION OF B CELL ACTIVATION	79	3.42e-01	4.59e-01	0.1630	-3.27e-03	1.05e-01	3.80e-02	1.07e-01	4.86e-02	2.49e-02	9.60e-01	1.08e-01	5.59e-01	1.02e-01	4.56e-01	7.02e-01
GOBP BIOMINERAL TISSUE DEVELOPMENT	117	1.44e-02	4.58e-02	0.1630	-7.67e-02	8.94e-02	1.05e-01	-3.20e-02	-1.10e-03	-2.84e-02	1.52e-01	9.48e-02	5.02e-02	5.50e-01	9.84e-01	5.95e-01
GOBP SPERM MOTILITY	80	2.74e-01	3.94e-01	0.1630	-7.55e-03	1.08e-01	2.91e-02	-8.74e-02	7.33e-02	-3.30e-02	9.07e-01	9.47e-02	6.53e-01	1.76e-01	2.57e-01	6.10e-01
GOBP REGULATION OF CELL DIFFERENTIATION	1145	3.03e-22	1.54e-20	0.1630	-4.43e-02	6.05e-02	1.11e-01	7.47e-02	1.03e-02	5.40e-02	1.16e-02	5.64e-04	2.08e-10	2.05e-05	5.59e-01	2.08e-03
GOMF PHOSPHATIDYLINOSITOL BINDING	238	1.55e-05	1.25e-04	0.1630	-8.11e-02	5.54e-02	7.31e-02	9.74e-02	8.84e-03	4.55e-02	3.12e-02	1.41e-01	5.22e-02	9.66e-03	8.14e-01	2.27e-01
GOBP CELL RECOGNITION	97	1.06e-01	2.03e-01	0.1630	-1.13e-01	5.51e-02	8.17e-02	-9.55e-03	2.90e-02	5.60e-02	5.48e-02	3.48e-01	1.64e-01	8.71e-01	6.22e-01	3.40e-01
GOBP CENTRAL NERVOUS SYSTEM DEVELOPMENT	728	2.89e-13	6.70e-12	0.1630	-5.89e-02	8.39e-02	9.64e-02	5.40e-02	1.93e-02	5.86e-02	6.86e-03	1.17e-04	9.64e-06	1.31e-02	3.75e-01	7.17e-03
GOBP POSITIVE REGULATION OF CELL DIFFERENTIATION	641	4.05e-12	8.57e-11	0.1630	-5.09e-02	7.24e-02	1.07e-01	6.29e-02	2.80e-02	5.08e-02	2.79e-02	1.77e-03	4.23e-06	6.57e-03	2.27e-01	2.83e-02
GOBP POSITIVE REGULATION OF INTRACELLULAR SIGNAL TRANSDUCTION	826	5.59e-13	1.27e-11	0.1630	-4.46e-02	4.32e-02	1.01e-01	7.24e-02	1.75e-02	8.31e-02	2.96e-02	3.49e-02	8.61e-07	4.10e-04	3.92e-01	4.96e-05
GOMF SIGNALING RECEPTOR BINDING	998	4.06e-17	1.33e-15	0.1630	-3.20e-02	4.60e-02	1.30e-01	5.55e-02	-6.42e-03	5.87e-02	8.78e-02	1.40e-02	4.49e-12	3.04e-03	7.32e-01	1.73e-03
GOBP HORMONE TRANSPORT	221	2.05e-03	9.36e-03	0.1630	-7.79e-02	2.51e-03	1.26e-01	-3.44e-02	-2.98e-02	4.98e-02	4.61e-02	9.49e-01	1.27e-03	3.78e-01	4.45e-01	2.02e-01
GOBP MUSCLE CELL DIFFERENTIATION	292	6.33e-05	4.51e-04	0.1630	-3.46e-02	5.16e-02	1.27e-01	5.52e-02	-3.40e-02	4.65e-02	3.09e-01	1.29e-01	1.82e-04	1.05e-01	3.18e-01	1.72e-01
GOMF HYDROLASE ACTIVITY ACTING ON ESTER BONDS	647	6.40e-10	1.06e-08	0.1630	-9.02e-02	-9.25e-02	-4.33e-02	7.89e-02	2.06e-02	3.44e-02	9.04e-05	5.96e-05	6.03e-02	6.17e-04	3.72e-01	1.36e-01
GOBP POSITIVE REGULATION OF ESTABLISHMENT OF PROTEIN LOCALIZATION	276	9.74e-06	8.22e-05	0.1620	-1.11e-01	-5.15e-02	4.41e-02	7.93e-02	8.65e-03	5.59e-02	1.52e-03	1.41e-01	2.08e-01	2.34e-02	8.05e-01	1.10e-01
GOBP MUSCLE CELL CELLULAR HOMEOSTASIS	20	7.82e-01	8.24e-01	0.1620	-9.67e-02	3.68e-02	2.77e-02	-3.67e-03	-3.93e-02	-1.16e-01	4.54e-01	7.76e-01	8.30e-01	9.77e-01	7.61e-01	3.71e-01
GOBP REGULATION OF LOCOMOTION	800	3.77e-19	1.49e-17	0.1620	-7.09e-02	4.06e-02	1.29e-01	4.01e-02	-1.46e-02	3.43e-02	6.60e-04	5.12e-02	5.38e-10	5.42e-02	4.82e-01	9.98e-02
GOMF FATTY ACID BINDING	30	8.29e-01	8.62e-01	0.1620	-7.64e-02	6.16e-02	1.06e-02	-8.37e-02	-4.45e-02	8.72e-02	4.69e-01	5.59e-01	9.20e-01	4.28e-01	6.73e-01	4.08e-01
GOBP NEGATIVE REGULATION OF ERK1 AND ERK2 CASCADE	54	1.07e-01	2.06e-01	0.1620	-9.64e-02	1.20e-02	1.27e-01	2.17e-02	1.10e-02	-1.19e-02	2.21e-01	8.79e-01	1.06e-01	7.82e-01	8.89e-01	8.80e-01
GOBP POSITIVE REGULATION OF AUTOPHAGY	145	4.90e-04	2.76e-03	0.1620	-1.15e-01	-1.03e-02	4.14e-03	9.68e-02	-5.98e-02	-1.02e-02	1.73e-02	8.31e-01	9.31e-01	4.43e-02	2.14e-01	8.32e-01
GOMF ACTIVE TRANSMEMBRANE TRANSPORTER ACTIVITY	348	2.21e-06	2.17e-05	0.1620	-5.64e-02	-1.19e-01	3.23e-02	5.59e-02	-6.71e-02	-1.39e-02	7.09e-02	1.33e-04	3.01e-01	7.31e-02	3.14e-02	6.56e-01
GOBP EMBRYO DEVELOPMENT	813	4.58e-19	1.79e-17	0.1620	-5.51e-02	4.30e-02	7.49e-02	1.16e-01	3.17e-02	3.48e-02	7.58e-03	3.73e-02	2.89e-04	1.75e-08	1.25e-01	9.15e-02
GOBP REPLICATIVE SENESCENCE	16	9.70e-01	9.75e-01	0.1620	7.43e-02	-8.11e-02	-9.07e-02	1.32e-02	-2.31e-02	-7.21e-02	6.07e-01	5.74e-01	5.30e-01	9.27e-01	8.73e-01	6.18e-01
GOBP CELL PROJECTION ORGANIZATION	1254	8.35e-22	4.09e-20	0.1620	-5.53e-02	8.72e-02	7.59e-02	5.80e-02	5.88e-02	5.45e-02	9.97e-04	2.10e-07	6.37e-06	5.55e-04	4.68e-04	1.19e-03
GOBP HEAD DEVELOPMENT	556	1.19e-09	1.88e-08	0.1620	-6.04e-02	8.31e-02	8.29e-02	6.14e-02	2.62e-02	6.56e-02	1.49e-02	8.13e-04	8.33e-04	1.34e-02	2.92e-01	8.24e-03
GOBP POSITIVE REGULATION OF AMIDE METABOLIC PROCESS	25	5.97e-01	6.79e-01	0.1620	-9.51e-02	6.75e-02	7.96e-02	5.98e-02	-4.30e-02	-2.87e-02	4.10e-01	5.59e-01	4.91e-01	6.05e-01	7.10e-01	8.04e-01
GOBP RESPONSE TO CATECHOLAMINE	41	2.51e-01	3.70e-01	0.1620	-7.16e-02	4.23e-02	7.52e-02	1.10e-01	-5.19e-03	-3.93e-02	4.27e-01	6.39e-01	4.05e-01	2.25e-01	9.54e-01	6.63e-01
GOBP REGULATION OF B CELL ACTIVATION	122	9.24e-02	1.85e-01	0.1620	-1.68e-02	6.28e-02	1.03e-01	8.30e-02	-2.60e-02	6.07e-02	7.48e-01	2.31e-01	4.88e-02	1.13e-01	6.20e-01	2.47e-01
GOBP TERPENOID METABOLIC PROCESS	56	4.67e-01	5.70e-01	0.1620	-6.09e-02	-4.94e-02	-1.79e-02	4.99e-02	1.16e-01	6.15e-02	4.30e-01	5.23e-01	8.17e-01	5.18e-01	1.34e-01	4.26e-01
GOBP POSITIVE REGULATION OF CYTOKINE PRODUCTION	418	9.00e-07	9.48e-06	0.1620	-9.00e-02	6.58e-02	7.35e-02	2.03e-02	-1.41e-02	8.77e-02	1.59e-03	2.10e-02	9.95e-03	4.77e-01	6.21e-01	2.12e-03
GOCC FILAMENTOUS ACTIN	25	5.91e-01	6.74e-01	0.1620	-2.42e-02	-1.02e-01	1.15e-01	1.13e-02	-3.23e-02	-2.95e-02	8.34e-01	3.80e-01	3.20e-01	9.22e-01	7.80e-01	7.99e-01
GOMF PASSIVE TRANSMEMBRANE TRANSPORTER ACTIVITY	301	2.70e-03	1.18e-02	0.1610	7.63e-02	4.38e-02	1.25e-01	-3.25e-02	-3.54e-02	2.15e-02	2.28e-02	1.92e-01	1.98e-04	3.33e-01	2.91e-01	5.22e-01
GOBP INSULIN SECRETION INVOLVED IN CELLULAR RESPONSE TO GLUCOSE STIMULUS	52	3.18e-01	4.37e-01	0.1610	-1.47e-01	-2.90e-02	-2.11e-03	3.69e-02	-2.64e-02	-3.81e-02	6.63e-02	7.18e-01	9.79e-01	6.45e-01	7.42e-01	6.35e-01
GOBP REGULATION OF HORMONE SECRETION	176	1.09e-02	3.70e-02	0.1610	-4.01e-02	1.82e-02	1.43e-01	-3.42e-02	-4.11e-02	2.90e-02	3.59e-01	6.77e-01	1.10e-03	4.33e-01	3.47e-01	5.06e-01
GOBP CYTOSKELETON ORGANIZATION	1216	1.32e-20	5.90e-19	0.1610	-3.55e-02	5.30e-03	1.01e-01	9.18e-02	-8.91e-03	7.67e-02	3.74e-02	7.56e-01	3.37e-09	7.42e-08	6.01e-01	6.78e-06
GOMF CYTOKINE BINDING	120	4.18e-01	5.28e-01	0.1610	-8.86e-03	5.59e-02	1.15e-01	-1.95e-02	-1.69e-02	9.39e-02	8.67e-01	2.90e-01	3.01e-02	7.12e-01	7.49e-01	7.55e-02
GOBP POSITIVE REGULATION OF PHOSPHORYLATION	467	1.56e-07	1.84e-06	0.1600	-7.23e-02	1.17e-02	1.08e-01	4.30e-02	-4.26e-03	8.26e-02	7.47e-03	6.64e-01	6.37e-05	1.12e-01	8.75e-01	2.23e-03
GOBP CIRCADIAN RHYTHM	156	5.99e-05	4.30e-04	0.1600	-9.61e-02	3.50e-02	7.99e-02	9.11e-02	1.20e-02	-2.03e-02	3.84e-02	4.50e-01	8.49e-02	4.96e-02	7.96e-01	6.62e-01
GOCC DENDRITIC TREE	446	6.94e-09	1.00e-07	0.1600	-6.76e-02	9.40e-02	1.00e-01	3.40e-02	-4.59e-04	3.30e-02	1.44e-02	6.66e-04	2.93e-04	2.19e-01	9.87e-01	2.33e-01
GOBP REGULATION OF LEUKOCYTE PROLIFERATION	222	1.49e-02	4.71e-02	0.1600	-2.68e-03	4.24e-02	1.13e-01	6.39e-02	3.92e-02	7.43e-02	9.45e-01	2.76e-01	3.80e-03	1.01e-01	3.15e-01	5.65e-02
GOCC CILIARY BASE	36	8.05e-01	8.44e-01	0.1600	-7.27e-02	-7.44e-03	-4.11e-02	8.01e-02	1.01e-01	4.53e-02	4.51e-01	9.38e-01	6.70e-01	4.05e-01	2.96e-01	6.38e-01
GOBP REGULATION OF CARBOHYDRATE METABOLIC PROCESS	150	2.16e-03	9.81e-03	0.1600	-3.83e-02	3.23e-02	6.33e-02	1.23e-01	6.00e-02	-1.63e-02	4.19e-01	4.95e-01	1.81e-01	9.16e-03	2.05e-01	7.30e-01
GOBP POSITIVE REGULATION OF REGULATORY T CELL DIFFERENTIATION	22	9.22e-01	9.35e-01	0.1600	2.23e-02	-9.86e-02	-5.47e-02	3.88e-03	3.50e-02	-1.05e-01	8.56e-01	4.23e-01	6.57e-01	9.75e-01	7.76e-01	3.93e-01
GOBP POSITIVE REGULATION OF CELL ACTIVATION	329	1.34e-04	8.79e-04	0.1600	-1.01e-02	6.53e-02	8.71e-02	1.02e-01	2.19e-02	5.05e-02	7.54e-01	4.17e-02	6.61e-03	1.40e-03	4.94e-01	1.16e-01
GOBP SKELETAL SYSTEM DEVELOPMENT	331	3.97e-08	5.12e-07	0.1600	-7.42e-02	8.90e-02	8.22e-02	5.84e-02	4.33e-02	-2.10e-03	2.04e-02	5.42e-03	1.02e-02	6.78e-02	1.76e-01	9.48e-01
GOBP ENDOTHELIAL CELL MIGRATION	173	4.64e-05	3.40e-04	0.1590	-7.12e-02	2.76e-02	1.24e-01	-2.01e-02	6.28e-02	3.43e-03	1.06e-01	5.31e-01	5.07e-03	6.48e-01	1.54e-01	9.38e-01
GOBP REGULATION OF ENDOTHELIAL CELL MIGRATION	132	4.70e-05	3.43e-04	0.1590	-8.64e-02	-4.26e-02	1.18e-01	2.28e-03	4.23e-02	-1.88e-02	8.67e-02	3.98e-01	1.88e-02	9.64e-01	4.02e-01	7.09e-01
GOBP MONOATOMIC ION TRANSPORT	863	1.98e-12	4.33e-11	0.1590	-1.80e-02	-2.22e-02	1.34e-01	4.60e-03	-6.81e-02	4.54e-02	3.70e-01	2.69e-01	2.68e-11	8.19e-01	6.89e-04	2.37e-02
GOBP MITOCHONDRION DISTRIBUTION	17	8.42e-01	8.72e-01	0.1590	-9.91e-02	5.85e-02	-4.20e-03	1.33e-02	-9.71e-02	5.00e-02	4.79e-01	6.76e-01	9.76e-01	9.24e-01	4.88e-01	7.21e-01
GOBP CYTOKINE PRODUCTION	670	5.66e-13	1.28e-11	0.1590	-8.28e-02	5.30e-02	6.31e-02	7.58e-02	2.60e-02	7.24e-02	2.59e-04	1.95e-02	5.39e-03	8.22e-04	2.52e-01	1.40e-03
GOBP GLIOGENESIS	257	6.22e-06	5.54e-05	0.1590	-8.81e-02	3.19e-03	1.26e-01	1.78e-02	-3.08e-02	2.22e-02	1.51e-02	9.30e-01	5.31e-04	6.24e-01	3.96e-01	5.41e-01
GOBP NEGATIVE REGULATION OF DNA BINDING TRANSCRIPTION FACTOR ACTIVITY	117	6.65e-02	1.45e-01	0.1590	-6.18e-02	-2.01e-02	1.29e-01	1.68e-02	-2.89e-02	5.81e-02	2.49e-01	7.07e-01	1.62e-02	7.54e-01	5.90e-01	2.78e-01
GOBP CELLULAR RESPONSE TO STEROID HORMONE STIMULUS	167	3.65e-03	1.52e-02	0.1590	-9.36e-02	-2.65e-02	6.41e-02	8.40e-02	-3.34e-02	5.90e-02	3.68e-02	5.54e-01	1.53e-01	6.10e-02	4.57e-01	1.88e-01
GOBP RESPONSE TO METAL ION	257	7.37e-04	3.92e-03	0.1590	-8.05e-02	-3.17e-02	9.72e-02	3.61e-02	-1.78e-02	8.15e-02	2.63e-02	3.82e-01	7.29e-03	3.20e-01	6.24e-01	2.44e-02
GOMF LIPASE ACTIVITY	100	1.00e-01	1.96e-01	0.1590	-7.37e-02	-1.61e-02	8.08e-02	6.13e-02	5.07e-02	8.13e-02	2.03e-01	7.81e-01	1.63e-01	2.89e-01	3.81e-01	1.60e-01
GOBP GLIAL CELL DEVELOPMENT	102	5.90e-03	2.24e-02	0.1590	-1.05e-01	-3.11e-02	1.09e-01	-8.48e-03	-1.75e-02	-2.99e-02	6.69e-02	5.87e-01	5.73e-02	8.82e-01	7.61e-01	6.02e-01
GOBP ORGANIC ACID TRANSMEMBRANE TRANSPORT	115	1.07e-02	3.63e-02	0.1580	-7.92e-02	-4.92e-02	2.70e-02	1.11e-01	-5.72e-02	-1.43e-02	1.42e-01	3.62e-01	6.17e-01	4.06e-02	2.90e-01	7.91e-01
GOBP SUPEROXIDE METABOLIC PROCESS	52	1.44e-01	2.54e-01	0.1580	-3.19e-02	-2.17e-02	4.82e-02	-1.09e-01	8.59e-02	-4.47e-02	6.91e-01	7.87e-01	5.48e-01	1.73e-01	2.84e-01	5.77e-01
GOBP NEGATIVE REGULATION OF MOLECULAR FUNCTION	551	5.26e-08	6.68e-07	0.1580	-8.53e-02	-2.97e-02	8.20e-02	3.87e-02	-1.92e-02	9.14e-02	6.23e-04	2.34e-01	1.00e-03	1.21e-01	4.42e-01	2.43e-04
GOBP OSTEOBLAST PROLIFERATION	26	7.62e-01	8.09e-01	0.1580	4.06e-04	3.11e-02	8.35e-02	-1.17e-01	1.63e-02	-5.48e-02	9.97e-01	7.83e-01	4.61e-01	3.00e-01	8.86e-01	6.29e-01
GOMF PHOSPHORIC ESTER HYDROLASE ACTIVITY	304	4.50e-05	3.31e-04	0.1580	-7.69e-02	8.99e-04	7.70e-02	7.78e-02	-1.99e-02	8.18e-02	2.12e-02	9.78e-01	2.10e-02	1.97e-02	5.51e-01	1.42e-02
GOCC TRANS GOLGI NETWORK	236	4.43e-04	2.53e-03	0.1580	-1.23e-01	-1.29e-04	-1.40e-02	6.13e-02	3.54e-02	6.78e-02	1.13e-03	9.97e-01	7.10e-01	1.05e-01	3.49e-01	7.28e-02
GOMF SNARE BINDING	86	2.63e-01	3.83e-01	0.1580	-1.15e-01	-2.93e-02	2.14e-02	4.76e-02	-1.05e-02	8.99e-02	6.62e-02	6.39e-01	7.32e-01	4.46e-01	8.67e-01	1.50e-01
GOBP REGULATION OF MICROTUBULE POLYMERIZATION	55	3.92e-01	5.05e-01	0.1580	-1.78e-04	9.36e-03	2.80e-02	1.55e-01	-8.21e-03	-6.18e-03	9.98e-01	9.04e-01	7.20e-01	4.74e-02	9.16e-01	9.37e-01
GOBP NERVOUS SYSTEM PROCESS	724	1.45e-09	2.24e-08	0.1580	-6.39e-02	6.89e-02	1.02e-01	-1.21e-02	1.44e-02	7.25e-02	3.44e-03	1.61e-03	2.99e-06	5.79e-01	5.10e-01	9.00e-04
GOBP APOPTOTIC SIGNALING PATHWAY	524	1.73e-09	2.64e-08	0.1580	-8.60e-02	-8.46e-02	3.55e-02	7.39e-02	7.58e-03	5.92e-02	7.63e-04	9.26e-04	1.65e-01	3.80e-03	7.67e-01	2.04e-02
GOBP REGULATION OF ATP METABOLIC PROCESS	61	4.10e-01	5.21e-01	0.1580	1.24e-02	-5.59e-02	1.70e-02	1.45e-01	-1.34e-02	-5.70e-03	8.67e-01	4.50e-01	8.18e-01	5.01e-02	8.56e-01	9.39e-01
GOBP AMINOGLYCAN METABOLIC PROCESS	102	2.77e-02	7.55e-02	0.1580	-8.31e-02	-3.55e-02	9.23e-02	4.69e-02	-7.64e-02	-9.72e-03	1.47e-01	5.35e-01	1.07e-01	4.13e-01	1.82e-01	8.65e-01
GOMF ACYLTRANSFERASE ACTIVITY	627	6.12e-14	1.51e-12	0.1570	-1.14e-01	-1.17e-02	-1.37e-02	8.23e-02	-2.21e-02	6.53e-02	1.17e-06	6.16e-01	5.58e-01	4.37e-04	3.46e-01	5.30e-03
GOBP PATTERN SPECIFICATION PROCESS	264	2.08e-03	9.50e-03	0.1570	-4.29e-03	1.05e-01	7.41e-02	2.94e-02	8.63e-02	1.46e-04	9.04e-01	3.45e-03	3.84e-02	4.10e-01	1.59e-02	9.97e-01
GOBP NEGATIVE REGULATION OF MITOCHONDRIAL FUSION	8	9.90e-01	9.91e-01	0.1570	-8.89e-02	-1.15e-01	2.55e-02	5.11e-02	-8.73e-03	1.58e-02	6.63e-01	5.73e-01	9.01e-01	8.02e-01	9.66e-01	9.38e-01
GOBP RENAL SYSTEM DEVELOPMENT	217	2.60e-02	7.24e-02	0.1570	-1.04e-01	1.69e-02	6.68e-02	-4.99e-02	-6.73e-02	4.51e-02	8.13e-03	6.69e-01	8.98e-02	2.05e-01	8.75e-02	2.52e-01
GOBP POSITIVE REGULATION OF COLD INDUCED THERMOGENESIS	78	7.27e-02	1.55e-01	0.1570	-9.47e-02	-5.91e-02	7.41e-02	4.80e-02	-6.11e-02	-2.62e-02	1.48e-01	3.67e-01	2.58e-01	4.63e-01	3.51e-01	6.89e-01
GOCC PERIKARYON	102	2.14e-01	3.32e-01	0.1570	-2.84e-03	5.01e-02	6.93e-02	1.20e-01	1.54e-02	5.07e-02	9.60e-01	3.82e-01	2.27e-01	3.60e-02	7.88e-01	3.76e-01
GOBP POSITIVE REGULATION OF CATALYTIC ACTIVITY	688	3.14e-11	5.95e-10	0.1570	-7.86e-02	-1.94e-02	9.15e-02	5.07e-02	-4.22e-02	7.26e-02	4.46e-04	3.85e-01	4.34e-05	2.36e-02	5.95e-02	1.18e-03
GOBP NEGATIVE REGULATION OF NUCLEOBASE CONTAINING COMPOUND METABOLIC PROCESS	1184	8.46e-25	5.30e-23	0.1570	-3.60e-02	-6.90e-03	1.25e-02	1.49e-01	3.04e-02	1.10e-03	3.69e-02	6.90e-01	4.70e-01	6.95e-18	7.84e-02	9.49e-01
GOMF ZINC ION BINDING	671	9.10e-12	1.83e-10	0.1570	-5.46e-02	2.22e-02	-7.89e-03	1.27e-01	5.54e-02	4.28e-02	1.59e-02	3.26e-01	7.28e-01	2.14e-08	1.45e-02	5.86e-02
GOCC DYNEIN COMPLEX	45	4.14e-01	5.24e-01	0.1560	-3.65e-02	-1.09e-02	-6.72e-02	-9.60e-02	-2.32e-02	9.36e-02	6.72e-01	8.99e-01	4.35e-01	2.65e-01	7.88e-01	2.77e-01
GOBP REGULATION OF MRNA CATABOLIC PROCESS	167	1.07e-03	5.39e-03	0.1560	-9.04e-02	-1.20e-02	-9.88e-03	1.24e-01	-1.25e-02	2.38e-02	4.38e-02	7.90e-01	8.26e-01	5.83e-03	7.80e-01	5.96e-01
GOCC MICROTUBULE	390	7.96e-06	6.91e-05	0.1560	-3.39e-02	-7.28e-02	1.50e-02	1.16e-01	1.26e-02	6.44e-02	2.51e-01	1.36e-02	6.11e-01	8.70e-05	6.70e-01	2.90e-02
GOBP MYOBLAST DIFFERENTIATION	81	3.41e-01	4.58e-01	0.1560	-1.54e-02	1.02e-01	1.05e-01	4.38e-02	-1.02e-02	2.84e-02	8.10e-01	1.13e-01	1.04e-01	4.96e-01	8.74e-01	6.59e-01
GOBP VITAMIN CATABOLIC PROCESS	8	9.68e-01	9.73e-01	0.1560	1.90e-04	-1.83e-02	-7.69e-02	-3.02e-02	9.06e-03	1.31e-01	9.99e-01	9.29e-01	7.07e-01	8.82e-01	9.65e-01	5.22e-01
GOMF ALCOHOL BINDING	66	1.18e-01	2.21e-01	0.1560	-1.07e-01	-1.04e-03	9.99e-02	3.26e-02	-4.16e-02	-6.96e-03	1.32e-01	9.88e-01	1.60e-01	6.47e-01	5.59e-01	9.22e-01
GOBP POSITIVE REGULATION OF ATP METABOLIC PROCESS	23	9.52e-01	9.61e-01	0.1560	-5.70e-02	-2.30e-02	3.14e-02	1.07e-03	-7.19e-02	1.20e-01	6.36e-01	8.49e-01	7.94e-01	9.93e-01	5.50e-01	3.20e-01
GOBP POSITIVE REGULATION OF CELL POPULATION PROLIFERATION	686	6.80e-08	8.52e-07	0.1560	-3.43e-02	1.05e-02	1.09e-01	4.47e-02	-8.70e-03	9.50e-02	1.26e-01	6.38e-01	1.24e-06	4.59e-02	6.98e-01	2.25e-05
GOBP PHOSPHATIDYLGLYCEROL METABOLIC PROCESS	28	6.46e-01	7.19e-01	0.1550	-6.86e-02	2.49e-02	8.63e-02	9.38e-02	5.02e-02	4.61e-03	5.30e-01	8.20e-01	4.29e-01	3.90e-01	6.46e-01	9.66e-01
GOCC NEURON SPINE	128	5.87e-02	1.33e-01	0.1550	-7.13e-02	7.76e-02	9.73e-02	1.69e-02	3.08e-02	4.80e-02	1.64e-01	1.30e-01	5.73e-02	7.41e-01	5.48e-01	3.48e-01
GOBP NEGATIVE REGULATION OF SIGNALING	1131	1.40e-21	6.85e-20	0.1550	-5.57e-02	3.80e-02	9.80e-02	8.11e-02	-8.83e-03	5.71e-02	1.58e-03	3.15e-02	2.76e-08	4.34e-06	6.17e-01	1.20e-03
GOBP NEGATIVE REGULATION OF FAT CELL DIFFERENTIATION	37	4.41e-01	5.49e-01	0.1550	3.28e-02	-2.77e-02	8.12e-02	-4.89e-02	-1.81e-02	-1.14e-01	7.30e-01	7.71e-01	3.93e-01	6.07e-01	8.49e-01	2.32e-01
GOBP MICROTUBULE ORGANIZING CENTER ORGANIZATION	142	4.96e-02	1.17e-01	0.1550	-5.71e-02	-1.96e-02	-5.15e-02	8.23e-02	5.41e-02	8.91e-02	2.40e-01	6.87e-01	2.89e-01	9.05e-02	2.66e-01	6.69e-02
GOBP RESPONSE TO CARBOHYDRATE	175	1.18e-04	7.83e-04	0.1550	-1.21e-01	8.23e-03	8.68e-02	-1.62e-02	-1.03e-02	-3.69e-02	5.94e-03	8.51e-01	4.75e-02	7.11e-01	8.13e-01	4.00e-01
GOMF AMINO ACID BINDING	30	7.66e-01	8.12e-01	0.1540	-5.85e-02	-4.02e-02	2.00e-02	1.11e-01	7.53e-02	1.94e-02	5.80e-01	7.03e-01	8.49e-01	2.93e-01	4.75e-01	8.54e-01
GOBP PHOSPHATIDYLINOSITOL 3 KINASE PROTEIN KINASE B SIGNAL TRANSDUCTION	229	2.50e-03	1.11e-02	0.1530	-7.34e-02	-1.08e-02	1.10e-01	2.86e-03	-7.07e-02	3.11e-02	5.56e-02	7.79e-01	4.19e-03	9.41e-01	6.54e-02	4.18e-01
GOBP CARBOHYDRATE METABOLIC PROCESS	463	4.26e-12	8.93e-11	0.1530	-9.82e-02	-5.15e-02	3.10e-02	9.76e-02	2.51e-02	-7.88e-03	2.95e-04	5.77e-02	2.53e-01	3.22e-04	3.55e-01	7.71e-01
GOBP NUCLEOBASE CONTAINING SMALL MOLECULE CATABOLIC PROCESS	28	9.26e-01	9.38e-01	0.1530	2.68e-02	-1.81e-02	3.50e-02	6.22e-02	2.00e-02	1.30e-01	8.06e-01	8.68e-01	7.49e-01	5.69e-01	8.55e-01	2.34e-01
GOBP REGULATION OF NEURON DIFFERENTIATION	116	3.46e-01	4.63e-01	0.1530	1.08e-02	4.84e-02	9.73e-02	6.74e-02	4.84e-02	6.79e-02	8.41e-01	3.68e-01	7.04e-02	2.10e-01	3.68e-01	2.06e-01
GOBP REGULATION OF MUSCLE CELL DIFFERENTIATION	107	1.85e-02	5.56e-02	0.1530	-1.86e-02	4.44e-02	5.47e-02	1.06e-01	3.03e-02	-7.68e-02	7.39e-01	4.27e-01	3.28e-01	5.80e-02	5.89e-01	1.70e-01
GOBP POSITIVE REGULATION OF INTRACELLULAR PROTEIN TRANSPORT	86	7.64e-02	1.61e-01	0.1530	-1.07e-01	2.28e-02	2.21e-02	7.16e-02	7.51e-02	-8.69e-03	8.52e-02	7.15e-01	7.24e-01	2.51e-01	2.28e-01	8.89e-01
GOBP MONOSACCHARIDE TRANSMEMBRANE TRANSPORT	94	1.69e-02	5.19e-02	0.1520	-1.21e-01	-2.35e-03	5.55e-02	1.87e-02	6.79e-02	-2.16e-02	4.20e-02	9.69e-01	3.53e-01	7.53e-01	2.55e-01	7.17e-01
GOBP POSITIVE REGULATION OF DNA BINDING TRANSCRIPTION FACTOR ACTIVITY	179	2.36e-02	6.71e-02	0.1520	7.23e-04	7.70e-02	9.70e-02	8.12e-02	-1.83e-02	3.10e-02	9.87e-01	7.55e-02	2.52e-02	6.11e-02	6.73e-01	4.75e-01
GOMF RECEPTOR TYROSINE KINASE BINDING	68	3.83e-01	4.96e-01	0.1520	3.83e-02	5.53e-02	3.37e-02	1.29e-01	-1.94e-02	-2.17e-02	5.85e-01	4.30e-01	6.31e-01	6.54e-02	7.82e-01	7.57e-01
GOBP FAT SOLUBLE VITAMIN METABOLIC PROCESS	26	7.64e-01	8.11e-01	0.1520	-1.38e-02	-3.26e-02	-3.24e-02	-8.80e-02	1.09e-01	-3.70e-02	9.03e-01	7.74e-01	7.75e-01	4.37e-01	3.38e-01	7.44e-01
GOBP REGENERATION	152	9.39e-02	1.87e-01	0.1520	-1.46e-02	5.50e-02	1.20e-01	-2.16e-02	-7.05e-02	1.08e-02	7.56e-01	2.42e-01	1.06e-02	6.46e-01	1.34e-01	8.18e-01
GOBP ORGANIC ACID BIOSYNTHETIC PROCESS	254	1.19e-03	5.89e-03	0.1520	-9.86e-02	-8.35e-02	2.76e-02	2.78e-02	2.28e-02	6.63e-02	6.82e-03	2.19e-02	4.49e-01	4.46e-01	5.32e-01	6.88e-02
GOCC CILIUM	560	1.25e-06	1.29e-05	0.1520	-5.12e-02	3.05e-02	-6.72e-02	-7.50e-03	1.22e-01	-8.14e-03	3.82e-02	2.18e-01	6.54e-03	7.62e-01	7.55e-07	7.42e-01
GOBP REGULATION OF GENERATION OF PRECURSOR METABOLITES AND ENERGY	119	9.43e-02	1.88e-01	0.1520	-3.89e-02	-7.36e-02	3.68e-02	1.04e-01	1.89e-02	5.97e-02	4.63e-01	1.65e-01	4.88e-01	4.96e-02	7.21e-01	2.61e-01
GOBP CELLULAR RESPONSE TO RADIATION	152	1.05e-01	2.03e-01	0.1520	-3.78e-02	-1.09e-01	-3.66e-02	5.60e-02	-7.26e-02	9.98e-03	4.21e-01	2.09e-02	4.36e-01	2.34e-01	1.22e-01	8.32e-01
GOBP ENERGY RESERVE METABOLIC PROCESS	74	1.89e-01	3.04e-01	0.1510	-1.25e-01	1.47e-02	5.02e-02	4.84e-02	-2.08e-02	4.25e-02	6.32e-02	8.27e-01	4.55e-01	4.72e-01	7.57e-01	5.27e-01
GOBP REGULATION OF FATTY ACID METABOLIC PROCESS	67	3.20e-01	4.40e-01	0.1510	-7.58e-03	6.95e-02	4.78e-02	1.09e-01	4.39e-02	-4.34e-02	9.15e-01	3.25e-01	4.99e-01	1.22e-01	5.34e-01	5.39e-01
GOCC POLYMERIC CYTOSKELETAL FIBER	531	8.01e-08	9.98e-07	0.1510	-2.59e-02	-5.93e-02	5.24e-02	1.06e-01	6.72e-04	6.78e-02	3.07e-01	1.94e-02	3.89e-02	2.80e-05	9.79e-01	7.56e-03
GOCC SOMATODENDRITIC COMPARTMENT	602	1.15e-08	1.60e-07	0.1510	-3.37e-02	7.67e-02	1.08e-01	4.59e-02	1.48e-02	4.30e-02	1.58e-01	1.31e-03	6.19e-06	5.46e-02	5.35e-01	7.18e-02
GOBP POSITIVE REGULATION OF EPITHELIAL CELL APOPTOTIC PROCESS	30	7.58e-01	8.06e-01	0.1510	-6.14e-02	-6.36e-02	5.82e-02	3.53e-02	6.94e-02	7.43e-02	5.61e-01	5.47e-01	5.81e-01	7.38e-01	5.10e-01	4.81e-01
GOCC INTERMEDIATE FILAMENT CYTOSKELETON	90	5.87e-01	6.70e-01	0.1510	4.21e-02	5.11e-02	4.81e-02	1.16e-01	3.42e-02	3.68e-02	4.90e-01	4.02e-01	4.30e-01	5.62e-02	5.75e-01	5.46e-01
GOMF ORGANIC ACID TRANSMEMBRANE TRANSPORTER ACTIVITY	121	6.88e-02	1.49e-01	0.1510	3.21e-02	8.80e-03	6.09e-02	1.26e-01	-4.57e-02	-6.96e-03	5.42e-01	8.67e-01	2.47e-01	1.69e-02	3.86e-01	8.95e-01
GOBP NEGATIVE REGULATION OF CELL POPULATION PROLIFERATION	544	1.24e-07	1.49e-06	0.1510	-2.55e-02	2.01e-02	1.31e-01	3.38e-02	-1.10e-02	5.65e-02	3.10e-01	4.24e-01	1.64e-07	1.78e-01	6.60e-01	2.43e-02
GOBP CHEMICAL HOMEOSTASIS	765	7.35e-14	1.80e-12	0.1510	-8.13e-02	-3.34e-02	8.32e-02	6.30e-02	-2.51e-02	5.83e-02	1.32e-04	1.16e-01	9.08e-05	3.04e-03	2.38e-01	6.09e-03
GOBP NEGATIVE REGULATION OF INTRINSIC APOPTOTIC SIGNALING PATHWAY IN RESPONSE TO DNA DAMAGE	27	6.37e-01	7.13e-01	0.1500	-6.01e-02	-1.13e-01	3.74e-02	-3.79e-02	5.84e-02	2.10e-03	5.89e-01	3.10e-01	7.37e-01	7.33e-01	5.99e-01	9.85e-01
GOBP POSITIVE REGULATION OF KINASE ACTIVITY	235	1.03e-02	3.51e-02	0.1500	-7.08e-02	-1.41e-02	7.23e-02	4.91e-02	-4.12e-03	9.85e-02	6.16e-02	7.09e-01	5.62e-02	1.95e-01	9.13e-01	9.27e-03
GOBP REGULATION OF AEROBIC RESPIRATION	31	8.56e-01	8.83e-01	0.1500	-4.38e-02	-1.39e-01	-2.91e-02	-8.43e-04	2.17e-02	4.53e-03	6.73e-01	1.80e-01	7.79e-01	9.94e-01	8.34e-01	9.65e-01
GOBP POSITIVE REGULATION OF TYPE II INTERFERON PRODUCTION	68	1.40e-01	2.49e-01	0.1500	-5.33e-02	6.04e-02	5.22e-02	1.14e-01	-1.04e-02	-1.03e-02	4.48e-01	3.89e-01	4.57e-01	1.03e-01	8.83e-01	8.83e-01
GOBP POSITIVE REGULATION OF PROTEIN TRANSPORT	204	3.56e-04	2.10e-03	0.1500	-1.25e-01	-1.60e-02	4.61e-02	4.44e-02	3.97e-02	2.94e-02	2.06e-03	6.93e-01	2.56e-01	2.75e-01	3.28e-01	4.69e-01
GOBP PYRIMIDINE CONTAINING COMPOUND CATABOLIC PROCESS	39	8.43e-01	8.72e-01	0.1500	6.47e-03	-5.18e-02	2.91e-02	6.43e-02	2.20e-02	1.19e-01	9.44e-01	5.76e-01	7.53e-01	4.87e-01	8.12e-01	1.98e-01
GOBP LYMPHOID PROGENITOR CELL DIFFERENTIATION	21	9.67e-01	9.73e-01	0.1500	1.35e-02	1.16e-01	5.83e-02	-6.28e-02	3.68e-02	-3.62e-03	9.15e-01	3.57e-01	6.44e-01	6.18e-01	7.71e-01	9.77e-01
GOCC SUPRAMOLECULAR POLYMER	710	2.09e-08	2.82e-07	0.1500	-1.58e-02	-3.72e-02	7.96e-02	7.94e-02	-1.20e-02	8.91e-02	4.73e-01	9.13e-02	3.06e-04	3.16e-04	5.85e-01	5.29e-05
GOBP MUSCLE STRUCTURE DEVELOPMENT	496	2.85e-06	2.75e-05	0.1490	-4.46e-03	5.34e-02	1.17e-01	6.31e-02	-5.99e-03	4.15e-02	8.65e-01	4.18e-02	7.88e-06	1.62e-02	8.19e-01	1.14e-01
GOBP REGULATION OF CELLULAR KETONE METABOLIC PROCESS	100	3.91e-02	9.80e-02	0.1490	-5.13e-02	2.18e-02	4.25e-02	1.28e-01	2.50e-02	-1.95e-02	3.76e-01	7.07e-01	4.62e-01	2.68e-02	6.66e-01	7.36e-01
GOBP INSULIN SECRETION	146	4.10e-03	1.67e-02	0.1490	-7.44e-02	9.06e-03	1.27e-01	-8.09e-03	-2.19e-02	-1.77e-03	1.21e-01	8.50e-01	8.12e-03	8.66e-01	6.47e-01	9.71e-01
GOBP LONG CHAIN FATTY ACID METABOLIC PROCESS	81	1.01e-01	1.97e-01	0.1490	-1.23e-02	-1.05e-01	-2.47e-02	-5.22e-03	1.02e-01	-7.14e-03	8.49e-01	1.02e-01	7.01e-01	9.35e-01	1.13e-01	9.12e-01
GOBP RESPONSE TO ABIOTIC STIMULUS	892	1.57e-16	4.86e-15	0.1490	-6.47e-02	-2.43e-02	8.44e-02	8.15e-02	3.96e-03	6.06e-02	1.06e-03	2.19e-01	1.95e-05	3.72e-05	8.41e-01	2.15e-03
GOMF COPPER ION BINDING	47	7.72e-01	8.16e-01	0.1490	-2.86e-03	-8.10e-02	-9.53e-02	-7.17e-02	-2.61e-02	-2.44e-02	9.73e-01	3.36e-01	2.58e-01	3.95e-01	7.57e-01	7.72e-01
GOBP CELL CELL RECOGNITION	44	6.63e-01	7.31e-01	0.1490	-3.52e-03	-4.44e-02	7.31e-02	1.16e-01	-3.35e-03	3.63e-02	9.68e-01	6.10e-01	4.01e-01	1.84e-01	9.69e-01	6.77e-01
GOBP ADAPTIVE THERMOGENESIS	136	6.94e-03	2.57e-02	0.1480	-1.23e-01	-3.62e-02	4.94e-02	1.25e-02	-3.64e-02	-4.05e-02	1.32e-02	4.67e-01	3.20e-01	8.01e-01	4.63e-01	4.15e-01
GOBP NEGATIVE REGULATION OF RESPONSE TO STIMULUS	1351	1.08e-22	5.65e-21	0.1480	-4.50e-02	2.84e-02	8.83e-02	8.95e-02	-8.04e-03	5.73e-02	5.57e-03	8.08e-02	5.31e-08	3.57e-08	6.20e-01	4.15e-04
GOBP SMOOTH MUSCLE CELL APOPTOTIC PROCESS	25	7.69e-01	8.15e-01	0.1480	6.17e-02	-9.69e-02	8.48e-02	-2.33e-02	-2.94e-02	-1.37e-02	5.93e-01	4.02e-01	4.63e-01	8.40e-01	7.99e-01	9.05e-01
GOBP ACTIVATION OF PROTEIN KINASE ACTIVITY	59	6.08e-01	6.88e-01	0.1480	-4.28e-02	-3.00e-02	7.57e-03	8.13e-02	-6.09e-04	1.12e-01	5.70e-01	6.90e-01	9.20e-01	2.80e-01	9.94e-01	1.37e-01
GOBP XENOBIOTIC CATABOLIC PROCESS	18	9.84e-01	9.86e-01	0.1480	-1.37e-02	-3.02e-02	7.28e-02	-7.58e-02	-3.20e-02	9.38e-02	9.20e-01	8.25e-01	5.93e-01	5.78e-01	8.14e-01	4.91e-01
GOBP T CELL PROLIFERATION	184	1.42e-02	4.54e-02	0.1480	-4.22e-02	-1.40e-02	7.32e-02	9.52e-02	3.02e-02	6.77e-02	3.23e-01	7.43e-01	8.68e-02	2.59e-02	4.81e-01	1.13e-01
GOCC SCHAFFER COLLATERAL CA1 SYNAPSE	69	3.09e-01	4.29e-01	0.1480	-1.11e-01	-1.65e-03	8.56e-02	1.62e-02	-1.01e-02	4.31e-02	1.10e-01	9.81e-01	2.19e-01	8.16e-01	8.85e-01	5.36e-01
GOBP LIPID METABOLIC PROCESS	1067	6.02e-17	1.94e-15	0.1480	-1.13e-01	-6.45e-02	1.64e-02	4.05e-02	2.14e-02	4.93e-02	3.93e-10	3.78e-04	3.66e-01	2.55e-02	2.39e-01	6.53e-03
GOMF AMINO ACID TRANSMEMBRANE TRANSPORTER ACTIVITY	63	3.57e-01	4.73e-01	0.1480	1.60e-02	-2.47e-02	2.94e-02	8.37e-02	-1.11e-01	-2.59e-02	8.26e-01	7.35e-01	6.87e-01	2.50e-01	1.27e-01	7.22e-01
GOBP REGULATION OF MORPHOGENESIS OF A BRANCHING STRUCTURE	32	9.00e-01	9.18e-01	0.1480	3.49e-02	1.02e-01	4.48e-02	-6.27e-02	6.46e-02	-1.02e-02	7.32e-01	3.19e-01	6.61e-01	5.40e-01	5.27e-01	9.21e-01
GOBP NEGATIVE REGULATION OF CELL CYCLE G1 S PHASE TRANSITION	67	3.35e-01	4.52e-01	0.1470	-5.98e-02	-5.53e-02	-9.18e-03	9.95e-02	-6.72e-02	2.49e-02	3.97e-01	4.34e-01	8.97e-01	1.59e-01	3.41e-01	7.25e-01
GOBP TRANSMISSION OF NERVE IMPULSE	39	9.15e-01	9.30e-01	0.1470	4.44e-02	1.67e-02	1.04e-01	-5.90e-02	-5.09e-02	5.12e-02	6.31e-01	8.57e-01	2.62e-01	5.24e-01	5.83e-01	5.80e-01
GOBP EPITHELIUM DEVELOPMENT	799	8.49e-14	2.07e-12	0.1470	-5.00e-02	4.70e-02	1.14e-01	4.67e-02	1.30e-02	4.14e-02	1.62e-02	2.39e-02	4.84e-08	2.48e-02	5.32e-01	4.66e-02
GOBP GLIAL CELL DIFFERENTIATION	186	4.70e-04	2.67e-03	0.1470	-6.56e-02	3.16e-02	1.26e-01	2.24e-02	2.37e-05	5.22e-03	1.23e-01	4.57e-01	3.07e-03	5.99e-01	1.00e+00	9.02e-01
GOBP REGULATION OF HORMONE LEVELS	355	8.53e-04	4.46e-03	0.1470	-5.77e-02	1.71e-02	1.14e-01	-1.81e-02	-2.06e-02	6.49e-02	6.17e-02	5.80e-01	2.18e-04	5.59e-01	5.06e-01	3.56e-02
GOBP REGULATION OF MYOBLAST DIFFERENTIATION	53	4.04e-01	5.15e-01	0.1470	-1.16e-02	6.59e-02	3.63e-02	1.24e-01	-1.95e-02	-6.82e-03	8.84e-01	4.07e-01	6.48e-01	1.18e-01	8.06e-01	9.32e-01
GOBP SINGLE FERTILIZATION	91	4.93e-01	5.92e-01	0.1470	-5.55e-02	-6.82e-02	6.67e-02	1.64e-02	-8.13e-02	5.00e-02	3.60e-01	2.61e-01	2.71e-01	7.87e-01	1.80e-01	4.09e-01
GOBP POSITIVE REGULATION OF PROTEIN KINASE ACTIVITY	204	2.27e-02	6.53e-02	0.1470	-8.27e-02	-5.58e-03	7.59e-02	3.48e-02	-3.63e-02	7.95e-02	4.17e-02	8.91e-01	6.17e-02	3.91e-01	3.72e-01	5.03e-02
GOBP INTRACELLULAR GLUCOSE HOMEOSTASIS	121	2.53e-02	7.07e-02	0.1470	-8.49e-02	1.63e-02	9.19e-02	3.82e-02	-6.38e-02	6.02e-03	1.07e-01	7.57e-01	8.08e-02	4.68e-01	2.26e-01	9.09e-01
GOMF SULFUR COMPOUND TRANSMEMBRANE TRANSPORTER ACTIVITY	47	7.45e-01	7.97e-01	0.1460	4.46e-02	-3.99e-02	-1.25e-02	1.11e-01	-1.52e-03	-7.28e-02	5.97e-01	6.36e-01	8.82e-01	1.87e-01	9.86e-01	3.88e-01
GOBP GLYCOSYL COMPOUND CATABOLIC PROCESS	31	9.23e-01	9.35e-01	0.1460	-5.97e-02	-1.19e-01	-3.75e-02	-4.48e-02	7.87e-03	1.10e-02	5.65e-01	2.50e-01	7.18e-01	6.66e-01	9.40e-01	9.16e-01
GOBP RESPONSE TO ARSENIC CONTAINING SUBSTANCE	28	6.97e-01	7.60e-01	0.1460	-6.54e-02	2.70e-02	1.19e-01	-2.34e-02	-1.90e-02	-3.55e-02	5.49e-01	8.05e-01	2.75e-01	8.30e-01	8.62e-01	7.45e-01
GOMF COLLAGEN BINDING	54	6.10e-01	6.89e-01	0.1460	-5.96e-02	1.12e-01	1.78e-02	-5.37e-02	2.83e-02	-3.59e-02	4.49e-01	1.55e-01	8.21e-01	4.95e-01	7.19e-01	6.48e-01
GOBP LIPID HOMEOSTASIS	124	1.03e-01	1.99e-01	0.1460	-5.74e-02	-3.18e-02	9.60e-02	4.41e-02	-6.48e-02	4.06e-02	2.70e-01	5.41e-01	6.50e-02	3.96e-01	2.13e-01	4.35e-01
GOBP TUMOR NECROSIS FACTOR MEDIATED SIGNALING PATHWAY	98	1.41e-01	2.51e-01	0.1460	-8.55e-02	4.09e-02	6.09e-02	5.76e-02	5.44e-02	4.79e-02	1.43e-01	4.84e-01	2.98e-01	3.24e-01	3.52e-01	4.12e-01
GOBP ORGANIC HYDROXY COMPOUND METABOLIC PROCESS	406	2.16e-06	2.14e-05	0.1460	-8.66e-02	-6.36e-02	4.00e-02	6.19e-02	2.48e-02	6.07e-02	2.77e-03	2.80e-02	1.67e-01	3.24e-02	3.92e-01	3.58e-02
GOBP EMBRYONIC DIGIT MORPHOGENESIS	34	6.98e-01	7.60e-01	0.1460	-6.83e-02	7.54e-02	-1.64e-02	4.94e-02	1.54e-02	8.92e-02	4.90e-01	4.47e-01	8.68e-01	6.18e-01	8.76e-01	3.68e-01
GOBP POSITIVE REGULATION OF STRIATED MUSCLE CONTRACTION	11	9.91e-01	9.91e-01	0.1460	9.17e-02	4.40e-02	9.34e-02	-4.43e-02	9.08e-03	-1.19e-02	5.98e-01	8.00e-01	5.92e-01	7.99e-01	9.58e-01	9.46e-01
GOBP VITAMIN METABOLIC PROCESS	89	2.55e-01	3.75e-01	0.1460	-3.58e-02	-8.18e-02	-4.57e-02	2.46e-02	1.02e-01	-1.01e-02	5.59e-01	1.82e-01	4.56e-01	6.88e-01	9.52e-02	8.69e-01
GOBP REGULATION OF EPITHELIAL CELL PROLIFERATION	253	6.48e-05	4.61e-04	0.1460	-3.52e-02	3.50e-02	1.35e-01	-1.14e-03	-2.13e-02	-9.88e-03	3.35e-01	3.38e-01	2.23e-04	9.75e-01	5.61e-01	7.87e-01
GOBP REGULATION OF POSITIVE CHEMOTAXIS	15	9.69e-01	9.74e-01	0.1450	8.10e-02	-7.71e-02	2.96e-02	-3.77e-02	-6.63e-02	-4.38e-02	5.87e-01	6.05e-01	8.42e-01	8.01e-01	6.57e-01	7.69e-01
GOBP OLIGODENDROCYTE DIFFERENTIATION	75	2.19e-01	3.38e-01	0.1450	-4.54e-02	1.31e-02	1.15e-01	6.69e-02	5.17e-03	3.13e-02	4.96e-01	8.45e-01	8.38e-02	3.16e-01	9.38e-01	6.40e-01
GOBP RESPONSE TO NUTRIENT LEVELS	376	3.20e-07	3.62e-06	0.1450	-1.06e-01	-1.21e-02	7.51e-02	2.87e-02	-5.48e-02	1.15e-02	4.04e-04	6.88e-01	1.24e-02	3.39e-01	6.79e-02	7.03e-01
GOBP POSITIVE REGULATION OF PEPTIDYL SERINE PHOSPHORYLATION	53	7.05e-01	7.65e-01	0.1450	-2.29e-03	4.13e-02	1.33e-01	-2.36e-02	-2.32e-02	2.04e-02	9.77e-01	6.03e-01	9.33e-02	7.66e-01	7.70e-01	7.97e-01
GOMF TETRAPYRROLE BINDING	98	2.35e-01	3.53e-01	0.1450	1.03e-02	-8.31e-02	2.69e-02	-8.02e-02	-3.73e-02	7.36e-02	8.60e-01	1.55e-01	6.46e-01	1.70e-01	5.24e-01	2.08e-01
GOBP PROTEIN CONTAINING COMPLEX LOCALIZATION	166	1.19e-01	2.21e-01	0.1450	-5.85e-02	-2.14e-02	-5.94e-02	6.15e-02	9.83e-02	9.53e-03	1.93e-01	6.34e-01	1.87e-01	1.71e-01	2.89e-02	8.32e-01
GOBP NEPHRON DEVELOPMENT	103	3.63e-01	4.78e-01	0.1450	-3.70e-02	5.29e-02	9.80e-02	-2.90e-02	-7.73e-02	1.80e-02	5.16e-01	3.53e-01	8.56e-02	6.11e-01	1.76e-01	7.52e-01
GOMF SERINE HYDROLASE ACTIVITY	109	4.61e-02	1.10e-01	0.1440	2.14e-02	-1.44e-02	1.34e-01	2.26e-02	-3.56e-02	-2.34e-02	7.00e-01	7.96e-01	1.59e-02	6.83e-01	5.20e-01	6.73e-01
GOCC CYTOSOLIC REGION	19	9.29e-01	9.40e-01	0.1440	-1.14e-01	-3.27e-02	-3.31e-02	6.56e-02	-3.70e-02	9.83e-03	3.91e-01	8.05e-01	8.03e-01	6.21e-01	7.80e-01	9.41e-01
GOBP REGULATION OF NUCLEOTIDE CATABOLIC PROCESS	45	6.27e-01	7.04e-01	0.1440	1.21e-02	4.00e-02	7.82e-02	1.02e-01	-5.05e-02	-3.51e-03	8.88e-01	6.43e-01	3.64e-01	2.37e-01	5.58e-01	9.68e-01
GOMF VITAMIN BINDING	110	3.13e-01	4.33e-01	0.1440	-6.51e-02	-1.02e-01	-4.46e-02	6.19e-02	2.08e-02	-1.31e-03	2.38e-01	6.55e-02	4.19e-01	2.62e-01	7.07e-01	9.81e-01
GOMF HSP70 PROTEIN BINDING	45	8.61e-01	8.87e-01	0.1440	-8.33e-02	-9.22e-02	2.21e-04	4.08e-03	-5.48e-03	7.21e-02	3.34e-01	2.85e-01	9.98e-01	9.62e-01	9.49e-01	4.02e-01
GOBP NEURONAL ION CHANNEL CLUSTERING	9	9.98e-01	9.98e-01	0.1430	-1.25e-02	-9.49e-02	-9.55e-02	-8.62e-03	3.20e-02	-3.43e-02	9.48e-01	6.22e-01	6.20e-01	9.64e-01	8.68e-01	8.58e-01
GOMF SH2 DOMAIN BINDING	42	9.21e-01	9.34e-01	0.1430	1.92e-02	-3.87e-02	8.16e-02	-1.08e-02	-9.93e-02	4.52e-02	8.29e-01	6.64e-01	3.60e-01	9.04e-01	2.65e-01	6.12e-01
GOCC CYTOPLASMIC REGION	225	2.28e-02	6.54e-02	0.1430	-4.65e-02	9.10e-02	1.73e-02	2.50e-02	7.46e-02	5.99e-02	2.30e-01	1.86e-02	6.55e-01	5.19e-01	5.40e-02	1.21e-01
GOBP ORGANOPHOSPHATE ESTER TRANSPORT	128	4.12e-02	1.02e-01	0.1430	-2.27e-02	-4.00e-03	6.20e-02	1.26e-01	1.44e-02	9.92e-03	6.58e-01	9.38e-01	2.26e-01	1.40e-02	7.79e-01	8.46e-01
GOBP PROTEIN LOCALIZATION TO POSTSYNAPSE	33	6.28e-01	7.04e-01	0.1430	-7.73e-02	3.21e-03	2.63e-02	4.06e-03	-1.85e-02	-1.16e-01	4.42e-01	9.75e-01	7.94e-01	9.68e-01	8.54e-01	2.49e-01
GOBP POSITIVE REGULATION OF LEUKOCYTE MEDIATED IMMUNITY	136	1.16e-02	3.88e-02	0.1430	-4.43e-02	7.92e-02	-1.23e-02	1.00e-01	1.86e-03	4.53e-02	3.72e-01	1.11e-01	8.04e-01	4.38e-02	9.70e-01	3.62e-01
GOBP REGULATION OF ADAPTIVE IMMUNE RESPONSE	194	3.10e-02	8.18e-02	0.1430	-4.57e-02	7.25e-02	7.30e-02	5.18e-02	4.94e-02	5.16e-02	2.72e-01	8.19e-02	7.96e-02	2.13e-01	2.36e-01	2.16e-01
GOBP LONG CHAIN FATTY ACID BIOSYNTHETIC PROCESS	20	9.63e-01	9.69e-01	0.1430	3.62e-04	-8.37e-02	-2.87e-02	-5.00e-02	-9.24e-03	-9.98e-02	9.98e-01	5.17e-01	8.24e-01	6.99e-01	9.43e-01	4.40e-01
GOBP MATERNAL PROCESS INVOLVED IN FEMALE PREGNANCY	44	5.69e-01	6.56e-01	0.1430	-7.62e-02	5.23e-02	1.06e-01	-2.09e-02	7.18e-03	-1.84e-03	3.82e-01	5.48e-01	2.22e-01	8.11e-01	9.34e-01	9.83e-01
GOBP ORGANELLE ASSEMBLY	886	2.30e-12	4.98e-11	0.1420	-7.60e-02	-3.72e-02	-5.97e-03	9.15e-02	2.86e-02	6.14e-02	1.27e-04	6.02e-02	7.63e-01	3.83e-06	1.49e-01	1.94e-03
GOBP REGULATION OF CALCIUM ION TRANSMEMBRANE TRANSPORTER ACTIVITY	47	8.64e-01	8.89e-01	0.1420	7.59e-03	1.13e-01	5.99e-02	3.80e-02	1.62e-02	4.53e-02	9.28e-01	1.81e-01	4.77e-01	6.52e-01	8.47e-01	5.91e-01
GOMF PHOSPHOLIPID BINDING	394	1.27e-07	1.53e-06	0.1420	-8.85e-02	-1.45e-02	6.70e-02	7.85e-02	-1.36e-02	3.42e-02	2.57e-03	6.22e-01	2.26e-02	7.48e-03	6.44e-01	2.44e-01
GOBP HOMEOSTATIC PROCESS	1315	1.76e-21	8.52e-20	0.1410	-7.86e-02	-1.86e-02	8.00e-02	5.96e-02	-1.78e-02	5.65e-02	1.75e-06	2.59e-01	1.14e-06	2.92e-04	2.79e-01	5.85e-04
GOBP POSITIVE REGULATION OF MUSCLE CELL DIFFERENTIATION	48	4.53e-01	5.58e-01	0.1410	-2.14e-02	5.99e-02	4.71e-02	9.68e-03	2.30e-02	-1.14e-01	7.97e-01	4.73e-01	5.72e-01	9.08e-01	7.82e-01	1.71e-01
GOBP CELLULAR PROCESS INVOLVED IN REPRODUCTION IN MULTICELLULAR ORGANISM	253	4.26e-02	1.04e-01	0.1410	-8.41e-02	-1.25e-02	7.52e-02	-1.62e-02	-4.16e-02	7.08e-02	2.13e-02	7.32e-01	3.95e-02	6.58e-01	2.55e-01	5.25e-02
GOBP CIRCADIAN REGULATION OF GENE EXPRESSION	60	1.93e-01	3.09e-01	0.1410	-4.95e-02	6.29e-02	7.66e-02	4.31e-02	-6.59e-03	-7.53e-02	5.08e-01	3.99e-01	3.05e-01	5.64e-01	9.30e-01	3.13e-01
GOBP REGULATION OF INSULIN SECRETION	124	2.13e-02	6.21e-02	0.1410	-3.49e-02	1.75e-02	1.32e-01	5.11e-03	-2.35e-02	-1.65e-02	5.02e-01	7.36e-01	1.13e-02	9.22e-01	6.51e-01	7.52e-01
GOMF ENZYME ACTIVATOR ACTIVITY	536	7.49e-09	1.07e-07	0.1400	-7.60e-02	1.16e-02	7.73e-02	6.39e-02	-3.71e-02	4.89e-02	2.62e-03	6.45e-01	2.22e-03	1.14e-02	1.42e-01	5.29e-02
GOBP PROTEIN LOCALIZATION TO CELL PERIPHERY	290	6.77e-05	4.79e-04	0.1400	-1.03e-01	-2.33e-03	7.62e-02	3.85e-02	-1.75e-02	3.77e-02	2.44e-03	9.46e-01	2.57e-02	2.59e-01	6.08e-01	2.70e-01
GOMF ENZYME REGULATOR ACTIVITY	1097	9.35e-16	2.66e-14	0.1400	-5.83e-02	-2.95e-03	7.41e-02	7.71e-02	-1.82e-02	6.72e-02	1.12e-03	8.69e-01	3.46e-05	1.65e-05	3.10e-01	1.76e-04
GOBP KIDNEY MORPHOGENESIS	58	6.22e-01	7.00e-01	0.1400	-2.71e-02	9.61e-02	5.63e-02	-2.04e-02	-6.39e-02	4.53e-02	7.21e-01	2.06e-01	4.58e-01	7.88e-01	4.00e-01	5.51e-01
GOMF LONG CHAIN FATTY ACID COA LIGASE ACTIVITY	13	9.89e-01	9.91e-01	0.1400	9.59e-03	4.28e-02	6.59e-02	6.99e-02	9.10e-02	1.32e-02	9.52e-01	7.89e-01	6.81e-01	6.62e-01	5.70e-01	9.35e-01
GOBP POSITIVE REGULATION OF PROTEIN SECRETION	109	7.03e-02	1.51e-01	0.1400	-1.16e-01	-1.01e-02	6.04e-02	2.83e-02	2.53e-02	3.12e-02	3.67e-02	8.55e-01	2.76e-01	6.10e-01	6.48e-01	5.74e-01
GOBP REGULATION OF CELLULAR SENESCENCE	40	9.16e-01	9.30e-01	0.1400	-1.03e-01	-5.01e-02	3.71e-02	-1.94e-02	-2.51e-02	6.42e-02	2.61e-01	5.84e-01	6.85e-01	8.32e-01	7.84e-01	4.83e-01
GOBP RESPIRATORY SYSTEM DEVELOPMENT	157	5.61e-03	2.16e-02	0.1400	-4.77e-02	2.68e-02	1.19e-01	8.51e-03	-4.16e-02	-2.56e-02	3.03e-01	5.62e-01	1.03e-02	8.54e-01	3.68e-01	5.80e-01
GOBP MICROTUBULE CYTOSKELETON ORGANIZATION	556	1.84e-06	1.84e-05	0.1400	-3.98e-02	-3.25e-02	2.22e-02	1.00e-01	2.36e-02	7.60e-02	1.09e-01	1.90e-01	3.72e-01	5.53e-05	3.41e-01	2.21e-03
GOBP POSITIVE REGULATION OF INTRACELLULAR TRANSPORT	126	9.98e-02	1.95e-01	0.1390	-5.20e-02	1.67e-02	3.51e-02	1.02e-01	6.21e-02	3.02e-02	3.13e-01	7.46e-01	4.97e-01	4.76e-02	2.29e-01	5.59e-01
GOBP NECROPTOTIC PROCESS	39	7.00e-01	7.61e-01	0.1390	-2.68e-02	1.15e-01	1.91e-02	4.59e-02	-7.64e-03	5.27e-02	7.72e-01	2.13e-01	8.36e-01	6.20e-01	9.34e-01	5.69e-01
GOBP POSITIVE REGULATION OF ADAPTIVE IMMUNE RESPONSE	119	2.34e-01	3.53e-01	0.1390	-1.13e-01	-2.24e-02	-5.31e-02	2.19e-02	2.99e-02	-4.24e-02	3.35e-02	6.73e-01	3.17e-01	6.80e-01	5.74e-01	4.25e-01
GOCC GLUTAMATERGIC SYNAPSE	310	3.78e-04	2.21e-03	0.1390	-4.18e-02	6.72e-02	8.78e-02	6.21e-02	9.35e-03	3.54e-02	2.06e-01	4.19e-02	7.84e-03	6.00e-02	7.77e-01	2.84e-01
GOBP NEGATIVE REGULATION OF CELLULAR SENESCENCE	20	9.61e-01	9.68e-01	0.1380	2.62e-02	4.97e-02	8.36e-02	9.45e-02	-1.74e-03	-9.71e-03	8.39e-01	7.01e-01	5.18e-01	4.65e-01	9.89e-01	9.40e-01
GOBP POSITIVE REGULATION OF INSULIN SECRETION	64	3.34e-01	4.52e-01	0.1380	-1.26e-01	-3.15e-02	4.16e-02	1.82e-02	-8.35e-03	-6.81e-03	8.03e-02	6.63e-01	5.65e-01	8.01e-01	9.08e-01	9.25e-01
GOBP NEUROMUSCULAR JUNCTION DEVELOPMENT	40	6.51e-01	7.23e-01	0.1380	3.85e-02	5.08e-02	-8.29e-02	6.86e-02	-2.89e-02	-5.16e-02	6.73e-01	5.79e-01	3.64e-01	4.53e-01	7.52e-01	5.72e-01
GOBP PROTEIN ACYLATION	86	2.51e-01	3.70e-01	0.1380	-1.26e-02	-4.82e-02	-7.87e-03	8.37e-02	-9.71e-02	9.98e-03	8.40e-01	4.40e-01	9.00e-01	1.80e-01	1.19e-01	8.73e-01
GOBP LENS FIBER CELL DIFFERENTIATION	29	7.74e-01	8.18e-01	0.1380	-2.12e-02	2.47e-02	8.60e-02	6.19e-02	-7.53e-02	-3.30e-02	8.43e-01	8.18e-01	4.23e-01	5.64e-01	4.83e-01	7.59e-01
GOMF HYDROLASE ACTIVITY ACTING ON CARBON NITROGEN BUT NOT PEPTIDE BONDS	120	1.49e-01	2.60e-01	0.1380	-2.38e-03	-5.33e-02	-3.24e-02	3.08e-02	1.04e-01	5.77e-02	9.64e-01	3.13e-01	5.40e-01	5.59e-01	4.93e-02	2.75e-01
GOBP SENSORY PERCEPTION	355	3.67e-03	1.52e-02	0.1380	-4.70e-02	5.77e-02	5.72e-02	-9.34e-02	-3.63e-02	-1.02e-02	1.28e-01	6.21e-02	6.40e-02	2.51e-03	2.40e-01	7.42e-01
GOBP PROGRAMMED NECROTIC CELL DEATH	50	8.71e-01	8.95e-01	0.1380	3.27e-02	7.30e-02	8.70e-03	9.45e-02	4.03e-02	4.38e-02	6.89e-01	3.72e-01	9.15e-01	2.48e-01	6.22e-01	5.92e-01
GOBP REGULATION OF INSULIN SECRETION INVOLVED IN CELLULAR RESPONSE TO GLUCOSE STIMULUS	43	5.46e-01	6.36e-01	0.1370	-8.55e-02	1.99e-03	-6.46e-03	9.29e-02	2.03e-02	-4.99e-02	3.32e-01	9.82e-01	9.42e-01	2.92e-01	8.18e-01	5.71e-01
GOMF PENTOSYLTRANSFERASE ACTIVITY	48	8.22e-01	8.56e-01	0.1370	-9.84e-02	-3.39e-02	-4.78e-02	-1.47e-02	1.85e-02	7.23e-02	2.38e-01	6.84e-01	5.67e-01	8.60e-01	8.25e-01	3.86e-01
GOBP REGULATION OF VOLTAGE GATED CALCIUM CHANNEL ACTIVITY	18	9.76e-01	9.79e-01	0.1370	2.90e-02	7.94e-02	1.50e-02	-8.59e-02	-5.48e-02	-3.30e-02	8.31e-01	5.60e-01	9.12e-01	5.28e-01	6.87e-01	8.09e-01
GOBP CYTOSKELETON DEPENDENT INTRACELLULAR TRANSPORT	187	8.24e-02	1.70e-01	0.1370	-4.40e-02	1.86e-02	1.49e-02	4.44e-02	4.33e-02	1.11e-01	2.99e-01	6.61e-01	7.26e-01	2.96e-01	3.07e-01	8.56e-03
GOBP REGULATION OF CELL POPULATION PROLIFERATION	1258	1.37e-15	3.84e-14	0.1370	-4.31e-02	4.20e-03	1.03e-01	4.12e-02	3.85e-03	6.65e-02	1.02e-02	8.02e-01	7.09e-10	1.41e-02	8.18e-01	7.36e-05
GOBP REGULATION OF DNA BINDING TRANSCRIPTION FACTOR ACTIVITY	290	2.04e-03	9.32e-03	0.1370	-2.89e-02	5.75e-02	9.71e-02	6.05e-02	2.35e-03	3.84e-02	3.98e-01	9.24e-02	4.44e-03	7.64e-02	9.45e-01	2.60e-01
GOCC NEURON PROJECTION	944	4.14e-12	8.73e-11	0.1370	-5.90e-02	6.41e-02	8.36e-02	3.53e-02	1.27e-02	5.19e-02	2.13e-03	8.49e-04	1.38e-05	6.66e-02	5.10e-01	6.95e-03
GOBP REGULATION OF IMMUNOGLOBULIN PRODUCTION	68	6.77e-01	7.44e-01	0.1370	2.91e-02	-1.13e-02	-1.80e-02	1.23e-01	1.97e-02	4.22e-02	6.79e-01	8.72e-01	7.97e-01	7.87e-02	7.79e-01	5.47e-01
GOMF PEPTIDE BINDING	212	2.96e-02	7.95e-02	0.1360	-8.81e-02	-6.05e-02	-4.86e-03	5.98e-02	1.67e-02	5.74e-02	2.71e-02	1.29e-01	9.03e-01	1.34e-01	6.75e-01	1.50e-01
GOBP CELLULAR RESPONSE TO CARBOHYDRATE STIMULUS	117	2.93e-02	7.87e-02	0.1360	-9.02e-02	4.11e-02	8.35e-02	2.45e-02	-2.98e-02	-1.56e-02	9.18e-02	4.43e-01	1.19e-01	6.48e-01	5.78e-01	7.71e-01
GOBP POSITIVE REGULATION OF TRANSFERASE ACTIVITY	298	4.41e-03	1.76e-02	0.1360	-7.28e-02	-5.53e-02	2.94e-02	5.93e-02	-4.62e-03	7.56e-02	3.08e-02	1.01e-01	3.83e-01	7.84e-02	8.91e-01	2.48e-02
GOBP MULTICELLULAR ORGANISMAL LEVEL HOMEOSTASIS	637	8.41e-09	1.20e-07	0.1360	-5.93e-02	3.48e-02	8.21e-02	6.30e-02	8.36e-03	5.39e-02	1.06e-02	1.34e-01	4.10e-04	6.67e-03	7.19e-01	2.03e-02
GOBP EXTRINSIC APOPTOTIC SIGNALING PATHWAY	191	5.52e-03	2.13e-02	0.1360	-1.02e-01	-3.86e-02	6.46e-02	2.06e-02	2.09e-02	3.89e-02	1.52e-02	3.58e-01	1.24e-01	6.23e-01	6.19e-01	3.54e-01
GOMF MONOATOMIC CATION TRANSMEMBRANE TRANSPORTER ACTIVITY	456	2.18e-05	1.71e-04	0.1360	-7.15e-03	-6.35e-02	9.70e-02	2.58e-02	-5.66e-02	3.16e-02	7.94e-01	2.01e-02	3.87e-04	3.45e-01	3.84e-02	2.48e-01
GOBP POSITIVE REGULATION OF PROGRAMMED CELL DEATH	452	1.86e-05	1.47e-04	0.1350	-7.77e-02	-4.41e-02	6.83e-02	3.92e-02	-1.56e-02	6.07e-02	4.64e-03	1.08e-01	1.28e-02	1.53e-01	5.70e-01	2.70e-02
GOBP RESPONSE TO INTERLEUKIN 1	83	1.48e-01	2.58e-01	0.1340	-4.87e-02	-1.57e-02	1.22e-01	-2.14e-03	-2.41e-02	-6.52e-03	4.43e-01	8.04e-01	5.57e-02	9.73e-01	7.04e-01	9.18e-01
GOBP TRANSMEMBRANE TRANSPORT	1131	6.99e-12	1.43e-10	0.1340	-5.51e-02	-7.24e-02	6.85e-02	1.02e-02	-6.12e-02	3.17e-02	1.79e-03	4.04e-05	1.03e-04	5.64e-01	5.20e-04	7.22e-02
GOBP CARBOHYDRATE TRANSPORT	108	2.69e-02	7.40e-02	0.1330	-1.04e-01	6.60e-03	5.27e-02	8.65e-03	5.55e-02	-3.30e-02	6.29e-02	9.06e-01	3.44e-01	8.77e-01	3.19e-01	5.54e-01
GOCC POSTSYNAPSE	478	1.93e-06	1.93e-05	0.1330	-5.18e-02	4.32e-02	9.88e-02	4.43e-02	-9.48e-03	3.74e-02	5.23e-02	1.06e-01	2.16e-04	9.69e-02	7.23e-01	1.61e-01
GOCC PRESYNAPSE	402	7.62e-06	6.64e-05	0.1330	-7.74e-02	-2.63e-04	8.20e-02	5.17e-02	-1.95e-02	4.44e-02	7.73e-03	9.93e-01	4.82e-03	7.55e-02	5.02e-01	1.27e-01
GOBP POSITIVE REGULATION OF TORC1 SIGNALING	54	5.78e-01	6.64e-01	0.1330	-1.22e-02	-1.63e-02	5.39e-02	1.09e-01	-4.92e-02	1.07e-02	8.77e-01	8.36e-01	4.93e-01	1.66e-01	5.32e-01	8.92e-01
GOMF PROTEIN TYROSINE KINASE BINDING	95	3.83e-01	4.97e-01	0.1330	4.17e-02	6.59e-02	5.82e-02	8.00e-02	-4.16e-02	-1.00e-02	4.83e-01	2.67e-01	3.27e-01	1.78e-01	4.84e-01	8.66e-01
GOBP MONOCARBOXYLIC ACID BIOSYNTHETIC PROCESS	171	6.99e-02	1.51e-01	0.1330	-7.75e-02	-3.47e-02	5.63e-02	3.23e-02	2.49e-02	7.48e-02	8.06e-02	4.34e-01	2.04e-01	4.67e-01	5.75e-01	9.14e-02
GOBP REGULATION OF FEEDING BEHAVIOR	17	9.59e-01	9.66e-01	0.1330	-5.00e-02	6.15e-02	4.88e-02	-6.51e-02	4.63e-02	-5.07e-02	7.21e-01	6.60e-01	7.27e-01	6.42e-01	7.41e-01	7.18e-01
GOBP PROTEIN HOMOOLIGOMERIZATION	156	9.58e-02	1.90e-01	0.1330	-1.27e-02	-1.44e-02	8.69e-02	8.14e-02	1.64e-02	5.29e-02	7.84e-01	7.57e-01	6.10e-02	7.92e-02	7.24e-01	2.55e-01
GOBP REPRODUCTIVE PROCESS	1007	4.17e-10	7.08e-09	0.1330	-7.11e-02	-2.06e-02	6.99e-02	3.18e-02	-2.62e-02	7.44e-02	1.37e-04	2.70e-01	1.77e-04	8.82e-02	1.59e-01	6.52e-05
GOBP OLEFINIC COMPOUND METABOLIC PROCESS	100	1.54e-01	2.65e-01	0.1320	-2.19e-02	-7.35e-02	-2.91e-02	-4.11e-03	1.03e-01	-1.52e-02	7.05e-01	2.04e-01	6.15e-01	9.43e-01	7.60e-02	7.93e-01
GOBP LONG TERM SYNAPTIC POTENTIATION	63	6.25e-01	7.01e-01	0.1320	-5.45e-02	1.53e-02	1.91e-02	3.91e-02	-3.08e-02	1.07e-01	4.54e-01	8.34e-01	7.93e-01	5.92e-01	6.73e-01	1.42e-01
GOCC TRANSPORTER COMPLEX	325	1.14e-03	5.67e-03	0.1320	2.89e-02	-9.11e-02	6.95e-02	2.14e-02	-4.43e-02	3.35e-02	3.71e-01	4.77e-03	3.14e-02	5.07e-01	1.69e-01	2.99e-01
GOBP CELLULAR RESPONSE TO XENOBIOTIC STIMULUS	128	8.80e-02	1.78e-01	0.1320	-1.93e-02	5.04e-02	1.11e-01	3.06e-02	3.33e-02	8.13e-03	7.06e-01	3.25e-01	2.96e-02	5.50e-01	5.16e-01	8.74e-01
GOBP POSITIVE REGULATION OF MYELOID LEUKOCYTE DIFFERENTIATION	43	6.92e-01	7.56e-01	0.1310	-1.24e-01	-1.83e-02	1.68e-02	3.21e-02	1.44e-02	5.82e-03	1.60e-01	8.36e-01	8.49e-01	7.16e-01	8.70e-01	9.47e-01
GOCC SYNAPSE	1079	8.85e-14	2.15e-12	0.1310	-8.63e-02	-2.32e-02	7.40e-02	2.63e-02	-2.73e-02	4.83e-02	1.73e-06	1.99e-01	4.15e-05	1.45e-01	1.30e-01	7.43e-03
GOBP SPECIFICATION OF SYMMETRY	95	8.40e-02	1.72e-01	0.1310	-5.57e-02	1.25e-02	3.57e-02	-2.92e-02	1.01e-01	-3.96e-02	3.48e-01	8.33e-01	5.48e-01	6.23e-01	8.83e-02	5.05e-01
GOBP MULTICELLULAR ORGANISMAL REPRODUCTIVE PROCESS	624	1.81e-05	1.44e-04	0.1310	-9.01e-02	-1.30e-02	4.64e-02	1.15e-02	-2.91e-02	7.53e-02	1.23e-04	5.81e-01	4.78e-02	6.25e-01	2.15e-01	1.33e-03
GOBP REGULATION OF PROTEIN SECRETION	192	9.58e-03	3.31e-02	0.1310	-5.13e-02	6.35e-03	1.15e-01	1.97e-02	-1.01e-02	2.56e-02	2.20e-01	8.79e-01	5.93e-03	6.38e-01	8.10e-01	5.41e-01
GOBP PEPTIDE TRANSPORT	183	2.38e-03	1.07e-02	0.1300	-4.40e-02	3.07e-02	1.12e-01	9.88e-04	3.73e-02	-2.63e-03	3.04e-01	4.73e-01	8.74e-03	9.82e-01	3.84e-01	9.51e-01
GOBP POSITIVE REGULATION OF SMALL MOLECULE METABOLIC PROCESS	104	2.88e-02	7.76e-02	0.1300	-1.36e-02	-1.09e-02	6.82e-02	6.87e-02	5.92e-02	-6.11e-02	8.11e-01	8.47e-01	2.30e-01	2.26e-01	2.97e-01	2.82e-01
GOMF GLYCOSAMINOGLYCAN BINDING	149	2.77e-02	7.55e-02	0.1300	-8.87e-02	-5.93e-03	8.77e-02	-2.28e-03	-3.40e-02	-5.60e-03	6.16e-02	9.01e-01	6.47e-02	9.62e-01	4.74e-01	9.06e-01
GOMF SULFUR COMPOUND BINDING	190	1.58e-01	2.70e-01	0.1290	-8.56e-02	-8.38e-02	-3.94e-02	8.66e-03	2.45e-02	-1.28e-02	4.18e-02	4.64e-02	3.49e-01	8.37e-01	5.61e-01	7.62e-01
GOBP POSITIVE REGULATION OF MUSCLE CELL APOPTOTIC PROCESS	22	9.79e-01	9.82e-01	0.1290	-6.76e-02	-4.77e-03	-5.86e-02	1.93e-02	3.23e-02	-8.52e-02	5.83e-01	9.69e-01	6.34e-01	8.76e-01	7.93e-01	4.89e-01
GOMF IRON ION BINDING	100	3.00e-01	4.19e-01	0.1290	-3.56e-02	-1.03e-01	-1.13e-02	5.39e-03	4.52e-02	4.91e-02	5.39e-01	7.38e-02	8.45e-01	9.26e-01	4.35e-01	3.96e-01
GOBP REGULATION OF SMALL MOLECULE METABOLIC PROCESS	251	3.49e-04	2.06e-03	0.1290	-4.82e-02	-5.91e-03	3.16e-02	9.99e-02	5.06e-02	-2.58e-02	1.88e-01	8.72e-01	3.89e-01	6.41e-03	1.68e-01	4.81e-01
GOBP ACTIVATION OF CYSTEINE TYPE ENDOPEPTIDASE ACTIVITY INVOLVED IN APOPTOTIC PROCESS	66	8.47e-01	8.76e-01	0.1280	-1.13e-02	-7.37e-03	5.06e-02	8.66e-03	-3.45e-02	1.12e-01	8.74e-01	9.17e-01	4.77e-01	9.03e-01	6.28e-01	1.17e-01
GOBP POSITIVE REGULATION OF GENE EXPRESSION	939	2.73e-10	4.72e-09	0.1280	-7.38e-02	-2.96e-03	5.96e-02	4.61e-02	-2.72e-02	6.75e-02	1.28e-04	8.78e-01	1.99e-03	1.67e-02	1.58e-01	4.62e-04
GOBP CELL PROJECTION ASSEMBLY	538	1.14e-05	9.48e-05	0.1270	-6.09e-02	4.08e-02	1.42e-02	3.86e-02	9.17e-02	2.70e-02	1.58e-02	1.05e-01	5.73e-01	1.26e-01	2.77e-04	2.84e-01
GOBP REGULATION OF PEPTIDE TRANSPORT	141	4.00e-02	9.96e-02	0.1270	-1.29e-02	3.62e-02	1.20e-01	-4.20e-03	3.99e-03	-1.81e-02	7.92e-01	4.58e-01	1.42e-02	9.31e-01	9.35e-01	7.11e-01
GOMF ACYLTRANSFERASE ACTIVITY TRANSFERRING GROUPS OTHER THAN AMINO ACYL GROUPS	193	7.66e-02	1.61e-01	0.1270	-1.13e-01	-3.67e-02	-2.43e-02	2.31e-02	-2.72e-02	1.22e-02	6.80e-03	3.79e-01	5.61e-01	5.80e-01	5.15e-01	7.71e-01
GOBP LOCOMOTORY BEHAVIOR	133	8.58e-02	1.75e-01	0.1270	-8.48e-02	3.00e-02	6.28e-02	4.54e-02	-2.64e-02	3.59e-02	9.13e-02	5.51e-01	2.11e-01	3.66e-01	5.99e-01	4.74e-01
GOCC CALCIUM CHANNEL COMPLEX	53	4.44e-01	5.51e-01	0.1270	-1.54e-02	-4.20e-02	1.09e-01	-2.48e-02	2.50e-02	2.89e-02	8.46e-01	5.97e-01	1.68e-01	7.55e-01	7.53e-01	7.16e-01
GOCC 9PLUS2 MOTILE CILIUM	121	2.07e-01	3.23e-01	0.1270	1.94e-02	5.14e-02	-5.11e-02	-5.46e-02	8.59e-02	8.37e-03	7.12e-01	3.29e-01	3.32e-01	2.99e-01	1.03e-01	8.74e-01
GOCC ACTIN BASED CELL PROJECTION	177	3.46e-01	4.62e-01	0.1270	-6.58e-02	2.51e-02	5.27e-02	-5.54e-02	-6.24e-02	3.62e-02	1.31e-01	5.64e-01	2.27e-01	2.04e-01	1.52e-01	4.06e-01
GOBP PEPTIDYL AMINO ACID MODIFICATION	694	8.31e-09	1.18e-07	0.1250	-8.25e-02	-1.19e-02	3.28e-02	6.73e-02	-1.82e-02	5.26e-02	2.12e-04	5.93e-01	1.41e-01	2.53e-03	4.13e-01	1.84e-02
GOBP POSITIVE REGULATION OF LEUKOCYTE PROLIFERATION	134	4.89e-01	5.88e-01	0.1250	2.89e-02	3.61e-02	6.49e-02	7.42e-02	5.59e-02	2.50e-02	5.64e-01	4.70e-01	1.94e-01	1.38e-01	2.64e-01	6.17e-01
GOMF MOLECULAR FUNCTION ACTIVATOR ACTIVITY	809	4.31e-10	7.27e-09	0.1250	-3.15e-02	1.93e-02	9.98e-02	5.55e-02	-1.59e-02	3.06e-02	1.28e-01	3.51e-01	1.44e-06	7.35e-03	4.42e-01	1.39e-01
GOMF MONOATOMIC ION TRANSMEMBRANE TRANSPORTER ACTIVITY	529	3.42e-05	2.59e-04	0.1250	-6.28e-04	-4.83e-02	9.80e-02	1.62e-02	-4.96e-02	2.93e-02	9.80e-01	5.76e-02	1.16e-04	5.23e-01	5.11e-02	2.49e-01
GOMF TRANSITION METAL ION BINDING	866	1.75e-09	2.67e-08	0.1240	-6.49e-02	-1.29e-02	-5.72e-03	8.74e-02	4.05e-02	4.04e-02	1.19e-03	5.19e-01	7.75e-01	1.27e-05	4.30e-02	4.37e-02
GOBP REGULATION OF MICROTUBULE BASED PROCESS	215	9.16e-02	1.84e-01	0.1240	-3.87e-02	2.79e-02	-1.56e-02	8.31e-02	6.68e-02	3.75e-02	3.29e-01	4.81e-01	6.94e-01	3.58e-02	9.16e-02	3.43e-01
GOBP POSITIVE REGULATION OF AUTOPHAGY OF MITOCHONDRION	18	9.88e-01	9.89e-01	0.1240	-1.69e-03	-4.17e-02	3.70e-02	7.19e-02	-5.96e-02	5.86e-02	9.90e-01	7.60e-01	7.86e-01	5.97e-01	6.62e-01	6.67e-01
GOBP REGULATION OF NUCLEOTIDE METABOLIC PROCESS	77	5.08e-01	6.03e-01	0.1230	-1.07e-02	-5.65e-02	8.16e-03	1.07e-01	2.84e-03	-1.97e-02	8.72e-01	3.91e-01	9.01e-01	1.05e-01	9.66e-01	7.65e-01
GOMF MODIFIED AMINO ACID BINDING	77	5.94e-01	6.76e-01	0.1230	-1.05e-01	-5.21e-02	1.66e-03	-1.95e-02	3.20e-02	8.23e-03	1.13e-01	4.29e-01	9.80e-01	7.68e-01	6.27e-01	9.01e-01
GOMF ORGANIC ANION TRANSMEMBRANE TRANSPORTER ACTIVITY	184	5.17e-02	1.20e-01	0.1230	3.69e-02	3.32e-02	3.37e-02	8.63e-02	-3.74e-02	-5.10e-02	3.89e-01	4.37e-01	4.31e-01	4.35e-02	3.82e-01	2.32e-01
GOBP MICROTUBULE BASED PROCESS	780	6.86e-07	7.41e-06	0.1230	-5.48e-02	-2.63e-02	1.69e-02	6.65e-02	2.47e-02	7.75e-02	9.24e-03	2.12e-01	4.22e-01	1.60e-03	2.42e-01	2.36e-04
GOBP CELLULAR RESPONSE TO ABIOTIC STIMULUS	279	2.22e-03	1.00e-02	0.1220	-7.35e-02	-3.52e-02	4.65e-02	6.51e-02	-3.26e-02	2.74e-02	3.48e-02	3.12e-01	1.81e-01	6.13e-02	3.49e-01	4.31e-01
GOBP POSITIVE REGULATION OF T CELL PROLIFERATION	84	5.70e-01	6.57e-01	0.1220	-2.65e-02	-3.36e-02	-1.47e-02	1.02e-01	4.59e-02	-1.51e-02	6.75e-01	5.94e-01	8.16e-01	1.06e-01	4.67e-01	8.11e-01
GOBP REGULATION OF PRODUCTION OF MOLECULAR MEDIATOR OF IMMUNE RESPONSE	163	1.01e-01	1.97e-01	0.1220	-6.29e-02	4.54e-02	6.71e-02	4.63e-02	-1.23e-03	4.63e-02	1.66e-01	3.17e-01	1.40e-01	3.08e-01	9.78e-01	3.08e-01
GOBP REGULATION OF T CELL PROLIFERATION	151	1.49e-01	2.60e-01	0.1220	-4.49e-02	-2.15e-02	6.58e-02	6.91e-02	1.31e-02	5.52e-02	3.41e-01	6.48e-01	1.63e-01	1.43e-01	7.80e-01	2.42e-01
GOBP AMIDE TRANSPORT	229	9.47e-04	4.86e-03	0.1210	-6.88e-02	-1.06e-03	9.88e-02	5.52e-03	1.34e-02	7.94e-03	7.29e-02	9.78e-01	1.00e-02	8.85e-01	7.28e-01	8.36e-01
GOBP MUSCLE CELL APOPTOTIC PROCESS	63	7.10e-01	7.70e-01	0.1210	1.96e-03	-2.80e-03	6.20e-02	9.93e-02	2.32e-02	2.20e-02	9.79e-01	9.69e-01	3.95e-01	1.73e-01	7.50e-01	7.62e-01
GOBP DEVELOPMENTAL PROCESS INVOLVED IN REPRODUCTION	653	6.12e-06	5.47e-05	0.1210	-8.65e-02	-1.14e-02	5.72e-02	1.68e-02	-2.39e-02	5.41e-02	1.64e-04	6.21e-01	1.27e-02	4.64e-01	2.98e-01	1.84e-02
GOBP RESPONSE TO TUMOR CELL	40	8.11e-01	8.48e-01	0.1210	-4.47e-02	-3.05e-02	-9.39e-03	1.03e-01	7.06e-03	-3.14e-02	6.25e-01	7.38e-01	9.18e-01	2.61e-01	9.38e-01	7.31e-01
GOBP POSITIVE REGULATION OF PRODUCTION OF MOLECULAR MEDIATOR OF IMMUNE RESPONSE	118	1.34e-01	2.41e-01	0.1210	-1.03e-01	3.92e-02	2.76e-02	3.57e-02	1.27e-03	2.02e-02	5.31e-02	4.62e-01	6.04e-01	5.02e-01	9.81e-01	7.05e-01
GOBP GAMETE GENERATION	532	5.04e-04	2.83e-03	0.1210	-9.19e-02	-2.13e-02	2.08e-02	1.24e-02	-2.87e-02	6.55e-02	2.90e-04	4.02e-01	4.13e-01	6.25e-01	2.57e-01	9.74e-03
GOBP SEXUAL REPRODUCTION	728	1.20e-05	9.91e-05	0.1200	-7.11e-02	-4.00e-02	2.78e-02	3.78e-02	-2.70e-02	6.99e-02	1.10e-03	6.64e-02	2.01e-01	8.27e-02	2.16e-01	1.32e-03
GOBP NEURON MATURATION	34	8.71e-01	8.95e-01	0.1200	-6.03e-02	4.88e-03	8.70e-02	6.50e-03	3.49e-02	4.29e-02	5.43e-01	9.61e-01	3.80e-01	9.48e-01	7.25e-01	6.65e-01
GOBP REGULATION OF LIPID METABOLIC PROCESS	232	3.19e-03	1.36e-02	0.1190	-6.74e-02	-6.71e-03	5.70e-02	7.63e-02	1.30e-02	1.85e-02	7.69e-02	8.60e-01	1.35e-01	4.53e-02	7.32e-01	6.27e-01
GOBP MICROTUBULE BASED TRANSPORT	191	1.39e-01	2.47e-01	0.1180	-5.85e-02	2.30e-02	-2.17e-02	4.70e-03	6.69e-02	7.12e-02	1.63e-01	5.84e-01	6.05e-01	9.11e-01	1.11e-01	8.99e-02
GOBP AMINO ACID TRANSPORT	110	1.84e-01	2.98e-01	0.1170	-7.69e-02	-1.14e-02	1.77e-02	4.67e-02	-7.05e-02	-1.36e-02	1.64e-01	8.36e-01	7.48e-01	3.98e-01	2.01e-01	8.05e-01
GOMF PHOSPHOLIPASE ACTIVITY	82	6.52e-01	7.24e-01	0.1170	-4.03e-02	-3.62e-02	6.36e-02	3.66e-02	1.76e-02	7.08e-02	5.28e-01	5.71e-01	3.20e-01	5.67e-01	7.83e-01	2.68e-01
GOMF INORGANIC MOLECULAR ENTITY TRANSMEMBRANE TRANSPORTER ACTIVITY	504	7.34e-05	5.16e-04	0.1170	-7.03e-03	-4.99e-02	8.76e-02	4.69e-03	-5.82e-02	3.46e-03	7.87e-01	5.51e-02	7.61e-04	8.57e-01	2.55e-02	8.94e-01
GOBP ORGANIC ACID TRANSPORT	234	4.93e-03	1.94e-02	0.1160	-5.53e-02	3.44e-02	8.87e-02	3.32e-02	-1.44e-02	2.10e-03	1.45e-01	3.65e-01	1.94e-02	3.82e-01	7.05e-01	9.56e-01
GOBP PRIMARY ALCOHOL METABOLIC PROCESS	62	7.93e-01	8.33e-01	0.1150	-8.12e-02	-2.58e-02	-6.38e-02	4.32e-02	1.89e-03	5.94e-03	2.69e-01	7.26e-01	3.85e-01	5.56e-01	9.79e-01	9.36e-01
GOMF EXTRACELLULAR MATRIX BINDING	46	6.04e-01	6.84e-01	0.1140	-1.23e-02	5.46e-03	5.47e-02	1.84e-02	-3.69e-03	-9.74e-02	8.85e-01	9.49e-01	5.21e-01	8.29e-01	9.65e-01	2.53e-01
GOBP MESONEPHRIC TUBULE MORPHOGENESIS	39	9.63e-01	9.69e-01	0.1140	-4.10e-02	2.22e-02	8.24e-02	-3.31e-02	-4.97e-02	2.13e-02	6.58e-01	8.10e-01	3.73e-01	7.20e-01	5.91e-01	8.18e-01
GOBP PROTEIN COMPLEX OLIGOMERIZATION	211	9.69e-02	1.92e-01	0.1130	-2.26e-02	-2.97e-02	2.95e-02	8.96e-02	3.48e-02	3.61e-02	5.72e-01	4.57e-01	4.60e-01	2.50e-02	3.84e-01	3.66e-01
GOMF VITAMIN B6 BINDING	45	9.09e-01	9.25e-01	0.1130	-2.01e-02	-4.10e-02	8.78e-02	8.99e-03	-4.12e-02	3.34e-02	8.15e-01	6.34e-01	3.08e-01	9.17e-01	6.32e-01	6.99e-01
GOBP LIPID MODIFICATION	162	3.89e-01	5.02e-01	0.1120	-4.53e-02	-1.87e-02	-4.86e-02	6.19e-02	5.88e-02	2.46e-02	3.20e-01	6.81e-01	2.86e-01	1.74e-01	1.97e-01	5.89e-01
GOMF SECONDARY ACTIVE TRANSMEMBRANE TRANSPORTER ACTIVITY	204	1.41e-02	4.53e-02	0.1110	-4.12e-02	4.84e-03	8.85e-02	4.73e-02	-2.35e-02	-2.38e-03	3.11e-01	9.05e-01	2.94e-02	2.45e-01	5.63e-01	9.53e-01
GOCC BASEMENT MEMBRANE	62	7.38e-01	7.91e-01	0.1110	-3.87e-03	4.02e-02	9.00e-02	-4.51e-02	2.17e-02	-1.02e-03	9.58e-01	5.84e-01	2.20e-01	5.39e-01	7.67e-01	9.89e-01
GOBP OLIGODENDROCYTE DEVELOPMENT	34	9.14e-01	9.29e-01	0.1090	-4.51e-02	-2.24e-02	4.80e-02	2.59e-02	6.33e-02	4.95e-02	6.49e-01	8.22e-01	6.28e-01	7.94e-01	5.23e-01	6.18e-01
GOBP DETECTION OF ABIOTIC STIMULUS	88	8.11e-01	8.47e-01	0.1090	3.19e-02	6.53e-02	5.72e-02	-5.73e-02	2.27e-03	3.98e-03	6.05e-01	2.90e-01	3.53e-01	3.53e-01	9.71e-01	9.49e-01
GOMF HEPARIN BINDING	107	4.54e-01	5.60e-01	0.1080	-4.40e-02	-3.23e-02	7.78e-02	-7.75e-03	-5.15e-02	-3.57e-03	4.32e-01	5.64e-01	1.64e-01	8.90e-01	3.58e-01	9.49e-01
GOBP SPERMATID DIFFERENTIATION	140	6.16e-01	6.94e-01	0.1080	-6.28e-02	8.98e-03	5.66e-02	-8.91e-03	-3.81e-02	5.30e-02	2.00e-01	8.55e-01	2.48e-01	8.56e-01	4.37e-01	2.79e-01
GOBP NEPHRON MORPHOGENESIS	44	9.62e-01	9.68e-01	0.1070	1.33e-02	5.96e-02	7.64e-02	4.08e-02	5.01e-03	1.40e-02	8.79e-01	4.94e-01	3.80e-01	6.40e-01	9.54e-01	8.73e-01
GOCC CELL BODY	398	5.63e-03	2.16e-02	0.1060	-1.18e-02	4.21e-03	8.80e-02	4.52e-02	6.11e-03	3.51e-02	6.87e-01	8.85e-01	2.60e-03	1.22e-01	8.34e-01	2.30e-01
GOBP SMAD PROTEIN SIGNAL TRANSDUCTION	65	8.26e-01	8.59e-01	0.1050	-3.25e-02	4.50e-02	3.99e-02	1.13e-02	-5.15e-02	6.01e-02	6.50e-01	5.30e-01	5.78e-01	8.75e-01	4.73e-01	4.02e-01
GOBP MALE GAMETE GENERATION	413	1.90e-02	5.68e-02	0.1050	-8.21e-02	-1.30e-02	3.98e-03	6.88e-03	-2.97e-02	5.65e-02	4.22e-03	6.51e-01	8.90e-01	8.10e-01	3.01e-01	4.88e-02
GOBP SENSORY PERCEPTION OF MECHANICAL STIMULUS	119	6.07e-01	6.87e-01	0.1040	-8.07e-02	-1.48e-02	-5.66e-03	-4.75e-02	5.23e-03	-4.32e-02	1.29e-01	7.80e-01	9.15e-01	3.70e-01	9.21e-01	4.16e-01
GOMF LIPID BINDING	659	1.16e-06	1.20e-05	0.1040	-5.93e-02	-1.75e-02	5.68e-02	5.49e-02	-1.49e-02	2.38e-02	9.51e-03	4.43e-01	1.29e-02	1.62e-02	5.15e-01	2.97e-01
GOCC POSTSYNAPTIC SPECIALIZATION	258	2.16e-02	6.29e-02	0.1030	-5.88e-02	2.97e-02	7.59e-02	1.70e-02	6.71e-03	1.65e-02	1.04e-01	4.11e-01	3.58e-02	6.38e-01	8.53e-01	6.49e-01
GOBP POSITIVE REGULATION OF CARBOHYDRATE METABOLIC PROCESS	59	5.85e-01	6.69e-01	0.1030	-7.97e-02	-1.03e-02	4.22e-02	4.03e-02	-1.40e-02	-2.53e-02	2.89e-01	8.91e-01	5.76e-01	5.92e-01	8.52e-01	7.37e-01
GOBP RESPONSE TO AXON INJURY	60	8.62e-01	8.88e-01	0.1030	-7.34e-02	3.78e-02	-2.47e-02	-2.77e-02	-6.24e-03	-4.83e-02	3.26e-01	6.13e-01	7.40e-01	7.11e-01	9.33e-01	5.18e-01
GOCC NEURON TO NEURON SYNAPSE	269	2.58e-02	7.20e-02	0.1030	-6.70e-02	2.28e-02	6.49e-02	2.48e-02	-4.80e-04	2.62e-02	5.86e-02	5.19e-01	6.72e-02	4.84e-01	9.89e-01	4.59e-01
GOBP RENAL TUBULE DEVELOPMENT	59	8.76e-01	8.99e-01	0.1030	-2.13e-03	6.38e-02	7.01e-02	-1.68e-02	-2.31e-02	-2.64e-02	9.77e-01	3.96e-01	3.52e-01	8.23e-01	7.59e-01	7.26e-01
GOBP RESPONSE TO RADIATION	358	1.42e-02	4.55e-02	0.1010	-3.35e-02	-1.17e-02	4.27e-03	9.11e-02	1.54e-02	2.11e-02	2.77e-01	7.03e-01	8.90e-01	3.07e-03	6.17e-01	4.94e-01
GOBP FERTILIZATION	121	7.20e-01	7.78e-01	0.1010	-9.69e-03	-2.75e-02	6.09e-02	4.24e-02	-3.74e-02	4.97e-02	8.54e-01	6.02e-01	2.47e-01	4.20e-01	4.77e-01	3.45e-01
GOBP MICROTUBULE BASED MOVEMENT	329	1.78e-01	2.93e-01	0.1000	-1.34e-02	2.92e-02	2.57e-02	2.05e-02	4.35e-02	7.79e-02	6.76e-01	3.63e-01	4.24e-01	5.23e-01	1.75e-01	1.51e-02
GOBP POSITIVE REGULATION OF PEPTIDE SECRETION	75	5.77e-01	6.63e-01	0.1000	-9.18e-02	-1.45e-02	2.91e-02	1.17e-02	1.85e-02	-1.09e-02	1.69e-01	8.28e-01	6.63e-01	8.61e-01	7.82e-01	8.71e-01
GOCC ACROSOMAL VESICLE	86	4.81e-01	5.82e-01	0.1000	-5.27e-02	5.76e-02	3.25e-02	6.11e-03	-2.82e-04	-5.35e-02	3.98e-01	3.56e-01	6.02e-01	9.22e-01	9.96e-01	3.92e-01
GOBP ACIDIC AMINO ACID TRANSPORT	47	9.68e-01	9.73e-01	0.0991	-2.94e-02	5.04e-02	5.81e-02	1.95e-02	5.46e-04	5.15e-02	7.27e-01	5.50e-01	4.91e-01	8.17e-01	9.95e-01	5.41e-01
GOCC CLUSTER OF ACTIN BASED CELL PROJECTIONS	125	7.95e-01	8.34e-01	0.0975	-2.07e-02	-8.90e-03	7.41e-02	-3.48e-02	-3.94e-02	2.73e-02	6.89e-01	8.64e-01	1.52e-01	5.02e-01	4.47e-01	5.98e-01
GOBP ORGANIC ANION TRANSPORT	310	3.74e-03	1.55e-02	0.0963	-4.68e-02	3.25e-02	7.19e-02	2.30e-02	-8.84e-03	-1.59e-02	1.57e-01	3.25e-01	2.95e-02	4.86e-01	7.89e-01	6.30e-01
GOBP NEGATIVE REGULATION OF PLASMA MEMBRANE BOUNDED CELL PROJECTION ASSEMBLY	34	9.83e-01	9.85e-01	0.0938	-4.61e-02	1.95e-02	1.07e-02	-3.33e-02	-6.97e-02	1.49e-02	6.42e-01	8.44e-01	9.14e-01	7.37e-01	4.82e-01	8.80e-01
GOMF TRANSPORTER ACTIVITY	867	4.59e-06	4.20e-05	0.0929	-1.62e-02	-5.19e-02	4.96e-02	4.77e-02	-2.94e-02	9.23e-03	4.20e-01	9.62e-03	1.32e-02	1.73e-02	1.43e-01	6.45e-01
GOBP DICARBOXYLIC ACID TRANSPORT	71	8.35e-01	8.67e-01	0.0910	-8.12e-02	-2.38e-02	-6.23e-03	2.25e-02	2.24e-02	-8.65e-03	2.37e-01	7.29e-01	9.28e-01	7.43e-01	7.44e-01	9.00e-01
GOBP T CELL MEDIATED IMMUNITY	120	4.37e-01	5.44e-01	0.0894	-4.66e-02	4.66e-02	-2.64e-03	5.82e-02	3.87e-03	1.54e-02	3.78e-01	3.78e-01	9.60e-01	2.71e-01	9.42e-01	7.70e-01
GOBP REGULATION OF T CELL MEDIATED IMMUNITY	90	5.77e-01	6.63e-01	0.0871	-4.85e-02	9.20e-03	5.35e-03	6.32e-02	-3.36e-02	-1.66e-03	4.26e-01	8.80e-01	9.30e-01	3.00e-01	5.81e-01	9.78e-01
GOMF PEPTIDASE ACTIVITY	421	3.07e-02	8.14e-02	0.0870	-7.21e-02	-2.06e-02	3.78e-03	2.84e-02	2.63e-02	2.09e-02	1.12e-02	4.70e-01	8.94e-01	3.18e-01	3.55e-01	4.62e-01
GOMF METALLOPEPTIDASE ACTIVITY	128	6.45e-01	7.19e-01	0.0839	-6.68e-02	-1.24e-02	3.37e-02	-3.43e-02	-2.68e-03	-1.00e-02	1.92e-01	8.09e-01	5.10e-01	5.03e-01	9.58e-01	8.45e-01
GOMF ENDOPEPTIDASE ACTIVITY	260	3.21e-01	4.41e-01	0.0792	-2.08e-02	-1.86e-02	2.67e-02	6.30e-02	1.39e-02	2.47e-02	5.63e-01	6.06e-01	4.58e-01	8.01e-02	7.00e-01	4.93e-01
GOBP RESPONSE TO LIGHT STIMULUS	262	2.87e-01	4.06e-01	0.0709	-1.12e-02	5.57e-03	2.39e-02	6.41e-02	-1.25e-02	-4.76e-03	7.54e-01	8.77e-01	5.05e-01	7.39e-02	7.29e-01	8.95e-01
GOBP XENOBIOTIC METABOLIC PROCESS	79	9.67e-01	9.73e-01	0.0605	8.86e-03	2.16e-02	4.75e-02	-1.87e-02	2.25e-02	1.41e-03	8.92e-01	7.40e-01	4.66e-01	7.74e-01	7.30e-01	9.83e-01

---

Detailed Gene set reports

GOBP ANTIGEN PROCESSING AND PRESENTATION ENDOGENOUS LIPID ANTIGEN VIA MHC CLASS IB

GOBP ANTIGEN PROCESSING AND PRESENTATION ENDOGENOUS LIPID ANTIGEN VIA MHC CLASS IB

metric	value
setSize	5
pMANOVA	1.6e-06
p.adjustMANOVA	1.62e-05
s.dist	2.05
s.crp_t0_adj	-0.82
s.crp_eos_adj	-0.945
s.crp_pod1_adj	-0.962
s.avb_t0_adj	-0.559
s.avb_eos_adj	-0.835
s.avb_pod1_adj	-0.846
p.crp_t0_adj	0.0015
p.crp_eos_adj	0.000252
p.crp_pod1_adj	0.000195
p.avb_t0_adj	0.0304
p.avb_eos_adj	0.00123
p.avb_pod1_adj	0.00106

Warning: Removed 396 rows containing missing values or values outside the scale range (`geom_tile()`).
Removed 396 rows containing missing values or values outside the scale range (`geom_tile()`).
Removed 396 rows containing missing values or values outside the scale range (`geom_tile()`).
Removed 396 rows containing missing values or values outside the scale range (`geom_tile()`).
Removed 396 rows containing missing values or values outside the scale range (`geom_tile()`).
Removed 396 rows containing missing values or values outside the scale range (`geom_tile()`).
Removed 396 rows containing missing values or values outside the scale range (`geom_tile()`).
Removed 396 rows containing missing values or values outside the scale range (`geom_tile()`).
Removed 396 rows containing missing values or values outside the scale range (`geom_tile()`).
Removed 396 rows containing missing values or values outside the scale range (`geom_tile()`).
Removed 396 rows containing missing values or values outside the scale range (`geom_tile()`).
Removed 396 rows containing missing values or values outside the scale range (`geom_tile()`).
Removed 396 rows containing missing values or values outside the scale range (`geom_tile()`).
Removed 396 rows containing missing values or values outside the scale range (`geom_tile()`).
Removed 396 rows containing missing values or values outside the scale range (`geom_tile()`).

Top 20 genes

Gene	d3	d2
CD1E	-10843	-10111
CD1B	-10819	-10124
CD1C	-10581	-9413
CD1A	-10614	-9265
CD1D	-9382	-8858

Click HERE to show all gene set members

All member genes

	crp_t0_adj	crp_eos_adj	crp_pod1_adj	avb_t0_adj	avb_eos_adj	avb_pod1_adj
CD1A	-7808	-9265	-10614	-1410	-7879	-8910
CD1B	-10298	-10124	-10819	-9695	-9602	-10089
CD1C	-4940	-9413	-10581	-1683	-4429	-7047
CD1D	-9100	-8858	-9382	-8908	-8266	-6321
CD1E	-10341	-10111	-10843	-6470	-9456	-10082

---

---

GOMF LIPID ANTIGEN BINDING

GOMF LIPID ANTIGEN BINDING

metric	value
setSize	5
pMANOVA	1.6e-06
p.adjustMANOVA	1.62e-05
s.dist	2.05
s.crp_t0_adj	-0.82
s.crp_eos_adj	-0.945
s.crp_pod1_adj	-0.962
s.avb_t0_adj	-0.559
s.avb_eos_adj	-0.835
s.avb_pod1_adj	-0.846
p.crp_t0_adj	0.0015
p.crp_eos_adj	0.000252
p.crp_pod1_adj	0.000195
p.avb_t0_adj	0.0304
p.avb_eos_adj	0.00123
p.avb_pod1_adj	0.00106

Warning: Removed 396 rows containing missing values or values outside the scale range (`geom_tile()`).
Removed 396 rows containing missing values or values outside the scale range (`geom_tile()`).
Removed 396 rows containing missing values or values outside the scale range (`geom_tile()`).
Removed 396 rows containing missing values or values outside the scale range (`geom_tile()`).
Removed 396 rows containing missing values or values outside the scale range (`geom_tile()`).
Removed 396 rows containing missing values or values outside the scale range (`geom_tile()`).
Removed 396 rows containing missing values or values outside the scale range (`geom_tile()`).
Removed 396 rows containing missing values or values outside the scale range (`geom_tile()`).
Removed 396 rows containing missing values or values outside the scale range (`geom_tile()`).
Removed 396 rows containing missing values or values outside the scale range (`geom_tile()`).
Removed 396 rows containing missing values or values outside the scale range (`geom_tile()`).
Removed 396 rows containing missing values or values outside the scale range (`geom_tile()`).
Removed 396 rows containing missing values or values outside the scale range (`geom_tile()`).
Removed 396 rows containing missing values or values outside the scale range (`geom_tile()`).
Removed 396 rows containing missing values or values outside the scale range (`geom_tile()`).

Top 20 genes

Gene	d3	d2
CD1E	-10843	-10111
CD1B	-10819	-10124
CD1C	-10581	-9413
CD1A	-10614	-9265
CD1D	-9382	-8858

Click HERE to show all gene set members

All member genes

	crp_t0_adj	crp_eos_adj	crp_pod1_adj	avb_t0_adj	avb_eos_adj	avb_pod1_adj
CD1A	-7808	-9265	-10614	-1410	-7879	-8910
CD1B	-10298	-10124	-10819	-9695	-9602	-10089
CD1C	-4940	-9413	-10581	-1683	-4429	-7047
CD1D	-9100	-8858	-9382	-8908	-8266	-6321
CD1E	-10341	-10111	-10843	-6470	-9456	-10082

---

---

GOMF INTERLEUKIN 1 RECEPTOR ACTIVITY

GOMF INTERLEUKIN 1 RECEPTOR ACTIVITY

metric	value
setSize	5
pMANOVA	0.00015
p.adjustMANOVA	0.00097
s.dist	1.6
s.crp_t0_adj	-0.612
s.crp_eos_adj	-0.216
s.crp_pod1_adj	0.856
s.avb_t0_adj	-0.638
s.avb_eos_adj	-0.95
s.avb_pod1_adj	0.328
p.crp_t0_adj	0.0177
p.crp_eos_adj	0.403
p.crp_pod1_adj	0.000918
p.avb_t0_adj	0.0135
p.avb_eos_adj	0.000235
p.avb_pod1_adj	0.204

Warning: Removed 396 rows containing missing values or values outside the scale range (`geom_tile()`).
Removed 396 rows containing missing values or values outside the scale range (`geom_tile()`).
Removed 396 rows containing missing values or values outside the scale range (`geom_tile()`).
Removed 396 rows containing missing values or values outside the scale range (`geom_tile()`).
Removed 396 rows containing missing values or values outside the scale range (`geom_tile()`).
Removed 396 rows containing missing values or values outside the scale range (`geom_tile()`).
Removed 396 rows containing missing values or values outside the scale range (`geom_tile()`).
Removed 396 rows containing missing values or values outside the scale range (`geom_tile()`).
Removed 396 rows containing missing values or values outside the scale range (`geom_tile()`).
Removed 396 rows containing missing values or values outside the scale range (`geom_tile()`).
Removed 396 rows containing missing values or values outside the scale range (`geom_tile()`).
Removed 396 rows containing missing values or values outside the scale range (`geom_tile()`).
Removed 396 rows containing missing values or values outside the scale range (`geom_tile()`).
Removed 396 rows containing missing values or values outside the scale range (`geom_tile()`).
Removed 396 rows containing missing values or values outside the scale range (`geom_tile()`).

Top 20 genes

Gene	d5	d3
IL1R2	-9639	9918
IL1RAP	-9449	9054
IL18R1	-9283	8683
IL1R1	-7873	9526
IL1RL1	-9448	6133

Click HERE to show all gene set members

All member genes

	crp_t0_adj	crp_eos_adj	crp_pod1_adj	avb_t0_adj	avb_eos_adj	avb_pod1_adj
IL18R1	-5014	6310	8683	-7400	-9283	9961
IL1R1	-992	7827	9526	-2657	-7873	254
IL1R2	-6707	-9122	9918	-9975	-9639	-9761
IL1RAP	-8510	-5561	9054	-2818	-9449	8001
IL1RL1	-10382	-8903	6133	-9446	-9448	10779

---

---

GOMF OLIGOSACCHARYL TRANSFERASE ACTIVITY

GOMF OLIGOSACCHARYL TRANSFERASE ACTIVITY

metric	value
setSize	5
pMANOVA	8.51e-05
p.adjustMANOVA	0.000586
s.dist	1.56
s.crp_t0_adj	-0.85
s.crp_eos_adj	-0.773
s.crp_pod1_adj	0.314
s.avb_t0_adj	0.0279
s.avb_eos_adj	-0.664
s.avb_pod1_adj	0.749
p.crp_t0_adj	0.001
p.crp_eos_adj	0.00275
p.crp_pod1_adj	0.224
p.avb_t0_adj	0.914
p.avb_eos_adj	0.0101
p.avb_pod1_adj	0.00373

Warning: Removed 396 rows containing missing values or values outside the scale range (`geom_tile()`).
Removed 396 rows containing missing values or values outside the scale range (`geom_tile()`).
Removed 396 rows containing missing values or values outside the scale range (`geom_tile()`).
Removed 396 rows containing missing values or values outside the scale range (`geom_tile()`).
Removed 396 rows containing missing values or values outside the scale range (`geom_tile()`).
Removed 396 rows containing missing values or values outside the scale range (`geom_tile()`).
Removed 396 rows containing missing values or values outside the scale range (`geom_tile()`).
Removed 396 rows containing missing values or values outside the scale range (`geom_tile()`).
Removed 396 rows containing missing values or values outside the scale range (`geom_tile()`).
Removed 396 rows containing missing values or values outside the scale range (`geom_tile()`).
Removed 396 rows containing missing values or values outside the scale range (`geom_tile()`).
Removed 396 rows containing missing values or values outside the scale range (`geom_tile()`).
Removed 396 rows containing missing values or values outside the scale range (`geom_tile()`).
Removed 396 rows containing missing values or values outside the scale range (`geom_tile()`).
Removed 396 rows containing missing values or values outside the scale range (`geom_tile()`).

Top 20 genes

Gene	d1	d2
OSTC	-10269	-9711
RPN2	-9385	-8855
RPN1	-6748	-8935
STT3B	-10048	-5301
STT3A	-7622	-5936

Click HERE to show all gene set members

All member genes

	crp_t0_adj	crp_eos_adj	crp_pod1_adj	avb_t0_adj	avb_eos_adj	avb_pod1_adj
OSTC	-10269	-9711	-3196	-5189	-5417	8550
RPN1	-6748	-8935	4327	6051	-7877	6275
RPN2	-9385	-8855	7309	1263	-5893	6994
STT3A	-7622	-5936	3113	6058	-6469	9356
STT3B	-10048	-5301	3271	-5489	-5020	10187

---

---

GOMF UNMETHYLATED CPG BINDING

GOMF UNMETHYLATED CPG BINDING

metric	value
setSize	10
pMANOVA	3.38e-06
p.adjustMANOVA	3.2e-05
s.dist	1.45
s.crp_t0_adj	0.648
s.crp_eos_adj	0.699
s.crp_pod1_adj	0.366
s.avb_t0_adj	0.864
s.avb_eos_adj	0.564
s.avb_pod1_adj	0.0763
p.crp_t0_adj	0.00039
p.crp_eos_adj	0.000128
p.crp_pod1_adj	0.0453
p.avb_t0_adj	2.2e-06
p.avb_eos_adj	0.00202
p.avb_pod1_adj	0.676

Warning: Removed 396 rows containing missing values or values outside the scale range (`geom_tile()`).
Removed 396 rows containing missing values or values outside the scale range (`geom_tile()`).
Removed 396 rows containing missing values or values outside the scale range (`geom_tile()`).
Removed 396 rows containing missing values or values outside the scale range (`geom_tile()`).
Removed 396 rows containing missing values or values outside the scale range (`geom_tile()`).
Removed 396 rows containing missing values or values outside the scale range (`geom_tile()`).
Removed 396 rows containing missing values or values outside the scale range (`geom_tile()`).
Removed 396 rows containing missing values or values outside the scale range (`geom_tile()`).
Removed 396 rows containing missing values or values outside the scale range (`geom_tile()`).
Removed 396 rows containing missing values or values outside the scale range (`geom_tile()`).
Removed 396 rows containing missing values or values outside the scale range (`geom_tile()`).
Removed 396 rows containing missing values or values outside the scale range (`geom_tile()`).
Removed 396 rows containing missing values or values outside the scale range (`geom_tile()`).
Removed 396 rows containing missing values or values outside the scale range (`geom_tile()`).
Removed 396 rows containing missing values or values outside the scale range (`geom_tile()`).

Top 20 genes

Gene	d4	d2
DNMT3A	10669	10630
TLR9	10482	10099
KDM2B	10208	10274
KDM2A	10757	9659
MECP2	10446	9029
MBD1	9114	7250
KMT2B	10289	6136
KMT2A	5035	10123
FBXL19	7973	4125
CXXC1	8327	1

Click HERE to show all gene set members

All member genes

	crp_t0_adj	crp_eos_adj	crp_pod1_adj	avb_t0_adj	avb_eos_adj	avb_pod1_adj
CXXC1	8011	1	678	8327	4543	-5093
DNMT3A	8504	10630	9368	10669	10614	10007
FBXL19	6461	4125	8609	7973	4438	2422
KDM2A	2789	9659	7771	10757	10126	6232
KDM2B	6696	10274	-8924	10208	11035	-9957
KMT2A	9524	10123	5681	5035	5242	7438
KMT2B	7718	6136	5893	10289	-1378	-1382
MBD1	6493	7250	7466	9114	2904	2429
MECP2	5233	9029	-2506	10446	9255	-491
TLR9	7825	10099	1032	10482	10945	412

---

---

GOBP ANTIGEN PROCESSING AND PRESENTATION OF LIPID ANTIGEN VIA MHC CLASS IB

GOBP ANTIGEN PROCESSING AND PRESENTATION OF LIPID ANTIGEN VIA MHC CLASS IB

metric	value
setSize	7
pMANOVA	0.000141
p.adjustMANOVA	0.000918
s.dist	1.42
s.crp_t0_adj	-0.681
s.crp_eos_adj	-0.681
s.crp_pod1_adj	-0.574
s.avb_t0_adj	-0.284
s.avb_eos_adj	-0.688
s.avb_pod1_adj	-0.453
p.crp_t0_adj	0.0018
p.crp_eos_adj	0.00179
p.crp_pod1_adj	0.00853
p.avb_t0_adj	0.193
p.avb_eos_adj	0.00161
p.avb_pod1_adj	0.038

Warning: Removed 396 rows containing missing values or values outside the scale range (`geom_tile()`).
Removed 396 rows containing missing values or values outside the scale range (`geom_tile()`).
Removed 396 rows containing missing values or values outside the scale range (`geom_tile()`).
Removed 396 rows containing missing values or values outside the scale range (`geom_tile()`).
Removed 396 rows containing missing values or values outside the scale range (`geom_tile()`).
Removed 396 rows containing missing values or values outside the scale range (`geom_tile()`).
Removed 396 rows containing missing values or values outside the scale range (`geom_tile()`).
Removed 396 rows containing missing values or values outside the scale range (`geom_tile()`).
Removed 396 rows containing missing values or values outside the scale range (`geom_tile()`).
Removed 396 rows containing missing values or values outside the scale range (`geom_tile()`).
Removed 396 rows containing missing values or values outside the scale range (`geom_tile()`).
Removed 396 rows containing missing values or values outside the scale range (`geom_tile()`).
Removed 396 rows containing missing values or values outside the scale range (`geom_tile()`).
Removed 396 rows containing missing values or values outside the scale range (`geom_tile()`).
Removed 396 rows containing missing values or values outside the scale range (`geom_tile()`).

Top 20 genes

Gene	d5	d1
CD1B	-9602	-10298
CD1E	-9456	-10341
CD1D	-8266	-9100
CD1A	-7879	-7808
CD1C	-4429	-4940
AP3B1	-990	-9591

Click HERE to show all gene set members

All member genes

	crp_t0_adj	crp_eos_adj	crp_pod1_adj	avb_t0_adj	avb_eos_adj	avb_pod1_adj
AP3B1	-9591	-759	921	-568	-990	9199
AP3D1	2778	1062	6722	9563	-4104	2721
CD1A	-7808	-9265	-10614	-1410	-7879	-8910
CD1B	-10298	-10124	-10819	-9695	-9602	-10089
CD1C	-4940	-9413	-10581	-1683	-4429	-7047
CD1D	-9100	-8858	-9382	-8908	-8266	-6321
CD1E	-10341	-10111	-10843	-6470	-9456	-10082

---

---

GOCC SARCOPLASMIC RETICULUM LUMEN

GOCC SARCOPLASMIC RETICULUM LUMEN

metric	value
setSize	5
pMANOVA	0.000244
p.adjustMANOVA	0.0015
s.dist	1.4
s.crp_t0_adj	-0.295
s.crp_eos_adj	-0.261
s.crp_pod1_adj	0.78
s.avb_t0_adj	0.447
s.avb_eos_adj	-0.426
s.avb_pod1_adj	0.909
p.crp_t0_adj	0.253
p.crp_eos_adj	0.313
p.crp_pod1_adj	0.00251
p.avb_t0_adj	0.0837
p.avb_eos_adj	0.099
p.avb_pod1_adj	0.000428

Warning: Removed 396 rows containing missing values or values outside the scale range (`geom_tile()`).
Removed 396 rows containing missing values or values outside the scale range (`geom_tile()`).
Removed 396 rows containing missing values or values outside the scale range (`geom_tile()`).
Removed 396 rows containing missing values or values outside the scale range (`geom_tile()`).
Removed 396 rows containing missing values or values outside the scale range (`geom_tile()`).
Removed 396 rows containing missing values or values outside the scale range (`geom_tile()`).
Removed 396 rows containing missing values or values outside the scale range (`geom_tile()`).
Removed 396 rows containing missing values or values outside the scale range (`geom_tile()`).
Removed 396 rows containing missing values or values outside the scale range (`geom_tile()`).
Removed 396 rows containing missing values or values outside the scale range (`geom_tile()`).
Removed 396 rows containing missing values or values outside the scale range (`geom_tile()`).
Removed 396 rows containing missing values or values outside the scale range (`geom_tile()`).
Removed 396 rows containing missing values or values outside the scale range (`geom_tile()`).
Removed 396 rows containing missing values or values outside the scale range (`geom_tile()`).
Removed 396 rows containing missing values or values outside the scale range (`geom_tile()`).

Top 20 genes

Gene	d6	d3
CALR	10500	10017
HSP90B1	10493	7926
MANF	9970	8053
CASQ1	10583	6724
CALU	8255	6628

Click HERE to show all gene set members

All member genes

	crp_t0_adj	crp_eos_adj	crp_pod1_adj	avb_t0_adj	avb_eos_adj	avb_pod1_adj
CALR	-2580	-6422	10017	7398	-7590	10500
CALU	-9776	-4034	6628	-5327	-6735	8255
CASQ1	10347	10846	6724	10661	10699	10583
HSP90B1	-8995	-7009	7926	4755	-5995	10493
MANF	-3917	-5171	8053	7222	-8536	9970

---

---

GOMF GUANYLATE CYCLASE ACTIVITY

GOMF GUANYLATE CYCLASE ACTIVITY

metric	value
setSize	5
pMANOVA	0.00515
p.adjustMANOVA	0.0201
s.dist	1.37
s.crp_t0_adj	-0.509
s.crp_eos_adj	-0.661
s.crp_pod1_adj	0.312
s.avb_t0_adj	-0.464
s.avb_eos_adj	-0.591
s.avb_pod1_adj	0.727
p.crp_t0_adj	0.0487
p.crp_eos_adj	0.0105
p.crp_pod1_adj	0.228
p.avb_t0_adj	0.0723
p.avb_eos_adj	0.0221
p.avb_pod1_adj	0.00486

Warning: Removed 396 rows containing missing values or values outside the scale range (`geom_tile()`).
Removed 396 rows containing missing values or values outside the scale range (`geom_tile()`).
Removed 396 rows containing missing values or values outside the scale range (`geom_tile()`).
Removed 396 rows containing missing values or values outside the scale range (`geom_tile()`).
Removed 396 rows containing missing values or values outside the scale range (`geom_tile()`).
Removed 396 rows containing missing values or values outside the scale range (`geom_tile()`).
Removed 396 rows containing missing values or values outside the scale range (`geom_tile()`).
Removed 396 rows containing missing values or values outside the scale range (`geom_tile()`).
Removed 396 rows containing missing values or values outside the scale range (`geom_tile()`).
Removed 396 rows containing missing values or values outside the scale range (`geom_tile()`).
Removed 396 rows containing missing values or values outside the scale range (`geom_tile()`).
Removed 396 rows containing missing values or values outside the scale range (`geom_tile()`).
Removed 396 rows containing missing values or values outside the scale range (`geom_tile()`).
Removed 396 rows containing missing values or values outside the scale range (`geom_tile()`).
Removed 396 rows containing missing values or values outside the scale range (`geom_tile()`).

Top 20 genes

Gene	d6	d2
GUCY1A1	9692	-9287
GUCY2D	10623	-8047
GUCY2C	8498	-5891
GUCY1B1	4590	-9661

Click HERE to show all gene set members

All member genes

	crp_t0_adj	crp_eos_adj	crp_pod1_adj	avb_t0_adj	avb_eos_adj	avb_pod1_adj
GUCY1A1	-7809	-9287	5253	-7472	-7042	9692
GUCY1B1	-4281	-9661	6904	-5867	-8629	4590
GUCY2C	-8996	-5891	4020	-9243	-9375	8498
GUCY2D	-9026	-8047	-608	-4294	-9458	10623
NPR2	3946	65	-865	3706	7669	6820

---

---

GOCC SIGNAL PEPTIDASE COMPLEX

GOCC SIGNAL PEPTIDASE COMPLEX

metric	value
setSize	5
pMANOVA	0.00296
p.adjustMANOVA	0.0128
s.dist	1.34
s.crp_t0_adj	-0.734
s.crp_eos_adj	-0.756
s.crp_pod1_adj	-0.333
s.avb_t0_adj	-0.338
s.avb_eos_adj	-0.43
s.avb_pod1_adj	0.527
p.crp_t0_adj	0.0045
p.crp_eos_adj	0.00341
p.crp_pod1_adj	0.197
p.avb_t0_adj	0.191
p.avb_eos_adj	0.0959
p.avb_pod1_adj	0.0411

Warning: Removed 396 rows containing missing values or values outside the scale range (`geom_tile()`).
Removed 396 rows containing missing values or values outside the scale range (`geom_tile()`).
Removed 396 rows containing missing values or values outside the scale range (`geom_tile()`).
Removed 396 rows containing missing values or values outside the scale range (`geom_tile()`).
Removed 396 rows containing missing values or values outside the scale range (`geom_tile()`).
Removed 396 rows containing missing values or values outside the scale range (`geom_tile()`).
Removed 396 rows containing missing values or values outside the scale range (`geom_tile()`).
Removed 396 rows containing missing values or values outside the scale range (`geom_tile()`).
Removed 396 rows containing missing values or values outside the scale range (`geom_tile()`).
Removed 396 rows containing missing values or values outside the scale range (`geom_tile()`).
Removed 396 rows containing missing values or values outside the scale range (`geom_tile()`).
Removed 396 rows containing missing values or values outside the scale range (`geom_tile()`).
Removed 396 rows containing missing values or values outside the scale range (`geom_tile()`).
Removed 396 rows containing missing values or values outside the scale range (`geom_tile()`).
Removed 396 rows containing missing values or values outside the scale range (`geom_tile()`).

Top 20 genes

Gene	d2	d1
SEC11A	-9803	-9636
SPCS1	-9620	-6283
SEC11C	-8741	-5740
SPCS2	-6756	-6412
SPCS3	-2908	-9898

Click HERE to show all gene set members

All member genes

	crp_t0_adj	crp_eos_adj	crp_pod1_adj	avb_t0_adj	avb_eos_adj	avb_pod1_adj
SEC11A	-9636	-9803	-10401	-5100	5650	549
SEC11C	-5740	-8741	-7142	-1948	-6159	7249
SPCS1	-6283	-9620	-6320	-4686	-5517	5813
SPCS2	-6412	-6756	3513	160	-6402	10097
SPCS3	-9898	-2908	1178	-4946	-5940	6015

---

---

GOMF SERINE TYPE CARBOXYPEPTIDASE ACTIVITY

GOMF SERINE TYPE CARBOXYPEPTIDASE ACTIVITY

metric	value
setSize	5
pMANOVA	0.00062
p.adjustMANOVA	0.00337
s.dist	1.34
s.crp_t0_adj	-0.83
s.crp_eos_adj	-0.671
s.crp_pod1_adj	0.171
s.avb_t0_adj	-0.743
s.avb_eos_adj	-0.16
s.avb_pod1_adj	0.206
p.crp_t0_adj	0.0013
p.crp_eos_adj	0.00931
p.crp_pod1_adj	0.507
p.avb_t0_adj	0.00402
p.avb_eos_adj	0.536
p.avb_pod1_adj	0.425

Warning: Removed 396 rows containing missing values or values outside the scale range (`geom_tile()`).
Removed 396 rows containing missing values or values outside the scale range (`geom_tile()`).
Removed 396 rows containing missing values or values outside the scale range (`geom_tile()`).
Removed 396 rows containing missing values or values outside the scale range (`geom_tile()`).
Removed 396 rows containing missing values or values outside the scale range (`geom_tile()`).
Removed 396 rows containing missing values or values outside the scale range (`geom_tile()`).
Removed 396 rows containing missing values or values outside the scale range (`geom_tile()`).
Removed 396 rows containing missing values or values outside the scale range (`geom_tile()`).
Removed 396 rows containing missing values or values outside the scale range (`geom_tile()`).
Removed 396 rows containing missing values or values outside the scale range (`geom_tile()`).
Removed 396 rows containing missing values or values outside the scale range (`geom_tile()`).
Removed 396 rows containing missing values or values outside the scale range (`geom_tile()`).
Removed 396 rows containing missing values or values outside the scale range (`geom_tile()`).
Removed 396 rows containing missing values or values outside the scale range (`geom_tile()`).
Removed 396 rows containing missing values or values outside the scale range (`geom_tile()`).

Top 20 genes

Gene	d1	d4
SCPEP1	-10295	-9646
CPD	-10309	-9105
PRCP	-8379	-6753
CPVL	-8776	-5233
CTSA	-5287	-7079

Click HERE to show all gene set members

All member genes

	crp_t0_adj	crp_eos_adj	crp_pod1_adj	avb_t0_adj	avb_eos_adj	avb_pod1_adj
CPD	-10309	-4257	9535	-9105	-9570	10462
CPVL	-8776	-7815	-10662	-5233	10825	-7076
CTSA	-5287	-8312	9246	-7079	-7354	6740
PRCP	-8379	-5933	-9705	-6753	10751	-5462
SCPEP1	-10295	-7069	8911	-9646	-8808	8173

---

---

GOBP SIALYLATION

GOBP SIALYLATION

metric	value
setSize	6
pMANOVA	0.00367
p.adjustMANOVA	0.0152
s.dist	1.33
s.crp_t0_adj	0.344
s.crp_eos_adj	0.494
s.crp_pod1_adj	0.57
s.avb_t0_adj	0.664
s.avb_eos_adj	0.46
s.avb_pod1_adj	0.647
p.crp_t0_adj	0.145
p.crp_eos_adj	0.0362
p.crp_pod1_adj	0.0157
p.avb_t0_adj	0.00486
p.avb_eos_adj	0.051
p.avb_pod1_adj	0.00603

Warning: Removed 396 rows containing missing values or values outside the scale range (`geom_tile()`).
Removed 396 rows containing missing values or values outside the scale range (`geom_tile()`).
Removed 396 rows containing missing values or values outside the scale range (`geom_tile()`).
Removed 396 rows containing missing values or values outside the scale range (`geom_tile()`).
Removed 396 rows containing missing values or values outside the scale range (`geom_tile()`).
Removed 396 rows containing missing values or values outside the scale range (`geom_tile()`).
Removed 396 rows containing missing values or values outside the scale range (`geom_tile()`).
Removed 396 rows containing missing values or values outside the scale range (`geom_tile()`).
Removed 396 rows containing missing values or values outside the scale range (`geom_tile()`).
Removed 396 rows containing missing values or values outside the scale range (`geom_tile()`).
Removed 396 rows containing missing values or values outside the scale range (`geom_tile()`).
Removed 396 rows containing missing values or values outside the scale range (`geom_tile()`).
Removed 396 rows containing missing values or values outside the scale range (`geom_tile()`).
Removed 396 rows containing missing values or values outside the scale range (`geom_tile()`).
Removed 396 rows containing missing values or values outside the scale range (`geom_tile()`).

Top 20 genes

Gene	d4	d6
ST3GAL4	10521	9834
ST3GAL2	10025	9158
ST6GALNAC2	7519	6880
ST3GAL1	8368	5621
ST6GAL1	5214	5231
ST8SIA4	1696	6505

Click HERE to show all gene set members

All member genes

	crp_t0_adj	crp_eos_adj	crp_pod1_adj	avb_t0_adj	avb_eos_adj	avb_pod1_adj
ST3GAL1	7063	8366	7806	8368	-2229	5621
ST3GAL2	3395	7067	9316	10025	10342	9158
ST3GAL4	-1742	-2617	7940	10521	10337	9834
ST6GAL1	10033	8406	3586	5214	9023	5231
ST6GALNAC2	9777	3174	-1783	7519	-3894	6880
ST8SIA4	-6135	9052	7057	1696	10527	6505

---

---

GOMF LARGE RIBOSOMAL SUBUNIT RRNA BINDING

GOMF LARGE RIBOSOMAL SUBUNIT RRNA BINDING

metric	value
setSize	5
pMANOVA	0.0109
p.adjustMANOVA	0.037
s.dist	1.31
s.crp_t0_adj	-0.389
s.crp_eos_adj	-0.938
s.crp_pod1_adj	-0.748
s.avb_t0_adj	-0.0977
s.avb_eos_adj	-0.126
s.avb_pod1_adj	-0.336
p.crp_t0_adj	0.132
p.crp_eos_adj	0.000282
p.crp_pod1_adj	0.00377
p.avb_t0_adj	0.705
p.avb_eos_adj	0.624
p.avb_pod1_adj	0.193

Warning: Removed 396 rows containing missing values or values outside the scale range (`geom_tile()`).
Removed 396 rows containing missing values or values outside the scale range (`geom_tile()`).
Removed 396 rows containing missing values or values outside the scale range (`geom_tile()`).
Removed 396 rows containing missing values or values outside the scale range (`geom_tile()`).
Removed 396 rows containing missing values or values outside the scale range (`geom_tile()`).
Removed 396 rows containing missing values or values outside the scale range (`geom_tile()`).
Removed 396 rows containing missing values or values outside the scale range (`geom_tile()`).
Removed 396 rows containing missing values or values outside the scale range (`geom_tile()`).
Removed 396 rows containing missing values or values outside the scale range (`geom_tile()`).
Removed 396 rows containing missing values or values outside the scale range (`geom_tile()`).
Removed 396 rows containing missing values or values outside the scale range (`geom_tile()`).
Removed 396 rows containing missing values or values outside the scale range (`geom_tile()`).
Removed 396 rows containing missing values or values outside the scale range (`geom_tile()`).
Removed 396 rows containing missing values or values outside the scale range (`geom_tile()`).
Removed 396 rows containing missing values or values outside the scale range (`geom_tile()`).

Top 20 genes

Gene	d2	d3
RPUSD4	-10113	-10789
RPL12	-9532	-8915
RPL23	-9420	-7803
MRPL11	-9363	-7688
RPLP0	-8953	-5802

Click HERE to show all gene set members

All member genes

	crp_t0_adj	crp_eos_adj	crp_pod1_adj	avb_t0_adj	avb_eos_adj	avb_pod1_adj
MRPL11	756	-9363	-7688	2603	-1222	-3564
RPL12	-2752	-9532	-8915	373	4403	2316
RPL23	-7249	-9420	-7803	-2425	1304	-1573
RPLP0	-2819	-8953	-5802	-1710	-756	-2991
RPUSD4	-7774	-10113	-10789	-2748	-6140	-9864

---

---

GOMF NEUROTROPHIN BINDING

GOMF NEUROTROPHIN BINDING

metric	value
setSize	7
pMANOVA	0.000672
p.adjustMANOVA	0.00362
s.dist	1.31
s.crp_t0_adj	-0.103
s.crp_eos_adj	-0.253
s.crp_pod1_adj	0.765
s.avb_t0_adj	-0.481
s.avb_eos_adj	-0.792
s.avb_pod1_adj	0.434
p.crp_t0_adj	0.638
p.crp_eos_adj	0.247
p.crp_pod1_adj	0.000453
p.avb_t0_adj	0.0276
p.avb_eos_adj	0.000286
p.avb_pod1_adj	0.0469

Warning: Removed 396 rows containing missing values or values outside the scale range (`geom_tile()`).
Removed 396 rows containing missing values or values outside the scale range (`geom_tile()`).
Removed 396 rows containing missing values or values outside the scale range (`geom_tile()`).
Removed 396 rows containing missing values or values outside the scale range (`geom_tile()`).
Removed 396 rows containing missing values or values outside the scale range (`geom_tile()`).
Removed 396 rows containing missing values or values outside the scale range (`geom_tile()`).
Removed 396 rows containing missing values or values outside the scale range (`geom_tile()`).
Removed 396 rows containing missing values or values outside the scale range (`geom_tile()`).
Removed 396 rows containing missing values or values outside the scale range (`geom_tile()`).
Removed 396 rows containing missing values or values outside the scale range (`geom_tile()`).
Removed 396 rows containing missing values or values outside the scale range (`geom_tile()`).
Removed 396 rows containing missing values or values outside the scale range (`geom_tile()`).
Removed 396 rows containing missing values or values outside the scale range (`geom_tile()`).
Removed 396 rows containing missing values or values outside the scale range (`geom_tile()`).
Removed 396 rows containing missing values or values outside the scale range (`geom_tile()`).

Top 20 genes

Gene	d5	d3
FURIN	-8481	9658
NGFR	-9641	7928
SORT1	-9510	7911
A2M	-8497	8191
FSTL4	-9063	6484
PCSK6	-9021	4532

Click HERE to show all gene set members

All member genes

	crp_t0_adj	crp_eos_adj	crp_pod1_adj	avb_t0_adj	avb_eos_adj	avb_pod1_adj
A2M	9045	9315	8191	-9077	-8497	4140
FSTL4	2527	-6598	6484	-4850	-9063	5455
FURIN	-709	5808	9658	8793	-8481	268
NGFR	-8544	-9172	7928	-7780	-9641	6338
NTRK1	1407	1026	9270	-3697	1890	10882
PCSK6	-1202	-9525	4532	-8172	-9021	-2450
SORT1	-9243	-6782	7911	-8879	-9510	10076

---

---

GOBP GANGLIOSIDE CATABOLIC PROCESS

GOBP GANGLIOSIDE CATABOLIC PROCESS

metric	value
setSize	5
pMANOVA	0.00211
p.adjustMANOVA	0.00962
s.dist	1.3
s.crp_t0_adj	-0.837
s.crp_eos_adj	-0.664
s.crp_pod1_adj	-0.353
s.avb_t0_adj	-0.525
s.avb_eos_adj	0.0558
s.avb_pod1_adj	-0.39
p.crp_t0_adj	0.00119
p.crp_eos_adj	0.0101
p.crp_pod1_adj	0.172
p.avb_t0_adj	0.042
p.avb_eos_adj	0.829
p.avb_pod1_adj	0.131

Warning: Removed 396 rows containing missing values or values outside the scale range (`geom_tile()`).
Removed 396 rows containing missing values or values outside the scale range (`geom_tile()`).
Removed 396 rows containing missing values or values outside the scale range (`geom_tile()`).
Removed 396 rows containing missing values or values outside the scale range (`geom_tile()`).
Removed 396 rows containing missing values or values outside the scale range (`geom_tile()`).
Removed 396 rows containing missing values or values outside the scale range (`geom_tile()`).
Removed 396 rows containing missing values or values outside the scale range (`geom_tile()`).
Removed 396 rows containing missing values or values outside the scale range (`geom_tile()`).
Removed 396 rows containing missing values or values outside the scale range (`geom_tile()`).
Removed 396 rows containing missing values or values outside the scale range (`geom_tile()`).
Removed 396 rows containing missing values or values outside the scale range (`geom_tile()`).
Removed 396 rows containing missing values or values outside the scale range (`geom_tile()`).
Removed 396 rows containing missing values or values outside the scale range (`geom_tile()`).
Removed 396 rows containing missing values or values outside the scale range (`geom_tile()`).
Removed 396 rows containing missing values or values outside the scale range (`geom_tile()`).

Top 20 genes

Gene	d1	d2
HEXA	-9144	-10051
GM2A	-10003	-5785
HEXB	-10368	-5573
NEU1	-5301	-7889
NEU3	-8582	-3702

Click HERE to show all gene set members

All member genes

	crp_t0_adj	crp_eos_adj	crp_pod1_adj	avb_t0_adj	avb_eos_adj	avb_pod1_adj
GM2A	-10003	-5785	7993	-9553	-9196	5207
HEXA	-9144	-10051	-10844	-6772	-6571	-10078
HEXB	-10368	-5573	-10017	-7195	8281	-4591
NEU1	-5301	-7889	3392	3945	5705	820
NEU3	-8582	-3702	-10737	-6808	8954	-9863

---

---

GOMF C PALMITOYLTRANSFERASE ACTIVITY

GOMF C PALMITOYLTRANSFERASE ACTIVITY

metric	value
setSize	5
pMANOVA	0.0199
p.adjustMANOVA	0.0591
s.dist	1.3
s.crp_t0_adj	-0.456
s.crp_eos_adj	-0.473
s.crp_pod1_adj	0.281
s.avb_t0_adj	-0.481
s.avb_eos_adj	-0.84
s.avb_pod1_adj	0.497
p.crp_t0_adj	0.0775
p.crp_eos_adj	0.0669
p.crp_pod1_adj	0.277
p.avb_t0_adj	0.0626
p.avb_eos_adj	0.00114
p.avb_pod1_adj	0.0545

Warning: Removed 396 rows containing missing values or values outside the scale range (`geom_tile()`).
Removed 396 rows containing missing values or values outside the scale range (`geom_tile()`).
Removed 396 rows containing missing values or values outside the scale range (`geom_tile()`).
Removed 396 rows containing missing values or values outside the scale range (`geom_tile()`).
Removed 396 rows containing missing values or values outside the scale range (`geom_tile()`).
Removed 396 rows containing missing values or values outside the scale range (`geom_tile()`).
Removed 396 rows containing missing values or values outside the scale range (`geom_tile()`).
Removed 396 rows containing missing values or values outside the scale range (`geom_tile()`).
Removed 396 rows containing missing values or values outside the scale range (`geom_tile()`).
Removed 396 rows containing missing values or values outside the scale range (`geom_tile()`).
Removed 396 rows containing missing values or values outside the scale range (`geom_tile()`).
Removed 396 rows containing missing values or values outside the scale range (`geom_tile()`).
Removed 396 rows containing missing values or values outside the scale range (`geom_tile()`).
Removed 396 rows containing missing values or values outside the scale range (`geom_tile()`).
Removed 396 rows containing missing values or values outside the scale range (`geom_tile()`).

Top 20 genes

Gene	d5	d6
SPTLC2	-9629	10216
SPTSSB	-9419	9732
SPTLC3	-6601	7969
SPTLC1	-6624	7840

Click HERE to show all gene set members

All member genes

	crp_t0_adj	crp_eos_adj	crp_pod1_adj	avb_t0_adj	avb_eos_adj	avb_pod1_adj
SPTLC1	-9039	-1935	5883	-2754	-6624	7840
SPTLC2	-9234	-8519	6190	-5355	-9629	10216
SPTLC3	-2863	5047	5056	-7809	-6601	7969
SPTSSA	-10125	-8255	-10554	-9574	-7649	-7655
SPTSSB	7887	-9303	6512	1446	-9419	9732

---

---

GOBP VIRAL TRANSLATIONAL TERMINATION REINITIATION

GOBP VIRAL TRANSLATIONAL TERMINATION REINITIATION

metric	value
setSize	5
pMANOVA	0.0111
p.adjustMANOVA	0.0375
s.dist	1.3
s.crp_t0_adj	-0.274
s.crp_eos_adj	-0.814
s.crp_pod1_adj	-0.758
s.avb_t0_adj	0.0841
s.avb_eos_adj	-0.241
s.avb_pod1_adj	-0.557
p.crp_t0_adj	0.289
p.crp_eos_adj	0.00163
p.crp_pod1_adj	0.00334
p.avb_t0_adj	0.745
p.avb_eos_adj	0.35
p.avb_pod1_adj	0.0309

Warning: Removed 396 rows containing missing values or values outside the scale range (`geom_tile()`).
Removed 396 rows containing missing values or values outside the scale range (`geom_tile()`).
Removed 396 rows containing missing values or values outside the scale range (`geom_tile()`).
Removed 396 rows containing missing values or values outside the scale range (`geom_tile()`).
Removed 396 rows containing missing values or values outside the scale range (`geom_tile()`).
Removed 396 rows containing missing values or values outside the scale range (`geom_tile()`).
Removed 396 rows containing missing values or values outside the scale range (`geom_tile()`).
Removed 396 rows containing missing values or values outside the scale range (`geom_tile()`).
Removed 396 rows containing missing values or values outside the scale range (`geom_tile()`).
Removed 396 rows containing missing values or values outside the scale range (`geom_tile()`).
Removed 396 rows containing missing values or values outside the scale range (`geom_tile()`).
Removed 396 rows containing missing values or values outside the scale range (`geom_tile()`).
Removed 396 rows containing missing values or values outside the scale range (`geom_tile()`).
Removed 396 rows containing missing values or values outside the scale range (`geom_tile()`).
Removed 396 rows containing missing values or values outside the scale range (`geom_tile()`).

Top 20 genes

Gene	d2	d3
EIF3L	-8972	-10506
EIF3G	-8614	-8858
EIF3D	-8726	-8591
EIF3B	-8019	-7890
EIF3A	-6532	-5661

Click HERE to show all gene set members

All member genes

	crp_t0_adj	crp_eos_adj	crp_pod1_adj	avb_t0_adj	avb_eos_adj	avb_pod1_adj
EIF3A	-6555	-6532	-5661	3892	-2067	-1004
EIF3B	2442	-8019	-7890	5467	-5432	-9464
EIF3D	-3648	-8726	-8591	413	-386	-2324
EIF3G	1955	-8614	-8858	659	-1485	-7542
EIF3L	-7983	-8972	-10506	-4780	915	-6963

---

---

GOMF NERVE GROWTH FACTOR BINDING

GOMF NERVE GROWTH FACTOR BINDING

metric	value
setSize	6
pMANOVA	0.00346
p.adjustMANOVA	0.0145
s.dist	1.29
s.crp_t0_adj	-0.158
s.crp_eos_adj	-0.184
s.crp_pod1_adj	0.785
s.avb_t0_adj	-0.48
s.avb_eos_adj	-0.766
s.avb_pod1_adj	0.426
p.crp_t0_adj	0.503
p.crp_eos_adj	0.434
p.crp_pod1_adj	0.00087
p.avb_t0_adj	0.0417
p.avb_eos_adj	0.00115
p.avb_pod1_adj	0.0709

Warning: Removed 396 rows containing missing values or values outside the scale range (`geom_tile()`).
Removed 396 rows containing missing values or values outside the scale range (`geom_tile()`).
Removed 396 rows containing missing values or values outside the scale range (`geom_tile()`).
Removed 396 rows containing missing values or values outside the scale range (`geom_tile()`).
Removed 396 rows containing missing values or values outside the scale range (`geom_tile()`).
Removed 396 rows containing missing values or values outside the scale range (`geom_tile()`).
Removed 396 rows containing missing values or values outside the scale range (`geom_tile()`).
Removed 396 rows containing missing values or values outside the scale range (`geom_tile()`).
Removed 396 rows containing missing values or values outside the scale range (`geom_tile()`).
Removed 396 rows containing missing values or values outside the scale range (`geom_tile()`).
Removed 396 rows containing missing values or values outside the scale range (`geom_tile()`).
Removed 396 rows containing missing values or values outside the scale range (`geom_tile()`).
Removed 396 rows containing missing values or values outside the scale range (`geom_tile()`).
Removed 396 rows containing missing values or values outside the scale range (`geom_tile()`).
Removed 396 rows containing missing values or values outside the scale range (`geom_tile()`).

Top 20 genes

Gene	d3	d5
FURIN	9658	-8481
NGFR	7928	-9641
SORT1	7911	-9510
A2M	8191	-8497
PCSK6	4532	-9021

Click HERE to show all gene set members

All member genes

	crp_t0_adj	crp_eos_adj	crp_pod1_adj	avb_t0_adj	avb_eos_adj	avb_pod1_adj
A2M	9045	9315	8191	-9077	-8497	4140
FURIN	-709	5808	9658	8793	-8481	268
NGFR	-8544	-9172	7928	-7780	-9641	6338
NTRK1	1407	1026	9270	-3697	1890	10882
PCSK6	-1202	-9525	4532	-8172	-9021	-2450
SORT1	-9243	-6782	7911	-8879	-9510	10076

---

---

GOCC EUKARYOTIC TRANSLATION INITIATION FACTOR 3 COMPLEX EIF3M

GOCC EUKARYOTIC TRANSLATION INITIATION FACTOR 3 COMPLEX EIF3M

metric	value
setSize	7
pMANOVA	0.00224
p.adjustMANOVA	0.0101
s.dist	1.29
s.crp_t0_adj	-0.47
s.crp_eos_adj	-0.831
s.crp_pod1_adj	-0.727
s.avb_t0_adj	-0.127
s.avb_eos_adj	-0.257
s.avb_pod1_adj	-0.36
p.crp_t0_adj	0.0311
p.crp_eos_adj	0.000141
p.crp_pod1_adj	0.000859
p.avb_t0_adj	0.562
p.avb_eos_adj	0.239
p.avb_pod1_adj	0.0987

Warning: Removed 396 rows containing missing values or values outside the scale range (`geom_tile()`).
Removed 396 rows containing missing values or values outside the scale range (`geom_tile()`).
Removed 396 rows containing missing values or values outside the scale range (`geom_tile()`).
Removed 396 rows containing missing values or values outside the scale range (`geom_tile()`).
Removed 396 rows containing missing values or values outside the scale range (`geom_tile()`).
Removed 396 rows containing missing values or values outside the scale range (`geom_tile()`).
Removed 396 rows containing missing values or values outside the scale range (`geom_tile()`).
Removed 396 rows containing missing values or values outside the scale range (`geom_tile()`).
Removed 396 rows containing missing values or values outside the scale range (`geom_tile()`).
Removed 396 rows containing missing values or values outside the scale range (`geom_tile()`).
Removed 396 rows containing missing values or values outside the scale range (`geom_tile()`).
Removed 396 rows containing missing values or values outside the scale range (`geom_tile()`).
Removed 396 rows containing missing values or values outside the scale range (`geom_tile()`).
Removed 396 rows containing missing values or values outside the scale range (`geom_tile()`).
Removed 396 rows containing missing values or values outside the scale range (`geom_tile()`).

Top 20 genes

Gene	d2	d3
EIF3M	-10013	-10530
EIF3H	-9541	-8402
EIF3D	-8726	-8591
EIF3B	-8019	-7890
EIF3F	-6438	-8899
EIF3I	-9182	-5901
EIF3A	-6532	-5661

Click HERE to show all gene set members

All member genes

	crp_t0_adj	crp_eos_adj	crp_pod1_adj	avb_t0_adj	avb_eos_adj	avb_pod1_adj
EIF3A	-6555	-6532	-5661	3892	-2067	-1004
EIF3B	2442	-8019	-7890	5467	-5432	-9464
EIF3D	-3648	-8726	-8591	413	-386	-2324
EIF3F	-2465	-6438	-8899	-1946	3572	-7920
EIF3H	-8189	-9541	-8402	-7090	-2343	-1930
EIF3I	-5272	-9182	-5901	-583	-2761	1841
EIF3M	-10102	-10013	-10530	-7758	-3580	-2925

---

---

GOMF PHOSPHATIDYLETHANOLAMINE FLIPPASE ACTIVITY

GOMF PHOSPHATIDYLETHANOLAMINE FLIPPASE ACTIVITY

metric	value
setSize	5
pMANOVA	0.00644
p.adjustMANOVA	0.0241
s.dist	1.28
s.crp_t0_adj	0.308
s.crp_eos_adj	0.616
s.crp_pod1_adj	0.69
s.avb_t0_adj	0.482
s.avb_eos_adj	-0.148
s.avb_pod1_adj	0.662
p.crp_t0_adj	0.233
p.crp_eos_adj	0.017
p.crp_pod1_adj	0.00751
p.avb_t0_adj	0.0619
p.avb_eos_adj	0.566
p.avb_pod1_adj	0.0103

Warning: Removed 396 rows containing missing values or values outside the scale range (`geom_tile()`).
Removed 396 rows containing missing values or values outside the scale range (`geom_tile()`).
Removed 396 rows containing missing values or values outside the scale range (`geom_tile()`).
Removed 396 rows containing missing values or values outside the scale range (`geom_tile()`).
Removed 396 rows containing missing values or values outside the scale range (`geom_tile()`).
Removed 396 rows containing missing values or values outside the scale range (`geom_tile()`).
Removed 396 rows containing missing values or values outside the scale range (`geom_tile()`).
Removed 396 rows containing missing values or values outside the scale range (`geom_tile()`).
Removed 396 rows containing missing values or values outside the scale range (`geom_tile()`).
Removed 396 rows containing missing values or values outside the scale range (`geom_tile()`).
Removed 396 rows containing missing values or values outside the scale range (`geom_tile()`).
Removed 396 rows containing missing values or values outside the scale range (`geom_tile()`).
Removed 396 rows containing missing values or values outside the scale range (`geom_tile()`).
Removed 396 rows containing missing values or values outside the scale range (`geom_tile()`).
Removed 396 rows containing missing values or values outside the scale range (`geom_tile()`).

Top 20 genes

Gene	d3	d6
ATP11B	8535	10190
ATP11C	9152	7867
ATP11A	8530	6205
ATP8A2	2782	10077
ABCB1	5611	2484

Click HERE to show all gene set members

All member genes

	crp_t0_adj	crp_eos_adj	crp_pod1_adj	avb_t0_adj	avb_eos_adj	avb_pod1_adj
ABCB1	9627	10880	5611	7909	23	2484
ATP11A	-608	9128	8530	6141	-5253	6205
ATP11B	-4332	6664	8535	709	-6481	10190
ATP11C	3800	3717	9152	1322	-2959	7867
ATP8A2	8293	3931	2782	10491	11106	10077

---

---

GOBP CANNABINOID SIGNALING PATHWAY

GOBP CANNABINOID SIGNALING PATHWAY

metric	value
setSize	6
pMANOVA	0.00379
p.adjustMANOVA	0.0156
s.dist	1.28
s.crp_t0_adj	-0.215
s.crp_eos_adj	-0.565
s.crp_pod1_adj	-0.00637
s.avb_t0_adj	-0.612
s.avb_eos_adj	-0.926
s.avb_pod1_adj	-0.183
p.crp_t0_adj	0.362
p.crp_eos_adj	0.0166
p.crp_pod1_adj	0.978
p.avb_t0_adj	0.00939
p.avb_eos_adj	8.6e-05
p.avb_pod1_adj	0.437

Warning: Removed 396 rows containing missing values or values outside the scale range (`geom_tile()`).
Removed 396 rows containing missing values or values outside the scale range (`geom_tile()`).
Removed 396 rows containing missing values or values outside the scale range (`geom_tile()`).
Removed 396 rows containing missing values or values outside the scale range (`geom_tile()`).
Removed 396 rows containing missing values or values outside the scale range (`geom_tile()`).
Removed 396 rows containing missing values or values outside the scale range (`geom_tile()`).
Removed 396 rows containing missing values or values outside the scale range (`geom_tile()`).
Removed 396 rows containing missing values or values outside the scale range (`geom_tile()`).
Removed 396 rows containing missing values or values outside the scale range (`geom_tile()`).
Removed 396 rows containing missing values or values outside the scale range (`geom_tile()`).
Removed 396 rows containing missing values or values outside the scale range (`geom_tile()`).
Removed 396 rows containing missing values or values outside the scale range (`geom_tile()`).
Removed 396 rows containing missing values or values outside the scale range (`geom_tile()`).
Removed 396 rows containing missing values or values outside the scale range (`geom_tile()`).
Removed 396 rows containing missing values or values outside the scale range (`geom_tile()`).

Top 20 genes

Gene	d5	d4
ALOX15B	-9667	-10255
CNR1	-8612	-8384
MGLL	-8005	-8607
GPR55	-9189	-3665
CNR2	-8220	-3380
ABHD6	-9607	-2859

Click HERE to show all gene set members

All member genes

	crp_t0_adj	crp_eos_adj	crp_pod1_adj	avb_t0_adj	avb_eos_adj	avb_pod1_adj
ABHD6	4347	-9851	3474	-2859	-9607	4063
ALOX15B	-10387	-10110	-8319	-10255	-9667	-10092
CNR1	-700	1694	6517	-8384	-8612	2249
CNR2	6100	2659	6309	-3380	-8220	2509
GPR55	-7526	-8220	-9357	-3665	-9189	-8865
MGLL	-4684	-9497	-1039	-8607	-8005	977

---

---

GOBP SHORT CHAIN FATTY ACID CATABOLIC PROCESS

GOBP SHORT CHAIN FATTY ACID CATABOLIC PROCESS

metric	value
setSize	6
pMANOVA	0.000854
p.adjustMANOVA	0.00446
s.dist	1.27
s.crp_t0_adj	-0.343
s.crp_eos_adj	-0.713
s.crp_pod1_adj	-0.708
s.avb_t0_adj	0.0958
s.avb_eos_adj	0.439
s.avb_pod1_adj	-0.529
p.crp_t0_adj	0.145
p.crp_eos_adj	0.0025
p.crp_pod1_adj	0.00268
p.avb_t0_adj	0.684
p.avb_eos_adj	0.0628
p.avb_pod1_adj	0.0247

Warning: Removed 396 rows containing missing values or values outside the scale range (`geom_tile()`).
Removed 396 rows containing missing values or values outside the scale range (`geom_tile()`).
Removed 396 rows containing missing values or values outside the scale range (`geom_tile()`).
Removed 396 rows containing missing values or values outside the scale range (`geom_tile()`).
Removed 396 rows containing missing values or values outside the scale range (`geom_tile()`).
Removed 396 rows containing missing values or values outside the scale range (`geom_tile()`).
Removed 396 rows containing missing values or values outside the scale range (`geom_tile()`).
Removed 396 rows containing missing values or values outside the scale range (`geom_tile()`).
Removed 396 rows containing missing values or values outside the scale range (`geom_tile()`).
Removed 396 rows containing missing values or values outside the scale range (`geom_tile()`).
Removed 396 rows containing missing values or values outside the scale range (`geom_tile()`).
Removed 396 rows containing missing values or values outside the scale range (`geom_tile()`).
Removed 396 rows containing missing values or values outside the scale range (`geom_tile()`).
Removed 396 rows containing missing values or values outside the scale range (`geom_tile()`).
Removed 396 rows containing missing values or values outside the scale range (`geom_tile()`).

Top 20 genes

Gene	d2	d3
MCEE	-9975	-10235
PHYH	-8999	-8619
PCCB	-6565	-10448
PCK2	-7624	-4794
ACADS	-8296	-3173
PCCA	-1196	-9378

Click HERE to show all gene set members

All member genes

	crp_t0_adj	crp_eos_adj	crp_pod1_adj	avb_t0_adj	avb_eos_adj	avb_pod1_adj
ACADS	-2919	-8296	-3173	2238	-1597	-6306
MCEE	-7206	-9975	-10235	-600	9953	-4179
PCCA	-6178	-1196	-9378	-822	9491	-6960
PCCB	-3769	-6565	-10448	3014	2862	-8760
PCK2	2720	-7624	-4794	6052	5333	-40
PHYH	-3591	-8999	-8619	-2364	6707	-4757

---

---

GOCC IGA IMMUNOGLOBULIN COMPLEX

GOCC IGA IMMUNOGLOBULIN COMPLEX

metric	value
setSize	7
pMANOVA	3.99e-05
p.adjustMANOVA	0.000298
s.dist	1.26
s.crp_t0_adj	-0.241
s.crp_eos_adj	-0.875
s.crp_pod1_adj	-0.0402
s.avb_t0_adj	0.171
s.avb_eos_adj	-0.755
s.avb_pod1_adj	0.418
p.crp_t0_adj	0.27
p.crp_eos_adj	6.07e-05
p.crp_pod1_adj	0.854
p.avb_t0_adj	0.433
p.avb_eos_adj	0.000545
p.avb_pod1_adj	0.0558

Warning: Removed 396 rows containing missing values or values outside the scale range (`geom_tile()`).
Removed 396 rows containing missing values or values outside the scale range (`geom_tile()`).
Removed 396 rows containing missing values or values outside the scale range (`geom_tile()`).
Removed 396 rows containing missing values or values outside the scale range (`geom_tile()`).
Removed 396 rows containing missing values or values outside the scale range (`geom_tile()`).
Removed 396 rows containing missing values or values outside the scale range (`geom_tile()`).
Removed 396 rows containing missing values or values outside the scale range (`geom_tile()`).
Removed 396 rows containing missing values or values outside the scale range (`geom_tile()`).
Removed 396 rows containing missing values or values outside the scale range (`geom_tile()`).
Removed 396 rows containing missing values or values outside the scale range (`geom_tile()`).
Removed 396 rows containing missing values or values outside the scale range (`geom_tile()`).
Removed 396 rows containing missing values or values outside the scale range (`geom_tile()`).
Removed 396 rows containing missing values or values outside the scale range (`geom_tile()`).
Removed 396 rows containing missing values or values outside the scale range (`geom_tile()`).
Removed 396 rows containing missing values or values outside the scale range (`geom_tile()`).

Top 20 genes

Gene	d2	d5
IGHA1	-9549	-8521
IGHA2	-9491	-7703
JCHAIN	-9038	-7610
IGKC	-9089	-7541
IGLC1	-8437	-7572
IGKV3-20	-9321	-4543
IGLC3	-6796	-6106

Click HERE to show all gene set members

All member genes

	crp_t0_adj	crp_eos_adj	crp_pod1_adj	avb_t0_adj	avb_eos_adj	avb_pod1_adj
IGHA1	-3836	-9549	-3439	4182	-8521	3305
IGHA2	-7522	-9491	-4041	-1547	-7703	3094
IGKC	3109	-9089	2037	6705	-7541	7614
IGKV3-20	6774	-9321	1136	9483	-4543	9785
IGLC1	-6983	-8437	-5794	-4675	-7572	-970
IGLC3	-1591	-6796	4245	-1381	-6106	1467
JCHAIN	-6850	-9038	548	1537	-7610	9225

---

---

GOMF PROTEIN PHOSPHATASE 2B BINDING

GOMF PROTEIN PHOSPHATASE 2B BINDING

metric	value
setSize	5
pMANOVA	0.0042
p.adjustMANOVA	0.017
s.dist	1.26
s.crp_t0_adj	0.0595
s.crp_eos_adj	0.299
s.crp_pod1_adj	0.486
s.avb_t0_adj	0.495
s.avb_eos_adj	0.633
s.avb_pod1_adj	0.786
p.crp_t0_adj	0.818
p.crp_eos_adj	0.247
p.crp_pod1_adj	0.0598
p.avb_t0_adj	0.0555
p.avb_eos_adj	0.0142
p.avb_pod1_adj	0.00234

Warning: Removed 396 rows containing missing values or values outside the scale range (`geom_tile()`).
Removed 396 rows containing missing values or values outside the scale range (`geom_tile()`).
Removed 396 rows containing missing values or values outside the scale range (`geom_tile()`).
Removed 396 rows containing missing values or values outside the scale range (`geom_tile()`).
Removed 396 rows containing missing values or values outside the scale range (`geom_tile()`).
Removed 396 rows containing missing values or values outside the scale range (`geom_tile()`).
Removed 396 rows containing missing values or values outside the scale range (`geom_tile()`).
Removed 396 rows containing missing values or values outside the scale range (`geom_tile()`).
Removed 396 rows containing missing values or values outside the scale range (`geom_tile()`).
Removed 396 rows containing missing values or values outside the scale range (`geom_tile()`).
Removed 396 rows containing missing values or values outside the scale range (`geom_tile()`).
Removed 396 rows containing missing values or values outside the scale range (`geom_tile()`).
Removed 396 rows containing missing values or values outside the scale range (`geom_tile()`).
Removed 396 rows containing missing values or values outside the scale range (`geom_tile()`).
Removed 396 rows containing missing values or values outside the scale range (`geom_tile()`).

Top 20 genes

Gene	d6	d5
AKAP5	10236	10846
SLC9A1	9528	10417
ATP2B4	8589	9410
SOD1	4530	5730
PPP3CB	10432	1113

Click HERE to show all gene set members

All member genes

	crp_t0_adj	crp_eos_adj	crp_pod1_adj	avb_t0_adj	avb_eos_adj	avb_pod1_adj
AKAP5	6727	10893	5345	9950	10846	10236
ATP2B4	1784	10046	9097	8278	9410	8589
PPP3CB	-9640	-2437	3808	-5250	1113	10432
SLC9A1	766	7762	9818	7209	10417	9528
SOD1	4083	-8625	-4193	7040	5730	4530

---

---

GOCC PROTEASOME CORE COMPLEX ALPHA SUBUNIT COMPLEX

GOCC PROTEASOME CORE COMPLEX ALPHA SUBUNIT COMPLEX

metric	value
setSize	7
pMANOVA	7.39e-05
p.adjustMANOVA	0.000519
s.dist	1.25
s.crp_t0_adj	-0.61
s.crp_eos_adj	-0.75
s.crp_pod1_adj	-0.229
s.avb_t0_adj	-0.398
s.avb_eos_adj	-0.133
s.avb_pod1_adj	0.628
p.crp_t0_adj	0.00517
p.crp_eos_adj	0.000588
p.crp_pod1_adj	0.295
p.avb_t0_adj	0.0685
p.avb_eos_adj	0.542
p.avb_pod1_adj	0.00402

Warning: Removed 396 rows containing missing values or values outside the scale range (`geom_tile()`).
Removed 396 rows containing missing values or values outside the scale range (`geom_tile()`).
Removed 396 rows containing missing values or values outside the scale range (`geom_tile()`).
Removed 396 rows containing missing values or values outside the scale range (`geom_tile()`).
Removed 396 rows containing missing values or values outside the scale range (`geom_tile()`).
Removed 396 rows containing missing values or values outside the scale range (`geom_tile()`).
Removed 396 rows containing missing values or values outside the scale range (`geom_tile()`).
Removed 396 rows containing missing values or values outside the scale range (`geom_tile()`).
Removed 396 rows containing missing values or values outside the scale range (`geom_tile()`).
Removed 396 rows containing missing values or values outside the scale range (`geom_tile()`).
Removed 396 rows containing missing values or values outside the scale range (`geom_tile()`).
Removed 396 rows containing missing values or values outside the scale range (`geom_tile()`).
Removed 396 rows containing missing values or values outside the scale range (`geom_tile()`).
Removed 396 rows containing missing values or values outside the scale range (`geom_tile()`).
Removed 396 rows containing missing values or values outside the scale range (`geom_tile()`).

Top 20 genes

Gene	d2	d6
PSMA6	-9490	8195
PSMA1	-7433	10002
PSMA5	-8930	7815
PSMA4	-6472	7653
PSMA2	-8427	4852
PSMA3	-3834	7214
PSMA7	-7936	3264

Click HERE to show all gene set members

All member genes

	crp_t0_adj	crp_eos_adj	crp_pod1_adj	avb_t0_adj	avb_eos_adj	avb_pod1_adj
PSMA1	-8968	-7433	2596	-6426	-3136	10002
PSMA2	-6110	-8427	-5209	-5120	993	4852
PSMA3	-7644	-3834	-7515	-4833	-73	7214
PSMA4	-6981	-6472	-2673	-3177	7608	7653
PSMA5	-3367	-8930	-5124	-2556	3504	7815
PSMA6	-8584	-9490	-742	-7478	-7990	8195
PSMA7	-2423	-7936	-506	2049	-4764	3264

---

---

GOMF PRIMARY AMINE OXIDASE ACTIVITY

GOMF PRIMARY AMINE OXIDASE ACTIVITY

metric	value
setSize	6
pMANOVA	1.76e-05
p.adjustMANOVA	0.000141
s.dist	1.24
s.crp_t0_adj	0.515
s.crp_eos_adj	0.209
s.crp_pod1_adj	-0.336
s.avb_t0_adj	-0.681
s.avb_eos_adj	-0.0696
s.avb_pod1_adj	-0.81
p.crp_t0_adj	0.0289
p.crp_eos_adj	0.375
p.crp_pod1_adj	0.154
p.avb_t0_adj	0.00386
p.avb_eos_adj	0.768
p.avb_pod1_adj	0.000586

Warning: Removed 396 rows containing missing values or values outside the scale range (`geom_tile()`).
Removed 396 rows containing missing values or values outside the scale range (`geom_tile()`).
Removed 396 rows containing missing values or values outside the scale range (`geom_tile()`).
Removed 396 rows containing missing values or values outside the scale range (`geom_tile()`).
Removed 396 rows containing missing values or values outside the scale range (`geom_tile()`).
Removed 396 rows containing missing values or values outside the scale range (`geom_tile()`).
Removed 396 rows containing missing values or values outside the scale range (`geom_tile()`).
Removed 396 rows containing missing values or values outside the scale range (`geom_tile()`).
Removed 396 rows containing missing values or values outside the scale range (`geom_tile()`).
Removed 396 rows containing missing values or values outside the scale range (`geom_tile()`).
Removed 396 rows containing missing values or values outside the scale range (`geom_tile()`).
Removed 396 rows containing missing values or values outside the scale range (`geom_tile()`).
Removed 396 rows containing missing values or values outside the scale range (`geom_tile()`).
Removed 396 rows containing missing values or values outside the scale range (`geom_tile()`).
Removed 396 rows containing missing values or values outside the scale range (`geom_tile()`).

Top 20 genes

Gene	d6	d4
AOC2	-10048	-9504
AOC3	-9850	-8499
DDO	-8191	-8165
MAOB	-9661	-6360
AOC1	-2804	-9427

Click HERE to show all gene set members

All member genes

	crp_t0_adj	crp_eos_adj	crp_pod1_adj	avb_t0_adj	avb_eos_adj	avb_pod1_adj
AOC1	649	7589	5908	-9427	-243	-2804
AOC2	10570	5586	-4388	-9504	-6955	-10048
AOC3	10425	6962	-6372	-8499	-5252	-9850
DDO	-4812	-7781	-8113	-8165	6717	-8191
IL4I1	7213	9720	-9749	462	10926	-8167
MAOB	9164	-6586	-510	-6360	-4500	-9661

---

---

GOBP GLUCURONATE CATABOLIC PROCESS TO XYLULOSE 5 PHOSPHATE

GOBP GLUCURONATE CATABOLIC PROCESS TO XYLULOSE 5 PHOSPHATE

metric	value
setSize	5
pMANOVA	0.00431
p.adjustMANOVA	0.0173
s.dist	1.24
s.crp_t0_adj	-0.565
s.crp_eos_adj	-0.599
s.crp_pod1_adj	-0.719
s.avb_t0_adj	0.0257
s.avb_eos_adj	0.551
s.avb_pod1_adj	-0.209
p.crp_t0_adj	0.0288
p.crp_eos_adj	0.0203
p.crp_pod1_adj	0.00537
p.avb_t0_adj	0.921
p.avb_eos_adj	0.0328
p.avb_pod1_adj	0.418

Warning: Removed 396 rows containing missing values or values outside the scale range (`geom_tile()`).
Removed 396 rows containing missing values or values outside the scale range (`geom_tile()`).
Removed 396 rows containing missing values or values outside the scale range (`geom_tile()`).
Removed 396 rows containing missing values or values outside the scale range (`geom_tile()`).
Removed 396 rows containing missing values or values outside the scale range (`geom_tile()`).
Removed 396 rows containing missing values or values outside the scale range (`geom_tile()`).
Removed 396 rows containing missing values or values outside the scale range (`geom_tile()`).
Removed 396 rows containing missing values or values outside the scale range (`geom_tile()`).
Removed 396 rows containing missing values or values outside the scale range (`geom_tile()`).
Removed 396 rows containing missing values or values outside the scale range (`geom_tile()`).
Removed 396 rows containing missing values or values outside the scale range (`geom_tile()`).
Removed 396 rows containing missing values or values outside the scale range (`geom_tile()`).
Removed 396 rows containing missing values or values outside the scale range (`geom_tile()`).
Removed 396 rows containing missing values or values outside the scale range (`geom_tile()`).
Removed 396 rows containing missing values or values outside the scale range (`geom_tile()`).

Top 20 genes

Gene	d3	d2
XYLB	-10062	-8946
CRYL1	-9077	-8426
AKR1A1	-7171	-8841
DCXR	-6103	-9298

Click HERE to show all gene set members

All member genes

	crp_t0_adj	crp_eos_adj	crp_pod1_adj	avb_t0_adj	avb_eos_adj	avb_pod1_adj
AKR1A1	-302	-8841	-7171	960	5917	-6249
CRYL1	-9560	-8426	-9077	-7512	6500	480
DCXR	-7399	-9298	-6103	6011	3004	2771
SORD	-7959	5918	-7051	4109	11049	-6317
XYLB	-3867	-8946	-10062	-990	6746	323

---

---

GOCC BOX C D RNP COMPLEX

GOCC BOX C D RNP COMPLEX

metric	value
setSize	5
pMANOVA	0.00957
p.adjustMANOVA	0.0331
s.dist	1.23
s.crp_t0_adj	0.0616
s.crp_eos_adj	-0.777
s.crp_pod1_adj	-0.721
s.avb_t0_adj	0.0224
s.avb_eos_adj	-0.181
s.avb_pod1_adj	-0.6
p.crp_t0_adj	0.811
p.crp_eos_adj	0.00261
p.crp_pod1_adj	0.00524
p.avb_t0_adj	0.931
p.avb_eos_adj	0.484
p.avb_pod1_adj	0.0203

Warning: Removed 396 rows containing missing values or values outside the scale range (`geom_tile()`).
Removed 396 rows containing missing values or values outside the scale range (`geom_tile()`).
Removed 396 rows containing missing values or values outside the scale range (`geom_tile()`).
Removed 396 rows containing missing values or values outside the scale range (`geom_tile()`).
Removed 396 rows containing missing values or values outside the scale range (`geom_tile()`).
Removed 396 rows containing missing values or values outside the scale range (`geom_tile()`).
Removed 396 rows containing missing values or values outside the scale range (`geom_tile()`).
Removed 396 rows containing missing values or values outside the scale range (`geom_tile()`).
Removed 396 rows containing missing values or values outside the scale range (`geom_tile()`).
Removed 396 rows containing missing values or values outside the scale range (`geom_tile()`).
Removed 396 rows containing missing values or values outside the scale range (`geom_tile()`).
Removed 396 rows containing missing values or values outside the scale range (`geom_tile()`).
Removed 396 rows containing missing values or values outside the scale range (`geom_tile()`).
Removed 396 rows containing missing values or values outside the scale range (`geom_tile()`).
Removed 396 rows containing missing values or values outside the scale range (`geom_tile()`).

Top 20 genes

Gene	d2	d3
SNU13	-8306	-9398
RRP9	-7443	-9718
FBL	-8295	-7754
NOP56	-8743	-6195
NOP58	-6161	-6510

Click HERE to show all gene set members

All member genes

	crp_t0_adj	crp_eos_adj	crp_pod1_adj	avb_t0_adj	avb_eos_adj	avb_pod1_adj
FBL	-1082	-8295	-7754	2421	2424	-2363
NOP56	5938	-8743	-6195	2965	-1508	-8488
NOP58	-4656	-6161	-6510	-7986	-3284	-2893
RRP9	8044	-7443	-9718	4533	-1909	-9537
SNU13	-4411	-8306	-9398	472	-988	-6236

---

---

GOBP NEGATIVE REGULATION OF FIBROBLAST APOPTOTIC PROCESS

GOBP NEGATIVE REGULATION OF FIBROBLAST APOPTOTIC PROCESS

metric	value
setSize	6
pMANOVA	0.00189
p.adjustMANOVA	0.00875
s.dist	1.23
s.crp_t0_adj	-0.12
s.crp_eos_adj	0.373
s.crp_pod1_adj	0.682
s.avb_t0_adj	0.388
s.avb_eos_adj	0.246
s.avb_pod1_adj	0.821
p.crp_t0_adj	0.61
p.crp_eos_adj	0.114
p.crp_pod1_adj	0.00383
p.avb_t0_adj	0.0999
p.avb_eos_adj	0.297
p.avb_pod1_adj	0.000493

Warning: Removed 396 rows containing missing values or values outside the scale range (`geom_tile()`).
Removed 396 rows containing missing values or values outside the scale range (`geom_tile()`).
Removed 396 rows containing missing values or values outside the scale range (`geom_tile()`).
Removed 396 rows containing missing values or values outside the scale range (`geom_tile()`).
Removed 396 rows containing missing values or values outside the scale range (`geom_tile()`).
Removed 396 rows containing missing values or values outside the scale range (`geom_tile()`).
Removed 396 rows containing missing values or values outside the scale range (`geom_tile()`).
Removed 396 rows containing missing values or values outside the scale range (`geom_tile()`).
Removed 396 rows containing missing values or values outside the scale range (`geom_tile()`).
Removed 396 rows containing missing values or values outside the scale range (`geom_tile()`).
Removed 396 rows containing missing values or values outside the scale range (`geom_tile()`).
Removed 396 rows containing missing values or values outside the scale range (`geom_tile()`).
Removed 396 rows containing missing values or values outside the scale range (`geom_tile()`).
Removed 396 rows containing missing values or values outside the scale range (`geom_tile()`).
Removed 396 rows containing missing values or values outside the scale range (`geom_tile()`).

Top 20 genes

Gene	d6	d3
PIK3CG	10874	9790
GAS6	10184	10116
CHD8	9091	9214
PIK3CA	8795	5409
API5	8831	2732
CFDP1	6429	3722

Click HERE to show all gene set members

All member genes

	crp_t0_adj	crp_eos_adj	crp_pod1_adj	avb_t0_adj	avb_eos_adj	avb_pod1_adj
API5	-4090	3869	2732	-285	928	8831
CFDP1	-6851	-9026	3722	-6035	913	6429
CHD8	-612	10182	9214	10420	2961	9091
GAS6	9556	3556	10116	10065	663	10184
PIK3CA	-5737	6653	5409	1360	4068	8795
PIK3CG	857	10593	9790	10415	11069	10874

---

---

GOBP REGULATION OF COMPLEMENT DEPENDENT CYTOTOXICITY

GOBP REGULATION OF COMPLEMENT DEPENDENT CYTOTOXICITY

metric	value
setSize	8
pMANOVA	0.000825
p.adjustMANOVA	0.00432
s.dist	1.22
s.crp_t0_adj	0.225
s.crp_eos_adj	0.675
s.crp_pod1_adj	0.774
s.avb_t0_adj	-0.0418
s.avb_eos_adj	-0.156
s.avb_pod1_adj	0.602
p.crp_t0_adj	0.27
p.crp_eos_adj	0.000943
p.crp_pod1_adj	0.000151
p.avb_t0_adj	0.838
p.avb_eos_adj	0.445
p.avb_pod1_adj	0.00319

Warning: Removed 396 rows containing missing values or values outside the scale range (`geom_tile()`).
Removed 396 rows containing missing values or values outside the scale range (`geom_tile()`).
Removed 396 rows containing missing values or values outside the scale range (`geom_tile()`).
Removed 396 rows containing missing values or values outside the scale range (`geom_tile()`).
Removed 396 rows containing missing values or values outside the scale range (`geom_tile()`).
Removed 396 rows containing missing values or values outside the scale range (`geom_tile()`).
Removed 396 rows containing missing values or values outside the scale range (`geom_tile()`).
Removed 396 rows containing missing values or values outside the scale range (`geom_tile()`).
Removed 396 rows containing missing values or values outside the scale range (`geom_tile()`).
Removed 396 rows containing missing values or values outside the scale range (`geom_tile()`).
Removed 396 rows containing missing values or values outside the scale range (`geom_tile()`).
Removed 396 rows containing missing values or values outside the scale range (`geom_tile()`).
Removed 396 rows containing missing values or values outside the scale range (`geom_tile()`).
Removed 396 rows containing missing values or values outside the scale range (`geom_tile()`).
Removed 396 rows containing missing values or values outside the scale range (`geom_tile()`).

Top 20 genes

Gene	d3	d2
CR1	10157	10738
CR1L	9957	10876
CD55	10148	10547
IL10	9654	10073
IL4	9160	9203
TGFB2	9593	4321
CFH	4759	4987

Click HERE to show all gene set members

All member genes

	crp_t0_adj	crp_eos_adj	crp_pod1_adj	avb_t0_adj	avb_eos_adj	avb_pod1_adj
CD55	-1495	10547	10148	4675	-2442	10875
CD59	-994	-910	-1052	2563	-8040	6806
CFH	9347	4987	4759	-10080	-8744	-6802
CR1	1981	10738	10157	-3761	-1471	10883
CR1L	-4294	10876	9957	-8171	3253	9698
IL10	7100	10073	9654	3351	-8357	992
IL4	6623	9203	9160	2085	9711	10833
TGFB2	1620	4321	9593	7788	9746	10543

---

---

GOBP REGULATION OF CONNECTIVE TISSUE REPLACEMENT

GOBP REGULATION OF CONNECTIVE TISSUE REPLACEMENT

metric	value
setSize	5
pMANOVA	0.0117
p.adjustMANOVA	0.039
s.dist	1.21
s.crp_t0_adj	-0.117
s.crp_eos_adj	0.304
s.crp_pod1_adj	0.664
s.avb_t0_adj	-0.205
s.avb_eos_adj	-0.659
s.avb_pod1_adj	0.657
p.crp_t0_adj	0.651
p.crp_eos_adj	0.239
p.crp_pod1_adj	0.0101
p.avb_t0_adj	0.428
p.avb_eos_adj	0.0107
p.avb_pod1_adj	0.011

Warning: Removed 396 rows containing missing values or values outside the scale range (`geom_tile()`).
Removed 396 rows containing missing values or values outside the scale range (`geom_tile()`).
Removed 396 rows containing missing values or values outside the scale range (`geom_tile()`).
Removed 396 rows containing missing values or values outside the scale range (`geom_tile()`).
Removed 396 rows containing missing values or values outside the scale range (`geom_tile()`).
Removed 396 rows containing missing values or values outside the scale range (`geom_tile()`).
Removed 396 rows containing missing values or values outside the scale range (`geom_tile()`).
Removed 396 rows containing missing values or values outside the scale range (`geom_tile()`).
Removed 396 rows containing missing values or values outside the scale range (`geom_tile()`).
Removed 396 rows containing missing values or values outside the scale range (`geom_tile()`).
Removed 396 rows containing missing values or values outside the scale range (`geom_tile()`).
Removed 396 rows containing missing values or values outside the scale range (`geom_tile()`).
Removed 396 rows containing missing values or values outside the scale range (`geom_tile()`).
Removed 396 rows containing missing values or values outside the scale range (`geom_tile()`).
Removed 396 rows containing missing values or values outside the scale range (`geom_tile()`).

Top 20 genes

Gene	d3	d5
PPARG	10179	-9361
ROCK1	7950	-9540
RUNX1	10159	-5408
ROCK2	5989	-2334

Click HERE to show all gene set members

All member genes

	crp_t0_adj	crp_eos_adj	crp_pod1_adj	avb_t0_adj	avb_eos_adj	avb_pod1_adj
PPARG	3855	-1240	10179	-7164	-9361	7915
PPP3CA	-3852	7912	-1056	23	-3746	532
ROCK1	-8308	-3409	7950	-7751	-9540	9481
ROCK2	-6741	4035	5989	-3037	-2334	7945
RUNX1	9489	10602	10159	8402	-5408	10639

---

---

GOCC ENDOPLASMIC RETICULUM CHAPERONE COMPLEX

GOCC ENDOPLASMIC RETICULUM CHAPERONE COMPLEX

metric	value
setSize	11
pMANOVA	9.15e-08
p.adjustMANOVA	1.13e-06
s.dist	1.2
s.crp_t0_adj	-0.361
s.crp_eos_adj	-0.527
s.crp_pod1_adj	0.545
s.avb_t0_adj	0.269
s.avb_eos_adj	-0.583
s.avb_pod1_adj	0.576
p.crp_t0_adj	0.0383
p.crp_eos_adj	0.00246
p.crp_pod1_adj	0.00175
p.avb_t0_adj	0.122
p.avb_eos_adj	0.000812
p.avb_pod1_adj	0.000938

Warning: Removed 396 rows containing missing values or values outside the scale range (`geom_tile()`).
Removed 396 rows containing missing values or values outside the scale range (`geom_tile()`).
Removed 396 rows containing missing values or values outside the scale range (`geom_tile()`).
Removed 396 rows containing missing values or values outside the scale range (`geom_tile()`).
Removed 396 rows containing missing values or values outside the scale range (`geom_tile()`).
Removed 396 rows containing missing values or values outside the scale range (`geom_tile()`).
Removed 396 rows containing missing values or values outside the scale range (`geom_tile()`).
Removed 396 rows containing missing values or values outside the scale range (`geom_tile()`).
Removed 396 rows containing missing values or values outside the scale range (`geom_tile()`).
Removed 396 rows containing missing values or values outside the scale range (`geom_tile()`).
Removed 396 rows containing missing values or values outside the scale range (`geom_tile()`).
Removed 396 rows containing missing values or values outside the scale range (`geom_tile()`).
Removed 396 rows containing missing values or values outside the scale range (`geom_tile()`).
Removed 396 rows containing missing values or values outside the scale range (`geom_tile()`).
Removed 396 rows containing missing values or values outside the scale range (`geom_tile()`).

Top 20 genes

Gene	d5	d6
HSPA5	-8846	10303
HYOU1	-8636	10288
DNAJB11	-7482	10554
PDIA6	-6954	10551
HSP90B1	-5995	10493
SDF2L1	-7685	6255
PPIB	-5890	7566
P4HB	-6037	6581
MZB1	-1908	9845

Click HERE to show all gene set members

All member genes

	crp_t0_adj	crp_eos_adj	crp_pod1_adj	avb_t0_adj	avb_eos_adj	avb_pod1_adj
DNAJB11	-8329	-872	9796	2126	-7482	10554
DNAJC10	-9096	2395	-10555	-6386	8647	-7701
HSP90B1	-8995	-7009	7926	4755	-5995	10493
HSPA5	-9847	-2637	9540	4444	-8846	10303
HYOU1	-1158	-4619	9831	10538	-8636	10288
MZB1	8362	-7024	4792	8484	-1908	9845
P4HB	-6849	-7646	6395	2993	-6037	6581
PDIA6	-9041	-7939	9502	2447	-6954	10551
PPIB	-6183	-8933	3000	4224	-5890	7566
SDF2L1	5491	-5916	5093	5443	-7685	6255
UGT1A1	5241	-6552	3976	-5234	-7303	-3742

---

---

GOBP REGULATION OF NITRIC OXIDE MEDIATED SIGNAL TRANSDUCTION

GOBP REGULATION OF NITRIC OXIDE MEDIATED SIGNAL TRANSDUCTION

metric	value
setSize	5
pMANOVA	0.00272
p.adjustMANOVA	0.0119
s.dist	1.2
s.crp_t0_adj	-0.369
s.crp_eos_adj	-0.533
s.crp_pod1_adj	0.501
s.avb_t0_adj	-0.489
s.avb_eos_adj	-0.706
s.avb_pod1_adj	-0.157
p.crp_t0_adj	0.154
p.crp_eos_adj	0.0389
p.crp_pod1_adj	0.0524
p.avb_t0_adj	0.058
p.avb_eos_adj	0.00626
p.avb_pod1_adj	0.543

Warning: Removed 396 rows containing missing values or values outside the scale range (`geom_tile()`).
Removed 396 rows containing missing values or values outside the scale range (`geom_tile()`).
Removed 396 rows containing missing values or values outside the scale range (`geom_tile()`).
Removed 396 rows containing missing values or values outside the scale range (`geom_tile()`).
Removed 396 rows containing missing values or values outside the scale range (`geom_tile()`).
Removed 396 rows containing missing values or values outside the scale range (`geom_tile()`).
Removed 396 rows containing missing values or values outside the scale range (`geom_tile()`).
Removed 396 rows containing missing values or values outside the scale range (`geom_tile()`).
Removed 396 rows containing missing values or values outside the scale range (`geom_tile()`).
Removed 396 rows containing missing values or values outside the scale range (`geom_tile()`).
Removed 396 rows containing missing values or values outside the scale range (`geom_tile()`).
Removed 396 rows containing missing values or values outside the scale range (`geom_tile()`).
Removed 396 rows containing missing values or values outside the scale range (`geom_tile()`).
Removed 396 rows containing missing values or values outside the scale range (`geom_tile()`).
Removed 396 rows containing missing values or values outside the scale range (`geom_tile()`).

Top 20 genes

Gene	d5	d2
PDE5A	-8706	-9154
GUCY1A1	-7042	-9287
THBS1	-9550	-2919
CBS	-8809	-1693

Click HERE to show all gene set members

All member genes

	crp_t0_adj	crp_eos_adj	crp_pod1_adj	avb_t0_adj	avb_eos_adj	avb_pod1_adj
CBS	9249	-1693	2354	-4124	-8809	-9522
GUCY1A1	-7809	-9287	5253	-7472	-7042	9692
PDE5A	-6238	-9154	4735	-3649	-8706	9531
THBS1	-9542	-2919	9064	-9742	-9550	-9747
VEGFA	-4440	-3072	3245	486	1234	-6220

---

---

GOMF HEMOGLOBIN BINDING

GOMF HEMOGLOBIN BINDING

metric	value
setSize	7
pMANOVA	0.00618
p.adjustMANOVA	0.0233
s.dist	1.19
s.crp_t0_adj	0.335
s.crp_eos_adj	0.338
s.crp_pod1_adj	0.728
s.avb_t0_adj	0.429
s.avb_eos_adj	0.114
s.avb_pod1_adj	0.686
p.crp_t0_adj	0.124
p.crp_eos_adj	0.122
p.crp_pod1_adj	0.000848
p.avb_t0_adj	0.0493
p.avb_eos_adj	0.603
p.avb_pod1_adj	0.00168

Warning: Removed 396 rows containing missing values or values outside the scale range (`geom_tile()`).
Removed 396 rows containing missing values or values outside the scale range (`geom_tile()`).
Removed 396 rows containing missing values or values outside the scale range (`geom_tile()`).
Removed 396 rows containing missing values or values outside the scale range (`geom_tile()`).
Removed 396 rows containing missing values or values outside the scale range (`geom_tile()`).
Removed 396 rows containing missing values or values outside the scale range (`geom_tile()`).
Removed 396 rows containing missing values or values outside the scale range (`geom_tile()`).
Removed 396 rows containing missing values or values outside the scale range (`geom_tile()`).
Removed 396 rows containing missing values or values outside the scale range (`geom_tile()`).
Removed 396 rows containing missing values or values outside the scale range (`geom_tile()`).
Removed 396 rows containing missing values or values outside the scale range (`geom_tile()`).
Removed 396 rows containing missing values or values outside the scale range (`geom_tile()`).
Removed 396 rows containing missing values or values outside the scale range (`geom_tile()`).
Removed 396 rows containing missing values or values outside the scale range (`geom_tile()`).
Removed 396 rows containing missing values or values outside the scale range (`geom_tile()`).

Top 20 genes

Gene	d3	d6
HP	10049	10877
AHSP	9239	9168
HBD	9147	8055
SLC4A1	8529	7904
HBG1	6704	8970
HBB	7413	5800
HBG2	158	2488

Click HERE to show all gene set members

All member genes

	crp_t0_adj	crp_eos_adj	crp_pod1_adj	avb_t0_adj	avb_eos_adj	avb_pod1_adj
AHSP	10631	9455	9239	7830	575	9168
HBB	10539	4995	7413	8372	1347	5800
HBD	10634	10325	9147	10201	3265	8055
HBG1	-10334	-7800	6704	-8448	1374	8970
HBG2	-242	-2761	158	2612	-324	2488
HP	-6343	3182	10049	4367	3768	10877
SLC4A1	10632	10121	8529	8363	4290	7904

---

---

GOMF NITRITE REDUCTASE ACTIVITY

GOMF NITRITE REDUCTASE ACTIVITY

metric	value
setSize	5
pMANOVA	0.0373
p.adjustMANOVA	0.0945
s.dist	1.19
s.crp_t0_adj	-0.348
s.crp_eos_adj	-0.431
s.crp_pod1_adj	0.454
s.avb_t0_adj	-0.371
s.avb_eos_adj	-0.837
s.avb_pod1_adj	0.264
p.crp_t0_adj	0.177
p.crp_eos_adj	0.0949
p.crp_pod1_adj	0.0787
p.avb_t0_adj	0.151
p.avb_eos_adj	0.00119
p.avb_pod1_adj	0.306

Warning: Removed 396 rows containing missing values or values outside the scale range (`geom_tile()`).
Removed 396 rows containing missing values or values outside the scale range (`geom_tile()`).
Removed 396 rows containing missing values or values outside the scale range (`geom_tile()`).
Removed 396 rows containing missing values or values outside the scale range (`geom_tile()`).
Removed 396 rows containing missing values or values outside the scale range (`geom_tile()`).
Removed 396 rows containing missing values or values outside the scale range (`geom_tile()`).
Removed 396 rows containing missing values or values outside the scale range (`geom_tile()`).
Removed 396 rows containing missing values or values outside the scale range (`geom_tile()`).
Removed 396 rows containing missing values or values outside the scale range (`geom_tile()`).
Removed 396 rows containing missing values or values outside the scale range (`geom_tile()`).
Removed 396 rows containing missing values or values outside the scale range (`geom_tile()`).
Removed 396 rows containing missing values or values outside the scale range (`geom_tile()`).
Removed 396 rows containing missing values or values outside the scale range (`geom_tile()`).
Removed 396 rows containing missing values or values outside the scale range (`geom_tile()`).
Removed 396 rows containing missing values or values outside the scale range (`geom_tile()`).

Top 20 genes

Gene	d5	d3
MTARC1	-9354	9369
MTARC2	-8773	9969
CYB5R3	-8034	6202
CBS	-8809	2354

Click HERE to show all gene set members

All member genes

	crp_t0_adj	crp_eos_adj	crp_pod1_adj	avb_t0_adj	avb_eos_adj	avb_pod1_adj
CBS	9249	-1693	2354	-4124	-8809	-9522
CYB5B	-3737	-6579	-5705	6759	-4776	10339
CYB5R3	-3387	-8318	6202	-1982	-8034	3663
MTARC1	-9984	-1218	9369	-9920	-9354	1251
MTARC2	-9867	-2953	9969	-8982	-8773	10164

---

---

GOCC BASEMENT MEMBRANE COLLAGEN TRIMER

GOCC BASEMENT MEMBRANE COLLAGEN TRIMER

metric	value
setSize	5
pMANOVA	0.00306
p.adjustMANOVA	0.0131
s.dist	1.19
s.crp_t0_adj	-0.104
s.crp_eos_adj	0.393
s.crp_pod1_adj	0.395
s.avb_t0_adj	-0.777
s.avb_eos_adj	-0.64
s.avb_pod1_adj	-0.272
p.crp_t0_adj	0.688
p.crp_eos_adj	0.128
p.crp_pod1_adj	0.127
p.avb_t0_adj	0.00263
p.avb_eos_adj	0.0131
p.avb_pod1_adj	0.293

Warning: Removed 396 rows containing missing values or values outside the scale range (`geom_tile()`).
Removed 396 rows containing missing values or values outside the scale range (`geom_tile()`).
Removed 396 rows containing missing values or values outside the scale range (`geom_tile()`).
Removed 396 rows containing missing values or values outside the scale range (`geom_tile()`).
Removed 396 rows containing missing values or values outside the scale range (`geom_tile()`).
Removed 396 rows containing missing values or values outside the scale range (`geom_tile()`).
Removed 396 rows containing missing values or values outside the scale range (`geom_tile()`).
Removed 396 rows containing missing values or values outside the scale range (`geom_tile()`).
Removed 396 rows containing missing values or values outside the scale range (`geom_tile()`).
Removed 396 rows containing missing values or values outside the scale range (`geom_tile()`).
Removed 396 rows containing missing values or values outside the scale range (`geom_tile()`).
Removed 396 rows containing missing values or values outside the scale range (`geom_tile()`).
Removed 396 rows containing missing values or values outside the scale range (`geom_tile()`).
Removed 396 rows containing missing values or values outside the scale range (`geom_tile()`).
Removed 396 rows containing missing values or values outside the scale range (`geom_tile()`).

Top 20 genes

Gene	d4	d5
COL4A3	-9853	-6745
COL4A2	-9907	-6038
COL4A5	-6593	-8371
COL4A4	-8893	-5741
COL8A1	-4363	-2536

Click HERE to show all gene set members

All member genes

	crp_t0_adj	crp_eos_adj	crp_pod1_adj	avb_t0_adj	avb_eos_adj	avb_pod1_adj
COL4A2	-2067	6929	-1128	-9907	-6038	-9752
COL4A3	-2712	876	5352	-9853	-6745	-4837
COL4A4	-3914	435	5816	-8893	-5741	-2432
COL4A5	5226	5443	7719	-6593	-8371	2403
COL8A1	-1399	8886	1306	-4363	-2536	2328

---

---

GOBP ESTABLISHMENT OF MITOTIC SISTER CHROMATID COHESION

GOBP ESTABLISHMENT OF MITOTIC SISTER CHROMATID COHESION

metric	value
setSize	7
pMANOVA	9.66e-06
p.adjustMANOVA	8.16e-05
s.dist	1.18
s.crp_t0_adj	-0.476
s.crp_eos_adj	0.497
s.crp_pod1_adj	0.476
s.avb_t0_adj	0.43
s.avb_eos_adj	0.218
s.avb_pod1_adj	0.685
p.crp_t0_adj	0.0293
p.crp_eos_adj	0.0228
p.crp_pod1_adj	0.0293
p.avb_t0_adj	0.049
p.avb_eos_adj	0.317
p.avb_pod1_adj	0.0017

Warning: Removed 396 rows containing missing values or values outside the scale range (`geom_tile()`).
Removed 396 rows containing missing values or values outside the scale range (`geom_tile()`).
Removed 396 rows containing missing values or values outside the scale range (`geom_tile()`).
Removed 396 rows containing missing values or values outside the scale range (`geom_tile()`).
Removed 396 rows containing missing values or values outside the scale range (`geom_tile()`).
Removed 396 rows containing missing values or values outside the scale range (`geom_tile()`).
Removed 396 rows containing missing values or values outside the scale range (`geom_tile()`).
Removed 396 rows containing missing values or values outside the scale range (`geom_tile()`).
Removed 396 rows containing missing values or values outside the scale range (`geom_tile()`).
Removed 396 rows containing missing values or values outside the scale range (`geom_tile()`).
Removed 396 rows containing missing values or values outside the scale range (`geom_tile()`).
Removed 396 rows containing missing values or values outside the scale range (`geom_tile()`).
Removed 396 rows containing missing values or values outside the scale range (`geom_tile()`).
Removed 396 rows containing missing values or values outside the scale range (`geom_tile()`).
Removed 396 rows containing missing values or values outside the scale range (`geom_tile()`).

Top 20 genes

Gene	d6	d2
NIPBL	8122	9688
STAG2	8838	8252
NAA50	9172	4277
STAG1	7842	4723
RAD21	6416	5424
SMC1A	4296	5824
SMC3	8504	1067

Click HERE to show all gene set members

All member genes

	crp_t0_adj	crp_eos_adj	crp_pod1_adj	avb_t0_adj	avb_eos_adj	avb_pod1_adj
NAA50	-5576	4277	7665	4953	4063	9172
NIPBL	-805	9688	6731	5644	-455	8122
RAD21	-4585	5424	2726	190	-665	6416
SMC1A	-3131	5824	6936	8994	3441	4296
SMC3	-4730	1067	1395	4981	7987	8504
STAG1	-8920	4723	2332	3329	2864	7842
STAG2	-6430	8252	4867	5247	4763	8838

---

---

GOCC OLIGOSACCHARYLTRANSFERASE COMPLEX

GOCC OLIGOSACCHARYLTRANSFERASE COMPLEX

metric	value
setSize	13
pMANOVA	3.61e-08
p.adjustMANOVA	4.7e-07
s.dist	1.18
s.crp_t0_adj	-0.617
s.crp_eos_adj	-0.803
s.crp_pod1_adj	-0.0895
s.avb_t0_adj	0.171
s.avb_eos_adj	-0.408
s.avb_pod1_adj	0.409
p.crp_t0_adj	0.000118
p.crp_eos_adj	5.26e-07
p.crp_pod1_adj	0.576
p.avb_t0_adj	0.286
p.avb_eos_adj	0.0109
p.avb_pod1_adj	0.0106

Warning: Removed 396 rows containing missing values or values outside the scale range (`geom_tile()`).
Removed 396 rows containing missing values or values outside the scale range (`geom_tile()`).
Removed 396 rows containing missing values or values outside the scale range (`geom_tile()`).
Removed 396 rows containing missing values or values outside the scale range (`geom_tile()`).
Removed 396 rows containing missing values or values outside the scale range (`geom_tile()`).
Removed 396 rows containing missing values or values outside the scale range (`geom_tile()`).
Removed 396 rows containing missing values or values outside the scale range (`geom_tile()`).
Removed 396 rows containing missing values or values outside the scale range (`geom_tile()`).
Removed 396 rows containing missing values or values outside the scale range (`geom_tile()`).
Removed 396 rows containing missing values or values outside the scale range (`geom_tile()`).
Removed 396 rows containing missing values or values outside the scale range (`geom_tile()`).
Removed 396 rows containing missing values or values outside the scale range (`geom_tile()`).
Removed 396 rows containing missing values or values outside the scale range (`geom_tile()`).
Removed 396 rows containing missing values or values outside the scale range (`geom_tile()`).
Removed 396 rows containing missing values or values outside the scale range (`geom_tile()`).

Top 20 genes

Gene	d2	d1
OSTC	-9711	-10269
DAD1	-9928	-9506
RPN2	-8855	-9385
DDOST	-8701	-8930
OST4	-10119	-6736
MLEC	-7144	-9376
RPN1	-8935	-6748
MAGT1	-6394	-8842
STT3B	-5301	-10048
STT3A	-5936	-7622
TREX1	-8452	-433

Click HERE to show all gene set members

All member genes

	crp_t0_adj	crp_eos_adj	crp_pod1_adj	avb_t0_adj	avb_eos_adj	avb_pod1_adj
DAD1	-9506	-9928	-4305	-2269	-4299	7667
DDOST	-8930	-8701	-1142	3049	-3395	5377
KRTCAP2	2931	-7677	-2829	5447	-3850	-4572
MAGT1	-8842	-6394	4024	-2234	-8050	10587
MLEC	-9376	-7144	-6712	10635	9942	4749
OST4	-6736	-10119	-3989	-2067	-8428	7400
OSTC	-10269	-9711	-3196	-5189	-5417	8550
RPN1	-6748	-8935	4327	6051	-7877	6275
RPN2	-9385	-8855	7309	1263	-5893	6994
STT3A	-7622	-5936	3113	6058	-6469	9356
STT3B	-10048	-5301	3271	-5489	-5020	10187
TMEM258	2250	-7633	-6603	5724	-1362	-3473
TREX1	-433	-8452	-9858	5578	5451	-7978

---

---

GOBP SA NODE CELL TO ATRIAL CARDIAC MUSCLE CELL SIGNALING

GOBP SA NODE CELL TO ATRIAL CARDIAC MUSCLE CELL SIGNALING

metric	value
setSize	5
pMANOVA	0.0275
p.adjustMANOVA	0.0753
s.dist	1.18
s.crp_t0_adj	-0.122
s.crp_eos_adj	0.217
s.crp_pod1_adj	0.741
s.avb_t0_adj	-0.62
s.avb_eos_adj	-0.498
s.avb_pod1_adj	0.391
p.crp_t0_adj	0.635
p.crp_eos_adj	0.4
p.crp_pod1_adj	0.0041
p.avb_t0_adj	0.0164
p.avb_eos_adj	0.0539
p.avb_pod1_adj	0.13

Warning: Removed 396 rows containing missing values or values outside the scale range (`geom_tile()`).
Removed 396 rows containing missing values or values outside the scale range (`geom_tile()`).
Removed 396 rows containing missing values or values outside the scale range (`geom_tile()`).
Removed 396 rows containing missing values or values outside the scale range (`geom_tile()`).
Removed 396 rows containing missing values or values outside the scale range (`geom_tile()`).
Removed 396 rows containing missing values or values outside the scale range (`geom_tile()`).
Removed 396 rows containing missing values or values outside the scale range (`geom_tile()`).
Removed 396 rows containing missing values or values outside the scale range (`geom_tile()`).
Removed 396 rows containing missing values or values outside the scale range (`geom_tile()`).
Removed 396 rows containing missing values or values outside the scale range (`geom_tile()`).
Removed 396 rows containing missing values or values outside the scale range (`geom_tile()`).
Removed 396 rows containing missing values or values outside the scale range (`geom_tile()`).
Removed 396 rows containing missing values or values outside the scale range (`geom_tile()`).
Removed 396 rows containing missing values or values outside the scale range (`geom_tile()`).
Removed 396 rows containing missing values or values outside the scale range (`geom_tile()`).

Top 20 genes

Gene	d3	d4
ANK2	9609	-8649
CACNA1D	8471	-9601
SCN3B	5811	-10182
SCN5A	6174	-4156

Click HERE to show all gene set members

All member genes

	crp_t0_adj	crp_eos_adj	crp_pod1_adj	avb_t0_adj	avb_eos_adj	avb_pod1_adj
ANK2	2181	-475	9609	-8649	-5994	2924
CACNA1D	-6872	8474	8471	-9601	-4913	4026
RYR2	6682	-6222	7215	1230	-8464	9756
SCN3B	-5995	3871	5811	-10182	6585	8381
SCN5A	-1842	7681	6174	-4156	-9139	-2534

---

---

GOMF MHC CLASS I PROTEIN COMPLEX BINDING

GOMF MHC CLASS I PROTEIN COMPLEX BINDING

metric	value
setSize	7
pMANOVA	0.000505
p.adjustMANOVA	0.00283
s.dist	1.18
s.crp_t0_adj	0.526
s.crp_eos_adj	0.523
s.crp_pod1_adj	0.271
s.avb_t0_adj	0.7
s.avb_eos_adj	0.0689
s.avb_pod1_adj	0.519
p.crp_t0_adj	0.016
p.crp_eos_adj	0.0165
p.crp_pod1_adj	0.214
p.avb_t0_adj	0.00135
p.avb_eos_adj	0.752
p.avb_pod1_adj	0.0173

Warning: Removed 396 rows containing missing values or values outside the scale range (`geom_tile()`).
Removed 396 rows containing missing values or values outside the scale range (`geom_tile()`).
Removed 396 rows containing missing values or values outside the scale range (`geom_tile()`).
Removed 396 rows containing missing values or values outside the scale range (`geom_tile()`).
Removed 396 rows containing missing values or values outside the scale range (`geom_tile()`).
Removed 396 rows containing missing values or values outside the scale range (`geom_tile()`).
Removed 396 rows containing missing values or values outside the scale range (`geom_tile()`).
Removed 396 rows containing missing values or values outside the scale range (`geom_tile()`).
Removed 396 rows containing missing values or values outside the scale range (`geom_tile()`).
Removed 396 rows containing missing values or values outside the scale range (`geom_tile()`).
Removed 396 rows containing missing values or values outside the scale range (`geom_tile()`).
Removed 396 rows containing missing values or values outside the scale range (`geom_tile()`).
Removed 396 rows containing missing values or values outside the scale range (`geom_tile()`).
Removed 396 rows containing missing values or values outside the scale range (`geom_tile()`).
Removed 396 rows containing missing values or values outside the scale range (`geom_tile()`).

Top 20 genes

Gene	d4	d1
KLRC1	10434	7095
TAPBP	9519	6630
KLRC2	4562	10527
CD160	8636	4582
CD8A	4923	7135
KLRD1	5562	3187
TAPBPL	9565	355

Click HERE to show all gene set members

All member genes

	crp_t0_adj	crp_eos_adj	crp_pod1_adj	avb_t0_adj	avb_eos_adj	avb_pod1_adj
CD160	4582	3941	-5799	8636	7532	2684
CD8A	7135	10562	6227	4923	-1725	7885
KLRC1	7095	8272	3477	10434	-3375	9787
KLRC2	10527	10683	9026	4562	70	7519
KLRD1	3187	5669	5413	5562	-9288	8192
TAPBP	6630	7948	8399	9519	9454	7703
TAPBPL	355	-5880	-9146	9565	8336	-2752

---

---

GOBP REGULATION OF CALCIUM ION EXPORT ACROSS PLASMA MEMBRANE

GOBP REGULATION OF CALCIUM ION EXPORT ACROSS PLASMA MEMBRANE

metric	value
setSize	5
pMANOVA	0.0387
p.adjustMANOVA	0.0971
s.dist	1.18
s.crp_t0_adj	-0.357
s.crp_eos_adj	-0.747
s.crp_pod1_adj	0.118
s.avb_t0_adj	-0.323
s.avb_eos_adj	-0.679
s.avb_pod1_adj	0.35
p.crp_t0_adj	0.167
p.crp_eos_adj	0.00381
p.crp_pod1_adj	0.648
p.avb_t0_adj	0.212
p.avb_eos_adj	0.00857
p.avb_pod1_adj	0.176

Warning: Removed 396 rows containing missing values or values outside the scale range (`geom_tile()`).
Removed 396 rows containing missing values or values outside the scale range (`geom_tile()`).
Removed 396 rows containing missing values or values outside the scale range (`geom_tile()`).
Removed 396 rows containing missing values or values outside the scale range (`geom_tile()`).
Removed 396 rows containing missing values or values outside the scale range (`geom_tile()`).
Removed 396 rows containing missing values or values outside the scale range (`geom_tile()`).
Removed 396 rows containing missing values or values outside the scale range (`geom_tile()`).
Removed 396 rows containing missing values or values outside the scale range (`geom_tile()`).
Removed 396 rows containing missing values or values outside the scale range (`geom_tile()`).
Removed 396 rows containing missing values or values outside the scale range (`geom_tile()`).
Removed 396 rows containing missing values or values outside the scale range (`geom_tile()`).
Removed 396 rows containing missing values or values outside the scale range (`geom_tile()`).
Removed 396 rows containing missing values or values outside the scale range (`geom_tile()`).
Removed 396 rows containing missing values or values outside the scale range (`geom_tile()`).
Removed 396 rows containing missing values or values outside the scale range (`geom_tile()`).

Top 20 genes

Gene	d2	d5
CALM2	-10094	-9628
RGS9	-4753	-9259
YWHAE	-8581	-5068
CALM3	-9124	-4185
CALM1	-4817	-3303

Click HERE to show all gene set members

All member genes

	crp_t0_adj	crp_eos_adj	crp_pod1_adj	avb_t0_adj	avb_eos_adj	avb_pod1_adj
CALM1	-1238	-4817	7087	-2397	-3303	10739
CALM2	-10169	-10094	-8671	-8817	-9628	972
CALM3	-2171	-9124	29	3985	-4185	5202
RGS9	3585	-4753	18	-8362	-9259	-5521
YWHAE	-8161	-8581	6060	-142	-5068	8979

---

---

GOBP NEGATIVE REGULATION OF INTERFERON ALPHA PRODUCTION

GOBP NEGATIVE REGULATION OF INTERFERON ALPHA PRODUCTION

metric	value
setSize	6
pMANOVA	0.0184
p.adjustMANOVA	0.0552
s.dist	1.18
s.crp_t0_adj	0.279
s.crp_eos_adj	0.53
s.crp_pod1_adj	0.53
s.avb_t0_adj	0.58
s.avb_eos_adj	0.372
s.avb_pod1_adj	0.52
p.crp_t0_adj	0.236
p.crp_eos_adj	0.0245
p.crp_pod1_adj	0.0245
p.avb_t0_adj	0.0139
p.avb_eos_adj	0.114
p.avb_pod1_adj	0.0274

Warning: Removed 396 rows containing missing values or values outside the scale range (`geom_tile()`).
Removed 396 rows containing missing values or values outside the scale range (`geom_tile()`).
Removed 396 rows containing missing values or values outside the scale range (`geom_tile()`).
Removed 396 rows containing missing values or values outside the scale range (`geom_tile()`).
Removed 396 rows containing missing values or values outside the scale range (`geom_tile()`).
Removed 396 rows containing missing values or values outside the scale range (`geom_tile()`).
Removed 396 rows containing missing values or values outside the scale range (`geom_tile()`).
Removed 396 rows containing missing values or values outside the scale range (`geom_tile()`).
Removed 396 rows containing missing values or values outside the scale range (`geom_tile()`).
Removed 396 rows containing missing values or values outside the scale range (`geom_tile()`).
Removed 396 rows containing missing values or values outside the scale range (`geom_tile()`).
Removed 396 rows containing missing values or values outside the scale range (`geom_tile()`).
Removed 396 rows containing missing values or values outside the scale range (`geom_tile()`).
Removed 396 rows containing missing values or values outside the scale range (`geom_tile()`).
Removed 396 rows containing missing values or values outside the scale range (`geom_tile()`).

Top 20 genes

Gene	d4	d2
PTPRS	10713	9831
NLRC3	5355	9328
LILRA4	10472	4207
IL10	3351	10073
HAVCR2	9534	1961

Click HERE to show all gene set members

All member genes

	crp_t0_adj	crp_eos_adj	crp_pod1_adj	avb_t0_adj	avb_eos_adj	avb_pod1_adj
HAVCR2	4306	1961	5174	9534	3812	5220
IL10	7100	10073	9654	3351	-8357	992
LILRA4	3730	4207	8512	10472	11038	10901
NLRC3	3563	9328	-5119	5355	7973	-3584
NMI	-1558	349	6246	-1377	2779	10766
PTPRS	1200	9831	6971	10713	11318	10911

---

---

GOBP COMPLEMENT DEPENDENT CYTOTOXICITY

GOBP COMPLEMENT DEPENDENT CYTOTOXICITY

metric	value
setSize	11
pMANOVA	7.39e-05
p.adjustMANOVA	0.000519
s.dist	1.18
s.crp_t0_adj	0.148
s.crp_eos_adj	0.575
s.crp_pod1_adj	0.73
s.avb_t0_adj	-0.0239
s.avb_eos_adj	-0.0137
s.avb_pod1_adj	0.704
p.crp_t0_adj	0.395
p.crp_eos_adj	0.000951
p.crp_pod1_adj	2.74e-05
p.avb_t0_adj	0.891
p.avb_eos_adj	0.937
p.avb_pod1_adj	5.2e-05

Warning: Removed 396 rows containing missing values or values outside the scale range (`geom_tile()`).
Removed 396 rows containing missing values or values outside the scale range (`geom_tile()`).
Removed 396 rows containing missing values or values outside the scale range (`geom_tile()`).
Removed 396 rows containing missing values or values outside the scale range (`geom_tile()`).
Removed 396 rows containing missing values or values outside the scale range (`geom_tile()`).
Removed 396 rows containing missing values or values outside the scale range (`geom_tile()`).
Removed 396 rows containing missing values or values outside the scale range (`geom_tile()`).
Removed 396 rows containing missing values or values outside the scale range (`geom_tile()`).
Removed 396 rows containing missing values or values outside the scale range (`geom_tile()`).
Removed 396 rows containing missing values or values outside the scale range (`geom_tile()`).
Removed 396 rows containing missing values or values outside the scale range (`geom_tile()`).
Removed 396 rows containing missing values or values outside the scale range (`geom_tile()`).
Removed 396 rows containing missing values or values outside the scale range (`geom_tile()`).
Removed 396 rows containing missing values or values outside the scale range (`geom_tile()`).
Removed 396 rows containing missing values or values outside the scale range (`geom_tile()`).

Top 20 genes

Gene	d3	d6
CR1	10157	10883
CD55	10148	10875
TGFB2	9593	10543
IL4	9160	10833
CR1L	9957	9698
RAB27A	8425	10782
IGHG1	7935	10619
C3	1999	10611
IL10	9654	992

Click HERE to show all gene set members

All member genes

	crp_t0_adj	crp_eos_adj	crp_pod1_adj	avb_t0_adj	avb_eos_adj	avb_pod1_adj
C3	-2756	-1712	1999	-4008	7834	10611
CD55	-1495	10547	10148	4675	-2442	10875
CD59	-994	-910	-1052	2563	-8040	6806
CFH	9347	4987	4759	-10080	-8744	-6802
CR1	1981	10738	10157	-3761	-1471	10883
CR1L	-4294	10876	9957	-8171	3253	9698
IGHG1	10360	2941	7935	10716	4520	10619
IL10	7100	10073	9654	3351	-8357	992
IL4	6623	9203	9160	2085	9711	10833
RAB27A	-9078	9667	8425	-5219	1729	10782
TGFB2	1620	4321	9593	7788	9746	10543

---

---

GOCC MHC CLASS II PROTEIN COMPLEX

GOCC MHC CLASS II PROTEIN COMPLEX

metric	value
setSize	15
pMANOVA	1.6e-08
p.adjustMANOVA	2.2e-07
s.dist	1.17
s.crp_t0_adj	0.0425
s.crp_eos_adj	-0.451
s.crp_pod1_adj	-0.671
s.avb_t0_adj	0.289
s.avb_eos_adj	0.592
s.avb_pod1_adj	-0.54
p.crp_t0_adj	0.775
p.crp_eos_adj	0.00252
p.crp_pod1_adj	6.88e-06
p.avb_t0_adj	0.0528
p.avb_eos_adj	7.25e-05
p.avb_pod1_adj	0.000289

Warning: Removed 396 rows containing missing values or values outside the scale range (`geom_tile()`).
Removed 396 rows containing missing values or values outside the scale range (`geom_tile()`).
Removed 396 rows containing missing values or values outside the scale range (`geom_tile()`).
Removed 396 rows containing missing values or values outside the scale range (`geom_tile()`).
Removed 396 rows containing missing values or values outside the scale range (`geom_tile()`).
Removed 396 rows containing missing values or values outside the scale range (`geom_tile()`).
Removed 396 rows containing missing values or values outside the scale range (`geom_tile()`).
Removed 396 rows containing missing values or values outside the scale range (`geom_tile()`).
Removed 396 rows containing missing values or values outside the scale range (`geom_tile()`).
Removed 396 rows containing missing values or values outside the scale range (`geom_tile()`).
Removed 396 rows containing missing values or values outside the scale range (`geom_tile()`).
Removed 396 rows containing missing values or values outside the scale range (`geom_tile()`).
Removed 396 rows containing missing values or values outside the scale range (`geom_tile()`).
Removed 396 rows containing missing values or values outside the scale range (`geom_tile()`).
Removed 396 rows containing missing values or values outside the scale range (`geom_tile()`).

Top 20 genes

Gene	d3	d5
HLA-DMB	-10822	11345
HLA-DMA	-10824	11132
HLA-DRA	-10805	10691
HLA-DPA1	-10583	10914
HLA-DQA1	-10553	10513
CD74	-10582	10196
HLA-DPB1	-10369	10214
HLA-DRB1	-10623	9571
HLA-DRB5	-6058	8186
HLA-DQB1	-10579	3665
HLA-DQB2	-2039	8613
HLA-DOA	-1363	7237

Click HERE to show all gene set members

All member genes

	crp_t0_adj	crp_eos_adj	crp_pod1_adj	avb_t0_adj	avb_eos_adj	avb_pod1_adj
B2M	-9787	-9924	-9859	-3506	-5339	5049
CD74	841	-5480	-10582	6653	10196	-9077
HLA-DMA	3509	-5533	-10824	6671	11132	-10053
HLA-DMB	6012	242	-10822	8196	11345	-10070
HLA-DOA	7337	-16	-1363	4116	7237	916
HLA-DOB	2940	-2478	673	-2954	-1238	-2436
HLA-DPA1	396	-8210	-10583	4392	10914	-6658
HLA-DPB1	8146	-4160	-10369	3161	10214	-9196
HLA-DQA1	-9616	-6439	-10553	4210	10513	-6253
HLA-DQA2	3077	-426	3656	-247	268	1692
HLA-DQB1	-10143	-6457	-10579	-1513	3665	-8161
HLA-DQB2	7617	2118	-2039	-1089	8613	-3842
HLA-DRA	-7003	-8885	-10805	4590	10691	-8393
HLA-DRB1	-572	-7919	-10623	7672	9571	-8552
HLA-DRB5	5729	-1708	-6058	8846	8186	-4167

---

---

GOCC CYTOSOLIC LARGE RIBOSOMAL SUBUNIT

GOCC CYTOSOLIC LARGE RIBOSOMAL SUBUNIT

metric	value
setSize	52
pMANOVA	2.48e-31
p.adjustMANOVA	2.58e-29
s.dist	1.17
s.crp_t0_adj	-0.255
s.crp_eos_adj	-0.876
s.crp_pod1_adj	-0.69
s.avb_t0_adj	-0.0976
s.avb_eos_adj	-0.00894
s.avb_pod1_adj	-0.235
p.crp_t0_adj	0.00146
p.crp_eos_adj	7.43e-28
p.crp_pod1_adj	7.08e-18
p.avb_t0_adj	0.224
p.avb_eos_adj	0.911
p.avb_pod1_adj	0.00331

Warning: Removed 396 rows containing missing values or values outside the scale range (`geom_tile()`).
Removed 396 rows containing missing values or values outside the scale range (`geom_tile()`).
Removed 396 rows containing missing values or values outside the scale range (`geom_tile()`).
Removed 396 rows containing missing values or values outside the scale range (`geom_tile()`).
Removed 396 rows containing missing values or values outside the scale range (`geom_tile()`).
Removed 396 rows containing missing values or values outside the scale range (`geom_tile()`).
Removed 396 rows containing missing values or values outside the scale range (`geom_tile()`).
Removed 396 rows containing missing values or values outside the scale range (`geom_tile()`).
Removed 396 rows containing missing values or values outside the scale range (`geom_tile()`).
Removed 396 rows containing missing values or values outside the scale range (`geom_tile()`).
Removed 396 rows containing missing values or values outside the scale range (`geom_tile()`).
Removed 396 rows containing missing values or values outside the scale range (`geom_tile()`).
Removed 396 rows containing missing values or values outside the scale range (`geom_tile()`).
Removed 396 rows containing missing values or values outside the scale range (`geom_tile()`).
Removed 396 rows containing missing values or values outside the scale range (`geom_tile()`).

Top 20 genes

Gene	d2	d3
RPL29	-9652	-9844
RPL7L1	-9714	-9622
RPL4	-9745	-9578
RPL7	-9819	-9495
RPL35A	-9810	-9364
RPL5	-9726	-9296
RPL26	-9387	-9522
RPL34	-9432	-9406
RPL6	-9635	-8939
RPL18	-9242	-9308
RPL7A	-9533	-8984
RPL12	-9532	-8915
RPL10	-9167	-9137
RPL15	-9523	-8791
RPL8	-9466	-8839
RPL22	-9248	-9002
RPL36A	-9682	-8580
RPL11	-9263	-8876
RPL21	-9627	-8521
UBA52	-9138	-8674

Click HERE to show all gene set members

All member genes

	crp_t0_adj	crp_eos_adj	crp_pod1_adj	avb_t0_adj	avb_eos_adj	avb_pod1_adj
RPL10	-3705	-9167	-9137	-260	1694	-5198
RPL10A	-1979	-9579	-8043	-283	682	-1296
RPL11	-3089	-9263	-8876	-654	588	-2520
RPL12	-2752	-9532	-8915	373	4403	2316
RPL13	5917	-7041	-5763	2104	6501	2464
RPL13A	1072	-9131	-8577	-487	1888	-4029
RPL14	-5556	-9615	-8205	-4360	1128	509
RPL15	-6557	-9523	-8791	-3699	-1586	-4994
RPL17	-3771	-9211	-8307	-1318	1770	54
RPL18	-835	-9242	-9308	-618	1086	-5236
RPL18A	-218	-9027	-8172	-1102	403	-5581
RPL19	-2231	-9236	-8248	-691	908	-2496
RPL21	-5820	-9627	-8521	-4771	1793	-1138
RPL22	-6366	-9248	-9002	-3603	3957	52
RPL23	-7249	-9420	-7803	-2425	1304	-1573
RPL23A	-6304	-8773	-8640	-7182	555	-3392
RPL24	-6905	-9799	-7959	-4361	-593	782
RPL26	-3994	-9387	-9522	-222	379	-4607
RPL26L1	-3775	-8443	1506	-1254	-4671	3840
RPL27	-2120	-9517	-7209	-2440	-72	-1560
RPL27A	-1124	-8915	-7166	2709	4684	1491
RPL28	4558	-7064	-6507	2471	-394	-2856
RPL29	-4076	-9652	-9844	-3937	-855	-7173
RPL3	-3185	-8502	-8670	-1991	1351	-4095
RPL30	-2372	-9198	-8610	-510	-384	-4911
RPL31	-2271	-9112	-8328	146	3518	-3516
RPL32	-1227	-9273	-7765	1693	-547	-3264
RPL34	-4086	-9432	-9406	-842	1705	-5248
RPL35	5207	-8962	-5290	4185	3131	-2729
RPL35A	-4602	-9810	-9364	-2137	535	-2149
RPL36	3025	-7125	-5804	363	2651	-3238
RPL36A	-4529	-9682	-8580	-4795	1682	-3387
RPL36AL	3974	-6334	314	3561	-5086	3574
RPL37	2174	-7802	-6596	4357	-752	-4024
RPL37A	-797	-9181	-6452	3270	1168	-2045
RPL38	-2767	-8226	-7482	546	645	-5149
RPL39	-7773	-9081	-8028	-4974	-1335	-5117
RPL39L	-2179	-8103	-9774	9197	4471	-6715
RPL4	-7404	-9745	-9578	-4759	468	-2919
RPL41	-2134	-9061	-6688	4053	-151	-221
RPL5	-7820	-9726	-9296	-5906	1947	-1347
RPL6	-6768	-9635	-8939	-5292	674	-1097
RPL7	-7395	-9819	-9495	-3808	3689	-2235
RPL7A	-4924	-9533	-8984	-4385	-1202	-2703
RPL7L1	-4661	-9714	-9622	3313	-4293	5601
RPL8	-2894	-9466	-8839	-2437	-1803	-7318
RPL9	4794	-203	453	7430	4384	1761
RPLP0	-2819	-8953	-5802	-1710	-756	-2991
RPLP1	3361	-6765	-4215	2475	4472	-541
RPLP2	3116	-6920	-6938	-538	2802	-3189
UBA52	-2556	-9138	-8674	-1579	-3439	-4257
ZCCHC17	-6583	-9919	-6325	-3373	-5901	7956

---

---

GOBP N ACYLPHOSPHATIDYLETHANOLAMINE METABOLIC PROCESS

GOBP N ACYLPHOSPHATIDYLETHANOLAMINE METABOLIC PROCESS

metric	value
setSize	6
pMANOVA	0.0271
p.adjustMANOVA	0.0745
s.dist	1.17
s.crp_t0_adj	-0.378
s.crp_eos_adj	-0.474
s.crp_pod1_adj	-0.791
s.avb_t0_adj	-0.128
s.avb_eos_adj	0.102
s.avb_pod1_adj	-0.593
p.crp_t0_adj	0.109
p.crp_eos_adj	0.0443
p.crp_pod1_adj	0.00079
p.avb_t0_adj	0.586
p.avb_eos_adj	0.664
p.avb_pod1_adj	0.0118

Warning: Removed 396 rows containing missing values or values outside the scale range (`geom_tile()`).
Removed 396 rows containing missing values or values outside the scale range (`geom_tile()`).
Removed 396 rows containing missing values or values outside the scale range (`geom_tile()`).
Removed 396 rows containing missing values or values outside the scale range (`geom_tile()`).
Removed 396 rows containing missing values or values outside the scale range (`geom_tile()`).
Removed 396 rows containing missing values or values outside the scale range (`geom_tile()`).
Removed 396 rows containing missing values or values outside the scale range (`geom_tile()`).
Removed 396 rows containing missing values or values outside the scale range (`geom_tile()`).
Removed 396 rows containing missing values or values outside the scale range (`geom_tile()`).
Removed 396 rows containing missing values or values outside the scale range (`geom_tile()`).
Removed 396 rows containing missing values or values outside the scale range (`geom_tile()`).
Removed 396 rows containing missing values or values outside the scale range (`geom_tile()`).
Removed 396 rows containing missing values or values outside the scale range (`geom_tile()`).
Removed 396 rows containing missing values or values outside the scale range (`geom_tile()`).
Removed 396 rows containing missing values or values outside the scale range (`geom_tile()`).

Top 20 genes

Gene	d3	d6
PLAAT3	-10483	-8540
ABHD4	-9633	-8861
NAAA	-7704	-8940
PLAAT1	-5681	-9828
NAPEPLD	-9218	-4745

Click HERE to show all gene set members

All member genes

	crp_t0_adj	crp_eos_adj	crp_pod1_adj	avb_t0_adj	avb_eos_adj	avb_pod1_adj
ABHD4	-8492	-5628	-9633	2621	2446	-8861
NAAA	-8656	-8242	-7704	-6044	4285	-8940
NAPEPLD	-2090	3235	-9218	5258	8906	-4745
PLAAT1	-1597	-9867	-5681	-9319	-9178	-9828
PLAAT3	-6270	-1809	-10483	-6733	-3941	-8540
PLAAT4	3985	-5307	-9195	7585	9028	5877

---

---

GOBP GANGLIOSIDE BIOSYNTHETIC PROCESS VIA LACTOSYLCERAMIDE

GOBP GANGLIOSIDE BIOSYNTHETIC PROCESS VIA LACTOSYLCERAMIDE

metric	value
setSize	5
pMANOVA	0.022
p.adjustMANOVA	0.0639
s.dist	1.17
s.crp_t0_adj	0.207
s.crp_eos_adj	0.298
s.crp_pod1_adj	0.699
s.avb_t0_adj	0.482
s.avb_eos_adj	-0.217
s.avb_pod1_adj	0.684
p.crp_t0_adj	0.424
p.crp_eos_adj	0.248
p.crp_pod1_adj	0.00678
p.avb_t0_adj	0.062
p.avb_eos_adj	0.401
p.avb_pod1_adj	0.00809

Warning: Removed 396 rows containing missing values or values outside the scale range (`geom_tile()`).
Removed 396 rows containing missing values or values outside the scale range (`geom_tile()`).
Removed 396 rows containing missing values or values outside the scale range (`geom_tile()`).
Removed 396 rows containing missing values or values outside the scale range (`geom_tile()`).
Removed 396 rows containing missing values or values outside the scale range (`geom_tile()`).
Removed 396 rows containing missing values or values outside the scale range (`geom_tile()`).
Removed 396 rows containing missing values or values outside the scale range (`geom_tile()`).
Removed 396 rows containing missing values or values outside the scale range (`geom_tile()`).
Removed 396 rows containing missing values or values outside the scale range (`geom_tile()`).
Removed 396 rows containing missing values or values outside the scale range (`geom_tile()`).
Removed 396 rows containing missing values or values outside the scale range (`geom_tile()`).
Removed 396 rows containing missing values or values outside the scale range (`geom_tile()`).
Removed 396 rows containing missing values or values outside the scale range (`geom_tile()`).
Removed 396 rows containing missing values or values outside the scale range (`geom_tile()`).
Removed 396 rows containing missing values or values outside the scale range (`geom_tile()`).

Top 20 genes

Gene	d3	d6
B4GALT5	10165	10771
ST3GAL2	9316	9158
B4GALT6	5742	9735
ST3GAL1	7806	5621
ST3GAL3	2048	2658

Click HERE to show all gene set members

All member genes

	crp_t0_adj	crp_eos_adj	crp_pod1_adj	avb_t0_adj	avb_eos_adj	avb_pod1_adj
B4GALT5	5949	9896	10165	7814	-7217	10771
B4GALT6	-9318	1125	5742	5513	-1210	9735
ST3GAL1	7063	8366	7806	8368	-2229	5621
ST3GAL2	3395	7067	9316	10025	10342	9158
ST3GAL3	4359	-8859	2048	-5154	-6855	2658

---

---

GOMF MITOCHONDRION TARGETING SEQUENCE BINDING

GOMF MITOCHONDRION TARGETING SEQUENCE BINDING

metric	value
setSize	5
pMANOVA	0.0482
p.adjustMANOVA	0.114
s.dist	1.17
s.crp_t0_adj	-0.746
s.crp_eos_adj	-0.614
s.crp_pod1_adj	-0.55
s.avb_t0_adj	-0.324
s.avb_eos_adj	-0.148
s.avb_pod1_adj	0.0291
p.crp_t0_adj	0.00385
p.crp_eos_adj	0.0173
p.crp_pod1_adj	0.0331
p.avb_t0_adj	0.21
p.avb_eos_adj	0.567
p.avb_pod1_adj	0.91

Warning: Removed 396 rows containing missing values or values outside the scale range (`geom_tile()`).
Removed 396 rows containing missing values or values outside the scale range (`geom_tile()`).
Removed 396 rows containing missing values or values outside the scale range (`geom_tile()`).
Removed 396 rows containing missing values or values outside the scale range (`geom_tile()`).
Removed 396 rows containing missing values or values outside the scale range (`geom_tile()`).
Removed 396 rows containing missing values or values outside the scale range (`geom_tile()`).
Removed 396 rows containing missing values or values outside the scale range (`geom_tile()`).
Removed 396 rows containing missing values or values outside the scale range (`geom_tile()`).
Removed 396 rows containing missing values or values outside the scale range (`geom_tile()`).
Removed 396 rows containing missing values or values outside the scale range (`geom_tile()`).
Removed 396 rows containing missing values or values outside the scale range (`geom_tile()`).
Removed 396 rows containing missing values or values outside the scale range (`geom_tile()`).
Removed 396 rows containing missing values or values outside the scale range (`geom_tile()`).
Removed 396 rows containing missing values or values outside the scale range (`geom_tile()`).
Removed 396 rows containing missing values or values outside the scale range (`geom_tile()`).

Top 20 genes

Gene	d1	d2
TOMM20	-9432	-9566
TOMM22	-8475	-9758
TIMM22	-5808	-7224
TOMM70	-7539	-4248

Click HERE to show all gene set members

All member genes

	crp_t0_adj	crp_eos_adj	crp_pod1_adj	avb_t0_adj	avb_eos_adj	avb_pod1_adj
TIMM22	-5808	-7224	-7568	-5644	-6296	-3233
TOMM20	-9432	-9566	-10482	-6886	-3836	-4002
TOMM22	-8475	-9758	-7346	-2768	-3019	3592
TOMM40L	-7380	409	-2098	473	7182	-747
TOMM70	-7539	-4248	-3115	-960	2430	7919

---

---

GOCC TOM COMPLEX

GOCC TOM COMPLEX

metric	value
setSize	7
pMANOVA	0.0039
p.adjustMANOVA	0.016
s.dist	1.16
s.crp_t0_adj	-0.409
s.crp_eos_adj	-0.789
s.crp_pod1_adj	-0.632
s.avb_t0_adj	-0.302
s.avb_eos_adj	-0.265
s.avb_pod1_adj	-0.0614
p.crp_t0_adj	0.0608
p.crp_eos_adj	0.000299
p.crp_pod1_adj	0.00376
p.avb_t0_adj	0.166
p.avb_eos_adj	0.225
p.avb_pod1_adj	0.778

Warning: Removed 396 rows containing missing values or values outside the scale range (`geom_tile()`).
Removed 396 rows containing missing values or values outside the scale range (`geom_tile()`).
Removed 396 rows containing missing values or values outside the scale range (`geom_tile()`).
Removed 396 rows containing missing values or values outside the scale range (`geom_tile()`).
Removed 396 rows containing missing values or values outside the scale range (`geom_tile()`).
Removed 396 rows containing missing values or values outside the scale range (`geom_tile()`).
Removed 396 rows containing missing values or values outside the scale range (`geom_tile()`).
Removed 396 rows containing missing values or values outside the scale range (`geom_tile()`).
Removed 396 rows containing missing values or values outside the scale range (`geom_tile()`).
Removed 396 rows containing missing values or values outside the scale range (`geom_tile()`).
Removed 396 rows containing missing values or values outside the scale range (`geom_tile()`).
Removed 396 rows containing missing values or values outside the scale range (`geom_tile()`).
Removed 396 rows containing missing values or values outside the scale range (`geom_tile()`).
Removed 396 rows containing missing values or values outside the scale range (`geom_tile()`).
Removed 396 rows containing missing values or values outside the scale range (`geom_tile()`).

Top 20 genes

Gene	d2	d3
TOMM20	-9566	-10482
TOMM6	-9741	-8733
TOMM40	-8244	-9247
TOMM22	-9758	-7346
TOMM5	-9905	-3544
TOMM7	-3932	-6417
TOMM70	-4248	-3115

Click HERE to show all gene set members

All member genes

	crp_t0_adj	crp_eos_adj	crp_pod1_adj	avb_t0_adj	avb_eos_adj	avb_pod1_adj
TOMM20	-9432	-9566	-10482	-6886	-3836	-4002
TOMM22	-8475	-9758	-7346	-2768	-3019	3592
TOMM40	345	-8244	-9247	-1624	-6566	-8805
TOMM5	-921	-9905	-3544	-3530	-6969	-1087
TOMM6	-5532	-9741	-8733	-4602	-2211	767
TOMM7	2272	-3932	-6417	-163	6605	-107
TOMM70	-7539	-4248	-3115	-960	2430	7919

---

---

GOBP BRUSH BORDER ASSEMBLY

GOBP BRUSH BORDER ASSEMBLY

metric	value
setSize	5
pMANOVA	0.0231
p.adjustMANOVA	0.0662
s.dist	1.16
s.crp_t0_adj	0.632
s.crp_eos_adj	0.209
s.crp_pod1_adj	0.512
s.avb_t0_adj	0.53
s.avb_eos_adj	0.497
s.avb_pod1_adj	0.346
p.crp_t0_adj	0.0145
p.crp_eos_adj	0.417
p.crp_pod1_adj	0.0474
p.avb_t0_adj	0.0402
p.avb_eos_adj	0.0544
p.avb_pod1_adj	0.181

Warning: Removed 396 rows containing missing values or values outside the scale range (`geom_tile()`).
Removed 396 rows containing missing values or values outside the scale range (`geom_tile()`).
Removed 396 rows containing missing values or values outside the scale range (`geom_tile()`).
Removed 396 rows containing missing values or values outside the scale range (`geom_tile()`).
Removed 396 rows containing missing values or values outside the scale range (`geom_tile()`).
Removed 396 rows containing missing values or values outside the scale range (`geom_tile()`).
Removed 396 rows containing missing values or values outside the scale range (`geom_tile()`).
Removed 396 rows containing missing values or values outside the scale range (`geom_tile()`).
Removed 396 rows containing missing values or values outside the scale range (`geom_tile()`).
Removed 396 rows containing missing values or values outside the scale range (`geom_tile()`).
Removed 396 rows containing missing values or values outside the scale range (`geom_tile()`).
Removed 396 rows containing missing values or values outside the scale range (`geom_tile()`).
Removed 396 rows containing missing values or values outside the scale range (`geom_tile()`).
Removed 396 rows containing missing values or values outside the scale range (`geom_tile()`).
Removed 396 rows containing missing values or values outside the scale range (`geom_tile()`).

Top 20 genes

Gene	d1	d4
CDHR5	7230	10522
MYO7B	10032	6583
CALML4	4565	6240
CTNS	2230	7756

Click HERE to show all gene set members

All member genes

	crp_t0_adj	crp_eos_adj	crp_pod1_adj	avb_t0_adj	avb_eos_adj	avb_pod1_adj
CALML4	4565	-2675	103	6240	9285	2430
CDHR2	9736	8792	-1678	-2023	10644	-465
CDHR5	7230	6584	9182	10522	10264	9061
CTNS	2230	-8024	7460	7756	-5576	-1726
MYO7B	10032	8246	10173	6583	5734	10863

---

---

GOBP REGULATION OF ENDOPLASMIC RETICULUM TUBULAR NETWORK ORGANIZATION

GOBP REGULATION OF ENDOPLASMIC RETICULUM TUBULAR NETWORK ORGANIZATION

metric	value
setSize	6
pMANOVA	0.00438
p.adjustMANOVA	0.0175
s.dist	1.16
s.crp_t0_adj	-0.555
s.crp_eos_adj	0.00412
s.crp_pod1_adj	0.482
s.avb_t0_adj	-0.0906
s.avb_eos_adj	-0.31
s.avb_pod1_adj	0.832
p.crp_t0_adj	0.0186
p.crp_eos_adj	0.986
p.crp_pod1_adj	0.0408
p.avb_t0_adj	0.701
p.avb_eos_adj	0.189
p.avb_pod1_adj	0.000418

Warning: Removed 396 rows containing missing values or values outside the scale range (`geom_tile()`).
Removed 396 rows containing missing values or values outside the scale range (`geom_tile()`).
Removed 396 rows containing missing values or values outside the scale range (`geom_tile()`).
Removed 396 rows containing missing values or values outside the scale range (`geom_tile()`).
Removed 396 rows containing missing values or values outside the scale range (`geom_tile()`).
Removed 396 rows containing missing values or values outside the scale range (`geom_tile()`).
Removed 396 rows containing missing values or values outside the scale range (`geom_tile()`).
Removed 396 rows containing missing values or values outside the scale range (`geom_tile()`).
Removed 396 rows containing missing values or values outside the scale range (`geom_tile()`).
Removed 396 rows containing missing values or values outside the scale range (`geom_tile()`).
Removed 396 rows containing missing values or values outside the scale range (`geom_tile()`).
Removed 396 rows containing missing values or values outside the scale range (`geom_tile()`).
Removed 396 rows containing missing values or values outside the scale range (`geom_tile()`).
Removed 396 rows containing missing values or values outside the scale range (`geom_tile()`).
Removed 396 rows containing missing values or values outside the scale range (`geom_tile()`).

Top 20 genes

Gene	d6	d1
LNPK	9500	-10210
TMEM33	10436	-8391
RAB3GAP2	10393	-5975
ARL6IP1	5011	-6966
ATL3	10214	-2127
RAB3GAP1	9308	-624

Click HERE to show all gene set members

All member genes

	crp_t0_adj	crp_eos_adj	crp_pod1_adj	avb_t0_adj	avb_eos_adj	avb_pod1_adj
ARL6IP1	-6966	-2857	-3247	4720	-3346	5011
ATL3	-2127	-622	9613	-4751	-8159	10214
LNPK	-10210	-5220	4679	-6903	-5420	9500
RAB3GAP1	-624	1651	1108	5124	4170	9308
RAB3GAP2	-5975	6672	7990	5	-115	10393
TMEM33	-8391	2931	8266	-2434	-1574	10436

---

---

Here is the session info with all the versions of packages used.

sessionInfo()

## R version 4.4.1 (2024-06-14)
## Platform: x86_64-pc-linux-gnu
## Running under: Ubuntu 22.04.5 LTS
## 
## Matrix products: default
## BLAS:   /usr/lib/x86_64-linux-gnu/blas/libblas.so.3.10.0 
## LAPACK: /usr/lib/x86_64-linux-gnu/lapack/liblapack.so.3.10.0
## 
## locale:
##  [1] LC_CTYPE=en_US.UTF-8          LC_NUMERIC=C                 
##  [3] LC_TIME=en_US.UTF-8           LC_COLLATE=en_US.UTF-8       
##  [5] LC_MONETARY=en_US.UTF-8       LC_MESSAGES=en_US.UTF-8      
##  [7] LC_PAPER=en_US.UTF-8          LC_NAME=en_US.UTF-8          
##  [9] LC_ADDRESS=en_US.UTF-8        LC_TELEPHONE=en_US.UTF-8     
## [11] LC_MEASUREMENT=en_US.UTF-8    LC_IDENTIFICATION=en_US.UTF-8
## 
## time zone: Australia/Melbourne
## tzcode source: system (glibc)
## 
## attached base packages:
## [1] stats4    stats     graphics  grDevices utils     datasets  methods  
## [8] base     
## 
## other attached packages:
##  [1] pkgload_1.4.0               GGally_2.2.1               
##  [3] beeswarm_0.4.0              gtools_3.9.5               
##  [5] tibble_3.2.1                echarts4r_0.4.5            
##  [7] xlsx_0.6.5                  DT_0.33                    
##  [9] eulerr_7.0.2                ggplot2_3.5.1              
## [11] kableExtra_1.4.0            MASS_7.3-61                
## [13] mitch_1.17.4                DESeq2_1.44.0              
## [15] SummarizedExperiment_1.34.0 Biobase_2.64.0             
## [17] MatrixGenerics_1.16.0       matrixStats_1.4.1          
## [19] GenomicRanges_1.56.1        GenomeInfoDb_1.40.1        
## [21] IRanges_2.38.1              S4Vectors_0.42.1           
## [23] BiocGenerics_0.50.0         dplyr_1.1.4                
## [25] WGCNA_1.73                  fastcluster_1.2.6          
## [27] dynamicTreeCut_1.63-1       reshape2_1.4.4             
## [29] gplots_3.2.0               
## 
## loaded via a namespace (and not attached):
##   [1] RColorBrewer_1.1-3      rstudioapi_0.17.1       jsonlite_1.8.9         
##   [4] magrittr_2.0.3          farver_2.1.2            rmarkdown_2.28         
##   [7] zlibbioc_1.50.0         vctrs_0.6.5             memoise_2.0.1.9000     
##  [10] base64enc_0.1-3         progress_1.2.3          htmltools_0.5.8.1      
##  [13] S4Arrays_1.4.1          SparseArray_1.4.8       Formula_1.2-5          
##  [16] sass_0.4.9              bslib_0.8.0             KernSmooth_2.23-24     
##  [19] htmlwidgets_1.6.4       plyr_1.8.9              impute_1.78.0          
##  [22] cachem_1.1.0            mime_0.12               lifecycle_1.0.4        
##  [25] iterators_1.0.14        pkgconfig_2.0.3         Matrix_1.7-0           
##  [28] R6_2.5.1                fastmap_1.2.0           GenomeInfoDbData_1.2.12
##  [31] shiny_1.9.1             digest_0.6.37           colorspace_2.1-1       
##  [34] AnnotationDbi_1.66.0    Hmisc_5.1-3             RSQLite_2.3.7          
##  [37] labeling_0.4.3          fansi_1.0.6             httr_1.4.7             
##  [40] abind_1.4-8             compiler_4.4.1          bit64_4.5.2            
##  [43] withr_3.0.1             doParallel_1.0.17       htmlTable_2.4.3        
##  [46] backports_1.5.0         BiocParallel_1.38.0     DBI_1.2.3              
##  [49] ggstats_0.7.0           highr_0.11              DelayedArray_0.30.1    
##  [52] caTools_1.18.3          tools_4.4.1             foreign_0.8-87         
##  [55] httpuv_1.6.15           nnet_7.3-19             glue_1.8.0             
##  [58] promises_1.3.0          grid_4.4.1              checkmate_2.3.2        
##  [61] cluster_2.1.6           generics_0.1.3          gtable_0.3.5           
##  [64] preprocessCore_1.66.0   tidyr_1.3.1             hms_1.1.3              
##  [67] data.table_1.16.0       xml2_1.3.6              utf8_1.2.4             
##  [70] XVector_0.44.0          foreach_1.5.2           pillar_1.9.0           
##  [73] stringr_1.5.1           later_1.3.2             rJava_1.0-11           
##  [76] splines_4.4.1           lattice_0.22-6          survival_3.7-0         
##  [79] bit_4.5.0               tidyselect_1.2.1        GO.db_3.19.1           
##  [82] locfit_1.5-9.10         Biostrings_2.72.1       knitr_1.48             
##  [85] gridExtra_2.3           svglite_2.1.3           xfun_0.48              
##  [88] stringi_1.8.4           UCSC.utils_1.0.0        yaml_2.3.10            
##  [91] xlsxjars_0.6.1          evaluate_1.0.1          codetools_0.2-20       
##  [94] cli_3.6.3               rpart_4.1.23            xtable_1.8-4           
##  [97] systemfonts_1.1.0       jquerylib_0.1.4         munsell_0.5.1          
## [100] Rcpp_1.0.13             png_0.1-8               parallel_4.4.1         
## [103] blob_1.2.4              prettyunits_1.2.0       bitops_1.0-9           
## [106] viridisLite_0.4.2       scales_1.3.0            purrr_1.0.2            
## [109] crayon_1.5.3            rlang_1.1.4             KEGGREST_1.44.1

END of report